data_2l7w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l7w _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 3.7 p . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.336 0.589 . . . . 2.1 109.673 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.3 155.92 34.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.784 -0.644 . . . . 1.81 109.953 -168.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.67 2.21 6.95 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 112.331 0.493 . . . . 0.95 112.331 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 m -55.91 -21.85 22.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.77 0.319 . . . . 2.19 111.755 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -101.13 27.6 5.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.563 -0.289 . . . . 3.07 110.701 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.566 ' HE3' ' HB2' ' A' ' 20' ' ' GLN . 5.1 p-90 -70.64 -28.44 64.81 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.639 0.607 . . . . 4.76 112.639 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -144.96 14.59 1.51 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.713 -0.395 . . . . 0.98 111.139 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.63 -115.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.483 -0.647 . . . . 0.52 111.483 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.1 Cg_endo -51.28 -46.2 32.69 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.356 2.704 . . . . 0.61 110.925 167.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.613 HD13 ' HA3' ' A' ' 38' ' ' GLY . 11.5 mt -88.97 103.44 16.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.15 -0.932 . . . . 1.85 110.125 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.18 65.35 4.33 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.257 0.551 . . . . 1.31 110.546 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 121' ' ' VAL . 15.5 mt -76.16 -15.05 60.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.543 . . . . 0.61 110.45 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -66.73 -8.46 28.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 2.61 111.308 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.465 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 9.4 mt-10 -81.85 -7.62 59.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.235 -0.439 . . . . 1.93 110.107 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.749 HG21 ' HD3' ' A' ' 71' ' ' PRO . 53.3 t -124.88 -61.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 1.26 111.389 -175.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -125.2 169.34 12.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.678 -0.409 . . . . 2.99 110.404 -172.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -90.5 25.37 2.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 1.6 111.799 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.566 ' HB2' ' HE3' ' A' ' 8' ' ' TRP . 1.6 tt0 67.05 120.48 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 O-C-N 124.151 0.907 . . . . 4.38 110.986 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 19.2 Cg_exo -65.17 158.37 52.46 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.403 2.069 . . . . 0.69 112.124 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.849 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.4 pt20 -73.42 -16.19 61.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 1.87 111.034 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.76 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 21.2 m80 -149.36 156.43 39.59 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.691 -0.686 . . . . 2.35 109.565 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 6.3 Cg_endo -87.28 126.66 2.35 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.891 2.394 . . . . 0.44 110.97 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 22.2 tp -75.92 140.44 42.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.791 0.329 . . . . 0.33 110.916 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.4 ' H ' HD12 ' A' ' 25' ' ' LEU . 78.1 m-70 -106.04 119.74 39.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 2.12 109.625 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 53' ' ' ILE . 21.8 t -126.17 138.19 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.995 -0.742 . . . . 1.12 108.995 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -136.74 136.95 39.4 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.026 0.441 . . . . 0.78 110.655 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.593 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 60.9 t80 -99.65 169.3 9.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.315 -0.624 . . . . 1.23 109.315 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.86 65.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.471 0.653 . . . . 0.6 110.488 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.593 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -116.03 20.06 13.19 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.028 -0.987 . . . . 0.81 112.673 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 45' ' ' GLN . . . -154.36 -170.5 3.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.845 0.355 . . . . 0.56 110.416 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.92 159.76 24.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.35 109.82 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.69 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.1 t -122.4 63.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.253 -1.388 . . . . 0.39 107.253 166.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.4 t70 -100.27 19.89 15.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.154 -0.93 . . . . 0.99 109.808 -173.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 44.5 mt-10 -144.05 131.1 20.54 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.09 -0.959 . . . . 2.56 108.593 172.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.547 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -74.66 111.33 9.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.416 0.627 . . . . 0.46 110.272 -172.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 80.53 21.27 64.6 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.295 -0.866 . . . . 0.59 111.89 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.69 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.26 149.76 44.23 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.474 -0.565 . . . . 1.04 109.474 175.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.96 127.81 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.267 0.555 . . . . 1.16 110.54 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.496 HD21 HG13 ' A' ' 46' ' ' VAL . 8.9 tp -131.18 169.12 16.36 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.634 -0.876 . . . . 0.45 108.634 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.82 151.81 58.22 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 120.582 -0.447 . . . . 1.0 111.535 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 63.3 Cg_exo -53.64 -39.6 82.48 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.017 2.478 . . . . 1.0 112.075 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -35.24 61.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.109 -0.496 . . . . 1.24 111.404 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 44.9 mt-30 -82.79 -23.14 33.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 1.74 112.125 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.552 ' HB ' ' OH ' ' A' ' 106' ' ' TYR . 30.0 m -119.88 30.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.195 0.521 . . . . 1.1 112.169 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.62 6.31 21.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.955 0.407 . . . . 1.32 111.089 -176.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.582 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 36.4 m-20 -148.59 172.88 13.81 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.509 -0.552 . . . . 2.4 109.509 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -62.77 149.4 89.59 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 110.017 -0.364 . . . . 1.78 110.017 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.64 145.7 23.4 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.963 1.775 . . . . 0.41 110.266 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -18.7 62.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.491 -0.322 . . . . 0.88 110.728 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.432 ' C ' HG21 ' A' ' 53' ' ' ILE . 58.2 m -159.66 144.7 15.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.872 0.694 . . . . 0.65 112.872 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -140.39 164.79 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.705 -1.134 . . . . 0.33 108.041 170.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.729 ' HA ' HD11 ' A' ' 58' ' ' LEU . 28.9 t 176.17 122.26 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.764 -0.458 . . . . 0.8 109.764 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.592 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 45.7 p-90 -81.0 166.67 20.59 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.757 -0.831 . . . . 3.63 108.757 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.414 ' HB3' ' CG ' ' A' ' 23' ' ' HIS . 17.1 t70 -65.64 83.06 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 1.51 111.081 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.92 31.48 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.655 -0.702 . . . . 0.9 112.319 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.906 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 8.4 tt -66.33 129.05 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.008 0.432 . . . . 0.62 111.062 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.729 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.5 t70 -77.75 -29.92 51.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.854 -0.612 . . . . 0.74 112.078 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.672 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 74.8 m 76.76 -6.12 2.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.096 -0.956 . . . . 1.51 110.926 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.22 6.64 14.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.155 -0.545 . . . . 0.84 112.39 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.729 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.8 mtpt -100.69 152.53 20.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.015 0.436 . . . . 2.12 111.093 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.559 HD23 ' HE2' ' A' ' 93' ' ' LYS . 44.2 mt -97.25 130.98 44.39 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.557 -0.905 . . . . 1.23 108.557 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.906 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -130.2 163.94 25.6 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.636 -0.505 . . . . 1.61 109.636 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.556 HG22 HG11 ' A' ' 90' ' ' VAL . 75.2 m -102.32 104.82 15.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.459 -0.571 . . . . 0.87 109.459 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.66 HD11 HG11 ' A' ' 124' ' ' VAL . 43.7 tp -102.49 115.33 30.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.124 0.488 . . . . 1.35 110.527 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 88' ' ' LEU . 23.3 t -120.88 129.04 76.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.713 -0.676 . . . . 0.54 111.06 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.872 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.3 mt -83.37 136.76 34.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 0.65 108.478 167.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.715 HG21 HG12 ' A' ' 17' ' ' VAL . 15.1 t -140.27 163.69 32.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.205 -0.294 . . . . 1.04 110.205 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 17.7 t70 -155.95 103.27 2.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.304 0.573 . . . . 1.92 110.858 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.749 ' HD3' HG21 ' A' ' 17' ' ' VAL . 12.4 Cg_endo -56.98 -34.89 98.45 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.65 2.9 . . . . 1.25 114.169 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.56 38.87 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.986 0.365 . . . . 1.29 111.986 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' A' ' 84' ' ' TRP . . . -104.68 127.62 28.53 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 111.488 0.181 . . . . 0.56 111.488 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 92.9 Cg_endo -85.12 -24.03 10.8 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.435 -1.485 . . . . 0.7 112.859 -0.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.566 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.9 p -135.4 154.85 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.032 -0.531 . . . . 1.1 110.09 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -72.15 -24.6 61.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.388 -0.369 . . . . 3.39 111.134 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.495 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 3.2 ptpt -72.03 -21.86 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 1.83 110.535 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.22 86.88 1.01 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.306 -0.861 . . . . 1.37 109.24 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -86.38 86.65 0.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.509 2.139 . . . . 0.9 112.507 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 22.2 mttm -70.98 -53.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.936 -1.483 . . . . 1.53 111.689 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.768 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 85.2 m-85 -78.28 12.07 2.08 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.894 -0.594 . . . . 1.54 111.027 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 24.2 ttt180 -73.15 125.42 27.67 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.8 0.44 . . . . 3.38 110.267 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.495 ' OE2' ' HA ' ' A' ' 17' ' ' VAL . 23.1 mt-10 -94.84 134.33 37.59 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.846 0.458 . . . . 2.23 110.457 2.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.721 ' HE1' ' HB2' ' A' ' 146' ' ' ARG . 4.8 t90 -89.34 91.12 8.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.939 -0.393 . . . . 1.77 109.939 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 12.5 p80 -74.57 109.52 8.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.778 -0.823 . . . . 2.19 108.778 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.41 -8.47 54.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.803 -0.635 . . . . 2.74 112.233 -168.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.872 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 30.3 t80 -166.29 142.93 5.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.06 -0.348 . . . . 2.21 110.06 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.6 tp -142.77 114.65 8.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.981 0.419 . . . . 0.68 110.623 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.547 HG13 ' HE2' ' A' ' 92' ' ' MET . 0.9 OUTLIER -132.57 134.93 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.35 110.74 176.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.711 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 15.0 m -129.03 158.01 41.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.138 -1.06 . . . . 0.3 108.138 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.675 ' OD1' ' HB3' ' A' ' 130' ' ' PRO . 6.1 t30 63.78 19.69 11.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.023 0.44 . . . . 2.09 109.925 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.547 ' HE2' HG13 ' A' ' 89' ' ' VAL . 8.0 ttm -67.4 106.9 2.24 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.781 -0.822 . . . . 0.34 108.781 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.559 ' HE2' HD23 ' A' ' 63' ' ' LEU . 13.2 ttmt -83.55 89.68 7.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.994 -1.003 . . . . 1.73 111.077 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 83.98 -126.26 7.49 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.636 -1.166 . . . . 0.35 113.208 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.555 ' HB3' HD22 ' A' ' 58' ' ' LEU . 29.6 p30 -117.32 27.62 8.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.315 -0.442 . . . . 1.59 110.88 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -97.12 112.46 24.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.321 0.582 . . . . 0.77 109.658 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 53' ' ' ILE . 5.1 mm -58.53 -26.44 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.408 -1.269 . . . . 0.45 111.349 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 m -87.6 -31.34 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.117 -0.492 . . . . 1.15 111.718 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.1 m -80.29 19.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.266 0.469 . . . . 1.26 112.266 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.476 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -102.61 114.11 4.79 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 111.189 -0.764 . . . . 0.44 111.189 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 84.9 m -58.54 107.0 0.45 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.67 . . . . 1.06 109.776 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.94 116.42 29.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.084 . . . . 1.15 112.333 -172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 133' ' ' CYS . 9.3 mt -98.61 -51.48 3.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.974 0.893 . . . . 0.48 108.859 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.1 t -118.61 102.23 8.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.394 -1.275 . . . . 0.62 107.747 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -65.24 157.63 28.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.547 -0.751 . . . . 1.15 112.323 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.552 ' OH ' ' HB ' ' A' ' 46' ' ' VAL . 85.7 t80 -74.19 107.52 6.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.595 -0.729 . . . . 4.98 109.172 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.685 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.4 t -84.69 -26.91 6.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.566 -0.743 . . . . 0.86 112.242 -172.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.23 -174.41 19.7 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 111.13 -0.788 . . . . 0.95 111.13 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.7 t -78.21 134.47 37.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.429 0.614 . . . . 0.89 109.811 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.622 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -160.0 66.06 0.27 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.367 -0.444 . . . . 0.82 112.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.872 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 46.4 Cg_endo -99.15 149.52 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.89 3.06 . . . . 1.01 113.78 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.601 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 26.6 Cg_exo -64.07 143.32 84.24 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.074 2.516 . . . . 0.96 112.443 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 121.19 17.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 2.39 110.823 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.46 15.11 30.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.86 -0.686 . . . . 1.3 112.367 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.601 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 72.1 p -96.68 -1.19 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.947 0.403 . . . . 1.04 111.028 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.36 -161.89 27.85 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.042 -0.823 . . . . 1.97 111.042 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.6 mm? -79.95 99.06 7.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.36 0.6 . . . . 0.94 109.567 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -72.1 120.54 17.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.883 -1.053 . . . . 2.85 109.09 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.862 ' HB2' ' HG ' ' A' ' 168' ' ' CYS . 3.8 ptp85 -121.96 99.76 6.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.914 0.709 . . . . 2.78 112.914 -165.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.56 ' HB3' HD22 ' A' ' 68' ' ' LEU . 65.9 m-85 -82.09 129.39 34.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.444 -0.576 . . . . 1.13 109.444 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.5 t -102.33 133.56 45.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.925 -0.579 . . . . 0.31 109.719 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.678 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 67.2 m95 -88.32 119.59 28.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.754 -0.832 . . . . 2.96 108.754 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.26 118.77 32.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 117.797 0.271 . . . . 0.41 110.815 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.66 HG11 HD11 ' A' ' 66' ' ' LEU . 1.9 m -102.36 133.22 46.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.069 -0.652 . . . . 0.43 109.262 172.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 92.2 m-85 -106.84 155.68 19.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.875 0.369 . . . . 5.41 111.084 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.689 ' HB2' HG23 ' A' ' 164' ' ' VAL . 12.3 tp10 -101.32 119.95 39.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.304 -0.862 . . . . 2.41 110.833 -176.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.722 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -133.46 150.06 51.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.461 -0.791 . . . . 1.31 109.991 174.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.407 ' OD1' ' HG3' ' A' ' 129' ' ' ARG . 1.6 p30 -83.4 -12.47 56.42 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.183 -0.917 . . . . 2.4 111.452 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.509 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . 65.9 mtp180 -135.9 163.06 53.08 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 4.07 111.837 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.675 ' HB3' ' OD1' ' A' ' 91' ' ' ASN . 19.3 Cg_exo -71.85 24.71 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.806 1 C-N-CA 125.61 4.207 . . . . 1.21 115.833 -170.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.711 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? 71.99 -178.76 0.21 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.685 0.755 . . . . 1.16 112.909 172.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -165.72 79.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.221 -1.354 . . . . 3.23 108.896 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.556 ' HB2' HD13 ' A' ' 103' ' ' LEU . 63.0 m -101.94 115.89 31.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.705 . . . . 2.79 110.33 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.44 19.52 8.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.534 -0.757 . . . . 2.96 110.485 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -66.08 125.24 89.76 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.562 -0.744 . . . . 1.39 110.466 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.46 129.02 21.97 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.239 2.626 . . . . 1.38 112.713 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.31 116.66 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.43 . . . . 0.94 110.34 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.9 mt -106.19 2.48 26.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.339 0.496 . . . . 1.61 112.339 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.0 p 52.04 -157.66 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.536 0.522 . . . . 1.88 110.009 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.685 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.3 p-10 -98.01 -6.03 32.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.256 -0.646 . . . . 1.33 109.256 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.589 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 12.4 mtt180 -84.99 141.47 30.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.241 -0.436 . . . . 3.83 110.352 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.552 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 30.5 m 72.66 125.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.219 0.949 . . . . 1.32 111.103 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.489 ' HA2' ' CD ' ' A' ' 146' ' ' ARG . . . -107.53 -5.97 33.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.437 -0.801 . . . . 1.13 113.006 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.403 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 12.4 t70 -56.94 -54.15 49.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.324 0.583 . . . . 2.66 112.542 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.403 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 1.7 m80 -87.89 7.3 31.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.506 -0.77 . . . . 2.18 111.672 -168.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.721 ' HB2' ' HE1' ' A' ' 84' ' ' TRP . 28.1 mtp85 -88.84 -16.15 32.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.084 0.469 . . . . 5.37 110.742 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -112.07 173.08 15.22 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.489 -0.863 . . . . 0.9 112.485 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.768 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.4 mttt 69.61 36.55 2.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.841 0.829 . . . . 1.59 110.836 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -123.09 172.4 8.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.809 -1.087 . . . . 2.27 109.261 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.491 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 13.0 mmmm -117.26 133.0 56.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 1.87 111.932 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.737 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.6 m -67.35 -26.27 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.664 -0.698 . . . . 0.96 110.005 173.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.36 -38.33 90.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.76 109.627 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 m -63.78 -34.53 78.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.656 -0.702 . . . . 1.22 110.462 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.737 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 59.7 m-85 -71.56 -47.5 54.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 1.1 111.523 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 152' ' ' ALA . 6.9 ptm180 -66.9 -39.92 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.647 0.26 . . . . 3.36 110.571 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -71.95 -25.78 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.607 -0.269 . . . . 1.52 111.185 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 43.6 tptt -53.91 -52.92 59.02 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.355 -0.384 . . . . 2.13 111.309 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.629 ' HD2' HD12 ' A' ' 160' ' ' LEU . 16.6 t80 -111.25 10.61 21.74 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.788 -0.765 . . . . 5.77 111.322 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.8 39.34 4.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.035 -0.53 . . . . 2.42 112.395 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.629 HD12 ' HD2' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -80.95 125.11 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.236 -0.653 . . . . 1.27 109.236 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -60.32 -85.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 4.0 111.874 -168.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -135.66 160.9 65.9 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.721 -0.474 . . . . 1.21 109.721 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.529 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 37.0 Cg_exo -58.44 142.24 97.74 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.68 2.254 . . . . 0.68 112.748 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.849 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.6 t -88.42 -36.06 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 109.385 -0.598 . . . . 0.5 109.385 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.68 143.45 25.49 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.667 -0.697 . . . . 0.29 111.232 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.9 145.59 14.81 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.055 -0.975 . . . . 0.24 111.587 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.458 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 14.3 t -158.03 133.61 8.98 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.584 -0.525 . . . . 0.34 109.584 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.862 ' HG ' ' HB2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -107.24 141.9 37.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.213 0.53 . . . . 2.16 111.418 -175.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 30.5 p90 -124.23 117.92 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.748 -1.204 . . . . 1.31 107.748 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -101.73 132.96 47.16 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.725 -0.79 . . . . 2.53 111.103 179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -149.91 145.89 26.76 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.561 -1.199 . . . . 0.75 108.687 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.872 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 13.8 pt-20 -131.58 -160.3 1.03 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.697 -0.401 . . . . 2.38 111.021 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.831 ' HA ' HG23 ' A' ' 177' ' ' VAL . 24.3 t90 -64.89 85.05 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.866 0.467 . . . . 4.71 111.38 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.596 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 8.5 p-10 -74.47 -59.12 2.87 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.361 -0.212 . . . . 1.53 110.757 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.5 t70 173.43 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.808 0.843 . . . . 1.26 109.897 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -81.97 -9.08 59.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 2.46 111.64 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.831 HG23 ' HA ' ' A' ' 173' ' ' TRP . 69.2 t -54.67 -53.24 62.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 0.58 111.561 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.3 Cg_exo -49.7 -35.26 37.98 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.888 2.392 . . . . 0.68 112.891 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.638 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 38.1 mmtm -74.47 -23.79 58.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.962 0.356 . . . . 2.62 111.962 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.636 HD12 HG12 ' A' ' 107' ' ' VAL . 28.4 tp -70.76 -44.3 67.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.916 -0.772 . . . . 1.18 108.916 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.03 -34.52 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.762 -0.654 . . . . 2.11 109.242 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.638 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.5 mm-40 -56.48 -42.37 78.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.931 -1.031 . . . . 1.53 110.89 172.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.439 ' NE2' HD22 ' A' ' 140' ' ' ASN . 39.9 tt0 -77.82 -38.0 47.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.572 -0.74 . . . . 2.16 112.41 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 21.5 mt -63.29 0.24 0.7 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 0.87 113.479 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 12.8 m -67.58 -19.55 65.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.086 -0.709 . . . . 1.38 109.086 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 104.14 44.17 1.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.586 -1.006 . . . . 1.17 110.586 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.563 -0.732 . . . . 2.45 109.832 -178.495 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 36' ' ' GLU . 16.5 t . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.482 0.658 . . . . 2.1 110.522 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 6' ' ' SER . 20.1 t70 -148.98 157.71 43.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.35 -0.841 . . . . 1.81 109.445 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.96 19.28 0.15 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 111.53 0.196 . . . . 0.95 111.53 -176.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 4' ' ' ASP . 27.5 t -68.67 -19.92 64.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 2.19 110.364 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.844 ' HB3' HD12 ' A' ' 12' ' ' LEU . 90.9 mttt -113.82 30.67 7.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.727 -0.67 . . . . 3.07 110.597 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.567 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -72.88 -33.94 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.312 -0.404 . . . . 4.76 112.041 -173.252 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.744 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 36.5 p -150.21 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.673 -0.411 . . . . 0.98 111.894 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -79.73 -126.58 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.456 -0.878 . . . . 0.52 110.946 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.9 Cg_endo -51.87 -36.43 63.38 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.219 2.613 . . . . 0.61 110.214 166.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.844 HD12 ' HB3' ' A' ' 7' ' ' LYS . 40.7 mt -87.74 81.83 7.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.772 -1.103 . . . . 1.85 109.282 170.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -74.73 63.13 1.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.474 0.654 . . . . 1.31 110.703 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.539 HD11 ' HG ' ' A' ' 168' ' ' CYS . 33.8 mt -78.91 -21.62 47.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.548 -0.751 . . . . 0.61 110.617 -176.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.744 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -73.18 6.88 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.587 -0.733 . . . . 2.61 110.647 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -79.45 -22.51 44.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.428 0.633 . . . . 1.93 110.091 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.898 HG12 HG21 ' A' ' 69' ' ' THR . 3.0 t -86.03 -65.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 1.26 110.669 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.401 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.88 -178.11 5.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.491 -0.484 . . . . 2.99 111.095 -176.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -62.1 179.1 0.31 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.766 0.826 . . . . 1.6 112.125 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.505 ' HG2' ' HD1' ' A' ' 8' ' ' TRP . 27.0 mt-30 -90.74 128.6 47.68 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.126 -0.488 . . . . 4.38 110.128 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 10.1 Cg_exo -70.41 159.34 53.26 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.264 1.976 . . . . 0.69 112.292 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.878 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 5.4 pt20 -77.48 -15.62 59.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.754 -0.657 . . . . 1.87 111.153 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.766 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.8 m80 -153.02 159.73 31.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 2.35 110.089 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 3.8 Cg_endo -86.16 130.85 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.329 2.686 . . . . 0.44 110.919 174.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 29.9 tp -79.84 143.45 34.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.646 0.26 . . . . 0.33 110.897 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -114.94 110.11 19.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 2.12 110.236 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 53' ' ' ILE . 17.0 t -114.71 146.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.546 -0.538 . . . . 1.12 109.546 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.54 144.57 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.335 0.254 . . . . 0.78 110.819 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.459 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 36.3 t80 -110.41 173.99 6.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.268 -0.642 . . . . 1.23 109.268 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.06 -52.88 63.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.451 0.643 . . . . 0.6 110.398 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.24 -6.56 44.85 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.237 -0.892 . . . . 0.81 112.724 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.02 -171.37 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.56 110.831 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.68 154.7 16.23 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.004 -0.544 . . . . 0.35 109.999 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.86 HG23 ' HZ3' ' A' ' 122' ' ' TRP . 88.2 t -101.56 63.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.548 -1.649 . . . . 0.39 106.548 163.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.24 18.69 2.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.036 -1.438 . . . . 0.99 110.163 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.3 mm-40 -159.7 142.12 13.57 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.457 -0.792 . . . . 2.56 109.881 173.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -76.48 111.59 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.644 -0.873 . . . . 0.46 108.644 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.678 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 86.7 20.93 52.79 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.666 -0.778 . . . . 0.59 112.424 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.72 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.67 152.18 30.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.286 -0.635 . . . . 1.04 109.286 172.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.6 p -81.78 136.77 22.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.182 0.515 . . . . 1.16 110.975 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.473 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.0 tp -131.11 169.03 16.44 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.057 -1.09 . . . . 0.45 108.057 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 p -123.21 152.43 63.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 119.472 -0.891 . . . . 1.0 113.129 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 75.9 Cg_exo -51.74 -33.92 51.98 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.608 3.539 . . . . 1.0 114.05 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -65.4 -32.34 73.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.614 0.721 . . . . 1.24 110.756 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -82.33 -43.91 16.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.012 -0.995 . . . . 1.74 111.451 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.555 HG21 ' HE2' ' A' ' 169' ' ' TYR . 12.3 m -102.64 30.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.265 0.469 . . . . 1.1 112.265 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.74 -12.05 59.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.465 -0.568 . . . . 1.32 109.465 175.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -167.98 2.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.492 -0.776 . . . . 2.4 109.836 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -77.94 158.78 77.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.088 -0.338 . . . . 1.78 110.088 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 59.9 Cg_endo -79.23 161.44 26.05 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.996 1.797 . . . . 0.41 111.127 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.1 t -80.41 -22.4 41.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.55 -0.295 . . . . 0.88 110.363 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.401 ' C ' HG21 ' A' ' 53' ' ' ILE . 58.4 m -162.68 143.51 9.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.391 0.615 . . . . 0.65 112.478 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.02 167.17 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.819 -1.082 . . . . 0.33 108.274 170.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.66 ' HA ' HD11 ' A' ' 58' ' ' LEU . 30.6 t 175.91 128.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.8 109.909 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.574 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 53.4 p-90 -91.07 160.91 15.35 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.519 -1.289 . . . . 3.63 107.519 172.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.29 84.18 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.074 0.464 . . . . 1.51 111.092 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.92 17.44 2.79 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.401 -0.818 . . . . 0.9 112.022 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.684 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 5.4 tt -57.02 127.13 30.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.919 0.39 . . . . 0.62 110.429 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.776 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 31.5 t70 -75.91 -24.21 55.57 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.608 . . . . 0.74 112.01 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.638 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 67.2 m 68.89 15.35 8.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.278 -0.874 . . . . 1.51 110.422 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.55 -33.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.601 -0.727 . . . . 0.84 112.666 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.776 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 24.7 mtpt -71.34 149.89 45.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 2.12 110.72 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.747 HD22 ' HG2' ' A' ' 93' ' ' LYS . 3.8 mt -85.77 125.45 33.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.337 -0.847 . . . . 1.23 109.494 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.684 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 5.5 m-85 -120.84 148.09 44.5 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.714 -0.394 . . . . 1.61 110.436 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.62 HG22 HG11 ' A' ' 90' ' ' VAL . 62.7 m -96.89 104.97 17.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.87 108.148 170.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 43.4 tp -104.39 109.09 20.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.668 -0.696 . . . . 1.35 109.658 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 88' ' ' LEU . 25.6 t -111.97 127.44 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.696 -0.684 . . . . 0.54 110.429 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.983 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.3 mt -88.27 134.12 33.88 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.542 -0.91 . . . . 0.65 108.542 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.898 HG21 HG12 ' A' ' 17' ' ' VAL . 9.7 t -137.58 156.45 48.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.459 -0.2 . . . . 1.04 110.459 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 10.2 t70 -140.15 94.89 8.59 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.306 -0.628 . . . . 1.92 109.306 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.543 ' HD3' HG21 ' A' ' 17' ' ' VAL . 9.5 Cg_endo -52.2 -36.68 68.03 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.722 2.948 . . . . 1.25 113.734 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.8 m-20 -89.32 43.83 1.17 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 1.29 111.542 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.68 139.28 19.94 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.446 -0.343 . . . . 0.56 110.143 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -80.18 -28.51 7.15 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 123.084 -1.632 . . . . 0.7 112.813 2.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.629 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 84.7 p -125.67 149.75 48.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.079 -0.51 . . . . 1.1 110.371 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.548 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 3.0 tmm_? -65.03 -28.91 69.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.419 0.628 . . . . 3.39 109.651 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 8.0 ptpt -74.48 -21.06 59.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.848 -0.615 . . . . 1.83 110.992 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.408 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.0 t70 -159.63 88.9 1.97 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.485 . . . . 1.37 110.26 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 83.6 Cg_endo -84.37 93.63 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.67 2.247 . . . . 0.9 113.234 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.5 mttm -83.9 -41.29 17.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.216 -0.902 . . . . 1.53 111.065 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.835 ' HH ' HH11 ' A' ' 146' ' ' ARG . 30.6 m-85 -78.98 8.47 5.57 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 116.032 -0.531 . . . . 1.54 111.798 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -65.74 125.22 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.729 -0.471 . . . . 3.38 109.729 177.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' OE1' HG13 ' A' ' 151' ' ' VAL . 5.1 tm-20 -93.12 134.13 35.59 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.49 0.716 . . . . 2.23 109.878 -0.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.402 ' HE1' ' HB3' ' A' ' 146' ' ' ARG . 80.7 t90 -108.67 131.08 55.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.63 -0.507 . . . . 1.77 109.63 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 20.1 p80 -112.17 141.12 46.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.379 0.609 . . . . 2.19 111.328 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.983 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 7.2 t60 -82.6 -39.39 22.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.202 -0.908 . . . . 2.74 110.884 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.6 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 20.3 p90 -167.16 173.18 9.3 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.601 -0.518 . . . . 2.21 109.601 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.718 HD21 ' HH ' ' A' ' 158' ' ' TYR . 16.6 tp -134.62 113.04 11.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.68 110.178 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.6 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 1.8 t -121.25 132.11 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.641 -0.708 . . . . 0.35 110.146 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.75 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 6.2 m -129.71 162.94 36.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.084 -0.962 . . . . 0.3 108.64 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.745 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 72.2 m-20 58.43 23.24 10.41 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.721 0.638 . . . . 2.09 111.418 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.602 ' HE3' ' HA ' ' A' ' 97' ' ' ILE . 9.4 ttm -73.84 102.69 4.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.1 -1.074 . . . . 0.34 108.1 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.747 ' HG2' HD22 ' A' ' 63' ' ' LEU . 2.8 mtpm? -77.1 93.77 3.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.265 -0.879 . . . . 1.73 110.951 -171.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 85.37 -127.63 8.32 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.542 -0.754 . . . . 0.35 112.633 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.554 ' HB3' HD22 ' A' ' 58' ' ' LEU . 10.3 p30 -111.96 18.01 19.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.225 0.536 . . . . 1.59 110.551 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -81.5 99.88 9.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.621 . . . . 0.77 110.07 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.602 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 5.0 mm -56.3 -30.17 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.774 -1.103 . . . . 0.45 111.389 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 m -75.92 -42.56 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.084 -0.507 . . . . 1.15 111.856 -172.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -79.93 8.16 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 1.26 111.712 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.575 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -71.95 102.06 1.1 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.881 -0.887 . . . . 0.44 110.881 173.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.0 m -59.07 106.88 0.47 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.412 0.625 . . . . 1.06 110.018 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.7 116.75 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.806 -1.088 . . . . 1.15 111.327 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.434 HD12 ' HG ' ' A' ' 88' ' ' LEU . 41.8 mt -96.74 -37.49 10.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.036 0.922 . . . . 0.48 109.213 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.8 t -127.9 115.5 18.68 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.386 -1.339 . . . . 0.62 107.386 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 16.5 t0 -65.32 161.3 19.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.764 -0.653 . . . . 1.15 112.656 -168.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 24.0 p90 -85.46 61.91 7.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.383 -0.826 . . . . 4.98 112.367 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.918 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 60.3 t -42.29 -49.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 114.294 1.22 . . . . 0.86 114.294 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.39 -168.97 13.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.154 -1.022 . . . . 0.95 113.048 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 35.8 t -78.77 147.93 33.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.363 -0.236 . . . . 0.89 110.363 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.932 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 172.48 61.83 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 O-C-N 123.418 0.449 . . . . 0.82 112.36 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.762 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 9.4 Cg_endo -91.9 132.44 1.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.111 2.541 . . . . 1.01 112.382 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.593 ' HB2' HG21 ' A' ' 115' ' ' THR . 84.4 Cg_exo -50.03 143.8 23.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.263 2.642 . . . . 0.96 112.435 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 113.16 3.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.494 . . . . 2.39 110.926 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.49 -2.35 27.84 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.961 -0.638 . . . . 1.3 112.299 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.629 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 74.4 p -77.83 -21.69 51.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.817 0.341 . . . . 1.04 111.273 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.34 -153.19 17.16 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.862 -0.608 . . . . 1.97 111.846 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -98.5 110.83 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.927 -0.397 . . . . 0.94 109.927 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -77.07 109.56 11.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.177 -0.465 . . . . 2.85 110.019 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.574 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 7.0 ptt180 -101.9 92.56 4.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.636 . . . . 2.78 111.468 -171.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 41.0 m-85 -78.79 120.8 23.95 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.674 -0.694 . . . . 1.13 109.791 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 168' ' ' CYS . 15.1 t -98.57 128.89 49.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.31 110.479 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.86 ' HZ3' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -89.5 119.64 30.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.041 -0.527 . . . . 2.96 109.77 178.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 48.9 mt -116.43 119.15 34.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.378 -0.231 . . . . 0.41 110.378 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.513 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -117.71 137.44 51.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 0.43 110.961 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 1.034 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 49.1 t80 -140.78 133.26 28.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.589 -0.278 . . . . 5.41 110.322 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -83.06 116.32 22.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.807 -0.812 . . . . 2.41 108.807 170.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -78.74 174.39 11.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.498 0.666 . . . . 1.31 112.03 -168.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.28 -22.46 63.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.682 -1.145 . . . . 2.4 109.823 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.629 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 8.2 ptt180 -146.49 163.06 31.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.444 -1.253 . . . . 4.07 111.31 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.506 ' HA ' HD11 ' A' ' 63' ' ' LEU . 48.3 Cg_exo -64.95 41.87 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.757 0 C-N-CA 124.684 3.589 . . . . 1.21 113.403 169.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 2.7 mm? 74.42 167.42 0.29 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.934 -1.03 . . . . 1.16 113.152 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -157.15 71.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.991 -1.459 . . . . 3.23 107.844 171.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 3.8 p -93.39 -75.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.077 -0.965 . . . . 2.79 110.958 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 56.34 31.29 18.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.461 0.648 . . . . 2.96 109.886 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -82.32 139.85 45.18 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.046 -0.979 . . . . 1.39 109.841 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.72 112.44 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.898 2.399 . . . . 1.38 112.446 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.47 131.04 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 0.94 111.065 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.9 mt -110.83 149.39 30.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.05 -0.523 . . . . 1.61 110.639 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 141' ' ' ARG . 37.6 m -102.86 157.74 16.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.283 -1.006 . . . . 1.88 108.283 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.918 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 11.7 p-10 -81.59 30.36 0.36 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.396 0.617 . . . . 1.33 111.579 -173.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.619 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 14.2 mtt180 -115.54 147.48 40.65 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.884 -0.784 . . . . 3.83 108.884 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.568 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 16.5 m 66.18 178.15 0.21 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.94 0.775 . . . . 1.32 110.599 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -143.39 33.17 1.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.041 -1.076 . . . . 1.13 112.701 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.66 -27.41 63.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.049 0.388 . . . . 2.66 112.049 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -113.78 67.49 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.076 0.465 . . . . 2.18 110.9 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.835 HH11 ' HH ' ' A' ' 81' ' ' TYR . 99.3 mtt180 -79.71 -79.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.711 -0.677 . . . . 5.37 112.114 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.12 -142.73 3.52 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.9 113.009 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.7 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 39.7 mttm 66.33 34.15 6.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.719 0.771 . . . . 1.59 109.944 -173.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.463 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 69.8 m-85 -113.63 177.06 4.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.82 -1.082 . . . . 2.27 109.647 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 11.4 mmmm -119.75 112.24 19.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.366 -0.379 . . . . 1.87 111.945 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.781 HG22 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.49 -36.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.96 111.791 172.152 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.81 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.76 110.617 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.5 m -65.17 -44.86 87.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 1.22 110.263 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.607 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 66.9 m-85 -59.11 -47.01 86.85 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.601 0.715 . . . . 1.1 110.199 174.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.5 ' HD3' ' HA ' ' A' ' 161' ' ' ARG . 28.9 ttm180 -59.21 -48.64 80.87 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.809 -1.087 . . . . 3.36 111.634 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -66.76 -36.53 82.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.36 0.6 . . . . 1.52 110.637 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -55.83 -51.04 68.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.078 -0.965 . . . . 2.13 111.41 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.718 ' HH ' HD21 ' A' ' 88' ' ' LEU . 22.7 m-85 -83.29 -5.6 59.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.729 -0.669 . . . . 5.77 111.416 -174.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 68.53 46.74 0.97 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.814 0.816 . . . . 2.42 111.134 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 1.034 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.6 mp -105.69 175.39 5.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.666 -1.152 . . . . 1.27 110.378 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.912 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 6.1 tpt180 -147.64 -158.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.52 -0.918 . . . . 4.0 108.52 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.912 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -47.74 142.25 6.91 Favored Pre-proline 0 C--O 1.231 0.125 0 CA-C-O 121.122 0.487 . . . . 1.21 111.732 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.609 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 7.9 Cg_exo -70.2 161.31 46.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.651 2.901 . . . . 0.68 113.191 -168.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.878 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -87.69 -24.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.014 -0.994 . . . . 0.5 109.236 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -159.83 150.29 18.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.701 -0.681 . . . . 0.29 111.63 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.61 149.87 21.88 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.086 -0.961 . . . . 0.24 111.607 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.528 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.1 t -167.88 152.74 6.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.677 -0.86 . . . . 0.34 108.677 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.63 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 14.3 p -129.21 148.07 51.11 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.164 -0.614 . . . . 2.16 111.355 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.611 ' HB3' HG22 ' A' ' 34' ' ' VAL . 32.1 p90 -130.05 127.85 40.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.003 -1.11 . . . . 1.31 108.003 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -105.14 132.91 50.76 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.897 -0.721 . . . . 2.53 111.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -131.2 144.31 51.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.411 -0.813 . . . . 0.75 109.24 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.762 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 pt-20 -126.74 -161.73 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 2.38 111.103 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 1.016 ' HA ' HG23 ' A' ' 177' ' ' VAL . 4.1 t90 -71.93 81.48 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 4.71 111.036 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.527 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 5.6 t70 -73.08 -61.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.341 -0.39 . . . . 1.53 110.859 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.6 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 29.0 t70 172.79 -35.04 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.402 -0.817 . . . . 1.26 110.087 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -80.54 13.1 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 2.46 111.516 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 1.016 HG23 ' HA ' ' A' ' 173' ' ' TRP . 84.0 t -72.59 -53.37 5.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.931 -0.577 . . . . 0.58 110.105 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.711 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.2 Cg_exo -50.84 -30.8 31.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.693 2.262 . . . . 0.68 111.902 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.2 mmmt -72.4 -23.56 61.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 2.62 111.473 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.932 HD22 ' HA3' ' A' ' 110' ' ' GLY . 14.8 tp -70.9 -44.13 66.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.414 -0.587 . . . . 1.18 109.414 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.66 -40.28 91.48 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.556 0.693 . . . . 2.11 109.273 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 8.2 mm-40 -56.41 -48.3 77.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.671 -1.15 . . . . 1.53 110.647 171.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.334 -0.848 . . . . 2.16 111.97 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.568 ' HA ' ' H ' ' A' ' 142' ' ' SER . 40.4 mt -68.42 2.78 2.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.577 -0.283 . . . . 0.87 111.629 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.624 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.7 m -78.8 -2.73 40.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.336 0.589 . . . . 1.38 109.869 173.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 76.44 60.57 2.99 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.313 -0.858 . . . . 1.17 111.29 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.4 mmmt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.577 -0.725 . . . . 2.45 110.549 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' A' ' 24' ' ' PRO . 23.4 t . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 121.359 0.599 . . . . 2.1 110.134 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.449 ' CG ' ' HG ' ' A' ' 6' ' ' SER . 30.4 p-10 -143.46 31.02 1.35 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.977 -1.011 . . . . 1.81 110.628 -177.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 68.85 10.7 8.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.071 -1.422 . . . . 0.95 113.041 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.449 ' HG ' ' CG ' ' A' ' 4' ' ' ASP . 70.5 m -67.12 -8.97 34.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.539 0.57 . . . . 2.19 112.539 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.84 ' HB3' HD13 ' A' ' 12' ' ' LEU . 99.4 mttt -133.68 36.12 3.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.29 -0.256 . . . . 3.07 111.333 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.45 -17.96 40.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.274 0.472 . . . . 4.76 112.274 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 p -153.42 20.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.872 0.368 . . . . 0.98 111.595 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -80.88 -124.67 0.62 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.006 -0.838 . . . . 0.52 111.006 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 14.3 Cg_endo -53.61 -35.45 77.38 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.261 2.641 . . . . 0.61 110.679 166.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 7' ' ' LYS . 25.3 mt -87.57 86.04 7.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 1.85 109.322 172.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 60.9 0.72 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.307 0.575 . . . . 1.31 110.898 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 121' ' ' VAL . 20.9 mt -73.2 -19.56 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.61 110.275 -176.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -64.55 -22.53 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 2.61 110.846 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -64.86 -25.29 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.38 0.609 . . . . 1.93 109.66 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.579 HG11 HG22 ' A' ' 151' ' ' VAL . 92.1 t -92.39 -70.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.024 -0.989 . . . . 1.26 110.154 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.48 174.67 5.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 2.99 110.621 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.96 29.64 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 1.6 112.282 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.516 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 27.9 mt-30 64.26 112.45 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.02 0.825 . . . . 4.38 111.005 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 19.9 Cg_exo -63.98 152.05 82.56 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.439 2.092 . . . . 0.69 112.759 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.886 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.3 pt20 -76.66 -18.77 58.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.281 -0.872 . . . . 1.87 111.021 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.783 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 40.0 m-70 -145.53 159.43 48.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 123.658 0.783 . . . . 2.35 109.068 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' CB ' HG13 ' A' ' 3' ' ' VAL . 5.4 Cg_endo -85.93 131.05 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.706 2.271 . . . . 0.44 111.967 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' A' ' 122' ' ' TRP . 15.6 tp -82.01 145.04 30.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.731 0.301 . . . . 0.33 110.478 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.483 ' H ' HD12 ' A' ' 25' ' ' LEU . 32.8 m80 -116.49 127.82 54.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.88 -0.415 . . . . 2.12 109.88 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG11 HG22 ' A' ' 53' ' ' ILE . 23.0 t -132.25 140.92 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.355 -0.609 . . . . 1.12 109.355 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -137.59 142.82 41.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.983 0.421 . . . . 0.78 110.789 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -105.16 176.72 5.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.157 -0.683 . . . . 1.23 109.157 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -52.66 62.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.448 0.642 . . . . 0.6 110.284 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.45 7.59 32.25 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.167 -0.924 . . . . 0.81 112.597 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.15 -170.97 3.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.56 110.53 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.25 163.49 25.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.589 -0.732 . . . . 0.35 109.34 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.748 HG22 ' HB3' ' A' ' 169' ' ' TYR . 88.6 t -116.52 66.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.304 -1.369 . . . . 0.39 107.304 165.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.0 14.01 33.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.053 -0.976 . . . . 0.99 109.608 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.793 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.1 tm-20 -138.07 122.38 18.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.126 -1.435 . . . . 2.56 107.126 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -68.1 111.54 4.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.426 0.631 . . . . 0.46 110.685 -170.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.716 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 84.06 10.19 81.06 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.54 -0.754 . . . . 0.59 112.409 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -64.2 154.25 35.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 110.28 -0.267 . . . . 1.04 110.28 176.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.31 127.77 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.469 0.652 . . . . 1.16 111.296 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.52 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.0 tp -124.69 169.12 12.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.823 -1.177 . . . . 0.45 107.823 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p -118.17 151.95 49.89 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 119.48 -0.888 . . . . 1.0 112.718 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 51.0 Cg_exo -56.38 -34.47 94.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.875 3.05 . . . . 1.0 113.284 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -33.67 72.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 1.24 110.696 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -82.12 -46.68 13.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.036 . . . . 1.74 111.395 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.52 ' CG1' HD21 ' A' ' 41' ' ' LEU . 6.1 m -95.62 28.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 112.731 0.641 . . . . 1.1 112.731 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -85.8 -11.7 52.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.823 0.344 . . . . 1.32 110.617 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -135.5 -151.88 0.44 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 2.4 109.285 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -87.92 158.64 50.05 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.149 -0.315 . . . . 1.78 110.149 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 76.3 Cg_endo -83.5 165.37 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.237 1.958 . . . . 0.41 110.573 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 t -88.09 -20.31 25.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.599 -0.441 . . . . 0.88 110.596 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.442 ' C ' HG21 ' A' ' 53' ' ' ILE . 73.3 m -158.69 142.58 15.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.085 0.469 . . . . 0.65 111.918 -177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -141.09 170.05 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.33 108.471 171.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.739 ' HA ' HD11 ' A' ' 58' ' ' LEU . 40.4 t 174.23 116.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.517 0.511 . . . . 0.8 109.866 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.499 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 54.4 p-90 -76.97 159.56 29.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.669 -0.863 . . . . 3.63 108.669 173.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 29.3 t70 -68.63 85.36 0.3 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.054 0.454 . . . . 1.51 110.5 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.47 6.33 3.83 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.492 -0.776 . . . . 0.9 112.259 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -51.71 129.41 26.08 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.163 0.506 . . . . 0.62 111.554 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -79.25 -28.11 42.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.74 111.404 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.635 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 24.3 t 67.14 22.07 9.92 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.125 -0.943 . . . . 1.51 110.08 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -42.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.784 -0.722 . . . . 0.84 113.079 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -90.73 169.08 11.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 120.823 0.344 . . . . 2.12 110.772 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.1 mt -93.8 147.52 22.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.711 -0.677 . . . . 1.23 109.344 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.494 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.0 m-85 -135.09 168.56 18.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.265 -0.643 . . . . 1.61 109.265 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.795 HG21 HG11 ' A' ' 90' ' ' VAL . 2.4 m -103.83 104.43 14.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.325 -0.62 . . . . 0.87 109.325 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.72 HD13 ' HD1' ' A' ' 122' ' ' TRP . 57.7 tp -108.16 117.01 33.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.034 0.445 . . . . 1.35 110.616 -174.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.9 t -114.89 147.09 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.083 -0.508 . . . . 0.54 110.38 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.945 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.2 mt -110.5 122.11 46.95 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.78 -1.192 . . . . 0.65 107.78 166.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 9.0 t -133.16 151.28 51.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.726 0.298 . . . . 1.04 110.711 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.65 ' OD2' ' HB3' ' A' ' 84' ' ' TRP . 4.6 p-10 -132.31 101.8 14.57 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-O 121.613 0.721 . . . . 1.92 111.213 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.499 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 4.1 Cg_endo -48.06 -38.4 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.828 3.018 . . . . 1.25 114.386 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.85 48.82 1.4 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -171.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.46 127.76 27.56 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.176 -0.305 . . . . 0.56 110.176 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -82.64 -30.46 4.78 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.315 -1.536 . . . . 0.7 113.142 -1.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.673 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -121.16 157.81 29.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.107 -0.497 . . . . 1.1 110.944 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -67.81 -45.53 74.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 3.39 111.342 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.693 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -72.35 -19.31 61.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 1.83 111.442 -175.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.97 84.24 5.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.2 0.524 . . . . 1.37 110.141 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.87 102.24 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.643 2.228 . . . . 0.9 112.691 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 16.9 mttm -83.09 -55.23 4.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.981 -1.008 . . . . 1.53 110.669 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.67 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.7 m-85 -82.86 19.77 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.145 -0.934 . . . . 1.54 111.481 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 50.3 ttp180 -65.72 124.05 21.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.36 -0.382 . . . . 3.38 110.21 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.0 mp0 -102.4 138.99 38.59 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.819 0.342 . . . . 2.23 110.957 0.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.65 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 17.1 t90 -88.19 161.91 16.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.412 -1.329 . . . . 1.77 107.412 171.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 11.0 p80 -138.04 114.67 10.51 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.184 0.516 . . . . 2.19 110.435 -174.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.945 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 3.7 t-160 -52.99 -42.57 65.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.029 -0.987 . . . . 2.74 110.585 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.48 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 18.5 p90 -167.55 163.33 14.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.706 0.288 . . . . 2.21 110.747 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.468 ' CD1' HG22 ' A' ' 67' ' ' VAL . 20.8 tp -126.83 114.18 17.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.68 109.23 175.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.48 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 1.5 t -119.78 134.06 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.534 0.683 . . . . 0.35 111.182 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 65' ' ' THR . 6.2 m -128.04 168.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.477 -0.934 . . . . 0.3 108.477 175.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.743 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.8 m-20 59.11 21.77 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.075 0.464 . . . . 2.09 111.3 173.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.492 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.9 ttm -76.72 115.07 16.15 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.673 -0.862 . . . . 0.34 108.673 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -82.72 98.32 9.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.125 -0.943 . . . . 1.73 111.039 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.635 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 69.59 -119.42 9.17 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.203 -0.908 . . . . 0.35 112.273 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.584 ' HB3' HD22 ' A' ' 58' ' ' LEU . 28.6 p-10 -114.57 25.54 10.93 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.09 0.471 . . . . 1.59 110.598 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.4 106.03 18.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.343 0.592 . . . . 0.77 109.977 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.458 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 5.1 mm -56.81 -29.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.729 -1.123 . . . . 0.45 111.913 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.1 m -81.85 -37.27 27.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.883 0.698 . . . . 1.15 112.883 -170.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.6 p -67.27 -19.59 65.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.85 0.315 . . . . 1.26 111.85 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.492 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -57.06 105.65 0.58 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.859 -0.61 . . . . 0.44 112.982 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 97.7 m -65.16 107.31 1.52 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.282 0.563 . . . . 1.06 110.004 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.509 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.6 p -76.78 119.15 24.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.184 -0.916 . . . . 1.15 111.287 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 133' ' ' CYS . 57.1 mt -97.39 -47.03 5.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.091 0.948 . . . . 0.48 109.159 172.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 t -114.35 106.02 13.82 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.977 -1.49 . . . . 0.62 106.977 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.906 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.3 OUTLIER -56.89 156.97 6.04 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.763 0.664 . . . . 1.15 112.178 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.3 p90 -77.25 87.8 3.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 4.98 111.095 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.691 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 24.0 t -61.77 -53.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.76 -0.655 . . . . 0.86 110.68 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 115.98 -164.89 12.19 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.086 -1.054 . . . . 0.95 112.548 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.631 ' HA ' ' HH ' ' A' ' 120' ' ' TYR . 23.9 t -77.89 131.98 37.73 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.568 0.216 . . . . 0.89 110.545 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.647 ' H ' ' HH ' ' A' ' 120' ' ' TYR . . . -154.42 68.11 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.82 112.713 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.834 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 20.4 Cg_endo -96.33 113.19 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.434 2.756 . . . . 1.01 112.708 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.617 ' HB2' HG21 ' A' ' 115' ' ' THR . 89.1 Cg_exo -51.15 143.23 33.13 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.798 2.332 . . . . 0.96 111.709 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 110.97 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.25 0.548 . . . . 2.39 110.952 -175.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.48 21.63 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 1.3 112.312 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.673 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 70.1 p -77.41 -30.3 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.628 0.252 . . . . 1.04 111.415 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.95 -168.78 12.88 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.41 -0.676 . . . . 1.97 111.41 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -80.28 108.97 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.243 0.544 . . . . 0.94 109.916 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.834 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 2.2 t60 -79.74 106.21 11.6 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 2.85 109.535 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.818 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp180 -97.57 114.67 26.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.402 1.096 . . . . 2.78 111.358 -172.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.647 ' HH ' ' H ' ' A' ' 110' ' ' GLY . 28.7 m-85 -92.31 120.65 33.05 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.231 -1.349 . . . . 1.13 108.683 172.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 168' ' ' CYS . 19.4 t -97.99 128.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.619 . . . . 0.31 109.81 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.914 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.02 119.2 29.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.127 -0.694 . . . . 2.96 109.127 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.88 119.92 27.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.374 0.131 . . . . 0.41 111.169 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 66' ' ' LEU . 1.5 m -104.85 136.17 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.566 -0.454 . . . . 0.43 109.869 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 88.4 m-85 -114.5 148.7 37.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.441 . . . . 5.41 110.483 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -101.42 119.06 38.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.836 -0.62 . . . . 2.41 110.837 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.723 ' HG2' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -104.2 160.83 14.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 1.31 110.479 176.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.04 -26.57 64.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.879 -1.055 . . . . 2.4 110.172 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.57 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 11.8 ptp180 -159.24 171.83 6.87 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 4.07 111.132 -174.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 81.3 Cg_exo -48.08 148.37 7.0 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.098 2.532 . . . . 1.21 112.677 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.723 HD23 ' HG2' ' A' ' 127' ' ' GLN . 3.1 mm? -78.12 152.63 32.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.884 -0.598 . . . . 1.16 111.263 -172.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -130.98 68.05 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.643 -0.873 . . . . 3.23 108.643 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.666 ' HB2' HD13 ' A' ' 103' ' ' LEU . 66.3 m -95.72 106.44 18.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.233 -0.894 . . . . 2.79 110.897 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.22 31.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.636 -0.711 . . . . 2.96 110.357 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 11.8 mm-40 -71.32 150.17 94.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.357 -0.838 . . . . 1.39 110.426 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.36 106.64 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.325 2.684 . . . . 1.38 113.138 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.2 mm -63.54 121.33 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.94 110.863 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 69.1 mt -105.49 155.07 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 1.61 110.266 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.574 ' C ' ' H ' ' A' ' 141' ' ' ARG . 65.5 m -113.45 17.17 18.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.73 -0.668 . . . . 1.88 110.737 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.906 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.1 OUTLIER 65.49 -29.21 0.12 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.21 1.404 . . . . 1.33 111.705 -178.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.9 ttt180 -56.45 140.15 46.79 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.68 0.792 . . . . 3.83 111.088 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.435 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 28.6 m 73.78 114.05 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 124.194 0.934 . . . . 1.32 111.639 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.01 12.8 34.82 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.436 -0.802 . . . . 1.13 112.303 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.571 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 25.7 t70 -66.76 -38.65 87.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.597 0.713 . . . . 2.66 110.676 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.571 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 3.5 m80 -98.34 59.53 1.34 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.039 -0.982 . . . . 2.18 109.597 -172.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -86.71 -92.95 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.832 -0.622 . . . . 5.37 112.371 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -119.99 -156.22 9.89 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.232 -0.985 . . . . 0.9 113.633 -166.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.67 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 94.5 mttt 65.66 24.61 11.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.147 0.975 . . . . 1.59 109.755 -171.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.54 95.27 5.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.372 -1.286 . . . . 2.27 108.236 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 22.0 mmmt -54.05 129.98 36.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.215 -0.902 . . . . 1.87 112.622 -173.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.654 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 29.0 m -65.48 -23.72 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.443 -0.577 . . . . 0.96 109.443 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.466 ' HA ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.49 -42.14 98.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.36 -0.837 . . . . 0.76 109.577 172.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 37.2 m -64.82 -32.54 74.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.018 -0.537 . . . . 1.22 110.22 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.654 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 27.6 m-85 -69.91 -48.86 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 1.1 111.068 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.578 ' HD2' ' HG3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -67.23 -29.36 68.99 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.954 -0.298 . . . . 3.36 110.832 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.578 ' HG3' ' HD2' ' A' ' 155' ' ' ARG . 54.7 mtmt -77.49 -26.91 51.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.783 -0.19 . . . . 1.52 111.401 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -54.45 -53.9 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.537 -0.302 . . . . 2.13 111.136 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.425 ' OH ' ' HG3' ' A' ' 129' ' ' ARG . 12.9 t80 -111.1 5.99 20.53 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.485 -0.886 . . . . 5.77 110.597 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 58.81 53.68 5.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.326 -0.852 . . . . 2.42 112.467 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 125' ' ' TYR . 0.4 OUTLIER -81.08 -12.31 59.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.272 -0.877 . . . . 1.27 110.303 176.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 161' ' ' ARG . 7.5 tpt180 69.9 -87.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.978 -1.01 . . . . 4.0 112.297 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -128.07 156.51 76.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.821 0.343 . . . . 1.21 111.211 -171.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.3 Cg_exo -71.24 139.78 35.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.285 2.657 . . . . 0.68 112.464 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.886 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -87.74 -30.78 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.5 109.376 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.781 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.85 143.7 21.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.987 -0.552 . . . . 0.29 111.544 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.698 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.55 143.27 11.28 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 114.926 -1.034 . . . . 0.24 111.881 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.5 t -156.83 133.61 10.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.34 108.927 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.818 ' SG ' ' HB2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -110.31 151.29 27.59 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.568 0.699 . . . . 2.16 111.756 -173.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.748 ' HB3' HG22 ' A' ' 34' ' ' VAL . 49.2 p90 -137.73 127.51 25.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.657 -1.609 . . . . 1.31 106.657 173.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -105.55 133.25 50.6 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.363 -0.935 . . . . 2.53 111.435 177.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.08 -0.964 . . . . 0.75 110.072 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.53 ' HB3' HD13 ' A' ' 117' ' ' LEU . 9.0 pt-20 -120.72 -168.94 1.73 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 2.38 110.947 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.904 ' HA ' HG23 ' A' ' 177' ' ' VAL . 29.4 t90 -83.99 77.3 9.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.786 -0.643 . . . . 4.71 109.729 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -57.04 4.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.654 -0.248 . . . . 1.53 111.257 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.0 t70 175.68 -33.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.358 0.663 . . . . 1.26 110.73 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.65 6.7 14.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.908 0.385 . . . . 2.46 111.925 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.904 HG23 ' HA ' ' A' ' 173' ' ' TRP . 66.3 t -69.42 -53.52 12.81 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.281 -0.418 . . . . 0.58 110.083 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.773 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 61.7 Cg_exo -51.32 -37.03 59.52 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.609 2.206 . . . . 0.68 112.021 169.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.5 mmmt -67.7 -24.37 65.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.165 -0.47 . . . . 2.62 111.705 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 58.3 tp -69.11 -47.44 65.15 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.57 -0.53 . . . . 1.18 109.57 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.8 -38.68 79.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 2.11 109.42 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.658 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.9 mm-40 -57.26 -43.08 82.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.892 -1.049 . . . . 1.53 111.267 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -76.55 -30.34 57.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.707 0.632 . . . . 2.16 112.707 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 84.9 mt -63.39 1.47 0.52 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.996 0.739 . . . . 0.87 112.996 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.691 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 49.3 m -88.81 3.05 52.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.463 0.649 . . . . 1.38 109.789 170.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.536 ' N ' ' HG3' ' A' ' 141' ' ' ARG . . . 69.45 51.65 25.44 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.066 -0.97 . . . . 1.17 111.335 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.691 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.4 mmmt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.456 -0.783 . . . . 2.45 110.072 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.579 ' HB ' ' CD2' ' A' ' 26' ' ' HIS . 21.4 t . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 121.363 0.601 . . . . 2.1 112.131 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 6' ' ' SER . 24.0 t70 -144.78 157.96 43.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.175 -1.375 . . . . 1.81 107.524 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -75.19 23.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.09 0.405 . . . . 0.95 111.882 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.0 t -72.27 -16.72 61.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 2.19 110.123 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.477 ' HB3' HD12 ' A' ' 12' ' ' LEU . 37.8 mttm -122.13 31.41 6.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 3.07 111.173 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -26.36 31.63 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.245 0.832 . . . . 4.76 113.245 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -152.43 25.51 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.014 -0.429 . . . . 0.98 111.377 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.16 -122.39 0.96 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.753 -0.939 . . . . 0.52 110.753 174.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.457 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -51.9 -38.49 68.5 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.255 2.636 . . . . 0.61 110.921 167.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.641 HD13 ' HA3' ' A' ' 38' ' ' GLY . 45.9 mt -87.37 89.09 7.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.258 -0.883 . . . . 1.85 109.661 173.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.53 71.75 1.86 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.412 0.625 . . . . 1.31 110.485 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 121' ' ' VAL . 23.8 mt -80.12 -11.98 59.71 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.795 . . . . 0.61 110.04 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.507 ' HG2' ' HG3' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -67.69 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.446 -0.797 . . . . 2.61 110.859 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -77.5 -20.11 54.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.707 0.765 . . . . 1.93 109.423 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 151' ' ' VAL . 62.8 t -98.13 -57.03 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.53 -1.214 . . . . 1.26 111.341 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -134.92 172.79 12.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.459 -0.337 . . . . 2.99 110.685 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -85.93 31.61 0.62 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.538 0.94 . . . . 1.6 113.538 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.507 ' HG3' ' HG2' ' A' ' 15' ' ' GLN . 97.7 mt-30 64.4 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.541 0 O-C-N 123.507 0.505 . . . . 4.38 110.721 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.604 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 15.2 Cg_exo -66.35 150.4 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.207 1.938 . . . . 0.69 112.671 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.8 pt20 -72.39 -15.92 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.125 -0.943 . . . . 1.87 111.264 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.779 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 24.1 m80 -148.91 157.43 40.39 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 2.35 109.274 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 5.5 Cg_endo -86.82 127.33 2.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.44 111.266 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.859 HD21 ' HB3' ' A' ' 122' ' ' TRP . 22.8 tp -76.61 144.3 39.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.997 -0.372 . . . . 0.33 109.997 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.579 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 36.0 m80 -122.91 109.23 13.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.045 0.45 . . . . 2.12 110.038 176.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 53' ' ' ILE . 39.6 t -112.93 139.3 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.61 . . . . 1.12 109.476 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -133.26 142.2 48.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.431 0.634 . . . . 0.78 110.938 -176.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -102.54 171.12 7.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 1.23 109.006 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.65 -51.86 61.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.37 0.605 . . . . 0.6 110.773 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.97 9.52 15.81 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.066 -0.97 . . . . 0.81 112.478 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.68 -171.01 3.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 122.631 -0.335 . . . . 0.56 110.469 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.13 155.32 18.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.158 -0.474 . . . . 0.35 110.351 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.748 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.6 t -102.32 63.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.804 -1.554 . . . . 0.39 106.804 163.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.31 20.78 8.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.887 -1.051 . . . . 0.99 109.384 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.5 tm-20 -145.67 119.93 9.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.047 -1.094 . . . . 2.56 108.047 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.644 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -66.45 110.63 3.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.997 0.427 . . . . 0.46 109.959 -175.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.87 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 93.27 2.44 65.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.068 -0.587 . . . . 0.59 112.703 177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -67.05 149.39 50.66 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.764 0.316 . . . . 1.04 110.677 -178.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.11 132.01 33.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.357 0.598 . . . . 1.16 111.043 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.523 HD21 ' CG1' ' A' ' 46' ' ' VAL . 6.8 tp -124.11 169.2 11.93 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.391 -1.337 . . . . 0.45 107.391 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 7.1 p -114.67 150.46 44.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 118.804 -1.159 . . . . 1.0 113.141 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.682 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 52.9 Cg_exo -55.74 -32.43 84.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.435 3.423 . . . . 1.0 113.91 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -65.12 -36.65 84.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.644 0.735 . . . . 1.24 110.189 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -75.28 -56.38 4.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.799 -1.091 . . . . 1.74 110.603 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.526 ' HB ' ' HH ' ' A' ' 169' ' ' TYR . 28.7 m -89.31 28.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.884 0.698 . . . . 1.1 112.884 -173.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.625 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -85.64 -15.49 42.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.766 -0.828 . . . . 1.32 108.766 172.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.46 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 17.9 t-20 -121.12 -170.29 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.714 -1.13 . . . . 2.4 108.988 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 86.2 mtt180 -85.42 161.51 51.25 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.445 -0.576 . . . . 1.78 109.445 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 66.8 Cg_endo -78.96 160.38 27.14 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.819 1.68 . . . . 0.41 110.539 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 t -85.23 -18.17 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.915 -0.402 . . . . 0.88 109.915 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.495 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 70.1 m -159.36 147.99 17.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.27 0.557 . . . . 0.65 111.778 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.593 HD11 ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -139.69 167.87 18.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.145 -1.057 . . . . 0.33 108.145 170.057 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.735 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 38.5 t 179.01 114.27 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.102 0.477 . . . . 0.8 110.168 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.523 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 56.3 p-90 -78.4 157.34 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.088 -1.078 . . . . 3.63 108.088 172.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.67 88.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.191 0.52 . . . . 1.51 110.918 -175.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.5 20.59 4.62 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.444 -0.798 . . . . 0.9 112.275 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.735 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -51.1 130.3 25.76 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.107 0.563 . . . . 0.62 111.485 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.681 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 24.1 t70 -75.72 -28.68 58.66 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.808 -0.633 . . . . 0.74 111.451 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.667 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 43.0 m 69.18 9.44 7.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.389 -0.823 . . . . 1.51 110.733 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -135.53 -43.77 0.11 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.849 -0.691 . . . . 0.84 113.253 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.854 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 20.2 mtpt -66.59 149.63 50.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 2.12 110.645 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.96 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.1 mt -88.09 126.77 35.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.555 -0.748 . . . . 1.23 109.239 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.854 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -118.84 161.4 20.23 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.224 0.465 . . . . 1.61 110.889 177.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.424 ' OG1' HD21 ' A' ' 131' ' ' LEU . 89.6 m -97.4 105.3 17.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.87 109.259 172.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.85 110.13 22.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.471 -0.786 . . . . 1.35 109.835 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG22 HD11 ' A' ' 88' ' ' LEU . 21.6 t -115.32 126.7 72.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.018 0.437 . . . . 0.54 111.055 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -91.19 131.39 36.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.215 -1.031 . . . . 0.65 108.215 166.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 12.0 t -133.63 140.64 47.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.877 -0.329 . . . . 1.04 110.339 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.637 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 38.2 t70 -121.85 97.58 46.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 121.132 0.491 . . . . 1.92 110.064 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 10.7 Cg_endo -56.14 178.31 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.2 2.6 . . . . 1.25 112.538 171.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.829 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 71.3 m-20 52.56 35.7 18.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.926 -1.034 . . . . 1.29 112.861 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.99 138.48 19.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.148 -0.315 . . . . 0.56 110.148 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.637 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 56.7 Cg_endo -77.27 -34.52 3.28 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.089 -1.629 . . . . 0.7 112.968 0.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.694 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.1 p -119.87 156.81 30.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 1.1 110.214 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 46.8 mtm180 -72.48 -23.53 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 3.39 111.482 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.758 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -92.72 -11.62 33.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 1.83 110.947 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.45 78.58 6.28 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-O 121.583 0.706 . . . . 1.37 109.584 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.79 95.15 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.848 2.365 . . . . 0.9 113.348 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.637 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 12.1 mttm -81.74 -52.29 7.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.095 -0.957 . . . . 1.53 111.17 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.612 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 50.7 m-85 -76.53 -5.44 47.63 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.886 -0.597 . . . . 1.54 111.897 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.536 ' HG3' ' HA ' ' A' ' 71' ' ' PRO . 70.1 ttt180 -67.43 130.36 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.275 -0.17 . . . . 3.38 110.867 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.521 ' OE2' ' HB3' ' A' ' 71' ' ' PRO . 29.9 mm-40 -86.96 130.8 34.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.981 0.42 . . . . 2.23 110.771 -0.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.659 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.5 t90 -86.75 91.18 8.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 1.77 109.513 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 35.2 p-80 -67.19 121.72 16.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.529 0.681 . . . . 2.19 109.979 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.936 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 30.3 t-80 -65.39 -34.86 79.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.034 -0.985 . . . . 2.74 110.369 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.683 ' HD2' ' HD1' ' A' ' 86' ' ' HIS . 39.6 p90 -168.8 172.39 7.86 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.578 -0.527 . . . . 2.21 109.578 175.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.547 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.2 tp -132.22 113.7 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.641 -0.503 . . . . 0.68 109.641 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.602 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 1.8 t -121.28 132.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.533 0.682 . . . . 0.35 110.678 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.441 ' CG1' ' HG ' ' A' ' 131' ' ' LEU . 9.1 m -128.45 167.4 23.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.879 -1.156 . . . . 0.3 107.879 175.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.96 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.5 m-20 60.71 19.66 9.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.203 0.525 . . . . 2.09 110.895 172.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.582 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 9.1 ttm -73.97 114.57 12.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.971 -0.752 . . . . 0.34 108.971 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 ttmm -80.82 98.56 7.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.512 -1.222 . . . . 1.73 110.988 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.667 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 62.68 -115.3 7.83 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.512 -0.851 . . . . 0.35 112.312 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.726 ' HB3' HD22 ' A' ' 58' ' ' LEU . 28.2 p-10 -115.06 24.34 11.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.933 0.396 . . . . 1.59 111.611 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.06 103.0 15.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.451 0.643 . . . . 0.77 110.247 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.558 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 7.7 mm -56.18 -32.34 34.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.851 -1.068 . . . . 0.45 111.831 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 m -78.98 -37.39 39.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.091 -0.504 . . . . 1.15 111.779 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.3 p -61.05 -29.69 69.88 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.728 0.299 . . . . 1.26 111.331 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.582 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -50.38 107.77 0.4 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.536 -0.756 . . . . 0.44 112.669 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.4 m -72.29 107.8 5.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.256 0.551 . . . . 1.06 109.923 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 p -76.46 122.18 30.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 1.15 111.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.547 HD12 ' HG ' ' A' ' 88' ' ' LEU . 66.0 mt -100.47 -45.69 5.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.085 0.945 . . . . 0.48 109.32 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.1 t -122.92 112.34 17.73 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.171 -1.418 . . . . 0.62 107.171 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 4.1 t0 -59.05 159.94 6.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.944 -1.026 . . . . 1.15 113.024 -167.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HE2' ' HA ' ' A' ' 48' ' ' ASN . 3.3 p90 -80.16 86.66 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.3 -0.864 . . . . 4.98 110.764 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.864 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 38.3 t -63.97 -46.05 95.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.86 111.087 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.527 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 109.51 -168.13 13.13 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.467 -0.873 . . . . 0.95 112.577 174.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.453 ' O ' HD22 ' A' ' 180' ' ' LEU . 30.9 t -70.29 133.24 46.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.89 109.935 174.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.584 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -169.73 61.22 0.19 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.695 -0.764 . . . . 0.82 112.891 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 97.7 Cg_endo -93.35 140.39 1.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.072 2.515 . . . . 1.01 112.434 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.642 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 37.1 Cg_exo -61.55 141.84 92.86 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.702 2.268 . . . . 0.96 111.598 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.45 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -69.02 123.93 22.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 2.39 110.987 -176.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.77 59.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 1.3 112.642 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.694 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 75.1 p -78.82 -12.68 60.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 1.04 110.706 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.29 165.92 41.78 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.18 -0.768 . . . . 1.97 111.18 -174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.893 HD11 ' HG3' ' A' ' 170' ' ' GLN . 3.8 mm? -79.49 130.13 35.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.317 -0.623 . . . . 0.94 109.317 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.433 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 4.2 m170 -92.63 -121.32 0.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.975 -1.12 . . . . 2.85 107.975 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.755 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 14.3 ptt-85 177.3 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.344 0.498 . . . . 2.78 112.344 169.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.637 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 31.4 m-85 -69.86 101.2 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.768 -0.826 . . . . 1.13 108.768 173.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.705 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.3 t -89.99 126.07 42.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.957 0.408 . . . . 0.31 109.949 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.859 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.06 117.9 28.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.812 -0.81 . . . . 2.96 108.812 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -122.07 129.01 52.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.511 0.195 . . . . 0.41 110.94 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 165' ' ' ALA . 1.3 m -112.21 131.78 62.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.43 110.139 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.628 ' CB ' HD21 ' A' ' 160' ' ' LEU . 97.8 m-85 -117.69 122.5 43.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.252 -0.885 . . . . 5.41 109.258 174.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.98 113.08 25.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.012 0.434 . . . . 2.41 109.873 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.591 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -80.57 175.6 10.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.665 -0.698 . . . . 1.31 109.439 177.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.02 -6.34 57.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.729 -0.669 . . . . 2.4 109.851 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.484 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.2 ptp180 -165.65 167.38 9.16 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 115.307 -0.86 . . . . 4.07 111.267 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.611 ' HG3' HD11 ' A' ' 63' ' ' LEU . 35.6 Cg_exo -55.58 147.71 57.59 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.979 2.453 . . . . 1.21 111.631 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.572 HD23 ' HG2' ' A' ' 127' ' ' GLN . 3.8 mm? -71.83 148.89 45.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.621 . . . . 1.16 112.532 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -103.26 77.81 1.56 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.707 -1.22 . . . . 3.23 107.707 165.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.412 ' SG ' HD23 ' A' ' 103' ' ' LEU . 1.2 p -90.62 99.79 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.399 -0.818 . . . . 2.79 111.797 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.2 14.03 21.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.506 -0.77 . . . . 2.96 109.102 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.26 135.28 96.05 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.39 110.278 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.64 116.56 2.81 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.017 2.478 . . . . 1.38 112.946 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.6 mm -69.03 115.95 8.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.005 -0.368 . . . . 0.94 110.005 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.565 HD13 ' HB3' ' A' ' 145' ' ' HIS . 31.6 mt -114.93 152.61 32.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.427 0.632 . . . . 1.61 111.26 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -96.51 154.13 17.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.055 -0.975 . . . . 1.88 108.609 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.864 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 -77.88 -1.41 31.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 1.33 111.024 -173.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.736 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 88.4 mtt180 -78.94 157.2 28.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.581 -0.525 . . . . 3.83 109.581 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.498 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 79.8 p 58.06 117.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.82 1.248 . . . . 1.32 112.651 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.546 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -79.35 18.21 7.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.309 -0.859 . . . . 1.13 113.514 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.601 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 29.3 t70 -69.82 -41.34 75.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.559 0.695 . . . . 2.66 110.4 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.601 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 4.4 m80 -95.11 46.48 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.174 -0.921 . . . . 2.18 110.862 -170.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 51.3 mtt180 -76.77 -78.78 0.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.026 0.441 . . . . 5.37 111.925 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -137.57 -121.58 2.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.107 -1.044 . . . . 0.9 113.042 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.612 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 47.2 mttm 64.88 29.17 12.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.616 0.722 . . . . 1.59 110.51 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -127.52 146.87 50.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.903 -1.044 . . . . 2.27 109.77 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -87.59 140.57 29.38 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.038 -0.528 . . . . 1.87 111.098 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 17' ' ' VAL . 3.0 t -62.11 -35.18 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.43 -0.952 . . . . 0.96 108.43 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.75 81.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.396 -1.275 . . . . 0.76 110.448 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 74.1 m -59.31 -47.07 86.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 1.22 111.349 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 157' ' ' LYS . 59.1 m-85 -62.49 -48.97 77.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.827 0.822 . . . . 1.1 110.611 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -60.1 -49.3 78.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.414 -1.266 . . . . 3.36 111.135 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -67.73 -26.48 66.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 1.52 111.502 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 45.0 tptt -52.6 -53.25 49.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 2.13 111.626 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.415 ' HB3' HD13 ' A' ' 160' ' ' LEU . 17.2 t80 -104.41 14.94 29.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.845 -0.742 . . . . 5.77 110.422 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 60.37 47.67 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.158 -0.928 . . . . 2.42 111.857 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.628 HD21 ' CB ' ' A' ' 125' ' ' TYR . 5.5 mp -80.1 138.9 37.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.388 -0.824 . . . . 1.27 108.875 173.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -72.18 -82.32 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.079 0.4 . . . . 4.0 112.079 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.17 164.54 36.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.882 -0.414 . . . . 1.21 109.882 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.604 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 20.0 Cg_exo -62.3 134.62 49.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.621 2.214 . . . . 0.68 112.566 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.861 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.1 t -89.73 -31.74 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 109.593 -0.521 . . . . 0.5 109.593 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.779 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -155.08 145.01 21.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.16 -0.616 . . . . 0.29 111.876 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.652 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.1 140.45 9.12 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.023 -0.99 . . . . 0.24 111.74 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.403 ' HG1' HG23 ' A' ' 3' ' ' VAL . 12.9 t -152.99 127.41 9.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.532 -0.544 . . . . 0.34 109.532 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.87 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.55 144.29 29.71 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.263 0.554 . . . . 2.16 112.082 -174.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.648 ' HB3' HG22 ' A' ' 34' ' ' VAL . 5.9 p90 -133.27 122.52 24.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.279 -1.378 . . . . 1.31 107.279 168.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.893 ' HG3' HD11 ' A' ' 117' ' ' LEU . 3.9 tp-100 -101.44 156.31 17.54 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.042 -1.036 . . . . 2.53 111.626 171.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.51 ' H ' ' CD ' ' A' ' 170' ' ' GLN . . . -149.0 139.07 22.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.422 -0.353 . . . . 0.75 110.206 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.665 ' HB3' HD12 ' A' ' 117' ' ' LEU . 12.2 pt-20 -106.65 -168.44 1.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.05 0.452 . . . . 2.38 111.87 -173.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.766 ' HA ' HG23 ' A' ' 177' ' ' VAL . 6.9 t90 -77.81 71.38 4.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.661 -0.699 . . . . 4.71 110.168 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.682 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 1.5 t70 -72.59 -62.49 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 1.53 112.615 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.592 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.0 t70 -175.06 -45.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.067 0.46 . . . . 1.26 111.143 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 5.1 m-85 -80.45 7.94 8.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 2.46 111.979 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.766 HG23 ' HA ' ' A' ' 173' ' ' TRP . 94.4 t -72.91 -54.32 4.68 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.3 -0.409 . . . . 0.58 110.083 171.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.733 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -51.92 -41.92 60.82 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.358 2.039 . . . . 0.68 111.868 169.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 0.5 OUTLIER -65.85 -25.16 67.07 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.397 -0.365 . . . . 2.62 111.068 178.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 66.5 tp -68.4 -47.62 66.84 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.229 -0.656 . . . . 1.18 109.229 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.43 -39.43 83.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.82 -0.627 . . . . 2.11 109.478 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 16.4 mm-40 -56.0 -44.45 78.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.772 -1.104 . . . . 1.53 110.795 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.31 -32.45 58.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.366 -0.834 . . . . 2.16 111.958 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 83.0 mt -63.6 -7.07 6.27 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.181 0.437 . . . . 0.87 112.181 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.593 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 16.4 m -68.19 -11.42 59.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.489 0.661 . . . . 1.38 109.714 172.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.736 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 87.23 54.83 2.48 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.137 -0.938 . . . . 1.17 110.88 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.1 mmmt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.503 -0.76 . . . . 2.45 110.328 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.719 0.295 . . . . 2.1 111.546 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -146.29 37.83 1.04 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.768 0.794 . . . . 1.81 110.12 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 24' ' ' PRO . 2.1 mm? 58.88 37.01 24.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.509 -1.223 . . . . 0.95 108.416 -165.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -58.2 -42.93 87.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.456 -1.247 . . . . 2.19 112.021 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.893 ' HB2' HD13 ' A' ' 12' ' ' LEU . 49.9 mttm -136.48 60.94 1.65 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 3.07 109.482 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.448 ' CE3' ' HB2' ' A' ' 20' ' ' GLN . 22.5 p-90 -69.06 -35.75 76.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.13 -0.941 . . . . 4.76 112.009 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 84.5 p -147.24 17.56 1.2 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.542 -0.463 . . . . 0.98 111.904 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -75.52 -124.67 0.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.758 . . . . 0.52 111.782 177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.4 Cg_endo -49.94 -40.41 49.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.248 2.632 . . . . 0.61 110.268 168.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.893 HD13 ' HB2' ' A' ' 7' ' ' LYS . 22.2 mt -88.1 83.62 6.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.85 -1.068 . . . . 1.85 109.218 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 m -74.57 62.66 1.04 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.618 0.723 . . . . 1.31 110.397 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.526 HD11 ' HG ' ' A' ' 168' ' ' CYS . 46.0 mt -76.52 -17.46 59.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 0.61 110.825 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.7 OUTLIER -64.99 -21.53 66.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.877 -0.601 . . . . 2.61 109.919 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.66 -28.51 65.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.35 0.595 . . . . 1.93 110.65 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.714 HG12 HG21 ' A' ' 69' ' ' THR . 52.0 t -83.99 -73.47 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.265 -0.88 . . . . 1.26 109.684 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 151' ' ' VAL . 48.3 t0 -139.32 161.19 38.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.846 -0.615 . . . . 2.99 109.659 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 163' ' ' PRO . 32.6 mt-10 -64.09 153.42 37.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.652 -0.703 . . . . 1.6 111.846 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.448 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 20.1 tt0 -56.05 124.26 58.24 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 4.38 110.34 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 19.6 Cg_exo -64.47 154.84 69.57 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.318 2.012 . . . . 0.69 112.069 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.91 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.8 pt20 -73.74 -15.55 61.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.606 -0.725 . . . . 1.87 111.121 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.72 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 19.5 m80 -146.45 158.81 46.45 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 2.35 108.995 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 8.1 Cg_endo -88.53 132.55 2.56 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.952 2.435 . . . . 0.44 111.519 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.837 HD21 ' HB3' ' A' ' 122' ' ' TRP . 15.3 tp -84.5 139.83 31.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.33 111.018 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -106.8 131.33 54.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.468 . . . . 2.12 109.93 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.506 HG13 HG22 ' A' ' 53' ' ' ILE . 16.1 t -134.39 142.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.12 -0.696 . . . . 1.12 109.12 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -140.76 140.96 34.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.917 0.389 . . . . 0.78 110.83 -176.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -105.61 178.28 4.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.751 -0.833 . . . . 1.23 108.751 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -52.18 57.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.507 0.67 . . . . 0.6 110.463 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.57 -0.14 49.67 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.26 -0.882 . . . . 0.81 112.836 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.76 -169.8 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.56 110.966 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.56 152.84 16.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.651 -0.704 . . . . 0.35 109.645 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.681 HG23 ' HZ3' ' A' ' 122' ' ' TRP . 99.7 t -106.73 64.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.26 -1.385 . . . . 0.39 107.26 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -93.39 6.31 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.014 -0.993 . . . . 0.99 109.704 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 43.8 mt-10 -133.91 132.7 40.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.191 -0.913 . . . . 2.56 109.071 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.6 OUTLIER -75.74 109.56 9.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.139 -0.689 . . . . 0.46 109.139 -176.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.683 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 93.07 6.18 63.43 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.536 -0.756 . . . . 0.59 112.777 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.55 147.68 52.95 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.493 -0.558 . . . . 1.04 109.493 176.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.47 134.7 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.094 0.473 . . . . 1.16 110.957 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.578 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.4 tp -127.41 169.32 13.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.662 -0.866 . . . . 0.45 108.662 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 25.1 p -121.08 156.64 56.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.287 -0.565 . . . . 1.0 112.227 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.742 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 12.0 Cg_endo -55.5 -30.23 72.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.288 3.325 . . . . 1.0 114.402 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -69.87 -32.48 70.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.64 0.733 . . . . 1.24 110.774 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -79.98 -29.19 39.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.846 -1.07 . . . . 1.74 111.241 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' A' ' 41' ' ' LEU . 16.7 m -118.21 30.19 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.451 . . . . 1.1 111.762 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.605 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.01 -21.08 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.601 -0.518 . . . . 1.32 109.601 176.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.0 -170.85 2.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.316 -0.857 . . . . 2.4 109.617 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.1 156.85 89.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.362 -0.607 . . . . 1.78 109.362 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.93 153.72 25.6 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.588 1.526 . . . . 0.41 109.962 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -80.15 -14.93 58.09 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.353 -0.539 . . . . 0.88 110.555 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.451 ' C ' HG21 ' A' ' 53' ' ' ILE . 69.6 m -161.51 143.38 11.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.457 0.54 . . . . 0.65 112.457 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -140.17 175.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.104 -1.072 . . . . 0.33 108.104 170.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.781 ' HA ' HD11 ' A' ' 58' ' ' LEU . 47.8 t 169.56 125.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.497 0.498 . . . . 0.8 110.039 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.602 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 60.2 p-90 -88.13 153.7 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.672 -0.862 . . . . 3.63 108.672 173.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.76 91.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 1.51 110.954 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.66 8.71 8.09 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.836 -0.62 . . . . 0.9 112.42 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 54' ' ' SER . 7.7 tt -56.76 129.0 39.4 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.848 0.459 . . . . 0.62 110.857 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.39 -29.04 56.96 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.771 -0.65 . . . . 0.74 111.744 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.648 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.2 m 74.23 0.33 3.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.475 -0.784 . . . . 1.51 110.821 -175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.31 -34.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.058 -0.591 . . . . 0.84 113.879 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -97.34 166.72 11.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.37 0.605 . . . . 2.12 112.076 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.0 mt -91.9 134.02 35.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.758 -1.11 . . . . 1.23 110.109 -175.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.559 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 7.0 m-85 -124.35 162.83 22.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.892 0.314 . . . . 1.61 110.194 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.559 ' HG1' HD21 ' A' ' 131' ' ' LEU . 86.3 m -102.15 109.74 21.51 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.557 -0.534 . . . . 0.87 109.557 174.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.595 HD11 HG11 ' A' ' 124' ' ' VAL . 53.0 tp -109.09 118.89 37.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.773 0.321 . . . . 1.35 110.523 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.1 130.58 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.54 110.742 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.661 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -90.88 141.91 28.33 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.756 -0.831 . . . . 0.65 108.756 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.714 HG21 HG12 ' A' ' 17' ' ' VAL . 12.9 t -140.62 148.13 40.42 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.889 -0.324 . . . . 1.04 110.66 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 22.5 t70 -133.82 97.44 15.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 121.265 0.555 . . . . 1.92 109.959 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.55 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 3.4 Cg_endo -45.78 -47.63 13.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.489 3.459 . . . . 1.25 114.827 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 76' ' ' ARG . 30.1 m-20 -86.98 52.77 2.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.473 0.545 . . . . 1.29 112.473 -167.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.67 20.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.15 -0.477 . . . . 0.56 110.115 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 85.9 Cg_endo -82.14 -23.53 13.43 Favored 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.527 -1.447 . . . . 0.7 112.858 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.714 ' HB3' HG22 ' A' ' 115' ' ' THR . 6.4 p -137.74 153.66 49.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 1.1 110.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HG3' ' OD1' ' A' ' 72' ' ' ASP . 78.9 ttt180 -68.82 -23.15 64.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.328 0.585 . . . . 3.39 110.499 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.544 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.4 ptpt -76.21 -17.05 59.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.81 -0.632 . . . . 1.83 110.496 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 7.9 t0 -162.97 72.63 2.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 1.37 109.876 -172.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.28 87.99 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.266 1.978 . . . . 0.9 112.179 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.3 mttm -76.27 -51.42 12.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.449 -1.25 . . . . 1.53 110.548 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.654 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 86.5 m-85 -80.37 19.29 0.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.155 -0.93 . . . . 1.54 111.555 -171.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.686 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 17.2 ttp180 -69.54 126.64 30.34 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.16 -0.311 . . . . 3.38 110.16 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.686 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 2.2 mp0 -98.66 135.35 40.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.945 0.402 . . . . 2.23 110.471 -4.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.585 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.7 t90 -80.94 135.45 35.88 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.15 -0.685 . . . . 1.77 109.15 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 6.4 p80 -108.29 132.47 53.66 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.251 -0.58 . . . . 2.19 109.453 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.661 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.2 t-160 -83.75 -26.37 29.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.135 -0.484 . . . . 2.74 111.514 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.713 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 23.4 p90 -168.74 178.55 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.302 -0.629 . . . . 2.21 109.302 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.3 tp -141.41 114.26 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.155 0.285 . . . . 0.68 110.416 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.713 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -120.39 132.4 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.422 0.63 . . . . 0.35 110.931 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 65' ' ' THR . 13.5 m -133.46 166.02 30.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.149 -1.056 . . . . 0.3 108.149 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.743 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t-20 62.16 17.38 9.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.742 0.306 . . . . 2.09 110.292 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.524 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 9.2 ttm -70.27 108.53 4.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.761 -0.829 . . . . 0.34 108.761 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.2 ttmm -83.48 90.42 7.21 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.817 -1.083 . . . . 1.73 110.633 -171.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.648 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.52 -126.62 7.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.943 -1.026 . . . . 0.35 112.271 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.527 ' HB3' HD22 ' A' ' 58' ' ' LEU . 3.7 p-10 -111.78 24.2 12.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.411 0.624 . . . . 1.59 110.354 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.07 110.75 22.12 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.459 -0.791 . . . . 0.77 110.157 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.6 mm -62.28 -23.7 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.489 -1.232 . . . . 0.45 111.188 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.8 m -81.52 -40.74 22.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 1.15 112.272 -172.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.1 p -70.64 -21.41 62.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.642 0.238 . . . . 1.26 111.642 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.524 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -58.22 102.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.266 -0.492 . . . . 0.44 112.324 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.5 m -68.83 106.93 2.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.445 -0.576 . . . . 1.06 109.445 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.588 HG23 ' HA ' ' A' ' 105' ' ' ASP . 14.8 p -90.72 116.21 31.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.316 -0.856 . . . . 1.15 110.898 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mt -89.59 -45.92 9.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.015 0.912 . . . . 0.48 109.364 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.2 t -112.1 106.67 15.36 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.387 -1.708 . . . . 0.62 106.387 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.96 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.7 t0 -62.39 161.29 11.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.15 112.529 -165.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -78.07 100.44 6.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.377 -0.829 . . . . 4.98 108.902 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.84 HG12 HD13 ' A' ' 180' ' ' LEU . 33.1 t -71.12 -39.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.645 . . . . 0.86 112.263 -173.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.51 171.45 28.08 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.768 -0.729 . . . . 0.95 112.665 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.742 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 27.7 t -61.54 139.6 58.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.149 0.474 . . . . 0.89 110.723 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.84 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -176.63 61.82 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.82 111.613 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.884 ' HD2' HG22 ' A' ' 177' ' ' VAL . 87.0 Cg_endo -85.46 136.18 5.42 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.553 2.169 . . . . 1.01 112.929 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.695 ' HB2' HG23 ' A' ' 115' ' ' THR . 42.2 Cg_exo -57.51 148.18 74.23 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.77 2.313 . . . . 0.96 111.533 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 125.19 28.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.248 -0.433 . . . . 2.39 111.092 -176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.58 18.6 37.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.814 -0.708 . . . . 1.3 112.049 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.714 HG22 ' HB3' ' A' ' 75' ' ' SER . 70.3 p -103.55 -12.89 16.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.764 0.316 . . . . 1.04 111.423 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.46 21.36 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.56 -0.616 . . . . 1.97 111.56 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.5 mm? -86.41 129.1 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.831 0.348 . . . . 0.94 110.181 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.8 m-70 -94.1 115.63 27.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.89 -0.411 . . . . 2.85 109.89 177.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.55 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 6.0 ptt180 -104.29 84.94 2.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 2.78 110.689 -172.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.609 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 22.2 m-85 -69.28 117.24 10.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.539 -0.755 . . . . 1.13 109.539 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 168' ' ' CYS . 11.6 t -95.9 129.24 46.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.841 -0.618 . . . . 0.31 110.152 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.837 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.56 118.92 28.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.908 -0.587 . . . . 2.96 109.594 178.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.08 119.29 33.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.389 -0.226 . . . . 0.41 110.389 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -108.26 136.3 44.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.356 -0.538 . . . . 0.43 109.958 174.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.593 ' HB2' HD21 ' A' ' 160' ' ' LEU . 55.9 m-85 -113.88 144.25 43.35 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.904 -0.589 . . . . 5.41 109.773 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -105.87 112.0 24.89 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.485 -0.561 . . . . 2.41 109.485 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.559 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.13 179.25 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.31 109.788 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.51 -27.33 37.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.659 0.742 . . . . 2.4 109.258 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.65 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 3.5 ptp180 -153.86 174.39 3.83 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 114.535 -1.212 . . . . 4.07 111.619 -171.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 55.7 Cg_exo -52.23 152.8 14.22 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.096 2.53 . . . . 1.21 112.119 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.559 HD21 ' HG1' ' A' ' 65' ' ' THR . 4.4 mm? -76.53 152.78 35.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 1.16 111.977 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.76 68.96 0.68 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.225 -0.898 . . . . 3.23 108.749 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 p -82.75 118.71 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.471 -0.786 . . . . 2.79 111.159 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.36 8.88 33.87 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.703 -0.851 . . . . 2.96 108.703 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.54 116.92 47.91 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.667 -1.151 . . . . 1.39 109.943 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.63 131.28 32.7 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.933 2.422 . . . . 1.38 112.155 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.4 mm -59.32 115.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.743 -0.466 . . . . 0.94 109.743 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 145' ' ' HIS . 77.9 mt -96.46 -13.93 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.61 112.422 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 m 59.91 -172.51 0.12 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.933 0.397 . . . . 1.88 110.313 -172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.96 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 25.1 p-10 -115.69 37.95 3.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.204 0.526 . . . . 1.33 110.207 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.593 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 6.9 mtm180 -116.29 136.08 53.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.276 0.56 . . . . 3.83 111.809 -169.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.659 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.2 m 66.96 2.23 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.876 -1.056 . . . . 1.32 113.585 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.63 92.49 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.508 -0.769 . . . . 1.13 111.784 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.83 -49.97 73.82 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.047 0.758 . . . . 2.66 113.047 -172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.591 ' HB2' HD11 ' A' ' 138' ' ' LEU . 43.1 m80 -117.0 69.24 0.75 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.868 -0.79 . . . . 2.18 108.868 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.454 ' O ' ' HD1' ' A' ' 84' ' ' TRP . 5.1 ttm180 -73.81 -81.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.31 -1.314 . . . . 5.37 112.189 -170.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -124.38 -168.41 12.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.174 -1.012 . . . . 0.9 112.926 -169.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.654 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.2 mttt 67.73 29.18 6.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.603 0.716 . . . . 1.59 110.099 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.67 113.16 25.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.882 -1.054 . . . . 2.27 109.415 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 12.3 mmmm -69.94 127.98 34.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.313 0.578 . . . . 1.87 111.767 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.742 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 0.2 OUTLIER -58.43 -33.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.992 -1.004 . . . . 0.96 111.44 175.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.58 -35.53 80.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.76 110.415 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.1 m -68.4 -35.5 77.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 -0.227 . . . . 1.22 110.874 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.742 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 64.9 m-85 -58.96 -52.58 65.13 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.032 0.444 . . . . 1.1 110.522 176.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 2.7 ptt-85 -69.12 -38.53 78.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.013 -0.54 . . . . 3.36 111.422 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.5 mtmt -61.29 -28.42 69.18 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.75 0.278 . . . . 1.52 111.75 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -54.88 -54.01 48.01 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.122 0.264 . . . . 2.13 111.547 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.465 ' HB3' HD13 ' A' ' 160' ' ' LEU . 12.9 t80 -105.1 15.04 28.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.575 -0.85 . . . . 5.77 110.479 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 61.91 45.91 7.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 2.42 111.739 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 125' ' ' TYR . 7.0 mp -81.52 176.35 9.75 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.472 -0.785 . . . . 1.27 110.604 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.0 tpt180 -101.74 -164.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.267 -0.424 . . . . 4.0 110.5 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.569 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -71.44 166.17 41.76 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 109.704 -0.48 . . . . 1.21 109.704 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.515 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 31.9 Cg_exo -55.2 138.04 78.28 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.68 113.08 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.91 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -88.76 -29.85 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 CA-C-N 115.555 -0.748 . . . . 0.5 109.027 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.91 148.19 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.442 -0.503 . . . . 0.29 111.358 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.747 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -151.22 147.01 16.48 Favored Glycine 0 N--CA 1.436 -1.317 0 CA-C-N 115.161 -0.927 . . . . 0.24 112.273 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -165.54 139.67 4.69 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.431 -0.951 . . . . 0.34 108.431 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 16.6 p -118.63 144.95 45.81 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 2.16 111.265 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.2 p90 -127.85 127.1 42.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.655 -1.239 . . . . 1.31 107.655 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -106.03 133.17 51.16 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.659 -0.651 . . . . 2.53 111.734 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -128.92 145.96 51.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.195 -0.911 . . . . 0.75 109.616 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.633 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -121.36 -172.3 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.661 0.267 . . . . 2.38 110.863 -177.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.973 ' HA ' HG23 ' A' ' 177' ' ' VAL . 29.9 t90 -74.76 82.8 2.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.74 -0.467 . . . . 4.71 109.74 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 0.3 OUTLIER -72.09 -61.62 1.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.867 -0.606 . . . . 1.53 111.293 176.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.581 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.4 t70 169.55 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.826 0.704 . . . . 1.26 109.644 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 60.7 m-85 -81.22 10.82 4.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.219 0.533 . . . . 2.46 111.346 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.973 HG23 ' HA ' ' A' ' 173' ' ' TRP . 74.8 t -72.31 -49.39 9.32 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.58 110.712 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.8 Cg_exo -49.05 -26.34 10.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.947 2.431 . . . . 0.68 113.06 170.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.58 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 18.1 mmmt -67.4 -24.65 65.69 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.34 0.256 . . . . 2.62 111.629 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.84 HD13 HG12 ' A' ' 107' ' ' VAL . 21.5 tp -78.25 -40.75 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.112 -0.635 . . . . 1.18 109.358 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.65 -35.26 74.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.944 -0.762 . . . . 2.11 108.944 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 0.9 OUTLIER -55.51 -56.49 19.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.495 -1.23 . . . . 1.53 109.73 172.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -69.6 -39.02 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.705 -1.134 . . . . 2.16 112.549 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.659 ' HA ' ' H ' ' A' ' 142' ' ' SER . 74.1 mt -71.5 6.99 1.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.005 0.431 . . . . 0.87 111.686 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.498 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 19.9 m -77.76 -3.45 41.34 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.31 -0.626 . . . . 1.38 109.31 168.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 75.1 49.67 9.36 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.839 -0.904 . . . . 1.17 110.839 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.498 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.1 mmtp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.678 -0.677 . . . . 2.45 110.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 121.051 0.453 . . . . 2.1 111.953 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -146.13 160.53 41.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.889 -1.152 . . . . 1.81 107.889 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.5 mm? -81.93 30.78 0.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.95 111.005 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -76.92 -18.44 58.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.139 0.495 . . . . 2.19 110.517 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -114.36 33.44 5.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.052 0.453 . . . . 3.07 110.25 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.735 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.1 p90 -73.89 -28.2 61.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 4.76 111.921 -174.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -147.65 11.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.98 110.641 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -76.75 -118.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.84 -0.618 . . . . 0.52 111.671 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.2 Cg_endo -49.21 -45.89 28.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.232 2.621 . . . . 0.61 110.703 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.735 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 9.4 mp -89.72 102.21 14.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.298 -0.864 . . . . 1.85 111.249 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 65.98 2.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.19 0.519 . . . . 1.31 110.408 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 121' ' ' VAL . 22.0 mt -74.32 -17.45 60.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.61 111.423 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -69.65 -5.99 28.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.294 -0.412 . . . . 2.61 111.44 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.14 -14.12 60.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.938 0.399 . . . . 1.93 111.41 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.914 HG12 HG21 ' A' ' 69' ' ' THR . 60.9 t -91.49 -71.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.509 -0.769 . . . . 1.26 110.744 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 23.4 t0 -155.26 176.38 12.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.483 -0.932 . . . . 2.99 108.483 -170.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.89 100.1 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.864 -0.421 . . . . 1.6 109.864 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.735 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -43.14 128.58 3.41 Favored Pre-proline 0 C--O 1.234 0.283 0 O-C-N 124.142 0.901 . . . . 4.38 110.38 -176.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.617 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 53.0 Cg_exo -52.87 166.86 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.499 2.799 . . . . 0.69 114.516 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.893 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 9.7 pt20 -84.16 -11.88 55.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.474 -1.239 . . . . 1.87 111.812 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.734 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 14.8 m-70 -147.02 157.78 45.94 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 123.11 0.564 . . . . 2.35 110.072 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.3 Cg_endo -86.42 123.5 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.326 2.684 . . . . 0.44 111.652 176.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 16.9 tp -79.06 136.36 37.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.716 0.294 . . . . 0.33 110.732 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.31 117.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.924 -0.399 . . . . 2.12 109.924 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 34' ' ' VAL . 26.4 t -123.27 144.62 32.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.171 -0.678 . . . . 1.12 109.171 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 144.22 32.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.797 0.332 . . . . 0.78 110.701 -173.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.476 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 17.8 t80 -108.92 178.52 4.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 1.23 109.348 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -52.8 64.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 0.6 110.843 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.69 11.23 15.84 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.596 -0.729 . . . . 0.81 112.494 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.44 -171.3 3.38 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.877 0.37 . . . . 0.56 110.164 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.69 154.23 17.94 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.88 -0.6 . . . . 0.35 109.543 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.75 HG23 ' HZ3' ' A' ' 122' ' ' TRP . 89.9 t -100.16 61.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 106.968 -1.493 . . . . 0.39 106.968 166.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -96.14 27.68 3.56 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.402 -1.272 . . . . 0.99 109.301 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -153.98 125.76 7.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.917 -1.142 . . . . 2.56 107.917 173.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.512 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.8 OUTLIER -74.67 110.38 8.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.081 0.467 . . . . 0.46 109.963 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.779 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 98.81 -3.27 58.81 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.635 -0.793 . . . . 0.59 112.483 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.728 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -62.85 150.44 41.72 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.304 0.242 . . . . 1.04 110.393 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.61 127.57 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 1.16 110.672 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tp -115.87 169.72 9.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.153 -1.425 . . . . 0.45 107.153 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 2.6 p -113.47 150.17 42.77 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.88 -1.128 . . . . 1.0 113.369 -174.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 35.8 Cg_exo -61.23 -27.78 84.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.208 3.272 . . . . 1.0 113.196 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.455 HG22 ' CD2' ' A' ' 176' ' ' TYR . 10.4 p -65.3 -40.28 93.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.84 . . . . 1.24 109.972 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -81.46 -50.87 8.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.466 -1.243 . . . . 1.74 111.399 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.796 ' HB ' ' HE2' ' A' ' 169' ' ' TYR . 3.8 m -85.56 25.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.209 0.528 . . . . 1.1 112.366 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -81.25 -20.03 41.84 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.083 -0.71 . . . . 1.32 109.083 175.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -119.5 -161.88 0.89 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.84 -1.073 . . . . 2.4 110.052 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.585 HH22 HG23 ' A' ' 89' ' ' VAL . 29.5 mtp180 -91.38 165.84 20.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.168 -0.308 . . . . 1.78 110.168 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 57.3 Cg_endo -75.81 169.13 22.85 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.912 1.742 . . . . 0.41 110.725 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -91.3 -18.39 24.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.787 -0.365 . . . . 0.88 110.121 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.421 ' C ' HG21 ' A' ' 53' ' ' ILE . 74.0 m -160.77 142.52 12.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.65 112.101 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.541 HD13 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -137.99 168.21 20.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.322 -0.992 . . . . 0.33 108.322 171.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.687 ' HA ' HD11 ' A' ' 58' ' ' LEU . 47.3 t 169.18 122.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.368 0.417 . . . . 0.8 110.333 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.51 ' CB ' ' HB1' ' A' ' 165' ' ' ALA . 46.8 p-90 -82.65 150.99 26.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.165 -1.42 . . . . 3.63 107.165 169.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' CG ' ' HD1' ' A' ' 23' ' ' HIS . 12.5 p-10 -68.28 87.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.826 0.822 . . . . 1.51 111.15 -174.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.71 -1.38 3.2 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.919 -1.037 . . . . 0.9 111.626 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.687 HD11 ' HA ' ' A' ' 54' ' ' SER . 7.8 tt -52.17 128.61 25.42 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.087 0.555 . . . . 0.62 110.336 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.767 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 33.9 t70 -75.09 -27.18 59.8 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.74 111.757 -173.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.617 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 15.9 m 73.03 2.56 4.42 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.979 -1.01 . . . . 1.51 110.192 -172.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.81 -9.06 2.6 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.127 -0.559 . . . . 0.84 113.5 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.767 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 35.4 mtpt -94.75 161.05 14.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.251 0.525 . . . . 2.12 109.918 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 60.8 mt -95.11 134.49 37.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.399 -0.593 . . . . 1.23 109.399 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -133.59 145.92 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.42 -0.585 . . . . 1.61 109.42 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.666 HG22 HG11 ' A' ' 90' ' ' VAL . 60.2 m -95.96 105.27 17.27 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.704 -0.85 . . . . 0.87 108.704 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 HG11 ' A' ' 124' ' ' VAL . 49.3 tp -100.54 109.93 22.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 1.35 110.193 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 88' ' ' LEU . 27.4 t -110.15 121.1 62.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.54 110.533 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.942 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.0 mt -81.91 138.98 34.91 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.465 -0.939 . . . . 0.65 108.465 167.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.914 HG21 HG12 ' A' ' 17' ' ' VAL . 8.9 t -144.79 147.39 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.858 -0.337 . . . . 1.04 110.858 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 9.1 t0 -131.84 95.56 22.37 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.546 0.688 . . . . 1.92 109.745 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 18.8 Cg_endo -60.01 -11.63 16.11 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 124.126 3.217 . . . . 1.25 114.065 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 118' ' ' HIS . 2.3 t70 -106.61 26.46 9.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.405 0.621 . . . . 1.29 110.431 -167.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.575 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -103.33 144.79 29.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.052 -0.522 . . . . 0.56 111.591 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.45 ' HD3' ' HD2' ' A' ' 81' ' ' TYR . 96.0 Cg_endo -84.86 -24.47 10.2 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.207 -1.58 . . . . 0.7 112.819 -0.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.575 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 62.1 p -134.72 149.67 50.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 1.1 109.371 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HB2' ' OD2' ' A' ' 72' ' ' ASP . 41.0 ttm180 -69.69 -26.86 64.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 3.39 111.473 -177.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -69.82 -23.5 63.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.44 -0.345 . . . . 1.83 111.025 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -157.62 84.03 2.84 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.912 0.386 . . . . 1.37 110.379 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.5 81.54 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.593 2.195 . . . . 0.9 112.025 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.2 mttm -66.68 -48.18 70.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.295 -1.321 . . . . 1.53 111.46 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.653 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 48.7 m-85 -83.59 8.82 13.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.343 -0.844 . . . . 1.54 112.16 -166.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 53.9 ttp180 -58.28 122.79 14.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 3.38 110.794 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mp0 -101.14 131.93 46.85 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.839 0.352 . . . . 2.23 110.796 -2.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.575 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 12.5 t90 -79.52 93.66 5.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 1.77 110.113 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.9 p-80 -67.44 123.8 21.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.352 0.596 . . . . 2.19 109.421 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.942 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 11.5 t60 -76.64 -30.76 56.99 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.622 -0.717 . . . . 2.74 110.324 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.0 p90 -168.48 174.2 7.03 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.6 -0.519 . . . . 2.21 109.6 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HG ' HD12 ' A' ' 103' ' ' LEU . 19.7 tp -134.55 114.2 12.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.907 -0.405 . . . . 0.68 109.907 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.585 HG23 HH22 ' A' ' 49' ' ' ARG . 1.7 t -123.54 131.76 72.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.757 -0.656 . . . . 0.35 110.903 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.666 HG11 HG22 ' A' ' 65' ' ' THR . 15.0 m -133.28 163.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.957 -1.02 . . . . 0.3 108.529 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' A' ' 130' ' ' PRO . 2.5 t-20 62.85 18.34 10.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.333 0.396 . . . . 2.09 110.008 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.585 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 5.4 ttm -69.94 106.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.074 -0.713 . . . . 0.34 109.074 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 93' ' ' LYS . 12.9 ttmm -84.21 89.72 7.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.616 -1.175 . . . . 1.73 110.697 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 82.48 -127.18 7.82 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.875 -1.057 . . . . 0.35 112.632 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.589 ' HB3' HD22 ' A' ' 58' ' ' LEU . 26.5 p-10 -115.6 24.02 11.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 1.59 111.432 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -89.42 105.71 17.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.378 0.608 . . . . 0.77 109.729 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.541 HD11 HD13 ' A' ' 53' ' ' ILE . 10.7 mm -49.98 -35.91 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.291 -1.322 . . . . 0.45 111.387 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 m -80.88 -31.49 35.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.685 -0.689 . . . . 1.15 111.834 -172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -72.76 -11.21 60.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 1.26 111.565 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.585 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -71.0 102.33 1.05 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.554 -0.831 . . . . 0.44 111.602 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.9 m -61.98 109.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.478 0.656 . . . . 1.06 110.066 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.6 p -83.2 117.49 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.825 -1.079 . . . . 1.15 111.588 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 47.3 mt -92.85 -39.02 11.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.018 0.913 . . . . 0.48 109.372 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 22.0 t -127.44 110.27 12.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.446 -1.316 . . . . 0.62 107.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.973 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -56.76 161.78 2.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.122 0.889 . . . . 1.15 112.921 -170.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -83.86 101.33 11.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.37 -0.832 . . . . 4.98 110.283 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.774 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 25.9 t -69.3 -41.46 81.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.893 -0.594 . . . . 0.86 111.748 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.39 -176.55 24.39 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.95 112.333 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.442 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 27.0 t -63.7 123.17 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.67 0.235 . . . . 0.89 110.803 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -154.3 61.74 0.37 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.9 -0.667 . . . . 0.82 112.708 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.539 ' HD2' HG22 ' A' ' 177' ' ' VAL . 73.9 Cg_endo -94.51 123.35 0.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.922 2.415 . . . . 1.01 112.669 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.66 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.7 Cg_exo -52.56 140.77 54.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.884 2.39 . . . . 0.96 111.814 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.503 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -64.53 125.31 24.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.141 0.495 . . . . 2.39 110.839 -177.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.08 -4.02 60.55 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.615 -0.802 . . . . 1.3 112.856 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.66 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 74.0 p -78.1 -15.82 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.699 -0.295 . . . . 1.04 111.261 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 171.33 39.37 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.876 -0.602 . . . . 1.97 111.862 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.37 115.58 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.956 -0.757 . . . . 0.94 108.956 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.755 ' N ' ' HG2' ' A' ' 170' ' ' GLN . 75.2 m-70 -88.61 -134.3 0.09 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.2 -0.667 . . . . 2.85 109.2 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.735 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 2.8 ptt180 -176.53 100.9 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.743 0.646 . . . . 2.78 112.743 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.453 ' HD1' ' HB2' ' A' ' 70' ' ' ASP . 19.3 m-85 -77.78 106.79 9.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.359 -0.978 . . . . 1.13 108.359 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.606 HG23 HD21 ' A' ' 14' ' ' LEU . 5.2 t -96.26 133.48 37.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.412 -0.358 . . . . 0.31 110.122 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.784 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -87.74 119.41 28.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.652 -0.499 . . . . 2.96 109.652 178.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.5 mt -115.31 117.77 31.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.71 -0.478 . . . . 0.41 109.71 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.669 HG11 HD11 ' A' ' 66' ' ' LEU . 1.7 m -104.18 128.93 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.179 -0.608 . . . . 0.43 109.663 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.518 ' HD2' ' O ' ' A' ' 161' ' ' ARG . 21.0 m-85 -109.72 124.76 51.8 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.069 -0.715 . . . . 5.41 109.069 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.92 131.15 43.99 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.346 -0.541 . . . . 2.41 109.689 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.539 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 20.7 mt-30 -93.7 130.35 39.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.943 -0.572 . . . . 1.31 111.044 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.69 -11.17 59.85 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.509 -0.922 . . . . 2.4 108.509 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 1.1 ptt180 -164.71 150.57 8.95 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 114.44 -1.255 . . . . 4.07 109.919 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.599 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 15.1 Cg_exo -66.56 132.68 29.72 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.198 2.599 . . . . 1.21 112.49 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.674 HD12 ' SG ' ' A' ' 133' ' ' CYS . 3.6 mm? -64.17 151.69 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.753 -0.658 . . . . 1.16 111.335 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 39.08 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.25 1.024 . . . . 3.23 109.866 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.746 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.7 m -53.44 138.49 33.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.51 -1.677 . . . . 2.79 113.058 -172.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.55 18.18 10.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.07 -0.968 . . . . 2.96 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.746 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.8 mm-40 -69.14 126.71 92.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.758 -0.655 . . . . 1.39 110.413 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.06 116.43 2.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.162 2.575 . . . . 1.38 112.288 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mm -63.0 115.08 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.94 110.553 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 67.5 mt -100.61 146.4 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.533 -0.543 . . . . 1.61 109.533 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 141' ' ' ARG . 55.5 m -111.35 35.39 3.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.721 -0.672 . . . . 1.88 111.234 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.973 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.4 OUTLIER 63.22 -18.61 0.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.027 1.331 . . . . 1.33 113.537 175.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.4 mtt180 -84.55 135.9 34.02 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.188 -0.301 . . . . 3.83 110.188 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.613 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.9 m 81.97 131.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.97 1.419 . . . . 1.32 110.641 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.12 33.98 5.91 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.479 -0.782 . . . . 1.13 112.399 -175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.01 -30.48 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.625 0.25 . . . . 2.66 111.424 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.99 70.61 1.35 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.211 0.529 . . . . 2.18 111.013 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.451 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 49.3 mtt180 -79.94 -66.06 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 5.37 110.419 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -130.36 -143.42 5.36 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.693 -0.765 . . . . 0.9 112.079 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 64.83 23.55 12.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.516 0.674 . . . . 1.59 110.473 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -119.79 125.97 49.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.997 -1.002 . . . . 2.27 108.394 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -76.9 127.76 33.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.333 0.587 . . . . 1.87 111.703 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 4.5 m -61.01 -31.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.04 -0.982 . . . . 0.96 110.967 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.74 -39.77 92.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.773 -0.649 . . . . 0.76 109.999 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.7 m -67.56 -34.77 77.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.396 -0.366 . . . . 1.22 111.127 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.892 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 33.2 m-85 -59.28 -50.32 74.46 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.579 0.704 . . . . 1.1 110.058 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -63.02 -50.15 71.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.875 -1.057 . . . . 3.36 111.139 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.0 mtmt -62.32 -27.92 69.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.281 -0.418 . . . . 1.52 111.766 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -53.98 -53.48 52.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.193 -0.458 . . . . 2.13 111.352 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -103.97 9.92 36.41 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.274 -0.571 . . . . 5.77 111.222 -173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 65.37 44.0 3.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.558 0.694 . . . . 2.42 110.18 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 160' ' ' LEU . 2.3 tp -78.45 164.68 24.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.062 -0.972 . . . . 1.27 111.037 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.638 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 22.4 tpt180 -86.9 -179.47 6.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 4.0 109.763 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.638 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -75.93 160.4 78.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.119 -0.326 . . . . 1.21 110.119 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.472 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 23.4 Cg_exo -60.69 141.97 96.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.802 2.335 . . . . 0.68 113.201 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.893 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.1 t -95.06 -39.44 10.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.608 -0.723 . . . . 0.5 110.15 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.701 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -136.94 145.02 43.74 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.035 -0.666 . . . . 0.29 111.794 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.784 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.39 149.11 21.22 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.258 -0.883 . . . . 0.24 112.626 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 25' ' ' LEU . 12.5 t -170.59 142.0 1.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.369 -0.604 . . . . 0.34 109.369 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.779 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -108.9 144.72 36.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.032 0.444 . . . . 2.16 111.93 -174.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.796 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 1.9 p90 -137.63 105.5 5.64 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.007 -0.738 . . . . 1.31 109.007 171.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.755 ' HG2' ' N ' ' A' ' 118' ' ' HIS . 7.8 tp-100 -100.39 169.61 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.679 -1.263 . . . . 2.53 112.132 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 170' ' ' GLN . . . -146.23 160.19 42.31 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.134 -0.691 . . . . 0.75 109.134 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.44 -171.99 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.314 -0.403 . . . . 2.38 110.448 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.614 ' HA ' HG23 ' A' ' 177' ' ' VAL . 8.3 t90 -80.48 68.85 6.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.435 . . . . 4.71 109.897 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.8 -61.33 1.82 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.453 -0.34 . . . . 1.53 111.839 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 16.6 t70 -168.94 -55.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.088 0.403 . . . . 1.26 112.088 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.455 ' CD2' HG22 ' A' ' 44' ' ' THR . 50.7 m-85 -81.57 11.21 4.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.48 0.548 . . . . 2.46 112.48 -176.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.701 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 91.3 t -71.61 -53.68 7.23 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.579 -0.526 . . . . 0.58 109.579 171.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.701 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.0 Cg_exo -49.74 -43.22 41.16 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.706 2.271 . . . . 0.68 112.603 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.637 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 4.7 mmmp? -70.35 -24.69 63.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.896 0.332 . . . . 2.62 111.896 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 51.7 tp -70.39 -47.63 59.95 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.333 -0.617 . . . . 1.18 109.333 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.22 -37.44 77.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 2.11 109.449 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 4.8 mm-40 -60.14 -45.68 92.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.91 -1.041 . . . . 1.53 111.271 172.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.07 -32.49 72.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 2.16 111.864 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 63.4 mt -63.13 0.11 0.66 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.149 0.796 . . . . 0.87 113.149 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.474 ' HB2' ' HE2' ' A' ' 187' ' ' LYS . 14.5 m -74.07 -9.86 59.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.305 0.574 . . . . 1.38 109.967 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.61 58.26 3.9 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.591 -1.003 . . . . 1.17 110.591 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.474 ' HE2' ' HB2' ' A' ' 185' ' ' SER . 71.1 mmtt . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.341 -0.838 . . . . 2.45 110.655 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 121.307 0.575 . . . . 2.1 111.647 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -155.22 154.81 32.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.562 -0.533 . . . . 1.81 109.562 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.421 ' O ' ' HE3' ' A' ' 8' ' ' TRP . 2.3 mm? -81.19 27.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.48 0.178 . . . . 0.95 111.48 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 2.0 m -62.5 -29.89 70.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.991 0.424 . . . . 2.19 111.391 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.528 ' HB2' HD13 ' A' ' 12' ' ' LEU . 6.8 mptt -120.66 51.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.397 -0.365 . . . . 3.07 110.109 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.421 ' HE3' ' O ' ' A' ' 5' ' ' LEU . 12.9 p90 -72.39 -23.32 61.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.45 . . . . 4.76 111.244 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 70.7 p -148.34 7.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.427 -0.509 . . . . 0.98 112.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.455 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.14 -122.28 0.08 OUTLIER Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.806 -0.711 . . . . 0.52 112.102 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.0 Cg_endo -49.37 -42.35 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.259 2.639 . . . . 0.61 110.253 168.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.673 HD12 ' HG ' ' A' ' 168' ' ' CYS . 17.7 mt -88.0 81.98 7.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.646 -1.161 . . . . 1.85 109.323 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -74.7 62.14 1.04 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.542 0.687 . . . . 1.31 110.438 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.477 HD21 HG23 ' A' ' 121' ' ' VAL . 36.4 mt -79.04 -19.93 50.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.183 -0.917 . . . . 0.61 110.922 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -61.13 -15.5 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 2.61 111.262 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.7 -32.8 74.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.95 0.405 . . . . 1.93 110.984 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.491 HG11 HG22 ' A' ' 151' ' ' VAL . 98.1 t -90.33 -64.15 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.532 -0.758 . . . . 1.26 110.883 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.471 ' HA ' HH22 ' A' ' 155' ' ' ARG . 5.8 p-10 -115.06 175.95 5.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.077 0.465 . . . . 2.99 111.101 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 20.6 mt-10 -95.09 33.92 1.46 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.879 -0.6 . . . . 1.6 111.412 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER 52.38 133.67 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.217 1.407 . . . . 4.38 113.459 -176.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -80.74 154.17 20.23 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.843 2.362 . . . . 0.69 113.711 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.833 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 6.3 pt20 -74.51 -18.75 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.793 -1.094 . . . . 1.87 111.011 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.755 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.1 m80 -145.93 156.87 51.34 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.525 -0.761 . . . . 2.35 109.7 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 5.0 Cg_endo -85.83 127.43 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 123.056 2.504 . . . . 0.44 111.16 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 17.9 tp -76.97 142.04 40.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.492 -0.322 . . . . 0.33 110.572 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 27.0 m-70 -109.26 115.58 30.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.565 -0.531 . . . . 2.12 109.565 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 HG13 HG22 ' A' ' 53' ' ' ILE . 15.2 t -126.48 119.81 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 1.12 109.691 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -117.68 138.8 51.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.158 0.504 . . . . 0.78 110.411 -177.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -98.16 172.41 7.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.94 -0.573 . . . . 1.23 109.474 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.8 -52.28 64.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.215 0.531 . . . . 0.6 110.739 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.98 -14.68 14.46 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.351 -0.84 . . . . 0.81 112.549 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.37 -170.0 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.021 0.438 . . . . 0.56 110.614 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.74 141.76 8.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.762 -0.653 . . . . 0.35 110.464 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.652 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 92.6 t -91.73 61.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.929 -1.508 . . . . 0.39 106.929 165.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -85.59 10.61 12.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.672 -1.149 . . . . 0.99 110.702 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.1 tt0 -146.16 134.38 21.71 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.732 -0.667 . . . . 2.56 109.431 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -73.48 111.27 8.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.46 -0.571 . . . . 0.46 109.46 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 90.5 17.59 51.96 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.156 -0.545 . . . . 0.59 112.548 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.85 150.68 32.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 1.04 109.703 174.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.9 p -78.73 134.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 1.16 110.66 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.5 tp -131.37 169.7 15.66 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.276 -1.009 . . . . 0.45 108.276 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 3.3 p -122.01 158.1 55.97 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.623 0.601 . . . . 1.0 112.623 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 9.5 Cg_endo -51.35 -48.76 19.69 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.528 2.819 . . . . 1.0 113.818 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 p -61.73 -32.84 73.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 1.24 111.687 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.73 -11.44 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.995 -0.548 . . . . 1.74 111.604 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.592 ' CG1' HD21 ' A' ' 41' ' ' LEU . 29.4 m -129.65 28.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.354 0.597 . . . . 1.1 111.112 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.32 -21.77 25.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.555 -0.748 . . . . 1.32 110.135 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.03 -173.0 2.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.839 -0.618 . . . . 2.4 109.569 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.86 155.38 77.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.108 -0.33 . . . . 1.78 110.108 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.6 152.87 29.9 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.117 1.878 . . . . 0.41 110.732 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 t -76.8 -18.25 58.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.419 -0.355 . . . . 0.88 110.057 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.48 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 58.8 m -160.33 143.29 13.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.556 0.693 . . . . 0.65 112.363 -176.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.512 HD13 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.66 168.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.864 -1.162 . . . . 0.33 107.864 170.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.749 ' HA ' HD11 ' A' ' 58' ' ' LEU . 37.3 t 171.96 123.9 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.484 -0.561 . . . . 0.8 109.484 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.638 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 45.3 p-90 -82.23 154.75 25.26 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.862 -1.162 . . . . 3.63 107.862 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.59 89.13 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.009 0.433 . . . . 1.51 110.861 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.91 13.09 4.64 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.487 -0.778 . . . . 0.9 112.011 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.749 HD11 ' HA ' ' A' ' 54' ' ' SER . 5.3 tt -54.23 129.52 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.19 0.519 . . . . 0.62 111.267 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.725 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 36.1 t70 -76.42 -27.93 56.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.74 111.531 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.598 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 50.2 m 72.91 1.0 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.054 -0.975 . . . . 1.51 110.52 -172.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.65 -26.87 1.52 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.69 -0.686 . . . . 0.84 112.733 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.725 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 34.3 mtpt -77.53 149.27 34.93 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.086 0.469 . . . . 2.12 110.549 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.627 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 43.0 mt -87.69 126.72 35.14 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.163 -0.926 . . . . 1.23 108.736 173.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 1.7 m-85 -121.44 163.69 18.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.52 -0.472 . . . . 1.61 110.168 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.957 HG21 HG11 ' A' ' 90' ' ' VAL . 4.0 m -106.56 105.35 15.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.129 -0.693 . . . . 0.87 109.129 173.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 HG11 ' A' ' 124' ' ' VAL . 52.8 tp -102.8 116.34 32.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.001 0.429 . . . . 1.35 110.517 -176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.6 t -119.78 129.91 74.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.049 -0.523 . . . . 0.54 110.67 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 1.058 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.1 mt -93.38 137.06 33.05 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.791 -0.818 . . . . 0.65 108.791 171.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 7.0 t -139.47 149.2 43.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.656 0.265 . . . . 1.04 111.65 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 16.0 t0 -133.8 90.71 26.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.538 0.685 . . . . 1.92 109.697 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.9 Cg_endo -54.81 -26.54 48.31 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 124.034 3.156 . . . . 1.25 114.431 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 58.5 m-20 -85.16 36.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.065 0.395 . . . . 1.29 112.065 -168.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.93 140.34 20.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.19 -0.319 . . . . 0.56 111.566 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 73.0 Cg_endo -78.88 -28.04 7.86 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 122.848 -1.73 . . . . 0.7 112.037 -0.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.652 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -133.37 143.47 48.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.182 -0.917 . . . . 1.1 108.761 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 37.3 ttp180 -72.33 -23.08 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 3.39 112.23 -174.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.686 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -75.57 -11.51 60.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.49 . . . . 1.83 110.419 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -162.14 75.5 2.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 1.37 109.572 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.06 103.33 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.656 2.237 . . . . 0.9 112.994 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.6 mttm -88.05 -48.64 7.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.704 -1.134 . . . . 1.53 110.918 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.701 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 56.0 m-85 -80.45 2.4 25.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.14 -0.937 . . . . 1.54 112.336 -165.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -60.62 128.69 37.84 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.241 -0.651 . . . . 3.38 109.241 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 6.1 tm-20 -88.45 128.71 35.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.933 0.893 . . . . 2.23 110.903 2.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.435 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 22.1 t90 -114.75 91.92 3.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.819 -0.628 . . . . 1.77 109.86 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.762 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 4.5 p-80 -83.92 158.88 21.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.061 0.934 . . . . 2.19 112.535 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 1.058 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t-80 -100.99 -38.45 8.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.047 -1.433 . . . . 2.74 111.378 -172.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.601 ' HB2' ' HD1' ' A' ' 86' ' ' HIS . 55.3 t80 -167.11 137.58 3.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.076 -0.249 . . . . 2.21 110.469 -165.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.65 HD21 ' HH ' ' A' ' 158' ' ' TYR . 22.4 tp -126.74 114.42 17.95 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.249 0.343 . . . . 0.68 110.41 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.79 135.93 61.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.421 0.629 . . . . 0.35 110.823 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.957 HG11 HG21 ' A' ' 65' ' ' THR . 8.1 m -130.19 162.65 37.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.3 108.851 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.627 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.0 OUTLIER 61.54 20.21 11.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.321 0.388 . . . . 2.09 110.863 177.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.512 ' HE2' ' HB2' ' A' ' 92' ' ' MET . 11.2 ttm -70.49 111.31 5.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.83 -0.804 . . . . 0.34 108.83 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 93' ' ' LYS . 18.1 ttmm -87.78 87.4 7.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.893 -1.048 . . . . 1.73 110.341 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 88.57 -129.52 9.65 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 114.878 -1.055 . . . . 0.35 112.495 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.512 ' HB3' HD22 ' A' ' 58' ' ' LEU . 32.3 p30 -116.17 27.13 9.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 1.59 110.888 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -93.93 112.51 24.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.77 109.924 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.512 HD11 HD13 ' A' ' 53' ' ' ILE . 5.6 mm -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.578 -1.192 . . . . 0.45 111.231 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.9 m -85.59 -34.33 21.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.887 -0.597 . . . . 1.15 112.023 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -63.49 -29.4 70.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.26 111.766 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.494 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -58.21 110.91 2.74 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.791 -0.64 . . . . 0.44 113.471 -177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.0 m -70.58 107.43 3.88 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.195 -0.668 . . . . 1.06 109.195 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 105' ' ' ASP . 8.3 p -87.29 145.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.67 0.748 . . . . 1.15 111.989 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.452 ' N ' HG21 ' A' ' 102' ' ' VAL . 13.8 mt -119.4 -32.3 4.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.689 -1.141 . . . . 0.48 109.12 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 14.7 t -131.55 102.02 5.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.769 -1.196 . . . . 0.62 107.769 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.901 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.9 OUTLIER -64.59 169.07 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 1.15 113.2 -167.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.445 ' HD1' ' H ' ' A' ' 106' ' ' TYR . 4.1 p90 -74.34 88.73 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.947 -1.024 . . . . 4.98 110.936 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.702 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 23.8 t -66.49 -49.15 77.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.86 111.082 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.566 ' HA3' ' HZ3' ' A' ' 47' ' ' LYS . . . 112.53 -170.18 13.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.798 -0.715 . . . . 0.95 112.338 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.9 t -67.3 125.56 26.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 0.89 109.824 173.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.697 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -159.01 63.55 0.3 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.615 -0.802 . . . . 0.82 112.922 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.555 ' HB2' ' HD1' ' A' ' 173' ' ' TRP . 10.1 Cg_endo -89.68 133.73 2.21 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.884 2.39 . . . . 1.01 111.844 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.716 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 53.0 Cg_exo -53.32 129.35 33.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.149 . . . . 0.96 111.196 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.528 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.8 OUTLIER -60.56 121.36 11.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.191 0.52 . . . . 2.39 111.712 -174.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.68 -6.39 52.21 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.479 -0.782 . . . . 1.3 113.252 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.716 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -80.65 -5.98 57.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.2 0.444 . . . . 1.04 112.2 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.62 178.38 45.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.915 -0.659 . . . . 1.97 111.571 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.56 144.93 56.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.94 110.657 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 1.0 OUTLIER -121.93 130.88 53.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.138 -0.69 . . . . 2.85 109.138 174.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 8.4 ptp85 -110.72 95.71 5.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.4 0.619 . . . . 2.78 111.361 -170.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.612 ' HA ' ' O ' ' A' ' 69' ' ' THR . 36.8 m-85 -73.87 113.55 11.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 1.13 109.357 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 168' ' ' CYS . 7.1 t -90.52 129.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.604 -0.726 . . . . 0.31 110.062 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.646 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 77.4 m95 -87.54 117.98 26.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.943 -1.132 . . . . 2.96 107.943 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.52 118.37 30.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.24 -0.184 . . . . 0.41 110.557 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 66' ' ' LEU . 1.2 m -105.33 128.24 59.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.342 -0.614 . . . . 0.43 109.342 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.405 ' HB2' ' CD2' ' A' ' 160' ' ' LEU . 88.2 m-85 -110.62 146.53 35.98 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.794 -0.639 . . . . 5.41 109.618 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.9 tt0 -105.58 109.88 22.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.028 -0.533 . . . . 2.41 109.954 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.645 ' HG2' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -72.38 172.52 10.25 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.447 -0.797 . . . . 1.31 109.644 177.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -85.59 -15.21 43.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.794 -0.639 . . . . 2.4 109.397 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.484 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 5.2 ppt_? -158.1 168.5 12.32 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.138 -0.937 . . . . 4.07 110.861 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.52 ' HG3' HD11 ' A' ' 63' ' ' LEU . 87.2 Cg_exo -47.93 147.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.045 2.497 . . . . 1.21 113.025 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.796 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -71.5 157.05 38.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.795 -0.638 . . . . 1.16 112.006 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -146.93 79.36 1.52 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.092 -0.958 . . . . 3.23 108.493 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 3.5 m -102.25 139.9 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.086 0.469 . . . . 2.79 111.183 -173.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -112.89 17.73 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 2.96 109.533 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 15.8 mm-40 -68.81 132.17 90.82 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.259 -0.882 . . . . 1.39 110.941 -174.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.13 111.36 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.465 2.776 . . . . 1.38 113.065 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' A' ' 103' ' ' LEU . 42.9 mm -62.24 125.64 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.711 -0.677 . . . . 0.94 111.583 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -112.12 141.22 46.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.566 -0.531 . . . . 1.61 109.566 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 141' ' ' ARG . 19.6 m -102.13 40.59 1.32 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.569 -0.741 . . . . 1.88 110.728 -173.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.901 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 59.11 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.992 1.317 . . . . 1.33 113.506 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.598 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 47.0 mtt85 -84.59 155.78 21.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.121 -0.696 . . . . 3.83 109.121 173.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.554 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 10.3 p 52.72 120.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.769 1.227 . . . . 1.32 113.05 -171.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -97.3 30.99 8.21 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.119 -0.946 . . . . 1.13 112.308 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.54 -34.67 72.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.937 0.717 . . . . 2.66 112.937 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -125.65 42.05 3.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.305 0.574 . . . . 2.18 111.417 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.422 ' HD2' HG23 ' A' ' 107' ' ' VAL . 42.7 mtp180 -87.47 -18.3 30.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.031 -0.532 . . . . 5.37 112.157 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -145.25 -171.59 15.04 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 119.056 -1.545 . . . . 0.9 114.884 -173.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.701 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.0 mttt 61.87 37.5 15.27 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 114.319 -0.94 . . . . 1.59 110.887 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 80.4 m-85 -120.71 173.99 6.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.275 -1.33 . . . . 2.27 108.281 170.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 12.1 mmmm -117.27 123.53 46.8 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.679 -0.408 . . . . 1.87 111.679 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.491 HG22 HG11 ' A' ' 17' ' ' VAL . 6.6 m -57.98 -26.09 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.852 -0.613 . . . . 0.96 110.791 174.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -68.15 -43.59 77.93 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.905 -0.589 . . . . 0.76 109.93 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.579 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 23.7 m -61.88 -39.16 90.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 1.22 110.273 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -62.53 -48.85 77.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.248 -0.433 . . . . 1.1 110.96 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.8 ptp180 -67.38 -33.8 75.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.86 -0.336 . . . . 3.36 110.723 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 48.8 mtmt -67.94 -28.63 67.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 1.52 110.825 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -72.8 -51.88 17.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 2.13 110.965 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.688 ' HB2' HD13 ' A' ' 160' ' ' LEU . 12.3 m-85 -84.48 -2.11 56.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.363 -0.38 . . . . 5.77 111.978 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 19.4 mm-40 69.19 45.63 0.86 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.689 0.757 . . . . 2.42 110.932 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.688 HD13 ' HB2' ' A' ' 158' ' ' TYR . 5.7 mp -99.53 140.17 34.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.768 -1.106 . . . . 1.27 109.541 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -88.97 -84.43 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 4.0 111.451 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.53 163.16 48.93 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.579 -0.526 . . . . 1.21 109.579 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.576 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.8 133.27 41.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.48 2.12 . . . . 0.68 112.128 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.833 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -89.12 -31.49 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 108.927 -0.768 . . . . 0.5 108.927 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.755 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.57 144.64 24.58 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.5 -0.773 . . . . 0.29 111.261 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.94 146.82 16.66 Favored Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 115.006 -0.997 . . . . 0.24 111.682 176.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.766 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.4 t -160.11 131.21 5.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.945 -0.761 . . . . 0.34 108.945 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.673 ' HG ' HD12 ' A' ' 12' ' ' LEU . 16.5 p -110.91 138.25 47.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.177 0.513 . . . . 2.16 110.862 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.602 ' HB3' HG22 ' A' ' 34' ' ' VAL . 28.1 p90 -119.57 125.37 48.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.078 -1.082 . . . . 1.31 108.078 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -103.92 132.2 50.4 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.754 -0.779 . . . . 2.53 109.928 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -124.33 140.04 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 0.75 111.613 -172.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.62 151.67 26.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 2.38 111.341 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.999 ' HA ' HG23 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -76.26 68.35 2.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.21 -0.904 . . . . 4.71 108.949 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.54 -61.53 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.143 -0.935 . . . . 1.53 112.32 -170.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.595 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.2 t70 -171.44 -38.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.868 0.366 . . . . 1.26 111.802 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -80.03 2.04 25.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 2.46 110.605 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.999 HG23 ' HA ' ' A' ' 173' ' ' TRP . 48.7 t -69.46 -51.22 17.17 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.761 -0.654 . . . . 0.58 111.371 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.595 ' HD2' ' O ' ' A' ' 175' ' ' ASP . 84.9 Cg_exo -50.29 -31.72 30.6 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.253 1.968 . . . . 0.68 112.567 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.08 -22.68 63.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.401 . . . . 2.62 111.42 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.697 HD22 ' HA3' ' A' ' 110' ' ' GLY . 42.6 tp -68.36 -44.45 75.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.313 -0.555 . . . . 1.18 109.591 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -61.4 -37.8 84.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.292 -0.633 . . . . 2.11 109.292 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.659 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.3 mm-40 -55.19 -42.03 72.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.909 -1.041 . . . . 1.53 110.319 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.58 ' HA ' ' HB2' ' A' ' 187' ' ' LYS . 5.4 tt0 -77.35 -35.31 54.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 2.16 112.453 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 80.7 mt -63.34 -2.85 1.63 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.003 0.372 . . . . 0.87 112.003 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.745 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.4 m -81.53 13.94 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 1.38 109.566 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.598 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 69.84 46.31 53.59 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.065 -0.97 . . . . 1.17 111.201 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.745 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.451 -0.785 . . . . 2.45 109.993 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.835 0.35 . . . . 2.1 110.277 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.529 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 15.6 t70 -162.2 156.57 21.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.816 -0.809 . . . . 1.81 108.816 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.46 20.8 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.657 0.265 . . . . 0.95 111.101 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -11.73 61.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.126 0.488 . . . . 2.19 110.906 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HB3' HD12 ' A' ' 12' ' ' LEU . 95.3 mttt -116.86 30.88 7.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 3.07 110.352 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.835 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -75.62 -23.4 56.37 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.452 0.538 . . . . 4.76 112.452 -173.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 13.7 p -152.9 26.47 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 0.98 111.199 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.97 -119.66 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.014 -0.834 . . . . 0.52 111.014 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 19.4 Cg_endo -55.47 -36.47 94.27 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.832 2.355 . . . . 0.61 110.329 164.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.669 HD13 ' HA3' ' A' ' 38' ' ' GLY . 13.4 mt -89.05 85.74 6.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.638 -1.164 . . . . 1.85 110.669 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -74.78 62.41 1.08 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.334 0.588 . . . . 1.31 110.728 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.546 HD11 ' HG ' ' A' ' 168' ' ' CYS . 46.7 mt -78.03 -16.67 57.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.61 111.577 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -12.29 56.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.272 0.558 . . . . 2.61 110.43 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -67.92 -20.27 65.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 1.93 111.056 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.825 HG12 HG21 ' A' ' 69' ' ' THR . 70.6 t -92.09 -66.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.794 -0.639 . . . . 1.26 110.791 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.75 170.86 14.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 2.99 110.682 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -70.22 105.79 3.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 1.6 109.285 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.835 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 27.5 mm-40 -47.53 134.73 10.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 O-C-N 123.91 0.756 . . . . 4.38 112.346 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 39.0 Cg_exo -62.43 169.04 8.72 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.389 3.392 . . . . 0.69 114.898 -167.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.897 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 11.4 pt20 -82.25 -13.25 57.33 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.74 -1.118 . . . . 1.87 111.907 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.755 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.6 m170 -149.09 159.52 37.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.871 -0.604 . . . . 2.35 109.544 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 3.9 Cg_endo -85.44 127.96 3.4 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.079 2.519 . . . . 0.44 111.101 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.499 HD22 ' CG1' ' A' ' 124' ' ' VAL . 26.9 tp -78.0 147.84 34.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.735 0.303 . . . . 0.33 110.854 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -116.72 107.72 15.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.867 -0.42 . . . . 2.12 109.867 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 53' ' ' ILE . 6.9 t -114.56 127.91 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.085 -0.709 . . . . 1.12 109.085 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -126.27 138.82 53.65 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.923 0.392 . . . . 0.78 110.678 -176.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -101.51 170.96 7.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.019 -0.537 . . . . 1.23 109.66 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.82 68.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.463 0.649 . . . . 0.6 110.654 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.47 13.67 25.42 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.253 -0.885 . . . . 0.81 112.511 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.4 -171.1 3.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.935 0.398 . . . . 0.56 110.634 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.451 ' HB1' HG22 ' A' ' 28' ' ' THR . . . -163.48 147.1 10.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.757 -0.656 . . . . 0.35 110.203 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.802 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -104.36 58.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.084 -1.45 . . . . 0.39 107.084 165.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.74 30.26 1.85 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.99 109.793 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.4 tt0 -157.86 127.91 6.14 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.126 -0.943 . . . . 2.56 108.827 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -68.58 111.17 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.46 110.026 -176.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.669 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 87.11 14.86 63.64 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.447 -0.797 . . . . 0.59 112.756 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.802 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.89 147.03 47.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 1.04 109.653 175.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.412 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.2 p -74.38 132.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.912 0.387 . . . . 1.16 110.956 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.596 HD21 ' CG1' ' A' ' 46' ' ' VAL . 6.3 tp -132.46 167.21 20.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.952 -0.759 . . . . 0.45 108.952 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.86 157.07 47.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.699 0.629 . . . . 1.0 112.699 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 89.3 Cg_exo -50.56 -45.84 32.77 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.158 2.572 . . . . 1.0 113.044 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.617 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 8.2 p -54.65 -39.63 68.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.58 0.705 . . . . 1.24 111.214 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -83.32 -7.91 59.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.01 -0.995 . . . . 1.74 112.425 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.596 ' CG1' HD21 ' A' ' 41' ' ' LEU . 17.8 m -131.84 27.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.372 0.606 . . . . 1.1 111.543 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HZ1' ' HA3' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -95.55 5.36 51.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 1.32 110.574 -175.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -152.5 179.02 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 2.4 109.442 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HB3' HG23 ' A' ' 97' ' ' ILE . 76.4 mtt180 -68.53 148.47 98.12 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.118 -0.327 . . . . 1.78 110.118 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.43 166.29 26.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.059 1.839 . . . . 0.41 110.823 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -87.92 -19.09 27.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.894 -0.41 . . . . 0.88 109.894 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.513 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 47.6 m -158.1 143.11 16.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.785 0.661 . . . . 0.65 112.785 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -140.27 157.67 25.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.502 -1.226 . . . . 0.33 107.915 170.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.662 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 30.4 t 173.77 135.42 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.11 -0.7 . . . . 0.8 109.11 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.79 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -88.96 177.1 6.75 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 3.63 108.229 173.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.67 76.86 0.11 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.873 0.368 . . . . 1.51 110.693 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.88 40.4 0.99 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.293 -0.48 . . . . 0.9 112.84 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.662 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 7.5 tt -65.17 127.87 33.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.62 110.145 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.2 -30.5 68.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.844 -0.616 . . . . 0.74 111.947 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.531 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 44.8 m 72.14 -3.69 2.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.12 -0.946 . . . . 1.51 110.752 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.64 5.7 26.18 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.834 -0.621 . . . . 0.84 112.501 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.0 mmpt? -111.86 160.33 17.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.614 0.245 . . . . 2.12 110.366 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.76 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 mt -97.46 141.85 30.03 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.518 -1.29 . . . . 1.23 107.518 168.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.668 ' CE2' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -136.72 147.2 46.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.842 -0.343 . . . . 1.61 110.205 -178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.863 HG21 HG11 ' A' ' 90' ' ' VAL . 4.4 m -95.7 104.76 16.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.622 -0.881 . . . . 0.87 108.622 174.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.1 tp -101.7 109.12 20.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.587 -0.733 . . . . 1.35 109.387 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.459 HG22 ' CD1' ' A' ' 88' ' ' LEU . 20.9 t -115.3 122.45 69.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.405 -0.361 . . . . 0.54 110.95 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.877 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -86.62 134.03 33.66 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.744 -0.836 . . . . 0.65 108.744 169.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.825 HG21 HG12 ' A' ' 17' ' ' VAL . 13.3 t -138.9 148.56 43.78 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.928 -0.309 . . . . 1.04 111.073 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.517 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 30.4 t70 -131.22 99.37 17.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.264 0.554 . . . . 1.92 110.217 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.517 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.3 Cg_endo -53.4 -34.29 70.57 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 124.179 3.252 . . . . 1.25 114.437 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.795 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -89.96 40.2 0.99 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.174 0.435 . . . . 1.29 112.174 -168.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.06 144.92 29.65 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.708 -0.224 . . . . 0.56 111.506 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.0 Cg_endo -83.83 -20.58 18.78 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 123.259 -1.559 . . . . 0.7 112.102 -0.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.694 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 77.7 p -134.87 146.82 49.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 1.1 109.846 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.795 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 58.7 mtp180 -70.3 -22.74 62.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.916 0.339 . . . . 3.39 111.916 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.78 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.45 -14.8 45.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.277 0.561 . . . . 1.83 110.517 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.44 79.51 4.9 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.004 -0.739 . . . . 1.37 109.004 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.97 81.28 1.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.863 2.376 . . . . 0.9 113.049 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.503 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 13.6 mttm -71.99 -51.57 21.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.514 -1.221 . . . . 1.53 111.251 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.687 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 38.9 m-85 -86.39 19.11 2.89 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.401 -0.818 . . . . 1.54 111.896 -167.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 6.7 ttp180 -67.05 127.19 31.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.856 -0.611 . . . . 3.38 110.06 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.8 mp0 -98.2 138.61 35.22 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.328 0.251 . . . . 2.23 110.36 -1.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.44 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 5.9 t90 -89.88 105.81 18.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 1.77 110.03 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.9 p80 -80.82 122.43 27.18 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.452 0.644 . . . . 2.19 110.203 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.877 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.6 t-160 -61.8 -40.56 95.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.981 -1.009 . . . . 2.74 110.649 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.524 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 26.0 p90 -167.17 178.45 5.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.622 -0.511 . . . . 2.21 109.622 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.8 tp -141.84 113.65 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.708 0.289 . . . . 0.68 110.247 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.524 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.8 t -120.42 132.47 69.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.817 -0.628 . . . . 0.35 110.573 176.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.863 HG11 HG21 ' A' ' 65' ' ' THR . 3.8 m -129.92 166.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.095 -1.076 . . . . 0.3 108.095 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.76 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 91.1 m-20 60.85 20.44 10.65 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 123.486 0.491 . . . . 2.09 111.141 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.575 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.6 ttm -72.28 115.17 11.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.693 -0.854 . . . . 0.34 108.693 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 93' ' ' LYS . 15.1 ttmm -87.06 93.17 9.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.314 -0.857 . . . . 1.73 111.307 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 60' ' ' SER . . . 80.33 -129.75 9.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 114.829 -1.078 . . . . 0.35 112.48 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.459 ' HB3' HD22 ' A' ' 58' ' ' LEU . 26.1 p30 -112.91 22.12 14.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.604 0.716 . . . . 1.59 110.512 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.31 112.79 24.48 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.992 -1.004 . . . . 0.77 109.609 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.467 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 5.3 mm -59.95 -27.6 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.358 -1.292 . . . . 0.45 111.103 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -69.73 -51.36 34.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 1.15 112.112 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 p -61.85 -20.55 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.822 0.675 . . . . 1.26 112.822 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.575 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -52.91 103.08 0.11 Allowed Glycine 0 N--CA 1.449 -0.455 0 O-C-N 123.352 0.408 . . . . 0.44 112.92 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.4 m -68.05 107.39 2.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.436 0.636 . . . . 1.06 109.773 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.68 120.77 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.896 -1.047 . . . . 1.15 111.617 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.617 HD23 ' HG ' ' A' ' 133' ' ' CYS . 55.8 mt -99.32 -44.71 6.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.227 1.013 . . . . 0.48 109.289 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.9 t -120.51 111.9 18.27 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.885 -1.524 . . . . 0.62 106.885 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.832 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 2.3 t0 -64.84 162.04 17.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.551 -0.75 . . . . 1.15 112.018 -170.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 31.0 p90 -81.23 61.22 4.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.339 0.866 . . . . 4.98 113.339 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.907 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 27.0 t -37.54 -47.32 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.017 0.927 . . . . 0.86 113.365 -171.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.588 ' HA3' ' HZ1' ' A' ' 47' ' ' LYS . . . 107.12 -172.45 17.97 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.655 -0.783 . . . . 0.95 112.505 173.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.524 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.4 t -68.9 117.29 10.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.564 -0.532 . . . . 0.89 109.564 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.764 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -148.2 61.43 0.44 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.389 -0.91 . . . . 0.82 112.662 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.651 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 9.8 Cg_endo -91.87 127.15 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.495 2.796 . . . . 1.01 112.734 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.591 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.9 Cg_exo -53.8 146.02 47.53 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.796 2.331 . . . . 0.96 111.775 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.418 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -62.51 119.61 9.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.288 -0.414 . . . . 2.39 111.221 -177.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.9 -1.51 55.29 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.861 -0.685 . . . . 1.3 113.146 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.694 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 77.7 p -77.39 -26.33 51.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.998 0.399 . . . . 1.04 112.002 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 -178.61 17.83 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.953 -0.641 . . . . 1.97 112.232 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.749 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.4 mm? -81.8 116.85 21.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.615 0.245 . . . . 0.94 110.39 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.676 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 40.6 m-70 -92.81 126.8 38.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.416 -0.356 . . . . 2.85 110.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.475 HH11 ' HA ' ' A' ' 12' ' ' LEU . 8.9 ptt180 -108.56 85.92 2.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.757 -0.656 . . . . 2.78 110.664 -172.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.499 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 5.8 m-85 -69.73 116.69 10.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.592 -0.731 . . . . 1.13 109.549 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 168' ' ' CYS . 15.1 t -97.43 128.96 48.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.037 -0.528 . . . . 0.31 110.714 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.663 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 48.7 m95 -88.57 121.54 31.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.177 -0.675 . . . . 2.96 109.177 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.2 mt -118.31 119.91 36.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.624 0.193 . . . . 0.41 110.791 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.499 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -117.52 140.0 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.722 0.296 . . . . 0.43 111.121 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.707 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 89.3 t80 -129.53 129.09 44.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.177 -0.465 . . . . 5.41 109.812 174.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.63 103.2 2.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.549 0.69 . . . . 2.41 109.22 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 23.0 mt-30 -58.41 135.85 57.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.033 -0.985 . . . . 1.31 112.028 -171.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.8 -13.25 61.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.486 -0.779 . . . . 2.4 109.603 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 7.7 ptp180 -173.51 161.75 3.31 Favored Pre-proline 0 CA--C 1.515 -0.381 0 CA-C-N 114.838 -1.073 . . . . 4.07 109.637 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.58 136.22 65.74 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.9 2.4 . . . . 1.21 110.691 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 158' ' ' TYR . 4.1 mm? -68.11 146.89 53.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.721 1.008 . . . . 1.16 113.721 -167.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -99.1 96.52 7.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.176 -1.375 . . . . 3.23 108.073 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.617 ' HG ' HD23 ' A' ' 103' ' ' LEU . 1.4 p -124.88 109.64 13.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.91 -0.586 . . . . 2.79 111.728 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -102.72 18.18 22.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.908 -0.775 . . . . 2.96 108.908 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.79 135.41 96.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.183 -0.917 . . . . 1.39 111.195 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.5 113.89 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.39 2.727 . . . . 1.38 112.531 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.49 120.28 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.94 110.056 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 71.3 mt -99.66 154.59 18.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.13 0.49 . . . . 1.61 110.54 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.676 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 72.1 m -108.03 31.56 5.43 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.263 -0.881 . . . . 1.88 109.689 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.907 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 54.9 12.53 0.61 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.485 1.116 . . . . 1.33 111.553 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.676 ' HG3' ' O ' ' A' ' 139' ' ' SER . 17.1 mtm180 -96.71 146.85 24.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.83 110.097 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.628 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.4 m 77.89 131.14 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.519 1.137 . . . . 1.32 111.958 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.623 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -87.46 -6.5 77.46 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.086 -0.961 . . . . 1.13 112.655 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.521 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 28.7 t70 -54.46 -42.75 70.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.605 0.717 . . . . 2.66 111.374 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.521 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 5.9 m80 -97.3 20.01 12.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.354 -0.839 . . . . 2.18 111.012 -173.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.623 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 63.9 mtt180 -76.7 -69.92 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 5.37 111.835 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -117.3 -173.01 16.32 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.217 -0.992 . . . . 0.9 113.369 -171.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.687 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.5 mttt 68.33 21.89 8.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.728 0.775 . . . . 1.59 110.602 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.648 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 87.7 m-85 -111.3 97.71 6.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.807 -1.088 . . . . 2.27 108.476 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 13.2 mmmm -59.49 123.27 16.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 1.87 112.168 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' CG1' ' A' ' 17' ' ' VAL . 16.8 m -63.84 -25.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.242 -0.89 . . . . 0.96 110.6 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.73 72.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.76 109.608 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 m -59.81 -43.7 94.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 1.22 110.633 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.648 ' CE1' ' HB3' ' A' ' 149' ' ' PHE . 7.0 m-85 -58.56 -53.27 60.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.037 -0.528 . . . . 1.1 111.584 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -69.76 -39.74 76.52 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.479 -0.488 . . . . 3.36 111.379 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.61 -32.3 72.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.97 0.414 . . . . 1.52 110.405 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -66.8 -51.38 56.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.527 -0.76 . . . . 2.13 110.918 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.665 ' HB3' HD13 ' A' ' 131' ' ' LEU . 21.6 m-85 -80.23 3.91 19.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.075 -0.511 . . . . 5.77 111.744 -172.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 8.4 mm-40 70.55 30.67 3.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.589 0.555 . . . . 2.42 111.016 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.707 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.3 mp -102.34 134.24 45.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.563 -0.744 . . . . 1.27 109.79 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.421 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 7.8 tpt180 -102.74 -78.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 4.0 111.181 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -125.85 145.77 52.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 1.21 110.805 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.538 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 2.9 Cg_exo -74.61 161.63 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.908 3.072 . . . . 0.68 113.537 -172.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.897 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 14.4 t -91.43 -26.88 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.632 -1.167 . . . . 0.5 109.895 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 55' ' ' TRP . . . -152.58 145.2 24.2 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.003 -0.679 . . . . 0.29 112.231 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.44 151.05 23.36 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.035 -0.984 . . . . 0.24 112.018 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.564 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.1 t -165.57 141.15 5.11 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.449 -0.945 . . . . 0.34 108.449 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 17.3 p -119.0 149.32 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.034 -0.667 . . . . 2.16 111.045 -175.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.767 ' HB3' HG22 ' A' ' 34' ' ' VAL . 35.7 p90 -130.32 129.71 43.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.94 -1.133 . . . . 1.31 107.94 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -101.52 133.78 45.63 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.867 -0.733 . . . . 2.53 111.417 177.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.94 152.17 49.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.75 109.501 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.749 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -126.37 -162.41 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.006 0.432 . . . . 2.38 111.322 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.418 ' CG ' ' HG2' ' A' ' 113' ' ' LYS . 89.6 t90 -70.46 103.2 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.96 -0.564 . . . . 4.71 110.343 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.521 ' H ' HG23 ' A' ' 177' ' ' VAL . 2.0 t70 -73.69 -62.06 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.583 -0.28 . . . . 1.53 110.371 171.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 11.5 t70 169.45 -50.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 1.26 110.434 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 44' ' ' THR . 2.4 p90 -82.72 9.8 8.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.189 0.519 . . . . 2.46 111.094 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.764 HG12 ' HA2' ' A' ' 110' ' ' GLY . 48.1 t -58.47 -49.15 95.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.094 -0.503 . . . . 0.58 109.972 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 175' ' ' ASP . 72.9 Cg_exo -47.89 -33.75 20.59 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.039 2.493 . . . . 0.68 112.899 168.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.649 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 3.0 mmmp? -72.69 -25.56 61.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.636 0.255 . . . . 2.62 111.108 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.512 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 62.5 tp -70.58 -44.29 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.049 -0.723 . . . . 1.18 109.049 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.27 -32.95 74.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.316 -0.856 . . . . 2.11 109.446 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.5 mm-40 -60.84 -38.29 85.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.955 -1.02 . . . . 1.53 111.02 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.33 -27.08 56.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.74 -0.663 . . . . 2.16 111.439 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.628 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.2 mt -65.93 6.6 0.35 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.852 0.686 . . . . 0.87 112.852 -177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.714 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.2 m -77.15 8.31 4.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 1.38 109.955 173.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 68.89 50.54 34.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.104 -0.798 . . . . 1.17 111.104 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.714 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.8 mmmt . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.667 -0.682 . . . . 2.45 110.582 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 110.275 -0.268 . . . . 2.1 110.275 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.738 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 2.2 p30 -163.39 179.93 6.98 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.142 -1.058 . . . . 1.81 108.142 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 8' ' ' TRP . 2.7 mm? -80.93 36.01 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.95 110.866 -170.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 4' ' ' ASP . 21.7 m -51.91 -40.1 60.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 2.19 111.834 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.534 ' HB2' HD13 ' A' ' 12' ' ' LEU . 92.0 mttt -116.17 46.16 1.62 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.868 -0.419 . . . . 3.07 109.868 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.598 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -66.43 -24.21 66.42 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.286 -0.416 . . . . 4.76 111.328 -173.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.1 p -151.6 26.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.951 -0.3 . . . . 0.98 111.347 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.85 -125.5 0.81 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.888 -0.885 . . . . 0.52 110.888 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -52.02 -36.29 64.45 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.109 2.54 . . . . 0.61 110.342 167.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.717 HD11 ' HA3' ' A' ' 38' ' ' GLY . 35.3 mt -87.87 79.26 8.14 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.825 -1.08 . . . . 1.85 109.606 171.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -71.44 66.73 0.48 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.615 0.722 . . . . 1.31 109.82 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.918 HD23 HH11 ' A' ' 119' ' ' ARG . 44.1 mt -80.45 -16.39 54.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.741 -0.663 . . . . 0.61 110.65 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -64.13 -16.17 61.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.589 -0.732 . . . . 2.61 111.225 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 39.3 mt-10 -62.34 -30.33 71.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.189 0.519 . . . . 1.93 110.546 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.722 HG12 HG21 ' A' ' 69' ' ' THR . 85.7 t -93.41 -64.03 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.16 -174.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -130.04 169.05 15.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.152 -0.476 . . . . 2.99 110.219 -171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -74.57 88.16 2.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.443 -0.947 . . . . 1.6 108.443 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.598 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 2.7 tp-100 -38.34 122.61 1.1 Allowed Pre-proline 0 C--O 1.237 0.433 0 O-C-N 124.925 1.391 . . . . 4.38 111.901 -166.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.703 ' HG3' ' HB2' ' A' ' 163' ' ' PRO . 81.5 Cg_exo -50.29 161.64 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 125.235 3.957 . . . . 0.69 116.193 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.884 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 12.6 pt20 -79.1 -6.96 57.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 113.837 -1.529 . . . . 1.87 111.46 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.708 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.6 m170 -154.28 158.85 32.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.468 -0.787 . . . . 2.35 109.236 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.738 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 6.0 Cg_endo -86.74 129.12 2.98 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.193 2.595 . . . . 0.44 111.844 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' A' ' 122' ' ' TRP . 21.5 tp -78.88 144.54 34.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.654 -0.248 . . . . 0.33 110.728 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.428 ' H ' HD12 ' A' ' 25' ' ' LEU . 86.2 m-70 -112.64 112.94 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 2.12 109.89 174.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG12 HG22 ' A' ' 53' ' ' ILE . 12.0 t -121.12 137.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.423 -0.584 . . . . 1.12 109.423 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -132.4 141.24 48.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.271 0.558 . . . . 0.78 111.063 -177.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -103.14 173.32 6.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.857 -0.794 . . . . 1.23 108.857 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.41 -52.29 65.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.291 0.567 . . . . 0.6 110.347 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.96 14.77 23.83 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.178 -0.919 . . . . 0.81 112.999 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.54 -172.25 4.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.56 111.148 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.95 151.61 12.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.71 -0.677 . . . . 0.35 110.05 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 169' ' ' TYR . 86.2 t -109.23 65.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.157 -1.423 . . . . 0.39 107.157 164.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.83 21.07 16.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.002 -0.999 . . . . 0.99 109.15 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -145.83 128.1 15.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.687 -1.227 . . . . 2.56 107.687 176.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -77.96 111.74 14.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.611 0.72 . . . . 0.46 110.803 -170.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.748 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 83.17 22.35 57.28 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.742 -1.117 . . . . 0.59 111.385 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.753 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -77.68 148.73 34.84 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.388 -0.597 . . . . 1.04 109.388 173.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.96 133.44 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.001 0.429 . . . . 1.16 110.874 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.4 tp -131.58 170.29 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.45 108.618 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.6 p -120.03 158.46 50.25 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.317 0.858 . . . . 1.0 113.317 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 74.9 Cg_exo -50.29 -49.19 17.12 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.438 2.759 . . . . 1.0 113.569 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.7 p -55.72 -42.83 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.462 0.649 . . . . 1.24 111.52 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -73.21 -12.32 60.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.874 -1.057 . . . . 1.74 112.225 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.605 ' CG1' HD21 ' A' ' 41' ' ' LEU . 31.5 m -131.7 28.25 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.087 0.47 . . . . 1.1 111.455 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.635 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -85.12 -33.85 22.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.818 -0.628 . . . . 1.32 110.467 -176.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.414 ' HB3' ' H ' ' A' ' 49' ' ' ARG . 3.8 m-20 -108.46 -155.89 0.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.786 -0.643 . . . . 2.4 109.556 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.414 ' H ' ' HB3' ' A' ' 48' ' ' ASN . 53.9 mtt180 -84.01 157.19 63.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.394 -0.595 . . . . 1.78 109.394 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.4 160.44 28.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.755 1.637 . . . . 0.41 110.594 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -82.15 -20.72 37.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.105 -0.332 . . . . 0.88 110.105 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.543 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 57.9 m -160.32 144.86 14.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.239 0.542 . . . . 0.65 112.056 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.1 168.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.154 -0.93 . . . . 0.33 108.575 171.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.76 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 29.3 t 174.04 122.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.462 -0.57 . . . . 0.8 109.462 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.674 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -79.45 179.52 7.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.337 -0.986 . . . . 3.63 108.337 174.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.8 80.8 0.29 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.15 0.5 . . . . 1.51 110.473 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.17 41.58 1.51 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.633 -0.712 . . . . 0.9 112.386 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.76 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -55.54 133.74 50.41 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.83 0.452 . . . . 0.62 111.51 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.55 -27.38 60.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.848 -0.615 . . . . 0.74 111.867 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.608 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 49.3 m 68.23 8.32 6.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.561 -0.745 . . . . 1.51 110.834 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.68 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -137.17 -47.87 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.905 -0.589 . . . . 0.84 112.662 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.752 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 8.3 mmpt? -58.66 144.54 42.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.231 0.538 . . . . 2.12 111.411 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.716 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 31.0 mt -86.82 127.73 35.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.111 -0.95 . . . . 1.23 109.486 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.752 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -122.3 158.66 29.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.55 -0.46 . . . . 1.61 110.278 176.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.719 HG22 HG11 ' A' ' 90' ' ' VAL . 96.0 m -98.51 109.39 22.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.392 -0.596 . . . . 0.87 109.392 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 tp -106.15 116.83 32.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.864 -0.607 . . . . 1.35 110.052 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.406 HG22 HD11 ' A' ' 88' ' ' LEU . 21.9 t -120.98 132.43 70.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.76 0.314 . . . . 0.54 110.74 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.897 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -97.49 131.57 44.0 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.508 -0.923 . . . . 0.65 108.508 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.722 HG21 HG12 ' A' ' 17' ' ' VAL . 11.0 t -138.82 147.53 42.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.142 0.428 . . . . 1.04 111.657 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 25.6 t70 -131.28 97.43 19.82 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.161 0.505 . . . . 1.92 109.805 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.9 Cg_endo -51.63 -34.56 53.58 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.99 3.127 . . . . 1.25 114.298 176.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -86.97 44.82 1.2 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.654 0.612 . . . . 1.29 112.654 -170.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -104.08 142.12 23.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.687 -0.233 . . . . 0.56 110.706 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.538 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 92.1 Cg_endo -85.07 -24.76 9.58 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 123.465 -1.473 . . . . 0.7 113.096 -0.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.688 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 13.2 p -128.76 146.45 50.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 1.1 109.793 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.725 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 50.8 mtp180 -65.99 -21.89 66.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 3.39 111.141 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 6.0 ptpt -79.66 -14.26 58.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 1.83 110.829 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 16.4 t70 -162.09 80.51 1.88 Allowed Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.007 -0.542 . . . . 1.37 110.188 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 85.6 Cg_endo -80.95 87.21 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.543 2.162 . . . . 0.9 112.93 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -74.74 -50.97 15.49 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.738 -1.119 . . . . 1.53 110.661 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.669 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.1 m-85 -85.45 21.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 1.54 111.742 -166.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 29.4 ttt180 -71.66 129.56 38.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.382 -0.372 . . . . 3.38 110.685 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 3.0 mp0 -96.44 132.04 42.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.859 0.361 . . . . 2.23 110.632 -3.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.55 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 11.9 t90 -82.65 140.3 33.23 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.012 -0.736 . . . . 1.77 109.012 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 28.6 p80 -117.72 127.15 53.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.633 0.73 . . . . 2.19 111.258 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.897 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 15.5 t-80 -65.45 -35.89 82.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.806 -1.088 . . . . 2.74 110.36 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.543 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 12.0 p90 -168.06 176.79 5.9 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.651 -0.249 . . . . 2.21 110.363 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.458 ' HG ' HD12 ' A' ' 103' ' ' LEU . 21.5 tp -135.77 113.53 11.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.68 109.657 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.66 133.23 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.648 -0.706 . . . . 0.35 110.19 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.875 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 22.2 m -133.94 161.75 40.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.285 -0.871 . . . . 0.3 108.956 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.716 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t30 60.71 22.01 11.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.661 0.601 . . . . 2.09 110.353 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.611 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 6.7 ttm -71.88 110.3 6.31 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.175 -0.676 . . . . 0.34 109.175 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 20.9 ttmm -80.34 98.28 7.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.21 . . . . 1.73 111.133 -173.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.81 -121.76 20.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.603 -0.726 . . . . 0.35 112.509 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.713 ' HB3' HD22 ' A' ' 58' ' ' LEU . 28.8 p-10 -113.26 21.42 15.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.567 -0.316 . . . . 1.59 111.735 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -89.51 104.22 16.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.415 0.626 . . . . 0.77 109.848 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -55.55 -31.28 28.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.584 -1.189 . . . . 0.45 111.561 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -81.04 -26.38 36.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 1.15 111.602 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.05 -13.04 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.492 -0.322 . . . . 1.26 111.225 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.611 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -70.62 100.53 0.83 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.78 -0.724 . . . . 0.44 111.579 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.2 m -60.24 106.55 0.54 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.476 0.655 . . . . 1.06 109.668 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -80.19 113.1 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.847 -1.07 . . . . 1.15 111.214 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.458 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.7 mt -93.2 -41.97 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.99 0.9 . . . . 0.48 109.243 174.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.9 t -122.68 112.22 17.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.192 -1.41 . . . . 0.62 107.192 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.628 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 3.4 t70 -59.96 164.41 3.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.652 -0.704 . . . . 1.15 112.217 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 10.3 p90 -79.24 72.27 5.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.269 -0.878 . . . . 4.98 111.002 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 28.1 t -51.45 -44.68 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 0.86 111.447 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.686 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 97.72 -171.75 26.57 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.26 -0.971 . . . . 0.95 113.416 171.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 41.0 t -73.42 128.68 36.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.778 -0.452 . . . . 0.89 109.778 174.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.621 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 171.99 58.64 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.211 -0.995 . . . . 0.82 113.706 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -86.69 -176.66 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.628 2.219 . . . . 1.01 111.005 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.629 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 48.1 Cg_exo -57.14 142.25 94.38 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.464 1.443 . . . . 0.96 111.81 172.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.414 ' CD ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -66.1 114.69 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.514 -0.766 . . . . 2.39 111.46 -177.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.15 12.7 38.59 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 1.3 113.698 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 34.0 p -81.65 2.09 31.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.82 1.044 . . . . 1.04 113.82 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.25 -179.73 27.16 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.612 -0.804 . . . . 1.97 112.375 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -83.41 118.03 23.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.938 0.399 . . . . 0.94 110.141 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.688 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 47.1 m-70 -91.39 117.76 29.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.103 -0.499 . . . . 2.85 110.952 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.918 HH11 HD23 ' A' ' 14' ' ' LEU . 9.9 ptt180 -91.51 82.01 5.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.67 -0.695 . . . . 2.78 111.313 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.533 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 42.4 m-85 -67.76 109.39 3.33 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.753 -0.832 . . . . 1.13 108.753 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.555 HG23 HD21 ' A' ' 14' ' ' LEU . 21.9 t -88.09 127.32 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.901 -0.59 . . . . 0.31 109.971 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.833 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.92 117.53 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.486 -0.931 . . . . 2.96 108.486 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 mt -121.26 127.57 51.52 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.959 0.162 . . . . 0.41 110.899 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.601 HG21 ' HE3' ' A' ' 55' ' ' TRP . 1.1 m -114.4 131.54 66.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.459 -0.496 . . . . 0.43 109.917 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.687 ' HB2' HD21 ' A' ' 160' ' ' LEU . 48.4 m-85 -111.95 149.13 32.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.325 -0.62 . . . . 5.41 109.325 176.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.93 126.66 48.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.671 0.748 . . . . 2.41 110.449 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -96.82 175.51 6.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.183 -0.917 . . . . 1.31 108.714 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.53 2.71 42.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.547 0.689 . . . . 2.4 109.498 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -160.66 164.98 18.24 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.947 -1.024 . . . . 4.07 111.206 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HG3' HD12 ' A' ' 63' ' ' LEU . 46.2 Cg_exo -58.01 155.42 33.81 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.027 2.485 . . . . 1.21 110.946 169.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.875 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.4 mm? -84.14 145.91 28.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.311 0.577 . . . . 1.16 112.143 -172.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -124.31 66.06 1.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.142 -0.935 . . . . 3.23 108.741 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 5.2 m -93.6 120.99 34.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.537 -0.756 . . . . 2.79 110.395 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.88 14.97 30.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 2.96 109.936 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -64.73 132.14 95.35 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.429 -0.805 . . . . 1.39 110.563 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -47.09 117.08 2.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.539 2.826 . . . . 1.38 113.067 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.19 118.67 6.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.94 110.496 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.4 mt -92.7 156.08 17.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 1.61 110.608 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 50.2 m -116.03 32.57 6.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.88 110.172 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.733 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER 66.75 -21.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.238 1.415 . . . . 1.33 113.45 175.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.546 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 54.9 mtt180 -78.31 135.44 37.51 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.776 -0.37 . . . . 3.83 110.868 -175.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.664 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 62.1 m 81.84 146.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.559 -1.201 . . . . 1.32 110.674 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.446 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -108.22 12.71 37.04 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.867 -0.682 . . . . 1.13 113.038 -170.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.17 -15.22 62.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.324 0.49 . . . . 2.66 112.324 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -121.58 34.85 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.087 0.47 . . . . 2.18 110.324 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.446 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 26.6 mtt180 -81.05 -69.68 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.662 -0.699 . . . . 5.37 111.902 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -128.31 -164.38 11.55 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.447 -0.882 . . . . 0.9 112.763 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.669 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 65.43 25.27 11.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.441 0.639 . . . . 1.59 110.229 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.26 112.31 21.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.083 -0.962 . . . . 2.27 109.095 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.18 122.17 17.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.805 -0.634 . . . . 1.87 111.525 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.794 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.2 m -62.85 -27.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.96 110.351 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.31 -43.34 99.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.76 109.759 172.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.9 m -63.87 -39.33 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.944 -0.571 . . . . 1.22 110.618 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.794 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 50.4 m-85 -58.81 -52.05 67.37 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.649 -0.251 . . . . 1.1 110.999 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.943 -0.303 . . . . 3.36 111.358 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.4 mtmt -64.17 -42.25 96.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.38 0.609 . . . . 1.52 109.935 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -58.77 -53.27 60.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 2.13 111.449 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.41 -3.33 58.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 5.77 111.493 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 68.22 40.89 2.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.792 -0.64 . . . . 2.42 111.27 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 125' ' ' TYR . 5.4 mp -95.97 146.34 24.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.451 -0.795 . . . . 1.27 112.008 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.777 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 14.5 tpt180 -82.73 -171.24 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.291 -0.868 . . . . 4.0 109.853 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.777 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -60.98 155.74 52.35 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 1.21 110.639 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.703 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 13.2 Cg_exo -66.7 141.93 61.89 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.968 2.445 . . . . 0.68 112.279 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.884 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 12.2 t -89.47 -34.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.794 -0.639 . . . . 0.5 110.092 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -146.26 141.37 27.28 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.903 -0.719 . . . . 0.29 112.128 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.641 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.56 148.94 20.93 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.024 -0.989 . . . . 0.24 111.976 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.6 t -159.85 133.05 6.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.798 -0.816 . . . . 0.34 108.798 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.601 ' H ' HD22 ' A' ' 37' ' ' LEU . 22.2 p -111.07 142.42 43.25 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 2.16 111.33 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.767 ' HB3' HG22 ' A' ' 34' ' ' VAL . 32.3 p90 -126.61 134.14 50.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.567 -0.901 . . . . 1.31 108.567 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.75 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 24.1 mp0 -98.6 131.88 44.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.212 -0.595 . . . . 2.53 110.104 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -121.21 142.37 49.98 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.36 0.412 . . . . 0.75 110.345 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -97.18 -171.8 2.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 2.38 111.263 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.858 ' HA ' HG23 ' A' ' 177' ' ' VAL . 28.5 p90 -97.41 53.62 1.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.226 -0.897 . . . . 4.71 110.508 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.495 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 32.6 t70 -60.28 -61.74 2.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.6 0.963 . . . . 1.53 113.6 -168.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.665 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.9 t70 -167.4 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.017 0.377 . . . . 1.26 112.017 -175.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -71.95 -3.89 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.148 0.499 . . . . 2.46 110.876 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.858 HG23 ' HA ' ' A' ' 173' ' ' TRP . 25.6 t -71.02 -55.1 6.78 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.749 . . . . 0.58 111.316 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.677 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.4 Cg_exo -58.2 -32.09 94.98 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.999 1.799 . . . . 0.68 111.764 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.3 mmmt -74.06 -24.77 59.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 2.62 111.913 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 43.9 tp -70.53 -47.25 61.33 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.13 -0.628 . . . . 1.18 109.375 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -59.27 -35.46 73.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.603 -0.726 . . . . 2.11 109.405 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.66 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.3 -51.48 68.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.807 -1.088 . . . . 1.53 111.002 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -69.17 -32.04 71.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 2.16 112.277 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 68.1 mt -62.77 3.65 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.503 0.927 . . . . 0.87 113.503 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.583 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 47.7 m -82.84 13.34 3.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.413 0.625 . . . . 1.38 109.336 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.82 44.1 57.14 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.368 -0.833 . . . . 1.17 111.162 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.583 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 28.8 mmmt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.344 -0.836 . . . . 2.45 109.841 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.624 HG12 ' HB2' ' A' ' 37' ' ' LEU . 21.2 t . . . . . 0 C--O 1.235 0.295 0 N-CA-C 110.217 -0.29 . . . . 2.1 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.27 33.93 0.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.057 0.932 . . . . 1.81 110.49 -173.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.5 mm? 60.11 20.86 10.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.414 -1.266 . . . . 0.95 110.757 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.72 -33.72 64.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.613 0.765 . . . . 2.19 112.334 -171.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.588 ' CB ' HD12 ' A' ' 12' ' ' LEU . 76.1 mttt -135.75 50.18 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.207 -0.451 . . . . 3.07 110.375 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.462 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -72.87 -28.71 62.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.341 0.497 . . . . 4.76 112.341 -176.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 19.5 p -152.65 29.11 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.98 111.208 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.472 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.26 -122.69 0.83 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.957 -0.857 . . . . 0.52 110.957 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.6 Cg_endo -52.8 -37.56 76.7 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.222 2.615 . . . . 0.61 110.343 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.744 HD13 ' HA3' ' A' ' 38' ' ' GLY . 16.5 mt -87.73 83.06 7.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.951 -1.022 . . . . 1.85 109.657 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -73.5 63.42 0.8 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.519 0.676 . . . . 1.31 110.497 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.555 HD11 ' HG ' ' A' ' 168' ' ' CYS . 58.9 mt -71.19 -16.6 62.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.729 -0.669 . . . . 0.61 109.79 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -70.42 -4.47 22.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.49 -0.777 . . . . 2.61 110.694 177.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.89 -27.06 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.624 -0.88 . . . . 1.93 108.624 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.741 HG11 HG22 ' A' ' 151' ' ' VAL . 60.0 t -99.1 -71.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.609 -1.178 . . . . 1.26 110.408 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HB2' HH22 ' A' ' 155' ' ' ARG . 7.5 p-10 -110.7 153.35 25.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.391 0.615 . . . . 2.99 111.564 -172.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 26.1 mt-10 -65.51 142.15 58.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.001 -1.0 . . . . 1.6 109.326 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 98.7 mt-30 -55.61 120.59 33.17 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 123.335 0.397 . . . . 4.38 111.132 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 20' ' ' GLN . 23.2 Cg_exo -64.27 162.08 31.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.051 2.501 . . . . 0.69 112.685 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.922 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.9 pt20 -84.82 -12.85 52.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.779 -0.646 . . . . 1.87 111.217 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.773 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 66.3 m-70 -153.2 161.43 29.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.415 -0.957 . . . . 2.35 108.415 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 56' ' ' ASP . 5.7 Cg_endo -88.22 132.27 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.852 2.368 . . . . 0.44 112.233 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 122' ' ' TRP . 28.3 tp -78.31 144.75 35.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.807 -0.442 . . . . 0.33 109.807 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.467 ' H ' HD12 ' A' ' 25' ' ' LEU . 31.4 m80 -122.81 113.35 19.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.609 -0.515 . . . . 2.12 109.609 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.534 HG12 HG22 ' A' ' 53' ' ' ILE . 10.6 t -117.65 136.43 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.731 -0.47 . . . . 1.12 109.731 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.469 HG22 ' HB1' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -134.45 136.79 43.48 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.061 0.458 . . . . 0.78 111.076 -176.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.676 ' HH ' HD21 ' A' ' 48' ' ' ASN . 46.4 t80 -97.16 176.26 5.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.975 -0.75 . . . . 1.23 108.975 175.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.68 62.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.508 0.671 . . . . 0.6 110.191 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.91 1.56 31.74 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 115.089 -0.959 . . . . 0.81 112.666 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.16 -174.75 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.633 0.254 . . . . 0.56 110.605 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HB1' HG22 ' A' ' 28' ' ' THR . . . -163.58 149.64 11.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.154 -0.476 . . . . 0.35 110.392 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.779 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 96.2 t -101.78 62.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 106.71 -1.589 . . . . 0.39 106.71 163.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.77 -9.3 59.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.032 -1.44 . . . . 0.99 110.882 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.706 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -131.44 134.56 46.34 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.567 -0.901 . . . . 2.56 108.567 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.624 ' HB2' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -75.84 109.62 9.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.376 -0.601 . . . . 0.46 109.376 -175.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.786 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 85.07 23.38 49.16 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.391 -0.822 . . . . 0.59 112.471 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.779 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -80.19 149.52 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.627 -0.508 . . . . 1.04 109.627 171.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -73.86 133.02 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.155 0.502 . . . . 1.16 110.983 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.466 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.9 tp -131.06 168.55 17.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.115 -1.069 . . . . 0.45 108.115 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.517 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 23.2 p -121.87 157.13 58.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 119.569 -0.853 . . . . 1.0 112.349 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 10.1 Cg_endo -51.53 -41.99 57.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.093 2.529 . . . . 1.0 113.028 -176.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -62.71 -26.82 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.111 -0.495 . . . . 1.24 112.159 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -82.27 -25.34 34.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.945 -0.571 . . . . 1.74 111.289 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG21 ' CE2' ' A' ' 169' ' ' TYR . 18.5 m -122.01 29.11 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 1.1 111.552 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.12 -7.33 58.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.014 -0.539 . . . . 1.32 110.202 -177.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.676 HD21 ' HH ' ' A' ' 29' ' ' TYR . 59.2 m-80 -127.26 -174.91 3.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.603 -0.726 . . . . 2.4 109.315 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.592 ' NH2' ' HB ' ' A' ' 102' ' ' VAL . 72.5 mtt180 -77.0 155.11 82.84 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.75 -0.463 . . . . 1.78 109.75 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.23 153.42 18.62 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.06 1.84 . . . . 0.41 110.874 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -79.25 -18.57 52.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.909 0.385 . . . . 0.88 110.223 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -157.0 141.35 16.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.524 0.678 . . . . 0.65 112.446 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.534 HG22 HG12 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.23 158.28 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.773 -1.103 . . . . 0.33 108.503 172.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.698 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 26.3 t -179.23 122.04 0.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.976 -0.379 . . . . 0.8 109.976 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.79 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -76.12 156.0 34.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.347 -1.353 . . . . 3.63 107.347 170.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 17.8 t70 -59.84 85.9 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.25 0.548 . . . . 1.51 110.715 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.93 15.17 5.33 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.61 -0.723 . . . . 0.9 112.765 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.698 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 3.2 tt -50.79 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.505 . . . . 0.62 111.182 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.669 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.4 t70 -71.14 -29.97 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.644 -0.707 . . . . 0.74 111.453 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.495 ' N ' HD23 ' A' ' 58' ' ' LEU . 19.8 m 72.82 15.44 4.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.679 -1.146 . . . . 1.51 110.245 -173.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.78 -6.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.474 -0.87 . . . . 0.84 114.03 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.669 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.5 mtpt -96.17 161.27 14.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.028 0.914 . . . . 2.12 110.46 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 51.5 mt -90.97 132.32 36.04 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.878 -0.786 . . . . 1.23 108.878 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.561 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -132.83 147.72 52.31 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.646 -0.421 . . . . 1.61 110.317 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.614 HG22 HG11 ' A' ' 90' ' ' VAL . 65.5 m -95.54 105.57 17.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.772 -0.825 . . . . 0.87 108.772 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 57.1 tp -106.49 113.48 27.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.552 -0.749 . . . . 1.35 109.697 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 88' ' ' LEU . 44.3 t -114.42 129.45 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.54 110.452 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 68' ' ' LEU . 2.0 mt -85.17 124.04 31.37 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.64 -0.874 . . . . 0.65 108.64 168.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -135.83 138.18 42.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.926 0.393 . . . . 1.04 110.011 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 17.6 p-10 -125.93 102.23 28.45 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 121.523 0.678 . . . . 1.92 110.729 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -54.77 -177.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.378 2.718 . . . . 1.25 112.808 170.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.635 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.6 m-20 55.1 41.42 31.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 1.29 111.274 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.57 140.58 21.22 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 115.726 -0.67 . . . . 0.56 110.176 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 90.6 Cg_endo -81.65 -26.44 9.03 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.003 -1.665 . . . . 0.7 112.475 2.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.763 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 89.3 p -123.11 146.13 47.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.592 . . . . 1.1 110.314 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.635 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 74.4 ttt180 -67.55 -23.21 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 3.39 111.257 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.641 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -82.87 -18.35 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 1.83 111.064 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.15 90.12 2.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.048 -0.524 . . . . 1.37 109.875 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 91.8 Cg_endo -85.33 93.46 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.863 2.375 . . . . 0.9 113.814 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.4 mttm -82.69 -50.3 8.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.749 0.785 . . . . 1.53 110.477 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.771 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 63.7 m-85 -88.1 25.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.966 -1.015 . . . . 1.54 111.225 -170.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.688 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.52 128.7 33.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.306 -0.406 . . . . 3.38 110.445 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.688 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.0 mp0 -94.83 149.59 21.09 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.067 0.46 . . . . 2.23 110.773 -3.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.505 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 4.4 t90 -92.06 137.37 32.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.08 -1.081 . . . . 1.77 108.08 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.48 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 9.1 p-80 -110.5 141.06 44.17 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.339 -0.615 . . . . 2.19 109.339 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 -15.14 12.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.248 0.833 . . . . 2.74 113.248 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 3.2 p90 -169.38 166.59 10.34 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.447 -0.205 . . . . 2.21 110.447 162.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 67' ' ' VAL . 33.6 tp -133.84 113.96 12.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.151 -0.477 . . . . 0.68 109.922 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -123.83 132.47 71.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.746 -0.661 . . . . 0.35 110.658 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.614 HG11 HG22 ' A' ' 65' ' ' THR . 22.1 m -134.02 161.17 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.101 -0.954 . . . . 0.3 108.793 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.3 t30 63.37 16.79 9.79 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.506 0.504 . . . . 2.09 110.273 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.603 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 6.8 ttm -67.42 111.8 4.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.718 -0.845 . . . . 0.34 108.718 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -87.64 96.89 10.59 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.005 -0.998 . . . . 1.73 111.016 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.63 -126.49 9.11 Favored Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 114.857 -1.065 . . . . 0.35 112.284 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.54 ' HB3' HD22 ' A' ' 58' ' ' LEU . 4.4 p-10 -112.56 23.26 13.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 1.59 110.7 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.9 109.02 19.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.77 109.908 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -59.45 -33.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.45 110.625 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.3 m -73.6 -34.75 65.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.795 -0.638 . . . . 1.15 111.951 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.5 -6.16 48.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.882 0.327 . . . . 1.26 111.882 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.603 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -70.82 96.6 0.6 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.451 -0.881 . . . . 0.44 111.836 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.8 m -60.96 107.73 0.76 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.456 0.646 . . . . 1.06 110.325 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.592 ' HB ' ' NH2' ' A' ' 49' ' ' ARG . 7.5 p -87.51 130.25 37.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.86 -1.064 . . . . 1.15 111.76 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 10.3 mt -112.2 -49.94 2.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.101 0.953 . . . . 0.48 108.874 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.3 t -109.58 99.67 8.83 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.005 -1.48 . . . . 0.62 107.005 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.48 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 3.7 m-20 -56.86 157.58 5.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.139 -0.937 . . . . 1.15 113.114 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 14.7 p90 -74.31 107.58 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.782 -1.099 . . . . 4.98 110.143 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.647 HG22 ' HB2' ' A' ' 140' ' ' ASN . 23.3 t -80.72 -15.69 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.543 0.687 . . . . 0.86 110.276 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.53 -146.61 22.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.998 -0.62 . . . . 0.95 111.801 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.557 ' O ' HD22 ' A' ' 180' ' ' LEU . 14.2 t -83.2 140.92 32.28 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.677 -0.49 . . . . 0.89 109.677 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.61 68.5 0.19 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.354 -0.927 . . . . 0.82 113.747 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 177' ' ' VAL . 57.6 Cg_endo -98.35 122.7 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.527 2.818 . . . . 1.01 112.304 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.695 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 74.3 Cg_exo -50.93 146.68 20.92 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.045 2.497 . . . . 0.96 112.474 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 116.92 5.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 2.39 111.482 -174.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.27 64.19 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.952 -0.567 . . . . 1.3 113.777 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.763 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 51.3 p -79.82 -62.76 1.59 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.087 0.444 . . . . 1.04 112.113 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.35 178.06 30.12 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.07 -0.812 . . . . 1.97 111.07 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -71.74 106.89 4.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.972 0.415 . . . . 0.94 110.557 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 3.4 m-70 -77.31 116.55 18.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 2.85 110.115 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.811 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 9.7 ptt180 -94.87 90.09 5.89 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.464 -0.789 . . . . 2.78 110.642 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 1.0 OUTLIER -73.99 107.63 6.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.86 -0.793 . . . . 1.13 108.86 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 168' ' ' CYS . 19.9 t -90.36 129.52 41.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.569 -0.742 . . . . 0.31 109.479 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.628 ' HB2' HD21 ' A' ' 25' ' ' LEU . 23.3 m95 -89.93 119.74 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.397 -0.964 . . . . 2.96 108.397 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 79.5 mt -113.72 119.68 38.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.734 0.243 . . . . 0.41 111.205 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.51 HG11 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -119.18 135.22 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.249 0.547 . . . . 0.43 111.328 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.788 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 72.3 t80 -128.35 128.88 45.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 5.41 109.121 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.656 ' H ' HG21 ' A' ' 164' ' ' VAL . 6.5 pt-20 -67.53 107.63 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.096 -0.705 . . . . 2.41 109.096 175.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.528 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 18.6 mt-30 -56.42 137.56 52.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.387 -0.824 . . . . 1.31 112.392 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.42 -26.17 68.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.887 -1.051 . . . . 2.4 108.691 168.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.528 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 8.6 ptp180 -167.29 158.73 10.31 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 114.111 -1.404 . . . . 4.07 109.762 -177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.452 ' HA ' ' NE2' ' A' ' 127' ' ' GLN . 15.4 Cg_exo -61.69 131.95 37.94 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.759 2.306 . . . . 1.21 110.383 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.471 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.2 mm? -64.41 152.35 41.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.955 1.094 . . . . 1.16 113.955 -166.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -109.65 85.69 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.224 -1.353 . . . . 3.23 108.651 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.755 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 58.3 m -132.06 116.35 16.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 2.79 111.412 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -106.26 39.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.714 -0.847 . . . . 2.96 108.714 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.9 mm-40 -73.89 131.44 81.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.801 -1.091 . . . . 1.39 110.585 -173.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.8 119.96 4.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.408 2.739 . . . . 1.38 112.7 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 15.2 mm -70.11 115.2 8.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.578 -0.527 . . . . 0.94 109.578 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.88 -14.44 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.651 0.611 . . . . 1.61 112.651 -170.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.427 ' HA ' ' CG ' ' A' ' 105' ' ' ASP . 37.1 m 55.43 23.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.489 0.922 . . . . 1.88 113.489 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.647 ' HB2' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER 60.29 -2.78 0.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.21 1.004 . . . . 1.33 113.515 172.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.559 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 66.5 mtt180 -100.12 135.91 40.83 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.16 -0.338 . . . . 3.83 110.137 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.549 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.0 m 82.26 131.9 0.05 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 124.524 1.14 . . . . 1.32 111.396 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.7 41.6 2.16 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.196 -0.911 . . . . 1.13 113.109 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -71.68 -34.34 69.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 2.66 110.921 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -125.34 73.51 1.32 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 2.18 110.721 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.42 ' HB3' ' CE2' ' A' ' 84' ' ' TRP . 63.8 mtt180 -78.73 -77.15 0.17 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.155 -0.93 . . . . 5.37 111.549 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -132.72 -137.16 3.88 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.708 -0.758 . . . . 0.9 112.908 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.771 ' CG ' ' HA ' ' A' ' 81' ' ' TYR . 90.3 mttt 65.04 28.37 12.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.717 0.77 . . . . 1.59 110.246 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -103.92 167.94 9.45 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.909 -1.041 . . . . 2.27 108.763 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 11.8 mmmm -117.35 117.53 29.75 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.002 -0.37 . . . . 1.87 110.002 173.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.741 HG22 HG11 ' A' ' 17' ' ' VAL . 27.8 m -61.14 -24.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 0.96 110.8 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.15 82.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.852 -0.613 . . . . 0.76 109.505 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.9 m -65.53 -35.43 80.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 1.22 110.692 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.671 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 26.9 m-85 -58.65 -56.36 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.752 0.31 . . . . 1.1 110.685 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.481 HH22 ' HB2' ' A' ' 18' ' ' ASP . 18.4 ptp180 -66.02 -43.22 88.28 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.271 -0.422 . . . . 3.36 110.682 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -62.79 -36.16 82.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.682 0.277 . . . . 1.52 111.607 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -63.04 -45.17 93.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.165 0.507 . . . . 2.13 110.846 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.443 ' HB3' HD13 ' A' ' 131' ' ' LEU . 20.8 m-85 -83.0 1.86 37.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 5.77 110.478 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 64.19 33.07 12.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.163 -0.926 . . . . 2.42 111.125 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.788 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -92.79 179.19 5.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.652 -1.158 . . . . 1.27 109.14 173.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.697 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.9 tpt180 -149.05 -146.91 0.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.422 -0.585 . . . . 4.0 109.422 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.697 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -55.22 143.47 54.77 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 121.109 0.481 . . . . 1.21 111.038 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 4.1 Cg_exo -73.01 157.39 51.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.798 2.998 . . . . 0.68 112.813 -170.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.922 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -86.1 -24.48 6.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.562 -0.903 . . . . 0.5 108.562 174.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 55' ' ' TRP . . . -158.97 148.35 18.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.667 -0.697 . . . . 0.29 111.915 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.9 153.72 25.53 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.638 -1.165 . . . . 0.24 110.918 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.404 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.7 t -166.44 144.08 5.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.83 -0.804 . . . . 0.34 108.83 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.563 ' HB3' HG22 ' A' ' 121' ' ' VAL . 25.4 p -124.93 141.83 51.87 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.074 -0.65 . . . . 2.16 111.483 -173.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.757 ' HB3' HG22 ' A' ' 34' ' ' VAL . 26.0 p90 -123.92 130.75 53.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.254 -1.017 . . . . 1.31 108.254 171.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.811 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 24.4 mp0 -97.78 132.47 43.37 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 2.53 110.17 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.502 ' HB2' ' HE1' ' A' ' 120' ' ' TYR . . . -134.68 145.59 48.68 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.089 -0.708 . . . . 0.75 109.089 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -124.78 -170.54 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 2.38 111.562 -176.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.971 ' HA ' HG23 ' A' ' 177' ' ' VAL . 36.1 p90 -80.18 54.67 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 4.71 112.1 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -50.55 -60.44 3.02 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.487 0.551 . . . . 1.53 112.487 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.575 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.6 t70 -173.68 -44.53 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.007 0.432 . . . . 1.26 111.283 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -80.42 6.99 10.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.21 -0.45 . . . . 2.46 111.667 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.971 HG23 ' HA ' ' A' ' 173' ' ' TRP . 71.2 t -72.54 -52.79 6.28 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.077 -0.51 . . . . 0.58 110.546 174.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -50.35 -34.26 40.2 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.464 2.109 . . . . 0.68 112.158 169.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.7 mmmt -74.09 -25.19 59.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 2.62 111.196 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 24.9 tp -70.53 -44.91 66.57 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.275 -0.639 . . . . 1.18 109.275 172.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -58.32 -40.12 81.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.07 -0.715 . . . . 2.11 109.07 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.58 -50.67 71.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.81 -1.086 . . . . 1.53 110.897 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -65.18 -33.09 75.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.635 -0.711 . . . . 2.16 112.16 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 55.8 mt -66.47 4.29 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.87 111.641 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.822 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.3 m -79.71 3.13 20.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 1.38 109.581 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 79.04 48.0 7.24 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.162 -0.926 . . . . 1.17 111.306 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.822 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.0 mmmt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.508 -0.758 . . . . 2.45 110.241 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.74 HG13 ' HB2' ' A' ' 37' ' ' LEU . 22.5 t . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.806 0.336 . . . . 2.1 110.835 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.09 155.21 41.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.85 -0.796 . . . . 1.81 108.85 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.49 8.12 14.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.863 0.69 . . . . 0.95 112.863 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 t -66.15 -27.07 67.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.977 0.417 . . . . 2.19 111.042 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 66.2 mttm -92.57 9.43 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.47 -0.332 . . . . 3.07 111.655 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 57.4 t-105 -66.58 -24.96 66.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.398 0.518 . . . . 4.76 112.398 -172.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.461 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 14.1 p -136.33 21.53 3.19 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.36 -0.536 . . . . 0.98 111.8 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.6 -126.37 1.45 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.822 -0.704 . . . . 0.52 111.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.12 -35.46 62.36 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.334 2.689 . . . . 0.61 110.056 166.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.643 HD11 ' HA3' ' A' ' 38' ' ' GLY . 12.5 mt -87.6 86.8 7.24 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.564 -1.198 . . . . 1.85 108.986 171.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.8 m -78.44 66.97 4.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.485 0.66 . . . . 1.31 110.467 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.464 HD11 ' HG ' ' A' ' 168' ' ' CYS . 29.0 mt -78.75 -4.97 51.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.468 -0.787 . . . . 0.61 111.216 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.461 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 12.9 mm100 -68.27 -13.4 62.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.047 0.451 . . . . 2.61 110.39 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.52 -28.14 69.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 1.93 110.262 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.495 ' CG1' HG22 ' A' ' 151' ' ' VAL . 71.5 t -86.36 -73.57 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.118 -0.946 . . . . 1.26 110.653 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -162.5 169.06 20.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.818 -0.353 . . . . 2.99 110.811 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -49.04 147.41 2.87 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.089 0.956 . . . . 1.6 113.279 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.754 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 68.1 mt-30 -59.37 128.39 85.68 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 115.536 -0.756 . . . . 4.38 109.913 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 11.1 Cg_exo -70.02 157.28 60.4 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.913 2.409 . . . . 0.69 111.893 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.875 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 7.2 pt20 -73.4 -18.79 61.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 1.87 111.314 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.804 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 47.2 m-70 -148.07 160.23 37.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.606 -0.725 . . . . 2.35 109.139 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 3.0 Cg_endo -86.0 131.92 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.05 2.5 . . . . 0.44 111.832 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.875 HD21 ' HB3' ' A' ' 122' ' ' TRP . 20.6 tp -80.68 141.08 35.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.328 . . . . 0.33 110.724 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.418 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.41 123.91 51.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.445 -0.343 . . . . 2.12 110.15 170.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.522 HG13 HG22 ' A' ' 53' ' ' ILE . 17.6 t -121.5 143.26 34.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.525 -0.917 . . . . 1.12 108.525 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -136.86 142.83 42.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.135 0.493 . . . . 0.78 110.791 -176.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -108.64 176.91 4.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.16 -0.681 . . . . 1.23 109.16 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.89 -51.81 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.6 111.803 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.75 -13.34 9.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.677 -0.692 . . . . 0.81 112.835 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.26 -165.12 1.36 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.56 110.914 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.0 165.99 26.61 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.367 -0.833 . . . . 0.35 109.748 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.736 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 93.4 t -107.44 64.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.303 -1.739 . . . . 0.39 106.303 160.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.12 1.72 49.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.198 -1.364 . . . . 0.99 109.949 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 43.7 mt-10 -135.62 126.06 26.75 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.408 -0.815 . . . . 2.56 109.865 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.74 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -71.95 110.13 6.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.149 -0.686 . . . . 0.46 109.149 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.896 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 90.01 28.31 18.49 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.258 -0.883 . . . . 0.59 111.973 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.736 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -93.29 151.05 20.04 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.842 -0.429 . . . . 1.04 109.842 174.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.4 p -78.19 135.98 25.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 1.16 111.098 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.471 HD21 ' CG1' ' A' ' 46' ' ' VAL . 8.4 tp -131.46 170.58 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.152 -1.425 . . . . 0.45 107.152 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 p -116.17 148.61 41.89 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 118.669 -1.212 . . . . 1.0 113.362 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 1.073 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 53.4 Cg_exo -55.38 -40.76 83.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.491 3.461 . . . . 1.0 113.914 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -33.32 63.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.517 0.675 . . . . 1.24 110.715 174.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -81.75 -58.46 2.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.909 . . . . 1.74 110.704 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' CG1' HD21 ' A' ' 41' ' ' LEU . 6.3 m -81.42 28.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.386 0.612 . . . . 1.1 112.079 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.67 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -82.21 -31.44 30.32 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.69 -0.856 . . . . 1.32 108.69 174.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.417 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 19.0 m120 -112.13 -149.78 0.45 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.849 -1.069 . . . . 2.4 110.319 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.495 ' HB3' HG23 ' A' ' 97' ' ' ILE . 99.5 mtt180 -99.11 157.25 34.39 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.246 -0.433 . . . . 1.78 109.964 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.98 166.28 25.18 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.402 2.068 . . . . 0.41 110.574 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.404 ' C ' ' HG ' ' A' ' 52' ' ' SER . 5.6 t -81.48 -25.47 36.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.03 0.443 . . . . 0.88 110.018 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.497 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.2 m -159.27 149.56 19.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.165 0.507 . . . . 0.65 111.97 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -141.12 158.71 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.288 -1.004 . . . . 0.33 108.288 171.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.724 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 32.7 t -176.4 113.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.917 0.389 . . . . 0.8 110.104 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.775 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -72.42 157.67 37.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.664 -1.235 . . . . 3.63 107.664 172.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.97 87.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.523 0.514 . . . . 1.51 110.611 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.3 21.51 4.05 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.753 -0.658 . . . . 0.9 112.749 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.724 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -57.69 129.14 40.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.984 0.421 . . . . 0.62 110.565 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.554 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 26.2 t70 -79.69 -27.74 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.505 . . . . 0.74 111.502 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.536 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 52.7 m 77.84 -5.67 2.08 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.3 1.0 . . . . 1.51 110.278 -171.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.31 21.49 5.15 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.874 -0.603 . . . . 0.84 112.794 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.554 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 9.7 mtpt -113.0 145.02 41.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 122.535 -0.391 . . . . 2.12 110.752 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 44.5 mt -91.0 124.87 35.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.191 -0.67 . . . . 1.23 109.191 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.654 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -127.18 161.38 28.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.754 -0.379 . . . . 1.61 109.98 177.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.635 HG22 HG11 ' A' ' 90' ' ' VAL . 63.3 m -97.45 106.57 18.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.715 -0.846 . . . . 0.87 108.715 169.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.2 tp -103.58 109.37 21.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.448 -0.796 . . . . 1.35 109.69 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.5 t -113.87 136.74 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.54 110.69 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.83 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.8 mt -104.61 126.4 51.66 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.336 -0.987 . . . . 0.65 108.336 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 10.1 t -135.22 150.75 50.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.878 0.37 . . . . 1.04 111.315 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 6.8 t70 -130.47 94.25 30.19 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-O 121.51 0.671 . . . . 1.92 110.39 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 13.0 Cg_endo -56.49 -30.91 84.2 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.83 3.02 . . . . 1.25 114.108 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -90.74 39.58 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.641 . . . . 1.29 112.732 -167.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 81' ' ' TYR . . . -104.48 140.44 21.07 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.77 -0.456 . . . . 0.56 109.77 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 98.3 Cg_endo -80.19 -21.62 17.38 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.864 -1.307 . . . . 0.7 113.351 2.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.603 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 88.5 p -139.75 162.85 34.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.746 -0.206 . . . . 1.1 111.072 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.462 ' NE ' HH12 ' A' ' 119' ' ' ARG . 1.0 OUTLIER -64.4 -36.8 85.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.234 0.54 . . . . 3.39 110.61 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.515 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 4.2 ptpt -71.63 -18.17 62.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 1.83 111.224 -175.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.5 t70 -161.43 86.62 1.65 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.402 . . . . 1.37 110.648 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -84.0 91.64 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.902 2.401 . . . . 0.9 112.946 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 39.3 mttm -82.63 -45.37 14.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 1.53 110.793 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.727 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.9 m-85 -81.0 16.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 1.54 111.776 -171.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.92 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 9.1 ttp180 -62.3 125.04 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.068 -0.345 . . . . 3.38 110.068 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.92 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.1 mp0 -107.72 133.98 51.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.503 0.321 . . . . 2.23 110.356 -4.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -76.9 164.85 25.41 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.813 -1.18 . . . . 1.77 107.813 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 p80 -145.94 123.18 11.55 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.826 -0.546 . . . . 2.19 110.329 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.83 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.3 t-160 -62.13 -40.86 97.35 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.418 -0.81 . . . . 2.74 109.552 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.9 p90 -167.77 171.56 9.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.963 -0.295 . . . . 2.21 110.465 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HD12 ' A' ' 103' ' ' LEU . 30.1 tp -129.96 113.09 14.16 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.144 -0.687 . . . . 0.68 109.144 173.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.36 134.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.847 -0.615 . . . . 0.35 110.649 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.936 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 19.7 m -134.53 157.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.63 -0.714 . . . . 0.3 109.61 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.585 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t30 61.18 22.28 12.62 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.601 0.563 . . . . 2.09 110.455 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.543 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.6 ttm -70.71 111.68 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.725 -0.843 . . . . 0.34 108.725 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HE2' HD23 ' A' ' 63' ' ' LEU . 18.2 ttmm -87.59 100.38 12.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.162 -0.926 . . . . 1.73 111.045 -172.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 77.17 -122.84 6.29 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.255 -0.884 . . . . 0.35 112.883 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.6 ' HB3' HD22 ' A' ' 58' ' ' LEU . 9.2 p30 -118.14 21.09 12.94 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 1.59 110.736 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.68 105.68 15.66 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.787 -0.642 . . . . 0.77 109.77 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 49' ' ' ARG . 4.8 mm -62.89 -25.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.867 -1.06 . . . . 0.45 111.384 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 m -84.41 -29.62 26.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 1.15 111.994 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 m -80.26 -3.84 50.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.943 0.402 . . . . 1.26 111.706 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.543 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -71.14 106.42 1.88 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.761 -0.733 . . . . 0.44 111.303 175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.2 m -64.31 106.84 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.228 -0.656 . . . . 1.06 109.228 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.19 111.8 24.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.43 -0.805 . . . . 1.15 110.86 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.485 HD12 ' HG ' ' A' ' 88' ' ' LEU . 5.1 mt -87.85 -39.96 14.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.039 0.923 . . . . 0.48 109.935 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.4 t -114.36 105.88 13.66 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.72 -1.585 . . . . 0.62 106.72 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.2 t70 -57.73 158.1 6.59 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.873 0.733 . . . . 1.15 111.992 -169.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 23.0 p90 -85.74 77.54 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 4.98 111.305 -171.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.785 HG22 ' HA ' ' A' ' 140' ' ' ASN . 36.7 t -60.48 -45.05 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.86 111.485 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.673 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 106.24 -168.33 14.8 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.385 -0.912 . . . . 0.95 112.576 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.9 t -65.91 126.63 29.15 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.759 -0.46 . . . . 0.89 109.759 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.616 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -152.56 54.49 0.46 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.994 -0.622 . . . . 0.82 112.727 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 1.057 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 11.3 Cg_endo -98.52 153.61 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.022 3.148 . . . . 1.01 113.232 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HB2' HG21 ' A' ' 115' ' ' THR . 31.6 Cg_exo -61.34 150.16 86.14 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.008 2.472 . . . . 0.96 112.499 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -67.17 122.05 16.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.347 -0.842 . . . . 2.39 111.571 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.6 50.33 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.927 -0.654 . . . . 1.3 112.996 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.603 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 21.7 p -78.5 -13.59 59.76 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.943 0.72 . . . . 1.04 112.943 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.31 24.31 6.56 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.09 -1.052 . . . . 1.97 113.38 172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.668 HD13 ' HG2' ' A' ' 172' ' ' GLU . 4.0 mm? 68.56 103.79 0.05 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.807 -0.697 . . . . 0.94 111.549 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 11.6 m170 -76.64 134.18 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.789 -0.641 . . . . 2.85 109.695 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 1.009 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 8.0 ptp85 -112.9 96.7 6.1 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.347 0.594 . . . . 2.78 111.094 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 45.4 m-85 -72.15 114.59 10.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.511 -0.768 . . . . 1.13 109.247 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 168' ' ' CYS . 31.3 t -90.4 129.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.61 -0.723 . . . . 0.31 110.439 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.875 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.56 119.49 30.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.546 -0.752 . . . . 2.96 109.396 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 84.0 mt -118.37 127.61 53.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.333 0.111 . . . . 0.41 111.089 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.53 139.41 42.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.43 109.352 171.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.83 164.32 15.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.862 0.363 . . . . 5.41 111.427 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.62 118.2 33.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.438 -0.801 . . . . 2.41 109.071 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.536 ' HG2' HD23 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -97.81 166.96 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.184 0.516 . . . . 1.31 110.477 -175.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.52 -22.31 54.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.513 -0.767 . . . . 2.4 109.563 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.79 164.18 19.67 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.821 -1.081 . . . . 4.07 110.277 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.477 ' HG3' HD11 ' A' ' 63' ' ' LEU . 53.7 Cg_exo -51.74 135.67 49.67 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.605 2.203 . . . . 1.21 112.02 175.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.936 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.3 mm? -55.63 147.48 18.16 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.2 0.815 . . . . 1.16 113.2 -171.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -130.73 80.36 1.94 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.574 -1.194 . . . . 3.23 108.09 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 90' ' ' VAL . 60.1 m -104.1 112.86 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.765 -0.652 . . . . 2.79 110.23 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.53 18.58 12.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.09 -0.959 . . . . 2.96 110.216 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.87 130.2 94.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.444 -0.798 . . . . 1.39 109.999 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -47.44 118.55 2.99 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.309 2.673 . . . . 1.38 113.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.3 mm -60.43 115.76 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.971 -0.558 . . . . 0.94 110.618 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.8 152.19 19.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 1.61 109.841 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 m -99.59 156.43 17.07 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.089 -1.078 . . . . 1.88 108.089 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.785 ' HA ' HG22 ' A' ' 107' ' ' VAL . 1.7 p-10 -81.89 6.85 14.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.333 0.587 . . . . 1.33 110.432 -174.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.552 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 46.6 mtt-85 -102.76 135.49 44.31 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.548 -0.751 . . . . 3.83 109.427 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.574 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.9 m 83.27 140.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.828 1.33 . . . . 1.32 110.551 -175.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -102.22 46.71 1.22 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.511 -0.768 . . . . 1.13 111.433 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.454 ' CG ' ' HD1' ' A' ' 145' ' ' HIS . 9.6 p-10 -70.98 -29.96 66.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.928 0.394 . . . . 2.66 111.489 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.454 ' HD1' ' CG ' ' A' ' 144' ' ' ASP . 23.6 m80 -124.51 70.05 1.11 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.037 0.446 . . . . 2.18 111.232 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 63.7 mtp180 -87.93 30.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 5.37 111.989 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.77 -143.83 17.81 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.176 -1.012 . . . . 0.9 113.388 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.727 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.8 mttt 60.94 42.21 13.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.855 0.836 . . . . 1.59 110.687 -174.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -133.66 158.38 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.444 -1.253 . . . . 2.27 108.872 174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 12.3 mmmm -96.8 120.84 37.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.15 0.282 . . . . 1.87 110.775 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.604 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.7 m -61.27 -33.05 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.96 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -58.84 -44.6 90.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.886 -0.597 . . . . 0.76 109.736 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.4 m -62.13 -37.75 86.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.479 . . . . 1.22 111.064 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 48.1 m-85 -59.27 -56.74 18.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.898 0.38 . . . . 1.1 110.742 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.599 ' HB2' ' HB2' ' A' ' 160' ' ' LEU . 4.3 ppt_? -71.13 -28.77 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.111 0.412 . . . . 3.36 112.111 -176.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 52.5 mtmt -65.8 -25.99 67.48 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.404 -0.185 . . . . 1.52 111.331 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 17.8 tptm -53.17 -46.37 68.9 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.58 0.229 . . . . 2.13 110.716 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -99.8 11.81 38.3 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.77 -0.772 . . . . 5.77 109.957 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.18 41.31 6.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.171 -0.922 . . . . 2.42 112.83 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 155' ' ' ARG . 6.4 mp -73.74 137.2 43.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.466 -0.788 . . . . 1.27 109.171 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.459 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -86.0 -53.28 5.18 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.7 0.63 . . . . 4.0 112.7 -169.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -164.8 161.95 14.95 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.947 -0.57 . . . . 1.21 110.233 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.586 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 15.9 Cg_exo -66.96 140.6 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.845 2.363 . . . . 0.68 112.776 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.875 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -86.61 -29.55 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.739 -0.837 . . . . 0.5 108.739 173.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.804 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -152.57 146.77 25.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.616 -0.72 . . . . 0.29 111.221 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.87 156.85 27.13 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.2 -0.909 . . . . 0.24 111.716 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 5.8 t -168.87 151.12 4.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.571 -0.9 . . . . 0.34 108.571 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.563 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 26.5 p -129.37 140.34 51.4 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.878 -0.729 . . . . 2.16 111.371 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.668 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.1 p90 -122.1 137.47 54.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.16 -1.052 . . . . 1.31 108.16 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 1.009 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 26.2 mp0 -100.04 133.58 44.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.468 0.576 . . . . 2.53 110.985 177.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -157.4 114.32 3.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.75 110.069 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 1.057 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 6.4 pt-20 -109.94 -91.08 0.46 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 119.649 -0.82 . . . . 2.38 111.77 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.873 ' H ' ' HG3' ' A' ' 172' ' ' GLU . 18.7 t90 -117.34 78.79 1.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.887 0.767 . . . . 4.71 111.672 -170.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 1.073 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -76.0 -59.64 2.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.658 -0.417 . . . . 1.53 110.937 173.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.1 t70 -178.84 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.339 0.137 0 N-CA-C 111.924 0.342 . . . . 1.26 111.924 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.67 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.45 5.49 14.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 2.46 111.851 -178.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 173' ' ' TRP . 84.0 t -72.57 -53.5 5.74 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.068 -0.514 . . . . 0.58 110.978 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.734 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.4 Cg_exo -49.78 -45.36 32.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.383 2.056 . . . . 0.68 111.882 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.17 -24.25 64.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.506 -0.315 . . . . 2.62 111.654 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.671 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 48.4 tp -68.98 -47.85 64.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.187 -0.605 . . . . 1.18 109.393 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.73 -37.9 80.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.47 0.652 . . . . 2.11 109.479 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.62 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 7.5 mm-40 -56.22 -47.87 77.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.706 -1.134 . . . . 1.53 111.148 172.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.09 -29.38 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.416 -0.811 . . . . 2.16 112.927 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 64.5 mt -63.29 5.95 0.14 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.227 0.825 . . . . 0.87 113.227 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.746 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 16.5 m -82.78 -1.97 53.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.307 0.575 . . . . 1.38 109.532 168.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 84.85 45.59 5.96 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.783 -0.927 . . . . 1.17 110.783 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.746 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.2 mmtp . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.739 -0.648 . . . . 2.45 110.385 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.232 0.171 0 CA-C-O 121.701 0.762 . . . . 2.1 111.751 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.549 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 19.2 t70 -162.78 159.93 24.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.083 -1.417 . . . . 1.81 107.816 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.55 24.08 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.74 0.245 . . . . 0.95 111.088 -173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 4' ' ' ASP . 3.4 m -51.56 -53.71 35.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.965 -0.561 . . . . 2.19 111.805 -172.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.595 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.5 tptm -125.16 49.2 1.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.275 0.56 . . . . 3.07 109.941 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.482 ' HB3' HE21 ' A' ' 20' ' ' GLN . 2.8 t90 -74.58 -8.54 56.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.517 -0.765 . . . . 4.76 111.046 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 9.0 p -136.36 22.92 3.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.223 0.535 . . . . 0.98 110.56 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.595 ' HA3' ' HG3' ' A' ' 7' ' ' LYS . . . -86.9 -120.44 1.3 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.516 -0.633 . . . . 0.52 111.516 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.51 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 11.6 Cg_endo -51.35 -40.49 61.78 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.551 2.834 . . . . 0.61 110.402 167.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.635 HD13 ' HA3' ' A' ' 38' ' ' GLY . 19.2 mt -87.34 88.22 7.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.012 -0.995 . . . . 1.85 109.045 171.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 4.6 m -75.66 63.87 1.64 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.509 0.671 . . . . 1.31 110.674 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD21 HG23 ' A' ' 121' ' ' VAL . 27.8 mt -75.94 -7.94 55.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.693 -0.685 . . . . 0.61 110.091 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 6.5 tp-100 -73.38 -7.82 53.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 2.61 110.992 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.561 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 22.1 mt-10 -63.45 -37.06 85.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.176 -0.676 . . . . 1.93 109.176 171.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.888 HG11 HG22 ' A' ' 151' ' ' VAL . 31.9 t -76.65 -73.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.494 -1.23 . . . . 1.26 111.635 -175.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.487 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 30.3 t0 -152.09 170.19 20.55 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.633 -0.506 . . . . 2.99 109.633 -172.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' HH12 ' A' ' 155' ' ' ARG . 30.8 mt-10 -60.3 149.96 31.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.472 0.545 . . . . 1.6 112.472 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.482 HE21 ' HB3' ' A' ' 8' ' ' TRP . 52.0 mt-30 -60.54 120.43 52.36 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 115.444 -0.798 . . . . 4.38 109.118 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 36.8 Cg_exo -58.7 155.42 37.5 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.656 2.237 . . . . 0.69 112.396 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.93 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 10.1 pt20 -71.64 -17.56 62.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.455 -0.793 . . . . 1.87 111.265 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.799 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 53.1 m-70 -149.75 157.47 38.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.534 0.734 . . . . 2.35 109.172 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 2.1 Cg_endo -84.89 129.82 4.08 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.97 2.447 . . . . 0.44 112.019 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 122' ' ' TRP . 22.1 tp -78.95 139.79 38.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.522 0.201 . . . . 0.33 110.594 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -110.99 125.73 54.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.47 -0.567 . . . . 2.12 109.47 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.515 HG11 HG22 ' A' ' 53' ' ' ILE . 13.0 t -131.65 135.66 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.426 -0.583 . . . . 1.12 109.426 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -137.15 137.9 39.7 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.001 0.429 . . . . 0.78 110.736 -177.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -98.38 175.41 6.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.38 -0.97 . . . . 1.23 108.38 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.25 59.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.247 0.546 . . . . 0.6 110.855 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.2 -7.99 34.32 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.415 -0.812 . . . . 0.81 112.606 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.07 -173.17 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.719 -0.283 . . . . 0.56 110.412 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.1 166.05 23.95 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.224 -0.444 . . . . 0.35 110.246 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' A' ' 169' ' ' TYR . 89.4 t -113.23 64.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 106.521 -1.659 . . . . 0.39 106.521 162.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.14 16.1 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.438 -1.255 . . . . 0.99 109.78 -174.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.733 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 4.6 tm-20 -148.5 125.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.071 -1.085 . . . . 2.56 108.071 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.633 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.9 OUTLIER -71.86 110.19 6.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.847 -0.427 . . . . 0.46 109.847 -174.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.662 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 88.71 14.83 60.67 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.708 -0.678 . . . . 0.59 112.573 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -72.29 154.64 40.86 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 110.145 -0.316 . . . . 1.04 110.145 175.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.454 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 8.8 p -80.34 129.6 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.301 0.572 . . . . 1.16 110.972 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 46' ' ' VAL . 6.2 tp -124.2 165.13 18.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.559 -1.274 . . . . 0.45 107.559 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.97 152.69 49.0 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 119.148 -1.021 . . . . 1.0 113.375 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.633 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 70.9 Cg_exo -51.38 -46.43 31.52 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.401 2.734 . . . . 1.0 113.338 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -27.58 65.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.998 0.428 . . . . 1.24 111.452 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.2 -48.68 10.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.978 -0.556 . . . . 1.74 110.914 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 41' ' ' LEU . 10.7 m -95.17 29.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.53 0.681 . . . . 1.1 112.323 -175.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 6.52 42.77 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.31 -0.626 . . . . 1.32 109.31 178.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -148.17 177.85 9.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.118 -0.946 . . . . 2.4 109.572 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -78.88 152.36 77.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.405 -0.361 . . . . 1.78 110.096 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.09 156.59 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.403 2.068 . . . . 0.41 111.479 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -77.45 -23.76 50.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.88 110.355 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.477 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 67.3 m -153.02 141.07 20.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.66 0.615 . . . . 0.65 112.66 -175.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -140.82 166.26 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.997 -1.001 . . . . 0.33 108.313 169.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.744 ' HA ' HD11 ' A' ' 58' ' ' LEU . 31.3 t 176.12 117.7 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.985 0.421 . . . . 0.8 110.096 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.672 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 29.9 p-90 -79.27 154.82 28.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.707 -1.22 . . . . 3.63 107.707 172.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' HB3' ' HD1' ' A' ' 23' ' ' HIS . 35.7 t70 -64.64 85.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.811 0.339 . . . . 1.51 111.364 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.02 20.3 2.28 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.991 -0.549 . . . . 0.9 112.021 -175.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.744 HD11 ' HA ' ' A' ' 54' ' ' SER . 4.5 tt -63.01 129.07 38.78 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.937 0.495 . . . . 0.62 111.072 -177.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.514 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 26.1 t70 -74.82 -28.0 60.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.054 -0.521 . . . . 0.74 111.635 -175.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.624 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.7 m 74.32 2.12 4.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.302 -0.863 . . . . 1.51 110.422 -172.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -130.21 -35.81 0.41 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.671 -0.695 . . . . 0.84 112.372 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.553 ' HZ1' ' CD ' ' A' ' 126' ' ' GLU . 12.2 mtpt -63.29 146.26 53.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.908 0.385 . . . . 2.12 110.302 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.812 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 25.6 mt -87.37 138.7 31.25 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.794 -1.187 . . . . 1.23 107.794 172.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 11.5 m-85 -128.71 157.51 41.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 1.61 109.822 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.464 ' HG1' HD21 ' A' ' 131' ' ' LEU . 91.8 m -96.86 105.28 17.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.397 -0.594 . . . . 0.87 109.397 172.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 17.6 tp -100.84 109.6 21.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.444 -0.798 . . . . 1.35 109.563 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.1 125.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.45 . . . . 0.54 110.987 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.493 HD23 ' HE1' ' A' ' 169' ' ' TYR . 3.4 mt -85.5 129.86 34.72 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.416 -0.957 . . . . 0.65 108.416 167.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.837 HG21 HG12 ' A' ' 17' ' ' VAL . 9.0 t -138.11 138.79 39.04 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.7 -0.481 . . . . 1.04 109.7 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.522 ' HB3' ' HA ' ' A' ' 120' ' ' TYR . 11.2 p-10 -132.67 99.78 15.3 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-O 121.617 0.722 . . . . 1.92 111.026 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.48 -173.9 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.582 2.854 . . . . 1.25 112.386 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.842 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 2.1 m-20 56.93 33.81 23.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.17 0.509 . . . . 1.29 111.127 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 81' ' ' TYR . . . -104.34 137.19 19.16 Favored Pre-proline 0 C--O 1.22 -0.469 0 CA-C-N 116.054 -0.521 . . . . 0.56 110.647 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.638 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -79.5 -31.12 5.1 Favored 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.016 -1.66 . . . . 0.7 112.556 0.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 115' ' ' THR . 92.7 p -125.24 153.44 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 1.1 109.977 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.842 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 45.5 mtp180 -71.99 -23.18 61.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.301 -0.409 . . . . 3.39 111.599 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.758 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.73 -10.89 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.932 0.396 . . . . 1.83 110.79 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -155.2 82.3 3.95 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.34 -0.615 . . . . 1.37 109.34 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -89.1 97.67 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.034 2.489 . . . . 0.9 113.279 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 6.5 mtmm -88.13 -58.7 2.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.119 -0.946 . . . . 1.53 111.16 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.501 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 70.0 m-85 -66.89 -23.37 65.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.969 -0.56 . . . . 1.54 110.994 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.561 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -48.0 117.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.412 0.445 . . . . 3.38 109.891 177.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -89.71 130.99 35.91 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.561 0.744 . . . . 2.23 112.217 7.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.518 ' HD1' ' N ' ' A' ' 85' ' ' HIS . 4.6 t90 -90.56 134.37 34.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.832 -0.803 . . . . 1.77 108.832 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.518 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 13.8 p-80 -106.07 129.74 54.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.876 -0.787 . . . . 2.19 108.876 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.403 ' CB ' ' HB3' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -91.11 -23.76 20.2 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.29 0.478 . . . . 2.74 112.29 -171.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.608 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 6.5 p90 -169.2 170.7 8.5 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.062 -0.347 . . . . 2.21 110.062 167.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.9 tp -131.89 114.0 14.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.546 -0.297 . . . . 0.68 110.411 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.476 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 2.0 t -119.92 133.4 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.05 -0.523 . . . . 0.35 110.827 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.447 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 5.3 m -131.61 168.1 24.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.123 -1.065 . . . . 0.3 108.123 174.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.812 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 8.8 m-20 59.96 19.28 8.33 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.37 0.419 . . . . 2.09 111.588 173.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.624 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 9.6 ttm -74.16 111.26 9.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.464 -0.939 . . . . 0.34 108.464 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.3 ttmm -79.71 91.5 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.191 -0.913 . . . . 1.73 111.196 -170.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.635 ' HA2' ' HE1' ' A' ' 64' ' ' TYR . . . 72.41 -117.45 6.24 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.857 -1.065 . . . . 0.35 112.166 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.66 ' HB3' HD22 ' A' ' 58' ' ' LEU . 27.6 p-10 -111.55 26.38 10.71 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.428 0.632 . . . . 1.59 110.122 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.428 ' HB3' ' HG ' ' A' ' 99' ' ' SER . 16.7 t70 -89.39 104.19 16.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.247 -0.888 . . . . 0.77 109.946 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.453 HD11 HD13 ' A' ' 53' ' ' ILE . 4.6 mm -59.85 -28.55 41.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.111 -0.949 . . . . 0.45 111.233 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.1 m -78.65 -42.76 27.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 1.15 112.469 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.428 ' HG ' ' HB3' ' A' ' 96' ' ' ASP . 20.0 p -65.21 -24.16 67.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.412 0.523 . . . . 1.26 112.412 -174.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.624 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -53.46 99.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.761 0.663 . . . . 0.44 113.316 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 99.4 m -65.78 105.45 1.28 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.121 -0.696 . . . . 1.06 109.121 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 9.5 p -93.4 109.57 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.4 -0.818 . . . . 1.15 110.839 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.67 -41.78 23.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.12 0.962 . . . . 0.48 109.824 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.0 t -115.04 100.19 7.99 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.247 -1.39 . . . . 0.62 107.247 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.807 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -52.69 156.85 1.77 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.298 0.999 . . . . 1.15 113.161 -167.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 4.1 p90 -76.61 96.19 4.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.942 -1.026 . . . . 4.98 110.739 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.832 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 21.8 t -67.72 -31.63 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.844 -0.616 . . . . 0.86 111.76 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.45 173.09 49.49 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.756 -0.735 . . . . 0.95 111.912 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 38.7 t -54.53 135.7 45.69 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.22 0.51 . . . . 0.89 110.834 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.87 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 169.77 70.68 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.82 113.289 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.14 150.23 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.739 2.293 . . . . 1.01 110.898 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.67 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 85.0 Cg_exo -43.48 126.48 5.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.728 2.286 . . . . 0.96 112.321 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.516 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -61.68 115.5 4.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 2.39 110.749 -175.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.72 23.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.716 -0.754 . . . . 1.3 112.407 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.67 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.7 p -76.86 -60.99 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.758 0.279 . . . . 1.04 111.405 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.41 28.33 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.857 -0.687 . . . . 1.97 112.081 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.711 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.1 mm? -73.21 123.27 23.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.94 110.477 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.436 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -102.01 112.81 25.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.051 0.453 . . . . 2.85 110.35 176.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.514 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 2.0 ptt180 -85.74 90.5 8.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.504 -0.771 . . . . 2.78 110.703 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.638 ' HE2' ' HB2' ' A' ' 171' ' ' ALA . 3.3 m-85 -74.29 112.57 10.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.022 -0.733 . . . . 1.13 109.022 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 168' ' ' CYS . 13.8 t -94.01 126.01 46.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.948 -0.569 . . . . 0.31 109.638 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.674 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.34 119.56 30.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.721 -0.672 . . . . 2.96 109.738 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 83.6 mt -115.99 138.62 51.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.647 -0.131 . . . . 0.41 110.647 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -122.69 140.71 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.695 -0.483 . . . . 0.43 109.695 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.638 ' HB2' HD21 ' A' ' 160' ' ' LEU . 97.2 m-85 -117.37 165.54 13.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.996 0.427 . . . . 5.41 111.191 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.553 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 5.2 tp10 -110.38 137.61 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.25 -0.886 . . . . 2.41 109.983 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.624 ' HG3' ' HG ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.26 153.84 47.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.357 0.599 . . . . 1.31 110.014 177.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.01 -2.17 46.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.045 -0.98 . . . . 2.4 111.051 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.527 HH22 ' HB2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -166.17 168.61 7.41 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.16 -0.927 . . . . 4.07 109.753 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HG3' HD11 ' A' ' 63' ' ' LEU . 76.1 Cg_exo -53.15 150.54 24.4 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.559 2.173 . . . . 1.21 111.791 171.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.464 HD21 ' HG1' ' A' ' 65' ' ' THR . 4.5 mm? -72.21 158.45 35.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.633 0.73 . . . . 1.16 112.42 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.71 127.2 32.33 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.584 -1.265 . . . . 3.23 107.584 167.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.9 m -146.44 -63.23 0.3 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.866 -0.606 . . . . 2.79 109.728 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 58.83 37.99 24.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.395 0.617 . . . . 2.96 110.809 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.58 137.0 63.32 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.264 -0.88 . . . . 1.39 109.54 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.85 106.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.132 2.554 . . . . 1.38 112.175 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.7 mm -55.77 119.12 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.534 -0.757 . . . . 0.94 111.36 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 81.4 mt -88.49 158.71 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.086 -0.709 . . . . 1.61 109.086 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.676 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 64.5 m -112.63 31.28 6.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.713 -0.221 . . . . 1.88 111.008 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.832 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.1 p-10 54.92 12.64 0.63 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.202 0.939 . . . . 1.33 111.693 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.676 ' HG3' ' O ' ' A' ' 139' ' ' SER . 5.5 mtm180 -98.2 153.61 18.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.933 -0.395 . . . . 3.83 109.933 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.625 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 44.4 m 67.5 165.68 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.275 -0.875 . . . . 1.32 111.824 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.0 23.07 5.93 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.474 -0.87 . . . . 1.13 112.401 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -71.01 -26.25 63.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.205 0.446 . . . . 2.66 112.205 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -131.27 61.01 1.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.304 0.573 . . . . 2.18 110.751 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.88 -71.05 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.264 -0.88 . . . . 5.37 110.663 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -124.44 -153.41 8.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.53 -0.843 . . . . 0.9 112.226 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.2 mttt 66.51 32.5 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.151 0.977 . . . . 1.59 109.831 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -124.9 103.97 8.34 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.11 -1.405 . . . . 2.27 108.81 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -62.85 120.19 10.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 1.87 111.875 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.888 HG22 HG11 ' A' ' 17' ' ' VAL . 8.2 m -62.66 -31.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.96 110.581 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -59.12 -38.8 80.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.866 -0.606 . . . . 0.76 110.154 174.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.6 m -66.86 -38.6 86.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.546 . . . . 1.22 110.624 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.752 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 62.0 m-85 -61.56 -53.07 61.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 1.1 111.126 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.69 HH12 ' HG3' ' A' ' 19' ' ' GLU . 8.7 ptm180 -66.21 -39.69 89.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 3.36 111.641 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.8 mtmt -68.08 -46.77 70.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.605 0.24 . . . . 1.52 111.169 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -60.87 -51.64 68.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.069 -0.514 . . . . 2.13 111.587 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.67 0.08 31.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.271 -0.422 . . . . 5.77 111.624 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.527 ' HB2' HH22 ' A' ' 129' ' ' ARG . 70.8 mm-40 66.1 46.36 2.15 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.763 0.664 . . . . 2.42 110.996 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 125' ' ' TYR . 5.6 mp -102.35 15.09 30.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.643 0.608 . . . . 1.27 112.643 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 61.89 -94.45 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.649 0.38 . . . . 4.0 111.809 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -154.3 168.82 11.11 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 109.455 -0.572 . . . . 1.21 109.455 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 38.9 Cg_exo -57.16 129.03 32.14 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.406 2.071 . . . . 0.68 112.91 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.93 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -84.38 -33.06 8.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.279 -0.638 . . . . 0.5 109.279 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.799 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.23 149.79 29.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.831 -0.622 . . . . 0.29 111.258 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -153.25 144.75 11.73 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.357 -0.838 . . . . 0.24 112.009 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -157.97 137.78 12.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.45 -0.574 . . . . 0.34 109.45 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.736 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -108.54 144.93 35.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.325 0.583 . . . . 2.16 111.791 -174.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.668 ' HB3' HG22 ' A' ' 34' ' ' VAL . 34.0 p90 -135.07 119.62 18.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.378 -1.341 . . . . 1.31 107.378 172.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -100.14 133.23 44.83 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.866 -0.734 . . . . 2.53 111.451 -178.325 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.638 ' HB2' ' HE2' ' A' ' 120' ' ' TYR . . . -129.87 147.99 51.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.491 -0.777 . . . . 0.75 109.739 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.711 ' HB3' HD13 ' A' ' 117' ' ' LEU . 12.6 pt-20 -110.71 -172.52 2.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.045 -0.525 . . . . 2.38 111.09 -176.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.897 ' HA ' HG23 ' A' ' 177' ' ' VAL . 0.7 OUTLIER -85.11 64.47 8.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 4.71 111.173 -177.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.633 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.7 t70 -53.16 -61.78 2.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.573 -0.739 . . . . 1.53 112.332 -176.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.568 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.3 t70 -177.27 -40.74 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.943 0.402 . . . . 1.26 110.92 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -78.17 2.73 17.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.079 0.466 . . . . 2.46 111.058 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.897 HG23 ' HA ' ' A' ' 173' ' ' TRP . 39.8 t -72.52 -53.83 5.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.58 110.507 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 73.4 Cg_exo -52.79 -33.5 60.85 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.128 1.886 . . . . 0.68 111.966 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 43.4 mmtm -74.35 -24.92 59.24 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.737 0.273 . . . . 2.62 111.737 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.87 HD22 ' HA3' ' A' ' 110' ' ' GLY . 62.3 tp -66.57 -46.16 76.92 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.764 -0.828 . . . . 1.18 108.764 170.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -60.44 -37.97 82.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.355 -0.839 . . . . 2.11 109.533 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.681 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 24.9 mm-40 -56.65 -41.57 77.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.299 -0.864 . . . . 1.53 111.088 172.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.48 -31.63 57.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.615 -0.721 . . . . 2.16 111.881 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.625 ' HA ' ' H ' ' A' ' 142' ' ' SER . 21.2 mt -65.1 5.64 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.629 0.603 . . . . 0.87 112.629 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 16.9 m -66.07 -19.89 65.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.613 0.72 . . . . 1.38 109.791 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 88.76 62.93 1.35 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.145 -0.934 . . . . 1.17 110.791 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt . . . . . 0 C--O 1.244 0.78 0 CA-C-O 118.449 -0.786 . . . . 2.45 109.984 -176.833 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 24' ' ' PRO . 4.5 t . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.783 -0.451 . . . . 2.1 109.783 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -154.36 158.74 40.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.928 -0.397 . . . . 1.81 109.928 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -95.19 22.69 6.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.688 -0.233 . . . . 0.95 110.962 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 m -80.05 -1.3 39.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 2.19 111.481 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.594 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 11.3 mptt -118.87 22.28 12.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.321 -0.622 . . . . 3.07 109.321 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.644 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 1.9 p90 -61.93 -32.79 73.23 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 4.76 113.565 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -139.99 18.59 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.988 -0.445 . . . . 0.98 111.508 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.484 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.15 -122.14 0.78 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.263 -0.735 . . . . 0.52 111.263 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.484 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.5 Cg_endo -50.1 -40.64 50.64 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.539 2.826 . . . . 0.61 110.696 167.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.621 HD12 ' HG ' ' A' ' 168' ' ' CYS . 23.1 mt -87.23 78.49 8.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.21 -0.904 . . . . 1.85 108.752 170.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -73.26 64.98 0.82 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.702 0.763 . . . . 1.31 110.507 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.461 HD21 ' CG2' ' A' ' 121' ' ' VAL . 28.7 mt -81.44 -7.05 59.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.181 -0.918 . . . . 0.61 111.326 -173.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -2.06 20.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.428 0.632 . . . . 2.61 110.332 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.87 -7.67 55.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 1.93 110.743 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.806 HG12 HG21 ' A' ' 69' ' ' THR . 71.3 t -98.5 -70.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.684 . . . . 1.26 111.112 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.682 ' OD2' ' HD2' ' A' ' 155' ' ' ARG . 22.2 t0 -164.32 -178.45 5.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.807 -1.183 . . . . 2.99 107.807 -167.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.35 149.84 41.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.322 0.582 . . . . 1.6 111.104 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.644 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 5.6 tp60 -81.87 138.6 46.57 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.735 . . . . 4.38 110.736 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 13.4 Cg_exo -68.51 164.86 31.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.021 2.481 . . . . 0.69 112.95 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.949 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.9 pt20 -90.52 -1.62 57.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.765 . . . . 1.87 111.929 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.74 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.4 m170 -158.88 159.78 29.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 123.059 0.544 . . . . 2.35 109.919 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.3 Cg_endo -84.83 127.46 3.6 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.059 2.506 . . . . 0.44 111.251 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 122' ' ' TRP . 36.0 tp -79.85 145.66 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.694 -0.23 . . . . 0.33 110.768 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.44 ' H ' HD12 ' A' ' 25' ' ' LEU . 51.0 m-70 -114.72 121.24 42.73 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.982 -0.748 . . . . 2.12 108.982 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 53' ' ' ILE . 19.4 t -122.83 144.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.108 -0.701 . . . . 1.12 109.108 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -140.02 136.32 33.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.237 0.542 . . . . 0.78 111.107 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.527 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 46.0 t80 -101.97 170.2 8.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.174 -0.676 . . . . 1.23 109.174 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.47 63.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.342 0.591 . . . . 0.6 110.391 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.527 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -117.45 19.16 11.68 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.123 -0.944 . . . . 0.81 112.703 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.7 -172.37 4.2 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.56 110.783 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.37 154.9 17.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.991 -0.55 . . . . 0.35 110.13 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.718 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 87.8 t -119.21 68.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.192 -1.41 . . . . 0.39 107.192 164.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -105.7 21.56 17.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.979 -1.01 . . . . 0.99 108.851 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 22.4 tt0 -144.42 117.58 8.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.718 -1.128 . . . . 2.56 108.486 174.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.657 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -66.88 110.56 3.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.46 109.475 -177.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 95.24 12.94 53.9 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.531 -0.759 . . . . 0.59 112.557 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -78.93 149.05 32.44 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.09 -0.337 . . . . 1.04 110.09 177.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.9 134.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 1.16 111.324 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.588 HD21 ' CG1' ' A' ' 46' ' ' VAL . 8.2 tp -132.27 171.11 14.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.703 -0.851 . . . . 0.45 108.703 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -120.5 150.81 52.89 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.67 0.748 . . . . 1.0 112.485 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.863 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 72.4 Cg_exo -54.92 -29.99 66.64 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.604 3.536 . . . . 1.0 113.963 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -42.53 88.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.659 0.742 . . . . 1.24 110.275 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -74.93 -14.4 60.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.613 -1.176 . . . . 1.74 111.822 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.588 ' CG1' HD21 ' A' ' 41' ' ' LEU . 24.9 m -125.48 24.32 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.173 0.511 . . . . 1.1 111.647 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.75 -18.55 40.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.505 0.669 . . . . 1.32 109.206 177.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.415 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 52.0 t30 -125.03 -179.58 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.701 -1.136 . . . . 2.4 108.751 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.88 150.68 78.66 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.616 -0.513 . . . . 1.78 109.616 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.438 ' O ' HG13 ' A' ' 97' ' ' ILE . 55.2 Cg_endo -73.88 158.75 46.04 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.978 1.785 . . . . 0.41 110.436 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.446 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.6 t -79.75 -18.8 50.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 0.88 109.858 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.45 ' O ' HG21 ' A' ' 53' ' ' ILE . 60.1 m -161.21 147.41 14.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.632 0.73 . . . . 0.65 112.164 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -139.13 165.6 23.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.756 -1.111 . . . . 0.33 108.249 170.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.719 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 30.4 t 178.96 111.98 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.938 0.399 . . . . 0.8 109.929 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.633 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 51.1 p-90 -68.87 167.97 14.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.552 -1.277 . . . . 3.63 107.552 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -70.2 70.31 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.191 0.519 . . . . 1.51 111.187 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.83 22.99 0.64 Allowed Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.446 -0.797 . . . . 0.9 112.423 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.719 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 4.7 tt -54.88 132.31 46.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.89 0.476 . . . . 0.62 111.674 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 60' ' ' SER . 18.8 t70 -78.9 -28.81 44.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.844 -0.616 . . . . 0.74 111.996 -175.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.676 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 64.6 m 71.82 1.97 4.11 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.462 -0.79 . . . . 1.51 110.769 -172.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.65 14.54 4.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.992 -0.549 . . . . 0.84 112.719 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 1.5 mmpt? -119.26 164.82 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 2.12 109.956 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 63.7 mt -103.2 125.6 49.96 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.367 -0.605 . . . . 1.23 109.367 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -120.72 148.33 44.1 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.806 -0.357 . . . . 1.61 110.812 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.917 HG21 HG11 ' A' ' 90' ' ' VAL . 3.1 m -96.56 105.74 17.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.691 -0.855 . . . . 0.87 108.691 173.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.555 HD11 HG11 ' A' ' 124' ' ' VAL . 50.2 tp -109.69 117.76 34.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.274 -0.421 . . . . 1.35 110.907 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG22 HD11 ' A' ' 88' ' ' LEU . 21.0 t -119.0 123.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.865 -0.607 . . . . 0.54 110.553 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.973 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 1.2 mt -90.03 133.68 34.68 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.038 -1.097 . . . . 0.65 108.038 168.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.806 HG21 HG12 ' A' ' 17' ' ' VAL . 8.8 t -142.75 149.16 38.36 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.692 -0.403 . . . . 1.04 111.84 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.602 ' CG ' ' HD1' ' A' ' 118' ' ' HIS . 10.8 t70 -135.71 97.5 12.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 121.522 0.677 . . . . 1.92 109.488 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.515 ' HD3' HG23 ' A' ' 17' ' ' VAL . 18.6 Cg_endo -57.82 -7.42 3.35 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 124.62 3.547 . . . . 1.25 115.848 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 1.8 m-20 -124.77 51.42 1.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.533 0.683 . . . . 1.29 111.534 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -104.58 143.77 27.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.19 -0.913 . . . . 0.56 109.391 172.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 34.6 Cg_endo -70.92 -35.89 2.62 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.53 -1.446 . . . . 0.7 113.431 1.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.475 ' HB3' HG22 ' A' ' 115' ' ' THR . 72.2 p -131.59 166.82 20.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 1.1 111.312 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.555 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 51.5 ttt180 -71.33 -23.09 61.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.0 -0.546 . . . . 3.39 110.839 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.677 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.15 -11.52 38.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.509 . . . . 1.83 110.656 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.666 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 6.9 t70 -149.64 79.73 7.83 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.699 -0.682 . . . . 1.37 109.958 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -89.77 94.24 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.741 2.294 . . . . 0.9 113.287 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.9 mttm -88.17 -44.09 11.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.284 -0.871 . . . . 1.53 110.541 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.657 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 27.9 m-85 -88.54 18.12 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.175 -0.921 . . . . 1.54 112.032 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.7 ttm180 -64.2 125.83 25.78 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.916 0.135 . . . . 3.38 111.236 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.0 mp0 -97.67 134.25 41.11 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.065 -0.346 . . . . 2.23 110.065 -5.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.563 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 11.2 t90 -80.57 100.32 8.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.427 0.632 . . . . 1.77 109.927 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 33.2 p-80 -84.2 126.08 32.8 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.553 0.692 . . . . 2.19 110.18 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.973 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 19.5 t-80 -67.9 -34.7 77.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.05 -0.977 . . . . 2.74 110.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.468 ' HD1' ' HD1' ' A' ' 86' ' ' HIS . 44.2 p90 -169.29 170.67 8.4 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.117 0.261 . . . . 2.21 110.311 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.546 HD11 HG22 ' A' ' 67' ' ' VAL . 17.0 tp -133.33 114.08 13.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.065 -0.516 . . . . 0.68 109.701 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.32 132.54 70.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.6 0.714 . . . . 0.35 111.153 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.917 HG11 HG21 ' A' ' 65' ' ' THR . 9.9 m -130.86 160.53 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.85 -1.068 . . . . 0.3 108.419 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.551 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t-20 62.62 20.52 12.08 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.203 0.314 . . . . 2.09 110.625 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.591 ' HE3' ' HA ' ' A' ' 97' ' ' ILE . 8.3 ttm -71.51 110.35 6.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.277 -0.638 . . . . 0.34 109.277 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.01 94.71 5.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.578 -1.192 . . . . 1.73 110.937 -171.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.676 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 72.72 -120.27 7.37 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.801 -1.09 . . . . 0.35 112.426 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.594 ' HB3' HD22 ' A' ' 58' ' ' LEU . 8.7 p30 -112.76 17.59 18.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.188 0.518 . . . . 1.59 110.473 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.58 102.53 12.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.707 -0.679 . . . . 0.77 109.911 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.591 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 3.8 mm -58.71 -27.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.702 -1.135 . . . . 0.45 111.624 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -77.94 -38.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 1.15 111.975 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 m -74.87 -3.55 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 1.26 112.005 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.478 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -72.74 106.79 2.04 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.363 -0.695 . . . . 0.44 111.363 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -61.46 107.39 0.78 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.281 0.562 . . . . 1.06 109.734 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.8 p -83.47 113.28 22.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.081 -0.963 . . . . 1.15 111.4 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' A' ' 133' ' ' CYS . 40.6 mt -90.4 -45.8 8.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.79 0.805 . . . . 0.48 109.537 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.6 t -122.84 112.25 17.65 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.132 -1.433 . . . . 0.62 107.132 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 10.7 t0 -61.99 164.97 5.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.42 -0.809 . . . . 1.15 112.699 -168.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 13.8 p90 -82.69 92.08 7.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 4.98 110.76 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.716 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 40.3 t -75.09 -46.29 39.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.177 0.513 . . . . 0.86 111.02 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.683 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 109.84 -174.82 18.14 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.439 -0.886 . . . . 0.95 112.996 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 43' ' ' PRO . 42.2 t -66.58 140.25 57.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.287 -0.634 . . . . 0.89 109.287 172.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.705 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -174.13 55.52 0.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.71 -0.757 . . . . 0.82 112.854 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 57.5 Cg_endo -96.05 157.02 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.327 2.684 . . . . 1.01 112.516 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.601 ' O ' HG21 ' A' ' 115' ' ' THR . 53.0 Cg_exo -54.89 154.54 21.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.058 2.505 . . . . 0.96 112.282 174.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.3 116.5 15.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.77 0.319 . . . . 2.39 111.034 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.77 34.35 4.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.652 -0.785 . . . . 1.3 112.924 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 112' ' ' PRO . 82.7 p -77.98 -18.27 56.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.729 0.3 . . . . 1.04 110.637 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.41 3.14 44.21 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 120.916 -0.659 . . . . 1.97 112.132 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.526 HD12 ' HG2' ' A' ' 172' ' ' GLU . 4.1 mm? 71.69 102.52 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.299 -0.951 . . . . 0.94 111.079 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.602 ' HD1' ' CG ' ' A' ' 70' ' ' ASP . 21.4 t-80 -110.69 -172.33 2.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.416 -0.957 . . . . 2.85 108.416 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.564 ' H ' ' ND1' ' A' ' 118' ' ' HIS . 1.3 ptp180 -147.55 120.22 8.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.282 0.563 . . . . 2.78 111.676 -163.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.632 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 6.5 m-85 -80.34 127.33 32.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.577 -1.192 . . . . 1.13 108.825 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' CG2' HD21 ' A' ' 14' ' ' LEU . 16.9 t -104.19 130.83 54.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.154 -0.475 . . . . 0.31 110.856 -177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.681 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 27.0 m95 -89.56 120.3 30.74 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 2.96 108.935 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 86.5 mt -115.49 118.59 33.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.934 0.334 . . . . 0.41 110.77 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -116.46 139.82 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.399 -0.223 . . . . 0.43 110.399 177.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.854 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 71.3 t80 -127.03 137.28 53.03 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.866 -0.334 . . . . 5.41 111.0 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.521 ' H ' HG21 ' A' ' 164' ' ' VAL . 9.1 tp10 -88.05 96.65 10.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.49 -0.93 . . . . 2.41 108.49 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.487 ' HA ' ' CE2' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -72.63 167.72 20.16 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.251 0.548 . . . . 1.31 109.696 -176.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -80.84 -4.62 55.35 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.464 -0.789 . . . . 2.4 109.747 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 3.2 ptp180 -165.06 161.9 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.337 -0.847 . . . . 4.07 110.913 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HG3' HD11 ' A' ' 63' ' ' LEU . 51.4 Cg_exo -55.91 143.72 80.95 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.509 2.806 . . . . 1.21 112.442 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' A' ' 90' ' ' VAL . 2.3 mm? -79.91 141.83 35.72 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.328 -0.396 . . . . 1.16 110.767 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -132.64 67.26 1.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.435 -0.95 . . . . 3.23 108.435 168.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.756 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 61.4 m -82.23 122.65 28.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.178 -0.919 . . . . 2.79 110.443 -177.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.39 25.55 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.926 -0.579 . . . . 2.96 110.26 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.756 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 12.8 mm-40 -62.38 142.18 96.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.52 -0.764 . . . . 1.39 109.894 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.69 110.14 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.313 2.675 . . . . 1.38 112.696 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.41 115.49 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.94 110.323 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.8 mt -108.15 155.54 20.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.284 0.564 . . . . 1.61 110.639 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.9 m -105.11 159.26 15.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.176 -1.046 . . . . 1.88 108.176 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.716 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.0 p-10 -78.75 7.11 7.5 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.739 -0.384 . . . . 1.33 110.666 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.556 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 11.0 mtt180 -98.17 135.17 40.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.548 -0.538 . . . . 3.83 109.548 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.683 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 20.5 m 73.38 117.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 O-C-N 124.316 1.01 . . . . 1.32 109.686 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.21 27.66 15.12 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.583 -0.818 . . . . 1.13 113.669 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -71.29 -25.13 62.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.929 0.395 . . . . 2.66 111.026 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.92 30.48 6.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.949 0.404 . . . . 2.18 111.177 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.563 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 42.7 mtp180 -60.9 -46.39 90.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 5.37 110.782 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.52 -154.82 7.71 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.743 -0.741 . . . . 0.9 111.889 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.657 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.0 mttt 67.2 17.32 10.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.254 0.55 . . . . 1.59 111.137 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -122.13 112.24 17.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.441 -0.799 . . . . 2.27 109.106 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -62.45 129.7 41.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 1.87 112.496 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.603 HG22 ' CG1' ' A' ' 17' ' ' VAL . 4.6 m -62.94 -32.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.96 110.761 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.21 95.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.586 -0.734 . . . . 0.76 110.02 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 1.22 110.693 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.598 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 32.7 m-85 -61.73 -50.62 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 1.1 110.965 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.682 ' HD2' ' OD2' ' A' ' 18' ' ' ASP . 6.5 ptm85 -70.12 -40.01 75.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.396 -0.365 . . . . 3.36 111.135 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -66.05 -26.03 67.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 111.637 0.236 . . . . 1.52 111.637 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -53.76 -49.36 68.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.679 0.275 . . . . 2.13 110.608 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -99.64 15.31 27.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.759 -0.776 . . . . 5.77 109.917 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 58.4 43.6 19.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.295 -0.866 . . . . 2.42 111.682 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.854 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 3.4 mp -86.13 120.54 27.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.767 -0.651 . . . . 1.27 111.027 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.895 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -79.62 -173.7 3.92 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.914 -0.402 . . . . 4.0 109.914 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.895 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -43.5 146.41 0.93 Allowed Pre-proline 0 N--CA 1.466 0.328 0 C-N-CA 123.82 0.848 . . . . 1.21 113.009 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 6.5 Cg_exo -71.54 169.65 20.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.965 3.11 . . . . 0.68 113.969 -170.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.949 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 21.4 t -95.3 -30.8 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.5 110.364 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.3 146.9 27.78 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.828 -0.749 . . . . 0.29 112.302 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.681 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.97 148.07 19.12 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 114.458 -1.246 . . . . 0.24 111.603 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.657 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 10.5 t -159.72 149.43 18.33 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.469 -0.937 . . . . 0.34 108.469 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.621 ' HG ' HD12 ' A' ' 12' ' ' LEU . 21.2 p -123.8 146.68 48.17 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.12 -0.632 . . . . 2.16 111.166 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 33.4 p90 -130.23 142.03 50.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.413 -1.329 . . . . 1.31 107.413 175.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 1.1 pt20 -115.66 134.64 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.192 -0.603 . . . . 2.53 111.558 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.14 153.87 33.64 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.751 0.657 . . . . 0.75 110.072 -172.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.562 ' CG ' ' H ' ' A' ' 173' ' ' TRP . 2.5 pt-20 -133.91 -106.73 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.677 0.621 . . . . 2.38 112.677 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.774 ' HA ' HG23 ' A' ' 177' ' ' VAL . 31.9 t90 -118.12 84.1 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.15 0.5 . . . . 4.71 110.232 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.863 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 7.2 t70 -73.26 -62.4 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.898 -0.592 . . . . 1.53 111.725 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.552 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 14.4 t70 173.41 -44.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.776 -0.647 . . . . 1.26 109.675 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -80.34 9.55 5.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.548 -0.751 . . . . 2.46 111.117 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 173' ' ' TRP . 83.9 t -72.8 -53.99 5.04 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.58 109.926 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.6 Cg_exo -51.53 -37.8 63.31 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.299 1.999 . . . . 0.68 111.424 169.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.632 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.7 mmtp -71.54 -23.38 61.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 2.62 111.38 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.66 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.4 tp -67.81 -48.24 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.052 -0.722 . . . . 1.18 109.052 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.7 -32.39 73.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.01 -0.541 . . . . 2.11 109.737 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 11.7 mm-40 -55.7 -48.45 75.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.39 -0.823 . . . . 1.53 110.329 171.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.98 -33.16 63.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.288 -0.869 . . . . 2.16 112.002 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.683 ' HA ' ' H ' ' A' ' 142' ' ' SER . 37.6 mt -63.16 -1.83 1.14 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.496 0.554 . . . . 0.87 112.496 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.676 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 13.1 m -73.7 -2.62 24.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.434 0.635 . . . . 1.38 109.92 172.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.556 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.14 39.8 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.835 -0.906 . . . . 1.17 110.835 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.519 -0.753 . . . . 2.45 110.061 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' A' ' 36' ' ' GLU . 19.8 t . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.153 0.501 . . . . 2.1 111.462 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.473 ' O ' HD11 ' A' ' 37' ' ' LEU . 2.5 p30 -155.61 163.49 39.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.153 -1.054 . . . . 1.81 108.153 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -88.28 29.11 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.633 -0.427 . . . . 0.95 111.081 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 -7.82 59.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.303 0.573 . . . . 2.19 109.867 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 8.7 mptt -113.33 29.09 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 3.07 109.608 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.628 ' HZ3' ' HG3' ' A' ' 15' ' ' GLN . 11.4 p-90 -67.87 -36.11 79.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.356 -0.838 . . . . 4.76 111.693 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 75.3 p -144.03 19.92 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.646 -0.421 . . . . 0.98 111.601 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.44 -118.37 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.86 -0.686 . . . . 0.52 111.633 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.4 Cg_endo -47.14 -51.77 8.87 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.434 2.756 . . . . 0.61 110.787 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.853 HD23 HD22 ' A' ' 14' ' ' LEU . 6.5 mp -88.95 98.39 11.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 1.85 110.831 171.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 69.6 m -76.49 66.17 2.46 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.334 0.588 . . . . 1.31 110.26 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.853 HD22 HD23 ' A' ' 12' ' ' LEU . 57.9 mt -73.85 -16.88 61.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.509 -0.769 . . . . 0.61 111.225 -176.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.628 ' HG3' ' HZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -64.09 -15.08 58.84 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.05 0.452 . . . . 2.61 110.857 -178.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -60.4 -23.27 64.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.255 0.55 . . . . 1.93 110.666 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.887 HG12 HG21 ' A' ' 69' ' ' THR . 87.3 t -103.53 -64.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.328 -0.851 . . . . 1.26 110.877 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HB3' HD13 ' A' ' 123' ' ' LEU . 4.8 p-10 -116.43 172.44 7.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.134 0.492 . . . . 2.99 111.283 -175.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.58 28.65 1.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.632 -0.713 . . . . 1.6 112.365 -171.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.402 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 4.5 tt0 65.41 116.95 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 123.191 0.596 . . . . 4.38 110.691 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.468 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 20.4 Cg_exo -65.77 158.74 52.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.683 2.255 . . . . 0.69 112.959 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.881 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.4 pt20 -77.41 -13.89 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.247 -0.888 . . . . 1.87 110.789 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.738 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 70.7 m-70 -149.73 156.51 38.67 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-N 115.461 -0.79 . . . . 2.35 109.458 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -85.84 125.98 2.85 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.955 2.437 . . . . 0.44 110.771 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 27.0 tp -80.02 148.12 31.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.874 0.369 . . . . 0.33 111.012 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.483 ' H ' HD12 ' A' ' 25' ' ' LEU . 33.1 m170 -118.12 128.73 55.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.775 -0.454 . . . . 2.12 109.775 170.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.638 HG11 HG22 ' A' ' 53' ' ' ILE . 32.6 t -128.8 119.64 50.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.825 -0.806 . . . . 1.12 108.825 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.6 OUTLIER -115.68 138.49 51.04 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.343 0.592 . . . . 0.78 111.431 -171.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.424 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 33.6 t80 -100.31 176.78 5.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.784 -0.644 . . . . 1.23 109.275 174.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.58 65.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.277 0.561 . . . . 0.6 110.63 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.57 -0.57 29.24 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.438 -0.801 . . . . 0.81 112.845 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.54 -174.22 3.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.56 110.914 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.75 144.25 8.64 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.56 -0.746 . . . . 0.35 110.022 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.803 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.7 t -95.06 69.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 106.996 -1.483 . . . . 0.39 106.996 163.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -103.22 28.4 6.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.106 -0.952 . . . . 0.99 109.236 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.709 ' HA ' HG21 ' A' ' 3' ' ' VAL . 49.9 mt-10 -150.32 134.05 16.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.765 -1.107 . . . . 2.56 109.086 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.709 ' HB2' HG12 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.36 114.02 11.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.46 110.136 -175.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' CA ' HE22 ' A' ' 170' ' ' GLN . . . 78.88 29.59 51.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.9 -0.667 . . . . 0.59 111.518 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -90.29 152.92 20.83 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.22 0.208 . . . . 1.04 110.625 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.7 p -78.77 134.68 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.335 0.588 . . . . 1.16 111.487 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.565 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.6 tp -132.87 169.87 16.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.462 -0.94 . . . . 0.45 108.462 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.6 p -115.02 151.39 45.54 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.024 -0.67 . . . . 1.0 112.309 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 50.5 Cg_exo -56.91 -28.96 80.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.164 3.243 . . . . 1.0 113.298 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 p -65.09 -41.21 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.615 0.721 . . . . 1.24 110.528 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -80.47 -17.69 50.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.684 -1.144 . . . . 1.74 111.414 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.565 ' CG1' HD21 ' A' ' 41' ' ' LEU . 28.2 m -125.66 30.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 1.1 111.439 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.545 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -78.08 -21.93 49.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.457 0.646 . . . . 1.32 109.266 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 49' ' ' ARG . 3.3 t-20 -131.89 177.91 7.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.404 -1.271 . . . . 2.4 108.725 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.551 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 98.7 mtt180 -67.13 151.97 96.57 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.188 -0.301 . . . . 1.78 110.188 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 60.6 Cg_endo -74.75 161.68 38.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.192 1.928 . . . . 0.41 110.744 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -82.12 -21.24 36.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.107 0.48 . . . . 0.88 109.919 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.485 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -158.56 149.82 20.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.65 111.96 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.638 HG22 HG11 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -138.5 165.29 25.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.05 -1.093 . . . . 0.33 108.05 169.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.727 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 39.7 t -179.86 116.85 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.192 0.52 . . . . 0.8 110.204 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.511 ' NE1' ' HA ' ' A' ' 58' ' ' LEU . 45.7 p-90 -78.78 163.27 25.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.189 -1.041 . . . . 3.63 108.189 172.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.18 86.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.086 0.47 . . . . 1.51 110.939 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.0 29.44 2.81 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.677 -0.692 . . . . 0.9 112.472 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.727 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 3.3 tt -60.66 129.83 43.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.04 0.447 . . . . 0.62 110.853 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.738 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -80.69 -21.38 41.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.74 111.927 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.649 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 75.7 m 69.56 2.01 3.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.456 -0.793 . . . . 1.51 110.957 -171.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.15 -2.63 3.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.731 -0.747 . . . . 0.84 113.336 -176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.738 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 38.6 mtpt -93.93 145.69 24.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.451 0.625 . . . . 2.12 109.637 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.768 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 2.9 mt -84.77 144.01 28.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.665 -1.235 . . . . 1.23 107.665 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.53 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -140.72 166.05 25.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.841 -0.8 . . . . 1.61 108.841 173.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 88.5 m -105.03 105.16 15.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.222 -0.659 . . . . 0.87 109.222 171.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.558 HD11 HG11 ' A' ' 124' ' ' VAL . 52.1 tp -104.59 115.57 30.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.232 0.539 . . . . 1.35 110.429 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.11 123.72 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.645 -0.707 . . . . 0.54 110.489 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.628 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 5.5 mt -81.51 139.38 35.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.167 -1.049 . . . . 0.65 108.167 167.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.887 HG21 HG12 ' A' ' 17' ' ' VAL . 14.8 t -140.73 153.59 45.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.695 -0.402 . . . . 1.04 110.94 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.508 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 15.7 t70 -140.69 102.16 6.49 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.251 0.548 . . . . 1.92 110.219 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -55.37 -28.93 65.7 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.746 2.964 . . . . 1.25 114.788 174.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -100.43 43.81 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 1.29 111.974 -167.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 84' ' ' TRP . . . -108.51 136.43 19.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 122.241 -0.287 . . . . 0.56 110.872 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.66 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 66.2 Cg_endo -74.85 -25.75 9.89 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.277 -1.551 . . . . 0.7 112.657 0.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 115' ' ' THR . 86.6 p -139.07 160.3 40.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.604 . . . . 1.1 109.945 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -72.32 -26.16 61.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 3.39 111.858 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.758 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.85 -13.41 48.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.146 0.498 . . . . 1.83 110.508 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.522 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 21.8 t0 -150.9 73.01 8.73 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.357 -0.838 . . . . 1.37 109.149 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -89.99 88.87 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.765 2.31 . . . . 0.9 113.034 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.66 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 38.0 mttm -78.2 -45.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.773 -1.103 . . . . 1.53 111.035 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.706 ' HB3' ' HD1' ' A' ' 84' ' ' TRP . 77.8 m-85 -82.74 10.62 7.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.194 -0.912 . . . . 1.54 111.986 -169.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 37.8 ttp180 -70.16 127.76 33.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.185 -0.302 . . . . 3.38 110.185 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 48.9 mt-10 -94.6 129.6 41.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.025 0.44 . . . . 2.23 110.56 0.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.706 ' HD1' ' HB3' ' A' ' 81' ' ' TYR . 9.9 t90 -88.48 90.3 8.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 1.77 109.756 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.5 p80 -75.61 120.15 20.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.596 0.712 . . . . 2.19 109.872 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 6.1 t-160 -70.75 -24.44 62.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.365 -0.834 . . . . 2.74 111.011 -172.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.721 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 19.0 p90 -168.26 179.03 4.67 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.696 -0.483 . . . . 2.21 109.696 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 24.2 tp -142.75 114.48 8.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.68 110.434 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.721 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -126.49 132.37 70.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.35 110.475 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' A' ' 131' ' ' LEU . 6.4 m -124.54 166.2 20.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.722 -1.214 . . . . 0.3 107.722 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.768 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 92.8 m-20 59.56 19.55 8.07 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.374 0.421 . . . . 2.09 111.363 172.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.567 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 10.8 ttm -71.64 108.48 5.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.582 -0.895 . . . . 0.34 108.582 175.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.696 ' HG2' HD22 ' A' ' 63' ' ' LEU . 1.9 mtpm? -82.03 94.79 7.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.083 -0.962 . . . . 1.73 111.091 -170.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.5 -119.65 5.58 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.06 -0.973 . . . . 0.35 112.58 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.716 ' HB3' HD22 ' A' ' 58' ' ' LEU . 25.3 p-10 -117.62 29.94 7.56 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 1.59 111.002 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -96.71 105.59 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.534 0.683 . . . . 0.77 110.034 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 50' ' ' PRO . 8.4 mm -58.6 -33.38 48.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.565 -1.198 . . . . 0.45 111.459 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.2 m -82.61 -35.51 26.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.844 -0.616 . . . . 1.15 111.906 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 m -73.28 -6.04 43.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.493 -0.321 . . . . 1.26 111.711 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.567 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -66.3 107.87 2.16 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.628 -0.589 . . . . 0.44 111.628 175.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -57.99 107.01 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.534 0.683 . . . . 1.06 109.602 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.8 p -85.91 121.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.826 -1.079 . . . . 1.15 111.631 -173.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 135' ' ' GLU . 68.7 mt -102.0 -46.73 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.161 -0.927 . . . . 0.48 109.255 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.0 t -126.16 108.21 11.1 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.162 -1.422 . . . . 0.62 107.162 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.4 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.7 t0 -57.2 155.72 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 1.15 112.673 -169.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.478 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 43.2 t80 -74.02 95.32 2.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.29 -0.868 . . . . 4.98 109.783 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.4 t -78.96 142.34 14.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.268 -1.012 . . . . 0.86 108.268 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.21 179.33 45.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.95 112.975 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.616 ' HG ' ' HB2' ' A' ' 171' ' ' ALA . 28.7 t -54.92 141.3 34.06 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.16 0.184 . . . . 0.89 111.084 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.557 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -164.83 70.55 0.19 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.168 -0.539 . . . . 0.82 112.367 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.763 ' HD2' HG22 ' A' ' 177' ' ' VAL . 89.4 Cg_endo -92.53 133.76 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.022 2.481 . . . . 1.01 113.257 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.615 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 38.5 Cg_exo -59.11 137.31 78.57 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.649 2.233 . . . . 0.96 111.395 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.515 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.08 118.21 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 2.39 111.005 -178.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.63 -3.07 32.34 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.555 -0.831 . . . . 1.3 112.087 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.615 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 62.1 p -81.77 -10.47 59.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 1.04 110.57 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.16 -155.94 19.97 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.267 -0.733 . . . . 1.97 111.267 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.881 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -90.37 108.23 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.56 -0.533 . . . . 0.94 109.56 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.746 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -72.22 113.75 9.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 2.85 110.474 -175.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 1.005 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 1.1 ptt180 -102.77 95.12 5.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.315 0.579 . . . . 2.78 112.201 -169.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.589 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 16.9 m-85 -83.81 120.52 26.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.536 -0.756 . . . . 1.13 109.123 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.719 HG22 ' HB2' ' A' ' 168' ' ' CYS . 6.7 t -100.14 131.98 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 110.008 -0.367 . . . . 0.31 110.008 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.68 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 69.2 m95 -88.07 119.52 28.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.205 -0.665 . . . . 2.96 109.205 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 18' ' ' ASP . 45.6 mt -118.85 118.79 32.5 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 121.104 -0.238 . . . . 0.41 110.654 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 66' ' ' LEU . 1.4 m -105.12 128.36 59.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.165 -0.68 . . . . 0.43 109.165 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.65 ' CB ' HD21 ' A' ' 160' ' ' LEU . 86.2 m-85 -107.64 162.26 14.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.372 -0.376 . . . . 5.41 111.006 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.94 113.13 26.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.717 0.77 . . . . 2.41 112.806 -171.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.801 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -107.71 148.65 29.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.419 -0.809 . . . . 1.31 110.064 171.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.17 -9.5 59.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.302 -0.863 . . . . 2.4 110.716 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.466 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.5 ptp180 -147.59 168.09 12.02 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.601 -0.727 . . . . 4.07 111.641 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 22.6 Cg_exo -61.61 141.26 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.707 2.272 . . . . 1.21 110.539 172.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.791 HD23 ' HG2' ' A' ' 127' ' ' GLN . 3.2 mm? -73.9 145.21 44.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.681 0.623 . . . . 1.16 112.681 -169.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -102.2 104.34 14.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.965 -1.016 . . . . 3.23 108.811 171.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.442 ' CB ' HD13 ' A' ' 103' ' ' LEU . 1.3 p -124.44 112.23 16.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.113 -0.494 . . . . 2.79 111.803 -175.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -99.19 13.53 32.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.033 -0.729 . . . . 2.96 109.033 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.448 ' HB2' HD22 ' A' ' 103' ' ' LEU . 9.2 mm-40 -63.04 130.01 93.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.212 -0.904 . . . . 1.39 110.56 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.56 112.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.032 2.488 . . . . 1.38 112.435 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.5 mm -61.87 115.57 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 0.94 110.855 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.14 152.27 23.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 1.61 109.808 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.5 m -91.33 -173.44 3.61 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.676 -0.861 . . . . 1.88 108.676 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.714 ' HA ' HG22 ' A' ' 107' ' ' VAL . 2.1 p-10 -92.86 7.62 43.07 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.015 -0.674 . . . . 1.33 110.175 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.863 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 85.7 mtt180 -95.97 145.45 25.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 3.83 109.972 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.589 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 21.9 m 73.85 126.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.145 -0.934 . . . . 1.32 111.516 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.81 33.9 5.41 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.298 -0.865 . . . . 1.13 111.709 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -52.75 19.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 2.66 113.312 -172.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -122.19 47.44 1.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.427 0.632 . . . . 2.18 111.304 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.402 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 22.6 mmt180 -88.17 -27.44 21.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.728 -0.669 . . . . 5.37 111.138 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -129.33 -169.0 12.47 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.982 -1.104 . . . . 0.9 113.121 -174.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.699 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 79.3 mttt 65.99 34.33 7.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.603 0.715 . . . . 1.59 110.805 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.78 167.53 12.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.078 -0.964 . . . . 2.27 109.608 174.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -116.81 120.95 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.199 -0.455 . . . . 1.87 111.083 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.785 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 35.6 m -64.83 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.96 110.301 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.58 -44.68 93.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.024 -0.534 . . . . 0.76 109.708 172.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.3 m -64.16 -38.39 90.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 1.22 110.099 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.785 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.5 m-85 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.58 -0.282 . . . . 1.1 111.315 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.6 ptp180 -63.84 -43.87 94.89 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.979 -0.288 . . . . 3.36 110.345 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -68.64 -29.9 68.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.32 . . . . 1.52 111.119 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -59.09 -51.9 68.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 2.13 111.376 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -89.95 4.27 50.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.965 -0.561 . . . . 5.77 111.711 -173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 72.16 33.12 1.62 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.762 0.664 . . . . 2.42 111.213 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 127' ' ' GLN . 4.5 mp -100.54 172.44 7.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.21 -0.904 . . . . 1.27 109.372 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.501 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 31.0 tpt180 -131.99 -95.92 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.317 -0.553 . . . . 4.0 111.953 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -105.28 146.28 32.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.919 0.39 . . . . 1.21 110.989 -173.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 17.0 Cg_exo -65.71 141.74 67.32 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.274 2.649 . . . . 0.68 112.872 -170.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.881 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.0 t -78.16 -32.66 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.5 109.757 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.765 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -154.08 147.52 25.01 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.276 -0.569 . . . . 0.29 111.695 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.68 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.58 144.14 11.87 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.937 -1.029 . . . . 0.24 111.592 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -159.25 135.2 8.81 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.152 -0.684 . . . . 0.34 109.152 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.841 ' SG ' ' HB2' ' A' ' 119' ' ' ARG . 27.3 t -113.54 145.88 40.54 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.398 -0.521 . . . . 2.16 111.696 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.677 ' HB3' HG22 ' A' ' 34' ' ' VAL . 27.0 p90 -129.08 131.18 47.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.067 -0.716 . . . . 1.31 109.067 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 1.005 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 17.3 mp0 -98.46 132.22 44.09 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.441 -0.504 . . . . 2.53 110.272 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.616 ' HB2' ' HG ' ' A' ' 109' ' ' SER . . . -122.57 139.06 54.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.848 -0.427 . . . . 0.75 109.848 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.545 ' HB3' HD13 ' A' ' 117' ' ' LEU . 11.4 pt-20 -105.18 -168.76 1.51 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.073 -0.512 . . . . 2.38 110.939 -176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.8 ' HA ' HG23 ' A' ' 177' ' ' VAL . 22.7 t90 -87.23 78.57 8.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 4.71 109.847 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.596 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -72.81 -59.17 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.35 -0.386 . . . . 1.53 111.086 -177.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 15.4 t70 175.81 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.987 0.515 . . . . 1.26 110.479 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.48 ' HB3' ' CD ' ' A' ' 47' ' ' LYS . 36.9 m-85 -81.28 -0.64 41.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 2.46 111.758 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.805 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 99.1 t -63.25 -54.83 41.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.17 -0.468 . . . . 0.58 110.794 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.805 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.0 Cg_exo -50.77 -43.71 44.99 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.658 2.239 . . . . 0.68 111.923 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.67 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 30.3 mmmt -66.24 -23.55 66.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.08 -0.509 . . . . 2.62 111.917 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.681 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 36.0 tp -66.04 -48.67 70.31 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.058 -0.657 . . . . 1.18 109.574 172.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.26 -35.19 79.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.356 0.598 . . . . 2.11 109.656 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.67 ' HG3' ' HD2' ' A' ' 179' ' ' LYS . 4.8 mm-40 -55.97 -48.26 76.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.927 -1.033 . . . . 1.53 110.122 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -74.39 -33.47 63.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 2.16 112.187 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 71.1 mt -62.25 -10.69 11.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.646 0.26 . . . . 0.87 111.66 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.589 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 50.9 m -77.08 6.99 5.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.224 0.535 . . . . 1.38 110.441 173.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.863 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 68.89 60.82 5.02 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.268 -0.878 . . . . 1.17 111.327 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.6 mmmt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.518 -0.753 . . . . 2.45 111.125 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 25' ' ' LEU . 14.0 t . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.319 0.58 . . . . 2.1 111.007 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 6' ' ' SER . 32.0 t70 -152.04 158.15 42.64 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.752 -1.113 . . . . 1.81 108.268 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.463 HD12 HE21 ' A' ' 20' ' ' GLN . 2.7 mm? -78.9 30.91 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.837 0.351 . . . . 0.95 110.765 -175.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.621 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 3.9 m -59.1 -54.69 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.97 -0.559 . . . . 2.19 111.581 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.621 ' HD2' ' HB2' ' A' ' 6' ' ' SER . 8.8 mptt -99.73 40.48 1.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.819 0.342 . . . . 3.07 110.288 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 3.4 p-90 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.779 -0.646 . . . . 4.76 112.094 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 p -141.54 20.62 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.907 0.384 . . . . 0.98 111.394 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.77 -122.54 0.31 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.35 -0.7 . . . . 0.52 111.35 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.456 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.4 Cg_endo -51.48 -40.12 63.49 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.13 2.553 . . . . 0.61 109.815 166.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.699 HD13 ' HA3' ' A' ' 38' ' ' GLY . 25.9 mt -87.73 81.26 7.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.433 -1.258 . . . . 1.85 109.863 172.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 7.4 m -71.75 66.97 0.56 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.05 -0.722 . . . . 1.31 109.05 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.776 HD23 HH11 ' A' ' 119' ' ' ARG . 46.0 mt -75.16 -12.74 60.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.698 -0.683 . . . . 0.61 110.797 -175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -65.65 -15.19 62.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 2.61 111.237 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 13' ' ' SER . 40.2 mt-10 -66.16 -21.72 66.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.165 0.507 . . . . 1.93 110.078 175.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.799 HG12 HG21 ' A' ' 69' ' ' THR . 76.1 t -89.56 -71.59 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.464 -0.789 . . . . 1.26 110.775 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.585 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 9.8 t70 -156.58 174.72 15.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.543 -0.54 . . . . 2.99 109.543 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -63.95 120.84 12.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.298 . . . . 1.6 110.285 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.568 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 48.2 tp60 -53.82 127.93 53.49 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.752 -0.658 . . . . 4.38 110.567 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.635 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.0 Cg_exo -58.28 161.89 13.03 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.331 2.688 . . . . 0.69 113.498 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.925 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 8.8 pt20 -69.86 -19.48 63.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.894 -1.048 . . . . 1.87 112.0 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.682 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m80 -146.56 159.04 45.64 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.165 -0.47 . . . . 2.35 110.424 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.43 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.2 Cg_endo -85.19 128.65 3.67 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.208 2.605 . . . . 0.44 111.436 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 26.7 tp -80.84 146.89 30.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.526 0.203 . . . . 0.33 110.769 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -115.38 109.54 18.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.103 -0.332 . . . . 2.12 110.103 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 53' ' ' ILE . 13.8 t -116.35 140.4 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 1.12 110.049 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -137.59 137.66 38.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.3 -0.409 . . . . 0.78 110.889 -177.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.645 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 22.2 t80 -97.36 177.26 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.833 -0.802 . . . . 1.23 108.833 174.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.41 -52.53 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.514 0.673 . . . . 0.6 110.059 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.17 8.79 38.78 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.006 -0.997 . . . . 0.81 112.651 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.57 -169.7 3.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.56 110.704 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.51 158.2 23.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.737 -0.665 . . . . 0.35 109.8 176.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.834 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 79.8 t -111.43 65.87 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.624 -1.621 . . . . 0.39 106.624 163.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -97.69 25.31 5.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.17 0.986 . . . . 0.99 109.062 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.6 122.57 10.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.524 -1.217 . . . . 2.56 108.02 174.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.2 tt -70.94 111.37 6.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.194 0.521 . . . . 0.46 109.709 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.699 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 82.15 26.26 49.01 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.343 -0.844 . . . . 0.59 111.862 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.834 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -83.74 153.17 24.3 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.93 -0.396 . . . . 1.04 109.93 174.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.55 133.46 30.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.425 0.631 . . . . 1.16 111.285 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.557 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.8 tp -131.22 170.08 15.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.558 -0.904 . . . . 0.45 108.558 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.36 152.41 54.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 O-C-N 121.665 -0.647 . . . . 1.0 112.491 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 77.1 Cg_exo -51.78 -35.35 58.33 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.749 3.633 . . . . 1.0 114.722 -171.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.9 p -65.64 -35.03 79.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.712 0.768 . . . . 1.24 110.36 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.43 -14.14 55.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.4 -1.273 . . . . 1.74 111.686 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.557 ' CG1' HD21 ' A' ' 41' ' ' LEU . 23.9 m -128.49 20.04 2.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.287 0.565 . . . . 1.1 111.656 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.594 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.79 -26.55 31.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.751 -0.659 . . . . 1.32 109.545 179.217 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -116.77 -178.02 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.699 -1.137 . . . . 2.4 109.182 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.531 ' HB3' HG23 ' A' ' 97' ' ' ILE . 77.9 mtt180 -72.9 152.9 91.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.932 -0.766 . . . . 1.78 108.932 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.645 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 49.2 Cg_endo -74.94 175.02 11.77 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.413 1.409 . . . . 0.41 110.39 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -96.93 -16.26 20.75 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.274 -0.571 . . . . 0.88 110.059 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.459 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 75.3 m -159.75 144.32 14.99 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.65 112.436 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -141.24 169.21 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.996 -1.112 . . . . 0.33 107.996 171.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.693 ' HA ' HD11 ' A' ' 58' ' ' LEU . 36.8 t 176.87 127.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.918 0.39 . . . . 0.8 110.088 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.539 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 32.8 p-90 -92.91 167.73 11.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.933 -1.136 . . . . 3.63 107.933 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.4 78.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 1.51 111.045 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.02 26.01 0.86 Allowed Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.565 -0.743 . . . . 0.9 112.06 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.839 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 2.7 tt -65.35 128.48 36.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.071 0.462 . . . . 0.62 110.939 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.747 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 33.5 t70 -75.39 -25.68 57.84 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 0.74 111.756 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.631 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 25.3 p 70.0 8.87 6.88 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.475 1.11 . . . . 1.51 110.331 -171.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -3.4 1.42 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.84 113.405 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.747 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 39.5 mtpt -96.51 151.97 19.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.38 0.59 . . . . 2.12 110.217 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.681 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 45.2 mt -88.15 124.96 34.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.629 -0.714 . . . . 1.23 109.977 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.839 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 2.6 m-85 -120.99 152.0 39.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.919 -0.312 . . . . 1.61 110.683 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.459 ' OG1' HD21 ' A' ' 131' ' ' LEU . 57.1 m -97.32 110.63 23.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 0.87 109.149 170.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.607 HD11 HG11 ' A' ' 124' ' ' VAL . 48.8 tp -113.16 118.69 35.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 1.35 110.497 -175.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.3 t -116.64 126.29 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.54 110.619 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.926 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 2.9 mt -92.76 133.76 35.72 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.472 -0.936 . . . . 0.65 108.472 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.799 HG21 HG12 ' A' ' 17' ' ' VAL . 9.3 t -137.55 147.42 45.12 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.616 -0.434 . . . . 1.04 111.899 -176.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 18.5 t70 -123.82 97.15 41.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.69 -0.686 . . . . 1.92 109.8 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.2 Cg_endo -51.39 -35.11 53.3 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 124.076 3.184 . . . . 1.25 114.797 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.608 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 60.8 m-20 -99.45 49.69 0.94 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 1.29 112.397 -168.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.45 142.75 25.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.56 110.295 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 98.5 Cg_endo -83.66 -23.11 13.38 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.814 -1.328 . . . . 0.7 112.753 1.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 24.7 p -129.67 144.13 51.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 1.1 109.816 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.608 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 40.0 ttt180 -62.46 -26.68 68.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 3.39 111.212 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.516 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 4.8 ptpt -76.25 -21.64 56.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.042 0.449 . . . . 1.83 111.111 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 18.1 t70 -154.14 85.6 3.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.022 -0.536 . . . . 1.37 109.674 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -82.2 87.91 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.451 2.101 . . . . 0.9 112.717 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -75.15 -49.88 18.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.039 -0.982 . . . . 1.53 110.085 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.718 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.2 m-85 -84.53 22.1 1.36 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.916 -1.038 . . . . 1.54 111.903 -169.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.5 ttm180 -74.9 127.74 33.91 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.136 0.272 . . . . 3.38 110.522 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' OE1' HG21 ' A' ' 151' ' ' VAL . 4.2 mp0 -97.04 137.44 36.12 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.043 0.449 . . . . 2.23 110.497 -3.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.53 ' CD1' ' HG2' ' A' ' 146' ' ' ARG . 16.8 t90 -85.37 146.04 27.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.996 -1.113 . . . . 1.77 107.996 173.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 48.6 p-80 -122.04 129.48 52.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.282 0.563 . . . . 2.19 110.357 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.926 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 38.5 t-80 -68.1 -34.74 76.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.032 -0.986 . . . . 2.74 110.09 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.632 ' HD2' ' HD1' ' A' ' 86' ' ' HIS . 40.3 p90 -168.69 172.62 7.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.045 -0.354 . . . . 2.21 110.045 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.461 ' CD1' HG22 ' A' ' 67' ' ' VAL . 44.0 tp -133.96 113.9 12.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.507 -0.553 . . . . 0.68 109.507 173.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 1.5 t -120.92 134.73 63.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.819 -0.628 . . . . 0.35 110.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.499 ' CG1' ' HG ' ' A' ' 131' ' ' LEU . 15.9 m -132.79 161.47 41.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 107.691 -1.226 . . . . 0.3 107.691 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.681 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 t30 63.34 18.16 10.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.221 0.534 . . . . 2.09 110.221 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.509 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 8.0 ttm -68.11 111.36 4.44 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.94 -0.763 . . . . 0.34 108.94 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -85.71 101.83 13.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.722 -1.126 . . . . 1.73 111.318 -170.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.15 -124.2 27.47 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 114.959 -1.019 . . . . 0.35 112.43 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.609 ' HB3' HD22 ' A' ' 58' ' ' LEU . 3.7 p-10 -110.56 21.79 16.18 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.982 0.42 . . . . 1.59 110.756 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.79 109.4 20.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.723 0.773 . . . . 0.77 109.971 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 49' ' ' ARG . 5.3 mm -62.38 -31.18 50.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.097 -1.41 . . . . 0.45 111.246 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.1 m -78.29 -37.09 45.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.874 -0.603 . . . . 1.15 111.997 -172.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.3 m -70.05 -8.6 50.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.765 0.283 . . . . 1.26 111.765 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.509 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -67.41 100.11 0.57 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.977 -0.63 . . . . 0.44 111.779 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.5 m -60.33 107.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.671 0.748 . . . . 1.06 110.11 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 105' ' ' ASP . 4.6 p -86.69 127.63 40.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.667 -1.151 . . . . 1.15 111.527 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 11.3 mt -102.01 -54.72 2.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.116 0.96 . . . . 0.48 109.141 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.1 t -106.43 100.15 9.69 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.885 -1.524 . . . . 0.62 106.885 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.978 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -55.37 160.7 2.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.002 -0.999 . . . . 1.15 112.782 -169.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.1 p90 -74.09 90.76 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.514 -0.766 . . . . 4.98 110.879 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.666 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.6 t -63.96 -40.07 87.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.902 -0.59 . . . . 0.86 110.353 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.564 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 103.3 -173.03 21.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.667 -0.778 . . . . 0.95 112.7 174.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.433 ' HA ' ' HH ' ' A' ' 120' ' ' TYR . 12.3 t -64.6 115.03 4.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.411 -0.589 . . . . 0.89 109.411 172.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.645 ' HA3' HD21 ' A' ' 180' ' ' LEU . . . -144.68 58.18 0.52 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.82 112.943 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.647 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -89.21 125.71 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.303 2.669 . . . . 1.01 111.94 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.721 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 82.5 Cg_exo -46.21 132.98 15.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.415 2.076 . . . . 0.96 111.273 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.446 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.0 110.83 2.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.005 -0.543 . . . . 2.39 111.012 -171.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.0 -5.27 25.59 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.594 -0.73 . . . . 1.3 113.062 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.721 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -77.58 -9.92 59.21 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.698 0.629 . . . . 1.04 112.698 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.01 -170.48 25.01 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.707 . . . . 1.97 111.994 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -73.42 144.82 46.19 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.866 0.365 . . . . 0.94 110.757 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.647 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.6 m-70 -120.76 123.0 41.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.073 -0.512 . . . . 2.85 110.303 176.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.816 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 11.1 ptt180 -100.0 92.17 5.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.536 -0.756 . . . . 2.78 111.406 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 69' ' ' THR . 40.6 m-85 -75.74 112.2 11.87 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.157 -0.683 . . . . 1.13 109.157 175.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.0 t -96.49 133.74 36.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.774 . . . . 0.31 109.66 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.6 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 35.5 m95 -89.29 132.61 34.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.193 -0.669 . . . . 2.96 109.193 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 82.7 mt -127.62 118.33 23.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.742 0.246 . . . . 0.41 110.344 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.607 HG11 HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -114.2 145.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.716 0.293 . . . . 0.43 110.434 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.758 ' HH ' ' H ' ' A' ' 161' ' ' ARG . 35.8 t80 -123.87 153.46 41.06 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.613 -0.514 . . . . 5.41 109.613 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -108.35 88.87 2.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.033 -0.729 . . . . 2.41 109.033 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.623 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -74.7 175.04 8.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.971 0.891 . . . . 1.31 111.795 -172.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.86 -16.48 28.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.774 -1.557 . . . . 2.4 109.964 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.955 ' HD2' ' HH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -144.63 160.53 47.28 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.413 -0.812 . . . . 4.07 111.204 -176.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' ' 63' ' ' LEU . 25.5 Cg_exo -70.43 14.12 0.31 Allowed 'Trans proline' 0 N--CA 1.484 0.919 0 C-N-CA 124.81 3.674 . . . . 1.21 114.501 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 130' ' ' PRO . 4.1 mm? 81.13 168.34 0.14 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.679 0.792 . . . . 1.16 112.864 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -160.53 78.48 0.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.315 -1.312 . . . . 3.23 107.75 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.725 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.1 m -99.91 130.04 46.05 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.451 -0.795 . . . . 2.79 111.214 -173.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -93.74 18.73 9.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.34 -0.845 . . . . 2.96 109.975 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 6.9 mm-40 -76.23 116.37 55.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.476 -0.783 . . . . 1.39 109.923 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.72 137.37 42.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.362 2.708 . . . . 1.38 113.63 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.0 mm -73.47 115.77 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.764 -0.458 . . . . 0.94 109.764 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -92.02 -10.86 37.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.966 0.728 . . . . 1.61 112.966 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.9 m 51.98 25.12 2.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.292 0.849 . . . . 1.88 113.292 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.978 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.1 p-10 50.54 21.99 0.97 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.202 1.001 . . . . 1.33 113.414 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.501 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 46.4 mtt180 -110.32 142.22 42.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.189 -0.3 . . . . 3.83 110.189 172.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.572 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 55.0 m 77.07 151.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.215 0.947 . . . . 1.32 111.703 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 146' ' ' ARG . . . -120.41 14.03 10.13 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.486 -0.779 . . . . 1.13 112.849 -174.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.48 -22.27 62.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.472 . . . . 2.66 111.035 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -119.82 46.3 1.97 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.228 -0.656 . . . . 2.18 109.228 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.53 ' HG2' ' CD1' ' A' ' 84' ' ' TRP . 10.0 ttm180 -75.14 -71.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.145 -0.934 . . . . 5.37 111.531 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -120.42 -154.66 9.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 0.9 112.31 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.718 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.0 mttt 65.45 35.77 7.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.402 0.62 . . . . 1.59 110.256 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -120.11 104.45 10.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.169 -0.923 . . . . 2.27 109.745 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HZ2' ' CD ' ' A' ' 83' ' ' GLU . 21.0 mmmt -53.84 120.56 6.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.916 -0.584 . . . . 1.87 111.785 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.885 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 2.4 m -62.04 -29.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.96 111.183 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.741 ' HB3' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -37.55 87.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.76 110.169 174.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.6 m -65.99 -33.29 75.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.546 -0.297 . . . . 1.22 110.785 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.885 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 49.9 m-85 -62.24 -54.1 45.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.054 0.454 . . . . 1.1 110.56 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 9.6 ptt180 -70.01 -51.57 31.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 3.36 111.853 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.741 ' HE2' ' HB3' ' A' ' 152' ' ' ALA . 58.7 mtmt -62.01 -24.5 67.08 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.427 -0.17 . . . . 1.52 111.367 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -52.05 -53.12 46.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 2.13 111.425 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.955 ' HH ' ' HD2' ' A' ' 129' ' ' ARG . 12.7 t80 -104.43 29.55 6.0 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.796 -0.762 . . . . 5.77 110.511 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 71.53 26.59 3.17 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.252 -0.886 . . . . 2.42 111.842 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.699 ' HG ' ' CD1' ' A' ' 125' ' ' TYR . 7.8 mp -83.68 124.51 30.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.901 -0.407 . . . . 1.27 109.901 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.758 ' H ' ' HH ' ' A' ' 125' ' ' TYR . 43.6 tpt85 -73.26 -75.87 0.14 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.721 -0.672 . . . . 4.0 112.6 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.545 ' H ' ' HE2' ' A' ' 125' ' ' TYR . . . -150.51 150.99 30.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.547 0.213 . . . . 1.21 110.668 -176.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.503 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.42 152.17 78.6 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.55 2.833 . . . . 0.68 114.016 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.925 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.6 t -93.81 -37.39 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 115.025 -0.989 . . . . 0.5 110.568 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -143.27 144.16 32.02 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.011 -0.676 . . . . 0.29 111.703 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.635 ' HA3' ' HG2' ' A' ' 21' ' ' PRO . . . -146.7 150.88 23.19 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.114 -0.948 . . . . 0.24 112.343 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.558 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.2 t -164.62 156.08 15.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.293 -1.003 . . . . 0.34 108.293 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.802 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -131.42 150.23 52.23 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.872 -0.517 . . . . 2.16 112.04 -172.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.751 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.1 p90 -136.0 135.01 39.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.608 -0.886 . . . . 1.31 108.608 171.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.816 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 12.9 mp0 -99.65 133.8 43.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.575 0.625 . . . . 2.53 110.386 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.48 137.33 54.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.935 0.397 . . . . 0.75 111.416 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.98 -170.2 3.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.447 -0.797 . . . . 2.38 110.914 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.945 ' HA ' HG23 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -105.48 77.39 1.28 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.979 -0.748 . . . . 4.71 108.979 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.495 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 13.7 t70 -72.19 -61.24 1.86 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.167 0.803 . . . . 1.53 113.167 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.638 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 12.4 t70 -167.5 -46.78 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.216 0.532 . . . . 1.26 110.951 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.449 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 37.9 m-85 -71.8 -2.8 18.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 2.46 111.691 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.945 HG23 ' HA ' ' A' ' 173' ' ' TRP . 66.8 t -73.17 -55.37 3.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.57 -0.286 . . . . 0.58 111.414 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.749 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 47.6 Cg_exo -58.22 -29.72 88.49 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.271 1.98 . . . . 0.68 111.274 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.626 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.0 mmmm -74.7 -24.77 58.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.573 -0.74 . . . . 2.62 111.17 177.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.665 HD23 HG12 ' A' ' 107' ' ' VAL . 51.2 tp -76.08 -42.07 48.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.502 -0.555 . . . . 1.18 109.502 172.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -58.87 -38.27 78.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.69 -0.686 . . . . 2.11 109.185 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.626 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.8 mm-40 -58.21 -42.73 86.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.791 -1.095 . . . . 1.53 110.985 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -76.41 -32.23 58.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 2.16 112.759 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.572 ' HA ' ' H ' ' A' ' 142' ' ' SER . 60.9 mt -62.99 -4.97 2.52 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.786 0.662 . . . . 0.87 112.786 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.507 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 20.1 m -78.65 1.49 22.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.531 0.682 . . . . 1.38 109.766 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.501 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 76.37 50.94 6.99 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.1 -0.954 . . . . 1.17 111.184 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.7 mmmt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.359 -0.829 . . . . 2.45 110.37 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 7.2 p . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 121.283 0.563 . . . . 2.1 111.013 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 6' ' ' SER . 25.2 t70 -167.03 163.43 15.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.696 -0.853 . . . . 1.81 108.696 -172.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.56 25.81 0.14 Allowed 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 120.537 0.208 . . . . 0.95 111.113 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 4' ' ' ASP . 31.1 m -62.91 -27.34 69.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 2.19 111.692 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -116.38 48.26 1.29 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.87 0.367 . . . . 3.07 110.258 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -75.09 -29.74 60.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 4.76 111.724 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 36.6 p -148.14 11.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.535 -0.466 . . . . 0.98 112.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.46 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.729 . . . . 0.52 111.733 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.3 Cg_endo -48.88 -48.83 16.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.201 2.601 . . . . 0.61 110.381 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.692 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 8.1 mp -87.99 88.94 7.8 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.354 -0.839 . . . . 1.85 110.258 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 7.4 m -76.12 67.02 2.37 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.354 0.597 . . . . 1.31 110.095 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 121' ' ' VAL . 23.5 mt -71.12 -13.91 62.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.496 -0.775 . . . . 0.61 111.164 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -65.61 -14.84 61.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.131 -0.486 . . . . 2.61 111.477 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.34 -19.76 65.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.29 0.567 . . . . 1.93 110.507 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.857 HG11 HG22 ' A' ' 151' ' ' VAL . 40.6 t -93.76 -72.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.477 -0.783 . . . . 1.26 111.27 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 19' ' ' GLU . 25.5 t70 -149.97 -170.99 3.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.557 -0.905 . . . . 2.99 108.557 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.794 ' HG3' HH12 ' A' ' 155' ' ' ARG . 15.6 mt-10 -81.64 163.72 22.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.789 0.804 . . . . 1.6 113.114 -167.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.49 126.95 89.29 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.415 -1.266 . . . . 4.38 110.387 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 6.3 Cg_exo -75.28 154.25 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.839 1.693 . . . . 0.69 111.166 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.964 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 20.4 pt20 -81.44 -1.19 44.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.293 -0.412 . . . . 1.87 111.726 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.763 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 13.7 m80 -160.54 159.95 25.83 Favored Pre-proline 0 CA--C 1.516 -0.362 0 C-N-CA 123.35 0.66 . . . . 2.35 109.583 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -86.87 128.54 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 123.132 2.555 . . . . 0.44 110.994 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 43.9 tp -80.1 145.9 32.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.696 0.284 . . . . 0.33 111.183 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -109.36 130.33 55.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.311 -0.626 . . . . 2.12 109.311 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 53' ' ' ILE . 16.0 t -134.16 118.8 29.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.487 -0.931 . . . . 1.12 108.487 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.444 HG22 ' CB ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -117.98 136.78 53.29 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 0.78 111.283 -172.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -97.0 173.82 7.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.279 -0.637 . . . . 1.23 109.279 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.52 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.5 0.667 . . . . 0.6 110.548 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 -6.14 37.55 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.163 -0.926 . . . . 0.81 112.763 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.91 -171.96 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.858 0.329 . . . . 0.56 110.52 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.73 153.73 17.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.113 -0.494 . . . . 0.35 110.301 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.798 HG23 ' HZ3' ' A' ' 122' ' ' TRP . 84.9 t -109.85 69.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 107.406 -1.331 . . . . 0.39 107.406 165.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.539 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 34.2 t70 -102.49 20.46 17.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.967 -1.015 . . . . 0.99 109.072 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 52.3 mt-10 -143.84 134.54 25.05 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.48 -1.236 . . . . 2.56 108.955 172.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.675 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -81.36 112.49 18.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.794 -0.639 . . . . 0.46 109.985 -174.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.59 52.53 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.256 -0.738 . . . . 0.59 111.256 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.67 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.09 149.44 26.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.321 -0.251 . . . . 1.04 110.321 177.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 10.2 p -74.52 131.81 34.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 1.16 110.967 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.468 HD21 HG13 ' A' ' 46' ' ' VAL . 9.2 tp -133.0 170.7 15.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.485 -0.931 . . . . 0.45 108.485 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -121.24 149.86 52.71 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 119.4 -0.92 . . . . 1.0 111.802 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.73 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 39.8 Cg_exo -61.31 -28.62 84.73 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.201 3.267 . . . . 1.0 113.651 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -28.61 67.37 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.546 0.689 . . . . 1.24 110.542 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 42' ' ' THR . 97.5 mt-30 -77.88 -52.94 8.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.848 -1.069 . . . . 1.74 111.228 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.553 HG21 ' CE2' ' A' ' 169' ' ' TYR . 3.9 m -99.16 32.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.695 0.628 . . . . 1.1 112.695 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.82 -30.72 61.49 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.346 -0.542 . . . . 1.32 110.039 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.06 179.88 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 2.4 109.971 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 96.8 mtt180 -66.89 159.38 76.06 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.868 0.366 . . . . 1.78 110.797 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 71.3 Cg_endo -79.57 157.54 25.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.072 1.848 . . . . 0.41 110.944 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -82.23 -18.06 43.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.684 -0.488 . . . . 0.88 109.684 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.427 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 71.5 m -160.68 147.24 15.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.504 0.669 . . . . 0.65 112.003 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.46 166.29 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.33 108.207 169.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.713 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 43.5 t 176.82 111.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.122 0.487 . . . . 0.8 110.323 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.609 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 51.4 p-90 -73.3 152.89 40.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.616 -1.253 . . . . 3.63 107.616 171.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.66 89.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.51 111.12 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.48 17.45 4.35 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.757 -0.656 . . . . 0.9 112.236 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.808 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 1.3 tt -51.9 129.07 25.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.113 0.565 . . . . 0.62 111.734 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.741 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 17.9 t70 -72.28 -30.67 65.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.538 -0.756 . . . . 0.74 111.503 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.442 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.4 m 76.46 -5.6 2.15 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.818 -1.083 . . . . 1.51 110.604 -172.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.06 -8.34 5.61 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.948 -0.644 . . . . 0.84 113.556 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.741 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 29.4 mtpt -94.7 142.85 26.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.423 0.611 . . . . 2.12 110.962 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.676 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 46.7 mt -78.56 125.65 29.65 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.539 -0.912 . . . . 1.23 108.539 171.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.808 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -121.13 163.04 19.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.465 -0.494 . . . . 1.61 109.978 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.636 HG22 HG11 ' A' ' 90' ' ' VAL . 69.1 m -104.24 105.49 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.355 -0.609 . . . . 0.87 109.355 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.558 HD23 ' HE2' ' A' ' 87' ' ' PHE . 25.3 tp -100.25 114.58 28.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.766 -0.457 . . . . 1.35 109.766 -177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.7 t -116.71 121.77 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.907 0.384 . . . . 0.54 111.344 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 1.014 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -81.52 134.38 35.51 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.555 -1.276 . . . . 0.65 107.555 168.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.848 HG21 HG12 ' A' ' 17' ' ' VAL . 10.3 t -140.35 142.74 35.56 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.014 0.435 . . . . 1.04 110.479 176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 7.1 p-10 -130.66 95.59 25.93 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-O 121.653 0.74 . . . . 1.92 110.188 174.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.5 Cg_endo -52.92 -31.95 54.98 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.937 3.091 . . . . 1.25 112.837 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.732 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 5.1 m-20 -82.79 45.98 1.04 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 1.29 111.094 -172.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 81' ' ' TYR . . . -104.41 130.23 23.65 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.696 -0.483 . . . . 0.56 109.696 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.3 Cg_endo -79.17 -30.38 5.78 Favored 'Cis proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.147 -1.605 . . . . 0.7 112.982 1.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.711 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 98.6 p -125.59 156.64 38.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.33 -0.395 . . . . 1.1 111.224 -177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.732 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 52.0 ttp180 -72.19 -23.85 61.33 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.049 -0.523 . . . . 3.39 111.129 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.717 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.08 -11.26 39.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.434 . . . . 1.83 110.64 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -156.32 84.32 3.25 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 1.37 109.814 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.95 91.74 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.065 2.51 . . . . 0.9 113.353 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.514 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.8 mttm -76.11 -49.59 16.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.162 -0.926 . . . . 1.53 110.849 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.81 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 91.8 m-85 -82.78 14.05 3.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.798 -1.092 . . . . 1.54 111.538 -169.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.5 ttt180 -67.02 128.49 36.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.956 -0.566 . . . . 3.38 111.024 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 2.5 mp0 -99.7 137.15 38.57 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.876 0.369 . . . . 2.23 110.545 -3.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.525 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.2 t90 -93.79 130.48 39.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.923 -0.769 . . . . 1.77 108.923 175.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 44.1 p-80 -98.66 123.18 42.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.999 -0.741 . . . . 2.19 108.999 173.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -91.57 -11.13 38.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.553 -0.749 . . . . 2.74 111.714 -170.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 1.014 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 40.8 t80 -167.95 136.23 2.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.873 -0.417 . . . . 2.21 109.873 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.818 HD21 ' HH ' ' A' ' 158' ' ' TYR . 22.7 tp -134.28 114.42 12.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.68 110.263 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.09 135.49 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.681 -0.69 . . . . 0.35 110.638 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.641 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 13.9 m -130.09 163.57 35.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.115 -0.948 . . . . 0.3 108.612 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.9 t-20 64.94 14.22 9.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.841 0.353 . . . . 2.09 110.416 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.563 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 14.3 ttm -68.93 103.97 1.96 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.702 -0.851 . . . . 0.34 108.702 174.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.521 ' HE2' HD23 ' A' ' 63' ' ' LEU . 21.2 ttmm -85.73 98.53 10.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.401 -0.818 . . . . 1.73 110.918 -171.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.29 -123.09 6.0 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.971 -1.013 . . . . 0.35 112.186 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.604 ' HB3' HD22 ' A' ' 58' ' ' LEU . 5.3 p-10 -118.1 31.08 6.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.539 0.685 . . . . 1.59 110.391 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.62 114.96 27.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.062 -0.972 . . . . 0.77 110.289 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.496 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 3.1 mm -66.81 -19.95 26.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.698 -1.137 . . . . 0.45 110.951 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.1 m -80.34 -52.99 7.04 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.669 0.618 . . . . 1.15 112.669 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 p -61.67 -20.79 63.82 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.714 0.293 . . . . 1.26 111.712 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.563 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -57.02 102.18 0.19 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.765 -0.652 . . . . 0.44 111.987 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 107.17 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.453 0.644 . . . . 1.06 109.723 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.501 ' O ' HD13 ' A' ' 137' ' ' ILE . 2.6 p -74.51 118.27 19.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.825 -1.08 . . . . 1.15 111.846 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.553 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.3 mt -97.83 -45.26 6.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.971 0.891 . . . . 0.48 108.888 172.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.8 t -126.57 106.46 9.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.615 -1.175 . . . . 0.62 107.858 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.792 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 6.3 t0 -61.86 158.15 16.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 1.15 112.387 -169.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -78.91 98.67 6.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.026 -0.988 . . . . 4.98 109.664 -178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.686 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 30.1 t -74.56 -23.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.86 111.471 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.11 -179.65 45.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.413 -0.898 . . . . 0.95 111.858 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.3 t -60.54 133.62 56.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.862 -0.422 . . . . 0.89 109.862 172.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.63 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -172.53 66.01 0.13 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.814 -0.708 . . . . 0.82 112.337 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -93.29 140.24 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.816 2.344 . . . . 1.01 112.977 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HB2' HG21 ' A' ' 115' ' ' THR . 72.6 Cg_exo -51.15 135.01 44.82 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.531 2.154 . . . . 0.96 111.331 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 117.0 5.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.213 -0.292 . . . . 2.39 110.213 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.46 -4.28 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.798 -0.715 . . . . 1.3 111.963 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.711 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 72.9 p -79.13 -16.59 56.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.763 0.316 . . . . 1.04 111.302 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.75 -169.4 23.22 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.844 -0.616 . . . . 1.97 111.846 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.41 HD13 ' HG2' ' A' ' 172' ' ' GLU . 4.6 mm? -70.39 98.3 1.4 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.94 109.935 175.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -75.77 103.93 6.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.421 -0.809 . . . . 2.85 109.204 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.839 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -99.72 92.96 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.405 0.621 . . . . 2.78 111.668 -173.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.545 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 1.1 m-85 -76.88 133.44 39.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 1.13 109.449 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.84 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.4 t -108.63 133.16 54.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.948 -0.39 . . . . 0.31 109.948 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.798 ' HZ3' HG23 ' A' ' 34' ' ' VAL . 1.5 m-90 -89.53 127.84 35.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.372 -0.603 . . . . 2.96 109.372 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 mt -118.75 119.39 34.29 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.867 -0.419 . . . . 0.41 109.867 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.543 HG13 ' HB3' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -106.96 132.68 53.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.41 -0.516 . . . . 0.43 109.682 175.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.57 ' HB2' HD21 ' A' ' 160' ' ' LEU . 24.3 m-85 -115.35 149.55 37.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.147 -0.478 . . . . 5.41 110.055 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.31 117.93 35.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.154 0.502 . . . . 2.41 109.894 174.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.583 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -89.88 158.86 17.25 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.626 -0.879 . . . . 1.31 108.626 173.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -76.4 -10.83 59.69 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.601 -0.727 . . . . 2.4 110.805 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.644 ' NH2' ' HB2' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -162.56 177.31 1.98 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 4.07 109.246 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.497 ' HG3' HD12 ' A' ' 63' ' ' LEU . 51.3 Cg_exo -54.0 174.54 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.275 1.984 . . . . 1.21 112.589 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.641 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.6 mm? -93.38 163.73 13.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.52 0.563 . . . . 1.16 112.52 -171.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.95 45.57 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.62 1.2 . . . . 3.23 109.868 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.2 p -62.65 -69.17 0.28 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.264 -1.789 . . . . 2.79 111.664 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 57.87 32.34 21.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.837 0.827 . . . . 2.96 110.173 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.529 ' HB2' HD22 ' A' ' 103' ' ' LEU . 57.9 mm-40 -81.85 139.99 46.83 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.547 -0.751 . . . . 1.39 110.809 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.38 125.2 8.75 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.37 2.714 . . . . 1.38 112.397 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 102' ' ' VAL . 33.4 mm -76.94 123.1 32.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.94 111.454 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.9 mt -94.82 155.37 16.83 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.346 -0.613 . . . . 1.61 109.346 174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.535 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.0 m -119.41 38.37 3.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.558 0.218 . . . . 1.88 111.508 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.792 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.9 OUTLIER 56.76 0.81 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.714 1.206 . . . . 1.33 113.418 177.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.536 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.0 mtt180 -97.64 148.51 23.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.919 -0.488 . . . . 3.83 109.797 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.572 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.4 m 74.46 115.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.113 0.883 . . . . 1.32 112.364 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -87.9 38.17 3.19 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 1.13 111.54 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.577 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 22.9 t70 -71.05 -39.91 71.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.77 0.795 . . . . 2.66 110.757 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.577 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 7.1 m80 -99.25 64.68 1.37 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.088 -0.96 . . . . 2.18 110.053 -171.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.581 ' O ' ' HB3' ' A' ' 81' ' ' TYR . 26.9 mtm180 -87.09 39.74 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 5.37 112.048 -175.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . 76.91 -117.4 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.935 -0.65 . . . . 0.9 114.001 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.81 ' CG ' ' HA ' ' A' ' 81' ' ' TYR . 79.9 mttt 60.35 39.85 18.25 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.121 0.486 . . . . 1.59 110.8 -171.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.442 ' HD2' ' CE2' ' A' ' 154' ' ' PHE . 43.5 t80 -150.37 135.83 18.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.846 -0.616 . . . . 2.27 109.622 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -54.17 119.56 5.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.507 -0.77 . . . . 1.87 112.792 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.857 HG22 HG11 ' A' ' 17' ' ' VAL . 4.3 m -59.03 -35.15 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.335 -0.848 . . . . 0.96 110.832 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.78 -33.02 72.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.863 -0.608 . . . . 0.76 110.456 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -70.47 -37.71 74.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.242 -0.435 . . . . 1.22 110.667 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.442 ' CE2' ' HD2' ' A' ' 149' ' ' PHE . 53.7 m-85 -64.28 -48.22 76.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.702 0.763 . . . . 1.1 109.518 173.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.794 HH12 ' HG3' ' A' ' 19' ' ' GLU . 21.3 ttt180 -55.59 -50.31 70.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.4 -1.273 . . . . 3.36 111.723 177.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -70.63 -28.91 65.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 1.52 111.126 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 44.3 tptt -59.84 -40.51 88.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 2.13 110.818 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.818 ' HH ' HD21 ' A' ' 88' ' ' LEU . 22.5 m-85 -88.53 5.97 40.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.077 -0.511 . . . . 5.77 110.516 -177.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.644 ' HB2' ' NH2' ' A' ' 129' ' ' ARG . 34.0 mm-40 67.21 33.85 5.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.261 -0.881 . . . . 2.42 111.336 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 125' ' ' TYR . 4.0 mp -90.62 140.64 29.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.666 0.269 . . . . 1.27 111.28 -177.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -71.56 -78.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 4.0 111.385 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.92 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.61 -0.515 . . . . 1.21 109.61 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.528 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 23.2 Cg_exo -60.95 137.95 75.61 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.592 2.195 . . . . 0.68 113.276 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.964 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 6.3 t -93.18 -26.94 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 115.465 -0.789 . . . . 0.5 109.279 174.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.763 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.56 147.35 25.3 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.917 -0.583 . . . . 0.29 111.806 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -144.32 142.21 10.84 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.725 -1.125 . . . . 0.24 111.429 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.675 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 7.6 t -155.72 137.04 13.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.149 -0.686 . . . . 0.34 109.149 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.84 ' HB2' HG22 ' A' ' 121' ' ' VAL . 6.7 t -116.51 145.26 43.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.24 0.543 . . . . 2.16 111.106 -174.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.553 ' CE2' HG21 ' A' ' 46' ' ' VAL . 25.2 p90 -128.52 129.62 46.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.346 -1.353 . . . . 1.31 107.346 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.812 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -110.47 132.52 54.11 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.714 -0.794 . . . . 2.53 111.044 -178.25 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -149.33 135.64 19.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.75 109.558 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.41 ' HG2' HD13 ' A' ' 117' ' ' LEU . 4.1 pt-20 -118.26 -136.75 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.51 -0.314 . . . . 2.38 110.907 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.428 ' HA ' HG23 ' A' ' 177' ' ' VAL . 83.7 t90 -80.27 96.91 6.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 4.71 111.746 -172.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.73 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 3.1 t70 -73.62 -62.16 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 1.53 110.396 170.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.556 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.7 t70 159.29 -39.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.024 1.329 . . . . 1.26 108.373 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.03 0.24 36.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 2.46 110.864 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.758 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 76.8 t -62.49 -53.92 53.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.02 -0.536 . . . . 0.58 110.478 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.2 Cg_exo -51.97 -35.46 60.79 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.468 2.112 . . . . 0.68 112.022 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 13.5 mmmm -73.9 -26.97 60.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 2.62 111.499 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.63 HD22 ' HA3' ' A' ' 110' ' ' GLY . 44.0 tp -69.09 -46.91 66.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 1.18 109.063 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.35 -34.94 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 2.11 109.393 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.659 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.2 mm-40 -63.28 -43.87 96.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.985 -1.007 . . . . 1.53 110.922 173.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' A' ' 187' ' ' LYS . 2.4 tt0 -65.29 -27.84 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 2.16 111.406 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 59.4 mt -66.31 6.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.511 0.559 . . . . 0.87 112.511 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.733 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 15.3 m -80.99 0.15 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.674 0.75 . . . . 1.38 109.086 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.536 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.52 33.07 17.52 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 114.916 -1.038 . . . . 1.17 111.228 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.733 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 31.6 mmtp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.372 -0.823 . . . . 2.45 110.991 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 2.7 p . . . . . 0 N--CA 1.444 -0.73 0 CA-C-O 121.714 0.768 . . . . 2.1 110.224 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.454 ' HA ' ' CB ' ' A' ' 24' ' ' PRO . 3.4 p30 -169.56 -175.48 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.921 -1.036 . . . . 1.81 108.557 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.61 24.81 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.918 0.34 . . . . 0.95 111.918 -173.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 t -72.9 -19.88 61.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.731 0.777 . . . . 2.19 109.388 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -117.33 36.72 4.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 3.07 110.174 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.802 ' HB2' HE21 ' A' ' 20' ' ' GLN . 0.2 OUTLIER -78.4 -37.22 44.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 4.76 112.294 -176.43 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 11.6 p -145.3 27.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.98 110.995 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.87 -122.31 0.31 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.912 -0.875 . . . . 0.52 110.912 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.524 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.72 -38.56 77.3 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.183 2.588 . . . . 0.61 110.568 166.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.686 HD13 ' HA3' ' A' ' 38' ' ' GLY . 17.5 mt -87.85 83.73 7.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.916 -1.038 . . . . 1.85 110.027 173.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.34 68.96 0.79 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.375 0.607 . . . . 1.31 110.112 175.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.715 HD23 HH11 ' A' ' 119' ' ' ARG . 57.0 mt -79.21 -16.83 55.94 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.702 -0.681 . . . . 0.61 110.775 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.811 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 9.3 tm0? -69.1 -12.87 62.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.362 0.601 . . . . 2.61 110.534 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.16 -23.74 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.139 0.495 . . . . 1.93 109.78 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 69' ' ' THR . 48.6 t -90.44 -68.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.225 -0.898 . . . . 1.26 110.722 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -119.9 -177.24 3.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.713 -0.676 . . . . 2.99 109.917 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 16.8 mt-10 -90.56 20.26 4.74 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.854 0.316 . . . . 1.6 111.854 -173.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.811 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 5.7 mm100 67.82 136.85 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.361 1.038 . . . . 4.38 112.427 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.603 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 4.3 Cg_exo -79.83 157.79 24.36 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.229 2.62 . . . . 0.69 112.804 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.928 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.5 pt20 -77.94 -27.09 49.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.893 -1.049 . . . . 1.87 111.857 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.75 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 79.6 m-70 -132.48 158.55 75.38 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.843 -0.799 . . . . 2.35 108.843 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' CB ' ' HA ' ' A' ' 4' ' ' ASP . 4.3 Cg_endo -85.81 128.27 3.28 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.664 2.243 . . . . 0.44 111.113 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.616 HD21 ' HB2' ' A' ' 122' ' ' TRP . 38.0 tp -78.66 148.4 33.18 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.093 -0.336 . . . . 0.33 110.093 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.442 ' H ' HD12 ' A' ' 25' ' ' LEU . 44.5 m80 -118.89 130.14 55.57 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.502 -0.555 . . . . 2.12 109.502 172.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 34' ' ' VAL . 19.2 t -127.75 146.26 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.682 -0.858 . . . . 1.12 108.682 177.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 143.18 32.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.974 0.416 . . . . 0.78 111.05 -177.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.531 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 34.5 t80 -110.77 173.22 6.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.5 -0.556 . . . . 1.23 109.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.51 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.18 0.514 . . . . 0.6 110.886 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.38 15.44 10.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.399 -0.818 . . . . 0.81 112.361 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.32 -172.79 4.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.885 0.374 . . . . 0.56 110.734 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -164.01 159.89 21.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.797 -0.638 . . . . 0.35 110.041 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 169' ' ' TYR . 87.3 t -114.3 67.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.585 -1.635 . . . . 0.39 106.585 162.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -102.63 23.19 12.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.582 -1.19 . . . . 0.99 109.092 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -150.93 132.95 15.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.852 -1.067 . . . . 2.56 108.304 174.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -76.65 110.76 11.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.182 0.515 . . . . 0.46 109.703 -173.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.686 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 86.7 16.73 61.17 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.343 -0.844 . . . . 0.59 112.227 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.13 149.92 44.29 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.399 -0.593 . . . . 1.04 109.399 173.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.05 129.32 37.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.441 0.639 . . . . 1.16 111.029 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.6 tp -120.91 169.39 10.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.181 -1.044 . . . . 0.45 108.181 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.1 p -128.04 151.73 76.41 Favored Pre-proline 0 C--N 1.322 -0.587 0 C-N-CA 119.724 -0.79 . . . . 1.0 112.512 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.2 Cg_exo -55.58 -24.65 45.93 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.303 3.335 . . . . 1.0 114.01 -176.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -62.88 -38.3 90.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 122.11 0.957 . . . . 1.24 110.093 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.09 -46.19 14.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.785 -1.552 . . . . 1.74 111.266 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG13 ' CE2' ' A' ' 169' ' ' TYR . 6.7 m -100.51 31.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.459 0.54 . . . . 1.1 112.459 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -82.66 -7.87 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.419 0.628 . . . . 1.32 109.367 172.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -142.0 -177.82 5.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.952 -1.022 . . . . 2.4 109.072 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -71.79 156.26 91.3 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.765 -0.457 . . . . 1.78 109.765 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 57.8 Cg_endo -76.62 162.65 32.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.612 1.541 . . . . 0.41 110.216 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.4 t -85.67 -19.2 31.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.631 -0.427 . . . . 0.88 110.152 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.409 ' C ' HG21 ' A' ' 53' ' ' ILE . 69.0 m -159.5 147.43 17.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.65 112.413 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -139.36 172.44 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.825 -1.08 . . . . 0.33 108.382 170.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.72 ' HA ' HD11 ' A' ' 58' ' ' LEU . 30.5 t 170.97 127.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.462 0.476 . . . . 0.8 110.013 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.76 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -81.87 162.06 22.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.459 -0.941 . . . . 3.63 108.459 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 22.2 t70 -59.43 79.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.237 0.542 . . . . 1.51 110.712 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.71 24.44 3.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.751 -0.659 . . . . 0.9 112.958 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.72 HD11 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -54.3 128.25 30.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.067 0.434 . . . . 0.62 110.547 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.676 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 29.5 t70 -78.38 -12.76 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.74 111.439 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 70.7 p 51.23 30.04 5.45 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.94 -1.027 . . . . 1.51 110.906 -173.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.38 8.17 0.21 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.594 -0.73 . . . . 0.84 112.873 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.676 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 19.4 mtpt -109.99 157.49 19.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 2.12 109.481 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 65.3 mt -94.54 125.09 38.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.798 -0.816 . . . . 1.23 108.798 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.593 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -120.11 149.62 41.92 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.634 -0.426 . . . . 1.61 110.76 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.646 HG22 HG11 ' A' ' 90' ' ' VAL . 61.3 m -96.87 105.95 18.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.511 -0.922 . . . . 0.87 108.511 170.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.623 HD13 ' HB3' ' A' ' 122' ' ' TRP . 47.5 tp -106.8 109.87 21.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.716 -0.674 . . . . 1.35 110.189 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.1 t -114.79 123.02 70.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.745 -0.661 . . . . 0.54 110.679 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.4 mt -84.37 137.93 33.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.723 -0.843 . . . . 0.65 108.723 169.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.743 HG21 HG12 ' A' ' 17' ' ' VAL . 11.3 t -139.68 145.1 37.99 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.847 -0.341 . . . . 1.04 110.635 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.515 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 24.8 t70 -128.85 96.39 29.54 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.324 0.583 . . . . 1.92 110.273 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.0 Cg_endo -51.36 -37.85 61.61 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.046 3.164 . . . . 1.25 114.747 178.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.602 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 44.1 m-20 -96.33 46.69 1.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.341 0.497 . . . . 1.29 112.341 -166.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.82 137.91 19.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.56 110.794 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.5 Cg_endo -82.39 -20.19 20.36 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.44 -1.483 . . . . 0.7 112.465 0.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.756 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 96.6 p -134.01 146.8 50.74 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.832 -0.622 . . . . 1.1 110.472 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.602 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 63.1 ttt180 -66.45 -26.39 67.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.208 -0.451 . . . . 3.39 111.796 -174.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.705 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -89.0 -11.22 44.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.029 0.443 . . . . 1.83 110.862 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -153.2 82.37 4.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.856 -0.611 . . . . 1.37 109.528 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 96.1 Cg_endo -87.95 88.23 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.81 2.34 . . . . 0.9 113.16 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.517 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.7 mttm -71.52 -53.44 13.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.15 -0.932 . . . . 1.53 110.726 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 36.2 m-85 -78.75 17.83 0.67 Allowed 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.211 -0.904 . . . . 1.54 111.642 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 79' ' ' PRO . 32.4 ttt180 -74.2 129.59 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.216 0.323 . . . . 3.38 111.71 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 22.1 mp0 -89.05 140.51 29.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 122.807 0.443 . . . . 2.23 110.605 -6.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.558 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.1 t90 -86.21 91.5 8.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.532 -0.544 . . . . 1.77 109.532 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.1 p80 -71.86 121.84 19.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.768 0.794 . . . . 2.19 109.698 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.756 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t60 -72.72 -35.22 67.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.917 -1.038 . . . . 2.74 111.166 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.721 ' HD1' ' HB2' ' A' ' 68' ' ' LEU . 2.4 p90 -168.08 178.16 5.2 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.666 -0.494 . . . . 2.21 109.666 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.4 tp -140.71 114.01 8.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.776 0.322 . . . . 0.68 110.64 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 t -121.85 133.01 69.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.78 -0.645 . . . . 0.35 110.667 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.646 HG11 HG22 ' A' ' 65' ' ' THR . 16.2 m -133.37 161.55 41.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.409 -0.96 . . . . 0.3 108.409 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t-20 62.55 18.98 10.92 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.383 0.427 . . . . 2.09 110.608 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.588 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.6 ttm -68.18 110.67 4.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.789 -0.819 . . . . 0.34 108.789 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE2' HD23 ' A' ' 63' ' ' LEU . 13.8 ttmm -91.57 97.33 10.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.177 -0.92 . . . . 1.73 111.012 -171.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 64' ' ' TYR . . . 81.91 -130.62 9.82 Favored Glycine 0 CA--C 1.505 -0.568 0 CA-C-N 115.242 -0.89 . . . . 0.35 112.45 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 30.8 p-10 -117.29 26.48 9.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.098 0.475 . . . . 1.59 111.044 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.77 110.43 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.77 110.034 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 50' ' ' PRO . 7.3 mm -58.86 -28.92 39.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.511 -1.222 . . . . 0.45 111.396 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -82.24 -29.99 31.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.982 -0.554 . . . . 1.15 111.765 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -77.73 -6.68 54.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.845 0.313 . . . . 1.26 111.845 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.588 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -76.43 107.11 2.28 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.913 -0.661 . . . . 0.44 111.828 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 106.97 0.46 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.403 0.62 . . . . 1.06 110.332 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.561 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.3 p -89.55 109.52 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.827 -1.079 . . . . 1.15 111.203 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.497 HD12 ' HG ' ' A' ' 88' ' ' LEU . 29.4 mt -89.18 -45.25 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.023 -0.99 . . . . 0.48 109.813 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 t -116.65 105.76 12.79 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.952 -1.499 . . . . 0.62 106.952 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.561 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.2 t0 -54.88 150.97 9.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.15 112.831 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -77.37 103.29 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.114 -0.948 . . . . 4.98 109.223 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.821 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 48.4 t -78.33 -57.62 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.148 -0.478 . . . . 0.86 112.244 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 132.85 175.59 14.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.647 -0.787 . . . . 0.95 112.435 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.3 t -61.14 131.82 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.486 0.143 . . . . 0.89 110.66 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.499 ' H ' ' HH ' ' A' ' 120' ' ' TYR . . . -152.46 63.89 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 O-C-N 123.573 0.546 . . . . 0.82 112.297 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 177' ' ' VAL . 4.0 Cg_endo -90.34 113.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.611 2.874 . . . . 1.01 112.593 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.702 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.3 Cg_exo -56.43 147.74 66.6 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.897 2.398 . . . . 0.96 111.986 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 117.08 9.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.097 -0.502 . . . . 2.39 111.063 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.46 6.15 56.63 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.953 -0.642 . . . . 1.3 112.7 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 80.0 p -89.42 -22.68 22.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 1.04 111.728 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.61 173.29 20.1 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.828 -0.624 . . . . 1.97 111.743 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.3 mm? -74.72 113.15 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.062 -0.347 . . . . 0.94 110.062 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.693 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.0 m-70 -79.76 116.21 19.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 2.85 110.52 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.715 HH11 HD23 ' A' ' 14' ' ' LEU . 13.5 ptt180 -98.34 85.36 3.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.601 -0.727 . . . . 2.78 110.781 -172.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 20.7 m-85 -71.73 114.11 9.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.257 -0.645 . . . . 1.13 109.257 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.559 HG23 HD21 ' A' ' 14' ' ' LEU . 19.4 t -94.68 130.58 43.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.169 -0.469 . . . . 0.31 110.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.655 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 59.7 m95 -88.68 119.27 29.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.895 -0.78 . . . . 2.96 108.895 177.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.4 mt -113.84 118.61 34.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.709 0.232 . . . . 0.41 110.683 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -117.53 136.68 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.43 110.788 179.136 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.847 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 59.0 t80 -132.03 129.01 39.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.423 -0.353 . . . . 5.41 110.256 173.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.621 ' HG2' HG21 ' A' ' 164' ' ' VAL . 8.9 pt-20 -82.22 104.62 12.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.76 -0.829 . . . . 2.41 108.76 171.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.24 168.21 19.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.169 0.509 . . . . 1.31 109.752 -176.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.65 -7.2 53.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.582 -0.735 . . . . 2.4 110.347 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.498 ' HG3' ' HE2' ' A' ' 158' ' ' TYR . 20.0 ptt180 -167.01 160.23 11.02 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.561 -0.745 . . . . 4.07 111.02 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HG3' HD11 ' A' ' 63' ' ' LEU . 31.2 Cg_exo -56.75 140.45 91.02 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.544 2.829 . . . . 1.21 112.596 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.539 HD21 ' OG1' ' A' ' 65' ' ' THR . 3.8 mm? -65.16 149.52 49.77 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.401 0.519 . . . . 1.16 112.401 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 11.6 tptm -120.96 90.68 3.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 3.23 107.781 164.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.446 ' HG ' HD23 ' A' ' 103' ' ' LEU . 4.8 p -70.52 -69.77 0.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.334 -0.848 . . . . 2.79 111.961 -171.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 59.26 28.96 18.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.267 0.556 . . . . 2.96 109.753 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -99.62 138.23 20.39 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.427 -0.806 . . . . 1.39 109.426 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.28 115.17 1.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.113 2.542 . . . . 1.38 112.871 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.27 118.15 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.909 -0.404 . . . . 0.94 109.909 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.4 mt -114.78 147.88 39.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.459 . . . . 1.61 110.55 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -86.21 169.82 12.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.285 -0.871 . . . . 1.88 109.237 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.821 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 14.3 p-10 -86.13 30.49 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.112 0.482 . . . . 1.33 111.571 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.574 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 96.8 mtt180 -117.96 148.26 42.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.426 -0.352 . . . . 3.83 110.557 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.653 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 25.4 m 71.06 141.16 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.938 -1.028 . . . . 1.32 111.232 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.03 28.71 14.4 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.585 -0.734 . . . . 1.13 111.519 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.64 -51.61 26.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.316 0.647 . . . . 2.66 112.672 -172.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -117.73 31.03 6.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.41 0.624 . . . . 2.18 111.327 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.415 ' HB3' ' HE1' ' A' ' 84' ' ' TRP . 18.0 mmt180 -87.65 -36.03 17.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 5.37 110.56 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -117.19 176.02 15.99 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.551 -0.833 . . . . 0.9 112.707 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.732 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.3 mttt 64.33 41.94 5.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.535 0.683 . . . . 1.59 111.449 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.98 149.02 49.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.044 -0.98 . . . . 2.27 109.252 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -97.96 122.93 41.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.991 0.424 . . . . 1.87 111.697 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.634 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.8 m -61.29 -26.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.672 -0.695 . . . . 0.96 110.224 174.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -61.7 -46.79 88.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.364 -0.834 . . . . 0.76 110.186 173.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.0 m -63.97 -35.92 82.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.094 -0.503 . . . . 1.22 110.823 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.634 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.6 m-85 -65.27 -49.98 67.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.399 -0.364 . . . . 1.1 111.093 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 1.8 ptm180 -69.0 -39.31 79.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 3.36 111.02 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.72 -27.58 68.43 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 111.503 0.186 . . . . 1.52 111.503 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -53.93 -54.06 44.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 2.13 111.495 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.498 ' HE2' ' HG3' ' A' ' 129' ' ' ARG . 9.2 t80 -107.58 18.87 20.94 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.766 -0.773 . . . . 5.77 110.75 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 63.78 46.87 3.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.408 -0.814 . . . . 2.42 111.149 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.847 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -91.47 123.14 34.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.185 -0.916 . . . . 1.27 109.831 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.455 ' HD2' ' HA ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -86.52 -150.39 0.15 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.4 -0.364 . . . . 4.0 110.441 -178.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -62.73 142.85 96.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 1.21 110.541 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 16.5 Cg_exo -66.33 160.73 43.93 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 123.795 2.997 . . . . 0.68 113.513 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.928 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.7 t -89.74 -35.58 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-N 115.48 -0.782 . . . . 0.5 110.089 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' A' ' 55' ' ' TRP . . . -149.72 145.91 26.93 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.912 -0.715 . . . . 0.29 111.75 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.36 143.02 10.34 Favored Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.545 -1.207 . . . . 0.24 111.344 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 t -155.5 142.4 19.04 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.055 -1.091 . . . . 0.34 108.055 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.615 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 13.1 p -120.31 141.27 50.17 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.951 -0.699 . . . . 2.16 110.551 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.623 ' HB3' HG22 ' A' ' 34' ' ' VAL . 41.0 p90 -125.56 123.29 38.77 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.693 -1.225 . . . . 1.31 107.693 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.693 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -101.03 132.39 46.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.621 -0.832 . . . . 2.53 110.623 177.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.07 155.75 29.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.567 -0.742 . . . . 0.75 110.696 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.39 -177.38 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.173 0.511 . . . . 2.38 111.38 -175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.706 ' HA ' HG23 ' A' ' 177' ' ' VAL . 30.0 t90 -84.99 78.44 9.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 4.71 109.018 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 9.2 t70 -71.99 -62.74 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 1.53 111.687 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 33.5 t70 174.69 -35.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.277 0.56 . . . . 1.26 110.917 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -80.21 5.26 15.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 2.46 110.999 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.79 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 64.8 t -72.42 -54.45 5.34 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.58 110.479 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 77.2 Cg_exo -51.47 -37.73 62.5 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.545 2.163 . . . . 0.68 112.33 172.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.6 mmmt -73.09 -23.3 60.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 2.62 111.42 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.799 HD12 HG12 ' A' ' 107' ' ' VAL . 40.3 tp -69.62 -46.59 65.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.104 -0.702 . . . . 1.18 109.104 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -59.61 -36.86 77.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 2.11 109.811 173.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.658 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.1 mm-40 -54.73 -46.65 74.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.83 -1.077 . . . . 1.53 110.339 172.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -73.73 -36.01 65.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.474 -0.785 . . . . 2.16 111.744 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.653 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.7 mt -67.16 5.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.263 0.468 . . . . 0.87 112.263 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.663 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 33.8 m -84.12 0.02 50.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.377 0.608 . . . . 1.38 109.462 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.574 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.35 55.34 8.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.223 -0.899 . . . . 1.17 111.346 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.663 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 1.4 mmmp? . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.169 -0.919 . . . . 2.45 110.75 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 24' ' ' PRO . 7.4 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 120.947 0.403 . . . . 2.1 111.434 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -154.11 153.47 31.91 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.175 -0.676 . . . . 1.81 109.175 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.16 16.19 0.8 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.851 0.315 . . . . 0.95 111.851 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.3 t -64.14 -16.18 61.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 2.19 110.805 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -113.47 31.48 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 3.07 110.536 -177.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.646 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.4 OUTLIER -73.55 -41.27 63.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.852 0.358 . . . . 4.76 111.93 -174.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 61.9 p -145.03 32.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.463 0.649 . . . . 0.98 110.003 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.12 -118.1 0.21 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.966 -0.854 . . . . 0.52 110.966 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 18.6 Cg_endo -56.89 -38.37 96.07 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 123.175 2.583 . . . . 0.61 110.854 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' ' 7' ' ' LYS . 9.3 mt -88.58 101.75 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.85 110.034 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.663 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -83.29 71.34 10.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.837 0.827 . . . . 1.31 110.106 175.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.474 HD21 HG23 ' A' ' 121' ' ' VAL . 22.7 mt -79.09 -15.49 58.1 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.465 -0.789 . . . . 0.61 109.915 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.627 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -74.46 -6.67 49.65 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.375 -0.83 . . . . 2.61 111.204 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.663 ' HG3' ' O ' ' A' ' 13' ' ' SER . 14.2 mt-10 -68.91 -22.83 64.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.323 0.582 . . . . 1.93 109.577 177.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.891 HG11 HG22 ' A' ' 151' ' ' VAL . 46.1 t -89.03 -71.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.163 -0.926 . . . . 1.26 111.41 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -149.74 174.65 12.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.935 -0.575 . . . . 2.99 109.525 -172.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -54.95 151.04 9.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.288 0.566 . . . . 1.6 111.279 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.627 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 27.6 mm-40 -86.96 138.27 32.94 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.872 -0.603 . . . . 4.38 109.942 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.639 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 8.1 Cg_exo -71.24 161.52 45.51 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.377 2.718 . . . . 0.69 113.299 -170.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.7 pt20 -82.38 -18.07 43.32 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.326 -0.852 . . . . 1.87 111.74 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.748 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.2 m80 -141.9 159.68 58.5 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 2.35 109.538 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.678 ' HB2' HG13 ' A' ' 3' ' ' VAL . 5.0 Cg_endo -85.72 125.73 2.87 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.763 2.309 . . . . 0.44 111.175 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.75 HD21 ' HB3' ' A' ' 122' ' ' TRP . 16.2 tp -71.55 137.74 48.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.33 110.131 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.59 107.82 19.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.8 -0.444 . . . . 2.12 109.8 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 53' ' ' ILE . 6.6 t -114.46 143.34 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.149 -0.686 . . . . 1.12 109.149 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.39 139.58 31.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.99 0.424 . . . . 0.78 111.413 -174.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -104.72 173.34 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.238 -0.653 . . . . 1.23 109.238 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.17 66.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.485 0.659 . . . . 0.6 110.726 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.1 -0.87 33.68 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.28 -0.873 . . . . 0.81 112.957 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.36 -170.39 2.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.56 111.266 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.39 154.4 16.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.63 -0.713 . . . . 0.35 109.734 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.71 HG22 ' HB3' ' A' ' 169' ' ' TYR . 86.6 t -113.14 69.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.145 -1.428 . . . . 0.39 107.145 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 20.5 t70 -105.41 18.55 22.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.234 -0.894 . . . . 0.99 109.358 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.35 135.85 24.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.521 -0.918 . . . . 2.56 108.521 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.555 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -80.79 111.38 17.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.405 0.622 . . . . 0.46 110.547 -171.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.583 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 91.32 11.74 60.7 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.989 -1.005 . . . . 0.59 111.848 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.4 144.53 46.35 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.394 -0.595 . . . . 1.04 109.394 176.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 9.7 p -77.24 136.2 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 1.16 110.99 -178.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.596 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.2 tp -131.99 168.85 17.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.556 -0.905 . . . . 0.45 108.556 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.92 152.04 48.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.565 -0.454 . . . . 1.0 112.045 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.836 ' HG3' ' HG ' ' A' ' 109' ' ' SER . 50.3 Cg_exo -57.41 -34.11 97.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.805 3.003 . . . . 1.0 112.855 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.499 HG21 ' CD1' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -60.37 -39.91 88.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.463 0.649 . . . . 1.24 110.772 176.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -81.64 -13.24 58.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.943 -1.026 . . . . 1.74 111.752 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.644 ' HB ' ' HH ' ' A' ' 106' ' ' TYR . 33.0 m -128.24 28.65 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 1.1 111.583 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HZ2' HD13 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -86.76 -10.75 52.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.414 0.626 . . . . 1.32 109.337 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -132.91 174.21 10.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.745 -1.116 . . . . 2.4 108.38 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -71.29 153.56 94.08 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 110.229 -0.286 . . . . 1.78 110.229 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.35 156.18 46.02 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.136 1.89 . . . . 0.41 110.844 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -77.71 -20.78 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.809 0.338 . . . . 0.88 110.216 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.419 ' C ' HG21 ' A' ' 53' ' ' ILE . 71.5 m -159.07 143.56 15.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.482 0.658 . . . . 0.65 112.619 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.587 HD13 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -137.83 164.34 28.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.778 -1.101 . . . . 0.33 108.155 170.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.757 ' HA ' HD11 ' A' ' 58' ' ' LEU . 35.1 t 174.69 118.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.15 -0.315 . . . . 0.8 110.15 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.816 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -73.12 155.76 39.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.273 -1.01 . . . . 3.63 108.273 172.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.89 88.05 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.042 0.448 . . . . 1.51 110.302 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.95 10.62 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.64 -0.709 . . . . 0.9 112.182 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.757 HD11 ' HA ' ' A' ' 54' ' ' SER . 3.8 tt -51.03 128.74 22.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.09 0.556 . . . . 0.62 111.37 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.758 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 24.4 t70 -72.73 -32.59 65.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.723 -0.671 . . . . 0.74 111.332 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.531 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.7 t 71.52 15.02 6.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 114.998 -1.001 . . . . 1.51 109.831 -174.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.53 10.52 2.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.526 -0.761 . . . . 0.84 112.901 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.758 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 22.9 mtpt -117.76 154.45 31.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.803 -0.443 . . . . 2.12 109.803 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.797 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 24.2 mt -92.5 130.87 38.04 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.796 -0.816 . . . . 1.23 108.796 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.65 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -125.54 158.36 34.76 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.56 -0.456 . . . . 1.61 110.871 176.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.477 ' OG1' HD21 ' A' ' 131' ' ' LEU . 60.0 m -97.72 106.14 18.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.149 -0.685 . . . . 0.87 109.149 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.595 HD11 HG11 ' A' ' 124' ' ' VAL . 53.0 tp -104.24 111.23 23.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 1.35 110.394 -176.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.74 125.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 0.54 110.727 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.5 -0.926 . . . . 0.65 108.5 167.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.735 HG21 HG12 ' A' ' 17' ' ' VAL . 10.6 t -136.66 146.81 46.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.04 -0.355 . . . . 1.04 110.04 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.454 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 14.9 t0 -126.28 97.27 34.75 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.457 -0.571 . . . . 1.92 109.457 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.503 ' HD3' HG22 ' A' ' 17' ' ' VAL . 6.5 Cg_endo -49.08 -46.89 23.73 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.904 3.069 . . . . 1.25 113.485 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.65 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 7.4 m-20 -90.81 53.09 2.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.422 0.629 . . . . 1.29 111.14 -171.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.479 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -103.98 138.88 19.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.932 -0.576 . . . . 0.56 110.828 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.593 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 88.1 Cg_endo -83.43 -22.7 14.35 Favored 'Cis proline' 0 C--N 1.343 0.282 0 C-N-CA 123.327 -1.531 . . . . 0.7 112.621 1.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.59 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 58.9 p -128.46 147.3 50.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.565 -0.743 . . . . 1.1 110.277 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.65 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 21.2 ttt180 -64.6 -26.65 68.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.257 0.551 . . . . 3.39 110.429 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.538 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 4.9 ptpt -78.72 -14.83 59.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 1.83 110.89 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t70 -162.94 87.49 1.33 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.942 -0.572 . . . . 1.37 110.111 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.2 Cg_endo -85.2 83.92 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.697 2.265 . . . . 0.9 112.806 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -72.08 -47.85 48.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.884 -1.053 . . . . 1.53 110.48 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.662 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 54.6 m-85 -88.53 21.28 2.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.002 -0.999 . . . . 1.54 111.729 -168.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.846 ' HD3' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -74.01 125.85 29.18 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.173 -0.306 . . . . 3.38 110.173 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.846 ' HG3' ' HD3' ' A' ' 82' ' ' ARG . 1.5 mp0 -94.87 138.78 32.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.043 0.449 . . . . 2.23 110.986 -2.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.479 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 16.0 t90 -91.72 138.64 31.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.188 -0.671 . . . . 1.77 109.188 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -113.44 133.61 55.1 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.221 -0.659 . . . . 2.19 109.221 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 5.2 t60 -82.75 -35.81 26.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.72 -0.673 . . . . 2.74 110.527 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.676 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 22.0 p90 -167.62 177.19 6.01 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.552 -0.536 . . . . 2.21 109.552 177.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 103' ' ' LEU . 23.3 tp -141.27 113.8 8.22 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.245 0.341 . . . . 0.68 110.25 176.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.676 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.668 -0.697 . . . . 0.35 110.57 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.514 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 4.5 m -129.05 166.88 25.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.591 -0.892 . . . . 0.3 108.591 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.797 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 m-20 60.45 18.89 8.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.955 0.407 . . . . 2.09 111.172 172.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.463 ' HB2' ' HE2' ' A' ' 92' ' ' MET . 8.4 ttm -72.49 116.71 13.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.97 -0.752 . . . . 0.34 108.97 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.3 ttmm -90.4 100.63 13.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.126 -0.943 . . . . 1.73 110.972 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 75.59 -121.42 6.37 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.353 -0.839 . . . . 0.35 112.537 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.501 ' HB3' HD22 ' A' ' 58' ' ' LEU . 28.2 p30 -120.55 29.09 7.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.208 0.528 . . . . 1.59 111.052 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -97.15 109.61 22.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.834 -0.621 . . . . 0.77 110.183 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 53' ' ' ILE . 7.6 mm -54.74 -30.86 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.716 -1.129 . . . . 0.45 111.483 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.0 m -83.21 -35.53 25.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.016 -0.538 . . . . 1.15 112.32 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.8 p -61.28 -24.97 66.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 1.26 111.759 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.436 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -54.8 110.11 1.53 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.65 -0.704 . . . . 0.44 113.012 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.4 m -66.44 107.59 2.09 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.344 -0.613 . . . . 1.06 109.344 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.3 126.63 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.223 -0.898 . . . . 1.15 111.579 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 ' HG ' ' A' ' 88' ' ' LEU . 22.8 mt -106.87 -49.6 3.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.181 0.991 . . . . 0.48 108.713 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.8 t -120.57 112.72 19.28 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.678 -1.601 . . . . 0.62 106.678 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.916 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.3 t0 -70.52 167.95 17.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.407 0.623 . . . . 1.15 112.429 -166.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.644 ' HH ' ' HB ' ' A' ' 46' ' ' VAL . 65.7 t80 -83.52 88.24 7.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.973 -1.012 . . . . 4.98 109.731 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.847 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.0 t -61.72 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.713 -0.676 . . . . 0.86 112.094 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.451 ' HA3' ' HZ3' ' A' ' 47' ' ' LYS . . . 114.88 -176.96 17.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.95 111.695 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.836 ' HG ' ' HG3' ' A' ' 43' ' ' PRO . 29.0 t -71.69 127.06 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.975 0.387 . . . . 0.89 110.536 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.515 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -150.51 63.67 0.4 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.805 -0.712 . . . . 0.82 112.448 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.628 ' HB3' ' CE1' ' A' ' 118' ' ' HIS . 96.5 Cg_endo -93.05 145.36 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.062 2.508 . . . . 1.01 113.3 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.522 ' HD2' HG23 ' A' ' 115' ' ' THR . 32.1 Cg_exo -60.56 154.04 57.0 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.641 2.227 . . . . 0.96 111.351 169.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.434 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -68.43 126.46 29.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 2.39 110.896 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.76 37.1 20.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 1.3 113.221 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 28.6 p -84.32 -13.12 53.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.393 0.516 . . . . 1.04 112.393 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 89.83 11.77 63.17 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.27 -0.967 . . . . 1.97 112.101 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 172' ' ' GLU . 3.8 mm? 72.37 100.79 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.593 0.819 . . . . 0.94 111.446 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.628 ' CE1' ' HB3' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -96.26 164.75 12.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.043 -0.725 . . . . 2.85 109.043 175.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.595 HH11 HD21 ' A' ' 12' ' ' LEU . 2.7 ptt180 -127.29 106.22 9.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.015 0.436 . . . . 2.78 112.061 -160.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.579 ' OH ' ' HE1' ' A' ' 118' ' ' HIS . 6.8 m-85 -73.66 110.79 8.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.848 -0.797 . . . . 1.13 108.848 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 168' ' ' CYS . 16.6 t -94.82 125.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.291 -0.413 . . . . 0.31 110.373 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.75 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -87.99 118.6 27.66 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.091 -0.707 . . . . 2.96 109.091 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.98 119.03 33.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.578 -0.156 . . . . 0.41 110.578 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 66' ' ' LEU . 1.7 m -105.61 126.24 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.157 -0.617 . . . . 0.43 109.824 173.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.423 ' HB2' HD21 ' A' ' 160' ' ' LEU . 47.1 m-85 -108.09 124.21 49.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 5.41 109.02 175.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.535 ' HB2' HG21 ' A' ' 164' ' ' VAL . 27.6 tt0 -94.38 96.98 9.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.991 0.424 . . . . 2.41 110.137 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.65 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -73.24 163.97 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.77 -0.65 . . . . 1.31 109.67 175.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.76 3.14 38.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.56 -0.746 . . . . 2.4 110.04 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.406 ' HD2' ' HH ' ' A' ' 158' ' ' TYR . 0.8 OUTLIER -165.64 153.23 9.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 4.07 111.355 -169.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.468 ' HG3' HD11 ' A' ' 63' ' ' LEU . 32.0 Cg_exo -59.59 141.08 96.61 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.701 2.934 . . . . 1.21 112.094 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.541 HD23 ' HG2' ' A' ' 127' ' ' GLN . 3.6 mm? -68.43 151.56 46.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 1.16 112.434 -170.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -115.9 64.23 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.403 -0.962 . . . . 3.23 108.403 171.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 46.2 m -96.98 92.4 6.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.218 -0.901 . . . . 2.79 110.194 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.85 40.66 0.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.963 . . . . 2.96 109.976 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -89.16 127.98 53.33 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.16 -0.927 . . . . 1.39 110.091 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.1 127.85 18.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.225 2.617 . . . . 1.38 112.588 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.25 121.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.94 110.11 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.4 mt -98.82 -13.95 19.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.393 -0.367 . . . . 1.61 111.815 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.547 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m 55.65 -162.23 0.16 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.428 -0.351 . . . . 1.88 110.669 -173.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.916 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.2 p-10 -117.72 16.43 14.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.162 0.506 . . . . 1.33 111.072 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.539 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 23.2 mtt180 -107.71 137.27 46.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.205 -0.452 . . . . 3.83 109.988 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.568 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 67.9 m 74.42 113.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.185 0.928 . . . . 1.32 111.089 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.4 36.06 2.96 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.293 -0.867 . . . . 1.13 112.296 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.557 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 16.5 t70 -70.01 -51.25 33.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.677 0.751 . . . . 2.66 110.387 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.557 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 8.8 m80 -92.79 53.86 2.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.968 -1.015 . . . . 2.18 110.437 -173.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 146' ' ' ARG . 44.0 mtt85 -76.49 -83.91 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.644 -0.707 . . . . 5.37 111.343 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -126.29 -154.74 8.73 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.655 -0.783 . . . . 0.9 112.777 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.662 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 81.0 mttt 65.93 23.18 11.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.787 0.803 . . . . 1.59 109.789 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -107.66 173.57 6.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.632 -1.167 . . . . 2.27 108.876 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.35 119.94 37.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.549 -0.296 . . . . 1.87 111.187 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.899 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 18.4 m -66.06 -25.36 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.423 -0.584 . . . . 0.96 109.423 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.02 83.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.194 -0.912 . . . . 0.76 109.986 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 57.4 m -66.91 -36.74 82.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.426 -0.352 . . . . 1.22 110.996 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.899 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 52.0 m-85 -61.7 -49.95 74.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.732 0.301 . . . . 1.1 110.799 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.481 ' HG3' ' N ' ' A' ' 156' ' ' LYS . 5.9 ptp180 -69.15 -44.47 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.509 -0.314 . . . . 3.36 111.199 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 155' ' ' ARG . 58.5 mtmt -63.04 -26.99 69.1 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.436 0.161 . . . . 1.52 111.436 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -53.15 -50.57 64.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.52 0.512 . . . . 2.13 110.721 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.406 ' HH ' ' HD2' ' A' ' 129' ' ' ARG . 27.2 t80 -104.09 9.92 36.18 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.18 -0.608 . . . . 5.77 110.511 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 57.51 39.79 27.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.2 1.0 . . . . 2.42 110.229 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.544 HD12 ' H ' ' A' ' 161' ' ' ARG . 1.7 tp -76.22 156.06 33.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.057 -1.429 . . . . 1.27 111.552 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.544 ' H ' HD12 ' A' ' 160' ' ' LEU . 9.0 mpt_? -96.87 -166.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 4.0 111.856 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.04 158.08 77.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.38 -0.373 . . . . 1.21 111.892 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -70.38 150.52 64.59 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.269 2.646 . . . . 0.68 113.205 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 10.5 t -93.72 -31.47 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.448 -0.796 . . . . 0.5 109.861 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.816 ' HB1' ' HB2' ' A' ' 55' ' ' TRP . . . -147.44 146.45 29.56 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.997 -0.681 . . . . 0.29 112.109 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -150.74 155.76 26.34 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.72 -1.127 . . . . 0.24 111.655 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.436 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.2 t -169.73 133.2 1.23 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.897 -0.779 . . . . 0.34 108.897 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 12' ' ' LEU . 17.5 p -110.93 141.15 44.75 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.257 -0.577 . . . . 2.16 110.609 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.71 ' HB3' HG22 ' A' ' 34' ' ' VAL . 25.9 p90 -127.32 123.16 35.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.419 -0.956 . . . . 1.31 108.419 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -100.08 138.14 37.56 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.439 -0.504 . . . . 2.53 110.672 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -138.01 146.92 43.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.94 -0.573 . . . . 0.75 109.976 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HB3' HD13 ' A' ' 117' ' ' LEU . 14.1 pt-20 -121.67 -168.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.34 . . . . 2.38 111.34 -176.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.813 ' HA ' HG23 ' A' ' 177' ' ' VAL . 14.1 t90 -76.91 83.85 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 4.71 110.887 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.554 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.5 p-10 -74.41 -59.83 2.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 111.545 0.202 . . . . 1.53 111.545 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.9 t70 178.05 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.086 0.555 . . . . 1.26 110.185 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.499 ' CD1' HG21 ' A' ' 44' ' ' THR . 72.4 m-85 -82.53 -2.27 53.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 2.46 111.874 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.813 HG23 ' HA ' ' A' ' 173' ' ' TRP . 94.4 t -58.7 -54.04 60.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.473 -0.33 . . . . 0.58 110.49 172.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.759 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.5 Cg_exo -51.31 -36.1 56.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.635 2.223 . . . . 0.68 112.445 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 29.2 mmmt -74.12 -24.71 59.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 2.62 110.78 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 59.0 tp -69.44 -46.09 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.429 -0.582 . . . . 1.18 109.429 172.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.445 -0.798 . . . . 2.11 108.898 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 42.5 mm-40 -58.19 -50.21 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.803 -1.09 . . . . 1.53 110.941 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.445 ' NE2' HD22 ' A' ' 140' ' ' ASN . 34.8 tt0 -64.17 -33.81 76.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.581 -0.736 . . . . 2.16 111.934 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 77.1 mt -62.47 0.03 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.691 0.626 . . . . 0.87 112.691 -177.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.606 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.6 m -82.2 8.9 9.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.063 0.459 . . . . 1.38 110.133 171.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.6 54.95 9.12 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.974 -0.85 . . . . 1.17 110.974 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.606 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.6 mmmt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.576 -0.726 . . . . 2.45 110.981 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.698 HG13 ' HB2' ' A' ' 24' ' ' PRO . 3.7 t . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 121.799 0.809 . . . . 2.1 111.873 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 6' ' ' SER . 16.6 t70 -159.18 157.09 30.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.119 -1.067 . . . . 1.81 108.119 177.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.95 22.6 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.048 -0.261 . . . . 0.95 111.631 -174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 4' ' ' ASP . 20.4 m -67.64 -21.21 65.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 2.19 111.505 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.95 37.07 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 3.07 110.192 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.452 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 9.0 p-90 -75.76 -29.03 58.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.42 0.526 . . . . 4.76 112.42 -174.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 70.8 p -156.18 20.27 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.98 111.017 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -82.6 -117.64 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.664 -0.575 . . . . 0.52 111.664 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.6 Cg_endo -51.65 -42.08 58.24 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.225 2.616 . . . . 0.61 110.279 167.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.714 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 10.2 mp -90.01 94.91 9.98 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.747 -1.115 . . . . 1.85 110.965 172.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -74.2 61.45 0.86 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.351 0.596 . . . . 1.31 110.211 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' A' ' 12' ' ' LEU . 40.5 mt -68.46 -13.41 62.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.61 110.902 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.406 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 22.3 mm-40 -73.57 -1.29 18.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.086 -0.506 . . . . 2.61 111.675 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.57 -10.58 59.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.169 0.509 . . . . 1.93 109.792 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.894 HG12 HG21 ' A' ' 69' ' ' THR . 58.7 t -92.83 -76.82 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 1.26 110.196 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.586 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 10.1 t70 -155.59 -178.25 7.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.396 -0.964 . . . . 2.99 108.396 -175.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.74 152.99 41.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.047 0.451 . . . . 1.6 110.766 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 8.2 tp-100 -78.12 129.88 74.14 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.072 -0.513 . . . . 4.38 110.413 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.2 Cg_exo -58.22 159.39 19.08 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.965 2.443 . . . . 0.69 113.001 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.933 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 20.3 pt20 -78.96 -8.18 58.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 1.87 111.653 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.885 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 64.8 m-70 -148.17 157.63 42.49 Favored Pre-proline 0 CA--C 1.515 -0.385 0 C-N-CA 123.246 0.619 . . . . 2.35 109.78 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.698 ' HB2' HG13 ' A' ' 3' ' ' VAL . 5.6 Cg_endo -87.67 123.94 1.85 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.318 2.679 . . . . 0.44 111.239 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 20.6 tp -79.04 131.58 36.32 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.32 -0.237 . . . . 0.33 111.353 -175.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -100.04 112.9 25.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.007 -0.368 . . . . 2.12 110.007 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.606 ' HB ' ' HB ' ' A' ' 34' ' ' VAL . 22.1 t -116.59 142.03 32.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.264 -0.643 . . . . 1.12 109.264 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -136.3 138.93 42.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.903 0.382 . . . . 0.78 110.117 -177.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -99.87 171.58 7.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.447 -0.575 . . . . 1.23 109.447 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.65 62.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.6 110.596 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.53 9.37 19.67 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.432 -0.804 . . . . 0.81 112.504 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.34 -168.23 2.68 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 110.165 -0.309 . . . . 0.56 110.165 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -161.36 155.23 22.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.252 -0.431 . . . . 0.35 110.768 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.724 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.8 t -107.77 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.919 -1.512 . . . . 0.39 106.919 166.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.69 22.2 4.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.99 109.833 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -150.64 130.24 13.08 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.051 -0.977 . . . . 2.56 109.847 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.943 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.1 tt -71.96 112.92 8.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.342 -0.614 . . . . 0.46 109.342 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.598 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 89.97 19.22 47.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.89 -0.671 . . . . 0.59 112.256 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.724 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.6 147.26 27.08 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.275 -0.639 . . . . 1.04 109.275 175.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.495 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.3 p -78.42 130.45 36.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.283 0.563 . . . . 1.16 110.821 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.514 HD21 ' HD2' ' A' ' 169' ' ' TYR . 8.7 tp -129.99 149.74 51.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.545 -1.279 . . . . 0.45 107.545 177.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 3.9 p -95.86 150.74 37.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 C-N-CA 119.47 -0.892 . . . . 1.0 112.665 -170.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.918 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 82.3 Cg_exo -51.68 -22.74 13.8 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.674 3.583 . . . . 1.0 114.374 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.484 HG22 ' CD2' ' A' ' 176' ' ' TYR . 2.2 p -71.09 -53.77 13.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.672 0.748 . . . . 1.24 109.816 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.65 -43.39 93.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.42 -1.264 . . . . 1.74 111.544 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 43' ' ' PRO . 2.5 m -91.97 13.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 1.1 111.903 -173.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -82.68 -28.71 30.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.162 -0.472 . . . . 1.32 110.391 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.407 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 18.1 m120 -109.23 -169.86 1.56 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.62 -0.718 . . . . 2.4 110.668 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -86.14 158.05 55.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.274 -0.639 . . . . 1.78 109.274 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.471 ' HG3' ' CH2' ' A' ' 122' ' ' TRP . 72.0 Cg_endo -81.64 160.43 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.112 1.875 . . . . 0.41 111.004 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -81.61 -21.23 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.141 0.496 . . . . 0.88 109.878 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.52 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 69.2 m -158.11 143.49 16.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.362 0.601 . . . . 0.65 112.551 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -139.92 161.0 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.717 -1.129 . . . . 0.33 107.955 170.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.637 ' HA ' HD11 ' A' ' 58' ' ' LEU . 37.9 t 176.02 119.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.98 0.419 . . . . 0.8 110.421 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.534 ' CB ' ' HB1' ' A' ' 165' ' ' ALA . 50.0 p-90 -81.15 147.93 29.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.848 -1.538 . . . . 3.63 106.848 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -66.38 91.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.859 0.837 . . . . 1.51 110.904 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.32 -1.31 3.68 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 114.864 -1.062 . . . . 0.9 111.799 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 95' ' ' ASN . 7.1 tt -54.68 128.58 33.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.83 0.452 . . . . 0.62 110.511 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.743 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -77.8 -26.95 50.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.092 -0.504 . . . . 0.74 111.67 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.706 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.5 p 70.59 13.33 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.396 1.078 . . . . 1.51 110.5 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -133.05 -25.66 0.65 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.84 113.263 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.743 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 18.8 mtpt -84.22 156.74 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.968 0.384 . . . . 2.12 110.084 -175.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.959 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.9 mt -92.29 128.16 38.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.72 -0.474 . . . . 1.23 109.72 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.506 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 17.3 m-85 -121.37 150.78 40.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.601 0.239 . . . . 1.61 110.523 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.874 HG21 HG11 ' A' ' 90' ' ' VAL . 2.7 m -97.16 105.91 18.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.638 -0.875 . . . . 0.87 108.638 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.632 HD11 HG11 ' A' ' 124' ' ' VAL . 49.7 tp -109.23 113.01 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.823 -0.626 . . . . 1.35 110.46 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.8 t -112.51 123.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.916 -0.584 . . . . 0.54 110.754 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.981 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.4 mt -88.64 131.65 34.89 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.744 -0.836 . . . . 0.65 108.744 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.894 HG21 HG12 ' A' ' 17' ' ' VAL . 8.8 t -139.05 148.91 43.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.867 0.365 . . . . 1.04 111.302 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.481 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 27.7 t70 -127.45 94.56 37.89 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.758 -0.655 . . . . 1.92 109.487 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.8 Cg_endo -50.79 -40.06 57.28 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 124.153 3.236 . . . . 1.25 113.799 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.756 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.8 m-20 -86.54 43.03 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.605 0.594 . . . . 1.29 112.605 -167.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.11 138.1 19.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.801 -0.181 . . . . 0.56 110.615 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 87.8 Cg_endo -83.28 -24.49 11.13 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.575 -1.427 . . . . 0.7 112.993 1.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.683 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.9 p -130.81 150.85 51.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.177 -0.465 . . . . 1.1 109.933 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.756 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 42.5 mtm105 -67.83 -23.55 65.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.934 -0.575 . . . . 3.39 111.878 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.657 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.6 -10.68 39.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 1.83 111.145 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 13.4 t70 -154.18 77.01 5.63 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.176 0.512 . . . . 1.37 110.116 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 81.5 Cg_endo -79.42 86.37 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.532 2.154 . . . . 0.9 112.363 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.483 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.6 mttm -70.67 -50.3 38.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.747 -1.115 . . . . 1.53 110.589 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.661 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.9 m-85 -82.05 20.93 0.94 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.453 -0.794 . . . . 1.54 111.437 -172.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.513 ' HB2' ' HB2' ' A' ' 79' ' ' PRO . 8.0 tmm_? -71.97 123.58 23.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.888 -0.412 . . . . 3.38 109.888 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 4.8 mp0 -100.08 135.95 40.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.895 0.379 . . . . 2.23 110.886 -0.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -79.38 146.52 32.8 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.977 -1.12 . . . . 1.77 107.977 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 47.0 p-80 -124.51 127.54 47.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 2.19 110.751 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.981 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.7 t60 -70.66 -37.15 73.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.906 -1.043 . . . . 2.74 110.219 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.4 p90 -168.36 173.61 7.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.01 -0.367 . . . . 2.21 110.01 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 103' ' ' LEU . 18.4 tp -134.95 113.98 12.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.087 -0.506 . . . . 0.68 109.776 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.71 132.64 70.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.671 -0.695 . . . . 0.35 110.627 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.874 HG11 HG21 ' A' ' 65' ' ' THR . 5.6 m -128.15 164.93 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.312 -0.996 . . . . 0.3 108.312 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.959 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.0 m-20 59.16 18.64 6.66 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 123.526 0.516 . . . . 2.09 111.096 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.64 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 8.3 ttm -70.12 110.01 4.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.34 108.588 176.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 19.4 ttmm -76.48 92.67 3.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.733 -1.121 . . . . 1.73 111.179 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.706 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.2 -123.13 6.75 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.853 -1.067 . . . . 0.35 112.898 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.659 ' HB3' HD22 ' A' ' 58' ' ' LEU . 26.1 p-10 -113.41 22.27 14.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.332 -0.434 . . . . 1.59 111.024 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.63 106.84 18.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.489 0.661 . . . . 0.77 109.919 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.6 mm -57.01 -30.66 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.307 -1.315 . . . . 0.45 111.274 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -82.87 -26.68 31.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 1.15 111.655 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -84.82 14.9 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 1.26 111.616 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.64 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -89.93 109.35 3.62 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.787 -0.72 . . . . 0.44 111.902 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.4 m -61.55 106.26 0.63 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.363 0.601 . . . . 1.06 109.549 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 p -85.8 121.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.257 -0.883 . . . . 1.15 111.414 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.555 HD12 ' HG ' ' A' ' 88' ' ' LEU . 18.4 mt -100.48 -43.13 6.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.012 0.911 . . . . 0.48 109.231 173.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 t -123.98 110.39 14.74 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.159 -1.423 . . . . 0.62 107.159 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.882 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -59.31 164.44 3.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.851 -0.613 . . . . 1.15 112.469 -171.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 11.0 p90 -80.76 98.27 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.414 -0.812 . . . . 4.98 110.231 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.796 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.6 t -67.33 -53.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.86 111.332 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.449 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 117.41 -162.53 12.87 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.551 -0.833 . . . . 0.95 112.312 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.959 ' HA ' ' HH ' ' A' ' 120' ' ' TYR . 29.0 t -77.72 117.56 19.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.919 -0.4 . . . . 0.89 109.919 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.582 ' HA3' HD21 ' A' ' 180' ' ' LEU . . . -143.47 57.04 0.55 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.699 -0.763 . . . . 0.82 112.461 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.747 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 1.4 Cg_endo -87.01 131.25 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.245 2.63 . . . . 1.01 112.346 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.674 ' HB2' HG21 ' A' ' 115' ' ' THR . 52.7 Cg_exo -56.74 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.207 1.938 . . . . 0.96 110.53 171.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.17 112.87 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 2.39 110.528 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.89 -6.38 19.97 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.842 -0.694 . . . . 1.3 112.121 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.683 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 78.4 p -83.92 -20.95 32.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.772 0.32 . . . . 1.04 111.318 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.77 -174.24 19.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.155 -0.545 . . . . 1.97 112.381 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.483 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 4.4 mm? -68.59 122.82 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.667 0.27 . . . . 0.94 110.726 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.747 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.8 m-70 -98.45 121.55 40.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.129 0.49 . . . . 2.85 110.207 176.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.714 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 1.6 ptt180 -107.13 94.11 4.92 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.083 -0.962 . . . . 2.78 111.461 -168.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.959 ' HH ' ' HA ' ' A' ' 109' ' ' SER . 33.6 m-85 -75.15 111.06 10.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.195 -0.669 . . . . 1.13 109.195 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.7 t -94.76 132.46 38.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.785 -0.643 . . . . 0.31 110.09 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.746 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 31.0 m95 -89.4 121.89 32.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.303 -0.629 . . . . 2.96 109.303 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 76.1 mt -116.47 117.5 30.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.159 0.436 . . . . 0.41 110.221 175.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.632 HG11 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -115.07 137.89 47.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.263 -0.273 . . . . 0.43 110.263 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.825 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 47.9 t80 -130.6 137.63 49.74 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.301 -0.259 . . . . 5.41 110.301 175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.414 ' CD ' ' HZ2' ' A' ' 62' ' ' LYS . 30.5 tt0 -91.71 105.07 17.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.227 -0.657 . . . . 2.41 109.227 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.98 175.1 9.87 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.428 0.632 . . . . 1.31 111.29 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.17 -29.27 66.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.103 -0.953 . . . . 2.4 109.231 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.922 ' HG3' ' HH ' ' A' ' 158' ' ' TYR . 10.9 ptt-85 -159.66 164.59 19.95 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.511 -1.222 . . . . 4.07 111.254 -172.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.586 ' HG3' HD11 ' A' ' 63' ' ' LEU . 31.4 Cg_exo -55.86 142.98 83.33 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.453 2.769 . . . . 1.21 112.916 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.573 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.0 mm? -68.97 154.43 42.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.567 0.951 . . . . 1.16 113.567 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.447 ' HE2' ' OD2' ' A' ' 134' ' ' ASP . 21.5 tptm -141.35 86.78 2.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.44 -1.255 . . . . 3.23 108.0 167.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.74 -46.42 8.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.774 -0.648 . . . . 2.79 112.678 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 132' ' ' LYS . 61.7 m-20 57.32 47.55 16.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 2.96 110.7 -174.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -99.43 146.92 32.61 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.539 -0.755 . . . . 1.39 109.973 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.73 106.19 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.133 2.555 . . . . 1.38 112.474 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.43 115.36 2.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.241 -0.436 . . . . 0.94 110.659 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.0 mt -109.38 147.52 32.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 1.61 110.203 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 58.0 m -109.32 36.64 2.85 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.572 -0.74 . . . . 1.88 110.38 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.882 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.8 OUTLIER 57.05 4.56 0.18 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.62 1.168 . . . . 1.33 113.041 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.553 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 83.9 mtt180 -97.39 136.27 38.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 3.83 110.819 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.608 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 53.7 m 77.46 118.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.582 -1.19 . . . . 1.32 111.147 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -89.42 34.08 4.12 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.169 -0.923 . . . . 1.13 112.426 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.68 -28.83 63.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.23 0.538 . . . . 2.66 110.597 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -119.87 68.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 2.18 110.852 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 78.5 mtt180 -75.52 -76.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.182 0.515 . . . . 5.37 111.063 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.4 -148.05 5.97 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.664 -0.779 . . . . 0.9 112.532 -174.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.661 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 68.25 17.76 9.28 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.51 0.671 . . . . 1.59 110.208 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -110.01 104.68 13.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.235 -0.893 . . . . 2.27 109.303 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -54.82 120.65 7.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.635 -0.711 . . . . 1.87 112.2 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.782 HG22 HG11 ' A' ' 17' ' ' VAL . 4.6 m -60.38 -30.1 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.611 -0.722 . . . . 0.96 110.705 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.12 -35.47 80.38 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.76 110.445 173.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.454 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 69.1 m -68.59 -33.96 74.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 1.22 110.306 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.694 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 58.1 m-85 -67.39 -43.66 80.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 1.1 110.44 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 21.4 ptt180 -69.53 -41.46 75.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.327 -0.397 . . . . 3.36 110.354 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 53.6 mtmt -62.61 -27.31 69.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.564 0.221 . . . . 1.52 111.416 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -53.61 -53.33 53.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 2.13 110.909 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.922 ' HH ' ' HG3' ' A' ' 129' ' ' ARG . 5.2 t80 -107.89 20.96 18.09 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.439 -0.904 . . . . 5.77 111.011 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.57 42.59 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.384 -0.825 . . . . 2.42 111.69 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.825 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.2 mp -90.77 155.27 18.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.265 -0.88 . . . . 1.27 109.751 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.929 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -122.87 -153.85 0.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.454 -0.573 . . . . 4.0 109.454 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.929 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -53.98 140.31 51.72 Favored Pre-proline 0 N--CA 1.456 -0.165 0 CA-C-O 121.168 0.509 . . . . 1.21 111.114 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.447 ' HG2' ' HG3' ' A' ' 21' ' ' PRO . 7.0 Cg_exo -70.65 170.7 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.981 3.121 . . . . 0.68 113.404 -167.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.933 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -92.8 -36.07 7.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 115.155 -0.929 . . . . 0.5 110.058 177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -144.84 144.21 31.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.153 -0.619 . . . . 0.29 111.962 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 150.8 23.1 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.813 -1.085 . . . . 0.24 112.093 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.943 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -167.82 152.57 6.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.403 -0.962 . . . . 0.34 108.403 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.704 ' HG ' ' HB2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -122.03 142.72 50.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.985 0.421 . . . . 2.16 111.091 -176.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.685 ' HB3' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -130.0 109.97 11.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 1.31 108.671 172.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -100.09 133.89 43.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.381 0.511 . . . . 2.53 112.381 -170.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.36 151.4 44.42 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.146 -0.934 . . . . 0.75 109.625 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -113.27 -64.29 1.33 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.516 0.932 . . . . 2.38 113.516 -173.039 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.756 ' HA ' HG23 ' A' ' 177' ' ' VAL . 12.8 t90 178.45 74.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.017 -0.364 . . . . 4.71 110.017 -176.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.918 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -72.48 -62.21 1.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.795 0.294 . . . . 1.53 111.795 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.572 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 32.0 t70 177.18 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.095 -0.502 . . . . 1.26 110.915 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.484 ' CD2' HG22 ' A' ' 44' ' ' THR . 11.2 m-30 -78.79 1.58 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.384 -0.371 . . . . 2.46 111.667 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 173' ' ' TRP . 72.7 t -67.57 -54.21 19.11 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.58 110.204 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.729 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.4 Cg_exo -51.4 -35.25 53.92 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.331 2.021 . . . . 0.68 112.35 170.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.671 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 26.3 mmmt -72.79 -24.75 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.848 0.314 . . . . 2.62 111.848 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.728 HD23 HG12 ' A' ' 107' ' ' VAL . 55.2 tp -70.49 -46.29 64.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.033 -0.729 . . . . 1.18 109.033 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.32 -37.98 79.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.559 -0.746 . . . . 2.11 109.331 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.671 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.0 mm-40 -56.18 -55.57 31.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.808 -1.087 . . . . 1.53 110.687 170.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -63.73 -33.35 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 2.16 112.333 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 76.4 mt -63.76 -1.14 1.23 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.4 0.519 . . . . 0.87 112.4 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.455 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.8 m -78.13 -2.81 39.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.444 0.64 . . . . 1.38 109.534 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.553 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 77.51 44.13 13.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.197 -0.911 . . . . 1.17 111.206 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.455 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.3 mmmt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.341 -0.837 . . . . 2.45 110.597 -174.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 24' ' ' PRO . 3.5 t . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.549 0.69 . . . . 2.1 111.725 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.471 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 27.9 t70 -152.84 157.7 41.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.57 -0.9 . . . . 1.81 108.57 176.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.44 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.8 mm? -79.18 28.85 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.667 0.27 . . . . 0.95 110.804 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 4' ' ' ASP . 7.9 m -62.96 -29.12 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 2.19 111.18 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 12' ' ' LEU . 90.5 mttt -124.51 50.84 1.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.158 -0.474 . . . . 3.07 110.231 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.613 ' HD1' ' HG3' ' A' ' 15' ' ' GLN . 4.8 p90 -71.61 -38.65 70.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 4.76 111.453 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.69 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 73.9 p -142.9 24.14 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.98 111.451 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.516 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.25 -125.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.15 -0.78 . . . . 0.52 111.15 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.7 Cg_endo -51.11 -40.62 59.62 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 123.326 2.684 . . . . 0.61 110.049 168.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 38' ' ' GLY . 36.4 mt -88.71 78.25 7.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.688 -1.142 . . . . 1.85 109.319 169.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 1.2 m -73.72 64.1 0.91 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.547 0.689 . . . . 1.31 109.907 176.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.788 HD11 ' HG ' ' A' ' 168' ' ' CYS . 12.0 mt -79.73 -30.18 40.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.551 -0.749 . . . . 0.61 110.39 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.69 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 74.7 mm-40 -73.74 16.13 0.23 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.915 0.709 . . . . 2.61 112.915 -175.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.7 mt-10 -82.63 -13.53 56.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.851 -0.796 . . . . 1.93 108.851 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.893 HG11 HG22 ' A' ' 151' ' ' VAL . 49.0 t -85.36 -74.92 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 114.878 -1.055 . . . . 1.26 111.525 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -122.09 -157.91 0.75 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.178 -0.465 . . . . 2.99 111.14 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -87.15 151.26 23.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 1.6 110.445 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 40.7 mt-30 -67.12 126.15 92.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.934 -0.395 . . . . 4.38 109.934 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -73.23 159.41 47.21 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.214 1.943 . . . . 0.69 111.824 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.915 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 21.0 pt20 -74.62 -13.45 60.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.74 -0.664 . . . . 1.87 111.491 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.784 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 3.1 m80 -160.93 164.57 18.8 Favored Pre-proline 0 CA--C 1.519 -0.249 0 CA-C-O 121.016 0.436 . . . . 2.35 110.83 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.689 ' HB2' HG13 ' A' ' 3' ' ' VAL . 3.6 Cg_endo -85.82 131.14 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.487 2.792 . . . . 0.44 111.438 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.84 HD21 ' HB3' ' A' ' 122' ' ' TRP . 25.6 tp -80.52 143.58 33.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.691 0.282 . . . . 0.33 111.457 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.485 ' H ' HD12 ' A' ' 25' ' ' LEU . 63.2 m-70 -110.07 123.98 50.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.753 -0.462 . . . . 2.12 109.753 172.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 53' ' ' ILE . 14.8 t -130.37 134.93 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.072 -0.714 . . . . 1.12 109.072 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.433 HG22 ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -127.37 140.64 52.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.093 0.473 . . . . 0.78 110.435 -177.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.543 ' HH ' ' H ' ' A' ' 48' ' ' ASN . 25.2 t80 -103.12 172.67 6.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.541 -0.54 . . . . 1.23 109.541 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.8 67.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.492 0.663 . . . . 0.6 110.678 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.43 4.33 33.02 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.316 -0.856 . . . . 0.81 112.753 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.44 -168.54 3.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.56 110.472 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.36 149.95 14.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.977 -0.556 . . . . 0.35 109.905 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.72 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -105.29 60.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.167 -1.42 . . . . 0.39 107.167 166.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.27 25.63 5.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.0 0.905 . . . . 0.99 109.921 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.684 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 16.9 tt0 -148.31 128.0 13.34 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.833 -1.076 . . . . 2.56 108.582 167.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.634 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -69.62 111.41 5.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 0.46 109.546 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.88 16.47 59.63 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.83 -0.623 . . . . 0.59 113.029 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.72 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.91 149.28 41.55 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.507 -0.553 . . . . 1.04 109.507 174.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.41 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 14.4 p -75.54 132.77 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 1.16 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.9 tp -131.92 170.59 14.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.93 -0.767 . . . . 0.45 108.93 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -122.94 152.18 62.42 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 179.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.744 ' HG3' ' HG ' ' A' ' 109' ' ' SER . 87.8 Cg_exo -50.93 -46.47 30.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.319 2.679 . . . . 1.0 113.981 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.49 -31.65 64.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 1.24 111.75 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -83.71 -10.73 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.815 -0.629 . . . . 1.74 112.113 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.541 ' CG1' HD21 ' A' ' 41' ' ' LEU . 30.4 m -131.72 30.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.547 0.689 . . . . 1.1 111.007 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.612 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.73 -29.21 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 1.32 110.854 -174.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.543 ' H ' ' HH ' ' A' ' 29' ' ' TYR . 10.6 m120 -114.83 -173.21 2.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 2.4 110.225 174.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.16 155.41 87.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.15 -0.315 . . . . 1.78 110.15 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.44 155.66 28.43 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.799 1.666 . . . . 0.41 110.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -78.47 -23.31 46.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.238 -0.282 . . . . 0.88 110.238 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.433 ' C ' HG21 ' A' ' 53' ' ' ILE . 72.1 m -159.79 147.23 16.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.65 112.083 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.658 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.57 170.21 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.283 -0.871 . . . . 0.33 108.973 172.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.713 ' HA ' HD11 ' A' ' 58' ' ' LEU . 29.2 t 179.52 116.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.406 0.622 . . . . 0.8 109.631 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.545 ' CG ' HG21 ' A' ' 124' ' ' VAL . 1.2 p90 -100.85 -171.2 1.96 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.226 -0.897 . . . . 3.63 110.116 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HB3' HG11 ' A' ' 164' ' ' VAL . 22.1 t0 -69.61 119.58 14.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.005 0.431 . . . . 1.51 111.004 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.24 34.48 54.87 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.742 -0.742 . . . . 0.9 112.656 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.713 HD11 ' HA ' ' A' ' 54' ' ' SER . 4.3 tt -67.53 125.41 26.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.919 -0.771 . . . . 0.62 108.919 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.668 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 23.9 t70 -89.85 -12.79 38.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.74 110.884 -173.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.664 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 54.3 m 62.13 20.81 11.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.948 -1.024 . . . . 1.51 109.558 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -153.86 -24.4 0.04 OUTLIER Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.866 -0.683 . . . . 0.84 113.852 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.668 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 45.4 mtpt -77.0 156.82 31.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.661 0.731 . . . . 2.12 109.904 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.707 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 37.2 mt -94.0 125.17 38.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.947 -0.76 . . . . 1.23 108.947 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.9 m-85 -125.03 156.94 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.745 -0.382 . . . . 1.61 110.002 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.627 HG22 HG11 ' A' ' 90' ' ' VAL . 46.7 m -98.07 110.98 23.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.547 . . . . 0.87 109.522 175.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.0 tp -107.48 109.75 21.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.177 -0.465 . . . . 1.35 109.753 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.3 t -117.93 120.81 65.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.54 111.112 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.843 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.5 mt -83.22 145.96 28.85 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.947 -0.76 . . . . 0.65 108.947 168.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.744 HG21 HG12 ' A' ' 17' ' ' VAL . 10.5 t -146.46 145.69 30.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.683 0.278 . . . . 1.04 110.936 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.503 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 28.2 t70 -125.59 98.37 34.68 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 1.92 109.421 174.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.505 ' HB3' HG21 ' A' ' 17' ' ' VAL . 9.4 Cg_endo -50.32 -38.04 51.48 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 124.135 3.224 . . . . 1.25 114.216 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.586 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 71.3 m-20 -103.59 54.18 0.75 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.293 0.568 . . . . 1.29 111.928 -165.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 81' ' ' TYR . . . -104.64 137.12 19.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.56 109.864 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 63.6 Cg_endo -74.44 -30.27 6.08 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.682 -1.383 . . . . 0.7 113.268 1.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.533 ' HB3' HG22 ' A' ' 115' ' ' THR . 33.6 p -137.88 165.95 25.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.589 -0.278 . . . . 1.1 110.877 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.586 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 29.2 mtp180 -68.04 -36.61 80.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 3.39 110.851 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.715 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -76.13 -12.68 60.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.53 . . . . 1.83 111.711 -176.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.549 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.3 t70 -154.93 77.56 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 1.37 110.258 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.92 97.54 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.608 2.205 . . . . 0.9 112.885 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 26.4 mttm -85.52 -48.41 8.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.848 -1.069 . . . . 1.53 110.197 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.656 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 87.4 m-85 -79.99 14.16 1.94 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.145 -0.934 . . . . 1.54 111.55 -171.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.0 ttt85 -66.83 125.14 24.95 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.991 0.367 . . . . 3.38 111.991 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.797 ' HG2' HG13 ' A' ' 17' ' ' VAL . 6.2 mp0 -95.45 140.15 30.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.671 0.388 . . . . 2.23 110.154 -5.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.509 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 14.4 t90 -86.4 91.15 8.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.529 . . . . 1.77 110.106 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.7 p80 -63.16 130.43 44.56 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.419 -0.586 . . . . 2.19 109.419 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.843 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.9 t60 -79.22 -31.88 43.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.898 -0.592 . . . . 2.74 110.958 -173.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.638 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 28.7 p90 -168.42 178.56 4.79 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.198 -0.668 . . . . 2.21 109.198 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.1 tp -140.39 113.56 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.388 . . . . 0.68 110.064 175.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.638 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.7 t -122.77 130.32 74.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.592 -0.731 . . . . 0.35 110.707 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.627 HG11 HG22 ' A' ' 65' ' ' THR . 13.4 m -133.62 165.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.986 -1.006 . . . . 0.3 108.496 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.707 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.2 t30 63.54 13.37 7.17 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.024 -0.361 . . . . 2.09 110.024 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.568 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.9 ttm -67.67 101.98 1.12 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.603 -0.888 . . . . 0.34 108.603 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.8 ttmm -80.74 92.87 6.1 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.096 -1.411 . . . . 1.73 110.982 -170.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.664 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 78.13 -130.38 10.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.913 -1.039 . . . . 0.35 112.668 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.636 ' HB3' HD22 ' A' ' 58' ' ' LEU . 25.8 p-10 -109.92 24.43 13.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.21 0.528 . . . . 1.59 110.735 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.98 107.11 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.835 -0.621 . . . . 0.77 109.951 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.464 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 4.5 mm -56.37 -32.71 36.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.573 -1.194 . . . . 0.45 110.856 -177.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.3 m -73.01 -26.41 61.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.748 -0.66 . . . . 1.15 112.002 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.7 m -78.44 -6.56 55.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 1.26 111.42 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.568 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -76.42 102.42 1.61 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.645 -0.788 . . . . 0.44 112.11 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.1 m -68.46 107.99 3.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.464 0.65 . . . . 1.06 109.655 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -79.57 119.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.892 -1.049 . . . . 1.15 112.102 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.14 -39.12 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.03 0.919 . . . . 0.48 109.159 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.7 t -128.08 114.79 17.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.257 -1.386 . . . . 0.62 107.257 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.445 ' HA ' HG21 ' A' ' 102' ' ' VAL . 6.9 t0 -63.01 161.72 12.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.569 0.699 . . . . 1.15 112.784 -168.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -91.09 93.91 9.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.984 -1.007 . . . . 4.98 109.318 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.867 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 54.5 t -71.02 -46.18 68.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.167 0.508 . . . . 0.86 111.89 -176.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.423 ' HA3' ' NZ ' ' A' ' 47' ' ' LYS . . . 115.86 -177.94 17.31 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.358 -0.925 . . . . 0.95 112.294 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.744 ' HG ' ' HG3' ' A' ' 43' ' ' PRO . 30.8 t -64.13 122.37 16.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.551 0.176 . . . . 0.89 111.336 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.43 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -142.72 63.87 0.5 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.051 -0.595 . . . . 0.82 111.908 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.728 ' HD2' HG22 ' A' ' 177' ' ' VAL . 43.9 Cg_endo -97.7 121.9 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.504 2.803 . . . . 1.01 112.673 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 50.7 Cg_exo -54.5 154.37 20.02 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.63 2.22 . . . . 0.96 111.736 173.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -72.02 131.04 42.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.433 . . . . 2.39 111.146 -175.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.03 14.88 73.88 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.772 -0.649 . . . . 1.3 113.163 175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 75' ' ' SER . 35.5 p -77.73 -15.37 59.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.672 0.619 . . . . 1.04 112.672 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 103.92 13.02 28.46 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.141 -1.028 . . . . 1.97 112.823 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.0 mm? 76.94 105.08 0.07 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 124.604 0.826 . . . . 0.94 111.142 177.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 5.0 m170 -66.66 121.23 14.93 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.383 -0.826 . . . . 2.85 110.044 175.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 13.1 ptp180 -116.3 80.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.832 0.825 . . . . 2.78 110.364 -175.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.485 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 7.3 m-85 -63.69 120.26 11.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.289 -1.323 . . . . 1.13 109.688 -177.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 168' ' ' CYS . 24.6 t -97.94 131.68 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.107 -0.497 . . . . 0.31 110.511 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.84 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.51 119.68 30.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.586 -0.733 . . . . 2.96 110.057 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -116.77 123.77 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.481 -0.192 . . . . 0.41 110.481 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.545 HG21 ' CG ' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -122.47 137.64 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.577 0.227 . . . . 0.43 111.098 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.996 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 17.7 t80 -136.66 140.65 42.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.085 -0.339 . . . . 5.41 110.085 171.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 7.3 pt-20 -89.06 112.32 23.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.197 0.522 . . . . 2.41 109.75 171.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.567 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -73.16 172.39 11.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.31 110.013 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.98 -18.43 53.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.218 -0.901 . . . . 2.4 109.408 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.425 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 11.4 ptt-85 -158.28 162.22 27.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.9 -1.046 . . . . 4.07 111.67 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.52 ' HG3' HD11 ' A' ' 63' ' ' LEU . 26.0 Cg_exo -57.74 140.83 94.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.274 2.649 . . . . 1.21 111.575 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.623 ' HG ' HG12 ' A' ' 90' ' ' VAL . 3.2 mm? -64.57 143.72 57.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.156 0.503 . . . . 1.16 111.817 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -129.32 61.46 1.54 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.232 -1.025 . . . . 3.23 108.232 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.958 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 86.2 m -77.22 -55.42 5.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.253 -1.34 . . . . 2.79 111.52 -172.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 60.85 35.02 19.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.292 0.568 . . . . 2.96 110.195 -172.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.958 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 59.0 mm-40 -77.62 137.23 63.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 108.616 -0.883 . . . . 1.39 108.616 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.78 106.95 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.273 2.649 . . . . 1.38 112.728 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.1 mm -61.94 115.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.94 110.546 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -104.43 149.28 25.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.267 0.556 . . . . 1.61 110.352 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 162.39 13.53 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.416 -0.957 . . . . 1.88 108.416 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.867 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.2 p-10 -77.49 16.84 0.58 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.98 0.419 . . . . 1.33 111.45 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.681 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 54.0 mtt180 -104.8 136.75 43.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.663 -0.495 . . . . 3.83 109.663 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.591 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 49.3 m 77.27 117.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.18 0.992 . . . . 1.32 111.232 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -106.29 41.56 2.14 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.301 -0.863 . . . . 1.13 112.794 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.614 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 14.1 t70 -72.25 -47.82 47.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 2.66 109.78 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.614 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 14.4 m80 -97.63 54.35 1.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.633 -1.167 . . . . 2.18 110.672 -173.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.509 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 76.9 mtt180 -69.71 -77.29 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 5.37 111.017 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -120.74 -143.05 6.66 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.792 -0.718 . . . . 0.9 112.478 -174.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.656 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 67.36 18.51 10.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.963 0.887 . . . . 1.59 109.769 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.18 105.58 13.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.397 -1.274 . . . . 2.27 108.223 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -59.99 129.88 43.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.189 -0.459 . . . . 1.87 111.81 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.893 HG22 HG11 ' A' ' 17' ' ' VAL . 17.1 m -64.39 -24.92 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.96 110.306 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB3' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -44.41 90.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.431 -0.804 . . . . 0.76 109.599 172.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -61.39 -40.53 94.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 1.22 111.033 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.594 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 37.2 m-85 -58.3 -53.94 52.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.435 . . . . 1.1 111.396 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -70.76 -45.42 64.79 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.98 -0.288 . . . . 3.36 111.217 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.506 ' HE2' ' HB3' ' A' ' 152' ' ' ALA . 58.8 mtmt -62.17 -25.95 68.06 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.724 0.297 . . . . 1.52 111.356 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.48 -52.76 58.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 2.13 111.053 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 12.4 t80 -102.14 18.64 20.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.88 -0.728 . . . . 5.77 110.541 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.66 38.38 5.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.354 -0.839 . . . . 2.42 111.948 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.996 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.0 mp -88.76 148.78 23.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.875 -0.602 . . . . 1.27 109.703 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.521 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 13.2 tpt180 -117.91 -152.15 0.5 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.468 -0.333 . . . . 4.0 110.126 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.521 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -56.0 143.97 60.27 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-O 120.989 0.424 . . . . 1.21 111.278 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.695 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 4.8 Cg_exo -73.2 159.88 46.4 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.876 3.05 . . . . 0.68 113.723 -170.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.915 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 11.8 t -81.34 -31.02 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.086 -0.961 . . . . 0.5 109.751 173.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.784 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -156.95 148.76 22.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.053 -0.659 . . . . 0.29 111.855 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.676 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 147.04 17.64 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.24 111.349 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.634 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.0 t -160.58 149.6 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.969 -0.752 . . . . 0.34 108.969 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.788 ' HG ' HD11 ' A' ' 14' ' ' LEU . 15.4 p -126.9 149.02 49.99 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.894 -0.722 . . . . 2.16 111.589 -175.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.671 ' HB3' HG22 ' A' ' 34' ' ' VAL . 46.2 p90 -129.08 127.61 41.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.887 -1.153 . . . . 1.31 107.887 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.648 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.65 133.01 50.21 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.045 -0.662 . . . . 2.53 110.07 178.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -120.82 141.75 50.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.75 112.199 -170.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' A' ' 117' ' ' LEU . 46.2 mt-10 -89.21 -173.1 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.809 -1.087 . . . . 2.38 111.617 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.709 ' HA ' HG23 ' A' ' 177' ' ' VAL . 55.7 t90 -98.3 75.65 2.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.361 -0.977 . . . . 4.71 108.361 175.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.419 ' HB3' HG22 ' A' ' 42' ' ' THR . 7.2 p-10 -73.13 -57.19 4.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.386 -0.37 . . . . 1.53 111.906 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.524 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.8 t70 179.44 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.118 0.567 . . . . 1.26 110.335 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -81.34 0.78 35.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 2.46 112.113 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.788 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 93.2 t -67.88 -54.66 15.93 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.342 -0.244 . . . . 0.58 110.342 174.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.788 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.3 Cg_exo -53.83 -43.06 61.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.504 2.136 . . . . 0.68 111.949 171.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.677 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.3 mmmm -70.83 -24.3 62.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 2.62 111.561 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.69 HD12 HG12 ' A' ' 107' ' ' VAL . 61.9 tp -66.99 -47.85 70.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 1.18 109.529 172.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.61 -37.76 87.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.66 -0.7 . . . . 2.11 109.445 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.3 mm-40 -56.56 -44.87 81.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.932 -1.031 . . . . 1.53 110.842 172.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.96 -29.85 65.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.745 . . . . 2.16 111.497 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.591 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.2 mt -64.85 -8.66 16.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.934 0.346 . . . . 0.87 111.934 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.484 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 66.6 m -73.91 -3.11 26.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 1.38 110.364 172.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.681 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.54 58.04 6.2 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.826 -0.91 . . . . 1.17 110.826 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.9 mmmt . . . . . 0 C--O 1.241 0.654 0 CA-C-O 118.651 -0.69 . . . . 2.45 111.304 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.275 0.084 . . . . 5.4 111.043 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.27 160.36 39.07 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.562 2.175 . . . . 2.58 112.386 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 3.7 p -106.12 125.9 61.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.153 -0.931 . . . . 2.1 109.673 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.3 155.92 34.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.784 -0.644 . . . . 1.81 109.953 -168.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.67 2.21 6.95 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 112.331 0.493 . . . . 0.95 112.331 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 m -55.91 -21.85 22.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.77 0.319 . . . . 2.19 111.755 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -101.13 27.6 5.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.563 -0.289 . . . . 3.07 110.701 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.566 ' HE3' ' HB2' ' A' ' 20' ' ' GLN . 5.1 p-90 -70.64 -28.44 64.81 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.639 0.607 . . . . 4.76 112.639 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -144.96 14.59 1.51 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.713 -0.395 . . . . 0.98 111.139 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.63 -115.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.483 -0.647 . . . . 0.52 111.483 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.1 Cg_endo -51.28 -46.2 32.69 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.356 2.704 . . . . 0.61 110.925 167.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.613 HD13 ' HA3' ' A' ' 38' ' ' GLY . 11.5 mt -88.97 103.44 16.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.15 -0.932 . . . . 1.85 110.125 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.18 65.35 4.33 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.257 0.551 . . . . 1.31 110.546 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 121' ' ' VAL . 15.5 mt -76.16 -15.05 60.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.543 . . . . 0.61 110.45 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -66.73 -8.46 28.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 2.61 111.308 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 9.4 mt-10 -81.85 -7.62 59.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.235 -0.439 . . . . 1.93 110.107 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.749 HG21 ' HD3' ' A' ' 71' ' ' PRO . 53.3 t -124.88 -61.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 1.26 111.389 -175.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -125.2 169.34 12.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.678 -0.409 . . . . 2.99 110.404 -172.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -90.5 25.37 2.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 1.6 111.799 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.566 ' HB2' ' HE3' ' A' ' 8' ' ' TRP . 1.6 tt0 67.05 120.48 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 O-C-N 124.151 0.907 . . . . 4.38 110.986 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 19.2 Cg_exo -65.17 158.37 52.46 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.403 2.069 . . . . 0.69 112.124 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.849 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.4 pt20 -73.42 -16.19 61.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 1.87 111.034 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.76 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 21.2 m80 -149.36 156.43 39.59 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.691 -0.686 . . . . 2.35 109.565 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 6.3 Cg_endo -87.28 126.66 2.35 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.891 2.394 . . . . 0.44 110.97 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 22.2 tp -75.92 140.44 42.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.791 0.329 . . . . 0.33 110.916 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.4 ' H ' HD12 ' A' ' 25' ' ' LEU . 78.1 m-70 -106.04 119.74 39.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 2.12 109.625 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 53' ' ' ILE . 21.8 t -126.17 138.19 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.995 -0.742 . . . . 1.12 108.995 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -136.74 136.95 39.4 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.026 0.441 . . . . 0.78 110.655 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.593 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 60.9 t80 -99.65 169.3 9.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.315 -0.624 . . . . 1.23 109.315 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.86 65.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.471 0.653 . . . . 0.6 110.488 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.593 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -116.03 20.06 13.19 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.028 -0.987 . . . . 0.81 112.673 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 45' ' ' GLN . . . -154.36 -170.5 3.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.845 0.355 . . . . 0.56 110.416 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.92 159.76 24.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.35 109.82 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.69 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.1 t -122.4 63.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.253 -1.388 . . . . 0.39 107.253 166.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.4 t70 -100.27 19.89 15.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.154 -0.93 . . . . 0.99 109.808 -173.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 44.5 mt-10 -144.05 131.1 20.54 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.09 -0.959 . . . . 2.56 108.593 172.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.547 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -74.66 111.33 9.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.416 0.627 . . . . 0.46 110.272 -172.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 80.53 21.27 64.6 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.295 -0.866 . . . . 0.59 111.89 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.69 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.26 149.76 44.23 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.474 -0.565 . . . . 1.04 109.474 175.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.96 127.81 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.267 0.555 . . . . 1.16 110.54 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.496 HD21 HG13 ' A' ' 46' ' ' VAL . 8.9 tp -131.18 169.12 16.36 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.634 -0.876 . . . . 0.45 108.634 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.82 151.81 58.22 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 120.582 -0.447 . . . . 1.0 111.535 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 63.3 Cg_exo -53.64 -39.6 82.48 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.017 2.478 . . . . 1.0 112.075 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -35.24 61.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.109 -0.496 . . . . 1.24 111.404 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 44.9 mt-30 -82.79 -23.14 33.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 1.74 112.125 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.552 ' HB ' ' OH ' ' A' ' 106' ' ' TYR . 30.0 m -119.88 30.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.195 0.521 . . . . 1.1 112.169 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.62 6.31 21.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.955 0.407 . . . . 1.32 111.089 -176.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.582 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 36.4 m-20 -148.59 172.88 13.81 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.509 -0.552 . . . . 2.4 109.509 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -62.77 149.4 89.59 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 110.017 -0.364 . . . . 1.78 110.017 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.64 145.7 23.4 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.963 1.775 . . . . 0.41 110.266 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -18.7 62.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.491 -0.322 . . . . 0.88 110.728 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.432 ' C ' HG21 ' A' ' 53' ' ' ILE . 58.2 m -159.66 144.7 15.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.872 0.694 . . . . 0.65 112.872 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -140.39 164.79 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.705 -1.134 . . . . 0.33 108.041 170.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.729 ' HA ' HD11 ' A' ' 58' ' ' LEU . 28.9 t 176.17 122.26 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.764 -0.458 . . . . 0.8 109.764 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.592 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 45.7 p-90 -81.0 166.67 20.59 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.757 -0.831 . . . . 3.63 108.757 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.414 ' HB3' ' CG ' ' A' ' 23' ' ' HIS . 17.1 t70 -65.64 83.06 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 1.51 111.081 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.92 31.48 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.655 -0.702 . . . . 0.9 112.319 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.906 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 8.4 tt -66.33 129.05 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.008 0.432 . . . . 0.62 111.062 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.729 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.5 t70 -77.75 -29.92 51.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.854 -0.612 . . . . 0.74 112.078 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.672 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 74.8 m 76.76 -6.12 2.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.096 -0.956 . . . . 1.51 110.926 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.22 6.64 14.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.155 -0.545 . . . . 0.84 112.39 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.729 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.8 mtpt -100.69 152.53 20.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.015 0.436 . . . . 2.12 111.093 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.559 HD23 ' HE2' ' A' ' 93' ' ' LYS . 44.2 mt -97.25 130.98 44.39 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.557 -0.905 . . . . 1.23 108.557 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.906 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -130.2 163.94 25.6 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.636 -0.505 . . . . 1.61 109.636 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.556 HG22 HG11 ' A' ' 90' ' ' VAL . 75.2 m -102.32 104.82 15.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.459 -0.571 . . . . 0.87 109.459 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.66 HD11 HG11 ' A' ' 124' ' ' VAL . 43.7 tp -102.49 115.33 30.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.124 0.488 . . . . 1.35 110.527 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 88' ' ' LEU . 23.3 t -120.88 129.04 76.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.713 -0.676 . . . . 0.54 111.06 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.872 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.3 mt -83.37 136.76 34.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 0.65 108.478 167.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.715 HG21 HG12 ' A' ' 17' ' ' VAL . 15.1 t -140.27 163.69 32.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.205 -0.294 . . . . 1.04 110.205 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 17.7 t70 -155.95 103.27 2.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.304 0.573 . . . . 1.92 110.858 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.749 ' HD3' HG21 ' A' ' 17' ' ' VAL . 12.4 Cg_endo -56.98 -34.89 98.45 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.65 2.9 . . . . 1.25 114.169 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.56 38.87 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.986 0.365 . . . . 1.29 111.986 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' A' ' 84' ' ' TRP . . . -104.68 127.62 28.53 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 111.488 0.181 . . . . 0.56 111.488 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 92.9 Cg_endo -85.12 -24.03 10.8 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.435 -1.485 . . . . 0.7 112.859 -0.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.566 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.9 p -135.4 154.85 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.032 -0.531 . . . . 1.1 110.09 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -72.15 -24.6 61.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.388 -0.369 . . . . 3.39 111.134 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.495 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 3.2 ptpt -72.03 -21.86 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 1.83 110.535 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.22 86.88 1.01 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.306 -0.861 . . . . 1.37 109.24 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -86.38 86.65 0.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.509 2.139 . . . . 0.9 112.507 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 22.2 mttm -70.98 -53.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.936 -1.483 . . . . 1.53 111.689 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.768 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 85.2 m-85 -78.28 12.07 2.08 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.894 -0.594 . . . . 1.54 111.027 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 24.2 ttt180 -73.15 125.42 27.67 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.8 0.44 . . . . 3.38 110.267 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.495 ' OE2' ' HA ' ' A' ' 17' ' ' VAL . 23.1 mt-10 -94.84 134.33 37.59 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.846 0.458 . . . . 2.23 110.457 2.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.721 ' HE1' ' HB2' ' A' ' 146' ' ' ARG . 4.8 t90 -89.34 91.12 8.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.939 -0.393 . . . . 1.77 109.939 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 12.5 p80 -74.57 109.52 8.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.778 -0.823 . . . . 2.19 108.778 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.41 -8.47 54.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.803 -0.635 . . . . 2.74 112.233 -168.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.872 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 30.3 t80 -166.29 142.93 5.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.06 -0.348 . . . . 2.21 110.06 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.6 tp -142.77 114.65 8.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.981 0.419 . . . . 0.68 110.623 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.547 HG13 ' HE2' ' A' ' 92' ' ' MET . 0.9 OUTLIER -132.57 134.93 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.35 110.74 176.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.711 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 15.0 m -129.03 158.01 41.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.138 -1.06 . . . . 0.3 108.138 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.675 ' OD1' ' HB3' ' A' ' 130' ' ' PRO . 6.1 t30 63.78 19.69 11.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.023 0.44 . . . . 2.09 109.925 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.547 ' HE2' HG13 ' A' ' 89' ' ' VAL . 8.0 ttm -67.4 106.9 2.24 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.781 -0.822 . . . . 0.34 108.781 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.559 ' HE2' HD23 ' A' ' 63' ' ' LEU . 13.2 ttmt -83.55 89.68 7.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.994 -1.003 . . . . 1.73 111.077 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 83.98 -126.26 7.49 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.636 -1.166 . . . . 0.35 113.208 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.555 ' HB3' HD22 ' A' ' 58' ' ' LEU . 29.6 p30 -117.32 27.62 8.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.315 -0.442 . . . . 1.59 110.88 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -97.12 112.46 24.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.321 0.582 . . . . 0.77 109.658 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 53' ' ' ILE . 5.1 mm -58.53 -26.44 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.408 -1.269 . . . . 0.45 111.349 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 m -87.6 -31.34 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.117 -0.492 . . . . 1.15 111.718 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.1 m -80.29 19.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.266 0.469 . . . . 1.26 112.266 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.476 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -102.61 114.11 4.79 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 111.189 -0.764 . . . . 0.44 111.189 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 84.9 m -58.54 107.0 0.45 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.67 . . . . 1.06 109.776 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.94 116.42 29.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.084 . . . . 1.15 112.333 -172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 133' ' ' CYS . 9.3 mt -98.61 -51.48 3.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.974 0.893 . . . . 0.48 108.859 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.1 t -118.61 102.23 8.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.394 -1.275 . . . . 0.62 107.747 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -65.24 157.63 28.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.547 -0.751 . . . . 1.15 112.323 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.552 ' OH ' ' HB ' ' A' ' 46' ' ' VAL . 85.7 t80 -74.19 107.52 6.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.595 -0.729 . . . . 4.98 109.172 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.685 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.4 t -84.69 -26.91 6.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.566 -0.743 . . . . 0.86 112.242 -172.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.23 -174.41 19.7 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 111.13 -0.788 . . . . 0.95 111.13 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.7 t -78.21 134.47 37.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.429 0.614 . . . . 0.89 109.811 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.622 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -160.0 66.06 0.27 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.367 -0.444 . . . . 0.82 112.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.872 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 46.4 Cg_endo -99.15 149.52 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.89 3.06 . . . . 1.01 113.78 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.601 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 26.6 Cg_exo -64.07 143.32 84.24 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.074 2.516 . . . . 0.96 112.443 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 121.19 17.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 2.39 110.823 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.46 15.11 30.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.86 -0.686 . . . . 1.3 112.367 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.601 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 72.1 p -96.68 -1.19 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.947 0.403 . . . . 1.04 111.028 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.36 -161.89 27.85 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.042 -0.823 . . . . 1.97 111.042 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.6 mm? -79.95 99.06 7.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.36 0.6 . . . . 0.94 109.567 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -72.1 120.54 17.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.883 -1.053 . . . . 2.85 109.09 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.862 ' HB2' ' HG ' ' A' ' 168' ' ' CYS . 3.8 ptp85 -121.96 99.76 6.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.914 0.709 . . . . 2.78 112.914 -165.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' HB3' HD22 ' A' ' 68' ' ' LEU . 65.9 m-85 -82.09 129.39 34.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.444 -0.576 . . . . 1.13 109.444 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.5 t -102.33 133.56 45.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.925 -0.579 . . . . 0.31 109.719 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.678 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 67.2 m95 -88.32 119.59 28.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.754 -0.832 . . . . 2.96 108.754 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.26 118.77 32.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 117.797 0.271 . . . . 0.41 110.815 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.66 HG11 HD11 ' A' ' 66' ' ' LEU . 1.9 m -102.36 133.22 46.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.069 -0.652 . . . . 0.43 109.262 172.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 92.2 m-85 -106.84 155.68 19.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.875 0.369 . . . . 5.41 111.084 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.689 ' HB2' HG23 ' A' ' 164' ' ' VAL . 12.3 tp10 -101.32 119.95 39.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.304 -0.862 . . . . 2.41 110.833 -176.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.722 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -133.46 150.06 51.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.461 -0.791 . . . . 1.31 109.991 174.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.407 ' OD1' ' HG3' ' A' ' 129' ' ' ARG . 1.6 p30 -83.4 -12.47 56.42 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.183 -0.917 . . . . 2.4 111.452 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.509 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . 65.9 mtp180 -135.9 163.06 53.08 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 4.07 111.837 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.675 ' HB3' ' OD1' ' A' ' 91' ' ' ASN . 19.3 Cg_exo -71.85 24.71 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.806 1 C-N-CA 125.61 4.207 . . . . 1.21 115.833 -170.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.711 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? 71.99 -178.76 0.21 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.685 0.755 . . . . 1.16 112.909 172.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -165.72 79.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.221 -1.354 . . . . 3.23 108.896 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.556 ' HB2' HD13 ' A' ' 103' ' ' LEU . 63.0 m -101.94 115.89 31.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.705 . . . . 2.79 110.33 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.44 19.52 8.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.534 -0.757 . . . . 2.96 110.485 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -66.08 125.24 89.76 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.562 -0.744 . . . . 1.39 110.466 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.46 129.02 21.97 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.239 2.626 . . . . 1.38 112.713 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.31 116.66 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.43 . . . . 0.94 110.34 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.9 mt -106.19 2.48 26.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.339 0.496 . . . . 1.61 112.339 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.0 p 52.04 -157.66 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.536 0.522 . . . . 1.88 110.009 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.685 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.3 p-10 -98.01 -6.03 32.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.256 -0.646 . . . . 1.33 109.256 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.589 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 12.4 mtt180 -84.99 141.47 30.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.241 -0.436 . . . . 3.83 110.352 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.552 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 30.5 m 72.66 125.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.219 0.949 . . . . 1.32 111.103 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.489 ' HA2' ' CD ' ' A' ' 146' ' ' ARG . . . -107.53 -5.97 33.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.437 -0.801 . . . . 1.13 113.006 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.403 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 12.4 t70 -56.94 -54.15 49.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.324 0.583 . . . . 2.66 112.542 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.403 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 1.7 m80 -87.89 7.3 31.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.506 -0.77 . . . . 2.18 111.672 -168.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.721 ' HB2' ' HE1' ' A' ' 84' ' ' TRP . 28.1 mtp85 -88.84 -16.15 32.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.084 0.469 . . . . 5.37 110.742 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -112.07 173.08 15.22 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.489 -0.863 . . . . 0.9 112.485 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.768 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.4 mttt 69.61 36.55 2.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.841 0.829 . . . . 1.59 110.836 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -123.09 172.4 8.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.809 -1.087 . . . . 2.27 109.261 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.491 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 13.0 mmmm -117.26 133.0 56.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 1.87 111.932 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.737 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.6 m -67.35 -26.27 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.664 -0.698 . . . . 0.96 110.005 173.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.36 -38.33 90.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.76 109.627 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 m -63.78 -34.53 78.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.656 -0.702 . . . . 1.22 110.462 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.737 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 59.7 m-85 -71.56 -47.5 54.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 1.1 111.523 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 152' ' ' ALA . 6.9 ptm180 -66.9 -39.92 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.647 0.26 . . . . 3.36 110.571 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -71.95 -25.78 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.607 -0.269 . . . . 1.52 111.185 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 43.6 tptt -53.91 -52.92 59.02 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.355 -0.384 . . . . 2.13 111.309 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.629 ' HD2' HD12 ' A' ' 160' ' ' LEU . 16.6 t80 -111.25 10.61 21.74 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.788 -0.765 . . . . 5.77 111.322 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.8 39.34 4.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.035 -0.53 . . . . 2.42 112.395 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.629 HD12 ' HD2' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -80.95 125.11 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.236 -0.653 . . . . 1.27 109.236 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -60.32 -85.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 4.0 111.874 -168.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -135.66 160.9 65.9 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.721 -0.474 . . . . 1.21 109.721 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.529 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 37.0 Cg_exo -58.44 142.24 97.74 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.68 2.254 . . . . 0.68 112.748 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.849 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.6 t -88.42 -36.06 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 109.385 -0.598 . . . . 0.5 109.385 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.76 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.68 143.45 25.49 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.667 -0.697 . . . . 0.29 111.232 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.9 145.59 14.81 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.055 -0.975 . . . . 0.24 111.587 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.458 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 14.3 t -158.03 133.61 8.98 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.584 -0.525 . . . . 0.34 109.584 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.862 ' HG ' ' HB2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -107.24 141.9 37.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.213 0.53 . . . . 2.16 111.418 -175.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 30.5 p90 -124.23 117.92 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.748 -1.204 . . . . 1.31 107.748 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -101.73 132.96 47.16 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.725 -0.79 . . . . 2.53 111.103 179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -149.91 145.89 26.76 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.561 -1.199 . . . . 0.75 108.687 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.872 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 13.8 pt-20 -131.58 -160.3 1.03 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.697 -0.401 . . . . 2.38 111.021 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.831 ' HA ' HG23 ' A' ' 177' ' ' VAL . 24.3 t90 -64.89 85.05 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.866 0.467 . . . . 4.71 111.38 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.596 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 8.5 p-10 -74.47 -59.12 2.87 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.361 -0.212 . . . . 1.53 110.757 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.5 t70 173.43 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.808 0.843 . . . . 1.26 109.897 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -81.97 -9.08 59.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 2.46 111.64 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.831 HG23 ' HA ' ' A' ' 173' ' ' TRP . 69.2 t -54.67 -53.24 62.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 0.58 111.561 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.3 Cg_exo -49.7 -35.26 37.98 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.888 2.392 . . . . 0.68 112.891 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.638 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 38.1 mmtm -74.47 -23.79 58.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.962 0.356 . . . . 2.62 111.962 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.636 HD12 HG12 ' A' ' 107' ' ' VAL . 28.4 tp -70.76 -44.3 67.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.916 -0.772 . . . . 1.18 108.916 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.03 -34.52 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.762 -0.654 . . . . 2.11 109.242 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.638 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.5 mm-40 -56.48 -42.37 78.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.931 -1.031 . . . . 1.53 110.89 172.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.439 ' NE2' HD22 ' A' ' 140' ' ' ASN . 39.9 tt0 -77.82 -38.0 47.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.572 -0.74 . . . . 2.16 112.41 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 21.5 mt -63.29 0.24 0.7 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 0.87 113.479 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 12.8 m -67.58 -19.55 65.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.086 -0.709 . . . . 1.38 109.086 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 104.14 44.17 1.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.586 -1.006 . . . . 1.17 110.586 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.563 -0.732 . . . . 2.45 109.832 -178.495 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.214 0.054 . . . . 5.4 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.67 98.39 0.24 Allowed 'Trans proline' 0 CA--C 1.515 -0.447 0 C-N-CA 122.874 2.383 . . . . 2.58 112.131 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 36' ' ' GLU . 16.5 t 65.4 113.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.572 -1.195 . . . . 2.1 110.522 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 6' ' ' SER . 20.1 t70 -148.98 157.71 43.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.35 -0.841 . . . . 1.81 109.445 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.96 19.28 0.15 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 111.53 0.196 . . . . 0.95 111.53 -176.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 4' ' ' ASP . 27.5 t -68.67 -19.92 64.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 2.19 110.364 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.844 ' HB3' HD12 ' A' ' 12' ' ' LEU . 90.9 mttt -113.82 30.67 7.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.727 -0.67 . . . . 3.07 110.597 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.567 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -72.88 -33.94 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.312 -0.404 . . . . 4.76 112.041 -173.252 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.744 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 36.5 p -150.21 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.673 -0.411 . . . . 0.98 111.894 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -79.73 -126.58 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.456 -0.878 . . . . 0.52 110.946 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.9 Cg_endo -51.87 -36.43 63.38 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.219 2.613 . . . . 0.61 110.214 166.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.844 HD12 ' HB3' ' A' ' 7' ' ' LYS . 40.7 mt -87.74 81.83 7.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.772 -1.103 . . . . 1.85 109.282 170.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -74.73 63.13 1.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.474 0.654 . . . . 1.31 110.703 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.539 HD11 ' HG ' ' A' ' 168' ' ' CYS . 33.8 mt -78.91 -21.62 47.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.548 -0.751 . . . . 0.61 110.617 -176.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.744 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -73.18 6.88 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.587 -0.733 . . . . 2.61 110.647 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -79.45 -22.51 44.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.428 0.633 . . . . 1.93 110.091 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.898 HG12 HG21 ' A' ' 69' ' ' THR . 3.0 t -86.03 -65.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 1.26 110.669 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.401 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.88 -178.11 5.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.491 -0.484 . . . . 2.99 111.095 -176.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -62.1 179.1 0.31 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.766 0.826 . . . . 1.6 112.125 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.505 ' HG2' ' HD1' ' A' ' 8' ' ' TRP . 27.0 mt-30 -90.74 128.6 47.68 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.126 -0.488 . . . . 4.38 110.128 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 10.1 Cg_exo -70.41 159.34 53.26 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.264 1.976 . . . . 0.69 112.292 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.878 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 5.4 pt20 -77.48 -15.62 59.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.754 -0.657 . . . . 1.87 111.153 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.766 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.8 m80 -153.02 159.73 31.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 2.35 110.089 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 3.8 Cg_endo -86.16 130.85 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.329 2.686 . . . . 0.44 110.919 174.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 29.9 tp -79.84 143.45 34.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.646 0.26 . . . . 0.33 110.897 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -114.94 110.11 19.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 2.12 110.236 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 53' ' ' ILE . 17.0 t -114.71 146.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.546 -0.538 . . . . 1.12 109.546 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.54 144.57 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.335 0.254 . . . . 0.78 110.819 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.459 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 36.3 t80 -110.41 173.99 6.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.268 -0.642 . . . . 1.23 109.268 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.06 -52.88 63.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.451 0.643 . . . . 0.6 110.398 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.24 -6.56 44.85 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.237 -0.892 . . . . 0.81 112.724 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.02 -171.37 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.56 110.831 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.68 154.7 16.23 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.004 -0.544 . . . . 0.35 109.999 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.86 HG23 ' HZ3' ' A' ' 122' ' ' TRP . 88.2 t -101.56 63.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.548 -1.649 . . . . 0.39 106.548 163.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.24 18.69 2.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.036 -1.438 . . . . 0.99 110.163 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.3 mm-40 -159.7 142.12 13.57 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.457 -0.792 . . . . 2.56 109.881 173.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -76.48 111.59 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.644 -0.873 . . . . 0.46 108.644 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.678 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 86.7 20.93 52.79 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.666 -0.778 . . . . 0.59 112.424 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.72 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.67 152.18 30.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.286 -0.635 . . . . 1.04 109.286 172.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.6 p -81.78 136.77 22.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.182 0.515 . . . . 1.16 110.975 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.473 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.0 tp -131.11 169.03 16.44 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.057 -1.09 . . . . 0.45 108.057 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 p -123.21 152.43 63.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 119.472 -0.891 . . . . 1.0 113.129 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 75.9 Cg_exo -51.74 -33.92 51.98 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.608 3.539 . . . . 1.0 114.05 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -65.4 -32.34 73.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.614 0.721 . . . . 1.24 110.756 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -82.33 -43.91 16.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.012 -0.995 . . . . 1.74 111.451 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.555 HG21 ' HE2' ' A' ' 169' ' ' TYR . 12.3 m -102.64 30.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.265 0.469 . . . . 1.1 112.265 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.74 -12.05 59.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.465 -0.568 . . . . 1.32 109.465 175.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -167.98 2.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.492 -0.776 . . . . 2.4 109.836 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -77.94 158.78 77.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.088 -0.338 . . . . 1.78 110.088 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 59.9 Cg_endo -79.23 161.44 26.05 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.996 1.797 . . . . 0.41 111.127 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.1 t -80.41 -22.4 41.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.55 -0.295 . . . . 0.88 110.363 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.401 ' C ' HG21 ' A' ' 53' ' ' ILE . 58.4 m -162.68 143.51 9.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.391 0.615 . . . . 0.65 112.478 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.02 167.17 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.819 -1.082 . . . . 0.33 108.274 170.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.66 ' HA ' HD11 ' A' ' 58' ' ' LEU . 30.6 t 175.91 128.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.8 109.909 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.574 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 53.4 p-90 -91.07 160.91 15.35 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.519 -1.289 . . . . 3.63 107.519 172.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.29 84.18 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.074 0.464 . . . . 1.51 111.092 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.92 17.44 2.79 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.401 -0.818 . . . . 0.9 112.022 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.684 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 5.4 tt -57.02 127.13 30.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.919 0.39 . . . . 0.62 110.429 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.776 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 31.5 t70 -75.91 -24.21 55.57 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.608 . . . . 0.74 112.01 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.638 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 67.2 m 68.89 15.35 8.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.278 -0.874 . . . . 1.51 110.422 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.55 -33.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.601 -0.727 . . . . 0.84 112.666 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.776 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 24.7 mtpt -71.34 149.89 45.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 2.12 110.72 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.747 HD22 ' HG2' ' A' ' 93' ' ' LYS . 3.8 mt -85.77 125.45 33.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.337 -0.847 . . . . 1.23 109.494 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.684 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 5.5 m-85 -120.84 148.09 44.5 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.714 -0.394 . . . . 1.61 110.436 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.62 HG22 HG11 ' A' ' 90' ' ' VAL . 62.7 m -96.89 104.97 17.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.87 108.148 170.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 43.4 tp -104.39 109.09 20.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.668 -0.696 . . . . 1.35 109.658 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 88' ' ' LEU . 25.6 t -111.97 127.44 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.696 -0.684 . . . . 0.54 110.429 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.983 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.3 mt -88.27 134.12 33.88 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.542 -0.91 . . . . 0.65 108.542 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.898 HG21 HG12 ' A' ' 17' ' ' VAL . 9.7 t -137.58 156.45 48.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.459 -0.2 . . . . 1.04 110.459 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 10.2 t70 -140.15 94.89 8.59 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.306 -0.628 . . . . 1.92 109.306 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.543 ' HD3' HG21 ' A' ' 17' ' ' VAL . 9.5 Cg_endo -52.2 -36.68 68.03 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.722 2.948 . . . . 1.25 113.734 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.8 m-20 -89.32 43.83 1.17 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 1.29 111.542 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.68 139.28 19.94 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.446 -0.343 . . . . 0.56 110.143 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -80.18 -28.51 7.15 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 123.084 -1.632 . . . . 0.7 112.813 2.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.629 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 84.7 p -125.67 149.75 48.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.079 -0.51 . . . . 1.1 110.371 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.548 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 3.0 tmm_? -65.03 -28.91 69.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.419 0.628 . . . . 3.39 109.651 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 8.0 ptpt -74.48 -21.06 59.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.848 -0.615 . . . . 1.83 110.992 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.408 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.0 t70 -159.63 88.9 1.97 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.485 . . . . 1.37 110.26 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 83.6 Cg_endo -84.37 93.63 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.67 2.247 . . . . 0.9 113.234 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.5 mttm -83.9 -41.29 17.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.216 -0.902 . . . . 1.53 111.065 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.835 ' HH ' HH11 ' A' ' 146' ' ' ARG . 30.6 m-85 -78.98 8.47 5.57 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 116.032 -0.531 . . . . 1.54 111.798 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -65.74 125.22 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.729 -0.471 . . . . 3.38 109.729 177.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' OE1' HG13 ' A' ' 151' ' ' VAL . 5.1 tm-20 -93.12 134.13 35.59 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.49 0.716 . . . . 2.23 109.878 -0.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.402 ' HE1' ' HB3' ' A' ' 146' ' ' ARG . 80.7 t90 -108.67 131.08 55.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.63 -0.507 . . . . 1.77 109.63 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 20.1 p80 -112.17 141.12 46.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.379 0.609 . . . . 2.19 111.328 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.983 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 7.2 t60 -82.6 -39.39 22.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.202 -0.908 . . . . 2.74 110.884 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.6 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 20.3 p90 -167.16 173.18 9.3 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.601 -0.518 . . . . 2.21 109.601 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.718 HD21 ' HH ' ' A' ' 158' ' ' TYR . 16.6 tp -134.62 113.04 11.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.68 110.178 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.6 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 1.8 t -121.25 132.11 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.641 -0.708 . . . . 0.35 110.146 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.75 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 6.2 m -129.71 162.94 36.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.084 -0.962 . . . . 0.3 108.64 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.745 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 72.2 m-20 58.43 23.24 10.41 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.721 0.638 . . . . 2.09 111.418 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.602 ' HE3' ' HA ' ' A' ' 97' ' ' ILE . 9.4 ttm -73.84 102.69 4.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.1 -1.074 . . . . 0.34 108.1 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.747 ' HG2' HD22 ' A' ' 63' ' ' LEU . 2.8 mtpm? -77.1 93.77 3.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.265 -0.879 . . . . 1.73 110.951 -171.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 85.37 -127.63 8.32 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.542 -0.754 . . . . 0.35 112.633 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.554 ' HB3' HD22 ' A' ' 58' ' ' LEU . 10.3 p30 -111.96 18.01 19.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.225 0.536 . . . . 1.59 110.551 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -81.5 99.88 9.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.621 . . . . 0.77 110.07 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.602 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 5.0 mm -56.3 -30.17 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.774 -1.103 . . . . 0.45 111.389 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 m -75.92 -42.56 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.084 -0.507 . . . . 1.15 111.856 -172.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -79.93 8.16 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 1.26 111.712 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.575 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -71.95 102.06 1.1 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.881 -0.887 . . . . 0.44 110.881 173.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.0 m -59.07 106.88 0.47 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.412 0.625 . . . . 1.06 110.018 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.7 116.75 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.806 -1.088 . . . . 1.15 111.327 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.434 HD12 ' HG ' ' A' ' 88' ' ' LEU . 41.8 mt -96.74 -37.49 10.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.036 0.922 . . . . 0.48 109.213 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.8 t -127.9 115.5 18.68 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.386 -1.339 . . . . 0.62 107.386 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 16.5 t0 -65.32 161.3 19.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.764 -0.653 . . . . 1.15 112.656 -168.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 24.0 p90 -85.46 61.91 7.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.383 -0.826 . . . . 4.98 112.367 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.918 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 60.3 t -42.29 -49.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 114.294 1.22 . . . . 0.86 114.294 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.39 -168.97 13.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.154 -1.022 . . . . 0.95 113.048 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 35.8 t -78.77 147.93 33.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.363 -0.236 . . . . 0.89 110.363 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.932 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 172.48 61.83 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 O-C-N 123.418 0.449 . . . . 0.82 112.36 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.762 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 9.4 Cg_endo -91.9 132.44 1.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.111 2.541 . . . . 1.01 112.382 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.593 ' HB2' HG21 ' A' ' 115' ' ' THR . 84.4 Cg_exo -50.03 143.8 23.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.263 2.642 . . . . 0.96 112.435 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 113.16 3.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.494 . . . . 2.39 110.926 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.49 -2.35 27.84 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.961 -0.638 . . . . 1.3 112.299 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.629 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 74.4 p -77.83 -21.69 51.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.817 0.341 . . . . 1.04 111.273 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.34 -153.19 17.16 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.862 -0.608 . . . . 1.97 111.846 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -98.5 110.83 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.927 -0.397 . . . . 0.94 109.927 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -77.07 109.56 11.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.177 -0.465 . . . . 2.85 110.019 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.574 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 7.0 ptt180 -101.9 92.56 4.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.636 . . . . 2.78 111.468 -171.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 41.0 m-85 -78.79 120.8 23.95 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.674 -0.694 . . . . 1.13 109.791 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 168' ' ' CYS . 15.1 t -98.57 128.89 49.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.31 110.479 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.86 ' HZ3' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -89.5 119.64 30.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.041 -0.527 . . . . 2.96 109.77 178.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 48.9 mt -116.43 119.15 34.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.378 -0.231 . . . . 0.41 110.378 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.513 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -117.71 137.44 51.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 0.43 110.961 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 1.034 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 49.1 t80 -140.78 133.26 28.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.589 -0.278 . . . . 5.41 110.322 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -83.06 116.32 22.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.807 -0.812 . . . . 2.41 108.807 170.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -78.74 174.39 11.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.498 0.666 . . . . 1.31 112.03 -168.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.28 -22.46 63.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.682 -1.145 . . . . 2.4 109.823 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.629 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 8.2 ptt180 -146.49 163.06 31.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.444 -1.253 . . . . 4.07 111.31 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.506 ' HA ' HD11 ' A' ' 63' ' ' LEU . 48.3 Cg_exo -64.95 41.87 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.757 0 C-N-CA 124.684 3.589 . . . . 1.21 113.403 169.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.75 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 2.7 mm? 74.42 167.42 0.29 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.934 -1.03 . . . . 1.16 113.152 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -157.15 71.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.991 -1.459 . . . . 3.23 107.844 171.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 3.8 p -93.39 -75.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.077 -0.965 . . . . 2.79 110.958 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 56.34 31.29 18.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.461 0.648 . . . . 2.96 109.886 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -82.32 139.85 45.18 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.046 -0.979 . . . . 1.39 109.841 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.72 112.44 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.898 2.399 . . . . 1.38 112.446 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.47 131.04 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 0.94 111.065 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.9 mt -110.83 149.39 30.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.05 -0.523 . . . . 1.61 110.639 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 141' ' ' ARG . 37.6 m -102.86 157.74 16.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.283 -1.006 . . . . 1.88 108.283 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.918 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 11.7 p-10 -81.59 30.36 0.36 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.396 0.617 . . . . 1.33 111.579 -173.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.619 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 14.2 mtt180 -115.54 147.48 40.65 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.884 -0.784 . . . . 3.83 108.884 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.568 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 16.5 m 66.18 178.15 0.21 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.94 0.775 . . . . 1.32 110.599 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -143.39 33.17 1.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.041 -1.076 . . . . 1.13 112.701 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.66 -27.41 63.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.049 0.388 . . . . 2.66 112.049 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -113.78 67.49 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.076 0.465 . . . . 2.18 110.9 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.835 HH11 ' HH ' ' A' ' 81' ' ' TYR . 99.3 mtt180 -79.71 -79.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.711 -0.677 . . . . 5.37 112.114 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.12 -142.73 3.52 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.9 113.009 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.7 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 39.7 mttm 66.33 34.15 6.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.719 0.771 . . . . 1.59 109.944 -173.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.463 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 69.8 m-85 -113.63 177.06 4.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.82 -1.082 . . . . 2.27 109.647 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 11.4 mmmm -119.75 112.24 19.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.366 -0.379 . . . . 1.87 111.945 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.781 HG22 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.49 -36.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.96 111.791 172.152 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.81 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.76 110.617 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.5 m -65.17 -44.86 87.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 1.22 110.263 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.607 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 66.9 m-85 -59.11 -47.01 86.85 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.601 0.715 . . . . 1.1 110.199 174.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.5 ' HD3' ' HA ' ' A' ' 161' ' ' ARG . 28.9 ttm180 -59.21 -48.64 80.87 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.809 -1.087 . . . . 3.36 111.634 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -66.76 -36.53 82.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.36 0.6 . . . . 1.52 110.637 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -55.83 -51.04 68.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.078 -0.965 . . . . 2.13 111.41 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.718 ' HH ' HD21 ' A' ' 88' ' ' LEU . 22.7 m-85 -83.29 -5.6 59.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.729 -0.669 . . . . 5.77 111.416 -174.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 68.53 46.74 0.97 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.814 0.816 . . . . 2.42 111.134 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 1.034 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.6 mp -105.69 175.39 5.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.666 -1.152 . . . . 1.27 110.378 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.912 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 6.1 tpt180 -147.64 -158.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.52 -0.918 . . . . 4.0 108.52 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.912 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -47.74 142.25 6.91 Favored Pre-proline 0 C--O 1.231 0.125 0 CA-C-O 121.122 0.487 . . . . 1.21 111.732 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.609 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 7.9 Cg_exo -70.2 161.31 46.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.651 2.901 . . . . 0.68 113.191 -168.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.878 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -87.69 -24.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.014 -0.994 . . . . 0.5 109.236 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -159.83 150.29 18.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.701 -0.681 . . . . 0.29 111.63 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.61 149.87 21.88 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.086 -0.961 . . . . 0.24 111.607 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.528 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.1 t -167.88 152.74 6.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.677 -0.86 . . . . 0.34 108.677 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.63 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 14.3 p -129.21 148.07 51.11 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.164 -0.614 . . . . 2.16 111.355 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.611 ' HB3' HG22 ' A' ' 34' ' ' VAL . 32.1 p90 -130.05 127.85 40.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.003 -1.11 . . . . 1.31 108.003 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -105.14 132.91 50.76 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.897 -0.721 . . . . 2.53 111.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -131.2 144.31 51.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.411 -0.813 . . . . 0.75 109.24 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.762 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 pt-20 -126.74 -161.73 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 2.38 111.103 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 1.016 ' HA ' HG23 ' A' ' 177' ' ' VAL . 4.1 t90 -71.93 81.48 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 4.71 111.036 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.527 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 5.6 t70 -73.08 -61.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.341 -0.39 . . . . 1.53 110.859 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.6 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 29.0 t70 172.79 -35.04 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.402 -0.817 . . . . 1.26 110.087 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -80.54 13.1 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 2.46 111.516 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 1.016 HG23 ' HA ' ' A' ' 173' ' ' TRP . 84.0 t -72.59 -53.37 5.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.931 -0.577 . . . . 0.58 110.105 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.711 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.2 Cg_exo -50.84 -30.8 31.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.693 2.262 . . . . 0.68 111.902 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.2 mmmt -72.4 -23.56 61.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 2.62 111.473 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.932 HD22 ' HA3' ' A' ' 110' ' ' GLY . 14.8 tp -70.9 -44.13 66.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.414 -0.587 . . . . 1.18 109.414 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.66 -40.28 91.48 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.556 0.693 . . . . 2.11 109.273 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 8.2 mm-40 -56.41 -48.3 77.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.671 -1.15 . . . . 1.53 110.647 171.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.334 -0.848 . . . . 2.16 111.97 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.568 ' HA ' ' H ' ' A' ' 142' ' ' SER . 40.4 mt -68.42 2.78 2.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.577 -0.283 . . . . 0.87 111.629 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.624 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.7 m -78.8 -2.73 40.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.336 0.589 . . . . 1.38 109.869 173.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 76.44 60.57 2.99 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.313 -0.858 . . . . 1.17 111.29 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.4 mmmt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.577 -0.725 . . . . 2.45 110.549 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 13.7 tpt . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 110.216 -0.29 . . . . 5.4 110.216 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 19.3 Cg_exo -66.92 149.03 83.05 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.488 2.125 . . . . 2.58 111.067 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' A' ' 24' ' ' PRO . 23.4 t -78.04 105.35 7.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.359 0.599 . . . . 2.1 110.134 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' CG ' ' HG ' ' A' ' 6' ' ' SER . 30.4 p-10 -143.46 31.02 1.35 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.977 -1.011 . . . . 1.81 110.628 -177.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 68.85 10.7 8.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.071 -1.422 . . . . 0.95 113.041 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.449 ' HG ' ' CG ' ' A' ' 4' ' ' ASP . 70.5 m -67.12 -8.97 34.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.539 0.57 . . . . 2.19 112.539 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.84 ' HB3' HD13 ' A' ' 12' ' ' LEU . 99.4 mttt -133.68 36.12 3.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.29 -0.256 . . . . 3.07 111.333 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.45 -17.96 40.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.274 0.472 . . . . 4.76 112.274 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 p -153.42 20.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.872 0.368 . . . . 0.98 111.595 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -80.88 -124.67 0.62 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.006 -0.838 . . . . 0.52 111.006 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 14.3 Cg_endo -53.61 -35.45 77.38 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.261 2.641 . . . . 0.61 110.679 166.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 7' ' ' LYS . 25.3 mt -87.57 86.04 7.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 1.85 109.322 172.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 60.9 0.72 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.307 0.575 . . . . 1.31 110.898 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 121' ' ' VAL . 20.9 mt -73.2 -19.56 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.61 110.275 -176.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -64.55 -22.53 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 2.61 110.846 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -64.86 -25.29 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.38 0.609 . . . . 1.93 109.66 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.579 HG11 HG22 ' A' ' 151' ' ' VAL . 92.1 t -92.39 -70.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.024 -0.989 . . . . 1.26 110.154 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.48 174.67 5.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 2.99 110.621 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.96 29.64 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 1.6 112.282 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.516 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 27.9 mt-30 64.26 112.45 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.02 0.825 . . . . 4.38 111.005 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 19.9 Cg_exo -63.98 152.05 82.56 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.439 2.092 . . . . 0.69 112.759 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.886 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.3 pt20 -76.66 -18.77 58.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.281 -0.872 . . . . 1.87 111.021 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.783 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 40.0 m-70 -145.53 159.43 48.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 123.658 0.783 . . . . 2.35 109.068 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' CB ' HG13 ' A' ' 3' ' ' VAL . 5.4 Cg_endo -85.93 131.05 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.706 2.271 . . . . 0.44 111.967 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' A' ' 122' ' ' TRP . 15.6 tp -82.01 145.04 30.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.731 0.301 . . . . 0.33 110.478 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.483 ' H ' HD12 ' A' ' 25' ' ' LEU . 32.8 m80 -116.49 127.82 54.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.88 -0.415 . . . . 2.12 109.88 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG11 HG22 ' A' ' 53' ' ' ILE . 23.0 t -132.25 140.92 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.355 -0.609 . . . . 1.12 109.355 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -137.59 142.82 41.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.983 0.421 . . . . 0.78 110.789 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -105.16 176.72 5.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.157 -0.683 . . . . 1.23 109.157 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -52.66 62.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.448 0.642 . . . . 0.6 110.284 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.45 7.59 32.25 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.167 -0.924 . . . . 0.81 112.597 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.15 -170.97 3.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.56 110.53 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.25 163.49 25.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.589 -0.732 . . . . 0.35 109.34 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.748 HG22 ' HB3' ' A' ' 169' ' ' TYR . 88.6 t -116.52 66.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.304 -1.369 . . . . 0.39 107.304 165.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.0 14.01 33.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.053 -0.976 . . . . 0.99 109.608 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.793 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.1 tm-20 -138.07 122.38 18.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.126 -1.435 . . . . 2.56 107.126 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -68.1 111.54 4.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.426 0.631 . . . . 0.46 110.685 -170.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.716 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 84.06 10.19 81.06 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.54 -0.754 . . . . 0.59 112.409 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -64.2 154.25 35.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 110.28 -0.267 . . . . 1.04 110.28 176.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.31 127.77 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.469 0.652 . . . . 1.16 111.296 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.52 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.0 tp -124.69 169.12 12.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.823 -1.177 . . . . 0.45 107.823 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p -118.17 151.95 49.89 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 119.48 -0.888 . . . . 1.0 112.718 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 51.0 Cg_exo -56.38 -34.47 94.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.875 3.05 . . . . 1.0 113.284 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -33.67 72.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 1.24 110.696 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -82.12 -46.68 13.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.036 . . . . 1.74 111.395 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.52 ' CG1' HD21 ' A' ' 41' ' ' LEU . 6.1 m -95.62 28.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 112.731 0.641 . . . . 1.1 112.731 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -85.8 -11.7 52.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.823 0.344 . . . . 1.32 110.617 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -135.5 -151.88 0.44 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 2.4 109.285 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -87.92 158.64 50.05 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.149 -0.315 . . . . 1.78 110.149 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 76.3 Cg_endo -83.5 165.37 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.237 1.958 . . . . 0.41 110.573 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 t -88.09 -20.31 25.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.599 -0.441 . . . . 0.88 110.596 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.442 ' C ' HG21 ' A' ' 53' ' ' ILE . 73.3 m -158.69 142.58 15.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.085 0.469 . . . . 0.65 111.918 -177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -141.09 170.05 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.33 108.471 171.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.739 ' HA ' HD11 ' A' ' 58' ' ' LEU . 40.4 t 174.23 116.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.517 0.511 . . . . 0.8 109.866 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.499 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 54.4 p-90 -76.97 159.56 29.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.669 -0.863 . . . . 3.63 108.669 173.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 29.3 t70 -68.63 85.36 0.3 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.054 0.454 . . . . 1.51 110.5 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.47 6.33 3.83 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.492 -0.776 . . . . 0.9 112.259 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -51.71 129.41 26.08 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.163 0.506 . . . . 0.62 111.554 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -79.25 -28.11 42.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.74 111.404 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.635 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 24.3 t 67.14 22.07 9.92 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.125 -0.943 . . . . 1.51 110.08 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -42.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.784 -0.722 . . . . 0.84 113.079 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -90.73 169.08 11.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 120.823 0.344 . . . . 2.12 110.772 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.1 mt -93.8 147.52 22.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.711 -0.677 . . . . 1.23 109.344 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.494 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.0 m-85 -135.09 168.56 18.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.265 -0.643 . . . . 1.61 109.265 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.795 HG21 HG11 ' A' ' 90' ' ' VAL . 2.4 m -103.83 104.43 14.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.325 -0.62 . . . . 0.87 109.325 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.72 HD13 ' HD1' ' A' ' 122' ' ' TRP . 57.7 tp -108.16 117.01 33.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.034 0.445 . . . . 1.35 110.616 -174.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.9 t -114.89 147.09 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.083 -0.508 . . . . 0.54 110.38 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.945 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.2 mt -110.5 122.11 46.95 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.78 -1.192 . . . . 0.65 107.78 166.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 9.0 t -133.16 151.28 51.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.726 0.298 . . . . 1.04 110.711 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.65 ' OD2' ' HB3' ' A' ' 84' ' ' TRP . 4.6 p-10 -132.31 101.8 14.57 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-O 121.613 0.721 . . . . 1.92 111.213 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.499 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 4.1 Cg_endo -48.06 -38.4 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.828 3.018 . . . . 1.25 114.386 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.85 48.82 1.4 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -171.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.46 127.76 27.56 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.176 -0.305 . . . . 0.56 110.176 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -82.64 -30.46 4.78 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.315 -1.536 . . . . 0.7 113.142 -1.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.673 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -121.16 157.81 29.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.107 -0.497 . . . . 1.1 110.944 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -67.81 -45.53 74.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 3.39 111.342 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.693 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -72.35 -19.31 61.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 1.83 111.442 -175.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.97 84.24 5.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.2 0.524 . . . . 1.37 110.141 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.87 102.24 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.643 2.228 . . . . 0.9 112.691 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 16.9 mttm -83.09 -55.23 4.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.981 -1.008 . . . . 1.53 110.669 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.67 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.7 m-85 -82.86 19.77 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.145 -0.934 . . . . 1.54 111.481 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 50.3 ttp180 -65.72 124.05 21.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.36 -0.382 . . . . 3.38 110.21 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.0 mp0 -102.4 138.99 38.59 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.819 0.342 . . . . 2.23 110.957 0.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.65 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 17.1 t90 -88.19 161.91 16.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.412 -1.329 . . . . 1.77 107.412 171.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 11.0 p80 -138.04 114.67 10.51 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.184 0.516 . . . . 2.19 110.435 -174.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.945 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 3.7 t-160 -52.99 -42.57 65.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.029 -0.987 . . . . 2.74 110.585 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.48 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 18.5 p90 -167.55 163.33 14.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.706 0.288 . . . . 2.21 110.747 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.468 ' CD1' HG22 ' A' ' 67' ' ' VAL . 20.8 tp -126.83 114.18 17.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.68 109.23 175.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.48 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 1.5 t -119.78 134.06 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.534 0.683 . . . . 0.35 111.182 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 65' ' ' THR . 6.2 m -128.04 168.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.477 -0.934 . . . . 0.3 108.477 175.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.743 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.8 m-20 59.11 21.77 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.075 0.464 . . . . 2.09 111.3 173.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.492 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.9 ttm -76.72 115.07 16.15 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.673 -0.862 . . . . 0.34 108.673 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -82.72 98.32 9.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.125 -0.943 . . . . 1.73 111.039 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.635 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 69.59 -119.42 9.17 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.203 -0.908 . . . . 0.35 112.273 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.584 ' HB3' HD22 ' A' ' 58' ' ' LEU . 28.6 p-10 -114.57 25.54 10.93 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.09 0.471 . . . . 1.59 110.598 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.4 106.03 18.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.343 0.592 . . . . 0.77 109.977 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.458 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 5.1 mm -56.81 -29.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.729 -1.123 . . . . 0.45 111.913 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.1 m -81.85 -37.27 27.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.883 0.698 . . . . 1.15 112.883 -170.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.6 p -67.27 -19.59 65.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.85 0.315 . . . . 1.26 111.85 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.492 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -57.06 105.65 0.58 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.859 -0.61 . . . . 0.44 112.982 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 97.7 m -65.16 107.31 1.52 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.282 0.563 . . . . 1.06 110.004 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.509 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.6 p -76.78 119.15 24.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.184 -0.916 . . . . 1.15 111.287 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 133' ' ' CYS . 57.1 mt -97.39 -47.03 5.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.091 0.948 . . . . 0.48 109.159 172.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 t -114.35 106.02 13.82 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.977 -1.49 . . . . 0.62 106.977 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.906 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.3 OUTLIER -56.89 156.97 6.04 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.763 0.664 . . . . 1.15 112.178 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.3 p90 -77.25 87.8 3.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 4.98 111.095 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.691 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 24.0 t -61.77 -53.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.76 -0.655 . . . . 0.86 110.68 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 115.98 -164.89 12.19 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.086 -1.054 . . . . 0.95 112.548 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.631 ' HA ' ' HH ' ' A' ' 120' ' ' TYR . 23.9 t -77.89 131.98 37.73 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.568 0.216 . . . . 0.89 110.545 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.647 ' H ' ' HH ' ' A' ' 120' ' ' TYR . . . -154.42 68.11 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.82 112.713 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.834 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 20.4 Cg_endo -96.33 113.19 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.434 2.756 . . . . 1.01 112.708 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.617 ' HB2' HG21 ' A' ' 115' ' ' THR . 89.1 Cg_exo -51.15 143.23 33.13 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.798 2.332 . . . . 0.96 111.709 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 110.97 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.25 0.548 . . . . 2.39 110.952 -175.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.48 21.63 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 1.3 112.312 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.673 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 70.1 p -77.41 -30.3 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.628 0.252 . . . . 1.04 111.415 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.95 -168.78 12.88 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.41 -0.676 . . . . 1.97 111.41 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -80.28 108.97 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.243 0.544 . . . . 0.94 109.916 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.834 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 2.2 t60 -79.74 106.21 11.6 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 2.85 109.535 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.818 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp180 -97.57 114.67 26.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.402 1.096 . . . . 2.78 111.358 -172.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.647 ' HH ' ' H ' ' A' ' 110' ' ' GLY . 28.7 m-85 -92.31 120.65 33.05 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.231 -1.349 . . . . 1.13 108.683 172.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 168' ' ' CYS . 19.4 t -97.99 128.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.619 . . . . 0.31 109.81 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.914 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.02 119.2 29.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.127 -0.694 . . . . 2.96 109.127 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.88 119.92 27.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.374 0.131 . . . . 0.41 111.169 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 66' ' ' LEU . 1.5 m -104.85 136.17 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.566 -0.454 . . . . 0.43 109.869 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 88.4 m-85 -114.5 148.7 37.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.441 . . . . 5.41 110.483 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -101.42 119.06 38.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.836 -0.62 . . . . 2.41 110.837 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.723 ' HG2' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -104.2 160.83 14.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 1.31 110.479 176.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.04 -26.57 64.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.879 -1.055 . . . . 2.4 110.172 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.57 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 11.8 ptp180 -159.24 171.83 6.87 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 4.07 111.132 -174.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 81.3 Cg_exo -48.08 148.37 7.0 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.098 2.532 . . . . 1.21 112.677 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.723 HD23 ' HG2' ' A' ' 127' ' ' GLN . 3.1 mm? -78.12 152.63 32.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.884 -0.598 . . . . 1.16 111.263 -172.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -130.98 68.05 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.643 -0.873 . . . . 3.23 108.643 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.666 ' HB2' HD13 ' A' ' 103' ' ' LEU . 66.3 m -95.72 106.44 18.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.233 -0.894 . . . . 2.79 110.897 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.22 31.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.636 -0.711 . . . . 2.96 110.357 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 11.8 mm-40 -71.32 150.17 94.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.357 -0.838 . . . . 1.39 110.426 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.36 106.64 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.325 2.684 . . . . 1.38 113.138 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.2 mm -63.54 121.33 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.94 110.863 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 69.1 mt -105.49 155.07 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 1.61 110.266 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.574 ' C ' ' H ' ' A' ' 141' ' ' ARG . 65.5 m -113.45 17.17 18.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.73 -0.668 . . . . 1.88 110.737 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.906 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.1 OUTLIER 65.49 -29.21 0.12 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.21 1.404 . . . . 1.33 111.705 -178.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.9 ttt180 -56.45 140.15 46.79 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.68 0.792 . . . . 3.83 111.088 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.435 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 28.6 m 73.78 114.05 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 124.194 0.934 . . . . 1.32 111.639 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.01 12.8 34.82 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.436 -0.802 . . . . 1.13 112.303 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.571 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 25.7 t70 -66.76 -38.65 87.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.597 0.713 . . . . 2.66 110.676 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.571 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 3.5 m80 -98.34 59.53 1.34 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.039 -0.982 . . . . 2.18 109.597 -172.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -86.71 -92.95 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.832 -0.622 . . . . 5.37 112.371 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -119.99 -156.22 9.89 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.232 -0.985 . . . . 0.9 113.633 -166.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.67 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 94.5 mttt 65.66 24.61 11.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.147 0.975 . . . . 1.59 109.755 -171.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.54 95.27 5.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.372 -1.286 . . . . 2.27 108.236 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 22.0 mmmt -54.05 129.98 36.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.215 -0.902 . . . . 1.87 112.622 -173.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.654 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 29.0 m -65.48 -23.72 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.443 -0.577 . . . . 0.96 109.443 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.466 ' HA ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.49 -42.14 98.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.36 -0.837 . . . . 0.76 109.577 172.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 37.2 m -64.82 -32.54 74.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.018 -0.537 . . . . 1.22 110.22 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.654 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 27.6 m-85 -69.91 -48.86 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 1.1 111.068 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.578 ' HD2' ' HG3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -67.23 -29.36 68.99 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.954 -0.298 . . . . 3.36 110.832 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.578 ' HG3' ' HD2' ' A' ' 155' ' ' ARG . 54.7 mtmt -77.49 -26.91 51.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.783 -0.19 . . . . 1.52 111.401 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -54.45 -53.9 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.537 -0.302 . . . . 2.13 111.136 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.425 ' OH ' ' HG3' ' A' ' 129' ' ' ARG . 12.9 t80 -111.1 5.99 20.53 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.485 -0.886 . . . . 5.77 110.597 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 58.81 53.68 5.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.326 -0.852 . . . . 2.42 112.467 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 125' ' ' TYR . 0.4 OUTLIER -81.08 -12.31 59.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.272 -0.877 . . . . 1.27 110.303 176.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 161' ' ' ARG . 7.5 tpt180 69.9 -87.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.978 -1.01 . . . . 4.0 112.297 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -128.07 156.51 76.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.821 0.343 . . . . 1.21 111.211 -171.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.3 Cg_exo -71.24 139.78 35.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.285 2.657 . . . . 0.68 112.464 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.886 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -87.74 -30.78 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.5 109.376 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.781 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.85 143.7 21.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.987 -0.552 . . . . 0.29 111.544 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.698 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.55 143.27 11.28 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 114.926 -1.034 . . . . 0.24 111.881 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.5 t -156.83 133.61 10.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.34 108.927 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.818 ' SG ' ' HB2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -110.31 151.29 27.59 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.568 0.699 . . . . 2.16 111.756 -173.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.748 ' HB3' HG22 ' A' ' 34' ' ' VAL . 49.2 p90 -137.73 127.51 25.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.657 -1.609 . . . . 1.31 106.657 173.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -105.55 133.25 50.6 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.363 -0.935 . . . . 2.53 111.435 177.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.08 -0.964 . . . . 0.75 110.072 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.53 ' HB3' HD13 ' A' ' 117' ' ' LEU . 9.0 pt-20 -120.72 -168.94 1.73 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 2.38 110.947 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.904 ' HA ' HG23 ' A' ' 177' ' ' VAL . 29.4 t90 -83.99 77.3 9.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.786 -0.643 . . . . 4.71 109.729 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -57.04 4.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.654 -0.248 . . . . 1.53 111.257 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.0 t70 175.68 -33.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.358 0.663 . . . . 1.26 110.73 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.65 6.7 14.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.908 0.385 . . . . 2.46 111.925 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.904 HG23 ' HA ' ' A' ' 173' ' ' TRP . 66.3 t -69.42 -53.52 12.81 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.281 -0.418 . . . . 0.58 110.083 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.773 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 61.7 Cg_exo -51.32 -37.03 59.52 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.609 2.206 . . . . 0.68 112.021 169.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.5 mmmt -67.7 -24.37 65.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.165 -0.47 . . . . 2.62 111.705 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 58.3 tp -69.11 -47.44 65.15 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.57 -0.53 . . . . 1.18 109.57 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.8 -38.68 79.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 2.11 109.42 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.658 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.9 mm-40 -57.26 -43.08 82.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.892 -1.049 . . . . 1.53 111.267 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -76.55 -30.34 57.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.707 0.632 . . . . 2.16 112.707 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 84.9 mt -63.39 1.47 0.52 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.996 0.739 . . . . 0.87 112.996 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.691 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 49.3 m -88.81 3.05 52.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.463 0.649 . . . . 1.38 109.789 170.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.536 ' N ' ' HG3' ' A' ' 141' ' ' ARG . . . 69.45 51.65 25.44 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.066 -0.97 . . . . 1.17 111.335 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.691 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.4 mmmt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.456 -0.783 . . . . 2.45 110.072 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.398 0.142 . . . . 5.4 110.999 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.04 139.75 25.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.95 2.433 . . . . 2.58 111.537 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.579 ' HB ' ' CD2' ' A' ' 26' ' ' HIS . 21.4 t -57.96 121.79 6.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.446 -0.797 . . . . 2.1 112.131 -171.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 6' ' ' SER . 24.0 t70 -144.78 157.96 43.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.175 -1.375 . . . . 1.81 107.524 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -75.19 23.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.09 0.405 . . . . 0.95 111.882 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.0 t -72.27 -16.72 61.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 2.19 110.123 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.477 ' HB3' HD12 ' A' ' 12' ' ' LEU . 37.8 mttm -122.13 31.41 6.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 3.07 111.173 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -26.36 31.63 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.245 0.832 . . . . 4.76 113.245 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -152.43 25.51 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.014 -0.429 . . . . 0.98 111.377 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.16 -122.39 0.96 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.753 -0.939 . . . . 0.52 110.753 174.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.457 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -51.9 -38.49 68.5 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.255 2.636 . . . . 0.61 110.921 167.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.641 HD13 ' HA3' ' A' ' 38' ' ' GLY . 45.9 mt -87.37 89.09 7.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.258 -0.883 . . . . 1.85 109.661 173.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.53 71.75 1.86 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.412 0.625 . . . . 1.31 110.485 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 121' ' ' VAL . 23.8 mt -80.12 -11.98 59.71 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.795 . . . . 0.61 110.04 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.507 ' HG2' ' HG3' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -67.69 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.446 -0.797 . . . . 2.61 110.859 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -77.5 -20.11 54.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.707 0.765 . . . . 1.93 109.423 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 151' ' ' VAL . 62.8 t -98.13 -57.03 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.53 -1.214 . . . . 1.26 111.341 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -134.92 172.79 12.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.459 -0.337 . . . . 2.99 110.685 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -85.93 31.61 0.62 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.538 0.94 . . . . 1.6 113.538 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.507 ' HG3' ' HG2' ' A' ' 15' ' ' GLN . 97.7 mt-30 64.4 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.541 0 O-C-N 123.507 0.505 . . . . 4.38 110.721 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.604 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 15.2 Cg_exo -66.35 150.4 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.207 1.938 . . . . 0.69 112.671 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.8 pt20 -72.39 -15.92 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.125 -0.943 . . . . 1.87 111.264 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.779 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 24.1 m80 -148.91 157.43 40.39 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 2.35 109.274 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 5.5 Cg_endo -86.82 127.33 2.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.44 111.266 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.859 HD21 ' HB3' ' A' ' 122' ' ' TRP . 22.8 tp -76.61 144.3 39.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.997 -0.372 . . . . 0.33 109.997 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.579 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 36.0 m80 -122.91 109.23 13.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.045 0.45 . . . . 2.12 110.038 176.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 53' ' ' ILE . 39.6 t -112.93 139.3 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.61 . . . . 1.12 109.476 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -133.26 142.2 48.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.431 0.634 . . . . 0.78 110.938 -176.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -102.54 171.12 7.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 1.23 109.006 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.65 -51.86 61.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.37 0.605 . . . . 0.6 110.773 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.97 9.52 15.81 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.066 -0.97 . . . . 0.81 112.478 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.68 -171.01 3.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 122.631 -0.335 . . . . 0.56 110.469 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.13 155.32 18.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.158 -0.474 . . . . 0.35 110.351 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.748 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.6 t -102.32 63.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.804 -1.554 . . . . 0.39 106.804 163.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.31 20.78 8.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.887 -1.051 . . . . 0.99 109.384 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.5 tm-20 -145.67 119.93 9.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.047 -1.094 . . . . 2.56 108.047 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.644 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -66.45 110.63 3.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.997 0.427 . . . . 0.46 109.959 -175.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.87 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 93.27 2.44 65.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.068 -0.587 . . . . 0.59 112.703 177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -67.05 149.39 50.66 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.764 0.316 . . . . 1.04 110.677 -178.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.11 132.01 33.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.357 0.598 . . . . 1.16 111.043 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.523 HD21 ' CG1' ' A' ' 46' ' ' VAL . 6.8 tp -124.11 169.2 11.93 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.391 -1.337 . . . . 0.45 107.391 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 7.1 p -114.67 150.46 44.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 118.804 -1.159 . . . . 1.0 113.141 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.682 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 52.9 Cg_exo -55.74 -32.43 84.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.435 3.423 . . . . 1.0 113.91 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -65.12 -36.65 84.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.644 0.735 . . . . 1.24 110.189 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -75.28 -56.38 4.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.799 -1.091 . . . . 1.74 110.603 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.526 ' HB ' ' HH ' ' A' ' 169' ' ' TYR . 28.7 m -89.31 28.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.884 0.698 . . . . 1.1 112.884 -173.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.625 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -85.64 -15.49 42.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.766 -0.828 . . . . 1.32 108.766 172.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.46 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 17.9 t-20 -121.12 -170.29 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.714 -1.13 . . . . 2.4 108.988 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 86.2 mtt180 -85.42 161.51 51.25 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.445 -0.576 . . . . 1.78 109.445 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 66.8 Cg_endo -78.96 160.38 27.14 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.819 1.68 . . . . 0.41 110.539 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 t -85.23 -18.17 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.915 -0.402 . . . . 0.88 109.915 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.495 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 70.1 m -159.36 147.99 17.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.27 0.557 . . . . 0.65 111.778 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.593 HD11 ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -139.69 167.87 18.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.145 -1.057 . . . . 0.33 108.145 170.057 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.735 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 38.5 t 179.01 114.27 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.102 0.477 . . . . 0.8 110.168 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.523 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 56.3 p-90 -78.4 157.34 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.088 -1.078 . . . . 3.63 108.088 172.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.67 88.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.191 0.52 . . . . 1.51 110.918 -175.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.5 20.59 4.62 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.444 -0.798 . . . . 0.9 112.275 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.735 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -51.1 130.3 25.76 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.107 0.563 . . . . 0.62 111.485 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.681 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 24.1 t70 -75.72 -28.68 58.66 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.808 -0.633 . . . . 0.74 111.451 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.667 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 43.0 m 69.18 9.44 7.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.389 -0.823 . . . . 1.51 110.733 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -135.53 -43.77 0.11 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.849 -0.691 . . . . 0.84 113.253 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.854 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 20.2 mtpt -66.59 149.63 50.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 2.12 110.645 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.96 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.1 mt -88.09 126.77 35.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.555 -0.748 . . . . 1.23 109.239 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.854 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -118.84 161.4 20.23 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.224 0.465 . . . . 1.61 110.889 177.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.424 ' OG1' HD21 ' A' ' 131' ' ' LEU . 89.6 m -97.4 105.3 17.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.87 109.259 172.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.85 110.13 22.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.471 -0.786 . . . . 1.35 109.835 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG22 HD11 ' A' ' 88' ' ' LEU . 21.6 t -115.32 126.7 72.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.018 0.437 . . . . 0.54 111.055 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -91.19 131.39 36.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.215 -1.031 . . . . 0.65 108.215 166.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 12.0 t -133.63 140.64 47.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.877 -0.329 . . . . 1.04 110.339 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.637 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 38.2 t70 -121.85 97.58 46.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 121.132 0.491 . . . . 1.92 110.064 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 10.7 Cg_endo -56.14 178.31 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.2 2.6 . . . . 1.25 112.538 171.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.829 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 71.3 m-20 52.56 35.7 18.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.926 -1.034 . . . . 1.29 112.861 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.99 138.48 19.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.148 -0.315 . . . . 0.56 110.148 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.637 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 56.7 Cg_endo -77.27 -34.52 3.28 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.089 -1.629 . . . . 0.7 112.968 0.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.694 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.1 p -119.87 156.81 30.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 1.1 110.214 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 46.8 mtm180 -72.48 -23.53 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 3.39 111.482 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.758 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -92.72 -11.62 33.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 1.83 110.947 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.45 78.58 6.28 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-O 121.583 0.706 . . . . 1.37 109.584 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.79 95.15 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.848 2.365 . . . . 0.9 113.348 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.637 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 12.1 mttm -81.74 -52.29 7.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.095 -0.957 . . . . 1.53 111.17 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.612 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 50.7 m-85 -76.53 -5.44 47.63 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.886 -0.597 . . . . 1.54 111.897 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.536 ' HG3' ' HA ' ' A' ' 71' ' ' PRO . 70.1 ttt180 -67.43 130.36 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.275 -0.17 . . . . 3.38 110.867 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.521 ' OE2' ' HB3' ' A' ' 71' ' ' PRO . 29.9 mm-40 -86.96 130.8 34.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.981 0.42 . . . . 2.23 110.771 -0.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.659 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.5 t90 -86.75 91.18 8.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 1.77 109.513 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 35.2 p-80 -67.19 121.72 16.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.529 0.681 . . . . 2.19 109.979 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.936 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 30.3 t-80 -65.39 -34.86 79.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.034 -0.985 . . . . 2.74 110.369 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.683 ' HD2' ' HD1' ' A' ' 86' ' ' HIS . 39.6 p90 -168.8 172.39 7.86 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.578 -0.527 . . . . 2.21 109.578 175.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.547 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.2 tp -132.22 113.7 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.641 -0.503 . . . . 0.68 109.641 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.602 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 1.8 t -121.28 132.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.533 0.682 . . . . 0.35 110.678 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.441 ' CG1' ' HG ' ' A' ' 131' ' ' LEU . 9.1 m -128.45 167.4 23.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.879 -1.156 . . . . 0.3 107.879 175.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.96 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.5 m-20 60.71 19.66 9.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.203 0.525 . . . . 2.09 110.895 172.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.582 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 9.1 ttm -73.97 114.57 12.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.971 -0.752 . . . . 0.34 108.971 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 ttmm -80.82 98.56 7.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.512 -1.222 . . . . 1.73 110.988 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.667 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 62.68 -115.3 7.83 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.512 -0.851 . . . . 0.35 112.312 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.726 ' HB3' HD22 ' A' ' 58' ' ' LEU . 28.2 p-10 -115.06 24.34 11.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.933 0.396 . . . . 1.59 111.611 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.06 103.0 15.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.451 0.643 . . . . 0.77 110.247 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.558 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 7.7 mm -56.18 -32.34 34.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.851 -1.068 . . . . 0.45 111.831 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 m -78.98 -37.39 39.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.091 -0.504 . . . . 1.15 111.779 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.3 p -61.05 -29.69 69.88 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.728 0.299 . . . . 1.26 111.331 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.582 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -50.38 107.77 0.4 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.536 -0.756 . . . . 0.44 112.669 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.4 m -72.29 107.8 5.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.256 0.551 . . . . 1.06 109.923 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 p -76.46 122.18 30.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 1.15 111.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.547 HD12 ' HG ' ' A' ' 88' ' ' LEU . 66.0 mt -100.47 -45.69 5.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.085 0.945 . . . . 0.48 109.32 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.1 t -122.92 112.34 17.73 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.171 -1.418 . . . . 0.62 107.171 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 4.1 t0 -59.05 159.94 6.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.944 -1.026 . . . . 1.15 113.024 -167.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HE2' ' HA ' ' A' ' 48' ' ' ASN . 3.3 p90 -80.16 86.66 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.3 -0.864 . . . . 4.98 110.764 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.864 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 38.3 t -63.97 -46.05 95.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.86 111.087 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.527 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 109.51 -168.13 13.13 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.467 -0.873 . . . . 0.95 112.577 174.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.453 ' O ' HD22 ' A' ' 180' ' ' LEU . 30.9 t -70.29 133.24 46.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.89 109.935 174.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.584 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -169.73 61.22 0.19 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.695 -0.764 . . . . 0.82 112.891 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 97.7 Cg_endo -93.35 140.39 1.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.072 2.515 . . . . 1.01 112.434 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.642 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 37.1 Cg_exo -61.55 141.84 92.86 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.702 2.268 . . . . 0.96 111.598 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.45 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -69.02 123.93 22.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 2.39 110.987 -176.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.77 59.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 1.3 112.642 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.694 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 75.1 p -78.82 -12.68 60.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 1.04 110.706 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.29 165.92 41.78 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.18 -0.768 . . . . 1.97 111.18 -174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.893 HD11 ' HG3' ' A' ' 170' ' ' GLN . 3.8 mm? -79.49 130.13 35.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.317 -0.623 . . . . 0.94 109.317 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.433 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 4.2 m170 -92.63 -121.32 0.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.975 -1.12 . . . . 2.85 107.975 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.755 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 14.3 ptt-85 177.3 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.344 0.498 . . . . 2.78 112.344 169.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.637 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 31.4 m-85 -69.86 101.2 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.768 -0.826 . . . . 1.13 108.768 173.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.705 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.3 t -89.99 126.07 42.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.957 0.408 . . . . 0.31 109.949 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.859 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.06 117.9 28.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.812 -0.81 . . . . 2.96 108.812 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -122.07 129.01 52.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.511 0.195 . . . . 0.41 110.94 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 165' ' ' ALA . 1.3 m -112.21 131.78 62.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.43 110.139 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.628 ' CB ' HD21 ' A' ' 160' ' ' LEU . 97.8 m-85 -117.69 122.5 43.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.252 -0.885 . . . . 5.41 109.258 174.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.98 113.08 25.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.012 0.434 . . . . 2.41 109.873 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.591 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -80.57 175.6 10.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.665 -0.698 . . . . 1.31 109.439 177.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.02 -6.34 57.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.729 -0.669 . . . . 2.4 109.851 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.484 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.2 ptp180 -165.65 167.38 9.16 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 115.307 -0.86 . . . . 4.07 111.267 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.611 ' HG3' HD11 ' A' ' 63' ' ' LEU . 35.6 Cg_exo -55.58 147.71 57.59 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.979 2.453 . . . . 1.21 111.631 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.572 HD23 ' HG2' ' A' ' 127' ' ' GLN . 3.8 mm? -71.83 148.89 45.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.621 . . . . 1.16 112.532 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -103.26 77.81 1.56 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.707 -1.22 . . . . 3.23 107.707 165.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.412 ' SG ' HD23 ' A' ' 103' ' ' LEU . 1.2 p -90.62 99.79 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.399 -0.818 . . . . 2.79 111.797 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.2 14.03 21.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.506 -0.77 . . . . 2.96 109.102 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.26 135.28 96.05 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.39 110.278 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.64 116.56 2.81 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.017 2.478 . . . . 1.38 112.946 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.6 mm -69.03 115.95 8.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.005 -0.368 . . . . 0.94 110.005 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.565 HD13 ' HB3' ' A' ' 145' ' ' HIS . 31.6 mt -114.93 152.61 32.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.427 0.632 . . . . 1.61 111.26 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -96.51 154.13 17.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.055 -0.975 . . . . 1.88 108.609 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.864 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 -77.88 -1.41 31.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 1.33 111.024 -173.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.736 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 88.4 mtt180 -78.94 157.2 28.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.581 -0.525 . . . . 3.83 109.581 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.498 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 79.8 p 58.06 117.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.82 1.248 . . . . 1.32 112.651 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.546 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -79.35 18.21 7.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.309 -0.859 . . . . 1.13 113.514 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.601 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 29.3 t70 -69.82 -41.34 75.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.559 0.695 . . . . 2.66 110.4 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.601 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 4.4 m80 -95.11 46.48 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.174 -0.921 . . . . 2.18 110.862 -170.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 51.3 mtt180 -76.77 -78.78 0.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.026 0.441 . . . . 5.37 111.925 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -137.57 -121.58 2.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.107 -1.044 . . . . 0.9 113.042 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.612 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 47.2 mttm 64.88 29.17 12.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.616 0.722 . . . . 1.59 110.51 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -127.52 146.87 50.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.903 -1.044 . . . . 2.27 109.77 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -87.59 140.57 29.38 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.038 -0.528 . . . . 1.87 111.098 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 17' ' ' VAL . 3.0 t -62.11 -35.18 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.43 -0.952 . . . . 0.96 108.43 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.75 81.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.396 -1.275 . . . . 0.76 110.448 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 74.1 m -59.31 -47.07 86.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 1.22 111.349 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 157' ' ' LYS . 59.1 m-85 -62.49 -48.97 77.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.827 0.822 . . . . 1.1 110.611 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -60.1 -49.3 78.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.414 -1.266 . . . . 3.36 111.135 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -67.73 -26.48 66.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 1.52 111.502 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 45.0 tptt -52.6 -53.25 49.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 2.13 111.626 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.415 ' HB3' HD13 ' A' ' 160' ' ' LEU . 17.2 t80 -104.41 14.94 29.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.845 -0.742 . . . . 5.77 110.422 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 60.37 47.67 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.158 -0.928 . . . . 2.42 111.857 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.628 HD21 ' CB ' ' A' ' 125' ' ' TYR . 5.5 mp -80.1 138.9 37.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.388 -0.824 . . . . 1.27 108.875 173.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -72.18 -82.32 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.079 0.4 . . . . 4.0 112.079 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.17 164.54 36.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.882 -0.414 . . . . 1.21 109.882 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.604 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 20.0 Cg_exo -62.3 134.62 49.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.621 2.214 . . . . 0.68 112.566 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.861 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.1 t -89.73 -31.74 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 109.593 -0.521 . . . . 0.5 109.593 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.779 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -155.08 145.01 21.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.16 -0.616 . . . . 0.29 111.876 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.652 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.1 140.45 9.12 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.023 -0.99 . . . . 0.24 111.74 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.403 ' HG1' HG23 ' A' ' 3' ' ' VAL . 12.9 t -152.99 127.41 9.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.532 -0.544 . . . . 0.34 109.532 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.87 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.55 144.29 29.71 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.263 0.554 . . . . 2.16 112.082 -174.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.648 ' HB3' HG22 ' A' ' 34' ' ' VAL . 5.9 p90 -133.27 122.52 24.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.279 -1.378 . . . . 1.31 107.279 168.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.893 ' HG3' HD11 ' A' ' 117' ' ' LEU . 3.9 tp-100 -101.44 156.31 17.54 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.042 -1.036 . . . . 2.53 111.626 171.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.51 ' H ' ' CD ' ' A' ' 170' ' ' GLN . . . -149.0 139.07 22.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.422 -0.353 . . . . 0.75 110.206 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.665 ' HB3' HD12 ' A' ' 117' ' ' LEU . 12.2 pt-20 -106.65 -168.44 1.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.05 0.452 . . . . 2.38 111.87 -173.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.766 ' HA ' HG23 ' A' ' 177' ' ' VAL . 6.9 t90 -77.81 71.38 4.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.661 -0.699 . . . . 4.71 110.168 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.682 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 1.5 t70 -72.59 -62.49 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 1.53 112.615 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.592 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.0 t70 -175.06 -45.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.067 0.46 . . . . 1.26 111.143 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 5.1 m-85 -80.45 7.94 8.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 2.46 111.979 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.766 HG23 ' HA ' ' A' ' 173' ' ' TRP . 94.4 t -72.91 -54.32 4.68 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.3 -0.409 . . . . 0.58 110.083 171.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.733 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -51.92 -41.92 60.82 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.358 2.039 . . . . 0.68 111.868 169.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 0.5 OUTLIER -65.85 -25.16 67.07 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.397 -0.365 . . . . 2.62 111.068 178.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 66.5 tp -68.4 -47.62 66.84 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.229 -0.656 . . . . 1.18 109.229 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.43 -39.43 83.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.82 -0.627 . . . . 2.11 109.478 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 16.4 mm-40 -56.0 -44.45 78.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.772 -1.104 . . . . 1.53 110.795 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.31 -32.45 58.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.366 -0.834 . . . . 2.16 111.958 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 83.0 mt -63.6 -7.07 6.27 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.181 0.437 . . . . 0.87 112.181 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.593 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 16.4 m -68.19 -11.42 59.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.489 0.661 . . . . 1.38 109.714 172.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.736 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 87.23 54.83 2.48 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.137 -0.938 . . . . 1.17 110.88 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.1 mmmt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.503 -0.76 . . . . 2.45 110.328 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 10.4 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.438 0.161 . . . . 5.4 110.574 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 16.7 Cg_exo -67.57 139.14 47.86 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.111 2.541 . . . . 2.58 112.151 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 t -55.83 123.88 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.48 -0.782 . . . . 2.1 111.546 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -146.29 37.83 1.04 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.768 0.794 . . . . 1.81 110.12 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 24' ' ' PRO . 2.1 mm? 58.88 37.01 24.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.509 -1.223 . . . . 0.95 108.416 -165.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -58.2 -42.93 87.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.456 -1.247 . . . . 2.19 112.021 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.893 ' HB2' HD13 ' A' ' 12' ' ' LEU . 49.9 mttm -136.48 60.94 1.65 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 3.07 109.482 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.448 ' CE3' ' HB2' ' A' ' 20' ' ' GLN . 22.5 p-90 -69.06 -35.75 76.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.13 -0.941 . . . . 4.76 112.009 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 84.5 p -147.24 17.56 1.2 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.542 -0.463 . . . . 0.98 111.904 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -75.52 -124.67 0.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.758 . . . . 0.52 111.782 177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.4 Cg_endo -49.94 -40.41 49.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.248 2.632 . . . . 0.61 110.268 168.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.893 HD13 ' HB2' ' A' ' 7' ' ' LYS . 22.2 mt -88.1 83.62 6.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.85 -1.068 . . . . 1.85 109.218 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 m -74.57 62.66 1.04 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.618 0.723 . . . . 1.31 110.397 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.526 HD11 ' HG ' ' A' ' 168' ' ' CYS . 46.0 mt -76.52 -17.46 59.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 0.61 110.825 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.7 OUTLIER -64.99 -21.53 66.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.877 -0.601 . . . . 2.61 109.919 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.66 -28.51 65.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.35 0.595 . . . . 1.93 110.65 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.714 HG12 HG21 ' A' ' 69' ' ' THR . 52.0 t -83.99 -73.47 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.265 -0.88 . . . . 1.26 109.684 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 151' ' ' VAL . 48.3 t0 -139.32 161.19 38.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.846 -0.615 . . . . 2.99 109.659 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 163' ' ' PRO . 32.6 mt-10 -64.09 153.42 37.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.652 -0.703 . . . . 1.6 111.846 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.448 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 20.1 tt0 -56.05 124.26 58.24 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 4.38 110.34 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 19.6 Cg_exo -64.47 154.84 69.57 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.318 2.012 . . . . 0.69 112.069 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.91 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.8 pt20 -73.74 -15.55 61.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.606 -0.725 . . . . 1.87 111.121 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.72 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 19.5 m80 -146.45 158.81 46.45 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 2.35 108.995 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 8.1 Cg_endo -88.53 132.55 2.56 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.952 2.435 . . . . 0.44 111.519 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.837 HD21 ' HB3' ' A' ' 122' ' ' TRP . 15.3 tp -84.5 139.83 31.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.33 111.018 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -106.8 131.33 54.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.468 . . . . 2.12 109.93 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.506 HG13 HG22 ' A' ' 53' ' ' ILE . 16.1 t -134.39 142.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.12 -0.696 . . . . 1.12 109.12 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -140.76 140.96 34.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.917 0.389 . . . . 0.78 110.83 -176.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -105.61 178.28 4.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.751 -0.833 . . . . 1.23 108.751 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -52.18 57.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.507 0.67 . . . . 0.6 110.463 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.57 -0.14 49.67 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.26 -0.882 . . . . 0.81 112.836 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.76 -169.8 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.56 110.966 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.56 152.84 16.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.651 -0.704 . . . . 0.35 109.645 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.681 HG23 ' HZ3' ' A' ' 122' ' ' TRP . 99.7 t -106.73 64.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.26 -1.385 . . . . 0.39 107.26 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -93.39 6.31 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.014 -0.993 . . . . 0.99 109.704 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 43.8 mt-10 -133.91 132.7 40.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.191 -0.913 . . . . 2.56 109.071 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.6 OUTLIER -75.74 109.56 9.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.139 -0.689 . . . . 0.46 109.139 -176.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.683 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 93.07 6.18 63.43 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.536 -0.756 . . . . 0.59 112.777 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.55 147.68 52.95 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.493 -0.558 . . . . 1.04 109.493 176.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.47 134.7 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.094 0.473 . . . . 1.16 110.957 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.578 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.4 tp -127.41 169.32 13.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.662 -0.866 . . . . 0.45 108.662 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 25.1 p -121.08 156.64 56.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.287 -0.565 . . . . 1.0 112.227 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.742 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 12.0 Cg_endo -55.5 -30.23 72.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.288 3.325 . . . . 1.0 114.402 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -69.87 -32.48 70.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.64 0.733 . . . . 1.24 110.774 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -79.98 -29.19 39.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.846 -1.07 . . . . 1.74 111.241 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' A' ' 41' ' ' LEU . 16.7 m -118.21 30.19 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.451 . . . . 1.1 111.762 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.605 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.01 -21.08 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.601 -0.518 . . . . 1.32 109.601 176.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.0 -170.85 2.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.316 -0.857 . . . . 2.4 109.617 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.1 156.85 89.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.362 -0.607 . . . . 1.78 109.362 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.93 153.72 25.6 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.588 1.526 . . . . 0.41 109.962 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -80.15 -14.93 58.09 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.353 -0.539 . . . . 0.88 110.555 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.451 ' C ' HG21 ' A' ' 53' ' ' ILE . 69.6 m -161.51 143.38 11.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.457 0.54 . . . . 0.65 112.457 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -140.17 175.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.104 -1.072 . . . . 0.33 108.104 170.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.781 ' HA ' HD11 ' A' ' 58' ' ' LEU . 47.8 t 169.56 125.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.497 0.498 . . . . 0.8 110.039 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.602 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 60.2 p-90 -88.13 153.7 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.672 -0.862 . . . . 3.63 108.672 173.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.76 91.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 1.51 110.954 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.66 8.71 8.09 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.836 -0.62 . . . . 0.9 112.42 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 54' ' ' SER . 7.7 tt -56.76 129.0 39.4 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.848 0.459 . . . . 0.62 110.857 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.39 -29.04 56.96 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.771 -0.65 . . . . 0.74 111.744 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.648 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.2 m 74.23 0.33 3.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.475 -0.784 . . . . 1.51 110.821 -175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.31 -34.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.058 -0.591 . . . . 0.84 113.879 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -97.34 166.72 11.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.37 0.605 . . . . 2.12 112.076 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.0 mt -91.9 134.02 35.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.758 -1.11 . . . . 1.23 110.109 -175.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.559 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 7.0 m-85 -124.35 162.83 22.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.892 0.314 . . . . 1.61 110.194 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.559 ' HG1' HD21 ' A' ' 131' ' ' LEU . 86.3 m -102.15 109.74 21.51 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.557 -0.534 . . . . 0.87 109.557 174.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.595 HD11 HG11 ' A' ' 124' ' ' VAL . 53.0 tp -109.09 118.89 37.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.773 0.321 . . . . 1.35 110.523 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.1 130.58 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.54 110.742 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.661 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -90.88 141.91 28.33 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.756 -0.831 . . . . 0.65 108.756 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.714 HG21 HG12 ' A' ' 17' ' ' VAL . 12.9 t -140.62 148.13 40.42 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.889 -0.324 . . . . 1.04 110.66 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 22.5 t70 -133.82 97.44 15.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 121.265 0.555 . . . . 1.92 109.959 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.55 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 3.4 Cg_endo -45.78 -47.63 13.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.489 3.459 . . . . 1.25 114.827 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 76' ' ' ARG . 30.1 m-20 -86.98 52.77 2.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.473 0.545 . . . . 1.29 112.473 -167.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.67 20.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.15 -0.477 . . . . 0.56 110.115 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 85.9 Cg_endo -82.14 -23.53 13.43 Favored 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.527 -1.447 . . . . 0.7 112.858 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.714 ' HB3' HG22 ' A' ' 115' ' ' THR . 6.4 p -137.74 153.66 49.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 1.1 110.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HG3' ' OD1' ' A' ' 72' ' ' ASP . 78.9 ttt180 -68.82 -23.15 64.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.328 0.585 . . . . 3.39 110.499 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.544 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.4 ptpt -76.21 -17.05 59.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.81 -0.632 . . . . 1.83 110.496 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 7.9 t0 -162.97 72.63 2.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 1.37 109.876 -172.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.28 87.99 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.266 1.978 . . . . 0.9 112.179 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.3 mttm -76.27 -51.42 12.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.449 -1.25 . . . . 1.53 110.548 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.654 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 86.5 m-85 -80.37 19.29 0.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.155 -0.93 . . . . 1.54 111.555 -171.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.686 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 17.2 ttp180 -69.54 126.64 30.34 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.16 -0.311 . . . . 3.38 110.16 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.686 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 2.2 mp0 -98.66 135.35 40.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.945 0.402 . . . . 2.23 110.471 -4.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.585 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.7 t90 -80.94 135.45 35.88 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.15 -0.685 . . . . 1.77 109.15 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 6.4 p80 -108.29 132.47 53.66 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.251 -0.58 . . . . 2.19 109.453 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.661 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.2 t-160 -83.75 -26.37 29.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.135 -0.484 . . . . 2.74 111.514 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.713 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 23.4 p90 -168.74 178.55 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.302 -0.629 . . . . 2.21 109.302 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.3 tp -141.41 114.26 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.155 0.285 . . . . 0.68 110.416 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.713 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -120.39 132.4 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.422 0.63 . . . . 0.35 110.931 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 65' ' ' THR . 13.5 m -133.46 166.02 30.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.149 -1.056 . . . . 0.3 108.149 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.743 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t-20 62.16 17.38 9.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.742 0.306 . . . . 2.09 110.292 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.524 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 9.2 ttm -70.27 108.53 4.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.761 -0.829 . . . . 0.34 108.761 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.2 ttmm -83.48 90.42 7.21 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.817 -1.083 . . . . 1.73 110.633 -171.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.648 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.52 -126.62 7.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.943 -1.026 . . . . 0.35 112.271 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.527 ' HB3' HD22 ' A' ' 58' ' ' LEU . 3.7 p-10 -111.78 24.2 12.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.411 0.624 . . . . 1.59 110.354 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.07 110.75 22.12 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.459 -0.791 . . . . 0.77 110.157 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.6 mm -62.28 -23.7 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.489 -1.232 . . . . 0.45 111.188 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.8 m -81.52 -40.74 22.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 1.15 112.272 -172.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.1 p -70.64 -21.41 62.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.642 0.238 . . . . 1.26 111.642 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.524 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -58.22 102.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.266 -0.492 . . . . 0.44 112.324 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.5 m -68.83 106.93 2.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.445 -0.576 . . . . 1.06 109.445 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.588 HG23 ' HA ' ' A' ' 105' ' ' ASP . 14.8 p -90.72 116.21 31.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.316 -0.856 . . . . 1.15 110.898 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mt -89.59 -45.92 9.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.015 0.912 . . . . 0.48 109.364 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.2 t -112.1 106.67 15.36 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.387 -1.708 . . . . 0.62 106.387 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.96 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.7 t0 -62.39 161.29 11.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.15 112.529 -165.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -78.07 100.44 6.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.377 -0.829 . . . . 4.98 108.902 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.84 HG12 HD13 ' A' ' 180' ' ' LEU . 33.1 t -71.12 -39.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.645 . . . . 0.86 112.263 -173.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.51 171.45 28.08 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.768 -0.729 . . . . 0.95 112.665 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.742 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 27.7 t -61.54 139.6 58.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.149 0.474 . . . . 0.89 110.723 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.84 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -176.63 61.82 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.82 111.613 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.884 ' HD2' HG22 ' A' ' 177' ' ' VAL . 87.0 Cg_endo -85.46 136.18 5.42 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.553 2.169 . . . . 1.01 112.929 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.695 ' HB2' HG23 ' A' ' 115' ' ' THR . 42.2 Cg_exo -57.51 148.18 74.23 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.77 2.313 . . . . 0.96 111.533 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 125.19 28.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.248 -0.433 . . . . 2.39 111.092 -176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.58 18.6 37.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.814 -0.708 . . . . 1.3 112.049 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.714 HG22 ' HB3' ' A' ' 75' ' ' SER . 70.3 p -103.55 -12.89 16.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.764 0.316 . . . . 1.04 111.423 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.46 21.36 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.56 -0.616 . . . . 1.97 111.56 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.5 mm? -86.41 129.1 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.831 0.348 . . . . 0.94 110.181 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.8 m-70 -94.1 115.63 27.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.89 -0.411 . . . . 2.85 109.89 177.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.55 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 6.0 ptt180 -104.29 84.94 2.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 2.78 110.689 -172.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.609 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 22.2 m-85 -69.28 117.24 10.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.539 -0.755 . . . . 1.13 109.539 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 168' ' ' CYS . 11.6 t -95.9 129.24 46.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.841 -0.618 . . . . 0.31 110.152 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.837 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.56 118.92 28.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.908 -0.587 . . . . 2.96 109.594 178.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.08 119.29 33.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.389 -0.226 . . . . 0.41 110.389 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -108.26 136.3 44.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.356 -0.538 . . . . 0.43 109.958 174.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.593 ' HB2' HD21 ' A' ' 160' ' ' LEU . 55.9 m-85 -113.88 144.25 43.35 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.904 -0.589 . . . . 5.41 109.773 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -105.87 112.0 24.89 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.485 -0.561 . . . . 2.41 109.485 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.559 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.13 179.25 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.31 109.788 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.51 -27.33 37.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.659 0.742 . . . . 2.4 109.258 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.65 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 3.5 ptp180 -153.86 174.39 3.83 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 114.535 -1.212 . . . . 4.07 111.619 -171.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 55.7 Cg_exo -52.23 152.8 14.22 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.096 2.53 . . . . 1.21 112.119 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.559 HD21 ' HG1' ' A' ' 65' ' ' THR . 4.4 mm? -76.53 152.78 35.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 1.16 111.977 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.76 68.96 0.68 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.225 -0.898 . . . . 3.23 108.749 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 p -82.75 118.71 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.471 -0.786 . . . . 2.79 111.159 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.36 8.88 33.87 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.703 -0.851 . . . . 2.96 108.703 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.54 116.92 47.91 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.667 -1.151 . . . . 1.39 109.943 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.63 131.28 32.7 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.933 2.422 . . . . 1.38 112.155 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.4 mm -59.32 115.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.743 -0.466 . . . . 0.94 109.743 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 145' ' ' HIS . 77.9 mt -96.46 -13.93 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.61 112.422 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 m 59.91 -172.51 0.12 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.933 0.397 . . . . 1.88 110.313 -172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.96 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 25.1 p-10 -115.69 37.95 3.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.204 0.526 . . . . 1.33 110.207 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.593 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 6.9 mtm180 -116.29 136.08 53.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.276 0.56 . . . . 3.83 111.809 -169.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.659 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.2 m 66.96 2.23 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.876 -1.056 . . . . 1.32 113.585 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.63 92.49 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.508 -0.769 . . . . 1.13 111.784 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.83 -49.97 73.82 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.047 0.758 . . . . 2.66 113.047 -172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.591 ' HB2' HD11 ' A' ' 138' ' ' LEU . 43.1 m80 -117.0 69.24 0.75 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.868 -0.79 . . . . 2.18 108.868 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.454 ' O ' ' HD1' ' A' ' 84' ' ' TRP . 5.1 ttm180 -73.81 -81.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.31 -1.314 . . . . 5.37 112.189 -170.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -124.38 -168.41 12.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.174 -1.012 . . . . 0.9 112.926 -169.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.654 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.2 mttt 67.73 29.18 6.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.603 0.716 . . . . 1.59 110.099 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.67 113.16 25.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.882 -1.054 . . . . 2.27 109.415 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 12.3 mmmm -69.94 127.98 34.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.313 0.578 . . . . 1.87 111.767 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.742 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 0.2 OUTLIER -58.43 -33.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.992 -1.004 . . . . 0.96 111.44 175.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.58 -35.53 80.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.76 110.415 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.1 m -68.4 -35.5 77.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 -0.227 . . . . 1.22 110.874 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.742 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 64.9 m-85 -58.96 -52.58 65.13 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.032 0.444 . . . . 1.1 110.522 176.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 2.7 ptt-85 -69.12 -38.53 78.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.013 -0.54 . . . . 3.36 111.422 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.5 mtmt -61.29 -28.42 69.18 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.75 0.278 . . . . 1.52 111.75 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -54.88 -54.01 48.01 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.122 0.264 . . . . 2.13 111.547 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.465 ' HB3' HD13 ' A' ' 160' ' ' LEU . 12.9 t80 -105.1 15.04 28.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.575 -0.85 . . . . 5.77 110.479 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 61.91 45.91 7.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 2.42 111.739 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 125' ' ' TYR . 7.0 mp -81.52 176.35 9.75 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.472 -0.785 . . . . 1.27 110.604 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.0 tpt180 -101.74 -164.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.267 -0.424 . . . . 4.0 110.5 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.569 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -71.44 166.17 41.76 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 109.704 -0.48 . . . . 1.21 109.704 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.515 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 31.9 Cg_exo -55.2 138.04 78.28 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.68 113.08 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.91 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -88.76 -29.85 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 CA-C-N 115.555 -0.748 . . . . 0.5 109.027 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.91 148.19 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.442 -0.503 . . . . 0.29 111.358 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.747 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -151.22 147.01 16.48 Favored Glycine 0 N--CA 1.436 -1.317 0 CA-C-N 115.161 -0.927 . . . . 0.24 112.273 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -165.54 139.67 4.69 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.431 -0.951 . . . . 0.34 108.431 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 16.6 p -118.63 144.95 45.81 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 2.16 111.265 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.2 p90 -127.85 127.1 42.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.655 -1.239 . . . . 1.31 107.655 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -106.03 133.17 51.16 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.659 -0.651 . . . . 2.53 111.734 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -128.92 145.96 51.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.195 -0.911 . . . . 0.75 109.616 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.633 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -121.36 -172.3 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.661 0.267 . . . . 2.38 110.863 -177.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.973 ' HA ' HG23 ' A' ' 177' ' ' VAL . 29.9 t90 -74.76 82.8 2.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.74 -0.467 . . . . 4.71 109.74 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 0.3 OUTLIER -72.09 -61.62 1.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.867 -0.606 . . . . 1.53 111.293 176.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.581 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.4 t70 169.55 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.826 0.704 . . . . 1.26 109.644 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 60.7 m-85 -81.22 10.82 4.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.219 0.533 . . . . 2.46 111.346 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.973 HG23 ' HA ' ' A' ' 173' ' ' TRP . 74.8 t -72.31 -49.39 9.32 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.58 110.712 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.8 Cg_exo -49.05 -26.34 10.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.947 2.431 . . . . 0.68 113.06 170.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.58 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 18.1 mmmt -67.4 -24.65 65.69 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.34 0.256 . . . . 2.62 111.629 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.84 HD13 HG12 ' A' ' 107' ' ' VAL . 21.5 tp -78.25 -40.75 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.112 -0.635 . . . . 1.18 109.358 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.65 -35.26 74.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.944 -0.762 . . . . 2.11 108.944 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 0.9 OUTLIER -55.51 -56.49 19.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.495 -1.23 . . . . 1.53 109.73 172.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -69.6 -39.02 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.705 -1.134 . . . . 2.16 112.549 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.659 ' HA ' ' H ' ' A' ' 142' ' ' SER . 74.1 mt -71.5 6.99 1.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.005 0.431 . . . . 0.87 111.686 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.498 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 19.9 m -77.76 -3.45 41.34 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.31 -0.626 . . . . 1.38 109.31 168.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 75.1 49.67 9.36 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.839 -0.904 . . . . 1.17 110.839 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.498 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.1 mmtp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.678 -0.677 . . . . 2.45 110.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.613 -0.143 . . . . 5.4 110.613 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 75.3 Cg_exo -50.33 132.15 33.66 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.581 2.854 . . . . 2.58 113.184 -173.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t -55.71 127.8 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.707 -1.133 . . . . 2.1 111.953 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -146.13 160.53 41.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.889 -1.152 . . . . 1.81 107.889 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.5 mm? -81.93 30.78 0.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.95 111.005 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -76.92 -18.44 58.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.139 0.495 . . . . 2.19 110.517 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -114.36 33.44 5.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.052 0.453 . . . . 3.07 110.25 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.735 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.1 p90 -73.89 -28.2 61.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 4.76 111.921 -174.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -147.65 11.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.98 110.641 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -76.75 -118.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.84 -0.618 . . . . 0.52 111.671 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.2 Cg_endo -49.21 -45.89 28.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.232 2.621 . . . . 0.61 110.703 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.735 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 9.4 mp -89.72 102.21 14.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.298 -0.864 . . . . 1.85 111.249 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 65.98 2.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.19 0.519 . . . . 1.31 110.408 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 121' ' ' VAL . 22.0 mt -74.32 -17.45 60.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.61 111.423 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -69.65 -5.99 28.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.294 -0.412 . . . . 2.61 111.44 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.14 -14.12 60.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.938 0.399 . . . . 1.93 111.41 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.914 HG12 HG21 ' A' ' 69' ' ' THR . 60.9 t -91.49 -71.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.509 -0.769 . . . . 1.26 110.744 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 23.4 t0 -155.26 176.38 12.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.483 -0.932 . . . . 2.99 108.483 -170.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.89 100.1 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.864 -0.421 . . . . 1.6 109.864 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.735 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -43.14 128.58 3.41 Favored Pre-proline 0 C--O 1.234 0.283 0 O-C-N 124.142 0.901 . . . . 4.38 110.38 -176.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.617 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 53.0 Cg_exo -52.87 166.86 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.499 2.799 . . . . 0.69 114.516 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.893 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 9.7 pt20 -84.16 -11.88 55.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.474 -1.239 . . . . 1.87 111.812 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.734 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 14.8 m-70 -147.02 157.78 45.94 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 123.11 0.564 . . . . 2.35 110.072 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.3 Cg_endo -86.42 123.5 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.326 2.684 . . . . 0.44 111.652 176.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 16.9 tp -79.06 136.36 37.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.716 0.294 . . . . 0.33 110.732 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.31 117.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.924 -0.399 . . . . 2.12 109.924 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 34' ' ' VAL . 26.4 t -123.27 144.62 32.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.171 -0.678 . . . . 1.12 109.171 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 144.22 32.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.797 0.332 . . . . 0.78 110.701 -173.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.476 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 17.8 t80 -108.92 178.52 4.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 1.23 109.348 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -52.8 64.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 0.6 110.843 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.69 11.23 15.84 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.596 -0.729 . . . . 0.81 112.494 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.44 -171.3 3.38 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.877 0.37 . . . . 0.56 110.164 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.69 154.23 17.94 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.88 -0.6 . . . . 0.35 109.543 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.75 HG23 ' HZ3' ' A' ' 122' ' ' TRP . 89.9 t -100.16 61.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 106.968 -1.493 . . . . 0.39 106.968 166.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -96.14 27.68 3.56 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.402 -1.272 . . . . 0.99 109.301 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -153.98 125.76 7.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.917 -1.142 . . . . 2.56 107.917 173.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.512 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.8 OUTLIER -74.67 110.38 8.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.081 0.467 . . . . 0.46 109.963 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.779 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 98.81 -3.27 58.81 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.635 -0.793 . . . . 0.59 112.483 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.728 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -62.85 150.44 41.72 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.304 0.242 . . . . 1.04 110.393 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.61 127.57 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 1.16 110.672 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tp -115.87 169.72 9.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.153 -1.425 . . . . 0.45 107.153 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 2.6 p -113.47 150.17 42.77 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.88 -1.128 . . . . 1.0 113.369 -174.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 35.8 Cg_exo -61.23 -27.78 84.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.208 3.272 . . . . 1.0 113.196 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.455 HG22 ' CD2' ' A' ' 176' ' ' TYR . 10.4 p -65.3 -40.28 93.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.84 . . . . 1.24 109.972 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -81.46 -50.87 8.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.466 -1.243 . . . . 1.74 111.399 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.796 ' HB ' ' HE2' ' A' ' 169' ' ' TYR . 3.8 m -85.56 25.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.209 0.528 . . . . 1.1 112.366 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -81.25 -20.03 41.84 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.083 -0.71 . . . . 1.32 109.083 175.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -119.5 -161.88 0.89 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.84 -1.073 . . . . 2.4 110.052 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.585 HH22 HG23 ' A' ' 89' ' ' VAL . 29.5 mtp180 -91.38 165.84 20.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.168 -0.308 . . . . 1.78 110.168 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 57.3 Cg_endo -75.81 169.13 22.85 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.912 1.742 . . . . 0.41 110.725 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -91.3 -18.39 24.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.787 -0.365 . . . . 0.88 110.121 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.421 ' C ' HG21 ' A' ' 53' ' ' ILE . 74.0 m -160.77 142.52 12.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.65 112.101 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.541 HD13 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -137.99 168.21 20.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.322 -0.992 . . . . 0.33 108.322 171.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.687 ' HA ' HD11 ' A' ' 58' ' ' LEU . 47.3 t 169.18 122.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.368 0.417 . . . . 0.8 110.333 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.51 ' CB ' ' HB1' ' A' ' 165' ' ' ALA . 46.8 p-90 -82.65 150.99 26.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.165 -1.42 . . . . 3.63 107.165 169.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' CG ' ' HD1' ' A' ' 23' ' ' HIS . 12.5 p-10 -68.28 87.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.826 0.822 . . . . 1.51 111.15 -174.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.71 -1.38 3.2 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.919 -1.037 . . . . 0.9 111.626 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.687 HD11 ' HA ' ' A' ' 54' ' ' SER . 7.8 tt -52.17 128.61 25.42 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.087 0.555 . . . . 0.62 110.336 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.767 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 33.9 t70 -75.09 -27.18 59.8 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.74 111.757 -173.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.617 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 15.9 m 73.03 2.56 4.42 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.979 -1.01 . . . . 1.51 110.192 -172.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.81 -9.06 2.6 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.127 -0.559 . . . . 0.84 113.5 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.767 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 35.4 mtpt -94.75 161.05 14.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.251 0.525 . . . . 2.12 109.918 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 60.8 mt -95.11 134.49 37.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.399 -0.593 . . . . 1.23 109.399 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -133.59 145.92 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.42 -0.585 . . . . 1.61 109.42 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.666 HG22 HG11 ' A' ' 90' ' ' VAL . 60.2 m -95.96 105.27 17.27 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.704 -0.85 . . . . 0.87 108.704 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 HG11 ' A' ' 124' ' ' VAL . 49.3 tp -100.54 109.93 22.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 1.35 110.193 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 88' ' ' LEU . 27.4 t -110.15 121.1 62.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.54 110.533 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.942 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.0 mt -81.91 138.98 34.91 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.465 -0.939 . . . . 0.65 108.465 167.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.914 HG21 HG12 ' A' ' 17' ' ' VAL . 8.9 t -144.79 147.39 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.858 -0.337 . . . . 1.04 110.858 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 9.1 t0 -131.84 95.56 22.37 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.546 0.688 . . . . 1.92 109.745 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 18.8 Cg_endo -60.01 -11.63 16.11 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 124.126 3.217 . . . . 1.25 114.065 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 118' ' ' HIS . 2.3 t70 -106.61 26.46 9.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.405 0.621 . . . . 1.29 110.431 -167.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.575 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -103.33 144.79 29.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.052 -0.522 . . . . 0.56 111.591 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.45 ' HD3' ' HD2' ' A' ' 81' ' ' TYR . 96.0 Cg_endo -84.86 -24.47 10.2 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.207 -1.58 . . . . 0.7 112.819 -0.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.575 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 62.1 p -134.72 149.67 50.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 1.1 109.371 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HB2' ' OD2' ' A' ' 72' ' ' ASP . 41.0 ttm180 -69.69 -26.86 64.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 3.39 111.473 -177.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -69.82 -23.5 63.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.44 -0.345 . . . . 1.83 111.025 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -157.62 84.03 2.84 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.912 0.386 . . . . 1.37 110.379 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.5 81.54 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.593 2.195 . . . . 0.9 112.025 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.2 mttm -66.68 -48.18 70.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.295 -1.321 . . . . 1.53 111.46 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.653 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 48.7 m-85 -83.59 8.82 13.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.343 -0.844 . . . . 1.54 112.16 -166.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 53.9 ttp180 -58.28 122.79 14.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 3.38 110.794 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mp0 -101.14 131.93 46.85 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.839 0.352 . . . . 2.23 110.796 -2.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.575 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 12.5 t90 -79.52 93.66 5.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 1.77 110.113 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.9 p-80 -67.44 123.8 21.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.352 0.596 . . . . 2.19 109.421 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.942 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 11.5 t60 -76.64 -30.76 56.99 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.622 -0.717 . . . . 2.74 110.324 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.0 p90 -168.48 174.2 7.03 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.6 -0.519 . . . . 2.21 109.6 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HG ' HD12 ' A' ' 103' ' ' LEU . 19.7 tp -134.55 114.2 12.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.907 -0.405 . . . . 0.68 109.907 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.585 HG23 HH22 ' A' ' 49' ' ' ARG . 1.7 t -123.54 131.76 72.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.757 -0.656 . . . . 0.35 110.903 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.666 HG11 HG22 ' A' ' 65' ' ' THR . 15.0 m -133.28 163.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.957 -1.02 . . . . 0.3 108.529 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' A' ' 130' ' ' PRO . 2.5 t-20 62.85 18.34 10.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.333 0.396 . . . . 2.09 110.008 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.585 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 5.4 ttm -69.94 106.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.074 -0.713 . . . . 0.34 109.074 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 93' ' ' LYS . 12.9 ttmm -84.21 89.72 7.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.616 -1.175 . . . . 1.73 110.697 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 82.48 -127.18 7.82 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.875 -1.057 . . . . 0.35 112.632 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.589 ' HB3' HD22 ' A' ' 58' ' ' LEU . 26.5 p-10 -115.6 24.02 11.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 1.59 111.432 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -89.42 105.71 17.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.378 0.608 . . . . 0.77 109.729 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.541 HD11 HD13 ' A' ' 53' ' ' ILE . 10.7 mm -49.98 -35.91 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.291 -1.322 . . . . 0.45 111.387 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 m -80.88 -31.49 35.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.685 -0.689 . . . . 1.15 111.834 -172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -72.76 -11.21 60.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 1.26 111.565 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.585 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -71.0 102.33 1.05 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.554 -0.831 . . . . 0.44 111.602 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.9 m -61.98 109.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.478 0.656 . . . . 1.06 110.066 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.6 p -83.2 117.49 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.825 -1.079 . . . . 1.15 111.588 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 47.3 mt -92.85 -39.02 11.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.018 0.913 . . . . 0.48 109.372 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 22.0 t -127.44 110.27 12.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.446 -1.316 . . . . 0.62 107.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.973 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -56.76 161.78 2.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.122 0.889 . . . . 1.15 112.921 -170.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -83.86 101.33 11.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.37 -0.832 . . . . 4.98 110.283 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.774 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 25.9 t -69.3 -41.46 81.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.893 -0.594 . . . . 0.86 111.748 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.39 -176.55 24.39 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.95 112.333 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.442 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 27.0 t -63.7 123.17 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.67 0.235 . . . . 0.89 110.803 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -154.3 61.74 0.37 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.9 -0.667 . . . . 0.82 112.708 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.539 ' HD2' HG22 ' A' ' 177' ' ' VAL . 73.9 Cg_endo -94.51 123.35 0.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.922 2.415 . . . . 1.01 112.669 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.66 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.7 Cg_exo -52.56 140.77 54.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.884 2.39 . . . . 0.96 111.814 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.503 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -64.53 125.31 24.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.141 0.495 . . . . 2.39 110.839 -177.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.08 -4.02 60.55 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.615 -0.802 . . . . 1.3 112.856 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.66 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 74.0 p -78.1 -15.82 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.699 -0.295 . . . . 1.04 111.261 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 171.33 39.37 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.876 -0.602 . . . . 1.97 111.862 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.37 115.58 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.956 -0.757 . . . . 0.94 108.956 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.755 ' N ' ' HG2' ' A' ' 170' ' ' GLN . 75.2 m-70 -88.61 -134.3 0.09 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.2 -0.667 . . . . 2.85 109.2 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.735 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 2.8 ptt180 -176.53 100.9 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.743 0.646 . . . . 2.78 112.743 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.453 ' HD1' ' HB2' ' A' ' 70' ' ' ASP . 19.3 m-85 -77.78 106.79 9.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.359 -0.978 . . . . 1.13 108.359 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.606 HG23 HD21 ' A' ' 14' ' ' LEU . 5.2 t -96.26 133.48 37.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.412 -0.358 . . . . 0.31 110.122 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.784 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -87.74 119.41 28.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.652 -0.499 . . . . 2.96 109.652 178.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.5 mt -115.31 117.77 31.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.71 -0.478 . . . . 0.41 109.71 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.669 HG11 HD11 ' A' ' 66' ' ' LEU . 1.7 m -104.18 128.93 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.179 -0.608 . . . . 0.43 109.663 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.518 ' HD2' ' O ' ' A' ' 161' ' ' ARG . 21.0 m-85 -109.72 124.76 51.8 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.069 -0.715 . . . . 5.41 109.069 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.92 131.15 43.99 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.346 -0.541 . . . . 2.41 109.689 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.539 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 20.7 mt-30 -93.7 130.35 39.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.943 -0.572 . . . . 1.31 111.044 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.69 -11.17 59.85 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.509 -0.922 . . . . 2.4 108.509 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 1.1 ptt180 -164.71 150.57 8.95 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 114.44 -1.255 . . . . 4.07 109.919 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.599 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 15.1 Cg_exo -66.56 132.68 29.72 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.198 2.599 . . . . 1.21 112.49 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.674 HD12 ' SG ' ' A' ' 133' ' ' CYS . 3.6 mm? -64.17 151.69 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.753 -0.658 . . . . 1.16 111.335 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 39.08 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.25 1.024 . . . . 3.23 109.866 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.746 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.7 m -53.44 138.49 33.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.51 -1.677 . . . . 2.79 113.058 -172.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.55 18.18 10.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.07 -0.968 . . . . 2.96 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.746 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.8 mm-40 -69.14 126.71 92.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.758 -0.655 . . . . 1.39 110.413 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.06 116.43 2.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.162 2.575 . . . . 1.38 112.288 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mm -63.0 115.08 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.94 110.553 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 67.5 mt -100.61 146.4 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.533 -0.543 . . . . 1.61 109.533 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 141' ' ' ARG . 55.5 m -111.35 35.39 3.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.721 -0.672 . . . . 1.88 111.234 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.973 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.4 OUTLIER 63.22 -18.61 0.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.027 1.331 . . . . 1.33 113.537 175.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.4 mtt180 -84.55 135.9 34.02 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.188 -0.301 . . . . 3.83 110.188 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.613 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.9 m 81.97 131.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.97 1.419 . . . . 1.32 110.641 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.12 33.98 5.91 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.479 -0.782 . . . . 1.13 112.399 -175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.01 -30.48 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.625 0.25 . . . . 2.66 111.424 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.99 70.61 1.35 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.211 0.529 . . . . 2.18 111.013 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.451 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 49.3 mtt180 -79.94 -66.06 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 5.37 110.419 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -130.36 -143.42 5.36 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.693 -0.765 . . . . 0.9 112.079 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 64.83 23.55 12.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.516 0.674 . . . . 1.59 110.473 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -119.79 125.97 49.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.997 -1.002 . . . . 2.27 108.394 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -76.9 127.76 33.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.333 0.587 . . . . 1.87 111.703 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 4.5 m -61.01 -31.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.04 -0.982 . . . . 0.96 110.967 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.74 -39.77 92.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.773 -0.649 . . . . 0.76 109.999 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.7 m -67.56 -34.77 77.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.396 -0.366 . . . . 1.22 111.127 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.892 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 33.2 m-85 -59.28 -50.32 74.46 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.579 0.704 . . . . 1.1 110.058 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -63.02 -50.15 71.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.875 -1.057 . . . . 3.36 111.139 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.0 mtmt -62.32 -27.92 69.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.281 -0.418 . . . . 1.52 111.766 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -53.98 -53.48 52.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.193 -0.458 . . . . 2.13 111.352 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -103.97 9.92 36.41 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.274 -0.571 . . . . 5.77 111.222 -173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 65.37 44.0 3.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.558 0.694 . . . . 2.42 110.18 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 160' ' ' LEU . 2.3 tp -78.45 164.68 24.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.062 -0.972 . . . . 1.27 111.037 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.638 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 22.4 tpt180 -86.9 -179.47 6.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 4.0 109.763 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.638 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -75.93 160.4 78.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.119 -0.326 . . . . 1.21 110.119 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.472 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 23.4 Cg_exo -60.69 141.97 96.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.802 2.335 . . . . 0.68 113.201 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.893 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.1 t -95.06 -39.44 10.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.608 -0.723 . . . . 0.5 110.15 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.701 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -136.94 145.02 43.74 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.035 -0.666 . . . . 0.29 111.794 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.784 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.39 149.11 21.22 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.258 -0.883 . . . . 0.24 112.626 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 25' ' ' LEU . 12.5 t -170.59 142.0 1.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.369 -0.604 . . . . 0.34 109.369 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.779 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -108.9 144.72 36.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.032 0.444 . . . . 2.16 111.93 -174.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.796 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 1.9 p90 -137.63 105.5 5.64 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.007 -0.738 . . . . 1.31 109.007 171.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.755 ' HG2' ' N ' ' A' ' 118' ' ' HIS . 7.8 tp-100 -100.39 169.61 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.679 -1.263 . . . . 2.53 112.132 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 170' ' ' GLN . . . -146.23 160.19 42.31 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.134 -0.691 . . . . 0.75 109.134 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.44 -171.99 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.314 -0.403 . . . . 2.38 110.448 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.614 ' HA ' HG23 ' A' ' 177' ' ' VAL . 8.3 t90 -80.48 68.85 6.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.435 . . . . 4.71 109.897 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.8 -61.33 1.82 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.453 -0.34 . . . . 1.53 111.839 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.605 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 16.6 t70 -168.94 -55.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.088 0.403 . . . . 1.26 112.088 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.455 ' CD2' HG22 ' A' ' 44' ' ' THR . 50.7 m-85 -81.57 11.21 4.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.48 0.548 . . . . 2.46 112.48 -176.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.701 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 91.3 t -71.61 -53.68 7.23 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.579 -0.526 . . . . 0.58 109.579 171.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.701 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.0 Cg_exo -49.74 -43.22 41.16 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.706 2.271 . . . . 0.68 112.603 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.637 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 4.7 mmmp? -70.35 -24.69 63.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.896 0.332 . . . . 2.62 111.896 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.659 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 51.7 tp -70.39 -47.63 59.95 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.333 -0.617 . . . . 1.18 109.333 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.22 -37.44 77.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 2.11 109.449 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 4.8 mm-40 -60.14 -45.68 92.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.91 -1.041 . . . . 1.53 111.271 172.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.07 -32.49 72.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 2.16 111.864 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 63.4 mt -63.13 0.11 0.66 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.149 0.796 . . . . 0.87 113.149 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.474 ' HB2' ' HE2' ' A' ' 187' ' ' LYS . 14.5 m -74.07 -9.86 59.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.305 0.574 . . . . 1.38 109.967 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.61 58.26 3.9 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.591 -1.003 . . . . 1.17 110.591 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.474 ' HE2' ' HB2' ' A' ' 185' ' ' SER . 71.1 mmtt . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.341 -0.838 . . . . 2.45 110.655 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.677 0.275 . . . . 5.4 110.967 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -70.4 108.97 2.32 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.933 2.422 . . . . 2.58 112.24 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t 65.88 129.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.335 -0.848 . . . . 2.1 111.647 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -155.22 154.81 32.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.562 -0.533 . . . . 1.81 109.562 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.421 ' O ' ' HE3' ' A' ' 8' ' ' TRP . 2.3 mm? -81.19 27.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.48 0.178 . . . . 0.95 111.48 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 2.0 m -62.5 -29.89 70.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.991 0.424 . . . . 2.19 111.391 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.528 ' HB2' HD13 ' A' ' 12' ' ' LEU . 6.8 mptt -120.66 51.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.397 -0.365 . . . . 3.07 110.109 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.421 ' HE3' ' O ' ' A' ' 5' ' ' LEU . 12.9 p90 -72.39 -23.32 61.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.45 . . . . 4.76 111.244 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 70.7 p -148.34 7.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.427 -0.509 . . . . 0.98 112.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.455 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.14 -122.28 0.08 OUTLIER Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.806 -0.711 . . . . 0.52 112.102 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.0 Cg_endo -49.37 -42.35 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.259 2.639 . . . . 0.61 110.253 168.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.673 HD12 ' HG ' ' A' ' 168' ' ' CYS . 17.7 mt -88.0 81.98 7.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.646 -1.161 . . . . 1.85 109.323 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -74.7 62.14 1.04 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.542 0.687 . . . . 1.31 110.438 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.477 HD21 HG23 ' A' ' 121' ' ' VAL . 36.4 mt -79.04 -19.93 50.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.183 -0.917 . . . . 0.61 110.922 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -61.13 -15.5 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 2.61 111.262 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.7 -32.8 74.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.95 0.405 . . . . 1.93 110.984 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG11 HG22 ' A' ' 151' ' ' VAL . 98.1 t -90.33 -64.15 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.532 -0.758 . . . . 1.26 110.883 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.471 ' HA ' HH22 ' A' ' 155' ' ' ARG . 5.8 p-10 -115.06 175.95 5.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.077 0.465 . . . . 2.99 111.101 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 20.6 mt-10 -95.09 33.92 1.46 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.879 -0.6 . . . . 1.6 111.412 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER 52.38 133.67 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.217 1.407 . . . . 4.38 113.459 -176.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -80.74 154.17 20.23 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.843 2.362 . . . . 0.69 113.711 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.833 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 6.3 pt20 -74.51 -18.75 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.793 -1.094 . . . . 1.87 111.011 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.755 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.1 m80 -145.93 156.87 51.34 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.525 -0.761 . . . . 2.35 109.7 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 5.0 Cg_endo -85.83 127.43 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 123.056 2.504 . . . . 0.44 111.16 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 17.9 tp -76.97 142.04 40.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.492 -0.322 . . . . 0.33 110.572 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 27.0 m-70 -109.26 115.58 30.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.565 -0.531 . . . . 2.12 109.565 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 HG13 HG22 ' A' ' 53' ' ' ILE . 15.2 t -126.48 119.81 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 1.12 109.691 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -117.68 138.8 51.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.158 0.504 . . . . 0.78 110.411 -177.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -98.16 172.41 7.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.94 -0.573 . . . . 1.23 109.474 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.8 -52.28 64.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.215 0.531 . . . . 0.6 110.739 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.98 -14.68 14.46 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.351 -0.84 . . . . 0.81 112.549 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.37 -170.0 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.021 0.438 . . . . 0.56 110.614 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.74 141.76 8.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.762 -0.653 . . . . 0.35 110.464 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.652 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 92.6 t -91.73 61.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.929 -1.508 . . . . 0.39 106.929 165.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -85.59 10.61 12.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.672 -1.149 . . . . 0.99 110.702 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.1 tt0 -146.16 134.38 21.71 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.732 -0.667 . . . . 2.56 109.431 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -73.48 111.27 8.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.46 -0.571 . . . . 0.46 109.46 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 90.5 17.59 51.96 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.156 -0.545 . . . . 0.59 112.548 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.85 150.68 32.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 1.04 109.703 174.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.9 p -78.73 134.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 1.16 110.66 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.5 tp -131.37 169.7 15.66 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.276 -1.009 . . . . 0.45 108.276 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 3.3 p -122.01 158.1 55.97 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.623 0.601 . . . . 1.0 112.623 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 9.5 Cg_endo -51.35 -48.76 19.69 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.528 2.819 . . . . 1.0 113.818 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 p -61.73 -32.84 73.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 1.24 111.687 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.73 -11.44 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.995 -0.548 . . . . 1.74 111.604 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.592 ' CG1' HD21 ' A' ' 41' ' ' LEU . 29.4 m -129.65 28.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.354 0.597 . . . . 1.1 111.112 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.32 -21.77 25.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.555 -0.748 . . . . 1.32 110.135 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.03 -173.0 2.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.839 -0.618 . . . . 2.4 109.569 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.86 155.38 77.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.108 -0.33 . . . . 1.78 110.108 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.6 152.87 29.9 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.117 1.878 . . . . 0.41 110.732 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 t -76.8 -18.25 58.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.419 -0.355 . . . . 0.88 110.057 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.48 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 58.8 m -160.33 143.29 13.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.556 0.693 . . . . 0.65 112.363 -176.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.512 HD13 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -138.66 168.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.864 -1.162 . . . . 0.33 107.864 170.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.749 ' HA ' HD11 ' A' ' 58' ' ' LEU . 37.3 t 171.96 123.9 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.484 -0.561 . . . . 0.8 109.484 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.638 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 45.3 p-90 -82.23 154.75 25.26 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.862 -1.162 . . . . 3.63 107.862 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.59 89.13 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.009 0.433 . . . . 1.51 110.861 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.91 13.09 4.64 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.487 -0.778 . . . . 0.9 112.011 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.749 HD11 ' HA ' ' A' ' 54' ' ' SER . 5.3 tt -54.23 129.52 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.19 0.519 . . . . 0.62 111.267 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.725 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 36.1 t70 -76.42 -27.93 56.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.74 111.531 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.598 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 50.2 m 72.91 1.0 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.054 -0.975 . . . . 1.51 110.52 -172.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.65 -26.87 1.52 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.69 -0.686 . . . . 0.84 112.733 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.725 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 34.3 mtpt -77.53 149.27 34.93 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.086 0.469 . . . . 2.12 110.549 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.627 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 43.0 mt -87.69 126.72 35.14 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.163 -0.926 . . . . 1.23 108.736 173.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 1.7 m-85 -121.44 163.69 18.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.52 -0.472 . . . . 1.61 110.168 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.957 HG21 HG11 ' A' ' 90' ' ' VAL . 4.0 m -106.56 105.35 15.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.129 -0.693 . . . . 0.87 109.129 173.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 HG11 ' A' ' 124' ' ' VAL . 52.8 tp -102.8 116.34 32.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.001 0.429 . . . . 1.35 110.517 -176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.6 t -119.78 129.91 74.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.049 -0.523 . . . . 0.54 110.67 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 1.058 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.1 mt -93.38 137.06 33.05 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.791 -0.818 . . . . 0.65 108.791 171.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 7.0 t -139.47 149.2 43.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.656 0.265 . . . . 1.04 111.65 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 16.0 t0 -133.8 90.71 26.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.538 0.685 . . . . 1.92 109.697 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.9 Cg_endo -54.81 -26.54 48.31 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 124.034 3.156 . . . . 1.25 114.431 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 58.5 m-20 -85.16 36.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.065 0.395 . . . . 1.29 112.065 -168.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.93 140.34 20.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.19 -0.319 . . . . 0.56 111.566 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 73.0 Cg_endo -78.88 -28.04 7.86 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 122.848 -1.73 . . . . 0.7 112.037 -0.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.652 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -133.37 143.47 48.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.182 -0.917 . . . . 1.1 108.761 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 37.3 ttp180 -72.33 -23.08 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 3.39 112.23 -174.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.686 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -75.57 -11.51 60.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.49 . . . . 1.83 110.419 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -162.14 75.5 2.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 1.37 109.572 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.06 103.33 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.656 2.237 . . . . 0.9 112.994 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.6 mttm -88.05 -48.64 7.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.704 -1.134 . . . . 1.53 110.918 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.701 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 56.0 m-85 -80.45 2.4 25.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.14 -0.937 . . . . 1.54 112.336 -165.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -60.62 128.69 37.84 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.241 -0.651 . . . . 3.38 109.241 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 6.1 tm-20 -88.45 128.71 35.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.933 0.893 . . . . 2.23 110.903 2.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.435 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 22.1 t90 -114.75 91.92 3.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.819 -0.628 . . . . 1.77 109.86 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.762 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 4.5 p-80 -83.92 158.88 21.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.061 0.934 . . . . 2.19 112.535 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 1.058 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t-80 -100.99 -38.45 8.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.047 -1.433 . . . . 2.74 111.378 -172.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.601 ' HB2' ' HD1' ' A' ' 86' ' ' HIS . 55.3 t80 -167.11 137.58 3.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.076 -0.249 . . . . 2.21 110.469 -165.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.65 HD21 ' HH ' ' A' ' 158' ' ' TYR . 22.4 tp -126.74 114.42 17.95 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.249 0.343 . . . . 0.68 110.41 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.79 135.93 61.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.421 0.629 . . . . 0.35 110.823 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.957 HG11 HG21 ' A' ' 65' ' ' THR . 8.1 m -130.19 162.65 37.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.3 108.851 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.627 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.0 OUTLIER 61.54 20.21 11.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.321 0.388 . . . . 2.09 110.863 177.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.512 ' HE2' ' HB2' ' A' ' 92' ' ' MET . 11.2 ttm -70.49 111.31 5.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.83 -0.804 . . . . 0.34 108.83 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 93' ' ' LYS . 18.1 ttmm -87.78 87.4 7.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.893 -1.048 . . . . 1.73 110.341 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 88.57 -129.52 9.65 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 114.878 -1.055 . . . . 0.35 112.495 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.512 ' HB3' HD22 ' A' ' 58' ' ' LEU . 32.3 p30 -116.17 27.13 9.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 1.59 110.888 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -93.93 112.51 24.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.77 109.924 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.512 HD11 HD13 ' A' ' 53' ' ' ILE . 5.6 mm -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.578 -1.192 . . . . 0.45 111.231 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.9 m -85.59 -34.33 21.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.887 -0.597 . . . . 1.15 112.023 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -63.49 -29.4 70.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.26 111.766 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.494 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -58.21 110.91 2.74 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.791 -0.64 . . . . 0.44 113.471 -177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.0 m -70.58 107.43 3.88 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.195 -0.668 . . . . 1.06 109.195 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 105' ' ' ASP . 8.3 p -87.29 145.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.67 0.748 . . . . 1.15 111.989 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.452 ' N ' HG21 ' A' ' 102' ' ' VAL . 13.8 mt -119.4 -32.3 4.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.689 -1.141 . . . . 0.48 109.12 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 14.7 t -131.55 102.02 5.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.769 -1.196 . . . . 0.62 107.769 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.901 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.9 OUTLIER -64.59 169.07 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 1.15 113.2 -167.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.445 ' HD1' ' H ' ' A' ' 106' ' ' TYR . 4.1 p90 -74.34 88.73 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.947 -1.024 . . . . 4.98 110.936 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.702 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 23.8 t -66.49 -49.15 77.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.86 111.082 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.566 ' HA3' ' HZ3' ' A' ' 47' ' ' LYS . . . 112.53 -170.18 13.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.798 -0.715 . . . . 0.95 112.338 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.9 t -67.3 125.56 26.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 0.89 109.824 173.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.697 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -159.01 63.55 0.3 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.615 -0.802 . . . . 0.82 112.922 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.555 ' HB2' ' HD1' ' A' ' 173' ' ' TRP . 10.1 Cg_endo -89.68 133.73 2.21 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.884 2.39 . . . . 1.01 111.844 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.716 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 53.0 Cg_exo -53.32 129.35 33.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.149 . . . . 0.96 111.196 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.528 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.8 OUTLIER -60.56 121.36 11.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.191 0.52 . . . . 2.39 111.712 -174.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.68 -6.39 52.21 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.479 -0.782 . . . . 1.3 113.252 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.716 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -80.65 -5.98 57.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.2 0.444 . . . . 1.04 112.2 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.62 178.38 45.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.915 -0.659 . . . . 1.97 111.571 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.56 144.93 56.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.94 110.657 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 1.0 OUTLIER -121.93 130.88 53.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.138 -0.69 . . . . 2.85 109.138 174.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 8.4 ptp85 -110.72 95.71 5.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.4 0.619 . . . . 2.78 111.361 -170.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.612 ' HA ' ' O ' ' A' ' 69' ' ' THR . 36.8 m-85 -73.87 113.55 11.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 1.13 109.357 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 168' ' ' CYS . 7.1 t -90.52 129.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.604 -0.726 . . . . 0.31 110.062 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.646 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 77.4 m95 -87.54 117.98 26.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.943 -1.132 . . . . 2.96 107.943 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.52 118.37 30.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.24 -0.184 . . . . 0.41 110.557 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 66' ' ' LEU . 1.2 m -105.33 128.24 59.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.342 -0.614 . . . . 0.43 109.342 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.405 ' HB2' ' CD2' ' A' ' 160' ' ' LEU . 88.2 m-85 -110.62 146.53 35.98 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.794 -0.639 . . . . 5.41 109.618 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.9 tt0 -105.58 109.88 22.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.028 -0.533 . . . . 2.41 109.954 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.645 ' HG2' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -72.38 172.52 10.25 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.447 -0.797 . . . . 1.31 109.644 177.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -85.59 -15.21 43.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.794 -0.639 . . . . 2.4 109.397 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.484 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 5.2 ppt_? -158.1 168.5 12.32 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.138 -0.937 . . . . 4.07 110.861 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.52 ' HG3' HD11 ' A' ' 63' ' ' LEU . 87.2 Cg_exo -47.93 147.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.045 2.497 . . . . 1.21 113.025 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.796 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -71.5 157.05 38.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.795 -0.638 . . . . 1.16 112.006 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -146.93 79.36 1.52 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.092 -0.958 . . . . 3.23 108.493 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 3.5 m -102.25 139.9 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.086 0.469 . . . . 2.79 111.183 -173.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -112.89 17.73 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 2.96 109.533 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 15.8 mm-40 -68.81 132.17 90.82 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.259 -0.882 . . . . 1.39 110.941 -174.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.13 111.36 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.465 2.776 . . . . 1.38 113.065 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' A' ' 103' ' ' LEU . 42.9 mm -62.24 125.64 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.711 -0.677 . . . . 0.94 111.583 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -112.12 141.22 46.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.566 -0.531 . . . . 1.61 109.566 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 141' ' ' ARG . 19.6 m -102.13 40.59 1.32 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.569 -0.741 . . . . 1.88 110.728 -173.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.901 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 59.11 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.992 1.317 . . . . 1.33 113.506 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.598 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 47.0 mtt85 -84.59 155.78 21.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.121 -0.696 . . . . 3.83 109.121 173.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.554 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 10.3 p 52.72 120.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.769 1.227 . . . . 1.32 113.05 -171.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -97.3 30.99 8.21 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.119 -0.946 . . . . 1.13 112.308 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.54 -34.67 72.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.937 0.717 . . . . 2.66 112.937 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -125.65 42.05 3.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.305 0.574 . . . . 2.18 111.417 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.422 ' HD2' HG23 ' A' ' 107' ' ' VAL . 42.7 mtp180 -87.47 -18.3 30.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.031 -0.532 . . . . 5.37 112.157 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -145.25 -171.59 15.04 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 119.056 -1.545 . . . . 0.9 114.884 -173.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.701 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.0 mttt 61.87 37.5 15.27 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 114.319 -0.94 . . . . 1.59 110.887 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 80.4 m-85 -120.71 173.99 6.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.275 -1.33 . . . . 2.27 108.281 170.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 12.1 mmmm -117.27 123.53 46.8 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.679 -0.408 . . . . 1.87 111.679 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.491 HG22 HG11 ' A' ' 17' ' ' VAL . 6.6 m -57.98 -26.09 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.852 -0.613 . . . . 0.96 110.791 174.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -68.15 -43.59 77.93 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.905 -0.589 . . . . 0.76 109.93 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.579 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 23.7 m -61.88 -39.16 90.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 1.22 110.273 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -62.53 -48.85 77.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.248 -0.433 . . . . 1.1 110.96 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.8 ptp180 -67.38 -33.8 75.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.86 -0.336 . . . . 3.36 110.723 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 48.8 mtmt -67.94 -28.63 67.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 1.52 110.825 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -72.8 -51.88 17.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 2.13 110.965 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.688 ' HB2' HD13 ' A' ' 160' ' ' LEU . 12.3 m-85 -84.48 -2.11 56.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.363 -0.38 . . . . 5.77 111.978 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 19.4 mm-40 69.19 45.63 0.86 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.689 0.757 . . . . 2.42 110.932 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.688 HD13 ' HB2' ' A' ' 158' ' ' TYR . 5.7 mp -99.53 140.17 34.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.768 -1.106 . . . . 1.27 109.541 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -88.97 -84.43 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 4.0 111.451 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.53 163.16 48.93 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.579 -0.526 . . . . 1.21 109.579 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.576 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.8 133.27 41.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.48 2.12 . . . . 0.68 112.128 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.833 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -89.12 -31.49 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 108.927 -0.768 . . . . 0.5 108.927 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.755 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.57 144.64 24.58 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.5 -0.773 . . . . 0.29 111.261 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.94 146.82 16.66 Favored Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 115.006 -0.997 . . . . 0.24 111.682 176.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.766 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.4 t -160.11 131.21 5.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.945 -0.761 . . . . 0.34 108.945 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.673 ' HG ' HD12 ' A' ' 12' ' ' LEU . 16.5 p -110.91 138.25 47.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.177 0.513 . . . . 2.16 110.862 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.602 ' HB3' HG22 ' A' ' 34' ' ' VAL . 28.1 p90 -119.57 125.37 48.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.078 -1.082 . . . . 1.31 108.078 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -103.92 132.2 50.4 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.754 -0.779 . . . . 2.53 109.928 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -124.33 140.04 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 0.75 111.613 -172.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.62 151.67 26.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 2.38 111.341 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.999 ' HA ' HG23 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -76.26 68.35 2.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.21 -0.904 . . . . 4.71 108.949 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.54 -61.53 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.143 -0.935 . . . . 1.53 112.32 -170.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.595 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.2 t70 -171.44 -38.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.868 0.366 . . . . 1.26 111.802 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -80.03 2.04 25.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 2.46 110.605 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.999 HG23 ' HA ' ' A' ' 173' ' ' TRP . 48.7 t -69.46 -51.22 17.17 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.761 -0.654 . . . . 0.58 111.371 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.595 ' HD2' ' O ' ' A' ' 175' ' ' ASP . 84.9 Cg_exo -50.29 -31.72 30.6 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.253 1.968 . . . . 0.68 112.567 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.08 -22.68 63.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.401 . . . . 2.62 111.42 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.697 HD22 ' HA3' ' A' ' 110' ' ' GLY . 42.6 tp -68.36 -44.45 75.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.313 -0.555 . . . . 1.18 109.591 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -61.4 -37.8 84.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.292 -0.633 . . . . 2.11 109.292 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.659 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.3 mm-40 -55.19 -42.03 72.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.909 -1.041 . . . . 1.53 110.319 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.58 ' HA ' ' HB2' ' A' ' 187' ' ' LYS . 5.4 tt0 -77.35 -35.31 54.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 2.16 112.453 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 80.7 mt -63.34 -2.85 1.63 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.003 0.372 . . . . 0.87 112.003 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.745 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.4 m -81.53 13.94 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 1.38 109.566 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.598 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 69.84 46.31 53.59 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.065 -0.97 . . . . 1.17 111.201 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.745 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.451 -0.785 . . . . 2.45 109.993 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.531 -0.174 . . . . 5.4 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.12 146.23 60.34 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.277 2.652 . . . . 2.58 112.779 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.66 134.57 26.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.844 -0.616 . . . . 2.1 110.277 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.529 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 15.6 t70 -162.2 156.57 21.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.816 -0.809 . . . . 1.81 108.816 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.46 20.8 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.657 0.265 . . . . 0.95 111.101 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -11.73 61.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.126 0.488 . . . . 2.19 110.906 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HB3' HD12 ' A' ' 12' ' ' LEU . 95.3 mttt -116.86 30.88 7.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 3.07 110.352 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.835 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -75.62 -23.4 56.37 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.452 0.538 . . . . 4.76 112.452 -173.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 13.7 p -152.9 26.47 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 0.98 111.199 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.97 -119.66 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.014 -0.834 . . . . 0.52 111.014 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 19.4 Cg_endo -55.47 -36.47 94.27 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.832 2.355 . . . . 0.61 110.329 164.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.669 HD13 ' HA3' ' A' ' 38' ' ' GLY . 13.4 mt -89.05 85.74 6.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.638 -1.164 . . . . 1.85 110.669 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -74.78 62.41 1.08 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.334 0.588 . . . . 1.31 110.728 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.546 HD11 ' HG ' ' A' ' 168' ' ' CYS . 46.7 mt -78.03 -16.67 57.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.61 111.577 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -12.29 56.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.272 0.558 . . . . 2.61 110.43 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -67.92 -20.27 65.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 1.93 111.056 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.825 HG12 HG21 ' A' ' 69' ' ' THR . 70.6 t -92.09 -66.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.794 -0.639 . . . . 1.26 110.791 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.75 170.86 14.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 2.99 110.682 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -70.22 105.79 3.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 1.6 109.285 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.835 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 27.5 mm-40 -47.53 134.73 10.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 O-C-N 123.91 0.756 . . . . 4.38 112.346 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 39.0 Cg_exo -62.43 169.04 8.72 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.389 3.392 . . . . 0.69 114.898 -167.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.897 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 11.4 pt20 -82.25 -13.25 57.33 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.74 -1.118 . . . . 1.87 111.907 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.755 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.6 m170 -149.09 159.52 37.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.871 -0.604 . . . . 2.35 109.544 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 3.9 Cg_endo -85.44 127.96 3.4 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.079 2.519 . . . . 0.44 111.101 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.499 HD22 ' CG1' ' A' ' 124' ' ' VAL . 26.9 tp -78.0 147.84 34.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.735 0.303 . . . . 0.33 110.854 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -116.72 107.72 15.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.867 -0.42 . . . . 2.12 109.867 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 53' ' ' ILE . 6.9 t -114.56 127.91 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.085 -0.709 . . . . 1.12 109.085 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -126.27 138.82 53.65 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.923 0.392 . . . . 0.78 110.678 -176.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -101.51 170.96 7.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.019 -0.537 . . . . 1.23 109.66 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.82 68.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.463 0.649 . . . . 0.6 110.654 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.47 13.67 25.42 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.253 -0.885 . . . . 0.81 112.511 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.4 -171.1 3.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.935 0.398 . . . . 0.56 110.634 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.451 ' HB1' HG22 ' A' ' 28' ' ' THR . . . -163.48 147.1 10.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.757 -0.656 . . . . 0.35 110.203 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.802 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -104.36 58.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.084 -1.45 . . . . 0.39 107.084 165.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.74 30.26 1.85 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.99 109.793 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.4 tt0 -157.86 127.91 6.14 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.126 -0.943 . . . . 2.56 108.827 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -68.58 111.17 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.46 110.026 -176.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.669 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 87.11 14.86 63.64 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.447 -0.797 . . . . 0.59 112.756 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.802 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.89 147.03 47.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 1.04 109.653 175.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.412 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.2 p -74.38 132.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.912 0.387 . . . . 1.16 110.956 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.596 HD21 ' CG1' ' A' ' 46' ' ' VAL . 6.3 tp -132.46 167.21 20.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.952 -0.759 . . . . 0.45 108.952 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.86 157.07 47.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.699 0.629 . . . . 1.0 112.699 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 89.3 Cg_exo -50.56 -45.84 32.77 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.158 2.572 . . . . 1.0 113.044 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.617 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 8.2 p -54.65 -39.63 68.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.58 0.705 . . . . 1.24 111.214 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -83.32 -7.91 59.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.01 -0.995 . . . . 1.74 112.425 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.596 ' CG1' HD21 ' A' ' 41' ' ' LEU . 17.8 m -131.84 27.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.372 0.606 . . . . 1.1 111.543 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HZ1' ' HA3' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -95.55 5.36 51.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 1.32 110.574 -175.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -152.5 179.02 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 2.4 109.442 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HB3' HG23 ' A' ' 97' ' ' ILE . 76.4 mtt180 -68.53 148.47 98.12 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.118 -0.327 . . . . 1.78 110.118 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.43 166.29 26.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.059 1.839 . . . . 0.41 110.823 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -87.92 -19.09 27.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.894 -0.41 . . . . 0.88 109.894 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.513 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 47.6 m -158.1 143.11 16.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.785 0.661 . . . . 0.65 112.785 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -140.27 157.67 25.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.502 -1.226 . . . . 0.33 107.915 170.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.662 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 30.4 t 173.77 135.42 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.11 -0.7 . . . . 0.8 109.11 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.79 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -88.96 177.1 6.75 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 3.63 108.229 173.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.67 76.86 0.11 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.873 0.368 . . . . 1.51 110.693 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.88 40.4 0.99 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.293 -0.48 . . . . 0.9 112.84 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.662 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 7.5 tt -65.17 127.87 33.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.62 110.145 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.2 -30.5 68.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.844 -0.616 . . . . 0.74 111.947 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.531 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 44.8 m 72.14 -3.69 2.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.12 -0.946 . . . . 1.51 110.752 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.64 5.7 26.18 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.834 -0.621 . . . . 0.84 112.501 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.0 mmpt? -111.86 160.33 17.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.614 0.245 . . . . 2.12 110.366 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.76 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 mt -97.46 141.85 30.03 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.518 -1.29 . . . . 1.23 107.518 168.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.668 ' CE2' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -136.72 147.2 46.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.842 -0.343 . . . . 1.61 110.205 -178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.863 HG21 HG11 ' A' ' 90' ' ' VAL . 4.4 m -95.7 104.76 16.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.622 -0.881 . . . . 0.87 108.622 174.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.1 tp -101.7 109.12 20.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.587 -0.733 . . . . 1.35 109.387 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.459 HG22 ' CD1' ' A' ' 88' ' ' LEU . 20.9 t -115.3 122.45 69.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.405 -0.361 . . . . 0.54 110.95 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.877 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -86.62 134.03 33.66 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.744 -0.836 . . . . 0.65 108.744 169.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.825 HG21 HG12 ' A' ' 17' ' ' VAL . 13.3 t -138.9 148.56 43.78 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.928 -0.309 . . . . 1.04 111.073 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.517 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 30.4 t70 -131.22 99.37 17.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.264 0.554 . . . . 1.92 110.217 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.517 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.3 Cg_endo -53.4 -34.29 70.57 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 124.179 3.252 . . . . 1.25 114.437 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.795 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -89.96 40.2 0.99 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.174 0.435 . . . . 1.29 112.174 -168.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.06 144.92 29.65 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.708 -0.224 . . . . 0.56 111.506 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.0 Cg_endo -83.83 -20.58 18.78 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 123.259 -1.559 . . . . 0.7 112.102 -0.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.694 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 77.7 p -134.87 146.82 49.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 1.1 109.846 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.795 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 58.7 mtp180 -70.3 -22.74 62.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.916 0.339 . . . . 3.39 111.916 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.78 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.45 -14.8 45.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.277 0.561 . . . . 1.83 110.517 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.44 79.51 4.9 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.004 -0.739 . . . . 1.37 109.004 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.97 81.28 1.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.863 2.376 . . . . 0.9 113.049 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.503 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 13.6 mttm -71.99 -51.57 21.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.514 -1.221 . . . . 1.53 111.251 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.687 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 38.9 m-85 -86.39 19.11 2.89 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.401 -0.818 . . . . 1.54 111.896 -167.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 6.7 ttp180 -67.05 127.19 31.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.856 -0.611 . . . . 3.38 110.06 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.8 mp0 -98.2 138.61 35.22 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.328 0.251 . . . . 2.23 110.36 -1.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.44 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 5.9 t90 -89.88 105.81 18.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 1.77 110.03 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.9 p80 -80.82 122.43 27.18 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.452 0.644 . . . . 2.19 110.203 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.877 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.6 t-160 -61.8 -40.56 95.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.981 -1.009 . . . . 2.74 110.649 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.524 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 26.0 p90 -167.17 178.45 5.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.622 -0.511 . . . . 2.21 109.622 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.8 tp -141.84 113.65 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.708 0.289 . . . . 0.68 110.247 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.524 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.8 t -120.42 132.47 69.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.817 -0.628 . . . . 0.35 110.573 176.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.863 HG11 HG21 ' A' ' 65' ' ' THR . 3.8 m -129.92 166.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.095 -1.076 . . . . 0.3 108.095 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.76 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 91.1 m-20 60.85 20.44 10.65 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 123.486 0.491 . . . . 2.09 111.141 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.575 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.6 ttm -72.28 115.17 11.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.693 -0.854 . . . . 0.34 108.693 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 93' ' ' LYS . 15.1 ttmm -87.06 93.17 9.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.314 -0.857 . . . . 1.73 111.307 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 60' ' ' SER . . . 80.33 -129.75 9.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 114.829 -1.078 . . . . 0.35 112.48 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.459 ' HB3' HD22 ' A' ' 58' ' ' LEU . 26.1 p30 -112.91 22.12 14.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.604 0.716 . . . . 1.59 110.512 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.31 112.79 24.48 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.992 -1.004 . . . . 0.77 109.609 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.467 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 5.3 mm -59.95 -27.6 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.358 -1.292 . . . . 0.45 111.103 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -69.73 -51.36 34.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 1.15 112.112 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 p -61.85 -20.55 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.822 0.675 . . . . 1.26 112.822 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.575 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -52.91 103.08 0.11 Allowed Glycine 0 N--CA 1.449 -0.455 0 O-C-N 123.352 0.408 . . . . 0.44 112.92 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.4 m -68.05 107.39 2.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.436 0.636 . . . . 1.06 109.773 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.68 120.77 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.896 -1.047 . . . . 1.15 111.617 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.617 HD23 ' HG ' ' A' ' 133' ' ' CYS . 55.8 mt -99.32 -44.71 6.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.227 1.013 . . . . 0.48 109.289 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.9 t -120.51 111.9 18.27 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.885 -1.524 . . . . 0.62 106.885 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.832 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 2.3 t0 -64.84 162.04 17.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.551 -0.75 . . . . 1.15 112.018 -170.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 31.0 p90 -81.23 61.22 4.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.339 0.866 . . . . 4.98 113.339 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.907 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 27.0 t -37.54 -47.32 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.017 0.927 . . . . 0.86 113.365 -171.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.588 ' HA3' ' HZ1' ' A' ' 47' ' ' LYS . . . 107.12 -172.45 17.97 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.655 -0.783 . . . . 0.95 112.505 173.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.524 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.4 t -68.9 117.29 10.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.564 -0.532 . . . . 0.89 109.564 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.764 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -148.2 61.43 0.44 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.389 -0.91 . . . . 0.82 112.662 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.651 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 9.8 Cg_endo -91.87 127.15 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.495 2.796 . . . . 1.01 112.734 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.591 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.9 Cg_exo -53.8 146.02 47.53 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.796 2.331 . . . . 0.96 111.775 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.418 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -62.51 119.61 9.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.288 -0.414 . . . . 2.39 111.221 -177.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.9 -1.51 55.29 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.861 -0.685 . . . . 1.3 113.146 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.694 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 77.7 p -77.39 -26.33 51.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.998 0.399 . . . . 1.04 112.002 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 -178.61 17.83 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.953 -0.641 . . . . 1.97 112.232 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.749 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.4 mm? -81.8 116.85 21.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.615 0.245 . . . . 0.94 110.39 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.676 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 40.6 m-70 -92.81 126.8 38.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.416 -0.356 . . . . 2.85 110.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.475 HH11 ' HA ' ' A' ' 12' ' ' LEU . 8.9 ptt180 -108.56 85.92 2.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.757 -0.656 . . . . 2.78 110.664 -172.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.499 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 5.8 m-85 -69.73 116.69 10.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.592 -0.731 . . . . 1.13 109.549 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 168' ' ' CYS . 15.1 t -97.43 128.96 48.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.037 -0.528 . . . . 0.31 110.714 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.663 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 48.7 m95 -88.57 121.54 31.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.177 -0.675 . . . . 2.96 109.177 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.2 mt -118.31 119.91 36.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.624 0.193 . . . . 0.41 110.791 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.499 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -117.52 140.0 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.722 0.296 . . . . 0.43 111.121 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.707 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 89.3 t80 -129.53 129.09 44.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.177 -0.465 . . . . 5.41 109.812 174.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.63 103.2 2.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.549 0.69 . . . . 2.41 109.22 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 23.0 mt-30 -58.41 135.85 57.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.033 -0.985 . . . . 1.31 112.028 -171.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.8 -13.25 61.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.486 -0.779 . . . . 2.4 109.603 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 7.7 ptp180 -173.51 161.75 3.31 Favored Pre-proline 0 CA--C 1.515 -0.381 0 CA-C-N 114.838 -1.073 . . . . 4.07 109.637 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.58 136.22 65.74 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.9 2.4 . . . . 1.21 110.691 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 158' ' ' TYR . 4.1 mm? -68.11 146.89 53.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.721 1.008 . . . . 1.16 113.721 -167.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -99.1 96.52 7.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.176 -1.375 . . . . 3.23 108.073 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.617 ' HG ' HD23 ' A' ' 103' ' ' LEU . 1.4 p -124.88 109.64 13.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.91 -0.586 . . . . 2.79 111.728 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -102.72 18.18 22.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.908 -0.775 . . . . 2.96 108.908 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.79 135.41 96.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.183 -0.917 . . . . 1.39 111.195 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.5 113.89 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.39 2.727 . . . . 1.38 112.531 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.49 120.28 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.94 110.056 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 71.3 mt -99.66 154.59 18.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.13 0.49 . . . . 1.61 110.54 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.676 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 72.1 m -108.03 31.56 5.43 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.263 -0.881 . . . . 1.88 109.689 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.907 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 54.9 12.53 0.61 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.485 1.116 . . . . 1.33 111.553 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.676 ' HG3' ' O ' ' A' ' 139' ' ' SER . 17.1 mtm180 -96.71 146.85 24.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.83 110.097 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.628 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.4 m 77.89 131.14 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.519 1.137 . . . . 1.32 111.958 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.623 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -87.46 -6.5 77.46 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.086 -0.961 . . . . 1.13 112.655 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.521 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 28.7 t70 -54.46 -42.75 70.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.605 0.717 . . . . 2.66 111.374 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.521 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 5.9 m80 -97.3 20.01 12.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.354 -0.839 . . . . 2.18 111.012 -173.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.623 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 63.9 mtt180 -76.7 -69.92 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 5.37 111.835 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -117.3 -173.01 16.32 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.217 -0.992 . . . . 0.9 113.369 -171.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.687 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.5 mttt 68.33 21.89 8.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.728 0.775 . . . . 1.59 110.602 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.648 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 87.7 m-85 -111.3 97.71 6.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.807 -1.088 . . . . 2.27 108.476 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 13.2 mmmm -59.49 123.27 16.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 1.87 112.168 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' CG1' ' A' ' 17' ' ' VAL . 16.8 m -63.84 -25.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.242 -0.89 . . . . 0.96 110.6 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.73 72.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.76 109.608 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 m -59.81 -43.7 94.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 1.22 110.633 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.648 ' CE1' ' HB3' ' A' ' 149' ' ' PHE . 7.0 m-85 -58.56 -53.27 60.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.037 -0.528 . . . . 1.1 111.584 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -69.76 -39.74 76.52 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.479 -0.488 . . . . 3.36 111.379 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.61 -32.3 72.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.97 0.414 . . . . 1.52 110.405 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -66.8 -51.38 56.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.527 -0.76 . . . . 2.13 110.918 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.665 ' HB3' HD13 ' A' ' 131' ' ' LEU . 21.6 m-85 -80.23 3.91 19.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.075 -0.511 . . . . 5.77 111.744 -172.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 8.4 mm-40 70.55 30.67 3.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.589 0.555 . . . . 2.42 111.016 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.707 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.3 mp -102.34 134.24 45.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.563 -0.744 . . . . 1.27 109.79 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.421 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 7.8 tpt180 -102.74 -78.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 4.0 111.181 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -125.85 145.77 52.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 1.21 110.805 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.538 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 2.9 Cg_exo -74.61 161.63 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.908 3.072 . . . . 0.68 113.537 -172.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.897 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 14.4 t -91.43 -26.88 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.632 -1.167 . . . . 0.5 109.895 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 55' ' ' TRP . . . -152.58 145.2 24.2 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.003 -0.679 . . . . 0.29 112.231 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.44 151.05 23.36 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.035 -0.984 . . . . 0.24 112.018 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.564 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.1 t -165.57 141.15 5.11 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.449 -0.945 . . . . 0.34 108.449 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 17.3 p -119.0 149.32 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.034 -0.667 . . . . 2.16 111.045 -175.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.767 ' HB3' HG22 ' A' ' 34' ' ' VAL . 35.7 p90 -130.32 129.71 43.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.94 -1.133 . . . . 1.31 107.94 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -101.52 133.78 45.63 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.867 -0.733 . . . . 2.53 111.417 177.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.94 152.17 49.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.75 109.501 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.749 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -126.37 -162.41 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.006 0.432 . . . . 2.38 111.322 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.418 ' CG ' ' HG2' ' A' ' 113' ' ' LYS . 89.6 t90 -70.46 103.2 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.96 -0.564 . . . . 4.71 110.343 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.521 ' H ' HG23 ' A' ' 177' ' ' VAL . 2.0 t70 -73.69 -62.06 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.583 -0.28 . . . . 1.53 110.371 171.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 11.5 t70 169.45 -50.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 1.26 110.434 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 44' ' ' THR . 2.4 p90 -82.72 9.8 8.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.189 0.519 . . . . 2.46 111.094 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.764 HG12 ' HA2' ' A' ' 110' ' ' GLY . 48.1 t -58.47 -49.15 95.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.094 -0.503 . . . . 0.58 109.972 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 175' ' ' ASP . 72.9 Cg_exo -47.89 -33.75 20.59 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.039 2.493 . . . . 0.68 112.899 168.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.649 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 3.0 mmmp? -72.69 -25.56 61.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.636 0.255 . . . . 2.62 111.108 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.512 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 62.5 tp -70.58 -44.29 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.049 -0.723 . . . . 1.18 109.049 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.27 -32.95 74.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.316 -0.856 . . . . 2.11 109.446 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.5 mm-40 -60.84 -38.29 85.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.955 -1.02 . . . . 1.53 111.02 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.33 -27.08 56.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.74 -0.663 . . . . 2.16 111.439 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.628 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.2 mt -65.93 6.6 0.35 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.852 0.686 . . . . 0.87 112.852 -177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.714 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.2 m -77.15 8.31 4.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 1.38 109.955 173.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 68.89 50.54 34.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.104 -0.798 . . . . 1.17 111.104 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.714 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.8 mmmt . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.667 -0.682 . . . . 2.45 110.582 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.141 -0.318 . . . . 5.4 110.141 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.46 104.41 1.57 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.341 2.027 . . . . 2.58 110.88 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.4 p -112.12 146.7 16.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.45 -1.25 . . . . 2.1 110.275 -173.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.738 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 2.2 p30 -163.39 179.93 6.98 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.142 -1.058 . . . . 1.81 108.142 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 8' ' ' TRP . 2.7 mm? -80.93 36.01 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.95 110.866 -170.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 4' ' ' ASP . 21.7 m -51.91 -40.1 60.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 2.19 111.834 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.534 ' HB2' HD13 ' A' ' 12' ' ' LEU . 92.0 mttt -116.17 46.16 1.62 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.868 -0.419 . . . . 3.07 109.868 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.598 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -66.43 -24.21 66.42 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.286 -0.416 . . . . 4.76 111.328 -173.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.1 p -151.6 26.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.951 -0.3 . . . . 0.98 111.347 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.85 -125.5 0.81 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.888 -0.885 . . . . 0.52 110.888 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -52.02 -36.29 64.45 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.109 2.54 . . . . 0.61 110.342 167.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.717 HD11 ' HA3' ' A' ' 38' ' ' GLY . 35.3 mt -87.87 79.26 8.14 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.825 -1.08 . . . . 1.85 109.606 171.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -71.44 66.73 0.48 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.615 0.722 . . . . 1.31 109.82 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.918 HD23 HH11 ' A' ' 119' ' ' ARG . 44.1 mt -80.45 -16.39 54.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.741 -0.663 . . . . 0.61 110.65 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -64.13 -16.17 61.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.589 -0.732 . . . . 2.61 111.225 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 39.3 mt-10 -62.34 -30.33 71.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.189 0.519 . . . . 1.93 110.546 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.722 HG12 HG21 ' A' ' 69' ' ' THR . 85.7 t -93.41 -64.03 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.16 -174.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -130.04 169.05 15.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.152 -0.476 . . . . 2.99 110.219 -171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -74.57 88.16 2.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.443 -0.947 . . . . 1.6 108.443 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.598 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 2.7 tp-100 -38.34 122.61 1.1 Allowed Pre-proline 0 C--O 1.237 0.433 0 O-C-N 124.925 1.391 . . . . 4.38 111.901 -166.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.703 ' HG3' ' HB2' ' A' ' 163' ' ' PRO . 81.5 Cg_exo -50.29 161.64 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 125.235 3.957 . . . . 0.69 116.193 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.884 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 12.6 pt20 -79.1 -6.96 57.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 113.837 -1.529 . . . . 1.87 111.46 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.708 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.6 m170 -154.28 158.85 32.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.468 -0.787 . . . . 2.35 109.236 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.738 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 6.0 Cg_endo -86.74 129.12 2.98 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.193 2.595 . . . . 0.44 111.844 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' A' ' 122' ' ' TRP . 21.5 tp -78.88 144.54 34.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.654 -0.248 . . . . 0.33 110.728 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.428 ' H ' HD12 ' A' ' 25' ' ' LEU . 86.2 m-70 -112.64 112.94 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 2.12 109.89 174.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG12 HG22 ' A' ' 53' ' ' ILE . 12.0 t -121.12 137.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.423 -0.584 . . . . 1.12 109.423 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -132.4 141.24 48.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.271 0.558 . . . . 0.78 111.063 -177.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -103.14 173.32 6.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.857 -0.794 . . . . 1.23 108.857 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.41 -52.29 65.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.291 0.567 . . . . 0.6 110.347 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.96 14.77 23.83 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.178 -0.919 . . . . 0.81 112.999 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.54 -172.25 4.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.56 111.148 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.95 151.61 12.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.71 -0.677 . . . . 0.35 110.05 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 169' ' ' TYR . 86.2 t -109.23 65.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.157 -1.423 . . . . 0.39 107.157 164.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.83 21.07 16.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.002 -0.999 . . . . 0.99 109.15 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -145.83 128.1 15.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.687 -1.227 . . . . 2.56 107.687 176.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -77.96 111.74 14.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.611 0.72 . . . . 0.46 110.803 -170.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.748 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 83.17 22.35 57.28 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.742 -1.117 . . . . 0.59 111.385 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.753 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -77.68 148.73 34.84 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.388 -0.597 . . . . 1.04 109.388 173.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.96 133.44 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.001 0.429 . . . . 1.16 110.874 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.4 tp -131.58 170.29 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.45 108.618 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.6 p -120.03 158.46 50.25 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.317 0.858 . . . . 1.0 113.317 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 74.9 Cg_exo -50.29 -49.19 17.12 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.438 2.759 . . . . 1.0 113.569 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.7 p -55.72 -42.83 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.462 0.649 . . . . 1.24 111.52 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -73.21 -12.32 60.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.874 -1.057 . . . . 1.74 112.225 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.605 ' CG1' HD21 ' A' ' 41' ' ' LEU . 31.5 m -131.7 28.25 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.087 0.47 . . . . 1.1 111.455 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.635 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -85.12 -33.85 22.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.818 -0.628 . . . . 1.32 110.467 -176.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.414 ' HB3' ' H ' ' A' ' 49' ' ' ARG . 3.8 m-20 -108.46 -155.89 0.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.786 -0.643 . . . . 2.4 109.556 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.414 ' H ' ' HB3' ' A' ' 48' ' ' ASN . 53.9 mtt180 -84.01 157.19 63.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.394 -0.595 . . . . 1.78 109.394 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.4 160.44 28.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.755 1.637 . . . . 0.41 110.594 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -82.15 -20.72 37.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.105 -0.332 . . . . 0.88 110.105 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.543 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 57.9 m -160.32 144.86 14.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.239 0.542 . . . . 0.65 112.056 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.1 168.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.154 -0.93 . . . . 0.33 108.575 171.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.76 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 29.3 t 174.04 122.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.462 -0.57 . . . . 0.8 109.462 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.674 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -79.45 179.52 7.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.337 -0.986 . . . . 3.63 108.337 174.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.8 80.8 0.29 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.15 0.5 . . . . 1.51 110.473 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.17 41.58 1.51 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.633 -0.712 . . . . 0.9 112.386 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.76 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -55.54 133.74 50.41 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.83 0.452 . . . . 0.62 111.51 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.55 -27.38 60.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.848 -0.615 . . . . 0.74 111.867 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.608 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 49.3 m 68.23 8.32 6.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.561 -0.745 . . . . 1.51 110.834 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.68 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -137.17 -47.87 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.905 -0.589 . . . . 0.84 112.662 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.752 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 8.3 mmpt? -58.66 144.54 42.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.231 0.538 . . . . 2.12 111.411 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.716 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 31.0 mt -86.82 127.73 35.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.111 -0.95 . . . . 1.23 109.486 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.752 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -122.3 158.66 29.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.55 -0.46 . . . . 1.61 110.278 176.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.719 HG22 HG11 ' A' ' 90' ' ' VAL . 96.0 m -98.51 109.39 22.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.392 -0.596 . . . . 0.87 109.392 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 tp -106.15 116.83 32.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.864 -0.607 . . . . 1.35 110.052 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.406 HG22 HD11 ' A' ' 88' ' ' LEU . 21.9 t -120.98 132.43 70.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.76 0.314 . . . . 0.54 110.74 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.897 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -97.49 131.57 44.0 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.508 -0.923 . . . . 0.65 108.508 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.722 HG21 HG12 ' A' ' 17' ' ' VAL . 11.0 t -138.82 147.53 42.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.142 0.428 . . . . 1.04 111.657 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 25.6 t70 -131.28 97.43 19.82 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.161 0.505 . . . . 1.92 109.805 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.9 Cg_endo -51.63 -34.56 53.58 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.99 3.127 . . . . 1.25 114.298 176.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -86.97 44.82 1.2 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.654 0.612 . . . . 1.29 112.654 -170.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -104.08 142.12 23.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.687 -0.233 . . . . 0.56 110.706 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.538 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 92.1 Cg_endo -85.07 -24.76 9.58 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 123.465 -1.473 . . . . 0.7 113.096 -0.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.688 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 13.2 p -128.76 146.45 50.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 1.1 109.793 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.725 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 50.8 mtp180 -65.99 -21.89 66.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 3.39 111.141 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 6.0 ptpt -79.66 -14.26 58.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 1.83 110.829 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 16.4 t70 -162.09 80.51 1.88 Allowed Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.007 -0.542 . . . . 1.37 110.188 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 85.6 Cg_endo -80.95 87.21 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.543 2.162 . . . . 0.9 112.93 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -74.74 -50.97 15.49 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.738 -1.119 . . . . 1.53 110.661 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.669 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.1 m-85 -85.45 21.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 1.54 111.742 -166.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 29.4 ttt180 -71.66 129.56 38.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.382 -0.372 . . . . 3.38 110.685 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 3.0 mp0 -96.44 132.04 42.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.859 0.361 . . . . 2.23 110.632 -3.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.55 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 11.9 t90 -82.65 140.3 33.23 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.012 -0.736 . . . . 1.77 109.012 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 28.6 p80 -117.72 127.15 53.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.633 0.73 . . . . 2.19 111.258 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.897 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 15.5 t-80 -65.45 -35.89 82.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.806 -1.088 . . . . 2.74 110.36 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.543 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 12.0 p90 -168.06 176.79 5.9 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.651 -0.249 . . . . 2.21 110.363 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.458 ' HG ' HD12 ' A' ' 103' ' ' LEU . 21.5 tp -135.77 113.53 11.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.68 109.657 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.66 133.23 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.648 -0.706 . . . . 0.35 110.19 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.875 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 22.2 m -133.94 161.75 40.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.285 -0.871 . . . . 0.3 108.956 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.716 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t30 60.71 22.01 11.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.661 0.601 . . . . 2.09 110.353 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.611 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 6.7 ttm -71.88 110.3 6.31 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.175 -0.676 . . . . 0.34 109.175 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 20.9 ttmm -80.34 98.28 7.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.21 . . . . 1.73 111.133 -173.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.81 -121.76 20.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.603 -0.726 . . . . 0.35 112.509 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.713 ' HB3' HD22 ' A' ' 58' ' ' LEU . 28.8 p-10 -113.26 21.42 15.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.567 -0.316 . . . . 1.59 111.735 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -89.51 104.22 16.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.415 0.626 . . . . 0.77 109.848 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -55.55 -31.28 28.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.584 -1.189 . . . . 0.45 111.561 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -81.04 -26.38 36.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 1.15 111.602 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.05 -13.04 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.492 -0.322 . . . . 1.26 111.225 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.611 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -70.62 100.53 0.83 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.78 -0.724 . . . . 0.44 111.579 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.2 m -60.24 106.55 0.54 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.476 0.655 . . . . 1.06 109.668 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -80.19 113.1 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.847 -1.07 . . . . 1.15 111.214 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.458 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.7 mt -93.2 -41.97 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.99 0.9 . . . . 0.48 109.243 174.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.9 t -122.68 112.22 17.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.192 -1.41 . . . . 0.62 107.192 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.628 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 3.4 t70 -59.96 164.41 3.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.652 -0.704 . . . . 1.15 112.217 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 10.3 p90 -79.24 72.27 5.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.269 -0.878 . . . . 4.98 111.002 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 28.1 t -51.45 -44.68 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 0.86 111.447 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.686 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 97.72 -171.75 26.57 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.26 -0.971 . . . . 0.95 113.416 171.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 41.0 t -73.42 128.68 36.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.778 -0.452 . . . . 0.89 109.778 174.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.621 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 171.99 58.64 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.211 -0.995 . . . . 0.82 113.706 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -86.69 -176.66 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.628 2.219 . . . . 1.01 111.005 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.629 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 48.1 Cg_exo -57.14 142.25 94.38 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.464 1.443 . . . . 0.96 111.81 172.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.414 ' CD ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -66.1 114.69 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.514 -0.766 . . . . 2.39 111.46 -177.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.15 12.7 38.59 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 1.3 113.698 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 34.0 p -81.65 2.09 31.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.82 1.044 . . . . 1.04 113.82 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.25 -179.73 27.16 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.612 -0.804 . . . . 1.97 112.375 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -83.41 118.03 23.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.938 0.399 . . . . 0.94 110.141 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.688 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 47.1 m-70 -91.39 117.76 29.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.103 -0.499 . . . . 2.85 110.952 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.918 HH11 HD23 ' A' ' 14' ' ' LEU . 9.9 ptt180 -91.51 82.01 5.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.67 -0.695 . . . . 2.78 111.313 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.533 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 42.4 m-85 -67.76 109.39 3.33 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.753 -0.832 . . . . 1.13 108.753 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.555 HG23 HD21 ' A' ' 14' ' ' LEU . 21.9 t -88.09 127.32 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.901 -0.59 . . . . 0.31 109.971 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.833 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.92 117.53 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.486 -0.931 . . . . 2.96 108.486 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 mt -121.26 127.57 51.52 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.959 0.162 . . . . 0.41 110.899 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.601 HG21 ' HE3' ' A' ' 55' ' ' TRP . 1.1 m -114.4 131.54 66.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.459 -0.496 . . . . 0.43 109.917 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.687 ' HB2' HD21 ' A' ' 160' ' ' LEU . 48.4 m-85 -111.95 149.13 32.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.325 -0.62 . . . . 5.41 109.325 176.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.93 126.66 48.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.671 0.748 . . . . 2.41 110.449 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -96.82 175.51 6.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.183 -0.917 . . . . 1.31 108.714 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.53 2.71 42.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.547 0.689 . . . . 2.4 109.498 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -160.66 164.98 18.24 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.947 -1.024 . . . . 4.07 111.206 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HG3' HD12 ' A' ' 63' ' ' LEU . 46.2 Cg_exo -58.01 155.42 33.81 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.027 2.485 . . . . 1.21 110.946 169.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.875 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.4 mm? -84.14 145.91 28.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.311 0.577 . . . . 1.16 112.143 -172.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -124.31 66.06 1.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.142 -0.935 . . . . 3.23 108.741 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 5.2 m -93.6 120.99 34.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.537 -0.756 . . . . 2.79 110.395 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.88 14.97 30.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 2.96 109.936 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -64.73 132.14 95.35 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.429 -0.805 . . . . 1.39 110.563 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -47.09 117.08 2.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.539 2.826 . . . . 1.38 113.067 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.19 118.67 6.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.94 110.496 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.4 mt -92.7 156.08 17.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 1.61 110.608 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 50.2 m -116.03 32.57 6.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.88 110.172 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.733 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER 66.75 -21.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.238 1.415 . . . . 1.33 113.45 175.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.546 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 54.9 mtt180 -78.31 135.44 37.51 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.776 -0.37 . . . . 3.83 110.868 -175.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.664 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 62.1 m 81.84 146.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.559 -1.201 . . . . 1.32 110.674 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.446 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -108.22 12.71 37.04 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.867 -0.682 . . . . 1.13 113.038 -170.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.17 -15.22 62.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.324 0.49 . . . . 2.66 112.324 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -121.58 34.85 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.087 0.47 . . . . 2.18 110.324 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.446 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 26.6 mtt180 -81.05 -69.68 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.662 -0.699 . . . . 5.37 111.902 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -128.31 -164.38 11.55 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.447 -0.882 . . . . 0.9 112.763 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.669 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 65.43 25.27 11.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.441 0.639 . . . . 1.59 110.229 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.26 112.31 21.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.083 -0.962 . . . . 2.27 109.095 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.18 122.17 17.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.805 -0.634 . . . . 1.87 111.525 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.794 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.2 m -62.85 -27.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.96 110.351 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.31 -43.34 99.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.76 109.759 172.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.9 m -63.87 -39.33 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.944 -0.571 . . . . 1.22 110.618 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.794 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 50.4 m-85 -58.81 -52.05 67.37 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.649 -0.251 . . . . 1.1 110.999 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.943 -0.303 . . . . 3.36 111.358 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.4 mtmt -64.17 -42.25 96.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.38 0.609 . . . . 1.52 109.935 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -58.77 -53.27 60.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 2.13 111.449 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.41 -3.33 58.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 5.77 111.493 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 68.22 40.89 2.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.792 -0.64 . . . . 2.42 111.27 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 125' ' ' TYR . 5.4 mp -95.97 146.34 24.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.451 -0.795 . . . . 1.27 112.008 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.777 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 14.5 tpt180 -82.73 -171.24 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.291 -0.868 . . . . 4.0 109.853 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.777 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -60.98 155.74 52.35 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 1.21 110.639 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.703 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 13.2 Cg_exo -66.7 141.93 61.89 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.968 2.445 . . . . 0.68 112.279 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.884 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 12.2 t -89.47 -34.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.794 -0.639 . . . . 0.5 110.092 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -146.26 141.37 27.28 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.903 -0.719 . . . . 0.29 112.128 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.641 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.56 148.94 20.93 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.024 -0.989 . . . . 0.24 111.976 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.6 t -159.85 133.05 6.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.798 -0.816 . . . . 0.34 108.798 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.601 ' H ' HD22 ' A' ' 37' ' ' LEU . 22.2 p -111.07 142.42 43.25 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 2.16 111.33 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.767 ' HB3' HG22 ' A' ' 34' ' ' VAL . 32.3 p90 -126.61 134.14 50.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.567 -0.901 . . . . 1.31 108.567 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.75 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 24.1 mp0 -98.6 131.88 44.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.212 -0.595 . . . . 2.53 110.104 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -121.21 142.37 49.98 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.36 0.412 . . . . 0.75 110.345 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -97.18 -171.8 2.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 2.38 111.263 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.858 ' HA ' HG23 ' A' ' 177' ' ' VAL . 28.5 p90 -97.41 53.62 1.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.226 -0.897 . . . . 4.71 110.508 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.495 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 32.6 t70 -60.28 -61.74 2.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.6 0.963 . . . . 1.53 113.6 -168.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.665 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.9 t70 -167.4 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.017 0.377 . . . . 1.26 112.017 -175.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -71.95 -3.89 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.148 0.499 . . . . 2.46 110.876 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.858 HG23 ' HA ' ' A' ' 173' ' ' TRP . 25.6 t -71.02 -55.1 6.78 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.749 . . . . 0.58 111.316 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.677 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.4 Cg_exo -58.2 -32.09 94.98 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.999 1.799 . . . . 0.68 111.764 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.3 mmmt -74.06 -24.77 59.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 2.62 111.913 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 43.9 tp -70.53 -47.25 61.33 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.13 -0.628 . . . . 1.18 109.375 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -59.27 -35.46 73.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.603 -0.726 . . . . 2.11 109.405 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.66 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.3 -51.48 68.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.807 -1.088 . . . . 1.53 111.002 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -69.17 -32.04 71.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 2.16 112.277 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 68.1 mt -62.77 3.65 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.503 0.927 . . . . 0.87 113.503 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.583 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 47.7 m -82.84 13.34 3.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.413 0.625 . . . . 1.38 109.336 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.82 44.1 57.14 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.368 -0.833 . . . . 1.17 111.162 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.583 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 28.8 mmmt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.344 -0.836 . . . . 2.45 109.841 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 121.293 0.568 . . . . 5.4 109.598 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.86 138.23 47.77 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 124.17 3.246 . . . . 2.58 114.22 -162.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.624 HG12 ' HB2' ' A' ' 37' ' ' LEU . 21.2 t -55.18 132.7 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.167 -1.378 . . . . 2.1 110.217 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.27 33.93 0.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.057 0.932 . . . . 1.81 110.49 -173.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.5 mm? 60.11 20.86 10.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.414 -1.266 . . . . 0.95 110.757 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.72 -33.72 64.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.613 0.765 . . . . 2.19 112.334 -171.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.588 ' CB ' HD12 ' A' ' 12' ' ' LEU . 76.1 mttt -135.75 50.18 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.207 -0.451 . . . . 3.07 110.375 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.462 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -72.87 -28.71 62.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.341 0.497 . . . . 4.76 112.341 -176.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 19.5 p -152.65 29.11 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.98 111.208 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.472 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.26 -122.69 0.83 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.957 -0.857 . . . . 0.52 110.957 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.6 Cg_endo -52.8 -37.56 76.7 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.222 2.615 . . . . 0.61 110.343 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.744 HD13 ' HA3' ' A' ' 38' ' ' GLY . 16.5 mt -87.73 83.06 7.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.951 -1.022 . . . . 1.85 109.657 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -73.5 63.42 0.8 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.519 0.676 . . . . 1.31 110.497 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.555 HD11 ' HG ' ' A' ' 168' ' ' CYS . 58.9 mt -71.19 -16.6 62.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.729 -0.669 . . . . 0.61 109.79 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -70.42 -4.47 22.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.49 -0.777 . . . . 2.61 110.694 177.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.89 -27.06 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.624 -0.88 . . . . 1.93 108.624 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.741 HG11 HG22 ' A' ' 151' ' ' VAL . 60.0 t -99.1 -71.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.609 -1.178 . . . . 1.26 110.408 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HB2' HH22 ' A' ' 155' ' ' ARG . 7.5 p-10 -110.7 153.35 25.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.391 0.615 . . . . 2.99 111.564 -172.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 26.1 mt-10 -65.51 142.15 58.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.001 -1.0 . . . . 1.6 109.326 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 98.7 mt-30 -55.61 120.59 33.17 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 123.335 0.397 . . . . 4.38 111.132 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 20' ' ' GLN . 23.2 Cg_exo -64.27 162.08 31.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.051 2.501 . . . . 0.69 112.685 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.922 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.9 pt20 -84.82 -12.85 52.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.779 -0.646 . . . . 1.87 111.217 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.773 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 66.3 m-70 -153.2 161.43 29.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.415 -0.957 . . . . 2.35 108.415 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 56' ' ' ASP . 5.7 Cg_endo -88.22 132.27 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.852 2.368 . . . . 0.44 112.233 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 122' ' ' TRP . 28.3 tp -78.31 144.75 35.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.807 -0.442 . . . . 0.33 109.807 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.467 ' H ' HD12 ' A' ' 25' ' ' LEU . 31.4 m80 -122.81 113.35 19.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.609 -0.515 . . . . 2.12 109.609 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.534 HG12 HG22 ' A' ' 53' ' ' ILE . 10.6 t -117.65 136.43 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.731 -0.47 . . . . 1.12 109.731 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.469 HG22 ' HB1' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -134.45 136.79 43.48 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.061 0.458 . . . . 0.78 111.076 -176.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.676 ' HH ' HD21 ' A' ' 48' ' ' ASN . 46.4 t80 -97.16 176.26 5.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.975 -0.75 . . . . 1.23 108.975 175.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.68 62.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.508 0.671 . . . . 0.6 110.191 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.91 1.56 31.74 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 115.089 -0.959 . . . . 0.81 112.666 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.16 -174.75 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.633 0.254 . . . . 0.56 110.605 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HB1' HG22 ' A' ' 28' ' ' THR . . . -163.58 149.64 11.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.154 -0.476 . . . . 0.35 110.392 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.779 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 96.2 t -101.78 62.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 106.71 -1.589 . . . . 0.39 106.71 163.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.77 -9.3 59.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.032 -1.44 . . . . 0.99 110.882 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.706 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -131.44 134.56 46.34 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.567 -0.901 . . . . 2.56 108.567 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.624 ' HB2' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -75.84 109.62 9.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.376 -0.601 . . . . 0.46 109.376 -175.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.786 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 85.07 23.38 49.16 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.391 -0.822 . . . . 0.59 112.471 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.779 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -80.19 149.52 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.627 -0.508 . . . . 1.04 109.627 171.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -73.86 133.02 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.155 0.502 . . . . 1.16 110.983 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.466 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.9 tp -131.06 168.55 17.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.115 -1.069 . . . . 0.45 108.115 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.517 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 23.2 p -121.87 157.13 58.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 119.569 -0.853 . . . . 1.0 112.349 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 10.1 Cg_endo -51.53 -41.99 57.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.093 2.529 . . . . 1.0 113.028 -176.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -62.71 -26.82 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.111 -0.495 . . . . 1.24 112.159 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -82.27 -25.34 34.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.945 -0.571 . . . . 1.74 111.289 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG21 ' CE2' ' A' ' 169' ' ' TYR . 18.5 m -122.01 29.11 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 1.1 111.552 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.12 -7.33 58.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.014 -0.539 . . . . 1.32 110.202 -177.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.676 HD21 ' HH ' ' A' ' 29' ' ' TYR . 59.2 m-80 -127.26 -174.91 3.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.603 -0.726 . . . . 2.4 109.315 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.592 ' NH2' ' HB ' ' A' ' 102' ' ' VAL . 72.5 mtt180 -77.0 155.11 82.84 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.75 -0.463 . . . . 1.78 109.75 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.23 153.42 18.62 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.06 1.84 . . . . 0.41 110.874 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -79.25 -18.57 52.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.909 0.385 . . . . 0.88 110.223 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -157.0 141.35 16.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.524 0.678 . . . . 0.65 112.446 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.534 HG22 HG12 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.23 158.28 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.773 -1.103 . . . . 0.33 108.503 172.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.698 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 26.3 t -179.23 122.04 0.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.976 -0.379 . . . . 0.8 109.976 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.79 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -76.12 156.0 34.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.347 -1.353 . . . . 3.63 107.347 170.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 17.8 t70 -59.84 85.9 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.25 0.548 . . . . 1.51 110.715 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.93 15.17 5.33 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.61 -0.723 . . . . 0.9 112.765 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.698 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 3.2 tt -50.79 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.505 . . . . 0.62 111.182 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.669 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.4 t70 -71.14 -29.97 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.644 -0.707 . . . . 0.74 111.453 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.495 ' N ' HD23 ' A' ' 58' ' ' LEU . 19.8 m 72.82 15.44 4.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.679 -1.146 . . . . 1.51 110.245 -173.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.78 -6.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.474 -0.87 . . . . 0.84 114.03 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.669 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.5 mtpt -96.17 161.27 14.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.028 0.914 . . . . 2.12 110.46 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 51.5 mt -90.97 132.32 36.04 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.878 -0.786 . . . . 1.23 108.878 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.561 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -132.83 147.72 52.31 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.646 -0.421 . . . . 1.61 110.317 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.614 HG22 HG11 ' A' ' 90' ' ' VAL . 65.5 m -95.54 105.57 17.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.772 -0.825 . . . . 0.87 108.772 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 57.1 tp -106.49 113.48 27.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.552 -0.749 . . . . 1.35 109.697 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 88' ' ' LEU . 44.3 t -114.42 129.45 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.54 110.452 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 68' ' ' LEU . 2.0 mt -85.17 124.04 31.37 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.64 -0.874 . . . . 0.65 108.64 168.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -135.83 138.18 42.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.926 0.393 . . . . 1.04 110.011 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 17.6 p-10 -125.93 102.23 28.45 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 121.523 0.678 . . . . 1.92 110.729 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -54.77 -177.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.378 2.718 . . . . 1.25 112.808 170.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.635 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.6 m-20 55.1 41.42 31.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 1.29 111.274 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.57 140.58 21.22 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 115.726 -0.67 . . . . 0.56 110.176 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 90.6 Cg_endo -81.65 -26.44 9.03 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.003 -1.665 . . . . 0.7 112.475 2.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.763 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 89.3 p -123.11 146.13 47.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.592 . . . . 1.1 110.314 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.635 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 74.4 ttt180 -67.55 -23.21 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 3.39 111.257 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.641 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -82.87 -18.35 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 1.83 111.064 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.15 90.12 2.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.048 -0.524 . . . . 1.37 109.875 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 91.8 Cg_endo -85.33 93.46 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.863 2.375 . . . . 0.9 113.814 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.4 mttm -82.69 -50.3 8.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.749 0.785 . . . . 1.53 110.477 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.771 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 63.7 m-85 -88.1 25.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.966 -1.015 . . . . 1.54 111.225 -170.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.688 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.52 128.7 33.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.306 -0.406 . . . . 3.38 110.445 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.688 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.0 mp0 -94.83 149.59 21.09 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.067 0.46 . . . . 2.23 110.773 -3.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.505 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 4.4 t90 -92.06 137.37 32.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.08 -1.081 . . . . 1.77 108.08 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.48 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 9.1 p-80 -110.5 141.06 44.17 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.339 -0.615 . . . . 2.19 109.339 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 -15.14 12.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.248 0.833 . . . . 2.74 113.248 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 3.2 p90 -169.38 166.59 10.34 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.447 -0.205 . . . . 2.21 110.447 162.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 67' ' ' VAL . 33.6 tp -133.84 113.96 12.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.151 -0.477 . . . . 0.68 109.922 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -123.83 132.47 71.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.746 -0.661 . . . . 0.35 110.658 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.614 HG11 HG22 ' A' ' 65' ' ' THR . 22.1 m -134.02 161.17 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.101 -0.954 . . . . 0.3 108.793 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.3 t30 63.37 16.79 9.79 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.506 0.504 . . . . 2.09 110.273 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.603 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 6.8 ttm -67.42 111.8 4.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.718 -0.845 . . . . 0.34 108.718 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -87.64 96.89 10.59 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.005 -0.998 . . . . 1.73 111.016 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.63 -126.49 9.11 Favored Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 114.857 -1.065 . . . . 0.35 112.284 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.54 ' HB3' HD22 ' A' ' 58' ' ' LEU . 4.4 p-10 -112.56 23.26 13.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 1.59 110.7 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.9 109.02 19.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.77 109.908 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -59.45 -33.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.45 110.625 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.3 m -73.6 -34.75 65.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.795 -0.638 . . . . 1.15 111.951 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.5 -6.16 48.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.882 0.327 . . . . 1.26 111.882 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.603 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -70.82 96.6 0.6 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.451 -0.881 . . . . 0.44 111.836 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.8 m -60.96 107.73 0.76 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.456 0.646 . . . . 1.06 110.325 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.592 ' HB ' ' NH2' ' A' ' 49' ' ' ARG . 7.5 p -87.51 130.25 37.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.86 -1.064 . . . . 1.15 111.76 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 10.3 mt -112.2 -49.94 2.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.101 0.953 . . . . 0.48 108.874 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.3 t -109.58 99.67 8.83 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.005 -1.48 . . . . 0.62 107.005 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.48 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 3.7 m-20 -56.86 157.58 5.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.139 -0.937 . . . . 1.15 113.114 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 14.7 p90 -74.31 107.58 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.782 -1.099 . . . . 4.98 110.143 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.647 HG22 ' HB2' ' A' ' 140' ' ' ASN . 23.3 t -80.72 -15.69 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.543 0.687 . . . . 0.86 110.276 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.53 -146.61 22.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.998 -0.62 . . . . 0.95 111.801 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.557 ' O ' HD22 ' A' ' 180' ' ' LEU . 14.2 t -83.2 140.92 32.28 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.677 -0.49 . . . . 0.89 109.677 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.61 68.5 0.19 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.354 -0.927 . . . . 0.82 113.747 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 177' ' ' VAL . 57.6 Cg_endo -98.35 122.7 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.527 2.818 . . . . 1.01 112.304 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.695 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 74.3 Cg_exo -50.93 146.68 20.92 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.045 2.497 . . . . 0.96 112.474 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 116.92 5.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 2.39 111.482 -174.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.27 64.19 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.952 -0.567 . . . . 1.3 113.777 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.763 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 51.3 p -79.82 -62.76 1.59 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.087 0.444 . . . . 1.04 112.113 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.35 178.06 30.12 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.07 -0.812 . . . . 1.97 111.07 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -71.74 106.89 4.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.972 0.415 . . . . 0.94 110.557 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 3.4 m-70 -77.31 116.55 18.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 2.85 110.115 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.811 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 9.7 ptt180 -94.87 90.09 5.89 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.464 -0.789 . . . . 2.78 110.642 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 1.0 OUTLIER -73.99 107.63 6.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.86 -0.793 . . . . 1.13 108.86 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 168' ' ' CYS . 19.9 t -90.36 129.52 41.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.569 -0.742 . . . . 0.31 109.479 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.628 ' HB2' HD21 ' A' ' 25' ' ' LEU . 23.3 m95 -89.93 119.74 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.397 -0.964 . . . . 2.96 108.397 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 79.5 mt -113.72 119.68 38.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.734 0.243 . . . . 0.41 111.205 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.51 HG11 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -119.18 135.22 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.249 0.547 . . . . 0.43 111.328 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.788 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 72.3 t80 -128.35 128.88 45.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 5.41 109.121 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.656 ' H ' HG21 ' A' ' 164' ' ' VAL . 6.5 pt-20 -67.53 107.63 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.096 -0.705 . . . . 2.41 109.096 175.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.528 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 18.6 mt-30 -56.42 137.56 52.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.387 -0.824 . . . . 1.31 112.392 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.42 -26.17 68.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.887 -1.051 . . . . 2.4 108.691 168.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.528 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 8.6 ptp180 -167.29 158.73 10.31 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 114.111 -1.404 . . . . 4.07 109.762 -177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.452 ' HA ' ' NE2' ' A' ' 127' ' ' GLN . 15.4 Cg_exo -61.69 131.95 37.94 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.759 2.306 . . . . 1.21 110.383 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.471 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.2 mm? -64.41 152.35 41.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.955 1.094 . . . . 1.16 113.955 -166.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -109.65 85.69 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.224 -1.353 . . . . 3.23 108.651 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.755 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 58.3 m -132.06 116.35 16.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 2.79 111.412 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -106.26 39.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.714 -0.847 . . . . 2.96 108.714 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.9 mm-40 -73.89 131.44 81.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.801 -1.091 . . . . 1.39 110.585 -173.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.8 119.96 4.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.408 2.739 . . . . 1.38 112.7 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 15.2 mm -70.11 115.2 8.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.578 -0.527 . . . . 0.94 109.578 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.88 -14.44 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.651 0.611 . . . . 1.61 112.651 -170.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.427 ' HA ' ' CG ' ' A' ' 105' ' ' ASP . 37.1 m 55.43 23.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.489 0.922 . . . . 1.88 113.489 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.647 ' HB2' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER 60.29 -2.78 0.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.21 1.004 . . . . 1.33 113.515 172.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.559 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 66.5 mtt180 -100.12 135.91 40.83 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.16 -0.338 . . . . 3.83 110.137 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.549 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.0 m 82.26 131.9 0.05 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 124.524 1.14 . . . . 1.32 111.396 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.7 41.6 2.16 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.196 -0.911 . . . . 1.13 113.109 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -71.68 -34.34 69.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 2.66 110.921 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -125.34 73.51 1.32 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 2.18 110.721 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.42 ' HB3' ' CE2' ' A' ' 84' ' ' TRP . 63.8 mtt180 -78.73 -77.15 0.17 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.155 -0.93 . . . . 5.37 111.549 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -132.72 -137.16 3.88 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.708 -0.758 . . . . 0.9 112.908 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.771 ' CG ' ' HA ' ' A' ' 81' ' ' TYR . 90.3 mttt 65.04 28.37 12.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.717 0.77 . . . . 1.59 110.246 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -103.92 167.94 9.45 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.909 -1.041 . . . . 2.27 108.763 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 11.8 mmmm -117.35 117.53 29.75 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.002 -0.37 . . . . 1.87 110.002 173.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.741 HG22 HG11 ' A' ' 17' ' ' VAL . 27.8 m -61.14 -24.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 0.96 110.8 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.15 82.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.852 -0.613 . . . . 0.76 109.505 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.9 m -65.53 -35.43 80.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 1.22 110.692 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.671 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 26.9 m-85 -58.65 -56.36 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.752 0.31 . . . . 1.1 110.685 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.481 HH22 ' HB2' ' A' ' 18' ' ' ASP . 18.4 ptp180 -66.02 -43.22 88.28 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.271 -0.422 . . . . 3.36 110.682 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -62.79 -36.16 82.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.682 0.277 . . . . 1.52 111.607 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -63.04 -45.17 93.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.165 0.507 . . . . 2.13 110.846 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.443 ' HB3' HD13 ' A' ' 131' ' ' LEU . 20.8 m-85 -83.0 1.86 37.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 5.77 110.478 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 64.19 33.07 12.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.163 -0.926 . . . . 2.42 111.125 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.788 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -92.79 179.19 5.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.652 -1.158 . . . . 1.27 109.14 173.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.697 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.9 tpt180 -149.05 -146.91 0.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.422 -0.585 . . . . 4.0 109.422 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.697 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -55.22 143.47 54.77 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 121.109 0.481 . . . . 1.21 111.038 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 4.1 Cg_exo -73.01 157.39 51.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.798 2.998 . . . . 0.68 112.813 -170.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.922 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -86.1 -24.48 6.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.562 -0.903 . . . . 0.5 108.562 174.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 55' ' ' TRP . . . -158.97 148.35 18.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.667 -0.697 . . . . 0.29 111.915 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.9 153.72 25.53 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.638 -1.165 . . . . 0.24 110.918 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.404 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.7 t -166.44 144.08 5.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.83 -0.804 . . . . 0.34 108.83 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.563 ' HB3' HG22 ' A' ' 121' ' ' VAL . 25.4 p -124.93 141.83 51.87 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.074 -0.65 . . . . 2.16 111.483 -173.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.757 ' HB3' HG22 ' A' ' 34' ' ' VAL . 26.0 p90 -123.92 130.75 53.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.254 -1.017 . . . . 1.31 108.254 171.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.811 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 24.4 mp0 -97.78 132.47 43.37 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 2.53 110.17 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.502 ' HB2' ' HE1' ' A' ' 120' ' ' TYR . . . -134.68 145.59 48.68 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.089 -0.708 . . . . 0.75 109.089 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -124.78 -170.54 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 2.38 111.562 -176.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.971 ' HA ' HG23 ' A' ' 177' ' ' VAL . 36.1 p90 -80.18 54.67 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 4.71 112.1 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -50.55 -60.44 3.02 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.487 0.551 . . . . 1.53 112.487 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.575 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.6 t70 -173.68 -44.53 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.007 0.432 . . . . 1.26 111.283 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -80.42 6.99 10.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.21 -0.45 . . . . 2.46 111.667 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.971 HG23 ' HA ' ' A' ' 173' ' ' TRP . 71.2 t -72.54 -52.79 6.28 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.077 -0.51 . . . . 0.58 110.546 174.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -50.35 -34.26 40.2 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.464 2.109 . . . . 0.68 112.158 169.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.7 mmmt -74.09 -25.19 59.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 2.62 111.196 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 24.9 tp -70.53 -44.91 66.57 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.275 -0.639 . . . . 1.18 109.275 172.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -58.32 -40.12 81.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.07 -0.715 . . . . 2.11 109.07 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.58 -50.67 71.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.81 -1.086 . . . . 1.53 110.897 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -65.18 -33.09 75.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.635 -0.711 . . . . 2.16 112.16 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 55.8 mt -66.47 4.29 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.87 111.641 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.822 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.3 m -79.71 3.13 20.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 1.38 109.581 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 79.04 48.0 7.24 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.162 -0.926 . . . . 1.17 111.306 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.822 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.0 mmmt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.508 -0.758 . . . . 2.45 110.241 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' SD ' ' HD2' ' A' ' 2' ' ' PRO . 6.0 tpt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.418 -0.586 . . . . 5.4 109.418 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.408 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 19.5 Cg_exo -37.15 135.78 0.36 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.249 3.299 . . . . 2.58 114.159 -175.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.74 HG13 ' HB2' ' A' ' 37' ' ' LEU . 22.5 t -73.83 148.71 8.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.881 -1.054 . . . . 2.1 110.835 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.09 155.21 41.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.85 -0.796 . . . . 1.81 108.85 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.49 8.12 14.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.863 0.69 . . . . 0.95 112.863 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 t -66.15 -27.07 67.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.977 0.417 . . . . 2.19 111.042 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 66.2 mttm -92.57 9.43 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.47 -0.332 . . . . 3.07 111.655 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 57.4 t-105 -66.58 -24.96 66.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.398 0.518 . . . . 4.76 112.398 -172.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.461 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 14.1 p -136.33 21.53 3.19 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.36 -0.536 . . . . 0.98 111.8 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.6 -126.37 1.45 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.822 -0.704 . . . . 0.52 111.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.12 -35.46 62.36 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.334 2.689 . . . . 0.61 110.056 166.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.643 HD11 ' HA3' ' A' ' 38' ' ' GLY . 12.5 mt -87.6 86.8 7.24 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.564 -1.198 . . . . 1.85 108.986 171.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.8 m -78.44 66.97 4.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.485 0.66 . . . . 1.31 110.467 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.464 HD11 ' HG ' ' A' ' 168' ' ' CYS . 29.0 mt -78.75 -4.97 51.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.468 -0.787 . . . . 0.61 111.216 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.461 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 12.9 mm100 -68.27 -13.4 62.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.047 0.451 . . . . 2.61 110.39 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.52 -28.14 69.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 1.93 110.262 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.495 ' CG1' HG22 ' A' ' 151' ' ' VAL . 71.5 t -86.36 -73.57 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.118 -0.946 . . . . 1.26 110.653 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -162.5 169.06 20.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.818 -0.353 . . . . 2.99 110.811 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -49.04 147.41 2.87 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.089 0.956 . . . . 1.6 113.279 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.754 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 68.1 mt-30 -59.37 128.39 85.68 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 115.536 -0.756 . . . . 4.38 109.913 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 11.1 Cg_exo -70.02 157.28 60.4 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.913 2.409 . . . . 0.69 111.893 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.875 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 7.2 pt20 -73.4 -18.79 61.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 1.87 111.314 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.804 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 47.2 m-70 -148.07 160.23 37.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.606 -0.725 . . . . 2.35 109.139 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 3.0 Cg_endo -86.0 131.92 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.05 2.5 . . . . 0.44 111.832 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.875 HD21 ' HB3' ' A' ' 122' ' ' TRP . 20.6 tp -80.68 141.08 35.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.328 . . . . 0.33 110.724 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.418 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.41 123.91 51.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.445 -0.343 . . . . 2.12 110.15 170.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.522 HG13 HG22 ' A' ' 53' ' ' ILE . 17.6 t -121.5 143.26 34.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.525 -0.917 . . . . 1.12 108.525 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -136.86 142.83 42.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.135 0.493 . . . . 0.78 110.791 -176.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -108.64 176.91 4.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.16 -0.681 . . . . 1.23 109.16 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.89 -51.81 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.6 111.803 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.75 -13.34 9.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.677 -0.692 . . . . 0.81 112.835 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.26 -165.12 1.36 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.56 110.914 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.0 165.99 26.61 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.367 -0.833 . . . . 0.35 109.748 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.736 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 93.4 t -107.44 64.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.303 -1.739 . . . . 0.39 106.303 160.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.12 1.72 49.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.198 -1.364 . . . . 0.99 109.949 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 43.7 mt-10 -135.62 126.06 26.75 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.408 -0.815 . . . . 2.56 109.865 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.74 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -71.95 110.13 6.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.149 -0.686 . . . . 0.46 109.149 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.896 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 90.01 28.31 18.49 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.258 -0.883 . . . . 0.59 111.973 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.736 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -93.29 151.05 20.04 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.842 -0.429 . . . . 1.04 109.842 174.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.4 p -78.19 135.98 25.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 1.16 111.098 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.471 HD21 ' CG1' ' A' ' 46' ' ' VAL . 8.4 tp -131.46 170.58 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.152 -1.425 . . . . 0.45 107.152 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 p -116.17 148.61 41.89 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 118.669 -1.212 . . . . 1.0 113.362 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 1.073 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 53.4 Cg_exo -55.38 -40.76 83.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.491 3.461 . . . . 1.0 113.914 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -33.32 63.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.517 0.675 . . . . 1.24 110.715 174.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -81.75 -58.46 2.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.909 . . . . 1.74 110.704 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.471 ' CG1' HD21 ' A' ' 41' ' ' LEU . 6.3 m -81.42 28.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.386 0.612 . . . . 1.1 112.079 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.67 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -82.21 -31.44 30.32 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.69 -0.856 . . . . 1.32 108.69 174.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.417 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 19.0 m120 -112.13 -149.78 0.45 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.849 -1.069 . . . . 2.4 110.319 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.495 ' HB3' HG23 ' A' ' 97' ' ' ILE . 99.5 mtt180 -99.11 157.25 34.39 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.246 -0.433 . . . . 1.78 109.964 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.98 166.28 25.18 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.402 2.068 . . . . 0.41 110.574 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.404 ' C ' ' HG ' ' A' ' 52' ' ' SER . 5.6 t -81.48 -25.47 36.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.03 0.443 . . . . 0.88 110.018 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.497 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.2 m -159.27 149.56 19.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.165 0.507 . . . . 0.65 111.97 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -141.12 158.71 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.288 -1.004 . . . . 0.33 108.288 171.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.724 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 32.7 t -176.4 113.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.917 0.389 . . . . 0.8 110.104 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.775 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -72.42 157.67 37.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.664 -1.235 . . . . 3.63 107.664 172.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.97 87.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.523 0.514 . . . . 1.51 110.611 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.3 21.51 4.05 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.753 -0.658 . . . . 0.9 112.749 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.724 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -57.69 129.14 40.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.984 0.421 . . . . 0.62 110.565 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.554 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 26.2 t70 -79.69 -27.74 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.505 . . . . 0.74 111.502 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.536 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 52.7 m 77.84 -5.67 2.08 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.3 1.0 . . . . 1.51 110.278 -171.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.31 21.49 5.15 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.874 -0.603 . . . . 0.84 112.794 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.554 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 9.7 mtpt -113.0 145.02 41.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 122.535 -0.391 . . . . 2.12 110.752 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 44.5 mt -91.0 124.87 35.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.191 -0.67 . . . . 1.23 109.191 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.654 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -127.18 161.38 28.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.754 -0.379 . . . . 1.61 109.98 177.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.635 HG22 HG11 ' A' ' 90' ' ' VAL . 63.3 m -97.45 106.57 18.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.715 -0.846 . . . . 0.87 108.715 169.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.2 tp -103.58 109.37 21.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.448 -0.796 . . . . 1.35 109.69 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.5 t -113.87 136.74 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.54 110.69 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.83 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.8 mt -104.61 126.4 51.66 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.336 -0.987 . . . . 0.65 108.336 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 10.1 t -135.22 150.75 50.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.878 0.37 . . . . 1.04 111.315 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 6.8 t70 -130.47 94.25 30.19 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-O 121.51 0.671 . . . . 1.92 110.39 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 13.0 Cg_endo -56.49 -30.91 84.2 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.83 3.02 . . . . 1.25 114.108 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -90.74 39.58 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.641 . . . . 1.29 112.732 -167.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 81' ' ' TYR . . . -104.48 140.44 21.07 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.77 -0.456 . . . . 0.56 109.77 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 98.3 Cg_endo -80.19 -21.62 17.38 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.864 -1.307 . . . . 0.7 113.351 2.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.603 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 88.5 p -139.75 162.85 34.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.746 -0.206 . . . . 1.1 111.072 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.462 ' NE ' HH12 ' A' ' 119' ' ' ARG . 1.0 OUTLIER -64.4 -36.8 85.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.234 0.54 . . . . 3.39 110.61 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.515 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 4.2 ptpt -71.63 -18.17 62.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 1.83 111.224 -175.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.5 t70 -161.43 86.62 1.65 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.402 . . . . 1.37 110.648 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -84.0 91.64 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.902 2.401 . . . . 0.9 112.946 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 39.3 mttm -82.63 -45.37 14.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 1.53 110.793 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.727 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.9 m-85 -81.0 16.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 1.54 111.776 -171.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.92 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 9.1 ttp180 -62.3 125.04 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.068 -0.345 . . . . 3.38 110.068 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.92 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.1 mp0 -107.72 133.98 51.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.503 0.321 . . . . 2.23 110.356 -4.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -76.9 164.85 25.41 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.813 -1.18 . . . . 1.77 107.813 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 p80 -145.94 123.18 11.55 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.826 -0.546 . . . . 2.19 110.329 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.83 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.3 t-160 -62.13 -40.86 97.35 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.418 -0.81 . . . . 2.74 109.552 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.9 p90 -167.77 171.56 9.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.963 -0.295 . . . . 2.21 110.465 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HD12 ' A' ' 103' ' ' LEU . 30.1 tp -129.96 113.09 14.16 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.144 -0.687 . . . . 0.68 109.144 173.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.36 134.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.847 -0.615 . . . . 0.35 110.649 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.936 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 19.7 m -134.53 157.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.63 -0.714 . . . . 0.3 109.61 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.585 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t30 61.18 22.28 12.62 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.601 0.563 . . . . 2.09 110.455 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.543 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.6 ttm -70.71 111.68 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.725 -0.843 . . . . 0.34 108.725 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HE2' HD23 ' A' ' 63' ' ' LEU . 18.2 ttmm -87.59 100.38 12.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.162 -0.926 . . . . 1.73 111.045 -172.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 77.17 -122.84 6.29 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.255 -0.884 . . . . 0.35 112.883 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.6 ' HB3' HD22 ' A' ' 58' ' ' LEU . 9.2 p30 -118.14 21.09 12.94 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 1.59 110.736 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.68 105.68 15.66 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.787 -0.642 . . . . 0.77 109.77 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 49' ' ' ARG . 4.8 mm -62.89 -25.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.867 -1.06 . . . . 0.45 111.384 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 m -84.41 -29.62 26.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 1.15 111.994 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 m -80.26 -3.84 50.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.943 0.402 . . . . 1.26 111.706 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.543 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -71.14 106.42 1.88 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.761 -0.733 . . . . 0.44 111.303 175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.2 m -64.31 106.84 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.228 -0.656 . . . . 1.06 109.228 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.19 111.8 24.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.43 -0.805 . . . . 1.15 110.86 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.485 HD12 ' HG ' ' A' ' 88' ' ' LEU . 5.1 mt -87.85 -39.96 14.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.039 0.923 . . . . 0.48 109.935 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.4 t -114.36 105.88 13.66 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.72 -1.585 . . . . 0.62 106.72 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.2 t70 -57.73 158.1 6.59 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.873 0.733 . . . . 1.15 111.992 -169.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 23.0 p90 -85.74 77.54 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 4.98 111.305 -171.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.785 HG22 ' HA ' ' A' ' 140' ' ' ASN . 36.7 t -60.48 -45.05 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.86 111.485 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.673 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 106.24 -168.33 14.8 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.385 -0.912 . . . . 0.95 112.576 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.9 t -65.91 126.63 29.15 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.759 -0.46 . . . . 0.89 109.759 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.616 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -152.56 54.49 0.46 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.994 -0.622 . . . . 0.82 112.727 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 1.057 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 11.3 Cg_endo -98.52 153.61 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.022 3.148 . . . . 1.01 113.232 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.474 ' HB2' HG21 ' A' ' 115' ' ' THR . 31.6 Cg_exo -61.34 150.16 86.14 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.008 2.472 . . . . 0.96 112.499 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -67.17 122.05 16.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.347 -0.842 . . . . 2.39 111.571 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.6 50.33 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.927 -0.654 . . . . 1.3 112.996 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.603 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 21.7 p -78.5 -13.59 59.76 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.943 0.72 . . . . 1.04 112.943 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.31 24.31 6.56 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.09 -1.052 . . . . 1.97 113.38 172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.668 HD13 ' HG2' ' A' ' 172' ' ' GLU . 4.0 mm? 68.56 103.79 0.05 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.807 -0.697 . . . . 0.94 111.549 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 11.6 m170 -76.64 134.18 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.789 -0.641 . . . . 2.85 109.695 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 1.009 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 8.0 ptp85 -112.9 96.7 6.1 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.347 0.594 . . . . 2.78 111.094 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 45.4 m-85 -72.15 114.59 10.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.511 -0.768 . . . . 1.13 109.247 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 168' ' ' CYS . 31.3 t -90.4 129.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.61 -0.723 . . . . 0.31 110.439 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.875 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.56 119.49 30.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.546 -0.752 . . . . 2.96 109.396 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 84.0 mt -118.37 127.61 53.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.333 0.111 . . . . 0.41 111.089 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.53 139.41 42.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.43 109.352 171.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.83 164.32 15.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.862 0.363 . . . . 5.41 111.427 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.62 118.2 33.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.438 -0.801 . . . . 2.41 109.071 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.536 ' HG2' HD23 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -97.81 166.96 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.184 0.516 . . . . 1.31 110.477 -175.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.52 -22.31 54.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.513 -0.767 . . . . 2.4 109.563 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.79 164.18 19.67 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.821 -1.081 . . . . 4.07 110.277 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.477 ' HG3' HD11 ' A' ' 63' ' ' LEU . 53.7 Cg_exo -51.74 135.67 49.67 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.605 2.203 . . . . 1.21 112.02 175.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.936 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.3 mm? -55.63 147.48 18.16 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.2 0.815 . . . . 1.16 113.2 -171.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -130.73 80.36 1.94 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.574 -1.194 . . . . 3.23 108.09 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 90' ' ' VAL . 60.1 m -104.1 112.86 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.765 -0.652 . . . . 2.79 110.23 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.53 18.58 12.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.09 -0.959 . . . . 2.96 110.216 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.87 130.2 94.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.444 -0.798 . . . . 1.39 109.999 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -47.44 118.55 2.99 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.309 2.673 . . . . 1.38 113.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.3 mm -60.43 115.76 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.971 -0.558 . . . . 0.94 110.618 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.8 152.19 19.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 1.61 109.841 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 m -99.59 156.43 17.07 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.089 -1.078 . . . . 1.88 108.089 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.785 ' HA ' HG22 ' A' ' 107' ' ' VAL . 1.7 p-10 -81.89 6.85 14.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.333 0.587 . . . . 1.33 110.432 -174.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.552 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 46.6 mtt-85 -102.76 135.49 44.31 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.548 -0.751 . . . . 3.83 109.427 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.574 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.9 m 83.27 140.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.828 1.33 . . . . 1.32 110.551 -175.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -102.22 46.71 1.22 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.511 -0.768 . . . . 1.13 111.433 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.454 ' CG ' ' HD1' ' A' ' 145' ' ' HIS . 9.6 p-10 -70.98 -29.96 66.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.928 0.394 . . . . 2.66 111.489 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.454 ' HD1' ' CG ' ' A' ' 144' ' ' ASP . 23.6 m80 -124.51 70.05 1.11 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.037 0.446 . . . . 2.18 111.232 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 63.7 mtp180 -87.93 30.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 5.37 111.989 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.77 -143.83 17.81 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.176 -1.012 . . . . 0.9 113.388 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.727 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.8 mttt 60.94 42.21 13.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.855 0.836 . . . . 1.59 110.687 -174.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -133.66 158.38 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.444 -1.253 . . . . 2.27 108.872 174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 12.3 mmmm -96.8 120.84 37.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.15 0.282 . . . . 1.87 110.775 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.604 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.7 m -61.27 -33.05 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.96 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -58.84 -44.6 90.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.886 -0.597 . . . . 0.76 109.736 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.4 m -62.13 -37.75 86.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.479 . . . . 1.22 111.064 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 48.1 m-85 -59.27 -56.74 18.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.898 0.38 . . . . 1.1 110.742 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.599 ' HB2' ' HB2' ' A' ' 160' ' ' LEU . 4.3 ppt_? -71.13 -28.77 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.111 0.412 . . . . 3.36 112.111 -176.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 52.5 mtmt -65.8 -25.99 67.48 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.404 -0.185 . . . . 1.52 111.331 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 17.8 tptm -53.17 -46.37 68.9 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.58 0.229 . . . . 2.13 110.716 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -99.8 11.81 38.3 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.77 -0.772 . . . . 5.77 109.957 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.18 41.31 6.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.171 -0.922 . . . . 2.42 112.83 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 155' ' ' ARG . 6.4 mp -73.74 137.2 43.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.466 -0.788 . . . . 1.27 109.171 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.459 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -86.0 -53.28 5.18 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.7 0.63 . . . . 4.0 112.7 -169.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -164.8 161.95 14.95 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.947 -0.57 . . . . 1.21 110.233 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.586 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 15.9 Cg_exo -66.96 140.6 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.845 2.363 . . . . 0.68 112.776 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.875 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -86.61 -29.55 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.739 -0.837 . . . . 0.5 108.739 173.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.804 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -152.57 146.77 25.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.616 -0.72 . . . . 0.29 111.221 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.87 156.85 27.13 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.2 -0.909 . . . . 0.24 111.716 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 5.8 t -168.87 151.12 4.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.571 -0.9 . . . . 0.34 108.571 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.563 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 26.5 p -129.37 140.34 51.4 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.878 -0.729 . . . . 2.16 111.371 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.668 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.1 p90 -122.1 137.47 54.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.16 -1.052 . . . . 1.31 108.16 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 1.009 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 26.2 mp0 -100.04 133.58 44.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.468 0.576 . . . . 2.53 110.985 177.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -157.4 114.32 3.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.75 110.069 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 1.057 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 6.4 pt-20 -109.94 -91.08 0.46 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 119.649 -0.82 . . . . 2.38 111.77 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.873 ' H ' ' HG3' ' A' ' 172' ' ' GLU . 18.7 t90 -117.34 78.79 1.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.887 0.767 . . . . 4.71 111.672 -170.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 1.073 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -76.0 -59.64 2.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.658 -0.417 . . . . 1.53 110.937 173.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.1 t70 -178.84 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.339 0.137 0 N-CA-C 111.924 0.342 . . . . 1.26 111.924 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.67 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.45 5.49 14.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 2.46 111.851 -178.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 173' ' ' TRP . 84.0 t -72.57 -53.5 5.74 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.068 -0.514 . . . . 0.58 110.978 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.734 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.4 Cg_exo -49.78 -45.36 32.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.383 2.056 . . . . 0.68 111.882 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.17 -24.25 64.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.506 -0.315 . . . . 2.62 111.654 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.671 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 48.4 tp -68.98 -47.85 64.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.187 -0.605 . . . . 1.18 109.393 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.73 -37.9 80.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.47 0.652 . . . . 2.11 109.479 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.62 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 7.5 mm-40 -56.22 -47.87 77.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.706 -1.134 . . . . 1.53 111.148 172.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.09 -29.38 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.416 -0.811 . . . . 2.16 112.927 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 64.5 mt -63.29 5.95 0.14 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.227 0.825 . . . . 0.87 113.227 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.746 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 16.5 m -82.78 -1.97 53.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.307 0.575 . . . . 1.38 109.532 168.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 84.85 45.59 5.96 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.783 -0.927 . . . . 1.17 110.783 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.746 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.2 mmtp . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.739 -0.648 . . . . 2.45 110.385 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.838 -0.43 . . . . 5.4 109.838 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.14 137.18 69.85 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.379 2.052 . . . . 2.58 110.711 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 t -57.68 105.06 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.701 0.762 . . . . 2.1 111.751 -172.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.549 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 19.2 t70 -162.78 159.93 24.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.083 -1.417 . . . . 1.81 107.816 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.55 24.08 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.74 0.245 . . . . 0.95 111.088 -173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 4' ' ' ASP . 3.4 m -51.56 -53.71 35.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.965 -0.561 . . . . 2.19 111.805 -172.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.595 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.5 tptm -125.16 49.2 1.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.275 0.56 . . . . 3.07 109.941 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.482 ' HB3' HE21 ' A' ' 20' ' ' GLN . 2.8 t90 -74.58 -8.54 56.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.517 -0.765 . . . . 4.76 111.046 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 9.0 p -136.36 22.92 3.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.223 0.535 . . . . 0.98 110.56 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.595 ' HA3' ' HG3' ' A' ' 7' ' ' LYS . . . -86.9 -120.44 1.3 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.516 -0.633 . . . . 0.52 111.516 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.51 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 11.6 Cg_endo -51.35 -40.49 61.78 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.551 2.834 . . . . 0.61 110.402 167.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.635 HD13 ' HA3' ' A' ' 38' ' ' GLY . 19.2 mt -87.34 88.22 7.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.012 -0.995 . . . . 1.85 109.045 171.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 4.6 m -75.66 63.87 1.64 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.509 0.671 . . . . 1.31 110.674 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD21 HG23 ' A' ' 121' ' ' VAL . 27.8 mt -75.94 -7.94 55.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.693 -0.685 . . . . 0.61 110.091 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 6.5 tp-100 -73.38 -7.82 53.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 2.61 110.992 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.561 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 22.1 mt-10 -63.45 -37.06 85.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.176 -0.676 . . . . 1.93 109.176 171.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.888 HG11 HG22 ' A' ' 151' ' ' VAL . 31.9 t -76.65 -73.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.494 -1.23 . . . . 1.26 111.635 -175.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.487 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 30.3 t0 -152.09 170.19 20.55 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.633 -0.506 . . . . 2.99 109.633 -172.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' HH12 ' A' ' 155' ' ' ARG . 30.8 mt-10 -60.3 149.96 31.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.472 0.545 . . . . 1.6 112.472 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.482 HE21 ' HB3' ' A' ' 8' ' ' TRP . 52.0 mt-30 -60.54 120.43 52.36 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 115.444 -0.798 . . . . 4.38 109.118 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 36.8 Cg_exo -58.7 155.42 37.5 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.656 2.237 . . . . 0.69 112.396 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.93 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 10.1 pt20 -71.64 -17.56 62.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.455 -0.793 . . . . 1.87 111.265 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.799 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 53.1 m-70 -149.75 157.47 38.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.534 0.734 . . . . 2.35 109.172 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 2.1 Cg_endo -84.89 129.82 4.08 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.97 2.447 . . . . 0.44 112.019 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 122' ' ' TRP . 22.1 tp -78.95 139.79 38.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.522 0.201 . . . . 0.33 110.594 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -110.99 125.73 54.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.47 -0.567 . . . . 2.12 109.47 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.515 HG11 HG22 ' A' ' 53' ' ' ILE . 13.0 t -131.65 135.66 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.426 -0.583 . . . . 1.12 109.426 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -137.15 137.9 39.7 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.001 0.429 . . . . 0.78 110.736 -177.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -98.38 175.41 6.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.38 -0.97 . . . . 1.23 108.38 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.25 59.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.247 0.546 . . . . 0.6 110.855 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.2 -7.99 34.32 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.415 -0.812 . . . . 0.81 112.606 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.07 -173.17 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.719 -0.283 . . . . 0.56 110.412 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.1 166.05 23.95 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.224 -0.444 . . . . 0.35 110.246 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' A' ' 169' ' ' TYR . 89.4 t -113.23 64.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 106.521 -1.659 . . . . 0.39 106.521 162.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.14 16.1 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.438 -1.255 . . . . 0.99 109.78 -174.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.733 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 4.6 tm-20 -148.5 125.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.071 -1.085 . . . . 2.56 108.071 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.633 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.9 OUTLIER -71.86 110.19 6.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.847 -0.427 . . . . 0.46 109.847 -174.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.662 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 88.71 14.83 60.67 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.708 -0.678 . . . . 0.59 112.573 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -72.29 154.64 40.86 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 110.145 -0.316 . . . . 1.04 110.145 175.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.454 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 8.8 p -80.34 129.6 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.301 0.572 . . . . 1.16 110.972 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 46' ' ' VAL . 6.2 tp -124.2 165.13 18.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.559 -1.274 . . . . 0.45 107.559 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.97 152.69 49.0 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 119.148 -1.021 . . . . 1.0 113.375 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.633 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 70.9 Cg_exo -51.38 -46.43 31.52 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.401 2.734 . . . . 1.0 113.338 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -27.58 65.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.998 0.428 . . . . 1.24 111.452 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.2 -48.68 10.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.978 -0.556 . . . . 1.74 110.914 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 41' ' ' LEU . 10.7 m -95.17 29.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.53 0.681 . . . . 1.1 112.323 -175.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 6.52 42.77 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.31 -0.626 . . . . 1.32 109.31 178.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -148.17 177.85 9.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.118 -0.946 . . . . 2.4 109.572 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -78.88 152.36 77.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.405 -0.361 . . . . 1.78 110.096 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.09 156.59 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.403 2.068 . . . . 0.41 111.479 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -77.45 -23.76 50.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.88 110.355 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.477 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 67.3 m -153.02 141.07 20.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.66 0.615 . . . . 0.65 112.66 -175.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -140.82 166.26 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.997 -1.001 . . . . 0.33 108.313 169.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.744 ' HA ' HD11 ' A' ' 58' ' ' LEU . 31.3 t 176.12 117.7 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.985 0.421 . . . . 0.8 110.096 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.672 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 29.9 p-90 -79.27 154.82 28.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.707 -1.22 . . . . 3.63 107.707 172.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' HB3' ' HD1' ' A' ' 23' ' ' HIS . 35.7 t70 -64.64 85.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.811 0.339 . . . . 1.51 111.364 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.02 20.3 2.28 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.991 -0.549 . . . . 0.9 112.021 -175.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.744 HD11 ' HA ' ' A' ' 54' ' ' SER . 4.5 tt -63.01 129.07 38.78 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.937 0.495 . . . . 0.62 111.072 -177.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.514 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 26.1 t70 -74.82 -28.0 60.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.054 -0.521 . . . . 0.74 111.635 -175.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.624 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.7 m 74.32 2.12 4.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.302 -0.863 . . . . 1.51 110.422 -172.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -130.21 -35.81 0.41 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.671 -0.695 . . . . 0.84 112.372 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.553 ' HZ1' ' CD ' ' A' ' 126' ' ' GLU . 12.2 mtpt -63.29 146.26 53.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.908 0.385 . . . . 2.12 110.302 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.812 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 25.6 mt -87.37 138.7 31.25 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.794 -1.187 . . . . 1.23 107.794 172.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 11.5 m-85 -128.71 157.51 41.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 1.61 109.822 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.464 ' HG1' HD21 ' A' ' 131' ' ' LEU . 91.8 m -96.86 105.28 17.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.397 -0.594 . . . . 0.87 109.397 172.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 17.6 tp -100.84 109.6 21.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.444 -0.798 . . . . 1.35 109.563 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.1 125.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.45 . . . . 0.54 110.987 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.493 HD23 ' HE1' ' A' ' 169' ' ' TYR . 3.4 mt -85.5 129.86 34.72 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.416 -0.957 . . . . 0.65 108.416 167.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.837 HG21 HG12 ' A' ' 17' ' ' VAL . 9.0 t -138.11 138.79 39.04 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.7 -0.481 . . . . 1.04 109.7 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.522 ' HB3' ' HA ' ' A' ' 120' ' ' TYR . 11.2 p-10 -132.67 99.78 15.3 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-O 121.617 0.722 . . . . 1.92 111.026 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.48 -173.9 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.582 2.854 . . . . 1.25 112.386 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.842 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 2.1 m-20 56.93 33.81 23.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.17 0.509 . . . . 1.29 111.127 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 81' ' ' TYR . . . -104.34 137.19 19.16 Favored Pre-proline 0 C--O 1.22 -0.469 0 CA-C-N 116.054 -0.521 . . . . 0.56 110.647 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.638 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -79.5 -31.12 5.1 Favored 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.016 -1.66 . . . . 0.7 112.556 0.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 115' ' ' THR . 92.7 p -125.24 153.44 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 1.1 109.977 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.842 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 45.5 mtp180 -71.99 -23.18 61.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.301 -0.409 . . . . 3.39 111.599 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.758 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.73 -10.89 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.932 0.396 . . . . 1.83 110.79 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -155.2 82.3 3.95 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.34 -0.615 . . . . 1.37 109.34 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -89.1 97.67 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.034 2.489 . . . . 0.9 113.279 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 6.5 mtmm -88.13 -58.7 2.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.119 -0.946 . . . . 1.53 111.16 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.501 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 70.0 m-85 -66.89 -23.37 65.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.969 -0.56 . . . . 1.54 110.994 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.561 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -48.0 117.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.412 0.445 . . . . 3.38 109.891 177.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -89.71 130.99 35.91 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.561 0.744 . . . . 2.23 112.217 7.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.518 ' HD1' ' N ' ' A' ' 85' ' ' HIS . 4.6 t90 -90.56 134.37 34.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.832 -0.803 . . . . 1.77 108.832 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.518 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 13.8 p-80 -106.07 129.74 54.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.876 -0.787 . . . . 2.19 108.876 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.403 ' CB ' ' HB3' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -91.11 -23.76 20.2 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.29 0.478 . . . . 2.74 112.29 -171.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.608 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 6.5 p90 -169.2 170.7 8.5 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.062 -0.347 . . . . 2.21 110.062 167.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.9 tp -131.89 114.0 14.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.546 -0.297 . . . . 0.68 110.411 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.476 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 2.0 t -119.92 133.4 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.05 -0.523 . . . . 0.35 110.827 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.447 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 5.3 m -131.61 168.1 24.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.123 -1.065 . . . . 0.3 108.123 174.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.812 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 8.8 m-20 59.96 19.28 8.33 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.37 0.419 . . . . 2.09 111.588 173.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.624 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 9.6 ttm -74.16 111.26 9.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.464 -0.939 . . . . 0.34 108.464 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.3 ttmm -79.71 91.5 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.191 -0.913 . . . . 1.73 111.196 -170.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.635 ' HA2' ' HE1' ' A' ' 64' ' ' TYR . . . 72.41 -117.45 6.24 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.857 -1.065 . . . . 0.35 112.166 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.66 ' HB3' HD22 ' A' ' 58' ' ' LEU . 27.6 p-10 -111.55 26.38 10.71 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.428 0.632 . . . . 1.59 110.122 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.428 ' HB3' ' HG ' ' A' ' 99' ' ' SER . 16.7 t70 -89.39 104.19 16.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.247 -0.888 . . . . 0.77 109.946 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.453 HD11 HD13 ' A' ' 53' ' ' ILE . 4.6 mm -59.85 -28.55 41.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.111 -0.949 . . . . 0.45 111.233 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.1 m -78.65 -42.76 27.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 1.15 112.469 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.428 ' HG ' ' HB3' ' A' ' 96' ' ' ASP . 20.0 p -65.21 -24.16 67.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.412 0.523 . . . . 1.26 112.412 -174.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.624 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -53.46 99.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.761 0.663 . . . . 0.44 113.316 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 99.4 m -65.78 105.45 1.28 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.121 -0.696 . . . . 1.06 109.121 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 9.5 p -93.4 109.57 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.4 -0.818 . . . . 1.15 110.839 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.67 -41.78 23.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.12 0.962 . . . . 0.48 109.824 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.0 t -115.04 100.19 7.99 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.247 -1.39 . . . . 0.62 107.247 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.807 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -52.69 156.85 1.77 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.298 0.999 . . . . 1.15 113.161 -167.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 4.1 p90 -76.61 96.19 4.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.942 -1.026 . . . . 4.98 110.739 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.832 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 21.8 t -67.72 -31.63 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.844 -0.616 . . . . 0.86 111.76 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.45 173.09 49.49 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.756 -0.735 . . . . 0.95 111.912 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 38.7 t -54.53 135.7 45.69 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.22 0.51 . . . . 0.89 110.834 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.87 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 169.77 70.68 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.82 113.289 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.14 150.23 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.739 2.293 . . . . 1.01 110.898 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.67 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 85.0 Cg_exo -43.48 126.48 5.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.728 2.286 . . . . 0.96 112.321 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.516 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -61.68 115.5 4.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 2.39 110.749 -175.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.72 23.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.716 -0.754 . . . . 1.3 112.407 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.67 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.7 p -76.86 -60.99 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.758 0.279 . . . . 1.04 111.405 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.41 28.33 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.857 -0.687 . . . . 1.97 112.081 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.711 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.1 mm? -73.21 123.27 23.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.94 110.477 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.436 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -102.01 112.81 25.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.051 0.453 . . . . 2.85 110.35 176.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.514 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 2.0 ptt180 -85.74 90.5 8.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.504 -0.771 . . . . 2.78 110.703 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.638 ' HE2' ' HB2' ' A' ' 171' ' ' ALA . 3.3 m-85 -74.29 112.57 10.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.022 -0.733 . . . . 1.13 109.022 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 168' ' ' CYS . 13.8 t -94.01 126.01 46.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.948 -0.569 . . . . 0.31 109.638 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.674 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.34 119.56 30.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.721 -0.672 . . . . 2.96 109.738 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 83.6 mt -115.99 138.62 51.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.647 -0.131 . . . . 0.41 110.647 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -122.69 140.71 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.695 -0.483 . . . . 0.43 109.695 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.638 ' HB2' HD21 ' A' ' 160' ' ' LEU . 97.2 m-85 -117.37 165.54 13.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.996 0.427 . . . . 5.41 111.191 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.553 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 5.2 tp10 -110.38 137.61 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.25 -0.886 . . . . 2.41 109.983 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.624 ' HG3' ' HG ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.26 153.84 47.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.357 0.599 . . . . 1.31 110.014 177.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.01 -2.17 46.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.045 -0.98 . . . . 2.4 111.051 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.527 HH22 ' HB2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -166.17 168.61 7.41 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.16 -0.927 . . . . 4.07 109.753 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HG3' HD11 ' A' ' 63' ' ' LEU . 76.1 Cg_exo -53.15 150.54 24.4 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.559 2.173 . . . . 1.21 111.791 171.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.464 HD21 ' HG1' ' A' ' 65' ' ' THR . 4.5 mm? -72.21 158.45 35.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.633 0.73 . . . . 1.16 112.42 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.71 127.2 32.33 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.584 -1.265 . . . . 3.23 107.584 167.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.9 m -146.44 -63.23 0.3 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.866 -0.606 . . . . 2.79 109.728 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 58.83 37.99 24.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.395 0.617 . . . . 2.96 110.809 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.58 137.0 63.32 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.264 -0.88 . . . . 1.39 109.54 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.85 106.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.132 2.554 . . . . 1.38 112.175 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.7 mm -55.77 119.12 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.534 -0.757 . . . . 0.94 111.36 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 81.4 mt -88.49 158.71 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.086 -0.709 . . . . 1.61 109.086 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.676 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 64.5 m -112.63 31.28 6.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.713 -0.221 . . . . 1.88 111.008 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.832 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.1 p-10 54.92 12.64 0.63 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.202 0.939 . . . . 1.33 111.693 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.676 ' HG3' ' O ' ' A' ' 139' ' ' SER . 5.5 mtm180 -98.2 153.61 18.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.933 -0.395 . . . . 3.83 109.933 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.625 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 44.4 m 67.5 165.68 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.275 -0.875 . . . . 1.32 111.824 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.0 23.07 5.93 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.474 -0.87 . . . . 1.13 112.401 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -71.01 -26.25 63.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.205 0.446 . . . . 2.66 112.205 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -131.27 61.01 1.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.304 0.573 . . . . 2.18 110.751 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.88 -71.05 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.264 -0.88 . . . . 5.37 110.663 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -124.44 -153.41 8.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.53 -0.843 . . . . 0.9 112.226 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.2 mttt 66.51 32.5 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.151 0.977 . . . . 1.59 109.831 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -124.9 103.97 8.34 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.11 -1.405 . . . . 2.27 108.81 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -62.85 120.19 10.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 1.87 111.875 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.888 HG22 HG11 ' A' ' 17' ' ' VAL . 8.2 m -62.66 -31.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.96 110.581 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -59.12 -38.8 80.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.866 -0.606 . . . . 0.76 110.154 174.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.6 m -66.86 -38.6 86.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.546 . . . . 1.22 110.624 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.752 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 62.0 m-85 -61.56 -53.07 61.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 1.1 111.126 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.69 HH12 ' HG3' ' A' ' 19' ' ' GLU . 8.7 ptm180 -66.21 -39.69 89.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 3.36 111.641 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.8 mtmt -68.08 -46.77 70.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.605 0.24 . . . . 1.52 111.169 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -60.87 -51.64 68.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.069 -0.514 . . . . 2.13 111.587 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.67 0.08 31.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.271 -0.422 . . . . 5.77 111.624 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.527 ' HB2' HH22 ' A' ' 129' ' ' ARG . 70.8 mm-40 66.1 46.36 2.15 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.763 0.664 . . . . 2.42 110.996 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 125' ' ' TYR . 5.6 mp -102.35 15.09 30.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.643 0.608 . . . . 1.27 112.643 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 61.89 -94.45 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.649 0.38 . . . . 4.0 111.809 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -154.3 168.82 11.11 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 109.455 -0.572 . . . . 1.21 109.455 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 38.9 Cg_exo -57.16 129.03 32.14 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.406 2.071 . . . . 0.68 112.91 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.93 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -84.38 -33.06 8.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.279 -0.638 . . . . 0.5 109.279 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.799 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.23 149.79 29.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.831 -0.622 . . . . 0.29 111.258 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -153.25 144.75 11.73 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.357 -0.838 . . . . 0.24 112.009 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -157.97 137.78 12.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.45 -0.574 . . . . 0.34 109.45 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.736 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -108.54 144.93 35.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.325 0.583 . . . . 2.16 111.791 -174.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.668 ' HB3' HG22 ' A' ' 34' ' ' VAL . 34.0 p90 -135.07 119.62 18.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.378 -1.341 . . . . 1.31 107.378 172.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -100.14 133.23 44.83 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.866 -0.734 . . . . 2.53 111.451 -178.325 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.638 ' HB2' ' HE2' ' A' ' 120' ' ' TYR . . . -129.87 147.99 51.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.491 -0.777 . . . . 0.75 109.739 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.711 ' HB3' HD13 ' A' ' 117' ' ' LEU . 12.6 pt-20 -110.71 -172.52 2.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.045 -0.525 . . . . 2.38 111.09 -176.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.897 ' HA ' HG23 ' A' ' 177' ' ' VAL . 0.7 OUTLIER -85.11 64.47 8.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 4.71 111.173 -177.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.633 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.7 t70 -53.16 -61.78 2.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.573 -0.739 . . . . 1.53 112.332 -176.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.568 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.3 t70 -177.27 -40.74 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.943 0.402 . . . . 1.26 110.92 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -78.17 2.73 17.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.079 0.466 . . . . 2.46 111.058 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.897 HG23 ' HA ' ' A' ' 173' ' ' TRP . 39.8 t -72.52 -53.83 5.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.58 110.507 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 73.4 Cg_exo -52.79 -33.5 60.85 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.128 1.886 . . . . 0.68 111.966 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 43.4 mmtm -74.35 -24.92 59.24 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.737 0.273 . . . . 2.62 111.737 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.87 HD22 ' HA3' ' A' ' 110' ' ' GLY . 62.3 tp -66.57 -46.16 76.92 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.764 -0.828 . . . . 1.18 108.764 170.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -60.44 -37.97 82.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.355 -0.839 . . . . 2.11 109.533 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.681 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 24.9 mm-40 -56.65 -41.57 77.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.299 -0.864 . . . . 1.53 111.088 172.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.48 -31.63 57.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.615 -0.721 . . . . 2.16 111.881 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.625 ' HA ' ' H ' ' A' ' 142' ' ' SER . 21.2 mt -65.1 5.64 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.629 0.603 . . . . 0.87 112.629 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 16.9 m -66.07 -19.89 65.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.613 0.72 . . . . 1.38 109.791 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 88.76 62.93 1.35 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.145 -0.934 . . . . 1.17 110.791 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt . . . . . 0 C--O 1.244 0.78 0 CA-C-O 118.449 -0.786 . . . . 2.45 109.984 -176.833 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 8.1 tpt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.768 -0.456 . . . . 5.4 109.768 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 20.2 Cg_exo -67.08 122.64 9.97 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.556 2.171 . . . . 2.58 111.835 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 24' ' ' PRO . 4.5 t -103.17 152.16 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.02 -0.536 . . . . 2.1 109.783 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -154.36 158.74 40.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.928 -0.397 . . . . 1.81 109.928 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -95.19 22.69 6.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.688 -0.233 . . . . 0.95 110.962 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 m -80.05 -1.3 39.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 2.19 111.481 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.594 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 11.3 mptt -118.87 22.28 12.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.321 -0.622 . . . . 3.07 109.321 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.644 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 1.9 p90 -61.93 -32.79 73.23 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 4.76 113.565 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -139.99 18.59 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.988 -0.445 . . . . 0.98 111.508 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.484 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.15 -122.14 0.78 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.263 -0.735 . . . . 0.52 111.263 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.484 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.5 Cg_endo -50.1 -40.64 50.64 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.539 2.826 . . . . 0.61 110.696 167.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.621 HD12 ' HG ' ' A' ' 168' ' ' CYS . 23.1 mt -87.23 78.49 8.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.21 -0.904 . . . . 1.85 108.752 170.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -73.26 64.98 0.82 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.702 0.763 . . . . 1.31 110.507 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.461 HD21 ' CG2' ' A' ' 121' ' ' VAL . 28.7 mt -81.44 -7.05 59.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.181 -0.918 . . . . 0.61 111.326 -173.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -2.06 20.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.428 0.632 . . . . 2.61 110.332 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.87 -7.67 55.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 1.93 110.743 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.806 HG12 HG21 ' A' ' 69' ' ' THR . 71.3 t -98.5 -70.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.684 . . . . 1.26 111.112 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.682 ' OD2' ' HD2' ' A' ' 155' ' ' ARG . 22.2 t0 -164.32 -178.45 5.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.807 -1.183 . . . . 2.99 107.807 -167.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.35 149.84 41.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.322 0.582 . . . . 1.6 111.104 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.644 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 5.6 tp60 -81.87 138.6 46.57 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.735 . . . . 4.38 110.736 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 13.4 Cg_exo -68.51 164.86 31.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.021 2.481 . . . . 0.69 112.95 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.949 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.9 pt20 -90.52 -1.62 57.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.765 . . . . 1.87 111.929 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.74 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.4 m170 -158.88 159.78 29.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 123.059 0.544 . . . . 2.35 109.919 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.3 Cg_endo -84.83 127.46 3.6 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.059 2.506 . . . . 0.44 111.251 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 122' ' ' TRP . 36.0 tp -79.85 145.66 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.694 -0.23 . . . . 0.33 110.768 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.44 ' H ' HD12 ' A' ' 25' ' ' LEU . 51.0 m-70 -114.72 121.24 42.73 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.982 -0.748 . . . . 2.12 108.982 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 53' ' ' ILE . 19.4 t -122.83 144.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.108 -0.701 . . . . 1.12 109.108 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -140.02 136.32 33.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.237 0.542 . . . . 0.78 111.107 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.527 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 46.0 t80 -101.97 170.2 8.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.174 -0.676 . . . . 1.23 109.174 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.47 63.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.342 0.591 . . . . 0.6 110.391 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -117.45 19.16 11.68 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.123 -0.944 . . . . 0.81 112.703 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.7 -172.37 4.2 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.56 110.783 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.37 154.9 17.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.991 -0.55 . . . . 0.35 110.13 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.718 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 87.8 t -119.21 68.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.192 -1.41 . . . . 0.39 107.192 164.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 1' ' ' MET . 28.2 t70 -105.7 21.56 17.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.979 -1.01 . . . . 0.99 108.851 -175.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 22.4 tt0 -144.42 117.58 8.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.718 -1.128 . . . . 2.56 108.486 174.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.657 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -66.88 110.56 3.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.46 109.475 -177.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 95.24 12.94 53.9 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.531 -0.759 . . . . 0.59 112.557 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -78.93 149.05 32.44 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.09 -0.337 . . . . 1.04 110.09 177.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.9 134.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 1.16 111.324 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.588 HD21 ' CG1' ' A' ' 46' ' ' VAL . 8.2 tp -132.27 171.11 14.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.703 -0.851 . . . . 0.45 108.703 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -120.5 150.81 52.89 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.67 0.748 . . . . 1.0 112.485 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.863 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 72.4 Cg_exo -54.92 -29.99 66.64 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.604 3.536 . . . . 1.0 113.963 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -42.53 88.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.659 0.742 . . . . 1.24 110.275 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -74.93 -14.4 60.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.613 -1.176 . . . . 1.74 111.822 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.588 ' CG1' HD21 ' A' ' 41' ' ' LEU . 24.9 m -125.48 24.32 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.173 0.511 . . . . 1.1 111.647 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.75 -18.55 40.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.505 0.669 . . . . 1.32 109.206 177.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.415 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 52.0 t30 -125.03 -179.58 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.701 -1.136 . . . . 2.4 108.751 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.88 150.68 78.66 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.616 -0.513 . . . . 1.78 109.616 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.438 ' O ' HG13 ' A' ' 97' ' ' ILE . 55.2 Cg_endo -73.88 158.75 46.04 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.978 1.785 . . . . 0.41 110.436 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.446 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.6 t -79.75 -18.8 50.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 0.88 109.858 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.45 ' O ' HG21 ' A' ' 53' ' ' ILE . 60.1 m -161.21 147.41 14.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.632 0.73 . . . . 0.65 112.164 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -139.13 165.6 23.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.756 -1.111 . . . . 0.33 108.249 170.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.719 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 30.4 t 178.96 111.98 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.938 0.399 . . . . 0.8 109.929 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.633 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 51.1 p-90 -68.87 167.97 14.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.552 -1.277 . . . . 3.63 107.552 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -70.2 70.31 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.191 0.519 . . . . 1.51 111.187 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.83 22.99 0.64 Allowed Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.446 -0.797 . . . . 0.9 112.423 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.719 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 4.7 tt -54.88 132.31 46.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.89 0.476 . . . . 0.62 111.674 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 60' ' ' SER . 18.8 t70 -78.9 -28.81 44.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.844 -0.616 . . . . 0.74 111.996 -175.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.676 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 64.6 m 71.82 1.97 4.11 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.462 -0.79 . . . . 1.51 110.769 -172.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.65 14.54 4.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.992 -0.549 . . . . 0.84 112.719 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 1.5 mmpt? -119.26 164.82 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 2.12 109.956 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 63.7 mt -103.2 125.6 49.96 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.367 -0.605 . . . . 1.23 109.367 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -120.72 148.33 44.1 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.806 -0.357 . . . . 1.61 110.812 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.917 HG21 HG11 ' A' ' 90' ' ' VAL . 3.1 m -96.56 105.74 17.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.691 -0.855 . . . . 0.87 108.691 173.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.555 HD11 HG11 ' A' ' 124' ' ' VAL . 50.2 tp -109.69 117.76 34.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.274 -0.421 . . . . 1.35 110.907 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG22 HD11 ' A' ' 88' ' ' LEU . 21.0 t -119.0 123.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.865 -0.607 . . . . 0.54 110.553 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.973 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 1.2 mt -90.03 133.68 34.68 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.038 -1.097 . . . . 0.65 108.038 168.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.806 HG21 HG12 ' A' ' 17' ' ' VAL . 8.8 t -142.75 149.16 38.36 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.692 -0.403 . . . . 1.04 111.84 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.602 ' CG ' ' HD1' ' A' ' 118' ' ' HIS . 10.8 t70 -135.71 97.5 12.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 121.522 0.677 . . . . 1.92 109.488 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.515 ' HD3' HG23 ' A' ' 17' ' ' VAL . 18.6 Cg_endo -57.82 -7.42 3.35 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 124.62 3.547 . . . . 1.25 115.848 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 1.8 m-20 -124.77 51.42 1.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.533 0.683 . . . . 1.29 111.534 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -104.58 143.77 27.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.19 -0.913 . . . . 0.56 109.391 172.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 34.6 Cg_endo -70.92 -35.89 2.62 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.53 -1.446 . . . . 0.7 113.431 1.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.475 ' HB3' HG22 ' A' ' 115' ' ' THR . 72.2 p -131.59 166.82 20.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 1.1 111.312 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.555 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 51.5 ttt180 -71.33 -23.09 61.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.0 -0.546 . . . . 3.39 110.839 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.677 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.15 -11.52 38.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.509 . . . . 1.83 110.656 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.666 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 6.9 t70 -149.64 79.73 7.83 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.699 -0.682 . . . . 1.37 109.958 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -89.77 94.24 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.741 2.294 . . . . 0.9 113.287 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.9 mttm -88.17 -44.09 11.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.284 -0.871 . . . . 1.53 110.541 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.657 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 27.9 m-85 -88.54 18.12 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.175 -0.921 . . . . 1.54 112.032 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.7 ttm180 -64.2 125.83 25.78 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.916 0.135 . . . . 3.38 111.236 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.0 mp0 -97.67 134.25 41.11 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.065 -0.346 . . . . 2.23 110.065 -5.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.563 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 11.2 t90 -80.57 100.32 8.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.427 0.632 . . . . 1.77 109.927 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 33.2 p-80 -84.2 126.08 32.8 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.553 0.692 . . . . 2.19 110.18 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.973 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 19.5 t-80 -67.9 -34.7 77.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.05 -0.977 . . . . 2.74 110.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.468 ' HD1' ' HD1' ' A' ' 86' ' ' HIS . 44.2 p90 -169.29 170.67 8.4 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.117 0.261 . . . . 2.21 110.311 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.546 HD11 HG22 ' A' ' 67' ' ' VAL . 17.0 tp -133.33 114.08 13.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.065 -0.516 . . . . 0.68 109.701 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.32 132.54 70.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.6 0.714 . . . . 0.35 111.153 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.917 HG11 HG21 ' A' ' 65' ' ' THR . 9.9 m -130.86 160.53 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.85 -1.068 . . . . 0.3 108.419 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.551 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t-20 62.62 20.52 12.08 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.203 0.314 . . . . 2.09 110.625 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.591 ' HE3' ' HA ' ' A' ' 97' ' ' ILE . 8.3 ttm -71.51 110.35 6.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.277 -0.638 . . . . 0.34 109.277 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.01 94.71 5.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.578 -1.192 . . . . 1.73 110.937 -171.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.676 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 72.72 -120.27 7.37 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.801 -1.09 . . . . 0.35 112.426 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.594 ' HB3' HD22 ' A' ' 58' ' ' LEU . 8.7 p30 -112.76 17.59 18.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.188 0.518 . . . . 1.59 110.473 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.58 102.53 12.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.707 -0.679 . . . . 0.77 109.911 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.591 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 3.8 mm -58.71 -27.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.702 -1.135 . . . . 0.45 111.624 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -77.94 -38.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 1.15 111.975 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 m -74.87 -3.55 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 1.26 112.005 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.478 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -72.74 106.79 2.04 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.363 -0.695 . . . . 0.44 111.363 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -61.46 107.39 0.78 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.281 0.562 . . . . 1.06 109.734 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.8 p -83.47 113.28 22.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.081 -0.963 . . . . 1.15 111.4 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' A' ' 133' ' ' CYS . 40.6 mt -90.4 -45.8 8.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.79 0.805 . . . . 0.48 109.537 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.6 t -122.84 112.25 17.65 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.132 -1.433 . . . . 0.62 107.132 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 10.7 t0 -61.99 164.97 5.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.42 -0.809 . . . . 1.15 112.699 -168.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 13.8 p90 -82.69 92.08 7.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 4.98 110.76 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.716 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 40.3 t -75.09 -46.29 39.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.177 0.513 . . . . 0.86 111.02 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.683 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 109.84 -174.82 18.14 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.439 -0.886 . . . . 0.95 112.996 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 43' ' ' PRO . 42.2 t -66.58 140.25 57.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.287 -0.634 . . . . 0.89 109.287 172.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.705 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -174.13 55.52 0.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.71 -0.757 . . . . 0.82 112.854 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 57.5 Cg_endo -96.05 157.02 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.327 2.684 . . . . 1.01 112.516 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.601 ' O ' HG21 ' A' ' 115' ' ' THR . 53.0 Cg_exo -54.89 154.54 21.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.058 2.505 . . . . 0.96 112.282 174.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.3 116.5 15.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.77 0.319 . . . . 2.39 111.034 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.77 34.35 4.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.652 -0.785 . . . . 1.3 112.924 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 112' ' ' PRO . 82.7 p -77.98 -18.27 56.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.729 0.3 . . . . 1.04 110.637 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.41 3.14 44.21 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 120.916 -0.659 . . . . 1.97 112.132 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.526 HD12 ' HG2' ' A' ' 172' ' ' GLU . 4.1 mm? 71.69 102.52 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.299 -0.951 . . . . 0.94 111.079 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.602 ' HD1' ' CG ' ' A' ' 70' ' ' ASP . 21.4 t-80 -110.69 -172.33 2.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.416 -0.957 . . . . 2.85 108.416 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.564 ' H ' ' ND1' ' A' ' 118' ' ' HIS . 1.3 ptp180 -147.55 120.22 8.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.282 0.563 . . . . 2.78 111.676 -163.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.632 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 6.5 m-85 -80.34 127.33 32.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.577 -1.192 . . . . 1.13 108.825 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' CG2' HD21 ' A' ' 14' ' ' LEU . 16.9 t -104.19 130.83 54.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.154 -0.475 . . . . 0.31 110.856 -177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.681 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 27.0 m95 -89.56 120.3 30.74 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 2.96 108.935 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 86.5 mt -115.49 118.59 33.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.934 0.334 . . . . 0.41 110.77 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -116.46 139.82 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.399 -0.223 . . . . 0.43 110.399 177.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.854 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 71.3 t80 -127.03 137.28 53.03 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.866 -0.334 . . . . 5.41 111.0 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.521 ' H ' HG21 ' A' ' 164' ' ' VAL . 9.1 tp10 -88.05 96.65 10.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.49 -0.93 . . . . 2.41 108.49 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.487 ' HA ' ' CE2' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -72.63 167.72 20.16 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.251 0.548 . . . . 1.31 109.696 -176.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -80.84 -4.62 55.35 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.464 -0.789 . . . . 2.4 109.747 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 3.2 ptp180 -165.06 161.9 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.337 -0.847 . . . . 4.07 110.913 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HG3' HD11 ' A' ' 63' ' ' LEU . 51.4 Cg_exo -55.91 143.72 80.95 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.509 2.806 . . . . 1.21 112.442 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' A' ' 90' ' ' VAL . 2.3 mm? -79.91 141.83 35.72 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.328 -0.396 . . . . 1.16 110.767 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -132.64 67.26 1.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.435 -0.95 . . . . 3.23 108.435 168.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.756 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 61.4 m -82.23 122.65 28.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.178 -0.919 . . . . 2.79 110.443 -177.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.39 25.55 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.926 -0.579 . . . . 2.96 110.26 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.756 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 12.8 mm-40 -62.38 142.18 96.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.52 -0.764 . . . . 1.39 109.894 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.69 110.14 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.313 2.675 . . . . 1.38 112.696 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.41 115.49 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.94 110.323 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.8 mt -108.15 155.54 20.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.284 0.564 . . . . 1.61 110.639 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.9 m -105.11 159.26 15.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.176 -1.046 . . . . 1.88 108.176 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.716 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.0 p-10 -78.75 7.11 7.5 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.739 -0.384 . . . . 1.33 110.666 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.556 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 11.0 mtt180 -98.17 135.17 40.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.548 -0.538 . . . . 3.83 109.548 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.683 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 20.5 m 73.38 117.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 O-C-N 124.316 1.01 . . . . 1.32 109.686 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.21 27.66 15.12 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.583 -0.818 . . . . 1.13 113.669 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -71.29 -25.13 62.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.929 0.395 . . . . 2.66 111.026 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.92 30.48 6.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.949 0.404 . . . . 2.18 111.177 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.563 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 42.7 mtp180 -60.9 -46.39 90.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 5.37 110.782 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.52 -154.82 7.71 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.743 -0.741 . . . . 0.9 111.889 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.657 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.0 mttt 67.2 17.32 10.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.254 0.55 . . . . 1.59 111.137 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -122.13 112.24 17.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.441 -0.799 . . . . 2.27 109.106 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -62.45 129.7 41.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 1.87 112.496 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.603 HG22 ' CG1' ' A' ' 17' ' ' VAL . 4.6 m -62.94 -32.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.96 110.761 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.21 95.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.586 -0.734 . . . . 0.76 110.02 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 1.22 110.693 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.598 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 32.7 m-85 -61.73 -50.62 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 1.1 110.965 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.682 ' HD2' ' OD2' ' A' ' 18' ' ' ASP . 6.5 ptm85 -70.12 -40.01 75.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.396 -0.365 . . . . 3.36 111.135 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -66.05 -26.03 67.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 111.637 0.236 . . . . 1.52 111.637 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -53.76 -49.36 68.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.679 0.275 . . . . 2.13 110.608 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -99.64 15.31 27.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.759 -0.776 . . . . 5.77 109.917 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 58.4 43.6 19.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.295 -0.866 . . . . 2.42 111.682 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.854 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 3.4 mp -86.13 120.54 27.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.767 -0.651 . . . . 1.27 111.027 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.895 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -79.62 -173.7 3.92 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.914 -0.402 . . . . 4.0 109.914 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.895 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -43.5 146.41 0.93 Allowed Pre-proline 0 N--CA 1.466 0.328 0 C-N-CA 123.82 0.848 . . . . 1.21 113.009 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 6.5 Cg_exo -71.54 169.65 20.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.965 3.11 . . . . 0.68 113.969 -170.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.949 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 21.4 t -95.3 -30.8 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.5 110.364 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.3 146.9 27.78 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.828 -0.749 . . . . 0.29 112.302 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.681 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.97 148.07 19.12 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 114.458 -1.246 . . . . 0.24 111.603 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.657 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 10.5 t -159.72 149.43 18.33 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.469 -0.937 . . . . 0.34 108.469 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.621 ' HG ' HD12 ' A' ' 12' ' ' LEU . 21.2 p -123.8 146.68 48.17 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.12 -0.632 . . . . 2.16 111.166 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 33.4 p90 -130.23 142.03 50.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.413 -1.329 . . . . 1.31 107.413 175.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 1.1 pt20 -115.66 134.64 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.192 -0.603 . . . . 2.53 111.558 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.14 153.87 33.64 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.751 0.657 . . . . 0.75 110.072 -172.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.562 ' CG ' ' H ' ' A' ' 173' ' ' TRP . 2.5 pt-20 -133.91 -106.73 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.677 0.621 . . . . 2.38 112.677 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.774 ' HA ' HG23 ' A' ' 177' ' ' VAL . 31.9 t90 -118.12 84.1 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.15 0.5 . . . . 4.71 110.232 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.863 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 7.2 t70 -73.26 -62.4 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.898 -0.592 . . . . 1.53 111.725 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.552 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 14.4 t70 173.41 -44.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.776 -0.647 . . . . 1.26 109.675 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -80.34 9.55 5.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.548 -0.751 . . . . 2.46 111.117 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 173' ' ' TRP . 83.9 t -72.8 -53.99 5.04 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.58 109.926 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.6 Cg_exo -51.53 -37.8 63.31 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.299 1.999 . . . . 0.68 111.424 169.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.632 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.7 mmtp -71.54 -23.38 61.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 2.62 111.38 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.66 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.4 tp -67.81 -48.24 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.052 -0.722 . . . . 1.18 109.052 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.7 -32.39 73.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.01 -0.541 . . . . 2.11 109.737 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 11.7 mm-40 -55.7 -48.45 75.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.39 -0.823 . . . . 1.53 110.329 171.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.98 -33.16 63.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.288 -0.869 . . . . 2.16 112.002 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.683 ' HA ' ' H ' ' A' ' 142' ' ' SER . 37.6 mt -63.16 -1.83 1.14 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.496 0.554 . . . . 0.87 112.496 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.676 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 13.1 m -73.7 -2.62 24.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.434 0.635 . . . . 1.38 109.92 172.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.556 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.14 39.8 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.835 -0.906 . . . . 1.17 110.835 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.519 -0.753 . . . . 2.45 110.061 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.789 -0.449 . . . . 5.4 109.789 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -46.59 137.3 15.47 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.617 2.878 . . . . 2.58 113.221 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' A' ' 36' ' ' GLU . 19.8 t -88.22 144.12 9.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.501 -0.772 . . . . 2.1 111.462 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' O ' HD11 ' A' ' 37' ' ' LEU . 2.5 p30 -155.61 163.49 39.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.153 -1.054 . . . . 1.81 108.153 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -88.28 29.11 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.633 -0.427 . . . . 0.95 111.081 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 -7.82 59.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.303 0.573 . . . . 2.19 109.867 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 8.7 mptt -113.33 29.09 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 3.07 109.608 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.628 ' HZ3' ' HG3' ' A' ' 15' ' ' GLN . 11.4 p-90 -67.87 -36.11 79.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.356 -0.838 . . . . 4.76 111.693 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 75.3 p -144.03 19.92 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.646 -0.421 . . . . 0.98 111.601 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.44 -118.37 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.86 -0.686 . . . . 0.52 111.633 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.4 Cg_endo -47.14 -51.77 8.87 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.434 2.756 . . . . 0.61 110.787 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.853 HD23 HD22 ' A' ' 14' ' ' LEU . 6.5 mp -88.95 98.39 11.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 1.85 110.831 171.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 69.6 m -76.49 66.17 2.46 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.334 0.588 . . . . 1.31 110.26 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.853 HD22 HD23 ' A' ' 12' ' ' LEU . 57.9 mt -73.85 -16.88 61.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.509 -0.769 . . . . 0.61 111.225 -176.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.628 ' HG3' ' HZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -64.09 -15.08 58.84 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.05 0.452 . . . . 2.61 110.857 -178.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -60.4 -23.27 64.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.255 0.55 . . . . 1.93 110.666 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.887 HG12 HG21 ' A' ' 69' ' ' THR . 87.3 t -103.53 -64.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.328 -0.851 . . . . 1.26 110.877 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HB3' HD13 ' A' ' 123' ' ' LEU . 4.8 p-10 -116.43 172.44 7.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.134 0.492 . . . . 2.99 111.283 -175.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.58 28.65 1.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.632 -0.713 . . . . 1.6 112.365 -171.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.402 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 4.5 tt0 65.41 116.95 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 123.191 0.596 . . . . 4.38 110.691 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.468 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 20.4 Cg_exo -65.77 158.74 52.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.683 2.255 . . . . 0.69 112.959 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.881 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.4 pt20 -77.41 -13.89 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.247 -0.888 . . . . 1.87 110.789 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.738 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 70.7 m-70 -149.73 156.51 38.67 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-N 115.461 -0.79 . . . . 2.35 109.458 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -85.84 125.98 2.85 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.955 2.437 . . . . 0.44 110.771 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 27.0 tp -80.02 148.12 31.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.874 0.369 . . . . 0.33 111.012 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.483 ' H ' HD12 ' A' ' 25' ' ' LEU . 33.1 m170 -118.12 128.73 55.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.775 -0.454 . . . . 2.12 109.775 170.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.638 HG11 HG22 ' A' ' 53' ' ' ILE . 32.6 t -128.8 119.64 50.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.825 -0.806 . . . . 1.12 108.825 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.6 OUTLIER -115.68 138.49 51.04 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.343 0.592 . . . . 0.78 111.431 -171.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.424 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 33.6 t80 -100.31 176.78 5.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.784 -0.644 . . . . 1.23 109.275 174.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.58 65.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.277 0.561 . . . . 0.6 110.63 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.57 -0.57 29.24 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.438 -0.801 . . . . 0.81 112.845 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.54 -174.22 3.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.56 110.914 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.75 144.25 8.64 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.56 -0.746 . . . . 0.35 110.022 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.803 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.7 t -95.06 69.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 106.996 -1.483 . . . . 0.39 106.996 163.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -103.22 28.4 6.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.106 -0.952 . . . . 0.99 109.236 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.709 ' HA ' HG21 ' A' ' 3' ' ' VAL . 49.9 mt-10 -150.32 134.05 16.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.765 -1.107 . . . . 2.56 109.086 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.709 ' HB2' HG12 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.36 114.02 11.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.46 110.136 -175.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' CA ' HE22 ' A' ' 170' ' ' GLN . . . 78.88 29.59 51.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.9 -0.667 . . . . 0.59 111.518 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -90.29 152.92 20.83 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.22 0.208 . . . . 1.04 110.625 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.7 p -78.77 134.68 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.335 0.588 . . . . 1.16 111.487 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.565 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.6 tp -132.87 169.87 16.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.462 -0.94 . . . . 0.45 108.462 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.6 p -115.02 151.39 45.54 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.024 -0.67 . . . . 1.0 112.309 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 50.5 Cg_exo -56.91 -28.96 80.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.164 3.243 . . . . 1.0 113.298 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 p -65.09 -41.21 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.615 0.721 . . . . 1.24 110.528 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -80.47 -17.69 50.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.684 -1.144 . . . . 1.74 111.414 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.565 ' CG1' HD21 ' A' ' 41' ' ' LEU . 28.2 m -125.66 30.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 1.1 111.439 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.545 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -78.08 -21.93 49.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.457 0.646 . . . . 1.32 109.266 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 49' ' ' ARG . 3.3 t-20 -131.89 177.91 7.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.404 -1.271 . . . . 2.4 108.725 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.551 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 98.7 mtt180 -67.13 151.97 96.57 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.188 -0.301 . . . . 1.78 110.188 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 60.6 Cg_endo -74.75 161.68 38.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.192 1.928 . . . . 0.41 110.744 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -82.12 -21.24 36.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.107 0.48 . . . . 0.88 109.919 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.485 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -158.56 149.82 20.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.65 111.96 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.638 HG22 HG11 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -138.5 165.29 25.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.05 -1.093 . . . . 0.33 108.05 169.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.727 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 39.7 t -179.86 116.85 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.192 0.52 . . . . 0.8 110.204 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.511 ' NE1' ' HA ' ' A' ' 58' ' ' LEU . 45.7 p-90 -78.78 163.27 25.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.189 -1.041 . . . . 3.63 108.189 172.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.18 86.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.086 0.47 . . . . 1.51 110.939 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.0 29.44 2.81 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.677 -0.692 . . . . 0.9 112.472 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.727 ' CD1' ' HA ' ' A' ' 54' ' ' SER . 3.3 tt -60.66 129.83 43.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.04 0.447 . . . . 0.62 110.853 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.738 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -80.69 -21.38 41.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.74 111.927 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.649 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 75.7 m 69.56 2.01 3.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.456 -0.793 . . . . 1.51 110.957 -171.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.15 -2.63 3.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.731 -0.747 . . . . 0.84 113.336 -176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.738 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 38.6 mtpt -93.93 145.69 24.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.451 0.625 . . . . 2.12 109.637 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.768 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 2.9 mt -84.77 144.01 28.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.665 -1.235 . . . . 1.23 107.665 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.53 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -140.72 166.05 25.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.841 -0.8 . . . . 1.61 108.841 173.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 88.5 m -105.03 105.16 15.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.222 -0.659 . . . . 0.87 109.222 171.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.558 HD11 HG11 ' A' ' 124' ' ' VAL . 52.1 tp -104.59 115.57 30.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.232 0.539 . . . . 1.35 110.429 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.11 123.72 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.645 -0.707 . . . . 0.54 110.489 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.628 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 5.5 mt -81.51 139.38 35.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.167 -1.049 . . . . 0.65 108.167 167.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.887 HG21 HG12 ' A' ' 17' ' ' VAL . 14.8 t -140.73 153.59 45.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.695 -0.402 . . . . 1.04 110.94 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.508 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 15.7 t70 -140.69 102.16 6.49 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.251 0.548 . . . . 1.92 110.219 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -55.37 -28.93 65.7 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.746 2.964 . . . . 1.25 114.788 174.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -100.43 43.81 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 1.29 111.974 -167.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 84' ' ' TRP . . . -108.51 136.43 19.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 122.241 -0.287 . . . . 0.56 110.872 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.66 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 66.2 Cg_endo -74.85 -25.75 9.89 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.277 -1.551 . . . . 0.7 112.657 0.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 115' ' ' THR . 86.6 p -139.07 160.3 40.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.604 . . . . 1.1 109.945 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -72.32 -26.16 61.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 3.39 111.858 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.758 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.85 -13.41 48.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.146 0.498 . . . . 1.83 110.508 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.522 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 21.8 t0 -150.9 73.01 8.73 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.357 -0.838 . . . . 1.37 109.149 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -89.99 88.87 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.765 2.31 . . . . 0.9 113.034 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.66 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 38.0 mttm -78.2 -45.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.773 -1.103 . . . . 1.53 111.035 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.706 ' HB3' ' HD1' ' A' ' 84' ' ' TRP . 77.8 m-85 -82.74 10.62 7.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.194 -0.912 . . . . 1.54 111.986 -169.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 37.8 ttp180 -70.16 127.76 33.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.185 -0.302 . . . . 3.38 110.185 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 48.9 mt-10 -94.6 129.6 41.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.025 0.44 . . . . 2.23 110.56 0.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.706 ' HD1' ' HB3' ' A' ' 81' ' ' TYR . 9.9 t90 -88.48 90.3 8.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 1.77 109.756 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.5 p80 -75.61 120.15 20.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.596 0.712 . . . . 2.19 109.872 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 6.1 t-160 -70.75 -24.44 62.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.365 -0.834 . . . . 2.74 111.011 -172.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.721 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 19.0 p90 -168.26 179.03 4.67 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.696 -0.483 . . . . 2.21 109.696 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 24.2 tp -142.75 114.48 8.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.68 110.434 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.721 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -126.49 132.37 70.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.35 110.475 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' A' ' 131' ' ' LEU . 6.4 m -124.54 166.2 20.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.722 -1.214 . . . . 0.3 107.722 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.768 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 92.8 m-20 59.56 19.55 8.07 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.374 0.421 . . . . 2.09 111.363 172.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.567 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 10.8 ttm -71.64 108.48 5.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.582 -0.895 . . . . 0.34 108.582 175.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.696 ' HG2' HD22 ' A' ' 63' ' ' LEU . 1.9 mtpm? -82.03 94.79 7.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.083 -0.962 . . . . 1.73 111.091 -170.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.5 -119.65 5.58 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.06 -0.973 . . . . 0.35 112.58 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.716 ' HB3' HD22 ' A' ' 58' ' ' LEU . 25.3 p-10 -117.62 29.94 7.56 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 1.59 111.002 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -96.71 105.59 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.534 0.683 . . . . 0.77 110.034 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 50' ' ' PRO . 8.4 mm -58.6 -33.38 48.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.565 -1.198 . . . . 0.45 111.459 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.2 m -82.61 -35.51 26.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.844 -0.616 . . . . 1.15 111.906 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 m -73.28 -6.04 43.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.493 -0.321 . . . . 1.26 111.711 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.567 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -66.3 107.87 2.16 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.628 -0.589 . . . . 0.44 111.628 175.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -57.99 107.01 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.534 0.683 . . . . 1.06 109.602 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.8 p -85.91 121.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.826 -1.079 . . . . 1.15 111.631 -173.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 135' ' ' GLU . 68.7 mt -102.0 -46.73 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.161 -0.927 . . . . 0.48 109.255 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.0 t -126.16 108.21 11.1 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.162 -1.422 . . . . 0.62 107.162 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.7 t0 -57.2 155.72 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 1.15 112.673 -169.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.478 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 43.2 t80 -74.02 95.32 2.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.29 -0.868 . . . . 4.98 109.783 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.4 t -78.96 142.34 14.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.268 -1.012 . . . . 0.86 108.268 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.21 179.33 45.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.95 112.975 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.616 ' HG ' ' HB2' ' A' ' 171' ' ' ALA . 28.7 t -54.92 141.3 34.06 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.16 0.184 . . . . 0.89 111.084 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.557 ' HA2' HG12 ' A' ' 177' ' ' VAL . . . -164.83 70.55 0.19 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.168 -0.539 . . . . 0.82 112.367 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.763 ' HD2' HG22 ' A' ' 177' ' ' VAL . 89.4 Cg_endo -92.53 133.76 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.022 2.481 . . . . 1.01 113.257 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.615 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 38.5 Cg_exo -59.11 137.31 78.57 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.649 2.233 . . . . 0.96 111.395 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.515 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.08 118.21 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 2.39 111.005 -178.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.63 -3.07 32.34 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.555 -0.831 . . . . 1.3 112.087 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.615 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 62.1 p -81.77 -10.47 59.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 1.04 110.57 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.16 -155.94 19.97 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.267 -0.733 . . . . 1.97 111.267 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.881 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -90.37 108.23 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.56 -0.533 . . . . 0.94 109.56 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.746 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -72.22 113.75 9.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 2.85 110.474 -175.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 1.005 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 1.1 ptt180 -102.77 95.12 5.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.315 0.579 . . . . 2.78 112.201 -169.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.589 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 16.9 m-85 -83.81 120.52 26.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.536 -0.756 . . . . 1.13 109.123 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.719 HG22 ' HB2' ' A' ' 168' ' ' CYS . 6.7 t -100.14 131.98 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 110.008 -0.367 . . . . 0.31 110.008 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.68 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 69.2 m95 -88.07 119.52 28.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.205 -0.665 . . . . 2.96 109.205 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 18' ' ' ASP . 45.6 mt -118.85 118.79 32.5 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 121.104 -0.238 . . . . 0.41 110.654 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 66' ' ' LEU . 1.4 m -105.12 128.36 59.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.165 -0.68 . . . . 0.43 109.165 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.65 ' CB ' HD21 ' A' ' 160' ' ' LEU . 86.2 m-85 -107.64 162.26 14.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.372 -0.376 . . . . 5.41 111.006 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.94 113.13 26.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.717 0.77 . . . . 2.41 112.806 -171.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.801 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -107.71 148.65 29.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.419 -0.809 . . . . 1.31 110.064 171.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.17 -9.5 59.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.302 -0.863 . . . . 2.4 110.716 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.466 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.5 ptp180 -147.59 168.09 12.02 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.601 -0.727 . . . . 4.07 111.641 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 22.6 Cg_exo -61.61 141.26 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.707 2.272 . . . . 1.21 110.539 172.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.791 HD23 ' HG2' ' A' ' 127' ' ' GLN . 3.2 mm? -73.9 145.21 44.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.681 0.623 . . . . 1.16 112.681 -169.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -102.2 104.34 14.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.965 -1.016 . . . . 3.23 108.811 171.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.442 ' CB ' HD13 ' A' ' 103' ' ' LEU . 1.3 p -124.44 112.23 16.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.113 -0.494 . . . . 2.79 111.803 -175.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -99.19 13.53 32.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.033 -0.729 . . . . 2.96 109.033 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.448 ' HB2' HD22 ' A' ' 103' ' ' LEU . 9.2 mm-40 -63.04 130.01 93.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.212 -0.904 . . . . 1.39 110.56 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.56 112.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.032 2.488 . . . . 1.38 112.435 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.5 mm -61.87 115.57 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 0.94 110.855 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.14 152.27 23.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 1.61 109.808 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.5 m -91.33 -173.44 3.61 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.676 -0.861 . . . . 1.88 108.676 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.714 ' HA ' HG22 ' A' ' 107' ' ' VAL . 2.1 p-10 -92.86 7.62 43.07 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.015 -0.674 . . . . 1.33 110.175 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.863 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 85.7 mtt180 -95.97 145.45 25.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 3.83 109.972 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.589 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 21.9 m 73.85 126.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.145 -0.934 . . . . 1.32 111.516 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.81 33.9 5.41 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.298 -0.865 . . . . 1.13 111.709 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -52.75 19.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 2.66 113.312 -172.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -122.19 47.44 1.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.427 0.632 . . . . 2.18 111.304 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.402 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 22.6 mmt180 -88.17 -27.44 21.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.728 -0.669 . . . . 5.37 111.138 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -129.33 -169.0 12.47 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.982 -1.104 . . . . 0.9 113.121 -174.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.699 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 79.3 mttt 65.99 34.33 7.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.603 0.715 . . . . 1.59 110.805 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.78 167.53 12.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.078 -0.964 . . . . 2.27 109.608 174.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -116.81 120.95 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.199 -0.455 . . . . 1.87 111.083 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.785 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 35.6 m -64.83 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.96 110.301 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.58 -44.68 93.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.024 -0.534 . . . . 0.76 109.708 172.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.3 m -64.16 -38.39 90.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 1.22 110.099 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.785 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.5 m-85 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.58 -0.282 . . . . 1.1 111.315 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.6 ptp180 -63.84 -43.87 94.89 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.979 -0.288 . . . . 3.36 110.345 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -68.64 -29.9 68.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.32 . . . . 1.52 111.119 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -59.09 -51.9 68.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 2.13 111.376 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -89.95 4.27 50.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.965 -0.561 . . . . 5.77 111.711 -173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 72.16 33.12 1.62 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.762 0.664 . . . . 2.42 111.213 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 127' ' ' GLN . 4.5 mp -100.54 172.44 7.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.21 -0.904 . . . . 1.27 109.372 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.501 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 31.0 tpt180 -131.99 -95.92 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.317 -0.553 . . . . 4.0 111.953 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -105.28 146.28 32.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.919 0.39 . . . . 1.21 110.989 -173.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 17.0 Cg_exo -65.71 141.74 67.32 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.274 2.649 . . . . 0.68 112.872 -170.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.881 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.0 t -78.16 -32.66 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.5 109.757 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.765 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -154.08 147.52 25.01 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.276 -0.569 . . . . 0.29 111.695 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.68 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.58 144.14 11.87 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.937 -1.029 . . . . 0.24 111.592 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -159.25 135.2 8.81 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.152 -0.684 . . . . 0.34 109.152 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.841 ' SG ' ' HB2' ' A' ' 119' ' ' ARG . 27.3 t -113.54 145.88 40.54 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.398 -0.521 . . . . 2.16 111.696 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.677 ' HB3' HG22 ' A' ' 34' ' ' VAL . 27.0 p90 -129.08 131.18 47.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.067 -0.716 . . . . 1.31 109.067 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 1.005 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 17.3 mp0 -98.46 132.22 44.09 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.441 -0.504 . . . . 2.53 110.272 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.616 ' HB2' ' HG ' ' A' ' 109' ' ' SER . . . -122.57 139.06 54.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.848 -0.427 . . . . 0.75 109.848 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.545 ' HB3' HD13 ' A' ' 117' ' ' LEU . 11.4 pt-20 -105.18 -168.76 1.51 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.073 -0.512 . . . . 2.38 110.939 -176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.8 ' HA ' HG23 ' A' ' 177' ' ' VAL . 22.7 t90 -87.23 78.57 8.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 4.71 109.847 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.596 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -72.81 -59.17 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.35 -0.386 . . . . 1.53 111.086 -177.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 15.4 t70 175.81 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.987 0.515 . . . . 1.26 110.479 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.48 ' HB3' ' CD ' ' A' ' 47' ' ' LYS . 36.9 m-85 -81.28 -0.64 41.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 2.46 111.758 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.805 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 99.1 t -63.25 -54.83 41.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.17 -0.468 . . . . 0.58 110.794 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.805 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.0 Cg_exo -50.77 -43.71 44.99 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.658 2.239 . . . . 0.68 111.923 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.67 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 30.3 mmmt -66.24 -23.55 66.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.08 -0.509 . . . . 2.62 111.917 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.681 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 36.0 tp -66.04 -48.67 70.31 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.058 -0.657 . . . . 1.18 109.574 172.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.26 -35.19 79.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.356 0.598 . . . . 2.11 109.656 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.67 ' HG3' ' HD2' ' A' ' 179' ' ' LYS . 4.8 mm-40 -55.97 -48.26 76.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.927 -1.033 . . . . 1.53 110.122 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -74.39 -33.47 63.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 2.16 112.187 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 71.1 mt -62.25 -10.69 11.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.646 0.26 . . . . 0.87 111.66 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.589 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 50.9 m -77.08 6.99 5.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.224 0.535 . . . . 1.38 110.441 173.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.863 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 68.89 60.82 5.02 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.268 -0.878 . . . . 1.17 111.327 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.6 mmmt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.518 -0.753 . . . . 2.45 111.125 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.524 0.202 . . . . 5.4 111.081 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.55 153.92 63.23 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.602 2.201 . . . . 2.58 111.242 173.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 25' ' ' LEU . 14.0 t -66.39 116.01 5.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.319 0.58 . . . . 2.1 111.007 -175.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 6' ' ' SER . 32.0 t70 -152.04 158.15 42.64 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.752 -1.113 . . . . 1.81 108.268 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.463 HD12 HE21 ' A' ' 20' ' ' GLN . 2.7 mm? -78.9 30.91 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.837 0.351 . . . . 0.95 110.765 -175.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.621 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 3.9 m -59.1 -54.69 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.97 -0.559 . . . . 2.19 111.581 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.621 ' HD2' ' HB2' ' A' ' 6' ' ' SER . 8.8 mptt -99.73 40.48 1.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.819 0.342 . . . . 3.07 110.288 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 3.4 p-90 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.779 -0.646 . . . . 4.76 112.094 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 p -141.54 20.62 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.907 0.384 . . . . 0.98 111.394 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.77 -122.54 0.31 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.35 -0.7 . . . . 0.52 111.35 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.456 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.4 Cg_endo -51.48 -40.12 63.49 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.13 2.553 . . . . 0.61 109.815 166.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.699 HD13 ' HA3' ' A' ' 38' ' ' GLY . 25.9 mt -87.73 81.26 7.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.433 -1.258 . . . . 1.85 109.863 172.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 7.4 m -71.75 66.97 0.56 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.05 -0.722 . . . . 1.31 109.05 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.776 HD23 HH11 ' A' ' 119' ' ' ARG . 46.0 mt -75.16 -12.74 60.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.698 -0.683 . . . . 0.61 110.797 -175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -65.65 -15.19 62.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 2.61 111.237 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 13' ' ' SER . 40.2 mt-10 -66.16 -21.72 66.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.165 0.507 . . . . 1.93 110.078 175.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.799 HG12 HG21 ' A' ' 69' ' ' THR . 76.1 t -89.56 -71.59 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.464 -0.789 . . . . 1.26 110.775 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.585 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 9.8 t70 -156.58 174.72 15.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.543 -0.54 . . . . 2.99 109.543 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -63.95 120.84 12.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.298 . . . . 1.6 110.285 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.568 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 48.2 tp60 -53.82 127.93 53.49 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.752 -0.658 . . . . 4.38 110.567 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.635 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.0 Cg_exo -58.28 161.89 13.03 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.331 2.688 . . . . 0.69 113.498 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.925 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 8.8 pt20 -69.86 -19.48 63.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.894 -1.048 . . . . 1.87 112.0 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.682 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m80 -146.56 159.04 45.64 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.165 -0.47 . . . . 2.35 110.424 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.43 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.2 Cg_endo -85.19 128.65 3.67 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.208 2.605 . . . . 0.44 111.436 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 26.7 tp -80.84 146.89 30.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.526 0.203 . . . . 0.33 110.769 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -115.38 109.54 18.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.103 -0.332 . . . . 2.12 110.103 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 53' ' ' ILE . 13.8 t -116.35 140.4 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 1.12 110.049 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -137.59 137.66 38.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.3 -0.409 . . . . 0.78 110.889 -177.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.645 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 22.2 t80 -97.36 177.26 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.833 -0.802 . . . . 1.23 108.833 174.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.41 -52.53 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.514 0.673 . . . . 0.6 110.059 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.17 8.79 38.78 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.006 -0.997 . . . . 0.81 112.651 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.57 -169.7 3.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.56 110.704 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.51 158.2 23.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.737 -0.665 . . . . 0.35 109.8 176.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.834 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 79.8 t -111.43 65.87 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.624 -1.621 . . . . 0.39 106.624 163.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -97.69 25.31 5.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.17 0.986 . . . . 0.99 109.062 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.6 122.57 10.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.524 -1.217 . . . . 2.56 108.02 174.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.2 tt -70.94 111.37 6.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.194 0.521 . . . . 0.46 109.709 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.699 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 82.15 26.26 49.01 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.343 -0.844 . . . . 0.59 111.862 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.834 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -83.74 153.17 24.3 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.93 -0.396 . . . . 1.04 109.93 174.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.55 133.46 30.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.425 0.631 . . . . 1.16 111.285 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.557 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.8 tp -131.22 170.08 15.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.558 -0.904 . . . . 0.45 108.558 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.36 152.41 54.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 O-C-N 121.665 -0.647 . . . . 1.0 112.491 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 77.1 Cg_exo -51.78 -35.35 58.33 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.749 3.633 . . . . 1.0 114.722 -171.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.9 p -65.64 -35.03 79.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.712 0.768 . . . . 1.24 110.36 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.43 -14.14 55.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.4 -1.273 . . . . 1.74 111.686 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.557 ' CG1' HD21 ' A' ' 41' ' ' LEU . 23.9 m -128.49 20.04 2.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.287 0.565 . . . . 1.1 111.656 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.594 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.79 -26.55 31.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.751 -0.659 . . . . 1.32 109.545 179.217 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -116.77 -178.02 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.699 -1.137 . . . . 2.4 109.182 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.531 ' HB3' HG23 ' A' ' 97' ' ' ILE . 77.9 mtt180 -72.9 152.9 91.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.932 -0.766 . . . . 1.78 108.932 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.645 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 49.2 Cg_endo -74.94 175.02 11.77 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.413 1.409 . . . . 0.41 110.39 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -96.93 -16.26 20.75 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.274 -0.571 . . . . 0.88 110.059 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.459 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 75.3 m -159.75 144.32 14.99 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.65 112.436 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -141.24 169.21 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.996 -1.112 . . . . 0.33 107.996 171.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.693 ' HA ' HD11 ' A' ' 58' ' ' LEU . 36.8 t 176.87 127.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.918 0.39 . . . . 0.8 110.088 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.539 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 32.8 p-90 -92.91 167.73 11.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.933 -1.136 . . . . 3.63 107.933 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.4 78.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 1.51 111.045 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.02 26.01 0.86 Allowed Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.565 -0.743 . . . . 0.9 112.06 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.839 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 2.7 tt -65.35 128.48 36.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.071 0.462 . . . . 0.62 110.939 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.747 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 33.5 t70 -75.39 -25.68 57.84 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 0.74 111.756 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.631 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 25.3 p 70.0 8.87 6.88 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.475 1.11 . . . . 1.51 110.331 -171.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -3.4 1.42 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.84 113.405 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.747 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 39.5 mtpt -96.51 151.97 19.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.38 0.59 . . . . 2.12 110.217 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.681 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 45.2 mt -88.15 124.96 34.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.629 -0.714 . . . . 1.23 109.977 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.839 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 2.6 m-85 -120.99 152.0 39.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.919 -0.312 . . . . 1.61 110.683 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.459 ' OG1' HD21 ' A' ' 131' ' ' LEU . 57.1 m -97.32 110.63 23.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 0.87 109.149 170.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.607 HD11 HG11 ' A' ' 124' ' ' VAL . 48.8 tp -113.16 118.69 35.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 1.35 110.497 -175.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.3 t -116.64 126.29 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.54 110.619 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.926 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 2.9 mt -92.76 133.76 35.72 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.472 -0.936 . . . . 0.65 108.472 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.799 HG21 HG12 ' A' ' 17' ' ' VAL . 9.3 t -137.55 147.42 45.12 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.616 -0.434 . . . . 1.04 111.899 -176.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 18.5 t70 -123.82 97.15 41.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.69 -0.686 . . . . 1.92 109.8 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.2 Cg_endo -51.39 -35.11 53.3 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 124.076 3.184 . . . . 1.25 114.797 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.608 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 60.8 m-20 -99.45 49.69 0.94 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 1.29 112.397 -168.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.45 142.75 25.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.56 110.295 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 98.5 Cg_endo -83.66 -23.11 13.38 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.814 -1.328 . . . . 0.7 112.753 1.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 24.7 p -129.67 144.13 51.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 1.1 109.816 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.608 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 40.0 ttt180 -62.46 -26.68 68.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 3.39 111.212 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.516 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 4.8 ptpt -76.25 -21.64 56.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.042 0.449 . . . . 1.83 111.111 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 18.1 t70 -154.14 85.6 3.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.022 -0.536 . . . . 1.37 109.674 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -82.2 87.91 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.451 2.101 . . . . 0.9 112.717 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -75.15 -49.88 18.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.039 -0.982 . . . . 1.53 110.085 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.718 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.2 m-85 -84.53 22.1 1.36 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.916 -1.038 . . . . 1.54 111.903 -169.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.5 ttm180 -74.9 127.74 33.91 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.136 0.272 . . . . 3.38 110.522 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' OE1' HG21 ' A' ' 151' ' ' VAL . 4.2 mp0 -97.04 137.44 36.12 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.043 0.449 . . . . 2.23 110.497 -3.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.53 ' CD1' ' HG2' ' A' ' 146' ' ' ARG . 16.8 t90 -85.37 146.04 27.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.996 -1.113 . . . . 1.77 107.996 173.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 48.6 p-80 -122.04 129.48 52.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.282 0.563 . . . . 2.19 110.357 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.926 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 38.5 t-80 -68.1 -34.74 76.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.032 -0.986 . . . . 2.74 110.09 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.632 ' HD2' ' HD1' ' A' ' 86' ' ' HIS . 40.3 p90 -168.69 172.62 7.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.045 -0.354 . . . . 2.21 110.045 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.461 ' CD1' HG22 ' A' ' 67' ' ' VAL . 44.0 tp -133.96 113.9 12.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.507 -0.553 . . . . 0.68 109.507 173.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HB ' ' HE1' ' A' ' 87' ' ' PHE . 1.5 t -120.92 134.73 63.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.819 -0.628 . . . . 0.35 110.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.499 ' CG1' ' HG ' ' A' ' 131' ' ' LEU . 15.9 m -132.79 161.47 41.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 107.691 -1.226 . . . . 0.3 107.691 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.681 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 t30 63.34 18.16 10.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.221 0.534 . . . . 2.09 110.221 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.509 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 8.0 ttm -68.11 111.36 4.44 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.94 -0.763 . . . . 0.34 108.94 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -85.71 101.83 13.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.722 -1.126 . . . . 1.73 111.318 -170.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.15 -124.2 27.47 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 114.959 -1.019 . . . . 0.35 112.43 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.609 ' HB3' HD22 ' A' ' 58' ' ' LEU . 3.7 p-10 -110.56 21.79 16.18 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.982 0.42 . . . . 1.59 110.756 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.79 109.4 20.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.723 0.773 . . . . 0.77 109.971 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 49' ' ' ARG . 5.3 mm -62.38 -31.18 50.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.097 -1.41 . . . . 0.45 111.246 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.1 m -78.29 -37.09 45.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.874 -0.603 . . . . 1.15 111.997 -172.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.3 m -70.05 -8.6 50.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.765 0.283 . . . . 1.26 111.765 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.509 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -67.41 100.11 0.57 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.977 -0.63 . . . . 0.44 111.779 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.5 m -60.33 107.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.671 0.748 . . . . 1.06 110.11 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 105' ' ' ASP . 4.6 p -86.69 127.63 40.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.667 -1.151 . . . . 1.15 111.527 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 11.3 mt -102.01 -54.72 2.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.116 0.96 . . . . 0.48 109.141 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.1 t -106.43 100.15 9.69 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.885 -1.524 . . . . 0.62 106.885 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.978 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -55.37 160.7 2.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.002 -0.999 . . . . 1.15 112.782 -169.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.1 p90 -74.09 90.76 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.514 -0.766 . . . . 4.98 110.879 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.666 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.6 t -63.96 -40.07 87.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.902 -0.59 . . . . 0.86 110.353 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.564 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 103.3 -173.03 21.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.667 -0.778 . . . . 0.95 112.7 174.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.433 ' HA ' ' HH ' ' A' ' 120' ' ' TYR . 12.3 t -64.6 115.03 4.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.411 -0.589 . . . . 0.89 109.411 172.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.645 ' HA3' HD21 ' A' ' 180' ' ' LEU . . . -144.68 58.18 0.52 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.82 112.943 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.647 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -89.21 125.71 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.303 2.669 . . . . 1.01 111.94 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.721 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 82.5 Cg_exo -46.21 132.98 15.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.415 2.076 . . . . 0.96 111.273 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.446 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.0 110.83 2.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.005 -0.543 . . . . 2.39 111.012 -171.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.0 -5.27 25.59 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.594 -0.73 . . . . 1.3 113.062 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.721 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -77.58 -9.92 59.21 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.698 0.629 . . . . 1.04 112.698 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.01 -170.48 25.01 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.707 . . . . 1.97 111.994 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -73.42 144.82 46.19 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.866 0.365 . . . . 0.94 110.757 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.647 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.6 m-70 -120.76 123.0 41.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.073 -0.512 . . . . 2.85 110.303 176.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.816 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 11.1 ptt180 -100.0 92.17 5.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.536 -0.756 . . . . 2.78 111.406 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 69' ' ' THR . 40.6 m-85 -75.74 112.2 11.87 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.157 -0.683 . . . . 1.13 109.157 175.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.0 t -96.49 133.74 36.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.774 . . . . 0.31 109.66 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.6 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 35.5 m95 -89.29 132.61 34.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.193 -0.669 . . . . 2.96 109.193 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 82.7 mt -127.62 118.33 23.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.742 0.246 . . . . 0.41 110.344 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.607 HG11 HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -114.2 145.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.716 0.293 . . . . 0.43 110.434 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.758 ' HH ' ' H ' ' A' ' 161' ' ' ARG . 35.8 t80 -123.87 153.46 41.06 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.613 -0.514 . . . . 5.41 109.613 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -108.35 88.87 2.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.033 -0.729 . . . . 2.41 109.033 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.623 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -74.7 175.04 8.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.971 0.891 . . . . 1.31 111.795 -172.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.86 -16.48 28.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.774 -1.557 . . . . 2.4 109.964 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.955 ' HD2' ' HH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -144.63 160.53 47.28 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.413 -0.812 . . . . 4.07 111.204 -176.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.537 ' HB3' HD11 ' A' ' 63' ' ' LEU . 25.5 Cg_exo -70.43 14.12 0.31 Allowed 'Trans proline' 0 N--CA 1.484 0.919 0 C-N-CA 124.81 3.674 . . . . 1.21 114.501 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 130' ' ' PRO . 4.1 mm? 81.13 168.34 0.14 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.679 0.792 . . . . 1.16 112.864 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -160.53 78.48 0.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.315 -1.312 . . . . 3.23 107.75 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.725 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.1 m -99.91 130.04 46.05 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.451 -0.795 . . . . 2.79 111.214 -173.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -93.74 18.73 9.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.34 -0.845 . . . . 2.96 109.975 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 6.9 mm-40 -76.23 116.37 55.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.476 -0.783 . . . . 1.39 109.923 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.72 137.37 42.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.362 2.708 . . . . 1.38 113.63 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.0 mm -73.47 115.77 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.764 -0.458 . . . . 0.94 109.764 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -92.02 -10.86 37.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.966 0.728 . . . . 1.61 112.966 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.9 m 51.98 25.12 2.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.292 0.849 . . . . 1.88 113.292 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.978 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.1 p-10 50.54 21.99 0.97 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.202 1.001 . . . . 1.33 113.414 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.501 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 46.4 mtt180 -110.32 142.22 42.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.189 -0.3 . . . . 3.83 110.189 172.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.572 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 55.0 m 77.07 151.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.215 0.947 . . . . 1.32 111.703 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 146' ' ' ARG . . . -120.41 14.03 10.13 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.486 -0.779 . . . . 1.13 112.849 -174.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.48 -22.27 62.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.472 . . . . 2.66 111.035 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -119.82 46.3 1.97 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.228 -0.656 . . . . 2.18 109.228 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.53 ' HG2' ' CD1' ' A' ' 84' ' ' TRP . 10.0 ttm180 -75.14 -71.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.145 -0.934 . . . . 5.37 111.531 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -120.42 -154.66 9.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 0.9 112.31 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.718 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.0 mttt 65.45 35.77 7.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.402 0.62 . . . . 1.59 110.256 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -120.11 104.45 10.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.169 -0.923 . . . . 2.27 109.745 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HZ2' ' CD ' ' A' ' 83' ' ' GLU . 21.0 mmmt -53.84 120.56 6.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.916 -0.584 . . . . 1.87 111.785 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.885 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 2.4 m -62.04 -29.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.96 111.183 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.741 ' HB3' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -37.55 87.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.76 110.169 174.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.6 m -65.99 -33.29 75.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.546 -0.297 . . . . 1.22 110.785 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.885 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 49.9 m-85 -62.24 -54.1 45.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.054 0.454 . . . . 1.1 110.56 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 9.6 ptt180 -70.01 -51.57 31.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 3.36 111.853 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.741 ' HE2' ' HB3' ' A' ' 152' ' ' ALA . 58.7 mtmt -62.01 -24.5 67.08 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.427 -0.17 . . . . 1.52 111.367 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -52.05 -53.12 46.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 2.13 111.425 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.955 ' HH ' ' HD2' ' A' ' 129' ' ' ARG . 12.7 t80 -104.43 29.55 6.0 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.796 -0.762 . . . . 5.77 110.511 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 71.53 26.59 3.17 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.252 -0.886 . . . . 2.42 111.842 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.699 ' HG ' ' CD1' ' A' ' 125' ' ' TYR . 7.8 mp -83.68 124.51 30.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.901 -0.407 . . . . 1.27 109.901 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.758 ' H ' ' HH ' ' A' ' 125' ' ' TYR . 43.6 tpt85 -73.26 -75.87 0.14 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.721 -0.672 . . . . 4.0 112.6 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.545 ' H ' ' HE2' ' A' ' 125' ' ' TYR . . . -150.51 150.99 30.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.547 0.213 . . . . 1.21 110.668 -176.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.503 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.42 152.17 78.6 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.55 2.833 . . . . 0.68 114.016 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.925 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.6 t -93.81 -37.39 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 115.025 -0.989 . . . . 0.5 110.568 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -143.27 144.16 32.02 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.011 -0.676 . . . . 0.29 111.703 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.635 ' HA3' ' HG2' ' A' ' 21' ' ' PRO . . . -146.7 150.88 23.19 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.114 -0.948 . . . . 0.24 112.343 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.558 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.2 t -164.62 156.08 15.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.293 -1.003 . . . . 0.34 108.293 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.802 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -131.42 150.23 52.23 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.872 -0.517 . . . . 2.16 112.04 -172.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.751 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.1 p90 -136.0 135.01 39.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.608 -0.886 . . . . 1.31 108.608 171.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.816 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 12.9 mp0 -99.65 133.8 43.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.575 0.625 . . . . 2.53 110.386 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.48 137.33 54.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.935 0.397 . . . . 0.75 111.416 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.98 -170.2 3.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.447 -0.797 . . . . 2.38 110.914 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.945 ' HA ' HG23 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -105.48 77.39 1.28 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.979 -0.748 . . . . 4.71 108.979 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.495 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 13.7 t70 -72.19 -61.24 1.86 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.167 0.803 . . . . 1.53 113.167 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.638 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 12.4 t70 -167.5 -46.78 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.216 0.532 . . . . 1.26 110.951 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.449 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 37.9 m-85 -71.8 -2.8 18.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 2.46 111.691 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.945 HG23 ' HA ' ' A' ' 173' ' ' TRP . 66.8 t -73.17 -55.37 3.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.57 -0.286 . . . . 0.58 111.414 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.749 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 47.6 Cg_exo -58.22 -29.72 88.49 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.271 1.98 . . . . 0.68 111.274 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.626 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.0 mmmm -74.7 -24.77 58.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.573 -0.74 . . . . 2.62 111.17 177.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.665 HD23 HG12 ' A' ' 107' ' ' VAL . 51.2 tp -76.08 -42.07 48.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.502 -0.555 . . . . 1.18 109.502 172.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -58.87 -38.27 78.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.69 -0.686 . . . . 2.11 109.185 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.626 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.8 mm-40 -58.21 -42.73 86.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.791 -1.095 . . . . 1.53 110.985 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -76.41 -32.23 58.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 2.16 112.759 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.572 ' HA ' ' H ' ' A' ' 142' ' ' SER . 60.9 mt -62.99 -4.97 2.52 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.786 0.662 . . . . 0.87 112.786 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.507 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 20.1 m -78.65 1.49 22.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.531 0.682 . . . . 1.38 109.766 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.501 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 76.37 50.94 6.99 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.1 -0.954 . . . . 1.17 111.184 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.7 mmmt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.359 -0.829 . . . . 2.45 110.37 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.5 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 10.1 tpt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.46 -0.2 . . . . 5.4 110.46 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.64 120.11 7.73 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.755 2.304 . . . . 2.58 111.78 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 7.2 p -58.57 133.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.746 -1.115 . . . . 2.1 111.013 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 6' ' ' SER . 25.2 t70 -167.03 163.43 15.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.696 -0.853 . . . . 1.81 108.696 -172.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.56 25.81 0.14 Allowed 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 120.537 0.208 . . . . 0.95 111.113 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 4' ' ' ASP . 31.1 m -62.91 -27.34 69.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 2.19 111.692 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -116.38 48.26 1.29 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.87 0.367 . . . . 3.07 110.258 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -75.09 -29.74 60.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 4.76 111.724 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 36.6 p -148.14 11.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.535 -0.466 . . . . 0.98 112.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.46 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.729 . . . . 0.52 111.733 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.3 Cg_endo -48.88 -48.83 16.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.201 2.601 . . . . 0.61 110.381 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.692 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 8.1 mp -87.99 88.94 7.8 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.354 -0.839 . . . . 1.85 110.258 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 7.4 m -76.12 67.02 2.37 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.354 0.597 . . . . 1.31 110.095 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 121' ' ' VAL . 23.5 mt -71.12 -13.91 62.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.496 -0.775 . . . . 0.61 111.164 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -65.61 -14.84 61.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.131 -0.486 . . . . 2.61 111.477 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.34 -19.76 65.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.29 0.567 . . . . 1.93 110.507 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.857 HG11 HG22 ' A' ' 151' ' ' VAL . 40.6 t -93.76 -72.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.477 -0.783 . . . . 1.26 111.27 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 19' ' ' GLU . 25.5 t70 -149.97 -170.99 3.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.557 -0.905 . . . . 2.99 108.557 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.794 ' HG3' HH12 ' A' ' 155' ' ' ARG . 15.6 mt-10 -81.64 163.72 22.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.789 0.804 . . . . 1.6 113.114 -167.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.49 126.95 89.29 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.415 -1.266 . . . . 4.38 110.387 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 6.3 Cg_exo -75.28 154.25 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.839 1.693 . . . . 0.69 111.166 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.964 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 20.4 pt20 -81.44 -1.19 44.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.293 -0.412 . . . . 1.87 111.726 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.763 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 13.7 m80 -160.54 159.95 25.83 Favored Pre-proline 0 CA--C 1.516 -0.362 0 C-N-CA 123.35 0.66 . . . . 2.35 109.583 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -86.87 128.54 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 123.132 2.555 . . . . 0.44 110.994 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 43.9 tp -80.1 145.9 32.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.696 0.284 . . . . 0.33 111.183 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -109.36 130.33 55.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.311 -0.626 . . . . 2.12 109.311 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 53' ' ' ILE . 16.0 t -134.16 118.8 29.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.487 -0.931 . . . . 1.12 108.487 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.444 HG22 ' CB ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -117.98 136.78 53.29 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 0.78 111.283 -172.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -97.0 173.82 7.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.279 -0.637 . . . . 1.23 109.279 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.52 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.5 0.667 . . . . 0.6 110.548 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 -6.14 37.55 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.163 -0.926 . . . . 0.81 112.763 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.91 -171.96 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.858 0.329 . . . . 0.56 110.52 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.73 153.73 17.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.113 -0.494 . . . . 0.35 110.301 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.798 HG23 ' HZ3' ' A' ' 122' ' ' TRP . 84.9 t -109.85 69.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 107.406 -1.331 . . . . 0.39 107.406 165.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.539 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 34.2 t70 -102.49 20.46 17.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.967 -1.015 . . . . 0.99 109.072 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.61 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 52.3 mt-10 -143.84 134.54 25.05 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.48 -1.236 . . . . 2.56 108.955 172.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.675 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -81.36 112.49 18.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.794 -0.639 . . . . 0.46 109.985 -174.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.59 52.53 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.256 -0.738 . . . . 0.59 111.256 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.67 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.09 149.44 26.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.321 -0.251 . . . . 1.04 110.321 177.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 10.2 p -74.52 131.81 34.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 1.16 110.967 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.468 HD21 HG13 ' A' ' 46' ' ' VAL . 9.2 tp -133.0 170.7 15.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.485 -0.931 . . . . 0.45 108.485 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -121.24 149.86 52.71 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 119.4 -0.92 . . . . 1.0 111.802 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.73 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 39.8 Cg_exo -61.31 -28.62 84.73 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.201 3.267 . . . . 1.0 113.651 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -28.61 67.37 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.546 0.689 . . . . 1.24 110.542 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 42' ' ' THR . 97.5 mt-30 -77.88 -52.94 8.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.848 -1.069 . . . . 1.74 111.228 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.553 HG21 ' CE2' ' A' ' 169' ' ' TYR . 3.9 m -99.16 32.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.695 0.628 . . . . 1.1 112.695 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.82 -30.72 61.49 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.346 -0.542 . . . . 1.32 110.039 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.06 179.88 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 2.4 109.971 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 96.8 mtt180 -66.89 159.38 76.06 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.868 0.366 . . . . 1.78 110.797 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 71.3 Cg_endo -79.57 157.54 25.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.072 1.848 . . . . 0.41 110.944 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -82.23 -18.06 43.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.684 -0.488 . . . . 0.88 109.684 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.427 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 71.5 m -160.68 147.24 15.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.504 0.669 . . . . 0.65 112.003 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.46 166.29 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.33 108.207 169.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.713 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 43.5 t 176.82 111.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.122 0.487 . . . . 0.8 110.323 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.609 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 51.4 p-90 -73.3 152.89 40.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.616 -1.253 . . . . 3.63 107.616 171.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.66 89.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.51 111.12 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.48 17.45 4.35 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.757 -0.656 . . . . 0.9 112.236 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.808 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 1.3 tt -51.9 129.07 25.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.113 0.565 . . . . 0.62 111.734 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.741 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 17.9 t70 -72.28 -30.67 65.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.538 -0.756 . . . . 0.74 111.503 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.442 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.4 m 76.46 -5.6 2.15 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.818 -1.083 . . . . 1.51 110.604 -172.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.06 -8.34 5.61 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.948 -0.644 . . . . 0.84 113.556 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.741 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 29.4 mtpt -94.7 142.85 26.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.423 0.611 . . . . 2.12 110.962 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.676 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 46.7 mt -78.56 125.65 29.65 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.539 -0.912 . . . . 1.23 108.539 171.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.808 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -121.13 163.04 19.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.465 -0.494 . . . . 1.61 109.978 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.636 HG22 HG11 ' A' ' 90' ' ' VAL . 69.1 m -104.24 105.49 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.355 -0.609 . . . . 0.87 109.355 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.558 HD23 ' HE2' ' A' ' 87' ' ' PHE . 25.3 tp -100.25 114.58 28.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.766 -0.457 . . . . 1.35 109.766 -177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.7 t -116.71 121.77 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.907 0.384 . . . . 0.54 111.344 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 1.014 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -81.52 134.38 35.51 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.555 -1.276 . . . . 0.65 107.555 168.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.848 HG21 HG12 ' A' ' 17' ' ' VAL . 10.3 t -140.35 142.74 35.56 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.014 0.435 . . . . 1.04 110.479 176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 7.1 p-10 -130.66 95.59 25.93 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-O 121.653 0.74 . . . . 1.92 110.188 174.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.5 Cg_endo -52.92 -31.95 54.98 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.937 3.091 . . . . 1.25 112.837 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.732 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 5.1 m-20 -82.79 45.98 1.04 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 1.29 111.094 -172.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 81' ' ' TYR . . . -104.41 130.23 23.65 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.696 -0.483 . . . . 0.56 109.696 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.3 Cg_endo -79.17 -30.38 5.78 Favored 'Cis proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.147 -1.605 . . . . 0.7 112.982 1.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.711 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 98.6 p -125.59 156.64 38.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.33 -0.395 . . . . 1.1 111.224 -177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.732 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 52.0 ttp180 -72.19 -23.85 61.33 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.049 -0.523 . . . . 3.39 111.129 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.717 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.08 -11.26 39.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.434 . . . . 1.83 110.64 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -156.32 84.32 3.25 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 1.37 109.814 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.95 91.74 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.065 2.51 . . . . 0.9 113.353 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.8 mttm -76.11 -49.59 16.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.162 -0.926 . . . . 1.53 110.849 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.81 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 91.8 m-85 -82.78 14.05 3.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.798 -1.092 . . . . 1.54 111.538 -169.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.5 ttt180 -67.02 128.49 36.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.956 -0.566 . . . . 3.38 111.024 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 2.5 mp0 -99.7 137.15 38.57 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.876 0.369 . . . . 2.23 110.545 -3.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.525 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.2 t90 -93.79 130.48 39.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.923 -0.769 . . . . 1.77 108.923 175.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 44.1 p-80 -98.66 123.18 42.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.999 -0.741 . . . . 2.19 108.999 173.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -91.57 -11.13 38.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.553 -0.749 . . . . 2.74 111.714 -170.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 1.014 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 40.8 t80 -167.95 136.23 2.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.873 -0.417 . . . . 2.21 109.873 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.818 HD21 ' HH ' ' A' ' 158' ' ' TYR . 22.7 tp -134.28 114.42 12.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.68 110.263 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.09 135.49 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.681 -0.69 . . . . 0.35 110.638 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.641 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 13.9 m -130.09 163.57 35.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.115 -0.948 . . . . 0.3 108.612 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.9 t-20 64.94 14.22 9.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.841 0.353 . . . . 2.09 110.416 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.563 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 14.3 ttm -68.93 103.97 1.96 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.702 -0.851 . . . . 0.34 108.702 174.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.521 ' HE2' HD23 ' A' ' 63' ' ' LEU . 21.2 ttmm -85.73 98.53 10.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.401 -0.818 . . . . 1.73 110.918 -171.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.29 -123.09 6.0 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.971 -1.013 . . . . 0.35 112.186 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.604 ' HB3' HD22 ' A' ' 58' ' ' LEU . 5.3 p-10 -118.1 31.08 6.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.539 0.685 . . . . 1.59 110.391 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.62 114.96 27.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.062 -0.972 . . . . 0.77 110.289 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.496 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 3.1 mm -66.81 -19.95 26.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.698 -1.137 . . . . 0.45 110.951 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.1 m -80.34 -52.99 7.04 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.669 0.618 . . . . 1.15 112.669 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 p -61.67 -20.79 63.82 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.714 0.293 . . . . 1.26 111.712 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.563 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -57.02 102.18 0.19 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.765 -0.652 . . . . 0.44 111.987 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 107.17 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.453 0.644 . . . . 1.06 109.723 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.501 ' O ' HD13 ' A' ' 137' ' ' ILE . 2.6 p -74.51 118.27 19.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.825 -1.08 . . . . 1.15 111.846 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.553 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.3 mt -97.83 -45.26 6.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.971 0.891 . . . . 0.48 108.888 172.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.8 t -126.57 106.46 9.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.615 -1.175 . . . . 0.62 107.858 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.792 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 6.3 t0 -61.86 158.15 16.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 1.15 112.387 -169.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -78.91 98.67 6.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.026 -0.988 . . . . 4.98 109.664 -178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.686 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 30.1 t -74.56 -23.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.86 111.471 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.11 -179.65 45.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.413 -0.898 . . . . 0.95 111.858 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.3 t -60.54 133.62 56.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.862 -0.422 . . . . 0.89 109.862 172.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.63 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -172.53 66.01 0.13 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.814 -0.708 . . . . 0.82 112.337 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -93.29 140.24 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.816 2.344 . . . . 1.01 112.977 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HB2' HG21 ' A' ' 115' ' ' THR . 72.6 Cg_exo -51.15 135.01 44.82 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.531 2.154 . . . . 0.96 111.331 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 117.0 5.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.213 -0.292 . . . . 2.39 110.213 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.46 -4.28 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.798 -0.715 . . . . 1.3 111.963 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.711 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 72.9 p -79.13 -16.59 56.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.763 0.316 . . . . 1.04 111.302 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.75 -169.4 23.22 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.844 -0.616 . . . . 1.97 111.846 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.41 HD13 ' HG2' ' A' ' 172' ' ' GLU . 4.6 mm? -70.39 98.3 1.4 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.94 109.935 175.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -75.77 103.93 6.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.421 -0.809 . . . . 2.85 109.204 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.839 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -99.72 92.96 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.405 0.621 . . . . 2.78 111.668 -173.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.545 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 1.1 m-85 -76.88 133.44 39.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 1.13 109.449 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.84 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.4 t -108.63 133.16 54.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.948 -0.39 . . . . 0.31 109.948 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.798 ' HZ3' HG23 ' A' ' 34' ' ' VAL . 1.5 m-90 -89.53 127.84 35.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.372 -0.603 . . . . 2.96 109.372 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 mt -118.75 119.39 34.29 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.867 -0.419 . . . . 0.41 109.867 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.543 HG13 ' HB3' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -106.96 132.68 53.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.41 -0.516 . . . . 0.43 109.682 175.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.57 ' HB2' HD21 ' A' ' 160' ' ' LEU . 24.3 m-85 -115.35 149.55 37.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.147 -0.478 . . . . 5.41 110.055 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.31 117.93 35.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.154 0.502 . . . . 2.41 109.894 174.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.583 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -89.88 158.86 17.25 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.626 -0.879 . . . . 1.31 108.626 173.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -76.4 -10.83 59.69 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.601 -0.727 . . . . 2.4 110.805 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.644 ' NH2' ' HB2' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -162.56 177.31 1.98 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 4.07 109.246 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.497 ' HG3' HD12 ' A' ' 63' ' ' LEU . 51.3 Cg_exo -54.0 174.54 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.275 1.984 . . . . 1.21 112.589 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.641 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.6 mm? -93.38 163.73 13.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.52 0.563 . . . . 1.16 112.52 -171.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.95 45.57 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.62 1.2 . . . . 3.23 109.868 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.2 p -62.65 -69.17 0.28 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.264 -1.789 . . . . 2.79 111.664 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 57.87 32.34 21.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.837 0.827 . . . . 2.96 110.173 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.529 ' HB2' HD22 ' A' ' 103' ' ' LEU . 57.9 mm-40 -81.85 139.99 46.83 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.547 -0.751 . . . . 1.39 110.809 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.38 125.2 8.75 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.37 2.714 . . . . 1.38 112.397 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 102' ' ' VAL . 33.4 mm -76.94 123.1 32.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.94 111.454 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.9 mt -94.82 155.37 16.83 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.346 -0.613 . . . . 1.61 109.346 174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.535 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.0 m -119.41 38.37 3.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.558 0.218 . . . . 1.88 111.508 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.792 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.9 OUTLIER 56.76 0.81 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.714 1.206 . . . . 1.33 113.418 177.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.536 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.0 mtt180 -97.64 148.51 23.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.919 -0.488 . . . . 3.83 109.797 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.572 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.4 m 74.46 115.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.113 0.883 . . . . 1.32 112.364 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -87.9 38.17 3.19 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 1.13 111.54 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.577 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 22.9 t70 -71.05 -39.91 71.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.77 0.795 . . . . 2.66 110.757 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.577 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 7.1 m80 -99.25 64.68 1.37 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.088 -0.96 . . . . 2.18 110.053 -171.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.581 ' O ' ' HB3' ' A' ' 81' ' ' TYR . 26.9 mtm180 -87.09 39.74 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 5.37 112.048 -175.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . 76.91 -117.4 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.935 -0.65 . . . . 0.9 114.001 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.81 ' CG ' ' HA ' ' A' ' 81' ' ' TYR . 79.9 mttt 60.35 39.85 18.25 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.121 0.486 . . . . 1.59 110.8 -171.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.442 ' HD2' ' CE2' ' A' ' 154' ' ' PHE . 43.5 t80 -150.37 135.83 18.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.846 -0.616 . . . . 2.27 109.622 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -54.17 119.56 5.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.507 -0.77 . . . . 1.87 112.792 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.857 HG22 HG11 ' A' ' 17' ' ' VAL . 4.3 m -59.03 -35.15 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.335 -0.848 . . . . 0.96 110.832 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.78 -33.02 72.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.863 -0.608 . . . . 0.76 110.456 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -70.47 -37.71 74.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.242 -0.435 . . . . 1.22 110.667 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.442 ' CE2' ' HD2' ' A' ' 149' ' ' PHE . 53.7 m-85 -64.28 -48.22 76.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.702 0.763 . . . . 1.1 109.518 173.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.794 HH12 ' HG3' ' A' ' 19' ' ' GLU . 21.3 ttt180 -55.59 -50.31 70.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.4 -1.273 . . . . 3.36 111.723 177.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -70.63 -28.91 65.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 1.52 111.126 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 44.3 tptt -59.84 -40.51 88.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 2.13 110.818 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.818 ' HH ' HD21 ' A' ' 88' ' ' LEU . 22.5 m-85 -88.53 5.97 40.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.077 -0.511 . . . . 5.77 110.516 -177.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.644 ' HB2' ' NH2' ' A' ' 129' ' ' ARG . 34.0 mm-40 67.21 33.85 5.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.261 -0.881 . . . . 2.42 111.336 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 125' ' ' TYR . 4.0 mp -90.62 140.64 29.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.666 0.269 . . . . 1.27 111.28 -177.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -71.56 -78.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 4.0 111.385 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.92 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.61 -0.515 . . . . 1.21 109.61 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.528 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 23.2 Cg_exo -60.95 137.95 75.61 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.592 2.195 . . . . 0.68 113.276 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.964 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 6.3 t -93.18 -26.94 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 115.465 -0.789 . . . . 0.5 109.279 174.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.763 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.56 147.35 25.3 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.917 -0.583 . . . . 0.29 111.806 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -144.32 142.21 10.84 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.725 -1.125 . . . . 0.24 111.429 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.675 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 7.6 t -155.72 137.04 13.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.149 -0.686 . . . . 0.34 109.149 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.84 ' HB2' HG22 ' A' ' 121' ' ' VAL . 6.7 t -116.51 145.26 43.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.24 0.543 . . . . 2.16 111.106 -174.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.553 ' CE2' HG21 ' A' ' 46' ' ' VAL . 25.2 p90 -128.52 129.62 46.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.346 -1.353 . . . . 1.31 107.346 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.812 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -110.47 132.52 54.11 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.714 -0.794 . . . . 2.53 111.044 -178.25 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -149.33 135.64 19.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.75 109.558 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.41 ' HG2' HD13 ' A' ' 117' ' ' LEU . 4.1 pt-20 -118.26 -136.75 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.51 -0.314 . . . . 2.38 110.907 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.428 ' HA ' HG23 ' A' ' 177' ' ' VAL . 83.7 t90 -80.27 96.91 6.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 4.71 111.746 -172.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.73 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 3.1 t70 -73.62 -62.16 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 1.53 110.396 170.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.556 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.7 t70 159.29 -39.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.024 1.329 . . . . 1.26 108.373 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.03 0.24 36.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 2.46 110.864 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.758 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 76.8 t -62.49 -53.92 53.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.02 -0.536 . . . . 0.58 110.478 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.2 Cg_exo -51.97 -35.46 60.79 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.468 2.112 . . . . 0.68 112.022 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 13.5 mmmm -73.9 -26.97 60.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 2.62 111.499 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.63 HD22 ' HA3' ' A' ' 110' ' ' GLY . 44.0 tp -69.09 -46.91 66.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 1.18 109.063 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.35 -34.94 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 2.11 109.393 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.659 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.2 mm-40 -63.28 -43.87 96.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.985 -1.007 . . . . 1.53 110.922 173.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' A' ' 187' ' ' LYS . 2.4 tt0 -65.29 -27.84 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 2.16 111.406 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 59.4 mt -66.31 6.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.511 0.559 . . . . 0.87 112.511 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.733 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 15.3 m -80.99 0.15 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.674 0.75 . . . . 1.38 109.086 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.536 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.52 33.07 17.52 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 114.916 -1.038 . . . . 1.17 111.228 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.733 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 31.6 mmtp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.372 -0.823 . . . . 2.45 110.991 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 1.1 mpt? . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.53 0.205 . . . . 5.4 110.499 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 16.8 Cg_exo -68.38 129.52 19.28 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.105 2.537 . . . . 2.58 112.728 -176.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 2.7 p -98.26 111.52 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 114.801 -1.09 . . . . 2.1 110.224 176.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' HA ' ' CB ' ' A' ' 24' ' ' PRO . 3.4 p30 -169.56 -175.48 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.921 -1.036 . . . . 1.81 108.557 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.61 24.81 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.918 0.34 . . . . 0.95 111.918 -173.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 t -72.9 -19.88 61.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.731 0.777 . . . . 2.19 109.388 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -117.33 36.72 4.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 3.07 110.174 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.802 ' HB2' HE21 ' A' ' 20' ' ' GLN . 0.2 OUTLIER -78.4 -37.22 44.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 4.76 112.294 -176.43 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 11.6 p -145.3 27.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.98 110.995 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.87 -122.31 0.31 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.912 -0.875 . . . . 0.52 110.912 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.524 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.72 -38.56 77.3 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.183 2.588 . . . . 0.61 110.568 166.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.686 HD13 ' HA3' ' A' ' 38' ' ' GLY . 17.5 mt -87.85 83.73 7.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.916 -1.038 . . . . 1.85 110.027 173.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.34 68.96 0.79 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.375 0.607 . . . . 1.31 110.112 175.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.715 HD23 HH11 ' A' ' 119' ' ' ARG . 57.0 mt -79.21 -16.83 55.94 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.702 -0.681 . . . . 0.61 110.775 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.811 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 9.3 tm0? -69.1 -12.87 62.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.362 0.601 . . . . 2.61 110.534 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.16 -23.74 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.139 0.495 . . . . 1.93 109.78 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 69' ' ' THR . 48.6 t -90.44 -68.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.225 -0.898 . . . . 1.26 110.722 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -119.9 -177.24 3.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.713 -0.676 . . . . 2.99 109.917 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 16.8 mt-10 -90.56 20.26 4.74 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.854 0.316 . . . . 1.6 111.854 -173.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.811 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 5.7 mm100 67.82 136.85 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.361 1.038 . . . . 4.38 112.427 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.603 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 4.3 Cg_exo -79.83 157.79 24.36 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.229 2.62 . . . . 0.69 112.804 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.928 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.5 pt20 -77.94 -27.09 49.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.893 -1.049 . . . . 1.87 111.857 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.75 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 79.6 m-70 -132.48 158.55 75.38 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.843 -0.799 . . . . 2.35 108.843 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' CB ' ' HA ' ' A' ' 4' ' ' ASP . 4.3 Cg_endo -85.81 128.27 3.28 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.664 2.243 . . . . 0.44 111.113 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.616 HD21 ' HB2' ' A' ' 122' ' ' TRP . 38.0 tp -78.66 148.4 33.18 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.093 -0.336 . . . . 0.33 110.093 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.442 ' H ' HD12 ' A' ' 25' ' ' LEU . 44.5 m80 -118.89 130.14 55.57 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.502 -0.555 . . . . 2.12 109.502 172.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 34' ' ' VAL . 19.2 t -127.75 146.26 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.682 -0.858 . . . . 1.12 108.682 177.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 143.18 32.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.974 0.416 . . . . 0.78 111.05 -177.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.531 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 34.5 t80 -110.77 173.22 6.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.5 -0.556 . . . . 1.23 109.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.51 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.18 0.514 . . . . 0.6 110.886 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.38 15.44 10.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.399 -0.818 . . . . 0.81 112.361 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.32 -172.79 4.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.885 0.374 . . . . 0.56 110.734 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -164.01 159.89 21.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.797 -0.638 . . . . 0.35 110.041 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 169' ' ' TYR . 87.3 t -114.3 67.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.585 -1.635 . . . . 0.39 106.585 162.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -102.63 23.19 12.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.582 -1.19 . . . . 0.99 109.092 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -150.93 132.95 15.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.852 -1.067 . . . . 2.56 108.304 174.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -76.65 110.76 11.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.182 0.515 . . . . 0.46 109.703 -173.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.686 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . 86.7 16.73 61.17 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.343 -0.844 . . . . 0.59 112.227 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.13 149.92 44.29 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.399 -0.593 . . . . 1.04 109.399 173.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.05 129.32 37.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.441 0.639 . . . . 1.16 111.029 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.6 tp -120.91 169.39 10.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.181 -1.044 . . . . 0.45 108.181 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.1 p -128.04 151.73 76.41 Favored Pre-proline 0 C--N 1.322 -0.587 0 C-N-CA 119.724 -0.79 . . . . 1.0 112.512 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.2 Cg_exo -55.58 -24.65 45.93 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.303 3.335 . . . . 1.0 114.01 -176.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -62.88 -38.3 90.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 122.11 0.957 . . . . 1.24 110.093 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.09 -46.19 14.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.785 -1.552 . . . . 1.74 111.266 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG13 ' CE2' ' A' ' 169' ' ' TYR . 6.7 m -100.51 31.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.459 0.54 . . . . 1.1 112.459 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -82.66 -7.87 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.419 0.628 . . . . 1.32 109.367 172.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -142.0 -177.82 5.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.952 -1.022 . . . . 2.4 109.072 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -71.79 156.26 91.3 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.765 -0.457 . . . . 1.78 109.765 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 57.8 Cg_endo -76.62 162.65 32.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.612 1.541 . . . . 0.41 110.216 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.4 t -85.67 -19.2 31.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.631 -0.427 . . . . 0.88 110.152 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.409 ' C ' HG21 ' A' ' 53' ' ' ILE . 69.0 m -159.5 147.43 17.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.65 112.413 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -139.36 172.44 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.825 -1.08 . . . . 0.33 108.382 170.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.72 ' HA ' HD11 ' A' ' 58' ' ' LEU . 30.5 t 170.97 127.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.462 0.476 . . . . 0.8 110.013 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.76 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -81.87 162.06 22.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.459 -0.941 . . . . 3.63 108.459 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 22.2 t70 -59.43 79.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.237 0.542 . . . . 1.51 110.712 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.71 24.44 3.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.751 -0.659 . . . . 0.9 112.958 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.72 HD11 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -54.3 128.25 30.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.067 0.434 . . . . 0.62 110.547 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.676 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 29.5 t70 -78.38 -12.76 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.74 111.439 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 70.7 p 51.23 30.04 5.45 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.94 -1.027 . . . . 1.51 110.906 -173.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.38 8.17 0.21 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.594 -0.73 . . . . 0.84 112.873 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.676 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 19.4 mtpt -109.99 157.49 19.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 2.12 109.481 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 65.3 mt -94.54 125.09 38.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.798 -0.816 . . . . 1.23 108.798 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.593 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -120.11 149.62 41.92 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.634 -0.426 . . . . 1.61 110.76 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.646 HG22 HG11 ' A' ' 90' ' ' VAL . 61.3 m -96.87 105.95 18.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.511 -0.922 . . . . 0.87 108.511 170.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.623 HD13 ' HB3' ' A' ' 122' ' ' TRP . 47.5 tp -106.8 109.87 21.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.716 -0.674 . . . . 1.35 110.189 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.1 t -114.79 123.02 70.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.745 -0.661 . . . . 0.54 110.679 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.4 mt -84.37 137.93 33.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.723 -0.843 . . . . 0.65 108.723 169.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.743 HG21 HG12 ' A' ' 17' ' ' VAL . 11.3 t -139.68 145.1 37.99 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.847 -0.341 . . . . 1.04 110.635 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.515 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 24.8 t70 -128.85 96.39 29.54 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.324 0.583 . . . . 1.92 110.273 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.0 Cg_endo -51.36 -37.85 61.61 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.046 3.164 . . . . 1.25 114.747 178.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.602 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 44.1 m-20 -96.33 46.69 1.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.341 0.497 . . . . 1.29 112.341 -166.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.82 137.91 19.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.56 110.794 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.5 Cg_endo -82.39 -20.19 20.36 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.44 -1.483 . . . . 0.7 112.465 0.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.756 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 96.6 p -134.01 146.8 50.74 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.832 -0.622 . . . . 1.1 110.472 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.602 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 63.1 ttt180 -66.45 -26.39 67.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.208 -0.451 . . . . 3.39 111.796 -174.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.705 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -89.0 -11.22 44.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.029 0.443 . . . . 1.83 110.862 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -153.2 82.37 4.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.856 -0.611 . . . . 1.37 109.528 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 96.1 Cg_endo -87.95 88.23 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.81 2.34 . . . . 0.9 113.16 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.517 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.7 mttm -71.52 -53.44 13.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.15 -0.932 . . . . 1.53 110.726 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 36.2 m-85 -78.75 17.83 0.67 Allowed 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.211 -0.904 . . . . 1.54 111.642 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 79' ' ' PRO . 32.4 ttt180 -74.2 129.59 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.216 0.323 . . . . 3.38 111.71 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 22.1 mp0 -89.05 140.51 29.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 122.807 0.443 . . . . 2.23 110.605 -6.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.558 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.1 t90 -86.21 91.5 8.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.532 -0.544 . . . . 1.77 109.532 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.1 p80 -71.86 121.84 19.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.768 0.794 . . . . 2.19 109.698 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.756 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t60 -72.72 -35.22 67.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.917 -1.038 . . . . 2.74 111.166 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.721 ' HD1' ' HB2' ' A' ' 68' ' ' LEU . 2.4 p90 -168.08 178.16 5.2 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.666 -0.494 . . . . 2.21 109.666 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.4 tp -140.71 114.01 8.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.776 0.322 . . . . 0.68 110.64 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 t -121.85 133.01 69.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.78 -0.645 . . . . 0.35 110.667 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.646 HG11 HG22 ' A' ' 65' ' ' THR . 16.2 m -133.37 161.55 41.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.409 -0.96 . . . . 0.3 108.409 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t-20 62.55 18.98 10.92 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.383 0.427 . . . . 2.09 110.608 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.588 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.6 ttm -68.18 110.67 4.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.789 -0.819 . . . . 0.34 108.789 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE2' HD23 ' A' ' 63' ' ' LEU . 13.8 ttmm -91.57 97.33 10.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.177 -0.92 . . . . 1.73 111.012 -171.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 64' ' ' TYR . . . 81.91 -130.62 9.82 Favored Glycine 0 CA--C 1.505 -0.568 0 CA-C-N 115.242 -0.89 . . . . 0.35 112.45 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 30.8 p-10 -117.29 26.48 9.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.098 0.475 . . . . 1.59 111.044 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.77 110.43 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.77 110.034 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 50' ' ' PRO . 7.3 mm -58.86 -28.92 39.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.511 -1.222 . . . . 0.45 111.396 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -82.24 -29.99 31.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.982 -0.554 . . . . 1.15 111.765 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -77.73 -6.68 54.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.845 0.313 . . . . 1.26 111.845 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.588 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -76.43 107.11 2.28 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.913 -0.661 . . . . 0.44 111.828 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 106.97 0.46 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.403 0.62 . . . . 1.06 110.332 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.561 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.3 p -89.55 109.52 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.827 -1.079 . . . . 1.15 111.203 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.497 HD12 ' HG ' ' A' ' 88' ' ' LEU . 29.4 mt -89.18 -45.25 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.023 -0.99 . . . . 0.48 109.813 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 t -116.65 105.76 12.79 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.952 -1.499 . . . . 0.62 106.952 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.561 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.2 t0 -54.88 150.97 9.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.15 112.831 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -77.37 103.29 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.114 -0.948 . . . . 4.98 109.223 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.821 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 48.4 t -78.33 -57.62 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.148 -0.478 . . . . 0.86 112.244 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 132.85 175.59 14.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.647 -0.787 . . . . 0.95 112.435 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.3 t -61.14 131.82 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.486 0.143 . . . . 0.89 110.66 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.499 ' H ' ' HH ' ' A' ' 120' ' ' TYR . . . -152.46 63.89 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 O-C-N 123.573 0.546 . . . . 0.82 112.297 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 177' ' ' VAL . 4.0 Cg_endo -90.34 113.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.611 2.874 . . . . 1.01 112.593 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.702 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.3 Cg_exo -56.43 147.74 66.6 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.897 2.398 . . . . 0.96 111.986 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 117.08 9.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.097 -0.502 . . . . 2.39 111.063 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.46 6.15 56.63 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.953 -0.642 . . . . 1.3 112.7 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 80.0 p -89.42 -22.68 22.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 1.04 111.728 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.61 173.29 20.1 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.828 -0.624 . . . . 1.97 111.743 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.3 mm? -74.72 113.15 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.062 -0.347 . . . . 0.94 110.062 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.693 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.0 m-70 -79.76 116.21 19.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 2.85 110.52 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.715 HH11 HD23 ' A' ' 14' ' ' LEU . 13.5 ptt180 -98.34 85.36 3.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.601 -0.727 . . . . 2.78 110.781 -172.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 20.7 m-85 -71.73 114.11 9.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.257 -0.645 . . . . 1.13 109.257 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.559 HG23 HD21 ' A' ' 14' ' ' LEU . 19.4 t -94.68 130.58 43.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.169 -0.469 . . . . 0.31 110.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.655 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 59.7 m95 -88.68 119.27 29.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.895 -0.78 . . . . 2.96 108.895 177.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.4 mt -113.84 118.61 34.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.709 0.232 . . . . 0.41 110.683 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -117.53 136.68 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.43 110.788 179.136 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.847 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 59.0 t80 -132.03 129.01 39.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.423 -0.353 . . . . 5.41 110.256 173.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.621 ' HG2' HG21 ' A' ' 164' ' ' VAL . 8.9 pt-20 -82.22 104.62 12.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.76 -0.829 . . . . 2.41 108.76 171.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.24 168.21 19.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.169 0.509 . . . . 1.31 109.752 -176.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.65 -7.2 53.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.582 -0.735 . . . . 2.4 110.347 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.498 ' HG3' ' HE2' ' A' ' 158' ' ' TYR . 20.0 ptt180 -167.01 160.23 11.02 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.561 -0.745 . . . . 4.07 111.02 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HG3' HD11 ' A' ' 63' ' ' LEU . 31.2 Cg_exo -56.75 140.45 91.02 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.544 2.829 . . . . 1.21 112.596 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.539 HD21 ' OG1' ' A' ' 65' ' ' THR . 3.8 mm? -65.16 149.52 49.77 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.401 0.519 . . . . 1.16 112.401 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 11.6 tptm -120.96 90.68 3.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 3.23 107.781 164.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.446 ' HG ' HD23 ' A' ' 103' ' ' LEU . 4.8 p -70.52 -69.77 0.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.334 -0.848 . . . . 2.79 111.961 -171.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 59.26 28.96 18.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.267 0.556 . . . . 2.96 109.753 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -99.62 138.23 20.39 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.427 -0.806 . . . . 1.39 109.426 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.28 115.17 1.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.113 2.542 . . . . 1.38 112.871 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.27 118.15 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.909 -0.404 . . . . 0.94 109.909 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.4 mt -114.78 147.88 39.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.459 . . . . 1.61 110.55 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -86.21 169.82 12.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.285 -0.871 . . . . 1.88 109.237 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.821 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 14.3 p-10 -86.13 30.49 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.112 0.482 . . . . 1.33 111.571 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.574 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 96.8 mtt180 -117.96 148.26 42.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.426 -0.352 . . . . 3.83 110.557 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.653 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 25.4 m 71.06 141.16 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.938 -1.028 . . . . 1.32 111.232 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.03 28.71 14.4 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.585 -0.734 . . . . 1.13 111.519 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.64 -51.61 26.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.316 0.647 . . . . 2.66 112.672 -172.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -117.73 31.03 6.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.41 0.624 . . . . 2.18 111.327 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.415 ' HB3' ' HE1' ' A' ' 84' ' ' TRP . 18.0 mmt180 -87.65 -36.03 17.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 5.37 110.56 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -117.19 176.02 15.99 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.551 -0.833 . . . . 0.9 112.707 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.732 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.3 mttt 64.33 41.94 5.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.535 0.683 . . . . 1.59 111.449 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.98 149.02 49.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.044 -0.98 . . . . 2.27 109.252 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -97.96 122.93 41.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.991 0.424 . . . . 1.87 111.697 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.634 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.8 m -61.29 -26.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.672 -0.695 . . . . 0.96 110.224 174.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -61.7 -46.79 88.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.364 -0.834 . . . . 0.76 110.186 173.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.0 m -63.97 -35.92 82.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.094 -0.503 . . . . 1.22 110.823 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.634 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.6 m-85 -65.27 -49.98 67.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.399 -0.364 . . . . 1.1 111.093 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 1.8 ptm180 -69.0 -39.31 79.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 3.36 111.02 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.72 -27.58 68.43 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 111.503 0.186 . . . . 1.52 111.503 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -53.93 -54.06 44.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 2.13 111.495 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.498 ' HE2' ' HG3' ' A' ' 129' ' ' ARG . 9.2 t80 -107.58 18.87 20.94 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.766 -0.773 . . . . 5.77 110.75 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 63.78 46.87 3.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.408 -0.814 . . . . 2.42 111.149 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.847 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -91.47 123.14 34.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.185 -0.916 . . . . 1.27 109.831 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.455 ' HD2' ' HA ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -86.52 -150.39 0.15 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.4 -0.364 . . . . 4.0 110.441 -178.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -62.73 142.85 96.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 1.21 110.541 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 16.5 Cg_exo -66.33 160.73 43.93 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 123.795 2.997 . . . . 0.68 113.513 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.928 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.7 t -89.74 -35.58 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-N 115.48 -0.782 . . . . 0.5 110.089 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' A' ' 55' ' ' TRP . . . -149.72 145.91 26.93 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.912 -0.715 . . . . 0.29 111.75 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.36 143.02 10.34 Favored Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.545 -1.207 . . . . 0.24 111.344 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 t -155.5 142.4 19.04 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.055 -1.091 . . . . 0.34 108.055 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.615 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 13.1 p -120.31 141.27 50.17 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.951 -0.699 . . . . 2.16 110.551 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.623 ' HB3' HG22 ' A' ' 34' ' ' VAL . 41.0 p90 -125.56 123.29 38.77 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.693 -1.225 . . . . 1.31 107.693 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.693 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -101.03 132.39 46.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.621 -0.832 . . . . 2.53 110.623 177.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.07 155.75 29.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.567 -0.742 . . . . 0.75 110.696 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.39 -177.38 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.173 0.511 . . . . 2.38 111.38 -175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.706 ' HA ' HG23 ' A' ' 177' ' ' VAL . 30.0 t90 -84.99 78.44 9.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 4.71 109.018 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 9.2 t70 -71.99 -62.74 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 1.53 111.687 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 33.5 t70 174.69 -35.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.277 0.56 . . . . 1.26 110.917 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -80.21 5.26 15.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 2.46 110.999 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.79 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 64.8 t -72.42 -54.45 5.34 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.58 110.479 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 77.2 Cg_exo -51.47 -37.73 62.5 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.545 2.163 . . . . 0.68 112.33 172.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.6 mmmt -73.09 -23.3 60.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 2.62 111.42 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.799 HD12 HG12 ' A' ' 107' ' ' VAL . 40.3 tp -69.62 -46.59 65.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.104 -0.702 . . . . 1.18 109.104 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -59.61 -36.86 77.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 2.11 109.811 173.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.658 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.1 mm-40 -54.73 -46.65 74.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.83 -1.077 . . . . 1.53 110.339 172.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -73.73 -36.01 65.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.474 -0.785 . . . . 2.16 111.744 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.653 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.7 mt -67.16 5.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.263 0.468 . . . . 0.87 112.263 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.663 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 33.8 m -84.12 0.02 50.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.377 0.608 . . . . 1.38 109.462 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.574 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.35 55.34 8.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.223 -0.899 . . . . 1.17 111.346 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.663 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 1.4 mmmp? . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.169 -0.919 . . . . 2.45 110.75 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 tpt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.719 -0.474 . . . . 5.4 109.719 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.88 111.63 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.236 2.624 . . . . 2.58 113.536 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 24' ' ' PRO . 7.4 p -54.16 146.06 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.633 -1.167 . . . . 2.1 111.434 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -154.11 153.47 31.91 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.175 -0.676 . . . . 1.81 109.175 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.16 16.19 0.8 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.851 0.315 . . . . 0.95 111.851 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.3 t -64.14 -16.18 61.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 2.19 110.805 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -113.47 31.48 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 3.07 110.536 -177.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.646 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.4 OUTLIER -73.55 -41.27 63.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.852 0.358 . . . . 4.76 111.93 -174.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 61.9 p -145.03 32.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.463 0.649 . . . . 0.98 110.003 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.12 -118.1 0.21 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.966 -0.854 . . . . 0.52 110.966 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 18.6 Cg_endo -56.89 -38.37 96.07 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 123.175 2.583 . . . . 0.61 110.854 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' ' 7' ' ' LYS . 9.3 mt -88.58 101.75 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.85 110.034 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.663 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -83.29 71.34 10.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.837 0.827 . . . . 1.31 110.106 175.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.474 HD21 HG23 ' A' ' 121' ' ' VAL . 22.7 mt -79.09 -15.49 58.1 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.465 -0.789 . . . . 0.61 109.915 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.627 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -74.46 -6.67 49.65 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.375 -0.83 . . . . 2.61 111.204 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.663 ' HG3' ' O ' ' A' ' 13' ' ' SER . 14.2 mt-10 -68.91 -22.83 64.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.323 0.582 . . . . 1.93 109.577 177.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.891 HG11 HG22 ' A' ' 151' ' ' VAL . 46.1 t -89.03 -71.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.163 -0.926 . . . . 1.26 111.41 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -149.74 174.65 12.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.935 -0.575 . . . . 2.99 109.525 -172.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -54.95 151.04 9.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.288 0.566 . . . . 1.6 111.279 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.627 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 27.6 mm-40 -86.96 138.27 32.94 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.872 -0.603 . . . . 4.38 109.942 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.639 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 8.1 Cg_exo -71.24 161.52 45.51 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.377 2.718 . . . . 0.69 113.299 -170.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.7 pt20 -82.38 -18.07 43.32 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.326 -0.852 . . . . 1.87 111.74 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.748 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.2 m80 -141.9 159.68 58.5 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 2.35 109.538 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.678 ' HB2' HG13 ' A' ' 3' ' ' VAL . 5.0 Cg_endo -85.72 125.73 2.87 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.763 2.309 . . . . 0.44 111.175 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.75 HD21 ' HB3' ' A' ' 122' ' ' TRP . 16.2 tp -71.55 137.74 48.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.33 110.131 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.59 107.82 19.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.8 -0.444 . . . . 2.12 109.8 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 53' ' ' ILE . 6.6 t -114.46 143.34 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.149 -0.686 . . . . 1.12 109.149 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.39 139.58 31.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.99 0.424 . . . . 0.78 111.413 -174.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -104.72 173.34 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.238 -0.653 . . . . 1.23 109.238 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.17 66.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.485 0.659 . . . . 0.6 110.726 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.1 -0.87 33.68 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.28 -0.873 . . . . 0.81 112.957 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.36 -170.39 2.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.56 111.266 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.39 154.4 16.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.63 -0.713 . . . . 0.35 109.734 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.71 HG22 ' HB3' ' A' ' 169' ' ' TYR . 86.6 t -113.14 69.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.145 -1.428 . . . . 0.39 107.145 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 20.5 t70 -105.41 18.55 22.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.234 -0.894 . . . . 0.99 109.358 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.35 135.85 24.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.521 -0.918 . . . . 2.56 108.521 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.555 HD22 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -80.79 111.38 17.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.405 0.622 . . . . 0.46 110.547 -171.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.583 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 91.32 11.74 60.7 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.989 -1.005 . . . . 0.59 111.848 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.4 144.53 46.35 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.394 -0.595 . . . . 1.04 109.394 176.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 9.7 p -77.24 136.2 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 1.16 110.99 -178.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.596 HD21 ' CG1' ' A' ' 46' ' ' VAL . 7.2 tp -131.99 168.85 17.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.556 -0.905 . . . . 0.45 108.556 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.92 152.04 48.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.565 -0.454 . . . . 1.0 112.045 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.836 ' HG3' ' HG ' ' A' ' 109' ' ' SER . 50.3 Cg_exo -57.41 -34.11 97.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.805 3.003 . . . . 1.0 112.855 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.499 HG21 ' CD1' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -60.37 -39.91 88.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.463 0.649 . . . . 1.24 110.772 176.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -81.64 -13.24 58.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.943 -1.026 . . . . 1.74 111.752 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.644 ' HB ' ' HH ' ' A' ' 106' ' ' TYR . 33.0 m -128.24 28.65 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 1.1 111.583 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HZ2' HD13 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -86.76 -10.75 52.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.414 0.626 . . . . 1.32 109.337 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -132.91 174.21 10.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.745 -1.116 . . . . 2.4 108.38 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -71.29 153.56 94.08 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 110.229 -0.286 . . . . 1.78 110.229 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.35 156.18 46.02 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.136 1.89 . . . . 0.41 110.844 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -77.71 -20.78 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.809 0.338 . . . . 0.88 110.216 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.419 ' C ' HG21 ' A' ' 53' ' ' ILE . 71.5 m -159.07 143.56 15.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.482 0.658 . . . . 0.65 112.619 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.587 HD13 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -137.83 164.34 28.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.778 -1.101 . . . . 0.33 108.155 170.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.757 ' HA ' HD11 ' A' ' 58' ' ' LEU . 35.1 t 174.69 118.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.15 -0.315 . . . . 0.8 110.15 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.816 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -73.12 155.76 39.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.273 -1.01 . . . . 3.63 108.273 172.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.89 88.05 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.042 0.448 . . . . 1.51 110.302 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.95 10.62 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.64 -0.709 . . . . 0.9 112.182 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.757 HD11 ' HA ' ' A' ' 54' ' ' SER . 3.8 tt -51.03 128.74 22.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.09 0.556 . . . . 0.62 111.37 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.758 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 24.4 t70 -72.73 -32.59 65.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.723 -0.671 . . . . 0.74 111.332 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.531 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.7 t 71.52 15.02 6.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 114.998 -1.001 . . . . 1.51 109.831 -174.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.53 10.52 2.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.526 -0.761 . . . . 0.84 112.901 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.758 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 22.9 mtpt -117.76 154.45 31.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.803 -0.443 . . . . 2.12 109.803 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.797 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 24.2 mt -92.5 130.87 38.04 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.796 -0.816 . . . . 1.23 108.796 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.65 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -125.54 158.36 34.76 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.56 -0.456 . . . . 1.61 110.871 176.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.477 ' OG1' HD21 ' A' ' 131' ' ' LEU . 60.0 m -97.72 106.14 18.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.149 -0.685 . . . . 0.87 109.149 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.595 HD11 HG11 ' A' ' 124' ' ' VAL . 53.0 tp -104.24 111.23 23.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 1.35 110.394 -176.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.74 125.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 0.54 110.727 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.5 -0.926 . . . . 0.65 108.5 167.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.735 HG21 HG12 ' A' ' 17' ' ' VAL . 10.6 t -136.66 146.81 46.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.04 -0.355 . . . . 1.04 110.04 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.454 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 14.9 t0 -126.28 97.27 34.75 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.457 -0.571 . . . . 1.92 109.457 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.503 ' HD3' HG22 ' A' ' 17' ' ' VAL . 6.5 Cg_endo -49.08 -46.89 23.73 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.904 3.069 . . . . 1.25 113.485 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.65 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 7.4 m-20 -90.81 53.09 2.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.422 0.629 . . . . 1.29 111.14 -171.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.479 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -103.98 138.88 19.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.932 -0.576 . . . . 0.56 110.828 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.593 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 88.1 Cg_endo -83.43 -22.7 14.35 Favored 'Cis proline' 0 C--N 1.343 0.282 0 C-N-CA 123.327 -1.531 . . . . 0.7 112.621 1.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.59 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 58.9 p -128.46 147.3 50.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.565 -0.743 . . . . 1.1 110.277 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.65 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 21.2 ttt180 -64.6 -26.65 68.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.257 0.551 . . . . 3.39 110.429 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.538 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . 4.9 ptpt -78.72 -14.83 59.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 1.83 110.89 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t70 -162.94 87.49 1.33 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.942 -0.572 . . . . 1.37 110.111 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.2 Cg_endo -85.2 83.92 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.697 2.265 . . . . 0.9 112.806 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -72.08 -47.85 48.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.884 -1.053 . . . . 1.53 110.48 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.662 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 54.6 m-85 -88.53 21.28 2.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.002 -0.999 . . . . 1.54 111.729 -168.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.846 ' HD3' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -74.01 125.85 29.18 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.173 -0.306 . . . . 3.38 110.173 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.846 ' HG3' ' HD3' ' A' ' 82' ' ' ARG . 1.5 mp0 -94.87 138.78 32.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.043 0.449 . . . . 2.23 110.986 -2.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.479 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 16.0 t90 -91.72 138.64 31.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.188 -0.671 . . . . 1.77 109.188 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -113.44 133.61 55.1 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.221 -0.659 . . . . 2.19 109.221 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 5.2 t60 -82.75 -35.81 26.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.72 -0.673 . . . . 2.74 110.527 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.676 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 22.0 p90 -167.62 177.19 6.01 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.552 -0.536 . . . . 2.21 109.552 177.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 103' ' ' LEU . 23.3 tp -141.27 113.8 8.22 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.245 0.341 . . . . 0.68 110.25 176.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.676 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.668 -0.697 . . . . 0.35 110.57 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.514 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 4.5 m -129.05 166.88 25.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.591 -0.892 . . . . 0.3 108.591 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.797 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 m-20 60.45 18.89 8.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.955 0.407 . . . . 2.09 111.172 172.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.463 ' HB2' ' HE2' ' A' ' 92' ' ' MET . 8.4 ttm -72.49 116.71 13.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.97 -0.752 . . . . 0.34 108.97 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.3 ttmm -90.4 100.63 13.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.126 -0.943 . . . . 1.73 110.972 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 75.59 -121.42 6.37 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.353 -0.839 . . . . 0.35 112.537 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.501 ' HB3' HD22 ' A' ' 58' ' ' LEU . 28.2 p30 -120.55 29.09 7.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.208 0.528 . . . . 1.59 111.052 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -97.15 109.61 22.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.834 -0.621 . . . . 0.77 110.183 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 53' ' ' ILE . 7.6 mm -54.74 -30.86 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.716 -1.129 . . . . 0.45 111.483 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.0 m -83.21 -35.53 25.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.016 -0.538 . . . . 1.15 112.32 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.8 p -61.28 -24.97 66.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 1.26 111.759 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.436 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -54.8 110.11 1.53 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.65 -0.704 . . . . 0.44 113.012 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.4 m -66.44 107.59 2.09 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.344 -0.613 . . . . 1.06 109.344 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.3 126.63 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.223 -0.898 . . . . 1.15 111.579 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 ' HG ' ' A' ' 88' ' ' LEU . 22.8 mt -106.87 -49.6 3.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.181 0.991 . . . . 0.48 108.713 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.8 t -120.57 112.72 19.28 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.678 -1.601 . . . . 0.62 106.678 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.916 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.3 t0 -70.52 167.95 17.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.407 0.623 . . . . 1.15 112.429 -166.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.644 ' HH ' ' HB ' ' A' ' 46' ' ' VAL . 65.7 t80 -83.52 88.24 7.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.973 -1.012 . . . . 4.98 109.731 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.847 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.0 t -61.72 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.713 -0.676 . . . . 0.86 112.094 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.451 ' HA3' ' HZ3' ' A' ' 47' ' ' LYS . . . 114.88 -176.96 17.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.95 111.695 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.836 ' HG ' ' HG3' ' A' ' 43' ' ' PRO . 29.0 t -71.69 127.06 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.975 0.387 . . . . 0.89 110.536 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.515 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . -150.51 63.67 0.4 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.805 -0.712 . . . . 0.82 112.448 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.628 ' HB3' ' CE1' ' A' ' 118' ' ' HIS . 96.5 Cg_endo -93.05 145.36 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.062 2.508 . . . . 1.01 113.3 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.522 ' HD2' HG23 ' A' ' 115' ' ' THR . 32.1 Cg_exo -60.56 154.04 57.0 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.641 2.227 . . . . 0.96 111.351 169.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.434 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -68.43 126.46 29.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 2.39 110.896 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.76 37.1 20.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 1.3 113.221 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 28.6 p -84.32 -13.12 53.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.393 0.516 . . . . 1.04 112.393 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 89.83 11.77 63.17 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.27 -0.967 . . . . 1.97 112.101 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 172' ' ' GLU . 3.8 mm? 72.37 100.79 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.593 0.819 . . . . 0.94 111.446 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.628 ' CE1' ' HB3' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -96.26 164.75 12.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.043 -0.725 . . . . 2.85 109.043 175.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.595 HH11 HD21 ' A' ' 12' ' ' LEU . 2.7 ptt180 -127.29 106.22 9.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.015 0.436 . . . . 2.78 112.061 -160.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.579 ' OH ' ' HE1' ' A' ' 118' ' ' HIS . 6.8 m-85 -73.66 110.79 8.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.848 -0.797 . . . . 1.13 108.848 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 168' ' ' CYS . 16.6 t -94.82 125.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.291 -0.413 . . . . 0.31 110.373 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.75 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -87.99 118.6 27.66 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.091 -0.707 . . . . 2.96 109.091 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.98 119.03 33.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.578 -0.156 . . . . 0.41 110.578 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 66' ' ' LEU . 1.7 m -105.61 126.24 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.157 -0.617 . . . . 0.43 109.824 173.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.423 ' HB2' HD21 ' A' ' 160' ' ' LEU . 47.1 m-85 -108.09 124.21 49.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 5.41 109.02 175.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.535 ' HB2' HG21 ' A' ' 164' ' ' VAL . 27.6 tt0 -94.38 96.98 9.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.991 0.424 . . . . 2.41 110.137 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.65 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -73.24 163.97 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.77 -0.65 . . . . 1.31 109.67 175.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.76 3.14 38.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.56 -0.746 . . . . 2.4 110.04 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.406 ' HD2' ' HH ' ' A' ' 158' ' ' TYR . 0.8 OUTLIER -165.64 153.23 9.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 4.07 111.355 -169.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.468 ' HG3' HD11 ' A' ' 63' ' ' LEU . 32.0 Cg_exo -59.59 141.08 96.61 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.701 2.934 . . . . 1.21 112.094 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.541 HD23 ' HG2' ' A' ' 127' ' ' GLN . 3.6 mm? -68.43 151.56 46.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 1.16 112.434 -170.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -115.9 64.23 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.403 -0.962 . . . . 3.23 108.403 171.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 46.2 m -96.98 92.4 6.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.218 -0.901 . . . . 2.79 110.194 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.85 40.66 0.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.963 . . . . 2.96 109.976 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -89.16 127.98 53.33 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.16 -0.927 . . . . 1.39 110.091 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.1 127.85 18.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.225 2.617 . . . . 1.38 112.588 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.25 121.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.94 110.11 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.4 mt -98.82 -13.95 19.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.393 -0.367 . . . . 1.61 111.815 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.547 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m 55.65 -162.23 0.16 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.428 -0.351 . . . . 1.88 110.669 -173.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.916 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.2 p-10 -117.72 16.43 14.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.162 0.506 . . . . 1.33 111.072 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.539 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 23.2 mtt180 -107.71 137.27 46.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.205 -0.452 . . . . 3.83 109.988 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.568 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 67.9 m 74.42 113.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.185 0.928 . . . . 1.32 111.089 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.4 36.06 2.96 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.293 -0.867 . . . . 1.13 112.296 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.557 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 16.5 t70 -70.01 -51.25 33.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.677 0.751 . . . . 2.66 110.387 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.557 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 8.8 m80 -92.79 53.86 2.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.968 -1.015 . . . . 2.18 110.437 -173.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 146' ' ' ARG . 44.0 mtt85 -76.49 -83.91 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.644 -0.707 . . . . 5.37 111.343 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -126.29 -154.74 8.73 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.655 -0.783 . . . . 0.9 112.777 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.662 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 81.0 mttt 65.93 23.18 11.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.787 0.803 . . . . 1.59 109.789 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -107.66 173.57 6.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.632 -1.167 . . . . 2.27 108.876 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.35 119.94 37.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.549 -0.296 . . . . 1.87 111.187 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.899 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 18.4 m -66.06 -25.36 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.423 -0.584 . . . . 0.96 109.423 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.02 83.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.194 -0.912 . . . . 0.76 109.986 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 57.4 m -66.91 -36.74 82.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.426 -0.352 . . . . 1.22 110.996 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.899 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 52.0 m-85 -61.7 -49.95 74.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.732 0.301 . . . . 1.1 110.799 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.481 ' HG3' ' N ' ' A' ' 156' ' ' LYS . 5.9 ptp180 -69.15 -44.47 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.509 -0.314 . . . . 3.36 111.199 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 155' ' ' ARG . 58.5 mtmt -63.04 -26.99 69.1 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.436 0.161 . . . . 1.52 111.436 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -53.15 -50.57 64.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.52 0.512 . . . . 2.13 110.721 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.406 ' HH ' ' HD2' ' A' ' 129' ' ' ARG . 27.2 t80 -104.09 9.92 36.18 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.18 -0.608 . . . . 5.77 110.511 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 57.51 39.79 27.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.2 1.0 . . . . 2.42 110.229 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.544 HD12 ' H ' ' A' ' 161' ' ' ARG . 1.7 tp -76.22 156.06 33.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.057 -1.429 . . . . 1.27 111.552 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.544 ' H ' HD12 ' A' ' 160' ' ' LEU . 9.0 mpt_? -96.87 -166.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 4.0 111.856 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.04 158.08 77.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.38 -0.373 . . . . 1.21 111.892 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -70.38 150.52 64.59 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.269 2.646 . . . . 0.68 113.205 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 10.5 t -93.72 -31.47 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.448 -0.796 . . . . 0.5 109.861 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.816 ' HB1' ' HB2' ' A' ' 55' ' ' TRP . . . -147.44 146.45 29.56 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.997 -0.681 . . . . 0.29 112.109 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -150.74 155.76 26.34 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.72 -1.127 . . . . 0.24 111.655 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.436 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.2 t -169.73 133.2 1.23 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.897 -0.779 . . . . 0.34 108.897 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 12' ' ' LEU . 17.5 p -110.93 141.15 44.75 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.257 -0.577 . . . . 2.16 110.609 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.71 ' HB3' HG22 ' A' ' 34' ' ' VAL . 25.9 p90 -127.32 123.16 35.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.419 -0.956 . . . . 1.31 108.419 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -100.08 138.14 37.56 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.439 -0.504 . . . . 2.53 110.672 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -138.01 146.92 43.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.94 -0.573 . . . . 0.75 109.976 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HB3' HD13 ' A' ' 117' ' ' LEU . 14.1 pt-20 -121.67 -168.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.34 . . . . 2.38 111.34 -176.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.813 ' HA ' HG23 ' A' ' 177' ' ' VAL . 14.1 t90 -76.91 83.85 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 4.71 110.887 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.554 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.5 p-10 -74.41 -59.83 2.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 111.545 0.202 . . . . 1.53 111.545 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.9 t70 178.05 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.086 0.555 . . . . 1.26 110.185 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.499 ' CD1' HG21 ' A' ' 44' ' ' THR . 72.4 m-85 -82.53 -2.27 53.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 2.46 111.874 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.813 HG23 ' HA ' ' A' ' 173' ' ' TRP . 94.4 t -58.7 -54.04 60.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.473 -0.33 . . . . 0.58 110.49 172.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.759 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.5 Cg_exo -51.31 -36.1 56.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.635 2.223 . . . . 0.68 112.445 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 29.2 mmmt -74.12 -24.71 59.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 2.62 110.78 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 59.0 tp -69.44 -46.09 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.429 -0.582 . . . . 1.18 109.429 172.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.445 -0.798 . . . . 2.11 108.898 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 42.5 mm-40 -58.19 -50.21 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.803 -1.09 . . . . 1.53 110.941 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.445 ' NE2' HD22 ' A' ' 140' ' ' ASN . 34.8 tt0 -64.17 -33.81 76.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.581 -0.736 . . . . 2.16 111.934 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 77.1 mt -62.47 0.03 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.691 0.626 . . . . 0.87 112.691 -177.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.606 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.6 m -82.2 8.9 9.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.063 0.459 . . . . 1.38 110.133 171.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.6 54.95 9.12 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.974 -0.85 . . . . 1.17 110.974 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.606 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.6 mmmt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.576 -0.726 . . . . 2.45 110.981 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 12.3 tpt . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.501 -0.185 . . . . 5.4 110.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 17.3 Cg_exo -68.36 93.41 0.41 Allowed 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 122.904 2.403 . . . . 2.58 111.826 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.698 HG13 ' HB2' ' A' ' 24' ' ' PRO . 3.7 t 61.47 113.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.214 -1.357 . . . . 2.1 111.873 -176.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 6' ' ' SER . 16.6 t70 -159.18 157.09 30.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.119 -1.067 . . . . 1.81 108.119 177.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.95 22.6 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.048 -0.261 . . . . 0.95 111.631 -174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 4' ' ' ASP . 20.4 m -67.64 -21.21 65.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 2.19 111.505 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.95 37.07 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 3.07 110.192 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.452 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 9.0 p-90 -75.76 -29.03 58.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.42 0.526 . . . . 4.76 112.42 -174.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 70.8 p -156.18 20.27 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.98 111.017 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -82.6 -117.64 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.664 -0.575 . . . . 0.52 111.664 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.6 Cg_endo -51.65 -42.08 58.24 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.225 2.616 . . . . 0.61 110.279 167.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.714 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 10.2 mp -90.01 94.91 9.98 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.747 -1.115 . . . . 1.85 110.965 172.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -74.2 61.45 0.86 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.351 0.596 . . . . 1.31 110.211 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' A' ' 12' ' ' LEU . 40.5 mt -68.46 -13.41 62.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.61 110.902 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 22.3 mm-40 -73.57 -1.29 18.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.086 -0.506 . . . . 2.61 111.675 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.57 -10.58 59.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.169 0.509 . . . . 1.93 109.792 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.894 HG12 HG21 ' A' ' 69' ' ' THR . 58.7 t -92.83 -76.82 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 1.26 110.196 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.586 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 10.1 t70 -155.59 -178.25 7.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.396 -0.964 . . . . 2.99 108.396 -175.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.74 152.99 41.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.047 0.451 . . . . 1.6 110.766 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 8.2 tp-100 -78.12 129.88 74.14 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.072 -0.513 . . . . 4.38 110.413 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.2 Cg_exo -58.22 159.39 19.08 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.965 2.443 . . . . 0.69 113.001 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.933 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 20.3 pt20 -78.96 -8.18 58.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 1.87 111.653 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.885 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 64.8 m-70 -148.17 157.63 42.49 Favored Pre-proline 0 CA--C 1.515 -0.385 0 C-N-CA 123.246 0.619 . . . . 2.35 109.78 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.698 ' HB2' HG13 ' A' ' 3' ' ' VAL . 5.6 Cg_endo -87.67 123.94 1.85 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.318 2.679 . . . . 0.44 111.239 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 20.6 tp -79.04 131.58 36.32 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.32 -0.237 . . . . 0.33 111.353 -175.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -100.04 112.9 25.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.007 -0.368 . . . . 2.12 110.007 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.606 ' HB ' ' HB ' ' A' ' 34' ' ' VAL . 22.1 t -116.59 142.03 32.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.264 -0.643 . . . . 1.12 109.264 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -136.3 138.93 42.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.903 0.382 . . . . 0.78 110.117 -177.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -99.87 171.58 7.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.447 -0.575 . . . . 1.23 109.447 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.65 62.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.6 110.596 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.53 9.37 19.67 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.432 -0.804 . . . . 0.81 112.504 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.34 -168.23 2.68 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 110.165 -0.309 . . . . 0.56 110.165 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -161.36 155.23 22.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.252 -0.431 . . . . 0.35 110.768 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.724 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.8 t -107.77 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.919 -1.512 . . . . 0.39 106.919 166.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.69 22.2 4.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.99 109.833 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -150.64 130.24 13.08 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.051 -0.977 . . . . 2.56 109.847 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.943 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.1 tt -71.96 112.92 8.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.342 -0.614 . . . . 0.46 109.342 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.598 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 89.97 19.22 47.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.89 -0.671 . . . . 0.59 112.256 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.724 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.6 147.26 27.08 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.275 -0.639 . . . . 1.04 109.275 175.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.495 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.3 p -78.42 130.45 36.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.283 0.563 . . . . 1.16 110.821 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.514 HD21 ' HD2' ' A' ' 169' ' ' TYR . 8.7 tp -129.99 149.74 51.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.545 -1.279 . . . . 0.45 107.545 177.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 3.9 p -95.86 150.74 37.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 C-N-CA 119.47 -0.892 . . . . 1.0 112.665 -170.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.918 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 82.3 Cg_exo -51.68 -22.74 13.8 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.674 3.583 . . . . 1.0 114.374 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.484 HG22 ' CD2' ' A' ' 176' ' ' TYR . 2.2 p -71.09 -53.77 13.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.672 0.748 . . . . 1.24 109.816 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.65 -43.39 93.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.42 -1.264 . . . . 1.74 111.544 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 43' ' ' PRO . 2.5 m -91.97 13.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 1.1 111.903 -173.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -82.68 -28.71 30.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.162 -0.472 . . . . 1.32 110.391 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 18.1 m120 -109.23 -169.86 1.56 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.62 -0.718 . . . . 2.4 110.668 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -86.14 158.05 55.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.274 -0.639 . . . . 1.78 109.274 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.471 ' HG3' ' CH2' ' A' ' 122' ' ' TRP . 72.0 Cg_endo -81.64 160.43 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.112 1.875 . . . . 0.41 111.004 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -81.61 -21.23 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.141 0.496 . . . . 0.88 109.878 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.52 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 69.2 m -158.11 143.49 16.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.362 0.601 . . . . 0.65 112.551 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -139.92 161.0 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.717 -1.129 . . . . 0.33 107.955 170.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.637 ' HA ' HD11 ' A' ' 58' ' ' LEU . 37.9 t 176.02 119.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.98 0.419 . . . . 0.8 110.421 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.534 ' CB ' ' HB1' ' A' ' 165' ' ' ALA . 50.0 p-90 -81.15 147.93 29.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.848 -1.538 . . . . 3.63 106.848 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -66.38 91.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.859 0.837 . . . . 1.51 110.904 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.32 -1.31 3.68 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 114.864 -1.062 . . . . 0.9 111.799 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 95' ' ' ASN . 7.1 tt -54.68 128.58 33.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.83 0.452 . . . . 0.62 110.511 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.743 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -77.8 -26.95 50.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.092 -0.504 . . . . 0.74 111.67 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.706 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.5 p 70.59 13.33 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.396 1.078 . . . . 1.51 110.5 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -133.05 -25.66 0.65 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.84 113.263 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.743 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 18.8 mtpt -84.22 156.74 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.968 0.384 . . . . 2.12 110.084 -175.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.959 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.9 mt -92.29 128.16 38.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.72 -0.474 . . . . 1.23 109.72 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.506 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 17.3 m-85 -121.37 150.78 40.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.601 0.239 . . . . 1.61 110.523 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.874 HG21 HG11 ' A' ' 90' ' ' VAL . 2.7 m -97.16 105.91 18.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.638 -0.875 . . . . 0.87 108.638 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.632 HD11 HG11 ' A' ' 124' ' ' VAL . 49.7 tp -109.23 113.01 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.823 -0.626 . . . . 1.35 110.46 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.8 t -112.51 123.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.916 -0.584 . . . . 0.54 110.754 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.981 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.4 mt -88.64 131.65 34.89 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.744 -0.836 . . . . 0.65 108.744 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.894 HG21 HG12 ' A' ' 17' ' ' VAL . 8.8 t -139.05 148.91 43.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.867 0.365 . . . . 1.04 111.302 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.481 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 27.7 t70 -127.45 94.56 37.89 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.758 -0.655 . . . . 1.92 109.487 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.8 Cg_endo -50.79 -40.06 57.28 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 124.153 3.236 . . . . 1.25 113.799 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.756 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.8 m-20 -86.54 43.03 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.605 0.594 . . . . 1.29 112.605 -167.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.11 138.1 19.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.801 -0.181 . . . . 0.56 110.615 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 87.8 Cg_endo -83.28 -24.49 11.13 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.575 -1.427 . . . . 0.7 112.993 1.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.683 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.9 p -130.81 150.85 51.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.177 -0.465 . . . . 1.1 109.933 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.756 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 42.5 mtm105 -67.83 -23.55 65.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.934 -0.575 . . . . 3.39 111.878 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.657 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.6 -10.68 39.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 1.83 111.145 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 13.4 t70 -154.18 77.01 5.63 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.176 0.512 . . . . 1.37 110.116 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 81.5 Cg_endo -79.42 86.37 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.532 2.154 . . . . 0.9 112.363 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.483 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.6 mttm -70.67 -50.3 38.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.747 -1.115 . . . . 1.53 110.589 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.661 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.9 m-85 -82.05 20.93 0.94 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.453 -0.794 . . . . 1.54 111.437 -172.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.513 ' HB2' ' HB2' ' A' ' 79' ' ' PRO . 8.0 tmm_? -71.97 123.58 23.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.888 -0.412 . . . . 3.38 109.888 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 4.8 mp0 -100.08 135.95 40.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.895 0.379 . . . . 2.23 110.886 -0.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -79.38 146.52 32.8 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.977 -1.12 . . . . 1.77 107.977 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 47.0 p-80 -124.51 127.54 47.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 2.19 110.751 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.981 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.7 t60 -70.66 -37.15 73.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.906 -1.043 . . . . 2.74 110.219 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.4 p90 -168.36 173.61 7.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.01 -0.367 . . . . 2.21 110.01 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 103' ' ' LEU . 18.4 tp -134.95 113.98 12.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.087 -0.506 . . . . 0.68 109.776 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.71 132.64 70.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.671 -0.695 . . . . 0.35 110.627 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.874 HG11 HG21 ' A' ' 65' ' ' THR . 5.6 m -128.15 164.93 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.312 -0.996 . . . . 0.3 108.312 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.959 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.0 m-20 59.16 18.64 6.66 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 123.526 0.516 . . . . 2.09 111.096 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.64 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 8.3 ttm -70.12 110.01 4.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.34 108.588 176.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 19.4 ttmm -76.48 92.67 3.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.733 -1.121 . . . . 1.73 111.179 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.706 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.2 -123.13 6.75 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.853 -1.067 . . . . 0.35 112.898 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.659 ' HB3' HD22 ' A' ' 58' ' ' LEU . 26.1 p-10 -113.41 22.27 14.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.332 -0.434 . . . . 1.59 111.024 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.63 106.84 18.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.489 0.661 . . . . 0.77 109.919 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.6 mm -57.01 -30.66 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.307 -1.315 . . . . 0.45 111.274 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -82.87 -26.68 31.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 1.15 111.655 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -84.82 14.9 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 1.26 111.616 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.64 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -89.93 109.35 3.62 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.787 -0.72 . . . . 0.44 111.902 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.4 m -61.55 106.26 0.63 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.363 0.601 . . . . 1.06 109.549 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 p -85.8 121.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.257 -0.883 . . . . 1.15 111.414 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.555 HD12 ' HG ' ' A' ' 88' ' ' LEU . 18.4 mt -100.48 -43.13 6.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.012 0.911 . . . . 0.48 109.231 173.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 t -123.98 110.39 14.74 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.159 -1.423 . . . . 0.62 107.159 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.882 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -59.31 164.44 3.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.851 -0.613 . . . . 1.15 112.469 -171.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 11.0 p90 -80.76 98.27 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.414 -0.812 . . . . 4.98 110.231 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.796 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.6 t -67.33 -53.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.86 111.332 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.449 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 117.41 -162.53 12.87 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.551 -0.833 . . . . 0.95 112.312 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.959 ' HA ' ' HH ' ' A' ' 120' ' ' TYR . 29.0 t -77.72 117.56 19.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.919 -0.4 . . . . 0.89 109.919 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.582 ' HA3' HD21 ' A' ' 180' ' ' LEU . . . -143.47 57.04 0.55 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.699 -0.763 . . . . 0.82 112.461 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.747 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 1.4 Cg_endo -87.01 131.25 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.245 2.63 . . . . 1.01 112.346 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.674 ' HB2' HG21 ' A' ' 115' ' ' THR . 52.7 Cg_exo -56.74 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.207 1.938 . . . . 0.96 110.53 171.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.17 112.87 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 2.39 110.528 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.89 -6.38 19.97 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.842 -0.694 . . . . 1.3 112.121 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.683 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 78.4 p -83.92 -20.95 32.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.772 0.32 . . . . 1.04 111.318 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.77 -174.24 19.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.155 -0.545 . . . . 1.97 112.381 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.483 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 4.4 mm? -68.59 122.82 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.667 0.27 . . . . 0.94 110.726 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.747 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.8 m-70 -98.45 121.55 40.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.129 0.49 . . . . 2.85 110.207 176.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.714 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 1.6 ptt180 -107.13 94.11 4.92 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.083 -0.962 . . . . 2.78 111.461 -168.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.959 ' HH ' ' HA ' ' A' ' 109' ' ' SER . 33.6 m-85 -75.15 111.06 10.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.195 -0.669 . . . . 1.13 109.195 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.7 t -94.76 132.46 38.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.785 -0.643 . . . . 0.31 110.09 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.746 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 31.0 m95 -89.4 121.89 32.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.303 -0.629 . . . . 2.96 109.303 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 76.1 mt -116.47 117.5 30.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.159 0.436 . . . . 0.41 110.221 175.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.632 HG11 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -115.07 137.89 47.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.263 -0.273 . . . . 0.43 110.263 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.825 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 47.9 t80 -130.6 137.63 49.74 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.301 -0.259 . . . . 5.41 110.301 175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.414 ' CD ' ' HZ2' ' A' ' 62' ' ' LYS . 30.5 tt0 -91.71 105.07 17.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.227 -0.657 . . . . 2.41 109.227 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.98 175.1 9.87 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.428 0.632 . . . . 1.31 111.29 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.17 -29.27 66.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.103 -0.953 . . . . 2.4 109.231 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.922 ' HG3' ' HH ' ' A' ' 158' ' ' TYR . 10.9 ptt-85 -159.66 164.59 19.95 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.511 -1.222 . . . . 4.07 111.254 -172.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.586 ' HG3' HD11 ' A' ' 63' ' ' LEU . 31.4 Cg_exo -55.86 142.98 83.33 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.453 2.769 . . . . 1.21 112.916 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.573 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.0 mm? -68.97 154.43 42.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.567 0.951 . . . . 1.16 113.567 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.447 ' HE2' ' OD2' ' A' ' 134' ' ' ASP . 21.5 tptm -141.35 86.78 2.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.44 -1.255 . . . . 3.23 108.0 167.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.74 -46.42 8.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.774 -0.648 . . . . 2.79 112.678 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 132' ' ' LYS . 61.7 m-20 57.32 47.55 16.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 2.96 110.7 -174.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -99.43 146.92 32.61 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.539 -0.755 . . . . 1.39 109.973 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.73 106.19 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.133 2.555 . . . . 1.38 112.474 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.43 115.36 2.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.241 -0.436 . . . . 0.94 110.659 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.0 mt -109.38 147.52 32.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 1.61 110.203 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 58.0 m -109.32 36.64 2.85 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.572 -0.74 . . . . 1.88 110.38 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.882 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.8 OUTLIER 57.05 4.56 0.18 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.62 1.168 . . . . 1.33 113.041 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.553 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 83.9 mtt180 -97.39 136.27 38.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 3.83 110.819 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.608 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 53.7 m 77.46 118.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.582 -1.19 . . . . 1.32 111.147 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -89.42 34.08 4.12 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.169 -0.923 . . . . 1.13 112.426 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.68 -28.83 63.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.23 0.538 . . . . 2.66 110.597 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -119.87 68.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 2.18 110.852 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 78.5 mtt180 -75.52 -76.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.182 0.515 . . . . 5.37 111.063 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.4 -148.05 5.97 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.664 -0.779 . . . . 0.9 112.532 -174.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.661 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 68.25 17.76 9.28 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.51 0.671 . . . . 1.59 110.208 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -110.01 104.68 13.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.235 -0.893 . . . . 2.27 109.303 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -54.82 120.65 7.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.635 -0.711 . . . . 1.87 112.2 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.782 HG22 HG11 ' A' ' 17' ' ' VAL . 4.6 m -60.38 -30.1 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.611 -0.722 . . . . 0.96 110.705 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.12 -35.47 80.38 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.76 110.445 173.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.454 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 69.1 m -68.59 -33.96 74.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 1.22 110.306 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.694 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 58.1 m-85 -67.39 -43.66 80.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 1.1 110.44 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 21.4 ptt180 -69.53 -41.46 75.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.327 -0.397 . . . . 3.36 110.354 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 53.6 mtmt -62.61 -27.31 69.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.564 0.221 . . . . 1.52 111.416 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -53.61 -53.33 53.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 2.13 110.909 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.922 ' HH ' ' HG3' ' A' ' 129' ' ' ARG . 5.2 t80 -107.89 20.96 18.09 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.439 -0.904 . . . . 5.77 111.011 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.57 42.59 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.384 -0.825 . . . . 2.42 111.69 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.825 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.2 mp -90.77 155.27 18.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.265 -0.88 . . . . 1.27 109.751 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.929 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -122.87 -153.85 0.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.454 -0.573 . . . . 4.0 109.454 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.929 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -53.98 140.31 51.72 Favored Pre-proline 0 N--CA 1.456 -0.165 0 CA-C-O 121.168 0.509 . . . . 1.21 111.114 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.447 ' HG2' ' HG3' ' A' ' 21' ' ' PRO . 7.0 Cg_exo -70.65 170.7 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.981 3.121 . . . . 0.68 113.404 -167.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.933 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -92.8 -36.07 7.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 115.155 -0.929 . . . . 0.5 110.058 177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -144.84 144.21 31.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.153 -0.619 . . . . 0.29 111.962 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 150.8 23.1 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.813 -1.085 . . . . 0.24 112.093 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.943 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -167.82 152.57 6.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.403 -0.962 . . . . 0.34 108.403 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.704 ' HG ' ' HB2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -122.03 142.72 50.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.985 0.421 . . . . 2.16 111.091 -176.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.685 ' HB3' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -130.0 109.97 11.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 1.31 108.671 172.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -100.09 133.89 43.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.381 0.511 . . . . 2.53 112.381 -170.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.36 151.4 44.42 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.146 -0.934 . . . . 0.75 109.625 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -113.27 -64.29 1.33 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.516 0.932 . . . . 2.38 113.516 -173.039 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.756 ' HA ' HG23 ' A' ' 177' ' ' VAL . 12.8 t90 178.45 74.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.017 -0.364 . . . . 4.71 110.017 -176.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.918 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -72.48 -62.21 1.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.795 0.294 . . . . 1.53 111.795 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.572 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 32.0 t70 177.18 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.095 -0.502 . . . . 1.26 110.915 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.484 ' CD2' HG22 ' A' ' 44' ' ' THR . 11.2 m-30 -78.79 1.58 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.384 -0.371 . . . . 2.46 111.667 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 173' ' ' TRP . 72.7 t -67.57 -54.21 19.11 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.58 110.204 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.729 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.4 Cg_exo -51.4 -35.25 53.92 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.331 2.021 . . . . 0.68 112.35 170.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.671 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 26.3 mmmt -72.79 -24.75 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.848 0.314 . . . . 2.62 111.848 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.728 HD23 HG12 ' A' ' 107' ' ' VAL . 55.2 tp -70.49 -46.29 64.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.033 -0.729 . . . . 1.18 109.033 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.32 -37.98 79.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.559 -0.746 . . . . 2.11 109.331 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.671 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.0 mm-40 -56.18 -55.57 31.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.808 -1.087 . . . . 1.53 110.687 170.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -63.73 -33.35 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 2.16 112.333 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 76.4 mt -63.76 -1.14 1.23 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.4 0.519 . . . . 0.87 112.4 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.455 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.8 m -78.13 -2.81 39.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.444 0.64 . . . . 1.38 109.534 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.553 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 77.51 44.13 13.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.197 -0.911 . . . . 1.17 111.206 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.455 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.3 mmmt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.341 -0.837 . . . . 2.45 110.597 -174.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' ' HD2' ' A' ' 2' ' ' PRO . 39.2 tpp . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.989 -0.375 . . . . 5.4 109.989 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.496 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 55.3 Cg_exo -54.52 113.68 1.48 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.353 2.702 . . . . 2.58 112.757 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 24' ' ' PRO . 3.5 t 67.29 113.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.101 -0.954 . . . . 2.1 111.725 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 27.9 t70 -152.84 157.7 41.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.57 -0.9 . . . . 1.81 108.57 176.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.44 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.8 mm? -79.18 28.85 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.667 0.27 . . . . 0.95 110.804 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 4' ' ' ASP . 7.9 m -62.96 -29.12 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 2.19 111.18 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 12' ' ' LEU . 90.5 mttt -124.51 50.84 1.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.158 -0.474 . . . . 3.07 110.231 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.613 ' HD1' ' HG3' ' A' ' 15' ' ' GLN . 4.8 p90 -71.61 -38.65 70.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 4.76 111.453 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.69 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 73.9 p -142.9 24.14 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.98 111.451 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.516 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.25 -125.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.15 -0.78 . . . . 0.52 111.15 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.7 Cg_endo -51.11 -40.62 59.62 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 123.326 2.684 . . . . 0.61 110.049 168.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 38' ' ' GLY . 36.4 mt -88.71 78.25 7.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.688 -1.142 . . . . 1.85 109.319 169.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 1.2 m -73.72 64.1 0.91 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.547 0.689 . . . . 1.31 109.907 176.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.788 HD11 ' HG ' ' A' ' 168' ' ' CYS . 12.0 mt -79.73 -30.18 40.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.551 -0.749 . . . . 0.61 110.39 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.69 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 74.7 mm-40 -73.74 16.13 0.23 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.915 0.709 . . . . 2.61 112.915 -175.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.7 mt-10 -82.63 -13.53 56.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.851 -0.796 . . . . 1.93 108.851 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.893 HG11 HG22 ' A' ' 151' ' ' VAL . 49.0 t -85.36 -74.92 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 114.878 -1.055 . . . . 1.26 111.525 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -122.09 -157.91 0.75 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.178 -0.465 . . . . 2.99 111.14 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -87.15 151.26 23.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 1.6 110.445 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 40.7 mt-30 -67.12 126.15 92.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.934 -0.395 . . . . 4.38 109.934 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -73.23 159.41 47.21 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.214 1.943 . . . . 0.69 111.824 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.915 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 21.0 pt20 -74.62 -13.45 60.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.74 -0.664 . . . . 1.87 111.491 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.784 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 3.1 m80 -160.93 164.57 18.8 Favored Pre-proline 0 CA--C 1.519 -0.249 0 CA-C-O 121.016 0.436 . . . . 2.35 110.83 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.689 ' HB2' HG13 ' A' ' 3' ' ' VAL . 3.6 Cg_endo -85.82 131.14 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.487 2.792 . . . . 0.44 111.438 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.84 HD21 ' HB3' ' A' ' 122' ' ' TRP . 25.6 tp -80.52 143.58 33.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.691 0.282 . . . . 0.33 111.457 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.485 ' H ' HD12 ' A' ' 25' ' ' LEU . 63.2 m-70 -110.07 123.98 50.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.753 -0.462 . . . . 2.12 109.753 172.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 53' ' ' ILE . 14.8 t -130.37 134.93 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.072 -0.714 . . . . 1.12 109.072 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.433 HG22 ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -127.37 140.64 52.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.093 0.473 . . . . 0.78 110.435 -177.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.543 ' HH ' ' H ' ' A' ' 48' ' ' ASN . 25.2 t80 -103.12 172.67 6.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.541 -0.54 . . . . 1.23 109.541 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.8 67.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.492 0.663 . . . . 0.6 110.678 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.43 4.33 33.02 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.316 -0.856 . . . . 0.81 112.753 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.44 -168.54 3.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.56 110.472 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.36 149.95 14.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.977 -0.556 . . . . 0.35 109.905 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.72 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -105.29 60.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.167 -1.42 . . . . 0.39 107.167 166.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.27 25.63 5.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.0 0.905 . . . . 0.99 109.921 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.684 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 16.9 tt0 -148.31 128.0 13.34 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.833 -1.076 . . . . 2.56 108.582 167.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.634 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -69.62 111.41 5.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 0.46 109.546 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.88 16.47 59.63 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.83 -0.623 . . . . 0.59 113.029 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.72 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.91 149.28 41.55 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.507 -0.553 . . . . 1.04 109.507 174.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.41 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 14.4 p -75.54 132.77 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 1.16 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.9 tp -131.92 170.59 14.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.93 -0.767 . . . . 0.45 108.93 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -122.94 152.18 62.42 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 179.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.744 ' HG3' ' HG ' ' A' ' 109' ' ' SER . 87.8 Cg_exo -50.93 -46.47 30.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.319 2.679 . . . . 1.0 113.981 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.49 -31.65 64.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 1.24 111.75 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -83.71 -10.73 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.815 -0.629 . . . . 1.74 112.113 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.541 ' CG1' HD21 ' A' ' 41' ' ' LEU . 30.4 m -131.72 30.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.547 0.689 . . . . 1.1 111.007 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.612 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.73 -29.21 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 1.32 110.854 -174.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.543 ' H ' ' HH ' ' A' ' 29' ' ' TYR . 10.6 m120 -114.83 -173.21 2.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 2.4 110.225 174.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.16 155.41 87.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.15 -0.315 . . . . 1.78 110.15 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.44 155.66 28.43 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.799 1.666 . . . . 0.41 110.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -78.47 -23.31 46.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.238 -0.282 . . . . 0.88 110.238 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.433 ' C ' HG21 ' A' ' 53' ' ' ILE . 72.1 m -159.79 147.23 16.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.65 112.083 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.658 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.57 170.21 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.283 -0.871 . . . . 0.33 108.973 172.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.713 ' HA ' HD11 ' A' ' 58' ' ' LEU . 29.2 t 179.52 116.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.406 0.622 . . . . 0.8 109.631 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.545 ' CG ' HG21 ' A' ' 124' ' ' VAL . 1.2 p90 -100.85 -171.2 1.96 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.226 -0.897 . . . . 3.63 110.116 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HB3' HG11 ' A' ' 164' ' ' VAL . 22.1 t0 -69.61 119.58 14.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.005 0.431 . . . . 1.51 111.004 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.24 34.48 54.87 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.742 -0.742 . . . . 0.9 112.656 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.713 HD11 ' HA ' ' A' ' 54' ' ' SER . 4.3 tt -67.53 125.41 26.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.919 -0.771 . . . . 0.62 108.919 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.668 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 23.9 t70 -89.85 -12.79 38.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.74 110.884 -173.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.664 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 54.3 m 62.13 20.81 11.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.948 -1.024 . . . . 1.51 109.558 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -153.86 -24.4 0.04 OUTLIER Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.866 -0.683 . . . . 0.84 113.852 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.668 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 45.4 mtpt -77.0 156.82 31.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.661 0.731 . . . . 2.12 109.904 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.707 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 37.2 mt -94.0 125.17 38.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.947 -0.76 . . . . 1.23 108.947 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.9 m-85 -125.03 156.94 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.745 -0.382 . . . . 1.61 110.002 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.627 HG22 HG11 ' A' ' 90' ' ' VAL . 46.7 m -98.07 110.98 23.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.547 . . . . 0.87 109.522 175.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.0 tp -107.48 109.75 21.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.177 -0.465 . . . . 1.35 109.753 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.3 t -117.93 120.81 65.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.54 111.112 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.843 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.5 mt -83.22 145.96 28.85 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.947 -0.76 . . . . 0.65 108.947 168.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.744 HG21 HG12 ' A' ' 17' ' ' VAL . 10.5 t -146.46 145.69 30.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.683 0.278 . . . . 1.04 110.936 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.503 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 28.2 t70 -125.59 98.37 34.68 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 1.92 109.421 174.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.505 ' HB3' HG21 ' A' ' 17' ' ' VAL . 9.4 Cg_endo -50.32 -38.04 51.48 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 124.135 3.224 . . . . 1.25 114.216 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.586 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 71.3 m-20 -103.59 54.18 0.75 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.293 0.568 . . . . 1.29 111.928 -165.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 81' ' ' TYR . . . -104.64 137.12 19.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.56 109.864 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 63.6 Cg_endo -74.44 -30.27 6.08 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.682 -1.383 . . . . 0.7 113.268 1.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.533 ' HB3' HG22 ' A' ' 115' ' ' THR . 33.6 p -137.88 165.95 25.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.589 -0.278 . . . . 1.1 110.877 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.586 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 29.2 mtp180 -68.04 -36.61 80.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 3.39 110.851 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.715 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -76.13 -12.68 60.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.53 . . . . 1.83 111.711 -176.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.549 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.3 t70 -154.93 77.56 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 1.37 110.258 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.92 97.54 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.608 2.205 . . . . 0.9 112.885 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 26.4 mttm -85.52 -48.41 8.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.848 -1.069 . . . . 1.53 110.197 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.656 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 87.4 m-85 -79.99 14.16 1.94 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.145 -0.934 . . . . 1.54 111.55 -171.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.0 ttt85 -66.83 125.14 24.95 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.991 0.367 . . . . 3.38 111.991 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.797 ' HG2' HG13 ' A' ' 17' ' ' VAL . 6.2 mp0 -95.45 140.15 30.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.671 0.388 . . . . 2.23 110.154 -5.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.509 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 14.4 t90 -86.4 91.15 8.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.529 . . . . 1.77 110.106 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.7 p80 -63.16 130.43 44.56 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.419 -0.586 . . . . 2.19 109.419 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.843 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.9 t60 -79.22 -31.88 43.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.898 -0.592 . . . . 2.74 110.958 -173.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.638 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 28.7 p90 -168.42 178.56 4.79 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.198 -0.668 . . . . 2.21 109.198 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.1 tp -140.39 113.56 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.388 . . . . 0.68 110.064 175.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.638 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.7 t -122.77 130.32 74.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.592 -0.731 . . . . 0.35 110.707 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.627 HG11 HG22 ' A' ' 65' ' ' THR . 13.4 m -133.62 165.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.986 -1.006 . . . . 0.3 108.496 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.707 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.2 t30 63.54 13.37 7.17 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.024 -0.361 . . . . 2.09 110.024 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.568 ' HE2' ' HA3' ' A' ' 100' ' ' GLY . 7.9 ttm -67.67 101.98 1.12 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.603 -0.888 . . . . 0.34 108.603 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.8 ttmm -80.74 92.87 6.1 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.096 -1.411 . . . . 1.73 110.982 -170.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.664 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 78.13 -130.38 10.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.913 -1.039 . . . . 0.35 112.668 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.636 ' HB3' HD22 ' A' ' 58' ' ' LEU . 25.8 p-10 -109.92 24.43 13.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.21 0.528 . . . . 1.59 110.735 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.98 107.11 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.835 -0.621 . . . . 0.77 109.951 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.464 ' HA ' ' HE3' ' A' ' 92' ' ' MET . 4.5 mm -56.37 -32.71 36.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.573 -1.194 . . . . 0.45 110.856 -177.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.3 m -73.01 -26.41 61.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.748 -0.66 . . . . 1.15 112.002 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.7 m -78.44 -6.56 55.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 1.26 111.42 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.568 ' HA3' ' HE2' ' A' ' 92' ' ' MET . . . -76.42 102.42 1.61 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.645 -0.788 . . . . 0.44 112.11 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.1 m -68.46 107.99 3.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.464 0.65 . . . . 1.06 109.655 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -79.57 119.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.892 -1.049 . . . . 1.15 112.102 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.14 -39.12 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.03 0.919 . . . . 0.48 109.159 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.7 t -128.08 114.79 17.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.257 -1.386 . . . . 0.62 107.257 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.445 ' HA ' HG21 ' A' ' 102' ' ' VAL . 6.9 t0 -63.01 161.72 12.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.569 0.699 . . . . 1.15 112.784 -168.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -91.09 93.91 9.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.984 -1.007 . . . . 4.98 109.318 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.867 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 54.5 t -71.02 -46.18 68.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.167 0.508 . . . . 0.86 111.89 -176.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.423 ' HA3' ' NZ ' ' A' ' 47' ' ' LYS . . . 115.86 -177.94 17.31 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.358 -0.925 . . . . 0.95 112.294 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.744 ' HG ' ' HG3' ' A' ' 43' ' ' PRO . 30.8 t -64.13 122.37 16.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.551 0.176 . . . . 0.89 111.336 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.43 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -142.72 63.87 0.5 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.051 -0.595 . . . . 0.82 111.908 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.728 ' HD2' HG22 ' A' ' 177' ' ' VAL . 43.9 Cg_endo -97.7 121.9 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.504 2.803 . . . . 1.01 112.673 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.501 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 50.7 Cg_exo -54.5 154.37 20.02 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.63 2.22 . . . . 0.96 111.736 173.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -72.02 131.04 42.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.433 . . . . 2.39 111.146 -175.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.03 14.88 73.88 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.772 -0.649 . . . . 1.3 113.163 175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 75' ' ' SER . 35.5 p -77.73 -15.37 59.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.672 0.619 . . . . 1.04 112.672 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 103.92 13.02 28.46 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.141 -1.028 . . . . 1.97 112.823 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.0 mm? 76.94 105.08 0.07 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 124.604 0.826 . . . . 0.94 111.142 177.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 5.0 m170 -66.66 121.23 14.93 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.383 -0.826 . . . . 2.85 110.044 175.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 13.1 ptp180 -116.3 80.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.832 0.825 . . . . 2.78 110.364 -175.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.485 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 7.3 m-85 -63.69 120.26 11.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.289 -1.323 . . . . 1.13 109.688 -177.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 168' ' ' CYS . 24.6 t -97.94 131.68 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.107 -0.497 . . . . 0.31 110.511 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.84 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.51 119.68 30.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.586 -0.733 . . . . 2.96 110.057 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -116.77 123.77 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.481 -0.192 . . . . 0.41 110.481 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.545 HG21 ' CG ' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -122.47 137.64 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.577 0.227 . . . . 0.43 111.098 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.996 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 17.7 t80 -136.66 140.65 42.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.085 -0.339 . . . . 5.41 110.085 171.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 7.3 pt-20 -89.06 112.32 23.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.197 0.522 . . . . 2.41 109.75 171.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.567 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -73.16 172.39 11.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.31 110.013 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.98 -18.43 53.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.218 -0.901 . . . . 2.4 109.408 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.425 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 11.4 ptt-85 -158.28 162.22 27.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.9 -1.046 . . . . 4.07 111.67 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.52 ' HG3' HD11 ' A' ' 63' ' ' LEU . 26.0 Cg_exo -57.74 140.83 94.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.274 2.649 . . . . 1.21 111.575 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.623 ' HG ' HG12 ' A' ' 90' ' ' VAL . 3.2 mm? -64.57 143.72 57.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.156 0.503 . . . . 1.16 111.817 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -129.32 61.46 1.54 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.232 -1.025 . . . . 3.23 108.232 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.958 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 86.2 m -77.22 -55.42 5.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.253 -1.34 . . . . 2.79 111.52 -172.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 60.85 35.02 19.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.292 0.568 . . . . 2.96 110.195 -172.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.958 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 59.0 mm-40 -77.62 137.23 63.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 108.616 -0.883 . . . . 1.39 108.616 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.78 106.95 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.273 2.649 . . . . 1.38 112.728 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.1 mm -61.94 115.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.94 110.546 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -104.43 149.28 25.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.267 0.556 . . . . 1.61 110.352 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 162.39 13.53 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.416 -0.957 . . . . 1.88 108.416 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.867 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.2 p-10 -77.49 16.84 0.58 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.98 0.419 . . . . 1.33 111.45 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.681 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 54.0 mtt180 -104.8 136.75 43.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.663 -0.495 . . . . 3.83 109.663 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.591 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 49.3 m 77.27 117.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.18 0.992 . . . . 1.32 111.232 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -106.29 41.56 2.14 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.301 -0.863 . . . . 1.13 112.794 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.614 ' HB3' ' HD1' ' A' ' 145' ' ' HIS . 14.1 t70 -72.25 -47.82 47.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 2.66 109.78 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.614 ' HD1' ' HB3' ' A' ' 144' ' ' ASP . 14.4 m80 -97.63 54.35 1.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.633 -1.167 . . . . 2.18 110.672 -173.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.509 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 76.9 mtt180 -69.71 -77.29 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 5.37 111.017 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -120.74 -143.05 6.66 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.792 -0.718 . . . . 0.9 112.478 -174.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.656 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 67.36 18.51 10.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.963 0.887 . . . . 1.59 109.769 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.18 105.58 13.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.397 -1.274 . . . . 2.27 108.223 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -59.99 129.88 43.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.189 -0.459 . . . . 1.87 111.81 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.893 HG22 HG11 ' A' ' 17' ' ' VAL . 17.1 m -64.39 -24.92 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.96 110.306 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB3' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -44.41 90.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.431 -0.804 . . . . 0.76 109.599 172.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -61.39 -40.53 94.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 1.22 111.033 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.594 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 37.2 m-85 -58.3 -53.94 52.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.435 . . . . 1.1 111.396 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -70.76 -45.42 64.79 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.98 -0.288 . . . . 3.36 111.217 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.506 ' HE2' ' HB3' ' A' ' 152' ' ' ALA . 58.8 mtmt -62.17 -25.95 68.06 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.724 0.297 . . . . 1.52 111.356 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.48 -52.76 58.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 2.13 111.053 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 12.4 t80 -102.14 18.64 20.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.88 -0.728 . . . . 5.77 110.541 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.66 38.38 5.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.354 -0.839 . . . . 2.42 111.948 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.996 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.0 mp -88.76 148.78 23.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.875 -0.602 . . . . 1.27 109.703 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.521 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 13.2 tpt180 -117.91 -152.15 0.5 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.468 -0.333 . . . . 4.0 110.126 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.521 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -56.0 143.97 60.27 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-O 120.989 0.424 . . . . 1.21 111.278 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.695 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 4.8 Cg_exo -73.2 159.88 46.4 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.876 3.05 . . . . 0.68 113.723 -170.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.915 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 11.8 t -81.34 -31.02 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.086 -0.961 . . . . 0.5 109.751 173.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.784 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -156.95 148.76 22.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.053 -0.659 . . . . 0.29 111.855 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.676 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 147.04 17.64 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.24 111.349 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.634 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.0 t -160.58 149.6 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.969 -0.752 . . . . 0.34 108.969 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.788 ' HG ' HD11 ' A' ' 14' ' ' LEU . 15.4 p -126.9 149.02 49.99 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.894 -0.722 . . . . 2.16 111.589 -175.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.671 ' HB3' HG22 ' A' ' 34' ' ' VAL . 46.2 p90 -129.08 127.61 41.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.887 -1.153 . . . . 1.31 107.887 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.648 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.65 133.01 50.21 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.045 -0.662 . . . . 2.53 110.07 178.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -120.82 141.75 50.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.75 112.199 -170.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' A' ' 117' ' ' LEU . 46.2 mt-10 -89.21 -173.1 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.809 -1.087 . . . . 2.38 111.617 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.709 ' HA ' HG23 ' A' ' 177' ' ' VAL . 55.7 t90 -98.3 75.65 2.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.361 -0.977 . . . . 4.71 108.361 175.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.419 ' HB3' HG22 ' A' ' 42' ' ' THR . 7.2 p-10 -73.13 -57.19 4.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.386 -0.37 . . . . 1.53 111.906 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.524 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.8 t70 179.44 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.118 0.567 . . . . 1.26 110.335 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -81.34 0.78 35.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 2.46 112.113 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.788 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 93.2 t -67.88 -54.66 15.93 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.342 -0.244 . . . . 0.58 110.342 174.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.788 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.3 Cg_exo -53.83 -43.06 61.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.504 2.136 . . . . 0.68 111.949 171.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.677 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.3 mmmm -70.83 -24.3 62.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 2.62 111.561 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.69 HD12 HG12 ' A' ' 107' ' ' VAL . 61.9 tp -66.99 -47.85 70.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 1.18 109.529 172.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.61 -37.76 87.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.66 -0.7 . . . . 2.11 109.445 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.3 mm-40 -56.56 -44.87 81.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.932 -1.031 . . . . 1.53 110.842 172.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.96 -29.85 65.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.745 . . . . 2.16 111.497 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.591 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.2 mt -64.85 -8.66 16.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.934 0.346 . . . . 0.87 111.934 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.484 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 66.6 m -73.91 -3.11 26.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 1.38 110.364 172.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.681 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.54 58.04 6.2 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.826 -0.91 . . . . 1.17 110.826 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.9 mmmt . . . . . 0 C--O 1.241 0.654 0 CA-C-O 118.651 -0.69 . . . . 2.45 111.304 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 3.7 p . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.336 0.589 . . . . 1.47 109.673 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.3 155.92 34.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.784 -0.644 . . . . 1.8100000000000001 109.953 -168.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.491 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -72.67 2.21 6.95 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 112.331 0.493 . . . . 0.69999999999999996 112.331 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 m -55.91 -21.85 22.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.77 0.319 . . . . 1.96 111.755 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -101.13 27.6 5.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.563 -0.289 . . . . 2.6600000000000001 110.701 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.576 ' HE3' ' HB2' ' A' ' 20' ' ' GLN . 5.1 p-90 -70.64 -28.44 64.81 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.639 0.607 . . . . 3.98 112.639 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -144.96 14.59 1.51 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.713 -0.395 . . . . 0.63 111.139 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.63 -115.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.483 -0.647 . . . . 0.47999999999999998 111.483 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.1 Cg_endo -51.28 -46.2 32.69 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.356 2.704 . . . . 0.53000000000000003 110.925 167.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.707 HD11 ' HA3' ' A' ' 38' ' ' GLY . 11.5 mt -88.97 103.44 16.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.15 -0.932 . . . . 1.1699999999999999 110.125 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.18 65.35 4.33 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.257 0.551 . . . . 0.70999999999999996 110.546 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.816 HD22 HG21 ' A' ' 121' ' ' VAL . 15.5 mt -76.16 -15.05 60.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.543 . . . . 0.45000000000000001 110.45 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -66.73 -8.46 28.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 2.1200000000000001 111.308 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.468 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 9.4 mt-10 -81.85 -7.62 59.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.235 -0.439 . . . . 1.9299999999999999 110.107 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.733 HG11 HG21 ' A' ' 69' ' ' THR . 53.3 t -124.88 -61.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 0.63 111.389 -175.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -125.2 169.34 12.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.678 -0.409 . . . . 2.9900000000000002 110.404 -172.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -90.5 25.37 2.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 1.6000000000000001 111.799 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.576 ' HB2' ' HE3' ' A' ' 8' ' ' TRP . 1.6 tt0 67.05 120.48 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 O-C-N 124.151 0.907 . . . . 3.5499999999999998 110.986 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 19.2 Cg_exo -65.17 158.37 52.46 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.403 2.069 . . . . 0.57999999999999996 112.124 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.857 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.4 pt20 -73.42 -16.19 61.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 1.3899999999999999 111.034 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.774 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 21.2 m80 -149.36 156.43 39.59 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.691 -0.686 . . . . 1.45 109.565 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 6.3 Cg_endo -87.28 126.66 2.35 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.891 2.394 . . . . 0.40000000000000002 110.97 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.2 tp -75.92 140.44 42.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.791 0.329 . . . . 0.28999999999999998 110.916 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -106.04 119.74 39.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 1.24 109.625 173.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.882 HG13 HG22 ' A' ' 53' ' ' ILE . 21.8 t -126.17 138.19 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.995 -0.742 . . . . 0.46999999999999997 108.995 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -136.74 136.95 39.4 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.026 0.441 . . . . 0.31 110.655 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 60.9 t80 -99.65 169.3 9.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.315 -0.624 . . . . 0.67000000000000004 109.315 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.86 65.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.471 0.653 . . . . 0.55000000000000004 110.488 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.651 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -116.03 20.06 13.19 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.028 -0.987 . . . . 0.81000000000000005 112.673 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 45' ' ' GLN . . . -154.36 -170.5 3.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.845 0.355 . . . . 0.46999999999999997 110.416 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.92 159.76 24.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.33000000000000002 109.82 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.722 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.1 t -122.4 63.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.253 -1.388 . . . . 0.39000000000000001 107.253 166.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.4 t70 -100.27 19.89 15.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.154 -0.93 . . . . 0.98999999999999999 109.808 -173.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 44.5 mt-10 -144.05 131.1 20.54 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.09 -0.959 . . . . 2.5600000000000001 108.593 172.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -74.66 111.33 9.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.416 0.627 . . . . 0.40999999999999998 110.272 -172.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.707 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 80.53 21.27 64.6 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.295 -0.866 . . . . 0.58999999999999997 111.89 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.722 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.26 149.76 44.23 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.474 -0.565 . . . . 0.34000000000000002 109.474 175.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.96 127.81 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.267 0.555 . . . . 0.55000000000000004 110.54 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.597 HD22 HG22 ' A' ' 34' ' ' VAL . 8.9 tp -131.18 169.12 16.36 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.634 -0.876 . . . . 0.45000000000000001 108.634 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.82 151.81 58.22 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 120.582 -0.447 . . . . 0.56000000000000005 111.535 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.639 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 63.3 Cg_exo -53.64 -39.6 82.48 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.017 2.478 . . . . 0.68000000000000005 112.075 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -35.24 61.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.109 -0.496 . . . . 0.76000000000000001 111.404 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 44.9 mt-30 -82.79 -23.14 33.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 1.5900000000000001 112.125 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.569 ' HB ' ' OH ' ' A' ' 106' ' ' TYR . 30.0 m -119.88 30.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.195 0.521 . . . . 0.66000000000000003 112.169 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 6.31 21.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.955 0.407 . . . . 0.79000000000000004 111.089 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 36.4 m-20 -148.59 172.88 13.81 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.509 -0.552 . . . . 1.9099999999999999 109.509 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -62.77 149.4 89.59 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 110.017 -0.364 . . . . 1.4299999999999999 110.017 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.64 145.7 23.4 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.963 1.775 . . . . 0.37 110.266 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -18.7 62.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.491 -0.322 . . . . 0.44 110.728 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.2 m -159.66 144.7 15.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.872 0.694 . . . . 0.38 112.872 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.882 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.39 164.79 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.705 -1.134 . . . . 0.29999999999999999 108.041 170.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.076 ' HA ' HD13 ' A' ' 58' ' ' LEU . 28.9 t 176.17 122.26 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.764 -0.458 . . . . 0.34999999999999998 109.764 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.7 p-90 -81.0 166.67 20.59 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.757 -0.831 . . . . 2.7200000000000002 108.757 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.425 ' HB3' ' CG ' ' A' ' 23' ' ' HIS . 17.1 t70 -65.64 83.06 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 1.51 111.081 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.92 31.48 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.655 -0.702 . . . . 0.80000000000000004 112.319 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.076 HD13 ' HA ' ' A' ' 54' ' ' SER . 8.4 tt -66.33 129.05 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.008 0.432 . . . . 0.57999999999999996 111.062 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.797 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.5 t70 -77.75 -29.92 51.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.854 -0.612 . . . . 0.73999999999999999 112.078 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.693 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 74.8 m 76.76 -6.12 2.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.096 -0.956 . . . . 1.03 110.926 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.22 6.64 14.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.155 -0.545 . . . . 0.83999999999999997 112.39 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.797 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.8 mtpt -100.69 152.53 20.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.015 0.436 . . . . 1.6699999999999999 111.093 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.774 HD21 ' HE2' ' A' ' 93' ' ' LYS . 44.2 mt -97.25 130.98 44.39 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.557 -0.905 . . . . 0.57999999999999996 108.557 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.722 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.2 OUTLIER -130.2 163.94 25.6 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.636 -0.505 . . . . 0.80000000000000004 109.636 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.609 HG23 HG12 ' A' ' 90' ' ' VAL . 75.2 m -102.32 104.82 15.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.459 -0.571 . . . . 0.35999999999999999 109.459 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.745 HD13 HG12 ' A' ' 124' ' ' VAL . 43.7 tp -102.49 115.33 30.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.124 0.488 . . . . 0.58999999999999997 110.527 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 88' ' ' LEU . 23.3 t -120.88 129.04 76.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.713 -0.676 . . . . 0.39000000000000001 111.06 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.889 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.3 mt -83.37 136.76 34.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 0.59999999999999998 108.478 167.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.733 HG21 HG11 ' A' ' 17' ' ' VAL . 15.1 t -140.27 163.69 32.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.205 -0.294 . . . . 0.35999999999999999 110.205 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 17.7 t70 -155.95 103.27 2.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.304 0.573 . . . . 1.9199999999999999 110.858 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.724 ' HD3' HG21 ' A' ' 17' ' ' VAL . 12.4 Cg_endo -56.98 -34.89 98.45 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.65 2.9 . . . . 1.25 114.169 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.56 38.87 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.986 0.365 . . . . 1.29 111.986 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' CB ' ' HB2' ' A' ' 84' ' ' TRP . . . -104.68 127.62 28.53 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 111.488 0.181 . . . . 0.5 111.488 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 92.9 Cg_endo -85.12 -24.03 10.8 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.435 -1.485 . . . . 0.62 112.859 -0.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.571 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.9 p -135.4 154.85 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.032 -0.531 . . . . 0.75 110.09 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -72.15 -24.6 61.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.388 -0.369 . . . . 2.8799999999999999 111.134 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 3.2 ptpt -72.03 -21.86 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 1.3799999999999999 110.535 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.22 86.88 1.01 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.306 -0.861 . . . . 1.3700000000000001 109.24 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -86.38 86.65 0.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.509 2.139 . . . . 0.80000000000000004 112.507 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 22.2 mttm -70.98 -53.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.936 -1.483 . . . . 1.02 111.689 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.81 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 85.2 m-85 -78.28 12.07 2.08 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.894 -0.594 . . . . 1.1699999999999999 111.027 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 24.2 ttt180 -73.15 125.42 27.67 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.8 0.44 . . . . 2.9300000000000002 110.267 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.512 ' OE1' ' HA ' ' A' ' 150' ' ' LYS . 23.1 mt-10 -94.84 134.33 37.59 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.846 0.458 . . . . 2.23 110.457 2.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.761 ' HE1' ' HB2' ' A' ' 146' ' ' ARG . 4.8 t90 -89.34 91.12 8.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.939 -0.393 . . . . 1.4299999999999999 109.939 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 12.5 p80 -74.57 109.52 8.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.778 -0.823 . . . . 1.26 108.778 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.41 -8.47 54.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.803 -0.635 . . . . 2.1400000000000001 112.233 -168.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.889 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 30.3 t80 -166.29 142.93 5.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.06 -0.348 . . . . 1.51 110.06 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.675 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.6 tp -142.77 114.65 8.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.981 0.419 . . . . 0.33000000000000002 110.623 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.555 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -132.57 134.93 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.31 110.74 176.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.709 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 15.0 m -129.03 158.01 41.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.138 -1.06 . . . . 0.27000000000000002 108.138 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.689 ' OD1' ' HB3' ' A' ' 130' ' ' PRO . 6.1 t30 63.78 19.69 11.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.023 0.44 . . . . 1.76 109.925 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.555 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.0 ttm -67.4 106.9 2.24 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.781 -0.822 . . . . 0.31 108.781 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.774 ' HE2' HD21 ' A' ' 63' ' ' LEU . 13.2 ttmt -83.55 89.68 7.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.994 -1.003 . . . . 1.21 111.077 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 83.98 -126.26 7.49 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.636 -1.166 . . . . 0.29999999999999999 113.208 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.478 ' HA ' HD11 ' A' ' 53' ' ' ILE . 29.6 p30 -117.32 27.62 8.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.315 -0.442 . . . . 1.04 110.88 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -97.12 112.46 24.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.321 0.582 . . . . 0.77000000000000002 109.658 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 53' ' ' ILE . 5.1 mm -58.53 -26.44 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.408 -1.269 . . . . 0.40999999999999998 111.349 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 m -87.6 -31.34 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.117 -0.492 . . . . 0.68000000000000005 111.718 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.1 m -80.29 19.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.266 0.469 . . . . 1.26 112.266 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 92' ' ' MET . . . -102.61 114.11 4.79 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 111.189 -0.764 . . . . 0.34999999999999998 111.189 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 84.9 m -58.54 107.0 0.45 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.67 . . . . 0.45000000000000001 109.776 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.94 116.42 29.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.084 . . . . 0.56999999999999995 112.333 -172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.675 HD12 ' HG ' ' A' ' 88' ' ' LEU . 9.3 mt -98.61 -51.48 3.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.974 0.893 . . . . 0.45000000000000001 108.859 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.1 t -118.61 102.23 8.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.394 -1.275 . . . . 0.37 107.747 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HB3' ' N ' ' A' ' 140' ' ' ASN . 38.2 t0 -65.24 157.63 28.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.547 -0.751 . . . . 1.1499999999999999 112.323 -169.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.569 ' OH ' ' HB ' ' A' ' 46' ' ' VAL . 85.7 t80 -74.19 107.52 6.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.595 -0.729 . . . . 4.6900000000000004 109.172 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.4 t -84.69 -26.91 6.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.566 -0.743 . . . . 0.85999999999999999 112.242 -172.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.23 -174.41 19.7 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 111.13 -0.788 . . . . 0.67000000000000004 111.13 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.639 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.7 t -78.21 134.47 37.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.429 0.614 . . . . 0.51000000000000001 109.811 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.655 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -160.0 66.06 0.27 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.367 -0.444 . . . . 0.81999999999999995 112.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.898 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 46.4 Cg_endo -99.15 149.52 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.89 3.06 . . . . 0.84999999999999998 113.78 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.594 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 26.6 Cg_exo -64.07 143.32 84.24 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.074 2.516 . . . . 0.87 112.443 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 121.19 17.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 1.8500000000000001 110.823 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.46 15.11 30.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.86 -0.686 . . . . 1.1799999999999999 112.367 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.594 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 72.1 p -96.68 -1.19 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.947 0.403 . . . . 0.96999999999999997 111.028 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.36 -161.89 27.85 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.042 -0.823 . . . . 1.97 111.042 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.6 mm? -79.95 99.06 7.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.36 0.6 . . . . 0.93999999999999995 109.567 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -72.1 120.54 17.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.883 -1.053 . . . . 2.23 109.09 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.849 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp85 -121.96 99.76 6.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.914 0.709 . . . . 2.3100000000000001 112.914 -165.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.608 ' HB3' HD22 ' A' ' 68' ' ' LEU . 65.9 m-85 -82.09 129.39 34.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.444 -0.576 . . . . 0.78000000000000003 109.444 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.961 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.5 t -102.33 133.56 45.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.925 -0.579 . . . . 0.27000000000000002 109.719 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.694 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 67.2 m95 -88.32 119.59 28.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.754 -0.832 . . . . 1.99 108.754 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.26 118.77 32.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 117.797 0.271 . . . . 0.38 110.815 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.745 HG12 HD13 ' A' ' 66' ' ' LEU . 1.9 m -102.36 133.22 46.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.069 -0.652 . . . . 0.31 109.262 172.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 92.2 m-85 -106.84 155.68 19.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.875 0.369 . . . . 5.1200000000000001 111.084 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.596 ' HB2' HG22 ' A' ' 164' ' ' VAL . 12.3 tp10 -101.32 119.95 39.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.304 -0.862 . . . . 2.4100000000000001 110.833 -176.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.722 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -133.46 150.06 51.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.461 -0.791 . . . . 1.3100000000000001 109.991 174.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 129' ' ' ARG . 1.6 p30 -83.4 -12.47 56.42 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.183 -0.917 . . . . 2.3999999999999999 111.452 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.505 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . 65.9 mtp180 -135.9 163.06 53.08 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 3.5099999999999998 111.837 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.689 ' HB3' ' OD1' ' A' ' 91' ' ' ASN . 19.3 Cg_exo -71.85 24.71 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.806 1 C-N-CA 125.61 4.207 . . . . 1.21 115.833 -170.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.709 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? 71.99 -178.76 0.21 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.685 0.755 . . . . 0.90000000000000002 112.909 172.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -165.72 79.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.221 -1.354 . . . . 2.8999999999999999 108.896 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.415 ' HB2' HD11 ' A' ' 103' ' ' LEU . 63.0 m -101.94 115.89 31.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.705 . . . . 1.8999999999999999 110.33 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.44 19.52 8.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.534 -0.757 . . . . 2.96 110.485 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -66.08 125.24 89.76 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.562 -0.744 . . . . 1.3899999999999999 110.466 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.46 129.02 21.97 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.239 2.626 . . . . 1.27 112.713 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.31 116.66 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.43 . . . . 0.85999999999999999 110.34 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.9 mt -106.19 2.48 26.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.339 0.496 . . . . 1.6100000000000001 112.339 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.0 p 52.04 -157.66 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.536 0.522 . . . . 1.8799999999999999 110.009 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.674 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 5.2 p30 -98.01 -6.03 32.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.256 -0.646 . . . . 0.75 109.256 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.617 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 12.4 mtt180 -84.99 141.47 30.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.241 -0.436 . . . . 3.3599999999999999 110.352 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.572 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 30.5 m 72.66 125.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.219 0.949 . . . . 0.94999999999999996 111.103 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.501 ' HA2' ' CD ' ' A' ' 146' ' ' ARG . . . -107.53 -5.97 33.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.437 -0.801 . . . . 1.1200000000000001 113.006 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.94 -54.15 49.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.324 0.583 . . . . 2.6600000000000001 112.542 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.89 7.3 31.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.506 -0.77 . . . . 1.8700000000000001 111.672 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.761 ' HB2' ' HE1' ' A' ' 84' ' ' TRP . 28.1 mtp85 -88.84 -16.15 32.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.084 0.469 . . . . 4.7300000000000004 110.742 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -112.07 173.08 15.22 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.489 -0.863 . . . . 0.65000000000000002 112.485 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.4 mttt 69.61 36.55 2.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.841 0.829 . . . . 1.0800000000000001 110.836 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -123.09 172.4 8.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.809 -1.087 . . . . 1.8899999999999999 109.261 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.512 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 13.0 mmmm -117.26 133.0 56.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 1.29 111.932 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.755 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.6 m -67.35 -26.27 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.664 -0.698 . . . . 0.78000000000000003 110.005 173.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.36 -38.33 90.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.67000000000000004 109.627 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 m -63.78 -34.53 78.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.656 -0.702 . . . . 0.77000000000000002 110.462 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.755 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 59.7 m-85 -71.56 -47.5 54.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.92000000000000004 111.523 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 152' ' ' ALA . 6.9 ptm180 -66.9 -39.92 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.647 0.26 . . . . 2.8900000000000001 110.571 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -71.95 -25.78 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.607 -0.269 . . . . 0.96999999999999997 111.185 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 43.6 tptt -53.91 -52.92 59.02 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.355 -0.384 . . . . 1.5800000000000001 111.309 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.581 ' HD2' HD11 ' A' ' 160' ' ' LEU . 16.6 t80 -111.25 10.61 21.74 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.788 -0.765 . . . . 5.4500000000000002 111.322 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.8 39.34 4.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.035 -0.53 . . . . 2.4199999999999999 112.395 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 127' ' ' GLN . 0.2 OUTLIER -80.95 125.11 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.236 -0.653 . . . . 1.27 109.236 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.401 ' HB3' ' H ' ' A' ' 162' ' ' ALA . 8.0 tpt180 -60.32 -85.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 3.5899999999999999 111.874 -168.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 161' ' ' ARG . . . -135.66 160.9 65.9 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.721 -0.474 . . . . 0.76000000000000001 109.721 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.455 ' HB2' ' CA ' ' A' ' 21' ' ' PRO . 37.0 Cg_exo -58.44 142.24 97.74 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.68 2.254 . . . . 0.53000000000000003 112.748 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.857 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.6 t -88.42 -36.06 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 109.385 -0.598 . . . . 0.44 109.385 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.774 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.68 143.45 25.49 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.667 -0.697 . . . . 0.27000000000000002 111.232 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.9 145.59 14.81 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.055 -0.975 . . . . 0.23999999999999999 111.587 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.484 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 14.3 t -158.03 133.61 8.98 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.584 -0.525 . . . . 0.34000000000000002 109.584 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.961 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -107.24 141.9 37.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.213 0.53 . . . . 1.1100000000000001 111.418 -175.126 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 30.5 p90 -124.23 117.92 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.748 -1.204 . . . . 0.80000000000000004 107.748 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 2.8 pt20 -101.73 132.96 47.16 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.725 -0.79 . . . . 2.5299999999999998 111.103 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.427 ' HB1' ' HD3' ' A' ' 43' ' ' PRO . . . -149.91 145.89 26.76 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.561 -1.199 . . . . 0.59999999999999998 108.687 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.898 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 13.8 pt-20 -131.58 -160.3 1.03 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.697 -0.401 . . . . 2.3799999999999999 111.021 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.731 ' HA ' HG21 ' A' ' 177' ' ' VAL . 24.3 t90 -64.89 85.05 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.866 0.467 . . . . 3.96 111.38 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.611 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 8.5 p-10 -74.47 -59.12 2.87 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.361 -0.212 . . . . 1.53 110.757 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.5 t70 173.43 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.808 0.843 . . . . 1.26 109.897 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -81.97 -9.08 59.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 2.2200000000000002 111.64 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.743 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 69.2 t -54.67 -53.24 62.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 0.5 111.561 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.743 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.3 Cg_exo -49.7 -35.26 37.98 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.888 2.392 . . . . 0.57999999999999996 112.891 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 38.1 mmtm -74.47 -23.79 58.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.962 0.356 . . . . 2.1400000000000001 111.962 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.655 HD23 ' HA3' ' A' ' 110' ' ' GLY . 28.4 tp -70.76 -44.3 67.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.916 -0.772 . . . . 0.66000000000000003 108.916 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.03 -34.52 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.762 -0.654 . . . . 1.8899999999999999 109.242 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.686 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.5 mm-40 -56.48 -42.37 78.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.931 -1.031 . . . . 1.53 110.89 172.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -77.82 -38.0 47.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.572 -0.74 . . . . 1.49 112.41 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 21.5 mt -63.29 0.24 0.7 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 0.76000000000000001 113.479 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.407 ' HB2' ' CE ' ' A' ' 187' ' ' LYS . 12.8 m -67.58 -19.55 65.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.086 -0.709 . . . . 1.05 109.086 170.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 104.14 44.17 1.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.586 -1.006 . . . . 1.1699999999999999 110.586 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.407 ' CE ' ' HB2' ' A' ' 185' ' ' SER . 22.9 mmtp . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.563 -0.732 . . . . 2.0 109.832 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 36' ' ' GLU . 16.5 t . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.482 0.658 . . . . 1.47 110.522 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 6' ' ' SER . 20.1 t70 -148.98 157.71 43.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.35 -0.841 . . . . 1.8100000000000001 109.445 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.415 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.7 mm? -74.96 19.28 0.15 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 111.53 0.196 . . . . 0.69999999999999996 111.53 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 4' ' ' ASP . 27.5 t -68.67 -19.92 64.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 1.96 110.364 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.877 ' HB3' HD12 ' A' ' 12' ' ' LEU . 90.9 mttt -113.82 30.67 7.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.727 -0.67 . . . . 2.6600000000000001 110.597 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.625 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -72.88 -33.94 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.312 -0.404 . . . . 3.98 112.041 -173.252 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.798 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 36.5 p -150.21 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.673 -0.411 . . . . 0.63 111.894 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -79.73 -126.58 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.456 -0.878 . . . . 0.47999999999999998 110.946 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.9 Cg_endo -51.87 -36.43 63.38 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.219 2.613 . . . . 0.53000000000000003 110.214 166.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.877 HD12 ' HB3' ' A' ' 7' ' ' LYS . 40.7 mt -87.74 81.83 7.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.772 -1.103 . . . . 1.1699999999999999 109.282 170.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -74.73 63.13 1.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.474 0.654 . . . . 0.70999999999999996 110.703 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 ' CG2' ' A' ' 121' ' ' VAL . 33.8 mt -78.91 -21.62 47.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.548 -0.751 . . . . 0.45000000000000001 110.617 -176.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.798 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -73.18 6.88 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.587 -0.733 . . . . 2.1200000000000001 110.647 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -79.45 -22.51 44.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.428 0.633 . . . . 1.9299999999999999 110.091 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.907 HG11 HG21 ' A' ' 69' ' ' THR . 3.0 t -86.03 -65.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.63 110.669 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.88 -178.11 5.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.491 -0.484 . . . . 2.9900000000000002 111.095 -176.046 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -62.1 179.1 0.31 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.766 0.826 . . . . 1.6000000000000001 112.125 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG2' ' HD1' ' A' ' 8' ' ' TRP . 27.0 mt-30 -90.74 128.6 47.68 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.126 -0.488 . . . . 3.5499999999999998 110.128 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.603 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 10.1 Cg_exo -70.41 159.34 53.26 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.264 1.976 . . . . 0.57999999999999996 112.292 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.898 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 8.5 pt20 -77.48 -15.62 59.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.754 -0.657 . . . . 1.3899999999999999 111.153 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.776 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.8 m80 -153.02 159.73 31.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 1.45 110.089 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.8 Cg_endo -86.16 130.85 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.329 2.686 . . . . 0.40000000000000002 110.919 174.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 124' ' ' VAL . 29.9 tp -79.84 143.45 34.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.646 0.26 . . . . 0.28999999999999998 110.897 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -114.94 110.11 19.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 1.24 110.236 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 53' ' ' ILE . 17.0 t -114.71 146.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.546 -0.538 . . . . 0.46999999999999997 109.546 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.54 144.57 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.335 0.254 . . . . 0.31 110.819 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.478 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 36.3 t80 -110.41 173.99 6.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.268 -0.642 . . . . 0.67000000000000004 109.268 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.06 -52.88 63.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.451 0.643 . . . . 0.55000000000000004 110.398 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.24 -6.56 44.85 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.237 -0.892 . . . . 0.81000000000000005 112.724 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.02 -171.37 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.46999999999999997 110.831 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.68 154.7 16.23 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 109.999 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 88.2 t -101.56 63.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.548 -1.649 . . . . 0.39000000000000001 106.548 163.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.24 18.69 2.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.036 -1.438 . . . . 0.98999999999999999 110.163 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.555 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.3 mm-40 -159.7 142.12 13.57 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.457 -0.792 . . . . 2.5600000000000001 109.881 173.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -76.48 111.59 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.644 -0.873 . . . . 0.40999999999999998 108.644 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.715 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 86.7 20.93 52.79 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.666 -0.778 . . . . 0.58999999999999997 112.424 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.67 152.18 30.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.286 -0.635 . . . . 0.34000000000000002 109.286 172.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.6 p -81.78 136.77 22.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.182 0.515 . . . . 0.55000000000000004 110.975 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 41' ' ' LEU . 7.0 tp -131.11 169.03 16.44 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.057 -1.09 . . . . 0.45000000000000001 108.057 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.3 p -123.21 152.43 63.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 119.472 -0.891 . . . . 0.56000000000000005 113.129 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 75.9 Cg_exo -51.74 -33.92 51.98 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.608 3.539 . . . . 0.68000000000000005 114.05 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -65.4 -32.34 73.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.614 0.721 . . . . 0.76000000000000001 110.756 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -82.33 -43.91 16.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.012 -0.995 . . . . 1.5900000000000001 111.451 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.552 HG21 ' HE2' ' A' ' 169' ' ' TYR . 12.3 m -102.64 30.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.265 0.469 . . . . 0.66000000000000003 112.265 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.74 -12.05 59.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.465 -0.568 . . . . 0.79000000000000004 109.465 175.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -167.98 2.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.492 -0.776 . . . . 1.9099999999999999 109.836 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.423 ' HD3' HG22 ' A' ' 97' ' ' ILE . 98.6 mtt180 -77.94 158.78 77.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.088 -0.338 . . . . 1.4299999999999999 110.088 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 59.9 Cg_endo -79.23 161.44 26.05 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.996 1.797 . . . . 0.37 111.127 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.413 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.1 t -80.41 -22.4 41.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.55 -0.295 . . . . 0.44 110.363 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.4 m -162.68 143.51 9.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.391 0.615 . . . . 0.38 112.478 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.913 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -137.02 167.17 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.819 -1.082 . . . . 0.29999999999999999 108.274 170.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.066 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.6 t 175.91 128.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.34999999999999998 109.909 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 53.4 p-90 -91.07 160.91 15.35 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.519 -1.289 . . . . 2.7200000000000002 107.519 172.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.29 84.18 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.074 0.464 . . . . 1.51 111.092 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.92 17.44 2.79 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.401 -0.818 . . . . 0.80000000000000004 112.022 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.066 HD13 ' HA ' ' A' ' 54' ' ' SER . 5.4 tt -57.02 127.13 30.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.919 0.39 . . . . 0.57999999999999996 110.429 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.822 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 31.5 t70 -75.91 -24.21 55.57 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.608 . . . . 0.73999999999999999 112.01 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.665 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 67.2 m 68.89 15.35 8.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.278 -0.874 . . . . 1.03 110.422 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.55 -33.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.601 -0.727 . . . . 0.83999999999999997 112.666 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.822 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 24.7 mtpt -71.34 149.89 45.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 1.6699999999999999 110.72 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.904 HD23 ' HG2' ' A' ' 93' ' ' LYS . 3.8 mt -85.77 125.45 33.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.337 -0.847 . . . . 0.57999999999999996 109.494 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.475 ' HE2' ' HA2' ' A' ' 94' ' ' GLY . 5.5 m-85 -120.84 148.09 44.5 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.714 -0.394 . . . . 0.80000000000000004 110.436 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.63 HG23 HG12 ' A' ' 90' ' ' VAL . 62.7 m -96.89 104.97 17.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.35999999999999999 108.148 170.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.537 HD13 HG12 ' A' ' 124' ' ' VAL . 43.4 tp -104.39 109.09 20.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.668 -0.696 . . . . 0.58999999999999997 109.658 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' CD1' ' A' ' 88' ' ' LEU . 25.6 t -111.97 127.44 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.696 -0.684 . . . . 0.39000000000000001 110.429 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.021 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.3 mt -88.27 134.12 33.88 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.542 -0.91 . . . . 0.59999999999999998 108.542 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.907 HG21 HG11 ' A' ' 17' ' ' VAL . 9.7 t -137.58 156.45 48.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.459 -0.2 . . . . 0.35999999999999999 110.459 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.493 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 10.2 t70 -140.15 94.89 8.59 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.306 -0.628 . . . . 1.9199999999999999 109.306 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.5 Cg_endo -52.2 -36.68 68.03 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.722 2.948 . . . . 1.25 113.734 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.8 m-20 -89.32 43.83 1.17 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 1.29 111.542 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.68 139.28 19.94 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.446 -0.343 . . . . 0.5 110.143 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -80.18 -28.51 7.15 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 123.084 -1.632 . . . . 0.62 112.813 2.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.646 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 84.7 p -125.67 149.75 48.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.079 -0.51 . . . . 0.75 110.371 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.552 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 3.0 tmm_? -65.03 -28.91 69.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.419 0.628 . . . . 2.8799999999999999 109.651 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.0 ptpt -74.48 -21.06 59.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.848 -0.615 . . . . 1.3799999999999999 110.992 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.0 t70 -159.63 88.9 1.97 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.485 . . . . 1.3700000000000001 110.26 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 83.6 Cg_endo -84.37 93.63 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.67 2.247 . . . . 0.80000000000000004 113.234 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.5 mttm -83.9 -41.29 17.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.216 -0.902 . . . . 1.02 111.065 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.731 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 30.6 m-85 -78.98 8.47 5.57 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 116.032 -0.531 . . . . 1.1699999999999999 111.798 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -65.74 125.22 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.729 -0.471 . . . . 2.9300000000000002 109.729 177.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE1' HG13 ' A' ' 151' ' ' VAL . 5.1 tm-20 -93.12 134.13 35.59 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.49 0.716 . . . . 2.23 109.878 -0.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE3' ' HB3' ' A' ' 70' ' ' ASP . 80.7 t90 -108.67 131.08 55.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.63 -0.507 . . . . 1.4299999999999999 109.63 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 20.1 p80 -112.17 141.12 46.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.379 0.609 . . . . 1.26 111.328 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 1.021 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 7.2 t60 -82.6 -39.39 22.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.202 -0.908 . . . . 2.1400000000000001 110.884 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.584 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 20.3 p90 -167.16 173.18 9.3 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.601 -0.518 . . . . 1.51 109.601 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.529 ' HG ' HD12 ' A' ' 103' ' ' LEU . 16.6 tp -134.62 113.04 11.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.33000000000000002 110.178 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.637 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.8 t -121.25 132.11 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.641 -0.708 . . . . 0.31 110.146 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 6.2 m -129.71 162.94 36.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.084 -0.962 . . . . 0.27000000000000002 108.64 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.741 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 72.2 m-20 58.43 23.24 10.41 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.721 0.638 . . . . 1.76 111.418 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.637 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.4 ttm -73.84 102.69 4.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.1 -1.074 . . . . 0.31 108.1 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.904 ' HG2' HD23 ' A' ' 63' ' ' LEU . 2.8 mtpm? -77.1 93.77 3.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.265 -0.879 . . . . 1.21 110.951 -171.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 85.37 -127.63 8.32 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.542 -0.754 . . . . 0.29999999999999999 112.633 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 53' ' ' ILE . 2.5 p-10 -111.96 18.01 19.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.225 0.536 . . . . 1.04 110.551 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -81.5 99.88 9.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.621 . . . . 0.77000000000000002 110.07 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.423 HG22 ' HD3' ' A' ' 49' ' ' ARG . 5.0 mm -56.3 -30.17 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.774 -1.103 . . . . 0.40999999999999998 111.389 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 m -75.92 -42.56 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.084 -0.507 . . . . 0.68000000000000005 111.856 -172.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -79.93 8.16 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 1.26 111.712 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.95 102.06 1.1 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.881 -0.887 . . . . 0.34999999999999998 110.881 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.0 m -59.07 106.88 0.47 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.412 0.625 . . . . 0.45000000000000001 110.018 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.7 116.75 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.806 -1.088 . . . . 0.56999999999999995 111.327 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.529 HD12 ' HG ' ' A' ' 88' ' ' LEU . 41.8 mt -96.74 -37.49 10.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.036 0.922 . . . . 0.45000000000000001 109.213 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.8 t -127.9 115.5 18.68 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.386 -1.339 . . . . 0.37 107.386 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 16.5 t0 -65.32 161.3 19.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.764 -0.653 . . . . 1.1499999999999999 112.656 -168.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 24.0 p90 -85.46 61.91 7.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.383 -0.826 . . . . 4.6900000000000004 112.367 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.898 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 60.3 t -42.29 -49.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 114.294 1.22 . . . . 0.85999999999999999 114.294 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.39 -168.97 13.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.154 -1.022 . . . . 0.67000000000000004 113.048 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 35.8 t -78.77 147.93 33.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.363 -0.236 . . . . 0.51000000000000001 110.363 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.855 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 172.48 61.83 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 O-C-N 123.418 0.449 . . . . 0.81999999999999995 112.36 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.783 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 9.4 Cg_endo -91.9 132.44 1.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.111 2.541 . . . . 0.84999999999999998 112.382 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.563 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 84.4 Cg_exo -50.03 143.8 23.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.263 2.642 . . . . 0.87 112.435 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 113.16 3.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.494 . . . . 1.8500000000000001 110.926 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.49 -2.35 27.84 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.961 -0.638 . . . . 1.1799999999999999 112.299 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.646 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 74.4 p -77.83 -21.69 51.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.273 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.34 -153.19 17.16 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.862 -0.608 . . . . 1.97 111.846 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -98.5 110.83 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.927 -0.397 . . . . 0.93999999999999995 109.927 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -77.07 109.56 11.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.177 -0.465 . . . . 2.23 110.019 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 7.0 ptt180 -101.9 92.56 4.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.636 . . . . 2.3100000000000001 111.468 -171.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 41.0 m-85 -78.79 120.8 23.95 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.674 -0.694 . . . . 0.78000000000000003 109.791 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.651 ' CG2' HD22 ' A' ' 14' ' ' LEU . 15.1 t -98.57 128.89 49.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.27000000000000002 110.479 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.764 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -89.5 119.64 30.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.041 -0.527 . . . . 1.99 109.77 178.043 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 48.9 mt -116.43 119.15 34.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.378 -0.231 . . . . 0.38 110.378 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.537 HG12 HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -117.71 137.44 51.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 0.31 110.961 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 1.037 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 49.1 t80 -140.78 133.26 28.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.589 -0.278 . . . . 5.1200000000000001 110.322 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.447 ' HG2' HG21 ' A' ' 164' ' ' VAL . 7.1 pt-20 -83.06 116.32 22.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.807 -0.812 . . . . 2.4100000000000001 108.807 170.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.64 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -78.74 174.39 11.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.498 0.666 . . . . 1.3100000000000001 112.03 -168.037 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.28 -22.46 63.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.682 -1.145 . . . . 2.3999999999999999 109.823 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.64 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 8.2 ptt180 -146.49 163.06 31.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.444 -1.253 . . . . 3.5099999999999998 111.31 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -64.95 41.87 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.757 0 C-N-CA 124.684 3.589 . . . . 1.21 113.403 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 2.7 mm? 74.42 167.42 0.29 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.934 -1.03 . . . . 0.90000000000000002 113.152 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -157.15 71.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.991 -1.459 . . . . 2.8999999999999999 107.844 171.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.438 ' SG ' HD21 ' A' ' 103' ' ' LEU . 3.8 p -93.39 -75.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.077 -0.965 . . . . 1.8999999999999999 110.958 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 56.34 31.29 18.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.461 0.648 . . . . 2.96 109.886 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 133' ' ' CYS . 32.3 mm-40 -82.32 139.85 45.18 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.046 -0.979 . . . . 1.3899999999999999 109.841 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.72 112.44 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.898 2.399 . . . . 1.27 112.446 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.47 131.04 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 0.85999999999999999 111.065 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.9 mt -110.83 149.39 30.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.05 -0.523 . . . . 1.6100000000000001 110.639 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.6 m -102.86 157.74 16.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.283 -1.006 . . . . 1.8799999999999999 108.283 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.898 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -81.59 30.36 0.36 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.396 0.617 . . . . 0.75 111.579 -173.399 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.654 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 14.2 mtt180 -115.54 147.48 40.65 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.884 -0.784 . . . . 3.3599999999999999 108.884 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.602 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 16.5 m 66.18 178.15 0.21 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.94 0.775 . . . . 0.94999999999999996 110.599 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -143.39 33.17 1.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.041 -1.076 . . . . 1.1200000000000001 112.701 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.66 -27.41 63.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.049 0.388 . . . . 2.6600000000000001 112.049 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -113.78 67.49 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.076 0.465 . . . . 1.8700000000000001 110.9 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 99.3 mtt180 -79.71 -79.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.711 -0.677 . . . . 4.7300000000000004 112.114 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.12 -142.73 3.52 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.65000000000000002 113.009 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.731 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 39.7 mttm 66.33 34.15 6.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.719 0.771 . . . . 1.0800000000000001 109.944 -173.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 69.8 m-85 -113.63 177.06 4.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.82 -1.082 . . . . 1.8899999999999999 109.647 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -119.75 112.24 19.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.366 -0.379 . . . . 1.29 111.945 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.741 HG21 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.49 -36.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.78000000000000003 111.791 172.152 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.81 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.67000000000000004 110.617 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.5 m -65.17 -44.86 87.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.77000000000000002 110.263 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.642 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 66.9 m-85 -59.11 -47.01 86.85 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.601 0.715 . . . . 0.92000000000000004 110.199 174.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 161' ' ' ARG . 28.9 ttm180 -59.21 -48.64 80.87 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.809 -1.087 . . . . 2.8900000000000001 111.634 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -66.76 -36.53 82.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.96999999999999997 110.637 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -55.83 -51.04 68.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.078 -0.965 . . . . 1.5800000000000001 111.41 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.454 ' CB ' HD13 ' A' ' 160' ' ' LEU . 22.7 m-85 -83.29 -5.6 59.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.729 -0.669 . . . . 5.4500000000000002 111.416 -174.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 68.53 46.74 0.97 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.814 0.816 . . . . 2.4199999999999999 111.134 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.037 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.6 mp -105.69 175.39 5.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.666 -1.152 . . . . 1.27 110.378 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.897 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 6.1 tpt180 -147.64 -158.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.52 -0.918 . . . . 3.5899999999999999 108.52 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.897 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -47.74 142.25 6.91 Favored Pre-proline 0 C--O 1.231 0.125 0 CA-C-O 121.122 0.487 . . . . 0.76000000000000001 111.732 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 7.9 Cg_exo -70.2 161.31 46.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.651 2.901 . . . . 0.53000000000000003 113.191 -168.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.898 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -87.69 -24.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.014 -0.994 . . . . 0.44 109.236 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.776 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -159.83 150.29 18.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.701 -0.681 . . . . 0.27000000000000002 111.63 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.556 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.61 149.87 21.88 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.086 -0.961 . . . . 0.23999999999999999 111.607 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.545 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.1 t -167.88 152.74 6.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.677 -0.86 . . . . 0.34000000000000002 108.677 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 14.3 p -129.21 148.07 51.11 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.164 -0.614 . . . . 1.1100000000000001 111.355 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.553 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 32.1 p90 -130.05 127.85 40.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.003 -1.11 . . . . 0.80000000000000004 108.003 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 1.4 pt20 -105.14 132.91 50.76 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.897 -0.721 . . . . 2.5299999999999998 111.643 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -131.2 144.31 51.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.411 -0.813 . . . . 0.59999999999999998 109.24 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.783 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 pt-20 -126.74 -161.73 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 2.3799999999999999 111.103 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.895 ' HA ' HG21 ' A' ' 177' ' ' VAL . 4.1 t90 -71.93 81.48 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 3.96 111.036 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.532 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 5.6 t70 -73.08 -61.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.341 -0.39 . . . . 1.53 110.859 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.592 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 29.0 t70 172.79 -35.04 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.402 -0.817 . . . . 1.26 110.087 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -80.54 13.1 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 2.2200000000000002 111.516 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.895 HG21 ' HA ' ' A' ' 173' ' ' TRP . 84.0 t -72.59 -53.37 5.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.931 -0.577 . . . . 0.5 110.105 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.752 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.2 Cg_exo -50.84 -30.8 31.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.693 2.262 . . . . 0.57999999999999996 111.902 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.2 mmmt -72.4 -23.56 61.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 2.1400000000000001 111.473 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.855 HD22 ' HA3' ' A' ' 110' ' ' GLY . 14.8 tp -70.9 -44.13 66.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.414 -0.587 . . . . 0.66000000000000003 109.414 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.66 -40.28 91.48 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.556 0.693 . . . . 1.8899999999999999 109.273 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 8.2 mm-40 -56.41 -48.3 77.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.671 -1.15 . . . . 1.53 110.647 171.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.334 -0.848 . . . . 1.49 111.97 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.602 ' HA ' ' H ' ' A' ' 142' ' ' SER . 40.4 mt -68.42 2.78 2.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.577 -0.283 . . . . 0.76000000000000001 111.629 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.656 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.7 m -78.8 -2.73 40.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.336 0.589 . . . . 1.05 109.869 173.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.654 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 76.44 60.57 2.99 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.313 -0.858 . . . . 1.1699999999999999 111.29 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.656 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.4 mmmt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.577 -0.725 . . . . 2.0 110.549 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 24' ' ' PRO . 23.4 t . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 121.359 0.599 . . . . 1.47 110.134 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -143.46 31.02 1.35 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.977 -1.011 . . . . 1.8100000000000001 110.628 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.4 mm? 68.85 10.7 8.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.071 -1.422 . . . . 0.69999999999999996 113.041 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -67.12 -8.97 34.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.539 0.57 . . . . 1.96 112.539 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.867 ' HB3' HD12 ' A' ' 12' ' ' LEU . 99.4 mttt -133.68 36.12 3.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.29 -0.256 . . . . 2.6600000000000001 111.333 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.45 -17.96 40.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.274 0.472 . . . . 3.98 112.274 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 p -153.42 20.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.872 0.368 . . . . 0.63 111.595 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.48 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -80.88 -124.67 0.62 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.006 -0.838 . . . . 0.47999999999999998 111.006 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 14.3 Cg_endo -53.61 -35.45 77.38 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.261 2.641 . . . . 0.53000000000000003 110.679 166.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 7' ' ' LYS . 25.3 mt -87.57 86.04 7.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 1.1699999999999999 109.322 172.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 60.9 0.72 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.70999999999999996 110.898 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.798 HD22 HG21 ' A' ' 121' ' ' VAL . 20.9 mt -73.2 -19.56 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.45000000000000001 110.275 -176.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -64.55 -22.53 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 2.1200000000000001 110.846 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -64.86 -25.29 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.38 0.609 . . . . 1.9299999999999999 109.66 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 151' ' ' VAL . 92.1 t -92.39 -70.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.024 -0.989 . . . . 0.63 110.154 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.48 174.67 5.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 2.9900000000000002 110.621 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.96 29.64 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 1.6000000000000001 112.282 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 27.9 mt-30 64.26 112.45 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.02 0.825 . . . . 3.5499999999999998 111.005 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 19.9 Cg_exo -63.98 152.05 82.56 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.439 2.092 . . . . 0.57999999999999996 112.759 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.872 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.3 pt20 -76.66 -18.77 58.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.281 -0.872 . . . . 1.3899999999999999 111.021 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.791 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 40.0 m-70 -145.53 159.43 48.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 123.658 0.783 . . . . 1.45 109.068 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB3' HG12 ' A' ' 3' ' ' VAL . 5.4 Cg_endo -85.93 131.05 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.706 2.271 . . . . 0.40000000000000002 111.967 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.913 HD23 ' HB3' ' A' ' 122' ' ' TRP . 15.6 tp -82.01 145.04 30.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.731 0.301 . . . . 0.28999999999999998 110.478 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.466 ' H ' HD12 ' A' ' 25' ' ' LEU . 32.8 m80 -116.49 127.82 54.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.88 -0.415 . . . . 1.24 109.88 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 53' ' ' ILE . 23.0 t -132.25 140.92 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.355 -0.609 . . . . 0.46999999999999997 109.355 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -137.59 142.82 41.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.983 0.421 . . . . 0.31 110.789 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 38.3 t80 -105.16 176.72 5.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.157 -0.683 . . . . 0.67000000000000004 109.157 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -52.66 62.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.448 0.642 . . . . 0.55000000000000004 110.284 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.45 7.59 32.25 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.167 -0.924 . . . . 0.81000000000000005 112.597 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB2' ' NE2' ' A' ' 45' ' ' GLN . . . -146.15 -170.97 3.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.46999999999999997 110.53 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.25 163.49 25.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.589 -0.732 . . . . 0.33000000000000002 109.34 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.758 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 88.6 t -116.52 66.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.304 -1.369 . . . . 0.39000000000000001 107.304 165.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.0 14.01 33.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.053 -0.976 . . . . 0.98999999999999999 109.608 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.803 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.1 tm-20 -138.07 122.38 18.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.126 -1.435 . . . . 2.5600000000000001 107.126 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -68.1 111.54 4.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.426 0.631 . . . . 0.40999999999999998 110.685 -170.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.757 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 84.06 10.19 81.06 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.54 -0.754 . . . . 0.58999999999999997 112.409 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -64.2 154.25 35.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 110.28 -0.267 . . . . 0.34000000000000002 110.28 176.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.31 127.77 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.469 0.652 . . . . 0.55000000000000004 111.296 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.5 HD22 HG22 ' A' ' 34' ' ' VAL . 7.0 tp -124.69 169.12 12.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.823 -1.177 . . . . 0.45000000000000001 107.823 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p -118.17 151.95 49.89 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 119.48 -0.888 . . . . 0.56000000000000005 112.718 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.603 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 51.0 Cg_exo -56.38 -34.47 94.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.875 3.05 . . . . 0.68000000000000005 113.284 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -33.67 72.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.76000000000000001 110.696 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 32' ' ' ALA . 93.1 mt-30 -82.12 -46.68 13.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.036 . . . . 1.5900000000000001 111.395 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG11 ' CE2' ' A' ' 169' ' ' TYR . 6.1 m -95.62 28.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 112.731 0.641 . . . . 0.66000000000000003 112.731 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -85.8 -11.7 52.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.823 0.344 . . . . 0.79000000000000004 110.617 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -135.5 -151.88 0.44 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 1.9099999999999999 109.285 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HD3' HG22 ' A' ' 97' ' ' ILE . 81.5 mtt180 -87.92 158.64 50.05 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.149 -0.315 . . . . 1.4299999999999999 110.149 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 76.3 Cg_endo -83.5 165.37 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.237 1.958 . . . . 0.37 110.573 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 t -88.09 -20.31 25.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.599 -0.441 . . . . 0.44 110.596 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -158.69 142.58 15.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.085 0.469 . . . . 0.38 111.918 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.09 170.05 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.29999999999999999 108.471 171.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.016 ' HA ' HD13 ' A' ' 58' ' ' LEU . 40.4 t 174.23 116.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.517 0.511 . . . . 0.34999999999999998 109.866 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 54.4 p-90 -76.97 159.56 29.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.669 -0.863 . . . . 2.7200000000000002 108.669 173.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 29.3 t70 -68.63 85.36 0.3 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.054 0.454 . . . . 1.51 110.5 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.47 6.33 3.83 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.492 -0.776 . . . . 0.80000000000000004 112.259 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.016 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -51.71 129.41 26.08 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.163 0.506 . . . . 0.57999999999999996 111.554 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -79.25 -28.11 42.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.73999999999999999 111.404 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.661 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 24.3 t 67.14 22.07 9.92 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.125 -0.943 . . . . 1.03 110.08 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -42.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.784 -0.722 . . . . 0.83999999999999997 113.079 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -90.73 169.08 11.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 120.823 0.344 . . . . 1.6699999999999999 110.772 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.1 mt -93.8 147.52 22.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.711 -0.677 . . . . 0.57999999999999996 109.344 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.503 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.0 m-85 -135.09 168.56 18.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.265 -0.643 . . . . 0.80000000000000004 109.265 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.877 HG23 HG12 ' A' ' 90' ' ' VAL . 2.4 m -103.83 104.43 14.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.325 -0.62 . . . . 0.35999999999999999 109.325 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.701 HD13 HG12 ' A' ' 124' ' ' VAL . 57.7 tp -108.16 117.01 33.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.034 0.445 . . . . 0.58999999999999997 110.616 -174.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.9 t -114.89 147.09 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.083 -0.508 . . . . 0.39000000000000001 110.38 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.97 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.2 mt -110.5 122.11 46.95 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.78 -1.192 . . . . 0.59999999999999998 107.78 166.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 9.0 t -133.16 151.28 51.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.726 0.298 . . . . 0.35999999999999999 110.711 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.654 ' OD2' ' HB3' ' A' ' 84' ' ' TRP . 4.6 p-10 -132.31 101.8 14.57 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-O 121.613 0.721 . . . . 1.9199999999999999 111.213 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 4.1 Cg_endo -48.06 -38.4 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.828 3.018 . . . . 1.25 114.386 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.85 48.82 1.4 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -171.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . . . -106.46 127.76 27.56 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.176 -0.305 . . . . 0.5 110.176 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.619 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -82.64 -30.46 4.78 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.315 -1.536 . . . . 0.62 113.142 -1.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.687 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -121.16 157.81 29.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.107 -0.497 . . . . 0.75 110.944 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -67.81 -45.53 74.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 2.8799999999999999 111.342 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.725 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -72.35 -19.31 61.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 1.3799999999999999 111.442 -175.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.97 84.24 5.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.2 0.524 . . . . 1.3700000000000001 110.141 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.87 102.24 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.643 2.228 . . . . 0.80000000000000004 112.691 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.619 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 16.9 mttm -83.09 -55.23 4.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.981 -1.008 . . . . 1.02 110.669 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.695 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.7 m-85 -82.86 19.77 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 111.481 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 50.3 ttp180 -65.72 124.05 21.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.36 -0.382 . . . . 2.9300000000000002 110.21 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.0 mp0 -102.4 138.99 38.59 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.819 0.342 . . . . 2.23 110.957 0.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.654 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 17.1 t90 -88.19 161.91 16.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.412 -1.329 . . . . 1.4299999999999999 107.412 171.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 11.0 p80 -138.04 114.67 10.51 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.184 0.516 . . . . 1.26 110.435 -174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.97 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 12.3 t-80 -52.99 -42.57 65.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.029 -0.987 . . . . 2.1400000000000001 110.585 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 18.5 p90 -167.55 163.33 14.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.706 0.288 . . . . 1.51 110.747 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.8 tp -126.83 114.18 17.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.33000000000000002 109.23 175.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.721 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -119.78 134.06 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.534 0.683 . . . . 0.31 111.182 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.877 HG12 HG23 ' A' ' 65' ' ' THR . 6.2 m -128.04 168.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.477 -0.934 . . . . 0.27000000000000002 108.477 175.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.767 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.8 m-20 59.11 21.77 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.075 0.464 . . . . 1.76 111.3 173.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.721 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.9 ttm -76.72 115.07 16.15 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.673 -0.862 . . . . 0.31 108.673 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -82.72 98.32 9.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.125 -0.943 . . . . 1.21 111.039 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 69.59 -119.42 9.17 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.203 -0.908 . . . . 0.29999999999999999 112.273 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.508 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.6 p-10 -114.57 25.54 10.93 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.09 0.471 . . . . 1.04 110.598 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.4 106.03 18.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.343 0.592 . . . . 0.77000000000000002 109.977 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.454 HG22 ' HD3' ' A' ' 49' ' ' ARG . 5.1 mm -56.81 -29.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 111.913 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.1 m -81.85 -37.27 27.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.883 0.698 . . . . 0.68000000000000005 112.883 -170.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.6 p -67.27 -19.59 65.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.85 0.315 . . . . 1.26 111.85 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.06 105.65 0.58 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.859 -0.61 . . . . 0.34999999999999998 112.982 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 97.7 m -65.16 107.31 1.52 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.282 0.563 . . . . 0.45000000000000001 110.004 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.6 p -76.78 119.15 24.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.184 -0.916 . . . . 0.56999999999999995 111.287 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 88' ' ' LEU . 57.1 mt -97.39 -47.03 5.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.091 0.948 . . . . 0.45000000000000001 109.159 172.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 t -114.35 106.02 13.82 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.977 -1.49 . . . . 0.37 106.977 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.3 OUTLIER -56.89 156.97 6.04 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.763 0.664 . . . . 1.1499999999999999 112.178 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.3 p90 -77.25 87.8 3.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 4.6900000000000004 111.095 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' ' 140' ' ' ASN . 24.0 t -61.77 -53.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.76 -0.655 . . . . 0.85999999999999999 110.68 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.493 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 115.98 -164.89 12.19 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.086 -1.054 . . . . 0.67000000000000004 112.548 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.476 ' OG ' ' HG3' ' A' ' 43' ' ' PRO . 23.9 t -77.89 131.98 37.73 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.568 0.216 . . . . 0.51000000000000001 110.545 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.42 68.11 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.81999999999999995 112.713 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.856 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 20.4 Cg_endo -96.33 113.19 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.434 2.756 . . . . 0.84999999999999998 112.708 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.604 ' HB2' HG23 ' A' ' 115' ' ' THR . 89.1 Cg_exo -51.15 143.23 33.13 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.798 2.332 . . . . 0.87 111.709 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 110.97 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.25 0.548 . . . . 1.8500000000000001 110.952 -175.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.48 21.63 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 1.1799999999999999 112.312 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.687 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 70.1 p -77.41 -30.3 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.628 0.252 . . . . 0.96999999999999997 111.415 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.95 -168.78 12.88 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.41 -0.676 . . . . 1.97 111.41 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -80.28 108.97 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.243 0.544 . . . . 0.93999999999999995 109.916 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 2.2 t60 -79.74 106.21 11.6 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 2.23 109.535 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.824 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp180 -97.57 114.67 26.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.402 1.096 . . . . 2.3100000000000001 111.358 -172.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 28.7 m-85 -92.31 120.65 33.05 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.231 -1.349 . . . . 0.78000000000000003 108.683 172.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 168' ' ' CYS . 19.4 t -97.99 128.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.619 . . . . 0.27000000000000002 109.81 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.913 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.02 119.2 29.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.127 -0.694 . . . . 1.99 109.127 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.88 119.92 27.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.374 0.131 . . . . 0.38 111.169 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.701 HG12 HD13 ' A' ' 66' ' ' LEU . 1.5 m -104.85 136.17 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.566 -0.454 . . . . 0.31 109.869 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 88.4 m-85 -114.5 148.7 37.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.441 . . . . 5.1200000000000001 110.483 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.1 tt0 -101.42 119.06 38.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.836 -0.62 . . . . 2.4100000000000001 110.837 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.56 ' HG2' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -104.2 160.83 14.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 1.3100000000000001 110.479 176.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.04 -26.57 64.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.879 -1.055 . . . . 2.3999999999999999 110.172 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.594 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 11.8 ptp180 -159.24 171.83 6.87 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 3.5099999999999998 111.132 -174.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 81.3 Cg_exo -48.08 148.37 7.0 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.098 2.532 . . . . 1.21 112.677 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.661 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -78.12 152.63 32.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.884 -0.598 . . . . 0.90000000000000002 111.263 -172.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -130.98 68.05 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.643 -0.873 . . . . 2.8999999999999999 108.643 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.475 ' HB2' HD11 ' A' ' 103' ' ' LEU . 66.3 m -95.72 106.44 18.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.233 -0.894 . . . . 1.8999999999999999 110.897 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.22 31.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.636 -0.711 . . . . 2.96 110.357 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 11.8 mm-40 -71.32 150.17 94.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.357 -0.838 . . . . 1.3899999999999999 110.426 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.36 106.64 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.325 2.684 . . . . 1.27 113.138 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.2 mm -63.54 121.33 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.85999999999999999 110.863 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 69.1 mt -105.49 155.07 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 1.6100000000000001 110.266 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 141' ' ' ARG . 65.5 m -113.45 17.17 18.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.73 -0.668 . . . . 1.8799999999999999 110.737 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.933 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.6 OUTLIER 65.49 -29.21 0.12 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.21 1.404 . . . . 0.75 111.705 -178.231 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.9 ttt180 -56.45 140.15 46.79 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.68 0.792 . . . . 3.3599999999999999 111.088 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 28.6 m 73.78 114.05 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 124.194 0.934 . . . . 0.94999999999999996 111.639 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.01 12.8 34.82 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.436 -0.802 . . . . 1.1200000000000001 112.303 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.76 -38.65 87.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.597 0.713 . . . . 2.6600000000000001 110.676 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -98.34 59.53 1.34 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.039 -0.982 . . . . 1.8700000000000001 109.597 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -86.71 -92.95 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.832 -0.622 . . . . 4.7300000000000004 112.371 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -119.99 -156.22 9.89 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.232 -0.985 . . . . 0.65000000000000002 113.633 -166.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.695 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 94.5 mttt 65.66 24.61 11.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.147 0.975 . . . . 1.0800000000000001 109.755 -171.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.54 95.27 5.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.372 -1.286 . . . . 1.8899999999999999 108.236 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.48 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 22.0 mmmt -54.05 129.98 36.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.215 -0.902 . . . . 1.29 112.622 -173.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.66 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 29.0 m -65.48 -23.72 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.443 -0.577 . . . . 0.78000000000000003 109.443 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.49 -42.14 98.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.36 -0.837 . . . . 0.67000000000000004 109.577 172.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 37.2 m -64.82 -32.54 74.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.018 -0.537 . . . . 0.77000000000000002 110.22 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.66 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 27.6 m-85 -69.91 -48.86 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.92000000000000004 111.068 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.621 ' HD2' ' HG3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -67.23 -29.36 68.99 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.954 -0.298 . . . . 2.8900000000000001 110.832 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.621 ' HG3' ' HD2' ' A' ' 155' ' ' ARG . 54.7 mtmt -77.49 -26.91 51.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.783 -0.19 . . . . 0.96999999999999997 111.401 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -54.45 -53.9 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.537 -0.302 . . . . 1.5800000000000001 111.136 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.435 ' OH ' ' HG3' ' A' ' 129' ' ' ARG . 12.9 t80 -111.1 5.99 20.53 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.485 -0.886 . . . . 5.4500000000000002 110.597 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 58.81 53.68 5.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.326 -0.852 . . . . 2.4199999999999999 112.467 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 125' ' ' TYR . 0.4 OUTLIER -81.08 -12.31 59.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.272 -0.877 . . . . 1.27 110.303 176.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.431 ' HD2' ' NH2' ' A' ' 155' ' ' ARG . 7.5 tpt180 69.9 -87.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.978 -1.01 . . . . 3.5899999999999999 112.297 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -128.07 156.51 76.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.821 0.343 . . . . 0.76000000000000001 111.211 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.3 Cg_exo -71.24 139.78 35.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.285 2.657 . . . . 0.53000000000000003 112.464 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.872 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -87.74 -30.78 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.376 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.85 143.7 21.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.987 -0.552 . . . . 0.27000000000000002 111.544 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.55 143.27 11.28 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 114.926 -1.034 . . . . 0.23999999999999999 111.881 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.5 t -156.83 133.61 10.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.34000000000000002 108.927 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.863 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -110.31 151.29 27.59 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.568 0.699 . . . . 1.1100000000000001 111.756 -173.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 120' ' ' TYR . 49.2 p90 -137.73 127.51 25.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.657 -1.609 . . . . 0.80000000000000004 106.657 173.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 4.1 pt20 -105.55 133.25 50.6 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.363 -0.935 . . . . 2.5299999999999998 111.435 177.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.08 -0.964 . . . . 0.59999999999999998 110.072 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.72 -168.94 1.73 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 2.3799999999999999 110.947 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.745 ' HA ' HG21 ' A' ' 177' ' ' VAL . 29.4 t90 -83.99 77.3 9.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.786 -0.643 . . . . 3.96 109.729 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -57.04 4.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.654 -0.248 . . . . 1.53 111.257 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.537 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.0 t70 175.68 -33.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.358 0.663 . . . . 1.26 110.73 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.65 6.7 14.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.908 0.385 . . . . 2.2200000000000002 111.925 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.808 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 66.3 t -69.42 -53.52 12.81 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.281 -0.418 . . . . 0.5 110.083 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.808 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 61.7 Cg_exo -51.32 -37.03 59.52 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.609 2.206 . . . . 0.57999999999999996 112.021 169.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.5 mmmt -67.7 -24.37 65.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.165 -0.47 . . . . 2.1400000000000001 111.705 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.644 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 58.3 tp -69.11 -47.44 65.15 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.66000000000000003 109.57 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.8 -38.68 79.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 1.8899999999999999 109.42 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.9 mm-40 -57.26 -43.08 82.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.892 -1.049 . . . . 1.53 111.267 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -76.55 -30.34 57.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.707 0.632 . . . . 1.49 112.707 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 84.9 mt -63.39 1.47 0.52 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.996 0.739 . . . . 0.76000000000000001 112.996 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.722 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 49.3 m -88.81 3.05 52.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.463 0.649 . . . . 1.05 109.789 170.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.539 ' N ' ' HG3' ' A' ' 141' ' ' ARG . . . 69.45 51.65 25.44 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.066 -0.97 . . . . 1.1699999999999999 111.335 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.4 mmmt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.456 -0.783 . . . . 2.0 110.072 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' A' ' 26' ' ' HIS . 21.4 t . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 121.363 0.601 . . . . 1.47 112.131 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 6' ' ' SER . 24.0 t70 -144.78 157.96 43.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.175 -1.375 . . . . 1.8100000000000001 107.524 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.438 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.0 mm? -75.19 23.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.09 0.405 . . . . 0.69999999999999996 111.882 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.0 t -72.27 -16.72 61.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 1.96 110.123 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HB3' HD12 ' A' ' 12' ' ' LEU . 37.8 mttm -122.13 31.41 6.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 2.6600000000000001 111.173 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -26.36 31.63 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.245 0.832 . . . . 3.98 113.245 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -152.43 25.51 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.014 -0.429 . . . . 0.63 111.377 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.16 -122.39 0.96 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.753 -0.939 . . . . 0.47999999999999998 110.753 174.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -51.9 -38.49 68.5 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.255 2.636 . . . . 0.53000000000000003 110.921 167.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.635 HD11 ' HA3' ' A' ' 38' ' ' GLY . 45.9 mt -87.37 89.09 7.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.258 -0.883 . . . . 1.1699999999999999 109.661 173.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.53 71.75 1.86 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.412 0.625 . . . . 0.70999999999999996 110.485 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.857 HD22 HG21 ' A' ' 121' ' ' VAL . 23.8 mt -80.12 -11.98 59.71 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.795 . . . . 0.45000000000000001 110.04 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.535 ' HG2' ' HG3' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -67.69 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.446 -0.797 . . . . 2.1200000000000001 110.859 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -77.5 -20.11 54.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.707 0.765 . . . . 1.9299999999999999 109.423 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG1' HG21 ' A' ' 151' ' ' VAL . 62.8 t -98.13 -57.03 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.53 -1.214 . . . . 0.63 111.341 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -134.92 172.79 12.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.459 -0.337 . . . . 2.9900000000000002 110.685 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -85.93 31.61 0.62 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.538 0.94 . . . . 1.6000000000000001 113.538 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HG3' ' HG2' ' A' ' 15' ' ' GLN . 97.7 mt-30 64.4 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.541 0 O-C-N 123.507 0.505 . . . . 3.5499999999999998 110.721 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 15.2 Cg_exo -66.35 150.4 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.207 1.938 . . . . 0.57999999999999996 112.671 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.879 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.8 pt20 -72.39 -15.92 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.125 -0.943 . . . . 1.3899999999999999 111.264 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.789 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 24.1 m80 -148.91 157.43 40.39 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 1.45 109.274 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.5 Cg_endo -86.82 127.33 2.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.40000000000000002 111.266 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.874 HD23 ' HB3' ' A' ' 122' ' ' TRP . 22.8 tp -76.61 144.3 39.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.997 -0.372 . . . . 0.28999999999999998 109.997 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.59 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 36.0 m80 -122.91 109.23 13.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.045 0.45 . . . . 1.24 110.038 176.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 53' ' ' ILE . 39.6 t -112.93 139.3 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.61 . . . . 0.46999999999999997 109.476 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -133.26 142.2 48.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.431 0.634 . . . . 0.31 110.938 -176.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -102.54 171.12 7.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.67000000000000004 109.006 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.65 -51.86 61.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.37 0.605 . . . . 0.55000000000000004 110.773 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.97 9.52 15.81 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.066 -0.97 . . . . 0.81000000000000005 112.478 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.68 -171.01 3.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 122.631 -0.335 . . . . 0.46999999999999997 110.469 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.13 155.32 18.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.158 -0.474 . . . . 0.33000000000000002 110.351 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.803 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.6 t -102.32 63.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.804 -1.554 . . . . 0.39000000000000001 106.804 163.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.31 20.78 8.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.887 -1.051 . . . . 0.98999999999999999 109.384 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.5 tm-20 -145.67 119.93 9.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.047 -1.094 . . . . 2.5600000000000001 108.047 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -66.45 110.63 3.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.997 0.427 . . . . 0.40999999999999998 109.959 -175.281 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.873 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 93.27 2.44 65.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.068 -0.587 . . . . 0.58999999999999997 112.703 177.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -67.05 149.39 50.66 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.764 0.316 . . . . 0.34000000000000002 110.677 -178.137 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.11 132.01 33.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.357 0.598 . . . . 0.55000000000000004 111.043 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.499 HD22 HG22 ' A' ' 34' ' ' VAL . 6.8 tp -124.11 169.2 11.93 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.391 -1.337 . . . . 0.45000000000000001 107.391 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.1 p -114.67 150.46 44.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 118.804 -1.159 . . . . 0.56000000000000005 113.141 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 52.9 Cg_exo -55.74 -32.43 84.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.435 3.423 . . . . 0.68000000000000005 113.91 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -65.12 -36.65 84.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.644 0.735 . . . . 0.76000000000000001 110.189 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -75.28 -56.38 4.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.799 -1.091 . . . . 1.5900000000000001 110.603 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG11 ' CE1' ' A' ' 169' ' ' TYR . 28.7 m -89.31 28.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.884 0.698 . . . . 0.66000000000000003 112.884 -173.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -85.64 -15.49 42.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.766 -0.828 . . . . 0.79000000000000004 108.766 172.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 17.9 t-20 -121.12 -170.29 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.714 -1.13 . . . . 1.9099999999999999 108.988 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 86.2 mtt180 -85.42 161.51 51.25 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.445 -0.576 . . . . 1.4299999999999999 109.445 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 66.8 Cg_endo -78.96 160.38 27.14 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.819 1.68 . . . . 0.37 110.539 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 t -85.23 -18.17 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.915 -0.402 . . . . 0.44 109.915 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 70.1 m -159.36 147.99 17.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.27 0.557 . . . . 0.38 111.778 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.935 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.69 167.87 18.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.145 -1.057 . . . . 0.29999999999999999 108.145 170.057 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.061 ' HA ' HD13 ' A' ' 58' ' ' LEU . 38.5 t 179.01 114.27 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.102 0.477 . . . . 0.34999999999999998 110.168 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 56.3 p-90 -78.4 157.34 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.088 -1.078 . . . . 2.7200000000000002 108.088 172.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.419 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 28.4 t70 -62.67 88.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.191 0.52 . . . . 1.51 110.918 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.5 20.59 4.62 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.444 -0.798 . . . . 0.80000000000000004 112.275 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.061 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -51.1 130.3 25.76 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.107 0.563 . . . . 0.57999999999999996 111.485 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.697 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 24.1 t70 -75.72 -28.68 58.66 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.808 -0.633 . . . . 0.73999999999999999 111.451 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.688 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 43.0 m 69.18 9.44 7.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.389 -0.823 . . . . 1.03 110.733 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -135.53 -43.77 0.11 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.849 -0.691 . . . . 0.83999999999999997 113.253 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.897 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 20.2 mtpt -66.59 149.63 50.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.6699999999999999 110.645 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.998 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.1 mt -88.09 126.77 35.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.555 -0.748 . . . . 0.57999999999999996 109.239 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.897 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -118.84 161.4 20.23 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.224 0.465 . . . . 0.80000000000000004 110.889 177.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.453 HG23 HG12 ' A' ' 90' ' ' VAL . 89.6 m -97.4 105.3 17.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.35999999999999999 109.259 172.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.85 110.13 22.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.471 -0.786 . . . . 0.58999999999999997 109.835 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.6 t -115.32 126.7 72.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.018 0.437 . . . . 0.39000000000000001 111.055 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.957 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -91.19 131.39 36.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.215 -1.031 . . . . 0.59999999999999998 108.215 166.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 12.0 t -133.63 140.64 47.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.877 -0.329 . . . . 0.35999999999999999 110.339 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.644 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 38.2 t70 -121.85 97.58 46.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 121.132 0.491 . . . . 1.9199999999999999 110.064 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 10.7 Cg_endo -56.14 178.31 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.2 2.6 . . . . 1.25 112.538 171.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.841 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 71.3 m-20 52.56 35.7 18.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.926 -1.034 . . . . 1.29 112.861 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.99 138.48 19.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.148 -0.315 . . . . 0.5 110.148 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.694 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 56.7 Cg_endo -77.27 -34.52 3.28 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.089 -1.629 . . . . 0.62 112.968 0.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.712 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.1 p -119.87 156.81 30.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 0.75 110.214 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.841 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 46.8 mtm180 -72.48 -23.53 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 2.8799999999999999 111.482 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.83 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -92.72 -11.62 33.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 1.3799999999999999 110.947 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.45 78.58 6.28 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-O 121.583 0.706 . . . . 1.3700000000000001 109.584 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.79 95.15 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.848 2.365 . . . . 0.80000000000000004 113.348 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.694 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 12.1 mttm -81.74 -52.29 7.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.095 -0.957 . . . . 1.02 111.17 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.634 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 50.7 m-85 -76.53 -5.44 47.63 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.886 -0.597 . . . . 1.1699999999999999 111.897 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.55 ' HG3' ' HA ' ' A' ' 71' ' ' PRO . 70.1 ttt180 -67.43 130.36 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.275 -0.17 . . . . 2.9300000000000002 110.867 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.516 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 29.9 mm-40 -86.96 130.8 34.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.981 0.42 . . . . 2.23 110.771 -0.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.673 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.5 t90 -86.75 91.18 8.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 1.4299999999999999 109.513 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 35.2 p-80 -67.19 121.72 16.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.529 0.681 . . . . 1.26 109.979 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.957 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 30.3 t-80 -65.39 -34.86 79.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.034 -0.985 . . . . 2.1400000000000001 110.369 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.589 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 39.6 p90 -168.8 172.39 7.86 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.578 -0.527 . . . . 1.51 109.578 175.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.2 tp -132.22 113.7 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.641 -0.503 . . . . 0.33000000000000002 109.641 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.68 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.8 t -121.28 132.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.533 0.682 . . . . 0.31 110.678 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 65' ' ' THR . 9.1 m -128.45 167.4 23.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.879 -1.156 . . . . 0.27000000000000002 107.879 175.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.998 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.5 m-20 60.71 19.66 9.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.203 0.525 . . . . 1.76 110.895 172.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.68 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.1 ttm -73.97 114.57 12.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.971 -0.752 . . . . 0.31 108.971 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 ttmm -80.82 98.56 7.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.512 -1.222 . . . . 1.21 110.988 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.688 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 62.68 -115.3 7.83 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.512 -0.851 . . . . 0.29999999999999999 112.312 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.58 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.2 p-10 -115.06 24.34 11.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.933 0.396 . . . . 1.04 111.611 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.06 103.0 15.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.451 0.643 . . . . 0.77000000000000002 110.247 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.437 ' H ' HG12 ' A' ' 97' ' ' ILE . 7.7 mm -56.18 -32.34 34.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.851 -1.068 . . . . 0.40999999999999998 111.831 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 m -78.98 -37.39 39.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.091 -0.504 . . . . 0.68000000000000005 111.779 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.3 p -61.05 -29.69 69.88 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.728 0.299 . . . . 1.26 111.331 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -50.38 107.77 0.4 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.536 -0.756 . . . . 0.34999999999999998 112.669 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.4 m -72.29 107.8 5.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.256 0.551 . . . . 0.45000000000000001 109.923 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 p -76.46 122.18 30.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.56999999999999995 111.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.644 HD12 ' HG ' ' A' ' 88' ' ' LEU . 66.0 mt -100.47 -45.69 5.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.085 0.945 . . . . 0.45000000000000001 109.32 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.1 t -122.92 112.34 17.73 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.171 -1.418 . . . . 0.37 107.171 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.637 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 4.1 t0 -59.05 159.94 6.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.944 -1.026 . . . . 1.1499999999999999 113.024 -167.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.511 ' H ' ' HD1' ' A' ' 106' ' ' TYR . 3.3 p90 -80.16 86.66 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.3 -0.864 . . . . 4.6900000000000004 110.764 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.864 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 38.3 t -63.97 -46.05 95.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.85999999999999999 111.087 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.541 ' HA2' ' HE2' ' A' ' 86' ' ' HIS . . . 109.51 -168.13 13.13 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.467 -0.873 . . . . 0.67000000000000004 112.577 174.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.9 t -70.29 133.24 46.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.51000000000000001 109.935 174.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -169.73 61.22 0.19 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.695 -0.764 . . . . 0.81999999999999995 112.891 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 97.7 Cg_endo -93.35 140.39 1.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.072 2.515 . . . . 0.84999999999999998 112.434 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 37.1 Cg_exo -61.55 141.84 92.86 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.702 2.268 . . . . 0.87 111.598 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.487 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -69.02 123.93 22.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.8500000000000001 110.987 -176.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.77 59.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 1.1799999999999999 112.642 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.712 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 75.1 p -78.82 -12.68 60.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 110.706 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.29 165.92 41.78 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.18 -0.768 . . . . 1.97 111.18 -174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.837 HD12 ' HG3' ' A' ' 170' ' ' GLN . 3.8 mm? -79.49 130.13 35.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.317 -0.623 . . . . 0.93999999999999995 109.317 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.567 ' H ' ' NE2' ' A' ' 170' ' ' GLN . 4.2 m170 -92.63 -121.32 0.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.975 -1.12 . . . . 2.23 107.975 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.783 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 14.3 ptt-85 177.3 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.344 0.498 . . . . 2.3100000000000001 112.344 169.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.644 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 31.4 m-85 -69.86 101.2 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.768 -0.826 . . . . 0.78000000000000003 108.768 173.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.857 HG21 HD22 ' A' ' 14' ' ' LEU . 17.3 t -89.99 126.07 42.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.957 0.408 . . . . 0.27000000000000002 109.949 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.874 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.06 117.9 28.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.812 -0.81 . . . . 1.99 108.812 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -122.07 129.01 52.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.511 0.195 . . . . 0.38 110.94 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 165' ' ' ALA . 1.3 m -112.21 131.78 62.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.31 110.139 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.64 ' CB ' HD23 ' A' ' 160' ' ' LEU . 97.8 m-85 -117.69 122.5 43.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.252 -0.885 . . . . 5.1200000000000001 109.258 174.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.98 113.08 25.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.012 0.434 . . . . 2.4100000000000001 109.873 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.6 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -80.57 175.6 10.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.665 -0.698 . . . . 1.3100000000000001 109.439 177.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.02 -6.34 57.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.729 -0.669 . . . . 2.3999999999999999 109.851 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.503 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.2 ptp180 -165.65 167.38 9.16 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 115.307 -0.86 . . . . 3.5099999999999998 111.267 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.545 ' HG3' HD12 ' A' ' 63' ' ' LEU . 35.6 Cg_exo -55.58 147.71 57.59 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.979 2.453 . . . . 1.21 111.631 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.453 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 3.8 mm? -71.83 148.89 45.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.621 . . . . 0.90000000000000002 112.532 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 15.4 tptm -103.26 77.81 1.56 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.707 -1.22 . . . . 2.8999999999999999 107.707 165.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.2 p -90.62 99.79 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.399 -0.818 . . . . 1.8999999999999999 111.797 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.2 14.03 21.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.506 -0.77 . . . . 2.96 109.102 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.26 135.28 96.05 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.3899999999999999 110.278 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.64 116.56 2.81 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.017 2.478 . . . . 1.27 112.946 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.6 mm -69.03 115.95 8.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.005 -0.368 . . . . 0.85999999999999999 110.005 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 145' ' ' HIS . 31.6 mt -114.93 152.61 32.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.427 0.632 . . . . 1.6100000000000001 111.26 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -96.51 154.13 17.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.055 -0.975 . . . . 1.8799999999999999 108.609 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.864 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 -77.88 -1.41 31.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.75 111.024 -173.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.742 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 88.4 mtt180 -78.94 157.2 28.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.581 -0.525 . . . . 3.3599999999999999 109.581 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.518 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 79.8 p 58.06 117.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.82 1.248 . . . . 0.94999999999999996 112.651 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -79.35 18.21 7.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.309 -0.859 . . . . 1.1200000000000001 113.514 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -69.82 -41.34 75.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.559 0.695 . . . . 2.6600000000000001 110.4 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.555 ' HB3' HD13 ' A' ' 138' ' ' LEU . 4.4 m80 -95.11 46.48 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.174 -0.921 . . . . 1.8700000000000001 110.862 -170.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 51.3 mtt180 -76.77 -78.78 0.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.026 0.441 . . . . 4.7300000000000004 111.925 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -137.57 -121.58 2.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.107 -1.044 . . . . 0.65000000000000002 113.042 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.634 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 47.2 mttm 64.88 29.17 12.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.616 0.722 . . . . 1.0800000000000001 110.51 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -127.52 146.87 50.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.903 -1.044 . . . . 1.8899999999999999 109.77 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 13.8 mmmm -87.59 140.57 29.38 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.038 -0.528 . . . . 1.29 111.098 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.558 HG21 ' CG1' ' A' ' 17' ' ' VAL . 3.0 t -62.11 -35.18 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.43 -0.952 . . . . 0.78000000000000003 108.43 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.75 81.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.396 -1.275 . . . . 0.67000000000000004 110.448 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 74.1 m -59.31 -47.07 86.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.77000000000000002 111.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.539 ' O ' ' HB3' ' A' ' 157' ' ' LYS . 59.1 m-85 -62.49 -48.97 77.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.827 0.822 . . . . 0.92000000000000004 110.611 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -60.1 -49.3 78.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.414 -1.266 . . . . 2.8900000000000001 111.135 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -67.73 -26.48 66.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.96999999999999997 111.502 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 45.0 tptt -52.6 -53.25 49.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 1.5800000000000001 111.626 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.507 ' HB3' HD13 ' A' ' 160' ' ' LEU . 17.2 t80 -104.41 14.94 29.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.845 -0.742 . . . . 5.4500000000000002 110.422 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 60.37 47.67 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.158 -0.928 . . . . 2.4199999999999999 111.857 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.64 HD23 ' CB ' ' A' ' 125' ' ' TYR . 5.5 mp -80.1 138.9 37.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.388 -0.824 . . . . 1.27 108.875 173.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -72.18 -82.32 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.079 0.4 . . . . 3.5899999999999999 112.079 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.17 164.54 36.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.882 -0.414 . . . . 0.76000000000000001 109.882 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.533 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 20.0 Cg_exo -62.3 134.62 49.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.621 2.214 . . . . 0.53000000000000003 112.566 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.879 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.1 t -89.73 -31.74 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 109.593 -0.521 . . . . 0.44 109.593 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.789 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -155.08 145.01 21.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.16 -0.616 . . . . 0.27000000000000002 111.876 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.1 140.45 9.12 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.023 -0.99 . . . . 0.23999999999999999 111.74 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -152.99 127.41 9.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.532 -0.544 . . . . 0.34000000000000002 109.532 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.873 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.55 144.29 29.71 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.263 0.554 . . . . 1.1100000000000001 112.082 -174.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.594 ' CE1' HG11 ' A' ' 46' ' ' VAL . 5.9 p90 -133.27 122.52 24.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.279 -1.378 . . . . 0.80000000000000004 107.279 168.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.837 ' HG3' HD12 ' A' ' 117' ' ' LEU . 19.2 tp60 -101.44 156.31 17.54 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.042 -1.036 . . . . 2.5299999999999998 111.626 171.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.489 ' H ' ' CD ' ' A' ' 170' ' ' GLN . . . -149.0 139.07 22.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.422 -0.353 . . . . 0.59999999999999998 110.206 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.766 ' HB3' HD11 ' A' ' 117' ' ' LEU . 12.2 pt-20 -106.65 -168.44 1.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.05 0.452 . . . . 2.3799999999999999 111.87 -173.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.621 ' HA ' HG21 ' A' ' 177' ' ' VAL . 6.9 t90 -77.81 71.38 4.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.661 -0.699 . . . . 3.96 110.168 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.683 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 1.5 t70 -72.59 -62.49 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 1.53 112.615 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.0 t70 -175.06 -45.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.067 0.46 . . . . 1.26 111.143 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.677 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 5.1 m-85 -80.45 7.94 8.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 2.2200000000000002 111.979 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.775 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 94.4 t -72.91 -54.32 4.68 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.083 171.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.775 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -51.92 -41.92 60.82 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.358 2.039 . . . . 0.57999999999999996 111.868 169.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 0.5 OUTLIER -65.85 -25.16 67.07 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.397 -0.365 . . . . 2.1400000000000001 111.068 178.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.688 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 66.5 tp -68.4 -47.62 66.84 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.229 -0.656 . . . . 0.66000000000000003 109.229 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.43 -39.43 83.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.82 -0.627 . . . . 1.8899999999999999 109.478 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 16.4 mm-40 -56.0 -44.45 78.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.772 -1.104 . . . . 1.53 110.795 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.31 -32.45 58.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.366 -0.834 . . . . 1.49 111.958 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 83.0 mt -63.6 -7.07 6.27 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.181 0.437 . . . . 0.76000000000000001 112.181 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.625 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 16.4 m -68.19 -11.42 59.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.489 0.661 . . . . 1.05 109.714 172.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.742 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 87.23 54.83 2.48 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.137 -0.938 . . . . 1.1699999999999999 110.88 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.1 mmmt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.503 -0.76 . . . . 2.0 110.328 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 24' ' ' PRO . 7.2 t . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.719 0.295 . . . . 1.47 111.546 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -146.29 37.83 1.04 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.768 0.794 . . . . 1.8100000000000001 110.12 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 24' ' ' PRO . 2.1 mm? 58.88 37.01 24.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.509 -1.223 . . . . 0.69999999999999996 108.416 -165.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -58.2 -42.93 87.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.456 -1.247 . . . . 1.96 112.021 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.926 ' HB2' HD12 ' A' ' 12' ' ' LEU . 49.9 mttm -136.48 60.94 1.65 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 2.6600000000000001 109.482 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.457 ' CE3' ' HB2' ' A' ' 20' ' ' GLN . 22.5 p-90 -69.06 -35.75 76.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.13 -0.941 . . . . 3.98 112.009 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 84.5 p -147.24 17.56 1.2 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.542 -0.463 . . . . 0.63 111.904 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -75.52 -124.67 0.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.758 . . . . 0.47999999999999998 111.782 177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.4 Cg_endo -49.94 -40.41 49.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.248 2.632 . . . . 0.53000000000000003 110.268 168.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.926 HD12 ' HB2' ' A' ' 7' ' ' LYS . 22.2 mt -88.1 83.62 6.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.85 -1.068 . . . . 1.1699999999999999 109.218 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 m -74.57 62.66 1.04 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.618 0.723 . . . . 0.70999999999999996 110.397 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.586 HD22 ' CG2' ' A' ' 121' ' ' VAL . 46.0 mt -76.52 -17.46 59.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 0.45000000000000001 110.825 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 17.5 tm0? -64.99 -21.53 66.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.877 -0.601 . . . . 2.1200000000000001 109.919 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.66 -28.51 65.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.35 0.595 . . . . 1.9299999999999999 110.65 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.747 HG11 HG21 ' A' ' 69' ' ' THR . 52.0 t -83.99 -73.47 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.265 -0.88 . . . . 0.63 109.684 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.779 ' HB2' HG21 ' A' ' 151' ' ' VAL . 48.3 t0 -139.32 161.19 38.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.846 -0.615 . . . . 2.9900000000000002 109.659 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 163' ' ' PRO . 32.6 mt-10 -64.09 153.42 37.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.652 -0.703 . . . . 1.6000000000000001 111.846 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.457 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 20.1 tt0 -56.05 124.26 58.24 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 3.5499999999999998 110.34 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 19.6 Cg_exo -64.47 154.84 69.57 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.318 2.012 . . . . 0.57999999999999996 112.069 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.934 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.8 pt20 -73.74 -15.55 61.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.606 -0.725 . . . . 1.3899999999999999 111.121 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.735 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 19.5 m80 -146.45 158.81 46.45 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 1.45 108.995 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 3' ' ' VAL . 8.1 Cg_endo -88.53 132.55 2.56 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.952 2.435 . . . . 0.40000000000000002 111.519 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.864 HD23 ' HB3' ' A' ' 122' ' ' TRP . 15.3 tp -84.5 139.83 31.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 111.018 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -106.8 131.33 54.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.468 . . . . 1.24 109.93 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 53' ' ' ILE . 16.1 t -134.39 142.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.12 -0.696 . . . . 0.46999999999999997 109.12 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -140.76 140.96 34.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.917 0.389 . . . . 0.31 110.83 -176.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -105.61 178.28 4.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.751 -0.833 . . . . 0.67000000000000004 108.751 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -52.18 57.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.507 0.67 . . . . 0.55000000000000004 110.463 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.57 -0.14 49.67 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.26 -0.882 . . . . 0.81000000000000005 112.836 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.76 -169.8 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.46999999999999997 110.966 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.56 152.84 16.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.651 -0.704 . . . . 0.33000000000000002 109.645 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.715 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 99.7 t -106.73 64.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.26 -1.385 . . . . 0.39000000000000001 107.26 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -93.39 6.31 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.014 -0.993 . . . . 0.98999999999999999 109.704 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 43.8 mt-10 -133.91 132.7 40.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.191 -0.913 . . . . 2.5600000000000001 109.071 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.6 OUTLIER -75.74 109.56 9.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.139 -0.689 . . . . 0.40999999999999998 109.139 -176.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.731 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 93.07 6.18 63.43 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.536 -0.756 . . . . 0.58999999999999997 112.777 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.715 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.55 147.68 52.95 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.493 -0.558 . . . . 0.34000000000000002 109.493 176.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.47 134.7 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.094 0.473 . . . . 0.55000000000000004 110.957 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 46' ' ' VAL . 7.4 tp -127.41 169.32 13.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.662 -0.866 . . . . 0.45000000000000001 108.662 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 25.1 p -121.08 156.64 56.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.287 -0.565 . . . . 0.56000000000000005 112.227 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.718 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 12.0 Cg_endo -55.5 -30.23 72.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.288 3.325 . . . . 0.68000000000000005 114.402 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -69.87 -32.48 70.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.76000000000000001 110.774 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -79.98 -29.19 39.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.846 -1.07 . . . . 1.5900000000000001 111.241 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.531 ' CG1' HD23 ' A' ' 41' ' ' LEU . 16.7 m -118.21 30.19 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.451 . . . . 0.66000000000000003 111.762 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.01 -21.08 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.601 -0.518 . . . . 0.79000000000000004 109.601 176.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -123.0 -170.85 2.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.316 -0.857 . . . . 1.9099999999999999 109.617 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.1 156.85 89.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.362 -0.607 . . . . 1.4299999999999999 109.362 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.93 153.72 25.6 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.588 1.526 . . . . 0.37 109.962 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -80.15 -14.93 58.09 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.353 -0.539 . . . . 0.44 110.555 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -161.51 143.38 11.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.457 0.54 . . . . 0.38 112.457 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.905 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -140.17 175.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.104 -1.072 . . . . 0.29999999999999999 108.104 170.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.976 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.8 t 169.56 125.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.497 0.498 . . . . 0.34999999999999998 110.039 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 60.2 p-90 -88.13 153.7 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.672 -0.862 . . . . 2.7200000000000002 108.672 173.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.76 91.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 1.51 110.954 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.66 8.71 8.09 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.836 -0.62 . . . . 0.80000000000000004 112.42 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.976 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.7 tt -56.76 129.0 39.4 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.848 0.459 . . . . 0.57999999999999996 110.857 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.39 -29.04 56.96 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.771 -0.65 . . . . 0.73999999999999999 111.744 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.669 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.2 m 74.23 0.33 3.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.475 -0.784 . . . . 1.03 110.821 -175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.31 -34.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.058 -0.591 . . . . 0.83999999999999997 113.879 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -97.34 166.72 11.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.37 0.605 . . . . 1.6699999999999999 112.076 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.746 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.0 mt -91.9 134.02 35.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.57999999999999996 110.109 -175.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.563 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 7.0 m-85 -124.35 162.83 22.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.892 0.314 . . . . 0.80000000000000004 110.194 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.478 HG23 HG12 ' A' ' 90' ' ' VAL . 86.3 m -102.15 109.74 21.51 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.557 -0.534 . . . . 0.35999999999999999 109.557 174.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 124' ' ' VAL . 53.0 tp -109.09 118.89 37.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.773 0.321 . . . . 0.58999999999999997 110.523 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.1 130.58 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.39000000000000001 110.742 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -90.88 141.91 28.33 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.756 -0.831 . . . . 0.59999999999999998 108.756 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.747 HG21 HG11 ' A' ' 17' ' ' VAL . 12.9 t -140.62 148.13 40.42 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.889 -0.324 . . . . 0.35999999999999999 110.66 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 22.5 t70 -133.82 97.44 15.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 121.265 0.555 . . . . 1.9199999999999999 109.959 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.555 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 3.4 Cg_endo -45.78 -47.63 13.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.489 3.459 . . . . 1.25 114.827 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 76' ' ' ARG . 30.1 m-20 -86.98 52.77 2.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.473 0.545 . . . . 1.29 112.473 -167.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.67 20.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.15 -0.477 . . . . 0.5 110.115 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 85.9 Cg_endo -82.14 -23.53 13.43 Favored 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.527 -1.447 . . . . 0.62 112.858 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.771 ' HB3' HG22 ' A' ' 115' ' ' THR . 6.4 p -137.74 153.66 49.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.75 110.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.501 ' HG3' ' OD1' ' A' ' 72' ' ' ASP . 78.9 ttt180 -68.82 -23.15 64.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.328 0.585 . . . . 2.8799999999999999 110.499 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.4 ptpt -76.21 -17.05 59.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.81 -0.632 . . . . 1.3799999999999999 110.496 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 7.9 t0 -162.97 72.63 2.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 1.3700000000000001 109.876 -172.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.28 87.99 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.266 1.978 . . . . 0.80000000000000004 112.179 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.3 mttm -76.27 -51.42 12.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.449 -1.25 . . . . 1.02 110.548 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 86.5 m-85 -80.37 19.29 0.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.155 -0.93 . . . . 1.1699999999999999 111.555 -171.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.695 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 17.2 ttp180 -69.54 126.64 30.34 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.16 -0.311 . . . . 2.9300000000000002 110.16 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.695 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 2.2 mp0 -98.66 135.35 40.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.945 0.402 . . . . 2.23 110.471 -4.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.61 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.7 t90 -80.94 135.45 35.88 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.15 -0.685 . . . . 1.4299999999999999 109.15 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 6.4 p80 -108.29 132.47 53.66 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.251 -0.58 . . . . 1.26 109.453 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.2 t-160 -83.75 -26.37 29.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.135 -0.484 . . . . 2.1400000000000001 111.514 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.696 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 23.4 p90 -168.74 178.55 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.302 -0.629 . . . . 1.51 109.302 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HG ' HD12 ' A' ' 103' ' ' LEU . 36.3 tp -141.41 114.26 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.155 0.285 . . . . 0.33000000000000002 110.416 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.697 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -120.39 132.4 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.422 0.63 . . . . 0.31 110.931 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.478 HG12 HG23 ' A' ' 65' ' ' THR . 13.5 m -133.46 166.02 30.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.149 -1.056 . . . . 0.27000000000000002 108.149 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t-20 62.16 17.38 9.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.742 0.306 . . . . 1.76 110.292 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.697 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.2 ttm -70.27 108.53 4.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.761 -0.829 . . . . 0.31 108.761 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.2 ttmm -83.48 90.42 7.21 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.817 -1.083 . . . . 1.21 110.633 -171.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.52 -126.62 7.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.943 -1.026 . . . . 0.29999999999999999 112.271 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 3.7 p-10 -111.78 24.2 12.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.411 0.624 . . . . 1.04 110.354 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.07 110.75 22.12 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.459 -0.791 . . . . 0.77000000000000002 110.157 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 97' ' ' ILE . 4.6 mm -62.28 -23.7 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.489 -1.232 . . . . 0.40999999999999998 111.188 -175.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.8 m -81.52 -40.74 22.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.68000000000000005 112.272 -172.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.1 p -70.64 -21.41 62.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.642 0.238 . . . . 1.26 111.642 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.22 102.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.266 -0.492 . . . . 0.34999999999999998 112.324 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.5 m -68.83 106.93 2.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.445 -0.576 . . . . 0.45000000000000001 109.445 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.589 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 14.8 p -90.72 116.21 31.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.316 -0.856 . . . . 0.56999999999999995 110.898 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.428 HD12 ' HG ' ' A' ' 88' ' ' LEU . 7.3 mt -89.59 -45.92 9.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.015 0.912 . . . . 0.45000000000000001 109.364 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.2 t -112.1 106.67 15.36 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.387 -1.708 . . . . 0.37 106.387 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.964 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.7 t0 -62.39 161.29 11.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.1499999999999999 112.529 -165.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -78.07 100.44 6.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.377 -0.829 . . . . 4.6900000000000004 108.902 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 33.1 t -71.12 -39.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.645 . . . . 0.85999999999999999 112.263 -173.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.51 171.45 28.08 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.768 -0.729 . . . . 0.67000000000000004 112.665 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.718 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 27.7 t -61.54 139.6 58.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.149 0.474 . . . . 0.51000000000000001 110.723 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.866 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -176.63 61.82 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.81999999999999995 111.613 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 177' ' ' VAL . 87.0 Cg_endo -85.46 136.18 5.42 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.553 2.169 . . . . 0.84999999999999998 112.929 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.757 ' HB2' HG21 ' A' ' 115' ' ' THR . 42.2 Cg_exo -57.51 148.18 74.23 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.77 2.313 . . . . 0.87 111.533 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.422 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -76.94 125.19 28.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.248 -0.433 . . . . 1.8500000000000001 111.092 -176.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.58 18.6 37.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.814 -0.708 . . . . 1.1799999999999999 112.049 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 75' ' ' SER . 70.3 p -103.55 -12.89 16.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.764 0.316 . . . . 0.96999999999999997 111.423 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.46 21.36 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.56 -0.616 . . . . 1.97 111.56 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -86.41 129.1 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.831 0.348 . . . . 0.93999999999999995 110.181 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.705 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.8 m-70 -94.1 115.63 27.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.89 -0.411 . . . . 2.23 109.89 177.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.572 ' HD2' HD21 ' A' ' 14' ' ' LEU . 6.0 ptt180 -104.29 84.94 2.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 2.3100000000000001 110.689 -172.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.621 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 22.2 m-85 -69.28 117.24 10.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.539 -0.755 . . . . 0.78000000000000003 109.539 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.586 ' CG2' HD22 ' A' ' 14' ' ' LEU . 11.6 t -95.9 129.24 46.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.841 -0.618 . . . . 0.27000000000000002 110.152 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.864 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.56 118.92 28.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.908 -0.587 . . . . 1.99 109.594 178.228 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.08 119.29 33.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.389 -0.226 . . . . 0.38 110.389 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -108.26 136.3 44.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.356 -0.538 . . . . 0.31 109.958 174.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.65 ' HB2' HD23 ' A' ' 160' ' ' LEU . 55.9 m-85 -113.88 144.25 43.35 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.904 -0.589 . . . . 5.1200000000000001 109.773 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.55 ' HB2' HG21 ' A' ' 164' ' ' VAL . 42.4 tt0 -105.87 112.0 24.89 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.485 -0.561 . . . . 2.4100000000000001 109.485 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.563 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.13 179.25 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.3100000000000001 109.788 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.51 -27.33 37.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.659 0.742 . . . . 2.3999999999999999 109.258 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.674 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 3.5 ptp180 -153.86 174.39 3.83 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 114.535 -1.212 . . . . 3.5099999999999998 111.619 -171.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.674 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 55.7 Cg_exo -52.23 152.8 14.22 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.096 2.53 . . . . 1.21 112.119 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.459 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.4 mm? -76.53 152.78 35.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 0.90000000000000002 111.977 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.76 68.96 0.68 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.225 -0.898 . . . . 2.8999999999999999 108.749 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 p -82.75 118.71 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.471 -0.786 . . . . 1.8999999999999999 111.159 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.36 8.88 33.87 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.703 -0.851 . . . . 2.96 108.703 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.54 116.92 47.91 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.667 -1.151 . . . . 1.3899999999999999 109.943 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.63 131.28 32.7 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.933 2.422 . . . . 1.27 112.155 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.4 mm -59.32 115.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.743 -0.466 . . . . 0.85999999999999999 109.743 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 145' ' ' HIS . 77.9 mt -96.46 -13.93 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.6100000000000001 112.422 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 2.4 m 59.91 -172.51 0.12 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.933 0.397 . . . . 1.8799999999999999 110.313 -172.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.964 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 25.1 p-10 -115.69 37.95 3.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.204 0.526 . . . . 0.75 110.207 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.636 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 6.9 mtm180 -116.29 136.08 53.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.276 0.56 . . . . 3.3599999999999999 111.809 -169.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.73 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.2 m 66.96 2.23 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.876 -1.056 . . . . 0.94999999999999996 113.585 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.63 92.49 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.508 -0.769 . . . . 1.1200000000000001 111.784 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.83 -49.97 73.82 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.047 0.758 . . . . 2.6600000000000001 113.047 -172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.595 ' HB2' HD13 ' A' ' 138' ' ' LEU . 43.1 m80 -117.0 69.24 0.75 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.868 -0.79 . . . . 1.8700000000000001 108.868 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.464 ' O ' ' HD1' ' A' ' 84' ' ' TRP . 5.1 ttm180 -73.81 -81.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.31 -1.314 . . . . 4.7300000000000004 112.189 -170.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.623 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -124.38 -168.41 12.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.174 -1.012 . . . . 0.65000000000000002 112.926 -169.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.2 mttt 67.73 29.18 6.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.603 0.716 . . . . 1.0800000000000001 110.099 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.67 113.16 25.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.882 -1.054 . . . . 1.8899999999999999 109.415 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 12.3 mmmm -69.94 127.98 34.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.313 0.578 . . . . 1.29 111.767 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.43 -33.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.992 -1.004 . . . . 0.78000000000000003 111.44 175.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.58 -35.53 80.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.67000000000000004 110.415 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.412 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 67.1 m -68.4 -35.5 77.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 -0.227 . . . . 0.77000000000000002 110.874 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.753 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 64.9 m-85 -58.96 -52.58 65.13 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.032 0.444 . . . . 0.92000000000000004 110.522 176.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 2.7 ptt-85 -69.12 -38.53 78.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.013 -0.54 . . . . 2.8900000000000001 111.422 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.5 mtmt -61.29 -28.42 69.18 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.75 0.278 . . . . 0.96999999999999997 111.75 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -54.88 -54.01 48.01 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.122 0.264 . . . . 1.5800000000000001 111.547 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.562 ' HB3' HD13 ' A' ' 160' ' ' LEU . 12.9 t80 -105.1 15.04 28.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.575 -0.85 . . . . 5.4500000000000002 110.479 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 61.91 45.91 7.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 2.4199999999999999 111.739 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.65 HD23 ' HB2' ' A' ' 125' ' ' TYR . 7.0 mp -81.52 176.35 9.75 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.472 -0.785 . . . . 1.27 110.604 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.559 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.0 tpt180 -101.74 -164.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.267 -0.424 . . . . 3.5899999999999999 110.5 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.559 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -71.44 166.17 41.76 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 109.704 -0.48 . . . . 0.76000000000000001 109.704 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 31.9 Cg_exo -55.2 138.04 78.28 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.53000000000000003 113.08 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.934 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -88.76 -29.85 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 CA-C-N 115.555 -0.748 . . . . 0.44 109.027 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.735 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.91 148.19 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.442 -0.503 . . . . 0.27000000000000002 111.358 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.761 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -151.22 147.01 16.48 Favored Glycine 0 N--CA 1.436 -1.317 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 112.273 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -165.54 139.67 4.69 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.431 -0.951 . . . . 0.34000000000000002 108.431 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.646 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 16.6 p -118.63 144.95 45.81 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 1.1100000000000001 111.265 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.2 p90 -127.85 127.1 42.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.655 -1.239 . . . . 0.80000000000000004 107.655 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.705 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 1.3 pt20 -106.03 133.17 51.16 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.659 -0.651 . . . . 2.5299999999999998 111.734 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -128.92 145.96 51.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.195 -0.911 . . . . 0.59999999999999998 109.616 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.409 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -121.36 -172.3 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.661 0.267 . . . . 2.3799999999999999 110.863 -177.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.981 ' HA ' HG21 ' A' ' 177' ' ' VAL . 29.9 t90 -74.76 82.8 2.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.74 -0.467 . . . . 3.96 109.74 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.47 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.3 OUTLIER -72.09 -61.62 1.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.867 -0.606 . . . . 1.53 111.293 176.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.573 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.4 t70 169.55 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.826 0.704 . . . . 1.26 109.644 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 60.7 m-85 -81.22 10.82 4.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.219 0.533 . . . . 2.2200000000000002 111.346 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.981 HG21 ' HA ' ' A' ' 173' ' ' TRP . 74.8 t -72.31 -49.39 9.32 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.5 110.712 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.8 Cg_exo -49.05 -26.34 10.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.947 2.431 . . . . 0.57999999999999996 113.06 170.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 18.1 mmmt -67.4 -24.65 65.69 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.34 0.256 . . . . 2.1400000000000001 111.629 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.866 HD23 ' HA3' ' A' ' 110' ' ' GLY . 21.5 tp -78.25 -40.75 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.112 -0.635 . . . . 0.66000000000000003 109.358 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.65 -35.26 74.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.944 -0.762 . . . . 1.8899999999999999 108.944 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 0.9 OUTLIER -55.51 -56.49 19.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.495 -1.23 . . . . 1.53 109.73 172.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -69.6 -39.02 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.705 -1.134 . . . . 1.49 112.549 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.73 ' HA ' ' H ' ' A' ' 142' ' ' SER . 74.1 mt -71.5 6.99 1.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 111.686 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.511 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 19.9 m -77.76 -3.45 41.34 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.31 -0.626 . . . . 1.05 109.31 168.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.636 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 75.1 49.67 9.36 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.839 -0.904 . . . . 1.1699999999999999 110.839 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.1 mmtp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.678 -0.677 . . . . 2.0 110.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 121.051 0.453 . . . . 1.47 111.953 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -146.13 160.53 41.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.889 -1.152 . . . . 1.8100000000000001 107.889 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 30.78 0.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.69999999999999996 111.005 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -76.92 -18.44 58.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.139 0.495 . . . . 1.96 110.517 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -114.36 33.44 5.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.052 0.453 . . . . 2.6600000000000001 110.25 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.732 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.1 p90 -73.89 -28.2 61.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 3.98 111.921 -174.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -147.65 11.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.63 110.641 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -76.75 -118.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.84 -0.618 . . . . 0.47999999999999998 111.671 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.2 Cg_endo -49.21 -45.89 28.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.232 2.621 . . . . 0.53000000000000003 110.703 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.755 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 9.4 mp -89.72 102.21 14.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.298 -0.864 . . . . 1.1699999999999999 111.249 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 65.98 2.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.70999999999999996 110.408 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 121' ' ' VAL . 22.0 mt -74.32 -17.45 60.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.45000000000000001 111.423 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -69.65 -5.99 28.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.294 -0.412 . . . . 2.1200000000000001 111.44 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.14 -14.12 60.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.938 0.399 . . . . 1.9299999999999999 111.41 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.924 HG11 HG21 ' A' ' 69' ' ' THR . 60.9 t -91.49 -71.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.509 -0.769 . . . . 0.63 110.744 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.541 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 23.4 t0 -155.26 176.38 12.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.483 -0.932 . . . . 2.9900000000000002 108.483 -170.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.89 100.1 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.864 -0.421 . . . . 1.6000000000000001 109.864 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.732 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -43.14 128.58 3.41 Favored Pre-proline 0 C--O 1.234 0.283 0 O-C-N 124.142 0.901 . . . . 3.5499999999999998 110.38 -176.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 53.0 Cg_exo -52.87 166.86 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.499 2.799 . . . . 0.57999999999999996 114.516 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.88 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 9.7 pt20 -84.16 -11.88 55.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.474 -1.239 . . . . 1.3899999999999999 111.812 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.73 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 14.8 m-70 -147.02 157.78 45.94 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 123.11 0.564 . . . . 1.45 110.072 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.42 123.5 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.326 2.684 . . . . 0.40000000000000002 111.652 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 16.9 tp -79.06 136.36 37.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.716 0.294 . . . . 0.28999999999999998 110.732 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.31 117.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.924 -0.399 . . . . 1.24 109.924 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.871 HG13 HG22 ' A' ' 53' ' ' ILE . 26.4 t -123.27 144.62 32.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.171 -0.678 . . . . 0.46999999999999997 109.171 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 144.22 32.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.797 0.332 . . . . 0.31 110.701 -173.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.469 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 17.8 t80 -108.92 178.52 4.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 0.67000000000000004 109.348 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -52.8 64.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 0.55000000000000004 110.843 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.69 11.23 15.84 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.596 -0.729 . . . . 0.81000000000000005 112.494 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.44 -171.3 3.38 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.877 0.37 . . . . 0.46999999999999997 110.164 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.69 154.23 17.94 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.88 -0.6 . . . . 0.33000000000000002 109.543 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.8 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 89.9 t -100.16 61.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 106.968 -1.493 . . . . 0.39000000000000001 106.968 166.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -96.14 27.68 3.56 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.402 -1.272 . . . . 0.98999999999999999 109.301 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -153.98 125.76 7.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.917 -1.142 . . . . 2.5600000000000001 107.917 173.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.8 OUTLIER -74.67 110.38 8.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.081 0.467 . . . . 0.40999999999999998 109.963 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.78 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 98.81 -3.27 58.81 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.635 -0.793 . . . . 0.58999999999999997 112.483 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -62.85 150.44 41.72 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.304 0.242 . . . . 0.34000000000000002 110.393 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.61 127.57 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.55000000000000004 110.672 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 34' ' ' VAL . 5.7 tp -115.87 169.72 9.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.153 -1.425 . . . . 0.45000000000000001 107.153 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 2.6 p -113.47 150.17 42.77 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.88 -1.128 . . . . 0.56000000000000005 113.369 -174.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 35.8 Cg_exo -61.23 -27.78 84.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.208 3.272 . . . . 0.68000000000000005 113.196 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.426 HG22 ' CD2' ' A' ' 176' ' ' TYR . 10.4 p -65.3 -40.28 93.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.84 . . . . 0.76000000000000001 109.972 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -81.46 -50.87 8.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.466 -1.243 . . . . 1.5900000000000001 111.399 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.79 ' HB ' ' HE2' ' A' ' 169' ' ' TYR . 3.8 m -85.56 25.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.209 0.528 . . . . 0.66000000000000003 112.366 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -81.25 -20.03 41.84 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.083 -0.71 . . . . 0.79000000000000004 109.083 175.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -119.5 -161.88 0.89 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.84 -1.073 . . . . 1.9099999999999999 110.052 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.645 HH22 HG21 ' A' ' 89' ' ' VAL . 29.5 mtp180 -91.38 165.84 20.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.168 -0.308 . . . . 1.4299999999999999 110.168 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 57.3 Cg_endo -75.81 169.13 22.85 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.912 1.742 . . . . 0.37 110.725 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -91.3 -18.39 24.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.787 -0.365 . . . . 0.44 110.121 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.0 m -160.77 142.52 12.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.38 112.101 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.871 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -137.99 168.21 20.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.322 -0.992 . . . . 0.29999999999999999 108.322 171.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.953 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.3 t 169.18 122.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.368 0.417 . . . . 0.34999999999999998 110.333 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.562 ' CB ' ' HB2' ' A' ' 165' ' ' ALA . 46.8 p-90 -82.65 150.99 26.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.165 -1.42 . . . . 2.7200000000000002 107.165 169.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -68.28 87.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.826 0.822 . . . . 1.51 111.15 -174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.71 -1.38 3.2 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.919 -1.037 . . . . 0.80000000000000004 111.626 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.953 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.8 tt -52.17 128.61 25.42 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.087 0.555 . . . . 0.57999999999999996 110.336 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.808 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 33.9 t70 -75.09 -27.18 59.8 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.73999999999999999 111.757 -173.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.634 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 15.9 m 73.03 2.56 4.42 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.979 -1.01 . . . . 1.03 110.192 -172.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.81 -9.06 2.6 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.127 -0.559 . . . . 0.83999999999999997 113.5 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.808 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 35.4 mtpt -94.75 161.05 14.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.251 0.525 . . . . 1.6699999999999999 109.918 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 60.8 mt -95.11 134.49 37.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.399 -0.593 . . . . 0.57999999999999996 109.399 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -133.59 145.92 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.42 -0.585 . . . . 0.80000000000000004 109.42 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.653 HG23 HG12 ' A' ' 90' ' ' VAL . 60.2 m -95.96 105.27 17.27 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.704 -0.85 . . . . 0.35999999999999999 108.704 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.737 HD13 HG12 ' A' ' 124' ' ' VAL . 49.3 tp -100.54 109.93 22.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.58999999999999997 110.193 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 88' ' ' LEU . 27.4 t -110.15 121.1 62.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.39000000000000001 110.533 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.974 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.0 mt -81.91 138.98 34.91 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.465 -0.939 . . . . 0.59999999999999998 108.465 167.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.924 HG21 HG11 ' A' ' 17' ' ' VAL . 8.9 t -144.79 147.39 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.858 -0.337 . . . . 0.35999999999999999 110.858 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 9.1 t0 -131.84 95.56 22.37 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.546 0.688 . . . . 1.9199999999999999 109.745 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 18.8 Cg_endo -60.01 -11.63 16.11 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 124.126 3.217 . . . . 1.25 114.065 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 118' ' ' HIS . 2.3 t70 -106.61 26.46 9.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.405 0.621 . . . . 1.29 110.431 -167.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' A' ' 84' ' ' TRP . . . -103.33 144.79 29.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.052 -0.522 . . . . 0.5 111.591 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -84.86 -24.47 10.2 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.207 -1.58 . . . . 0.62 112.819 -0.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.594 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 62.1 p -134.72 149.67 50.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.75 109.371 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.69 -26.86 64.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 2.8799999999999999 111.473 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.667 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -69.82 -23.5 63.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.44 -0.345 . . . . 1.3799999999999999 111.025 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -157.62 84.03 2.84 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.912 0.386 . . . . 1.3700000000000001 110.379 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.5 81.54 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.593 2.195 . . . . 0.80000000000000004 112.025 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.2 mttm -66.68 -48.18 70.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.295 -1.321 . . . . 1.02 111.46 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 48.7 m-85 -83.59 8.82 13.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.343 -0.844 . . . . 1.1699999999999999 112.16 -166.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 53.9 ttp180 -58.28 122.79 14.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 2.9300000000000002 110.794 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mp0 -101.14 131.93 46.85 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.839 0.352 . . . . 2.23 110.796 -2.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 12.5 t90 -79.52 93.66 5.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 1.4299999999999999 110.113 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.9 p-80 -67.44 123.8 21.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.352 0.596 . . . . 1.26 109.421 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.974 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 11.5 t60 -76.64 -30.76 56.99 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.622 -0.717 . . . . 2.1400000000000001 110.324 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.0 p90 -168.48 174.2 7.03 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.6 -0.519 . . . . 1.51 109.6 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' A' ' 103' ' ' LEU . 19.7 tp -134.55 114.2 12.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.907 -0.405 . . . . 0.33000000000000002 109.907 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.645 HG21 HH22 ' A' ' 49' ' ' ARG . 1.7 t -123.54 131.76 72.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.757 -0.656 . . . . 0.31 110.903 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.653 HG12 HG23 ' A' ' 65' ' ' THR . 15.0 m -133.28 163.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.957 -1.02 . . . . 0.27000000000000002 108.529 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.0 OUTLIER 62.85 18.34 10.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.333 0.396 . . . . 1.76 110.008 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.473 ' HE3' HG11 ' A' ' 89' ' ' VAL . 5.4 ttm -69.94 106.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.074 -0.713 . . . . 0.31 109.074 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 12.9 ttmm -84.21 89.72 7.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.616 -1.175 . . . . 1.21 110.697 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 82.48 -127.18 7.82 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.875 -1.057 . . . . 0.29999999999999999 112.632 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 26.5 p-10 -115.6 24.02 11.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 1.04 111.432 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -89.42 105.71 17.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.378 0.608 . . . . 0.77000000000000002 109.729 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.546 HD13 HD12 ' A' ' 53' ' ' ILE . 10.7 mm -49.98 -35.91 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.291 -1.322 . . . . 0.40999999999999998 111.387 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 m -80.88 -31.49 35.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.685 -0.689 . . . . 0.68000000000000005 111.834 -172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -72.76 -11.21 60.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 1.26 111.565 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.0 102.33 1.05 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.554 -0.831 . . . . 0.34999999999999998 111.602 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.9 m -61.98 109.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.478 0.656 . . . . 0.45000000000000001 110.066 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.6 p -83.2 117.49 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.825 -1.079 . . . . 0.56999999999999995 111.588 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.3 mt -92.85 -39.02 11.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.018 0.913 . . . . 0.45000000000000001 109.372 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 22.0 t -127.44 110.27 12.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.446 -1.316 . . . . 0.37 107.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.998 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -56.76 161.78 2.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.122 0.889 . . . . 1.1499999999999999 112.921 -170.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -83.86 101.33 11.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.37 -0.832 . . . . 4.6900000000000004 110.283 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.748 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 25.9 t -69.3 -41.46 81.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.893 -0.594 . . . . 0.85999999999999999 111.748 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.39 -176.55 24.39 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.67000000000000004 112.333 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.463 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 27.0 t -63.7 123.17 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.67 0.235 . . . . 0.51000000000000001 110.803 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -154.3 61.74 0.37 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.9 -0.667 . . . . 0.81999999999999995 112.708 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 73.9 Cg_endo -94.51 123.35 0.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.922 2.415 . . . . 0.84999999999999998 112.669 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.655 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.7 Cg_exo -52.56 140.77 54.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.884 2.39 . . . . 0.87 111.814 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.542 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -64.53 125.31 24.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.141 0.495 . . . . 1.8500000000000001 110.839 -177.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.08 -4.02 60.55 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.615 -0.802 . . . . 1.1799999999999999 112.856 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.655 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 74.0 p -78.1 -15.82 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.699 -0.295 . . . . 0.96999999999999997 111.261 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 171.33 39.37 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.876 -0.602 . . . . 1.97 111.862 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 172' ' ' GLU . 3.7 mm? -82.37 115.58 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.956 -0.757 . . . . 0.93999999999999995 108.956 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.774 ' N ' ' HG2' ' A' ' 170' ' ' GLN . 75.2 m-70 -88.61 -134.3 0.09 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.2 -0.667 . . . . 2.23 109.2 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.755 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 2.8 ptt180 -176.53 100.9 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.743 0.646 . . . . 2.3100000000000001 112.743 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' HD1' ' HB2' ' A' ' 70' ' ' ASP . 19.3 m-85 -77.78 106.79 9.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.359 -0.978 . . . . 0.78000000000000003 108.359 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.886 HG21 HD22 ' A' ' 14' ' ' LEU . 5.2 t -96.26 133.48 37.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.412 -0.358 . . . . 0.27000000000000002 110.122 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.8 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -87.74 119.41 28.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.652 -0.499 . . . . 1.99 109.652 178.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.5 mt -115.31 117.77 31.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.71 -0.478 . . . . 0.38 109.71 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.737 HG12 HD13 ' A' ' 66' ' ' LEU . 1.7 m -104.18 128.93 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.179 -0.608 . . . . 0.31 109.663 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.522 ' HD2' ' O ' ' A' ' 161' ' ' ARG . 21.0 m-85 -109.72 124.76 51.8 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.069 -0.715 . . . . 5.1200000000000001 109.069 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.92 131.15 43.99 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.346 -0.541 . . . . 2.4100000000000001 109.689 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 20.7 mt-30 -93.7 130.35 39.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.943 -0.572 . . . . 1.3100000000000001 111.044 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.69 -11.17 59.85 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.509 -0.922 . . . . 2.3999999999999999 108.509 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 1.1 ptt180 -164.71 150.57 8.95 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 114.44 -1.255 . . . . 3.5099999999999998 109.919 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HB3' ' OD1' ' A' ' 91' ' ' ASN . 15.1 Cg_exo -66.56 132.68 29.72 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.198 2.599 . . . . 1.21 112.49 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 133' ' ' CYS . 3.6 mm? -64.17 151.69 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.753 -0.658 . . . . 0.90000000000000002 111.335 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 39.08 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.25 1.024 . . . . 2.8999999999999999 109.866 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.762 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.7 m -53.44 138.49 33.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.51 -1.677 . . . . 1.8999999999999999 113.058 -172.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.55 18.18 10.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.07 -0.968 . . . . 2.96 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.762 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.8 mm-40 -69.14 126.71 92.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.758 -0.655 . . . . 1.3899999999999999 110.413 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.06 116.43 2.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.162 2.575 . . . . 1.27 112.288 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mm -63.0 115.08 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.85999999999999999 110.553 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 67.5 mt -100.61 146.4 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.533 -0.543 . . . . 1.6100000000000001 109.533 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 141' ' ' ARG . 55.5 m -111.35 35.39 3.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.721 -0.672 . . . . 1.8799999999999999 111.234 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.998 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.4 OUTLIER 63.22 -18.61 0.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.027 1.331 . . . . 0.75 113.537 175.055 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.4 mtt180 -84.55 135.9 34.02 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.188 -0.301 . . . . 3.3599999999999999 110.188 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.647 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.9 m 81.97 131.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.97 1.419 . . . . 0.94999999999999996 110.641 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.12 33.98 5.91 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 112.399 -175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.01 -30.48 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.625 0.25 . . . . 2.6600000000000001 111.424 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.99 70.61 1.35 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.211 0.529 . . . . 1.8700000000000001 111.013 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 49.3 mtt180 -79.94 -66.06 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 4.7300000000000004 110.419 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.467 ' H ' ' HD1' ' A' ' 81' ' ' TYR . . . -130.36 -143.42 5.36 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.693 -0.765 . . . . 0.65000000000000002 112.079 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.685 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 64.83 23.55 12.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.516 0.674 . . . . 1.0800000000000001 110.473 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -119.79 125.97 49.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.997 -1.002 . . . . 1.8899999999999999 108.394 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -76.9 127.76 33.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.333 0.587 . . . . 1.29 111.703 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.899 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 4.5 m -61.01 -31.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.04 -0.982 . . . . 0.78000000000000003 110.967 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.74 -39.77 92.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.773 -0.649 . . . . 0.67000000000000004 109.999 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.7 m -67.56 -34.77 77.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.396 -0.366 . . . . 0.77000000000000002 111.127 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.899 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 33.2 m-85 -59.28 -50.32 74.46 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.92000000000000004 110.058 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -63.02 -50.15 71.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.875 -1.057 . . . . 2.8900000000000001 111.139 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.0 mtmt -62.32 -27.92 69.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.281 -0.418 . . . . 0.96999999999999997 111.766 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -53.98 -53.48 52.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.193 -0.458 . . . . 1.5800000000000001 111.352 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.512 ' CG ' HD13 ' A' ' 131' ' ' LEU . 54.0 t80 -103.97 9.92 36.41 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.274 -0.571 . . . . 5.4500000000000002 111.222 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 65.37 44.0 3.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.558 0.694 . . . . 2.4199999999999999 110.18 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 160' ' ' LEU . 2.3 tp -78.45 164.68 24.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.062 -0.972 . . . . 1.27 111.037 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.633 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 22.4 tpt180 -86.9 -179.47 6.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 3.5899999999999999 109.763 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.633 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -75.93 160.4 78.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.119 -0.326 . . . . 0.76000000000000001 110.119 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.69 141.97 96.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.802 2.335 . . . . 0.53000000000000003 113.201 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.88 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.1 t -95.06 -39.44 10.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.608 -0.723 . . . . 0.44 110.15 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -136.94 145.02 43.74 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.035 -0.666 . . . . 0.27000000000000002 111.794 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.8 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.39 149.11 21.22 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.258 -0.883 . . . . 0.23999999999999999 112.626 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 25' ' ' LEU . 12.5 t -170.59 142.0 1.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.369 -0.604 . . . . 0.34000000000000002 109.369 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.78 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -108.9 144.72 36.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.032 0.444 . . . . 1.1100000000000001 111.93 -174.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.79 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 1.9 p90 -137.63 105.5 5.64 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.007 -0.738 . . . . 0.80000000000000004 109.007 171.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.774 ' HG2' ' N ' ' A' ' 118' ' ' HIS . 48.4 tp60 -100.39 169.61 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.679 -1.263 . . . . 2.5299999999999998 112.132 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' A' ' 170' ' ' GLN . . . -146.23 160.19 42.31 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.134 -0.691 . . . . 0.59999999999999998 109.134 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HB3' HD11 ' A' ' 117' ' ' LEU . 12.4 pt-20 -109.44 -171.99 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.314 -0.403 . . . . 2.3799999999999999 110.448 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.589 ' CZ2' ' HG3' ' A' ' 178' ' ' PRO . 8.3 t90 -80.48 68.85 6.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.435 . . . . 3.96 109.897 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.8 -61.33 1.82 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.453 -0.34 . . . . 1.53 111.839 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 16.6 t70 -168.94 -55.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.088 0.403 . . . . 1.26 112.088 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.426 ' CD2' HG22 ' A' ' 44' ' ' THR . 50.7 m-85 -81.57 11.21 4.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.48 0.548 . . . . 2.2200000000000002 112.48 -176.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.737 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 91.3 t -71.61 -53.68 7.23 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.579 -0.526 . . . . 0.5 109.579 171.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.0 Cg_exo -49.74 -43.22 41.16 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.706 2.271 . . . . 0.57999999999999996 112.603 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.669 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 4.7 mmmp? -70.35 -24.69 63.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.896 0.332 . . . . 2.1400000000000001 111.896 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.671 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 51.7 tp -70.39 -47.63 59.95 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.333 -0.617 . . . . 0.66000000000000003 109.333 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.22 -37.44 77.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 1.8899999999999999 109.449 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 4.8 mm-40 -60.14 -45.68 92.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.91 -1.041 . . . . 1.53 111.271 172.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.07 -32.49 72.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 1.49 111.864 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 63.4 mt -63.13 0.11 0.66 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.149 0.796 . . . . 0.76000000000000001 113.149 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.445 ' HB2' ' HE2' ' A' ' 187' ' ' LYS . 14.5 m -74.07 -9.86 59.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.305 0.574 . . . . 1.05 109.967 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.61 58.26 3.9 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.591 -1.003 . . . . 1.1699999999999999 110.591 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 182' ' ' GLU . 71.1 mmtt . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.341 -0.838 . . . . 2.0 110.655 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 121.307 0.575 . . . . 1.47 111.647 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -155.22 154.81 32.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.562 -0.533 . . . . 1.8100000000000001 109.562 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.461 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.3 mm? -81.19 27.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.48 0.178 . . . . 0.69999999999999996 111.48 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 2.0 m -62.5 -29.89 70.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.991 0.424 . . . . 1.96 111.391 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 12' ' ' LEU . 6.8 mptt -120.66 51.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.397 -0.365 . . . . 2.6600000000000001 110.109 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.42 ' HE3' ' O ' ' A' ' 5' ' ' LEU . 12.9 p90 -72.39 -23.32 61.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.45 . . . . 3.98 111.244 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 70.7 p -148.34 7.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.427 -0.509 . . . . 0.63 112.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.14 -122.28 0.08 OUTLIER Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.806 -0.711 . . . . 0.47999999999999998 112.102 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.0 Cg_endo -49.37 -42.35 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.259 2.639 . . . . 0.53000000000000003 110.253 168.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.597 HD11 ' HA3' ' A' ' 38' ' ' GLY . 17.7 mt -88.0 81.98 7.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.646 -1.161 . . . . 1.1699999999999999 109.323 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -74.7 62.14 1.04 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.542 0.687 . . . . 0.70999999999999996 110.438 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 121' ' ' VAL . 36.4 mt -79.04 -19.93 50.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.183 -0.917 . . . . 0.45000000000000001 110.922 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -61.13 -15.5 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 2.1200000000000001 111.262 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.7 -32.8 74.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 110.984 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.501 HG12 HG21 ' A' ' 151' ' ' VAL . 98.1 t -90.33 -64.15 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.532 -0.758 . . . . 0.63 110.883 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HA ' HH22 ' A' ' 155' ' ' ARG . 5.8 p-10 -115.06 175.95 5.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.077 0.465 . . . . 2.9900000000000002 111.101 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 20.6 mt-10 -95.09 33.92 1.46 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.879 -0.6 . . . . 1.6000000000000001 111.412 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER 52.38 133.67 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.217 1.407 . . . . 3.5499999999999998 113.459 -176.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' CA ' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -80.74 154.17 20.23 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.843 2.362 . . . . 0.57999999999999996 113.711 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.848 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 6.3 pt20 -74.51 -18.75 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.793 -1.094 . . . . 1.3899999999999999 111.011 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.77 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.1 m80 -145.93 156.87 51.34 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.525 -0.761 . . . . 1.45 109.7 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 5.0 Cg_endo -85.83 127.43 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 123.056 2.504 . . . . 0.40000000000000002 111.16 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.452 HD23 ' CB ' ' A' ' 122' ' ' TRP . 17.9 tp -76.97 142.04 40.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.492 -0.322 . . . . 0.28999999999999998 110.572 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 27.0 m-70 -109.26 115.58 30.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.565 -0.531 . . . . 1.24 109.565 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.862 HG13 HG22 ' A' ' 53' ' ' ILE . 15.2 t -126.48 119.81 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 0.46999999999999997 109.691 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -117.68 138.8 51.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.158 0.504 . . . . 0.31 110.411 -177.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -98.16 172.41 7.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.94 -0.573 . . . . 0.67000000000000004 109.474 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.8 -52.28 64.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.215 0.531 . . . . 0.55000000000000004 110.739 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.98 -14.68 14.46 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.351 -0.84 . . . . 0.81000000000000005 112.549 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.37 -170.0 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.021 0.438 . . . . 0.46999999999999997 110.614 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -162.74 141.76 8.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.762 -0.653 . . . . 0.33000000000000002 110.464 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 92.6 t -91.73 61.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.929 -1.508 . . . . 0.39000000000000001 106.929 165.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -85.59 10.61 12.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.672 -1.149 . . . . 0.98999999999999999 110.702 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.1 tt0 -146.16 134.38 21.71 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.732 -0.667 . . . . 2.5600000000000001 109.431 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.786 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -73.48 111.27 8.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.46 -0.571 . . . . 0.40999999999999998 109.46 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.597 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 90.5 17.59 51.96 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.156 -0.545 . . . . 0.58999999999999997 112.548 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.85 150.68 32.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 0.34000000000000002 109.703 174.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 12.9 p -78.73 134.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.55000000000000004 110.66 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.5 tp -131.37 169.7 15.66 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.276 -1.009 . . . . 0.45000000000000001 108.276 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 3.3 p -122.01 158.1 55.97 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.623 0.601 . . . . 0.56000000000000005 112.623 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 9.5 Cg_endo -51.35 -48.76 19.69 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.528 2.819 . . . . 0.68000000000000005 113.818 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 p -61.73 -32.84 73.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 0.76000000000000001 111.687 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -80.73 -11.44 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.995 -0.548 . . . . 1.5900000000000001 111.604 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.528 ' CG1' HD23 ' A' ' 41' ' ' LEU . 29.4 m -129.65 28.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.354 0.597 . . . . 0.66000000000000003 111.112 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.32 -21.77 25.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.555 -0.748 . . . . 0.79000000000000004 110.135 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.03 -173.0 2.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.839 -0.618 . . . . 1.9099999999999999 109.569 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.86 155.38 77.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.108 -0.33 . . . . 1.4299999999999999 110.108 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.6 152.87 29.9 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.117 1.878 . . . . 0.37 110.732 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 t -76.8 -18.25 58.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.419 -0.355 . . . . 0.44 110.057 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 58.8 m -160.33 143.29 13.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.556 0.693 . . . . 0.38 112.363 -176.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.862 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -138.66 168.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.864 -1.162 . . . . 0.29999999999999999 107.864 170.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.024 ' HA ' HD13 ' A' ' 58' ' ' LEU . 37.3 t 171.96 123.9 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.484 -0.561 . . . . 0.34999999999999998 109.484 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.724 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.3 p-90 -82.23 154.75 25.26 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.862 -1.162 . . . . 2.7200000000000002 107.862 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.59 89.13 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.009 0.433 . . . . 1.51 110.861 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.91 13.09 4.64 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.487 -0.778 . . . . 0.80000000000000004 112.011 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.024 HD13 ' HA ' ' A' ' 54' ' ' SER . 5.3 tt -54.23 129.52 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.19 0.519 . . . . 0.57999999999999996 111.267 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.778 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 36.1 t70 -76.42 -27.93 56.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.73999999999999999 111.531 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 50.2 m 72.91 1.0 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.054 -0.975 . . . . 1.03 110.52 -172.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.65 -26.87 1.52 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.69 -0.686 . . . . 0.83999999999999997 112.733 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.778 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 34.3 mtpt -77.53 149.27 34.93 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.086 0.469 . . . . 1.6699999999999999 110.549 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.636 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 43.0 mt -87.69 126.72 35.14 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.163 -0.926 . . . . 0.57999999999999996 108.736 173.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.7 m-85 -121.44 163.69 18.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.52 -0.472 . . . . 0.80000000000000004 110.168 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.981 HG23 HG12 ' A' ' 90' ' ' VAL . 4.0 m -106.56 105.35 15.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.129 -0.693 . . . . 0.35999999999999999 109.129 173.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.618 HD13 HG12 ' A' ' 124' ' ' VAL . 52.8 tp -102.8 116.34 32.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.001 0.429 . . . . 0.58999999999999997 110.517 -176.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.6 t -119.78 129.91 74.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.049 -0.523 . . . . 0.39000000000000001 110.67 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.1 mt -93.38 137.06 33.05 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.791 -0.818 . . . . 0.59999999999999998 108.791 171.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 7.0 t -139.47 149.2 43.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.656 0.265 . . . . 0.35999999999999999 111.65 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.56 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 16.0 t0 -133.8 90.71 26.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.538 0.685 . . . . 1.9199999999999999 109.697 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.9 Cg_endo -54.81 -26.54 48.31 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 124.034 3.156 . . . . 1.25 114.431 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 58.5 m-20 -85.16 36.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.065 0.395 . . . . 1.29 112.065 -168.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.93 140.34 20.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.19 -0.319 . . . . 0.5 111.566 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.0 Cg_endo -78.88 -28.04 7.86 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 122.848 -1.73 . . . . 0.62 112.037 -0.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -133.37 143.47 48.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.182 -0.917 . . . . 0.75 108.761 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 37.3 ttp180 -72.33 -23.08 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 2.8799999999999999 112.23 -174.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.763 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -75.57 -11.51 60.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.49 . . . . 1.3799999999999999 110.419 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -162.14 75.5 2.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 1.3700000000000001 109.572 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.06 103.33 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.656 2.237 . . . . 0.80000000000000004 112.994 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.6 mttm -88.05 -48.64 7.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.704 -1.134 . . . . 1.02 110.918 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.739 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 56.0 m-85 -80.45 2.4 25.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.14 -0.937 . . . . 1.1699999999999999 112.336 -165.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.3 ttp180 -60.62 128.69 37.84 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.241 -0.651 . . . . 2.9300000000000002 109.241 172.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 6.1 tm-20 -88.45 128.71 35.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.933 0.893 . . . . 2.23 110.903 2.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.44 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 22.1 t90 -114.75 91.92 3.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.819 -0.628 . . . . 1.4299999999999999 109.86 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 4.5 p-80 -83.92 158.88 21.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.061 0.934 . . . . 1.26 112.535 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 1.079 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t-80 -100.99 -38.45 8.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.047 -1.433 . . . . 2.1400000000000001 111.378 -172.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 55.3 t80 -167.11 137.58 3.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.076 -0.249 . . . . 1.51 110.469 -165.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.56 ' CD1' HG22 ' A' ' 67' ' ' VAL . 22.4 tp -126.74 114.42 17.95 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.249 0.343 . . . . 0.33000000000000002 110.41 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -123.79 135.93 61.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.421 0.629 . . . . 0.31 110.823 175.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.981 HG12 HG23 ' A' ' 65' ' ' THR . 8.1 m -130.19 162.65 37.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.27000000000000002 108.851 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.662 ' H ' HD23 ' A' ' 131' ' ' LEU . 1.0 OUTLIER 61.54 20.21 11.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.321 0.388 . . . . 1.76 110.863 177.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 89' ' ' VAL . 11.2 ttm -70.49 111.31 5.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.83 -0.804 . . . . 0.31 108.83 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.449 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 18.1 ttmm -87.78 87.4 7.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.893 -1.048 . . . . 1.21 110.341 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 88.57 -129.52 9.65 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 114.878 -1.055 . . . . 0.29999999999999999 112.495 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 32.3 p30 -116.17 27.13 9.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 1.04 110.888 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -93.93 112.51 24.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.77000000000000002 109.924 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 53' ' ' ILE . 5.6 mm -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.578 -1.192 . . . . 0.40999999999999998 111.231 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.9 m -85.59 -34.33 21.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.887 -0.597 . . . . 0.68000000000000005 112.023 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -63.49 -29.4 70.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.26 111.766 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.21 110.91 2.74 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.791 -0.64 . . . . 0.34999999999999998 113.471 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.0 m -70.58 107.43 3.88 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.195 -0.668 . . . . 0.45000000000000001 109.195 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 105' ' ' ASP . 8.3 p -87.29 145.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.67 0.748 . . . . 0.56999999999999995 111.989 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.531 HD12 ' HG ' ' A' ' 88' ' ' LEU . 13.8 mt -119.4 -32.3 4.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.689 -1.141 . . . . 0.45000000000000001 109.12 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 14.7 t -131.55 102.02 5.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.769 -1.196 . . . . 0.37 107.769 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.923 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.9 OUTLIER -64.59 169.07 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 1.1499999999999999 113.2 -167.326 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' H ' ' HD1' ' A' ' 106' ' ' TYR . 4.1 p90 -74.34 88.73 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.947 -1.024 . . . . 4.6900000000000004 110.936 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.68 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 23.8 t -66.49 -49.15 77.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.85999999999999999 111.082 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.53 -170.18 13.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.798 -0.715 . . . . 0.67000000000000004 112.338 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.9 t -67.3 125.56 26.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 0.51000000000000001 109.824 173.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.721 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -159.01 63.55 0.3 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.615 -0.802 . . . . 0.81999999999999995 112.922 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.554 ' HB2' ' HD1' ' A' ' 173' ' ' TRP . 10.1 Cg_endo -89.68 133.73 2.21 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.884 2.39 . . . . 0.84999999999999998 111.844 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.712 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 53.0 Cg_exo -53.32 129.35 33.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.149 . . . . 0.87 111.196 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.553 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.8 OUTLIER -60.56 121.36 11.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.191 0.52 . . . . 1.8500000000000001 111.712 -174.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.68 -6.39 52.21 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.479 -0.782 . . . . 1.1799999999999999 113.252 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.712 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -80.65 -5.98 57.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.2 0.444 . . . . 0.96999999999999997 112.2 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.62 178.38 45.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.915 -0.659 . . . . 1.97 111.571 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.56 144.93 56.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.93999999999999995 110.657 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 1.0 OUTLIER -121.93 130.88 53.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.138 -0.69 . . . . 2.23 109.138 174.259 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.634 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 8.4 ptp85 -110.72 95.71 5.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.4 0.619 . . . . 2.3100000000000001 111.361 -170.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 69' ' ' THR . 36.8 m-85 -73.87 113.55 11.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.78000000000000003 109.357 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.682 HG21 HD22 ' A' ' 14' ' ' LEU . 7.1 t -90.52 129.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.604 -0.726 . . . . 0.27000000000000002 110.062 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.665 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 77.4 m95 -87.54 117.98 26.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.943 -1.132 . . . . 1.99 107.943 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.52 118.37 30.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.24 -0.184 . . . . 0.38 110.557 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.618 HG12 HD13 ' A' ' 66' ' ' LEU . 1.2 m -105.33 128.24 59.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.342 -0.614 . . . . 0.31 109.342 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.47 ' HB2' HD23 ' A' ' 160' ' ' LEU . 88.2 m-85 -110.62 146.53 35.98 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.794 -0.639 . . . . 5.1200000000000001 109.618 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.648 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.9 tt0 -105.58 109.88 22.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.028 -0.533 . . . . 2.4100000000000001 109.954 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.642 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -72.38 172.52 10.25 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.447 -0.797 . . . . 1.3100000000000001 109.644 177.19 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -85.59 -15.21 43.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.794 -0.639 . . . . 2.3999999999999999 109.397 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.51 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 5.2 ppt_? -158.1 168.5 12.32 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.138 -0.937 . . . . 3.5099999999999998 110.861 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 87.2 Cg_exo -47.93 147.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.045 2.497 . . . . 1.21 113.025 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.803 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -71.5 157.05 38.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.795 -0.638 . . . . 0.90000000000000002 112.006 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -146.93 79.36 1.52 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.092 -0.958 . . . . 2.8999999999999999 108.493 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.576 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 3.5 m -102.25 139.9 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.086 0.469 . . . . 1.8999999999999999 111.183 -173.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -112.89 17.73 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 2.96 109.533 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 15.8 mm-40 -68.81 132.17 90.82 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.259 -0.882 . . . . 1.3899999999999999 110.941 -174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.13 111.36 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.465 2.776 . . . . 1.27 113.065 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.24 125.64 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.711 -0.677 . . . . 0.85999999999999999 111.583 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -112.12 141.22 46.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.566 -0.531 . . . . 1.6100000000000001 109.566 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 141' ' ' ARG . 19.6 m -102.13 40.59 1.32 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.569 -0.741 . . . . 1.8799999999999999 110.728 -173.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 59.11 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.992 1.317 . . . . 0.75 113.506 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.601 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 47.0 mtt85 -84.59 155.78 21.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.121 -0.696 . . . . 3.3599999999999999 109.121 173.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.591 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 10.3 p 52.72 120.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.769 1.227 . . . . 0.94999999999999996 113.05 -171.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -97.3 30.99 8.21 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.119 -0.946 . . . . 1.1200000000000001 112.308 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.54 -34.67 72.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.937 0.717 . . . . 2.6600000000000001 112.937 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -125.65 42.05 3.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.305 0.574 . . . . 1.8700000000000001 111.417 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.514 ' HD2' HG21 ' A' ' 107' ' ' VAL . 42.7 mtp180 -87.47 -18.3 30.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.031 -0.532 . . . . 4.7300000000000004 112.157 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -145.25 -171.59 15.04 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 119.056 -1.545 . . . . 0.65000000000000002 114.884 -173.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.739 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.0 mttt 61.87 37.5 15.27 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 114.319 -0.94 . . . . 1.0800000000000001 110.887 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 80.4 m-85 -120.71 173.99 6.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.275 -1.33 . . . . 1.8899999999999999 108.281 170.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 12.1 mmmm -117.27 123.53 46.8 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.679 -0.408 . . . . 1.29 111.679 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 17' ' ' VAL . 6.6 m -57.98 -26.09 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.852 -0.613 . . . . 0.78000000000000003 110.791 174.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -68.15 -43.59 77.93 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.905 -0.589 . . . . 0.67000000000000004 109.93 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.587 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 23.7 m -61.88 -39.16 90.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.77000000000000002 110.273 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -62.53 -48.85 77.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.248 -0.433 . . . . 0.92000000000000004 110.96 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.8 ptp180 -67.38 -33.8 75.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.86 -0.336 . . . . 2.8900000000000001 110.723 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 48.8 mtmt -67.94 -28.63 67.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 0.96999999999999997 110.825 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -72.8 -51.88 17.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 110.965 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.741 ' HB2' HD13 ' A' ' 160' ' ' LEU . 12.3 m-85 -84.48 -2.11 56.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.363 -0.38 . . . . 5.4500000000000002 111.978 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 19.4 mm-40 69.19 45.63 0.86 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.689 0.757 . . . . 2.4199999999999999 110.932 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.741 HD13 ' HB2' ' A' ' 158' ' ' TYR . 5.7 mp -99.53 140.17 34.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.768 -1.106 . . . . 1.27 109.541 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -88.97 -84.43 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 3.5899999999999999 111.451 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.53 163.16 48.93 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.76000000000000001 109.579 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.498 ' HB2' ' CA ' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.8 133.27 41.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.48 2.12 . . . . 0.53000000000000003 112.128 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.848 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -89.12 -31.49 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 108.927 -0.768 . . . . 0.44 108.927 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.77 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.57 144.64 24.58 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.5 -0.773 . . . . 0.27000000000000002 111.261 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.665 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.94 146.82 16.66 Favored Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 115.006 -0.997 . . . . 0.23999999999999999 111.682 176.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.786 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.4 t -160.11 131.21 5.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.945 -0.761 . . . . 0.34000000000000002 108.945 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 16.5 p -110.91 138.25 47.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.177 0.513 . . . . 1.1100000000000001 110.862 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 120' ' ' TYR . 28.1 p90 -119.57 125.37 48.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.078 -1.082 . . . . 0.80000000000000004 108.078 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 1.2 pt20 -103.92 132.2 50.4 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.754 -0.779 . . . . 2.5299999999999998 109.928 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -124.33 140.04 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 0.59999999999999998 111.613 -172.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.62 151.67 26.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 2.3799999999999999 111.341 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.973 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -76.26 68.35 2.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.21 -0.904 . . . . 3.96 108.949 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.54 -61.53 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.143 -0.935 . . . . 1.53 112.32 -170.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.591 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.2 t70 -171.44 -38.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.868 0.366 . . . . 1.26 111.802 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -80.03 2.04 25.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 2.2200000000000002 110.605 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.973 HG21 ' HA ' ' A' ' 173' ' ' TRP . 48.7 t -69.46 -51.22 17.17 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.761 -0.654 . . . . 0.5 111.371 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.9 Cg_exo -50.29 -31.72 30.6 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.253 1.968 . . . . 0.57999999999999996 112.567 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.68 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.08 -22.68 63.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.401 . . . . 2.1400000000000001 111.42 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.721 HD23 ' HA3' ' A' ' 110' ' ' GLY . 42.6 tp -68.36 -44.45 75.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.313 -0.555 . . . . 0.66000000000000003 109.591 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -61.4 -37.8 84.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.292 -0.633 . . . . 1.8899999999999999 109.292 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.68 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.3 mm-40 -55.19 -42.03 72.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.909 -1.041 . . . . 1.53 110.319 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.629 ' HA ' ' HB2' ' A' ' 187' ' ' LYS . 5.4 tt0 -77.35 -35.31 54.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 1.49 112.453 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.591 ' HA ' ' H ' ' A' ' 142' ' ' SER . 80.7 mt -63.34 -2.85 1.63 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.003 0.372 . . . . 0.76000000000000001 112.003 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.765 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.4 m -81.53 13.94 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 1.05 109.566 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.601 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 69.84 46.31 53.59 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.065 -0.97 . . . . 1.1699999999999999 111.201 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.765 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.451 -0.785 . . . . 2.0 109.993 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.835 0.35 . . . . 1.47 110.277 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.558 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 15.6 t70 -162.2 156.57 21.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.816 -0.809 . . . . 1.8100000000000001 108.816 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.457 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.8 mm? -80.46 20.8 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.657 0.265 . . . . 0.69999999999999996 111.101 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -11.73 61.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.126 0.488 . . . . 1.96 110.906 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.566 ' HB3' HD12 ' A' ' 12' ' ' LEU . 95.3 mttt -116.86 30.88 7.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 2.6600000000000001 110.352 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.821 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -75.62 -23.4 56.37 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.452 0.538 . . . . 3.98 112.452 -173.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 13.7 p -152.9 26.47 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 0.63 111.199 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.97 -119.66 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.014 -0.834 . . . . 0.47999999999999998 111.014 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 19.4 Cg_endo -55.47 -36.47 94.27 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.832 2.355 . . . . 0.53000000000000003 110.329 164.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.761 HD11 ' HA3' ' A' ' 38' ' ' GLY . 13.4 mt -89.05 85.74 6.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.638 -1.164 . . . . 1.1699999999999999 110.669 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -74.78 62.41 1.08 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.70999999999999996 110.728 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.577 HD22 ' CG2' ' A' ' 121' ' ' VAL . 46.7 mt -78.03 -16.67 57.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.45000000000000001 111.577 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.49 -12.29 56.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.272 0.558 . . . . 2.1200000000000001 110.43 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -67.92 -20.27 65.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 1.9299999999999999 111.056 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.814 HG11 HG21 ' A' ' 69' ' ' THR . 70.6 t -92.09 -66.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.794 -0.639 . . . . 0.63 110.791 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.75 170.86 14.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 2.9900000000000002 110.682 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -70.22 105.79 3.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 1.6000000000000001 109.285 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.821 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 27.5 mm-40 -47.53 134.73 10.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 O-C-N 123.91 0.756 . . . . 3.5499999999999998 112.346 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 39.0 Cg_exo -62.43 169.04 8.72 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.389 3.392 . . . . 0.57999999999999996 114.898 -167.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.901 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 11.4 pt20 -82.25 -13.25 57.33 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.74 -1.118 . . . . 1.3899999999999999 111.907 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.77 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.6 m170 -149.09 159.52 37.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.871 -0.604 . . . . 1.45 109.544 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 3.9 Cg_endo -85.44 127.96 3.4 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.079 2.519 . . . . 0.40000000000000002 111.101 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 122' ' ' TRP . 26.9 tp -78.0 147.84 34.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.735 0.303 . . . . 0.28999999999999998 110.854 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -116.72 107.72 15.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.867 -0.42 . . . . 1.24 109.867 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.903 HG13 HG22 ' A' ' 53' ' ' ILE . 6.9 t -114.56 127.91 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.085 -0.709 . . . . 0.46999999999999997 109.085 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -126.27 138.82 53.65 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.923 0.392 . . . . 0.31 110.678 -176.684 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.42 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 36.6 t80 -101.51 170.96 7.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.019 -0.537 . . . . 0.67000000000000004 109.66 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.82 68.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.463 0.649 . . . . 0.55000000000000004 110.654 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -112.47 13.67 25.42 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.253 -0.885 . . . . 0.81000000000000005 112.511 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.4 -171.1 3.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.935 0.398 . . . . 0.46999999999999997 110.634 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.48 147.1 10.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.757 -0.656 . . . . 0.33000000000000002 110.203 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.842 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -104.36 58.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.084 -1.45 . . . . 0.39000000000000001 107.084 165.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.74 30.26 1.85 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.98999999999999999 109.793 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.4 tt0 -157.86 127.91 6.14 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.126 -0.943 . . . . 2.5600000000000001 108.827 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.591 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -68.58 111.17 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.40999999999999998 110.026 -176.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.761 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.11 14.86 63.64 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.447 -0.797 . . . . 0.58999999999999997 112.756 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.842 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.89 147.03 47.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 0.34000000000000002 109.653 175.034 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.2 p -74.38 132.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.912 0.387 . . . . 0.55000000000000004 110.956 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.56 HD22 HG22 ' A' ' 34' ' ' VAL . 6.3 tp -132.46 167.21 20.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.952 -0.759 . . . . 0.45000000000000001 108.952 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.86 157.07 47.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.699 0.629 . . . . 0.56000000000000005 112.699 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 89.3 Cg_exo -50.56 -45.84 32.77 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.158 2.572 . . . . 0.68000000000000005 113.044 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.63 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 8.2 p -54.65 -39.63 68.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.58 0.705 . . . . 0.76000000000000001 111.214 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -83.32 -7.91 59.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.01 -0.995 . . . . 1.5900000000000001 112.425 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' CE1' ' A' ' 169' ' ' TYR . 17.8 m -131.84 27.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.372 0.606 . . . . 0.66000000000000003 111.543 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -95.55 5.36 51.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.79000000000000004 110.574 -175.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -152.5 179.02 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 109.442 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -68.53 148.47 98.12 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.118 -0.327 . . . . 1.4299999999999999 110.118 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.43 166.29 26.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.059 1.839 . . . . 0.37 110.823 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -87.92 -19.09 27.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.894 -0.41 . . . . 0.44 109.894 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.531 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 47.6 m -158.1 143.11 16.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.785 0.661 . . . . 0.38 112.785 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.903 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.27 157.67 25.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.502 -1.226 . . . . 0.29999999999999999 107.915 170.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.897 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 t 173.77 135.42 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.11 -0.7 . . . . 0.34999999999999998 109.11 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.789 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -88.96 177.1 6.75 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 2.7200000000000002 108.229 173.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.67 76.86 0.11 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.873 0.368 . . . . 1.51 110.693 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.88 40.4 0.99 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.293 -0.48 . . . . 0.80000000000000004 112.84 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.897 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.5 tt -65.17 127.87 33.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.57999999999999996 110.145 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.2 -30.5 68.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.844 -0.616 . . . . 0.73999999999999999 111.947 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.534 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 44.8 m 72.14 -3.69 2.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.12 -0.946 . . . . 1.03 110.752 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.64 5.7 26.18 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.834 -0.621 . . . . 0.83999999999999997 112.501 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 9.0 mmpt? -111.86 160.33 17.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.614 0.245 . . . . 1.6699999999999999 110.366 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.771 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 mt -97.46 141.85 30.03 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.518 -1.29 . . . . 0.57999999999999996 107.518 168.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CE2' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -136.72 147.2 46.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.842 -0.343 . . . . 0.80000000000000004 110.205 -178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.917 HG23 HG12 ' A' ' 90' ' ' VAL . 4.4 m -95.7 104.76 16.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.622 -0.881 . . . . 0.35999999999999999 108.622 174.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.1 tp -101.7 109.12 20.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.587 -0.733 . . . . 0.58999999999999997 109.387 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 88' ' ' LEU . 20.9 t -115.3 122.45 69.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.405 -0.361 . . . . 0.39000000000000001 110.95 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.911 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -86.62 134.03 33.66 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.744 -0.836 . . . . 0.59999999999999998 108.744 169.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.814 HG21 HG11 ' A' ' 17' ' ' VAL . 13.3 t -138.9 148.56 43.78 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.928 -0.309 . . . . 0.35999999999999999 111.073 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 30.4 t70 -131.22 99.37 17.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.264 0.554 . . . . 1.9199999999999999 110.217 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.531 ' HD3' HG21 ' A' ' 17' ' ' VAL . 10.3 Cg_endo -53.4 -34.29 70.57 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 124.179 3.252 . . . . 1.25 114.437 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.815 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -89.96 40.2 0.99 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.174 0.435 . . . . 1.29 112.174 -168.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.06 144.92 29.65 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.708 -0.224 . . . . 0.5 111.506 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.0 Cg_endo -83.83 -20.58 18.78 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 123.259 -1.559 . . . . 0.62 112.102 -0.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.714 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 77.7 p -134.87 146.82 49.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.75 109.846 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.815 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 58.7 mtp180 -70.3 -22.74 62.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.916 0.339 . . . . 2.8799999999999999 111.916 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.849 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.45 -14.8 45.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.277 0.561 . . . . 1.3799999999999999 110.517 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.44 79.51 4.9 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.004 -0.739 . . . . 1.3700000000000001 109.004 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.97 81.28 1.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.863 2.376 . . . . 0.80000000000000004 113.049 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 13.6 mttm -71.99 -51.57 21.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.514 -1.221 . . . . 1.02 111.251 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.715 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 38.9 m-85 -86.39 19.11 2.89 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.401 -0.818 . . . . 1.1699999999999999 111.896 -167.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 6.7 ttp180 -67.05 127.19 31.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.856 -0.611 . . . . 2.9300000000000002 110.06 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.8 mp0 -98.2 138.61 35.22 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.328 0.251 . . . . 2.23 110.36 -1.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.467 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 5.9 t90 -89.88 105.81 18.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 1.4299999999999999 110.03 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 52.9 p-80 -80.82 122.43 27.18 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.452 0.644 . . . . 1.26 110.203 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.911 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 7.0 t-80 -61.8 -40.56 95.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.981 -1.009 . . . . 2.1400000000000001 110.649 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 104' ' ' SER . 26.0 p90 -167.17 178.45 5.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.622 -0.511 . . . . 1.51 109.622 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.8 tp -141.84 113.65 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.708 0.289 . . . . 0.33000000000000002 110.247 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.53 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.8 t -120.42 132.47 69.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.817 -0.628 . . . . 0.31 110.573 176.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.917 HG12 HG23 ' A' ' 65' ' ' THR . 3.8 m -129.92 166.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.095 -1.076 . . . . 0.27000000000000002 108.095 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.771 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 91.1 m-20 60.85 20.44 10.65 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 123.486 0.491 . . . . 1.76 111.141 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.52 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -72.28 115.17 11.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.693 -0.854 . . . . 0.31 108.693 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 15.1 ttmm -87.06 93.17 9.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.314 -0.857 . . . . 1.21 111.307 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 60' ' ' SER . . . 80.33 -129.75 9.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 114.829 -1.078 . . . . 0.29999999999999999 112.48 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.473 ' HA ' HD11 ' A' ' 53' ' ' ILE . 26.1 p30 -112.91 22.12 14.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.604 0.716 . . . . 1.04 110.512 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.31 112.79 24.48 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.992 -1.004 . . . . 0.77000000000000002 109.609 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.453 HD13 HD12 ' A' ' 53' ' ' ILE . 5.3 mm -59.95 -27.6 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.358 -1.292 . . . . 0.40999999999999998 111.103 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -69.73 -51.36 34.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.68000000000000005 112.112 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 p -61.85 -20.55 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.822 0.675 . . . . 1.26 112.822 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 92' ' ' MET . . . -52.91 103.08 0.11 Allowed Glycine 0 N--CA 1.449 -0.455 0 O-C-N 123.352 0.408 . . . . 0.34999999999999998 112.92 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.4 m -68.05 107.39 2.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.436 0.636 . . . . 0.45000000000000001 109.773 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.68 120.77 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.896 -1.047 . . . . 0.56999999999999995 111.617 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 133' ' ' CYS . 55.8 mt -99.32 -44.71 6.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.227 1.013 . . . . 0.45000000000000001 109.289 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.9 t -120.51 111.9 18.27 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.885 -1.524 . . . . 0.37 106.885 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.842 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 2.3 t0 -64.84 162.04 17.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.551 -0.75 . . . . 1.1499999999999999 112.018 -170.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 31.0 p90 -81.23 61.22 4.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.339 0.866 . . . . 4.6900000000000004 113.339 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.926 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 27.0 t -37.54 -47.32 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.017 0.927 . . . . 0.85999999999999999 113.365 -171.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 47' ' ' LYS . . . 107.12 -172.45 17.97 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.655 -0.783 . . . . 0.67000000000000004 112.505 173.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.4 t -68.9 117.29 10.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.564 -0.532 . . . . 0.51000000000000001 109.564 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.767 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -148.2 61.43 0.44 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.389 -0.91 . . . . 0.81999999999999995 112.662 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.677 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 9.8 Cg_endo -91.87 127.15 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.495 2.796 . . . . 0.84999999999999998 112.734 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.579 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.9 Cg_exo -53.8 146.02 47.53 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.796 2.331 . . . . 0.87 111.775 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.457 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -62.51 119.61 9.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.288 -0.414 . . . . 1.8500000000000001 111.221 -177.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.9 -1.51 55.29 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.861 -0.685 . . . . 1.1799999999999999 113.146 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 77.7 p -77.39 -26.33 51.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.998 0.399 . . . . 0.96999999999999997 112.002 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 -178.61 17.83 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.953 -0.641 . . . . 1.97 112.232 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.4 mm? -81.8 116.85 21.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.615 0.245 . . . . 0.93999999999999995 110.39 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.695 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 40.6 m-70 -92.81 126.8 38.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.416 -0.356 . . . . 2.23 110.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.505 ' HD2' HD21 ' A' ' 14' ' ' LEU . 8.9 ptt180 -108.56 85.92 2.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.757 -0.656 . . . . 2.3100000000000001 110.664 -172.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.51 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 5.8 m-85 -69.73 116.69 10.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.592 -0.731 . . . . 0.78000000000000003 109.549 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.577 ' CG2' HD22 ' A' ' 14' ' ' LEU . 15.1 t -97.43 128.96 48.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.037 -0.528 . . . . 0.27000000000000002 110.714 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.679 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 48.7 m95 -88.57 121.54 31.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.177 -0.675 . . . . 1.99 109.177 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.2 mt -118.31 119.91 36.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.624 0.193 . . . . 0.38 110.791 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.497 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -117.52 140.0 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.722 0.296 . . . . 0.31 111.121 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.716 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 89.3 t80 -129.53 129.09 44.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.177 -0.465 . . . . 5.1200000000000001 109.812 174.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.63 103.2 2.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.549 0.69 . . . . 2.4100000000000001 109.22 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 23.0 mt-30 -58.41 135.85 57.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.033 -0.985 . . . . 1.3100000000000001 112.028 -171.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.8 -13.25 61.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.486 -0.779 . . . . 2.3999999999999999 109.603 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.544 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 7.7 ptp180 -173.51 161.75 3.31 Favored Pre-proline 0 CA--C 1.515 -0.381 0 CA-C-N 114.838 -1.073 . . . . 3.5099999999999998 109.637 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.58 136.22 65.74 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.9 2.4 . . . . 1.21 110.691 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 158' ' ' TYR . 4.1 mm? -68.11 146.89 53.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.721 1.008 . . . . 0.90000000000000002 113.721 -167.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -99.1 96.52 7.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.176 -1.375 . . . . 2.8999999999999999 108.073 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.455 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.4 p -124.88 109.64 13.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.91 -0.586 . . . . 1.8999999999999999 111.728 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -102.72 18.18 22.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.908 -0.775 . . . . 2.96 108.908 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.79 135.41 96.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.183 -0.917 . . . . 1.3899999999999999 111.195 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.5 113.89 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.39 2.727 . . . . 1.27 112.531 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.49 120.28 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.85999999999999999 110.056 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 71.3 mt -99.66 154.59 18.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.13 0.49 . . . . 1.6100000000000001 110.54 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.704 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 72.1 m -108.03 31.56 5.43 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.263 -0.881 . . . . 1.8799999999999999 109.689 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.926 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 9.1 p30 54.9 12.53 0.61 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.485 1.116 . . . . 0.75 111.553 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 139' ' ' SER . 17.1 mtm180 -96.71 146.85 24.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.3599999999999999 110.097 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.654 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.4 m 77.89 131.14 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.519 1.137 . . . . 0.94999999999999996 111.958 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.624 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -87.46 -6.5 77.46 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.086 -0.961 . . . . 1.1200000000000001 112.655 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.46 -42.75 70.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.605 0.717 . . . . 2.6600000000000001 111.374 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -97.3 20.01 12.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.354 -0.839 . . . . 1.8700000000000001 111.012 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.624 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 63.9 mtt180 -76.7 -69.92 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 4.7300000000000004 111.835 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.509 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -117.3 -173.01 16.32 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.217 -0.992 . . . . 0.65000000000000002 113.369 -171.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.715 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.5 mttt 68.33 21.89 8.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.728 0.775 . . . . 1.0800000000000001 110.602 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.661 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 87.7 m-85 -111.3 97.71 6.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.807 -1.088 . . . . 1.8899999999999999 108.476 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 13.2 mmmm -59.49 123.27 16.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 1.29 112.168 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.568 HG21 ' CG1' ' A' ' 17' ' ' VAL . 16.8 m -63.84 -25.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.242 -0.89 . . . . 0.78000000000000003 110.6 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.73 72.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.67000000000000004 109.608 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 m -59.81 -43.7 94.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.77000000000000002 110.633 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 149' ' ' PHE . 7.0 m-85 -58.56 -53.27 60.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.037 -0.528 . . . . 0.92000000000000004 111.584 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -69.76 -39.74 76.52 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.479 -0.488 . . . . 2.8900000000000001 111.379 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.61 -32.3 72.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.97 0.414 . . . . 0.96999999999999997 110.405 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -66.8 -51.38 56.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.527 -0.76 . . . . 1.5800000000000001 110.918 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.851 ' HB3' HD11 ' A' ' 131' ' ' LEU . 21.6 m-85 -80.23 3.91 19.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.075 -0.511 . . . . 5.4500000000000002 111.744 -172.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 8.4 mm-40 70.55 30.67 3.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.589 0.555 . . . . 2.4199999999999999 111.016 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.716 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.3 mp -102.34 134.24 45.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.563 -0.744 . . . . 1.27 109.79 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 7.8 tpt180 -102.74 -78.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 3.5899999999999999 111.181 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -125.85 145.77 52.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 0.76000000000000001 110.805 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 2.9 Cg_exo -74.61 161.63 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.908 3.072 . . . . 0.53000000000000003 113.537 -172.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.901 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 14.4 t -91.43 -26.88 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.632 -1.167 . . . . 0.44 109.895 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.789 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -152.58 145.2 24.2 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.003 -0.679 . . . . 0.27000000000000002 112.231 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.44 151.05 23.36 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.035 -0.984 . . . . 0.23999999999999999 112.018 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.591 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.1 t -165.57 141.15 5.11 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.449 -0.945 . . . . 0.34000000000000002 108.449 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.609 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 17.3 p -119.0 149.32 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.034 -0.667 . . . . 1.1100000000000001 111.045 -175.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.606 ' CE1' HG11 ' A' ' 46' ' ' VAL . 35.7 p90 -130.32 129.71 43.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.94 -1.133 . . . . 0.80000000000000004 107.94 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.695 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 1.2 pt20 -101.52 133.78 45.63 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.867 -0.733 . . . . 2.5299999999999998 111.417 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.94 152.17 49.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.59999999999999998 109.501 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.603 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -126.37 -162.41 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.006 0.432 . . . . 2.3799999999999999 111.322 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.457 ' CG ' ' HG2' ' A' ' 113' ' ' LYS . 89.6 t90 -70.46 103.2 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.96 -0.564 . . . . 3.96 110.343 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 2.0 t70 -73.69 -62.06 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.583 -0.28 . . . . 1.53 110.371 171.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.586 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 11.5 t70 169.45 -50.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 1.26 110.434 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.63 ' OH ' ' HA ' ' A' ' 44' ' ' THR . 2.4 p90 -82.72 9.8 8.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.189 0.519 . . . . 2.2200000000000002 111.094 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.767 HG13 ' HA2' ' A' ' 110' ' ' GLY . 48.1 t -58.47 -49.15 95.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.972 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 175' ' ' ASP . 72.9 Cg_exo -47.89 -33.75 20.59 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.039 2.493 . . . . 0.57999999999999996 112.899 168.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 3.0 mmmp? -72.69 -25.56 61.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.636 0.255 . . . . 2.1400000000000001 111.108 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.528 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 62.5 tp -70.58 -44.29 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.049 -0.723 . . . . 0.66000000000000003 109.049 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.27 -32.95 74.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.316 -0.856 . . . . 1.8899999999999999 109.446 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.5 mm-40 -60.84 -38.29 85.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.955 -1.02 . . . . 1.53 111.02 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -76.33 -27.08 56.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.74 -0.663 . . . . 1.49 111.439 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.654 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.2 mt -65.93 6.6 0.35 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.852 0.686 . . . . 0.76000000000000001 112.852 -177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.746 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.2 m -77.15 8.31 4.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 1.05 109.955 173.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 68.89 50.54 34.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.104 -0.798 . . . . 1.1699999999999999 111.104 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.746 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.8 mmmt . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.667 -0.682 . . . . 2.0 110.582 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 110.275 -0.268 . . . . 1.47 110.275 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.776 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 2.2 p30 -163.39 179.93 6.98 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.142 -1.058 . . . . 1.8100000000000001 108.142 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 8' ' ' TRP . 2.7 mm? -80.93 36.01 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.69999999999999996 110.866 -170.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -51.91 -40.1 60.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 1.96 111.834 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.572 ' HB2' HD12 ' A' ' 12' ' ' LEU . 92.0 mttt -116.17 46.16 1.62 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.868 -0.419 . . . . 2.6600000000000001 109.868 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.639 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -66.43 -24.21 66.42 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.286 -0.416 . . . . 3.98 111.328 -173.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.1 p -151.6 26.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.951 -0.3 . . . . 0.63 111.347 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.505 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.85 -125.5 0.81 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.888 -0.885 . . . . 0.47999999999999998 110.888 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -52.02 -36.29 64.45 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.109 2.54 . . . . 0.53000000000000003 110.342 167.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.773 HD11 ' HA3' ' A' ' 38' ' ' GLY . 35.3 mt -87.87 79.26 8.14 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.825 -1.08 . . . . 1.1699999999999999 109.606 171.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -71.44 66.73 0.48 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.615 0.722 . . . . 0.70999999999999996 109.82 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.927 HD23 HH11 ' A' ' 119' ' ' ARG . 44.1 mt -80.45 -16.39 54.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.741 -0.663 . . . . 0.45000000000000001 110.65 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -64.13 -16.17 61.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.589 -0.732 . . . . 2.1200000000000001 111.225 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.551 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 39.3 mt-10 -62.34 -30.33 71.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.189 0.519 . . . . 1.9299999999999999 110.546 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 69' ' ' THR . 85.7 t -93.41 -64.03 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.63 111.16 -174.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 163' ' ' PRO . 7.1 p-10 -130.04 169.05 15.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.152 -0.476 . . . . 2.9900000000000002 110.219 -171.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -74.57 88.16 2.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.443 -0.947 . . . . 1.6000000000000001 108.443 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 2.7 tp-100 -38.34 122.61 1.1 Allowed Pre-proline 0 C--O 1.237 0.433 0 O-C-N 124.925 1.391 . . . . 3.5499999999999998 111.901 -166.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.724 ' HG3' ' HB2' ' A' ' 163' ' ' PRO . 81.5 Cg_exo -50.29 161.64 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 125.235 3.957 . . . . 0.57999999999999996 116.193 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 12.6 pt20 -79.1 -6.96 57.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 113.837 -1.529 . . . . 1.3899999999999999 111.46 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.722 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.6 m170 -154.28 158.85 32.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.468 -0.787 . . . . 1.45 109.236 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.776 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 6.0 Cg_endo -86.74 129.12 2.98 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.193 2.595 . . . . 0.40000000000000002 111.844 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 ' HB3' ' A' ' 122' ' ' TRP . 21.5 tp -78.88 144.54 34.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.654 -0.248 . . . . 0.28999999999999998 110.728 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.403 ' H ' HD12 ' A' ' 25' ' ' LEU . 86.2 m-70 -112.64 112.94 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 1.24 109.89 174.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 53' ' ' ILE . 12.0 t -121.12 137.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.423 -0.584 . . . . 0.46999999999999997 109.423 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.557 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -132.4 141.24 48.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.271 0.558 . . . . 0.31 111.063 -177.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -103.14 173.32 6.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.857 -0.794 . . . . 0.67000000000000004 108.857 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.41 -52.29 65.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.291 0.567 . . . . 0.55000000000000004 110.347 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.96 14.77 23.83 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.178 -0.919 . . . . 0.81000000000000005 112.999 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.54 -172.25 4.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.46999999999999997 111.148 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.95 151.61 12.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.71 -0.677 . . . . 0.33000000000000002 110.05 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.795 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 86.2 t -109.23 65.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.157 -1.423 . . . . 0.39000000000000001 107.157 164.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.83 21.07 16.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.002 -0.999 . . . . 0.98999999999999999 109.15 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -145.83 128.1 15.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.687 -1.227 . . . . 2.5600000000000001 107.687 176.159 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -77.96 111.74 14.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.611 0.72 . . . . 0.40999999999999998 110.803 -170.122 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 83.17 22.35 57.28 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.742 -1.117 . . . . 0.58999999999999997 111.385 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -77.68 148.73 34.84 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.388 -0.597 . . . . 0.34000000000000002 109.388 173.322 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.96 133.44 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.001 0.429 . . . . 0.55000000000000004 110.874 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.566 HD22 HG22 ' A' ' 34' ' ' VAL . 7.4 tp -131.58 170.29 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.45000000000000001 108.618 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.6 p -120.03 158.46 50.25 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.317 0.858 . . . . 0.56000000000000005 113.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 74.9 Cg_exo -50.29 -49.19 17.12 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.438 2.759 . . . . 0.68000000000000005 113.569 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.7 p -55.72 -42.83 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.462 0.649 . . . . 0.76000000000000001 111.52 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -73.21 -12.32 60.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.874 -1.057 . . . . 1.5900000000000001 112.225 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.562 ' CG1' HD23 ' A' ' 41' ' ' LEU . 31.5 m -131.7 28.25 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.087 0.47 . . . . 0.66000000000000003 111.455 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -85.12 -33.85 22.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.818 -0.628 . . . . 0.79000000000000004 110.467 -176.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.46 -155.89 0.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.786 -0.643 . . . . 1.9099999999999999 109.556 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -84.01 157.19 63.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.394 -0.595 . . . . 1.4299999999999999 109.394 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.4 160.44 28.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.755 1.637 . . . . 0.37 110.594 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -82.15 -20.72 37.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.105 -0.332 . . . . 0.44 110.105 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 57.9 m -160.32 144.86 14.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.239 0.542 . . . . 0.38 112.056 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.971 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.1 168.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.154 -0.93 . . . . 0.29999999999999999 108.575 171.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.02 ' HA ' HD13 ' A' ' 58' ' ' LEU . 29.3 t 174.04 122.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.462 -0.57 . . . . 0.34999999999999998 109.462 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.737 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -79.45 179.52 7.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.337 -0.986 . . . . 2.7200000000000002 108.337 174.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.8 80.8 0.29 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.15 0.5 . . . . 1.51 110.473 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.17 41.58 1.51 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.633 -0.712 . . . . 0.80000000000000004 112.386 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.02 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -55.54 133.74 50.41 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.83 0.452 . . . . 0.57999999999999996 111.51 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.55 -27.38 60.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.848 -0.615 . . . . 0.73999999999999999 111.867 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.626 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 49.3 m 68.23 8.32 6.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.561 -0.745 . . . . 1.03 110.834 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.689 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -137.17 -47.87 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.905 -0.589 . . . . 0.83999999999999997 112.662 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.798 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 8.3 mmpt? -58.66 144.54 42.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.231 0.538 . . . . 1.6699999999999999 111.411 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.735 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 31.0 mt -86.82 127.73 35.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.111 -0.95 . . . . 0.57999999999999996 109.486 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.798 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -122.3 158.66 29.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.55 -0.46 . . . . 0.80000000000000004 110.278 176.319 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.724 HG23 HG12 ' A' ' 90' ' ' VAL . 96.0 m -98.51 109.39 22.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.392 -0.596 . . . . 0.35999999999999999 109.392 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 tp -106.15 116.83 32.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 110.052 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.9 t -120.98 132.43 70.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.76 0.314 . . . . 0.39000000000000001 110.74 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.922 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -97.49 131.57 44.0 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.508 -0.923 . . . . 0.59999999999999998 108.508 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.716 HG21 HG11 ' A' ' 17' ' ' VAL . 11.0 t -138.82 147.53 42.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.142 0.428 . . . . 0.35999999999999999 111.657 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 25.6 t70 -131.28 97.43 19.82 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.161 0.505 . . . . 1.9199999999999999 109.805 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.9 Cg_endo -51.63 -34.56 53.58 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.99 3.127 . . . . 1.25 114.298 176.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.737 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -86.97 44.82 1.2 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.654 0.612 . . . . 1.29 112.654 -170.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.08 142.12 23.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.687 -0.233 . . . . 0.5 110.706 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 92.1 Cg_endo -85.07 -24.76 9.58 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 123.465 -1.473 . . . . 0.62 113.096 -0.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.714 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 13.2 p -128.76 146.45 50.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.75 109.793 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.737 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 50.8 mtp180 -65.99 -21.89 66.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 2.8799999999999999 111.141 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 6.0 ptpt -79.66 -14.26 58.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 1.3799999999999999 110.829 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 16.4 t70 -162.09 80.51 1.88 Allowed Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.007 -0.542 . . . . 1.3700000000000001 110.188 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 85.6 Cg_endo -80.95 87.21 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.543 2.162 . . . . 0.80000000000000004 112.93 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -74.74 -50.97 15.49 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.738 -1.119 . . . . 1.02 110.661 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.708 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.1 m-85 -85.45 21.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 1.1699999999999999 111.742 -166.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.551 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 29.4 ttt180 -71.66 129.56 38.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.382 -0.372 . . . . 2.9300000000000002 110.685 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 3.0 mp0 -96.44 132.04 42.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.859 0.361 . . . . 2.23 110.632 -3.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.56 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 11.9 t90 -82.65 140.3 33.23 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.012 -0.736 . . . . 1.4299999999999999 109.012 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 28.6 p80 -117.72 127.15 53.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.633 0.73 . . . . 1.26 111.258 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.922 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 15.5 t-80 -65.45 -35.89 82.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.806 -1.088 . . . . 2.1400000000000001 110.36 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.548 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 12.0 p90 -168.06 176.79 5.9 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.651 -0.249 . . . . 1.51 110.363 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.55 ' HG ' HD12 ' A' ' 103' ' ' LEU . 21.5 tp -135.77 113.53 11.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.33000000000000002 109.657 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.714 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.9 t -119.66 133.23 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.648 -0.706 . . . . 0.31 110.19 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.897 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 22.2 m -133.94 161.75 40.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.285 -0.871 . . . . 0.27000000000000002 108.956 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t30 60.71 22.01 11.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.661 0.601 . . . . 1.76 110.353 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.714 ' HE3' HG11 ' A' ' 89' ' ' VAL . 6.7 ttm -71.88 110.3 6.31 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.175 -0.676 . . . . 0.31 109.175 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 20.9 ttmm -80.34 98.28 7.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.21 . . . . 1.21 111.133 -173.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.81 -121.76 20.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.603 -0.726 . . . . 0.29999999999999999 112.509 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.8 p-10 -113.26 21.42 15.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.567 -0.316 . . . . 1.04 111.735 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -89.51 104.22 16.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.415 0.626 . . . . 0.77000000000000002 109.848 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 97' ' ' ILE . 5.2 mm -55.55 -31.28 28.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.584 -1.189 . . . . 0.40999999999999998 111.561 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -81.04 -26.38 36.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.68000000000000005 111.602 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.05 -13.04 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.492 -0.322 . . . . 1.26 111.225 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.62 100.53 0.83 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.78 -0.724 . . . . 0.34999999999999998 111.579 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.2 m -60.24 106.55 0.54 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.476 0.655 . . . . 0.45000000000000001 109.668 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -80.19 113.1 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.847 -1.07 . . . . 0.56999999999999995 111.214 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.55 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.7 mt -93.2 -41.97 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.99 0.9 . . . . 0.45000000000000001 109.243 174.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 11.9 t -122.68 112.22 17.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.192 -1.41 . . . . 0.37 107.192 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 3.4 t70 -59.96 164.41 3.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.652 -0.704 . . . . 1.1499999999999999 112.217 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 10.3 p90 -79.24 72.27 5.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.269 -0.878 . . . . 4.6900000000000004 111.002 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.725 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 28.1 t -51.45 -44.68 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 0.85999999999999999 111.447 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.69 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 97.72 -171.75 26.57 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.26 -0.971 . . . . 0.67000000000000004 113.416 171.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 41.0 t -73.42 128.68 36.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.778 -0.452 . . . . 0.51000000000000001 109.778 174.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.602 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . 171.99 58.64 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.211 -0.995 . . . . 0.81999999999999995 113.706 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.405 ' HD3' ' H ' ' A' ' 110' ' ' GLY . 62.9 Cg_endo -86.69 -176.66 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.628 2.219 . . . . 0.84999999999999998 111.005 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.628 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 48.1 Cg_exo -57.14 142.25 94.38 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.464 1.443 . . . . 0.87 111.81 172.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.414 ' CD ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -66.1 114.69 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.514 -0.766 . . . . 1.8500000000000001 111.46 -177.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.15 12.7 38.59 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 1.1799999999999999 113.698 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 34.0 p -81.65 2.09 31.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.82 1.044 . . . . 0.96999999999999997 113.82 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.25 -179.73 27.16 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.612 -0.804 . . . . 1.97 112.375 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -83.41 118.03 23.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.938 0.399 . . . . 0.93999999999999995 110.141 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.692 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 47.1 m-70 -91.39 117.76 29.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.103 -0.499 . . . . 2.23 110.952 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.927 HH11 HD23 ' A' ' 14' ' ' LEU . 9.9 ptt180 -91.51 82.01 5.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.67 -0.695 . . . . 2.3100000000000001 111.313 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.548 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 42.4 m-85 -67.76 109.39 3.33 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.753 -0.832 . . . . 0.78000000000000003 108.753 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 14' ' ' LEU . 21.9 t -88.09 127.32 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.901 -0.59 . . . . 0.27000000000000002 109.971 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.846 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.92 117.53 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.486 -0.931 . . . . 1.99 108.486 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 mt -121.26 127.57 51.52 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.959 0.162 . . . . 0.38 110.899 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.602 HG21 ' HE3' ' A' ' 55' ' ' TRP . 1.1 m -114.4 131.54 66.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.459 -0.496 . . . . 0.31 109.917 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.729 ' HB2' HD23 ' A' ' 160' ' ' LEU . 48.4 m-85 -111.95 149.13 32.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.325 -0.62 . . . . 5.1200000000000001 109.325 176.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.93 126.66 48.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.671 0.748 . . . . 2.4100000000000001 110.449 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.506 ' HG2' HD21 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -96.82 175.51 6.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.183 -0.917 . . . . 1.3100000000000001 108.714 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.53 2.71 42.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.547 0.689 . . . . 2.3999999999999999 109.498 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.407 ' H ' ' HB2' ' A' ' 127' ' ' GLN . 1.3 ptp180 -160.66 164.98 18.24 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.947 -1.024 . . . . 3.5099999999999998 111.206 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.01 155.42 33.81 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.027 2.485 . . . . 1.21 110.946 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.897 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.4 mm? -84.14 145.91 28.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.311 0.577 . . . . 0.90000000000000002 112.143 -172.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -124.31 66.06 1.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.142 -0.935 . . . . 2.8999999999999999 108.741 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 5.2 m -93.6 120.99 34.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.537 -0.756 . . . . 1.8999999999999999 110.395 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.88 14.97 30.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 2.96 109.936 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -64.73 132.14 95.35 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.429 -0.805 . . . . 1.3899999999999999 110.563 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -47.09 117.08 2.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.539 2.826 . . . . 1.27 113.067 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.19 118.67 6.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.85999999999999999 110.496 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.4 mt -92.7 156.08 17.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 1.6100000000000001 110.608 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 50.2 m -116.03 32.57 6.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.8799999999999999 110.172 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.725 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER 66.75 -21.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.238 1.415 . . . . 0.75 113.45 175.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 54.9 mtt180 -78.31 135.44 37.51 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.776 -0.37 . . . . 3.3599999999999999 110.868 -175.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.713 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 62.1 m 81.84 146.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.559 -1.201 . . . . 0.94999999999999996 110.674 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.453 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -108.22 12.71 37.04 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.867 -0.682 . . . . 1.1200000000000001 113.038 -170.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.17 -15.22 62.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.324 0.49 . . . . 2.6600000000000001 112.324 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -121.58 34.85 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.087 0.47 . . . . 1.8700000000000001 110.324 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.453 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 26.6 mtt180 -81.05 -69.68 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.662 -0.699 . . . . 4.7300000000000004 111.902 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -128.31 -164.38 11.55 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.447 -0.882 . . . . 0.65000000000000002 112.763 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.708 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 65.43 25.27 11.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.441 0.639 . . . . 1.0800000000000001 110.229 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.26 112.31 21.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.083 -0.962 . . . . 1.8899999999999999 109.095 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 13.7 mmmm -67.18 122.17 17.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.805 -0.634 . . . . 1.29 111.525 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.801 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.2 m -62.85 -27.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.78000000000000003 110.351 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.31 -43.34 99.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.759 172.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 34.9 m -63.87 -39.33 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.944 -0.571 . . . . 0.77000000000000002 110.618 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.801 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 50.4 m-85 -58.81 -52.05 67.37 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.649 -0.251 . . . . 0.92000000000000004 110.999 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.943 -0.303 . . . . 2.8900000000000001 111.358 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.4 mtmt -64.17 -42.25 96.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.38 0.609 . . . . 0.96999999999999997 109.935 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -58.77 -53.27 60.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 1.5800000000000001 111.449 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.41 -3.33 58.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 5.4500000000000002 111.493 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 68.22 40.89 2.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.792 -0.64 . . . . 2.4199999999999999 111.27 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.729 HD23 ' HB2' ' A' ' 125' ' ' TYR . 5.4 mp -95.97 146.34 24.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.451 -0.795 . . . . 1.27 112.008 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.755 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 14.5 tpt180 -82.73 -171.24 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.291 -0.868 . . . . 3.5899999999999999 109.853 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.755 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -60.98 155.74 52.35 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.76000000000000001 110.639 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.724 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 13.2 Cg_exo -66.7 141.93 61.89 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.968 2.445 . . . . 0.53000000000000003 112.279 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.861 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 12.2 t -89.47 -34.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.794 -0.639 . . . . 0.44 110.092 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.737 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -146.26 141.37 27.28 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.903 -0.719 . . . . 0.27000000000000002 112.128 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.56 148.94 20.93 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.024 -0.989 . . . . 0.23999999999999999 111.976 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.6 t -159.85 133.05 6.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.798 -0.816 . . . . 0.34000000000000002 108.798 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.576 ' SG ' HD13 ' A' ' 12' ' ' LEU . 22.2 p -111.07 142.42 43.25 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 1.1100000000000001 111.33 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.548 ' CE2' ' HB2' ' A' ' 120' ' ' TYR . 32.3 p90 -126.61 134.14 50.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.567 -0.901 . . . . 0.80000000000000004 108.567 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.747 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 1.6 mp0 -98.6 131.88 44.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.212 -0.595 . . . . 2.5299999999999998 110.104 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -121.21 142.37 49.98 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.36 0.412 . . . . 0.59999999999999998 110.345 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -97.18 -171.8 2.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 2.3799999999999999 111.263 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.853 ' HA ' HG21 ' A' ' 177' ' ' VAL . 28.5 p90 -97.41 53.62 1.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.226 -0.897 . . . . 3.96 110.508 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.506 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 32.6 t70 -60.28 -61.74 2.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.6 0.963 . . . . 1.53 113.6 -168.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.668 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.9 t70 -167.4 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.017 0.377 . . . . 1.26 112.017 -175.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -71.95 -3.89 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.148 0.499 . . . . 2.2200000000000002 110.876 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.853 HG21 ' HA ' ' A' ' 173' ' ' TRP . 25.6 t -71.02 -55.1 6.78 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.749 . . . . 0.5 111.316 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.729 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.4 Cg_exo -58.2 -32.09 94.98 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.999 1.799 . . . . 0.57999999999999996 111.764 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.3 mmmt -74.06 -24.77 59.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 2.1400000000000001 111.913 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.686 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 43.9 tp -70.53 -47.25 61.33 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.13 -0.628 . . . . 0.66000000000000003 109.375 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -59.27 -35.46 73.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.603 -0.726 . . . . 1.8899999999999999 109.405 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.3 -51.48 68.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.807 -1.088 . . . . 1.53 111.002 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -69.17 -32.04 71.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 1.49 112.277 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.713 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.1 mt -62.77 3.65 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.503 0.927 . . . . 0.76000000000000001 113.503 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.611 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 47.7 m -82.84 13.34 3.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.413 0.625 . . . . 1.05 109.336 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.82 44.1 57.14 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.368 -0.833 . . . . 1.1699999999999999 111.162 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 28.8 mmmt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.344 -0.836 . . . . 2.0 109.841 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 37' ' ' LEU . 21.2 t . . . . . 0 C--O 1.235 0.295 0 N-CA-C 110.217 -0.29 . . . . 1.47 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.27 33.93 0.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.057 0.932 . . . . 1.8100000000000001 110.49 -173.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.552 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.5 mm? 60.11 20.86 10.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.414 -1.266 . . . . 0.69999999999999996 110.757 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.72 -33.72 64.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.613 0.765 . . . . 1.96 112.334 -171.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.645 ' CB ' HD12 ' A' ' 12' ' ' LEU . 76.1 mttt -135.75 50.18 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.207 -0.451 . . . . 2.6600000000000001 110.375 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.432 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -72.87 -28.71 62.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.341 0.497 . . . . 3.98 112.341 -176.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 19.5 p -152.65 29.11 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.63 111.208 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.26 -122.69 0.83 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.957 -0.857 . . . . 0.47999999999999998 110.957 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.6 Cg_endo -52.8 -37.56 76.7 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.222 2.615 . . . . 0.53000000000000003 110.343 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.833 HD11 ' HA3' ' A' ' 38' ' ' GLY . 16.5 mt -87.73 83.06 7.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.951 -1.022 . . . . 1.1699999999999999 109.657 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -73.5 63.42 0.8 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.519 0.676 . . . . 0.70999999999999996 110.497 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 121' ' ' VAL . 58.9 mt -71.19 -16.6 62.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.729 -0.669 . . . . 0.45000000000000001 109.79 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -70.42 -4.47 22.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.49 -0.777 . . . . 2.1200000000000001 110.694 177.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.89 -27.06 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.624 -0.88 . . . . 1.9299999999999999 108.624 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 151' ' ' VAL . 60.0 t -99.1 -71.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.609 -1.178 . . . . 0.63 110.408 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HB2' HH22 ' A' ' 155' ' ' ARG . 7.5 p-10 -110.7 153.35 25.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 111.564 -172.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 26.1 mt-10 -65.51 142.15 58.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.001 -1.0 . . . . 1.6000000000000001 109.326 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 98.7 mt-30 -55.61 120.59 33.17 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 123.335 0.397 . . . . 3.5499999999999998 111.132 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 20' ' ' GLN . 23.2 Cg_exo -64.27 162.08 31.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.051 2.501 . . . . 0.57999999999999996 112.685 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.899 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.9 pt20 -84.82 -12.85 52.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.779 -0.646 . . . . 1.3899999999999999 111.217 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.778 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 66.3 m-70 -153.2 161.43 29.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.415 -0.957 . . . . 1.45 108.415 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.7 Cg_endo -88.22 132.27 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.852 2.368 . . . . 0.40000000000000002 112.233 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 122' ' ' TRP . 28.3 tp -78.31 144.75 35.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.807 -0.442 . . . . 0.28999999999999998 109.807 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.463 ' H ' HD12 ' A' ' 25' ' ' LEU . 31.4 m80 -122.81 113.35 19.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.609 -0.515 . . . . 1.24 109.609 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 53' ' ' ILE . 10.6 t -117.65 136.43 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.731 -0.47 . . . . 0.46999999999999997 109.731 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -134.45 136.79 43.48 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.061 0.458 . . . . 0.31 111.076 -176.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -97.16 176.26 5.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.975 -0.75 . . . . 0.67000000000000004 108.975 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.68 62.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.508 0.671 . . . . 0.55000000000000004 110.191 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.91 1.56 31.74 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 115.089 -0.959 . . . . 0.81000000000000005 112.666 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB2' HE21 ' A' ' 45' ' ' GLN . . . -138.16 -174.75 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.633 0.254 . . . . 0.46999999999999997 110.605 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.58 149.64 11.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.154 -0.476 . . . . 0.33000000000000002 110.392 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.815 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 96.2 t -101.78 62.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 106.71 -1.589 . . . . 0.39000000000000001 106.71 163.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.77 -9.3 59.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.032 -1.44 . . . . 0.98999999999999999 110.882 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -131.44 134.56 46.34 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.567 -0.901 . . . . 2.5600000000000001 108.567 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.621 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -75.84 109.62 9.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.376 -0.601 . . . . 0.40999999999999998 109.376 -175.15 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.833 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 85.07 23.38 49.16 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.391 -0.822 . . . . 0.58999999999999997 112.471 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.815 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -80.19 149.52 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.627 -0.508 . . . . 0.34000000000000002 109.627 171.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -73.86 133.02 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.155 0.502 . . . . 0.55000000000000004 110.983 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.461 HD22 HG22 ' A' ' 34' ' ' VAL . 7.9 tp -131.06 168.55 17.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.115 -1.069 . . . . 0.45000000000000001 108.115 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 23.2 p -121.87 157.13 58.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 119.569 -0.853 . . . . 0.56000000000000005 112.349 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 10.1 Cg_endo -51.53 -41.99 57.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.093 2.529 . . . . 0.68000000000000005 113.028 -176.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -62.71 -26.82 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.111 -0.495 . . . . 0.76000000000000001 112.159 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 32' ' ' ALA . 56.7 mt-30 -82.27 -25.34 34.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.945 -0.571 . . . . 1.5900000000000001 111.289 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 169' ' ' TYR . 18.5 m -122.01 29.11 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.66000000000000003 111.552 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.12 -7.33 58.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.014 -0.539 . . . . 0.79000000000000004 110.202 -177.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.461 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 59.2 m-80 -127.26 -174.91 3.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.603 -0.726 . . . . 1.9099999999999999 109.315 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.597 ' NH2' ' HB ' ' A' ' 102' ' ' VAL . 72.5 mtt180 -77.0 155.11 82.84 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.75 -0.463 . . . . 1.4299999999999999 109.75 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.23 153.42 18.62 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.06 1.84 . . . . 0.37 110.874 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -79.25 -18.57 52.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.909 0.385 . . . . 0.44 110.223 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.482 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -157.0 141.35 16.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.524 0.678 . . . . 0.38 112.446 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.913 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.23 158.28 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.773 -1.103 . . . . 0.29999999999999999 108.503 172.128 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.115 ' HA ' HD13 ' A' ' 58' ' ' LEU . 26.3 t -179.23 122.04 0.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.976 -0.379 . . . . 0.34999999999999998 109.976 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.829 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -76.12 156.0 34.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.347 -1.353 . . . . 2.7200000000000002 107.347 170.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.529 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 17.8 t70 -59.84 85.9 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.25 0.548 . . . . 1.51 110.715 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.93 15.17 5.33 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.61 -0.723 . . . . 0.80000000000000004 112.765 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.115 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.2 tt -50.79 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.505 . . . . 0.57999999999999996 111.182 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.4 t70 -71.14 -29.97 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.644 -0.707 . . . . 0.73999999999999999 111.453 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 m 72.82 15.44 4.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.679 -1.146 . . . . 1.03 110.245 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.78 -6.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.474 -0.87 . . . . 0.83999999999999997 114.03 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.5 mtpt -96.17 161.27 14.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.028 0.914 . . . . 1.6699999999999999 110.46 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 51.5 mt -90.97 132.32 36.04 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.878 -0.786 . . . . 0.57999999999999996 108.878 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.564 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -132.83 147.72 52.31 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.646 -0.421 . . . . 0.80000000000000004 110.317 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.649 HG23 HG12 ' A' ' 90' ' ' VAL . 65.5 m -95.54 105.57 17.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.772 -0.825 . . . . 0.35999999999999999 108.772 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 57.1 tp -106.49 113.48 27.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.552 -0.749 . . . . 0.58999999999999997 109.697 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 88' ' ' LEU . 44.3 t -114.42 129.45 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.39000000000000001 110.452 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.0 mt -85.17 124.04 31.37 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.64 -0.874 . . . . 0.59999999999999998 108.64 168.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -135.83 138.18 42.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.926 0.393 . . . . 0.35999999999999999 110.011 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 17.6 p-10 -125.93 102.23 28.45 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 121.523 0.678 . . . . 1.9199999999999999 110.729 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -54.77 -177.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.378 2.718 . . . . 1.25 112.808 170.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.636 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.6 m-20 55.1 41.42 31.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 1.29 111.274 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.57 140.58 21.22 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 115.726 -0.67 . . . . 0.5 110.176 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.502 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 90.6 Cg_endo -81.65 -26.44 9.03 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.003 -1.665 . . . . 0.62 112.475 2.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.783 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 89.3 p -123.11 146.13 47.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.592 . . . . 0.75 110.314 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.636 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 74.4 ttt180 -67.55 -23.21 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 2.8799999999999999 111.257 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.722 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -82.87 -18.35 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 1.3799999999999999 111.064 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.15 90.12 2.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.048 -0.524 . . . . 1.3700000000000001 109.875 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 91.8 Cg_endo -85.33 93.46 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.863 2.375 . . . . 0.80000000000000004 113.814 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.502 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.4 mttm -82.69 -50.3 8.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.749 0.785 . . . . 1.02 110.477 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.79 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 63.7 m-85 -88.1 25.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.966 -1.015 . . . . 1.1699999999999999 111.225 -170.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.703 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.52 128.7 33.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.306 -0.406 . . . . 2.9300000000000002 110.445 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.703 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.0 mp0 -94.83 149.59 21.09 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.067 0.46 . . . . 2.23 110.773 -3.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.524 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 4.4 t90 -92.06 137.37 32.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.08 -1.081 . . . . 1.4299999999999999 108.08 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.473 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 9.1 p-80 -110.5 141.06 44.17 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.339 -0.615 . . . . 1.26 109.339 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 -15.14 12.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.248 0.833 . . . . 2.1400000000000001 113.248 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.496 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 3.2 p90 -169.38 166.59 10.34 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.447 -0.205 . . . . 1.51 110.447 162.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 67' ' ' VAL . 33.6 tp -133.84 113.96 12.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.151 -0.477 . . . . 0.33000000000000002 109.922 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.527 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -123.83 132.47 71.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.658 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 65' ' ' THR . 22.1 m -134.02 161.17 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.101 -0.954 . . . . 0.27000000000000002 108.793 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.3 t30 63.37 16.79 9.79 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.506 0.504 . . . . 1.76 110.273 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.527 ' HE3' HG11 ' A' ' 89' ' ' VAL . 6.8 ttm -67.42 111.8 4.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.718 -0.845 . . . . 0.31 108.718 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -87.64 96.89 10.59 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.005 -0.998 . . . . 1.21 111.016 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.63 -126.49 9.11 Favored Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 114.857 -1.065 . . . . 0.29999999999999999 112.284 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.534 ' HA ' HD11 ' A' ' 53' ' ' ILE . 4.4 p-10 -112.56 23.26 13.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 1.04 110.7 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.9 109.02 19.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.77000000000000002 109.908 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -59.45 -33.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.40999999999999998 110.625 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.3 m -73.6 -34.75 65.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.795 -0.638 . . . . 0.68000000000000005 111.951 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.5 -6.16 48.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.882 0.327 . . . . 1.26 111.882 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 92' ' ' MET . . . -70.82 96.6 0.6 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.451 -0.881 . . . . 0.34999999999999998 111.836 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.8 m -60.96 107.73 0.76 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.45000000000000001 110.325 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.597 ' HB ' ' NH2' ' A' ' 49' ' ' ARG . 7.5 p -87.51 130.25 37.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.86 -1.064 . . . . 0.56999999999999995 111.76 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 10.3 mt -112.2 -49.94 2.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.101 0.953 . . . . 0.45000000000000001 108.874 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.3 t -109.58 99.67 8.83 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.005 -1.48 . . . . 0.37 107.005 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.475 ' HB2' ' N ' ' A' ' 140' ' ' ASN . 3.7 m-20 -56.86 157.58 5.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.139 -0.937 . . . . 1.1499999999999999 113.114 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 14.7 p90 -74.31 107.58 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.782 -1.099 . . . . 4.6900000000000004 110.143 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.3 t -80.72 -15.69 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.543 0.687 . . . . 0.85999999999999999 110.276 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.53 -146.61 22.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.998 -0.62 . . . . 0.67000000000000004 111.801 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.593 ' O ' HD22 ' A' ' 180' ' ' LEU . 14.2 t -83.2 140.92 32.28 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.677 -0.49 . . . . 0.51000000000000001 109.677 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.61 68.5 0.19 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.354 -0.927 . . . . 0.81999999999999995 113.747 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.431 ' O ' HG11 ' A' ' 177' ' ' VAL . 57.6 Cg_endo -98.35 122.7 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.527 2.818 . . . . 0.84999999999999998 112.304 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 74.3 Cg_exo -50.93 146.68 20.92 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.045 2.497 . . . . 0.87 112.474 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 116.92 5.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 1.8500000000000001 111.482 -174.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.27 64.19 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.952 -0.567 . . . . 1.1799999999999999 113.777 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.783 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 51.3 p -79.82 -62.76 1.59 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.087 0.444 . . . . 0.96999999999999997 112.113 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.35 178.06 30.12 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.07 -0.812 . . . . 1.97 111.07 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -71.74 106.89 4.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.972 0.415 . . . . 0.93999999999999995 110.557 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 3.4 m-70 -77.31 116.55 18.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 2.23 110.115 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.819 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 9.7 ptt180 -94.87 90.09 5.89 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.464 -0.789 . . . . 2.3100000000000001 110.642 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.57 ' HE1' ' HB3' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.99 107.63 6.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.86 -0.793 . . . . 0.78000000000000003 108.86 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 168' ' ' CYS . 19.9 t -90.36 129.52 41.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.569 -0.742 . . . . 0.27000000000000002 109.479 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.643 ' HB2' HD23 ' A' ' 25' ' ' LEU . 23.3 m95 -89.93 119.74 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.397 -0.964 . . . . 1.99 108.397 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 79.5 mt -113.72 119.68 38.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.734 0.243 . . . . 0.38 111.205 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.565 HG12 HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -119.18 135.22 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.249 0.547 . . . . 0.31 111.328 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.79 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 72.3 t80 -128.35 128.88 45.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 5.1200000000000001 109.121 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.537 ' HG2' HG21 ' A' ' 164' ' ' VAL . 6.5 pt-20 -67.53 107.63 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.096 -0.705 . . . . 2.4100000000000001 109.096 175.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 18.6 mt-30 -56.42 137.56 52.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.387 -0.824 . . . . 1.3100000000000001 112.392 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.42 -26.17 68.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.887 -1.051 . . . . 2.3999999999999999 108.691 168.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 8.6 ptp180 -167.29 158.73 10.31 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 114.111 -1.404 . . . . 3.5099999999999998 109.762 -177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HA ' ' NE2' ' A' ' 127' ' ' GLN . 15.4 Cg_exo -61.69 131.95 37.94 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.759 2.306 . . . . 1.21 110.383 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.448 ' HG ' HG11 ' A' ' 90' ' ' VAL . 4.2 mm? -64.41 152.35 41.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.955 1.094 . . . . 0.90000000000000002 113.955 -166.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -109.65 85.69 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.224 -1.353 . . . . 2.8999999999999999 108.651 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.782 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 58.3 m -132.06 116.35 16.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 1.8999999999999999 111.412 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -106.26 39.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.714 -0.847 . . . . 2.96 108.714 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.9 mm-40 -73.89 131.44 81.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.801 -1.091 . . . . 1.3899999999999999 110.585 -173.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.8 119.96 4.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.408 2.739 . . . . 1.27 112.7 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 15.2 mm -70.11 115.2 8.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.578 -0.527 . . . . 0.85999999999999999 109.578 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.88 -14.44 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.651 0.611 . . . . 1.6100000000000001 112.651 -170.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' A' ' 105' ' ' ASP . 37.1 m 55.43 23.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.489 0.922 . . . . 1.8799999999999999 113.489 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.625 ' HA ' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER 60.29 -2.78 0.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.21 1.004 . . . . 0.75 113.515 172.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.584 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 66.5 mtt180 -100.12 135.91 40.83 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.16 -0.338 . . . . 3.3599999999999999 110.137 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.604 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.0 m 82.26 131.9 0.05 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 124.524 1.14 . . . . 0.94999999999999996 111.396 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.7 41.6 2.16 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.196 -0.911 . . . . 1.1200000000000001 113.109 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -71.68 -34.34 69.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 2.6600000000000001 110.921 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -125.34 73.51 1.32 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 1.8700000000000001 110.721 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.429 ' HB3' ' CE2' ' A' ' 84' ' ' TRP . 63.8 mtt180 -78.73 -77.15 0.17 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.155 -0.93 . . . . 4.7300000000000004 111.549 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -132.72 -137.16 3.88 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.708 -0.758 . . . . 0.65000000000000002 112.908 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.79 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 90.3 mttt 65.04 28.37 12.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.717 0.77 . . . . 1.0800000000000001 110.246 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -103.92 167.94 9.45 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.909 -1.041 . . . . 1.8899999999999999 108.763 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 11.8 mmmm -117.35 117.53 29.75 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.002 -0.37 . . . . 1.29 110.002 173.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.685 HG21 HG12 ' A' ' 17' ' ' VAL . 27.8 m -61.14 -24.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 0.78000000000000003 110.8 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.15 82.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.852 -0.613 . . . . 0.67000000000000004 109.505 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.9 m -65.53 -35.43 80.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.77000000000000002 110.692 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.684 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 26.9 m-85 -58.65 -56.36 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.92000000000000004 110.685 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.492 HH22 ' HB2' ' A' ' 18' ' ' ASP . 18.4 ptp180 -66.02 -43.22 88.28 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.8900000000000001 110.682 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -62.79 -36.16 82.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.682 0.277 . . . . 0.96999999999999997 111.607 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -63.04 -45.17 93.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.165 0.507 . . . . 1.5800000000000001 110.846 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 131' ' ' LEU . 20.8 m-85 -83.0 1.86 37.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 5.4500000000000002 110.478 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 64.19 33.07 12.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.163 -0.926 . . . . 2.4199999999999999 111.125 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.79 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -92.79 179.19 5.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.652 -1.158 . . . . 1.27 109.14 173.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.687 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.9 tpt180 -149.05 -146.91 0.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.422 -0.585 . . . . 3.5899999999999999 109.422 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.687 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -55.22 143.47 54.77 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 121.109 0.481 . . . . 0.76000000000000001 111.038 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 4.1 Cg_exo -73.01 157.39 51.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.798 2.998 . . . . 0.53000000000000003 112.813 -170.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.899 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -86.1 -24.48 6.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.562 -0.903 . . . . 0.44 108.562 174.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.829 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -158.97 148.35 18.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.667 -0.697 . . . . 0.27000000000000002 111.915 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.9 153.72 25.53 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.638 -1.165 . . . . 0.23999999999999999 110.918 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.427 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.7 t -166.44 144.08 5.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.83 -0.804 . . . . 0.34000000000000002 108.83 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.591 ' HB3' HG22 ' A' ' 121' ' ' VAL . 25.4 p -124.93 141.83 51.87 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.074 -0.65 . . . . 1.1100000000000001 111.483 -173.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.593 ' CE2' HG21 ' A' ' 46' ' ' VAL . 26.0 p90 -123.92 130.75 53.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.254 -1.017 . . . . 0.80000000000000004 108.254 171.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.819 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 1.8 mp0 -97.78 132.47 43.37 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 2.5299999999999998 110.17 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.57 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . . . -134.68 145.59 48.68 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.089 -0.708 . . . . 0.59999999999999998 109.089 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -170.54 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 2.3799999999999999 111.562 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.838 ' HA ' HG21 ' A' ' 177' ' ' VAL . 36.1 p90 -80.18 54.67 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 3.96 112.1 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -50.55 -60.44 3.02 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.487 0.551 . . . . 1.53 112.487 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.57 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.6 t70 -173.68 -44.53 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.007 0.432 . . . . 1.26 111.283 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -80.42 6.99 10.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.21 -0.45 . . . . 2.2200000000000002 111.667 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 173' ' ' TRP . 71.2 t -72.54 -52.79 6.28 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.077 -0.51 . . . . 0.5 110.546 174.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.688 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -50.35 -34.26 40.2 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.464 2.109 . . . . 0.57999999999999996 112.158 169.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.683 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.7 mmmt -74.09 -25.19 59.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 2.1400000000000001 111.196 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 24.9 tp -70.53 -44.91 66.57 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.275 -0.639 . . . . 0.66000000000000003 109.275 172.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -58.32 -40.12 81.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.07 -0.715 . . . . 1.8899999999999999 109.07 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.683 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.58 -50.67 71.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.81 -1.086 . . . . 1.53 110.897 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -65.18 -33.09 75.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.635 -0.711 . . . . 1.49 112.16 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 55.8 mt -66.47 4.29 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.76000000000000001 111.641 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.855 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.3 m -79.71 3.13 20.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 1.05 109.581 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 79.04 48.0 7.24 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.162 -0.926 . . . . 1.1699999999999999 111.306 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.855 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.0 mmmt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.508 -0.758 . . . . 2.0 110.241 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.756 HG13 ' HB2' ' A' ' 37' ' ' LEU . 22.5 t . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.806 0.336 . . . . 1.47 110.835 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.09 155.21 41.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.85 -0.796 . . . . 1.8100000000000001 108.85 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.6 mm? -83.49 8.12 14.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.863 0.69 . . . . 0.69999999999999996 112.863 -169.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 t -66.15 -27.07 67.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.977 0.417 . . . . 1.96 111.042 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 66.2 mttm -92.57 9.43 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.47 -0.332 . . . . 2.6600000000000001 111.655 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.764 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 57.4 t-105 -66.58 -24.96 66.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.398 0.518 . . . . 3.98 112.398 -172.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.499 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 14.1 p -136.33 21.53 3.19 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.36 -0.536 . . . . 0.63 111.8 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.6 -126.37 1.45 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.822 -0.704 . . . . 0.47999999999999998 111.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.12 -35.46 62.36 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.334 2.689 . . . . 0.53000000000000003 110.056 166.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.599 HD11 ' HA3' ' A' ' 38' ' ' GLY . 12.5 mt -87.6 86.8 7.24 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.564 -1.198 . . . . 1.1699999999999999 108.986 171.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.8 m -78.44 66.97 4.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.485 0.66 . . . . 0.70999999999999996 110.467 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 HG21 ' A' ' 121' ' ' VAL . 29.0 mt -78.75 -4.97 51.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.468 -0.787 . . . . 0.45000000000000001 111.216 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 12.9 mm100 -68.27 -13.4 62.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.047 0.451 . . . . 2.1200000000000001 110.39 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.52 -28.14 69.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 1.9299999999999999 110.262 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.58 ' CG1' HG21 ' A' ' 151' ' ' VAL . 71.5 t -86.36 -73.57 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.63 110.653 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -162.5 169.06 20.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.818 -0.353 . . . . 2.9900000000000002 110.811 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -49.04 147.41 2.87 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.089 0.956 . . . . 1.6000000000000001 113.279 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.764 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 68.1 mt-30 -59.37 128.39 85.68 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 115.536 -0.756 . . . . 3.5499999999999998 109.913 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 11.1 Cg_exo -70.02 157.28 60.4 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.913 2.409 . . . . 0.57999999999999996 111.893 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.852 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 13.9 pt20 -73.4 -18.79 61.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 1.3899999999999999 111.314 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.818 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 49.7 m80 -148.07 160.23 37.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.606 -0.725 . . . . 1.45 109.139 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.0 Cg_endo -86.0 131.92 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.05 2.5 . . . . 0.40000000000000002 111.832 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 122' ' ' TRP . 20.6 tp -80.68 141.08 35.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.328 . . . . 0.28999999999999998 110.724 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.42 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.41 123.91 51.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.445 -0.343 . . . . 1.24 110.15 170.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 53' ' ' ILE . 17.6 t -121.5 143.26 34.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.525 -0.917 . . . . 0.46999999999999997 108.525 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -136.86 142.83 42.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.135 0.493 . . . . 0.31 110.791 -176.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -108.64 176.91 4.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.16 -0.681 . . . . 0.67000000000000004 109.16 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.89 -51.81 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.55000000000000004 111.803 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.75 -13.34 9.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.677 -0.692 . . . . 0.81000000000000005 112.835 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.26 -165.12 1.36 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.46999999999999997 110.914 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.0 165.99 26.61 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.367 -0.833 . . . . 0.33000000000000002 109.748 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.77 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 93.4 t -107.44 64.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.303 -1.739 . . . . 0.39000000000000001 106.303 160.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.12 1.72 49.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.198 -1.364 . . . . 0.98999999999999999 109.949 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 43.7 mt-10 -135.62 126.06 26.75 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.408 -0.815 . . . . 2.5600000000000001 109.865 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.756 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -71.95 110.13 6.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.149 -0.686 . . . . 0.40999999999999998 109.149 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.628 ' C ' HE22 ' A' ' 170' ' ' GLN . . . 90.01 28.31 18.49 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.258 -0.883 . . . . 0.58999999999999997 111.973 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.77 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -93.29 151.05 20.04 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.842 -0.429 . . . . 0.34000000000000002 109.842 174.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.4 p -78.19 135.98 25.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.55000000000000004 111.098 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 169' ' ' TYR . 8.4 tp -131.46 170.58 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.152 -1.425 . . . . 0.45000000000000001 107.152 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 p -116.17 148.61 41.89 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 118.669 -1.212 . . . . 0.56000000000000005 113.362 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 1.079 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 53.4 Cg_exo -55.38 -40.76 83.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.491 3.461 . . . . 0.68000000000000005 113.914 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -33.32 63.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.517 0.675 . . . . 0.76000000000000001 110.715 174.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -81.75 -58.46 2.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.909 . . . . 1.5900000000000001 110.704 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 43' ' ' PRO . 6.3 m -81.42 28.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.386 0.612 . . . . 0.66000000000000003 112.079 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -82.21 -31.44 30.32 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.69 -0.856 . . . . 0.79000000000000004 108.69 174.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.437 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 19.0 m120 -112.13 -149.78 0.45 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.849 -1.069 . . . . 1.9099999999999999 110.319 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.579 ' HD3' HG22 ' A' ' 97' ' ' ILE . 99.5 mtt180 -99.11 157.25 34.39 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.246 -0.433 . . . . 1.4299999999999999 109.964 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.98 166.28 25.18 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.402 2.068 . . . . 0.37 110.574 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -81.48 -25.47 36.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.03 0.443 . . . . 0.44 110.018 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.2 m -159.27 149.56 19.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.165 0.507 . . . . 0.38 111.97 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.12 158.71 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.288 -1.004 . . . . 0.29999999999999999 108.288 171.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.103 ' HA ' HD13 ' A' ' 58' ' ' LEU . 32.7 t -176.4 113.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.917 0.389 . . . . 0.34999999999999998 110.104 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -72.42 157.67 37.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.664 -1.235 . . . . 2.7200000000000002 107.664 172.566 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' HB3' ' CD2' ' A' ' 23' ' ' HIS . 34.8 t70 -59.97 87.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.523 0.514 . . . . 1.51 110.611 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.3 21.51 4.05 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.753 -0.658 . . . . 0.80000000000000004 112.749 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.103 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -57.69 129.14 40.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.984 0.421 . . . . 0.57999999999999996 110.565 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.623 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 26.2 t70 -79.69 -27.74 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.505 . . . . 0.73999999999999999 111.502 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.535 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 52.7 m 77.84 -5.67 2.08 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.3 1.0 . . . . 1.03 110.278 -171.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.31 21.49 5.15 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.874 -0.603 . . . . 0.83999999999999997 112.794 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.623 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 9.7 mtpt -113.0 145.02 41.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 122.535 -0.391 . . . . 1.6699999999999999 110.752 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.617 HD21 ' HE2' ' A' ' 93' ' ' LYS . 44.5 mt -91.0 124.87 35.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.191 -0.67 . . . . 0.57999999999999996 109.191 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -127.18 161.38 28.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.754 -0.379 . . . . 0.80000000000000004 109.98 177.356 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.668 HG23 HG12 ' A' ' 90' ' ' VAL . 63.3 m -97.45 106.57 18.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.715 -0.846 . . . . 0.35999999999999999 108.715 169.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.2 tp -103.58 109.37 21.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.448 -0.796 . . . . 0.58999999999999997 109.69 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.5 t -113.87 136.74 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.39000000000000001 110.69 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.861 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.8 mt -104.61 126.4 51.66 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.73 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 10.1 t -135.22 150.75 50.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.878 0.37 . . . . 0.35999999999999999 111.315 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.468 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 6.8 t70 -130.47 94.25 30.19 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-O 121.51 0.671 . . . . 1.9199999999999999 110.39 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 13.0 Cg_endo -56.49 -30.91 84.2 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.83 3.02 . . . . 1.25 114.108 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -90.74 39.58 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.641 . . . . 1.29 112.732 -167.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.48 140.44 21.07 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.77 -0.456 . . . . 0.5 109.77 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.571 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 98.3 Cg_endo -80.19 -21.62 17.38 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.864 -1.307 . . . . 0.62 113.351 2.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 88.5 p -139.75 162.85 34.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.746 -0.206 . . . . 0.75 111.072 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.476 ' NE ' HH12 ' A' ' 119' ' ' ARG . 1.0 OUTLIER -64.4 -36.8 85.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.234 0.54 . . . . 2.8799999999999999 110.61 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.2 ptpt -71.63 -18.17 62.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 1.3799999999999999 111.224 -175.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.5 t70 -161.43 86.62 1.65 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.402 . . . . 1.3700000000000001 110.648 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.1 Cg_endo -84.0 91.64 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.902 2.401 . . . . 0.80000000000000004 112.946 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.571 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 39.3 mttm -82.63 -45.37 14.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 1.02 110.793 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.765 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.9 m-85 -81.0 16.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 1.1699999999999999 111.776 -171.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.93 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 9.1 ttp180 -62.3 125.04 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.068 -0.345 . . . . 2.9300000000000002 110.068 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.93 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.1 mp0 -107.72 133.98 51.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.503 0.321 . . . . 2.23 110.356 -4.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -76.9 164.85 25.41 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.813 -1.18 . . . . 1.4299999999999999 107.813 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.73 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 p80 -145.94 123.18 11.55 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.826 -0.546 . . . . 1.26 110.329 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.861 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.3 t-160 -62.13 -40.86 97.35 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.418 -0.81 . . . . 2.1400000000000001 109.552 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.9 p90 -167.77 171.56 9.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.963 -0.295 . . . . 1.51 110.465 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HG ' HD12 ' A' ' 103' ' ' LEU . 30.1 tp -129.96 113.09 14.16 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.144 -0.687 . . . . 0.33000000000000002 109.144 173.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.643 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.1 t -118.36 134.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.847 -0.615 . . . . 0.31 110.649 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.948 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 19.7 m -134.53 157.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.63 -0.714 . . . . 0.27000000000000002 109.61 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t30 61.18 22.28 12.62 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.601 0.563 . . . . 1.76 110.455 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.643 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -70.71 111.68 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.725 -0.843 . . . . 0.31 108.725 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 63' ' ' LEU . 18.2 ttmm -87.59 100.38 12.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.162 -0.926 . . . . 1.21 111.045 -172.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 77.17 -122.84 6.29 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.255 -0.884 . . . . 0.29999999999999999 112.883 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.575 ' HA ' HD11 ' A' ' 53' ' ' ILE . 3.1 p-10 -118.14 21.09 12.94 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 1.04 110.736 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.68 105.68 15.66 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.787 -0.642 . . . . 0.77000000000000002 109.77 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.579 HG22 ' HD3' ' A' ' 49' ' ' ARG . 4.8 mm -62.89 -25.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.867 -1.06 . . . . 0.40999999999999998 111.384 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 m -84.41 -29.62 26.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.68000000000000005 111.994 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 m -80.26 -3.84 50.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.943 0.402 . . . . 1.26 111.706 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.14 106.42 1.88 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.761 -0.733 . . . . 0.34999999999999998 111.303 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.2 m -64.31 106.84 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.228 -0.656 . . . . 0.45000000000000001 109.228 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.19 111.8 24.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.43 -0.805 . . . . 0.56999999999999995 110.86 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.598 HD12 ' HG ' ' A' ' 88' ' ' LEU . 5.1 mt -87.85 -39.96 14.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.039 0.923 . . . . 0.45000000000000001 109.935 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.4 t -114.36 105.88 13.66 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.72 -1.585 . . . . 0.37 106.72 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.2 t70 -57.73 158.1 6.59 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.873 0.733 . . . . 1.1499999999999999 111.992 -169.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 23.0 p90 -85.74 77.54 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 4.6900000000000004 111.305 -171.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 140' ' ' ASN . 36.7 t -60.48 -45.05 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.85999999999999999 111.485 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.682 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 106.24 -168.33 14.8 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.385 -0.912 . . . . 0.67000000000000004 112.576 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.9 t -65.91 126.63 29.15 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.759 -0.46 . . . . 0.51000000000000001 109.759 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.606 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -152.56 54.49 0.46 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.994 -0.622 . . . . 0.81999999999999995 112.727 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 1.025 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 11.3 Cg_endo -98.52 153.61 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.022 3.148 . . . . 0.84999999999999998 113.232 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 111' ' ' PRO . 31.6 Cg_exo -61.34 150.16 86.14 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.008 2.472 . . . . 0.87 112.499 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -67.17 122.05 16.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.347 -0.842 . . . . 1.8500000000000001 111.571 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.6 50.33 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.927 -0.654 . . . . 1.1799999999999999 112.996 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.612 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 21.7 p -78.5 -13.59 59.76 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.943 0.72 . . . . 0.96999999999999997 112.943 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.31 24.31 6.56 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.09 -1.052 . . . . 1.97 113.38 172.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.58 HD13 ' HG2' ' A' ' 172' ' ' GLU . 4.0 mm? 68.56 103.79 0.05 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.807 -0.697 . . . . 0.93999999999999995 111.549 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 11.6 m170 -76.64 134.18 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.789 -0.641 . . . . 2.23 109.695 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 1.035 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 8.0 ptp85 -112.9 96.7 6.1 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.347 0.594 . . . . 2.3100000000000001 111.094 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 45.4 m-85 -72.15 114.59 10.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.511 -0.768 . . . . 0.78000000000000003 109.247 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.618 HG21 HD22 ' A' ' 14' ' ' LEU . 31.3 t -90.4 129.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.61 -0.723 . . . . 0.27000000000000002 110.439 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.879 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.56 119.49 30.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.546 -0.752 . . . . 1.99 109.396 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 84.0 mt -118.37 127.61 53.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.333 0.111 . . . . 0.38 111.089 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.42 HG12 HD22 ' A' ' 25' ' ' LEU . 1.4 m -115.53 139.41 42.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.31 109.352 171.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CB ' HD23 ' A' ' 160' ' ' LEU . 84.9 m-85 -118.83 164.32 15.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.862 0.363 . . . . 5.1200000000000001 111.427 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.62 118.2 33.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.438 -0.801 . . . . 2.4100000000000001 109.071 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -97.81 166.96 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.184 0.516 . . . . 1.3100000000000001 110.477 -175.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.52 -22.31 54.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.513 -0.767 . . . . 2.3999999999999999 109.563 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.79 164.18 19.67 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.821 -1.081 . . . . 3.5099999999999998 110.277 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.463 ' HG3' HD12 ' A' ' 63' ' ' LEU . 53.7 Cg_exo -51.74 135.67 49.67 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.605 2.203 . . . . 1.21 112.02 175.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.948 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.3 mm? -55.63 147.48 18.16 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.2 0.815 . . . . 0.90000000000000002 113.2 -171.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -130.73 80.36 1.94 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.574 -1.194 . . . . 2.8999999999999999 108.09 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.477 ' SG ' HG11 ' A' ' 90' ' ' VAL . 60.1 m -104.1 112.86 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.765 -0.652 . . . . 1.8999999999999999 110.23 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.53 18.58 12.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.09 -0.959 . . . . 2.96 110.216 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.87 130.2 94.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.444 -0.798 . . . . 1.3899999999999999 109.999 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -47.44 118.55 2.99 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.309 2.673 . . . . 1.27 113.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.3 mm -60.43 115.76 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.971 -0.558 . . . . 0.85999999999999999 110.618 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.8 152.19 19.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 1.6100000000000001 109.841 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 m -99.59 156.43 17.07 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.089 -1.078 . . . . 1.8799999999999999 108.089 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.772 ' HA ' HG22 ' A' ' 107' ' ' VAL . 1.7 p-10 -81.89 6.85 14.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.333 0.587 . . . . 0.75 110.432 -174.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 46.6 mtt-85 -102.76 135.49 44.31 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.548 -0.751 . . . . 3.3599999999999999 109.427 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.61 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.9 m 83.27 140.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.828 1.33 . . . . 0.94999999999999996 110.551 -175.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -102.22 46.71 1.22 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.511 -0.768 . . . . 1.1200000000000001 111.433 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.98 -29.96 66.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.928 0.394 . . . . 2.6600000000000001 111.489 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -124.51 70.05 1.11 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.037 0.446 . . . . 1.8700000000000001 111.232 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 63.7 mtp180 -87.93 30.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 4.7300000000000004 111.989 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.77 -143.83 17.81 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.176 -1.012 . . . . 0.65000000000000002 113.388 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.765 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.8 mttt 60.94 42.21 13.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.855 0.836 . . . . 1.0800000000000001 110.687 -174.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -133.66 158.38 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.444 -1.253 . . . . 1.8899999999999999 108.872 174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 12.3 mmmm -96.8 120.84 37.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.15 0.282 . . . . 1.29 110.775 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.7 m -61.27 -33.05 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.78000000000000003 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -58.84 -44.6 90.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.736 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.4 m -62.13 -37.75 86.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.479 . . . . 0.77000000000000002 111.064 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.62 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 48.1 m-85 -59.27 -56.74 18.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.898 0.38 . . . . 0.92000000000000004 110.742 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 160' ' ' LEU . 4.3 ppt_? -71.13 -28.77 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.111 0.412 . . . . 2.8900000000000001 112.111 -176.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 52.5 mtmt -65.8 -25.99 67.48 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.404 -0.185 . . . . 0.96999999999999997 111.331 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 17.8 tptm -53.17 -46.37 68.9 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.58 0.229 . . . . 1.5800000000000001 110.716 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.43 ' HB3' HD13 ' A' ' 160' ' ' LEU . 20.7 t80 -99.8 11.81 38.3 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.77 -0.772 . . . . 5.4500000000000002 109.957 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.18 41.31 6.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.171 -0.922 . . . . 2.4199999999999999 112.83 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB2' ' HB2' ' A' ' 155' ' ' ARG . 6.4 mp -73.74 137.2 43.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.466 -0.788 . . . . 1.27 109.171 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -86.0 -53.28 5.18 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.7 0.63 . . . . 3.5899999999999999 112.7 -169.302 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -164.8 161.95 14.95 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.947 -0.57 . . . . 0.76000000000000001 110.233 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 15.9 Cg_exo -66.96 140.6 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.845 2.363 . . . . 0.53000000000000003 112.776 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.852 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -86.61 -29.55 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.739 -0.837 . . . . 0.44 108.739 173.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -152.57 146.77 25.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.616 -0.72 . . . . 0.27000000000000002 111.221 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.87 156.85 27.13 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.2 -0.909 . . . . 0.23999999999999999 111.716 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.615 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 5.8 t -168.87 151.12 4.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.571 -0.9 . . . . 0.34000000000000002 108.571 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 12' ' ' LEU . 26.5 p -129.37 140.34 51.4 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.878 -0.729 . . . . 1.1100000000000001 111.371 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 120' ' ' TYR . 51.1 p90 -122.1 137.47 54.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.16 -1.052 . . . . 0.80000000000000004 108.16 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 1.035 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 2.1 mp0 -100.04 133.58 44.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.468 0.576 . . . . 2.5299999999999998 110.985 177.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -157.4 114.32 3.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.59999999999999998 110.069 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 1.025 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 6.4 pt-20 -109.94 -91.08 0.46 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 119.649 -0.82 . . . . 2.3799999999999999 111.77 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.893 ' H ' ' HG3' ' A' ' 172' ' ' GLU . 18.7 t90 -117.34 78.79 1.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.887 0.767 . . . . 3.96 111.672 -170.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 1.079 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -76.0 -59.64 2.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.658 -0.417 . . . . 1.53 110.937 173.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.1 t70 -178.84 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.339 0.137 0 N-CA-C 111.924 0.342 . . . . 1.26 111.924 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.723 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.45 5.49 14.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 2.2200000000000002 111.851 -178.274 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.771 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 84.0 t -72.57 -53.5 5.74 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.068 -0.514 . . . . 0.5 110.978 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.771 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.4 Cg_exo -49.78 -45.36 32.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.383 2.056 . . . . 0.57999999999999996 111.882 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.634 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.17 -24.25 64.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.506 -0.315 . . . . 2.1400000000000001 111.654 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 48.4 tp -68.98 -47.85 64.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.187 -0.605 . . . . 0.66000000000000003 109.393 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.73 -37.9 80.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.47 0.652 . . . . 1.8899999999999999 109.479 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 7.5 mm-40 -56.22 -47.87 77.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.706 -1.134 . . . . 1.53 111.148 172.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.09 -29.38 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.416 -0.811 . . . . 1.49 112.927 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 64.5 mt -63.29 5.95 0.14 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.227 0.825 . . . . 0.76000000000000001 113.227 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.755 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 16.5 m -82.78 -1.97 53.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.307 0.575 . . . . 1.05 109.532 168.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 84.85 45.59 5.96 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.783 -0.927 . . . . 1.1699999999999999 110.783 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.755 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.2 mmtp . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.739 -0.648 . . . . 2.0 110.385 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.232 0.171 0 CA-C-O 121.701 0.762 . . . . 1.47 111.751 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 19.2 t70 -162.78 159.93 24.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.083 -1.417 . . . . 1.8100000000000001 107.816 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.528 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.2 mm? -80.55 24.08 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.74 0.245 . . . . 0.69999999999999996 111.088 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -51.56 -53.71 35.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.965 -0.561 . . . . 1.96 111.805 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.603 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.5 tptm -125.16 49.2 1.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.275 0.56 . . . . 2.6600000000000001 109.941 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.617 ' HD1' HD11 ' A' ' 37' ' ' LEU . 2.8 t90 -74.58 -8.54 56.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.517 -0.765 . . . . 3.98 111.046 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 9.0 p -136.36 22.92 3.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.223 0.535 . . . . 0.63 110.56 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA3' ' HG3' ' A' ' 7' ' ' LYS . . . -86.9 -120.44 1.3 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.516 -0.633 . . . . 0.47999999999999998 111.516 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 11.6 Cg_endo -51.35 -40.49 61.78 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.551 2.834 . . . . 0.53000000000000003 110.402 167.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.68 HD11 ' HA3' ' A' ' 38' ' ' GLY . 19.2 mt -87.34 88.22 7.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.012 -0.995 . . . . 1.1699999999999999 109.045 171.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 4.6 m -75.66 63.87 1.64 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.509 0.671 . . . . 0.70999999999999996 110.674 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 121' ' ' VAL . 27.8 mt -75.94 -7.94 55.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.693 -0.685 . . . . 0.45000000000000001 110.091 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 6.5 tp-100 -73.38 -7.82 53.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 2.1200000000000001 110.992 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.561 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 22.1 mt-10 -63.45 -37.06 85.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.176 -0.676 . . . . 1.9299999999999999 109.176 171.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.889 HG12 HG21 ' A' ' 151' ' ' VAL . 31.9 t -76.65 -73.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.494 -1.23 . . . . 0.63 111.635 -175.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.498 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 30.3 t0 -152.09 170.19 20.55 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.633 -0.506 . . . . 2.9900000000000002 109.633 -172.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.701 ' HG3' HH12 ' A' ' 155' ' ' ARG . 30.8 mt-10 -60.3 149.96 31.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.472 0.545 . . . . 1.6000000000000001 112.472 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 49.1 mt-30 -60.54 120.43 52.36 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 115.444 -0.798 . . . . 3.5499999999999998 109.118 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 36.8 Cg_exo -58.7 155.42 37.5 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.656 2.237 . . . . 0.57999999999999996 112.396 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.89 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 10.1 pt20 -71.64 -17.56 62.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.455 -0.793 . . . . 1.3899999999999999 111.265 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.81 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 53.1 m-70 -149.75 157.47 38.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.534 0.734 . . . . 1.45 109.172 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 2.1 Cg_endo -84.89 129.82 4.08 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.97 2.447 . . . . 0.40000000000000002 112.019 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.699 HD23 ' HB3' ' A' ' 122' ' ' TRP . 22.1 tp -78.95 139.79 38.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.522 0.201 . . . . 0.28999999999999998 110.594 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -110.99 125.73 54.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.47 -0.567 . . . . 1.24 109.47 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.92 HG13 HG22 ' A' ' 53' ' ' ILE . 13.0 t -131.65 135.66 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.426 -0.583 . . . . 0.46999999999999997 109.426 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.3 OUTLIER -137.15 137.9 39.7 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.001 0.429 . . . . 0.31 110.736 -177.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -98.38 175.41 6.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.38 -0.97 . . . . 0.67000000000000004 108.38 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.25 59.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.247 0.546 . . . . 0.55000000000000004 110.855 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.2 -7.99 34.32 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.415 -0.812 . . . . 0.81000000000000005 112.606 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.07 -173.17 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.719 -0.283 . . . . 0.46999999999999997 110.412 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.1 166.05 23.95 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.224 -0.444 . . . . 0.33000000000000002 110.246 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 89.4 t -113.23 64.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 106.521 -1.659 . . . . 0.39000000000000001 106.521 162.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.14 16.1 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.438 -1.255 . . . . 0.98999999999999999 109.78 -174.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 4.6 tm-20 -148.5 125.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.071 -1.085 . . . . 2.5600000000000001 108.071 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.9 OUTLIER -71.86 110.19 6.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.847 -0.427 . . . . 0.40999999999999998 109.847 -174.352 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.68 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 88.71 14.83 60.67 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.708 -0.678 . . . . 0.58999999999999997 112.573 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -72.29 154.64 40.86 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 110.145 -0.316 . . . . 0.34000000000000002 110.145 175.055 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 8.8 p -80.34 129.6 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.301 0.572 . . . . 0.55000000000000004 110.972 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.459 HD23 ' CG1' ' A' ' 46' ' ' VAL . 6.2 tp -124.2 165.13 18.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.559 -1.274 . . . . 0.45000000000000001 107.559 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.97 152.69 49.0 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 119.148 -1.021 . . . . 0.56000000000000005 113.375 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.651 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 70.9 Cg_exo -51.38 -46.43 31.52 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.401 2.734 . . . . 0.68000000000000005 113.338 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -27.58 65.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.998 0.428 . . . . 0.76000000000000001 111.452 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.2 -48.68 10.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.978 -0.556 . . . . 1.5900000000000001 110.914 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.493 HG11 ' CE2' ' A' ' 169' ' ' TYR . 10.7 m -95.17 29.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.53 0.681 . . . . 0.66000000000000003 112.323 -175.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 6.52 42.77 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.31 -0.626 . . . . 0.79000000000000004 109.31 178.16 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -148.17 177.85 9.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.118 -0.946 . . . . 1.9099999999999999 109.572 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -78.88 152.36 77.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.405 -0.361 . . . . 1.4299999999999999 110.096 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.09 156.59 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.403 2.068 . . . . 0.37 111.479 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -77.45 -23.76 50.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.44 110.355 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 67.3 m -153.02 141.07 20.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.66 0.615 . . . . 0.38 112.66 -175.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.92 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.82 166.26 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.997 -1.001 . . . . 0.29999999999999999 108.313 169.368 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.074 ' HA ' HD13 ' A' ' 58' ' ' LEU . 31.3 t 176.12 117.7 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.985 0.421 . . . . 0.34999999999999998 110.096 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 29.9 p-90 -79.27 154.82 28.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.707 -1.22 . . . . 2.7200000000000002 107.707 172.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.422 ' HB3' ' HD1' ' A' ' 23' ' ' HIS . 35.7 t70 -64.64 85.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.811 0.339 . . . . 1.51 111.364 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.02 20.3 2.28 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.991 -0.549 . . . . 0.80000000000000004 112.021 -175.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.074 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.5 tt -63.01 129.07 38.78 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.937 0.495 . . . . 0.57999999999999996 111.072 -177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.534 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 26.1 t70 -74.82 -28.0 60.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.054 -0.521 . . . . 0.73999999999999999 111.635 -175.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.637 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.7 m 74.32 2.12 4.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.302 -0.863 . . . . 1.03 110.422 -172.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -130.21 -35.81 0.41 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.671 -0.695 . . . . 0.83999999999999997 112.372 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 12.2 mtpt -63.29 146.26 53.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.908 0.385 . . . . 1.6699999999999999 110.302 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.838 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 25.6 mt -87.37 138.7 31.25 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.794 -1.187 . . . . 0.57999999999999996 107.794 172.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.639 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 11.5 m-85 -128.71 157.51 41.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.80000000000000004 109.822 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.446 HG23 HG12 ' A' ' 90' ' ' VAL . 91.8 m -96.86 105.28 17.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.397 -0.594 . . . . 0.35999999999999999 109.397 172.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 17.6 tp -100.84 109.6 21.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.444 -0.798 . . . . 0.58999999999999997 109.563 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.1 125.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.45 . . . . 0.39000000000000001 110.987 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 ' HE1' ' A' ' 169' ' ' TYR . 3.4 mt -85.5 129.86 34.72 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.416 -0.957 . . . . 0.59999999999999998 108.416 167.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.837 HG21 HG11 ' A' ' 17' ' ' VAL . 9.0 t -138.11 138.79 39.04 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.7 -0.481 . . . . 0.35999999999999999 109.7 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.557 ' HB3' ' HA ' ' A' ' 120' ' ' TYR . 11.2 p-10 -132.67 99.78 15.3 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-O 121.617 0.722 . . . . 1.9199999999999999 111.026 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.7 Cg_endo -55.48 -173.9 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.582 2.854 . . . . 1.25 112.386 171.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.858 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 2.1 m-20 56.93 33.81 23.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.17 0.509 . . . . 1.29 111.127 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' H ' ' HB2' ' A' ' 82' ' ' ARG . . . -104.34 137.19 19.16 Favored Pre-proline 0 C--O 1.22 -0.469 0 CA-C-N 116.054 -0.521 . . . . 0.5 110.647 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -79.5 -31.12 5.1 Favored 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.016 -1.66 . . . . 0.62 112.556 0.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.615 ' HB3' HG22 ' A' ' 115' ' ' THR . 92.7 p -125.24 153.44 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.75 109.977 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.858 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 45.5 mtp180 -71.99 -23.18 61.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.301 -0.409 . . . . 2.8799999999999999 111.599 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.832 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.73 -10.89 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.932 0.396 . . . . 1.3799999999999999 110.79 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -155.2 82.3 3.95 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.34 -0.615 . . . . 1.3700000000000001 109.34 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -89.1 97.67 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.034 2.489 . . . . 0.80000000000000004 113.279 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 6.5 mtmm -88.13 -58.7 2.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.119 -0.946 . . . . 1.02 111.16 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.506 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 70.0 m-85 -66.89 -23.37 65.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.969 -0.56 . . . . 1.1699999999999999 110.994 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.561 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -48.0 117.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.412 0.445 . . . . 2.9300000000000002 109.891 177.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 38.8 mt-10 -89.71 130.99 35.91 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.561 0.744 . . . . 2.23 112.217 7.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.524 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 4.6 t90 -90.56 134.37 34.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.832 -0.803 . . . . 1.4299999999999999 108.832 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.511 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 13.8 p-80 -106.07 129.74 54.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.876 -0.787 . . . . 1.26 108.876 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -91.11 -23.76 20.2 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.29 0.478 . . . . 2.1400000000000001 112.29 -171.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.501 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 6.5 p90 -169.2 170.7 8.5 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.062 -0.347 . . . . 1.51 110.062 167.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.9 tp -131.89 114.0 14.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.546 -0.297 . . . . 0.33000000000000002 110.411 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -119.92 133.4 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.05 -0.523 . . . . 0.31 110.827 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.458 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 5.3 m -131.61 168.1 24.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.123 -1.065 . . . . 0.27000000000000002 108.123 174.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.838 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 8.8 m-20 59.96 19.28 8.33 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.37 0.419 . . . . 1.76 111.588 173.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.467 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.6 ttm -74.16 111.26 9.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.464 -0.939 . . . . 0.31 108.464 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.3 ttmm -79.71 91.5 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.191 -0.913 . . . . 1.21 111.196 -170.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.639 ' HA2' ' HE1' ' A' ' 64' ' ' TYR . . . 72.41 -117.45 6.24 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.857 -1.065 . . . . 0.29999999999999999 112.166 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 53' ' ' ILE . 27.6 p-10 -111.55 26.38 10.71 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.428 0.632 . . . . 1.04 110.122 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.39 104.19 16.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.247 -0.888 . . . . 0.77000000000000002 109.946 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 53' ' ' ILE . 4.6 mm -59.85 -28.55 41.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.111 -0.949 . . . . 0.40999999999999998 111.233 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.1 m -78.65 -42.76 27.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.68000000000000005 112.469 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 p -65.21 -24.16 67.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.412 0.523 . . . . 1.26 112.412 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 99.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.761 0.663 . . . . 0.34999999999999998 113.316 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 99.4 m -65.78 105.45 1.28 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.121 -0.696 . . . . 0.45000000000000001 109.121 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 9.5 p -93.4 109.57 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.4 -0.818 . . . . 0.56999999999999995 110.839 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.67 -41.78 23.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.12 0.962 . . . . 0.45000000000000001 109.824 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.0 t -115.04 100.19 7.99 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.247 -1.39 . . . . 0.37 107.247 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -52.69 156.85 1.77 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.298 0.999 . . . . 1.1499999999999999 113.161 -167.615 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 4.1 p90 -76.61 96.19 4.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.942 -1.026 . . . . 4.6900000000000004 110.739 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.808 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 21.8 t -67.72 -31.63 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.844 -0.616 . . . . 0.85999999999999999 111.76 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.45 173.09 49.49 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.756 -0.735 . . . . 0.67000000000000004 111.912 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 38.7 t -54.53 135.7 45.69 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.22 0.51 . . . . 0.51000000000000001 110.834 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.885 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . 169.77 70.68 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.81999999999999995 113.289 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.14 150.23 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.739 2.293 . . . . 0.84999999999999998 110.898 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.667 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 85.0 Cg_exo -43.48 126.48 5.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.728 2.286 . . . . 0.87 112.321 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.538 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -61.68 115.5 4.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 1.8500000000000001 110.749 -175.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.72 23.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.716 -0.754 . . . . 1.1799999999999999 112.407 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.667 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.7 p -76.86 -60.99 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.758 0.279 . . . . 0.96999999999999997 111.405 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.41 28.33 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.857 -0.687 . . . . 1.97 112.081 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.1 mm? -73.21 123.27 23.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.93999999999999995 110.477 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -102.01 112.81 25.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.051 0.453 . . . . 2.23 110.35 176.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.537 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 2.0 ptt180 -85.74 90.5 8.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.504 -0.771 . . . . 2.3100000000000001 110.703 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.737 ' HE2' ' HB3' ' A' ' 171' ' ' ALA . 3.3 m-85 -74.29 112.57 10.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.022 -0.733 . . . . 0.78000000000000003 109.022 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 168' ' ' CYS . 13.8 t -94.01 126.01 46.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.948 -0.569 . . . . 0.27000000000000002 109.638 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.699 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.34 119.56 30.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.721 -0.672 . . . . 1.99 109.738 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 83.6 mt -115.99 138.62 51.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.647 -0.131 . . . . 0.38 110.647 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.507 HG12 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -122.69 140.71 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.695 -0.483 . . . . 0.31 109.695 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.61 ' HB2' HD23 ' A' ' 160' ' ' LEU . 97.2 m-85 -117.37 165.54 13.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.996 0.427 . . . . 5.1200000000000001 111.191 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -110.38 137.61 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.25 -0.886 . . . . 2.4100000000000001 109.983 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.63 ' HG3' ' HG ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.26 153.84 47.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.357 0.599 . . . . 1.3100000000000001 110.014 177.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.01 -2.17 46.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.045 -0.98 . . . . 2.3999999999999999 111.051 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.532 HH22 ' HB2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -166.17 168.61 7.41 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.16 -0.927 . . . . 3.5099999999999998 109.753 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.15 150.54 24.4 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.559 2.173 . . . . 1.21 111.791 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.458 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? -72.21 158.45 35.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.633 0.73 . . . . 0.90000000000000002 112.42 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.71 127.2 32.33 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.584 -1.265 . . . . 2.8999999999999999 107.584 167.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.9 m -146.44 -63.23 0.3 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.866 -0.606 . . . . 1.8999999999999999 109.728 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 58.83 37.99 24.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.395 0.617 . . . . 2.96 110.809 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.58 137.0 63.32 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.264 -0.88 . . . . 1.3899999999999999 109.54 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.85 106.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.132 2.554 . . . . 1.27 112.175 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.7 mm -55.77 119.12 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.534 -0.757 . . . . 0.85999999999999999 111.36 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 81.4 mt -88.49 158.71 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.086 -0.709 . . . . 1.6100000000000001 109.086 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.702 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 64.5 m -112.63 31.28 6.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.713 -0.221 . . . . 1.8799999999999999 111.008 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.838 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 1.1 p-10 54.92 12.64 0.63 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.202 0.939 . . . . 0.75 111.693 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.702 ' HG3' ' O ' ' A' ' 139' ' ' SER . 5.5 mtm180 -98.2 153.61 18.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.933 -0.395 . . . . 3.3599999999999999 109.933 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.663 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 44.4 m 67.5 165.68 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.275 -0.875 . . . . 0.94999999999999996 111.824 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.0 23.07 5.93 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.474 -0.87 . . . . 1.1200000000000001 112.401 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -71.01 -26.25 63.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.205 0.446 . . . . 2.6600000000000001 112.205 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -131.27 61.01 1.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.304 0.573 . . . . 1.8700000000000001 110.751 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.88 -71.05 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.264 -0.88 . . . . 4.7300000000000004 110.663 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -124.44 -153.41 8.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.53 -0.843 . . . . 0.65000000000000002 112.226 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.2 mttt 66.51 32.5 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.151 0.977 . . . . 1.0800000000000001 109.831 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -124.9 103.97 8.34 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.11 -1.405 . . . . 1.8899999999999999 108.81 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -62.85 120.19 10.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 1.29 111.875 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.889 HG21 HG12 ' A' ' 17' ' ' VAL . 8.2 m -62.66 -31.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.78000000000000003 110.581 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -59.12 -38.8 80.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.866 -0.606 . . . . 0.67000000000000004 110.154 174.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.6 m -66.86 -38.6 86.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.546 . . . . 0.77000000000000002 110.624 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.763 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 62.0 m-85 -61.56 -53.07 61.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.92000000000000004 111.126 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.701 HH12 ' HG3' ' A' ' 19' ' ' GLU . 8.7 ptm180 -66.21 -39.69 89.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 2.8900000000000001 111.641 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.8 mtmt -68.08 -46.77 70.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.605 0.24 . . . . 0.96999999999999997 111.169 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -60.87 -51.64 68.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.5800000000000001 111.587 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.67 0.08 31.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.271 -0.422 . . . . 5.4500000000000002 111.624 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.532 ' HB2' HH22 ' A' ' 129' ' ' ARG . 70.8 mm-40 66.1 46.36 2.15 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.763 0.664 . . . . 2.4199999999999999 110.996 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.63 ' HG ' ' HG3' ' A' ' 127' ' ' GLN . 5.6 mp -102.35 15.09 30.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.643 0.608 . . . . 1.27 112.643 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 61.89 -94.45 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.649 0.38 . . . . 3.5899999999999999 111.809 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -154.3 168.82 11.11 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 109.455 -0.572 . . . . 0.76000000000000001 109.455 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 38.9 Cg_exo -57.16 129.03 32.14 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.406 2.071 . . . . 0.53000000000000003 112.91 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.89 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -84.38 -33.06 8.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.279 -0.638 . . . . 0.44 109.279 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.81 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.23 149.79 29.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.831 -0.622 . . . . 0.27000000000000002 111.258 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -153.25 144.75 11.73 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.357 -0.838 . . . . 0.23999999999999999 112.009 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -157.97 137.78 12.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.45 -0.574 . . . . 0.34000000000000002 109.45 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.829 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -108.54 144.93 35.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.325 0.583 . . . . 1.1100000000000001 111.791 -174.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.52 ' HE1' HD21 ' A' ' 68' ' ' LEU . 34.0 p90 -135.07 119.62 18.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.378 -1.341 . . . . 0.80000000000000004 107.378 172.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 2.2 pt20 -100.14 133.23 44.83 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.866 -0.734 . . . . 2.5299999999999998 111.451 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.737 ' HB3' ' HE2' ' A' ' 120' ' ' TYR . . . -129.87 147.99 51.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.491 -0.777 . . . . 0.59999999999999998 109.739 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 117' ' ' LEU . 12.6 pt-20 -110.71 -172.52 2.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.045 -0.525 . . . . 2.3799999999999999 111.09 -176.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.84 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.7 OUTLIER -85.11 64.47 8.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 3.96 111.173 -177.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.7 t70 -53.16 -61.78 2.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.573 -0.739 . . . . 1.53 112.332 -176.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.556 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.3 t70 -177.27 -40.74 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.943 0.402 . . . . 1.26 110.92 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -78.17 2.73 17.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.079 0.466 . . . . 2.2200000000000002 111.058 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 173' ' ' TRP . 39.8 t -72.52 -53.83 5.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.5 110.507 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 73.4 Cg_exo -52.79 -33.5 60.85 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.128 1.886 . . . . 0.57999999999999996 111.966 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 43.4 mmtm -74.35 -24.92 59.24 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.737 0.273 . . . . 2.1400000000000001 111.737 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.885 HD23 ' HA3' ' A' ' 110' ' ' GLY . 62.3 tp -66.57 -46.16 76.92 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.66000000000000003 108.764 170.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -60.44 -37.97 82.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.355 -0.839 . . . . 1.8899999999999999 109.533 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.712 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 24.9 mm-40 -56.65 -41.57 77.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.299 -0.864 . . . . 1.53 111.088 172.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -76.48 -31.63 57.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.615 -0.721 . . . . 1.49 111.881 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.663 ' HA ' ' H ' ' A' ' 142' ' ' SER . 21.2 mt -65.1 5.64 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.629 0.603 . . . . 0.76000000000000001 112.629 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 16.9 m -66.07 -19.89 65.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.613 0.72 . . . . 1.05 109.791 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 88.76 62.93 1.35 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 110.791 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt . . . . . 0 C--O 1.244 0.78 0 CA-C-O 118.449 -0.786 . . . . 2.0 109.984 -176.833 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 24' ' ' PRO . 4.5 t . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.783 -0.451 . . . . 1.47 109.783 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -154.36 158.74 40.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.928 -0.397 . . . . 1.8100000000000001 109.928 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.57 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -95.19 22.69 6.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.688 -0.233 . . . . 0.69999999999999996 110.962 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 m -80.05 -1.3 39.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 1.96 111.481 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 11.3 mptt -118.87 22.28 12.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.321 -0.622 . . . . 2.6600000000000001 109.321 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.639 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 1.9 p90 -61.93 -32.79 73.23 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 3.98 113.565 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -139.99 18.59 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.988 -0.445 . . . . 0.63 111.508 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.15 -122.14 0.78 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.263 -0.735 . . . . 0.47999999999999998 111.263 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.5 Cg_endo -50.1 -40.64 50.64 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.539 2.826 . . . . 0.53000000000000003 110.696 167.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 23.1 mt -87.23 78.49 8.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.21 -0.904 . . . . 1.1699999999999999 108.752 170.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -73.26 64.98 0.82 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.702 0.763 . . . . 0.70999999999999996 110.507 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.653 HD22 ' CG2' ' A' ' 121' ' ' VAL . 28.7 mt -81.44 -7.05 59.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.181 -0.918 . . . . 0.45000000000000001 111.326 -173.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -2.06 20.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.428 0.632 . . . . 2.1200000000000001 110.332 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.87 -7.67 55.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 1.9299999999999999 110.743 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.806 HG11 HG21 ' A' ' 69' ' ' THR . 71.3 t -98.5 -70.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.684 . . . . 0.63 111.112 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.696 ' OD2' ' HD2' ' A' ' 155' ' ' ARG . 22.2 t0 -164.32 -178.45 5.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.807 -1.183 . . . . 2.9900000000000002 107.807 -167.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.35 149.84 41.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.322 0.582 . . . . 1.6000000000000001 111.104 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 1.6 tp-100 -81.87 138.6 46.57 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.735 . . . . 3.5499999999999998 110.736 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.641 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 13.4 Cg_exo -68.51 164.86 31.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.021 2.481 . . . . 0.57999999999999996 112.95 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.919 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.9 pt20 -90.52 -1.62 57.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.765 . . . . 1.3899999999999999 111.929 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.75 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.4 m170 -158.88 159.78 29.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 123.059 0.544 . . . . 1.45 109.919 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.3 Cg_endo -84.83 127.46 3.6 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.059 2.506 . . . . 0.40000000000000002 111.251 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 122' ' ' TRP . 36.0 tp -79.85 145.66 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.694 -0.23 . . . . 0.28999999999999998 110.768 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.416 ' H ' HD12 ' A' ' 25' ' ' LEU . 51.0 m-70 -114.72 121.24 42.73 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.982 -0.748 . . . . 1.24 108.982 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.906 HG13 HG22 ' A' ' 53' ' ' ILE . 19.4 t -122.83 144.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.108 -0.701 . . . . 0.46999999999999997 109.108 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -140.02 136.32 33.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.237 0.542 . . . . 0.31 111.107 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.602 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 46.0 t80 -101.97 170.2 8.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.174 -0.676 . . . . 0.67000000000000004 109.174 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.47 63.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.342 0.591 . . . . 0.55000000000000004 110.391 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.602 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -117.45 19.16 11.68 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.123 -0.944 . . . . 0.81000000000000005 112.703 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -151.7 -172.37 4.2 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.46999999999999997 110.783 177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.37 154.9 17.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.991 -0.55 . . . . 0.33000000000000002 110.13 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.754 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 87.8 t -119.21 68.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.192 -1.41 . . . . 0.39000000000000001 107.192 164.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -105.7 21.56 17.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.979 -1.01 . . . . 0.98999999999999999 108.851 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 22.4 tt0 -144.42 117.58 8.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.718 -1.128 . . . . 2.5600000000000001 108.486 174.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -66.88 110.56 3.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.40999999999999998 109.475 -177.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 95.24 12.94 53.9 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.531 -0.759 . . . . 0.58999999999999997 112.557 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.93 149.05 32.44 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.09 -0.337 . . . . 0.34000000000000002 110.09 177.262 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.9 134.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.55000000000000004 111.324 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 34' ' ' VAL . 8.2 tp -132.27 171.11 14.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.703 -0.851 . . . . 0.45000000000000001 108.703 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -120.5 150.81 52.89 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.67 0.748 . . . . 0.56000000000000005 112.485 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 72.4 Cg_exo -54.92 -29.99 66.64 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.604 3.536 . . . . 0.68000000000000005 113.963 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -42.53 88.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.659 0.742 . . . . 0.76000000000000001 110.275 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -74.93 -14.4 60.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.613 -1.176 . . . . 1.5900000000000001 111.822 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 169' ' ' TYR . 24.9 m -125.48 24.32 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.173 0.511 . . . . 0.66000000000000003 111.647 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.75 -18.55 40.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.505 0.669 . . . . 0.79000000000000004 109.206 177.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 52.0 t30 -125.03 -179.58 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.701 -1.136 . . . . 1.9099999999999999 108.751 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.88 150.68 78.66 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.616 -0.513 . . . . 1.4299999999999999 109.616 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' HG13 ' A' ' 97' ' ' ILE . 55.2 Cg_endo -73.88 158.75 46.04 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.978 1.785 . . . . 0.37 110.436 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.442 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.6 t -79.75 -18.8 50.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 0.44 109.858 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 m -161.21 147.41 14.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.632 0.73 . . . . 0.38 112.164 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.906 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.13 165.6 23.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.756 -1.111 . . . . 0.29999999999999999 108.249 170.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.034 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 t 178.96 111.98 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.938 0.399 . . . . 0.34999999999999998 109.929 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 51.1 p-90 -68.87 167.97 14.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.552 -1.277 . . . . 2.7200000000000002 107.552 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -70.2 70.31 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.191 0.519 . . . . 1.51 111.187 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.83 22.99 0.64 Allowed Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.446 -0.797 . . . . 0.80000000000000004 112.423 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.034 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.7 tt -54.88 132.31 46.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.89 0.476 . . . . 0.57999999999999996 111.674 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.432 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 18.8 t70 -78.9 -28.81 44.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.844 -0.616 . . . . 0.73999999999999999 111.996 -175.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.7 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 64.6 m 71.82 1.97 4.11 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.462 -0.79 . . . . 1.03 110.769 -172.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.65 14.54 4.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.992 -0.549 . . . . 0.83999999999999997 112.719 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 1.5 mmpt? -119.26 164.82 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 1.6699999999999999 109.956 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 63.7 mt -103.2 125.6 49.96 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.367 -0.605 . . . . 0.57999999999999996 109.367 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -120.72 148.33 44.1 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.806 -0.357 . . . . 0.80000000000000004 110.812 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.984 HG23 HG12 ' A' ' 90' ' ' VAL . 3.1 m -96.56 105.74 17.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.691 -0.855 . . . . 0.35999999999999999 108.691 173.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 124' ' ' VAL . 50.2 tp -109.69 117.76 34.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.274 -0.421 . . . . 0.58999999999999997 110.907 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.603 HG22 HD13 ' A' ' 88' ' ' LEU . 21.0 t -119.0 123.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.865 -0.607 . . . . 0.39000000000000001 110.553 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 1.2 mt -90.03 133.68 34.68 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.038 -1.097 . . . . 0.59999999999999998 108.038 168.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.806 HG21 HG11 ' A' ' 17' ' ' VAL . 8.8 t -142.75 149.16 38.36 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.692 -0.403 . . . . 0.35999999999999999 111.84 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 10.8 t70 -135.71 97.5 12.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 121.522 0.677 . . . . 1.9199999999999999 109.488 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.475 ' HG2' ' HE1' ' A' ' 118' ' ' HIS . 18.6 Cg_endo -57.82 -7.42 3.35 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 124.62 3.547 . . . . 1.25 115.848 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 1.8 m-20 -124.77 51.42 1.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.533 0.683 . . . . 1.29 111.534 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.58 143.77 27.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.19 -0.913 . . . . 0.5 109.391 172.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 34.6 Cg_endo -70.92 -35.89 2.62 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.53 -1.446 . . . . 0.62 113.431 1.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 115' ' ' THR . 72.2 p -131.59 166.82 20.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.75 111.312 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 51.5 ttt180 -71.33 -23.09 61.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.0 -0.546 . . . . 2.8799999999999999 110.839 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.736 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.15 -11.52 38.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.509 . . . . 1.3799999999999999 110.656 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 6.9 t70 -149.64 79.73 7.83 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.699 -0.682 . . . . 1.3700000000000001 109.958 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.2 Cg_endo -89.77 94.24 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.741 2.294 . . . . 0.80000000000000004 113.287 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.557 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.9 mttm -88.17 -44.09 11.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.284 -0.871 . . . . 1.02 110.541 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.687 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 27.9 m-85 -88.54 18.12 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.175 -0.921 . . . . 1.1699999999999999 112.032 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.7 ttm180 -64.2 125.83 25.78 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.916 0.135 . . . . 2.9300000000000002 111.236 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.0 mp0 -97.67 134.25 41.11 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.065 -0.346 . . . . 2.23 110.065 -5.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 11.2 t90 -80.57 100.32 8.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.427 0.632 . . . . 1.4299999999999999 109.927 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 33.2 p-80 -84.2 126.08 32.8 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.553 0.692 . . . . 1.26 110.18 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 1.006 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 19.5 t-80 -67.9 -34.7 77.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.05 -0.977 . . . . 2.1400000000000001 110.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 68' ' ' LEU . 44.2 p90 -169.29 170.67 8.4 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.117 0.261 . . . . 1.51 110.311 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HG ' HD12 ' A' ' 103' ' ' LEU . 17.0 tp -133.33 114.08 13.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.065 -0.516 . . . . 0.33000000000000002 109.701 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.807 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.7 t -122.32 132.54 70.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.6 0.714 . . . . 0.31 111.153 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.984 HG12 HG23 ' A' ' 65' ' ' THR . 9.9 m -130.86 160.53 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.85 -1.068 . . . . 0.27000000000000002 108.419 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 0.9 OUTLIER 62.62 20.52 12.08 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.203 0.314 . . . . 1.76 110.625 178.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.807 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.3 ttm -71.51 110.35 6.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.277 -0.638 . . . . 0.31 109.277 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.01 94.71 5.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.578 -1.192 . . . . 1.21 110.937 -171.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 72.72 -120.27 7.37 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.801 -1.09 . . . . 0.29999999999999999 112.426 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.533 ' HA ' HD11 ' A' ' 53' ' ' ILE . 2.9 p-10 -112.76 17.59 18.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.188 0.518 . . . . 1.04 110.473 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.58 102.53 12.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.707 -0.679 . . . . 0.77000000000000002 109.911 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 97' ' ' ILE . 3.8 mm -58.71 -27.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.702 -1.135 . . . . 0.40999999999999998 111.624 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -77.94 -38.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.68000000000000005 111.975 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 m -74.87 -3.55 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 1.26 112.005 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.74 106.79 2.04 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.363 -0.695 . . . . 0.34999999999999998 111.363 177.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -61.46 107.39 0.78 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.281 0.562 . . . . 0.45000000000000001 109.734 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.8 p -83.47 113.28 22.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.081 -0.963 . . . . 0.56999999999999995 111.4 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.632 HD12 ' HG ' ' A' ' 88' ' ' LEU . 40.6 mt -90.4 -45.8 8.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.79 0.805 . . . . 0.45000000000000001 109.537 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.6 t -122.84 112.25 17.65 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.132 -1.433 . . . . 0.37 107.132 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 10.7 t0 -61.99 164.97 5.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.42 -0.809 . . . . 1.1499999999999999 112.699 -168.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 13.8 p90 -82.69 92.08 7.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 4.6900000000000004 110.76 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.712 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 40.3 t -75.09 -46.29 39.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.177 0.513 . . . . 0.85999999999999999 111.02 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.691 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 109.84 -174.82 18.14 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.439 -0.886 . . . . 0.67000000000000004 112.996 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 43' ' ' PRO . 42.2 t -66.58 140.25 57.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.287 -0.634 . . . . 0.51000000000000001 109.287 172.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.725 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -174.13 55.52 0.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.71 -0.757 . . . . 0.81999999999999995 112.854 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 57.5 Cg_endo -96.05 157.02 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.327 2.684 . . . . 0.84999999999999998 112.516 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.6 ' O ' HG23 ' A' ' 115' ' ' THR . 53.0 Cg_exo -54.89 154.54 21.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.058 2.505 . . . . 0.87 112.282 174.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.3 116.5 15.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.77 0.319 . . . . 1.8500000000000001 111.034 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.77 34.35 4.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.652 -0.785 . . . . 1.1799999999999999 112.924 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 112' ' ' PRO . 82.7 p -77.98 -18.27 56.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.729 0.3 . . . . 0.96999999999999997 110.637 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 104.41 3.14 44.21 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 120.916 -0.659 . . . . 1.97 112.132 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 172' ' ' GLU . 4.1 mm? 71.69 102.52 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.299 -0.951 . . . . 0.93999999999999995 111.079 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.518 ' CG ' ' H ' ' A' ' 119' ' ' ARG . 21.4 t-80 -110.69 -172.33 2.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.416 -0.957 . . . . 2.23 108.416 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 1.3 ptp180 -147.55 120.22 8.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.282 0.563 . . . . 2.3100000000000001 111.676 -163.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 6.5 m-85 -80.34 127.33 32.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.577 -1.192 . . . . 0.78000000000000003 108.825 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.653 ' CG2' HD22 ' A' ' 14' ' ' LEU . 16.9 t -104.19 130.83 54.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.154 -0.475 . . . . 0.27000000000000002 110.856 -177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.696 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 27.0 m95 -89.56 120.3 30.74 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 1.99 108.935 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 86.5 mt -115.49 118.59 33.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.934 0.334 . . . . 0.38 110.77 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.636 HG12 HD13 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -116.46 139.82 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.399 -0.223 . . . . 0.31 110.399 177.228 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.856 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 71.3 t80 -127.03 137.28 53.03 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.866 -0.334 . . . . 5.1200000000000001 111.0 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.536 ' H ' ' CG2' ' A' ' 164' ' ' VAL . 9.1 tp10 -88.05 96.65 10.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.49 -0.93 . . . . 2.4100000000000001 108.49 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.626 ' HG2' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -72.63 167.72 20.16 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.251 0.548 . . . . 1.3100000000000001 109.696 -176.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -80.84 -4.62 55.35 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.464 -0.789 . . . . 2.3999999999999999 109.747 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 3.2 ptp180 -165.06 161.9 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.337 -0.847 . . . . 3.5099999999999998 110.913 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.416 ' HG3' HD12 ' A' ' 63' ' ' LEU . 51.4 Cg_exo -55.91 143.72 80.95 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.509 2.806 . . . . 1.21 112.442 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.626 HD11 ' HG2' ' A' ' 127' ' ' GLN . 2.3 mm? -79.91 141.83 35.72 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.90000000000000002 110.767 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 20.2 tptm -132.64 67.26 1.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.435 -0.95 . . . . 2.8999999999999999 108.435 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.779 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 61.4 m -82.23 122.65 28.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.178 -0.919 . . . . 1.8999999999999999 110.443 -177.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.39 25.55 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.926 -0.579 . . . . 2.96 110.26 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.779 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 12.8 mm-40 -62.38 142.18 96.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.52 -0.764 . . . . 1.3899999999999999 109.894 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.69 110.14 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.313 2.675 . . . . 1.27 112.696 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.41 115.49 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.85999999999999999 110.323 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.8 mt -108.15 155.54 20.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.284 0.564 . . . . 1.6100000000000001 110.639 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.9 m -105.11 159.26 15.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.176 -1.046 . . . . 1.8799999999999999 108.176 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.712 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 5.2 p30 -78.75 7.11 7.5 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.739 -0.384 . . . . 0.75 110.666 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.58 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 11.0 mtt180 -98.17 135.17 40.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.548 -0.538 . . . . 3.3599999999999999 109.548 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.719 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 20.5 m 73.38 117.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 O-C-N 124.316 1.01 . . . . 0.94999999999999996 109.686 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.21 27.66 15.12 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.583 -0.818 . . . . 1.1200000000000001 113.669 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -71.29 -25.13 62.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.929 0.395 . . . . 2.6600000000000001 111.026 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.92 30.48 6.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.949 0.404 . . . . 1.8700000000000001 111.177 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 42.7 mtp180 -60.9 -46.39 90.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 4.7300000000000004 110.782 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.52 -154.82 7.71 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.743 -0.741 . . . . 0.65000000000000002 111.889 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.687 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.0 mttt 67.2 17.32 10.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.254 0.55 . . . . 1.0800000000000001 111.137 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -122.13 112.24 17.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.441 -0.799 . . . . 1.8899999999999999 109.106 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -62.45 129.7 41.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 1.29 112.496 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.649 HG21 ' CG1' ' A' ' 17' ' ' VAL . 4.6 m -62.94 -32.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.78000000000000003 110.761 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.21 95.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.586 -0.734 . . . . 0.67000000000000004 110.02 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.77000000000000002 110.693 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.616 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 32.7 m-85 -61.73 -50.62 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 0.92000000000000004 110.965 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.696 ' HD2' ' OD2' ' A' ' 18' ' ' ASP . 6.5 ptm85 -70.12 -40.01 75.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.396 -0.365 . . . . 2.8900000000000001 111.135 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -66.05 -26.03 67.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 111.637 0.236 . . . . 0.96999999999999997 111.637 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -53.76 -49.36 68.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.679 0.275 . . . . 1.5800000000000001 110.608 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.516 ' HB3' HD13 ' A' ' 160' ' ' LEU . 6.6 t80 -99.64 15.31 27.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.759 -0.776 . . . . 5.4500000000000002 109.917 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 58.4 43.6 19.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.295 -0.866 . . . . 2.4199999999999999 111.682 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.856 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 3.4 mp -86.13 120.54 27.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.767 -0.651 . . . . 1.27 111.027 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.91 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -79.62 -173.7 3.92 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.914 -0.402 . . . . 3.5899999999999999 109.914 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.91 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -43.5 146.41 0.93 Allowed Pre-proline 0 N--CA 1.466 0.328 0 C-N-CA 123.82 0.848 . . . . 0.76000000000000001 113.009 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 6.5 Cg_exo -71.54 169.65 20.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.965 3.11 . . . . 0.53000000000000003 113.969 -170.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 21.4 t -95.3 -30.8 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.44 110.364 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.75 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.3 146.9 27.78 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.828 -0.749 . . . . 0.27000000000000002 112.302 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.97 148.07 19.12 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 114.458 -1.246 . . . . 0.23999999999999999 111.603 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 10.5 t -159.72 149.43 18.33 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.469 -0.937 . . . . 0.34000000000000002 108.469 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 21.2 p -123.8 146.68 48.17 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.12 -0.632 . . . . 1.1100000000000001 111.166 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 33.4 p90 -130.23 142.03 50.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.413 -1.329 . . . . 0.80000000000000004 107.413 175.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 1.1 pt20 -115.66 134.64 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.192 -0.603 . . . . 2.5299999999999998 111.558 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.14 153.87 33.64 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.751 0.657 . . . . 0.59999999999999998 110.072 -172.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.695 ' HG2' HD11 ' A' ' 117' ' ' LEU . 2.5 pt-20 -133.91 -106.73 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.677 0.621 . . . . 2.3799999999999999 112.677 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.695 ' HA ' HG21 ' A' ' 177' ' ' VAL . 31.9 t90 -118.12 84.1 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.15 0.5 . . . . 3.96 110.232 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.871 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 7.2 t70 -73.26 -62.4 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.898 -0.592 . . . . 1.53 111.725 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 14.4 t70 173.41 -44.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.776 -0.647 . . . . 1.26 109.675 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -80.34 9.55 5.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.548 -0.751 . . . . 2.2200000000000002 111.117 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.73 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 83.9 t -72.8 -53.99 5.04 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.5 109.926 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.73 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.6 Cg_exo -51.53 -37.8 63.31 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.299 1.999 . . . . 0.57999999999999996 111.424 169.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.677 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.7 mmtp -71.54 -23.38 61.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 2.1400000000000001 111.38 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.4 tp -67.81 -48.24 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.052 -0.722 . . . . 0.66000000000000003 109.052 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.7 -32.39 73.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.01 -0.541 . . . . 1.8899999999999999 109.737 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 11.7 mm-40 -55.7 -48.45 75.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.39 -0.823 . . . . 1.53 110.329 171.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -73.98 -33.16 63.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.288 -0.869 . . . . 1.49 112.002 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.719 ' HA ' ' H ' ' A' ' 142' ' ' SER . 37.6 mt -63.16 -1.83 1.14 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.496 0.554 . . . . 0.76000000000000001 112.496 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.708 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 13.1 m -73.7 -2.62 24.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.434 0.635 . . . . 1.05 109.92 172.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.14 39.8 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.835 -0.906 . . . . 1.1699999999999999 110.835 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.708 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.519 -0.753 . . . . 2.0 110.061 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.761 HG22 ' HA ' ' A' ' 36' ' ' GLU . 19.8 t . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.153 0.501 . . . . 1.47 111.462 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.432 ' O ' HD12 ' A' ' 37' ' ' LEU . 2.5 p30 -155.61 163.49 39.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.153 -1.054 . . . . 1.8100000000000001 108.153 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.522 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -88.28 29.11 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.633 -0.427 . . . . 0.69999999999999996 111.081 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 -7.82 59.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.303 0.573 . . . . 1.96 109.867 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 8.7 mptt -113.33 29.09 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 2.6600000000000001 109.608 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.648 ' HZ3' ' HG3' ' A' ' 15' ' ' GLN . 11.4 p-90 -67.87 -36.11 79.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.356 -0.838 . . . . 3.98 111.693 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 75.3 p -144.03 19.92 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.646 -0.421 . . . . 0.63 111.601 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.44 -118.37 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.86 -0.686 . . . . 0.47999999999999998 111.633 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.4 Cg_endo -47.14 -51.77 8.87 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.434 2.756 . . . . 0.53000000000000003 110.787 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.898 HD23 HD21 ' A' ' 14' ' ' LEU . 6.5 mp -88.95 98.39 11.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 1.1699999999999999 110.831 171.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 69.6 m -76.49 66.17 2.46 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.334 0.588 . . . . 0.70999999999999996 110.26 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.898 HD21 HD23 ' A' ' 12' ' ' LEU . 57.9 mt -73.85 -16.88 61.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.509 -0.769 . . . . 0.45000000000000001 111.225 -176.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.648 ' HG3' ' HZ3' ' A' ' 8' ' ' TRP . 19.0 tm0? -64.09 -15.08 58.84 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.05 0.452 . . . . 2.1200000000000001 110.857 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -60.4 -23.27 64.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.255 0.55 . . . . 1.9299999999999999 110.666 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.885 HG11 HG21 ' A' ' 69' ' ' THR . 87.3 t -103.53 -64.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.328 -0.851 . . . . 0.63 110.877 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HA ' HH22 ' A' ' 155' ' ' ARG . 4.8 p-10 -116.43 172.44 7.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.134 0.492 . . . . 2.9900000000000002 111.283 -175.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.58 28.65 1.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.632 -0.713 . . . . 1.6000000000000001 112.365 -171.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 4.5 tt0 65.41 116.95 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 123.191 0.596 . . . . 3.5499999999999998 110.691 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 20.4 Cg_exo -65.77 158.74 52.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.683 2.255 . . . . 0.57999999999999996 112.959 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.885 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.4 pt20 -77.41 -13.89 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.247 -0.888 . . . . 1.3899999999999999 110.789 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.748 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 70.7 m-70 -149.73 156.51 38.67 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-N 115.461 -0.79 . . . . 1.45 109.458 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -85.84 125.98 2.85 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.955 2.437 . . . . 0.40000000000000002 110.771 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.568 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 27.0 tp -80.02 148.12 31.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.874 0.369 . . . . 0.28999999999999998 111.012 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.47 ' H ' HD12 ' A' ' 25' ' ' LEU . 33.1 m170 -118.12 128.73 55.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.775 -0.454 . . . . 1.24 109.775 170.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.962 HG13 HG22 ' A' ' 53' ' ' ILE . 32.6 t -128.8 119.64 50.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.825 -0.806 . . . . 0.46999999999999997 108.825 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.6 OUTLIER -115.68 138.49 51.04 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.343 0.592 . . . . 0.31 111.431 -171.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 33.6 t80 -100.31 176.78 5.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.784 -0.644 . . . . 0.67000000000000004 109.275 174.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.58 65.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.277 0.561 . . . . 0.55000000000000004 110.63 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.57 -0.57 29.24 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.438 -0.801 . . . . 0.81000000000000005 112.845 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' NE2' ' A' ' 45' ' ' GLN . . . -135.54 -174.22 3.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.46999999999999997 110.914 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.75 144.25 8.64 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.56 -0.746 . . . . 0.33000000000000002 110.022 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.843 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.7 t -95.06 69.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 106.996 -1.483 . . . . 0.39000000000000001 106.996 163.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -103.22 28.4 6.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.106 -0.952 . . . . 0.98999999999999999 109.236 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' A' ' 3' ' ' VAL . 49.9 mt-10 -150.32 134.05 16.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.765 -1.107 . . . . 2.5600000000000001 109.086 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.722 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.36 114.02 11.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.40999999999999998 110.136 -175.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.88 29.59 51.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.9 -0.667 . . . . 0.58999999999999997 111.518 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.843 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -90.29 152.92 20.83 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.22 0.208 . . . . 0.34000000000000002 110.625 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.459 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.7 p -78.77 134.68 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.335 0.588 . . . . 0.55000000000000004 111.487 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 34' ' ' VAL . 7.6 tp -132.87 169.87 16.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.462 -0.94 . . . . 0.45000000000000001 108.462 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.6 p -115.02 151.39 45.54 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.024 -0.67 . . . . 0.56000000000000005 112.309 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 50.5 Cg_exo -56.91 -28.96 80.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.164 3.243 . . . . 0.68000000000000005 113.298 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 p -65.09 -41.21 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.615 0.721 . . . . 0.76000000000000001 110.528 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 32' ' ' ALA . 95.8 mt-30 -80.47 -17.69 50.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.684 -1.144 . . . . 1.5900000000000001 111.414 -175.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 42' ' ' THR . 28.2 m -125.66 30.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.66000000000000003 111.439 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -78.08 -21.93 49.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.457 0.646 . . . . 0.79000000000000004 109.266 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -131.89 177.91 7.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.404 -1.271 . . . . 1.9099999999999999 108.725 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.13 151.97 96.57 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.188 -0.301 . . . . 1.4299999999999999 110.188 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 60.6 Cg_endo -74.75 161.68 38.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.192 1.928 . . . . 0.37 110.744 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -82.12 -21.24 36.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.107 0.48 . . . . 0.44 109.919 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -158.56 149.82 20.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.38 111.96 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.962 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -138.5 165.29 25.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.05 -1.093 . . . . 0.29999999999999999 108.05 169.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.037 ' HA ' HD13 ' A' ' 58' ' ' LEU . 39.7 t -179.86 116.85 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.192 0.52 . . . . 0.34999999999999998 110.204 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.7 p-90 -78.78 163.27 25.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.189 -1.041 . . . . 2.7200000000000002 108.189 172.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.18 86.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.086 0.47 . . . . 1.51 110.939 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.0 29.44 2.81 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.677 -0.692 . . . . 0.80000000000000004 112.472 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.037 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.3 tt -60.66 129.83 43.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.04 0.447 . . . . 0.57999999999999996 110.853 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.801 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -80.69 -21.38 41.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.73999999999999999 111.927 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.659 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 75.7 m 69.56 2.01 3.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.456 -0.793 . . . . 1.03 110.957 -171.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.15 -2.63 3.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.731 -0.747 . . . . 0.83999999999999997 113.336 -176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.801 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 38.6 mtpt -93.93 145.69 24.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.451 0.625 . . . . 1.6699999999999999 109.637 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.907 HD23 ' HG2' ' A' ' 93' ' ' LYS . 2.9 mt -84.77 144.01 28.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.665 -1.235 . . . . 0.57999999999999996 107.665 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -140.72 166.05 25.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.841 -0.8 . . . . 0.80000000000000004 108.841 173.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 90' ' ' VAL . 88.5 m -105.03 105.16 15.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.222 -0.659 . . . . 0.35999999999999999 109.222 171.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.628 HD13 HG12 ' A' ' 124' ' ' VAL . 52.1 tp -104.59 115.57 30.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.232 0.539 . . . . 0.58999999999999997 110.429 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.0 t -121.11 123.72 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.645 -0.707 . . . . 0.39000000000000001 110.489 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 5.5 mt -81.51 139.38 35.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.167 -1.049 . . . . 0.59999999999999998 108.167 167.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.885 HG21 HG11 ' A' ' 17' ' ' VAL . 14.8 t -140.73 153.59 45.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.695 -0.402 . . . . 0.35999999999999999 110.94 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.523 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 15.7 t70 -140.69 102.16 6.49 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.251 0.548 . . . . 1.9199999999999999 110.219 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -55.37 -28.93 65.7 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.746 2.964 . . . . 1.25 114.788 174.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -100.43 43.81 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 1.29 111.974 -167.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 84' ' ' TRP . . . -108.51 136.43 19.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 122.241 -0.287 . . . . 0.5 110.872 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.714 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 66.2 Cg_endo -74.85 -25.75 9.89 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.277 -1.551 . . . . 0.62 112.657 0.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.562 ' HB3' HG22 ' A' ' 115' ' ' THR . 86.6 p -139.07 160.3 40.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.604 . . . . 0.75 109.945 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -72.32 -26.16 61.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 2.8799999999999999 111.858 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.824 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.85 -13.41 48.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.146 0.498 . . . . 1.3799999999999999 110.508 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.516 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 21.8 t0 -150.9 73.01 8.73 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.357 -0.838 . . . . 1.3700000000000001 109.149 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 43.6 Cg_endo -89.99 88.87 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.765 2.31 . . . . 0.80000000000000004 113.034 -175.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.714 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 38.0 mttm -78.2 -45.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.773 -1.103 . . . . 1.02 111.035 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 77.8 m-85 -82.74 10.62 7.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.194 -0.912 . . . . 1.1699999999999999 111.986 -169.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 37.8 ttp180 -70.16 127.76 33.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.185 -0.302 . . . . 2.9300000000000002 110.185 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 48.9 mt-10 -94.6 129.6 41.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.025 0.44 . . . . 2.23 110.56 0.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.706 ' HD1' ' HB3' ' A' ' 81' ' ' TYR . 9.9 t90 -88.48 90.3 8.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 1.4299999999999999 109.756 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.5 p80 -75.61 120.15 20.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.596 0.712 . . . . 1.26 109.872 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 6.1 t-160 -70.75 -24.44 62.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.365 -0.834 . . . . 2.1400000000000001 111.011 -172.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.735 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 19.0 p90 -168.26 179.03 4.67 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.696 -0.483 . . . . 1.51 109.696 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.408 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.2 tp -142.75 114.48 8.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.33000000000000002 110.434 174.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.735 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -126.49 132.37 70.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.31 110.475 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.648 ' HB ' HD23 ' A' ' 131' ' ' LEU . 6.4 m -124.54 166.2 20.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.722 -1.214 . . . . 0.27000000000000002 107.722 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.787 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 92.8 m-20 59.56 19.55 8.07 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.374 0.421 . . . . 1.76 111.363 172.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.709 ' HE3' HG11 ' A' ' 89' ' ' VAL . 10.8 ttm -71.64 108.48 5.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.582 -0.895 . . . . 0.31 108.582 175.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.907 ' HG2' HD23 ' A' ' 63' ' ' LEU . 1.9 mtpm? -82.03 94.79 7.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.083 -0.962 . . . . 1.21 111.091 -170.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.5 -119.65 5.58 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.06 -0.973 . . . . 0.29999999999999999 112.58 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.562 ' HA ' HD11 ' A' ' 53' ' ' ILE . 25.3 p-10 -117.62 29.94 7.56 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 1.04 111.002 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -96.71 105.59 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.534 0.683 . . . . 0.77000000000000002 110.034 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 97' ' ' ILE . 8.4 mm -58.6 -33.38 48.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.565 -1.198 . . . . 0.40999999999999998 111.459 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.2 m -82.61 -35.51 26.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.844 -0.616 . . . . 0.68000000000000005 111.906 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 m -73.28 -6.04 43.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.493 -0.321 . . . . 1.26 111.711 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.3 107.87 2.16 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.628 -0.589 . . . . 0.34999999999999998 111.628 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -57.99 107.01 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.534 0.683 . . . . 0.45000000000000001 109.602 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.8 p -85.91 121.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.826 -1.079 . . . . 0.56999999999999995 111.631 -173.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.508 HD22 ' HB2' ' A' ' 135' ' ' GLU . 68.7 mt -102.0 -46.73 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.161 -0.927 . . . . 0.45000000000000001 109.255 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.0 t -126.16 108.21 11.1 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.162 -1.422 . . . . 0.37 107.162 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.412 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.7 t0 -57.2 155.72 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 1.1499999999999999 112.673 -169.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 43.2 t80 -74.02 95.32 2.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.29 -0.868 . . . . 4.6900000000000004 109.783 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.4 t -78.96 142.34 14.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.268 -1.012 . . . . 0.85999999999999999 108.268 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.21 179.33 45.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.67000000000000004 112.975 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 28.7 t -54.92 141.3 34.06 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.16 0.184 . . . . 0.51000000000000001 111.084 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -164.83 70.55 0.19 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.168 -0.539 . . . . 0.81999999999999995 112.367 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.773 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 89.4 Cg_endo -92.53 133.76 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.022 2.481 . . . . 0.84999999999999998 113.257 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 38.5 Cg_exo -59.11 137.31 78.57 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.649 2.233 . . . . 0.87 111.395 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.554 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.08 118.21 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 1.8500000000000001 111.005 -178.18 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.63 -3.07 32.34 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.555 -0.831 . . . . 1.1799999999999999 112.087 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.609 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 62.1 p -81.77 -10.47 59.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 0.96999999999999997 110.57 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.16 -155.94 19.97 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.267 -0.733 . . . . 1.97 111.267 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -90.37 108.23 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.56 -0.533 . . . . 0.93999999999999995 109.56 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -72.22 113.75 9.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.474 -175.544 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 1.021 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 1.1 ptt180 -102.77 95.12 5.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.315 0.579 . . . . 2.3100000000000001 112.201 -169.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.603 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 16.9 m-85 -83.81 120.52 26.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.536 -0.756 . . . . 0.78000000000000003 109.123 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.847 HG21 HD22 ' A' ' 14' ' ' LEU . 6.7 t -100.14 131.98 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 110.008 -0.367 . . . . 0.27000000000000002 110.008 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.694 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 69.2 m95 -88.07 119.52 28.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.205 -0.665 . . . . 1.99 109.205 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.6 mt -118.85 118.79 32.5 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 121.104 -0.238 . . . . 0.38 110.654 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.628 HG12 HD13 ' A' ' 66' ' ' LEU . 1.4 m -105.12 128.36 59.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.165 -0.68 . . . . 0.31 109.165 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.655 ' CB ' HD23 ' A' ' 160' ' ' LEU . 86.2 m-85 -107.64 162.26 14.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.372 -0.376 . . . . 5.1200000000000001 111.006 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.94 113.13 26.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.717 0.77 . . . . 2.4100000000000001 112.806 -171.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.859 ' HB3' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -107.71 148.65 29.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.419 -0.809 . . . . 1.3100000000000001 110.064 171.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.17 -9.5 59.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.302 -0.863 . . . . 2.3999999999999999 110.716 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.475 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.5 ptp180 -147.59 168.09 12.02 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.601 -0.727 . . . . 3.5099999999999998 111.641 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 22.6 Cg_exo -61.61 141.26 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.707 2.272 . . . . 1.21 110.539 172.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.648 HD23 ' HB ' ' A' ' 90' ' ' VAL . 3.2 mm? -73.9 145.21 44.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.681 0.623 . . . . 0.90000000000000002 112.681 -169.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -102.2 104.34 14.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.965 -1.016 . . . . 2.8999999999999999 108.811 171.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.459 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.3 p -124.44 112.23 16.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.113 -0.494 . . . . 1.8999999999999999 111.803 -175.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -99.19 13.53 32.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.033 -0.729 . . . . 2.96 109.033 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HB2' HD22 ' A' ' 103' ' ' LEU . 9.2 mm-40 -63.04 130.01 93.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.212 -0.904 . . . . 1.3899999999999999 110.56 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.56 112.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.032 2.488 . . . . 1.27 112.435 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.5 mm -61.87 115.57 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 0.85999999999999999 110.855 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.14 152.27 23.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 1.6100000000000001 109.808 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.5 m -91.33 -173.44 3.61 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.676 -0.861 . . . . 1.8799999999999999 108.676 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.707 ' HA ' HG22 ' A' ' 107' ' ' VAL . 2.1 p-10 -92.86 7.62 43.07 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.015 -0.674 . . . . 0.75 110.175 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.879 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 85.7 mtt180 -95.97 145.45 25.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 3.3599999999999999 109.972 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.617 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 21.9 m 73.85 126.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.145 -0.934 . . . . 0.94999999999999996 111.516 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.81 33.9 5.41 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.298 -0.865 . . . . 1.1200000000000001 111.709 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -52.75 19.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 2.6600000000000001 113.312 -172.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -122.19 47.44 1.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.427 0.632 . . . . 1.8700000000000001 111.304 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.418 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 22.6 mmt180 -88.17 -27.44 21.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.728 -0.669 . . . . 4.7300000000000004 111.138 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -129.33 -169.0 12.47 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.982 -1.104 . . . . 0.65000000000000002 113.121 -174.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.732 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 79.3 mttt 65.99 34.33 7.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.603 0.715 . . . . 1.0800000000000001 110.805 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.78 167.53 12.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.078 -0.964 . . . . 1.8899999999999999 109.608 174.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -116.81 120.95 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.199 -0.455 . . . . 1.29 111.083 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.801 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 35.6 m -64.83 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.78000000000000003 110.301 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.58 -44.68 93.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.024 -0.534 . . . . 0.67000000000000004 109.708 172.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.3 m -64.16 -38.39 90.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.77000000000000002 110.099 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.801 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.5 m-85 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.58 -0.282 . . . . 0.92000000000000004 111.315 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.6 ptp180 -63.84 -43.87 94.89 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.979 -0.288 . . . . 2.8900000000000001 110.345 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -68.64 -29.9 68.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.32 . . . . 0.96999999999999997 111.119 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -59.09 -51.9 68.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 111.376 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.519 ' HB3' HD12 ' A' ' 131' ' ' LEU . 49.9 m-85 -89.95 4.27 50.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.965 -0.561 . . . . 5.4500000000000002 111.711 -173.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 72.16 33.12 1.62 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.762 0.664 . . . . 2.4199999999999999 111.213 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 127' ' ' GLN . 4.5 mp -100.54 172.44 7.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.21 -0.904 . . . . 1.27 109.372 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 31.0 tpt180 -131.99 -95.92 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.317 -0.553 . . . . 3.5899999999999999 111.953 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -105.28 146.28 32.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.919 0.39 . . . . 0.76000000000000001 110.989 -173.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 17.0 Cg_exo -65.71 141.74 67.32 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.274 2.649 . . . . 0.53000000000000003 112.872 -170.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.885 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.0 t -78.16 -32.66 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.44 109.757 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.748 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -154.08 147.52 25.01 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.276 -0.569 . . . . 0.27000000000000002 111.695 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.58 144.14 11.87 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.937 -1.029 . . . . 0.23999999999999999 111.592 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -159.25 135.2 8.81 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.152 -0.684 . . . . 0.34000000000000002 109.152 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.858 ' SG ' ' HB2' ' A' ' 119' ' ' ARG . 27.3 t -113.54 145.88 40.54 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.398 -0.521 . . . . 1.1100000000000001 111.696 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 27.0 p90 -129.08 131.18 47.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.067 -0.716 . . . . 0.80000000000000004 109.067 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 1.021 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 0.6 OUTLIER -98.46 132.22 44.09 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.441 -0.504 . . . . 2.5299999999999998 110.272 174.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.57 139.06 54.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.848 -0.427 . . . . 0.59999999999999998 109.848 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.18 -168.76 1.51 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.073 -0.512 . . . . 2.3799999999999999 110.939 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.69 ' HA ' HG21 ' A' ' 177' ' ' VAL . 22.7 t90 -87.23 78.57 8.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 3.96 109.847 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.609 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -72.81 -59.17 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.35 -0.386 . . . . 1.53 111.086 -177.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.572 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 15.4 t70 175.81 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.987 0.515 . . . . 1.26 110.479 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.495 ' HB3' ' CD ' ' A' ' 47' ' ' LYS . 36.9 m-85 -81.28 -0.64 41.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 2.2200000000000002 111.758 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.842 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 99.1 t -63.25 -54.83 41.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.17 -0.468 . . . . 0.5 110.794 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.842 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.0 Cg_exo -50.77 -43.71 44.99 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.658 2.239 . . . . 0.57999999999999996 111.923 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.675 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 30.3 mmmt -66.24 -23.55 66.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.08 -0.509 . . . . 2.1400000000000001 111.917 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.695 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 36.0 tp -66.04 -48.67 70.31 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.058 -0.657 . . . . 0.66000000000000003 109.574 172.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.26 -35.19 79.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.356 0.598 . . . . 1.8899999999999999 109.656 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.675 ' HG3' ' HD2' ' A' ' 179' ' ' LYS . 4.8 mm-40 -55.97 -48.26 76.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.927 -1.033 . . . . 1.53 110.122 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -74.39 -33.47 63.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 1.49 112.187 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 71.1 mt -62.25 -10.69 11.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.646 0.26 . . . . 0.76000000000000001 111.66 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.619 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 50.9 m -77.08 6.99 5.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.224 0.535 . . . . 1.05 110.441 173.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.879 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 68.89 60.82 5.02 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.268 -0.878 . . . . 1.1699999999999999 111.327 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.6 mmmt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.518 -0.753 . . . . 2.0 111.125 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.0 t . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.319 0.58 . . . . 1.47 111.007 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 6' ' ' SER . 32.0 t70 -152.04 158.15 42.64 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.752 -1.113 . . . . 1.8100000000000001 108.268 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.443 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.7 mm? -78.9 30.91 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.837 0.351 . . . . 0.69999999999999996 110.765 -175.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.647 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 3.9 m -59.1 -54.69 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.97 -0.559 . . . . 1.96 111.581 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HD2' ' HB2' ' A' ' 6' ' ' SER . 8.8 mptt -99.73 40.48 1.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.819 0.342 . . . . 2.6600000000000001 110.288 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.584 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 3.4 p-90 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.779 -0.646 . . . . 3.98 112.094 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 p -141.54 20.62 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.907 0.384 . . . . 0.63 111.394 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.77 -122.54 0.31 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.35 -0.7 . . . . 0.47999999999999998 111.35 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.4 Cg_endo -51.48 -40.12 63.49 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.13 2.553 . . . . 0.53000000000000003 109.815 166.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.854 HD11 ' HA3' ' A' ' 38' ' ' GLY . 25.9 mt -87.73 81.26 7.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.433 -1.258 . . . . 1.1699999999999999 109.863 172.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -71.75 66.97 0.56 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.05 -0.722 . . . . 0.70999999999999996 109.05 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 121' ' ' VAL . 46.0 mt -75.16 -12.74 60.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.698 -0.683 . . . . 0.45000000000000001 110.797 -175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -65.65 -15.19 62.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 2.1200000000000001 111.237 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.16 -21.72 66.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.165 0.507 . . . . 1.9299999999999999 110.078 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.789 HG11 HG21 ' A' ' 69' ' ' THR . 76.1 t -89.56 -71.59 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.464 -0.789 . . . . 0.63 110.775 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.582 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 9.8 t70 -156.58 174.72 15.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.543 -0.54 . . . . 2.9900000000000002 109.543 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -63.95 120.84 12.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.298 . . . . 1.6000000000000001 110.285 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.584 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 7.7 tp-100 -53.82 127.93 53.49 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.752 -0.658 . . . . 3.5499999999999998 110.567 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.662 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.0 Cg_exo -58.28 161.89 13.03 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.331 2.688 . . . . 0.57999999999999996 113.498 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.904 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 8.8 pt20 -69.86 -19.48 63.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.894 -1.048 . . . . 1.3899999999999999 112.0 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.695 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m80 -146.56 159.04 45.64 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.165 -0.47 . . . . 1.45 110.424 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.2 Cg_endo -85.19 128.65 3.67 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.208 2.605 . . . . 0.40000000000000002 111.436 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.48 HD22 ' CG1' ' A' ' 124' ' ' VAL . 26.7 tp -80.84 146.89 30.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.526 0.203 . . . . 0.28999999999999998 110.769 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -115.38 109.54 18.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.103 -0.332 . . . . 1.24 110.103 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.878 HG13 HG22 ' A' ' 53' ' ' ILE . 13.8 t -116.35 140.4 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.46999999999999997 110.049 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -137.59 137.66 38.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.3 -0.409 . . . . 0.31 110.889 -177.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.658 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 22.2 t80 -97.36 177.26 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.833 -0.802 . . . . 0.67000000000000004 108.833 174.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.41 -52.53 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.514 0.673 . . . . 0.55000000000000004 110.059 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.17 8.79 38.78 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.006 -0.997 . . . . 0.81000000000000005 112.651 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HB2' ' NE2' ' A' ' 45' ' ' GLN . . . -148.57 -169.7 3.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.46999999999999997 110.704 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.51 158.2 23.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.737 -0.665 . . . . 0.33000000000000002 109.8 176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.885 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 79.8 t -111.43 65.87 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.624 -1.621 . . . . 0.39000000000000001 106.624 163.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -97.69 25.31 5.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.17 0.986 . . . . 0.98999999999999999 109.062 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.6 122.57 10.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.524 -1.217 . . . . 2.5600000000000001 108.02 174.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.2 tt -70.94 111.37 6.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.194 0.521 . . . . 0.40999999999999998 109.709 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.854 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 82.15 26.26 49.01 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.343 -0.844 . . . . 0.58999999999999997 111.862 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -83.74 153.17 24.3 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.93 -0.396 . . . . 0.34000000000000002 109.93 174.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.55 133.46 30.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.425 0.631 . . . . 0.55000000000000004 111.285 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.8 tp -131.22 170.08 15.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.558 -0.904 . . . . 0.45000000000000001 108.558 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.36 152.41 54.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 O-C-N 121.665 -0.647 . . . . 0.56000000000000005 112.491 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 77.1 Cg_exo -51.78 -35.35 58.33 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.749 3.633 . . . . 0.68000000000000005 114.722 -171.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.9 p -65.64 -35.03 79.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.76000000000000001 110.36 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 32' ' ' ALA . 99.1 mt-30 -82.43 -14.14 55.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.4 -1.273 . . . . 1.5900000000000001 111.686 -175.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 41' ' ' LEU . 23.9 m -128.49 20.04 2.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.287 0.565 . . . . 0.66000000000000003 111.656 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.79 -26.55 31.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.751 -0.659 . . . . 0.79000000000000004 109.545 179.217 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -116.77 -178.02 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.699 -1.137 . . . . 1.9099999999999999 109.182 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' HB3' HG21 ' A' ' 97' ' ' ILE . 77.9 mtt180 -72.9 152.9 91.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.932 -0.766 . . . . 1.4299999999999999 108.932 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.658 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 49.2 Cg_endo -74.94 175.02 11.77 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.413 1.409 . . . . 0.37 110.39 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -96.93 -16.26 20.75 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.274 -0.571 . . . . 0.44 110.059 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.477 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 75.3 m -159.75 144.32 14.99 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.38 112.436 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.878 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.24 169.21 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.996 -1.112 . . . . 0.29999999999999999 107.996 171.368 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.083 ' HA ' HD13 ' A' ' 58' ' ' LEU . 36.8 t 176.87 127.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.918 0.39 . . . . 0.34999999999999998 110.088 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 32.8 p-90 -92.91 167.73 11.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.933 -1.136 . . . . 2.7200000000000002 107.933 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.4 78.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 1.51 111.045 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.02 26.01 0.86 Allowed Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.565 -0.743 . . . . 0.80000000000000004 112.06 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.083 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.7 tt -65.35 128.48 36.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.071 0.462 . . . . 0.57999999999999996 110.939 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.76 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 33.5 t70 -75.39 -25.68 57.84 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 0.73999999999999999 111.756 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 25.3 p 70.0 8.87 6.88 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.475 1.11 . . . . 1.03 110.331 -171.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -3.4 1.42 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.83999999999999997 113.405 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.76 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 39.5 mtpt -96.51 151.97 19.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.38 0.59 . . . . 1.6699999999999999 110.217 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.695 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 45.2 mt -88.15 124.96 34.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.629 -0.714 . . . . 0.57999999999999996 109.977 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.613 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.6 m-85 -120.99 152.0 39.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.919 -0.312 . . . . 0.80000000000000004 110.683 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.456 HG23 HG12 ' A' ' 90' ' ' VAL . 57.1 m -97.32 110.63 23.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 0.35999999999999999 109.149 170.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.672 HD13 HG12 ' A' ' 124' ' ' VAL . 48.8 tp -113.16 118.69 35.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.58999999999999997 110.497 -175.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.3 t -116.64 126.29 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.39000000000000001 110.619 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.963 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 2.9 mt -92.76 133.76 35.72 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.472 -0.936 . . . . 0.59999999999999998 108.472 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.789 HG21 HG11 ' A' ' 17' ' ' VAL . 9.3 t -137.55 147.42 45.12 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.616 -0.434 . . . . 0.35999999999999999 111.899 -176.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 18.5 t70 -123.82 97.15 41.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.69 -0.686 . . . . 1.9199999999999999 109.8 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.2 Cg_endo -51.39 -35.11 53.3 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 124.076 3.184 . . . . 1.25 114.797 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 60.8 m-20 -99.45 49.69 0.94 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 1.29 112.397 -168.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.45 142.75 25.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.5 110.295 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 98.5 Cg_endo -83.66 -23.11 13.38 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.814 -1.328 . . . . 0.62 112.753 1.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.689 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 24.7 p -129.67 144.13 51.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.75 109.816 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 40.0 ttt180 -62.46 -26.68 68.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 2.8799999999999999 111.212 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.8 ptpt -76.25 -21.64 56.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.042 0.449 . . . . 1.3799999999999999 111.111 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 18.1 t70 -154.14 85.6 3.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.022 -0.536 . . . . 1.3700000000000001 109.674 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -82.2 87.91 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.451 2.101 . . . . 0.80000000000000004 112.717 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 32.0 mttm -75.15 -49.88 18.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.039 -0.982 . . . . 1.02 110.085 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.759 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.2 m-85 -84.53 22.1 1.36 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 111.903 -169.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.5 ttm180 -74.9 127.74 33.91 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.136 0.272 . . . . 2.9300000000000002 110.522 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.508 ' OE1' HG22 ' A' ' 151' ' ' VAL . 4.2 mp0 -97.04 137.44 36.12 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.043 0.449 . . . . 2.23 110.497 -3.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.545 ' CD1' ' HG2' ' A' ' 146' ' ' ARG . 16.8 t90 -85.37 146.04 27.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.996 -1.113 . . . . 1.4299999999999999 107.996 173.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 48.6 p-80 -122.04 129.48 52.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.282 0.563 . . . . 1.26 110.357 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 38.5 t-80 -68.1 -34.74 76.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.032 -0.986 . . . . 2.1400000000000001 110.09 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.522 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 40.3 p90 -168.69 172.62 7.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.045 -0.354 . . . . 1.51 110.045 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HG ' HD12 ' A' ' 103' ' ' LEU . 44.0 tp -133.96 113.9 12.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.507 -0.553 . . . . 0.33000000000000002 109.507 173.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.617 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -120.92 134.73 63.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.819 -0.628 . . . . 0.31 110.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' A' ' 131' ' ' LEU . 15.9 m -132.79 161.47 41.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 107.691 -1.226 . . . . 0.27000000000000002 107.691 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.695 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 t30 63.34 18.16 10.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.221 0.534 . . . . 1.76 110.221 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.617 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.0 ttm -68.11 111.36 4.44 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.94 -0.763 . . . . 0.31 108.94 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.592 ' HE2' HD21 ' A' ' 63' ' ' LEU . 14.5 ttmt -85.71 101.83 13.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.722 -1.126 . . . . 1.21 111.318 -170.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.15 -124.2 27.47 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 114.959 -1.019 . . . . 0.29999999999999999 112.43 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.575 ' HA ' HD11 ' A' ' 53' ' ' ILE . 3.7 p-10 -110.56 21.79 16.18 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.982 0.42 . . . . 1.04 110.756 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.79 109.4 20.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.723 0.773 . . . . 0.77000000000000002 109.971 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 50' ' ' PRO . 5.3 mm -62.38 -31.18 50.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.097 -1.41 . . . . 0.40999999999999998 111.246 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.1 m -78.29 -37.09 45.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.874 -0.603 . . . . 0.68000000000000005 111.997 -172.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.3 m -70.05 -8.6 50.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.765 0.283 . . . . 1.26 111.765 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 92' ' ' MET . . . -67.41 100.11 0.57 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.977 -0.63 . . . . 0.34999999999999998 111.779 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.5 m -60.33 107.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.671 0.748 . . . . 0.45000000000000001 110.11 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 105' ' ' ASP . 4.6 p -86.69 127.63 40.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.667 -1.151 . . . . 0.56999999999999995 111.527 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 11.3 mt -102.01 -54.72 2.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.116 0.96 . . . . 0.45000000000000001 109.141 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.1 t -106.43 100.15 9.69 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.885 -1.524 . . . . 0.37 106.885 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 1.007 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -55.37 160.7 2.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.002 -0.999 . . . . 1.1499999999999999 112.782 -169.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.1 p90 -74.09 90.76 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.514 -0.766 . . . . 4.6900000000000004 110.879 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.707 HG12 HD21 ' A' ' 180' ' ' LEU . 35.6 t -63.96 -40.07 87.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.902 -0.59 . . . . 0.85999999999999999 110.353 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.559 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 103.3 -173.03 21.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.667 -0.778 . . . . 0.67000000000000004 112.7 174.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 t -64.6 115.03 4.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.411 -0.589 . . . . 0.51000000000000001 109.411 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.674 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -144.68 58.18 0.52 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.81999999999999995 112.943 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.671 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -89.21 125.71 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.303 2.669 . . . . 0.84999999999999998 111.94 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.719 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 82.5 Cg_exo -46.21 132.98 15.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.415 2.076 . . . . 0.87 111.273 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.0 110.83 2.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.005 -0.543 . . . . 1.8500000000000001 111.012 -171.366 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.0 -5.27 25.59 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.594 -0.73 . . . . 1.1799999999999999 113.062 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.719 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -77.58 -9.92 59.21 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.698 0.629 . . . . 0.96999999999999997 112.698 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.01 -170.48 25.01 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.707 . . . . 1.97 111.994 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -73.42 144.82 46.19 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.866 0.365 . . . . 0.93999999999999995 110.757 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.671 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.6 m-70 -120.76 123.0 41.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.073 -0.512 . . . . 2.23 110.303 176.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.842 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 11.1 ptt180 -100.0 92.17 5.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.536 -0.756 . . . . 2.3100000000000001 111.406 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 69' ' ' THR . 40.6 m-85 -75.74 112.2 11.87 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.157 -0.683 . . . . 0.78000000000000003 109.157 175.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.843 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.0 t -96.49 133.74 36.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.774 . . . . 0.27000000000000002 109.66 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.62 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 35.5 m95 -89.29 132.61 34.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.193 -0.669 . . . . 1.99 109.193 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 82.7 mt -127.62 118.33 23.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.742 0.246 . . . . 0.38 110.344 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.672 HG12 HD13 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -114.2 145.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.716 0.293 . . . . 0.31 110.434 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.702 ' CD1' ' HG ' ' A' ' 160' ' ' LEU . 35.8 t80 -123.87 153.46 41.06 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.613 -0.514 . . . . 5.1200000000000001 109.613 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -108.35 88.87 2.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.033 -0.729 . . . . 2.4100000000000001 109.033 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -74.7 175.04 8.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.971 0.891 . . . . 1.3100000000000001 111.795 -172.546 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.86 -16.48 28.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.774 -1.557 . . . . 2.3999999999999999 109.964 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.549 ' HD2' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -144.63 160.53 47.28 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.413 -0.812 . . . . 3.5099999999999998 111.204 -176.369 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 131' ' ' LEU . 25.5 Cg_exo -70.43 14.12 0.31 Allowed 'Trans proline' 0 N--CA 1.484 0.919 0 C-N-CA 124.81 3.674 . . . . 1.21 114.501 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.567 HD12 ' SG ' ' A' ' 133' ' ' CYS . 4.1 mm? 81.13 168.34 0.14 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.679 0.792 . . . . 0.90000000000000002 112.864 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -160.53 78.48 0.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.315 -1.312 . . . . 2.8999999999999999 107.75 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.753 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.1 m -99.91 130.04 46.05 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.451 -0.795 . . . . 1.8999999999999999 111.214 -173.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -93.74 18.73 9.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.34 -0.845 . . . . 2.96 109.975 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.753 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 6.9 mm-40 -76.23 116.37 55.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.476 -0.783 . . . . 1.3899999999999999 109.923 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.72 137.37 42.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.362 2.708 . . . . 1.27 113.63 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.0 mm -73.47 115.77 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.764 -0.458 . . . . 0.85999999999999999 109.764 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -92.02 -10.86 37.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.966 0.728 . . . . 1.6100000000000001 112.966 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.9 m 51.98 25.12 2.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.292 0.849 . . . . 1.8799999999999999 113.292 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 1.007 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.1 p-10 50.54 21.99 0.97 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.202 1.001 . . . . 0.75 113.414 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.516 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 46.4 mtt180 -110.32 142.22 42.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.189 -0.3 . . . . 3.3599999999999999 110.189 172.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.638 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 55.0 m 77.07 151.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.215 0.947 . . . . 0.94999999999999996 111.703 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 146' ' ' ARG . . . -120.41 14.03 10.13 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.486 -0.779 . . . . 1.1200000000000001 112.849 -174.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.48 -22.27 62.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.472 . . . . 2.6600000000000001 111.035 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -119.82 46.3 1.97 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.228 -0.656 . . . . 1.8700000000000001 109.228 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.545 ' HG2' ' CD1' ' A' ' 84' ' ' TRP . 10.0 ttm180 -75.14 -71.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.145 -0.934 . . . . 4.7300000000000004 111.531 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -120.42 -154.66 9.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 0.65000000000000002 112.31 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.759 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.0 mttt 65.45 35.77 7.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.402 0.62 . . . . 1.0800000000000001 110.256 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -120.11 104.45 10.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.169 -0.923 . . . . 1.8899999999999999 109.745 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -53.84 120.56 6.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.916 -0.584 . . . . 1.29 111.785 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 2.4 m -62.04 -29.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.78000000000000003 111.183 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.743 ' HB1' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -37.55 87.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.67000000000000004 110.169 174.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.6 m -65.99 -33.29 75.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.546 -0.297 . . . . 0.77000000000000002 110.785 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.892 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 49.9 m-85 -62.24 -54.1 45.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.054 0.454 . . . . 0.92000000000000004 110.56 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 9.6 ptt180 -70.01 -51.57 31.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 2.8900000000000001 111.853 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.743 ' HE2' ' HB1' ' A' ' 152' ' ' ALA . 58.7 mtmt -62.01 -24.5 67.08 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.427 -0.17 . . . . 0.96999999999999997 111.367 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -52.05 -53.12 46.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 1.5800000000000001 111.425 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.549 ' OH ' ' HD2' ' A' ' 129' ' ' ARG . 12.7 t80 -104.43 29.55 6.0 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.796 -0.762 . . . . 5.4500000000000002 110.511 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 71.53 26.59 3.17 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.252 -0.886 . . . . 2.4199999999999999 111.842 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.702 ' HG ' ' CD1' ' A' ' 125' ' ' TYR . 7.8 mp -83.68 124.51 30.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.901 -0.407 . . . . 1.27 109.901 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -73.26 -75.87 0.14 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.721 -0.672 . . . . 3.5899999999999999 112.6 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.56 ' H ' ' HE2' ' A' ' 125' ' ' TYR . . . -150.51 150.99 30.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.547 0.213 . . . . 0.76000000000000001 110.668 -176.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.42 152.17 78.6 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.55 2.833 . . . . 0.53000000000000003 114.016 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.904 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.6 t -93.81 -37.39 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 115.025 -0.989 . . . . 0.44 110.568 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -143.27 144.16 32.02 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.011 -0.676 . . . . 0.27000000000000002 111.703 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' A' ' 21' ' ' PRO . . . -146.7 150.88 23.19 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.114 -0.948 . . . . 0.23999999999999999 112.343 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.584 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.2 t -164.62 156.08 15.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.293 -1.003 . . . . 0.34000000000000002 108.293 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.843 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -131.42 150.23 52.23 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.872 -0.517 . . . . 1.1100000000000001 112.04 -172.026 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.496 ' HD2' ' HE1' ' A' ' 122' ' ' TRP . 51.1 p90 -136.0 135.01 39.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.608 -0.886 . . . . 0.80000000000000004 108.608 171.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.842 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -99.65 133.8 43.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.575 0.625 . . . . 2.5299999999999998 110.386 173.002 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.48 137.33 54.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.935 0.397 . . . . 0.59999999999999998 111.416 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.98 -170.2 3.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.447 -0.797 . . . . 2.3799999999999999 110.914 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.873 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -105.48 77.39 1.28 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.979 -0.748 . . . . 3.96 108.979 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.591 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 13.7 t70 -72.19 -61.24 1.86 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.167 0.803 . . . . 1.53 113.167 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.633 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 12.4 t70 -167.5 -46.78 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.216 0.532 . . . . 1.26 110.951 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 37.9 m-85 -71.8 -2.8 18.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 2.2200000000000002 111.691 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.873 HG21 ' HA ' ' A' ' 173' ' ' TRP . 66.8 t -73.17 -55.37 3.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.57 -0.286 . . . . 0.5 111.414 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 47.6 Cg_exo -58.22 -29.72 88.49 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.271 1.98 . . . . 0.57999999999999996 111.274 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.0 mmmm -74.7 -24.77 58.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 111.17 177.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.707 HD21 HG12 ' A' ' 107' ' ' VAL . 51.2 tp -76.08 -42.07 48.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.502 -0.555 . . . . 0.66000000000000003 109.502 172.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -58.87 -38.27 78.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.69 -0.686 . . . . 1.8899999999999999 109.185 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.676 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.8 mm-40 -58.21 -42.73 86.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.791 -1.095 . . . . 1.53 110.985 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -76.41 -32.23 58.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 1.49 112.759 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.638 ' HA ' ' H ' ' A' ' 142' ' ' SER . 60.9 mt -62.99 -4.97 2.52 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.786 0.662 . . . . 0.76000000000000001 112.786 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.533 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 20.1 m -78.65 1.49 22.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.531 0.682 . . . . 1.05 109.766 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 76.37 50.94 6.99 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.1 -0.954 . . . . 1.1699999999999999 111.184 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.533 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.7 mmmt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.359 -0.829 . . . . 2.0 110.37 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 7.2 p . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 121.283 0.563 . . . . 1.47 111.013 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 6' ' ' SER . 25.2 t70 -167.03 163.43 15.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.696 -0.853 . . . . 1.8100000000000001 108.696 -172.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -76.56 25.81 0.14 Allowed 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 120.537 0.208 . . . . 0.69999999999999996 111.113 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 4' ' ' ASP . 31.1 m -62.91 -27.34 69.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 1.96 111.692 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -116.38 48.26 1.29 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.87 0.367 . . . . 2.6600000000000001 110.258 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -75.09 -29.74 60.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 3.98 111.724 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 36.6 p -148.14 11.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.535 -0.466 . . . . 0.63 112.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.46 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.729 . . . . 0.47999999999999998 111.733 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.3 Cg_endo -48.88 -48.83 16.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.201 2.601 . . . . 0.53000000000000003 110.381 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.72 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 8.1 mp -87.99 88.94 7.8 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.354 -0.839 . . . . 1.1699999999999999 110.258 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 7.4 m -76.12 67.02 2.37 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.354 0.597 . . . . 0.70999999999999996 110.095 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 121' ' ' VAL . 23.5 mt -71.12 -13.91 62.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.496 -0.775 . . . . 0.45000000000000001 111.164 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -65.61 -14.84 61.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.131 -0.486 . . . . 2.1200000000000001 111.477 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.34 -19.76 65.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.29 0.567 . . . . 1.9299999999999999 110.507 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.903 HG12 HG21 ' A' ' 151' ' ' VAL . 40.6 t -93.76 -72.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.477 -0.783 . . . . 0.63 111.27 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 19' ' ' GLU . 25.5 t70 -149.97 -170.99 3.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.557 -0.905 . . . . 2.9900000000000002 108.557 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.821 ' HG3' HH12 ' A' ' 155' ' ' ARG . 15.6 mt-10 -81.64 163.72 22.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.789 0.804 . . . . 1.6000000000000001 113.114 -167.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.49 126.95 89.29 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.415 -1.266 . . . . 3.5499999999999998 110.387 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 6.3 Cg_exo -75.28 154.25 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.839 1.693 . . . . 0.57999999999999996 111.166 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.946 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 20.4 pt20 -81.44 -1.19 44.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.293 -0.412 . . . . 1.3899999999999999 111.726 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.769 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 13.7 m80 -160.54 159.95 25.83 Favored Pre-proline 0 CA--C 1.516 -0.362 0 C-N-CA 123.35 0.66 . . . . 1.45 109.583 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -86.87 128.54 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 123.132 2.555 . . . . 0.40000000000000002 110.994 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.607 HD22 HG12 ' A' ' 124' ' ' VAL . 43.9 tp -80.1 145.9 32.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.696 0.284 . . . . 0.28999999999999998 111.183 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -109.36 130.33 55.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.311 -0.626 . . . . 1.24 109.311 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 53' ' ' ILE . 16.0 t -134.16 118.8 29.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.487 -0.931 . . . . 0.46999999999999997 108.487 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.3 OUTLIER -117.98 136.78 53.29 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 0.31 111.283 -172.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -97.0 173.82 7.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.279 -0.637 . . . . 0.67000000000000004 109.279 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.52 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.5 0.667 . . . . 0.55000000000000004 110.548 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 -6.14 37.55 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.163 -0.926 . . . . 0.81000000000000005 112.763 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.91 -171.96 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.858 0.329 . . . . 0.46999999999999997 110.52 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.73 153.73 17.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.113 -0.494 . . . . 0.33000000000000002 110.301 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.795 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 84.9 t -109.85 69.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 107.406 -1.331 . . . . 0.39000000000000001 107.406 165.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 34.2 t70 -102.49 20.46 17.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.967 -1.015 . . . . 0.98999999999999999 109.072 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.631 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 52.3 mt-10 -143.84 134.54 25.05 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.48 -1.236 . . . . 2.5600000000000001 108.955 172.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.696 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -81.36 112.49 18.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.794 -0.639 . . . . 0.40999999999999998 109.985 -174.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.59 52.53 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.256 -0.738 . . . . 0.58999999999999997 111.256 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.705 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.09 149.44 26.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.321 -0.251 . . . . 0.34000000000000002 110.321 177.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 10.2 p -74.52 131.81 34.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 0.55000000000000004 110.967 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.611 HD22 HG22 ' A' ' 34' ' ' VAL . 9.2 tp -133.0 170.7 15.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.485 -0.931 . . . . 0.45000000000000001 108.485 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -121.24 149.86 52.71 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 119.4 -0.92 . . . . 0.56000000000000005 111.802 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.741 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 39.8 Cg_exo -61.31 -28.62 84.73 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.201 3.267 . . . . 0.68000000000000005 113.651 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -28.61 67.37 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.546 0.689 . . . . 0.76000000000000001 110.542 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 42' ' ' THR . 97.5 mt-30 -77.88 -52.94 8.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.848 -1.069 . . . . 1.5900000000000001 111.228 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 169' ' ' TYR . 3.9 m -99.16 32.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.695 0.628 . . . . 0.66000000000000003 112.695 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.82 -30.72 61.49 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.346 -0.542 . . . . 0.79000000000000004 110.039 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.06 179.88 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 1.9099999999999999 109.971 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 96.8 mtt180 -66.89 159.38 76.06 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.868 0.366 . . . . 1.4299999999999999 110.797 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 71.3 Cg_endo -79.57 157.54 25.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.072 1.848 . . . . 0.37 110.944 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -82.23 -18.06 43.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.684 -0.488 . . . . 0.44 109.684 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 71.5 m -160.68 147.24 15.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.504 0.669 . . . . 0.38 112.003 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.921 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -137.46 166.29 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.29999999999999999 108.207 169.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.084 ' HA ' HD13 ' A' ' 58' ' ' LEU . 43.5 t 176.82 111.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.122 0.487 . . . . 0.34999999999999998 110.323 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.638 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 51.4 p-90 -73.3 152.89 40.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.616 -1.253 . . . . 2.7200000000000002 107.616 171.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.66 89.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.51 111.12 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.48 17.45 4.35 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.757 -0.656 . . . . 0.80000000000000004 112.236 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.084 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.3 tt -51.9 129.07 25.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.113 0.565 . . . . 0.57999999999999996 111.734 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.748 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 17.9 t70 -72.28 -30.67 65.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.538 -0.756 . . . . 0.73999999999999999 111.503 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.446 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.4 m 76.46 -5.6 2.15 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.818 -1.083 . . . . 1.03 110.604 -172.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.06 -8.34 5.61 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.948 -0.644 . . . . 0.83999999999999997 113.556 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 29.4 mtpt -94.7 142.85 26.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.423 0.611 . . . . 1.6699999999999999 110.962 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.72 HD21 ' HE2' ' A' ' 93' ' ' LYS . 46.7 mt -78.56 125.65 29.65 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.539 -0.912 . . . . 0.57999999999999996 108.539 171.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.514 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -121.13 163.04 19.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.465 -0.494 . . . . 0.80000000000000004 109.978 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.695 HG23 HG12 ' A' ' 90' ' ' VAL . 69.1 m -104.24 105.49 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.355 -0.609 . . . . 0.35999999999999999 109.355 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.544 HD23 ' HE2' ' A' ' 87' ' ' PHE . 25.3 tp -100.25 114.58 28.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.766 -0.457 . . . . 0.58999999999999997 109.766 -177.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.7 t -116.71 121.77 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.907 0.384 . . . . 0.39000000000000001 111.344 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -81.52 134.38 35.51 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.555 -1.276 . . . . 0.59999999999999998 107.555 168.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.838 HG21 HG11 ' A' ' 17' ' ' VAL . 10.3 t -140.35 142.74 35.56 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.014 0.435 . . . . 0.35999999999999999 110.479 176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 7.1 p-10 -130.66 95.59 25.93 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-O 121.653 0.74 . . . . 1.9199999999999999 110.188 174.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.5 Cg_endo -52.92 -31.95 54.98 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.937 3.091 . . . . 1.25 112.837 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.734 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 5.1 m-20 -82.79 45.98 1.04 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 1.29 111.094 -172.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.41 130.23 23.65 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.696 -0.483 . . . . 0.5 109.696 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.583 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.3 Cg_endo -79.17 -30.38 5.78 Favored 'Cis proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.147 -1.605 . . . . 0.62 112.982 1.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.718 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 98.6 p -125.59 156.64 38.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.33 -0.395 . . . . 0.75 111.224 -177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.734 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 52.0 ttp180 -72.19 -23.85 61.33 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.049 -0.523 . . . . 2.8799999999999999 111.129 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.779 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.08 -11.26 39.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.434 . . . . 1.3799999999999999 110.64 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -156.32 84.32 3.25 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 1.3700000000000001 109.814 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.95 91.74 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.065 2.51 . . . . 0.80000000000000004 113.353 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.583 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.8 mttm -76.11 -49.59 16.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.162 -0.926 . . . . 1.02 110.849 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.822 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 91.8 m-85 -82.78 14.05 3.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.798 -1.092 . . . . 1.1699999999999999 111.538 -169.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.5 ttt180 -67.02 128.49 36.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.956 -0.566 . . . . 2.9300000000000002 111.024 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 2.5 mp0 -99.7 137.15 38.57 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.876 0.369 . . . . 2.23 110.545 -3.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.548 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.2 t90 -93.79 130.48 39.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.923 -0.769 . . . . 1.4299999999999999 108.923 175.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 44.1 p-80 -98.66 123.18 42.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.999 -0.741 . . . . 1.26 108.999 173.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -91.57 -11.13 38.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.553 -0.749 . . . . 2.1400000000000001 111.714 -170.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 1.034 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 40.8 t80 -167.95 136.23 2.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.873 -0.417 . . . . 1.51 109.873 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HG ' HD12 ' A' ' 103' ' ' LEU . 22.7 tp -134.28 114.42 12.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.33000000000000002 110.263 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.823 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -130.09 135.49 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.681 -0.69 . . . . 0.31 110.638 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.695 HG12 HG23 ' A' ' 65' ' ' THR . 13.9 m -130.09 163.57 35.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.115 -0.948 . . . . 0.27000000000000002 108.612 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.677 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.3 t30 64.94 14.22 9.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.841 0.353 . . . . 1.76 110.416 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.823 ' HE3' HG11 ' A' ' 89' ' ' VAL . 14.3 ttm -68.93 103.97 1.96 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.702 -0.851 . . . . 0.31 108.702 174.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.72 ' HE2' HD21 ' A' ' 63' ' ' LEU . 21.2 ttmm -85.73 98.53 10.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.401 -0.818 . . . . 1.21 110.918 -171.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.29 -123.09 6.0 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.971 -1.013 . . . . 0.29999999999999999 112.186 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.526 ' HA ' HD11 ' A' ' 53' ' ' ILE . 5.3 p-10 -118.1 31.08 6.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.539 0.685 . . . . 1.04 110.391 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.62 114.96 27.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.062 -0.972 . . . . 0.77000000000000002 110.289 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 97' ' ' ILE . 3.1 mm -66.81 -19.95 26.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.698 -1.137 . . . . 0.40999999999999998 110.951 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.1 m -80.34 -52.99 7.04 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.669 0.618 . . . . 0.68000000000000005 112.669 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 p -61.67 -20.79 63.82 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.714 0.293 . . . . 1.26 111.712 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.02 102.18 0.19 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.765 -0.652 . . . . 0.34999999999999998 111.987 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 107.17 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.453 0.644 . . . . 0.45000000000000001 109.723 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.486 ' O ' HD12 ' A' ' 137' ' ' ILE . 2.6 p -74.51 118.27 19.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.825 -1.08 . . . . 0.56999999999999995 111.846 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.72 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.3 mt -97.83 -45.26 6.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.971 0.891 . . . . 0.45000000000000001 108.888 172.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.8 t -126.57 106.46 9.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.615 -1.175 . . . . 0.37 107.858 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 6.3 t0 -61.86 158.15 16.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 1.1499999999999999 112.387 -169.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -78.91 98.67 6.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.026 -0.988 . . . . 4.6900000000000004 109.664 -178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.679 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 30.1 t -74.56 -23.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.85999999999999999 111.471 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.11 -179.65 45.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.413 -0.898 . . . . 0.67000000000000004 111.858 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.3 t -60.54 133.62 56.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.862 -0.422 . . . . 0.51000000000000001 109.862 172.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.657 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -172.53 66.01 0.13 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.814 -0.708 . . . . 0.81999999999999995 112.337 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -93.29 140.24 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.816 2.344 . . . . 0.84999999999999998 112.977 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HB2' HG23 ' A' ' 115' ' ' THR . 72.6 Cg_exo -51.15 135.01 44.82 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.531 2.154 . . . . 0.87 111.331 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 117.0 5.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.213 -0.292 . . . . 1.8500000000000001 110.213 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.46 -4.28 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.798 -0.715 . . . . 1.1799999999999999 111.963 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 72.9 p -79.13 -16.59 56.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.763 0.316 . . . . 0.96999999999999997 111.302 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.75 -169.4 23.22 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.844 -0.616 . . . . 1.97 111.846 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.39 98.3 1.4 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.93999999999999995 109.935 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -75.77 103.93 6.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.421 -0.809 . . . . 2.23 109.204 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.851 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -99.72 92.96 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.405 0.621 . . . . 2.3100000000000001 111.668 -173.54 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.551 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 1.1 m-85 -76.88 133.44 39.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.78000000000000003 109.449 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.4 t -108.63 133.16 54.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.948 -0.39 . . . . 0.27000000000000002 109.948 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.795 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 1.5 m-90 -89.53 127.84 35.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.372 -0.603 . . . . 1.99 109.372 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 mt -118.75 119.39 34.29 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.867 -0.419 . . . . 0.38 109.867 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.607 HG12 HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -106.96 132.68 53.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.41 -0.516 . . . . 0.31 109.682 175.158 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.619 ' HB2' HD23 ' A' ' 160' ' ' LEU . 24.3 m-85 -115.35 149.55 37.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.147 -0.478 . . . . 5.1200000000000001 110.055 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.537 ' HB2' HG21 ' A' ' 164' ' ' VAL . 42.6 tt0 -101.31 117.93 35.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.154 0.502 . . . . 2.4100000000000001 109.894 174.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -89.88 158.86 17.25 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.626 -0.879 . . . . 1.3100000000000001 108.626 173.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.401 ' OD2' ' HG3' ' A' ' 129' ' ' ARG . 2.3 p-10 -76.4 -10.83 59.69 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.601 -0.727 . . . . 2.3999999999999999 110.805 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.661 ' NH2' ' HB2' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -162.56 177.31 1.98 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 3.5099999999999998 109.246 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 51.3 Cg_exo -54.0 174.54 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.275 1.984 . . . . 1.21 112.589 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.66 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.6 mm? -93.38 163.73 13.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.52 0.563 . . . . 0.90000000000000002 112.52 -171.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.95 45.57 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.62 1.2 . . . . 2.8999999999999999 109.868 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.492 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.2 p -62.65 -69.17 0.28 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.264 -1.789 . . . . 1.8999999999999999 111.664 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 57.87 32.34 21.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.837 0.827 . . . . 2.96 110.173 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.637 ' HB2' HD22 ' A' ' 103' ' ' LEU . 57.9 mm-40 -81.85 139.99 46.83 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.547 -0.751 . . . . 1.3899999999999999 110.809 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.38 125.2 8.75 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.37 2.714 . . . . 1.27 112.397 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 102' ' ' VAL . 33.4 mm -76.94 123.1 32.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.85999999999999999 111.454 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.9 mt -94.82 155.37 16.83 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.346 -0.613 . . . . 1.6100000000000001 109.346 174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.0 m -119.41 38.37 3.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.558 0.218 . . . . 1.8799999999999999 111.508 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.9 OUTLIER 56.76 0.81 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.714 1.206 . . . . 0.75 113.418 177.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.554 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.0 mtt180 -97.64 148.51 23.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.919 -0.488 . . . . 3.3599999999999999 109.797 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.618 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.4 m 74.46 115.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.113 0.883 . . . . 0.94999999999999996 112.364 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -87.9 38.17 3.19 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 1.1200000000000001 111.54 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.05 -39.91 71.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.77 0.795 . . . . 2.6600000000000001 110.757 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -99.25 64.68 1.37 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.088 -0.96 . . . . 1.8700000000000001 110.053 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.584 ' O ' ' HB3' ' A' ' 81' ' ' TYR . 26.9 mtm180 -87.09 39.74 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 4.7300000000000004 112.048 -175.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . 76.91 -117.4 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.935 -0.65 . . . . 0.65000000000000002 114.001 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.822 ' CG ' ' HA ' ' A' ' 81' ' ' TYR . 79.9 mttt 60.35 39.85 18.25 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.121 0.486 . . . . 1.0800000000000001 110.8 -171.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.442 ' HD2' ' CE2' ' A' ' 154' ' ' PHE . 43.5 t80 -150.37 135.83 18.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.846 -0.616 . . . . 1.8899999999999999 109.622 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -54.17 119.56 5.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.507 -0.77 . . . . 1.29 112.792 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.903 HG21 HG12 ' A' ' 17' ' ' VAL . 4.3 m -59.03 -35.15 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.335 -0.848 . . . . 0.78000000000000003 110.832 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.78 -33.02 72.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.863 -0.608 . . . . 0.67000000000000004 110.456 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -70.47 -37.71 74.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.242 -0.435 . . . . 0.77000000000000002 110.667 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.442 ' CE2' ' HD2' ' A' ' 149' ' ' PHE . 53.7 m-85 -64.28 -48.22 76.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.702 0.763 . . . . 0.92000000000000004 109.518 173.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.821 HH12 ' HG3' ' A' ' 19' ' ' GLU . 21.3 ttt180 -55.59 -50.31 70.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.4 -1.273 . . . . 2.8900000000000001 111.723 177.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -70.63 -28.91 65.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.96999999999999997 111.126 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 44.3 tptt -59.84 -40.51 88.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 1.5800000000000001 110.818 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.49 ' HB3' ' CD1' ' A' ' 131' ' ' LEU . 22.5 m-85 -88.53 5.97 40.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.077 -0.511 . . . . 5.4500000000000002 110.516 -177.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.661 ' HB2' ' NH2' ' A' ' 129' ' ' ARG . 34.0 mm-40 67.21 33.85 5.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.261 -0.881 . . . . 2.4199999999999999 111.336 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 125' ' ' TYR . 4.0 mp -90.62 140.64 29.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.666 0.269 . . . . 1.27 111.28 -177.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -71.56 -78.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 3.5899999999999999 111.385 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -155.44 166.92 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.61 -0.515 . . . . 0.76000000000000001 109.61 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.544 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 23.2 Cg_exo -60.95 137.95 75.61 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.592 2.195 . . . . 0.53000000000000003 113.276 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.946 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 6.3 t -93.18 -26.94 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 115.465 -0.789 . . . . 0.44 109.279 174.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.769 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.56 147.35 25.3 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.917 -0.583 . . . . 0.27000000000000002 111.806 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -144.32 142.21 10.84 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.725 -1.125 . . . . 0.23999999999999999 111.429 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.696 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 7.6 t -155.72 137.04 13.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.149 -0.686 . . . . 0.34000000000000002 109.149 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.867 ' HB2' HG22 ' A' ' 121' ' ' VAL . 6.7 t -116.51 145.26 43.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.24 0.543 . . . . 1.1100000000000001 111.106 -174.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 25.2 p90 -128.52 129.62 46.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.346 -1.353 . . . . 0.80000000000000004 107.346 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.848 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 2.9 pt20 -110.47 132.52 54.11 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.714 -0.794 . . . . 2.5299999999999998 111.044 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -149.33 135.64 19.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.59999999999999998 109.558 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -118.26 -136.75 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.51 -0.314 . . . . 2.3799999999999999 110.907 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -80.27 96.91 6.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 3.96 111.746 -172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.741 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 3.1 t70 -73.62 -62.16 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 1.53 110.396 170.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.553 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.7 t70 159.29 -39.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.024 1.329 . . . . 1.26 108.373 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.03 0.24 36.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 2.2200000000000002 110.864 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.798 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 76.8 t -62.49 -53.92 53.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.02 -0.536 . . . . 0.5 110.478 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.798 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.2 Cg_exo -51.97 -35.46 60.79 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.468 2.112 . . . . 0.57999999999999996 112.022 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 13.5 mmmm -73.9 -26.97 60.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 2.1400000000000001 111.499 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.66 HD21 HG12 ' A' ' 107' ' ' VAL . 44.0 tp -69.09 -46.91 66.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.66000000000000003 109.063 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.35 -34.94 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 1.8899999999999999 109.393 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.714 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.2 mm-40 -63.28 -43.87 96.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.985 -1.007 . . . . 1.53 110.922 173.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.444 ' HA ' ' CG ' ' A' ' 187' ' ' LYS . 16.1 tt0 -65.29 -27.84 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.49 111.406 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.618 ' HA ' ' H ' ' A' ' 142' ' ' SER . 59.4 mt -66.31 6.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.511 0.559 . . . . 0.76000000000000001 112.511 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.739 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 15.3 m -80.99 0.15 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.674 0.75 . . . . 1.05 109.086 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.52 33.07 17.52 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 111.228 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.739 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 31.6 mmtp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.372 -0.823 . . . . 2.0 110.991 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 2.7 p . . . . . 0 N--CA 1.444 -0.73 0 CA-C-O 121.714 0.768 . . . . 1.47 110.224 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.459 ' HA ' ' CG ' ' A' ' 24' ' ' PRO . 3.4 p30 -169.56 -175.48 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.921 -1.036 . . . . 1.8100000000000001 108.557 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.474 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.5 mm? -78.61 24.81 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.918 0.34 . . . . 0.69999999999999996 111.918 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 t -72.9 -19.88 61.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.731 0.777 . . . . 1.96 109.388 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HB3' HD12 ' A' ' 12' ' ' LEU . 79.8 mttt -117.33 36.72 4.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 2.6600000000000001 110.174 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.4 -37.22 44.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 3.98 112.294 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 11.6 p -145.3 27.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.63 110.995 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.87 -122.31 0.31 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.912 -0.875 . . . . 0.47999999999999998 110.912 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.72 -38.56 77.3 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.183 2.588 . . . . 0.53000000000000003 110.568 166.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.788 HD11 ' HA3' ' A' ' 38' ' ' GLY . 17.5 mt -87.85 83.73 7.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 110.027 173.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.34 68.96 0.79 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.375 0.607 . . . . 0.70999999999999996 110.112 175.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 121' ' ' VAL . 57.0 mt -79.21 -16.83 55.94 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.702 -0.681 . . . . 0.45000000000000001 110.775 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.84 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 9.3 tm0? -69.1 -12.87 62.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.362 0.601 . . . . 2.1200000000000001 110.534 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.16 -23.74 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 109.78 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.726 HG11 HG21 ' A' ' 69' ' ' THR . 48.6 t -90.44 -68.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.722 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -119.9 -177.24 3.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.713 -0.676 . . . . 2.9900000000000002 109.917 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 16.8 mt-10 -90.56 20.26 4.74 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.854 0.316 . . . . 1.6000000000000001 111.854 -173.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.84 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 9.5 mm-40 67.82 136.85 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.361 1.038 . . . . 3.5499999999999998 112.427 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 4.3 Cg_exo -79.83 157.79 24.36 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.229 2.62 . . . . 0.57999999999999996 112.804 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.901 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.5 pt20 -77.94 -27.09 49.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.893 -1.049 . . . . 1.3899999999999999 111.857 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.762 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 79.6 m-70 -132.48 158.55 75.38 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.843 -0.799 . . . . 1.45 108.843 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CG ' ' HA ' ' A' ' 4' ' ' ASP . 4.3 Cg_endo -85.81 128.27 3.28 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.664 2.243 . . . . 0.40000000000000002 111.113 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 122' ' ' TRP . 38.0 tp -78.66 148.4 33.18 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.093 -0.336 . . . . 0.28999999999999998 110.093 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.429 ' H ' HD12 ' A' ' 25' ' ' LEU . 44.5 m80 -118.89 130.14 55.57 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.502 -0.555 . . . . 1.24 109.502 172.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.847 HG13 HG22 ' A' ' 53' ' ' ILE . 19.2 t -127.75 146.26 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.682 -0.858 . . . . 0.46999999999999997 108.682 177.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 143.18 32.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.974 0.416 . . . . 0.31 111.05 -177.341 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 34.5 t80 -110.77 173.22 6.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.5 -0.556 . . . . 0.67000000000000004 109.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.51 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.18 0.514 . . . . 0.55000000000000004 110.886 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.38 15.44 10.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.399 -0.818 . . . . 0.81000000000000005 112.361 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -146.32 -172.79 4.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.885 0.374 . . . . 0.46999999999999997 110.734 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.665 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -164.01 159.89 21.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.797 -0.638 . . . . 0.33000000000000002 110.041 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.67 HG13 ' HZ1' ' A' ' 39' ' ' LYS . 87.3 t -114.3 67.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.585 -1.635 . . . . 0.39000000000000001 106.585 162.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -102.63 23.19 12.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.582 -1.19 . . . . 0.98999999999999999 109.092 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -150.93 132.95 15.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.852 -1.067 . . . . 2.5600000000000001 108.304 174.146 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -76.65 110.76 11.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.182 0.515 . . . . 0.40999999999999998 109.703 -173.607 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 86.7 16.73 61.17 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.343 -0.844 . . . . 0.58999999999999997 112.227 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.67 ' HZ1' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.13 149.92 44.29 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.399 -0.593 . . . . 0.34000000000000002 109.399 173.619 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.05 129.32 37.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.441 0.639 . . . . 0.55000000000000004 111.029 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.6 tp -120.91 169.39 10.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.181 -1.044 . . . . 0.45000000000000001 108.181 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.1 p -128.04 151.73 76.41 Favored Pre-proline 0 C--N 1.322 -0.587 0 C-N-CA 119.724 -0.79 . . . . 0.56000000000000005 112.512 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.587 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.2 Cg_exo -55.58 -24.65 45.93 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.303 3.335 . . . . 0.68000000000000005 114.01 -176.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -62.88 -38.3 90.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 122.11 0.957 . . . . 0.76000000000000001 110.093 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.09 -46.19 14.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.785 -1.552 . . . . 1.5900000000000001 111.266 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 169' ' ' TYR . 6.7 m -100.51 31.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.459 0.54 . . . . 0.66000000000000003 112.459 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -82.66 -7.87 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.419 0.628 . . . . 0.79000000000000004 109.367 172.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -142.0 -177.82 5.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.952 -1.022 . . . . 1.9099999999999999 109.072 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -71.79 156.26 91.3 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.765 -0.457 . . . . 1.4299999999999999 109.765 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 57.8 Cg_endo -76.62 162.65 32.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.612 1.541 . . . . 0.37 110.216 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.4 t -85.67 -19.2 31.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.631 -0.427 . . . . 0.44 110.152 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -159.5 147.43 17.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.38 112.413 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.847 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.36 172.44 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.825 -1.08 . . . . 0.29999999999999999 108.382 170.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.042 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.5 t 170.97 127.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.462 0.476 . . . . 0.34999999999999998 110.013 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.838 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -81.87 162.06 22.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.459 -0.941 . . . . 2.7200000000000002 108.459 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 22.2 t70 -59.43 79.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.237 0.542 . . . . 1.51 110.712 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.71 24.44 3.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.751 -0.659 . . . . 0.80000000000000004 112.958 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.042 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -54.3 128.25 30.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.067 0.434 . . . . 0.57999999999999996 110.547 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.735 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 29.5 t70 -78.38 -12.76 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.73999999999999999 111.439 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.44 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 70.7 p 51.23 30.04 5.45 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.94 -1.027 . . . . 1.03 110.906 -173.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.38 8.17 0.21 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.594 -0.73 . . . . 0.83999999999999997 112.873 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.735 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 19.4 mtpt -109.99 157.49 19.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 1.6699999999999999 109.481 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 65.3 mt -94.54 125.09 38.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.798 -0.816 . . . . 0.57999999999999996 108.798 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.526 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -120.11 149.62 41.92 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.634 -0.426 . . . . 0.80000000000000004 110.76 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.682 HG23 HG12 ' A' ' 90' ' ' VAL . 61.3 m -96.87 105.95 18.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.511 -0.922 . . . . 0.35999999999999999 108.511 170.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.634 HD13 HG12 ' A' ' 124' ' ' VAL . 47.5 tp -106.8 109.87 21.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.716 -0.674 . . . . 0.58999999999999997 110.189 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.1 t -114.79 123.02 70.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.745 -0.661 . . . . 0.39000000000000001 110.679 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.79 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.4 mt -84.37 137.93 33.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.723 -0.843 . . . . 0.59999999999999998 108.723 169.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.726 HG21 HG11 ' A' ' 17' ' ' VAL . 11.3 t -139.68 145.1 37.99 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.847 -0.341 . . . . 0.35999999999999999 110.635 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 24.8 t70 -128.85 96.39 29.54 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.324 0.583 . . . . 1.9199999999999999 110.273 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.0 Cg_endo -51.36 -37.85 61.61 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.046 3.164 . . . . 1.25 114.747 178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 44.1 m-20 -96.33 46.69 1.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.341 0.497 . . . . 1.29 112.341 -166.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.82 137.91 19.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.5 110.794 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.5 Cg_endo -82.39 -20.19 20.36 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.44 -1.483 . . . . 0.62 112.465 0.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.775 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 96.6 p -134.01 146.8 50.74 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.832 -0.622 . . . . 0.75 110.472 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.591 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 63.1 ttt180 -66.45 -26.39 67.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.208 -0.451 . . . . 2.8799999999999999 111.796 -174.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.762 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -89.0 -11.22 44.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.029 0.443 . . . . 1.3799999999999999 110.862 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -153.2 82.37 4.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.856 -0.611 . . . . 1.3700000000000001 109.528 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 96.1 Cg_endo -87.95 88.23 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.81 2.34 . . . . 0.80000000000000004 113.16 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.576 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.7 mttm -71.52 -53.44 13.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.15 -0.932 . . . . 1.02 110.726 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.772 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 36.2 m-85 -78.75 17.83 0.67 Allowed 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.211 -0.904 . . . . 1.1699999999999999 111.642 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' A' ' 79' ' ' PRO . 32.4 ttt180 -74.2 129.59 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.216 0.323 . . . . 2.9300000000000002 111.71 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.485 ' HG2' HG13 ' A' ' 17' ' ' VAL . 22.1 mp0 -89.05 140.51 29.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 122.807 0.443 . . . . 2.23 110.605 -6.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.1 t90 -86.21 91.5 8.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.532 -0.544 . . . . 1.4299999999999999 109.532 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 45.6 p-80 -71.86 121.84 19.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.768 0.794 . . . . 1.26 109.698 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.79 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t60 -72.72 -35.22 67.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.917 -1.038 . . . . 2.1400000000000001 111.166 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.731 ' HD1' ' HB2' ' A' ' 68' ' ' LEU . 2.4 p90 -168.08 178.16 5.2 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.666 -0.494 . . . . 1.51 109.666 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.4 tp -140.71 114.01 8.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.776 0.322 . . . . 0.33000000000000002 110.64 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.651 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -121.85 133.01 69.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.78 -0.645 . . . . 0.31 110.667 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 65' ' ' THR . 16.2 m -133.37 161.55 41.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.409 -0.96 . . . . 0.27000000000000002 108.409 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.2 t30 62.55 18.98 10.92 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.383 0.427 . . . . 1.76 110.608 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.651 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -68.18 110.67 4.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.789 -0.819 . . . . 0.31 108.789 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.563 ' HE2' HD21 ' A' ' 63' ' ' LEU . 13.8 ttmm -91.57 97.33 10.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.177 -0.92 . . . . 1.21 111.012 -171.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 64' ' ' TYR . . . 81.91 -130.62 9.82 Favored Glycine 0 CA--C 1.505 -0.568 0 CA-C-N 115.242 -0.89 . . . . 0.29999999999999999 112.45 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 30.8 p-10 -117.29 26.48 9.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.098 0.475 . . . . 1.04 111.044 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.77 110.43 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.77000000000000002 110.034 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 50' ' ' PRO . 7.3 mm -58.86 -28.92 39.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.511 -1.222 . . . . 0.40999999999999998 111.396 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -82.24 -29.99 31.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.982 -0.554 . . . . 0.68000000000000005 111.765 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -77.73 -6.68 54.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.845 0.313 . . . . 1.26 111.845 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.43 107.11 2.28 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.913 -0.661 . . . . 0.34999999999999998 111.828 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 106.97 0.46 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.403 0.62 . . . . 0.45000000000000001 110.332 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.3 p -89.55 109.52 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.827 -1.079 . . . . 0.56999999999999995 111.203 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' A' ' 88' ' ' LEU . 29.4 mt -89.18 -45.25 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.023 -0.99 . . . . 0.45000000000000001 109.813 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 t -116.65 105.76 12.79 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.952 -1.499 . . . . 0.37 106.952 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.2 t0 -54.88 150.97 9.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.1499999999999999 112.831 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -77.37 103.29 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.114 -0.948 . . . . 4.6900000000000004 109.223 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 48.4 t -78.33 -57.62 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.148 -0.478 . . . . 0.85999999999999999 112.244 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 132.85 175.59 14.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.647 -0.787 . . . . 0.67000000000000004 112.435 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.482 ' HB2' HG23 ' A' ' 46' ' ' VAL . 30.3 t -61.14 131.82 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.486 0.143 . . . . 0.51000000000000001 110.66 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.451 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -152.46 63.89 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 O-C-N 123.573 0.546 . . . . 0.81999999999999995 112.297 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.609 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 4.0 Cg_endo -90.34 113.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.611 2.874 . . . . 0.84999999999999998 112.593 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.3 Cg_exo -56.43 147.74 66.6 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.897 2.398 . . . . 0.87 111.986 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 117.08 9.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.097 -0.502 . . . . 1.8500000000000001 111.063 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.46 6.15 56.63 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.953 -0.642 . . . . 1.1799999999999999 112.7 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.775 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 80.0 p -89.42 -22.68 22.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.96999999999999997 111.728 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.61 173.29 20.1 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.828 -0.624 . . . . 1.97 111.743 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.3 mm? -74.72 113.15 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.062 -0.347 . . . . 0.93999999999999995 110.062 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.718 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.0 m-70 -79.76 116.21 19.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 2.23 110.52 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.542 HH11 HD23 ' A' ' 14' ' ' LEU . 13.5 ptt180 -98.34 85.36 3.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.601 -0.727 . . . . 2.3100000000000001 110.781 -172.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.518 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 20.7 m-85 -71.73 114.11 9.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.257 -0.645 . . . . 0.78000000000000003 109.257 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.708 HG21 HD22 ' A' ' 14' ' ' LEU . 19.4 t -94.68 130.58 43.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.169 -0.469 . . . . 0.27000000000000002 110.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.668 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 59.7 m95 -88.68 119.27 29.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.895 -0.78 . . . . 1.99 108.895 177.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.4 mt -113.84 118.61 34.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.709 0.232 . . . . 0.38 110.683 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.634 HG12 HD13 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -117.53 136.68 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.31 110.788 179.136 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.859 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 59.0 t80 -132.03 129.01 39.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.423 -0.353 . . . . 5.1200000000000001 110.256 173.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.877 ' HG2' HG21 ' A' ' 164' ' ' VAL . 8.9 pt-20 -82.22 104.62 12.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.76 -0.829 . . . . 2.4100000000000001 108.76 171.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.24 168.21 19.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.169 0.509 . . . . 1.3100000000000001 109.752 -176.041 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.65 -7.2 53.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.582 -0.735 . . . . 2.3999999999999999 110.347 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HG3' ' HE2' ' A' ' 158' ' ' TYR . 20.0 ptt180 -167.01 160.23 11.02 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.561 -0.745 . . . . 3.5099999999999998 111.02 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HG3' HD12 ' A' ' 63' ' ' LEU . 31.2 Cg_exo -56.75 140.45 91.02 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.544 2.829 . . . . 1.21 112.596 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.8 mm? -65.16 149.52 49.77 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.401 0.519 . . . . 0.90000000000000002 112.401 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 11.6 tptm -120.96 90.68 3.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 2.8999999999999999 107.781 164.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' A' ' 103' ' ' LEU . 4.8 p -70.52 -69.77 0.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.334 -0.848 . . . . 1.8999999999999999 111.961 -171.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 59.26 28.96 18.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.267 0.556 . . . . 2.96 109.753 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -99.62 138.23 20.39 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.427 -0.806 . . . . 1.3899999999999999 109.426 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.28 115.17 1.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.113 2.542 . . . . 1.27 112.871 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.27 118.15 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.909 -0.404 . . . . 0.85999999999999999 109.909 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.4 mt -114.78 147.88 39.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.459 . . . . 1.6100000000000001 110.55 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -86.21 169.82 12.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.285 -0.871 . . . . 1.8799999999999999 109.237 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.815 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -86.13 30.49 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.112 0.482 . . . . 0.75 111.571 -175.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.583 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 96.8 mtt180 -117.96 148.26 42.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.426 -0.352 . . . . 3.3599999999999999 110.557 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.689 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 25.4 m 71.06 141.16 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.938 -1.028 . . . . 0.94999999999999996 111.232 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.03 28.71 14.4 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.585 -0.734 . . . . 1.1200000000000001 111.519 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.64 -51.61 26.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.316 0.647 . . . . 2.6600000000000001 112.672 -172.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -117.73 31.03 6.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.41 0.624 . . . . 1.8700000000000001 111.327 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.458 ' HB3' ' HE1' ' A' ' 84' ' ' TRP . 18.0 mmt180 -87.65 -36.03 17.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 4.7300000000000004 110.56 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -117.19 176.02 15.99 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.551 -0.833 . . . . 0.65000000000000002 112.707 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.772 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.3 mttt 64.33 41.94 5.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.535 0.683 . . . . 1.0800000000000001 111.449 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.98 149.02 49.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.044 -0.98 . . . . 1.8899999999999999 109.252 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -97.96 122.93 41.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.991 0.424 . . . . 1.29 111.697 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.645 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.8 m -61.29 -26.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.672 -0.695 . . . . 0.78000000000000003 110.224 174.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -61.7 -46.79 88.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.364 -0.834 . . . . 0.67000000000000004 110.186 173.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.0 m -63.97 -35.92 82.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.094 -0.503 . . . . 0.77000000000000002 110.823 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.645 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.6 m-85 -65.27 -49.98 67.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.399 -0.364 . . . . 0.92000000000000004 111.093 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 1.8 ptm180 -69.0 -39.31 79.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 2.8900000000000001 111.02 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.72 -27.58 68.43 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 111.503 0.186 . . . . 0.96999999999999997 111.503 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -53.93 -54.06 44.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 1.5800000000000001 111.495 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.517 ' HE2' ' HG3' ' A' ' 129' ' ' ARG . 9.2 t80 -107.58 18.87 20.94 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.766 -0.773 . . . . 5.4500000000000002 110.75 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 63.78 46.87 3.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.408 -0.814 . . . . 2.4199999999999999 111.149 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.859 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -91.47 123.14 34.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.185 -0.916 . . . . 1.27 109.831 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -86.52 -150.39 0.15 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.4 -0.364 . . . . 3.5899999999999999 110.441 -178.115 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -62.73 142.85 96.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 0.76000000000000001 110.541 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 16.5 Cg_exo -66.33 160.73 43.93 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 123.795 2.997 . . . . 0.53000000000000003 113.513 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.901 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.7 t -89.74 -35.58 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-N 115.48 -0.782 . . . . 0.44 110.089 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -149.72 145.91 26.93 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.912 -0.715 . . . . 0.27000000000000002 111.75 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.36 143.02 10.34 Favored Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.545 -1.207 . . . . 0.23999999999999999 111.344 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 t -155.5 142.4 19.04 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.055 -1.091 . . . . 0.34000000000000002 108.055 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.616 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 13.1 p -120.31 141.27 50.17 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.951 -0.699 . . . . 1.1100000000000001 110.551 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.0 p90 -125.56 123.29 38.77 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.693 -1.225 . . . . 0.80000000000000004 107.693 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.718 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 1.1 pt20 -101.03 132.39 46.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.621 -0.832 . . . . 2.5299999999999998 110.623 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.07 155.75 29.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.567 -0.742 . . . . 0.59999999999999998 110.696 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.39 -177.38 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.173 0.511 . . . . 2.3799999999999999 111.38 -175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.664 ' HA ' HG21 ' A' ' 177' ' ' VAL . 30.0 t90 -84.99 78.44 9.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 3.96 109.018 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 9.2 t70 -71.99 -62.74 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 1.53 111.687 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 33.5 t70 174.69 -35.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.277 0.56 . . . . 1.26 110.917 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -80.21 5.26 15.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 2.2200000000000002 110.999 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.825 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 64.8 t -72.42 -54.45 5.34 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.5 110.479 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 77.2 Cg_exo -51.47 -37.73 62.5 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.545 2.163 . . . . 0.57999999999999996 112.33 172.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.685 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.6 mmmt -73.09 -23.3 60.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 2.1400000000000001 111.42 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.783 HD11 HG12 ' A' ' 107' ' ' VAL . 40.3 tp -69.62 -46.59 65.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.104 -0.702 . . . . 0.66000000000000003 109.104 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -59.61 -36.86 77.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 1.8899999999999999 109.811 173.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.1 mm-40 -54.73 -46.65 74.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.83 -1.077 . . . . 1.53 110.339 172.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -73.73 -36.01 65.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.474 -0.785 . . . . 1.49 111.744 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.689 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.7 mt -67.16 5.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.263 0.468 . . . . 0.76000000000000001 112.263 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.694 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 33.8 m -84.12 0.02 50.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.377 0.608 . . . . 1.05 109.462 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.583 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.35 55.34 8.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.223 -0.899 . . . . 1.1699999999999999 111.346 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.694 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 1.4 mmmp? . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.169 -0.919 . . . . 2.0 110.75 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.619 HG13 ' HB2' ' A' ' 24' ' ' PRO . 7.4 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 120.947 0.403 . . . . 1.47 111.434 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -154.11 153.47 31.91 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.175 -0.676 . . . . 1.8100000000000001 109.175 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.516 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -78.16 16.19 0.8 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.851 0.315 . . . . 0.69999999999999996 111.851 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.3 t -64.14 -16.18 61.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 1.96 110.805 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.665 ' HB3' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -113.47 31.48 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 2.6600000000000001 110.536 -177.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.695 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.4 OUTLIER -73.55 -41.27 63.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.852 0.358 . . . . 3.98 111.93 -174.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.9 p -145.03 32.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.463 0.649 . . . . 0.63 110.003 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.12 -118.1 0.21 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.966 -0.854 . . . . 0.47999999999999998 110.966 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 18.6 Cg_endo -56.89 -38.37 96.07 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 123.175 2.583 . . . . 0.53000000000000003 110.854 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 7' ' ' LYS . 9.3 mt -88.58 101.75 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.1699999999999999 110.034 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -83.29 71.34 10.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.837 0.827 . . . . 0.70999999999999996 110.106 175.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.624 HD22 ' CG2' ' A' ' 121' ' ' VAL . 22.7 mt -79.09 -15.49 58.1 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.465 -0.789 . . . . 0.45000000000000001 109.915 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.655 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -74.46 -6.67 49.65 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.375 -0.83 . . . . 2.1200000000000001 111.204 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 13' ' ' SER . 14.2 mt-10 -68.91 -22.83 64.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.323 0.582 . . . . 1.9299999999999999 109.577 177.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.873 HG12 HG21 ' A' ' 151' ' ' VAL . 46.1 t -89.03 -71.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.163 -0.926 . . . . 0.63 111.41 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.487 ' HB2' HG21 ' A' ' 151' ' ' VAL . 26.5 t70 -149.74 174.65 12.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.935 -0.575 . . . . 2.9900000000000002 109.525 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -54.95 151.04 9.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.288 0.566 . . . . 1.6000000000000001 111.279 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.655 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 27.6 mm-40 -86.96 138.27 32.94 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.872 -0.603 . . . . 3.5499999999999998 109.942 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.67 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 8.1 Cg_exo -71.24 161.52 45.51 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.377 2.718 . . . . 0.57999999999999996 113.299 -170.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.7 pt20 -82.38 -18.07 43.32 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.326 -0.852 . . . . 1.3899999999999999 111.74 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.755 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 9.6 m-70 -141.9 159.68 58.5 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.538 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.619 ' HB2' HG13 ' A' ' 3' ' ' VAL . 5.0 Cg_endo -85.72 125.73 2.87 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.763 2.309 . . . . 0.40000000000000002 111.175 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 122' ' ' TRP . 16.2 tp -71.55 137.74 48.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.28999999999999998 110.131 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.59 107.82 19.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.8 -0.444 . . . . 1.24 109.8 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.928 HG13 HG22 ' A' ' 53' ' ' ILE . 6.6 t -114.46 143.34 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.149 -0.686 . . . . 0.46999999999999997 109.149 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.39 139.58 31.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.99 0.424 . . . . 0.31 111.413 -174.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -104.72 173.34 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.238 -0.653 . . . . 0.67000000000000004 109.238 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.17 66.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.485 0.659 . . . . 0.55000000000000004 110.726 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.1 -0.87 33.68 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.28 -0.873 . . . . 0.81000000000000005 112.957 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.36 -170.39 2.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.46999999999999997 111.266 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.39 154.4 16.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.63 -0.713 . . . . 0.33000000000000002 109.734 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.726 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 86.6 t -113.14 69.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.145 -1.428 . . . . 0.39000000000000001 107.145 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 20.5 t70 -105.41 18.55 22.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.234 -0.894 . . . . 0.98999999999999999 109.358 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.35 135.85 24.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.521 -0.918 . . . . 2.5600000000000001 108.521 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -80.79 111.38 17.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.405 0.622 . . . . 0.40999999999999998 110.547 -171.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 91.32 11.74 60.7 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.989 -1.005 . . . . 0.58999999999999997 111.848 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.726 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.4 144.53 46.35 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.394 -0.595 . . . . 0.34000000000000002 109.394 176.824 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 9.7 p -77.24 136.2 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.55000000000000004 110.99 -178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.629 HD22 HG22 ' A' ' 34' ' ' VAL . 7.2 tp -131.99 168.85 17.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.556 -0.905 . . . . 0.45000000000000001 108.556 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.92 152.04 48.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.565 -0.454 . . . . 0.56000000000000005 112.045 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 50.3 Cg_exo -57.41 -34.11 97.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.805 3.003 . . . . 0.68000000000000005 112.855 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.507 HG23 ' CD1' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -60.37 -39.91 88.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.463 0.649 . . . . 0.76000000000000001 110.772 176.07 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -81.64 -13.24 58.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.943 -1.026 . . . . 1.5900000000000001 111.752 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.601 HG11 ' CE2' ' A' ' 169' ' ' TYR . 33.0 m -128.24 28.65 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.66000000000000003 111.583 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.551 ' HZ2' HD13 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -86.76 -10.75 52.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.414 0.626 . . . . 0.79000000000000004 109.337 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -132.91 174.21 10.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.745 -1.116 . . . . 1.9099999999999999 108.38 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -71.29 153.56 94.08 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 110.229 -0.286 . . . . 1.4299999999999999 110.229 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.35 156.18 46.02 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.136 1.89 . . . . 0.37 110.844 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -77.71 -20.78 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.809 0.338 . . . . 0.44 110.216 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -159.07 143.56 15.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.482 0.658 . . . . 0.38 112.619 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.928 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -137.83 164.34 28.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.778 -1.101 . . . . 0.29999999999999999 108.155 170.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.016 ' HA ' HD13 ' A' ' 58' ' ' LEU . 35.1 t 174.69 118.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.15 -0.315 . . . . 0.34999999999999998 110.15 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.877 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -73.12 155.76 39.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.273 -1.01 . . . . 2.7200000000000002 108.273 172.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.89 88.05 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.042 0.448 . . . . 1.51 110.302 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.95 10.62 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.64 -0.709 . . . . 0.80000000000000004 112.182 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.016 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.8 tt -51.03 128.74 22.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.09 0.556 . . . . 0.57999999999999996 111.37 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.818 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 24.4 t70 -72.73 -32.59 65.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.723 -0.671 . . . . 0.73999999999999999 111.332 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.553 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.7 t 71.52 15.02 6.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 114.998 -1.001 . . . . 1.03 109.831 -174.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.53 10.52 2.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.526 -0.761 . . . . 0.83999999999999997 112.901 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.818 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 22.9 mtpt -117.76 154.45 31.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.803 -0.443 . . . . 1.6699999999999999 109.803 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.832 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 24.2 mt -92.5 130.87 38.04 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.796 -0.816 . . . . 0.57999999999999996 108.796 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.648 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -125.54 158.36 34.76 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.56 -0.456 . . . . 0.80000000000000004 110.871 176.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.459 HG23 HG12 ' A' ' 90' ' ' VAL . 60.0 m -97.72 106.14 18.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.149 -0.685 . . . . 0.35999999999999999 109.149 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 124' ' ' VAL . 53.0 tp -104.24 111.23 23.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.58999999999999997 110.394 -176.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.417 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.0 t -116.74 125.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 0.39000000000000001 110.727 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.5 -0.926 . . . . 0.59999999999999998 108.5 167.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.74 HG21 HG11 ' A' ' 17' ' ' VAL . 10.6 t -136.66 146.81 46.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.04 -0.355 . . . . 0.35999999999999999 110.04 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 14.9 t0 -126.28 97.27 34.75 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.457 -0.571 . . . . 1.9199999999999999 109.457 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.5 ' HD3' HG21 ' A' ' 17' ' ' VAL . 6.5 Cg_endo -49.08 -46.89 23.73 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.904 3.069 . . . . 1.25 113.485 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.655 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 7.4 m-20 -90.81 53.09 2.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.422 0.629 . . . . 1.29 111.14 -171.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.98 138.88 19.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.932 -0.576 . . . . 0.5 110.828 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.585 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 88.1 Cg_endo -83.43 -22.7 14.35 Favored 'Cis proline' 0 C--N 1.343 0.282 0 C-N-CA 123.327 -1.531 . . . . 0.62 112.621 1.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.657 ' HB3' HG22 ' A' ' 115' ' ' THR . 58.9 p -128.46 147.3 50.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.565 -0.743 . . . . 0.75 110.277 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.655 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 21.2 ttt180 -64.6 -26.65 68.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.257 0.551 . . . . 2.8799999999999999 110.429 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.9 ptpt -78.72 -14.83 59.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 1.3799999999999999 110.89 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t70 -162.94 87.49 1.33 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.942 -0.572 . . . . 1.3700000000000001 110.111 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.2 Cg_endo -85.2 83.92 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.697 2.265 . . . . 0.80000000000000004 112.806 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -72.08 -47.85 48.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.884 -1.053 . . . . 1.02 110.48 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.689 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 54.6 m-85 -88.53 21.28 2.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.002 -0.999 . . . . 1.1699999999999999 111.729 -168.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.858 ' HD3' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -74.01 125.85 29.18 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.173 -0.306 . . . . 2.9300000000000002 110.173 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.858 ' HG3' ' HD3' ' A' ' 82' ' ' ARG . 1.5 mp0 -94.87 138.78 32.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.043 0.449 . . . . 2.23 110.986 -2.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.602 ' HZ3' ' CE1' ' A' ' 118' ' ' HIS . 16.0 t90 -91.72 138.64 31.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.188 -0.671 . . . . 1.4299999999999999 109.188 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -113.44 133.61 55.1 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.221 -0.659 . . . . 1.26 109.221 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.88 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 5.2 t60 -82.75 -35.81 26.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.72 -0.673 . . . . 2.1400000000000001 110.527 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.689 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 22.0 p90 -167.62 177.19 6.01 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.552 -0.536 . . . . 1.51 109.552 177.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.57 ' HG ' HD12 ' A' ' 103' ' ' LEU . 23.3 tp -141.27 113.8 8.22 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.245 0.341 . . . . 0.33000000000000002 110.25 176.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.689 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.668 -0.697 . . . . 0.31 110.57 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.527 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 4.5 m -129.05 166.88 25.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.591 -0.892 . . . . 0.27000000000000002 108.591 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.832 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 m-20 60.45 18.89 8.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.955 0.407 . . . . 1.76 111.172 172.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.582 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.4 ttm -72.49 116.71 13.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.97 -0.752 . . . . 0.31 108.97 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.3 ttmm -90.4 100.63 13.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.126 -0.943 . . . . 1.21 110.972 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 75.59 -121.42 6.37 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.353 -0.839 . . . . 0.29999999999999999 112.537 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 28.2 p30 -120.55 29.09 7.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.208 0.528 . . . . 1.04 111.052 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -97.15 109.61 22.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.834 -0.621 . . . . 0.77000000000000002 110.183 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 53' ' ' ILE . 7.6 mm -54.74 -30.86 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.716 -1.129 . . . . 0.40999999999999998 111.483 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.0 m -83.21 -35.53 25.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.016 -0.538 . . . . 0.68000000000000005 112.32 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.8 p -61.28 -24.97 66.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 1.26 111.759 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.8 110.11 1.53 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.65 -0.704 . . . . 0.34999999999999998 113.012 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.4 m -66.44 107.59 2.09 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.344 -0.613 . . . . 0.45000000000000001 109.344 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.3 126.63 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.223 -0.898 . . . . 0.56999999999999995 111.579 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.57 HD12 ' HG ' ' A' ' 88' ' ' LEU . 22.8 mt -106.87 -49.6 3.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.181 0.991 . . . . 0.45000000000000001 108.713 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.8 t -120.57 112.72 19.28 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.678 -1.601 . . . . 0.37 106.678 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.3 t0 -70.52 167.95 17.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.407 0.623 . . . . 1.1499999999999999 112.429 -166.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -83.52 88.24 7.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.973 -1.012 . . . . 4.6900000000000004 109.731 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.839 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.0 t -61.72 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.713 -0.676 . . . . 0.85999999999999999 112.094 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.88 -176.96 17.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.67000000000000004 111.695 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.0 t -71.69 127.06 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.975 0.387 . . . . 0.51000000000000001 110.536 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.544 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -150.51 63.67 0.4 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.805 -0.712 . . . . 0.81999999999999995 112.448 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.609 ' HB3' ' CE1' ' A' ' 118' ' ' HIS . 96.5 Cg_endo -93.05 145.36 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.062 2.508 . . . . 0.84999999999999998 113.3 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HD2' HG21 ' A' ' 115' ' ' THR . 32.1 Cg_exo -60.56 154.04 57.0 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.641 2.227 . . . . 0.87 111.351 169.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -68.43 126.46 29.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 1.8500000000000001 110.896 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.76 37.1 20.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 1.1799999999999999 113.221 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 75' ' ' SER . 28.6 p -84.32 -13.12 53.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.393 0.516 . . . . 0.96999999999999997 112.393 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 89.83 11.77 63.17 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.27 -0.967 . . . . 1.97 112.101 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 172' ' ' GLU . 3.8 mm? 72.37 100.79 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.593 0.819 . . . . 0.93999999999999995 111.446 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.609 ' CE1' ' HB3' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -96.26 164.75 12.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.043 -0.725 . . . . 2.23 109.043 175.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.609 ' HD2' HD21 ' A' ' 14' ' ' LEU . 2.7 ptt180 -127.29 106.22 9.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.015 0.436 . . . . 2.3100000000000001 112.061 -160.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 6.8 m-85 -73.66 110.79 8.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.848 -0.797 . . . . 0.78000000000000003 108.848 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.624 ' CG2' HD22 ' A' ' 14' ' ' LEU . 16.6 t -94.82 125.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.291 -0.413 . . . . 0.27000000000000002 110.373 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.78 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -87.99 118.6 27.66 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.091 -0.707 . . . . 1.99 109.091 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.98 119.03 33.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.578 -0.156 . . . . 0.38 110.578 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.631 HG12 HD13 ' A' ' 66' ' ' LEU . 1.7 m -105.61 126.24 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.157 -0.617 . . . . 0.31 109.824 173.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -108.09 124.21 49.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 5.1200000000000001 109.02 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' HG21 ' A' ' 164' ' ' VAL . 27.6 tt0 -94.38 96.98 9.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.991 0.424 . . . . 2.4100000000000001 110.137 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.648 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -73.24 163.97 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.77 -0.65 . . . . 1.3100000000000001 109.67 175.129 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.76 3.14 38.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.56 -0.746 . . . . 2.3999999999999999 110.04 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.427 ' H ' ' HB2' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -165.64 153.23 9.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 3.5099999999999998 111.355 -169.325 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HG3' HD12 ' A' ' 63' ' ' LEU . 32.0 Cg_exo -59.59 141.08 96.61 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.701 2.934 . . . . 1.21 112.094 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.527 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.6 mm? -68.43 151.56 46.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.90000000000000002 112.434 -170.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -115.9 64.23 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.403 -0.962 . . . . 2.8999999999999999 108.403 171.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 46.2 m -96.98 92.4 6.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.218 -0.901 . . . . 1.8999999999999999 110.194 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.85 40.66 0.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.963 . . . . 2.96 109.976 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -89.16 127.98 53.33 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.16 -0.927 . . . . 1.3899999999999999 110.091 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.1 127.85 18.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.225 2.617 . . . . 1.27 112.588 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.25 121.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.85999999999999999 110.11 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.4 mt -98.82 -13.95 19.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.393 -0.367 . . . . 1.6100000000000001 111.815 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m 55.65 -162.23 0.16 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.428 -0.351 . . . . 1.8799999999999999 110.669 -173.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.933 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 5.3 p30 -117.72 16.43 14.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.162 0.506 . . . . 0.75 111.072 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.564 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 23.2 mtt180 -107.71 137.27 46.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.205 -0.452 . . . . 3.3599999999999999 109.988 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.601 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 67.9 m 74.42 113.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.185 0.928 . . . . 0.94999999999999996 111.089 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.4 36.06 2.96 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.293 -0.867 . . . . 1.1200000000000001 112.296 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.01 -51.25 33.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.677 0.751 . . . . 2.6600000000000001 110.387 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -92.79 53.86 2.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.968 -1.015 . . . . 1.8700000000000001 110.437 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 146' ' ' ARG . 44.0 mtt85 -76.49 -83.91 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.644 -0.707 . . . . 4.7300000000000004 111.343 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -126.29 -154.74 8.73 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.655 -0.783 . . . . 0.65000000000000002 112.777 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 81.0 mttt 65.93 23.18 11.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.787 0.803 . . . . 1.0800000000000001 109.789 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -107.66 173.57 6.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.632 -1.167 . . . . 1.8899999999999999 108.876 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.35 119.94 37.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.549 -0.296 . . . . 1.29 111.187 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.922 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 18.4 m -66.06 -25.36 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.423 -0.584 . . . . 0.78000000000000003 109.423 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.02 83.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.194 -0.912 . . . . 0.67000000000000004 109.986 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 57.4 m -66.91 -36.74 82.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.426 -0.352 . . . . 0.77000000000000002 110.996 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.922 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 52.0 m-85 -61.7 -49.95 74.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.732 0.301 . . . . 0.92000000000000004 110.799 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 156' ' ' LYS . 5.9 ptp180 -69.15 -44.47 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.509 -0.314 . . . . 2.8900000000000001 111.199 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.478 ' N ' ' HG3' ' A' ' 155' ' ' ARG . 58.5 mtmt -63.04 -26.99 69.1 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.436 0.161 . . . . 0.96999999999999997 111.436 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -53.15 -50.57 64.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.52 0.512 . . . . 1.5800000000000001 110.721 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -104.09 9.92 36.18 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.18 -0.608 . . . . 5.4500000000000002 110.511 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 57.51 39.79 27.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.2 1.0 . . . . 2.4199999999999999 110.229 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.539 HD12 ' H ' ' A' ' 161' ' ' ARG . 1.7 tp -76.22 156.06 33.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.057 -1.429 . . . . 1.27 111.552 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.539 ' H ' HD12 ' A' ' 160' ' ' LEU . 9.0 mpt_? -96.87 -166.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 3.5899999999999999 111.856 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.04 158.08 77.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.76000000000000001 111.892 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -70.38 150.52 64.59 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.269 2.646 . . . . 0.53000000000000003 113.205 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 10.5 t -93.72 -31.47 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.448 -0.796 . . . . 0.44 109.861 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -147.44 146.45 29.56 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.997 -0.681 . . . . 0.27000000000000002 112.109 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.744 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -150.74 155.76 26.34 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.72 -1.127 . . . . 0.23999999999999999 111.655 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.463 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.2 t -169.73 133.2 1.23 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.897 -0.779 . . . . 0.34000000000000002 108.897 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.617 ' SG ' HD13 ' A' ' 12' ' ' LEU . 17.5 p -110.93 141.15 44.75 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.257 -0.577 . . . . 1.1100000000000001 110.609 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.601 ' CE2' HG11 ' A' ' 46' ' ' VAL . 25.9 p90 -127.32 123.16 35.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.419 -0.956 . . . . 0.80000000000000004 108.419 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 40' ' ' VAL . 1.1 pt20 -100.08 138.14 37.56 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.439 -0.504 . . . . 2.5299999999999998 110.672 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.414 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . . . -138.01 146.92 43.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.94 -0.573 . . . . 0.59999999999999998 109.976 -174.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.444 ' HB3' ' CD1' ' A' ' 117' ' ' LEU . 14.1 pt-20 -121.67 -168.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.34 . . . . 2.3799999999999999 111.34 -176.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.697 ' HA ' HG21 ' A' ' 177' ' ' VAL . 14.1 t90 -76.91 83.85 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 3.96 110.887 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.569 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.5 p-10 -74.41 -59.83 2.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 111.545 0.202 . . . . 1.53 111.545 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.578 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.9 t70 178.05 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.086 0.555 . . . . 1.26 110.185 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 44' ' ' THR . 72.4 m-85 -82.53 -2.27 53.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 2.2200000000000002 111.874 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.799 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 94.4 t -58.7 -54.04 60.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.473 -0.33 . . . . 0.5 110.49 172.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.799 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.5 Cg_exo -51.31 -36.1 56.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.635 2.223 . . . . 0.57999999999999996 112.445 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 29.2 mmmt -74.12 -24.71 59.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 2.1400000000000001 110.78 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 59.0 tp -69.44 -46.09 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.429 -0.582 . . . . 0.66000000000000003 109.429 172.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.445 -0.798 . . . . 1.8899999999999999 108.898 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 42.5 mm-40 -58.19 -50.21 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.803 -1.09 . . . . 1.53 110.941 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -64.17 -33.81 76.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.581 -0.736 . . . . 1.49 111.934 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 77.1 mt -62.47 0.03 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.691 0.626 . . . . 0.76000000000000001 112.691 -177.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.637 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.6 m -82.2 8.9 9.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.063 0.459 . . . . 1.05 110.133 171.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.6 54.95 9.12 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.974 -0.85 . . . . 1.1699999999999999 110.974 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.637 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.6 mmmt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.576 -0.726 . . . . 2.0 110.981 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 24' ' ' PRO . 3.7 t . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 121.799 0.809 . . . . 1.47 111.873 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -159.18 157.09 30.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.119 -1.067 . . . . 1.8100000000000001 108.119 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD12 ' OE1' ' A' ' 20' ' ' GLN . 2.6 mm? -76.95 22.6 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.048 -0.261 . . . . 0.69999999999999996 111.631 -174.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 m -67.64 -21.21 65.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 1.96 111.505 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.95 37.07 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 2.6600000000000001 110.192 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.445 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 9.0 p-90 -75.76 -29.03 58.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.42 0.526 . . . . 3.98 112.42 -174.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.441 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 70.8 p -156.18 20.27 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.63 111.017 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -82.6 -117.64 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.664 -0.575 . . . . 0.47999999999999998 111.664 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.6 Cg_endo -51.65 -42.08 58.24 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.225 2.616 . . . . 0.53000000000000003 110.279 167.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.728 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 10.2 mp -90.01 94.91 9.98 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.747 -1.115 . . . . 1.1699999999999999 110.965 172.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -74.2 61.45 0.86 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.351 0.596 . . . . 0.70999999999999996 110.211 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.79 HD22 HG21 ' A' ' 121' ' ' VAL . 40.5 mt -68.46 -13.41 62.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.45000000000000001 110.902 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.441 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 13.5 mm100 -73.57 -1.29 18.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.086 -0.506 . . . . 2.1200000000000001 111.675 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.57 -10.58 59.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.169 0.509 . . . . 1.9299999999999999 109.792 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.869 HG11 HG21 ' A' ' 69' ' ' THR . 58.7 t -92.83 -76.82 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.63 110.196 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.596 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 10.1 t70 -155.59 -178.25 7.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.396 -0.964 . . . . 2.9900000000000002 108.396 -175.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.74 152.99 41.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.047 0.451 . . . . 1.6000000000000001 110.766 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.484 ' OE1' HD12 ' A' ' 5' ' ' LEU . 8.2 tp-100 -78.12 129.88 74.14 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.072 -0.513 . . . . 3.5499999999999998 110.413 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.2 Cg_exo -58.22 159.39 19.08 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.965 2.443 . . . . 0.57999999999999996 113.001 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.9 ' HG3' ' HD2' ' A' ' 23' ' ' HIS . 20.3 pt20 -78.96 -8.18 58.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 1.3899999999999999 111.653 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.9 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 64.8 m-70 -148.17 157.63 42.49 Favored Pre-proline 0 CA--C 1.515 -0.385 0 C-N-CA 123.246 0.619 . . . . 1.45 109.78 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.722 ' HB2' HG12 ' A' ' 3' ' ' VAL . 5.6 Cg_endo -87.67 123.94 1.85 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.318 2.679 . . . . 0.40000000000000002 111.239 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.55 ' O ' HG11 ' A' ' 3' ' ' VAL . 20.6 tp -79.04 131.58 36.32 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.32 -0.237 . . . . 0.28999999999999998 111.353 -175.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -100.04 112.9 25.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.007 -0.368 . . . . 1.24 110.007 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 53' ' ' ILE . 22.1 t -116.59 142.03 32.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.264 -0.643 . . . . 0.46999999999999997 109.264 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -136.3 138.93 42.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.903 0.382 . . . . 0.31 110.117 -177.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.405 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 42.7 t80 -99.87 171.58 7.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.447 -0.575 . . . . 0.67000000000000004 109.447 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.65 62.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.55000000000000004 110.596 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.53 9.37 19.67 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.432 -0.804 . . . . 0.81000000000000005 112.504 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -142.34 -168.23 2.68 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 110.165 -0.309 . . . . 0.46999999999999997 110.165 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -161.36 155.23 22.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 110.768 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.763 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.8 t -107.77 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.919 -1.512 . . . . 0.39000000000000001 106.919 166.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.69 22.2 4.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.98999999999999999 109.833 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -150.64 130.24 13.08 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.051 -0.977 . . . . 2.5600000000000001 109.847 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.966 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.1 tt -71.96 112.92 8.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.342 -0.614 . . . . 0.40999999999999998 109.342 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.598 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 89.97 19.22 47.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.89 -0.671 . . . . 0.58999999999999997 112.256 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.763 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.6 147.26 27.08 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.275 -0.639 . . . . 0.34000000000000002 109.275 175.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.3 p -78.42 130.45 36.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.283 0.563 . . . . 0.55000000000000004 110.821 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.697 HD23 ' HD2' ' A' ' 169' ' ' TYR . 8.7 tp -129.99 149.74 51.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.545 -1.279 . . . . 0.45000000000000001 107.545 177.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 46' ' ' VAL . 3.9 p -95.86 150.74 37.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 C-N-CA 119.47 -0.892 . . . . 0.56000000000000005 112.665 -170.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.935 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 82.3 Cg_exo -51.68 -22.74 13.8 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.674 3.583 . . . . 0.68000000000000005 114.374 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.485 HG22 ' CE2' ' A' ' 176' ' ' TYR . 2.2 p -71.09 -53.77 13.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.672 0.748 . . . . 0.76000000000000001 109.816 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.65 -43.39 93.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.42 -1.264 . . . . 1.5900000000000001 111.544 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 43' ' ' PRO . 2.5 m -91.97 13.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 0.66000000000000003 111.903 -173.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -82.68 -28.71 30.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.162 -0.472 . . . . 0.79000000000000004 110.391 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 18.1 m120 -109.23 -169.86 1.56 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.62 -0.718 . . . . 1.9099999999999999 110.668 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -86.14 158.05 55.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.274 -0.639 . . . . 1.4299999999999999 109.274 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 122' ' ' TRP . 72.0 Cg_endo -81.64 160.43 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.112 1.875 . . . . 0.37 111.004 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -81.61 -21.23 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.141 0.496 . . . . 0.44 109.878 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.537 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 69.2 m -158.11 143.49 16.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.362 0.601 . . . . 0.38 112.551 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.905 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.92 161.0 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.717 -1.129 . . . . 0.29999999999999999 107.955 170.514 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.984 ' HA ' HD13 ' A' ' 58' ' ' LEU . 37.9 t 176.02 119.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.98 0.419 . . . . 0.34999999999999998 110.421 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 165' ' ' ALA . 50.0 p-90 -81.15 147.93 29.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.848 -1.538 . . . . 2.7200000000000002 106.848 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -66.38 91.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.859 0.837 . . . . 1.51 110.904 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.32 -1.31 3.68 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 114.864 -1.062 . . . . 0.80000000000000004 111.799 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.984 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.1 tt -54.68 128.58 33.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.83 0.452 . . . . 0.57999999999999996 110.511 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.804 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -77.8 -26.95 50.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.092 -0.504 . . . . 0.73999999999999999 111.67 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.715 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.5 p 70.59 13.33 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.396 1.078 . . . . 1.03 110.5 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -133.05 -25.66 0.65 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.83999999999999997 113.263 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.804 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 18.8 mtpt -84.22 156.74 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.968 0.384 . . . . 1.6699999999999999 110.084 -175.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.978 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.9 mt -92.29 128.16 38.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.72 -0.474 . . . . 0.57999999999999996 109.72 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.51 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 17.3 m-85 -121.37 150.78 40.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.601 0.239 . . . . 0.80000000000000004 110.523 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.933 HG23 HG12 ' A' ' 90' ' ' VAL . 2.7 m -97.16 105.91 18.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.638 -0.875 . . . . 0.35999999999999999 108.638 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.705 HD13 HG12 ' A' ' 124' ' ' VAL . 49.7 tp -109.23 113.01 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.823 -0.626 . . . . 0.58999999999999997 110.46 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.8 t -112.51 123.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.916 -0.584 . . . . 0.39000000000000001 110.754 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.4 mt -88.64 131.65 34.89 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.744 -0.836 . . . . 0.59999999999999998 108.744 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.869 HG21 HG11 ' A' ' 17' ' ' VAL . 8.8 t -139.05 148.91 43.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.867 0.365 . . . . 0.35999999999999999 111.302 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 27.7 t70 -127.45 94.56 37.89 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.758 -0.655 . . . . 1.9199999999999999 109.487 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.8 Cg_endo -50.79 -40.06 57.28 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 124.153 3.236 . . . . 1.25 113.799 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.8 m-20 -86.54 43.03 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.605 0.594 . . . . 1.29 112.605 -167.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.11 138.1 19.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.801 -0.181 . . . . 0.5 110.615 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.548 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 87.8 Cg_endo -83.28 -24.49 11.13 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.575 -1.427 . . . . 0.62 112.993 1.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.9 p -130.81 150.85 51.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.177 -0.465 . . . . 0.75 109.933 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.778 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 42.5 mtm105 -67.83 -23.55 65.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.934 -0.575 . . . . 2.8799999999999999 111.878 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.724 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.6 -10.68 39.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 1.3799999999999999 111.145 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.418 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 13.4 t70 -154.18 77.01 5.63 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.176 0.512 . . . . 1.3700000000000001 110.116 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 81.5 Cg_endo -79.42 86.37 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.532 2.154 . . . . 0.80000000000000004 112.363 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.6 mttm -70.67 -50.3 38.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.747 -1.115 . . . . 1.02 110.589 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.69 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.9 m-85 -82.05 20.93 0.94 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.453 -0.794 . . . . 1.1699999999999999 111.437 -172.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 8.0 tmm_? -71.97 123.58 23.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.888 -0.412 . . . . 2.9300000000000002 109.888 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 4.8 mp0 -100.08 135.95 40.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.895 0.379 . . . . 2.23 110.886 -0.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.402 ' HD1' ' O ' ' A' ' 146' ' ' ARG . 15.1 t90 -79.38 146.52 32.8 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.977 -1.12 . . . . 1.4299999999999999 107.977 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 47.0 p-80 -124.51 127.54 47.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 1.26 110.751 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.997 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 21.0 t-80 -70.66 -37.15 73.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.906 -1.043 . . . . 2.1400000000000001 110.219 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.622 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.4 p90 -168.36 173.61 7.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.01 -0.367 . . . . 1.51 110.01 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.654 ' HG ' HD12 ' A' ' 103' ' ' LEU . 18.4 tp -134.95 113.98 12.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.087 -0.506 . . . . 0.33000000000000002 109.776 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -122.71 132.64 70.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.671 -0.695 . . . . 0.31 110.627 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.933 HG12 HG23 ' A' ' 65' ' ' THR . 5.6 m -128.15 164.93 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.312 -0.996 . . . . 0.27000000000000002 108.312 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.978 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.0 m-20 59.16 18.64 6.66 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 123.526 0.516 . . . . 1.76 111.096 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.3 ttm -70.12 110.01 4.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.31 108.588 176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 19.4 ttmm -76.48 92.67 3.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.733 -1.121 . . . . 1.21 111.179 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.715 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.2 -123.13 6.75 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.853 -1.067 . . . . 0.29999999999999999 112.898 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.51 ' HA ' HD11 ' A' ' 53' ' ' ILE . 26.1 p-10 -113.41 22.27 14.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.332 -0.434 . . . . 1.04 111.024 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.63 106.84 18.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.489 0.661 . . . . 0.77000000000000002 109.919 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 97' ' ' ILE . 4.6 mm -57.01 -30.66 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.307 -1.315 . . . . 0.40999999999999998 111.274 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -82.87 -26.68 31.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 0.68000000000000005 111.655 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -84.82 14.9 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 1.26 111.616 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 109.35 3.62 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.787 -0.72 . . . . 0.34999999999999998 111.902 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.4 m -61.55 106.26 0.63 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.363 0.601 . . . . 0.45000000000000001 109.549 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 p -85.8 121.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.257 -0.883 . . . . 0.56999999999999995 111.414 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.654 HD12 ' HG ' ' A' ' 88' ' ' LEU . 18.4 mt -100.48 -43.13 6.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.012 0.911 . . . . 0.45000000000000001 109.231 173.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 t -123.98 110.39 14.74 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.159 -1.423 . . . . 0.37 107.159 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.895 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -59.31 164.44 3.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.851 -0.613 . . . . 1.1499999999999999 112.469 -171.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 11.0 p90 -80.76 98.27 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.414 -0.812 . . . . 4.6900000000000004 110.231 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.775 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.6 t -67.33 -53.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.85999999999999999 111.332 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.41 -162.53 12.87 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.551 -0.833 . . . . 0.67000000000000004 112.312 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.595 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 29.0 t -77.72 117.56 19.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.919 -0.4 . . . . 0.51000000000000001 109.919 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.646 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -143.47 57.04 0.55 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.699 -0.763 . . . . 0.81999999999999995 112.461 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.767 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 1.4 Cg_endo -87.01 131.25 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.245 2.63 . . . . 0.84999999999999998 112.346 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.65 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.7 Cg_exo -56.74 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.207 1.938 . . . . 0.87 110.53 171.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.17 112.87 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 1.8500000000000001 110.528 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.89 -6.38 19.97 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.842 -0.694 . . . . 1.1799999999999999 112.121 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.709 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 78.4 p -83.92 -20.95 32.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.772 0.32 . . . . 0.96999999999999997 111.318 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.414 ' HA3' ' HE ' ' A' ' 76' ' ' ARG . . . 107.77 -174.24 19.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.155 -0.545 . . . . 1.97 112.381 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 4.4 mm? -68.59 122.82 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.667 0.27 . . . . 0.93999999999999995 110.726 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.767 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.8 m-70 -98.45 121.55 40.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.129 0.49 . . . . 2.23 110.207 176.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.728 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 1.6 ptt180 -107.13 94.11 4.92 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.083 -0.962 . . . . 2.3100000000000001 111.461 -168.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.635 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 33.6 m-85 -75.15 111.06 10.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.195 -0.669 . . . . 0.78000000000000003 109.195 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.7 t -94.76 132.46 38.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.785 -0.643 . . . . 0.27000000000000002 110.09 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.767 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 31.0 m95 -89.4 121.89 32.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.303 -0.629 . . . . 1.99 109.303 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 76.1 mt -116.47 117.5 30.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.159 0.436 . . . . 0.38 110.221 175.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.705 HG12 HD13 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -115.07 137.89 47.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.263 -0.273 . . . . 0.31 110.263 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.83 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 47.9 t80 -130.6 137.63 49.74 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.301 -0.259 . . . . 5.1200000000000001 110.301 175.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.71 105.07 17.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.227 -0.657 . . . . 2.4100000000000001 109.227 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.479 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -76.98 175.1 9.87 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.428 0.632 . . . . 1.3100000000000001 111.29 -173.535 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.17 -29.27 66.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.103 -0.953 . . . . 2.3999999999999999 109.231 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 10.9 ptt-85 -159.66 164.59 19.95 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.511 -1.222 . . . . 3.5099999999999998 111.254 -172.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.546 ' HG3' HD12 ' A' ' 63' ' ' LEU . 31.4 Cg_exo -55.86 142.98 83.33 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.453 2.769 . . . . 1.21 112.916 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.506 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.0 mm? -68.97 154.43 42.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.567 0.951 . . . . 0.90000000000000002 113.567 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HE2' ' OD2' ' A' ' 134' ' ' ASP . 21.5 tptm -141.35 86.78 2.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.44 -1.255 . . . . 2.8999999999999999 108.0 167.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.74 -46.42 8.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.774 -0.648 . . . . 1.8999999999999999 112.678 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.451 ' OD2' ' HE2' ' A' ' 132' ' ' LYS . 61.7 m-20 57.32 47.55 16.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 2.96 110.7 -174.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -99.43 146.92 32.61 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.539 -0.755 . . . . 1.3899999999999999 109.973 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.73 106.19 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.133 2.555 . . . . 1.27 112.474 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.43 115.36 2.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.241 -0.436 . . . . 0.85999999999999999 110.659 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.0 mt -109.38 147.52 32.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 1.6100000000000001 110.203 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 58.0 m -109.32 36.64 2.85 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.572 -0.74 . . . . 1.8799999999999999 110.38 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.895 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 4.5 p30 57.05 4.56 0.18 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.62 1.168 . . . . 0.75 113.041 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.58 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 83.9 mtt180 -97.39 136.27 38.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 3.3599999999999999 110.819 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.67 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 53.7 m 77.46 118.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.582 -1.19 . . . . 0.94999999999999996 111.147 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -89.42 34.08 4.12 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.169 -0.923 . . . . 1.1200000000000001 112.426 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.68 -28.83 63.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.23 0.538 . . . . 2.6600000000000001 110.597 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -119.87 68.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 1.8700000000000001 110.852 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 78.5 mtt180 -75.52 -76.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.182 0.515 . . . . 4.7300000000000004 111.063 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.4 -148.05 5.97 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.664 -0.779 . . . . 0.65000000000000002 112.532 -174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.69 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 68.25 17.76 9.28 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.51 0.671 . . . . 1.0800000000000001 110.208 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -110.01 104.68 13.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.235 -0.893 . . . . 1.8899999999999999 109.303 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -54.82 120.65 7.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.635 -0.711 . . . . 1.29 112.2 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 17' ' ' VAL . 4.6 m -60.38 -30.1 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.611 -0.722 . . . . 0.78000000000000003 110.705 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.12 -35.47 80.38 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.67000000000000004 110.445 173.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 69.1 m -68.59 -33.96 74.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.77000000000000002 110.306 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.704 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 58.1 m-85 -67.39 -43.66 80.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.92000000000000004 110.44 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 21.4 ptt180 -69.53 -41.46 75.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.327 -0.397 . . . . 2.8900000000000001 110.354 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 53.6 mtmt -62.61 -27.31 69.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.564 0.221 . . . . 0.96999999999999997 111.416 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -53.61 -53.33 53.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.5800000000000001 110.909 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 5.2 t80 -107.89 20.96 18.09 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.439 -0.904 . . . . 5.4500000000000002 111.011 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.57 42.59 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.384 -0.825 . . . . 2.4199999999999999 111.69 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.83 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.2 mp -90.77 155.27 18.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.265 -0.88 . . . . 1.27 109.751 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.926 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -122.87 -153.85 0.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.454 -0.573 . . . . 3.5899999999999999 109.454 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.926 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -53.98 140.31 51.72 Favored Pre-proline 0 N--CA 1.456 -0.165 0 CA-C-O 121.168 0.509 . . . . 0.76000000000000001 111.114 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 7.0 Cg_exo -70.65 170.7 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.981 3.121 . . . . 0.53000000000000003 113.404 -167.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.887 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -92.8 -36.07 7.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 115.155 -0.929 . . . . 0.44 110.058 177.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -144.84 144.21 31.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.153 -0.619 . . . . 0.27000000000000002 111.962 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.767 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 150.8 23.1 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.813 -1.085 . . . . 0.23999999999999999 112.093 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.966 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -167.82 152.57 6.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.403 -0.962 . . . . 0.34000000000000002 108.403 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.805 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -122.03 142.72 50.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.985 0.421 . . . . 1.1100000000000001 111.091 -176.202 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.697 ' HD2' HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -130.0 109.97 11.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 0.80000000000000004 108.671 172.195 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 4.3 pt20 -100.09 133.89 43.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.381 0.511 . . . . 2.5299999999999998 112.381 -170.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.36 151.4 44.42 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.146 -0.934 . . . . 0.59999999999999998 109.625 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -113.27 -64.29 1.33 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.516 0.932 . . . . 2.3799999999999999 113.516 -173.039 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.596 ' HA ' HG21 ' A' ' 177' ' ' VAL . 12.8 t90 178.45 74.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.017 -0.364 . . . . 3.96 110.017 -176.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.935 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -72.48 -62.21 1.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.795 0.294 . . . . 1.53 111.795 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.563 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 32.0 t70 177.18 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.095 -0.502 . . . . 1.26 110.915 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.485 ' CE2' HG22 ' A' ' 44' ' ' THR . 11.2 m-30 -78.79 1.58 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.384 -0.371 . . . . 2.2200000000000002 111.667 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.77 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 72.7 t -67.57 -54.21 19.11 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.5 110.204 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.77 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.4 Cg_exo -51.4 -35.25 53.92 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.331 2.021 . . . . 0.57999999999999996 112.35 170.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.693 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 26.3 mmmt -72.79 -24.75 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.848 0.314 . . . . 2.1400000000000001 111.848 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.2 tp -70.49 -46.29 64.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.033 -0.729 . . . . 0.66000000000000003 109.033 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.32 -37.98 79.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.559 -0.746 . . . . 1.8899999999999999 109.331 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.693 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.0 mm-40 -56.18 -55.57 31.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.808 -1.087 . . . . 1.53 110.687 170.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.73 -33.35 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 1.49 112.333 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 76.4 mt -63.76 -1.14 1.23 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.4 0.519 . . . . 0.76000000000000001 112.4 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.482 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.8 m -78.13 -2.81 39.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.444 0.64 . . . . 1.05 109.534 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 77.51 44.13 13.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.197 -0.911 . . . . 1.1699999999999999 111.206 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.482 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.3 mmmt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.341 -0.837 . . . . 2.0 110.597 -174.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.694 HG12 ' HB2' ' A' ' 24' ' ' PRO . 3.5 t . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.549 0.69 . . . . 1.47 111.725 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.5 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 27.9 t70 -152.84 157.7 41.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.57 -0.9 . . . . 1.8100000000000001 108.57 176.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.497 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.8 mm? -79.18 28.85 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.667 0.27 . . . . 0.69999999999999996 110.804 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 4' ' ' ASP . 7.9 m -62.96 -29.12 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 1.96 111.18 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.486 ' HB2' HD12 ' A' ' 12' ' ' LEU . 90.5 mttt -124.51 50.84 1.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.158 -0.474 . . . . 2.6600000000000001 110.231 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.624 ' HD1' ' HG3' ' A' ' 15' ' ' GLN . 4.8 p90 -71.61 -38.65 70.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 3.98 111.453 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.714 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 73.9 p -142.9 24.14 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.63 111.451 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.516 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.25 -125.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.15 -0.78 . . . . 0.47999999999999998 111.15 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.7 Cg_endo -51.11 -40.62 59.62 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 123.326 2.684 . . . . 0.53000000000000003 110.049 168.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.731 HD11 ' HA3' ' A' ' 38' ' ' GLY . 36.4 mt -88.71 78.25 7.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.688 -1.142 . . . . 1.1699999999999999 109.319 169.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 1.2 m -73.72 64.1 0.91 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.547 0.689 . . . . 0.70999999999999996 109.907 176.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.648 ' HB3' HG21 ' A' ' 121' ' ' VAL . 12.0 mt -79.73 -30.18 40.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.551 -0.749 . . . . 0.45000000000000001 110.39 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 74.7 mm-40 -73.74 16.13 0.23 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.915 0.709 . . . . 2.1200000000000001 112.915 -175.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.7 mt-10 -82.63 -13.53 56.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.851 -0.796 . . . . 1.9299999999999999 108.851 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.934 HG12 HG21 ' A' ' 151' ' ' VAL . 49.0 t -85.36 -74.92 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 114.878 -1.055 . . . . 0.63 111.525 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -122.09 -157.91 0.75 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.178 -0.465 . . . . 2.9900000000000002 111.14 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -87.15 151.26 23.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 1.6000000000000001 110.445 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 40.7 mt-30 -67.12 126.15 92.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.934 -0.395 . . . . 3.5499999999999998 109.934 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.694 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -73.23 159.41 47.21 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.214 1.943 . . . . 0.57999999999999996 111.824 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.867 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 21.0 pt20 -74.62 -13.45 60.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.74 -0.664 . . . . 1.3899999999999999 111.491 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.795 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 3.1 m80 -160.93 164.57 18.8 Favored Pre-proline 0 CA--C 1.519 -0.249 0 CA-C-O 121.016 0.436 . . . . 1.45 110.83 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.694 ' HB2' HG12 ' A' ' 3' ' ' VAL . 3.6 Cg_endo -85.82 131.14 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.487 2.792 . . . . 0.40000000000000002 111.438 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.864 HD23 ' HB3' ' A' ' 122' ' ' TRP . 25.6 tp -80.52 143.58 33.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.691 0.282 . . . . 0.28999999999999998 111.457 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.494 ' H ' HD12 ' A' ' 25' ' ' LEU . 63.2 m-70 -110.07 123.98 50.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.753 -0.462 . . . . 1.24 109.753 172.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.005 HG13 HG22 ' A' ' 53' ' ' ILE . 14.8 t -130.37 134.93 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.072 -0.714 . . . . 0.46999999999999997 109.072 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -127.37 140.64 52.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.093 0.473 . . . . 0.31 110.435 -177.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -103.12 172.67 6.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.541 -0.54 . . . . 0.67000000000000004 109.541 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.8 67.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.492 0.663 . . . . 0.55000000000000004 110.678 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.43 4.33 33.02 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.316 -0.856 . . . . 0.81000000000000005 112.753 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.44 -168.54 3.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.46999999999999997 110.472 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -162.36 149.95 14.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.977 -0.556 . . . . 0.33000000000000002 109.905 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.757 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -105.29 60.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.167 -1.42 . . . . 0.39000000000000001 107.167 166.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.27 25.63 5.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.0 0.905 . . . . 0.98999999999999999 109.921 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 16.9 tt0 -148.31 128.0 13.34 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.833 -1.076 . . . . 2.5600000000000001 108.582 167.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -69.62 111.41 5.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 0.40999999999999998 109.546 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.731 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.88 16.47 59.63 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.83 -0.623 . . . . 0.58999999999999997 113.029 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.91 149.28 41.55 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.507 -0.553 . . . . 0.34000000000000002 109.507 174.037 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 14.4 p -75.54 132.77 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.55000000000000004 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.9 tp -131.92 170.59 14.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.93 -0.767 . . . . 0.45000000000000001 108.93 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.94 152.18 62.42 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.209 0.448 . . . . 0.56000000000000005 112.209 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 87.8 Cg_exo -50.93 -46.47 30.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.319 2.679 . . . . 0.68000000000000005 113.981 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.49 -31.65 64.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 0.76000000000000001 111.75 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -83.71 -10.73 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.815 -0.629 . . . . 1.5900000000000001 112.113 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 41' ' ' LEU . 30.4 m -131.72 30.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.547 0.689 . . . . 0.66000000000000003 111.007 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.73 -29.21 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.79000000000000004 110.854 -174.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -114.83 -173.21 2.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 1.9099999999999999 110.225 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.16 155.41 87.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.15 -0.315 . . . . 1.4299999999999999 110.15 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.44 155.66 28.43 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.799 1.666 . . . . 0.37 110.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -78.47 -23.31 46.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.238 -0.282 . . . . 0.44 110.238 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.438 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.1 m -159.79 147.23 16.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.38 112.083 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.005 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.57 170.21 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.283 -0.871 . . . . 0.29999999999999999 108.973 172.477 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.008 ' HA ' HD13 ' A' ' 58' ' ' LEU . 29.2 t 179.52 116.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.406 0.622 . . . . 0.34999999999999998 109.631 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.549 ' CG ' HG21 ' A' ' 124' ' ' VAL . 1.2 p90 -100.85 -171.2 1.96 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.226 -0.897 . . . . 2.7200000000000002 110.116 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' HG12 ' A' ' 164' ' ' VAL . 22.1 t0 -69.61 119.58 14.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.005 0.431 . . . . 1.51 111.004 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.24 34.48 54.87 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.742 -0.742 . . . . 0.80000000000000004 112.656 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.008 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.3 tt -67.53 125.41 26.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.919 -0.771 . . . . 0.57999999999999996 108.919 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.673 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 23.9 t70 -89.85 -12.79 38.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.73999999999999999 110.884 -173.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.683 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 54.3 m 62.13 20.81 11.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.948 -1.024 . . . . 1.03 109.558 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.571 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -153.86 -24.4 0.04 OUTLIER Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.866 -0.683 . . . . 0.83999999999999997 113.852 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.673 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 45.4 mtpt -77.0 156.82 31.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.661 0.731 . . . . 1.6699999999999999 109.904 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.706 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 37.2 mt -94.0 125.17 38.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.947 -0.76 . . . . 0.57999999999999996 108.947 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.9 m-85 -125.03 156.94 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.745 -0.382 . . . . 0.80000000000000004 110.002 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.633 HG23 HG12 ' A' ' 90' ' ' VAL . 46.7 m -98.07 110.98 23.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.547 . . . . 0.35999999999999999 109.522 175.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.543 HD13 ' CZ3' ' A' ' 55' ' ' TRP . 21.0 tp -107.48 109.75 21.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.177 -0.465 . . . . 0.58999999999999997 109.753 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.3 t -117.93 120.81 65.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.39000000000000001 111.112 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.875 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.5 mt -83.22 145.96 28.85 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.947 -0.76 . . . . 0.59999999999999998 108.947 168.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.752 HG21 HG11 ' A' ' 17' ' ' VAL . 10.5 t -146.46 145.69 30.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.683 0.278 . . . . 0.35999999999999999 110.936 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 28.2 t70 -125.59 98.37 34.68 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 1.9199999999999999 109.421 174.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.4 Cg_endo -50.32 -38.04 51.48 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 124.135 3.224 . . . . 1.25 114.216 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 71.3 m-20 -103.59 54.18 0.75 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.293 0.568 . . . . 1.29 111.928 -165.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . . . -104.64 137.12 19.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.5 109.864 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 63.6 Cg_endo -74.44 -30.27 6.08 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.682 -1.383 . . . . 0.62 113.268 1.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.619 ' HB3' HG22 ' A' ' 115' ' ' THR . 33.6 p -137.88 165.95 25.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.589 -0.278 . . . . 0.75 110.877 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.589 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 29.2 mtp180 -68.04 -36.61 80.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 2.8799999999999999 110.851 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.761 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -76.13 -12.68 60.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.53 . . . . 1.3799999999999999 111.711 -176.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.537 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.3 t70 -154.93 77.56 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 1.3700000000000001 110.258 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.92 97.54 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.608 2.205 . . . . 0.80000000000000004 112.885 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.577 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 26.4 mttm -85.52 -48.41 8.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.848 -1.069 . . . . 1.02 110.197 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 87.4 m-85 -79.99 14.16 1.94 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 111.55 -171.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.0 ttt85 -66.83 125.14 24.95 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.991 0.367 . . . . 2.9300000000000002 111.991 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.839 ' HG2' HG13 ' A' ' 17' ' ' VAL . 6.2 mp0 -95.45 140.15 30.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.671 0.388 . . . . 2.23 110.154 -5.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 14.4 t90 -86.4 91.15 8.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.529 . . . . 1.4299999999999999 110.106 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 38.4 p-80 -63.16 130.43 44.56 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.419 -0.586 . . . . 1.26 109.419 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.9 t60 -79.22 -31.88 43.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.898 -0.592 . . . . 2.1400000000000001 110.958 -173.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.626 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 28.7 p90 -168.42 178.56 4.79 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.198 -0.668 . . . . 1.51 109.198 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.47 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.1 tp -140.39 113.56 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.388 . . . . 0.33000000000000002 110.064 175.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.742 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.7 t -122.77 130.32 74.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.592 -0.731 . . . . 0.31 110.707 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.633 HG12 HG23 ' A' ' 65' ' ' THR . 13.4 m -133.62 165.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.986 -1.006 . . . . 0.27000000000000002 108.496 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.706 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.2 t30 63.54 13.37 7.17 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.024 -0.361 . . . . 1.76 110.024 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.742 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.9 ttm -67.67 101.98 1.12 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.603 -0.888 . . . . 0.31 108.603 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.8 ttmm -80.74 92.87 6.1 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.096 -1.411 . . . . 1.21 110.982 -170.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 78.13 -130.38 10.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.913 -1.039 . . . . 0.29999999999999999 112.668 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.548 ' HA ' HD11 ' A' ' 53' ' ' ILE . 25.8 p-10 -109.92 24.43 13.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.21 0.528 . . . . 1.04 110.735 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.98 107.11 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.835 -0.621 . . . . 0.77000000000000002 109.951 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 97' ' ' ILE . 4.5 mm -56.37 -32.71 36.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.573 -1.194 . . . . 0.40999999999999998 110.856 -177.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.3 m -73.01 -26.41 61.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.748 -0.66 . . . . 0.68000000000000005 112.002 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.7 m -78.44 -6.56 55.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 1.26 111.42 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.42 102.42 1.61 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.645 -0.788 . . . . 0.34999999999999998 112.11 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.1 m -68.46 107.99 3.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.464 0.65 . . . . 0.45000000000000001 109.655 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -79.57 119.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.892 -1.049 . . . . 0.56999999999999995 112.102 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.435 HD12 ' HG ' ' A' ' 88' ' ' LEU . 61.9 mt -95.14 -39.12 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.03 0.919 . . . . 0.45000000000000001 109.159 171.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.7 t -128.08 114.79 17.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.257 -1.386 . . . . 0.37 107.257 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.468 ' HA ' HG21 ' A' ' 102' ' ' VAL . 6.9 t0 -63.01 161.72 12.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.569 0.699 . . . . 1.1499999999999999 112.784 -168.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -91.09 93.91 9.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.984 -1.007 . . . . 4.6900000000000004 109.318 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.849 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 54.5 t -71.02 -46.18 68.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.167 0.508 . . . . 0.85999999999999999 111.89 -176.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.429 ' HA3' ' NZ ' ' A' ' 47' ' ' LYS . . . 115.86 -177.94 17.31 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.358 -0.925 . . . . 0.67000000000000004 112.294 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.8 t -64.13 122.37 16.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.551 0.176 . . . . 0.51000000000000001 111.336 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -142.72 63.87 0.5 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.051 -0.595 . . . . 0.81999999999999995 111.908 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.642 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 43.9 Cg_endo -97.7 121.9 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.504 2.803 . . . . 0.84999999999999998 112.673 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.491 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 50.7 Cg_exo -54.5 154.37 20.02 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.63 2.22 . . . . 0.87 111.736 173.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -72.02 131.04 42.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.433 . . . . 1.8500000000000001 111.146 -175.356 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.03 14.88 73.88 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.772 -0.649 . . . . 1.1799999999999999 113.163 175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 75' ' ' SER . 35.5 p -77.73 -15.37 59.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.672 0.619 . . . . 0.96999999999999997 112.672 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 103.92 13.02 28.46 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.141 -1.028 . . . . 1.97 112.823 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.0 mm? 76.94 105.08 0.07 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 124.604 0.826 . . . . 0.93999999999999995 111.142 177.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.65 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 5.0 m170 -66.66 121.23 14.93 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.383 -0.826 . . . . 2.23 110.044 175.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.663 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 13.1 ptp180 -116.3 80.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.832 0.825 . . . . 2.3100000000000001 110.364 -175.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 7.3 m-85 -63.69 120.26 11.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.289 -1.323 . . . . 0.78000000000000003 109.688 -177.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.699 HG22 ' HB3' ' A' ' 168' ' ' CYS . 24.6 t -97.94 131.68 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.107 -0.497 . . . . 0.27000000000000002 110.511 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.864 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.51 119.68 30.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.586 -0.733 . . . . 1.99 110.057 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -116.77 123.77 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.481 -0.192 . . . . 0.38 110.481 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.549 HG21 ' CG ' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -122.47 137.64 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.577 0.227 . . . . 0.31 111.098 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.999 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 17.7 t80 -136.66 140.65 42.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.085 -0.339 . . . . 5.1200000000000001 110.085 171.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.568 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 7.3 pt-20 -89.06 112.32 23.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.197 0.522 . . . . 2.4100000000000001 109.75 171.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.16 172.39 11.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.3100000000000001 110.013 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.98 -18.43 53.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.218 -0.901 . . . . 2.3999999999999999 109.408 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 11.4 ptt-85 -158.28 162.22 27.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.9 -1.046 . . . . 3.5099999999999998 111.67 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.557 ' HG3' HD12 ' A' ' 63' ' ' LEU . 26.0 Cg_exo -57.74 140.83 94.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.274 2.649 . . . . 1.21 111.575 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.626 ' HG ' HG11 ' A' ' 90' ' ' VAL . 3.2 mm? -64.57 143.72 57.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.156 0.503 . . . . 0.90000000000000002 111.817 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -129.32 61.46 1.54 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.232 -1.025 . . . . 2.8999999999999999 108.232 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.983 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 86.2 m -77.22 -55.42 5.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.253 -1.34 . . . . 1.8999999999999999 111.52 -172.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 60.85 35.02 19.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.292 0.568 . . . . 2.96 110.195 -172.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.983 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 59.0 mm-40 -77.62 137.23 63.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 108.616 -0.883 . . . . 1.3899999999999999 108.616 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.78 106.95 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.273 2.649 . . . . 1.27 112.728 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.1 mm -61.94 115.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.85999999999999999 110.546 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -104.43 149.28 25.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.267 0.556 . . . . 1.6100000000000001 110.352 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 162.39 13.53 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.416 -0.957 . . . . 1.8799999999999999 108.416 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.849 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 5.0 p30 -77.49 16.84 0.58 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.98 0.419 . . . . 0.75 111.45 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.696 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 54.0 mtt180 -104.8 136.75 43.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.663 -0.495 . . . . 3.3599999999999999 109.663 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.615 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 49.3 m 77.27 117.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.18 0.992 . . . . 0.94999999999999996 111.232 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -106.29 41.56 2.14 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.301 -0.863 . . . . 1.1200000000000001 112.794 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.25 -47.82 47.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 2.6600000000000001 109.78 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -97.63 54.35 1.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.633 -1.167 . . . . 1.8700000000000001 110.672 -173.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 76.9 mtt180 -69.71 -77.29 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 4.7300000000000004 111.017 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -120.74 -143.05 6.66 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.792 -0.718 . . . . 0.65000000000000002 112.478 -174.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 67.36 18.51 10.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.963 0.887 . . . . 1.0800000000000001 109.769 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.18 105.58 13.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.397 -1.274 . . . . 1.8899999999999999 108.223 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -59.99 129.88 43.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.189 -0.459 . . . . 1.29 111.81 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.934 HG21 HG12 ' A' ' 17' ' ' VAL . 17.1 m -64.39 -24.92 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.78000000000000003 110.306 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.526 ' HB1' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -44.41 90.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.431 -0.804 . . . . 0.67000000000000004 109.599 172.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -61.39 -40.53 94.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.77000000000000002 111.033 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 37.2 m-85 -58.3 -53.94 52.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.435 . . . . 0.92000000000000004 111.396 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -70.76 -45.42 64.79 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.98 -0.288 . . . . 2.8900000000000001 111.217 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.526 ' HE2' ' HB1' ' A' ' 152' ' ' ALA . 58.8 mtmt -62.17 -25.95 68.06 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.724 0.297 . . . . 0.96999999999999997 111.356 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.48 -52.76 58.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 1.5800000000000001 111.053 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 12.4 t80 -102.14 18.64 20.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.88 -0.728 . . . . 5.4500000000000002 110.541 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.66 38.38 5.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.354 -0.839 . . . . 2.4199999999999999 111.948 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.999 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.0 mp -88.76 148.78 23.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.875 -0.602 . . . . 1.27 109.703 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.503 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 13.2 tpt180 -117.91 -152.15 0.5 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.468 -0.333 . . . . 3.5899999999999999 110.126 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.503 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -56.0 143.97 60.27 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-O 120.989 0.424 . . . . 0.76000000000000001 111.278 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.694 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 4.8 Cg_exo -73.2 159.88 46.4 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.876 3.05 . . . . 0.53000000000000003 113.723 -170.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.867 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 11.8 t -81.34 -31.02 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.086 -0.961 . . . . 0.44 109.751 173.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.795 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -156.95 148.76 22.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.053 -0.659 . . . . 0.27000000000000002 111.855 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.69 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 147.04 17.64 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.23999999999999999 111.349 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.638 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.0 t -160.58 149.6 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.969 -0.752 . . . . 0.34000000000000002 108.969 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.699 ' HB3' HG22 ' A' ' 121' ' ' VAL . 15.4 p -126.9 149.02 49.99 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.894 -0.722 . . . . 1.1100000000000001 111.589 -175.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 46.2 p90 -129.08 127.61 41.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.887 -1.153 . . . . 0.80000000000000004 107.887 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 1.2 pt20 -104.65 133.01 50.21 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.045 -0.662 . . . . 2.5299999999999998 110.07 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -120.82 141.75 50.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.59999999999999998 112.199 -170.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.641 ' HG2' HD11 ' A' ' 117' ' ' LEU . 46.2 mt-10 -89.21 -173.1 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.809 -1.087 . . . . 2.3799999999999999 111.617 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.537 ' HA ' HG21 ' A' ' 177' ' ' VAL . 55.7 t90 -98.3 75.65 2.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.361 -0.977 . . . . 3.96 108.361 175.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -73.13 -57.19 4.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.386 -0.37 . . . . 1.53 111.906 -172.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.524 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.8 t70 179.44 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.118 0.567 . . . . 1.26 110.335 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -81.34 0.78 35.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 2.2200000000000002 112.113 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.825 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 93.2 t -67.88 -54.66 15.93 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.342 -0.244 . . . . 0.5 110.342 174.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.3 Cg_exo -53.83 -43.06 61.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.504 2.136 . . . . 0.57999999999999996 111.949 171.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.3 mmmm -70.83 -24.3 62.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 2.1400000000000001 111.561 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.641 HD11 HG12 ' A' ' 107' ' ' VAL . 61.9 tp -66.99 -47.85 70.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 0.66000000000000003 109.529 172.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.61 -37.76 87.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.66 -0.7 . . . . 1.8899999999999999 109.445 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.729 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.3 mm-40 -56.56 -44.87 81.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.932 -1.031 . . . . 1.53 110.842 172.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.96 -29.85 65.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.745 . . . . 1.49 111.497 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.615 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.2 mt -64.85 -8.66 16.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.934 0.346 . . . . 0.76000000000000001 111.934 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.513 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 66.6 m -73.91 -3.11 26.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 1.05 110.364 172.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.696 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.54 58.04 6.2 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.826 -0.91 . . . . 1.1699999999999999 110.826 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.9 mmmt . . . . . 0 C--O 1.241 0.654 0 CA-C-O 118.651 -0.69 . . . . 2.0 111.304 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.275 0.084 . . . . 5.04 111.043 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.27 160.36 39.07 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.562 2.175 . . . . 2.1299999999999999 112.386 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 3.7 p -106.12 125.9 61.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.153 -0.931 . . . . 1.47 109.673 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.3 155.92 34.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.784 -0.644 . . . . 1.8100000000000001 109.953 -168.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.491 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -72.67 2.21 6.95 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 112.331 0.493 . . . . 0.69999999999999996 112.331 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 m -55.91 -21.85 22.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.77 0.319 . . . . 1.96 111.755 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -101.13 27.6 5.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.563 -0.289 . . . . 2.6600000000000001 110.701 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.576 ' HE3' ' HB2' ' A' ' 20' ' ' GLN . 5.1 p-90 -70.64 -28.44 64.81 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.639 0.607 . . . . 3.98 112.639 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -144.96 14.59 1.51 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.713 -0.395 . . . . 0.63 111.139 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.63 -115.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.483 -0.647 . . . . 0.47999999999999998 111.483 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.1 Cg_endo -51.28 -46.2 32.69 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.356 2.704 . . . . 0.53000000000000003 110.925 167.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.707 HD11 ' HA3' ' A' ' 38' ' ' GLY . 11.5 mt -88.97 103.44 16.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.15 -0.932 . . . . 1.1699999999999999 110.125 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.18 65.35 4.33 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.257 0.551 . . . . 0.70999999999999996 110.546 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.816 HD22 HG21 ' A' ' 121' ' ' VAL . 15.5 mt -76.16 -15.05 60.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.543 . . . . 0.45000000000000001 110.45 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -66.73 -8.46 28.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 2.1200000000000001 111.308 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.468 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 9.4 mt-10 -81.85 -7.62 59.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.235 -0.439 . . . . 1.9299999999999999 110.107 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.733 HG11 HG21 ' A' ' 69' ' ' THR . 53.3 t -124.88 -61.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 0.63 111.389 -175.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -125.2 169.34 12.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.678 -0.409 . . . . 2.9900000000000002 110.404 -172.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -90.5 25.37 2.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 1.6000000000000001 111.799 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.576 ' HB2' ' HE3' ' A' ' 8' ' ' TRP . 1.6 tt0 67.05 120.48 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 O-C-N 124.151 0.907 . . . . 3.5499999999999998 110.986 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 19.2 Cg_exo -65.17 158.37 52.46 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.403 2.069 . . . . 0.57999999999999996 112.124 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.857 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.4 pt20 -73.42 -16.19 61.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 1.3899999999999999 111.034 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.774 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 21.2 m80 -149.36 156.43 39.59 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.691 -0.686 . . . . 1.45 109.565 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 6.3 Cg_endo -87.28 126.66 2.35 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.891 2.394 . . . . 0.40000000000000002 110.97 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.2 tp -75.92 140.44 42.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.791 0.329 . . . . 0.28999999999999998 110.916 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -106.04 119.74 39.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 1.24 109.625 173.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.882 HG13 HG22 ' A' ' 53' ' ' ILE . 21.8 t -126.17 138.19 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.995 -0.742 . . . . 0.46999999999999997 108.995 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -136.74 136.95 39.4 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.026 0.441 . . . . 0.31 110.655 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 60.9 t80 -99.65 169.3 9.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.315 -0.624 . . . . 0.67000000000000004 109.315 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.86 65.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.471 0.653 . . . . 0.55000000000000004 110.488 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.651 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -116.03 20.06 13.19 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.028 -0.987 . . . . 0.81000000000000005 112.673 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 45' ' ' GLN . . . -154.36 -170.5 3.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.845 0.355 . . . . 0.46999999999999997 110.416 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.92 159.76 24.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.33000000000000002 109.82 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.722 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.1 t -122.4 63.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.253 -1.388 . . . . 0.39000000000000001 107.253 166.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.4 t70 -100.27 19.89 15.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.154 -0.93 . . . . 0.98999999999999999 109.808 -173.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 44.5 mt-10 -144.05 131.1 20.54 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.09 -0.959 . . . . 2.5600000000000001 108.593 172.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -74.66 111.33 9.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.416 0.627 . . . . 0.40999999999999998 110.272 -172.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.707 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 80.53 21.27 64.6 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.295 -0.866 . . . . 0.58999999999999997 111.89 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.722 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.26 149.76 44.23 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.474 -0.565 . . . . 0.34000000000000002 109.474 175.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.96 127.81 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.267 0.555 . . . . 0.55000000000000004 110.54 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.597 HD22 HG22 ' A' ' 34' ' ' VAL . 8.9 tp -131.18 169.12 16.36 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.634 -0.876 . . . . 0.45000000000000001 108.634 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.82 151.81 58.22 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 120.582 -0.447 . . . . 0.56000000000000005 111.535 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.639 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 63.3 Cg_exo -53.64 -39.6 82.48 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.017 2.478 . . . . 0.68000000000000005 112.075 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -35.24 61.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.109 -0.496 . . . . 0.76000000000000001 111.404 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 44.9 mt-30 -82.79 -23.14 33.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 1.5900000000000001 112.125 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.569 ' HB ' ' OH ' ' A' ' 106' ' ' TYR . 30.0 m -119.88 30.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.195 0.521 . . . . 0.66000000000000003 112.169 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 6.31 21.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.955 0.407 . . . . 0.79000000000000004 111.089 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 36.4 m-20 -148.59 172.88 13.81 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.509 -0.552 . . . . 1.9099999999999999 109.509 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -62.77 149.4 89.59 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 110.017 -0.364 . . . . 1.4299999999999999 110.017 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.64 145.7 23.4 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.963 1.775 . . . . 0.37 110.266 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -18.7 62.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.491 -0.322 . . . . 0.44 110.728 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.2 m -159.66 144.7 15.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.872 0.694 . . . . 0.38 112.872 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.882 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.39 164.79 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.705 -1.134 . . . . 0.29999999999999999 108.041 170.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.076 ' HA ' HD13 ' A' ' 58' ' ' LEU . 28.9 t 176.17 122.26 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.764 -0.458 . . . . 0.34999999999999998 109.764 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.7 p-90 -81.0 166.67 20.59 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.757 -0.831 . . . . 2.7200000000000002 108.757 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.425 ' HB3' ' CG ' ' A' ' 23' ' ' HIS . 17.1 t70 -65.64 83.06 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 1.51 111.081 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.92 31.48 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.655 -0.702 . . . . 0.80000000000000004 112.319 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.076 HD13 ' HA ' ' A' ' 54' ' ' SER . 8.4 tt -66.33 129.05 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.008 0.432 . . . . 0.57999999999999996 111.062 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.797 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.5 t70 -77.75 -29.92 51.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.854 -0.612 . . . . 0.73999999999999999 112.078 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.693 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 74.8 m 76.76 -6.12 2.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.096 -0.956 . . . . 1.03 110.926 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.22 6.64 14.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.155 -0.545 . . . . 0.83999999999999997 112.39 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.797 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.8 mtpt -100.69 152.53 20.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.015 0.436 . . . . 1.6699999999999999 111.093 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.774 HD21 ' HE2' ' A' ' 93' ' ' LYS . 44.2 mt -97.25 130.98 44.39 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.557 -0.905 . . . . 0.57999999999999996 108.557 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.722 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.2 OUTLIER -130.2 163.94 25.6 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.636 -0.505 . . . . 0.80000000000000004 109.636 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.609 HG23 HG12 ' A' ' 90' ' ' VAL . 75.2 m -102.32 104.82 15.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.459 -0.571 . . . . 0.35999999999999999 109.459 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.745 HD13 HG12 ' A' ' 124' ' ' VAL . 43.7 tp -102.49 115.33 30.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.124 0.488 . . . . 0.58999999999999997 110.527 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 88' ' ' LEU . 23.3 t -120.88 129.04 76.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.713 -0.676 . . . . 0.39000000000000001 111.06 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.889 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.3 mt -83.37 136.76 34.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 0.59999999999999998 108.478 167.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.733 HG21 HG11 ' A' ' 17' ' ' VAL . 15.1 t -140.27 163.69 32.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.205 -0.294 . . . . 0.35999999999999999 110.205 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 17.7 t70 -155.95 103.27 2.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.304 0.573 . . . . 1.9199999999999999 110.858 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.724 ' HD3' HG21 ' A' ' 17' ' ' VAL . 12.4 Cg_endo -56.98 -34.89 98.45 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.65 2.9 . . . . 1.25 114.169 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.56 38.87 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.986 0.365 . . . . 1.29 111.986 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' CB ' ' HB2' ' A' ' 84' ' ' TRP . . . -104.68 127.62 28.53 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 111.488 0.181 . . . . 0.5 111.488 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 92.9 Cg_endo -85.12 -24.03 10.8 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.435 -1.485 . . . . 0.62 112.859 -0.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.571 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.9 p -135.4 154.85 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.032 -0.531 . . . . 0.75 110.09 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -72.15 -24.6 61.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.388 -0.369 . . . . 2.8799999999999999 111.134 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 3.2 ptpt -72.03 -21.86 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 1.3799999999999999 110.535 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.22 86.88 1.01 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.306 -0.861 . . . . 1.3700000000000001 109.24 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -86.38 86.65 0.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.509 2.139 . . . . 0.80000000000000004 112.507 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 22.2 mttm -70.98 -53.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.936 -1.483 . . . . 1.02 111.689 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.81 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 85.2 m-85 -78.28 12.07 2.08 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.894 -0.594 . . . . 1.1699999999999999 111.027 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 24.2 ttt180 -73.15 125.42 27.67 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.8 0.44 . . . . 2.9300000000000002 110.267 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.512 ' OE1' ' HA ' ' A' ' 150' ' ' LYS . 23.1 mt-10 -94.84 134.33 37.59 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.846 0.458 . . . . 2.23 110.457 2.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.761 ' HE1' ' HB2' ' A' ' 146' ' ' ARG . 4.8 t90 -89.34 91.12 8.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.939 -0.393 . . . . 1.4299999999999999 109.939 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 12.5 p80 -74.57 109.52 8.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.778 -0.823 . . . . 1.26 108.778 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.41 -8.47 54.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.803 -0.635 . . . . 2.1400000000000001 112.233 -168.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.889 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 30.3 t80 -166.29 142.93 5.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.06 -0.348 . . . . 1.51 110.06 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.675 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.6 tp -142.77 114.65 8.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.981 0.419 . . . . 0.33000000000000002 110.623 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.555 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -132.57 134.93 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.31 110.74 176.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.709 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 15.0 m -129.03 158.01 41.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.138 -1.06 . . . . 0.27000000000000002 108.138 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.689 ' OD1' ' HB3' ' A' ' 130' ' ' PRO . 6.1 t30 63.78 19.69 11.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.023 0.44 . . . . 1.76 109.925 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.555 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.0 ttm -67.4 106.9 2.24 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.781 -0.822 . . . . 0.31 108.781 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.774 ' HE2' HD21 ' A' ' 63' ' ' LEU . 13.2 ttmt -83.55 89.68 7.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.994 -1.003 . . . . 1.21 111.077 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 83.98 -126.26 7.49 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.636 -1.166 . . . . 0.29999999999999999 113.208 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.478 ' HA ' HD11 ' A' ' 53' ' ' ILE . 29.6 p30 -117.32 27.62 8.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.315 -0.442 . . . . 1.04 110.88 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -97.12 112.46 24.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.321 0.582 . . . . 0.77000000000000002 109.658 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 53' ' ' ILE . 5.1 mm -58.53 -26.44 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.408 -1.269 . . . . 0.40999999999999998 111.349 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 m -87.6 -31.34 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.117 -0.492 . . . . 0.68000000000000005 111.718 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.1 m -80.29 19.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.266 0.469 . . . . 1.26 112.266 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 92' ' ' MET . . . -102.61 114.11 4.79 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 111.189 -0.764 . . . . 0.34999999999999998 111.189 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 84.9 m -58.54 107.0 0.45 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.67 . . . . 0.45000000000000001 109.776 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.94 116.42 29.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.084 . . . . 0.56999999999999995 112.333 -172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.675 HD12 ' HG ' ' A' ' 88' ' ' LEU . 9.3 mt -98.61 -51.48 3.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.974 0.893 . . . . 0.45000000000000001 108.859 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.1 t -118.61 102.23 8.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.394 -1.275 . . . . 0.37 107.747 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HB3' ' N ' ' A' ' 140' ' ' ASN . 38.2 t0 -65.24 157.63 28.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.547 -0.751 . . . . 1.1499999999999999 112.323 -169.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.569 ' OH ' ' HB ' ' A' ' 46' ' ' VAL . 85.7 t80 -74.19 107.52 6.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.595 -0.729 . . . . 4.6900000000000004 109.172 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.4 t -84.69 -26.91 6.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.566 -0.743 . . . . 0.85999999999999999 112.242 -172.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.23 -174.41 19.7 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 111.13 -0.788 . . . . 0.67000000000000004 111.13 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.639 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.7 t -78.21 134.47 37.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.429 0.614 . . . . 0.51000000000000001 109.811 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.655 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -160.0 66.06 0.27 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.367 -0.444 . . . . 0.81999999999999995 112.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.898 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 46.4 Cg_endo -99.15 149.52 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.89 3.06 . . . . 0.84999999999999998 113.78 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.594 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 26.6 Cg_exo -64.07 143.32 84.24 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.074 2.516 . . . . 0.87 112.443 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 121.19 17.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 1.8500000000000001 110.823 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.46 15.11 30.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.86 -0.686 . . . . 1.1799999999999999 112.367 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.594 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 72.1 p -96.68 -1.19 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.947 0.403 . . . . 0.96999999999999997 111.028 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.36 -161.89 27.85 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.042 -0.823 . . . . 1.97 111.042 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.6 mm? -79.95 99.06 7.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.36 0.6 . . . . 0.93999999999999995 109.567 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -72.1 120.54 17.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.883 -1.053 . . . . 2.23 109.09 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.849 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp85 -121.96 99.76 6.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.914 0.709 . . . . 2.3100000000000001 112.914 -165.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.608 ' HB3' HD22 ' A' ' 68' ' ' LEU . 65.9 m-85 -82.09 129.39 34.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.444 -0.576 . . . . 0.78000000000000003 109.444 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.961 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.5 t -102.33 133.56 45.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.925 -0.579 . . . . 0.27000000000000002 109.719 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.694 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 67.2 m95 -88.32 119.59 28.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.754 -0.832 . . . . 1.99 108.754 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.26 118.77 32.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 117.797 0.271 . . . . 0.38 110.815 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.745 HG12 HD13 ' A' ' 66' ' ' LEU . 1.9 m -102.36 133.22 46.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.069 -0.652 . . . . 0.31 109.262 172.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 92.2 m-85 -106.84 155.68 19.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.875 0.369 . . . . 5.1200000000000001 111.084 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.596 ' HB2' HG22 ' A' ' 164' ' ' VAL . 12.3 tp10 -101.32 119.95 39.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.304 -0.862 . . . . 2.4100000000000001 110.833 -176.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.722 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -133.46 150.06 51.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.461 -0.791 . . . . 1.3100000000000001 109.991 174.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 129' ' ' ARG . 1.6 p30 -83.4 -12.47 56.42 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.183 -0.917 . . . . 2.3999999999999999 111.452 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.505 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . 65.9 mtp180 -135.9 163.06 53.08 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 3.5099999999999998 111.837 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.689 ' HB3' ' OD1' ' A' ' 91' ' ' ASN . 19.3 Cg_exo -71.85 24.71 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.806 1 C-N-CA 125.61 4.207 . . . . 1.21 115.833 -170.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.709 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? 71.99 -178.76 0.21 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.685 0.755 . . . . 0.90000000000000002 112.909 172.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -165.72 79.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.221 -1.354 . . . . 2.8999999999999999 108.896 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.415 ' HB2' HD11 ' A' ' 103' ' ' LEU . 63.0 m -101.94 115.89 31.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.705 . . . . 1.8999999999999999 110.33 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.44 19.52 8.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.534 -0.757 . . . . 2.96 110.485 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -66.08 125.24 89.76 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.562 -0.744 . . . . 1.3899999999999999 110.466 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.46 129.02 21.97 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.239 2.626 . . . . 1.27 112.713 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.31 116.66 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.43 . . . . 0.85999999999999999 110.34 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.9 mt -106.19 2.48 26.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.339 0.496 . . . . 1.6100000000000001 112.339 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.0 p 52.04 -157.66 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.536 0.522 . . . . 1.8799999999999999 110.009 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.674 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 5.2 p30 -98.01 -6.03 32.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.256 -0.646 . . . . 0.75 109.256 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.617 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 12.4 mtt180 -84.99 141.47 30.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.241 -0.436 . . . . 3.3599999999999999 110.352 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.572 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 30.5 m 72.66 125.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.219 0.949 . . . . 0.94999999999999996 111.103 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.501 ' HA2' ' CD ' ' A' ' 146' ' ' ARG . . . -107.53 -5.97 33.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.437 -0.801 . . . . 1.1200000000000001 113.006 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.94 -54.15 49.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.324 0.583 . . . . 2.6600000000000001 112.542 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.89 7.3 31.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.506 -0.77 . . . . 1.8700000000000001 111.672 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.761 ' HB2' ' HE1' ' A' ' 84' ' ' TRP . 28.1 mtp85 -88.84 -16.15 32.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.084 0.469 . . . . 4.7300000000000004 110.742 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -112.07 173.08 15.22 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.489 -0.863 . . . . 0.65000000000000002 112.485 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.4 mttt 69.61 36.55 2.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.841 0.829 . . . . 1.0800000000000001 110.836 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -123.09 172.4 8.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.809 -1.087 . . . . 1.8899999999999999 109.261 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.512 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 13.0 mmmm -117.26 133.0 56.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 1.29 111.932 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.755 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.6 m -67.35 -26.27 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.664 -0.698 . . . . 0.78000000000000003 110.005 173.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.36 -38.33 90.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.67000000000000004 109.627 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 m -63.78 -34.53 78.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.656 -0.702 . . . . 0.77000000000000002 110.462 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.755 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 59.7 m-85 -71.56 -47.5 54.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.92000000000000004 111.523 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 152' ' ' ALA . 6.9 ptm180 -66.9 -39.92 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.647 0.26 . . . . 2.8900000000000001 110.571 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -71.95 -25.78 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.607 -0.269 . . . . 0.96999999999999997 111.185 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 43.6 tptt -53.91 -52.92 59.02 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.355 -0.384 . . . . 1.5800000000000001 111.309 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.581 ' HD2' HD11 ' A' ' 160' ' ' LEU . 16.6 t80 -111.25 10.61 21.74 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.788 -0.765 . . . . 5.4500000000000002 111.322 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.8 39.34 4.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.035 -0.53 . . . . 2.4199999999999999 112.395 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 127' ' ' GLN . 0.2 OUTLIER -80.95 125.11 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.236 -0.653 . . . . 1.27 109.236 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.401 ' HB3' ' H ' ' A' ' 162' ' ' ALA . 8.0 tpt180 -60.32 -85.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 3.5899999999999999 111.874 -168.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 161' ' ' ARG . . . -135.66 160.9 65.9 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.721 -0.474 . . . . 0.76000000000000001 109.721 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.455 ' HB2' ' CA ' ' A' ' 21' ' ' PRO . 37.0 Cg_exo -58.44 142.24 97.74 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.68 2.254 . . . . 0.53000000000000003 112.748 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.857 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.6 t -88.42 -36.06 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 109.385 -0.598 . . . . 0.44 109.385 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.774 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.68 143.45 25.49 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.667 -0.697 . . . . 0.27000000000000002 111.232 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.9 145.59 14.81 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.055 -0.975 . . . . 0.23999999999999999 111.587 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.484 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 14.3 t -158.03 133.61 8.98 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.584 -0.525 . . . . 0.34000000000000002 109.584 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.961 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -107.24 141.9 37.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.213 0.53 . . . . 1.1100000000000001 111.418 -175.126 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 30.5 p90 -124.23 117.92 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.748 -1.204 . . . . 0.80000000000000004 107.748 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 2.8 pt20 -101.73 132.96 47.16 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.725 -0.79 . . . . 2.5299999999999998 111.103 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.427 ' HB1' ' HD3' ' A' ' 43' ' ' PRO . . . -149.91 145.89 26.76 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.561 -1.199 . . . . 0.59999999999999998 108.687 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.898 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 13.8 pt-20 -131.58 -160.3 1.03 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.697 -0.401 . . . . 2.3799999999999999 111.021 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.731 ' HA ' HG21 ' A' ' 177' ' ' VAL . 24.3 t90 -64.89 85.05 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.866 0.467 . . . . 3.96 111.38 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.611 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 8.5 p-10 -74.47 -59.12 2.87 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.361 -0.212 . . . . 1.53 110.757 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.5 t70 173.43 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.808 0.843 . . . . 1.26 109.897 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -81.97 -9.08 59.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 2.2200000000000002 111.64 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.743 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 69.2 t -54.67 -53.24 62.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 0.5 111.561 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.743 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.3 Cg_exo -49.7 -35.26 37.98 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.888 2.392 . . . . 0.57999999999999996 112.891 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 38.1 mmtm -74.47 -23.79 58.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.962 0.356 . . . . 2.1400000000000001 111.962 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.655 HD23 ' HA3' ' A' ' 110' ' ' GLY . 28.4 tp -70.76 -44.3 67.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.916 -0.772 . . . . 0.66000000000000003 108.916 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.03 -34.52 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.762 -0.654 . . . . 1.8899999999999999 109.242 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.686 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.5 mm-40 -56.48 -42.37 78.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.931 -1.031 . . . . 1.53 110.89 172.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -77.82 -38.0 47.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.572 -0.74 . . . . 1.49 112.41 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 21.5 mt -63.29 0.24 0.7 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 0.76000000000000001 113.479 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.407 ' HB2' ' CE ' ' A' ' 187' ' ' LYS . 12.8 m -67.58 -19.55 65.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.086 -0.709 . . . . 1.05 109.086 170.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 104.14 44.17 1.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.586 -1.006 . . . . 1.1699999999999999 110.586 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.407 ' CE ' ' HB2' ' A' ' 185' ' ' SER . 22.9 mmtp . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.563 -0.732 . . . . 2.0 109.832 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.214 0.054 . . . . 5.04 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.67 98.39 0.24 Allowed 'Trans proline' 0 CA--C 1.515 -0.447 0 C-N-CA 122.874 2.383 . . . . 2.1299999999999999 112.131 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 36' ' ' GLU . 16.5 t 65.4 113.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.572 -1.195 . . . . 1.47 110.522 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 6' ' ' SER . 20.1 t70 -148.98 157.71 43.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.35 -0.841 . . . . 1.8100000000000001 109.445 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.415 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.7 mm? -74.96 19.28 0.15 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 111.53 0.196 . . . . 0.69999999999999996 111.53 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 4' ' ' ASP . 27.5 t -68.67 -19.92 64.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 1.96 110.364 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.877 ' HB3' HD12 ' A' ' 12' ' ' LEU . 90.9 mttt -113.82 30.67 7.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.727 -0.67 . . . . 2.6600000000000001 110.597 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.625 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -72.88 -33.94 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.312 -0.404 . . . . 3.98 112.041 -173.252 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.798 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 36.5 p -150.21 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.673 -0.411 . . . . 0.63 111.894 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -79.73 -126.58 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.456 -0.878 . . . . 0.47999999999999998 110.946 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.9 Cg_endo -51.87 -36.43 63.38 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.219 2.613 . . . . 0.53000000000000003 110.214 166.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.877 HD12 ' HB3' ' A' ' 7' ' ' LYS . 40.7 mt -87.74 81.83 7.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.772 -1.103 . . . . 1.1699999999999999 109.282 170.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -74.73 63.13 1.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.474 0.654 . . . . 0.70999999999999996 110.703 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 ' CG2' ' A' ' 121' ' ' VAL . 33.8 mt -78.91 -21.62 47.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.548 -0.751 . . . . 0.45000000000000001 110.617 -176.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.798 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -73.18 6.88 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.587 -0.733 . . . . 2.1200000000000001 110.647 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -79.45 -22.51 44.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.428 0.633 . . . . 1.9299999999999999 110.091 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.907 HG11 HG21 ' A' ' 69' ' ' THR . 3.0 t -86.03 -65.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.63 110.669 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.88 -178.11 5.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.491 -0.484 . . . . 2.9900000000000002 111.095 -176.046 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -62.1 179.1 0.31 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.766 0.826 . . . . 1.6000000000000001 112.125 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG2' ' HD1' ' A' ' 8' ' ' TRP . 27.0 mt-30 -90.74 128.6 47.68 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.126 -0.488 . . . . 3.5499999999999998 110.128 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.603 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 10.1 Cg_exo -70.41 159.34 53.26 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.264 1.976 . . . . 0.57999999999999996 112.292 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.898 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 8.5 pt20 -77.48 -15.62 59.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.754 -0.657 . . . . 1.3899999999999999 111.153 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.776 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.8 m80 -153.02 159.73 31.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 1.45 110.089 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.8 Cg_endo -86.16 130.85 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.329 2.686 . . . . 0.40000000000000002 110.919 174.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 124' ' ' VAL . 29.9 tp -79.84 143.45 34.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.646 0.26 . . . . 0.28999999999999998 110.897 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -114.94 110.11 19.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 1.24 110.236 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 53' ' ' ILE . 17.0 t -114.71 146.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.546 -0.538 . . . . 0.46999999999999997 109.546 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.54 144.57 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.335 0.254 . . . . 0.31 110.819 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.478 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 36.3 t80 -110.41 173.99 6.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.268 -0.642 . . . . 0.67000000000000004 109.268 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.06 -52.88 63.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.451 0.643 . . . . 0.55000000000000004 110.398 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.24 -6.56 44.85 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.237 -0.892 . . . . 0.81000000000000005 112.724 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.02 -171.37 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.46999999999999997 110.831 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.68 154.7 16.23 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 109.999 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 88.2 t -101.56 63.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.548 -1.649 . . . . 0.39000000000000001 106.548 163.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.24 18.69 2.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.036 -1.438 . . . . 0.98999999999999999 110.163 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.555 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.3 mm-40 -159.7 142.12 13.57 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.457 -0.792 . . . . 2.5600000000000001 109.881 173.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -76.48 111.59 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.644 -0.873 . . . . 0.40999999999999998 108.644 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.715 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 86.7 20.93 52.79 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.666 -0.778 . . . . 0.58999999999999997 112.424 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.67 152.18 30.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.286 -0.635 . . . . 0.34000000000000002 109.286 172.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.6 p -81.78 136.77 22.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.182 0.515 . . . . 0.55000000000000004 110.975 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 41' ' ' LEU . 7.0 tp -131.11 169.03 16.44 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.057 -1.09 . . . . 0.45000000000000001 108.057 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.3 p -123.21 152.43 63.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 119.472 -0.891 . . . . 0.56000000000000005 113.129 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 75.9 Cg_exo -51.74 -33.92 51.98 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.608 3.539 . . . . 0.68000000000000005 114.05 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -65.4 -32.34 73.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.614 0.721 . . . . 0.76000000000000001 110.756 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -82.33 -43.91 16.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.012 -0.995 . . . . 1.5900000000000001 111.451 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.552 HG21 ' HE2' ' A' ' 169' ' ' TYR . 12.3 m -102.64 30.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.265 0.469 . . . . 0.66000000000000003 112.265 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.74 -12.05 59.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.465 -0.568 . . . . 0.79000000000000004 109.465 175.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -167.98 2.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.492 -0.776 . . . . 1.9099999999999999 109.836 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.423 ' HD3' HG22 ' A' ' 97' ' ' ILE . 98.6 mtt180 -77.94 158.78 77.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.088 -0.338 . . . . 1.4299999999999999 110.088 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 59.9 Cg_endo -79.23 161.44 26.05 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.996 1.797 . . . . 0.37 111.127 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.413 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.1 t -80.41 -22.4 41.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.55 -0.295 . . . . 0.44 110.363 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.4 m -162.68 143.51 9.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.391 0.615 . . . . 0.38 112.478 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.913 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -137.02 167.17 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.819 -1.082 . . . . 0.29999999999999999 108.274 170.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.066 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.6 t 175.91 128.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.34999999999999998 109.909 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 53.4 p-90 -91.07 160.91 15.35 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.519 -1.289 . . . . 2.7200000000000002 107.519 172.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.29 84.18 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.074 0.464 . . . . 1.51 111.092 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.92 17.44 2.79 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.401 -0.818 . . . . 0.80000000000000004 112.022 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.066 HD13 ' HA ' ' A' ' 54' ' ' SER . 5.4 tt -57.02 127.13 30.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.919 0.39 . . . . 0.57999999999999996 110.429 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.822 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 31.5 t70 -75.91 -24.21 55.57 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.608 . . . . 0.73999999999999999 112.01 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.665 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 67.2 m 68.89 15.35 8.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.278 -0.874 . . . . 1.03 110.422 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.55 -33.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.601 -0.727 . . . . 0.83999999999999997 112.666 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.822 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 24.7 mtpt -71.34 149.89 45.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 1.6699999999999999 110.72 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.904 HD23 ' HG2' ' A' ' 93' ' ' LYS . 3.8 mt -85.77 125.45 33.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.337 -0.847 . . . . 0.57999999999999996 109.494 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.475 ' HE2' ' HA2' ' A' ' 94' ' ' GLY . 5.5 m-85 -120.84 148.09 44.5 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.714 -0.394 . . . . 0.80000000000000004 110.436 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.63 HG23 HG12 ' A' ' 90' ' ' VAL . 62.7 m -96.89 104.97 17.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.35999999999999999 108.148 170.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.537 HD13 HG12 ' A' ' 124' ' ' VAL . 43.4 tp -104.39 109.09 20.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.668 -0.696 . . . . 0.58999999999999997 109.658 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' CD1' ' A' ' 88' ' ' LEU . 25.6 t -111.97 127.44 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.696 -0.684 . . . . 0.39000000000000001 110.429 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.021 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.3 mt -88.27 134.12 33.88 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.542 -0.91 . . . . 0.59999999999999998 108.542 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.907 HG21 HG11 ' A' ' 17' ' ' VAL . 9.7 t -137.58 156.45 48.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.459 -0.2 . . . . 0.35999999999999999 110.459 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.493 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 10.2 t70 -140.15 94.89 8.59 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.306 -0.628 . . . . 1.9199999999999999 109.306 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.5 Cg_endo -52.2 -36.68 68.03 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.722 2.948 . . . . 1.25 113.734 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.8 m-20 -89.32 43.83 1.17 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 1.29 111.542 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.68 139.28 19.94 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.446 -0.343 . . . . 0.5 110.143 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -80.18 -28.51 7.15 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 123.084 -1.632 . . . . 0.62 112.813 2.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.646 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 84.7 p -125.67 149.75 48.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.079 -0.51 . . . . 0.75 110.371 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.552 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 3.0 tmm_? -65.03 -28.91 69.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.419 0.628 . . . . 2.8799999999999999 109.651 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.0 ptpt -74.48 -21.06 59.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.848 -0.615 . . . . 1.3799999999999999 110.992 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.0 t70 -159.63 88.9 1.97 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.485 . . . . 1.3700000000000001 110.26 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 83.6 Cg_endo -84.37 93.63 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.67 2.247 . . . . 0.80000000000000004 113.234 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.5 mttm -83.9 -41.29 17.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.216 -0.902 . . . . 1.02 111.065 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.731 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 30.6 m-85 -78.98 8.47 5.57 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 116.032 -0.531 . . . . 1.1699999999999999 111.798 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -65.74 125.22 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.729 -0.471 . . . . 2.9300000000000002 109.729 177.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE1' HG13 ' A' ' 151' ' ' VAL . 5.1 tm-20 -93.12 134.13 35.59 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.49 0.716 . . . . 2.23 109.878 -0.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE3' ' HB3' ' A' ' 70' ' ' ASP . 80.7 t90 -108.67 131.08 55.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.63 -0.507 . . . . 1.4299999999999999 109.63 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 20.1 p80 -112.17 141.12 46.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.379 0.609 . . . . 1.26 111.328 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 1.021 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 7.2 t60 -82.6 -39.39 22.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.202 -0.908 . . . . 2.1400000000000001 110.884 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.584 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 20.3 p90 -167.16 173.18 9.3 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.601 -0.518 . . . . 1.51 109.601 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.529 ' HG ' HD12 ' A' ' 103' ' ' LEU . 16.6 tp -134.62 113.04 11.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.33000000000000002 110.178 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.637 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.8 t -121.25 132.11 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.641 -0.708 . . . . 0.31 110.146 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 6.2 m -129.71 162.94 36.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.084 -0.962 . . . . 0.27000000000000002 108.64 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.741 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 72.2 m-20 58.43 23.24 10.41 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.721 0.638 . . . . 1.76 111.418 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.637 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.4 ttm -73.84 102.69 4.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.1 -1.074 . . . . 0.31 108.1 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.904 ' HG2' HD23 ' A' ' 63' ' ' LEU . 2.8 mtpm? -77.1 93.77 3.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.265 -0.879 . . . . 1.21 110.951 -171.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 85.37 -127.63 8.32 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.542 -0.754 . . . . 0.29999999999999999 112.633 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 53' ' ' ILE . 2.5 p-10 -111.96 18.01 19.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.225 0.536 . . . . 1.04 110.551 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -81.5 99.88 9.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.621 . . . . 0.77000000000000002 110.07 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.423 HG22 ' HD3' ' A' ' 49' ' ' ARG . 5.0 mm -56.3 -30.17 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.774 -1.103 . . . . 0.40999999999999998 111.389 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 m -75.92 -42.56 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.084 -0.507 . . . . 0.68000000000000005 111.856 -172.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -79.93 8.16 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 1.26 111.712 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.95 102.06 1.1 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.881 -0.887 . . . . 0.34999999999999998 110.881 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.0 m -59.07 106.88 0.47 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.412 0.625 . . . . 0.45000000000000001 110.018 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.7 116.75 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.806 -1.088 . . . . 0.56999999999999995 111.327 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.529 HD12 ' HG ' ' A' ' 88' ' ' LEU . 41.8 mt -96.74 -37.49 10.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.036 0.922 . . . . 0.45000000000000001 109.213 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.8 t -127.9 115.5 18.68 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.386 -1.339 . . . . 0.37 107.386 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 16.5 t0 -65.32 161.3 19.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.764 -0.653 . . . . 1.1499999999999999 112.656 -168.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 24.0 p90 -85.46 61.91 7.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.383 -0.826 . . . . 4.6900000000000004 112.367 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.898 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 60.3 t -42.29 -49.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 114.294 1.22 . . . . 0.85999999999999999 114.294 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.39 -168.97 13.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.154 -1.022 . . . . 0.67000000000000004 113.048 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 35.8 t -78.77 147.93 33.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.363 -0.236 . . . . 0.51000000000000001 110.363 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.855 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 172.48 61.83 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 O-C-N 123.418 0.449 . . . . 0.81999999999999995 112.36 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.783 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 9.4 Cg_endo -91.9 132.44 1.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.111 2.541 . . . . 0.84999999999999998 112.382 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.563 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 84.4 Cg_exo -50.03 143.8 23.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.263 2.642 . . . . 0.87 112.435 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 113.16 3.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.494 . . . . 1.8500000000000001 110.926 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.49 -2.35 27.84 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.961 -0.638 . . . . 1.1799999999999999 112.299 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.646 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 74.4 p -77.83 -21.69 51.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.273 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.34 -153.19 17.16 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.862 -0.608 . . . . 1.97 111.846 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -98.5 110.83 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.927 -0.397 . . . . 0.93999999999999995 109.927 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -77.07 109.56 11.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.177 -0.465 . . . . 2.23 110.019 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 7.0 ptt180 -101.9 92.56 4.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.636 . . . . 2.3100000000000001 111.468 -171.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 41.0 m-85 -78.79 120.8 23.95 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.674 -0.694 . . . . 0.78000000000000003 109.791 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.651 ' CG2' HD22 ' A' ' 14' ' ' LEU . 15.1 t -98.57 128.89 49.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.27000000000000002 110.479 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.764 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -89.5 119.64 30.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.041 -0.527 . . . . 1.99 109.77 178.043 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 48.9 mt -116.43 119.15 34.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.378 -0.231 . . . . 0.38 110.378 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.537 HG12 HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -117.71 137.44 51.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 0.31 110.961 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 1.037 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 49.1 t80 -140.78 133.26 28.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.589 -0.278 . . . . 5.1200000000000001 110.322 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.447 ' HG2' HG21 ' A' ' 164' ' ' VAL . 7.1 pt-20 -83.06 116.32 22.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.807 -0.812 . . . . 2.4100000000000001 108.807 170.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.64 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -78.74 174.39 11.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.498 0.666 . . . . 1.3100000000000001 112.03 -168.037 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.28 -22.46 63.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.682 -1.145 . . . . 2.3999999999999999 109.823 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.64 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 8.2 ptt180 -146.49 163.06 31.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.444 -1.253 . . . . 3.5099999999999998 111.31 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -64.95 41.87 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.757 0 C-N-CA 124.684 3.589 . . . . 1.21 113.403 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 2.7 mm? 74.42 167.42 0.29 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.934 -1.03 . . . . 0.90000000000000002 113.152 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -157.15 71.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.991 -1.459 . . . . 2.8999999999999999 107.844 171.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.438 ' SG ' HD21 ' A' ' 103' ' ' LEU . 3.8 p -93.39 -75.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.077 -0.965 . . . . 1.8999999999999999 110.958 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 56.34 31.29 18.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.461 0.648 . . . . 2.96 109.886 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 133' ' ' CYS . 32.3 mm-40 -82.32 139.85 45.18 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.046 -0.979 . . . . 1.3899999999999999 109.841 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.72 112.44 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.898 2.399 . . . . 1.27 112.446 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.47 131.04 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 0.85999999999999999 111.065 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.9 mt -110.83 149.39 30.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.05 -0.523 . . . . 1.6100000000000001 110.639 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.6 m -102.86 157.74 16.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.283 -1.006 . . . . 1.8799999999999999 108.283 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.898 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -81.59 30.36 0.36 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.396 0.617 . . . . 0.75 111.579 -173.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.654 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 14.2 mtt180 -115.54 147.48 40.65 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.884 -0.784 . . . . 3.3599999999999999 108.884 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.602 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 16.5 m 66.18 178.15 0.21 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.94 0.775 . . . . 0.94999999999999996 110.599 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -143.39 33.17 1.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.041 -1.076 . . . . 1.1200000000000001 112.701 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.66 -27.41 63.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.049 0.388 . . . . 2.6600000000000001 112.049 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -113.78 67.49 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.076 0.465 . . . . 1.8700000000000001 110.9 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 99.3 mtt180 -79.71 -79.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.711 -0.677 . . . . 4.7300000000000004 112.114 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.12 -142.73 3.52 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.65000000000000002 113.009 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.731 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 39.7 mttm 66.33 34.15 6.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.719 0.771 . . . . 1.0800000000000001 109.944 -173.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 69.8 m-85 -113.63 177.06 4.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.82 -1.082 . . . . 1.8899999999999999 109.647 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -119.75 112.24 19.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.366 -0.379 . . . . 1.29 111.945 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.741 HG21 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.49 -36.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.78000000000000003 111.791 172.152 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.81 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.67000000000000004 110.617 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.5 m -65.17 -44.86 87.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.77000000000000002 110.263 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.642 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 66.9 m-85 -59.11 -47.01 86.85 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.601 0.715 . . . . 0.92000000000000004 110.199 174.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 161' ' ' ARG . 28.9 ttm180 -59.21 -48.64 80.87 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.809 -1.087 . . . . 2.8900000000000001 111.634 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -66.76 -36.53 82.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.96999999999999997 110.637 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -55.83 -51.04 68.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.078 -0.965 . . . . 1.5800000000000001 111.41 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.454 ' CB ' HD13 ' A' ' 160' ' ' LEU . 22.7 m-85 -83.29 -5.6 59.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.729 -0.669 . . . . 5.4500000000000002 111.416 -174.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 68.53 46.74 0.97 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.814 0.816 . . . . 2.4199999999999999 111.134 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.037 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.6 mp -105.69 175.39 5.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.666 -1.152 . . . . 1.27 110.378 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.897 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 6.1 tpt180 -147.64 -158.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.52 -0.918 . . . . 3.5899999999999999 108.52 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.897 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -47.74 142.25 6.91 Favored Pre-proline 0 C--O 1.231 0.125 0 CA-C-O 121.122 0.487 . . . . 0.76000000000000001 111.732 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 7.9 Cg_exo -70.2 161.31 46.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.651 2.901 . . . . 0.53000000000000003 113.191 -168.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.898 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -87.69 -24.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.014 -0.994 . . . . 0.44 109.236 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.776 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -159.83 150.29 18.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.701 -0.681 . . . . 0.27000000000000002 111.63 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.556 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.61 149.87 21.88 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.086 -0.961 . . . . 0.23999999999999999 111.607 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.545 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.1 t -167.88 152.74 6.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.677 -0.86 . . . . 0.34000000000000002 108.677 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 14.3 p -129.21 148.07 51.11 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.164 -0.614 . . . . 1.1100000000000001 111.355 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.553 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 32.1 p90 -130.05 127.85 40.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.003 -1.11 . . . . 0.80000000000000004 108.003 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 1.4 pt20 -105.14 132.91 50.76 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.897 -0.721 . . . . 2.5299999999999998 111.643 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -131.2 144.31 51.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.411 -0.813 . . . . 0.59999999999999998 109.24 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.783 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 pt-20 -126.74 -161.73 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 2.3799999999999999 111.103 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.895 ' HA ' HG21 ' A' ' 177' ' ' VAL . 4.1 t90 -71.93 81.48 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 3.96 111.036 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.532 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 5.6 t70 -73.08 -61.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.341 -0.39 . . . . 1.53 110.859 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.592 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 29.0 t70 172.79 -35.04 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.402 -0.817 . . . . 1.26 110.087 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -80.54 13.1 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 2.2200000000000002 111.516 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.895 HG21 ' HA ' ' A' ' 173' ' ' TRP . 84.0 t -72.59 -53.37 5.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.931 -0.577 . . . . 0.5 110.105 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.752 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.2 Cg_exo -50.84 -30.8 31.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.693 2.262 . . . . 0.57999999999999996 111.902 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.2 mmmt -72.4 -23.56 61.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 2.1400000000000001 111.473 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.855 HD22 ' HA3' ' A' ' 110' ' ' GLY . 14.8 tp -70.9 -44.13 66.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.414 -0.587 . . . . 0.66000000000000003 109.414 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.66 -40.28 91.48 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.556 0.693 . . . . 1.8899999999999999 109.273 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 8.2 mm-40 -56.41 -48.3 77.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.671 -1.15 . . . . 1.53 110.647 171.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.334 -0.848 . . . . 1.49 111.97 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.602 ' HA ' ' H ' ' A' ' 142' ' ' SER . 40.4 mt -68.42 2.78 2.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.577 -0.283 . . . . 0.76000000000000001 111.629 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.656 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.7 m -78.8 -2.73 40.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.336 0.589 . . . . 1.05 109.869 173.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.654 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 76.44 60.57 2.99 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.313 -0.858 . . . . 1.1699999999999999 111.29 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.656 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.4 mmmt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.577 -0.725 . . . . 2.0 110.549 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.52 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 13.7 tpt . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 110.216 -0.29 . . . . 5.04 110.216 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 19.3 Cg_exo -66.92 149.03 83.05 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.488 2.125 . . . . 2.1299999999999999 111.067 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 24' ' ' PRO . 23.4 t -78.04 105.35 7.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.359 0.599 . . . . 1.47 110.134 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -143.46 31.02 1.35 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.977 -1.011 . . . . 1.8100000000000001 110.628 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.4 mm? 68.85 10.7 8.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.071 -1.422 . . . . 0.69999999999999996 113.041 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -67.12 -8.97 34.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.539 0.57 . . . . 1.96 112.539 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.867 ' HB3' HD12 ' A' ' 12' ' ' LEU . 99.4 mttt -133.68 36.12 3.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.29 -0.256 . . . . 2.6600000000000001 111.333 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.45 -17.96 40.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.274 0.472 . . . . 3.98 112.274 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 p -153.42 20.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.872 0.368 . . . . 0.63 111.595 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.48 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -80.88 -124.67 0.62 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.006 -0.838 . . . . 0.47999999999999998 111.006 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 14.3 Cg_endo -53.61 -35.45 77.38 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.261 2.641 . . . . 0.53000000000000003 110.679 166.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 7' ' ' LYS . 25.3 mt -87.57 86.04 7.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 1.1699999999999999 109.322 172.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 60.9 0.72 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.70999999999999996 110.898 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.798 HD22 HG21 ' A' ' 121' ' ' VAL . 20.9 mt -73.2 -19.56 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.45000000000000001 110.275 -176.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -64.55 -22.53 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 2.1200000000000001 110.846 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -64.86 -25.29 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.38 0.609 . . . . 1.9299999999999999 109.66 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 151' ' ' VAL . 92.1 t -92.39 -70.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.024 -0.989 . . . . 0.63 110.154 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.48 174.67 5.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 2.9900000000000002 110.621 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.96 29.64 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 1.6000000000000001 112.282 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 27.9 mt-30 64.26 112.45 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.02 0.825 . . . . 3.5499999999999998 111.005 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 19.9 Cg_exo -63.98 152.05 82.56 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.439 2.092 . . . . 0.57999999999999996 112.759 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.872 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.3 pt20 -76.66 -18.77 58.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.281 -0.872 . . . . 1.3899999999999999 111.021 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.791 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 40.0 m-70 -145.53 159.43 48.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 123.658 0.783 . . . . 1.45 109.068 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB3' HG12 ' A' ' 3' ' ' VAL . 5.4 Cg_endo -85.93 131.05 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.706 2.271 . . . . 0.40000000000000002 111.967 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.913 HD23 ' HB3' ' A' ' 122' ' ' TRP . 15.6 tp -82.01 145.04 30.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.731 0.301 . . . . 0.28999999999999998 110.478 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.466 ' H ' HD12 ' A' ' 25' ' ' LEU . 32.8 m80 -116.49 127.82 54.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.88 -0.415 . . . . 1.24 109.88 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 53' ' ' ILE . 23.0 t -132.25 140.92 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.355 -0.609 . . . . 0.46999999999999997 109.355 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -137.59 142.82 41.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.983 0.421 . . . . 0.31 110.789 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 38.3 t80 -105.16 176.72 5.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.157 -0.683 . . . . 0.67000000000000004 109.157 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -52.66 62.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.448 0.642 . . . . 0.55000000000000004 110.284 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.45 7.59 32.25 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.167 -0.924 . . . . 0.81000000000000005 112.597 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB2' ' NE2' ' A' ' 45' ' ' GLN . . . -146.15 -170.97 3.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.46999999999999997 110.53 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.25 163.49 25.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.589 -0.732 . . . . 0.33000000000000002 109.34 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.758 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 88.6 t -116.52 66.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.304 -1.369 . . . . 0.39000000000000001 107.304 165.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.0 14.01 33.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.053 -0.976 . . . . 0.98999999999999999 109.608 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.803 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.1 tm-20 -138.07 122.38 18.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.126 -1.435 . . . . 2.5600000000000001 107.126 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -68.1 111.54 4.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.426 0.631 . . . . 0.40999999999999998 110.685 -170.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.757 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 84.06 10.19 81.06 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.54 -0.754 . . . . 0.58999999999999997 112.409 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -64.2 154.25 35.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 110.28 -0.267 . . . . 0.34000000000000002 110.28 176.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.31 127.77 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.469 0.652 . . . . 0.55000000000000004 111.296 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.5 HD22 HG22 ' A' ' 34' ' ' VAL . 7.0 tp -124.69 169.12 12.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.823 -1.177 . . . . 0.45000000000000001 107.823 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p -118.17 151.95 49.89 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 119.48 -0.888 . . . . 0.56000000000000005 112.718 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.603 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 51.0 Cg_exo -56.38 -34.47 94.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.875 3.05 . . . . 0.68000000000000005 113.284 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -33.67 72.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.76000000000000001 110.696 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 32' ' ' ALA . 93.1 mt-30 -82.12 -46.68 13.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.036 . . . . 1.5900000000000001 111.395 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG11 ' CE2' ' A' ' 169' ' ' TYR . 6.1 m -95.62 28.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 112.731 0.641 . . . . 0.66000000000000003 112.731 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -85.8 -11.7 52.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.823 0.344 . . . . 0.79000000000000004 110.617 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -135.5 -151.88 0.44 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 1.9099999999999999 109.285 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HD3' HG22 ' A' ' 97' ' ' ILE . 81.5 mtt180 -87.92 158.64 50.05 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.149 -0.315 . . . . 1.4299999999999999 110.149 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 76.3 Cg_endo -83.5 165.37 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.237 1.958 . . . . 0.37 110.573 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 t -88.09 -20.31 25.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.599 -0.441 . . . . 0.44 110.596 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -158.69 142.58 15.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.085 0.469 . . . . 0.38 111.918 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.09 170.05 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.29999999999999999 108.471 171.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.016 ' HA ' HD13 ' A' ' 58' ' ' LEU . 40.4 t 174.23 116.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.517 0.511 . . . . 0.34999999999999998 109.866 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 54.4 p-90 -76.97 159.56 29.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.669 -0.863 . . . . 2.7200000000000002 108.669 173.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 29.3 t70 -68.63 85.36 0.3 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.054 0.454 . . . . 1.51 110.5 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.47 6.33 3.83 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.492 -0.776 . . . . 0.80000000000000004 112.259 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.016 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -51.71 129.41 26.08 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.163 0.506 . . . . 0.57999999999999996 111.554 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -79.25 -28.11 42.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.73999999999999999 111.404 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.661 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 24.3 t 67.14 22.07 9.92 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.125 -0.943 . . . . 1.03 110.08 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -42.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.784 -0.722 . . . . 0.83999999999999997 113.079 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -90.73 169.08 11.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 120.823 0.344 . . . . 1.6699999999999999 110.772 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.1 mt -93.8 147.52 22.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.711 -0.677 . . . . 0.57999999999999996 109.344 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.503 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.0 m-85 -135.09 168.56 18.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.265 -0.643 . . . . 0.80000000000000004 109.265 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.877 HG23 HG12 ' A' ' 90' ' ' VAL . 2.4 m -103.83 104.43 14.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.325 -0.62 . . . . 0.35999999999999999 109.325 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.701 HD13 HG12 ' A' ' 124' ' ' VAL . 57.7 tp -108.16 117.01 33.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.034 0.445 . . . . 0.58999999999999997 110.616 -174.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.9 t -114.89 147.09 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.083 -0.508 . . . . 0.39000000000000001 110.38 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.97 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.2 mt -110.5 122.11 46.95 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.78 -1.192 . . . . 0.59999999999999998 107.78 166.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 9.0 t -133.16 151.28 51.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.726 0.298 . . . . 0.35999999999999999 110.711 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.654 ' OD2' ' HB3' ' A' ' 84' ' ' TRP . 4.6 p-10 -132.31 101.8 14.57 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-O 121.613 0.721 . . . . 1.9199999999999999 111.213 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 4.1 Cg_endo -48.06 -38.4 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.828 3.018 . . . . 1.25 114.386 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.85 48.82 1.4 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -171.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . . . -106.46 127.76 27.56 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.176 -0.305 . . . . 0.5 110.176 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.619 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -82.64 -30.46 4.78 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.315 -1.536 . . . . 0.62 113.142 -1.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.687 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -121.16 157.81 29.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.107 -0.497 . . . . 0.75 110.944 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -67.81 -45.53 74.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 2.8799999999999999 111.342 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.725 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -72.35 -19.31 61.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 1.3799999999999999 111.442 -175.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.97 84.24 5.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.2 0.524 . . . . 1.3700000000000001 110.141 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.87 102.24 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.643 2.228 . . . . 0.80000000000000004 112.691 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.619 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 16.9 mttm -83.09 -55.23 4.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.981 -1.008 . . . . 1.02 110.669 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.695 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.7 m-85 -82.86 19.77 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 111.481 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 50.3 ttp180 -65.72 124.05 21.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.36 -0.382 . . . . 2.9300000000000002 110.21 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.0 mp0 -102.4 138.99 38.59 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.819 0.342 . . . . 2.23 110.957 0.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.654 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 17.1 t90 -88.19 161.91 16.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.412 -1.329 . . . . 1.4299999999999999 107.412 171.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 11.0 p80 -138.04 114.67 10.51 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.184 0.516 . . . . 1.26 110.435 -174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.97 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 12.3 t-80 -52.99 -42.57 65.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.029 -0.987 . . . . 2.1400000000000001 110.585 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 18.5 p90 -167.55 163.33 14.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.706 0.288 . . . . 1.51 110.747 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.8 tp -126.83 114.18 17.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.33000000000000002 109.23 175.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.721 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -119.78 134.06 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.534 0.683 . . . . 0.31 111.182 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.877 HG12 HG23 ' A' ' 65' ' ' THR . 6.2 m -128.04 168.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.477 -0.934 . . . . 0.27000000000000002 108.477 175.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.767 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.8 m-20 59.11 21.77 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.075 0.464 . . . . 1.76 111.3 173.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.721 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.9 ttm -76.72 115.07 16.15 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.673 -0.862 . . . . 0.31 108.673 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -82.72 98.32 9.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.125 -0.943 . . . . 1.21 111.039 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 69.59 -119.42 9.17 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.203 -0.908 . . . . 0.29999999999999999 112.273 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.508 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.6 p-10 -114.57 25.54 10.93 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.09 0.471 . . . . 1.04 110.598 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.4 106.03 18.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.343 0.592 . . . . 0.77000000000000002 109.977 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG22 ' HD3' ' A' ' 49' ' ' ARG . 5.1 mm -56.81 -29.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 111.913 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.1 m -81.85 -37.27 27.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.883 0.698 . . . . 0.68000000000000005 112.883 -170.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.6 p -67.27 -19.59 65.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.85 0.315 . . . . 1.26 111.85 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.06 105.65 0.58 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.859 -0.61 . . . . 0.34999999999999998 112.982 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 97.7 m -65.16 107.31 1.52 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.282 0.563 . . . . 0.45000000000000001 110.004 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.6 p -76.78 119.15 24.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.184 -0.916 . . . . 0.56999999999999995 111.287 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 88' ' ' LEU . 57.1 mt -97.39 -47.03 5.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.091 0.948 . . . . 0.45000000000000001 109.159 172.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 t -114.35 106.02 13.82 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.977 -1.49 . . . . 0.37 106.977 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.3 OUTLIER -56.89 156.97 6.04 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.763 0.664 . . . . 1.1499999999999999 112.178 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.3 p90 -77.25 87.8 3.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 4.6900000000000004 111.095 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' ' 140' ' ' ASN . 24.0 t -61.77 -53.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.76 -0.655 . . . . 0.85999999999999999 110.68 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.493 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 115.98 -164.89 12.19 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.086 -1.054 . . . . 0.67000000000000004 112.548 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.476 ' OG ' ' HG3' ' A' ' 43' ' ' PRO . 23.9 t -77.89 131.98 37.73 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.568 0.216 . . . . 0.51000000000000001 110.545 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.42 68.11 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.81999999999999995 112.713 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.856 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 20.4 Cg_endo -96.33 113.19 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.434 2.756 . . . . 0.84999999999999998 112.708 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.604 ' HB2' HG23 ' A' ' 115' ' ' THR . 89.1 Cg_exo -51.15 143.23 33.13 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.798 2.332 . . . . 0.87 111.709 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 110.97 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.25 0.548 . . . . 1.8500000000000001 110.952 -175.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.48 21.63 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 1.1799999999999999 112.312 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.687 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 70.1 p -77.41 -30.3 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.628 0.252 . . . . 0.96999999999999997 111.415 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.95 -168.78 12.88 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.41 -0.676 . . . . 1.97 111.41 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -80.28 108.97 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.243 0.544 . . . . 0.93999999999999995 109.916 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 2.2 t60 -79.74 106.21 11.6 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 2.23 109.535 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.824 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp180 -97.57 114.67 26.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.402 1.096 . . . . 2.3100000000000001 111.358 -172.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 28.7 m-85 -92.31 120.65 33.05 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.231 -1.349 . . . . 0.78000000000000003 108.683 172.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 168' ' ' CYS . 19.4 t -97.99 128.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.619 . . . . 0.27000000000000002 109.81 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.913 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.02 119.2 29.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.127 -0.694 . . . . 1.99 109.127 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.88 119.92 27.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.374 0.131 . . . . 0.38 111.169 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.701 HG12 HD13 ' A' ' 66' ' ' LEU . 1.5 m -104.85 136.17 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.566 -0.454 . . . . 0.31 109.869 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 88.4 m-85 -114.5 148.7 37.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.441 . . . . 5.1200000000000001 110.483 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.1 tt0 -101.42 119.06 38.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.836 -0.62 . . . . 2.4100000000000001 110.837 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.56 ' HG2' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -104.2 160.83 14.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 1.3100000000000001 110.479 176.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.04 -26.57 64.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.879 -1.055 . . . . 2.3999999999999999 110.172 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.594 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 11.8 ptp180 -159.24 171.83 6.87 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 3.5099999999999998 111.132 -174.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 81.3 Cg_exo -48.08 148.37 7.0 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.098 2.532 . . . . 1.21 112.677 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.661 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -78.12 152.63 32.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.884 -0.598 . . . . 0.90000000000000002 111.263 -172.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -130.98 68.05 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.643 -0.873 . . . . 2.8999999999999999 108.643 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.475 ' HB2' HD11 ' A' ' 103' ' ' LEU . 66.3 m -95.72 106.44 18.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.233 -0.894 . . . . 1.8999999999999999 110.897 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.22 31.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.636 -0.711 . . . . 2.96 110.357 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 11.8 mm-40 -71.32 150.17 94.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.357 -0.838 . . . . 1.3899999999999999 110.426 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.36 106.64 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.325 2.684 . . . . 1.27 113.138 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.2 mm -63.54 121.33 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.85999999999999999 110.863 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 69.1 mt -105.49 155.07 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 1.6100000000000001 110.266 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 141' ' ' ARG . 65.5 m -113.45 17.17 18.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.73 -0.668 . . . . 1.8799999999999999 110.737 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.933 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.6 OUTLIER 65.49 -29.21 0.12 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.21 1.404 . . . . 0.75 111.705 -178.231 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.9 ttt180 -56.45 140.15 46.79 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.68 0.792 . . . . 3.3599999999999999 111.088 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 28.6 m 73.78 114.05 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 124.194 0.934 . . . . 0.94999999999999996 111.639 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.01 12.8 34.82 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.436 -0.802 . . . . 1.1200000000000001 112.303 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.76 -38.65 87.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.597 0.713 . . . . 2.6600000000000001 110.676 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -98.34 59.53 1.34 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.039 -0.982 . . . . 1.8700000000000001 109.597 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -86.71 -92.95 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.832 -0.622 . . . . 4.7300000000000004 112.371 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -119.99 -156.22 9.89 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.232 -0.985 . . . . 0.65000000000000002 113.633 -166.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.695 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 94.5 mttt 65.66 24.61 11.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.147 0.975 . . . . 1.0800000000000001 109.755 -171.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.54 95.27 5.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.372 -1.286 . . . . 1.8899999999999999 108.236 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.48 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 22.0 mmmt -54.05 129.98 36.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.215 -0.902 . . . . 1.29 112.622 -173.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.66 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 29.0 m -65.48 -23.72 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.443 -0.577 . . . . 0.78000000000000003 109.443 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.49 -42.14 98.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.36 -0.837 . . . . 0.67000000000000004 109.577 172.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 37.2 m -64.82 -32.54 74.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.018 -0.537 . . . . 0.77000000000000002 110.22 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.66 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 27.6 m-85 -69.91 -48.86 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.92000000000000004 111.068 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.621 ' HD2' ' HG3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -67.23 -29.36 68.99 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.954 -0.298 . . . . 2.8900000000000001 110.832 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.621 ' HG3' ' HD2' ' A' ' 155' ' ' ARG . 54.7 mtmt -77.49 -26.91 51.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.783 -0.19 . . . . 0.96999999999999997 111.401 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -54.45 -53.9 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.537 -0.302 . . . . 1.5800000000000001 111.136 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.435 ' OH ' ' HG3' ' A' ' 129' ' ' ARG . 12.9 t80 -111.1 5.99 20.53 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.485 -0.886 . . . . 5.4500000000000002 110.597 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 58.81 53.68 5.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.326 -0.852 . . . . 2.4199999999999999 112.467 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 125' ' ' TYR . 0.4 OUTLIER -81.08 -12.31 59.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.272 -0.877 . . . . 1.27 110.303 176.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.431 ' HD2' ' NH2' ' A' ' 155' ' ' ARG . 7.5 tpt180 69.9 -87.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.978 -1.01 . . . . 3.5899999999999999 112.297 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -128.07 156.51 76.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.821 0.343 . . . . 0.76000000000000001 111.211 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.3 Cg_exo -71.24 139.78 35.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.285 2.657 . . . . 0.53000000000000003 112.464 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.872 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -87.74 -30.78 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.376 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.85 143.7 21.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.987 -0.552 . . . . 0.27000000000000002 111.544 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.55 143.27 11.28 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 114.926 -1.034 . . . . 0.23999999999999999 111.881 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.5 t -156.83 133.61 10.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.34000000000000002 108.927 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.863 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -110.31 151.29 27.59 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.568 0.699 . . . . 1.1100000000000001 111.756 -173.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 120' ' ' TYR . 49.2 p90 -137.73 127.51 25.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.657 -1.609 . . . . 0.80000000000000004 106.657 173.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 4.1 pt20 -105.55 133.25 50.6 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.363 -0.935 . . . . 2.5299999999999998 111.435 177.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.08 -0.964 . . . . 0.59999999999999998 110.072 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.72 -168.94 1.73 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 2.3799999999999999 110.947 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.745 ' HA ' HG21 ' A' ' 177' ' ' VAL . 29.4 t90 -83.99 77.3 9.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.786 -0.643 . . . . 3.96 109.729 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -57.04 4.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.654 -0.248 . . . . 1.53 111.257 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.537 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.0 t70 175.68 -33.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.358 0.663 . . . . 1.26 110.73 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.65 6.7 14.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.908 0.385 . . . . 2.2200000000000002 111.925 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.808 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 66.3 t -69.42 -53.52 12.81 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.281 -0.418 . . . . 0.5 110.083 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.808 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 61.7 Cg_exo -51.32 -37.03 59.52 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.609 2.206 . . . . 0.57999999999999996 112.021 169.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.5 mmmt -67.7 -24.37 65.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.165 -0.47 . . . . 2.1400000000000001 111.705 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.644 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 58.3 tp -69.11 -47.44 65.15 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.66000000000000003 109.57 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.8 -38.68 79.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 1.8899999999999999 109.42 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.9 mm-40 -57.26 -43.08 82.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.892 -1.049 . . . . 1.53 111.267 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -76.55 -30.34 57.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.707 0.632 . . . . 1.49 112.707 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 84.9 mt -63.39 1.47 0.52 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.996 0.739 . . . . 0.76000000000000001 112.996 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.722 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 49.3 m -88.81 3.05 52.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.463 0.649 . . . . 1.05 109.789 170.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.539 ' N ' ' HG3' ' A' ' 141' ' ' ARG . . . 69.45 51.65 25.44 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.066 -0.97 . . . . 1.1699999999999999 111.335 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.4 mmmt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.456 -0.783 . . . . 2.0 110.072 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.398 0.142 . . . . 5.04 110.999 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.04 139.75 25.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.95 2.433 . . . . 2.1299999999999999 111.537 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' A' ' 26' ' ' HIS . 21.4 t -57.96 121.79 6.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.446 -0.797 . . . . 1.47 112.131 -171.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 6' ' ' SER . 24.0 t70 -144.78 157.96 43.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.175 -1.375 . . . . 1.8100000000000001 107.524 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.438 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.0 mm? -75.19 23.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.09 0.405 . . . . 0.69999999999999996 111.882 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.0 t -72.27 -16.72 61.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 1.96 110.123 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HB3' HD12 ' A' ' 12' ' ' LEU . 37.8 mttm -122.13 31.41 6.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 2.6600000000000001 111.173 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -26.36 31.63 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.245 0.832 . . . . 3.98 113.245 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -152.43 25.51 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.014 -0.429 . . . . 0.63 111.377 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.16 -122.39 0.96 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.753 -0.939 . . . . 0.47999999999999998 110.753 174.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -51.9 -38.49 68.5 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.255 2.636 . . . . 0.53000000000000003 110.921 167.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.635 HD11 ' HA3' ' A' ' 38' ' ' GLY . 45.9 mt -87.37 89.09 7.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.258 -0.883 . . . . 1.1699999999999999 109.661 173.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.53 71.75 1.86 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.412 0.625 . . . . 0.70999999999999996 110.485 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.857 HD22 HG21 ' A' ' 121' ' ' VAL . 23.8 mt -80.12 -11.98 59.71 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.795 . . . . 0.45000000000000001 110.04 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.535 ' HG2' ' HG3' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -67.69 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.446 -0.797 . . . . 2.1200000000000001 110.859 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -77.5 -20.11 54.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.707 0.765 . . . . 1.9299999999999999 109.423 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG1' HG21 ' A' ' 151' ' ' VAL . 62.8 t -98.13 -57.03 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.53 -1.214 . . . . 0.63 111.341 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -134.92 172.79 12.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.459 -0.337 . . . . 2.9900000000000002 110.685 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -85.93 31.61 0.62 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.538 0.94 . . . . 1.6000000000000001 113.538 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HG3' ' HG2' ' A' ' 15' ' ' GLN . 97.7 mt-30 64.4 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.541 0 O-C-N 123.507 0.505 . . . . 3.5499999999999998 110.721 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 15.2 Cg_exo -66.35 150.4 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.207 1.938 . . . . 0.57999999999999996 112.671 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.879 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.8 pt20 -72.39 -15.92 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.125 -0.943 . . . . 1.3899999999999999 111.264 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.789 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 24.1 m80 -148.91 157.43 40.39 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 1.45 109.274 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.5 Cg_endo -86.82 127.33 2.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.40000000000000002 111.266 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.874 HD23 ' HB3' ' A' ' 122' ' ' TRP . 22.8 tp -76.61 144.3 39.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.997 -0.372 . . . . 0.28999999999999998 109.997 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.59 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 36.0 m80 -122.91 109.23 13.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.045 0.45 . . . . 1.24 110.038 176.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 53' ' ' ILE . 39.6 t -112.93 139.3 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.61 . . . . 0.46999999999999997 109.476 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -133.26 142.2 48.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.431 0.634 . . . . 0.31 110.938 -176.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -102.54 171.12 7.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.67000000000000004 109.006 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.65 -51.86 61.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.37 0.605 . . . . 0.55000000000000004 110.773 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.97 9.52 15.81 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.066 -0.97 . . . . 0.81000000000000005 112.478 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.68 -171.01 3.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 122.631 -0.335 . . . . 0.46999999999999997 110.469 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.13 155.32 18.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.158 -0.474 . . . . 0.33000000000000002 110.351 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.803 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.6 t -102.32 63.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.804 -1.554 . . . . 0.39000000000000001 106.804 163.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.31 20.78 8.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.887 -1.051 . . . . 0.98999999999999999 109.384 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.5 tm-20 -145.67 119.93 9.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.047 -1.094 . . . . 2.5600000000000001 108.047 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -66.45 110.63 3.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.997 0.427 . . . . 0.40999999999999998 109.959 -175.281 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.873 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 93.27 2.44 65.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.068 -0.587 . . . . 0.58999999999999997 112.703 177.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -67.05 149.39 50.66 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.764 0.316 . . . . 0.34000000000000002 110.677 -178.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.11 132.01 33.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.357 0.598 . . . . 0.55000000000000004 111.043 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.499 HD22 HG22 ' A' ' 34' ' ' VAL . 6.8 tp -124.11 169.2 11.93 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.391 -1.337 . . . . 0.45000000000000001 107.391 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.1 p -114.67 150.46 44.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 118.804 -1.159 . . . . 0.56000000000000005 113.141 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 52.9 Cg_exo -55.74 -32.43 84.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.435 3.423 . . . . 0.68000000000000005 113.91 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -65.12 -36.65 84.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.644 0.735 . . . . 0.76000000000000001 110.189 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -75.28 -56.38 4.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.799 -1.091 . . . . 1.5900000000000001 110.603 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG11 ' CE1' ' A' ' 169' ' ' TYR . 28.7 m -89.31 28.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.884 0.698 . . . . 0.66000000000000003 112.884 -173.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -85.64 -15.49 42.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.766 -0.828 . . . . 0.79000000000000004 108.766 172.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 17.9 t-20 -121.12 -170.29 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.714 -1.13 . . . . 1.9099999999999999 108.988 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 86.2 mtt180 -85.42 161.51 51.25 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.445 -0.576 . . . . 1.4299999999999999 109.445 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 66.8 Cg_endo -78.96 160.38 27.14 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.819 1.68 . . . . 0.37 110.539 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 t -85.23 -18.17 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.915 -0.402 . . . . 0.44 109.915 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 70.1 m -159.36 147.99 17.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.27 0.557 . . . . 0.38 111.778 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.935 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.69 167.87 18.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.145 -1.057 . . . . 0.29999999999999999 108.145 170.057 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.061 ' HA ' HD13 ' A' ' 58' ' ' LEU . 38.5 t 179.01 114.27 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.102 0.477 . . . . 0.34999999999999998 110.168 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 56.3 p-90 -78.4 157.34 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.088 -1.078 . . . . 2.7200000000000002 108.088 172.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.419 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 28.4 t70 -62.67 88.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.191 0.52 . . . . 1.51 110.918 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.5 20.59 4.62 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.444 -0.798 . . . . 0.80000000000000004 112.275 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.061 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -51.1 130.3 25.76 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.107 0.563 . . . . 0.57999999999999996 111.485 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.697 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 24.1 t70 -75.72 -28.68 58.66 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.808 -0.633 . . . . 0.73999999999999999 111.451 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.688 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 43.0 m 69.18 9.44 7.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.389 -0.823 . . . . 1.03 110.733 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -135.53 -43.77 0.11 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.849 -0.691 . . . . 0.83999999999999997 113.253 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.897 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 20.2 mtpt -66.59 149.63 50.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.6699999999999999 110.645 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.998 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.1 mt -88.09 126.77 35.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.555 -0.748 . . . . 0.57999999999999996 109.239 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.897 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -118.84 161.4 20.23 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.224 0.465 . . . . 0.80000000000000004 110.889 177.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.453 HG23 HG12 ' A' ' 90' ' ' VAL . 89.6 m -97.4 105.3 17.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.35999999999999999 109.259 172.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.85 110.13 22.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.471 -0.786 . . . . 0.58999999999999997 109.835 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.6 t -115.32 126.7 72.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.018 0.437 . . . . 0.39000000000000001 111.055 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.957 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -91.19 131.39 36.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.215 -1.031 . . . . 0.59999999999999998 108.215 166.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 12.0 t -133.63 140.64 47.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.877 -0.329 . . . . 0.35999999999999999 110.339 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.644 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 38.2 t70 -121.85 97.58 46.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 121.132 0.491 . . . . 1.9199999999999999 110.064 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 10.7 Cg_endo -56.14 178.31 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.2 2.6 . . . . 1.25 112.538 171.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.841 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 71.3 m-20 52.56 35.7 18.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.926 -1.034 . . . . 1.29 112.861 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.99 138.48 19.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.148 -0.315 . . . . 0.5 110.148 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.694 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 56.7 Cg_endo -77.27 -34.52 3.28 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.089 -1.629 . . . . 0.62 112.968 0.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.712 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.1 p -119.87 156.81 30.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 0.75 110.214 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.841 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 46.8 mtm180 -72.48 -23.53 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 2.8799999999999999 111.482 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.83 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -92.72 -11.62 33.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 1.3799999999999999 110.947 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.45 78.58 6.28 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-O 121.583 0.706 . . . . 1.3700000000000001 109.584 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.79 95.15 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.848 2.365 . . . . 0.80000000000000004 113.348 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.694 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 12.1 mttm -81.74 -52.29 7.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.095 -0.957 . . . . 1.02 111.17 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.634 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 50.7 m-85 -76.53 -5.44 47.63 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.886 -0.597 . . . . 1.1699999999999999 111.897 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.55 ' HG3' ' HA ' ' A' ' 71' ' ' PRO . 70.1 ttt180 -67.43 130.36 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.275 -0.17 . . . . 2.9300000000000002 110.867 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.516 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 29.9 mm-40 -86.96 130.8 34.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.981 0.42 . . . . 2.23 110.771 -0.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.673 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.5 t90 -86.75 91.18 8.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 1.4299999999999999 109.513 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 35.2 p-80 -67.19 121.72 16.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.529 0.681 . . . . 1.26 109.979 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.957 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 30.3 t-80 -65.39 -34.86 79.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.034 -0.985 . . . . 2.1400000000000001 110.369 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.589 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 39.6 p90 -168.8 172.39 7.86 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.578 -0.527 . . . . 1.51 109.578 175.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.2 tp -132.22 113.7 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.641 -0.503 . . . . 0.33000000000000002 109.641 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.68 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.8 t -121.28 132.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.533 0.682 . . . . 0.31 110.678 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 65' ' ' THR . 9.1 m -128.45 167.4 23.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.879 -1.156 . . . . 0.27000000000000002 107.879 175.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.998 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.5 m-20 60.71 19.66 9.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.203 0.525 . . . . 1.76 110.895 172.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.68 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.1 ttm -73.97 114.57 12.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.971 -0.752 . . . . 0.31 108.971 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 ttmm -80.82 98.56 7.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.512 -1.222 . . . . 1.21 110.988 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.688 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 62.68 -115.3 7.83 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.512 -0.851 . . . . 0.29999999999999999 112.312 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.58 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.2 p-10 -115.06 24.34 11.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.933 0.396 . . . . 1.04 111.611 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.06 103.0 15.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.451 0.643 . . . . 0.77000000000000002 110.247 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.437 ' H ' HG12 ' A' ' 97' ' ' ILE . 7.7 mm -56.18 -32.34 34.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.851 -1.068 . . . . 0.40999999999999998 111.831 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 m -78.98 -37.39 39.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.091 -0.504 . . . . 0.68000000000000005 111.779 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.3 p -61.05 -29.69 69.88 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.728 0.299 . . . . 1.26 111.331 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -50.38 107.77 0.4 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.536 -0.756 . . . . 0.34999999999999998 112.669 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.4 m -72.29 107.8 5.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.256 0.551 . . . . 0.45000000000000001 109.923 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 p -76.46 122.18 30.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.56999999999999995 111.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.644 HD12 ' HG ' ' A' ' 88' ' ' LEU . 66.0 mt -100.47 -45.69 5.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.085 0.945 . . . . 0.45000000000000001 109.32 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.1 t -122.92 112.34 17.73 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.171 -1.418 . . . . 0.37 107.171 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.637 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 4.1 t0 -59.05 159.94 6.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.944 -1.026 . . . . 1.1499999999999999 113.024 -167.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.511 ' H ' ' HD1' ' A' ' 106' ' ' TYR . 3.3 p90 -80.16 86.66 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.3 -0.864 . . . . 4.6900000000000004 110.764 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.864 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 38.3 t -63.97 -46.05 95.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.85999999999999999 111.087 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.541 ' HA2' ' HE2' ' A' ' 86' ' ' HIS . . . 109.51 -168.13 13.13 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.467 -0.873 . . . . 0.67000000000000004 112.577 174.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.9 t -70.29 133.24 46.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.51000000000000001 109.935 174.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -169.73 61.22 0.19 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.695 -0.764 . . . . 0.81999999999999995 112.891 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 97.7 Cg_endo -93.35 140.39 1.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.072 2.515 . . . . 0.84999999999999998 112.434 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 37.1 Cg_exo -61.55 141.84 92.86 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.702 2.268 . . . . 0.87 111.598 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.487 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -69.02 123.93 22.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.8500000000000001 110.987 -176.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.77 59.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 1.1799999999999999 112.642 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.712 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 75.1 p -78.82 -12.68 60.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 110.706 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.29 165.92 41.78 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.18 -0.768 . . . . 1.97 111.18 -174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.837 HD12 ' HG3' ' A' ' 170' ' ' GLN . 3.8 mm? -79.49 130.13 35.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.317 -0.623 . . . . 0.93999999999999995 109.317 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.567 ' H ' ' NE2' ' A' ' 170' ' ' GLN . 4.2 m170 -92.63 -121.32 0.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.975 -1.12 . . . . 2.23 107.975 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.783 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 14.3 ptt-85 177.3 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.344 0.498 . . . . 2.3100000000000001 112.344 169.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.644 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 31.4 m-85 -69.86 101.2 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.768 -0.826 . . . . 0.78000000000000003 108.768 173.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.857 HG21 HD22 ' A' ' 14' ' ' LEU . 17.3 t -89.99 126.07 42.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.957 0.408 . . . . 0.27000000000000002 109.949 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.874 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.06 117.9 28.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.812 -0.81 . . . . 1.99 108.812 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -122.07 129.01 52.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.511 0.195 . . . . 0.38 110.94 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 165' ' ' ALA . 1.3 m -112.21 131.78 62.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.31 110.139 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.64 ' CB ' HD23 ' A' ' 160' ' ' LEU . 97.8 m-85 -117.69 122.5 43.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.252 -0.885 . . . . 5.1200000000000001 109.258 174.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.98 113.08 25.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.012 0.434 . . . . 2.4100000000000001 109.873 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.6 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -80.57 175.6 10.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.665 -0.698 . . . . 1.3100000000000001 109.439 177.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.02 -6.34 57.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.729 -0.669 . . . . 2.3999999999999999 109.851 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.503 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.2 ptp180 -165.65 167.38 9.16 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 115.307 -0.86 . . . . 3.5099999999999998 111.267 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.545 ' HG3' HD12 ' A' ' 63' ' ' LEU . 35.6 Cg_exo -55.58 147.71 57.59 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.979 2.453 . . . . 1.21 111.631 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.453 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 3.8 mm? -71.83 148.89 45.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.621 . . . . 0.90000000000000002 112.532 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 15.4 tptm -103.26 77.81 1.56 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.707 -1.22 . . . . 2.8999999999999999 107.707 165.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.2 p -90.62 99.79 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.399 -0.818 . . . . 1.8999999999999999 111.797 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.2 14.03 21.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.506 -0.77 . . . . 2.96 109.102 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.26 135.28 96.05 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.3899999999999999 110.278 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.64 116.56 2.81 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.017 2.478 . . . . 1.27 112.946 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.6 mm -69.03 115.95 8.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.005 -0.368 . . . . 0.85999999999999999 110.005 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 145' ' ' HIS . 31.6 mt -114.93 152.61 32.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.427 0.632 . . . . 1.6100000000000001 111.26 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -96.51 154.13 17.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.055 -0.975 . . . . 1.8799999999999999 108.609 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.864 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 -77.88 -1.41 31.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.75 111.024 -173.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.742 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 88.4 mtt180 -78.94 157.2 28.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.581 -0.525 . . . . 3.3599999999999999 109.581 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.518 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 79.8 p 58.06 117.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.82 1.248 . . . . 0.94999999999999996 112.651 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -79.35 18.21 7.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.309 -0.859 . . . . 1.1200000000000001 113.514 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -69.82 -41.34 75.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.559 0.695 . . . . 2.6600000000000001 110.4 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.555 ' HB3' HD13 ' A' ' 138' ' ' LEU . 4.4 m80 -95.11 46.48 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.174 -0.921 . . . . 1.8700000000000001 110.862 -170.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 51.3 mtt180 -76.77 -78.78 0.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.026 0.441 . . . . 4.7300000000000004 111.925 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -137.57 -121.58 2.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.107 -1.044 . . . . 0.65000000000000002 113.042 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.634 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 47.2 mttm 64.88 29.17 12.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.616 0.722 . . . . 1.0800000000000001 110.51 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -127.52 146.87 50.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.903 -1.044 . . . . 1.8899999999999999 109.77 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 13.8 mmmm -87.59 140.57 29.38 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.038 -0.528 . . . . 1.29 111.098 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.558 HG21 ' CG1' ' A' ' 17' ' ' VAL . 3.0 t -62.11 -35.18 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.43 -0.952 . . . . 0.78000000000000003 108.43 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.75 81.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.396 -1.275 . . . . 0.67000000000000004 110.448 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 74.1 m -59.31 -47.07 86.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.77000000000000002 111.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.539 ' O ' ' HB3' ' A' ' 157' ' ' LYS . 59.1 m-85 -62.49 -48.97 77.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.827 0.822 . . . . 0.92000000000000004 110.611 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -60.1 -49.3 78.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.414 -1.266 . . . . 2.8900000000000001 111.135 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -67.73 -26.48 66.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.96999999999999997 111.502 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 45.0 tptt -52.6 -53.25 49.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 1.5800000000000001 111.626 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.507 ' HB3' HD13 ' A' ' 160' ' ' LEU . 17.2 t80 -104.41 14.94 29.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.845 -0.742 . . . . 5.4500000000000002 110.422 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 60.37 47.67 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.158 -0.928 . . . . 2.4199999999999999 111.857 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.64 HD23 ' CB ' ' A' ' 125' ' ' TYR . 5.5 mp -80.1 138.9 37.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.388 -0.824 . . . . 1.27 108.875 173.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -72.18 -82.32 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.079 0.4 . . . . 3.5899999999999999 112.079 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.17 164.54 36.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.882 -0.414 . . . . 0.76000000000000001 109.882 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.533 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 20.0 Cg_exo -62.3 134.62 49.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.621 2.214 . . . . 0.53000000000000003 112.566 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.879 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.1 t -89.73 -31.74 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 109.593 -0.521 . . . . 0.44 109.593 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.789 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -155.08 145.01 21.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.16 -0.616 . . . . 0.27000000000000002 111.876 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.1 140.45 9.12 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.023 -0.99 . . . . 0.23999999999999999 111.74 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -152.99 127.41 9.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.532 -0.544 . . . . 0.34000000000000002 109.532 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.873 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.55 144.29 29.71 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.263 0.554 . . . . 1.1100000000000001 112.082 -174.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.594 ' CE1' HG11 ' A' ' 46' ' ' VAL . 5.9 p90 -133.27 122.52 24.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.279 -1.378 . . . . 0.80000000000000004 107.279 168.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.837 ' HG3' HD12 ' A' ' 117' ' ' LEU . 19.2 tp60 -101.44 156.31 17.54 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.042 -1.036 . . . . 2.5299999999999998 111.626 171.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.489 ' H ' ' CD ' ' A' ' 170' ' ' GLN . . . -149.0 139.07 22.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.422 -0.353 . . . . 0.59999999999999998 110.206 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.766 ' HB3' HD11 ' A' ' 117' ' ' LEU . 12.2 pt-20 -106.65 -168.44 1.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.05 0.452 . . . . 2.3799999999999999 111.87 -173.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.621 ' HA ' HG21 ' A' ' 177' ' ' VAL . 6.9 t90 -77.81 71.38 4.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.661 -0.699 . . . . 3.96 110.168 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.683 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 1.5 t70 -72.59 -62.49 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 1.53 112.615 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.0 t70 -175.06 -45.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.067 0.46 . . . . 1.26 111.143 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.677 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 5.1 m-85 -80.45 7.94 8.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 2.2200000000000002 111.979 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.775 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 94.4 t -72.91 -54.32 4.68 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.083 171.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.775 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -51.92 -41.92 60.82 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.358 2.039 . . . . 0.57999999999999996 111.868 169.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 0.5 OUTLIER -65.85 -25.16 67.07 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.397 -0.365 . . . . 2.1400000000000001 111.068 178.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.688 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 66.5 tp -68.4 -47.62 66.84 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.229 -0.656 . . . . 0.66000000000000003 109.229 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.43 -39.43 83.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.82 -0.627 . . . . 1.8899999999999999 109.478 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 16.4 mm-40 -56.0 -44.45 78.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.772 -1.104 . . . . 1.53 110.795 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.31 -32.45 58.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.366 -0.834 . . . . 1.49 111.958 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 83.0 mt -63.6 -7.07 6.27 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.181 0.437 . . . . 0.76000000000000001 112.181 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.625 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 16.4 m -68.19 -11.42 59.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.489 0.661 . . . . 1.05 109.714 172.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.742 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 87.23 54.83 2.48 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.137 -0.938 . . . . 1.1699999999999999 110.88 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.1 mmmt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.503 -0.76 . . . . 2.0 110.328 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 10.4 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.438 0.161 . . . . 5.04 110.574 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 16.7 Cg_exo -67.57 139.14 47.86 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.111 2.541 . . . . 2.1299999999999999 112.151 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 24' ' ' PRO . 7.2 t -55.83 123.88 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.48 -0.782 . . . . 1.47 111.546 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -146.29 37.83 1.04 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.768 0.794 . . . . 1.8100000000000001 110.12 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 24' ' ' PRO . 2.1 mm? 58.88 37.01 24.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.509 -1.223 . . . . 0.69999999999999996 108.416 -165.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -58.2 -42.93 87.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.456 -1.247 . . . . 1.96 112.021 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.926 ' HB2' HD12 ' A' ' 12' ' ' LEU . 49.9 mttm -136.48 60.94 1.65 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 2.6600000000000001 109.482 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.457 ' CE3' ' HB2' ' A' ' 20' ' ' GLN . 22.5 p-90 -69.06 -35.75 76.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.13 -0.941 . . . . 3.98 112.009 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 84.5 p -147.24 17.56 1.2 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.542 -0.463 . . . . 0.63 111.904 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -75.52 -124.67 0.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.758 . . . . 0.47999999999999998 111.782 177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.4 Cg_endo -49.94 -40.41 49.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.248 2.632 . . . . 0.53000000000000003 110.268 168.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.926 HD12 ' HB2' ' A' ' 7' ' ' LYS . 22.2 mt -88.1 83.62 6.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.85 -1.068 . . . . 1.1699999999999999 109.218 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 m -74.57 62.66 1.04 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.618 0.723 . . . . 0.70999999999999996 110.397 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD22 ' CG2' ' A' ' 121' ' ' VAL . 46.0 mt -76.52 -17.46 59.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 0.45000000000000001 110.825 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 17.5 tm0? -64.99 -21.53 66.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.877 -0.601 . . . . 2.1200000000000001 109.919 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.66 -28.51 65.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.35 0.595 . . . . 1.9299999999999999 110.65 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.747 HG11 HG21 ' A' ' 69' ' ' THR . 52.0 t -83.99 -73.47 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.265 -0.88 . . . . 0.63 109.684 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.779 ' HB2' HG21 ' A' ' 151' ' ' VAL . 48.3 t0 -139.32 161.19 38.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.846 -0.615 . . . . 2.9900000000000002 109.659 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 163' ' ' PRO . 32.6 mt-10 -64.09 153.42 37.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.652 -0.703 . . . . 1.6000000000000001 111.846 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.457 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 20.1 tt0 -56.05 124.26 58.24 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 3.5499999999999998 110.34 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 19.6 Cg_exo -64.47 154.84 69.57 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.318 2.012 . . . . 0.57999999999999996 112.069 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.934 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.8 pt20 -73.74 -15.55 61.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.606 -0.725 . . . . 1.3899999999999999 111.121 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.735 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 19.5 m80 -146.45 158.81 46.45 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 1.45 108.995 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 3' ' ' VAL . 8.1 Cg_endo -88.53 132.55 2.56 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.952 2.435 . . . . 0.40000000000000002 111.519 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.864 HD23 ' HB3' ' A' ' 122' ' ' TRP . 15.3 tp -84.5 139.83 31.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 111.018 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -106.8 131.33 54.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.468 . . . . 1.24 109.93 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 53' ' ' ILE . 16.1 t -134.39 142.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.12 -0.696 . . . . 0.46999999999999997 109.12 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -140.76 140.96 34.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.917 0.389 . . . . 0.31 110.83 -176.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -105.61 178.28 4.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.751 -0.833 . . . . 0.67000000000000004 108.751 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -52.18 57.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.507 0.67 . . . . 0.55000000000000004 110.463 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.57 -0.14 49.67 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.26 -0.882 . . . . 0.81000000000000005 112.836 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.76 -169.8 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.46999999999999997 110.966 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.56 152.84 16.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.651 -0.704 . . . . 0.33000000000000002 109.645 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.715 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 99.7 t -106.73 64.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.26 -1.385 . . . . 0.39000000000000001 107.26 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -93.39 6.31 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.014 -0.993 . . . . 0.98999999999999999 109.704 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 43.8 mt-10 -133.91 132.7 40.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.191 -0.913 . . . . 2.5600000000000001 109.071 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.6 OUTLIER -75.74 109.56 9.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.139 -0.689 . . . . 0.40999999999999998 109.139 -176.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.731 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 93.07 6.18 63.43 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.536 -0.756 . . . . 0.58999999999999997 112.777 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.715 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.55 147.68 52.95 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.493 -0.558 . . . . 0.34000000000000002 109.493 176.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.47 134.7 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.094 0.473 . . . . 0.55000000000000004 110.957 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 46' ' ' VAL . 7.4 tp -127.41 169.32 13.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.662 -0.866 . . . . 0.45000000000000001 108.662 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 25.1 p -121.08 156.64 56.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.287 -0.565 . . . . 0.56000000000000005 112.227 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.718 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 12.0 Cg_endo -55.5 -30.23 72.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.288 3.325 . . . . 0.68000000000000005 114.402 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -69.87 -32.48 70.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.76000000000000001 110.774 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -79.98 -29.19 39.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.846 -1.07 . . . . 1.5900000000000001 111.241 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.531 ' CG1' HD23 ' A' ' 41' ' ' LEU . 16.7 m -118.21 30.19 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.451 . . . . 0.66000000000000003 111.762 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.01 -21.08 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.601 -0.518 . . . . 0.79000000000000004 109.601 176.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -123.0 -170.85 2.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.316 -0.857 . . . . 1.9099999999999999 109.617 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.1 156.85 89.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.362 -0.607 . . . . 1.4299999999999999 109.362 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.93 153.72 25.6 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.588 1.526 . . . . 0.37 109.962 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -80.15 -14.93 58.09 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.353 -0.539 . . . . 0.44 110.555 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -161.51 143.38 11.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.457 0.54 . . . . 0.38 112.457 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.905 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -140.17 175.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.104 -1.072 . . . . 0.29999999999999999 108.104 170.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.976 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.8 t 169.56 125.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.497 0.498 . . . . 0.34999999999999998 110.039 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 60.2 p-90 -88.13 153.7 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.672 -0.862 . . . . 2.7200000000000002 108.672 173.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.76 91.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 1.51 110.954 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.66 8.71 8.09 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.836 -0.62 . . . . 0.80000000000000004 112.42 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.976 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.7 tt -56.76 129.0 39.4 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.848 0.459 . . . . 0.57999999999999996 110.857 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.39 -29.04 56.96 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.771 -0.65 . . . . 0.73999999999999999 111.744 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.669 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.2 m 74.23 0.33 3.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.475 -0.784 . . . . 1.03 110.821 -175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.31 -34.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.058 -0.591 . . . . 0.83999999999999997 113.879 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -97.34 166.72 11.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.37 0.605 . . . . 1.6699999999999999 112.076 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.746 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.0 mt -91.9 134.02 35.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.57999999999999996 110.109 -175.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.563 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 7.0 m-85 -124.35 162.83 22.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.892 0.314 . . . . 0.80000000000000004 110.194 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.478 HG23 HG12 ' A' ' 90' ' ' VAL . 86.3 m -102.15 109.74 21.51 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.557 -0.534 . . . . 0.35999999999999999 109.557 174.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 124' ' ' VAL . 53.0 tp -109.09 118.89 37.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.773 0.321 . . . . 0.58999999999999997 110.523 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.1 130.58 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.39000000000000001 110.742 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -90.88 141.91 28.33 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.756 -0.831 . . . . 0.59999999999999998 108.756 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.747 HG21 HG11 ' A' ' 17' ' ' VAL . 12.9 t -140.62 148.13 40.42 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.889 -0.324 . . . . 0.35999999999999999 110.66 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 22.5 t70 -133.82 97.44 15.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 121.265 0.555 . . . . 1.9199999999999999 109.959 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.555 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 3.4 Cg_endo -45.78 -47.63 13.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.489 3.459 . . . . 1.25 114.827 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 76' ' ' ARG . 30.1 m-20 -86.98 52.77 2.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.473 0.545 . . . . 1.29 112.473 -167.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.67 20.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.15 -0.477 . . . . 0.5 110.115 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 85.9 Cg_endo -82.14 -23.53 13.43 Favored 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.527 -1.447 . . . . 0.62 112.858 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.771 ' HB3' HG22 ' A' ' 115' ' ' THR . 6.4 p -137.74 153.66 49.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.75 110.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.501 ' HG3' ' OD1' ' A' ' 72' ' ' ASP . 78.9 ttt180 -68.82 -23.15 64.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.328 0.585 . . . . 2.8799999999999999 110.499 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.4 ptpt -76.21 -17.05 59.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.81 -0.632 . . . . 1.3799999999999999 110.496 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 7.9 t0 -162.97 72.63 2.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 1.3700000000000001 109.876 -172.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.28 87.99 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.266 1.978 . . . . 0.80000000000000004 112.179 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.3 mttm -76.27 -51.42 12.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.449 -1.25 . . . . 1.02 110.548 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 86.5 m-85 -80.37 19.29 0.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.155 -0.93 . . . . 1.1699999999999999 111.555 -171.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.695 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 17.2 ttp180 -69.54 126.64 30.34 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.16 -0.311 . . . . 2.9300000000000002 110.16 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.695 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 2.2 mp0 -98.66 135.35 40.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.945 0.402 . . . . 2.23 110.471 -4.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.61 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.7 t90 -80.94 135.45 35.88 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.15 -0.685 . . . . 1.4299999999999999 109.15 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 6.4 p80 -108.29 132.47 53.66 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.251 -0.58 . . . . 1.26 109.453 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.2 t-160 -83.75 -26.37 29.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.135 -0.484 . . . . 2.1400000000000001 111.514 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.696 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 23.4 p90 -168.74 178.55 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.302 -0.629 . . . . 1.51 109.302 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HG ' HD12 ' A' ' 103' ' ' LEU . 36.3 tp -141.41 114.26 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.155 0.285 . . . . 0.33000000000000002 110.416 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.697 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -120.39 132.4 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.422 0.63 . . . . 0.31 110.931 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.478 HG12 HG23 ' A' ' 65' ' ' THR . 13.5 m -133.46 166.02 30.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.149 -1.056 . . . . 0.27000000000000002 108.149 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t-20 62.16 17.38 9.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.742 0.306 . . . . 1.76 110.292 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.697 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.2 ttm -70.27 108.53 4.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.761 -0.829 . . . . 0.31 108.761 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.2 ttmm -83.48 90.42 7.21 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.817 -1.083 . . . . 1.21 110.633 -171.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.52 -126.62 7.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.943 -1.026 . . . . 0.29999999999999999 112.271 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 3.7 p-10 -111.78 24.2 12.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.411 0.624 . . . . 1.04 110.354 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.07 110.75 22.12 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.459 -0.791 . . . . 0.77000000000000002 110.157 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 97' ' ' ILE . 4.6 mm -62.28 -23.7 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.489 -1.232 . . . . 0.40999999999999998 111.188 -175.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.8 m -81.52 -40.74 22.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.68000000000000005 112.272 -172.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.1 p -70.64 -21.41 62.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.642 0.238 . . . . 1.26 111.642 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.22 102.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.266 -0.492 . . . . 0.34999999999999998 112.324 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.5 m -68.83 106.93 2.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.445 -0.576 . . . . 0.45000000000000001 109.445 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.589 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 14.8 p -90.72 116.21 31.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.316 -0.856 . . . . 0.56999999999999995 110.898 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.428 HD12 ' HG ' ' A' ' 88' ' ' LEU . 7.3 mt -89.59 -45.92 9.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.015 0.912 . . . . 0.45000000000000001 109.364 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.2 t -112.1 106.67 15.36 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.387 -1.708 . . . . 0.37 106.387 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.964 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.7 t0 -62.39 161.29 11.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.1499999999999999 112.529 -165.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -78.07 100.44 6.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.377 -0.829 . . . . 4.6900000000000004 108.902 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 33.1 t -71.12 -39.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.645 . . . . 0.85999999999999999 112.263 -173.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.51 171.45 28.08 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.768 -0.729 . . . . 0.67000000000000004 112.665 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.718 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 27.7 t -61.54 139.6 58.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.149 0.474 . . . . 0.51000000000000001 110.723 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.866 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -176.63 61.82 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.81999999999999995 111.613 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 177' ' ' VAL . 87.0 Cg_endo -85.46 136.18 5.42 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.553 2.169 . . . . 0.84999999999999998 112.929 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.757 ' HB2' HG21 ' A' ' 115' ' ' THR . 42.2 Cg_exo -57.51 148.18 74.23 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.77 2.313 . . . . 0.87 111.533 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.422 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -76.94 125.19 28.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.248 -0.433 . . . . 1.8500000000000001 111.092 -176.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.58 18.6 37.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.814 -0.708 . . . . 1.1799999999999999 112.049 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 75' ' ' SER . 70.3 p -103.55 -12.89 16.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.764 0.316 . . . . 0.96999999999999997 111.423 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.46 21.36 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.56 -0.616 . . . . 1.97 111.56 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -86.41 129.1 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.831 0.348 . . . . 0.93999999999999995 110.181 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.705 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.8 m-70 -94.1 115.63 27.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.89 -0.411 . . . . 2.23 109.89 177.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.572 ' HD2' HD21 ' A' ' 14' ' ' LEU . 6.0 ptt180 -104.29 84.94 2.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 2.3100000000000001 110.689 -172.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.621 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 22.2 m-85 -69.28 117.24 10.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.539 -0.755 . . . . 0.78000000000000003 109.539 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.586 ' CG2' HD22 ' A' ' 14' ' ' LEU . 11.6 t -95.9 129.24 46.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.841 -0.618 . . . . 0.27000000000000002 110.152 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.864 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.56 118.92 28.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.908 -0.587 . . . . 1.99 109.594 178.228 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.08 119.29 33.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.389 -0.226 . . . . 0.38 110.389 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -108.26 136.3 44.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.356 -0.538 . . . . 0.31 109.958 174.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.65 ' HB2' HD23 ' A' ' 160' ' ' LEU . 55.9 m-85 -113.88 144.25 43.35 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.904 -0.589 . . . . 5.1200000000000001 109.773 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.55 ' HB2' HG21 ' A' ' 164' ' ' VAL . 42.4 tt0 -105.87 112.0 24.89 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.485 -0.561 . . . . 2.4100000000000001 109.485 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.563 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.13 179.25 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.3100000000000001 109.788 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.51 -27.33 37.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.659 0.742 . . . . 2.3999999999999999 109.258 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.674 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 3.5 ptp180 -153.86 174.39 3.83 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 114.535 -1.212 . . . . 3.5099999999999998 111.619 -171.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.674 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 55.7 Cg_exo -52.23 152.8 14.22 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.096 2.53 . . . . 1.21 112.119 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.459 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.4 mm? -76.53 152.78 35.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 0.90000000000000002 111.977 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.76 68.96 0.68 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.225 -0.898 . . . . 2.8999999999999999 108.749 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 p -82.75 118.71 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.471 -0.786 . . . . 1.8999999999999999 111.159 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.36 8.88 33.87 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.703 -0.851 . . . . 2.96 108.703 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.54 116.92 47.91 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.667 -1.151 . . . . 1.3899999999999999 109.943 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.63 131.28 32.7 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.933 2.422 . . . . 1.27 112.155 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.4 mm -59.32 115.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.743 -0.466 . . . . 0.85999999999999999 109.743 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 145' ' ' HIS . 77.9 mt -96.46 -13.93 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.6100000000000001 112.422 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 2.4 m 59.91 -172.51 0.12 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.933 0.397 . . . . 1.8799999999999999 110.313 -172.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.964 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 25.1 p-10 -115.69 37.95 3.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.204 0.526 . . . . 0.75 110.207 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.636 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 6.9 mtm180 -116.29 136.08 53.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.276 0.56 . . . . 3.3599999999999999 111.809 -169.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.73 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.2 m 66.96 2.23 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.876 -1.056 . . . . 0.94999999999999996 113.585 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.63 92.49 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.508 -0.769 . . . . 1.1200000000000001 111.784 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.83 -49.97 73.82 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.047 0.758 . . . . 2.6600000000000001 113.047 -172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.595 ' HB2' HD13 ' A' ' 138' ' ' LEU . 43.1 m80 -117.0 69.24 0.75 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.868 -0.79 . . . . 1.8700000000000001 108.868 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.464 ' O ' ' HD1' ' A' ' 84' ' ' TRP . 5.1 ttm180 -73.81 -81.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.31 -1.314 . . . . 4.7300000000000004 112.189 -170.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.623 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -124.38 -168.41 12.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.174 -1.012 . . . . 0.65000000000000002 112.926 -169.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.2 mttt 67.73 29.18 6.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.603 0.716 . . . . 1.0800000000000001 110.099 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.67 113.16 25.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.882 -1.054 . . . . 1.8899999999999999 109.415 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 12.3 mmmm -69.94 127.98 34.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.313 0.578 . . . . 1.29 111.767 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.43 -33.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.992 -1.004 . . . . 0.78000000000000003 111.44 175.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.58 -35.53 80.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.67000000000000004 110.415 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.412 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 67.1 m -68.4 -35.5 77.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 -0.227 . . . . 0.77000000000000002 110.874 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.753 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 64.9 m-85 -58.96 -52.58 65.13 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.032 0.444 . . . . 0.92000000000000004 110.522 176.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 2.7 ptt-85 -69.12 -38.53 78.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.013 -0.54 . . . . 2.8900000000000001 111.422 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.5 mtmt -61.29 -28.42 69.18 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.75 0.278 . . . . 0.96999999999999997 111.75 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -54.88 -54.01 48.01 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.122 0.264 . . . . 1.5800000000000001 111.547 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.562 ' HB3' HD13 ' A' ' 160' ' ' LEU . 12.9 t80 -105.1 15.04 28.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.575 -0.85 . . . . 5.4500000000000002 110.479 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 61.91 45.91 7.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 2.4199999999999999 111.739 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.65 HD23 ' HB2' ' A' ' 125' ' ' TYR . 7.0 mp -81.52 176.35 9.75 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.472 -0.785 . . . . 1.27 110.604 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.559 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.0 tpt180 -101.74 -164.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.267 -0.424 . . . . 3.5899999999999999 110.5 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.559 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -71.44 166.17 41.76 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 109.704 -0.48 . . . . 0.76000000000000001 109.704 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 31.9 Cg_exo -55.2 138.04 78.28 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.53000000000000003 113.08 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.934 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -88.76 -29.85 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 CA-C-N 115.555 -0.748 . . . . 0.44 109.027 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.735 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.91 148.19 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.442 -0.503 . . . . 0.27000000000000002 111.358 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.761 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -151.22 147.01 16.48 Favored Glycine 0 N--CA 1.436 -1.317 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 112.273 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -165.54 139.67 4.69 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.431 -0.951 . . . . 0.34000000000000002 108.431 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.646 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 16.6 p -118.63 144.95 45.81 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 1.1100000000000001 111.265 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.2 p90 -127.85 127.1 42.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.655 -1.239 . . . . 0.80000000000000004 107.655 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.705 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 1.3 pt20 -106.03 133.17 51.16 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.659 -0.651 . . . . 2.5299999999999998 111.734 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -128.92 145.96 51.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.195 -0.911 . . . . 0.59999999999999998 109.616 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.409 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -121.36 -172.3 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.661 0.267 . . . . 2.3799999999999999 110.863 -177.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.981 ' HA ' HG21 ' A' ' 177' ' ' VAL . 29.9 t90 -74.76 82.8 2.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.74 -0.467 . . . . 3.96 109.74 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.3 OUTLIER -72.09 -61.62 1.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.867 -0.606 . . . . 1.53 111.293 176.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.573 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.4 t70 169.55 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.826 0.704 . . . . 1.26 109.644 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 60.7 m-85 -81.22 10.82 4.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.219 0.533 . . . . 2.2200000000000002 111.346 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.981 HG21 ' HA ' ' A' ' 173' ' ' TRP . 74.8 t -72.31 -49.39 9.32 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.5 110.712 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.8 Cg_exo -49.05 -26.34 10.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.947 2.431 . . . . 0.57999999999999996 113.06 170.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 18.1 mmmt -67.4 -24.65 65.69 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.34 0.256 . . . . 2.1400000000000001 111.629 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.866 HD23 ' HA3' ' A' ' 110' ' ' GLY . 21.5 tp -78.25 -40.75 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.112 -0.635 . . . . 0.66000000000000003 109.358 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.65 -35.26 74.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.944 -0.762 . . . . 1.8899999999999999 108.944 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 0.9 OUTLIER -55.51 -56.49 19.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.495 -1.23 . . . . 1.53 109.73 172.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -69.6 -39.02 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.705 -1.134 . . . . 1.49 112.549 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.73 ' HA ' ' H ' ' A' ' 142' ' ' SER . 74.1 mt -71.5 6.99 1.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 111.686 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.511 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 19.9 m -77.76 -3.45 41.34 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.31 -0.626 . . . . 1.05 109.31 168.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.636 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 75.1 49.67 9.36 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.839 -0.904 . . . . 1.1699999999999999 110.839 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.1 mmtp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.678 -0.677 . . . . 2.0 110.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.613 -0.143 . . . . 5.04 110.613 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 75.3 Cg_exo -50.33 132.15 33.66 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.581 2.854 . . . . 2.1299999999999999 113.184 -173.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t -55.71 127.8 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.707 -1.133 . . . . 1.47 111.953 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -146.13 160.53 41.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.889 -1.152 . . . . 1.8100000000000001 107.889 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 30.78 0.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.69999999999999996 111.005 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -76.92 -18.44 58.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.139 0.495 . . . . 1.96 110.517 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -114.36 33.44 5.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.052 0.453 . . . . 2.6600000000000001 110.25 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.732 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.1 p90 -73.89 -28.2 61.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 3.98 111.921 -174.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -147.65 11.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.63 110.641 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -76.75 -118.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.84 -0.618 . . . . 0.47999999999999998 111.671 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.2 Cg_endo -49.21 -45.89 28.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.232 2.621 . . . . 0.53000000000000003 110.703 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.755 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 9.4 mp -89.72 102.21 14.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.298 -0.864 . . . . 1.1699999999999999 111.249 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 65.98 2.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.70999999999999996 110.408 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 121' ' ' VAL . 22.0 mt -74.32 -17.45 60.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.45000000000000001 111.423 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -69.65 -5.99 28.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.294 -0.412 . . . . 2.1200000000000001 111.44 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.14 -14.12 60.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.938 0.399 . . . . 1.9299999999999999 111.41 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.924 HG11 HG21 ' A' ' 69' ' ' THR . 60.9 t -91.49 -71.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.509 -0.769 . . . . 0.63 110.744 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.541 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 23.4 t0 -155.26 176.38 12.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.483 -0.932 . . . . 2.9900000000000002 108.483 -170.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.89 100.1 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.864 -0.421 . . . . 1.6000000000000001 109.864 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.732 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -43.14 128.58 3.41 Favored Pre-proline 0 C--O 1.234 0.283 0 O-C-N 124.142 0.901 . . . . 3.5499999999999998 110.38 -176.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 53.0 Cg_exo -52.87 166.86 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.499 2.799 . . . . 0.57999999999999996 114.516 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.88 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 9.7 pt20 -84.16 -11.88 55.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.474 -1.239 . . . . 1.3899999999999999 111.812 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.73 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 14.8 m-70 -147.02 157.78 45.94 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 123.11 0.564 . . . . 1.45 110.072 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.42 123.5 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.326 2.684 . . . . 0.40000000000000002 111.652 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 16.9 tp -79.06 136.36 37.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.716 0.294 . . . . 0.28999999999999998 110.732 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.31 117.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.924 -0.399 . . . . 1.24 109.924 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.871 HG13 HG22 ' A' ' 53' ' ' ILE . 26.4 t -123.27 144.62 32.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.171 -0.678 . . . . 0.46999999999999997 109.171 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 144.22 32.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.797 0.332 . . . . 0.31 110.701 -173.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.469 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 17.8 t80 -108.92 178.52 4.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 0.67000000000000004 109.348 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -52.8 64.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 0.55000000000000004 110.843 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.69 11.23 15.84 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.596 -0.729 . . . . 0.81000000000000005 112.494 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.44 -171.3 3.38 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.877 0.37 . . . . 0.46999999999999997 110.164 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.69 154.23 17.94 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.88 -0.6 . . . . 0.33000000000000002 109.543 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.8 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 89.9 t -100.16 61.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 106.968 -1.493 . . . . 0.39000000000000001 106.968 166.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -96.14 27.68 3.56 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.402 -1.272 . . . . 0.98999999999999999 109.301 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -153.98 125.76 7.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.917 -1.142 . . . . 2.5600000000000001 107.917 173.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.8 OUTLIER -74.67 110.38 8.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.081 0.467 . . . . 0.40999999999999998 109.963 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.78 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 98.81 -3.27 58.81 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.635 -0.793 . . . . 0.58999999999999997 112.483 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -62.85 150.44 41.72 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.304 0.242 . . . . 0.34000000000000002 110.393 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.61 127.57 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.55000000000000004 110.672 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 34' ' ' VAL . 5.7 tp -115.87 169.72 9.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.153 -1.425 . . . . 0.45000000000000001 107.153 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 2.6 p -113.47 150.17 42.77 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.88 -1.128 . . . . 0.56000000000000005 113.369 -174.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 35.8 Cg_exo -61.23 -27.78 84.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.208 3.272 . . . . 0.68000000000000005 113.196 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.426 HG22 ' CD2' ' A' ' 176' ' ' TYR . 10.4 p -65.3 -40.28 93.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.84 . . . . 0.76000000000000001 109.972 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -81.46 -50.87 8.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.466 -1.243 . . . . 1.5900000000000001 111.399 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.79 ' HB ' ' HE2' ' A' ' 169' ' ' TYR . 3.8 m -85.56 25.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.209 0.528 . . . . 0.66000000000000003 112.366 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -81.25 -20.03 41.84 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.083 -0.71 . . . . 0.79000000000000004 109.083 175.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -119.5 -161.88 0.89 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.84 -1.073 . . . . 1.9099999999999999 110.052 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.645 HH22 HG21 ' A' ' 89' ' ' VAL . 29.5 mtp180 -91.38 165.84 20.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.168 -0.308 . . . . 1.4299999999999999 110.168 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 57.3 Cg_endo -75.81 169.13 22.85 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.912 1.742 . . . . 0.37 110.725 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -91.3 -18.39 24.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.787 -0.365 . . . . 0.44 110.121 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.0 m -160.77 142.52 12.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.38 112.101 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.871 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -137.99 168.21 20.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.322 -0.992 . . . . 0.29999999999999999 108.322 171.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.953 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.3 t 169.18 122.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.368 0.417 . . . . 0.34999999999999998 110.333 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.562 ' CB ' ' HB2' ' A' ' 165' ' ' ALA . 46.8 p-90 -82.65 150.99 26.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.165 -1.42 . . . . 2.7200000000000002 107.165 169.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -68.28 87.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.826 0.822 . . . . 1.51 111.15 -174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.71 -1.38 3.2 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.919 -1.037 . . . . 0.80000000000000004 111.626 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.953 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.8 tt -52.17 128.61 25.42 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.087 0.555 . . . . 0.57999999999999996 110.336 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.808 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 33.9 t70 -75.09 -27.18 59.8 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.73999999999999999 111.757 -173.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.634 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 15.9 m 73.03 2.56 4.42 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.979 -1.01 . . . . 1.03 110.192 -172.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.81 -9.06 2.6 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.127 -0.559 . . . . 0.83999999999999997 113.5 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.808 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 35.4 mtpt -94.75 161.05 14.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.251 0.525 . . . . 1.6699999999999999 109.918 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 60.8 mt -95.11 134.49 37.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.399 -0.593 . . . . 0.57999999999999996 109.399 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -133.59 145.92 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.42 -0.585 . . . . 0.80000000000000004 109.42 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.653 HG23 HG12 ' A' ' 90' ' ' VAL . 60.2 m -95.96 105.27 17.27 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.704 -0.85 . . . . 0.35999999999999999 108.704 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.737 HD13 HG12 ' A' ' 124' ' ' VAL . 49.3 tp -100.54 109.93 22.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.58999999999999997 110.193 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 88' ' ' LEU . 27.4 t -110.15 121.1 62.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.39000000000000001 110.533 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.974 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.0 mt -81.91 138.98 34.91 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.465 -0.939 . . . . 0.59999999999999998 108.465 167.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.924 HG21 HG11 ' A' ' 17' ' ' VAL . 8.9 t -144.79 147.39 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.858 -0.337 . . . . 0.35999999999999999 110.858 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 9.1 t0 -131.84 95.56 22.37 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.546 0.688 . . . . 1.9199999999999999 109.745 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 18.8 Cg_endo -60.01 -11.63 16.11 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 124.126 3.217 . . . . 1.25 114.065 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 118' ' ' HIS . 2.3 t70 -106.61 26.46 9.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.405 0.621 . . . . 1.29 110.431 -167.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' A' ' 84' ' ' TRP . . . -103.33 144.79 29.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.052 -0.522 . . . . 0.5 111.591 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -84.86 -24.47 10.2 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.207 -1.58 . . . . 0.62 112.819 -0.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.594 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 62.1 p -134.72 149.67 50.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.75 109.371 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.69 -26.86 64.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 2.8799999999999999 111.473 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.667 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -69.82 -23.5 63.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.44 -0.345 . . . . 1.3799999999999999 111.025 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -157.62 84.03 2.84 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.912 0.386 . . . . 1.3700000000000001 110.379 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.5 81.54 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.593 2.195 . . . . 0.80000000000000004 112.025 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.2 mttm -66.68 -48.18 70.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.295 -1.321 . . . . 1.02 111.46 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 48.7 m-85 -83.59 8.82 13.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.343 -0.844 . . . . 1.1699999999999999 112.16 -166.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 53.9 ttp180 -58.28 122.79 14.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 2.9300000000000002 110.794 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mp0 -101.14 131.93 46.85 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.839 0.352 . . . . 2.23 110.796 -2.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 12.5 t90 -79.52 93.66 5.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 1.4299999999999999 110.113 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.9 p-80 -67.44 123.8 21.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.352 0.596 . . . . 1.26 109.421 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.974 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 11.5 t60 -76.64 -30.76 56.99 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.622 -0.717 . . . . 2.1400000000000001 110.324 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.0 p90 -168.48 174.2 7.03 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.6 -0.519 . . . . 1.51 109.6 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' A' ' 103' ' ' LEU . 19.7 tp -134.55 114.2 12.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.907 -0.405 . . . . 0.33000000000000002 109.907 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.645 HG21 HH22 ' A' ' 49' ' ' ARG . 1.7 t -123.54 131.76 72.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.757 -0.656 . . . . 0.31 110.903 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.653 HG12 HG23 ' A' ' 65' ' ' THR . 15.0 m -133.28 163.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.957 -1.02 . . . . 0.27000000000000002 108.529 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.0 OUTLIER 62.85 18.34 10.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.333 0.396 . . . . 1.76 110.008 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.473 ' HE3' HG11 ' A' ' 89' ' ' VAL . 5.4 ttm -69.94 106.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.074 -0.713 . . . . 0.31 109.074 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 12.9 ttmm -84.21 89.72 7.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.616 -1.175 . . . . 1.21 110.697 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 82.48 -127.18 7.82 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.875 -1.057 . . . . 0.29999999999999999 112.632 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 26.5 p-10 -115.6 24.02 11.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 1.04 111.432 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -89.42 105.71 17.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.378 0.608 . . . . 0.77000000000000002 109.729 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.546 HD13 HD12 ' A' ' 53' ' ' ILE . 10.7 mm -49.98 -35.91 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.291 -1.322 . . . . 0.40999999999999998 111.387 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 m -80.88 -31.49 35.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.685 -0.689 . . . . 0.68000000000000005 111.834 -172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -72.76 -11.21 60.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 1.26 111.565 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.0 102.33 1.05 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.554 -0.831 . . . . 0.34999999999999998 111.602 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.9 m -61.98 109.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.478 0.656 . . . . 0.45000000000000001 110.066 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.6 p -83.2 117.49 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.825 -1.079 . . . . 0.56999999999999995 111.588 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.3 mt -92.85 -39.02 11.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.018 0.913 . . . . 0.45000000000000001 109.372 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 22.0 t -127.44 110.27 12.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.446 -1.316 . . . . 0.37 107.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.998 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -56.76 161.78 2.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.122 0.889 . . . . 1.1499999999999999 112.921 -170.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -83.86 101.33 11.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.37 -0.832 . . . . 4.6900000000000004 110.283 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.748 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 25.9 t -69.3 -41.46 81.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.893 -0.594 . . . . 0.85999999999999999 111.748 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.39 -176.55 24.39 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.67000000000000004 112.333 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.463 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 27.0 t -63.7 123.17 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.67 0.235 . . . . 0.51000000000000001 110.803 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -154.3 61.74 0.37 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.9 -0.667 . . . . 0.81999999999999995 112.708 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 73.9 Cg_endo -94.51 123.35 0.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.922 2.415 . . . . 0.84999999999999998 112.669 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.655 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.7 Cg_exo -52.56 140.77 54.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.884 2.39 . . . . 0.87 111.814 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.542 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -64.53 125.31 24.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.141 0.495 . . . . 1.8500000000000001 110.839 -177.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.08 -4.02 60.55 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.615 -0.802 . . . . 1.1799999999999999 112.856 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.655 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 74.0 p -78.1 -15.82 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.699 -0.295 . . . . 0.96999999999999997 111.261 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 171.33 39.37 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.876 -0.602 . . . . 1.97 111.862 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 172' ' ' GLU . 3.7 mm? -82.37 115.58 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.956 -0.757 . . . . 0.93999999999999995 108.956 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.774 ' N ' ' HG2' ' A' ' 170' ' ' GLN . 75.2 m-70 -88.61 -134.3 0.09 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.2 -0.667 . . . . 2.23 109.2 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.755 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 2.8 ptt180 -176.53 100.9 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.743 0.646 . . . . 2.3100000000000001 112.743 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' HD1' ' HB2' ' A' ' 70' ' ' ASP . 19.3 m-85 -77.78 106.79 9.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.359 -0.978 . . . . 0.78000000000000003 108.359 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.886 HG21 HD22 ' A' ' 14' ' ' LEU . 5.2 t -96.26 133.48 37.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.412 -0.358 . . . . 0.27000000000000002 110.122 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.8 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -87.74 119.41 28.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.652 -0.499 . . . . 1.99 109.652 178.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.5 mt -115.31 117.77 31.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.71 -0.478 . . . . 0.38 109.71 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.737 HG12 HD13 ' A' ' 66' ' ' LEU . 1.7 m -104.18 128.93 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.179 -0.608 . . . . 0.31 109.663 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.522 ' HD2' ' O ' ' A' ' 161' ' ' ARG . 21.0 m-85 -109.72 124.76 51.8 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.069 -0.715 . . . . 5.1200000000000001 109.069 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.92 131.15 43.99 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.346 -0.541 . . . . 2.4100000000000001 109.689 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 20.7 mt-30 -93.7 130.35 39.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.943 -0.572 . . . . 1.3100000000000001 111.044 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.69 -11.17 59.85 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.509 -0.922 . . . . 2.3999999999999999 108.509 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 1.1 ptt180 -164.71 150.57 8.95 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 114.44 -1.255 . . . . 3.5099999999999998 109.919 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HB3' ' OD1' ' A' ' 91' ' ' ASN . 15.1 Cg_exo -66.56 132.68 29.72 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.198 2.599 . . . . 1.21 112.49 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 133' ' ' CYS . 3.6 mm? -64.17 151.69 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.753 -0.658 . . . . 0.90000000000000002 111.335 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 39.08 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.25 1.024 . . . . 2.8999999999999999 109.866 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.762 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.7 m -53.44 138.49 33.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.51 -1.677 . . . . 1.8999999999999999 113.058 -172.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.55 18.18 10.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.07 -0.968 . . . . 2.96 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.762 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.8 mm-40 -69.14 126.71 92.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.758 -0.655 . . . . 1.3899999999999999 110.413 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.06 116.43 2.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.162 2.575 . . . . 1.27 112.288 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mm -63.0 115.08 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.85999999999999999 110.553 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 67.5 mt -100.61 146.4 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.533 -0.543 . . . . 1.6100000000000001 109.533 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 141' ' ' ARG . 55.5 m -111.35 35.39 3.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.721 -0.672 . . . . 1.8799999999999999 111.234 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.998 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.4 OUTLIER 63.22 -18.61 0.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.027 1.331 . . . . 0.75 113.537 175.055 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.4 mtt180 -84.55 135.9 34.02 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.188 -0.301 . . . . 3.3599999999999999 110.188 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.647 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.9 m 81.97 131.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.97 1.419 . . . . 0.94999999999999996 110.641 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.12 33.98 5.91 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 112.399 -175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.01 -30.48 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.625 0.25 . . . . 2.6600000000000001 111.424 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.99 70.61 1.35 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.211 0.529 . . . . 1.8700000000000001 111.013 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 49.3 mtt180 -79.94 -66.06 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 4.7300000000000004 110.419 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.467 ' H ' ' HD1' ' A' ' 81' ' ' TYR . . . -130.36 -143.42 5.36 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.693 -0.765 . . . . 0.65000000000000002 112.079 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.685 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 64.83 23.55 12.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.516 0.674 . . . . 1.0800000000000001 110.473 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -119.79 125.97 49.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.997 -1.002 . . . . 1.8899999999999999 108.394 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -76.9 127.76 33.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.333 0.587 . . . . 1.29 111.703 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.899 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 4.5 m -61.01 -31.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.04 -0.982 . . . . 0.78000000000000003 110.967 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.74 -39.77 92.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.773 -0.649 . . . . 0.67000000000000004 109.999 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.7 m -67.56 -34.77 77.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.396 -0.366 . . . . 0.77000000000000002 111.127 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.899 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 33.2 m-85 -59.28 -50.32 74.46 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.92000000000000004 110.058 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -63.02 -50.15 71.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.875 -1.057 . . . . 2.8900000000000001 111.139 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.0 mtmt -62.32 -27.92 69.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.281 -0.418 . . . . 0.96999999999999997 111.766 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -53.98 -53.48 52.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.193 -0.458 . . . . 1.5800000000000001 111.352 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.512 ' CG ' HD13 ' A' ' 131' ' ' LEU . 54.0 t80 -103.97 9.92 36.41 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.274 -0.571 . . . . 5.4500000000000002 111.222 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 65.37 44.0 3.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.558 0.694 . . . . 2.4199999999999999 110.18 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 160' ' ' LEU . 2.3 tp -78.45 164.68 24.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.062 -0.972 . . . . 1.27 111.037 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.633 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 22.4 tpt180 -86.9 -179.47 6.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 3.5899999999999999 109.763 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.633 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -75.93 160.4 78.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.119 -0.326 . . . . 0.76000000000000001 110.119 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.69 141.97 96.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.802 2.335 . . . . 0.53000000000000003 113.201 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.88 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.1 t -95.06 -39.44 10.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.608 -0.723 . . . . 0.44 110.15 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -136.94 145.02 43.74 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.035 -0.666 . . . . 0.27000000000000002 111.794 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.8 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.39 149.11 21.22 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.258 -0.883 . . . . 0.23999999999999999 112.626 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 25' ' ' LEU . 12.5 t -170.59 142.0 1.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.369 -0.604 . . . . 0.34000000000000002 109.369 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.78 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -108.9 144.72 36.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.032 0.444 . . . . 1.1100000000000001 111.93 -174.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.79 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 1.9 p90 -137.63 105.5 5.64 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.007 -0.738 . . . . 0.80000000000000004 109.007 171.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.774 ' HG2' ' N ' ' A' ' 118' ' ' HIS . 48.4 tp60 -100.39 169.61 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.679 -1.263 . . . . 2.5299999999999998 112.132 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' A' ' 170' ' ' GLN . . . -146.23 160.19 42.31 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.134 -0.691 . . . . 0.59999999999999998 109.134 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HB3' HD11 ' A' ' 117' ' ' LEU . 12.4 pt-20 -109.44 -171.99 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.314 -0.403 . . . . 2.3799999999999999 110.448 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.589 ' CZ2' ' HG3' ' A' ' 178' ' ' PRO . 8.3 t90 -80.48 68.85 6.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.435 . . . . 3.96 109.897 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.8 -61.33 1.82 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.453 -0.34 . . . . 1.53 111.839 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 16.6 t70 -168.94 -55.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.088 0.403 . . . . 1.26 112.088 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.426 ' CD2' HG22 ' A' ' 44' ' ' THR . 50.7 m-85 -81.57 11.21 4.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.48 0.548 . . . . 2.2200000000000002 112.48 -176.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.737 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 91.3 t -71.61 -53.68 7.23 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.579 -0.526 . . . . 0.5 109.579 171.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.0 Cg_exo -49.74 -43.22 41.16 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.706 2.271 . . . . 0.57999999999999996 112.603 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.669 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 4.7 mmmp? -70.35 -24.69 63.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.896 0.332 . . . . 2.1400000000000001 111.896 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.671 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 51.7 tp -70.39 -47.63 59.95 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.333 -0.617 . . . . 0.66000000000000003 109.333 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.22 -37.44 77.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 1.8899999999999999 109.449 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 4.8 mm-40 -60.14 -45.68 92.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.91 -1.041 . . . . 1.53 111.271 172.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.07 -32.49 72.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 1.49 111.864 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 63.4 mt -63.13 0.11 0.66 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.149 0.796 . . . . 0.76000000000000001 113.149 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.445 ' HB2' ' HE2' ' A' ' 187' ' ' LYS . 14.5 m -74.07 -9.86 59.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.305 0.574 . . . . 1.05 109.967 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.61 58.26 3.9 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.591 -1.003 . . . . 1.1699999999999999 110.591 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 182' ' ' GLU . 71.1 mmtt . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.341 -0.838 . . . . 2.0 110.655 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.677 0.275 . . . . 5.04 110.967 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 14.9 Cg_exo -70.4 108.97 2.32 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.933 2.422 . . . . 2.1299999999999999 112.24 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t 65.88 129.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.335 -0.848 . . . . 1.47 111.647 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -155.22 154.81 32.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.562 -0.533 . . . . 1.8100000000000001 109.562 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.461 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.3 mm? -81.19 27.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.48 0.178 . . . . 0.69999999999999996 111.48 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 2.0 m -62.5 -29.89 70.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.991 0.424 . . . . 1.96 111.391 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 12' ' ' LEU . 6.8 mptt -120.66 51.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.397 -0.365 . . . . 2.6600000000000001 110.109 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.42 ' HE3' ' O ' ' A' ' 5' ' ' LEU . 12.9 p90 -72.39 -23.32 61.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.45 . . . . 3.98 111.244 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 70.7 p -148.34 7.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.427 -0.509 . . . . 0.63 112.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.14 -122.28 0.08 OUTLIER Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.806 -0.711 . . . . 0.47999999999999998 112.102 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.0 Cg_endo -49.37 -42.35 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.259 2.639 . . . . 0.53000000000000003 110.253 168.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.597 HD11 ' HA3' ' A' ' 38' ' ' GLY . 17.7 mt -88.0 81.98 7.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.646 -1.161 . . . . 1.1699999999999999 109.323 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -74.7 62.14 1.04 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.542 0.687 . . . . 0.70999999999999996 110.438 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 121' ' ' VAL . 36.4 mt -79.04 -19.93 50.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.183 -0.917 . . . . 0.45000000000000001 110.922 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -61.13 -15.5 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 2.1200000000000001 111.262 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.7 -32.8 74.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 110.984 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.501 HG12 HG21 ' A' ' 151' ' ' VAL . 98.1 t -90.33 -64.15 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.532 -0.758 . . . . 0.63 110.883 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HA ' HH22 ' A' ' 155' ' ' ARG . 5.8 p-10 -115.06 175.95 5.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.077 0.465 . . . . 2.9900000000000002 111.101 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 20.6 mt-10 -95.09 33.92 1.46 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.879 -0.6 . . . . 1.6000000000000001 111.412 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER 52.38 133.67 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.217 1.407 . . . . 3.5499999999999998 113.459 -176.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' CA ' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -80.74 154.17 20.23 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.843 2.362 . . . . 0.57999999999999996 113.711 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.848 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 6.3 pt20 -74.51 -18.75 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.793 -1.094 . . . . 1.3899999999999999 111.011 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.77 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.1 m80 -145.93 156.87 51.34 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.525 -0.761 . . . . 1.45 109.7 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 5.0 Cg_endo -85.83 127.43 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 123.056 2.504 . . . . 0.40000000000000002 111.16 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.452 HD23 ' CB ' ' A' ' 122' ' ' TRP . 17.9 tp -76.97 142.04 40.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.492 -0.322 . . . . 0.28999999999999998 110.572 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 38.6 m80 -109.26 115.58 30.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.565 -0.531 . . . . 1.24 109.565 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.862 HG13 HG22 ' A' ' 53' ' ' ILE . 15.2 t -126.48 119.81 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 0.46999999999999997 109.691 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -117.68 138.8 51.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.158 0.504 . . . . 0.31 110.411 -177.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -98.16 172.41 7.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.94 -0.573 . . . . 0.67000000000000004 109.474 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.8 -52.28 64.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.215 0.531 . . . . 0.55000000000000004 110.739 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.98 -14.68 14.46 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.351 -0.84 . . . . 0.81000000000000005 112.549 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.37 -170.0 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.021 0.438 . . . . 0.46999999999999997 110.614 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -162.74 141.76 8.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.762 -0.653 . . . . 0.33000000000000002 110.464 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 92.6 t -91.73 61.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.929 -1.508 . . . . 0.39000000000000001 106.929 165.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 2' ' ' PRO . 36.5 t70 -85.59 10.61 12.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.672 -1.149 . . . . 0.98999999999999999 110.702 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.1 tt0 -146.16 134.38 21.71 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.732 -0.667 . . . . 2.5600000000000001 109.431 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.786 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -73.48 111.27 8.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.46 -0.571 . . . . 0.40999999999999998 109.46 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.597 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 90.5 17.59 51.96 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.156 -0.545 . . . . 0.58999999999999997 112.548 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.85 150.68 32.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 0.34000000000000002 109.703 174.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 12.9 p -78.73 134.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.55000000000000004 110.66 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.5 tp -131.37 169.7 15.66 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.276 -1.009 . . . . 0.45000000000000001 108.276 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 3.3 p -122.01 158.1 55.97 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.623 0.601 . . . . 0.56000000000000005 112.623 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 9.5 Cg_endo -51.35 -48.76 19.69 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.528 2.819 . . . . 0.68000000000000005 113.818 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 p -61.73 -32.84 73.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 0.76000000000000001 111.687 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -80.73 -11.44 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.995 -0.548 . . . . 1.5900000000000001 111.604 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.528 ' CG1' HD23 ' A' ' 41' ' ' LEU . 29.4 m -129.65 28.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.354 0.597 . . . . 0.66000000000000003 111.112 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.32 -21.77 25.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.555 -0.748 . . . . 0.79000000000000004 110.135 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.03 -173.0 2.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.839 -0.618 . . . . 1.9099999999999999 109.569 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.86 155.38 77.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.108 -0.33 . . . . 1.4299999999999999 110.108 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.6 152.87 29.9 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.117 1.878 . . . . 0.37 110.732 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 t -76.8 -18.25 58.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.419 -0.355 . . . . 0.44 110.057 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 58.8 m -160.33 143.29 13.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.556 0.693 . . . . 0.38 112.363 -176.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.862 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -138.66 168.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.864 -1.162 . . . . 0.29999999999999999 107.864 170.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.024 ' HA ' HD13 ' A' ' 58' ' ' LEU . 37.3 t 171.96 123.9 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.484 -0.561 . . . . 0.34999999999999998 109.484 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.724 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.3 p-90 -82.23 154.75 25.26 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.862 -1.162 . . . . 2.7200000000000002 107.862 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.59 89.13 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.009 0.433 . . . . 1.51 110.861 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.91 13.09 4.64 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.487 -0.778 . . . . 0.80000000000000004 112.011 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.024 HD13 ' HA ' ' A' ' 54' ' ' SER . 5.3 tt -54.23 129.52 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.19 0.519 . . . . 0.57999999999999996 111.267 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.778 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 36.1 t70 -76.42 -27.93 56.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.73999999999999999 111.531 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 50.2 m 72.91 1.0 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.054 -0.975 . . . . 1.03 110.52 -172.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.65 -26.87 1.52 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.69 -0.686 . . . . 0.83999999999999997 112.733 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.778 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 34.3 mtpt -77.53 149.27 34.93 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.086 0.469 . . . . 1.6699999999999999 110.549 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.636 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 43.0 mt -87.69 126.72 35.14 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.163 -0.926 . . . . 0.57999999999999996 108.736 173.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.7 m-85 -121.44 163.69 18.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.52 -0.472 . . . . 0.80000000000000004 110.168 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.981 HG23 HG12 ' A' ' 90' ' ' VAL . 4.0 m -106.56 105.35 15.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.129 -0.693 . . . . 0.35999999999999999 109.129 173.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.618 HD13 HG12 ' A' ' 124' ' ' VAL . 52.8 tp -102.8 116.34 32.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.001 0.429 . . . . 0.58999999999999997 110.517 -176.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.6 t -119.78 129.91 74.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.049 -0.523 . . . . 0.39000000000000001 110.67 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.1 mt -93.38 137.06 33.05 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.791 -0.818 . . . . 0.59999999999999998 108.791 171.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 7.0 t -139.47 149.2 43.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.656 0.265 . . . . 0.35999999999999999 111.65 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.56 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 16.0 t0 -133.8 90.71 26.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.538 0.685 . . . . 1.9199999999999999 109.697 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.9 Cg_endo -54.81 -26.54 48.31 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 124.034 3.156 . . . . 1.25 114.431 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 58.5 m-20 -85.16 36.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.065 0.395 . . . . 1.29 112.065 -168.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.93 140.34 20.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.19 -0.319 . . . . 0.5 111.566 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.0 Cg_endo -78.88 -28.04 7.86 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 122.848 -1.73 . . . . 0.62 112.037 -0.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -133.37 143.47 48.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.182 -0.917 . . . . 0.75 108.761 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 37.3 ttp180 -72.33 -23.08 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 2.8799999999999999 112.23 -174.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.763 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -75.57 -11.51 60.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.49 . . . . 1.3799999999999999 110.419 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -162.14 75.5 2.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 1.3700000000000001 109.572 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.06 103.33 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.656 2.237 . . . . 0.80000000000000004 112.994 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.6 mttm -88.05 -48.64 7.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.704 -1.134 . . . . 1.02 110.918 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.739 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 56.0 m-85 -80.45 2.4 25.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.14 -0.937 . . . . 1.1699999999999999 112.336 -165.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.3 ttp180 -60.62 128.69 37.84 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.241 -0.651 . . . . 2.9300000000000002 109.241 172.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 6.1 tm-20 -88.45 128.71 35.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.933 0.893 . . . . 2.23 110.903 2.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.44 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 22.1 t90 -114.75 91.92 3.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.819 -0.628 . . . . 1.4299999999999999 109.86 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 4.5 p-80 -83.92 158.88 21.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.061 0.934 . . . . 1.26 112.535 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 1.079 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t-80 -100.99 -38.45 8.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.047 -1.433 . . . . 2.1400000000000001 111.378 -172.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 55.3 t80 -167.11 137.58 3.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.076 -0.249 . . . . 1.51 110.469 -165.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.56 ' CD1' HG22 ' A' ' 67' ' ' VAL . 22.4 tp -126.74 114.42 17.95 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.249 0.343 . . . . 0.33000000000000002 110.41 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -123.79 135.93 61.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.421 0.629 . . . . 0.31 110.823 175.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.981 HG12 HG23 ' A' ' 65' ' ' THR . 8.1 m -130.19 162.65 37.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.27000000000000002 108.851 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.662 ' H ' HD23 ' A' ' 131' ' ' LEU . 1.0 OUTLIER 61.54 20.21 11.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.321 0.388 . . . . 1.76 110.863 177.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 89' ' ' VAL . 11.2 ttm -70.49 111.31 5.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.83 -0.804 . . . . 0.31 108.83 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.449 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 18.1 ttmm -87.78 87.4 7.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.893 -1.048 . . . . 1.21 110.341 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 88.57 -129.52 9.65 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 114.878 -1.055 . . . . 0.29999999999999999 112.495 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 32.3 p30 -116.17 27.13 9.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 1.04 110.888 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -93.93 112.51 24.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.77000000000000002 109.924 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 53' ' ' ILE . 5.6 mm -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.578 -1.192 . . . . 0.40999999999999998 111.231 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.9 m -85.59 -34.33 21.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.887 -0.597 . . . . 0.68000000000000005 112.023 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -63.49 -29.4 70.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.26 111.766 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.21 110.91 2.74 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.791 -0.64 . . . . 0.34999999999999998 113.471 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.0 m -70.58 107.43 3.88 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.195 -0.668 . . . . 0.45000000000000001 109.195 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 105' ' ' ASP . 8.3 p -87.29 145.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.67 0.748 . . . . 0.56999999999999995 111.989 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.531 HD12 ' HG ' ' A' ' 88' ' ' LEU . 13.8 mt -119.4 -32.3 4.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.689 -1.141 . . . . 0.45000000000000001 109.12 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 14.7 t -131.55 102.02 5.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.769 -1.196 . . . . 0.37 107.769 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.923 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.9 OUTLIER -64.59 169.07 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 1.1499999999999999 113.2 -167.326 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' H ' ' HD1' ' A' ' 106' ' ' TYR . 4.1 p90 -74.34 88.73 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.947 -1.024 . . . . 4.6900000000000004 110.936 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.68 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 23.8 t -66.49 -49.15 77.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.85999999999999999 111.082 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.53 -170.18 13.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.798 -0.715 . . . . 0.67000000000000004 112.338 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.9 t -67.3 125.56 26.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 0.51000000000000001 109.824 173.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.721 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -159.01 63.55 0.3 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.615 -0.802 . . . . 0.81999999999999995 112.922 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.554 ' HB2' ' HD1' ' A' ' 173' ' ' TRP . 10.1 Cg_endo -89.68 133.73 2.21 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.884 2.39 . . . . 0.84999999999999998 111.844 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.712 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 53.0 Cg_exo -53.32 129.35 33.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.149 . . . . 0.87 111.196 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.553 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.8 OUTLIER -60.56 121.36 11.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.191 0.52 . . . . 1.8500000000000001 111.712 -174.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.68 -6.39 52.21 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.479 -0.782 . . . . 1.1799999999999999 113.252 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.712 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -80.65 -5.98 57.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.2 0.444 . . . . 0.96999999999999997 112.2 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.62 178.38 45.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.915 -0.659 . . . . 1.97 111.571 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.56 144.93 56.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.93999999999999995 110.657 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 1.0 OUTLIER -121.93 130.88 53.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.138 -0.69 . . . . 2.23 109.138 174.259 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.634 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 8.4 ptp85 -110.72 95.71 5.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.4 0.619 . . . . 2.3100000000000001 111.361 -170.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 69' ' ' THR . 36.8 m-85 -73.87 113.55 11.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.78000000000000003 109.357 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.682 HG21 HD22 ' A' ' 14' ' ' LEU . 7.1 t -90.52 129.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.604 -0.726 . . . . 0.27000000000000002 110.062 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.665 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 77.4 m95 -87.54 117.98 26.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.943 -1.132 . . . . 1.99 107.943 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.52 118.37 30.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.24 -0.184 . . . . 0.38 110.557 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.618 HG12 HD13 ' A' ' 66' ' ' LEU . 1.2 m -105.33 128.24 59.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.342 -0.614 . . . . 0.31 109.342 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.47 ' HB2' HD23 ' A' ' 160' ' ' LEU . 88.2 m-85 -110.62 146.53 35.98 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.794 -0.639 . . . . 5.1200000000000001 109.618 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.648 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.9 tt0 -105.58 109.88 22.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.028 -0.533 . . . . 2.4100000000000001 109.954 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.642 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -72.38 172.52 10.25 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.447 -0.797 . . . . 1.3100000000000001 109.644 177.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -85.59 -15.21 43.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.794 -0.639 . . . . 2.3999999999999999 109.397 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.51 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 5.2 ppt_? -158.1 168.5 12.32 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.138 -0.937 . . . . 3.5099999999999998 110.861 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 87.2 Cg_exo -47.93 147.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.045 2.497 . . . . 1.21 113.025 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.803 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -71.5 157.05 38.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.795 -0.638 . . . . 0.90000000000000002 112.006 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -146.93 79.36 1.52 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.092 -0.958 . . . . 2.8999999999999999 108.493 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.576 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 3.5 m -102.25 139.9 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.086 0.469 . . . . 1.8999999999999999 111.183 -173.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -112.89 17.73 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 2.96 109.533 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 15.8 mm-40 -68.81 132.17 90.82 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.259 -0.882 . . . . 1.3899999999999999 110.941 -174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.13 111.36 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.465 2.776 . . . . 1.27 113.065 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.24 125.64 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.711 -0.677 . . . . 0.85999999999999999 111.583 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -112.12 141.22 46.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.566 -0.531 . . . . 1.6100000000000001 109.566 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 141' ' ' ARG . 19.6 m -102.13 40.59 1.32 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.569 -0.741 . . . . 1.8799999999999999 110.728 -173.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 59.11 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.992 1.317 . . . . 0.75 113.506 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.601 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 47.0 mtt85 -84.59 155.78 21.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.121 -0.696 . . . . 3.3599999999999999 109.121 173.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.591 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 10.3 p 52.72 120.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.769 1.227 . . . . 0.94999999999999996 113.05 -171.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -97.3 30.99 8.21 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.119 -0.946 . . . . 1.1200000000000001 112.308 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.54 -34.67 72.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.937 0.717 . . . . 2.6600000000000001 112.937 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -125.65 42.05 3.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.305 0.574 . . . . 1.8700000000000001 111.417 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.514 ' HD2' HG21 ' A' ' 107' ' ' VAL . 42.7 mtp180 -87.47 -18.3 30.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.031 -0.532 . . . . 4.7300000000000004 112.157 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -145.25 -171.59 15.04 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 119.056 -1.545 . . . . 0.65000000000000002 114.884 -173.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.739 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.0 mttt 61.87 37.5 15.27 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 114.319 -0.94 . . . . 1.0800000000000001 110.887 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 80.4 m-85 -120.71 173.99 6.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.275 -1.33 . . . . 1.8899999999999999 108.281 170.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 12.1 mmmm -117.27 123.53 46.8 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.679 -0.408 . . . . 1.29 111.679 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 17' ' ' VAL . 6.6 m -57.98 -26.09 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.852 -0.613 . . . . 0.78000000000000003 110.791 174.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -68.15 -43.59 77.93 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.905 -0.589 . . . . 0.67000000000000004 109.93 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.587 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 23.7 m -61.88 -39.16 90.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.77000000000000002 110.273 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -62.53 -48.85 77.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.248 -0.433 . . . . 0.92000000000000004 110.96 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.8 ptp180 -67.38 -33.8 75.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.86 -0.336 . . . . 2.8900000000000001 110.723 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 48.8 mtmt -67.94 -28.63 67.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 0.96999999999999997 110.825 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -72.8 -51.88 17.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 110.965 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.741 ' HB2' HD13 ' A' ' 160' ' ' LEU . 12.3 m-85 -84.48 -2.11 56.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.363 -0.38 . . . . 5.4500000000000002 111.978 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 19.4 mm-40 69.19 45.63 0.86 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.689 0.757 . . . . 2.4199999999999999 110.932 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.741 HD13 ' HB2' ' A' ' 158' ' ' TYR . 5.7 mp -99.53 140.17 34.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.768 -1.106 . . . . 1.27 109.541 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -88.97 -84.43 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 3.5899999999999999 111.451 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.53 163.16 48.93 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.76000000000000001 109.579 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.498 ' HB2' ' CA ' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.8 133.27 41.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.48 2.12 . . . . 0.53000000000000003 112.128 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.848 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -89.12 -31.49 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 108.927 -0.768 . . . . 0.44 108.927 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.77 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.57 144.64 24.58 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.5 -0.773 . . . . 0.27000000000000002 111.261 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.665 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.94 146.82 16.66 Favored Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 115.006 -0.997 . . . . 0.23999999999999999 111.682 176.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.786 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.4 t -160.11 131.21 5.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.945 -0.761 . . . . 0.34000000000000002 108.945 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 16.5 p -110.91 138.25 47.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.177 0.513 . . . . 1.1100000000000001 110.862 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 120' ' ' TYR . 28.1 p90 -119.57 125.37 48.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.078 -1.082 . . . . 0.80000000000000004 108.078 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 1.2 pt20 -103.92 132.2 50.4 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.754 -0.779 . . . . 2.5299999999999998 109.928 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -124.33 140.04 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 0.59999999999999998 111.613 -172.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.62 151.67 26.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 2.3799999999999999 111.341 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.973 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -76.26 68.35 2.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.21 -0.904 . . . . 3.96 108.949 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.54 -61.53 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.143 -0.935 . . . . 1.53 112.32 -170.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.591 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.2 t70 -171.44 -38.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.868 0.366 . . . . 1.26 111.802 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -80.03 2.04 25.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 2.2200000000000002 110.605 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.973 HG21 ' HA ' ' A' ' 173' ' ' TRP . 48.7 t -69.46 -51.22 17.17 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.761 -0.654 . . . . 0.5 111.371 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.9 Cg_exo -50.29 -31.72 30.6 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.253 1.968 . . . . 0.57999999999999996 112.567 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.68 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.08 -22.68 63.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.401 . . . . 2.1400000000000001 111.42 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.721 HD23 ' HA3' ' A' ' 110' ' ' GLY . 42.6 tp -68.36 -44.45 75.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.313 -0.555 . . . . 0.66000000000000003 109.591 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -61.4 -37.8 84.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.292 -0.633 . . . . 1.8899999999999999 109.292 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.68 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.3 mm-40 -55.19 -42.03 72.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.909 -1.041 . . . . 1.53 110.319 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.629 ' HA ' ' HB2' ' A' ' 187' ' ' LYS . 5.4 tt0 -77.35 -35.31 54.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 1.49 112.453 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.591 ' HA ' ' H ' ' A' ' 142' ' ' SER . 80.7 mt -63.34 -2.85 1.63 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.003 0.372 . . . . 0.76000000000000001 112.003 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.765 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.4 m -81.53 13.94 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 1.05 109.566 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.601 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 69.84 46.31 53.59 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.065 -0.97 . . . . 1.1699999999999999 111.201 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.765 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.451 -0.785 . . . . 2.0 109.993 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 3.6 mpp? . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.531 -0.174 . . . . 5.04 110.531 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 51.8 Cg_exo -55.12 146.23 60.34 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.277 2.652 . . . . 2.1299999999999999 112.779 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.66 134.57 26.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.844 -0.616 . . . . 1.47 110.277 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.558 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 15.6 t70 -162.2 156.57 21.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.816 -0.809 . . . . 1.8100000000000001 108.816 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.457 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.8 mm? -80.46 20.8 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.657 0.265 . . . . 0.69999999999999996 111.101 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -11.73 61.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.126 0.488 . . . . 1.96 110.906 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.566 ' HB3' HD12 ' A' ' 12' ' ' LEU . 95.3 mttt -116.86 30.88 7.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 2.6600000000000001 110.352 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.821 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -75.62 -23.4 56.37 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.452 0.538 . . . . 3.98 112.452 -173.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 13.7 p -152.9 26.47 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 0.63 111.199 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.97 -119.66 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.014 -0.834 . . . . 0.47999999999999998 111.014 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 19.4 Cg_endo -55.47 -36.47 94.27 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.832 2.355 . . . . 0.53000000000000003 110.329 164.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.761 HD11 ' HA3' ' A' ' 38' ' ' GLY . 13.4 mt -89.05 85.74 6.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.638 -1.164 . . . . 1.1699999999999999 110.669 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -74.78 62.41 1.08 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.70999999999999996 110.728 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.577 HD22 ' CG2' ' A' ' 121' ' ' VAL . 46.7 mt -78.03 -16.67 57.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.45000000000000001 111.577 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.49 -12.29 56.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.272 0.558 . . . . 2.1200000000000001 110.43 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -67.92 -20.27 65.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 1.9299999999999999 111.056 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.814 HG11 HG21 ' A' ' 69' ' ' THR . 70.6 t -92.09 -66.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.794 -0.639 . . . . 0.63 110.791 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.75 170.86 14.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 2.9900000000000002 110.682 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -70.22 105.79 3.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 1.6000000000000001 109.285 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.821 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 27.5 mm-40 -47.53 134.73 10.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 O-C-N 123.91 0.756 . . . . 3.5499999999999998 112.346 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 39.0 Cg_exo -62.43 169.04 8.72 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.389 3.392 . . . . 0.57999999999999996 114.898 -167.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.901 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 11.4 pt20 -82.25 -13.25 57.33 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.74 -1.118 . . . . 1.3899999999999999 111.907 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.77 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.6 m170 -149.09 159.52 37.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.871 -0.604 . . . . 1.45 109.544 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 3.9 Cg_endo -85.44 127.96 3.4 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.079 2.519 . . . . 0.40000000000000002 111.101 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 122' ' ' TRP . 26.9 tp -78.0 147.84 34.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.735 0.303 . . . . 0.28999999999999998 110.854 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -116.72 107.72 15.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.867 -0.42 . . . . 1.24 109.867 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.903 HG13 HG22 ' A' ' 53' ' ' ILE . 6.9 t -114.56 127.91 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.085 -0.709 . . . . 0.46999999999999997 109.085 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -126.27 138.82 53.65 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.923 0.392 . . . . 0.31 110.678 -176.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.42 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 36.6 t80 -101.51 170.96 7.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.019 -0.537 . . . . 0.67000000000000004 109.66 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.82 68.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.463 0.649 . . . . 0.55000000000000004 110.654 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -112.47 13.67 25.42 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.253 -0.885 . . . . 0.81000000000000005 112.511 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.4 -171.1 3.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.935 0.398 . . . . 0.46999999999999997 110.634 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.48 147.1 10.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.757 -0.656 . . . . 0.33000000000000002 110.203 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.842 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -104.36 58.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.084 -1.45 . . . . 0.39000000000000001 107.084 165.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.74 30.26 1.85 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.98999999999999999 109.793 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.4 tt0 -157.86 127.91 6.14 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.126 -0.943 . . . . 2.5600000000000001 108.827 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.591 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -68.58 111.17 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.40999999999999998 110.026 -176.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.761 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.11 14.86 63.64 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.447 -0.797 . . . . 0.58999999999999997 112.756 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.842 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.89 147.03 47.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 0.34000000000000002 109.653 175.034 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.2 p -74.38 132.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.912 0.387 . . . . 0.55000000000000004 110.956 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.56 HD22 HG22 ' A' ' 34' ' ' VAL . 6.3 tp -132.46 167.21 20.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.952 -0.759 . . . . 0.45000000000000001 108.952 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.86 157.07 47.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.699 0.629 . . . . 0.56000000000000005 112.699 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 89.3 Cg_exo -50.56 -45.84 32.77 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.158 2.572 . . . . 0.68000000000000005 113.044 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.63 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 8.2 p -54.65 -39.63 68.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.58 0.705 . . . . 0.76000000000000001 111.214 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -83.32 -7.91 59.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.01 -0.995 . . . . 1.5900000000000001 112.425 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' CE1' ' A' ' 169' ' ' TYR . 17.8 m -131.84 27.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.372 0.606 . . . . 0.66000000000000003 111.543 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -95.55 5.36 51.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.79000000000000004 110.574 -175.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -152.5 179.02 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 109.442 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -68.53 148.47 98.12 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.118 -0.327 . . . . 1.4299999999999999 110.118 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.43 166.29 26.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.059 1.839 . . . . 0.37 110.823 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -87.92 -19.09 27.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.894 -0.41 . . . . 0.44 109.894 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.531 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 47.6 m -158.1 143.11 16.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.785 0.661 . . . . 0.38 112.785 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.903 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.27 157.67 25.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.502 -1.226 . . . . 0.29999999999999999 107.915 170.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.897 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 t 173.77 135.42 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.11 -0.7 . . . . 0.34999999999999998 109.11 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.789 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -88.96 177.1 6.75 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 2.7200000000000002 108.229 173.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.67 76.86 0.11 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.873 0.368 . . . . 1.51 110.693 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.88 40.4 0.99 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.293 -0.48 . . . . 0.80000000000000004 112.84 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.897 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.5 tt -65.17 127.87 33.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.57999999999999996 110.145 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.2 -30.5 68.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.844 -0.616 . . . . 0.73999999999999999 111.947 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.534 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 44.8 m 72.14 -3.69 2.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.12 -0.946 . . . . 1.03 110.752 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.64 5.7 26.18 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.834 -0.621 . . . . 0.83999999999999997 112.501 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 9.0 mmpt? -111.86 160.33 17.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.614 0.245 . . . . 1.6699999999999999 110.366 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.771 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 mt -97.46 141.85 30.03 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.518 -1.29 . . . . 0.57999999999999996 107.518 168.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CE2' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -136.72 147.2 46.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.842 -0.343 . . . . 0.80000000000000004 110.205 -178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.917 HG23 HG12 ' A' ' 90' ' ' VAL . 4.4 m -95.7 104.76 16.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.622 -0.881 . . . . 0.35999999999999999 108.622 174.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.1 tp -101.7 109.12 20.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.587 -0.733 . . . . 0.58999999999999997 109.387 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 88' ' ' LEU . 20.9 t -115.3 122.45 69.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.405 -0.361 . . . . 0.39000000000000001 110.95 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.911 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -86.62 134.03 33.66 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.744 -0.836 . . . . 0.59999999999999998 108.744 169.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.814 HG21 HG11 ' A' ' 17' ' ' VAL . 13.3 t -138.9 148.56 43.78 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.928 -0.309 . . . . 0.35999999999999999 111.073 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 30.4 t70 -131.22 99.37 17.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.264 0.554 . . . . 1.9199999999999999 110.217 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.531 ' HD3' HG21 ' A' ' 17' ' ' VAL . 10.3 Cg_endo -53.4 -34.29 70.57 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 124.179 3.252 . . . . 1.25 114.437 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.815 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -89.96 40.2 0.99 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.174 0.435 . . . . 1.29 112.174 -168.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.06 144.92 29.65 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.708 -0.224 . . . . 0.5 111.506 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.0 Cg_endo -83.83 -20.58 18.78 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 123.259 -1.559 . . . . 0.62 112.102 -0.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.714 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 77.7 p -134.87 146.82 49.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.75 109.846 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.815 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 58.7 mtp180 -70.3 -22.74 62.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.916 0.339 . . . . 2.8799999999999999 111.916 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.849 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.45 -14.8 45.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.277 0.561 . . . . 1.3799999999999999 110.517 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.44 79.51 4.9 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.004 -0.739 . . . . 1.3700000000000001 109.004 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.97 81.28 1.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.863 2.376 . . . . 0.80000000000000004 113.049 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 13.6 mttm -71.99 -51.57 21.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.514 -1.221 . . . . 1.02 111.251 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.715 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 38.9 m-85 -86.39 19.11 2.89 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.401 -0.818 . . . . 1.1699999999999999 111.896 -167.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 6.7 ttp180 -67.05 127.19 31.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.856 -0.611 . . . . 2.9300000000000002 110.06 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.8 mp0 -98.2 138.61 35.22 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.328 0.251 . . . . 2.23 110.36 -1.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.467 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 5.9 t90 -89.88 105.81 18.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 1.4299999999999999 110.03 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 52.9 p-80 -80.82 122.43 27.18 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.452 0.644 . . . . 1.26 110.203 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.911 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 7.0 t-80 -61.8 -40.56 95.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.981 -1.009 . . . . 2.1400000000000001 110.649 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 104' ' ' SER . 26.0 p90 -167.17 178.45 5.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.622 -0.511 . . . . 1.51 109.622 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.8 tp -141.84 113.65 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.708 0.289 . . . . 0.33000000000000002 110.247 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.53 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.8 t -120.42 132.47 69.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.817 -0.628 . . . . 0.31 110.573 176.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.917 HG12 HG23 ' A' ' 65' ' ' THR . 3.8 m -129.92 166.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.095 -1.076 . . . . 0.27000000000000002 108.095 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.771 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 91.1 m-20 60.85 20.44 10.65 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 123.486 0.491 . . . . 1.76 111.141 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.52 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -72.28 115.17 11.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.693 -0.854 . . . . 0.31 108.693 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 15.1 ttmm -87.06 93.17 9.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.314 -0.857 . . . . 1.21 111.307 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 60' ' ' SER . . . 80.33 -129.75 9.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 114.829 -1.078 . . . . 0.29999999999999999 112.48 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.473 ' HA ' HD11 ' A' ' 53' ' ' ILE . 26.1 p30 -112.91 22.12 14.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.604 0.716 . . . . 1.04 110.512 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.31 112.79 24.48 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.992 -1.004 . . . . 0.77000000000000002 109.609 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.453 HD13 HD12 ' A' ' 53' ' ' ILE . 5.3 mm -59.95 -27.6 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.358 -1.292 . . . . 0.40999999999999998 111.103 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -69.73 -51.36 34.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.68000000000000005 112.112 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 p -61.85 -20.55 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.822 0.675 . . . . 1.26 112.822 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 92' ' ' MET . . . -52.91 103.08 0.11 Allowed Glycine 0 N--CA 1.449 -0.455 0 O-C-N 123.352 0.408 . . . . 0.34999999999999998 112.92 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.4 m -68.05 107.39 2.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.436 0.636 . . . . 0.45000000000000001 109.773 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.68 120.77 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.896 -1.047 . . . . 0.56999999999999995 111.617 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 133' ' ' CYS . 55.8 mt -99.32 -44.71 6.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.227 1.013 . . . . 0.45000000000000001 109.289 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.9 t -120.51 111.9 18.27 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.885 -1.524 . . . . 0.37 106.885 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.842 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 2.3 t0 -64.84 162.04 17.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.551 -0.75 . . . . 1.1499999999999999 112.018 -170.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 31.0 p90 -81.23 61.22 4.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.339 0.866 . . . . 4.6900000000000004 113.339 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.926 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 27.0 t -37.54 -47.32 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.017 0.927 . . . . 0.85999999999999999 113.365 -171.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 47' ' ' LYS . . . 107.12 -172.45 17.97 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.655 -0.783 . . . . 0.67000000000000004 112.505 173.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.4 t -68.9 117.29 10.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.564 -0.532 . . . . 0.51000000000000001 109.564 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.767 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -148.2 61.43 0.44 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.389 -0.91 . . . . 0.81999999999999995 112.662 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.677 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 9.8 Cg_endo -91.87 127.15 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.495 2.796 . . . . 0.84999999999999998 112.734 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.579 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.9 Cg_exo -53.8 146.02 47.53 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.796 2.331 . . . . 0.87 111.775 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.457 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -62.51 119.61 9.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.288 -0.414 . . . . 1.8500000000000001 111.221 -177.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.9 -1.51 55.29 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.861 -0.685 . . . . 1.1799999999999999 113.146 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 77.7 p -77.39 -26.33 51.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.998 0.399 . . . . 0.96999999999999997 112.002 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 -178.61 17.83 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.953 -0.641 . . . . 1.97 112.232 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.4 mm? -81.8 116.85 21.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.615 0.245 . . . . 0.93999999999999995 110.39 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.695 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 40.6 m-70 -92.81 126.8 38.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.416 -0.356 . . . . 2.23 110.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.505 ' HD2' HD21 ' A' ' 14' ' ' LEU . 8.9 ptt180 -108.56 85.92 2.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.757 -0.656 . . . . 2.3100000000000001 110.664 -172.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.51 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 5.8 m-85 -69.73 116.69 10.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.592 -0.731 . . . . 0.78000000000000003 109.549 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.577 ' CG2' HD22 ' A' ' 14' ' ' LEU . 15.1 t -97.43 128.96 48.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.037 -0.528 . . . . 0.27000000000000002 110.714 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.679 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 48.7 m95 -88.57 121.54 31.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.177 -0.675 . . . . 1.99 109.177 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.2 mt -118.31 119.91 36.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.624 0.193 . . . . 0.38 110.791 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.497 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -117.52 140.0 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.722 0.296 . . . . 0.31 111.121 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.716 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 89.3 t80 -129.53 129.09 44.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.177 -0.465 . . . . 5.1200000000000001 109.812 174.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.63 103.2 2.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.549 0.69 . . . . 2.4100000000000001 109.22 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 23.0 mt-30 -58.41 135.85 57.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.033 -0.985 . . . . 1.3100000000000001 112.028 -171.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.8 -13.25 61.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.486 -0.779 . . . . 2.3999999999999999 109.603 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.544 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 7.7 ptp180 -173.51 161.75 3.31 Favored Pre-proline 0 CA--C 1.515 -0.381 0 CA-C-N 114.838 -1.073 . . . . 3.5099999999999998 109.637 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.58 136.22 65.74 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.9 2.4 . . . . 1.21 110.691 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 158' ' ' TYR . 4.1 mm? -68.11 146.89 53.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.721 1.008 . . . . 0.90000000000000002 113.721 -167.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -99.1 96.52 7.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.176 -1.375 . . . . 2.8999999999999999 108.073 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.455 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.4 p -124.88 109.64 13.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.91 -0.586 . . . . 1.8999999999999999 111.728 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -102.72 18.18 22.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.908 -0.775 . . . . 2.96 108.908 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.79 135.41 96.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.183 -0.917 . . . . 1.3899999999999999 111.195 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.5 113.89 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.39 2.727 . . . . 1.27 112.531 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.49 120.28 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.85999999999999999 110.056 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 71.3 mt -99.66 154.59 18.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.13 0.49 . . . . 1.6100000000000001 110.54 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.704 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 72.1 m -108.03 31.56 5.43 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.263 -0.881 . . . . 1.8799999999999999 109.689 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.926 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 9.1 p30 54.9 12.53 0.61 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.485 1.116 . . . . 0.75 111.553 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 139' ' ' SER . 17.1 mtm180 -96.71 146.85 24.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.3599999999999999 110.097 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.654 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.4 m 77.89 131.14 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.519 1.137 . . . . 0.94999999999999996 111.958 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.624 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -87.46 -6.5 77.46 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.086 -0.961 . . . . 1.1200000000000001 112.655 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.46 -42.75 70.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.605 0.717 . . . . 2.6600000000000001 111.374 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -97.3 20.01 12.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.354 -0.839 . . . . 1.8700000000000001 111.012 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.624 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 63.9 mtt180 -76.7 -69.92 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 4.7300000000000004 111.835 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.509 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -117.3 -173.01 16.32 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.217 -0.992 . . . . 0.65000000000000002 113.369 -171.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.715 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.5 mttt 68.33 21.89 8.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.728 0.775 . . . . 1.0800000000000001 110.602 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.661 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 87.7 m-85 -111.3 97.71 6.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.807 -1.088 . . . . 1.8899999999999999 108.476 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 13.2 mmmm -59.49 123.27 16.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 1.29 112.168 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.568 HG21 ' CG1' ' A' ' 17' ' ' VAL . 16.8 m -63.84 -25.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.242 -0.89 . . . . 0.78000000000000003 110.6 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.73 72.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.67000000000000004 109.608 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 m -59.81 -43.7 94.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.77000000000000002 110.633 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 149' ' ' PHE . 7.0 m-85 -58.56 -53.27 60.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.037 -0.528 . . . . 0.92000000000000004 111.584 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -69.76 -39.74 76.52 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.479 -0.488 . . . . 2.8900000000000001 111.379 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.61 -32.3 72.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.97 0.414 . . . . 0.96999999999999997 110.405 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -66.8 -51.38 56.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.527 -0.76 . . . . 1.5800000000000001 110.918 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.851 ' HB3' HD11 ' A' ' 131' ' ' LEU . 21.6 m-85 -80.23 3.91 19.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.075 -0.511 . . . . 5.4500000000000002 111.744 -172.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 8.4 mm-40 70.55 30.67 3.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.589 0.555 . . . . 2.4199999999999999 111.016 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.716 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.3 mp -102.34 134.24 45.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.563 -0.744 . . . . 1.27 109.79 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 7.8 tpt180 -102.74 -78.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 3.5899999999999999 111.181 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -125.85 145.77 52.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 0.76000000000000001 110.805 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 2.9 Cg_exo -74.61 161.63 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.908 3.072 . . . . 0.53000000000000003 113.537 -172.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.901 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 14.4 t -91.43 -26.88 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.632 -1.167 . . . . 0.44 109.895 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.789 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -152.58 145.2 24.2 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.003 -0.679 . . . . 0.27000000000000002 112.231 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.44 151.05 23.36 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.035 -0.984 . . . . 0.23999999999999999 112.018 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.591 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.1 t -165.57 141.15 5.11 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.449 -0.945 . . . . 0.34000000000000002 108.449 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.609 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 17.3 p -119.0 149.32 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.034 -0.667 . . . . 1.1100000000000001 111.045 -175.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.606 ' CE1' HG11 ' A' ' 46' ' ' VAL . 35.7 p90 -130.32 129.71 43.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.94 -1.133 . . . . 0.80000000000000004 107.94 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.695 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 1.2 pt20 -101.52 133.78 45.63 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.867 -0.733 . . . . 2.5299999999999998 111.417 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.94 152.17 49.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.59999999999999998 109.501 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.603 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -126.37 -162.41 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.006 0.432 . . . . 2.3799999999999999 111.322 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.457 ' CG ' ' HG2' ' A' ' 113' ' ' LYS . 89.6 t90 -70.46 103.2 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.96 -0.564 . . . . 3.96 110.343 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 2.0 t70 -73.69 -62.06 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.583 -0.28 . . . . 1.53 110.371 171.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.586 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 11.5 t70 169.45 -50.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 1.26 110.434 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.63 ' OH ' ' HA ' ' A' ' 44' ' ' THR . 2.4 p90 -82.72 9.8 8.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.189 0.519 . . . . 2.2200000000000002 111.094 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.767 HG13 ' HA2' ' A' ' 110' ' ' GLY . 48.1 t -58.47 -49.15 95.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.972 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 175' ' ' ASP . 72.9 Cg_exo -47.89 -33.75 20.59 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.039 2.493 . . . . 0.57999999999999996 112.899 168.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 3.0 mmmp? -72.69 -25.56 61.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.636 0.255 . . . . 2.1400000000000001 111.108 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.528 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 62.5 tp -70.58 -44.29 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.049 -0.723 . . . . 0.66000000000000003 109.049 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.27 -32.95 74.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.316 -0.856 . . . . 1.8899999999999999 109.446 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.5 mm-40 -60.84 -38.29 85.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.955 -1.02 . . . . 1.53 111.02 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -76.33 -27.08 56.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.74 -0.663 . . . . 1.49 111.439 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.654 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.2 mt -65.93 6.6 0.35 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.852 0.686 . . . . 0.76000000000000001 112.852 -177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.746 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.2 m -77.15 8.31 4.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 1.05 109.955 173.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 68.89 50.54 34.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.104 -0.798 . . . . 1.1699999999999999 111.104 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.746 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.8 mmmt . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.667 -0.682 . . . . 2.0 110.582 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.141 -0.318 . . . . 5.04 110.141 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.46 104.41 1.57 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.341 2.027 . . . . 2.1299999999999999 110.88 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.4 p -112.12 146.7 16.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.45 -1.25 . . . . 1.47 110.275 -173.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.776 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 2.2 p30 -163.39 179.93 6.98 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.142 -1.058 . . . . 1.8100000000000001 108.142 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 8' ' ' TRP . 2.7 mm? -80.93 36.01 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.69999999999999996 110.866 -170.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -51.91 -40.1 60.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 1.96 111.834 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.572 ' HB2' HD12 ' A' ' 12' ' ' LEU . 92.0 mttt -116.17 46.16 1.62 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.868 -0.419 . . . . 2.6600000000000001 109.868 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.639 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -66.43 -24.21 66.42 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.286 -0.416 . . . . 3.98 111.328 -173.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.1 p -151.6 26.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.951 -0.3 . . . . 0.63 111.347 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.505 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.85 -125.5 0.81 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.888 -0.885 . . . . 0.47999999999999998 110.888 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -52.02 -36.29 64.45 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.109 2.54 . . . . 0.53000000000000003 110.342 167.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.773 HD11 ' HA3' ' A' ' 38' ' ' GLY . 35.3 mt -87.87 79.26 8.14 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.825 -1.08 . . . . 1.1699999999999999 109.606 171.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -71.44 66.73 0.48 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.615 0.722 . . . . 0.70999999999999996 109.82 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.927 HD23 HH11 ' A' ' 119' ' ' ARG . 44.1 mt -80.45 -16.39 54.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.741 -0.663 . . . . 0.45000000000000001 110.65 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -64.13 -16.17 61.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.589 -0.732 . . . . 2.1200000000000001 111.225 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.551 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 39.3 mt-10 -62.34 -30.33 71.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.189 0.519 . . . . 1.9299999999999999 110.546 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 69' ' ' THR . 85.7 t -93.41 -64.03 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.63 111.16 -174.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 163' ' ' PRO . 7.1 p-10 -130.04 169.05 15.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.152 -0.476 . . . . 2.9900000000000002 110.219 -171.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -74.57 88.16 2.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.443 -0.947 . . . . 1.6000000000000001 108.443 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 2.7 tp-100 -38.34 122.61 1.1 Allowed Pre-proline 0 C--O 1.237 0.433 0 O-C-N 124.925 1.391 . . . . 3.5499999999999998 111.901 -166.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.724 ' HG3' ' HB2' ' A' ' 163' ' ' PRO . 81.5 Cg_exo -50.29 161.64 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 125.235 3.957 . . . . 0.57999999999999996 116.193 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 12.6 pt20 -79.1 -6.96 57.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 113.837 -1.529 . . . . 1.3899999999999999 111.46 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.722 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.6 m170 -154.28 158.85 32.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.468 -0.787 . . . . 1.45 109.236 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.776 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 6.0 Cg_endo -86.74 129.12 2.98 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.193 2.595 . . . . 0.40000000000000002 111.844 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 ' HB3' ' A' ' 122' ' ' TRP . 21.5 tp -78.88 144.54 34.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.654 -0.248 . . . . 0.28999999999999998 110.728 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.403 ' H ' HD12 ' A' ' 25' ' ' LEU . 86.2 m-70 -112.64 112.94 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 1.24 109.89 174.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 53' ' ' ILE . 12.0 t -121.12 137.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.423 -0.584 . . . . 0.46999999999999997 109.423 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.557 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -132.4 141.24 48.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.271 0.558 . . . . 0.31 111.063 -177.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -103.14 173.32 6.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.857 -0.794 . . . . 0.67000000000000004 108.857 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.41 -52.29 65.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.291 0.567 . . . . 0.55000000000000004 110.347 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.96 14.77 23.83 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.178 -0.919 . . . . 0.81000000000000005 112.999 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.54 -172.25 4.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.46999999999999997 111.148 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.95 151.61 12.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.71 -0.677 . . . . 0.33000000000000002 110.05 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.795 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 86.2 t -109.23 65.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.157 -1.423 . . . . 0.39000000000000001 107.157 164.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.83 21.07 16.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.002 -0.999 . . . . 0.98999999999999999 109.15 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -145.83 128.1 15.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.687 -1.227 . . . . 2.5600000000000001 107.687 176.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -77.96 111.74 14.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.611 0.72 . . . . 0.40999999999999998 110.803 -170.122 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 83.17 22.35 57.28 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.742 -1.117 . . . . 0.58999999999999997 111.385 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -77.68 148.73 34.84 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.388 -0.597 . . . . 0.34000000000000002 109.388 173.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.96 133.44 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.001 0.429 . . . . 0.55000000000000004 110.874 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.566 HD22 HG22 ' A' ' 34' ' ' VAL . 7.4 tp -131.58 170.29 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.45000000000000001 108.618 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.6 p -120.03 158.46 50.25 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.317 0.858 . . . . 0.56000000000000005 113.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 74.9 Cg_exo -50.29 -49.19 17.12 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.438 2.759 . . . . 0.68000000000000005 113.569 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.7 p -55.72 -42.83 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.462 0.649 . . . . 0.76000000000000001 111.52 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -73.21 -12.32 60.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.874 -1.057 . . . . 1.5900000000000001 112.225 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.562 ' CG1' HD23 ' A' ' 41' ' ' LEU . 31.5 m -131.7 28.25 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.087 0.47 . . . . 0.66000000000000003 111.455 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -85.12 -33.85 22.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.818 -0.628 . . . . 0.79000000000000004 110.467 -176.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.46 -155.89 0.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.786 -0.643 . . . . 1.9099999999999999 109.556 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -84.01 157.19 63.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.394 -0.595 . . . . 1.4299999999999999 109.394 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.4 160.44 28.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.755 1.637 . . . . 0.37 110.594 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -82.15 -20.72 37.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.105 -0.332 . . . . 0.44 110.105 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 57.9 m -160.32 144.86 14.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.239 0.542 . . . . 0.38 112.056 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.971 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.1 168.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.154 -0.93 . . . . 0.29999999999999999 108.575 171.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.02 ' HA ' HD13 ' A' ' 58' ' ' LEU . 29.3 t 174.04 122.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.462 -0.57 . . . . 0.34999999999999998 109.462 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.737 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -79.45 179.52 7.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.337 -0.986 . . . . 2.7200000000000002 108.337 174.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.8 80.8 0.29 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.15 0.5 . . . . 1.51 110.473 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.17 41.58 1.51 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.633 -0.712 . . . . 0.80000000000000004 112.386 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.02 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -55.54 133.74 50.41 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.83 0.452 . . . . 0.57999999999999996 111.51 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.55 -27.38 60.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.848 -0.615 . . . . 0.73999999999999999 111.867 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.626 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 49.3 m 68.23 8.32 6.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.561 -0.745 . . . . 1.03 110.834 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.689 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -137.17 -47.87 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.905 -0.589 . . . . 0.83999999999999997 112.662 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.798 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 8.3 mmpt? -58.66 144.54 42.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.231 0.538 . . . . 1.6699999999999999 111.411 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.735 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 31.0 mt -86.82 127.73 35.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.111 -0.95 . . . . 0.57999999999999996 109.486 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.798 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -122.3 158.66 29.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.55 -0.46 . . . . 0.80000000000000004 110.278 176.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.724 HG23 HG12 ' A' ' 90' ' ' VAL . 96.0 m -98.51 109.39 22.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.392 -0.596 . . . . 0.35999999999999999 109.392 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 tp -106.15 116.83 32.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 110.052 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.9 t -120.98 132.43 70.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.76 0.314 . . . . 0.39000000000000001 110.74 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.922 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -97.49 131.57 44.0 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.508 -0.923 . . . . 0.59999999999999998 108.508 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.716 HG21 HG11 ' A' ' 17' ' ' VAL . 11.0 t -138.82 147.53 42.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.142 0.428 . . . . 0.35999999999999999 111.657 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 25.6 t70 -131.28 97.43 19.82 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.161 0.505 . . . . 1.9199999999999999 109.805 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.9 Cg_endo -51.63 -34.56 53.58 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.99 3.127 . . . . 1.25 114.298 176.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.737 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -86.97 44.82 1.2 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.654 0.612 . . . . 1.29 112.654 -170.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.08 142.12 23.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.687 -0.233 . . . . 0.5 110.706 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 92.1 Cg_endo -85.07 -24.76 9.58 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 123.465 -1.473 . . . . 0.62 113.096 -0.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.714 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 13.2 p -128.76 146.45 50.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.75 109.793 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.737 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 50.8 mtp180 -65.99 -21.89 66.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 2.8799999999999999 111.141 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 6.0 ptpt -79.66 -14.26 58.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 1.3799999999999999 110.829 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 16.4 t70 -162.09 80.51 1.88 Allowed Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.007 -0.542 . . . . 1.3700000000000001 110.188 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 85.6 Cg_endo -80.95 87.21 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.543 2.162 . . . . 0.80000000000000004 112.93 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -74.74 -50.97 15.49 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.738 -1.119 . . . . 1.02 110.661 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.708 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.1 m-85 -85.45 21.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 1.1699999999999999 111.742 -166.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.551 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 29.4 ttt180 -71.66 129.56 38.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.382 -0.372 . . . . 2.9300000000000002 110.685 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 3.0 mp0 -96.44 132.04 42.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.859 0.361 . . . . 2.23 110.632 -3.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.56 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 11.9 t90 -82.65 140.3 33.23 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.012 -0.736 . . . . 1.4299999999999999 109.012 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 28.6 p80 -117.72 127.15 53.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.633 0.73 . . . . 1.26 111.258 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.922 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 15.5 t-80 -65.45 -35.89 82.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.806 -1.088 . . . . 2.1400000000000001 110.36 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.548 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 12.0 p90 -168.06 176.79 5.9 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.651 -0.249 . . . . 1.51 110.363 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.55 ' HG ' HD12 ' A' ' 103' ' ' LEU . 21.5 tp -135.77 113.53 11.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.33000000000000002 109.657 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.714 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.9 t -119.66 133.23 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.648 -0.706 . . . . 0.31 110.19 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.897 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 22.2 m -133.94 161.75 40.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.285 -0.871 . . . . 0.27000000000000002 108.956 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t30 60.71 22.01 11.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.661 0.601 . . . . 1.76 110.353 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.714 ' HE3' HG11 ' A' ' 89' ' ' VAL . 6.7 ttm -71.88 110.3 6.31 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.175 -0.676 . . . . 0.31 109.175 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 20.9 ttmm -80.34 98.28 7.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.21 . . . . 1.21 111.133 -173.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.81 -121.76 20.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.603 -0.726 . . . . 0.29999999999999999 112.509 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.8 p-10 -113.26 21.42 15.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.567 -0.316 . . . . 1.04 111.735 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -89.51 104.22 16.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.415 0.626 . . . . 0.77000000000000002 109.848 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 97' ' ' ILE . 5.2 mm -55.55 -31.28 28.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.584 -1.189 . . . . 0.40999999999999998 111.561 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -81.04 -26.38 36.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.68000000000000005 111.602 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.05 -13.04 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.492 -0.322 . . . . 1.26 111.225 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.62 100.53 0.83 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.78 -0.724 . . . . 0.34999999999999998 111.579 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.2 m -60.24 106.55 0.54 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.476 0.655 . . . . 0.45000000000000001 109.668 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -80.19 113.1 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.847 -1.07 . . . . 0.56999999999999995 111.214 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.55 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.7 mt -93.2 -41.97 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.99 0.9 . . . . 0.45000000000000001 109.243 174.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 11.9 t -122.68 112.22 17.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.192 -1.41 . . . . 0.37 107.192 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 3.4 t70 -59.96 164.41 3.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.652 -0.704 . . . . 1.1499999999999999 112.217 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 10.3 p90 -79.24 72.27 5.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.269 -0.878 . . . . 4.6900000000000004 111.002 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.725 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 28.1 t -51.45 -44.68 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 0.85999999999999999 111.447 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.69 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 97.72 -171.75 26.57 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.26 -0.971 . . . . 0.67000000000000004 113.416 171.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 41.0 t -73.42 128.68 36.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.778 -0.452 . . . . 0.51000000000000001 109.778 174.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.602 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . 171.99 58.64 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.211 -0.995 . . . . 0.81999999999999995 113.706 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.405 ' HD3' ' H ' ' A' ' 110' ' ' GLY . 62.9 Cg_endo -86.69 -176.66 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.628 2.219 . . . . 0.84999999999999998 111.005 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.628 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 48.1 Cg_exo -57.14 142.25 94.38 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.464 1.443 . . . . 0.87 111.81 172.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.414 ' CD ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -66.1 114.69 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.514 -0.766 . . . . 1.8500000000000001 111.46 -177.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.15 12.7 38.59 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 1.1799999999999999 113.698 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 34.0 p -81.65 2.09 31.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.82 1.044 . . . . 0.96999999999999997 113.82 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.25 -179.73 27.16 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.612 -0.804 . . . . 1.97 112.375 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -83.41 118.03 23.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.938 0.399 . . . . 0.93999999999999995 110.141 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.692 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 47.1 m-70 -91.39 117.76 29.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.103 -0.499 . . . . 2.23 110.952 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.927 HH11 HD23 ' A' ' 14' ' ' LEU . 9.9 ptt180 -91.51 82.01 5.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.67 -0.695 . . . . 2.3100000000000001 111.313 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.548 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 42.4 m-85 -67.76 109.39 3.33 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.753 -0.832 . . . . 0.78000000000000003 108.753 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 14' ' ' LEU . 21.9 t -88.09 127.32 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.901 -0.59 . . . . 0.27000000000000002 109.971 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.846 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.92 117.53 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.486 -0.931 . . . . 1.99 108.486 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 mt -121.26 127.57 51.52 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.959 0.162 . . . . 0.38 110.899 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.602 HG21 ' HE3' ' A' ' 55' ' ' TRP . 1.1 m -114.4 131.54 66.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.459 -0.496 . . . . 0.31 109.917 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.729 ' HB2' HD23 ' A' ' 160' ' ' LEU . 48.4 m-85 -111.95 149.13 32.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.325 -0.62 . . . . 5.1200000000000001 109.325 176.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.93 126.66 48.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.671 0.748 . . . . 2.4100000000000001 110.449 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.506 ' HG2' HD21 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -96.82 175.51 6.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.183 -0.917 . . . . 1.3100000000000001 108.714 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.53 2.71 42.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.547 0.689 . . . . 2.3999999999999999 109.498 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.407 ' H ' ' HB2' ' A' ' 127' ' ' GLN . 1.3 ptp180 -160.66 164.98 18.24 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.947 -1.024 . . . . 3.5099999999999998 111.206 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.01 155.42 33.81 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.027 2.485 . . . . 1.21 110.946 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.897 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.4 mm? -84.14 145.91 28.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.311 0.577 . . . . 0.90000000000000002 112.143 -172.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -124.31 66.06 1.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.142 -0.935 . . . . 2.8999999999999999 108.741 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 5.2 m -93.6 120.99 34.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.537 -0.756 . . . . 1.8999999999999999 110.395 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.88 14.97 30.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 2.96 109.936 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -64.73 132.14 95.35 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.429 -0.805 . . . . 1.3899999999999999 110.563 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -47.09 117.08 2.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.539 2.826 . . . . 1.27 113.067 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.19 118.67 6.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.85999999999999999 110.496 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.4 mt -92.7 156.08 17.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 1.6100000000000001 110.608 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 50.2 m -116.03 32.57 6.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.8799999999999999 110.172 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.725 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER 66.75 -21.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.238 1.415 . . . . 0.75 113.45 175.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 54.9 mtt180 -78.31 135.44 37.51 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.776 -0.37 . . . . 3.3599999999999999 110.868 -175.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.713 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 62.1 m 81.84 146.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.559 -1.201 . . . . 0.94999999999999996 110.674 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.453 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -108.22 12.71 37.04 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.867 -0.682 . . . . 1.1200000000000001 113.038 -170.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.17 -15.22 62.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.324 0.49 . . . . 2.6600000000000001 112.324 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -121.58 34.85 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.087 0.47 . . . . 1.8700000000000001 110.324 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.453 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 26.6 mtt180 -81.05 -69.68 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.662 -0.699 . . . . 4.7300000000000004 111.902 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -128.31 -164.38 11.55 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.447 -0.882 . . . . 0.65000000000000002 112.763 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.708 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 65.43 25.27 11.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.441 0.639 . . . . 1.0800000000000001 110.229 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.26 112.31 21.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.083 -0.962 . . . . 1.8899999999999999 109.095 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 13.7 mmmm -67.18 122.17 17.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.805 -0.634 . . . . 1.29 111.525 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.801 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.2 m -62.85 -27.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.78000000000000003 110.351 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.31 -43.34 99.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.759 172.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 34.9 m -63.87 -39.33 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.944 -0.571 . . . . 0.77000000000000002 110.618 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.801 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 50.4 m-85 -58.81 -52.05 67.37 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.649 -0.251 . . . . 0.92000000000000004 110.999 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.943 -0.303 . . . . 2.8900000000000001 111.358 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.4 mtmt -64.17 -42.25 96.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.38 0.609 . . . . 0.96999999999999997 109.935 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -58.77 -53.27 60.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 1.5800000000000001 111.449 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.41 -3.33 58.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 5.4500000000000002 111.493 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 68.22 40.89 2.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.792 -0.64 . . . . 2.4199999999999999 111.27 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.729 HD23 ' HB2' ' A' ' 125' ' ' TYR . 5.4 mp -95.97 146.34 24.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.451 -0.795 . . . . 1.27 112.008 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.755 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 14.5 tpt180 -82.73 -171.24 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.291 -0.868 . . . . 3.5899999999999999 109.853 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.755 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -60.98 155.74 52.35 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.76000000000000001 110.639 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.724 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 13.2 Cg_exo -66.7 141.93 61.89 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.968 2.445 . . . . 0.53000000000000003 112.279 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.861 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 12.2 t -89.47 -34.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.794 -0.639 . . . . 0.44 110.092 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.737 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -146.26 141.37 27.28 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.903 -0.719 . . . . 0.27000000000000002 112.128 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.56 148.94 20.93 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.024 -0.989 . . . . 0.23999999999999999 111.976 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.6 t -159.85 133.05 6.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.798 -0.816 . . . . 0.34000000000000002 108.798 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.576 ' SG ' HD13 ' A' ' 12' ' ' LEU . 22.2 p -111.07 142.42 43.25 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 1.1100000000000001 111.33 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.548 ' CE2' ' HB2' ' A' ' 120' ' ' TYR . 32.3 p90 -126.61 134.14 50.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.567 -0.901 . . . . 0.80000000000000004 108.567 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.747 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 1.6 mp0 -98.6 131.88 44.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.212 -0.595 . . . . 2.5299999999999998 110.104 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -121.21 142.37 49.98 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.36 0.412 . . . . 0.59999999999999998 110.345 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -97.18 -171.8 2.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 2.3799999999999999 111.263 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.853 ' HA ' HG21 ' A' ' 177' ' ' VAL . 28.5 p90 -97.41 53.62 1.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.226 -0.897 . . . . 3.96 110.508 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.506 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 32.6 t70 -60.28 -61.74 2.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.6 0.963 . . . . 1.53 113.6 -168.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.668 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.9 t70 -167.4 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.017 0.377 . . . . 1.26 112.017 -175.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -71.95 -3.89 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.148 0.499 . . . . 2.2200000000000002 110.876 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.853 HG21 ' HA ' ' A' ' 173' ' ' TRP . 25.6 t -71.02 -55.1 6.78 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.749 . . . . 0.5 111.316 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.729 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.4 Cg_exo -58.2 -32.09 94.98 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.999 1.799 . . . . 0.57999999999999996 111.764 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.3 mmmt -74.06 -24.77 59.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 2.1400000000000001 111.913 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.686 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 43.9 tp -70.53 -47.25 61.33 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.13 -0.628 . . . . 0.66000000000000003 109.375 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -59.27 -35.46 73.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.603 -0.726 . . . . 1.8899999999999999 109.405 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.3 -51.48 68.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.807 -1.088 . . . . 1.53 111.002 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -69.17 -32.04 71.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 1.49 112.277 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.713 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.1 mt -62.77 3.65 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.503 0.927 . . . . 0.76000000000000001 113.503 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.611 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 47.7 m -82.84 13.34 3.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.413 0.625 . . . . 1.05 109.336 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.82 44.1 57.14 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.368 -0.833 . . . . 1.1699999999999999 111.162 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 28.8 mmmt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.344 -0.836 . . . . 2.0 109.841 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 121.293 0.568 . . . . 5.04 109.598 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.86 138.23 47.77 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 124.17 3.246 . . . . 2.1299999999999999 114.22 -162.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 37' ' ' LEU . 21.2 t -55.18 132.7 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.167 -1.378 . . . . 1.47 110.217 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.27 33.93 0.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.057 0.932 . . . . 1.8100000000000001 110.49 -173.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.5 mm? 60.11 20.86 10.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.414 -1.266 . . . . 0.69999999999999996 110.757 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.72 -33.72 64.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.613 0.765 . . . . 1.96 112.334 -171.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.645 ' CB ' HD12 ' A' ' 12' ' ' LEU . 76.1 mttt -135.75 50.18 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.207 -0.451 . . . . 2.6600000000000001 110.375 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.432 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -72.87 -28.71 62.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.341 0.497 . . . . 3.98 112.341 -176.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 19.5 p -152.65 29.11 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.63 111.208 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.26 -122.69 0.83 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.957 -0.857 . . . . 0.47999999999999998 110.957 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.6 Cg_endo -52.8 -37.56 76.7 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.222 2.615 . . . . 0.53000000000000003 110.343 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.833 HD11 ' HA3' ' A' ' 38' ' ' GLY . 16.5 mt -87.73 83.06 7.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.951 -1.022 . . . . 1.1699999999999999 109.657 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -73.5 63.42 0.8 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.519 0.676 . . . . 0.70999999999999996 110.497 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 121' ' ' VAL . 58.9 mt -71.19 -16.6 62.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.729 -0.669 . . . . 0.45000000000000001 109.79 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -70.42 -4.47 22.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.49 -0.777 . . . . 2.1200000000000001 110.694 177.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.89 -27.06 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.624 -0.88 . . . . 1.9299999999999999 108.624 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 151' ' ' VAL . 60.0 t -99.1 -71.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.609 -1.178 . . . . 0.63 110.408 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HB2' HH22 ' A' ' 155' ' ' ARG . 7.5 p-10 -110.7 153.35 25.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 111.564 -172.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 26.1 mt-10 -65.51 142.15 58.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.001 -1.0 . . . . 1.6000000000000001 109.326 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 98.7 mt-30 -55.61 120.59 33.17 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 123.335 0.397 . . . . 3.5499999999999998 111.132 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 20' ' ' GLN . 23.2 Cg_exo -64.27 162.08 31.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.051 2.501 . . . . 0.57999999999999996 112.685 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.899 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.9 pt20 -84.82 -12.85 52.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.779 -0.646 . . . . 1.3899999999999999 111.217 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.778 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 66.3 m-70 -153.2 161.43 29.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.415 -0.957 . . . . 1.45 108.415 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.7 Cg_endo -88.22 132.27 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.852 2.368 . . . . 0.40000000000000002 112.233 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 122' ' ' TRP . 28.3 tp -78.31 144.75 35.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.807 -0.442 . . . . 0.28999999999999998 109.807 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.463 ' H ' HD12 ' A' ' 25' ' ' LEU . 31.4 m80 -122.81 113.35 19.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.609 -0.515 . . . . 1.24 109.609 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 53' ' ' ILE . 10.6 t -117.65 136.43 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.731 -0.47 . . . . 0.46999999999999997 109.731 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -134.45 136.79 43.48 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.061 0.458 . . . . 0.31 111.076 -176.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -97.16 176.26 5.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.975 -0.75 . . . . 0.67000000000000004 108.975 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.68 62.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.508 0.671 . . . . 0.55000000000000004 110.191 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.91 1.56 31.74 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 115.089 -0.959 . . . . 0.81000000000000005 112.666 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB2' HE21 ' A' ' 45' ' ' GLN . . . -138.16 -174.75 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.633 0.254 . . . . 0.46999999999999997 110.605 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.58 149.64 11.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.154 -0.476 . . . . 0.33000000000000002 110.392 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.815 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 96.2 t -101.78 62.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 106.71 -1.589 . . . . 0.39000000000000001 106.71 163.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.77 -9.3 59.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.032 -1.44 . . . . 0.98999999999999999 110.882 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -131.44 134.56 46.34 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.567 -0.901 . . . . 2.5600000000000001 108.567 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.621 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -75.84 109.62 9.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.376 -0.601 . . . . 0.40999999999999998 109.376 -175.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.833 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 85.07 23.38 49.16 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.391 -0.822 . . . . 0.58999999999999997 112.471 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.815 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -80.19 149.52 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.627 -0.508 . . . . 0.34000000000000002 109.627 171.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -73.86 133.02 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.155 0.502 . . . . 0.55000000000000004 110.983 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.461 HD22 HG22 ' A' ' 34' ' ' VAL . 7.9 tp -131.06 168.55 17.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.115 -1.069 . . . . 0.45000000000000001 108.115 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 23.2 p -121.87 157.13 58.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 119.569 -0.853 . . . . 0.56000000000000005 112.349 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 10.1 Cg_endo -51.53 -41.99 57.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.093 2.529 . . . . 0.68000000000000005 113.028 -176.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -62.71 -26.82 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.111 -0.495 . . . . 0.76000000000000001 112.159 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 32' ' ' ALA . 56.7 mt-30 -82.27 -25.34 34.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.945 -0.571 . . . . 1.5900000000000001 111.289 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 169' ' ' TYR . 18.5 m -122.01 29.11 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.66000000000000003 111.552 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.12 -7.33 58.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.014 -0.539 . . . . 0.79000000000000004 110.202 -177.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.461 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 59.2 m-80 -127.26 -174.91 3.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.603 -0.726 . . . . 1.9099999999999999 109.315 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.597 ' NH2' ' HB ' ' A' ' 102' ' ' VAL . 72.5 mtt180 -77.0 155.11 82.84 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.75 -0.463 . . . . 1.4299999999999999 109.75 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.23 153.42 18.62 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.06 1.84 . . . . 0.37 110.874 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -79.25 -18.57 52.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.909 0.385 . . . . 0.44 110.223 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.482 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -157.0 141.35 16.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.524 0.678 . . . . 0.38 112.446 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.913 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.23 158.28 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.773 -1.103 . . . . 0.29999999999999999 108.503 172.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.115 ' HA ' HD13 ' A' ' 58' ' ' LEU . 26.3 t -179.23 122.04 0.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.976 -0.379 . . . . 0.34999999999999998 109.976 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.829 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -76.12 156.0 34.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.347 -1.353 . . . . 2.7200000000000002 107.347 170.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.529 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 17.8 t70 -59.84 85.9 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.25 0.548 . . . . 1.51 110.715 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.93 15.17 5.33 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.61 -0.723 . . . . 0.80000000000000004 112.765 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.115 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.2 tt -50.79 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.505 . . . . 0.57999999999999996 111.182 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.4 t70 -71.14 -29.97 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.644 -0.707 . . . . 0.73999999999999999 111.453 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 m 72.82 15.44 4.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.679 -1.146 . . . . 1.03 110.245 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.78 -6.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.474 -0.87 . . . . 0.83999999999999997 114.03 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.5 mtpt -96.17 161.27 14.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.028 0.914 . . . . 1.6699999999999999 110.46 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 51.5 mt -90.97 132.32 36.04 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.878 -0.786 . . . . 0.57999999999999996 108.878 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.564 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -132.83 147.72 52.31 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.646 -0.421 . . . . 0.80000000000000004 110.317 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.649 HG23 HG12 ' A' ' 90' ' ' VAL . 65.5 m -95.54 105.57 17.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.772 -0.825 . . . . 0.35999999999999999 108.772 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 57.1 tp -106.49 113.48 27.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.552 -0.749 . . . . 0.58999999999999997 109.697 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 88' ' ' LEU . 44.3 t -114.42 129.45 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.39000000000000001 110.452 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.0 mt -85.17 124.04 31.37 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.64 -0.874 . . . . 0.59999999999999998 108.64 168.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -135.83 138.18 42.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.926 0.393 . . . . 0.35999999999999999 110.011 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 17.6 p-10 -125.93 102.23 28.45 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 121.523 0.678 . . . . 1.9199999999999999 110.729 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -54.77 -177.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.378 2.718 . . . . 1.25 112.808 170.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.636 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.6 m-20 55.1 41.42 31.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 1.29 111.274 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.57 140.58 21.22 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 115.726 -0.67 . . . . 0.5 110.176 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.502 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 90.6 Cg_endo -81.65 -26.44 9.03 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.003 -1.665 . . . . 0.62 112.475 2.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.783 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 89.3 p -123.11 146.13 47.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.592 . . . . 0.75 110.314 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.636 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 74.4 ttt180 -67.55 -23.21 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 2.8799999999999999 111.257 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.722 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -82.87 -18.35 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 1.3799999999999999 111.064 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.15 90.12 2.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.048 -0.524 . . . . 1.3700000000000001 109.875 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 91.8 Cg_endo -85.33 93.46 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.863 2.375 . . . . 0.80000000000000004 113.814 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.502 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.4 mttm -82.69 -50.3 8.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.749 0.785 . . . . 1.02 110.477 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.79 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 63.7 m-85 -88.1 25.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.966 -1.015 . . . . 1.1699999999999999 111.225 -170.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.703 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.52 128.7 33.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.306 -0.406 . . . . 2.9300000000000002 110.445 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.703 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.0 mp0 -94.83 149.59 21.09 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.067 0.46 . . . . 2.23 110.773 -3.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.524 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 4.4 t90 -92.06 137.37 32.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.08 -1.081 . . . . 1.4299999999999999 108.08 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.473 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 9.1 p-80 -110.5 141.06 44.17 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.339 -0.615 . . . . 1.26 109.339 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 -15.14 12.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.248 0.833 . . . . 2.1400000000000001 113.248 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.496 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 3.2 p90 -169.38 166.59 10.34 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.447 -0.205 . . . . 1.51 110.447 162.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 67' ' ' VAL . 33.6 tp -133.84 113.96 12.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.151 -0.477 . . . . 0.33000000000000002 109.922 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.527 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -123.83 132.47 71.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.658 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 65' ' ' THR . 22.1 m -134.02 161.17 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.101 -0.954 . . . . 0.27000000000000002 108.793 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.3 t30 63.37 16.79 9.79 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.506 0.504 . . . . 1.76 110.273 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.527 ' HE3' HG11 ' A' ' 89' ' ' VAL . 6.8 ttm -67.42 111.8 4.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.718 -0.845 . . . . 0.31 108.718 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -87.64 96.89 10.59 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.005 -0.998 . . . . 1.21 111.016 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.63 -126.49 9.11 Favored Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 114.857 -1.065 . . . . 0.29999999999999999 112.284 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.534 ' HA ' HD11 ' A' ' 53' ' ' ILE . 4.4 p-10 -112.56 23.26 13.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 1.04 110.7 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.9 109.02 19.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.77000000000000002 109.908 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -59.45 -33.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.40999999999999998 110.625 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.3 m -73.6 -34.75 65.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.795 -0.638 . . . . 0.68000000000000005 111.951 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.5 -6.16 48.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.882 0.327 . . . . 1.26 111.882 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 92' ' ' MET . . . -70.82 96.6 0.6 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.451 -0.881 . . . . 0.34999999999999998 111.836 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.8 m -60.96 107.73 0.76 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.45000000000000001 110.325 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.597 ' HB ' ' NH2' ' A' ' 49' ' ' ARG . 7.5 p -87.51 130.25 37.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.86 -1.064 . . . . 0.56999999999999995 111.76 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 10.3 mt -112.2 -49.94 2.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.101 0.953 . . . . 0.45000000000000001 108.874 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.3 t -109.58 99.67 8.83 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.005 -1.48 . . . . 0.37 107.005 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.475 ' HB2' ' N ' ' A' ' 140' ' ' ASN . 3.7 m-20 -56.86 157.58 5.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.139 -0.937 . . . . 1.1499999999999999 113.114 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 14.7 p90 -74.31 107.58 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.782 -1.099 . . . . 4.6900000000000004 110.143 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.3 t -80.72 -15.69 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.543 0.687 . . . . 0.85999999999999999 110.276 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.53 -146.61 22.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.998 -0.62 . . . . 0.67000000000000004 111.801 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.593 ' O ' HD22 ' A' ' 180' ' ' LEU . 14.2 t -83.2 140.92 32.28 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.677 -0.49 . . . . 0.51000000000000001 109.677 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.61 68.5 0.19 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.354 -0.927 . . . . 0.81999999999999995 113.747 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.431 ' O ' HG11 ' A' ' 177' ' ' VAL . 57.6 Cg_endo -98.35 122.7 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.527 2.818 . . . . 0.84999999999999998 112.304 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 74.3 Cg_exo -50.93 146.68 20.92 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.045 2.497 . . . . 0.87 112.474 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 116.92 5.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 1.8500000000000001 111.482 -174.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.27 64.19 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.952 -0.567 . . . . 1.1799999999999999 113.777 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.783 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 51.3 p -79.82 -62.76 1.59 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.087 0.444 . . . . 0.96999999999999997 112.113 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.35 178.06 30.12 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.07 -0.812 . . . . 1.97 111.07 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -71.74 106.89 4.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.972 0.415 . . . . 0.93999999999999995 110.557 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 3.4 m-70 -77.31 116.55 18.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 2.23 110.115 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.819 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 9.7 ptt180 -94.87 90.09 5.89 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.464 -0.789 . . . . 2.3100000000000001 110.642 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.57 ' HE1' ' HB3' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.99 107.63 6.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.86 -0.793 . . . . 0.78000000000000003 108.86 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 168' ' ' CYS . 19.9 t -90.36 129.52 41.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.569 -0.742 . . . . 0.27000000000000002 109.479 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.643 ' HB2' HD23 ' A' ' 25' ' ' LEU . 23.3 m95 -89.93 119.74 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.397 -0.964 . . . . 1.99 108.397 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 79.5 mt -113.72 119.68 38.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.734 0.243 . . . . 0.38 111.205 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.565 HG12 HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -119.18 135.22 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.249 0.547 . . . . 0.31 111.328 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.79 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 72.3 t80 -128.35 128.88 45.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 5.1200000000000001 109.121 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.537 ' HG2' HG21 ' A' ' 164' ' ' VAL . 6.5 pt-20 -67.53 107.63 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.096 -0.705 . . . . 2.4100000000000001 109.096 175.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 18.6 mt-30 -56.42 137.56 52.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.387 -0.824 . . . . 1.3100000000000001 112.392 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.42 -26.17 68.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.887 -1.051 . . . . 2.3999999999999999 108.691 168.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 8.6 ptp180 -167.29 158.73 10.31 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 114.111 -1.404 . . . . 3.5099999999999998 109.762 -177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HA ' ' NE2' ' A' ' 127' ' ' GLN . 15.4 Cg_exo -61.69 131.95 37.94 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.759 2.306 . . . . 1.21 110.383 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.448 ' HG ' HG11 ' A' ' 90' ' ' VAL . 4.2 mm? -64.41 152.35 41.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.955 1.094 . . . . 0.90000000000000002 113.955 -166.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -109.65 85.69 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.224 -1.353 . . . . 2.8999999999999999 108.651 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.782 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 58.3 m -132.06 116.35 16.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 1.8999999999999999 111.412 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -106.26 39.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.714 -0.847 . . . . 2.96 108.714 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.9 mm-40 -73.89 131.44 81.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.801 -1.091 . . . . 1.3899999999999999 110.585 -173.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.8 119.96 4.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.408 2.739 . . . . 1.27 112.7 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 15.2 mm -70.11 115.2 8.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.578 -0.527 . . . . 0.85999999999999999 109.578 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.88 -14.44 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.651 0.611 . . . . 1.6100000000000001 112.651 -170.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' A' ' 105' ' ' ASP . 37.1 m 55.43 23.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.489 0.922 . . . . 1.8799999999999999 113.489 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.625 ' HA ' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER 60.29 -2.78 0.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.21 1.004 . . . . 0.75 113.515 172.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.584 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 66.5 mtt180 -100.12 135.91 40.83 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.16 -0.338 . . . . 3.3599999999999999 110.137 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.604 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.0 m 82.26 131.9 0.05 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 124.524 1.14 . . . . 0.94999999999999996 111.396 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.7 41.6 2.16 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.196 -0.911 . . . . 1.1200000000000001 113.109 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -71.68 -34.34 69.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 2.6600000000000001 110.921 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -125.34 73.51 1.32 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 1.8700000000000001 110.721 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.429 ' HB3' ' CE2' ' A' ' 84' ' ' TRP . 63.8 mtt180 -78.73 -77.15 0.17 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.155 -0.93 . . . . 4.7300000000000004 111.549 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -132.72 -137.16 3.88 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.708 -0.758 . . . . 0.65000000000000002 112.908 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.79 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 90.3 mttt 65.04 28.37 12.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.717 0.77 . . . . 1.0800000000000001 110.246 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -103.92 167.94 9.45 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.909 -1.041 . . . . 1.8899999999999999 108.763 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 11.8 mmmm -117.35 117.53 29.75 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.002 -0.37 . . . . 1.29 110.002 173.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.685 HG21 HG12 ' A' ' 17' ' ' VAL . 27.8 m -61.14 -24.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 0.78000000000000003 110.8 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.15 82.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.852 -0.613 . . . . 0.67000000000000004 109.505 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.9 m -65.53 -35.43 80.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.77000000000000002 110.692 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.684 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 26.9 m-85 -58.65 -56.36 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.92000000000000004 110.685 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.492 HH22 ' HB2' ' A' ' 18' ' ' ASP . 18.4 ptp180 -66.02 -43.22 88.28 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.8900000000000001 110.682 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -62.79 -36.16 82.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.682 0.277 . . . . 0.96999999999999997 111.607 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -63.04 -45.17 93.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.165 0.507 . . . . 1.5800000000000001 110.846 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 131' ' ' LEU . 20.8 m-85 -83.0 1.86 37.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 5.4500000000000002 110.478 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 64.19 33.07 12.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.163 -0.926 . . . . 2.4199999999999999 111.125 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.79 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -92.79 179.19 5.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.652 -1.158 . . . . 1.27 109.14 173.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.687 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.9 tpt180 -149.05 -146.91 0.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.422 -0.585 . . . . 3.5899999999999999 109.422 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.687 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -55.22 143.47 54.77 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 121.109 0.481 . . . . 0.76000000000000001 111.038 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 4.1 Cg_exo -73.01 157.39 51.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.798 2.998 . . . . 0.53000000000000003 112.813 -170.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.899 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -86.1 -24.48 6.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.562 -0.903 . . . . 0.44 108.562 174.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.829 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -158.97 148.35 18.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.667 -0.697 . . . . 0.27000000000000002 111.915 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.9 153.72 25.53 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.638 -1.165 . . . . 0.23999999999999999 110.918 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.427 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.7 t -166.44 144.08 5.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.83 -0.804 . . . . 0.34000000000000002 108.83 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.591 ' HB3' HG22 ' A' ' 121' ' ' VAL . 25.4 p -124.93 141.83 51.87 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.074 -0.65 . . . . 1.1100000000000001 111.483 -173.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.593 ' CE2' HG21 ' A' ' 46' ' ' VAL . 26.0 p90 -123.92 130.75 53.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.254 -1.017 . . . . 0.80000000000000004 108.254 171.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.819 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 1.8 mp0 -97.78 132.47 43.37 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 2.5299999999999998 110.17 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.57 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . . . -134.68 145.59 48.68 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.089 -0.708 . . . . 0.59999999999999998 109.089 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -170.54 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 2.3799999999999999 111.562 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.838 ' HA ' HG21 ' A' ' 177' ' ' VAL . 36.1 p90 -80.18 54.67 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 3.96 112.1 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -50.55 -60.44 3.02 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.487 0.551 . . . . 1.53 112.487 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.57 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.6 t70 -173.68 -44.53 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.007 0.432 . . . . 1.26 111.283 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -80.42 6.99 10.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.21 -0.45 . . . . 2.2200000000000002 111.667 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 173' ' ' TRP . 71.2 t -72.54 -52.79 6.28 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.077 -0.51 . . . . 0.5 110.546 174.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.688 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -50.35 -34.26 40.2 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.464 2.109 . . . . 0.57999999999999996 112.158 169.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.683 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.7 mmmt -74.09 -25.19 59.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 2.1400000000000001 111.196 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 24.9 tp -70.53 -44.91 66.57 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.275 -0.639 . . . . 0.66000000000000003 109.275 172.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -58.32 -40.12 81.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.07 -0.715 . . . . 1.8899999999999999 109.07 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.683 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.58 -50.67 71.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.81 -1.086 . . . . 1.53 110.897 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -65.18 -33.09 75.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.635 -0.711 . . . . 1.49 112.16 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 55.8 mt -66.47 4.29 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.76000000000000001 111.641 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.855 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.3 m -79.71 3.13 20.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 1.05 109.581 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 79.04 48.0 7.24 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.162 -0.926 . . . . 1.1699999999999999 111.306 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.855 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.0 mmmt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.508 -0.758 . . . . 2.0 110.241 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' HD2' ' A' ' 2' ' ' PRO . 6.0 tpt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.418 -0.586 . . . . 5.04 109.418 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.446 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 19.5 Cg_exo -37.15 135.78 0.36 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.249 3.299 . . . . 2.1299999999999999 114.159 -175.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.756 HG13 ' HB2' ' A' ' 37' ' ' LEU . 22.5 t -73.83 148.71 8.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.881 -1.054 . . . . 1.47 110.835 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.09 155.21 41.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.85 -0.796 . . . . 1.8100000000000001 108.85 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.6 mm? -83.49 8.12 14.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.863 0.69 . . . . 0.69999999999999996 112.863 -169.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 t -66.15 -27.07 67.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.977 0.417 . . . . 1.96 111.042 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 66.2 mttm -92.57 9.43 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.47 -0.332 . . . . 2.6600000000000001 111.655 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.764 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 57.4 t-105 -66.58 -24.96 66.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.398 0.518 . . . . 3.98 112.398 -172.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.499 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 14.1 p -136.33 21.53 3.19 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.36 -0.536 . . . . 0.63 111.8 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.6 -126.37 1.45 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.822 -0.704 . . . . 0.47999999999999998 111.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.12 -35.46 62.36 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.334 2.689 . . . . 0.53000000000000003 110.056 166.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.599 HD11 ' HA3' ' A' ' 38' ' ' GLY . 12.5 mt -87.6 86.8 7.24 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.564 -1.198 . . . . 1.1699999999999999 108.986 171.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.8 m -78.44 66.97 4.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.485 0.66 . . . . 0.70999999999999996 110.467 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 HG21 ' A' ' 121' ' ' VAL . 29.0 mt -78.75 -4.97 51.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.468 -0.787 . . . . 0.45000000000000001 111.216 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 12.9 mm100 -68.27 -13.4 62.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.047 0.451 . . . . 2.1200000000000001 110.39 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.52 -28.14 69.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 1.9299999999999999 110.262 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.58 ' CG1' HG21 ' A' ' 151' ' ' VAL . 71.5 t -86.36 -73.57 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.63 110.653 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -162.5 169.06 20.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.818 -0.353 . . . . 2.9900000000000002 110.811 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -49.04 147.41 2.87 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.089 0.956 . . . . 1.6000000000000001 113.279 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.764 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 68.1 mt-30 -59.37 128.39 85.68 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 115.536 -0.756 . . . . 3.5499999999999998 109.913 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 11.1 Cg_exo -70.02 157.28 60.4 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.913 2.409 . . . . 0.57999999999999996 111.893 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.852 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 13.9 pt20 -73.4 -18.79 61.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 1.3899999999999999 111.314 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.818 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 49.7 m80 -148.07 160.23 37.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.606 -0.725 . . . . 1.45 109.139 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.0 Cg_endo -86.0 131.92 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.05 2.5 . . . . 0.40000000000000002 111.832 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 122' ' ' TRP . 20.6 tp -80.68 141.08 35.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.328 . . . . 0.28999999999999998 110.724 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.42 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.41 123.91 51.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.445 -0.343 . . . . 1.24 110.15 170.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 53' ' ' ILE . 17.6 t -121.5 143.26 34.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.525 -0.917 . . . . 0.46999999999999997 108.525 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -136.86 142.83 42.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.135 0.493 . . . . 0.31 110.791 -176.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -108.64 176.91 4.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.16 -0.681 . . . . 0.67000000000000004 109.16 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.89 -51.81 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.55000000000000004 111.803 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.75 -13.34 9.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.677 -0.692 . . . . 0.81000000000000005 112.835 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.26 -165.12 1.36 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.46999999999999997 110.914 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.0 165.99 26.61 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.367 -0.833 . . . . 0.33000000000000002 109.748 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.77 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 93.4 t -107.44 64.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.303 -1.739 . . . . 0.39000000000000001 106.303 160.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.12 1.72 49.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.198 -1.364 . . . . 0.98999999999999999 109.949 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 43.7 mt-10 -135.62 126.06 26.75 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.408 -0.815 . . . . 2.5600000000000001 109.865 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.756 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -71.95 110.13 6.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.149 -0.686 . . . . 0.40999999999999998 109.149 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.628 ' C ' HE22 ' A' ' 170' ' ' GLN . . . 90.01 28.31 18.49 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.258 -0.883 . . . . 0.58999999999999997 111.973 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.77 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -93.29 151.05 20.04 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.842 -0.429 . . . . 0.34000000000000002 109.842 174.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.4 p -78.19 135.98 25.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.55000000000000004 111.098 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 169' ' ' TYR . 8.4 tp -131.46 170.58 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.152 -1.425 . . . . 0.45000000000000001 107.152 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 p -116.17 148.61 41.89 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 118.669 -1.212 . . . . 0.56000000000000005 113.362 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 1.079 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 53.4 Cg_exo -55.38 -40.76 83.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.491 3.461 . . . . 0.68000000000000005 113.914 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -33.32 63.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.517 0.675 . . . . 0.76000000000000001 110.715 174.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -81.75 -58.46 2.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.909 . . . . 1.5900000000000001 110.704 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 43' ' ' PRO . 6.3 m -81.42 28.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.386 0.612 . . . . 0.66000000000000003 112.079 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -82.21 -31.44 30.32 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.69 -0.856 . . . . 0.79000000000000004 108.69 174.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.437 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 19.0 m120 -112.13 -149.78 0.45 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.849 -1.069 . . . . 1.9099999999999999 110.319 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.579 ' HD3' HG22 ' A' ' 97' ' ' ILE . 99.5 mtt180 -99.11 157.25 34.39 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.246 -0.433 . . . . 1.4299999999999999 109.964 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.98 166.28 25.18 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.402 2.068 . . . . 0.37 110.574 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -81.48 -25.47 36.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.03 0.443 . . . . 0.44 110.018 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.2 m -159.27 149.56 19.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.165 0.507 . . . . 0.38 111.97 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.12 158.71 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.288 -1.004 . . . . 0.29999999999999999 108.288 171.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.103 ' HA ' HD13 ' A' ' 58' ' ' LEU . 32.7 t -176.4 113.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.917 0.389 . . . . 0.34999999999999998 110.104 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -72.42 157.67 37.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.664 -1.235 . . . . 2.7200000000000002 107.664 172.566 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' HB3' ' CD2' ' A' ' 23' ' ' HIS . 34.8 t70 -59.97 87.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.523 0.514 . . . . 1.51 110.611 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.3 21.51 4.05 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.753 -0.658 . . . . 0.80000000000000004 112.749 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.103 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -57.69 129.14 40.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.984 0.421 . . . . 0.57999999999999996 110.565 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.623 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 26.2 t70 -79.69 -27.74 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.505 . . . . 0.73999999999999999 111.502 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.535 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 52.7 m 77.84 -5.67 2.08 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.3 1.0 . . . . 1.03 110.278 -171.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.31 21.49 5.15 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.874 -0.603 . . . . 0.83999999999999997 112.794 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.623 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 9.7 mtpt -113.0 145.02 41.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 122.535 -0.391 . . . . 1.6699999999999999 110.752 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.617 HD21 ' HE2' ' A' ' 93' ' ' LYS . 44.5 mt -91.0 124.87 35.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.191 -0.67 . . . . 0.57999999999999996 109.191 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -127.18 161.38 28.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.754 -0.379 . . . . 0.80000000000000004 109.98 177.356 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.668 HG23 HG12 ' A' ' 90' ' ' VAL . 63.3 m -97.45 106.57 18.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.715 -0.846 . . . . 0.35999999999999999 108.715 169.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.2 tp -103.58 109.37 21.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.448 -0.796 . . . . 0.58999999999999997 109.69 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.5 t -113.87 136.74 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.39000000000000001 110.69 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.861 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.8 mt -104.61 126.4 51.66 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.73 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 10.1 t -135.22 150.75 50.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.878 0.37 . . . . 0.35999999999999999 111.315 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 6.8 t70 -130.47 94.25 30.19 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-O 121.51 0.671 . . . . 1.9199999999999999 110.39 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 13.0 Cg_endo -56.49 -30.91 84.2 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.83 3.02 . . . . 1.25 114.108 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -90.74 39.58 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.641 . . . . 1.29 112.732 -167.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.48 140.44 21.07 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.77 -0.456 . . . . 0.5 109.77 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.571 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 98.3 Cg_endo -80.19 -21.62 17.38 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.864 -1.307 . . . . 0.62 113.351 2.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 88.5 p -139.75 162.85 34.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.746 -0.206 . . . . 0.75 111.072 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.476 ' NE ' HH12 ' A' ' 119' ' ' ARG . 1.0 OUTLIER -64.4 -36.8 85.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.234 0.54 . . . . 2.8799999999999999 110.61 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.2 ptpt -71.63 -18.17 62.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 1.3799999999999999 111.224 -175.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.5 t70 -161.43 86.62 1.65 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.402 . . . . 1.3700000000000001 110.648 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.1 Cg_endo -84.0 91.64 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.902 2.401 . . . . 0.80000000000000004 112.946 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.571 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 39.3 mttm -82.63 -45.37 14.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 1.02 110.793 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.765 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.9 m-85 -81.0 16.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 1.1699999999999999 111.776 -171.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.93 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 9.1 ttp180 -62.3 125.04 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.068 -0.345 . . . . 2.9300000000000002 110.068 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.93 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.1 mp0 -107.72 133.98 51.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.503 0.321 . . . . 2.23 110.356 -4.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -76.9 164.85 25.41 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.813 -1.18 . . . . 1.4299999999999999 107.813 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.73 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 p80 -145.94 123.18 11.55 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.826 -0.546 . . . . 1.26 110.329 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.861 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.3 t-160 -62.13 -40.86 97.35 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.418 -0.81 . . . . 2.1400000000000001 109.552 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.9 p90 -167.77 171.56 9.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.963 -0.295 . . . . 1.51 110.465 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HG ' HD12 ' A' ' 103' ' ' LEU . 30.1 tp -129.96 113.09 14.16 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.144 -0.687 . . . . 0.33000000000000002 109.144 173.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.643 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.1 t -118.36 134.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.847 -0.615 . . . . 0.31 110.649 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.948 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 19.7 m -134.53 157.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.63 -0.714 . . . . 0.27000000000000002 109.61 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t30 61.18 22.28 12.62 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.601 0.563 . . . . 1.76 110.455 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.643 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -70.71 111.68 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.725 -0.843 . . . . 0.31 108.725 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 63' ' ' LEU . 18.2 ttmm -87.59 100.38 12.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.162 -0.926 . . . . 1.21 111.045 -172.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 77.17 -122.84 6.29 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.255 -0.884 . . . . 0.29999999999999999 112.883 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.575 ' HA ' HD11 ' A' ' 53' ' ' ILE . 3.1 p-10 -118.14 21.09 12.94 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 1.04 110.736 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.68 105.68 15.66 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.787 -0.642 . . . . 0.77000000000000002 109.77 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.579 HG22 ' HD3' ' A' ' 49' ' ' ARG . 4.8 mm -62.89 -25.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.867 -1.06 . . . . 0.40999999999999998 111.384 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 m -84.41 -29.62 26.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.68000000000000005 111.994 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 m -80.26 -3.84 50.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.943 0.402 . . . . 1.26 111.706 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.14 106.42 1.88 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.761 -0.733 . . . . 0.34999999999999998 111.303 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.2 m -64.31 106.84 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.228 -0.656 . . . . 0.45000000000000001 109.228 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.19 111.8 24.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.43 -0.805 . . . . 0.56999999999999995 110.86 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.598 HD12 ' HG ' ' A' ' 88' ' ' LEU . 5.1 mt -87.85 -39.96 14.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.039 0.923 . . . . 0.45000000000000001 109.935 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.4 t -114.36 105.88 13.66 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.72 -1.585 . . . . 0.37 106.72 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.2 t70 -57.73 158.1 6.59 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.873 0.733 . . . . 1.1499999999999999 111.992 -169.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 23.0 p90 -85.74 77.54 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 4.6900000000000004 111.305 -171.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 140' ' ' ASN . 36.7 t -60.48 -45.05 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.85999999999999999 111.485 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.682 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 106.24 -168.33 14.8 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.385 -0.912 . . . . 0.67000000000000004 112.576 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.9 t -65.91 126.63 29.15 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.759 -0.46 . . . . 0.51000000000000001 109.759 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.606 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -152.56 54.49 0.46 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.994 -0.622 . . . . 0.81999999999999995 112.727 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 1.025 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 11.3 Cg_endo -98.52 153.61 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.022 3.148 . . . . 0.84999999999999998 113.232 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 111' ' ' PRO . 31.6 Cg_exo -61.34 150.16 86.14 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.008 2.472 . . . . 0.87 112.499 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -67.17 122.05 16.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.347 -0.842 . . . . 1.8500000000000001 111.571 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.6 50.33 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.927 -0.654 . . . . 1.1799999999999999 112.996 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.612 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 21.7 p -78.5 -13.59 59.76 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.943 0.72 . . . . 0.96999999999999997 112.943 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.31 24.31 6.56 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.09 -1.052 . . . . 1.97 113.38 172.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.58 HD13 ' HG2' ' A' ' 172' ' ' GLU . 4.0 mm? 68.56 103.79 0.05 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.807 -0.697 . . . . 0.93999999999999995 111.549 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 11.6 m170 -76.64 134.18 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.789 -0.641 . . . . 2.23 109.695 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 1.035 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 8.0 ptp85 -112.9 96.7 6.1 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.347 0.594 . . . . 2.3100000000000001 111.094 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 45.4 m-85 -72.15 114.59 10.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.511 -0.768 . . . . 0.78000000000000003 109.247 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.618 HG21 HD22 ' A' ' 14' ' ' LEU . 31.3 t -90.4 129.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.61 -0.723 . . . . 0.27000000000000002 110.439 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.879 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.56 119.49 30.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.546 -0.752 . . . . 1.99 109.396 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 84.0 mt -118.37 127.61 53.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.333 0.111 . . . . 0.38 111.089 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.42 HG12 HD22 ' A' ' 25' ' ' LEU . 1.4 m -115.53 139.41 42.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.31 109.352 171.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CB ' HD23 ' A' ' 160' ' ' LEU . 84.9 m-85 -118.83 164.32 15.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.862 0.363 . . . . 5.1200000000000001 111.427 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.62 118.2 33.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.438 -0.801 . . . . 2.4100000000000001 109.071 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -97.81 166.96 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.184 0.516 . . . . 1.3100000000000001 110.477 -175.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.52 -22.31 54.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.513 -0.767 . . . . 2.3999999999999999 109.563 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.79 164.18 19.67 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.821 -1.081 . . . . 3.5099999999999998 110.277 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.463 ' HG3' HD12 ' A' ' 63' ' ' LEU . 53.7 Cg_exo -51.74 135.67 49.67 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.605 2.203 . . . . 1.21 112.02 175.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.948 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.3 mm? -55.63 147.48 18.16 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.2 0.815 . . . . 0.90000000000000002 113.2 -171.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -130.73 80.36 1.94 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.574 -1.194 . . . . 2.8999999999999999 108.09 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.477 ' SG ' HG11 ' A' ' 90' ' ' VAL . 60.1 m -104.1 112.86 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.765 -0.652 . . . . 1.8999999999999999 110.23 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.53 18.58 12.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.09 -0.959 . . . . 2.96 110.216 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.87 130.2 94.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.444 -0.798 . . . . 1.3899999999999999 109.999 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -47.44 118.55 2.99 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.309 2.673 . . . . 1.27 113.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.3 mm -60.43 115.76 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.971 -0.558 . . . . 0.85999999999999999 110.618 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.8 152.19 19.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 1.6100000000000001 109.841 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 m -99.59 156.43 17.07 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.089 -1.078 . . . . 1.8799999999999999 108.089 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.772 ' HA ' HG22 ' A' ' 107' ' ' VAL . 1.7 p-10 -81.89 6.85 14.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.333 0.587 . . . . 0.75 110.432 -174.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 46.6 mtt-85 -102.76 135.49 44.31 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.548 -0.751 . . . . 3.3599999999999999 109.427 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.61 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.9 m 83.27 140.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.828 1.33 . . . . 0.94999999999999996 110.551 -175.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -102.22 46.71 1.22 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.511 -0.768 . . . . 1.1200000000000001 111.433 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.98 -29.96 66.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.928 0.394 . . . . 2.6600000000000001 111.489 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -124.51 70.05 1.11 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.037 0.446 . . . . 1.8700000000000001 111.232 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 63.7 mtp180 -87.93 30.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 4.7300000000000004 111.989 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.77 -143.83 17.81 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.176 -1.012 . . . . 0.65000000000000002 113.388 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.765 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.8 mttt 60.94 42.21 13.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.855 0.836 . . . . 1.0800000000000001 110.687 -174.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -133.66 158.38 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.444 -1.253 . . . . 1.8899999999999999 108.872 174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 12.3 mmmm -96.8 120.84 37.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.15 0.282 . . . . 1.29 110.775 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.7 m -61.27 -33.05 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.78000000000000003 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -58.84 -44.6 90.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.736 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.4 m -62.13 -37.75 86.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.479 . . . . 0.77000000000000002 111.064 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.62 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 48.1 m-85 -59.27 -56.74 18.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.898 0.38 . . . . 0.92000000000000004 110.742 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 160' ' ' LEU . 4.3 ppt_? -71.13 -28.77 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.111 0.412 . . . . 2.8900000000000001 112.111 -176.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 52.5 mtmt -65.8 -25.99 67.48 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.404 -0.185 . . . . 0.96999999999999997 111.331 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 17.8 tptm -53.17 -46.37 68.9 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.58 0.229 . . . . 1.5800000000000001 110.716 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.43 ' HB3' HD13 ' A' ' 160' ' ' LEU . 20.7 t80 -99.8 11.81 38.3 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.77 -0.772 . . . . 5.4500000000000002 109.957 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.18 41.31 6.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.171 -0.922 . . . . 2.4199999999999999 112.83 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB2' ' HB2' ' A' ' 155' ' ' ARG . 6.4 mp -73.74 137.2 43.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.466 -0.788 . . . . 1.27 109.171 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -86.0 -53.28 5.18 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.7 0.63 . . . . 3.5899999999999999 112.7 -169.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -164.8 161.95 14.95 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.947 -0.57 . . . . 0.76000000000000001 110.233 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 15.9 Cg_exo -66.96 140.6 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.845 2.363 . . . . 0.53000000000000003 112.776 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.852 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -86.61 -29.55 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.739 -0.837 . . . . 0.44 108.739 173.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -152.57 146.77 25.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.616 -0.72 . . . . 0.27000000000000002 111.221 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.87 156.85 27.13 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.2 -0.909 . . . . 0.23999999999999999 111.716 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.615 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 5.8 t -168.87 151.12 4.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.571 -0.9 . . . . 0.34000000000000002 108.571 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 12' ' ' LEU . 26.5 p -129.37 140.34 51.4 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.878 -0.729 . . . . 1.1100000000000001 111.371 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 120' ' ' TYR . 51.1 p90 -122.1 137.47 54.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.16 -1.052 . . . . 0.80000000000000004 108.16 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 1.035 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 2.1 mp0 -100.04 133.58 44.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.468 0.576 . . . . 2.5299999999999998 110.985 177.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -157.4 114.32 3.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.59999999999999998 110.069 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 1.025 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 6.4 pt-20 -109.94 -91.08 0.46 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 119.649 -0.82 . . . . 2.3799999999999999 111.77 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.893 ' H ' ' HG3' ' A' ' 172' ' ' GLU . 18.7 t90 -117.34 78.79 1.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.887 0.767 . . . . 3.96 111.672 -170.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 1.079 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -76.0 -59.64 2.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.658 -0.417 . . . . 1.53 110.937 173.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.1 t70 -178.84 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.339 0.137 0 N-CA-C 111.924 0.342 . . . . 1.26 111.924 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.723 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.45 5.49 14.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 2.2200000000000002 111.851 -178.274 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.771 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 84.0 t -72.57 -53.5 5.74 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.068 -0.514 . . . . 0.5 110.978 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.771 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.4 Cg_exo -49.78 -45.36 32.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.383 2.056 . . . . 0.57999999999999996 111.882 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.634 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.17 -24.25 64.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.506 -0.315 . . . . 2.1400000000000001 111.654 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 48.4 tp -68.98 -47.85 64.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.187 -0.605 . . . . 0.66000000000000003 109.393 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.73 -37.9 80.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.47 0.652 . . . . 1.8899999999999999 109.479 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 7.5 mm-40 -56.22 -47.87 77.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.706 -1.134 . . . . 1.53 111.148 172.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.09 -29.38 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.416 -0.811 . . . . 1.49 112.927 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 64.5 mt -63.29 5.95 0.14 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.227 0.825 . . . . 0.76000000000000001 113.227 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.755 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 16.5 m -82.78 -1.97 53.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.307 0.575 . . . . 1.05 109.532 168.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 84.85 45.59 5.96 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.783 -0.927 . . . . 1.1699999999999999 110.783 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.755 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.2 mmtp . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.739 -0.648 . . . . 2.0 110.385 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.838 -0.43 . . . . 5.04 109.838 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.14 137.18 69.85 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.379 2.052 . . . . 2.1299999999999999 110.711 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.0 t -57.68 105.06 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.701 0.762 . . . . 1.47 111.751 -172.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 19.2 t70 -162.78 159.93 24.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.083 -1.417 . . . . 1.8100000000000001 107.816 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.528 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.2 mm? -80.55 24.08 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.74 0.245 . . . . 0.69999999999999996 111.088 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -51.56 -53.71 35.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.965 -0.561 . . . . 1.96 111.805 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.603 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.5 tptm -125.16 49.2 1.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.275 0.56 . . . . 2.6600000000000001 109.941 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.617 ' HD1' HD11 ' A' ' 37' ' ' LEU . 2.8 t90 -74.58 -8.54 56.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.517 -0.765 . . . . 3.98 111.046 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 9.0 p -136.36 22.92 3.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.223 0.535 . . . . 0.63 110.56 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA3' ' HG3' ' A' ' 7' ' ' LYS . . . -86.9 -120.44 1.3 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.516 -0.633 . . . . 0.47999999999999998 111.516 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 11.6 Cg_endo -51.35 -40.49 61.78 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.551 2.834 . . . . 0.53000000000000003 110.402 167.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.68 HD11 ' HA3' ' A' ' 38' ' ' GLY . 19.2 mt -87.34 88.22 7.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.012 -0.995 . . . . 1.1699999999999999 109.045 171.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 4.6 m -75.66 63.87 1.64 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.509 0.671 . . . . 0.70999999999999996 110.674 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 121' ' ' VAL . 27.8 mt -75.94 -7.94 55.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.693 -0.685 . . . . 0.45000000000000001 110.091 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 6.5 tp-100 -73.38 -7.82 53.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 2.1200000000000001 110.992 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.561 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 22.1 mt-10 -63.45 -37.06 85.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.176 -0.676 . . . . 1.9299999999999999 109.176 171.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.889 HG12 HG21 ' A' ' 151' ' ' VAL . 31.9 t -76.65 -73.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.494 -1.23 . . . . 0.63 111.635 -175.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 30.3 t0 -152.09 170.19 20.55 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.633 -0.506 . . . . 2.9900000000000002 109.633 -172.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.701 ' HG3' HH12 ' A' ' 155' ' ' ARG . 30.8 mt-10 -60.3 149.96 31.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.472 0.545 . . . . 1.6000000000000001 112.472 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 49.1 mt-30 -60.54 120.43 52.36 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 115.444 -0.798 . . . . 3.5499999999999998 109.118 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 36.8 Cg_exo -58.7 155.42 37.5 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.656 2.237 . . . . 0.57999999999999996 112.396 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.89 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 10.1 pt20 -71.64 -17.56 62.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.455 -0.793 . . . . 1.3899999999999999 111.265 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.81 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 53.1 m-70 -149.75 157.47 38.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.534 0.734 . . . . 1.45 109.172 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 2.1 Cg_endo -84.89 129.82 4.08 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.97 2.447 . . . . 0.40000000000000002 112.019 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.699 HD23 ' HB3' ' A' ' 122' ' ' TRP . 22.1 tp -78.95 139.79 38.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.522 0.201 . . . . 0.28999999999999998 110.594 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -110.99 125.73 54.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.47 -0.567 . . . . 1.24 109.47 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.92 HG13 HG22 ' A' ' 53' ' ' ILE . 13.0 t -131.65 135.66 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.426 -0.583 . . . . 0.46999999999999997 109.426 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.3 OUTLIER -137.15 137.9 39.7 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.001 0.429 . . . . 0.31 110.736 -177.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -98.38 175.41 6.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.38 -0.97 . . . . 0.67000000000000004 108.38 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.25 59.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.247 0.546 . . . . 0.55000000000000004 110.855 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.2 -7.99 34.32 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.415 -0.812 . . . . 0.81000000000000005 112.606 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.07 -173.17 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.719 -0.283 . . . . 0.46999999999999997 110.412 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.1 166.05 23.95 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.224 -0.444 . . . . 0.33000000000000002 110.246 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 89.4 t -113.23 64.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 106.521 -1.659 . . . . 0.39000000000000001 106.521 162.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.14 16.1 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.438 -1.255 . . . . 0.98999999999999999 109.78 -174.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 4.6 tm-20 -148.5 125.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.071 -1.085 . . . . 2.5600000000000001 108.071 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.9 OUTLIER -71.86 110.19 6.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.847 -0.427 . . . . 0.40999999999999998 109.847 -174.352 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.68 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 88.71 14.83 60.67 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.708 -0.678 . . . . 0.58999999999999997 112.573 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -72.29 154.64 40.86 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 110.145 -0.316 . . . . 0.34000000000000002 110.145 175.055 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 8.8 p -80.34 129.6 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.301 0.572 . . . . 0.55000000000000004 110.972 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.459 HD23 ' CG1' ' A' ' 46' ' ' VAL . 6.2 tp -124.2 165.13 18.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.559 -1.274 . . . . 0.45000000000000001 107.559 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.97 152.69 49.0 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 119.148 -1.021 . . . . 0.56000000000000005 113.375 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.651 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 70.9 Cg_exo -51.38 -46.43 31.52 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.401 2.734 . . . . 0.68000000000000005 113.338 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -27.58 65.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.998 0.428 . . . . 0.76000000000000001 111.452 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.2 -48.68 10.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.978 -0.556 . . . . 1.5900000000000001 110.914 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.493 HG11 ' CE2' ' A' ' 169' ' ' TYR . 10.7 m -95.17 29.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.53 0.681 . . . . 0.66000000000000003 112.323 -175.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 6.52 42.77 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.31 -0.626 . . . . 0.79000000000000004 109.31 178.16 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -148.17 177.85 9.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.118 -0.946 . . . . 1.9099999999999999 109.572 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -78.88 152.36 77.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.405 -0.361 . . . . 1.4299999999999999 110.096 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.09 156.59 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.403 2.068 . . . . 0.37 111.479 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -77.45 -23.76 50.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.44 110.355 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 67.3 m -153.02 141.07 20.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.66 0.615 . . . . 0.38 112.66 -175.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.92 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.82 166.26 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.997 -1.001 . . . . 0.29999999999999999 108.313 169.368 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.074 ' HA ' HD13 ' A' ' 58' ' ' LEU . 31.3 t 176.12 117.7 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.985 0.421 . . . . 0.34999999999999998 110.096 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 29.9 p-90 -79.27 154.82 28.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.707 -1.22 . . . . 2.7200000000000002 107.707 172.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.422 ' HB3' ' HD1' ' A' ' 23' ' ' HIS . 35.7 t70 -64.64 85.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.811 0.339 . . . . 1.51 111.364 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.02 20.3 2.28 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.991 -0.549 . . . . 0.80000000000000004 112.021 -175.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.074 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.5 tt -63.01 129.07 38.78 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.937 0.495 . . . . 0.57999999999999996 111.072 -177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.534 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 26.1 t70 -74.82 -28.0 60.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.054 -0.521 . . . . 0.73999999999999999 111.635 -175.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.637 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.7 m 74.32 2.12 4.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.302 -0.863 . . . . 1.03 110.422 -172.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -130.21 -35.81 0.41 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.671 -0.695 . . . . 0.83999999999999997 112.372 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 12.2 mtpt -63.29 146.26 53.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.908 0.385 . . . . 1.6699999999999999 110.302 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.838 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 25.6 mt -87.37 138.7 31.25 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.794 -1.187 . . . . 0.57999999999999996 107.794 172.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.639 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 11.5 m-85 -128.71 157.51 41.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.80000000000000004 109.822 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.446 HG23 HG12 ' A' ' 90' ' ' VAL . 91.8 m -96.86 105.28 17.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.397 -0.594 . . . . 0.35999999999999999 109.397 172.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 17.6 tp -100.84 109.6 21.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.444 -0.798 . . . . 0.58999999999999997 109.563 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.1 125.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.45 . . . . 0.39000000000000001 110.987 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 ' HE1' ' A' ' 169' ' ' TYR . 3.4 mt -85.5 129.86 34.72 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.416 -0.957 . . . . 0.59999999999999998 108.416 167.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.837 HG21 HG11 ' A' ' 17' ' ' VAL . 9.0 t -138.11 138.79 39.04 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.7 -0.481 . . . . 0.35999999999999999 109.7 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.557 ' HB3' ' HA ' ' A' ' 120' ' ' TYR . 11.2 p-10 -132.67 99.78 15.3 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-O 121.617 0.722 . . . . 1.9199999999999999 111.026 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.7 Cg_endo -55.48 -173.9 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.582 2.854 . . . . 1.25 112.386 171.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.858 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 2.1 m-20 56.93 33.81 23.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.17 0.509 . . . . 1.29 111.127 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' H ' ' HB2' ' A' ' 82' ' ' ARG . . . -104.34 137.19 19.16 Favored Pre-proline 0 C--O 1.22 -0.469 0 CA-C-N 116.054 -0.521 . . . . 0.5 110.647 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -79.5 -31.12 5.1 Favored 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.016 -1.66 . . . . 0.62 112.556 0.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.615 ' HB3' HG22 ' A' ' 115' ' ' THR . 92.7 p -125.24 153.44 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.75 109.977 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.858 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 45.5 mtp180 -71.99 -23.18 61.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.301 -0.409 . . . . 2.8799999999999999 111.599 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.832 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.73 -10.89 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.932 0.396 . . . . 1.3799999999999999 110.79 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -155.2 82.3 3.95 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.34 -0.615 . . . . 1.3700000000000001 109.34 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -89.1 97.67 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.034 2.489 . . . . 0.80000000000000004 113.279 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 6.5 mtmm -88.13 -58.7 2.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.119 -0.946 . . . . 1.02 111.16 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.506 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 70.0 m-85 -66.89 -23.37 65.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.969 -0.56 . . . . 1.1699999999999999 110.994 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.561 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -48.0 117.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.412 0.445 . . . . 2.9300000000000002 109.891 177.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 38.8 mt-10 -89.71 130.99 35.91 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.561 0.744 . . . . 2.23 112.217 7.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.524 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 4.6 t90 -90.56 134.37 34.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.832 -0.803 . . . . 1.4299999999999999 108.832 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.511 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 13.8 p-80 -106.07 129.74 54.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.876 -0.787 . . . . 1.26 108.876 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -91.11 -23.76 20.2 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.29 0.478 . . . . 2.1400000000000001 112.29 -171.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.501 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 6.5 p90 -169.2 170.7 8.5 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.062 -0.347 . . . . 1.51 110.062 167.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.9 tp -131.89 114.0 14.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.546 -0.297 . . . . 0.33000000000000002 110.411 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -119.92 133.4 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.05 -0.523 . . . . 0.31 110.827 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.458 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 5.3 m -131.61 168.1 24.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.123 -1.065 . . . . 0.27000000000000002 108.123 174.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.838 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 8.8 m-20 59.96 19.28 8.33 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.37 0.419 . . . . 1.76 111.588 173.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.467 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.6 ttm -74.16 111.26 9.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.464 -0.939 . . . . 0.31 108.464 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.3 ttmm -79.71 91.5 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.191 -0.913 . . . . 1.21 111.196 -170.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.639 ' HA2' ' HE1' ' A' ' 64' ' ' TYR . . . 72.41 -117.45 6.24 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.857 -1.065 . . . . 0.29999999999999999 112.166 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 53' ' ' ILE . 27.6 p-10 -111.55 26.38 10.71 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.428 0.632 . . . . 1.04 110.122 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.39 104.19 16.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.247 -0.888 . . . . 0.77000000000000002 109.946 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 53' ' ' ILE . 4.6 mm -59.85 -28.55 41.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.111 -0.949 . . . . 0.40999999999999998 111.233 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.1 m -78.65 -42.76 27.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.68000000000000005 112.469 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 p -65.21 -24.16 67.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.412 0.523 . . . . 1.26 112.412 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 99.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.761 0.663 . . . . 0.34999999999999998 113.316 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 99.4 m -65.78 105.45 1.28 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.121 -0.696 . . . . 0.45000000000000001 109.121 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 9.5 p -93.4 109.57 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.4 -0.818 . . . . 0.56999999999999995 110.839 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.67 -41.78 23.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.12 0.962 . . . . 0.45000000000000001 109.824 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.0 t -115.04 100.19 7.99 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.247 -1.39 . . . . 0.37 107.247 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -52.69 156.85 1.77 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.298 0.999 . . . . 1.1499999999999999 113.161 -167.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 4.1 p90 -76.61 96.19 4.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.942 -1.026 . . . . 4.6900000000000004 110.739 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.808 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 21.8 t -67.72 -31.63 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.844 -0.616 . . . . 0.85999999999999999 111.76 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.45 173.09 49.49 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.756 -0.735 . . . . 0.67000000000000004 111.912 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 38.7 t -54.53 135.7 45.69 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.22 0.51 . . . . 0.51000000000000001 110.834 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.885 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . 169.77 70.68 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.81999999999999995 113.289 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.14 150.23 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.739 2.293 . . . . 0.84999999999999998 110.898 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.667 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 85.0 Cg_exo -43.48 126.48 5.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.728 2.286 . . . . 0.87 112.321 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.538 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -61.68 115.5 4.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 1.8500000000000001 110.749 -175.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.72 23.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.716 -0.754 . . . . 1.1799999999999999 112.407 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.667 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.7 p -76.86 -60.99 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.758 0.279 . . . . 0.96999999999999997 111.405 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.41 28.33 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.857 -0.687 . . . . 1.97 112.081 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.1 mm? -73.21 123.27 23.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.93999999999999995 110.477 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -102.01 112.81 25.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.051 0.453 . . . . 2.23 110.35 176.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.537 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 2.0 ptt180 -85.74 90.5 8.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.504 -0.771 . . . . 2.3100000000000001 110.703 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.737 ' HE2' ' HB3' ' A' ' 171' ' ' ALA . 3.3 m-85 -74.29 112.57 10.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.022 -0.733 . . . . 0.78000000000000003 109.022 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 168' ' ' CYS . 13.8 t -94.01 126.01 46.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.948 -0.569 . . . . 0.27000000000000002 109.638 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.699 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.34 119.56 30.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.721 -0.672 . . . . 1.99 109.738 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 83.6 mt -115.99 138.62 51.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.647 -0.131 . . . . 0.38 110.647 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.507 HG12 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -122.69 140.71 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.695 -0.483 . . . . 0.31 109.695 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.61 ' HB2' HD23 ' A' ' 160' ' ' LEU . 97.2 m-85 -117.37 165.54 13.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.996 0.427 . . . . 5.1200000000000001 111.191 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -110.38 137.61 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.25 -0.886 . . . . 2.4100000000000001 109.983 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.63 ' HG3' ' HG ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.26 153.84 47.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.357 0.599 . . . . 1.3100000000000001 110.014 177.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.01 -2.17 46.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.045 -0.98 . . . . 2.3999999999999999 111.051 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.532 HH22 ' HB2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -166.17 168.61 7.41 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.16 -0.927 . . . . 3.5099999999999998 109.753 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.15 150.54 24.4 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.559 2.173 . . . . 1.21 111.791 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.458 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? -72.21 158.45 35.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.633 0.73 . . . . 0.90000000000000002 112.42 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.71 127.2 32.33 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.584 -1.265 . . . . 2.8999999999999999 107.584 167.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.9 m -146.44 -63.23 0.3 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.866 -0.606 . . . . 1.8999999999999999 109.728 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 58.83 37.99 24.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.395 0.617 . . . . 2.96 110.809 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.58 137.0 63.32 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.264 -0.88 . . . . 1.3899999999999999 109.54 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.85 106.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.132 2.554 . . . . 1.27 112.175 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.7 mm -55.77 119.12 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.534 -0.757 . . . . 0.85999999999999999 111.36 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 81.4 mt -88.49 158.71 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.086 -0.709 . . . . 1.6100000000000001 109.086 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.702 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 64.5 m -112.63 31.28 6.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.713 -0.221 . . . . 1.8799999999999999 111.008 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.838 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 1.1 p-10 54.92 12.64 0.63 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.202 0.939 . . . . 0.75 111.693 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.702 ' HG3' ' O ' ' A' ' 139' ' ' SER . 5.5 mtm180 -98.2 153.61 18.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.933 -0.395 . . . . 3.3599999999999999 109.933 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.663 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 44.4 m 67.5 165.68 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.275 -0.875 . . . . 0.94999999999999996 111.824 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.0 23.07 5.93 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.474 -0.87 . . . . 1.1200000000000001 112.401 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -71.01 -26.25 63.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.205 0.446 . . . . 2.6600000000000001 112.205 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -131.27 61.01 1.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.304 0.573 . . . . 1.8700000000000001 110.751 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.88 -71.05 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.264 -0.88 . . . . 4.7300000000000004 110.663 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -124.44 -153.41 8.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.53 -0.843 . . . . 0.65000000000000002 112.226 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.2 mttt 66.51 32.5 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.151 0.977 . . . . 1.0800000000000001 109.831 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -124.9 103.97 8.34 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.11 -1.405 . . . . 1.8899999999999999 108.81 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -62.85 120.19 10.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 1.29 111.875 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.889 HG21 HG12 ' A' ' 17' ' ' VAL . 8.2 m -62.66 -31.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.78000000000000003 110.581 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -59.12 -38.8 80.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.866 -0.606 . . . . 0.67000000000000004 110.154 174.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.6 m -66.86 -38.6 86.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.546 . . . . 0.77000000000000002 110.624 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.763 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 62.0 m-85 -61.56 -53.07 61.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.92000000000000004 111.126 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.701 HH12 ' HG3' ' A' ' 19' ' ' GLU . 8.7 ptm180 -66.21 -39.69 89.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 2.8900000000000001 111.641 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.8 mtmt -68.08 -46.77 70.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.605 0.24 . . . . 0.96999999999999997 111.169 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -60.87 -51.64 68.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.5800000000000001 111.587 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.67 0.08 31.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.271 -0.422 . . . . 5.4500000000000002 111.624 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.532 ' HB2' HH22 ' A' ' 129' ' ' ARG . 70.8 mm-40 66.1 46.36 2.15 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.763 0.664 . . . . 2.4199999999999999 110.996 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.63 ' HG ' ' HG3' ' A' ' 127' ' ' GLN . 5.6 mp -102.35 15.09 30.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.643 0.608 . . . . 1.27 112.643 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 61.89 -94.45 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.649 0.38 . . . . 3.5899999999999999 111.809 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -154.3 168.82 11.11 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 109.455 -0.572 . . . . 0.76000000000000001 109.455 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 38.9 Cg_exo -57.16 129.03 32.14 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.406 2.071 . . . . 0.53000000000000003 112.91 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.89 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -84.38 -33.06 8.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.279 -0.638 . . . . 0.44 109.279 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.81 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.23 149.79 29.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.831 -0.622 . . . . 0.27000000000000002 111.258 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -153.25 144.75 11.73 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.357 -0.838 . . . . 0.23999999999999999 112.009 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -157.97 137.78 12.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.45 -0.574 . . . . 0.34000000000000002 109.45 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.829 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -108.54 144.93 35.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.325 0.583 . . . . 1.1100000000000001 111.791 -174.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.52 ' HE1' HD21 ' A' ' 68' ' ' LEU . 34.0 p90 -135.07 119.62 18.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.378 -1.341 . . . . 0.80000000000000004 107.378 172.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 2.2 pt20 -100.14 133.23 44.83 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.866 -0.734 . . . . 2.5299999999999998 111.451 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.737 ' HB3' ' HE2' ' A' ' 120' ' ' TYR . . . -129.87 147.99 51.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.491 -0.777 . . . . 0.59999999999999998 109.739 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 117' ' ' LEU . 12.6 pt-20 -110.71 -172.52 2.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.045 -0.525 . . . . 2.3799999999999999 111.09 -176.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.84 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.7 OUTLIER -85.11 64.47 8.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 3.96 111.173 -177.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.7 t70 -53.16 -61.78 2.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.573 -0.739 . . . . 1.53 112.332 -176.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.556 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.3 t70 -177.27 -40.74 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.943 0.402 . . . . 1.26 110.92 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -78.17 2.73 17.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.079 0.466 . . . . 2.2200000000000002 111.058 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 173' ' ' TRP . 39.8 t -72.52 -53.83 5.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.5 110.507 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 73.4 Cg_exo -52.79 -33.5 60.85 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.128 1.886 . . . . 0.57999999999999996 111.966 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 43.4 mmtm -74.35 -24.92 59.24 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.737 0.273 . . . . 2.1400000000000001 111.737 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.885 HD23 ' HA3' ' A' ' 110' ' ' GLY . 62.3 tp -66.57 -46.16 76.92 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.66000000000000003 108.764 170.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -60.44 -37.97 82.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.355 -0.839 . . . . 1.8899999999999999 109.533 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.712 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 24.9 mm-40 -56.65 -41.57 77.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.299 -0.864 . . . . 1.53 111.088 172.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -76.48 -31.63 57.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.615 -0.721 . . . . 1.49 111.881 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.663 ' HA ' ' H ' ' A' ' 142' ' ' SER . 21.2 mt -65.1 5.64 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.629 0.603 . . . . 0.76000000000000001 112.629 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 16.9 m -66.07 -19.89 65.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.613 0.72 . . . . 1.05 109.791 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 88.76 62.93 1.35 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 110.791 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt . . . . . 0 C--O 1.244 0.78 0 CA-C-O 118.449 -0.786 . . . . 2.0 109.984 -176.833 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 8.1 tpt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.768 -0.456 . . . . 5.04 109.768 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 20.2 Cg_exo -67.08 122.64 9.97 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.556 2.171 . . . . 2.1299999999999999 111.835 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 24' ' ' PRO . 4.5 t -103.17 152.16 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.02 -0.536 . . . . 1.47 109.783 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -154.36 158.74 40.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.928 -0.397 . . . . 1.8100000000000001 109.928 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.57 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -95.19 22.69 6.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.688 -0.233 . . . . 0.69999999999999996 110.962 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 m -80.05 -1.3 39.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 1.96 111.481 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 11.3 mptt -118.87 22.28 12.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.321 -0.622 . . . . 2.6600000000000001 109.321 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.639 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 1.9 p90 -61.93 -32.79 73.23 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 3.98 113.565 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -139.99 18.59 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.988 -0.445 . . . . 0.63 111.508 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.15 -122.14 0.78 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.263 -0.735 . . . . 0.47999999999999998 111.263 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.5 Cg_endo -50.1 -40.64 50.64 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.539 2.826 . . . . 0.53000000000000003 110.696 167.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 23.1 mt -87.23 78.49 8.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.21 -0.904 . . . . 1.1699999999999999 108.752 170.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -73.26 64.98 0.82 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.702 0.763 . . . . 0.70999999999999996 110.507 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.653 HD22 ' CG2' ' A' ' 121' ' ' VAL . 28.7 mt -81.44 -7.05 59.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.181 -0.918 . . . . 0.45000000000000001 111.326 -173.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -2.06 20.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.428 0.632 . . . . 2.1200000000000001 110.332 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.87 -7.67 55.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 1.9299999999999999 110.743 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.806 HG11 HG21 ' A' ' 69' ' ' THR . 71.3 t -98.5 -70.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.684 . . . . 0.63 111.112 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.696 ' OD2' ' HD2' ' A' ' 155' ' ' ARG . 22.2 t0 -164.32 -178.45 5.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.807 -1.183 . . . . 2.9900000000000002 107.807 -167.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.35 149.84 41.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.322 0.582 . . . . 1.6000000000000001 111.104 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 1.6 tp-100 -81.87 138.6 46.57 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.735 . . . . 3.5499999999999998 110.736 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.641 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 13.4 Cg_exo -68.51 164.86 31.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.021 2.481 . . . . 0.57999999999999996 112.95 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.919 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.9 pt20 -90.52 -1.62 57.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.765 . . . . 1.3899999999999999 111.929 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.75 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.4 m170 -158.88 159.78 29.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 123.059 0.544 . . . . 1.45 109.919 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.3 Cg_endo -84.83 127.46 3.6 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.059 2.506 . . . . 0.40000000000000002 111.251 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 122' ' ' TRP . 36.0 tp -79.85 145.66 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.694 -0.23 . . . . 0.28999999999999998 110.768 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.416 ' H ' HD12 ' A' ' 25' ' ' LEU . 51.0 m-70 -114.72 121.24 42.73 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.982 -0.748 . . . . 1.24 108.982 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.906 HG13 HG22 ' A' ' 53' ' ' ILE . 19.4 t -122.83 144.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.108 -0.701 . . . . 0.46999999999999997 109.108 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -140.02 136.32 33.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.237 0.542 . . . . 0.31 111.107 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.602 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 46.0 t80 -101.97 170.2 8.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.174 -0.676 . . . . 0.67000000000000004 109.174 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.47 63.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.342 0.591 . . . . 0.55000000000000004 110.391 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.602 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -117.45 19.16 11.68 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.123 -0.944 . . . . 0.81000000000000005 112.703 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -151.7 -172.37 4.2 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.46999999999999997 110.783 177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.37 154.9 17.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.991 -0.55 . . . . 0.33000000000000002 110.13 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.754 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 87.8 t -119.21 68.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.192 -1.41 . . . . 0.39000000000000001 107.192 164.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 1' ' ' MET . 28.2 t70 -105.7 21.56 17.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.979 -1.01 . . . . 0.98999999999999999 108.851 -175.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 22.4 tt0 -144.42 117.58 8.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.718 -1.128 . . . . 2.5600000000000001 108.486 174.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -66.88 110.56 3.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.40999999999999998 109.475 -177.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 95.24 12.94 53.9 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.531 -0.759 . . . . 0.58999999999999997 112.557 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.93 149.05 32.44 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.09 -0.337 . . . . 0.34000000000000002 110.09 177.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.9 134.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.55000000000000004 111.324 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 34' ' ' VAL . 8.2 tp -132.27 171.11 14.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.703 -0.851 . . . . 0.45000000000000001 108.703 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -120.5 150.81 52.89 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.67 0.748 . . . . 0.56000000000000005 112.485 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 72.4 Cg_exo -54.92 -29.99 66.64 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.604 3.536 . . . . 0.68000000000000005 113.963 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -42.53 88.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.659 0.742 . . . . 0.76000000000000001 110.275 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -74.93 -14.4 60.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.613 -1.176 . . . . 1.5900000000000001 111.822 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 169' ' ' TYR . 24.9 m -125.48 24.32 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.173 0.511 . . . . 0.66000000000000003 111.647 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.75 -18.55 40.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.505 0.669 . . . . 0.79000000000000004 109.206 177.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 52.0 t30 -125.03 -179.58 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.701 -1.136 . . . . 1.9099999999999999 108.751 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.88 150.68 78.66 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.616 -0.513 . . . . 1.4299999999999999 109.616 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' HG13 ' A' ' 97' ' ' ILE . 55.2 Cg_endo -73.88 158.75 46.04 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.978 1.785 . . . . 0.37 110.436 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.442 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.6 t -79.75 -18.8 50.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 0.44 109.858 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 m -161.21 147.41 14.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.632 0.73 . . . . 0.38 112.164 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.906 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.13 165.6 23.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.756 -1.111 . . . . 0.29999999999999999 108.249 170.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.034 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 t 178.96 111.98 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.938 0.399 . . . . 0.34999999999999998 109.929 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 51.1 p-90 -68.87 167.97 14.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.552 -1.277 . . . . 2.7200000000000002 107.552 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -70.2 70.31 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.191 0.519 . . . . 1.51 111.187 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.83 22.99 0.64 Allowed Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.446 -0.797 . . . . 0.80000000000000004 112.423 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.034 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.7 tt -54.88 132.31 46.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.89 0.476 . . . . 0.57999999999999996 111.674 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.432 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 18.8 t70 -78.9 -28.81 44.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.844 -0.616 . . . . 0.73999999999999999 111.996 -175.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.7 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 64.6 m 71.82 1.97 4.11 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.462 -0.79 . . . . 1.03 110.769 -172.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.65 14.54 4.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.992 -0.549 . . . . 0.83999999999999997 112.719 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 1.5 mmpt? -119.26 164.82 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 1.6699999999999999 109.956 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 63.7 mt -103.2 125.6 49.96 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.367 -0.605 . . . . 0.57999999999999996 109.367 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -120.72 148.33 44.1 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.806 -0.357 . . . . 0.80000000000000004 110.812 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.984 HG23 HG12 ' A' ' 90' ' ' VAL . 3.1 m -96.56 105.74 17.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.691 -0.855 . . . . 0.35999999999999999 108.691 173.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 124' ' ' VAL . 50.2 tp -109.69 117.76 34.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.274 -0.421 . . . . 0.58999999999999997 110.907 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG22 HD13 ' A' ' 88' ' ' LEU . 21.0 t -119.0 123.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.865 -0.607 . . . . 0.39000000000000001 110.553 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 1.2 mt -90.03 133.68 34.68 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.038 -1.097 . . . . 0.59999999999999998 108.038 168.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.806 HG21 HG11 ' A' ' 17' ' ' VAL . 8.8 t -142.75 149.16 38.36 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.692 -0.403 . . . . 0.35999999999999999 111.84 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 10.8 t70 -135.71 97.5 12.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 121.522 0.677 . . . . 1.9199999999999999 109.488 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.475 ' HG2' ' HE1' ' A' ' 118' ' ' HIS . 18.6 Cg_endo -57.82 -7.42 3.35 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 124.62 3.547 . . . . 1.25 115.848 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 1.8 m-20 -124.77 51.42 1.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.533 0.683 . . . . 1.29 111.534 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.58 143.77 27.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.19 -0.913 . . . . 0.5 109.391 172.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 34.6 Cg_endo -70.92 -35.89 2.62 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.53 -1.446 . . . . 0.62 113.431 1.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 115' ' ' THR . 72.2 p -131.59 166.82 20.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.75 111.312 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 51.5 ttt180 -71.33 -23.09 61.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.0 -0.546 . . . . 2.8799999999999999 110.839 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.736 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.15 -11.52 38.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.509 . . . . 1.3799999999999999 110.656 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 6.9 t70 -149.64 79.73 7.83 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.699 -0.682 . . . . 1.3700000000000001 109.958 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.2 Cg_endo -89.77 94.24 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.741 2.294 . . . . 0.80000000000000004 113.287 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.557 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.9 mttm -88.17 -44.09 11.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.284 -0.871 . . . . 1.02 110.541 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.687 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 27.9 m-85 -88.54 18.12 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.175 -0.921 . . . . 1.1699999999999999 112.032 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.7 ttm180 -64.2 125.83 25.78 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.916 0.135 . . . . 2.9300000000000002 111.236 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.0 mp0 -97.67 134.25 41.11 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.065 -0.346 . . . . 2.23 110.065 -5.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 11.2 t90 -80.57 100.32 8.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.427 0.632 . . . . 1.4299999999999999 109.927 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 33.2 p-80 -84.2 126.08 32.8 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.553 0.692 . . . . 1.26 110.18 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 1.006 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 19.5 t-80 -67.9 -34.7 77.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.05 -0.977 . . . . 2.1400000000000001 110.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 68' ' ' LEU . 44.2 p90 -169.29 170.67 8.4 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.117 0.261 . . . . 1.51 110.311 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HG ' HD12 ' A' ' 103' ' ' LEU . 17.0 tp -133.33 114.08 13.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.065 -0.516 . . . . 0.33000000000000002 109.701 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.807 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.7 t -122.32 132.54 70.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.6 0.714 . . . . 0.31 111.153 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.984 HG12 HG23 ' A' ' 65' ' ' THR . 9.9 m -130.86 160.53 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.85 -1.068 . . . . 0.27000000000000002 108.419 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 0.9 OUTLIER 62.62 20.52 12.08 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.203 0.314 . . . . 1.76 110.625 178.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.807 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.3 ttm -71.51 110.35 6.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.277 -0.638 . . . . 0.31 109.277 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.01 94.71 5.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.578 -1.192 . . . . 1.21 110.937 -171.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 72.72 -120.27 7.37 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.801 -1.09 . . . . 0.29999999999999999 112.426 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.533 ' HA ' HD11 ' A' ' 53' ' ' ILE . 2.9 p-10 -112.76 17.59 18.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.188 0.518 . . . . 1.04 110.473 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.58 102.53 12.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.707 -0.679 . . . . 0.77000000000000002 109.911 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 97' ' ' ILE . 3.8 mm -58.71 -27.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.702 -1.135 . . . . 0.40999999999999998 111.624 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -77.94 -38.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.68000000000000005 111.975 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 m -74.87 -3.55 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 1.26 112.005 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.74 106.79 2.04 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.363 -0.695 . . . . 0.34999999999999998 111.363 177.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -61.46 107.39 0.78 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.281 0.562 . . . . 0.45000000000000001 109.734 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.8 p -83.47 113.28 22.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.081 -0.963 . . . . 0.56999999999999995 111.4 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.632 HD12 ' HG ' ' A' ' 88' ' ' LEU . 40.6 mt -90.4 -45.8 8.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.79 0.805 . . . . 0.45000000000000001 109.537 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.6 t -122.84 112.25 17.65 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.132 -1.433 . . . . 0.37 107.132 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 10.7 t0 -61.99 164.97 5.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.42 -0.809 . . . . 1.1499999999999999 112.699 -168.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 13.8 p90 -82.69 92.08 7.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 4.6900000000000004 110.76 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.712 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 40.3 t -75.09 -46.29 39.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.177 0.513 . . . . 0.85999999999999999 111.02 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.691 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 109.84 -174.82 18.14 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.439 -0.886 . . . . 0.67000000000000004 112.996 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 43' ' ' PRO . 42.2 t -66.58 140.25 57.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.287 -0.634 . . . . 0.51000000000000001 109.287 172.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.725 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -174.13 55.52 0.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.71 -0.757 . . . . 0.81999999999999995 112.854 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 57.5 Cg_endo -96.05 157.02 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.327 2.684 . . . . 0.84999999999999998 112.516 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.6 ' O ' HG23 ' A' ' 115' ' ' THR . 53.0 Cg_exo -54.89 154.54 21.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.058 2.505 . . . . 0.87 112.282 174.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.3 116.5 15.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.77 0.319 . . . . 1.8500000000000001 111.034 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.77 34.35 4.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.652 -0.785 . . . . 1.1799999999999999 112.924 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 112' ' ' PRO . 82.7 p -77.98 -18.27 56.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.729 0.3 . . . . 0.96999999999999997 110.637 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 104.41 3.14 44.21 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 120.916 -0.659 . . . . 1.97 112.132 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 172' ' ' GLU . 4.1 mm? 71.69 102.52 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.299 -0.951 . . . . 0.93999999999999995 111.079 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.518 ' CG ' ' H ' ' A' ' 119' ' ' ARG . 21.4 t-80 -110.69 -172.33 2.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.416 -0.957 . . . . 2.23 108.416 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 1.3 ptp180 -147.55 120.22 8.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.282 0.563 . . . . 2.3100000000000001 111.676 -163.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 6.5 m-85 -80.34 127.33 32.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.577 -1.192 . . . . 0.78000000000000003 108.825 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.653 ' CG2' HD22 ' A' ' 14' ' ' LEU . 16.9 t -104.19 130.83 54.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.154 -0.475 . . . . 0.27000000000000002 110.856 -177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.696 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 27.0 m95 -89.56 120.3 30.74 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 1.99 108.935 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 86.5 mt -115.49 118.59 33.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.934 0.334 . . . . 0.38 110.77 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.636 HG12 HD13 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -116.46 139.82 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.399 -0.223 . . . . 0.31 110.399 177.228 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.856 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 71.3 t80 -127.03 137.28 53.03 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.866 -0.334 . . . . 5.1200000000000001 111.0 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.536 ' H ' ' CG2' ' A' ' 164' ' ' VAL . 9.1 tp10 -88.05 96.65 10.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.49 -0.93 . . . . 2.4100000000000001 108.49 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.626 ' HG2' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -72.63 167.72 20.16 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.251 0.548 . . . . 1.3100000000000001 109.696 -176.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -80.84 -4.62 55.35 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.464 -0.789 . . . . 2.3999999999999999 109.747 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 3.2 ptp180 -165.06 161.9 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.337 -0.847 . . . . 3.5099999999999998 110.913 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.416 ' HG3' HD12 ' A' ' 63' ' ' LEU . 51.4 Cg_exo -55.91 143.72 80.95 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.509 2.806 . . . . 1.21 112.442 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.626 HD11 ' HG2' ' A' ' 127' ' ' GLN . 2.3 mm? -79.91 141.83 35.72 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.90000000000000002 110.767 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 20.2 tptm -132.64 67.26 1.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.435 -0.95 . . . . 2.8999999999999999 108.435 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.779 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 61.4 m -82.23 122.65 28.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.178 -0.919 . . . . 1.8999999999999999 110.443 -177.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.39 25.55 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.926 -0.579 . . . . 2.96 110.26 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.779 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 12.8 mm-40 -62.38 142.18 96.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.52 -0.764 . . . . 1.3899999999999999 109.894 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.69 110.14 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.313 2.675 . . . . 1.27 112.696 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.41 115.49 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.85999999999999999 110.323 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.8 mt -108.15 155.54 20.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.284 0.564 . . . . 1.6100000000000001 110.639 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.9 m -105.11 159.26 15.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.176 -1.046 . . . . 1.8799999999999999 108.176 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.712 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 5.2 p30 -78.75 7.11 7.5 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.739 -0.384 . . . . 0.75 110.666 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.58 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 11.0 mtt180 -98.17 135.17 40.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.548 -0.538 . . . . 3.3599999999999999 109.548 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.719 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 20.5 m 73.38 117.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 O-C-N 124.316 1.01 . . . . 0.94999999999999996 109.686 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.21 27.66 15.12 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.583 -0.818 . . . . 1.1200000000000001 113.669 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -71.29 -25.13 62.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.929 0.395 . . . . 2.6600000000000001 111.026 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.92 30.48 6.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.949 0.404 . . . . 1.8700000000000001 111.177 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 42.7 mtp180 -60.9 -46.39 90.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 4.7300000000000004 110.782 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.52 -154.82 7.71 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.743 -0.741 . . . . 0.65000000000000002 111.889 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.687 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.0 mttt 67.2 17.32 10.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.254 0.55 . . . . 1.0800000000000001 111.137 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -122.13 112.24 17.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.441 -0.799 . . . . 1.8899999999999999 109.106 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -62.45 129.7 41.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 1.29 112.496 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.649 HG21 ' CG1' ' A' ' 17' ' ' VAL . 4.6 m -62.94 -32.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.78000000000000003 110.761 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.21 95.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.586 -0.734 . . . . 0.67000000000000004 110.02 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.77000000000000002 110.693 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.616 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 32.7 m-85 -61.73 -50.62 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 0.92000000000000004 110.965 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.696 ' HD2' ' OD2' ' A' ' 18' ' ' ASP . 6.5 ptm85 -70.12 -40.01 75.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.396 -0.365 . . . . 2.8900000000000001 111.135 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -66.05 -26.03 67.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 111.637 0.236 . . . . 0.96999999999999997 111.637 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -53.76 -49.36 68.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.679 0.275 . . . . 1.5800000000000001 110.608 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.516 ' HB3' HD13 ' A' ' 160' ' ' LEU . 6.6 t80 -99.64 15.31 27.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.759 -0.776 . . . . 5.4500000000000002 109.917 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 58.4 43.6 19.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.295 -0.866 . . . . 2.4199999999999999 111.682 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.856 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 3.4 mp -86.13 120.54 27.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.767 -0.651 . . . . 1.27 111.027 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.91 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -79.62 -173.7 3.92 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.914 -0.402 . . . . 3.5899999999999999 109.914 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.91 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -43.5 146.41 0.93 Allowed Pre-proline 0 N--CA 1.466 0.328 0 C-N-CA 123.82 0.848 . . . . 0.76000000000000001 113.009 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 6.5 Cg_exo -71.54 169.65 20.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.965 3.11 . . . . 0.53000000000000003 113.969 -170.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 21.4 t -95.3 -30.8 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.44 110.364 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.75 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.3 146.9 27.78 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.828 -0.749 . . . . 0.27000000000000002 112.302 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.97 148.07 19.12 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 114.458 -1.246 . . . . 0.23999999999999999 111.603 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 10.5 t -159.72 149.43 18.33 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.469 -0.937 . . . . 0.34000000000000002 108.469 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 21.2 p -123.8 146.68 48.17 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.12 -0.632 . . . . 1.1100000000000001 111.166 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 33.4 p90 -130.23 142.03 50.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.413 -1.329 . . . . 0.80000000000000004 107.413 175.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 1.1 pt20 -115.66 134.64 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.192 -0.603 . . . . 2.5299999999999998 111.558 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.14 153.87 33.64 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.751 0.657 . . . . 0.59999999999999998 110.072 -172.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.695 ' HG2' HD11 ' A' ' 117' ' ' LEU . 2.5 pt-20 -133.91 -106.73 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.677 0.621 . . . . 2.3799999999999999 112.677 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.695 ' HA ' HG21 ' A' ' 177' ' ' VAL . 31.9 t90 -118.12 84.1 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.15 0.5 . . . . 3.96 110.232 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.871 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 7.2 t70 -73.26 -62.4 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.898 -0.592 . . . . 1.53 111.725 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 14.4 t70 173.41 -44.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.776 -0.647 . . . . 1.26 109.675 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -80.34 9.55 5.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.548 -0.751 . . . . 2.2200000000000002 111.117 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.73 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 83.9 t -72.8 -53.99 5.04 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.5 109.926 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.73 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.6 Cg_exo -51.53 -37.8 63.31 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.299 1.999 . . . . 0.57999999999999996 111.424 169.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.677 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.7 mmtp -71.54 -23.38 61.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 2.1400000000000001 111.38 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.4 tp -67.81 -48.24 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.052 -0.722 . . . . 0.66000000000000003 109.052 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.7 -32.39 73.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.01 -0.541 . . . . 1.8899999999999999 109.737 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 11.7 mm-40 -55.7 -48.45 75.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.39 -0.823 . . . . 1.53 110.329 171.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -73.98 -33.16 63.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.288 -0.869 . . . . 1.49 112.002 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.719 ' HA ' ' H ' ' A' ' 142' ' ' SER . 37.6 mt -63.16 -1.83 1.14 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.496 0.554 . . . . 0.76000000000000001 112.496 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.708 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 13.1 m -73.7 -2.62 24.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.434 0.635 . . . . 1.05 109.92 172.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.14 39.8 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.835 -0.906 . . . . 1.1699999999999999 110.835 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.708 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.519 -0.753 . . . . 2.0 110.061 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.789 -0.449 . . . . 5.04 109.789 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -46.59 137.3 15.47 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.617 2.878 . . . . 2.1299999999999999 113.221 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.761 HG22 ' HA ' ' A' ' 36' ' ' GLU . 19.8 t -88.22 144.12 9.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.501 -0.772 . . . . 1.47 111.462 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.432 ' O ' HD12 ' A' ' 37' ' ' LEU . 2.5 p30 -155.61 163.49 39.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.153 -1.054 . . . . 1.8100000000000001 108.153 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.522 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -88.28 29.11 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.633 -0.427 . . . . 0.69999999999999996 111.081 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 -7.82 59.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.303 0.573 . . . . 1.96 109.867 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 8.7 mptt -113.33 29.09 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 2.6600000000000001 109.608 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.648 ' HZ3' ' HG3' ' A' ' 15' ' ' GLN . 11.4 p-90 -67.87 -36.11 79.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.356 -0.838 . . . . 3.98 111.693 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 75.3 p -144.03 19.92 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.646 -0.421 . . . . 0.63 111.601 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.44 -118.37 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.86 -0.686 . . . . 0.47999999999999998 111.633 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.4 Cg_endo -47.14 -51.77 8.87 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.434 2.756 . . . . 0.53000000000000003 110.787 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.898 HD23 HD21 ' A' ' 14' ' ' LEU . 6.5 mp -88.95 98.39 11.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 1.1699999999999999 110.831 171.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 69.6 m -76.49 66.17 2.46 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.334 0.588 . . . . 0.70999999999999996 110.26 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.898 HD21 HD23 ' A' ' 12' ' ' LEU . 57.9 mt -73.85 -16.88 61.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.509 -0.769 . . . . 0.45000000000000001 111.225 -176.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.648 ' HG3' ' HZ3' ' A' ' 8' ' ' TRP . 19.0 tm0? -64.09 -15.08 58.84 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.05 0.452 . . . . 2.1200000000000001 110.857 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -60.4 -23.27 64.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.255 0.55 . . . . 1.9299999999999999 110.666 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.885 HG11 HG21 ' A' ' 69' ' ' THR . 87.3 t -103.53 -64.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.328 -0.851 . . . . 0.63 110.877 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HA ' HH22 ' A' ' 155' ' ' ARG . 4.8 p-10 -116.43 172.44 7.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.134 0.492 . . . . 2.9900000000000002 111.283 -175.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.58 28.65 1.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.632 -0.713 . . . . 1.6000000000000001 112.365 -171.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 4.5 tt0 65.41 116.95 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 123.191 0.596 . . . . 3.5499999999999998 110.691 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 20.4 Cg_exo -65.77 158.74 52.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.683 2.255 . . . . 0.57999999999999996 112.959 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.885 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.4 pt20 -77.41 -13.89 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.247 -0.888 . . . . 1.3899999999999999 110.789 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.748 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 70.7 m-70 -149.73 156.51 38.67 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-N 115.461 -0.79 . . . . 1.45 109.458 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -85.84 125.98 2.85 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.955 2.437 . . . . 0.40000000000000002 110.771 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.568 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 27.0 tp -80.02 148.12 31.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.874 0.369 . . . . 0.28999999999999998 111.012 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.47 ' H ' HD12 ' A' ' 25' ' ' LEU . 33.1 m170 -118.12 128.73 55.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.775 -0.454 . . . . 1.24 109.775 170.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.962 HG13 HG22 ' A' ' 53' ' ' ILE . 32.6 t -128.8 119.64 50.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.825 -0.806 . . . . 0.46999999999999997 108.825 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.6 OUTLIER -115.68 138.49 51.04 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.343 0.592 . . . . 0.31 111.431 -171.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 33.6 t80 -100.31 176.78 5.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.784 -0.644 . . . . 0.67000000000000004 109.275 174.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.58 65.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.277 0.561 . . . . 0.55000000000000004 110.63 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.57 -0.57 29.24 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.438 -0.801 . . . . 0.81000000000000005 112.845 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' NE2' ' A' ' 45' ' ' GLN . . . -135.54 -174.22 3.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.46999999999999997 110.914 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.75 144.25 8.64 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.56 -0.746 . . . . 0.33000000000000002 110.022 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.843 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.7 t -95.06 69.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 106.996 -1.483 . . . . 0.39000000000000001 106.996 163.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -103.22 28.4 6.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.106 -0.952 . . . . 0.98999999999999999 109.236 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' A' ' 3' ' ' VAL . 49.9 mt-10 -150.32 134.05 16.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.765 -1.107 . . . . 2.5600000000000001 109.086 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.722 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.36 114.02 11.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.40999999999999998 110.136 -175.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.88 29.59 51.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.9 -0.667 . . . . 0.58999999999999997 111.518 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.843 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -90.29 152.92 20.83 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.22 0.208 . . . . 0.34000000000000002 110.625 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.459 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.7 p -78.77 134.68 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.335 0.588 . . . . 0.55000000000000004 111.487 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 34' ' ' VAL . 7.6 tp -132.87 169.87 16.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.462 -0.94 . . . . 0.45000000000000001 108.462 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.6 p -115.02 151.39 45.54 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.024 -0.67 . . . . 0.56000000000000005 112.309 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 50.5 Cg_exo -56.91 -28.96 80.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.164 3.243 . . . . 0.68000000000000005 113.298 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 p -65.09 -41.21 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.615 0.721 . . . . 0.76000000000000001 110.528 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 32' ' ' ALA . 95.8 mt-30 -80.47 -17.69 50.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.684 -1.144 . . . . 1.5900000000000001 111.414 -175.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 42' ' ' THR . 28.2 m -125.66 30.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.66000000000000003 111.439 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -78.08 -21.93 49.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.457 0.646 . . . . 0.79000000000000004 109.266 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -131.89 177.91 7.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.404 -1.271 . . . . 1.9099999999999999 108.725 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.13 151.97 96.57 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.188 -0.301 . . . . 1.4299999999999999 110.188 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 60.6 Cg_endo -74.75 161.68 38.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.192 1.928 . . . . 0.37 110.744 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -82.12 -21.24 36.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.107 0.48 . . . . 0.44 109.919 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -158.56 149.82 20.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.38 111.96 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.962 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -138.5 165.29 25.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.05 -1.093 . . . . 0.29999999999999999 108.05 169.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.037 ' HA ' HD13 ' A' ' 58' ' ' LEU . 39.7 t -179.86 116.85 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.192 0.52 . . . . 0.34999999999999998 110.204 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.7 p-90 -78.78 163.27 25.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.189 -1.041 . . . . 2.7200000000000002 108.189 172.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.18 86.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.086 0.47 . . . . 1.51 110.939 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.0 29.44 2.81 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.677 -0.692 . . . . 0.80000000000000004 112.472 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.037 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.3 tt -60.66 129.83 43.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.04 0.447 . . . . 0.57999999999999996 110.853 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.801 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -80.69 -21.38 41.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.73999999999999999 111.927 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.659 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 75.7 m 69.56 2.01 3.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.456 -0.793 . . . . 1.03 110.957 -171.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.15 -2.63 3.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.731 -0.747 . . . . 0.83999999999999997 113.336 -176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.801 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 38.6 mtpt -93.93 145.69 24.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.451 0.625 . . . . 1.6699999999999999 109.637 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.907 HD23 ' HG2' ' A' ' 93' ' ' LYS . 2.9 mt -84.77 144.01 28.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.665 -1.235 . . . . 0.57999999999999996 107.665 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -140.72 166.05 25.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.841 -0.8 . . . . 0.80000000000000004 108.841 173.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 90' ' ' VAL . 88.5 m -105.03 105.16 15.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.222 -0.659 . . . . 0.35999999999999999 109.222 171.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.628 HD13 HG12 ' A' ' 124' ' ' VAL . 52.1 tp -104.59 115.57 30.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.232 0.539 . . . . 0.58999999999999997 110.429 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.0 t -121.11 123.72 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.645 -0.707 . . . . 0.39000000000000001 110.489 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 5.5 mt -81.51 139.38 35.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.167 -1.049 . . . . 0.59999999999999998 108.167 167.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.885 HG21 HG11 ' A' ' 17' ' ' VAL . 14.8 t -140.73 153.59 45.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.695 -0.402 . . . . 0.35999999999999999 110.94 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 15.7 t70 -140.69 102.16 6.49 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.251 0.548 . . . . 1.9199999999999999 110.219 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -55.37 -28.93 65.7 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.746 2.964 . . . . 1.25 114.788 174.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -100.43 43.81 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 1.29 111.974 -167.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 84' ' ' TRP . . . -108.51 136.43 19.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 122.241 -0.287 . . . . 0.5 110.872 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.714 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 66.2 Cg_endo -74.85 -25.75 9.89 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.277 -1.551 . . . . 0.62 112.657 0.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.562 ' HB3' HG22 ' A' ' 115' ' ' THR . 86.6 p -139.07 160.3 40.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.604 . . . . 0.75 109.945 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -72.32 -26.16 61.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 2.8799999999999999 111.858 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.824 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.85 -13.41 48.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.146 0.498 . . . . 1.3799999999999999 110.508 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 21.8 t0 -150.9 73.01 8.73 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.357 -0.838 . . . . 1.3700000000000001 109.149 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 43.6 Cg_endo -89.99 88.87 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.765 2.31 . . . . 0.80000000000000004 113.034 -175.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.714 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 38.0 mttm -78.2 -45.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.773 -1.103 . . . . 1.02 111.035 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 77.8 m-85 -82.74 10.62 7.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.194 -0.912 . . . . 1.1699999999999999 111.986 -169.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 37.8 ttp180 -70.16 127.76 33.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.185 -0.302 . . . . 2.9300000000000002 110.185 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 48.9 mt-10 -94.6 129.6 41.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.025 0.44 . . . . 2.23 110.56 0.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.706 ' HD1' ' HB3' ' A' ' 81' ' ' TYR . 9.9 t90 -88.48 90.3 8.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 1.4299999999999999 109.756 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.5 p80 -75.61 120.15 20.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.596 0.712 . . . . 1.26 109.872 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 6.1 t-160 -70.75 -24.44 62.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.365 -0.834 . . . . 2.1400000000000001 111.011 -172.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.735 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 19.0 p90 -168.26 179.03 4.67 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.696 -0.483 . . . . 1.51 109.696 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.408 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.2 tp -142.75 114.48 8.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.33000000000000002 110.434 174.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.735 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -126.49 132.37 70.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.31 110.475 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.648 ' HB ' HD23 ' A' ' 131' ' ' LEU . 6.4 m -124.54 166.2 20.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.722 -1.214 . . . . 0.27000000000000002 107.722 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.787 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 92.8 m-20 59.56 19.55 8.07 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.374 0.421 . . . . 1.76 111.363 172.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.709 ' HE3' HG11 ' A' ' 89' ' ' VAL . 10.8 ttm -71.64 108.48 5.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.582 -0.895 . . . . 0.31 108.582 175.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.907 ' HG2' HD23 ' A' ' 63' ' ' LEU . 1.9 mtpm? -82.03 94.79 7.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.083 -0.962 . . . . 1.21 111.091 -170.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.5 -119.65 5.58 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.06 -0.973 . . . . 0.29999999999999999 112.58 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.562 ' HA ' HD11 ' A' ' 53' ' ' ILE . 25.3 p-10 -117.62 29.94 7.56 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 1.04 111.002 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -96.71 105.59 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.534 0.683 . . . . 0.77000000000000002 110.034 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 97' ' ' ILE . 8.4 mm -58.6 -33.38 48.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.565 -1.198 . . . . 0.40999999999999998 111.459 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.2 m -82.61 -35.51 26.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.844 -0.616 . . . . 0.68000000000000005 111.906 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 m -73.28 -6.04 43.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.493 -0.321 . . . . 1.26 111.711 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.3 107.87 2.16 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.628 -0.589 . . . . 0.34999999999999998 111.628 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -57.99 107.01 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.534 0.683 . . . . 0.45000000000000001 109.602 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.8 p -85.91 121.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.826 -1.079 . . . . 0.56999999999999995 111.631 -173.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.508 HD22 ' HB2' ' A' ' 135' ' ' GLU . 68.7 mt -102.0 -46.73 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.161 -0.927 . . . . 0.45000000000000001 109.255 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.0 t -126.16 108.21 11.1 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.162 -1.422 . . . . 0.37 107.162 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.412 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.7 t0 -57.2 155.72 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 1.1499999999999999 112.673 -169.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 43.2 t80 -74.02 95.32 2.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.29 -0.868 . . . . 4.6900000000000004 109.783 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.4 t -78.96 142.34 14.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.268 -1.012 . . . . 0.85999999999999999 108.268 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.21 179.33 45.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.67000000000000004 112.975 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 28.7 t -54.92 141.3 34.06 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.16 0.184 . . . . 0.51000000000000001 111.084 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -164.83 70.55 0.19 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.168 -0.539 . . . . 0.81999999999999995 112.367 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.773 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 89.4 Cg_endo -92.53 133.76 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.022 2.481 . . . . 0.84999999999999998 113.257 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 38.5 Cg_exo -59.11 137.31 78.57 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.649 2.233 . . . . 0.87 111.395 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.554 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.08 118.21 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 1.8500000000000001 111.005 -178.18 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.63 -3.07 32.34 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.555 -0.831 . . . . 1.1799999999999999 112.087 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.609 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 62.1 p -81.77 -10.47 59.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 0.96999999999999997 110.57 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.16 -155.94 19.97 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.267 -0.733 . . . . 1.97 111.267 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -90.37 108.23 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.56 -0.533 . . . . 0.93999999999999995 109.56 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -72.22 113.75 9.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.474 -175.544 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 1.021 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 1.1 ptt180 -102.77 95.12 5.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.315 0.579 . . . . 2.3100000000000001 112.201 -169.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.603 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 16.9 m-85 -83.81 120.52 26.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.536 -0.756 . . . . 0.78000000000000003 109.123 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.847 HG21 HD22 ' A' ' 14' ' ' LEU . 6.7 t -100.14 131.98 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 110.008 -0.367 . . . . 0.27000000000000002 110.008 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.694 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 69.2 m95 -88.07 119.52 28.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.205 -0.665 . . . . 1.99 109.205 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.6 mt -118.85 118.79 32.5 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 121.104 -0.238 . . . . 0.38 110.654 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.628 HG12 HD13 ' A' ' 66' ' ' LEU . 1.4 m -105.12 128.36 59.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.165 -0.68 . . . . 0.31 109.165 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.655 ' CB ' HD23 ' A' ' 160' ' ' LEU . 86.2 m-85 -107.64 162.26 14.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.372 -0.376 . . . . 5.1200000000000001 111.006 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.94 113.13 26.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.717 0.77 . . . . 2.4100000000000001 112.806 -171.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.859 ' HB3' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -107.71 148.65 29.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.419 -0.809 . . . . 1.3100000000000001 110.064 171.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.17 -9.5 59.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.302 -0.863 . . . . 2.3999999999999999 110.716 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.475 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.5 ptp180 -147.59 168.09 12.02 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.601 -0.727 . . . . 3.5099999999999998 111.641 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 22.6 Cg_exo -61.61 141.26 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.707 2.272 . . . . 1.21 110.539 172.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.648 HD23 ' HB ' ' A' ' 90' ' ' VAL . 3.2 mm? -73.9 145.21 44.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.681 0.623 . . . . 0.90000000000000002 112.681 -169.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -102.2 104.34 14.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.965 -1.016 . . . . 2.8999999999999999 108.811 171.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.459 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.3 p -124.44 112.23 16.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.113 -0.494 . . . . 1.8999999999999999 111.803 -175.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -99.19 13.53 32.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.033 -0.729 . . . . 2.96 109.033 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HB2' HD22 ' A' ' 103' ' ' LEU . 9.2 mm-40 -63.04 130.01 93.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.212 -0.904 . . . . 1.3899999999999999 110.56 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.56 112.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.032 2.488 . . . . 1.27 112.435 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.5 mm -61.87 115.57 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 0.85999999999999999 110.855 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.14 152.27 23.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 1.6100000000000001 109.808 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.5 m -91.33 -173.44 3.61 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.676 -0.861 . . . . 1.8799999999999999 108.676 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.707 ' HA ' HG22 ' A' ' 107' ' ' VAL . 2.1 p-10 -92.86 7.62 43.07 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.015 -0.674 . . . . 0.75 110.175 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.879 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 85.7 mtt180 -95.97 145.45 25.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 3.3599999999999999 109.972 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.617 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 21.9 m 73.85 126.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.145 -0.934 . . . . 0.94999999999999996 111.516 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.81 33.9 5.41 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.298 -0.865 . . . . 1.1200000000000001 111.709 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -52.75 19.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 2.6600000000000001 113.312 -172.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -122.19 47.44 1.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.427 0.632 . . . . 1.8700000000000001 111.304 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.418 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 22.6 mmt180 -88.17 -27.44 21.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.728 -0.669 . . . . 4.7300000000000004 111.138 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -129.33 -169.0 12.47 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.982 -1.104 . . . . 0.65000000000000002 113.121 -174.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.732 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 79.3 mttt 65.99 34.33 7.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.603 0.715 . . . . 1.0800000000000001 110.805 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.78 167.53 12.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.078 -0.964 . . . . 1.8899999999999999 109.608 174.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -116.81 120.95 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.199 -0.455 . . . . 1.29 111.083 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.801 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 35.6 m -64.83 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.78000000000000003 110.301 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.58 -44.68 93.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.024 -0.534 . . . . 0.67000000000000004 109.708 172.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.3 m -64.16 -38.39 90.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.77000000000000002 110.099 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.801 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.5 m-85 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.58 -0.282 . . . . 0.92000000000000004 111.315 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.6 ptp180 -63.84 -43.87 94.89 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.979 -0.288 . . . . 2.8900000000000001 110.345 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -68.64 -29.9 68.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.32 . . . . 0.96999999999999997 111.119 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -59.09 -51.9 68.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 111.376 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.519 ' HB3' HD12 ' A' ' 131' ' ' LEU . 49.9 m-85 -89.95 4.27 50.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.965 -0.561 . . . . 5.4500000000000002 111.711 -173.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 72.16 33.12 1.62 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.762 0.664 . . . . 2.4199999999999999 111.213 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 127' ' ' GLN . 4.5 mp -100.54 172.44 7.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.21 -0.904 . . . . 1.27 109.372 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 31.0 tpt180 -131.99 -95.92 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.317 -0.553 . . . . 3.5899999999999999 111.953 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -105.28 146.28 32.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.919 0.39 . . . . 0.76000000000000001 110.989 -173.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 17.0 Cg_exo -65.71 141.74 67.32 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.274 2.649 . . . . 0.53000000000000003 112.872 -170.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.885 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.0 t -78.16 -32.66 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.44 109.757 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.748 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -154.08 147.52 25.01 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.276 -0.569 . . . . 0.27000000000000002 111.695 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.58 144.14 11.87 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.937 -1.029 . . . . 0.23999999999999999 111.592 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -159.25 135.2 8.81 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.152 -0.684 . . . . 0.34000000000000002 109.152 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.858 ' SG ' ' HB2' ' A' ' 119' ' ' ARG . 27.3 t -113.54 145.88 40.54 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.398 -0.521 . . . . 1.1100000000000001 111.696 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 27.0 p90 -129.08 131.18 47.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.067 -0.716 . . . . 0.80000000000000004 109.067 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 1.021 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 0.6 OUTLIER -98.46 132.22 44.09 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.441 -0.504 . . . . 2.5299999999999998 110.272 174.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.57 139.06 54.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.848 -0.427 . . . . 0.59999999999999998 109.848 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.18 -168.76 1.51 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.073 -0.512 . . . . 2.3799999999999999 110.939 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.69 ' HA ' HG21 ' A' ' 177' ' ' VAL . 22.7 t90 -87.23 78.57 8.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 3.96 109.847 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.609 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -72.81 -59.17 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.35 -0.386 . . . . 1.53 111.086 -177.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.572 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 15.4 t70 175.81 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.987 0.515 . . . . 1.26 110.479 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.495 ' HB3' ' CD ' ' A' ' 47' ' ' LYS . 36.9 m-85 -81.28 -0.64 41.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 2.2200000000000002 111.758 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.842 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 99.1 t -63.25 -54.83 41.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.17 -0.468 . . . . 0.5 110.794 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.842 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.0 Cg_exo -50.77 -43.71 44.99 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.658 2.239 . . . . 0.57999999999999996 111.923 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.675 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 30.3 mmmt -66.24 -23.55 66.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.08 -0.509 . . . . 2.1400000000000001 111.917 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.695 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 36.0 tp -66.04 -48.67 70.31 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.058 -0.657 . . . . 0.66000000000000003 109.574 172.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.26 -35.19 79.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.356 0.598 . . . . 1.8899999999999999 109.656 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.675 ' HG3' ' HD2' ' A' ' 179' ' ' LYS . 4.8 mm-40 -55.97 -48.26 76.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.927 -1.033 . . . . 1.53 110.122 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -74.39 -33.47 63.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 1.49 112.187 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 71.1 mt -62.25 -10.69 11.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.646 0.26 . . . . 0.76000000000000001 111.66 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.619 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 50.9 m -77.08 6.99 5.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.224 0.535 . . . . 1.05 110.441 173.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.879 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 68.89 60.82 5.02 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.268 -0.878 . . . . 1.1699999999999999 111.327 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.6 mmmt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.518 -0.753 . . . . 2.0 111.125 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.524 0.202 . . . . 5.04 111.081 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.55 153.92 63.23 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.602 2.201 . . . . 2.1299999999999999 111.242 173.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.0 t -66.39 116.01 5.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.319 0.58 . . . . 1.47 111.007 -175.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 6' ' ' SER . 32.0 t70 -152.04 158.15 42.64 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.752 -1.113 . . . . 1.8100000000000001 108.268 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.443 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.7 mm? -78.9 30.91 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.837 0.351 . . . . 0.69999999999999996 110.765 -175.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.647 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 3.9 m -59.1 -54.69 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.97 -0.559 . . . . 1.96 111.581 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HD2' ' HB2' ' A' ' 6' ' ' SER . 8.8 mptt -99.73 40.48 1.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.819 0.342 . . . . 2.6600000000000001 110.288 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.584 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 3.4 p-90 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.779 -0.646 . . . . 3.98 112.094 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 p -141.54 20.62 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.907 0.384 . . . . 0.63 111.394 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.77 -122.54 0.31 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.35 -0.7 . . . . 0.47999999999999998 111.35 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.4 Cg_endo -51.48 -40.12 63.49 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.13 2.553 . . . . 0.53000000000000003 109.815 166.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.854 HD11 ' HA3' ' A' ' 38' ' ' GLY . 25.9 mt -87.73 81.26 7.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.433 -1.258 . . . . 1.1699999999999999 109.863 172.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -71.75 66.97 0.56 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.05 -0.722 . . . . 0.70999999999999996 109.05 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 121' ' ' VAL . 46.0 mt -75.16 -12.74 60.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.698 -0.683 . . . . 0.45000000000000001 110.797 -175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -65.65 -15.19 62.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 2.1200000000000001 111.237 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.16 -21.72 66.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.165 0.507 . . . . 1.9299999999999999 110.078 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.789 HG11 HG21 ' A' ' 69' ' ' THR . 76.1 t -89.56 -71.59 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.464 -0.789 . . . . 0.63 110.775 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.582 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 9.8 t70 -156.58 174.72 15.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.543 -0.54 . . . . 2.9900000000000002 109.543 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -63.95 120.84 12.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.298 . . . . 1.6000000000000001 110.285 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.584 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 7.7 tp-100 -53.82 127.93 53.49 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.752 -0.658 . . . . 3.5499999999999998 110.567 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.662 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.0 Cg_exo -58.28 161.89 13.03 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.331 2.688 . . . . 0.57999999999999996 113.498 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.904 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 8.8 pt20 -69.86 -19.48 63.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.894 -1.048 . . . . 1.3899999999999999 112.0 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.695 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m80 -146.56 159.04 45.64 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.165 -0.47 . . . . 1.45 110.424 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.2 Cg_endo -85.19 128.65 3.67 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.208 2.605 . . . . 0.40000000000000002 111.436 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.48 HD22 ' CG1' ' A' ' 124' ' ' VAL . 26.7 tp -80.84 146.89 30.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.526 0.203 . . . . 0.28999999999999998 110.769 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -115.38 109.54 18.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.103 -0.332 . . . . 1.24 110.103 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.878 HG13 HG22 ' A' ' 53' ' ' ILE . 13.8 t -116.35 140.4 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.46999999999999997 110.049 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -137.59 137.66 38.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.3 -0.409 . . . . 0.31 110.889 -177.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.658 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 22.2 t80 -97.36 177.26 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.833 -0.802 . . . . 0.67000000000000004 108.833 174.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.41 -52.53 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.514 0.673 . . . . 0.55000000000000004 110.059 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.17 8.79 38.78 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.006 -0.997 . . . . 0.81000000000000005 112.651 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HB2' ' NE2' ' A' ' 45' ' ' GLN . . . -148.57 -169.7 3.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.46999999999999997 110.704 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.51 158.2 23.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.737 -0.665 . . . . 0.33000000000000002 109.8 176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.885 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 79.8 t -111.43 65.87 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.624 -1.621 . . . . 0.39000000000000001 106.624 163.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -97.69 25.31 5.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.17 0.986 . . . . 0.98999999999999999 109.062 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.6 122.57 10.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.524 -1.217 . . . . 2.5600000000000001 108.02 174.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.2 tt -70.94 111.37 6.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.194 0.521 . . . . 0.40999999999999998 109.709 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.854 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 82.15 26.26 49.01 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.343 -0.844 . . . . 0.58999999999999997 111.862 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -83.74 153.17 24.3 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.93 -0.396 . . . . 0.34000000000000002 109.93 174.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.55 133.46 30.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.425 0.631 . . . . 0.55000000000000004 111.285 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.8 tp -131.22 170.08 15.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.558 -0.904 . . . . 0.45000000000000001 108.558 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.36 152.41 54.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 O-C-N 121.665 -0.647 . . . . 0.56000000000000005 112.491 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 77.1 Cg_exo -51.78 -35.35 58.33 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.749 3.633 . . . . 0.68000000000000005 114.722 -171.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.9 p -65.64 -35.03 79.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.76000000000000001 110.36 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 32' ' ' ALA . 99.1 mt-30 -82.43 -14.14 55.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.4 -1.273 . . . . 1.5900000000000001 111.686 -175.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 41' ' ' LEU . 23.9 m -128.49 20.04 2.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.287 0.565 . . . . 0.66000000000000003 111.656 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.79 -26.55 31.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.751 -0.659 . . . . 0.79000000000000004 109.545 179.217 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -116.77 -178.02 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.699 -1.137 . . . . 1.9099999999999999 109.182 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' HB3' HG21 ' A' ' 97' ' ' ILE . 77.9 mtt180 -72.9 152.9 91.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.932 -0.766 . . . . 1.4299999999999999 108.932 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.658 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 49.2 Cg_endo -74.94 175.02 11.77 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.413 1.409 . . . . 0.37 110.39 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -96.93 -16.26 20.75 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.274 -0.571 . . . . 0.44 110.059 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.477 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 75.3 m -159.75 144.32 14.99 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.38 112.436 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.878 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.24 169.21 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.996 -1.112 . . . . 0.29999999999999999 107.996 171.368 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.083 ' HA ' HD13 ' A' ' 58' ' ' LEU . 36.8 t 176.87 127.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.918 0.39 . . . . 0.34999999999999998 110.088 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 32.8 p-90 -92.91 167.73 11.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.933 -1.136 . . . . 2.7200000000000002 107.933 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.4 78.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 1.51 111.045 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.02 26.01 0.86 Allowed Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.565 -0.743 . . . . 0.80000000000000004 112.06 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.083 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.7 tt -65.35 128.48 36.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.071 0.462 . . . . 0.57999999999999996 110.939 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.76 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 33.5 t70 -75.39 -25.68 57.84 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 0.73999999999999999 111.756 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 25.3 p 70.0 8.87 6.88 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.475 1.11 . . . . 1.03 110.331 -171.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -3.4 1.42 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.83999999999999997 113.405 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.76 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 39.5 mtpt -96.51 151.97 19.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.38 0.59 . . . . 1.6699999999999999 110.217 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.695 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 45.2 mt -88.15 124.96 34.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.629 -0.714 . . . . 0.57999999999999996 109.977 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.613 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.6 m-85 -120.99 152.0 39.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.919 -0.312 . . . . 0.80000000000000004 110.683 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.456 HG23 HG12 ' A' ' 90' ' ' VAL . 57.1 m -97.32 110.63 23.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 0.35999999999999999 109.149 170.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.672 HD13 HG12 ' A' ' 124' ' ' VAL . 48.8 tp -113.16 118.69 35.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.58999999999999997 110.497 -175.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.3 t -116.64 126.29 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.39000000000000001 110.619 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.963 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 2.9 mt -92.76 133.76 35.72 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.472 -0.936 . . . . 0.59999999999999998 108.472 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.789 HG21 HG11 ' A' ' 17' ' ' VAL . 9.3 t -137.55 147.42 45.12 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.616 -0.434 . . . . 0.35999999999999999 111.899 -176.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 18.5 t70 -123.82 97.15 41.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.69 -0.686 . . . . 1.9199999999999999 109.8 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.2 Cg_endo -51.39 -35.11 53.3 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 124.076 3.184 . . . . 1.25 114.797 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 60.8 m-20 -99.45 49.69 0.94 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 1.29 112.397 -168.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.45 142.75 25.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.5 110.295 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 98.5 Cg_endo -83.66 -23.11 13.38 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.814 -1.328 . . . . 0.62 112.753 1.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.689 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 24.7 p -129.67 144.13 51.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.75 109.816 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 40.0 ttt180 -62.46 -26.68 68.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 2.8799999999999999 111.212 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.8 ptpt -76.25 -21.64 56.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.042 0.449 . . . . 1.3799999999999999 111.111 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 18.1 t70 -154.14 85.6 3.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.022 -0.536 . . . . 1.3700000000000001 109.674 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -82.2 87.91 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.451 2.101 . . . . 0.80000000000000004 112.717 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 32.0 mttm -75.15 -49.88 18.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.039 -0.982 . . . . 1.02 110.085 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.759 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.2 m-85 -84.53 22.1 1.36 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 111.903 -169.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.5 ttm180 -74.9 127.74 33.91 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.136 0.272 . . . . 2.9300000000000002 110.522 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' OE1' HG22 ' A' ' 151' ' ' VAL . 4.2 mp0 -97.04 137.44 36.12 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.043 0.449 . . . . 2.23 110.497 -3.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.545 ' CD1' ' HG2' ' A' ' 146' ' ' ARG . 16.8 t90 -85.37 146.04 27.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.996 -1.113 . . . . 1.4299999999999999 107.996 173.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 48.6 p-80 -122.04 129.48 52.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.282 0.563 . . . . 1.26 110.357 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 38.5 t-80 -68.1 -34.74 76.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.032 -0.986 . . . . 2.1400000000000001 110.09 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.522 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 40.3 p90 -168.69 172.62 7.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.045 -0.354 . . . . 1.51 110.045 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HG ' HD12 ' A' ' 103' ' ' LEU . 44.0 tp -133.96 113.9 12.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.507 -0.553 . . . . 0.33000000000000002 109.507 173.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.617 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -120.92 134.73 63.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.819 -0.628 . . . . 0.31 110.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' A' ' 131' ' ' LEU . 15.9 m -132.79 161.47 41.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 107.691 -1.226 . . . . 0.27000000000000002 107.691 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.695 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 t30 63.34 18.16 10.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.221 0.534 . . . . 1.76 110.221 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.617 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.0 ttm -68.11 111.36 4.44 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.94 -0.763 . . . . 0.31 108.94 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.592 ' HE2' HD21 ' A' ' 63' ' ' LEU . 14.5 ttmt -85.71 101.83 13.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.722 -1.126 . . . . 1.21 111.318 -170.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.15 -124.2 27.47 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 114.959 -1.019 . . . . 0.29999999999999999 112.43 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.575 ' HA ' HD11 ' A' ' 53' ' ' ILE . 3.7 p-10 -110.56 21.79 16.18 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.982 0.42 . . . . 1.04 110.756 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.79 109.4 20.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.723 0.773 . . . . 0.77000000000000002 109.971 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 50' ' ' PRO . 5.3 mm -62.38 -31.18 50.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.097 -1.41 . . . . 0.40999999999999998 111.246 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.1 m -78.29 -37.09 45.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.874 -0.603 . . . . 0.68000000000000005 111.997 -172.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.3 m -70.05 -8.6 50.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.765 0.283 . . . . 1.26 111.765 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 92' ' ' MET . . . -67.41 100.11 0.57 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.977 -0.63 . . . . 0.34999999999999998 111.779 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.5 m -60.33 107.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.671 0.748 . . . . 0.45000000000000001 110.11 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 105' ' ' ASP . 4.6 p -86.69 127.63 40.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.667 -1.151 . . . . 0.56999999999999995 111.527 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 11.3 mt -102.01 -54.72 2.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.116 0.96 . . . . 0.45000000000000001 109.141 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.1 t -106.43 100.15 9.69 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.885 -1.524 . . . . 0.37 106.885 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 1.007 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -55.37 160.7 2.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.002 -0.999 . . . . 1.1499999999999999 112.782 -169.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.1 p90 -74.09 90.76 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.514 -0.766 . . . . 4.6900000000000004 110.879 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.707 HG12 HD21 ' A' ' 180' ' ' LEU . 35.6 t -63.96 -40.07 87.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.902 -0.59 . . . . 0.85999999999999999 110.353 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.559 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 103.3 -173.03 21.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.667 -0.778 . . . . 0.67000000000000004 112.7 174.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 t -64.6 115.03 4.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.411 -0.589 . . . . 0.51000000000000001 109.411 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.674 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -144.68 58.18 0.52 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.81999999999999995 112.943 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.671 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -89.21 125.71 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.303 2.669 . . . . 0.84999999999999998 111.94 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.719 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 82.5 Cg_exo -46.21 132.98 15.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.415 2.076 . . . . 0.87 111.273 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.0 110.83 2.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.005 -0.543 . . . . 1.8500000000000001 111.012 -171.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.0 -5.27 25.59 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.594 -0.73 . . . . 1.1799999999999999 113.062 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.719 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -77.58 -9.92 59.21 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.698 0.629 . . . . 0.96999999999999997 112.698 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.01 -170.48 25.01 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.707 . . . . 1.97 111.994 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -73.42 144.82 46.19 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.866 0.365 . . . . 0.93999999999999995 110.757 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.671 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.6 m-70 -120.76 123.0 41.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.073 -0.512 . . . . 2.23 110.303 176.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.842 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 11.1 ptt180 -100.0 92.17 5.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.536 -0.756 . . . . 2.3100000000000001 111.406 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 69' ' ' THR . 40.6 m-85 -75.74 112.2 11.87 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.157 -0.683 . . . . 0.78000000000000003 109.157 175.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.843 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.0 t -96.49 133.74 36.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.774 . . . . 0.27000000000000002 109.66 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.62 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 35.5 m95 -89.29 132.61 34.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.193 -0.669 . . . . 1.99 109.193 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 82.7 mt -127.62 118.33 23.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.742 0.246 . . . . 0.38 110.344 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.672 HG12 HD13 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -114.2 145.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.716 0.293 . . . . 0.31 110.434 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.702 ' CD1' ' HG ' ' A' ' 160' ' ' LEU . 35.8 t80 -123.87 153.46 41.06 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.613 -0.514 . . . . 5.1200000000000001 109.613 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -108.35 88.87 2.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.033 -0.729 . . . . 2.4100000000000001 109.033 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -74.7 175.04 8.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.971 0.891 . . . . 1.3100000000000001 111.795 -172.546 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.86 -16.48 28.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.774 -1.557 . . . . 2.3999999999999999 109.964 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.549 ' HD2' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -144.63 160.53 47.28 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.413 -0.812 . . . . 3.5099999999999998 111.204 -176.369 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 131' ' ' LEU . 25.5 Cg_exo -70.43 14.12 0.31 Allowed 'Trans proline' 0 N--CA 1.484 0.919 0 C-N-CA 124.81 3.674 . . . . 1.21 114.501 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.567 HD12 ' SG ' ' A' ' 133' ' ' CYS . 4.1 mm? 81.13 168.34 0.14 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.679 0.792 . . . . 0.90000000000000002 112.864 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -160.53 78.48 0.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.315 -1.312 . . . . 2.8999999999999999 107.75 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.753 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.1 m -99.91 130.04 46.05 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.451 -0.795 . . . . 1.8999999999999999 111.214 -173.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -93.74 18.73 9.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.34 -0.845 . . . . 2.96 109.975 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.753 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 6.9 mm-40 -76.23 116.37 55.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.476 -0.783 . . . . 1.3899999999999999 109.923 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.72 137.37 42.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.362 2.708 . . . . 1.27 113.63 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.0 mm -73.47 115.77 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.764 -0.458 . . . . 0.85999999999999999 109.764 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -92.02 -10.86 37.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.966 0.728 . . . . 1.6100000000000001 112.966 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.9 m 51.98 25.12 2.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.292 0.849 . . . . 1.8799999999999999 113.292 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 1.007 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.1 p-10 50.54 21.99 0.97 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.202 1.001 . . . . 0.75 113.414 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.516 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 46.4 mtt180 -110.32 142.22 42.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.189 -0.3 . . . . 3.3599999999999999 110.189 172.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.638 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 55.0 m 77.07 151.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.215 0.947 . . . . 0.94999999999999996 111.703 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 146' ' ' ARG . . . -120.41 14.03 10.13 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.486 -0.779 . . . . 1.1200000000000001 112.849 -174.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.48 -22.27 62.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.472 . . . . 2.6600000000000001 111.035 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -119.82 46.3 1.97 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.228 -0.656 . . . . 1.8700000000000001 109.228 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.545 ' HG2' ' CD1' ' A' ' 84' ' ' TRP . 10.0 ttm180 -75.14 -71.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.145 -0.934 . . . . 4.7300000000000004 111.531 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -120.42 -154.66 9.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 0.65000000000000002 112.31 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.759 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.0 mttt 65.45 35.77 7.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.402 0.62 . . . . 1.0800000000000001 110.256 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -120.11 104.45 10.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.169 -0.923 . . . . 1.8899999999999999 109.745 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -53.84 120.56 6.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.916 -0.584 . . . . 1.29 111.785 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 2.4 m -62.04 -29.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.78000000000000003 111.183 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.743 ' HB1' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -37.55 87.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.67000000000000004 110.169 174.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.6 m -65.99 -33.29 75.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.546 -0.297 . . . . 0.77000000000000002 110.785 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.892 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 49.9 m-85 -62.24 -54.1 45.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.054 0.454 . . . . 0.92000000000000004 110.56 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 9.6 ptt180 -70.01 -51.57 31.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 2.8900000000000001 111.853 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.743 ' HE2' ' HB1' ' A' ' 152' ' ' ALA . 58.7 mtmt -62.01 -24.5 67.08 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.427 -0.17 . . . . 0.96999999999999997 111.367 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -52.05 -53.12 46.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 1.5800000000000001 111.425 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.549 ' OH ' ' HD2' ' A' ' 129' ' ' ARG . 12.7 t80 -104.43 29.55 6.0 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.796 -0.762 . . . . 5.4500000000000002 110.511 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 71.53 26.59 3.17 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.252 -0.886 . . . . 2.4199999999999999 111.842 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.702 ' HG ' ' CD1' ' A' ' 125' ' ' TYR . 7.8 mp -83.68 124.51 30.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.901 -0.407 . . . . 1.27 109.901 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -73.26 -75.87 0.14 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.721 -0.672 . . . . 3.5899999999999999 112.6 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.56 ' H ' ' HE2' ' A' ' 125' ' ' TYR . . . -150.51 150.99 30.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.547 0.213 . . . . 0.76000000000000001 110.668 -176.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.42 152.17 78.6 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.55 2.833 . . . . 0.53000000000000003 114.016 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.904 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.6 t -93.81 -37.39 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 115.025 -0.989 . . . . 0.44 110.568 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -143.27 144.16 32.02 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.011 -0.676 . . . . 0.27000000000000002 111.703 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' A' ' 21' ' ' PRO . . . -146.7 150.88 23.19 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.114 -0.948 . . . . 0.23999999999999999 112.343 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.584 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.2 t -164.62 156.08 15.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.293 -1.003 . . . . 0.34000000000000002 108.293 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.843 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -131.42 150.23 52.23 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.872 -0.517 . . . . 1.1100000000000001 112.04 -172.026 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.496 ' HD2' ' HE1' ' A' ' 122' ' ' TRP . 51.1 p90 -136.0 135.01 39.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.608 -0.886 . . . . 0.80000000000000004 108.608 171.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.842 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -99.65 133.8 43.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.575 0.625 . . . . 2.5299999999999998 110.386 173.002 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.48 137.33 54.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.935 0.397 . . . . 0.59999999999999998 111.416 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.98 -170.2 3.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.447 -0.797 . . . . 2.3799999999999999 110.914 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.873 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -105.48 77.39 1.28 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.979 -0.748 . . . . 3.96 108.979 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.591 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 13.7 t70 -72.19 -61.24 1.86 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.167 0.803 . . . . 1.53 113.167 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.633 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 12.4 t70 -167.5 -46.78 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.216 0.532 . . . . 1.26 110.951 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 37.9 m-85 -71.8 -2.8 18.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 2.2200000000000002 111.691 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.873 HG21 ' HA ' ' A' ' 173' ' ' TRP . 66.8 t -73.17 -55.37 3.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.57 -0.286 . . . . 0.5 111.414 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 47.6 Cg_exo -58.22 -29.72 88.49 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.271 1.98 . . . . 0.57999999999999996 111.274 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.0 mmmm -74.7 -24.77 58.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 111.17 177.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.707 HD21 HG12 ' A' ' 107' ' ' VAL . 51.2 tp -76.08 -42.07 48.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.502 -0.555 . . . . 0.66000000000000003 109.502 172.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -58.87 -38.27 78.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.69 -0.686 . . . . 1.8899999999999999 109.185 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.676 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.8 mm-40 -58.21 -42.73 86.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.791 -1.095 . . . . 1.53 110.985 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -76.41 -32.23 58.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 1.49 112.759 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.638 ' HA ' ' H ' ' A' ' 142' ' ' SER . 60.9 mt -62.99 -4.97 2.52 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.786 0.662 . . . . 0.76000000000000001 112.786 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.533 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 20.1 m -78.65 1.49 22.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.531 0.682 . . . . 1.05 109.766 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 76.37 50.94 6.99 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.1 -0.954 . . . . 1.1699999999999999 111.184 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.533 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.7 mmmt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.359 -0.829 . . . . 2.0 110.37 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.51 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 10.1 tpt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.46 -0.2 . . . . 5.04 110.46 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 31.2 Cg_exo -59.64 120.11 7.73 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.755 2.304 . . . . 2.1299999999999999 111.78 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 7.2 p -58.57 133.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.746 -1.115 . . . . 1.47 111.013 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 6' ' ' SER . 25.2 t70 -167.03 163.43 15.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.696 -0.853 . . . . 1.8100000000000001 108.696 -172.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -76.56 25.81 0.14 Allowed 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 120.537 0.208 . . . . 0.69999999999999996 111.113 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 4' ' ' ASP . 31.1 m -62.91 -27.34 69.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 1.96 111.692 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -116.38 48.26 1.29 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.87 0.367 . . . . 2.6600000000000001 110.258 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -75.09 -29.74 60.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 3.98 111.724 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 36.6 p -148.14 11.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.535 -0.466 . . . . 0.63 112.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.46 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.729 . . . . 0.47999999999999998 111.733 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.3 Cg_endo -48.88 -48.83 16.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.201 2.601 . . . . 0.53000000000000003 110.381 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.72 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 8.1 mp -87.99 88.94 7.8 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.354 -0.839 . . . . 1.1699999999999999 110.258 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 7.4 m -76.12 67.02 2.37 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.354 0.597 . . . . 0.70999999999999996 110.095 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 121' ' ' VAL . 23.5 mt -71.12 -13.91 62.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.496 -0.775 . . . . 0.45000000000000001 111.164 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -65.61 -14.84 61.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.131 -0.486 . . . . 2.1200000000000001 111.477 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.34 -19.76 65.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.29 0.567 . . . . 1.9299999999999999 110.507 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.903 HG12 HG21 ' A' ' 151' ' ' VAL . 40.6 t -93.76 -72.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.477 -0.783 . . . . 0.63 111.27 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 19' ' ' GLU . 25.5 t70 -149.97 -170.99 3.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.557 -0.905 . . . . 2.9900000000000002 108.557 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.821 ' HG3' HH12 ' A' ' 155' ' ' ARG . 15.6 mt-10 -81.64 163.72 22.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.789 0.804 . . . . 1.6000000000000001 113.114 -167.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.49 126.95 89.29 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.415 -1.266 . . . . 3.5499999999999998 110.387 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 6.3 Cg_exo -75.28 154.25 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.839 1.693 . . . . 0.57999999999999996 111.166 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.946 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 20.4 pt20 -81.44 -1.19 44.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.293 -0.412 . . . . 1.3899999999999999 111.726 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.769 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 13.7 m80 -160.54 159.95 25.83 Favored Pre-proline 0 CA--C 1.516 -0.362 0 C-N-CA 123.35 0.66 . . . . 1.45 109.583 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -86.87 128.54 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 123.132 2.555 . . . . 0.40000000000000002 110.994 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.607 HD22 HG12 ' A' ' 124' ' ' VAL . 43.9 tp -80.1 145.9 32.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.696 0.284 . . . . 0.28999999999999998 111.183 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -109.36 130.33 55.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.311 -0.626 . . . . 1.24 109.311 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 53' ' ' ILE . 16.0 t -134.16 118.8 29.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.487 -0.931 . . . . 0.46999999999999997 108.487 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.3 OUTLIER -117.98 136.78 53.29 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 0.31 111.283 -172.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -97.0 173.82 7.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.279 -0.637 . . . . 0.67000000000000004 109.279 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.52 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.5 0.667 . . . . 0.55000000000000004 110.548 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 -6.14 37.55 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.163 -0.926 . . . . 0.81000000000000005 112.763 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.91 -171.96 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.858 0.329 . . . . 0.46999999999999997 110.52 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.73 153.73 17.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.113 -0.494 . . . . 0.33000000000000002 110.301 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.795 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 84.9 t -109.85 69.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 107.406 -1.331 . . . . 0.39000000000000001 107.406 165.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 34.2 t70 -102.49 20.46 17.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.967 -1.015 . . . . 0.98999999999999999 109.072 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.631 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 52.3 mt-10 -143.84 134.54 25.05 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.48 -1.236 . . . . 2.5600000000000001 108.955 172.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.696 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -81.36 112.49 18.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.794 -0.639 . . . . 0.40999999999999998 109.985 -174.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.59 52.53 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.256 -0.738 . . . . 0.58999999999999997 111.256 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.705 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.09 149.44 26.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.321 -0.251 . . . . 0.34000000000000002 110.321 177.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 10.2 p -74.52 131.81 34.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 0.55000000000000004 110.967 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.611 HD22 HG22 ' A' ' 34' ' ' VAL . 9.2 tp -133.0 170.7 15.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.485 -0.931 . . . . 0.45000000000000001 108.485 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -121.24 149.86 52.71 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 119.4 -0.92 . . . . 0.56000000000000005 111.802 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.741 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 39.8 Cg_exo -61.31 -28.62 84.73 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.201 3.267 . . . . 0.68000000000000005 113.651 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -28.61 67.37 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.546 0.689 . . . . 0.76000000000000001 110.542 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 42' ' ' THR . 97.5 mt-30 -77.88 -52.94 8.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.848 -1.069 . . . . 1.5900000000000001 111.228 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 169' ' ' TYR . 3.9 m -99.16 32.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.695 0.628 . . . . 0.66000000000000003 112.695 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.82 -30.72 61.49 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.346 -0.542 . . . . 0.79000000000000004 110.039 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.06 179.88 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 1.9099999999999999 109.971 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 96.8 mtt180 -66.89 159.38 76.06 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.868 0.366 . . . . 1.4299999999999999 110.797 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 71.3 Cg_endo -79.57 157.54 25.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.072 1.848 . . . . 0.37 110.944 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -82.23 -18.06 43.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.684 -0.488 . . . . 0.44 109.684 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 71.5 m -160.68 147.24 15.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.504 0.669 . . . . 0.38 112.003 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.921 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -137.46 166.29 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.29999999999999999 108.207 169.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.084 ' HA ' HD13 ' A' ' 58' ' ' LEU . 43.5 t 176.82 111.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.122 0.487 . . . . 0.34999999999999998 110.323 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.638 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 51.4 p-90 -73.3 152.89 40.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.616 -1.253 . . . . 2.7200000000000002 107.616 171.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.66 89.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.51 111.12 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.48 17.45 4.35 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.757 -0.656 . . . . 0.80000000000000004 112.236 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.084 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.3 tt -51.9 129.07 25.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.113 0.565 . . . . 0.57999999999999996 111.734 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.748 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 17.9 t70 -72.28 -30.67 65.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.538 -0.756 . . . . 0.73999999999999999 111.503 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.446 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.4 m 76.46 -5.6 2.15 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.818 -1.083 . . . . 1.03 110.604 -172.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.06 -8.34 5.61 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.948 -0.644 . . . . 0.83999999999999997 113.556 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 29.4 mtpt -94.7 142.85 26.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.423 0.611 . . . . 1.6699999999999999 110.962 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.72 HD21 ' HE2' ' A' ' 93' ' ' LYS . 46.7 mt -78.56 125.65 29.65 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.539 -0.912 . . . . 0.57999999999999996 108.539 171.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.514 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -121.13 163.04 19.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.465 -0.494 . . . . 0.80000000000000004 109.978 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.695 HG23 HG12 ' A' ' 90' ' ' VAL . 69.1 m -104.24 105.49 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.355 -0.609 . . . . 0.35999999999999999 109.355 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.544 HD23 ' HE2' ' A' ' 87' ' ' PHE . 25.3 tp -100.25 114.58 28.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.766 -0.457 . . . . 0.58999999999999997 109.766 -177.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.7 t -116.71 121.77 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.907 0.384 . . . . 0.39000000000000001 111.344 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -81.52 134.38 35.51 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.555 -1.276 . . . . 0.59999999999999998 107.555 168.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.838 HG21 HG11 ' A' ' 17' ' ' VAL . 10.3 t -140.35 142.74 35.56 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.014 0.435 . . . . 0.35999999999999999 110.479 176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 7.1 p-10 -130.66 95.59 25.93 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-O 121.653 0.74 . . . . 1.9199999999999999 110.188 174.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.5 Cg_endo -52.92 -31.95 54.98 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.937 3.091 . . . . 1.25 112.837 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.734 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 5.1 m-20 -82.79 45.98 1.04 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 1.29 111.094 -172.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.41 130.23 23.65 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.696 -0.483 . . . . 0.5 109.696 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.583 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.3 Cg_endo -79.17 -30.38 5.78 Favored 'Cis proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.147 -1.605 . . . . 0.62 112.982 1.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.718 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 98.6 p -125.59 156.64 38.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.33 -0.395 . . . . 0.75 111.224 -177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.734 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 52.0 ttp180 -72.19 -23.85 61.33 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.049 -0.523 . . . . 2.8799999999999999 111.129 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.779 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.08 -11.26 39.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.434 . . . . 1.3799999999999999 110.64 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -156.32 84.32 3.25 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 1.3700000000000001 109.814 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.95 91.74 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.065 2.51 . . . . 0.80000000000000004 113.353 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.583 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.8 mttm -76.11 -49.59 16.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.162 -0.926 . . . . 1.02 110.849 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.822 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 91.8 m-85 -82.78 14.05 3.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.798 -1.092 . . . . 1.1699999999999999 111.538 -169.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.5 ttt180 -67.02 128.49 36.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.956 -0.566 . . . . 2.9300000000000002 111.024 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 2.5 mp0 -99.7 137.15 38.57 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.876 0.369 . . . . 2.23 110.545 -3.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.548 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.2 t90 -93.79 130.48 39.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.923 -0.769 . . . . 1.4299999999999999 108.923 175.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 44.1 p-80 -98.66 123.18 42.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.999 -0.741 . . . . 1.26 108.999 173.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -91.57 -11.13 38.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.553 -0.749 . . . . 2.1400000000000001 111.714 -170.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 1.034 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 40.8 t80 -167.95 136.23 2.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.873 -0.417 . . . . 1.51 109.873 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HG ' HD12 ' A' ' 103' ' ' LEU . 22.7 tp -134.28 114.42 12.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.33000000000000002 110.263 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.823 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -130.09 135.49 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.681 -0.69 . . . . 0.31 110.638 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.695 HG12 HG23 ' A' ' 65' ' ' THR . 13.9 m -130.09 163.57 35.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.115 -0.948 . . . . 0.27000000000000002 108.612 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.677 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.3 t30 64.94 14.22 9.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.841 0.353 . . . . 1.76 110.416 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.823 ' HE3' HG11 ' A' ' 89' ' ' VAL . 14.3 ttm -68.93 103.97 1.96 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.702 -0.851 . . . . 0.31 108.702 174.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.72 ' HE2' HD21 ' A' ' 63' ' ' LEU . 21.2 ttmm -85.73 98.53 10.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.401 -0.818 . . . . 1.21 110.918 -171.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.29 -123.09 6.0 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.971 -1.013 . . . . 0.29999999999999999 112.186 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.526 ' HA ' HD11 ' A' ' 53' ' ' ILE . 5.3 p-10 -118.1 31.08 6.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.539 0.685 . . . . 1.04 110.391 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.62 114.96 27.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.062 -0.972 . . . . 0.77000000000000002 110.289 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 97' ' ' ILE . 3.1 mm -66.81 -19.95 26.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.698 -1.137 . . . . 0.40999999999999998 110.951 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.1 m -80.34 -52.99 7.04 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.669 0.618 . . . . 0.68000000000000005 112.669 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 p -61.67 -20.79 63.82 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.714 0.293 . . . . 1.26 111.712 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.02 102.18 0.19 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.765 -0.652 . . . . 0.34999999999999998 111.987 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 107.17 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.453 0.644 . . . . 0.45000000000000001 109.723 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.486 ' O ' HD12 ' A' ' 137' ' ' ILE . 2.6 p -74.51 118.27 19.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.825 -1.08 . . . . 0.56999999999999995 111.846 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.72 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.3 mt -97.83 -45.26 6.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.971 0.891 . . . . 0.45000000000000001 108.888 172.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.8 t -126.57 106.46 9.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.615 -1.175 . . . . 0.37 107.858 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 6.3 t0 -61.86 158.15 16.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 1.1499999999999999 112.387 -169.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -78.91 98.67 6.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.026 -0.988 . . . . 4.6900000000000004 109.664 -178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.679 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 30.1 t -74.56 -23.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.85999999999999999 111.471 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.11 -179.65 45.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.413 -0.898 . . . . 0.67000000000000004 111.858 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.3 t -60.54 133.62 56.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.862 -0.422 . . . . 0.51000000000000001 109.862 172.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.657 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -172.53 66.01 0.13 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.814 -0.708 . . . . 0.81999999999999995 112.337 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -93.29 140.24 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.816 2.344 . . . . 0.84999999999999998 112.977 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HB2' HG23 ' A' ' 115' ' ' THR . 72.6 Cg_exo -51.15 135.01 44.82 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.531 2.154 . . . . 0.87 111.331 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 117.0 5.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.213 -0.292 . . . . 1.8500000000000001 110.213 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.46 -4.28 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.798 -0.715 . . . . 1.1799999999999999 111.963 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 72.9 p -79.13 -16.59 56.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.763 0.316 . . . . 0.96999999999999997 111.302 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.75 -169.4 23.22 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.844 -0.616 . . . . 1.97 111.846 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.39 98.3 1.4 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.93999999999999995 109.935 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -75.77 103.93 6.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.421 -0.809 . . . . 2.23 109.204 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.851 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -99.72 92.96 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.405 0.621 . . . . 2.3100000000000001 111.668 -173.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.551 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 1.1 m-85 -76.88 133.44 39.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.78000000000000003 109.449 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.4 t -108.63 133.16 54.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.948 -0.39 . . . . 0.27000000000000002 109.948 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.795 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 1.5 m-90 -89.53 127.84 35.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.372 -0.603 . . . . 1.99 109.372 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 mt -118.75 119.39 34.29 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.867 -0.419 . . . . 0.38 109.867 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.607 HG12 HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -106.96 132.68 53.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.41 -0.516 . . . . 0.31 109.682 175.158 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.619 ' HB2' HD23 ' A' ' 160' ' ' LEU . 24.3 m-85 -115.35 149.55 37.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.147 -0.478 . . . . 5.1200000000000001 110.055 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.537 ' HB2' HG21 ' A' ' 164' ' ' VAL . 42.6 tt0 -101.31 117.93 35.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.154 0.502 . . . . 2.4100000000000001 109.894 174.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -89.88 158.86 17.25 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.626 -0.879 . . . . 1.3100000000000001 108.626 173.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.401 ' OD2' ' HG3' ' A' ' 129' ' ' ARG . 2.3 p-10 -76.4 -10.83 59.69 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.601 -0.727 . . . . 2.3999999999999999 110.805 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.661 ' NH2' ' HB2' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -162.56 177.31 1.98 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 3.5099999999999998 109.246 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 51.3 Cg_exo -54.0 174.54 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.275 1.984 . . . . 1.21 112.589 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.66 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.6 mm? -93.38 163.73 13.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.52 0.563 . . . . 0.90000000000000002 112.52 -171.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.95 45.57 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.62 1.2 . . . . 2.8999999999999999 109.868 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.492 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.2 p -62.65 -69.17 0.28 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.264 -1.789 . . . . 1.8999999999999999 111.664 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 57.87 32.34 21.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.837 0.827 . . . . 2.96 110.173 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.637 ' HB2' HD22 ' A' ' 103' ' ' LEU . 57.9 mm-40 -81.85 139.99 46.83 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.547 -0.751 . . . . 1.3899999999999999 110.809 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.38 125.2 8.75 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.37 2.714 . . . . 1.27 112.397 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 102' ' ' VAL . 33.4 mm -76.94 123.1 32.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.85999999999999999 111.454 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.9 mt -94.82 155.37 16.83 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.346 -0.613 . . . . 1.6100000000000001 109.346 174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.0 m -119.41 38.37 3.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.558 0.218 . . . . 1.8799999999999999 111.508 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.9 OUTLIER 56.76 0.81 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.714 1.206 . . . . 0.75 113.418 177.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.554 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.0 mtt180 -97.64 148.51 23.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.919 -0.488 . . . . 3.3599999999999999 109.797 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.618 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.4 m 74.46 115.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.113 0.883 . . . . 0.94999999999999996 112.364 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -87.9 38.17 3.19 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 1.1200000000000001 111.54 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.05 -39.91 71.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.77 0.795 . . . . 2.6600000000000001 110.757 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -99.25 64.68 1.37 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.088 -0.96 . . . . 1.8700000000000001 110.053 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.584 ' O ' ' HB3' ' A' ' 81' ' ' TYR . 26.9 mtm180 -87.09 39.74 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 4.7300000000000004 112.048 -175.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . 76.91 -117.4 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.935 -0.65 . . . . 0.65000000000000002 114.001 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.822 ' CG ' ' HA ' ' A' ' 81' ' ' TYR . 79.9 mttt 60.35 39.85 18.25 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.121 0.486 . . . . 1.0800000000000001 110.8 -171.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.442 ' HD2' ' CE2' ' A' ' 154' ' ' PHE . 43.5 t80 -150.37 135.83 18.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.846 -0.616 . . . . 1.8899999999999999 109.622 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -54.17 119.56 5.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.507 -0.77 . . . . 1.29 112.792 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.903 HG21 HG12 ' A' ' 17' ' ' VAL . 4.3 m -59.03 -35.15 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.335 -0.848 . . . . 0.78000000000000003 110.832 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.78 -33.02 72.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.863 -0.608 . . . . 0.67000000000000004 110.456 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -70.47 -37.71 74.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.242 -0.435 . . . . 0.77000000000000002 110.667 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.442 ' CE2' ' HD2' ' A' ' 149' ' ' PHE . 53.7 m-85 -64.28 -48.22 76.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.702 0.763 . . . . 0.92000000000000004 109.518 173.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.821 HH12 ' HG3' ' A' ' 19' ' ' GLU . 21.3 ttt180 -55.59 -50.31 70.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.4 -1.273 . . . . 2.8900000000000001 111.723 177.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -70.63 -28.91 65.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.96999999999999997 111.126 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 44.3 tptt -59.84 -40.51 88.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 1.5800000000000001 110.818 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.49 ' HB3' ' CD1' ' A' ' 131' ' ' LEU . 22.5 m-85 -88.53 5.97 40.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.077 -0.511 . . . . 5.4500000000000002 110.516 -177.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.661 ' HB2' ' NH2' ' A' ' 129' ' ' ARG . 34.0 mm-40 67.21 33.85 5.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.261 -0.881 . . . . 2.4199999999999999 111.336 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 125' ' ' TYR . 4.0 mp -90.62 140.64 29.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.666 0.269 . . . . 1.27 111.28 -177.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -71.56 -78.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 3.5899999999999999 111.385 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -155.44 166.92 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.61 -0.515 . . . . 0.76000000000000001 109.61 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.544 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 23.2 Cg_exo -60.95 137.95 75.61 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.592 2.195 . . . . 0.53000000000000003 113.276 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.946 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 6.3 t -93.18 -26.94 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 115.465 -0.789 . . . . 0.44 109.279 174.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.769 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.56 147.35 25.3 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.917 -0.583 . . . . 0.27000000000000002 111.806 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -144.32 142.21 10.84 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.725 -1.125 . . . . 0.23999999999999999 111.429 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.696 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 7.6 t -155.72 137.04 13.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.149 -0.686 . . . . 0.34000000000000002 109.149 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.867 ' HB2' HG22 ' A' ' 121' ' ' VAL . 6.7 t -116.51 145.26 43.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.24 0.543 . . . . 1.1100000000000001 111.106 -174.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 25.2 p90 -128.52 129.62 46.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.346 -1.353 . . . . 0.80000000000000004 107.346 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.848 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 2.9 pt20 -110.47 132.52 54.11 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.714 -0.794 . . . . 2.5299999999999998 111.044 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -149.33 135.64 19.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.59999999999999998 109.558 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -118.26 -136.75 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.51 -0.314 . . . . 2.3799999999999999 110.907 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -80.27 96.91 6.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 3.96 111.746 -172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.741 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 3.1 t70 -73.62 -62.16 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 1.53 110.396 170.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.553 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.7 t70 159.29 -39.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.024 1.329 . . . . 1.26 108.373 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.03 0.24 36.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 2.2200000000000002 110.864 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.798 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 76.8 t -62.49 -53.92 53.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.02 -0.536 . . . . 0.5 110.478 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.798 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.2 Cg_exo -51.97 -35.46 60.79 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.468 2.112 . . . . 0.57999999999999996 112.022 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 13.5 mmmm -73.9 -26.97 60.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 2.1400000000000001 111.499 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.66 HD21 HG12 ' A' ' 107' ' ' VAL . 44.0 tp -69.09 -46.91 66.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.66000000000000003 109.063 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.35 -34.94 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 1.8899999999999999 109.393 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.714 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.2 mm-40 -63.28 -43.87 96.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.985 -1.007 . . . . 1.53 110.922 173.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.444 ' HA ' ' CG ' ' A' ' 187' ' ' LYS . 16.1 tt0 -65.29 -27.84 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.49 111.406 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.618 ' HA ' ' H ' ' A' ' 142' ' ' SER . 59.4 mt -66.31 6.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.511 0.559 . . . . 0.76000000000000001 112.511 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.739 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 15.3 m -80.99 0.15 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.674 0.75 . . . . 1.05 109.086 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.52 33.07 17.52 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 111.228 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.739 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 31.6 mmtp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.372 -0.823 . . . . 2.0 110.991 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 1.1 mpt? . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.53 0.205 . . . . 5.04 110.499 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 16.8 Cg_exo -68.38 129.52 19.28 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.105 2.537 . . . . 2.1299999999999999 112.728 -176.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 2.7 p -98.26 111.52 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 114.801 -1.09 . . . . 1.47 110.224 176.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.459 ' HA ' ' CG ' ' A' ' 24' ' ' PRO . 3.4 p30 -169.56 -175.48 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.921 -1.036 . . . . 1.8100000000000001 108.557 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.474 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.5 mm? -78.61 24.81 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.918 0.34 . . . . 0.69999999999999996 111.918 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 t -72.9 -19.88 61.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.731 0.777 . . . . 1.96 109.388 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HB3' HD12 ' A' ' 12' ' ' LEU . 79.8 mttt -117.33 36.72 4.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 2.6600000000000001 110.174 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.4 -37.22 44.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 3.98 112.294 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 11.6 p -145.3 27.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.63 110.995 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.87 -122.31 0.31 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.912 -0.875 . . . . 0.47999999999999998 110.912 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.72 -38.56 77.3 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.183 2.588 . . . . 0.53000000000000003 110.568 166.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.788 HD11 ' HA3' ' A' ' 38' ' ' GLY . 17.5 mt -87.85 83.73 7.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 110.027 173.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.34 68.96 0.79 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.375 0.607 . . . . 0.70999999999999996 110.112 175.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 121' ' ' VAL . 57.0 mt -79.21 -16.83 55.94 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.702 -0.681 . . . . 0.45000000000000001 110.775 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.84 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 9.3 tm0? -69.1 -12.87 62.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.362 0.601 . . . . 2.1200000000000001 110.534 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.16 -23.74 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 109.78 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.726 HG11 HG21 ' A' ' 69' ' ' THR . 48.6 t -90.44 -68.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.722 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -119.9 -177.24 3.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.713 -0.676 . . . . 2.9900000000000002 109.917 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 16.8 mt-10 -90.56 20.26 4.74 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.854 0.316 . . . . 1.6000000000000001 111.854 -173.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.84 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 9.5 mm-40 67.82 136.85 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.361 1.038 . . . . 3.5499999999999998 112.427 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 4.3 Cg_exo -79.83 157.79 24.36 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.229 2.62 . . . . 0.57999999999999996 112.804 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.901 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.5 pt20 -77.94 -27.09 49.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.893 -1.049 . . . . 1.3899999999999999 111.857 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.762 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 79.6 m-70 -132.48 158.55 75.38 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.843 -0.799 . . . . 1.45 108.843 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CG ' ' HA ' ' A' ' 4' ' ' ASP . 4.3 Cg_endo -85.81 128.27 3.28 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.664 2.243 . . . . 0.40000000000000002 111.113 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 122' ' ' TRP . 38.0 tp -78.66 148.4 33.18 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.093 -0.336 . . . . 0.28999999999999998 110.093 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.429 ' H ' HD12 ' A' ' 25' ' ' LEU . 44.5 m80 -118.89 130.14 55.57 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.502 -0.555 . . . . 1.24 109.502 172.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.847 HG13 HG22 ' A' ' 53' ' ' ILE . 19.2 t -127.75 146.26 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.682 -0.858 . . . . 0.46999999999999997 108.682 177.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 143.18 32.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.974 0.416 . . . . 0.31 111.05 -177.341 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 34.5 t80 -110.77 173.22 6.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.5 -0.556 . . . . 0.67000000000000004 109.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.51 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.18 0.514 . . . . 0.55000000000000004 110.886 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.38 15.44 10.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.399 -0.818 . . . . 0.81000000000000005 112.361 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -146.32 -172.79 4.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.885 0.374 . . . . 0.46999999999999997 110.734 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.665 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -164.01 159.89 21.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.797 -0.638 . . . . 0.33000000000000002 110.041 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.67 HG13 ' HZ1' ' A' ' 39' ' ' LYS . 87.3 t -114.3 67.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.585 -1.635 . . . . 0.39000000000000001 106.585 162.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -102.63 23.19 12.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.582 -1.19 . . . . 0.98999999999999999 109.092 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -150.93 132.95 15.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.852 -1.067 . . . . 2.5600000000000001 108.304 174.146 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -76.65 110.76 11.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.182 0.515 . . . . 0.40999999999999998 109.703 -173.607 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 86.7 16.73 61.17 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.343 -0.844 . . . . 0.58999999999999997 112.227 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.67 ' HZ1' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.13 149.92 44.29 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.399 -0.593 . . . . 0.34000000000000002 109.399 173.619 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.05 129.32 37.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.441 0.639 . . . . 0.55000000000000004 111.029 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.6 tp -120.91 169.39 10.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.181 -1.044 . . . . 0.45000000000000001 108.181 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.1 p -128.04 151.73 76.41 Favored Pre-proline 0 C--N 1.322 -0.587 0 C-N-CA 119.724 -0.79 . . . . 0.56000000000000005 112.512 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.587 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.2 Cg_exo -55.58 -24.65 45.93 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.303 3.335 . . . . 0.68000000000000005 114.01 -176.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -62.88 -38.3 90.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 122.11 0.957 . . . . 0.76000000000000001 110.093 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.09 -46.19 14.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.785 -1.552 . . . . 1.5900000000000001 111.266 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 169' ' ' TYR . 6.7 m -100.51 31.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.459 0.54 . . . . 0.66000000000000003 112.459 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -82.66 -7.87 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.419 0.628 . . . . 0.79000000000000004 109.367 172.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -142.0 -177.82 5.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.952 -1.022 . . . . 1.9099999999999999 109.072 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -71.79 156.26 91.3 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.765 -0.457 . . . . 1.4299999999999999 109.765 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 57.8 Cg_endo -76.62 162.65 32.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.612 1.541 . . . . 0.37 110.216 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.4 t -85.67 -19.2 31.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.631 -0.427 . . . . 0.44 110.152 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -159.5 147.43 17.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.38 112.413 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.847 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.36 172.44 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.825 -1.08 . . . . 0.29999999999999999 108.382 170.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.042 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.5 t 170.97 127.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.462 0.476 . . . . 0.34999999999999998 110.013 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.838 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -81.87 162.06 22.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.459 -0.941 . . . . 2.7200000000000002 108.459 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 22.2 t70 -59.43 79.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.237 0.542 . . . . 1.51 110.712 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.71 24.44 3.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.751 -0.659 . . . . 0.80000000000000004 112.958 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.042 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -54.3 128.25 30.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.067 0.434 . . . . 0.57999999999999996 110.547 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.735 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 29.5 t70 -78.38 -12.76 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.73999999999999999 111.439 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.44 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 70.7 p 51.23 30.04 5.45 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.94 -1.027 . . . . 1.03 110.906 -173.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.38 8.17 0.21 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.594 -0.73 . . . . 0.83999999999999997 112.873 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.735 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 19.4 mtpt -109.99 157.49 19.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 1.6699999999999999 109.481 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 65.3 mt -94.54 125.09 38.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.798 -0.816 . . . . 0.57999999999999996 108.798 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.526 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -120.11 149.62 41.92 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.634 -0.426 . . . . 0.80000000000000004 110.76 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.682 HG23 HG12 ' A' ' 90' ' ' VAL . 61.3 m -96.87 105.95 18.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.511 -0.922 . . . . 0.35999999999999999 108.511 170.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.634 HD13 HG12 ' A' ' 124' ' ' VAL . 47.5 tp -106.8 109.87 21.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.716 -0.674 . . . . 0.58999999999999997 110.189 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.1 t -114.79 123.02 70.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.745 -0.661 . . . . 0.39000000000000001 110.679 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.79 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.4 mt -84.37 137.93 33.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.723 -0.843 . . . . 0.59999999999999998 108.723 169.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.726 HG21 HG11 ' A' ' 17' ' ' VAL . 11.3 t -139.68 145.1 37.99 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.847 -0.341 . . . . 0.35999999999999999 110.635 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 24.8 t70 -128.85 96.39 29.54 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.324 0.583 . . . . 1.9199999999999999 110.273 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.0 Cg_endo -51.36 -37.85 61.61 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.046 3.164 . . . . 1.25 114.747 178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 44.1 m-20 -96.33 46.69 1.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.341 0.497 . . . . 1.29 112.341 -166.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.82 137.91 19.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.5 110.794 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.5 Cg_endo -82.39 -20.19 20.36 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.44 -1.483 . . . . 0.62 112.465 0.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.775 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 96.6 p -134.01 146.8 50.74 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.832 -0.622 . . . . 0.75 110.472 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.591 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 63.1 ttt180 -66.45 -26.39 67.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.208 -0.451 . . . . 2.8799999999999999 111.796 -174.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.762 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -89.0 -11.22 44.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.029 0.443 . . . . 1.3799999999999999 110.862 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -153.2 82.37 4.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.856 -0.611 . . . . 1.3700000000000001 109.528 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 96.1 Cg_endo -87.95 88.23 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.81 2.34 . . . . 0.80000000000000004 113.16 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.576 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.7 mttm -71.52 -53.44 13.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.15 -0.932 . . . . 1.02 110.726 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.772 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 36.2 m-85 -78.75 17.83 0.67 Allowed 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.211 -0.904 . . . . 1.1699999999999999 111.642 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' A' ' 79' ' ' PRO . 32.4 ttt180 -74.2 129.59 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.216 0.323 . . . . 2.9300000000000002 111.71 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.485 ' HG2' HG13 ' A' ' 17' ' ' VAL . 22.1 mp0 -89.05 140.51 29.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 122.807 0.443 . . . . 2.23 110.605 -6.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.1 t90 -86.21 91.5 8.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.532 -0.544 . . . . 1.4299999999999999 109.532 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 45.6 p-80 -71.86 121.84 19.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.768 0.794 . . . . 1.26 109.698 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.79 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t60 -72.72 -35.22 67.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.917 -1.038 . . . . 2.1400000000000001 111.166 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.731 ' HD1' ' HB2' ' A' ' 68' ' ' LEU . 2.4 p90 -168.08 178.16 5.2 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.666 -0.494 . . . . 1.51 109.666 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.4 tp -140.71 114.01 8.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.776 0.322 . . . . 0.33000000000000002 110.64 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.651 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -121.85 133.01 69.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.78 -0.645 . . . . 0.31 110.667 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 65' ' ' THR . 16.2 m -133.37 161.55 41.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.409 -0.96 . . . . 0.27000000000000002 108.409 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.2 t30 62.55 18.98 10.92 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.383 0.427 . . . . 1.76 110.608 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.651 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -68.18 110.67 4.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.789 -0.819 . . . . 0.31 108.789 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.563 ' HE2' HD21 ' A' ' 63' ' ' LEU . 13.8 ttmm -91.57 97.33 10.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.177 -0.92 . . . . 1.21 111.012 -171.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 64' ' ' TYR . . . 81.91 -130.62 9.82 Favored Glycine 0 CA--C 1.505 -0.568 0 CA-C-N 115.242 -0.89 . . . . 0.29999999999999999 112.45 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 30.8 p-10 -117.29 26.48 9.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.098 0.475 . . . . 1.04 111.044 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.77 110.43 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.77000000000000002 110.034 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 50' ' ' PRO . 7.3 mm -58.86 -28.92 39.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.511 -1.222 . . . . 0.40999999999999998 111.396 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -82.24 -29.99 31.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.982 -0.554 . . . . 0.68000000000000005 111.765 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -77.73 -6.68 54.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.845 0.313 . . . . 1.26 111.845 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.43 107.11 2.28 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.913 -0.661 . . . . 0.34999999999999998 111.828 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 106.97 0.46 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.403 0.62 . . . . 0.45000000000000001 110.332 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.3 p -89.55 109.52 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.827 -1.079 . . . . 0.56999999999999995 111.203 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' A' ' 88' ' ' LEU . 29.4 mt -89.18 -45.25 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.023 -0.99 . . . . 0.45000000000000001 109.813 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 t -116.65 105.76 12.79 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.952 -1.499 . . . . 0.37 106.952 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.2 t0 -54.88 150.97 9.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.1499999999999999 112.831 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -77.37 103.29 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.114 -0.948 . . . . 4.6900000000000004 109.223 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 48.4 t -78.33 -57.62 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.148 -0.478 . . . . 0.85999999999999999 112.244 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 132.85 175.59 14.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.647 -0.787 . . . . 0.67000000000000004 112.435 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.482 ' HB2' HG23 ' A' ' 46' ' ' VAL . 30.3 t -61.14 131.82 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.486 0.143 . . . . 0.51000000000000001 110.66 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.451 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -152.46 63.89 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 O-C-N 123.573 0.546 . . . . 0.81999999999999995 112.297 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.609 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 4.0 Cg_endo -90.34 113.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.611 2.874 . . . . 0.84999999999999998 112.593 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.3 Cg_exo -56.43 147.74 66.6 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.897 2.398 . . . . 0.87 111.986 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 117.08 9.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.097 -0.502 . . . . 1.8500000000000001 111.063 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.46 6.15 56.63 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.953 -0.642 . . . . 1.1799999999999999 112.7 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.775 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 80.0 p -89.42 -22.68 22.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.96999999999999997 111.728 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.61 173.29 20.1 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.828 -0.624 . . . . 1.97 111.743 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.3 mm? -74.72 113.15 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.062 -0.347 . . . . 0.93999999999999995 110.062 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.718 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.0 m-70 -79.76 116.21 19.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 2.23 110.52 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.542 HH11 HD23 ' A' ' 14' ' ' LEU . 13.5 ptt180 -98.34 85.36 3.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.601 -0.727 . . . . 2.3100000000000001 110.781 -172.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.518 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 20.7 m-85 -71.73 114.11 9.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.257 -0.645 . . . . 0.78000000000000003 109.257 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.708 HG21 HD22 ' A' ' 14' ' ' LEU . 19.4 t -94.68 130.58 43.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.169 -0.469 . . . . 0.27000000000000002 110.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.668 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 59.7 m95 -88.68 119.27 29.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.895 -0.78 . . . . 1.99 108.895 177.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.4 mt -113.84 118.61 34.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.709 0.232 . . . . 0.38 110.683 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.634 HG12 HD13 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -117.53 136.68 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.31 110.788 179.136 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.859 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 59.0 t80 -132.03 129.01 39.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.423 -0.353 . . . . 5.1200000000000001 110.256 173.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.877 ' HG2' HG21 ' A' ' 164' ' ' VAL . 8.9 pt-20 -82.22 104.62 12.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.76 -0.829 . . . . 2.4100000000000001 108.76 171.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.24 168.21 19.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.169 0.509 . . . . 1.3100000000000001 109.752 -176.041 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.65 -7.2 53.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.582 -0.735 . . . . 2.3999999999999999 110.347 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HG3' ' HE2' ' A' ' 158' ' ' TYR . 20.0 ptt180 -167.01 160.23 11.02 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.561 -0.745 . . . . 3.5099999999999998 111.02 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HG3' HD12 ' A' ' 63' ' ' LEU . 31.2 Cg_exo -56.75 140.45 91.02 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.544 2.829 . . . . 1.21 112.596 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.8 mm? -65.16 149.52 49.77 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.401 0.519 . . . . 0.90000000000000002 112.401 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 11.6 tptm -120.96 90.68 3.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 2.8999999999999999 107.781 164.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' A' ' 103' ' ' LEU . 4.8 p -70.52 -69.77 0.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.334 -0.848 . . . . 1.8999999999999999 111.961 -171.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 59.26 28.96 18.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.267 0.556 . . . . 2.96 109.753 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -99.62 138.23 20.39 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.427 -0.806 . . . . 1.3899999999999999 109.426 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.28 115.17 1.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.113 2.542 . . . . 1.27 112.871 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.27 118.15 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.909 -0.404 . . . . 0.85999999999999999 109.909 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.4 mt -114.78 147.88 39.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.459 . . . . 1.6100000000000001 110.55 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -86.21 169.82 12.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.285 -0.871 . . . . 1.8799999999999999 109.237 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.815 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -86.13 30.49 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.112 0.482 . . . . 0.75 111.571 -175.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.583 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 96.8 mtt180 -117.96 148.26 42.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.426 -0.352 . . . . 3.3599999999999999 110.557 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.689 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 25.4 m 71.06 141.16 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.938 -1.028 . . . . 0.94999999999999996 111.232 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.03 28.71 14.4 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.585 -0.734 . . . . 1.1200000000000001 111.519 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.64 -51.61 26.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.316 0.647 . . . . 2.6600000000000001 112.672 -172.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -117.73 31.03 6.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.41 0.624 . . . . 1.8700000000000001 111.327 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.458 ' HB3' ' HE1' ' A' ' 84' ' ' TRP . 18.0 mmt180 -87.65 -36.03 17.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 4.7300000000000004 110.56 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -117.19 176.02 15.99 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.551 -0.833 . . . . 0.65000000000000002 112.707 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.772 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.3 mttt 64.33 41.94 5.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.535 0.683 . . . . 1.0800000000000001 111.449 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.98 149.02 49.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.044 -0.98 . . . . 1.8899999999999999 109.252 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -97.96 122.93 41.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.991 0.424 . . . . 1.29 111.697 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.645 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.8 m -61.29 -26.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.672 -0.695 . . . . 0.78000000000000003 110.224 174.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -61.7 -46.79 88.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.364 -0.834 . . . . 0.67000000000000004 110.186 173.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.0 m -63.97 -35.92 82.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.094 -0.503 . . . . 0.77000000000000002 110.823 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.645 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.6 m-85 -65.27 -49.98 67.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.399 -0.364 . . . . 0.92000000000000004 111.093 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 1.8 ptm180 -69.0 -39.31 79.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 2.8900000000000001 111.02 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.72 -27.58 68.43 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 111.503 0.186 . . . . 0.96999999999999997 111.503 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -53.93 -54.06 44.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 1.5800000000000001 111.495 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.517 ' HE2' ' HG3' ' A' ' 129' ' ' ARG . 9.2 t80 -107.58 18.87 20.94 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.766 -0.773 . . . . 5.4500000000000002 110.75 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 63.78 46.87 3.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.408 -0.814 . . . . 2.4199999999999999 111.149 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.859 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -91.47 123.14 34.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.185 -0.916 . . . . 1.27 109.831 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -86.52 -150.39 0.15 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.4 -0.364 . . . . 3.5899999999999999 110.441 -178.115 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -62.73 142.85 96.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 0.76000000000000001 110.541 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 16.5 Cg_exo -66.33 160.73 43.93 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 123.795 2.997 . . . . 0.53000000000000003 113.513 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.901 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.7 t -89.74 -35.58 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-N 115.48 -0.782 . . . . 0.44 110.089 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -149.72 145.91 26.93 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.912 -0.715 . . . . 0.27000000000000002 111.75 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.36 143.02 10.34 Favored Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.545 -1.207 . . . . 0.23999999999999999 111.344 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 t -155.5 142.4 19.04 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.055 -1.091 . . . . 0.34000000000000002 108.055 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.616 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 13.1 p -120.31 141.27 50.17 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.951 -0.699 . . . . 1.1100000000000001 110.551 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.0 p90 -125.56 123.29 38.77 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.693 -1.225 . . . . 0.80000000000000004 107.693 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.718 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 1.1 pt20 -101.03 132.39 46.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.621 -0.832 . . . . 2.5299999999999998 110.623 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.07 155.75 29.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.567 -0.742 . . . . 0.59999999999999998 110.696 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.39 -177.38 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.173 0.511 . . . . 2.3799999999999999 111.38 -175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.664 ' HA ' HG21 ' A' ' 177' ' ' VAL . 30.0 t90 -84.99 78.44 9.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 3.96 109.018 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 9.2 t70 -71.99 -62.74 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 1.53 111.687 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 33.5 t70 174.69 -35.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.277 0.56 . . . . 1.26 110.917 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -80.21 5.26 15.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 2.2200000000000002 110.999 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.825 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 64.8 t -72.42 -54.45 5.34 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.5 110.479 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 77.2 Cg_exo -51.47 -37.73 62.5 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.545 2.163 . . . . 0.57999999999999996 112.33 172.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.685 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.6 mmmt -73.09 -23.3 60.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 2.1400000000000001 111.42 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.783 HD11 HG12 ' A' ' 107' ' ' VAL . 40.3 tp -69.62 -46.59 65.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.104 -0.702 . . . . 0.66000000000000003 109.104 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -59.61 -36.86 77.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 1.8899999999999999 109.811 173.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.1 mm-40 -54.73 -46.65 74.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.83 -1.077 . . . . 1.53 110.339 172.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -73.73 -36.01 65.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.474 -0.785 . . . . 1.49 111.744 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.689 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.7 mt -67.16 5.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.263 0.468 . . . . 0.76000000000000001 112.263 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.694 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 33.8 m -84.12 0.02 50.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.377 0.608 . . . . 1.05 109.462 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.583 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.35 55.34 8.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.223 -0.899 . . . . 1.1699999999999999 111.346 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.694 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 1.4 mmmp? . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.169 -0.919 . . . . 2.0 110.75 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 tpt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.719 -0.474 . . . . 5.04 109.719 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.88 111.63 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.236 2.624 . . . . 2.1299999999999999 113.536 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.619 HG13 ' HB2' ' A' ' 24' ' ' PRO . 7.4 p -54.16 146.06 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.633 -1.167 . . . . 1.47 111.434 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -154.11 153.47 31.91 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.175 -0.676 . . . . 1.8100000000000001 109.175 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -78.16 16.19 0.8 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.851 0.315 . . . . 0.69999999999999996 111.851 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.3 t -64.14 -16.18 61.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 1.96 110.805 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.665 ' HB3' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -113.47 31.48 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 2.6600000000000001 110.536 -177.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.695 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.4 OUTLIER -73.55 -41.27 63.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.852 0.358 . . . . 3.98 111.93 -174.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.9 p -145.03 32.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.463 0.649 . . . . 0.63 110.003 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.12 -118.1 0.21 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.966 -0.854 . . . . 0.47999999999999998 110.966 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 18.6 Cg_endo -56.89 -38.37 96.07 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 123.175 2.583 . . . . 0.53000000000000003 110.854 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 7' ' ' LYS . 9.3 mt -88.58 101.75 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.1699999999999999 110.034 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -83.29 71.34 10.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.837 0.827 . . . . 0.70999999999999996 110.106 175.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.624 HD22 ' CG2' ' A' ' 121' ' ' VAL . 22.7 mt -79.09 -15.49 58.1 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.465 -0.789 . . . . 0.45000000000000001 109.915 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.655 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -74.46 -6.67 49.65 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.375 -0.83 . . . . 2.1200000000000001 111.204 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 13' ' ' SER . 14.2 mt-10 -68.91 -22.83 64.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.323 0.582 . . . . 1.9299999999999999 109.577 177.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.873 HG12 HG21 ' A' ' 151' ' ' VAL . 46.1 t -89.03 -71.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.163 -0.926 . . . . 0.63 111.41 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.487 ' HB2' HG21 ' A' ' 151' ' ' VAL . 26.5 t70 -149.74 174.65 12.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.935 -0.575 . . . . 2.9900000000000002 109.525 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -54.95 151.04 9.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.288 0.566 . . . . 1.6000000000000001 111.279 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.655 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 27.6 mm-40 -86.96 138.27 32.94 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.872 -0.603 . . . . 3.5499999999999998 109.942 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.67 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 8.1 Cg_exo -71.24 161.52 45.51 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.377 2.718 . . . . 0.57999999999999996 113.299 -170.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.7 pt20 -82.38 -18.07 43.32 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.326 -0.852 . . . . 1.3899999999999999 111.74 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.755 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 9.6 m-70 -141.9 159.68 58.5 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.538 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.619 ' HB2' HG13 ' A' ' 3' ' ' VAL . 5.0 Cg_endo -85.72 125.73 2.87 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.763 2.309 . . . . 0.40000000000000002 111.175 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 122' ' ' TRP . 16.2 tp -71.55 137.74 48.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.28999999999999998 110.131 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.59 107.82 19.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.8 -0.444 . . . . 1.24 109.8 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.928 HG13 HG22 ' A' ' 53' ' ' ILE . 6.6 t -114.46 143.34 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.149 -0.686 . . . . 0.46999999999999997 109.149 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.39 139.58 31.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.99 0.424 . . . . 0.31 111.413 -174.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -104.72 173.34 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.238 -0.653 . . . . 0.67000000000000004 109.238 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.17 66.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.485 0.659 . . . . 0.55000000000000004 110.726 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.1 -0.87 33.68 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.28 -0.873 . . . . 0.81000000000000005 112.957 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.36 -170.39 2.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.46999999999999997 111.266 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.39 154.4 16.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.63 -0.713 . . . . 0.33000000000000002 109.734 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.726 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 86.6 t -113.14 69.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.145 -1.428 . . . . 0.39000000000000001 107.145 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 20.5 t70 -105.41 18.55 22.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.234 -0.894 . . . . 0.98999999999999999 109.358 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.35 135.85 24.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.521 -0.918 . . . . 2.5600000000000001 108.521 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -80.79 111.38 17.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.405 0.622 . . . . 0.40999999999999998 110.547 -171.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 91.32 11.74 60.7 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.989 -1.005 . . . . 0.58999999999999997 111.848 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.726 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.4 144.53 46.35 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.394 -0.595 . . . . 0.34000000000000002 109.394 176.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 9.7 p -77.24 136.2 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.55000000000000004 110.99 -178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.629 HD22 HG22 ' A' ' 34' ' ' VAL . 7.2 tp -131.99 168.85 17.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.556 -0.905 . . . . 0.45000000000000001 108.556 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.92 152.04 48.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.565 -0.454 . . . . 0.56000000000000005 112.045 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 50.3 Cg_exo -57.41 -34.11 97.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.805 3.003 . . . . 0.68000000000000005 112.855 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.507 HG23 ' CD1' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -60.37 -39.91 88.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.463 0.649 . . . . 0.76000000000000001 110.772 176.07 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -81.64 -13.24 58.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.943 -1.026 . . . . 1.5900000000000001 111.752 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.601 HG11 ' CE2' ' A' ' 169' ' ' TYR . 33.0 m -128.24 28.65 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.66000000000000003 111.583 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.551 ' HZ2' HD13 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -86.76 -10.75 52.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.414 0.626 . . . . 0.79000000000000004 109.337 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -132.91 174.21 10.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.745 -1.116 . . . . 1.9099999999999999 108.38 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -71.29 153.56 94.08 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 110.229 -0.286 . . . . 1.4299999999999999 110.229 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.35 156.18 46.02 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.136 1.89 . . . . 0.37 110.844 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -77.71 -20.78 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.809 0.338 . . . . 0.44 110.216 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -159.07 143.56 15.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.482 0.658 . . . . 0.38 112.619 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.928 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -137.83 164.34 28.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.778 -1.101 . . . . 0.29999999999999999 108.155 170.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.016 ' HA ' HD13 ' A' ' 58' ' ' LEU . 35.1 t 174.69 118.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.15 -0.315 . . . . 0.34999999999999998 110.15 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.877 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -73.12 155.76 39.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.273 -1.01 . . . . 2.7200000000000002 108.273 172.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.89 88.05 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.042 0.448 . . . . 1.51 110.302 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.95 10.62 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.64 -0.709 . . . . 0.80000000000000004 112.182 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.016 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.8 tt -51.03 128.74 22.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.09 0.556 . . . . 0.57999999999999996 111.37 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.818 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 24.4 t70 -72.73 -32.59 65.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.723 -0.671 . . . . 0.73999999999999999 111.332 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.553 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.7 t 71.52 15.02 6.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 114.998 -1.001 . . . . 1.03 109.831 -174.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.53 10.52 2.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.526 -0.761 . . . . 0.83999999999999997 112.901 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.818 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 22.9 mtpt -117.76 154.45 31.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.803 -0.443 . . . . 1.6699999999999999 109.803 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.832 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 24.2 mt -92.5 130.87 38.04 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.796 -0.816 . . . . 0.57999999999999996 108.796 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.648 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -125.54 158.36 34.76 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.56 -0.456 . . . . 0.80000000000000004 110.871 176.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.459 HG23 HG12 ' A' ' 90' ' ' VAL . 60.0 m -97.72 106.14 18.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.149 -0.685 . . . . 0.35999999999999999 109.149 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 124' ' ' VAL . 53.0 tp -104.24 111.23 23.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.58999999999999997 110.394 -176.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.417 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.0 t -116.74 125.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 0.39000000000000001 110.727 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.5 -0.926 . . . . 0.59999999999999998 108.5 167.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.74 HG21 HG11 ' A' ' 17' ' ' VAL . 10.6 t -136.66 146.81 46.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.04 -0.355 . . . . 0.35999999999999999 110.04 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 14.9 t0 -126.28 97.27 34.75 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.457 -0.571 . . . . 1.9199999999999999 109.457 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.5 ' HD3' HG21 ' A' ' 17' ' ' VAL . 6.5 Cg_endo -49.08 -46.89 23.73 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.904 3.069 . . . . 1.25 113.485 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.655 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 7.4 m-20 -90.81 53.09 2.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.422 0.629 . . . . 1.29 111.14 -171.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.98 138.88 19.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.932 -0.576 . . . . 0.5 110.828 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.585 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 88.1 Cg_endo -83.43 -22.7 14.35 Favored 'Cis proline' 0 C--N 1.343 0.282 0 C-N-CA 123.327 -1.531 . . . . 0.62 112.621 1.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.657 ' HB3' HG22 ' A' ' 115' ' ' THR . 58.9 p -128.46 147.3 50.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.565 -0.743 . . . . 0.75 110.277 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.655 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 21.2 ttt180 -64.6 -26.65 68.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.257 0.551 . . . . 2.8799999999999999 110.429 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.9 ptpt -78.72 -14.83 59.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 1.3799999999999999 110.89 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t70 -162.94 87.49 1.33 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.942 -0.572 . . . . 1.3700000000000001 110.111 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.2 Cg_endo -85.2 83.92 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.697 2.265 . . . . 0.80000000000000004 112.806 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -72.08 -47.85 48.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.884 -1.053 . . . . 1.02 110.48 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.689 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 54.6 m-85 -88.53 21.28 2.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.002 -0.999 . . . . 1.1699999999999999 111.729 -168.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.858 ' HD3' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -74.01 125.85 29.18 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.173 -0.306 . . . . 2.9300000000000002 110.173 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.858 ' HG3' ' HD3' ' A' ' 82' ' ' ARG . 1.5 mp0 -94.87 138.78 32.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.043 0.449 . . . . 2.23 110.986 -2.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.602 ' HZ3' ' CE1' ' A' ' 118' ' ' HIS . 16.0 t90 -91.72 138.64 31.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.188 -0.671 . . . . 1.4299999999999999 109.188 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -113.44 133.61 55.1 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.221 -0.659 . . . . 1.26 109.221 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.88 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 5.2 t60 -82.75 -35.81 26.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.72 -0.673 . . . . 2.1400000000000001 110.527 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.689 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 22.0 p90 -167.62 177.19 6.01 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.552 -0.536 . . . . 1.51 109.552 177.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.57 ' HG ' HD12 ' A' ' 103' ' ' LEU . 23.3 tp -141.27 113.8 8.22 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.245 0.341 . . . . 0.33000000000000002 110.25 176.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.689 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.668 -0.697 . . . . 0.31 110.57 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.527 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 4.5 m -129.05 166.88 25.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.591 -0.892 . . . . 0.27000000000000002 108.591 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.832 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 m-20 60.45 18.89 8.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.955 0.407 . . . . 1.76 111.172 172.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.582 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.4 ttm -72.49 116.71 13.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.97 -0.752 . . . . 0.31 108.97 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.3 ttmm -90.4 100.63 13.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.126 -0.943 . . . . 1.21 110.972 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 75.59 -121.42 6.37 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.353 -0.839 . . . . 0.29999999999999999 112.537 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 28.2 p30 -120.55 29.09 7.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.208 0.528 . . . . 1.04 111.052 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -97.15 109.61 22.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.834 -0.621 . . . . 0.77000000000000002 110.183 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 53' ' ' ILE . 7.6 mm -54.74 -30.86 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.716 -1.129 . . . . 0.40999999999999998 111.483 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.0 m -83.21 -35.53 25.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.016 -0.538 . . . . 0.68000000000000005 112.32 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.8 p -61.28 -24.97 66.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 1.26 111.759 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.8 110.11 1.53 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.65 -0.704 . . . . 0.34999999999999998 113.012 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.4 m -66.44 107.59 2.09 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.344 -0.613 . . . . 0.45000000000000001 109.344 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.3 126.63 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.223 -0.898 . . . . 0.56999999999999995 111.579 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.57 HD12 ' HG ' ' A' ' 88' ' ' LEU . 22.8 mt -106.87 -49.6 3.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.181 0.991 . . . . 0.45000000000000001 108.713 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.8 t -120.57 112.72 19.28 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.678 -1.601 . . . . 0.37 106.678 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.3 t0 -70.52 167.95 17.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.407 0.623 . . . . 1.1499999999999999 112.429 -166.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -83.52 88.24 7.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.973 -1.012 . . . . 4.6900000000000004 109.731 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.839 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.0 t -61.72 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.713 -0.676 . . . . 0.85999999999999999 112.094 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.88 -176.96 17.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.67000000000000004 111.695 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.0 t -71.69 127.06 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.975 0.387 . . . . 0.51000000000000001 110.536 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.544 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -150.51 63.67 0.4 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.805 -0.712 . . . . 0.81999999999999995 112.448 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.609 ' HB3' ' CE1' ' A' ' 118' ' ' HIS . 96.5 Cg_endo -93.05 145.36 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.062 2.508 . . . . 0.84999999999999998 113.3 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HD2' HG21 ' A' ' 115' ' ' THR . 32.1 Cg_exo -60.56 154.04 57.0 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.641 2.227 . . . . 0.87 111.351 169.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -68.43 126.46 29.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 1.8500000000000001 110.896 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.76 37.1 20.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 1.1799999999999999 113.221 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 75' ' ' SER . 28.6 p -84.32 -13.12 53.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.393 0.516 . . . . 0.96999999999999997 112.393 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 89.83 11.77 63.17 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.27 -0.967 . . . . 1.97 112.101 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 172' ' ' GLU . 3.8 mm? 72.37 100.79 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.593 0.819 . . . . 0.93999999999999995 111.446 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.609 ' CE1' ' HB3' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -96.26 164.75 12.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.043 -0.725 . . . . 2.23 109.043 175.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.609 ' HD2' HD21 ' A' ' 14' ' ' LEU . 2.7 ptt180 -127.29 106.22 9.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.015 0.436 . . . . 2.3100000000000001 112.061 -160.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 6.8 m-85 -73.66 110.79 8.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.848 -0.797 . . . . 0.78000000000000003 108.848 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.624 ' CG2' HD22 ' A' ' 14' ' ' LEU . 16.6 t -94.82 125.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.291 -0.413 . . . . 0.27000000000000002 110.373 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.78 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -87.99 118.6 27.66 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.091 -0.707 . . . . 1.99 109.091 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.98 119.03 33.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.578 -0.156 . . . . 0.38 110.578 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.631 HG12 HD13 ' A' ' 66' ' ' LEU . 1.7 m -105.61 126.24 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.157 -0.617 . . . . 0.31 109.824 173.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -108.09 124.21 49.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 5.1200000000000001 109.02 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' HG21 ' A' ' 164' ' ' VAL . 27.6 tt0 -94.38 96.98 9.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.991 0.424 . . . . 2.4100000000000001 110.137 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.648 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -73.24 163.97 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.77 -0.65 . . . . 1.3100000000000001 109.67 175.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.76 3.14 38.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.56 -0.746 . . . . 2.3999999999999999 110.04 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.427 ' H ' ' HB2' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -165.64 153.23 9.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 3.5099999999999998 111.355 -169.325 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HG3' HD12 ' A' ' 63' ' ' LEU . 32.0 Cg_exo -59.59 141.08 96.61 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.701 2.934 . . . . 1.21 112.094 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.527 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.6 mm? -68.43 151.56 46.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.90000000000000002 112.434 -170.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -115.9 64.23 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.403 -0.962 . . . . 2.8999999999999999 108.403 171.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 46.2 m -96.98 92.4 6.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.218 -0.901 . . . . 1.8999999999999999 110.194 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.85 40.66 0.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.963 . . . . 2.96 109.976 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -89.16 127.98 53.33 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.16 -0.927 . . . . 1.3899999999999999 110.091 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.1 127.85 18.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.225 2.617 . . . . 1.27 112.588 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.25 121.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.85999999999999999 110.11 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.4 mt -98.82 -13.95 19.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.393 -0.367 . . . . 1.6100000000000001 111.815 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m 55.65 -162.23 0.16 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.428 -0.351 . . . . 1.8799999999999999 110.669 -173.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.933 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 5.3 p30 -117.72 16.43 14.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.162 0.506 . . . . 0.75 111.072 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.564 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 23.2 mtt180 -107.71 137.27 46.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.205 -0.452 . . . . 3.3599999999999999 109.988 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.601 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 67.9 m 74.42 113.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.185 0.928 . . . . 0.94999999999999996 111.089 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.4 36.06 2.96 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.293 -0.867 . . . . 1.1200000000000001 112.296 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.01 -51.25 33.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.677 0.751 . . . . 2.6600000000000001 110.387 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -92.79 53.86 2.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.968 -1.015 . . . . 1.8700000000000001 110.437 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 146' ' ' ARG . 44.0 mtt85 -76.49 -83.91 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.644 -0.707 . . . . 4.7300000000000004 111.343 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -126.29 -154.74 8.73 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.655 -0.783 . . . . 0.65000000000000002 112.777 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 81.0 mttt 65.93 23.18 11.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.787 0.803 . . . . 1.0800000000000001 109.789 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -107.66 173.57 6.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.632 -1.167 . . . . 1.8899999999999999 108.876 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.35 119.94 37.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.549 -0.296 . . . . 1.29 111.187 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.922 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 18.4 m -66.06 -25.36 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.423 -0.584 . . . . 0.78000000000000003 109.423 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.02 83.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.194 -0.912 . . . . 0.67000000000000004 109.986 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 57.4 m -66.91 -36.74 82.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.426 -0.352 . . . . 0.77000000000000002 110.996 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.922 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 52.0 m-85 -61.7 -49.95 74.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.732 0.301 . . . . 0.92000000000000004 110.799 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 156' ' ' LYS . 5.9 ptp180 -69.15 -44.47 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.509 -0.314 . . . . 2.8900000000000001 111.199 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.478 ' N ' ' HG3' ' A' ' 155' ' ' ARG . 58.5 mtmt -63.04 -26.99 69.1 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.436 0.161 . . . . 0.96999999999999997 111.436 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -53.15 -50.57 64.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.52 0.512 . . . . 1.5800000000000001 110.721 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -104.09 9.92 36.18 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.18 -0.608 . . . . 5.4500000000000002 110.511 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 57.51 39.79 27.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.2 1.0 . . . . 2.4199999999999999 110.229 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.539 HD12 ' H ' ' A' ' 161' ' ' ARG . 1.7 tp -76.22 156.06 33.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.057 -1.429 . . . . 1.27 111.552 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.539 ' H ' HD12 ' A' ' 160' ' ' LEU . 9.0 mpt_? -96.87 -166.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 3.5899999999999999 111.856 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.04 158.08 77.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.76000000000000001 111.892 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -70.38 150.52 64.59 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.269 2.646 . . . . 0.53000000000000003 113.205 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 10.5 t -93.72 -31.47 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.448 -0.796 . . . . 0.44 109.861 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -147.44 146.45 29.56 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.997 -0.681 . . . . 0.27000000000000002 112.109 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.744 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -150.74 155.76 26.34 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.72 -1.127 . . . . 0.23999999999999999 111.655 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.463 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.2 t -169.73 133.2 1.23 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.897 -0.779 . . . . 0.34000000000000002 108.897 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.617 ' SG ' HD13 ' A' ' 12' ' ' LEU . 17.5 p -110.93 141.15 44.75 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.257 -0.577 . . . . 1.1100000000000001 110.609 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.601 ' CE2' HG11 ' A' ' 46' ' ' VAL . 25.9 p90 -127.32 123.16 35.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.419 -0.956 . . . . 0.80000000000000004 108.419 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 40' ' ' VAL . 1.1 pt20 -100.08 138.14 37.56 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.439 -0.504 . . . . 2.5299999999999998 110.672 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . . . -138.01 146.92 43.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.94 -0.573 . . . . 0.59999999999999998 109.976 -174.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.444 ' HB3' ' CD1' ' A' ' 117' ' ' LEU . 14.1 pt-20 -121.67 -168.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.34 . . . . 2.3799999999999999 111.34 -176.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.697 ' HA ' HG21 ' A' ' 177' ' ' VAL . 14.1 t90 -76.91 83.85 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 3.96 110.887 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.569 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.5 p-10 -74.41 -59.83 2.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 111.545 0.202 . . . . 1.53 111.545 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.578 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.9 t70 178.05 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.086 0.555 . . . . 1.26 110.185 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 44' ' ' THR . 72.4 m-85 -82.53 -2.27 53.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 2.2200000000000002 111.874 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.799 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 94.4 t -58.7 -54.04 60.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.473 -0.33 . . . . 0.5 110.49 172.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.799 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.5 Cg_exo -51.31 -36.1 56.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.635 2.223 . . . . 0.57999999999999996 112.445 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 29.2 mmmt -74.12 -24.71 59.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 2.1400000000000001 110.78 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 59.0 tp -69.44 -46.09 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.429 -0.582 . . . . 0.66000000000000003 109.429 172.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.445 -0.798 . . . . 1.8899999999999999 108.898 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 42.5 mm-40 -58.19 -50.21 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.803 -1.09 . . . . 1.53 110.941 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -64.17 -33.81 76.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.581 -0.736 . . . . 1.49 111.934 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 77.1 mt -62.47 0.03 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.691 0.626 . . . . 0.76000000000000001 112.691 -177.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.637 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.6 m -82.2 8.9 9.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.063 0.459 . . . . 1.05 110.133 171.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.6 54.95 9.12 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.974 -0.85 . . . . 1.1699999999999999 110.974 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.637 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.6 mmmt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.576 -0.726 . . . . 2.0 110.981 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 12.3 tpt . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.501 -0.185 . . . . 5.04 110.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 17.3 Cg_exo -68.36 93.41 0.41 Allowed 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 122.904 2.403 . . . . 2.1299999999999999 111.826 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 24' ' ' PRO . 3.7 t 61.47 113.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.214 -1.357 . . . . 1.47 111.873 -176.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -159.18 157.09 30.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.119 -1.067 . . . . 1.8100000000000001 108.119 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD12 ' OE1' ' A' ' 20' ' ' GLN . 2.6 mm? -76.95 22.6 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.048 -0.261 . . . . 0.69999999999999996 111.631 -174.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 m -67.64 -21.21 65.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 1.96 111.505 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.95 37.07 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 2.6600000000000001 110.192 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.445 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 9.0 p-90 -75.76 -29.03 58.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.42 0.526 . . . . 3.98 112.42 -174.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.441 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 70.8 p -156.18 20.27 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.63 111.017 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -82.6 -117.64 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.664 -0.575 . . . . 0.47999999999999998 111.664 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.6 Cg_endo -51.65 -42.08 58.24 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.225 2.616 . . . . 0.53000000000000003 110.279 167.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.728 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 10.2 mp -90.01 94.91 9.98 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.747 -1.115 . . . . 1.1699999999999999 110.965 172.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -74.2 61.45 0.86 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.351 0.596 . . . . 0.70999999999999996 110.211 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.79 HD22 HG21 ' A' ' 121' ' ' VAL . 40.5 mt -68.46 -13.41 62.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.45000000000000001 110.902 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.441 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 13.5 mm100 -73.57 -1.29 18.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.086 -0.506 . . . . 2.1200000000000001 111.675 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.57 -10.58 59.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.169 0.509 . . . . 1.9299999999999999 109.792 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.869 HG11 HG21 ' A' ' 69' ' ' THR . 58.7 t -92.83 -76.82 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.63 110.196 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.596 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 10.1 t70 -155.59 -178.25 7.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.396 -0.964 . . . . 2.9900000000000002 108.396 -175.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.74 152.99 41.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.047 0.451 . . . . 1.6000000000000001 110.766 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.484 ' OE1' HD12 ' A' ' 5' ' ' LEU . 8.2 tp-100 -78.12 129.88 74.14 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.072 -0.513 . . . . 3.5499999999999998 110.413 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.2 Cg_exo -58.22 159.39 19.08 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.965 2.443 . . . . 0.57999999999999996 113.001 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.9 ' HG3' ' HD2' ' A' ' 23' ' ' HIS . 20.3 pt20 -78.96 -8.18 58.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 1.3899999999999999 111.653 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.9 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 64.8 m-70 -148.17 157.63 42.49 Favored Pre-proline 0 CA--C 1.515 -0.385 0 C-N-CA 123.246 0.619 . . . . 1.45 109.78 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.722 ' HB2' HG12 ' A' ' 3' ' ' VAL . 5.6 Cg_endo -87.67 123.94 1.85 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.318 2.679 . . . . 0.40000000000000002 111.239 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.55 ' O ' HG11 ' A' ' 3' ' ' VAL . 20.6 tp -79.04 131.58 36.32 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.32 -0.237 . . . . 0.28999999999999998 111.353 -175.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -100.04 112.9 25.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.007 -0.368 . . . . 1.24 110.007 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 53' ' ' ILE . 22.1 t -116.59 142.03 32.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.264 -0.643 . . . . 0.46999999999999997 109.264 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -136.3 138.93 42.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.903 0.382 . . . . 0.31 110.117 -177.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.405 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 42.7 t80 -99.87 171.58 7.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.447 -0.575 . . . . 0.67000000000000004 109.447 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.65 62.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.55000000000000004 110.596 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.53 9.37 19.67 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.432 -0.804 . . . . 0.81000000000000005 112.504 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -142.34 -168.23 2.68 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 110.165 -0.309 . . . . 0.46999999999999997 110.165 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -161.36 155.23 22.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 110.768 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.763 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.8 t -107.77 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.919 -1.512 . . . . 0.39000000000000001 106.919 166.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.69 22.2 4.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.98999999999999999 109.833 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -150.64 130.24 13.08 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.051 -0.977 . . . . 2.5600000000000001 109.847 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.966 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.1 tt -71.96 112.92 8.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.342 -0.614 . . . . 0.40999999999999998 109.342 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.598 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 89.97 19.22 47.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.89 -0.671 . . . . 0.58999999999999997 112.256 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.763 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.6 147.26 27.08 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.275 -0.639 . . . . 0.34000000000000002 109.275 175.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.3 p -78.42 130.45 36.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.283 0.563 . . . . 0.55000000000000004 110.821 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.697 HD23 ' HD2' ' A' ' 169' ' ' TYR . 8.7 tp -129.99 149.74 51.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.545 -1.279 . . . . 0.45000000000000001 107.545 177.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 46' ' ' VAL . 3.9 p -95.86 150.74 37.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 C-N-CA 119.47 -0.892 . . . . 0.56000000000000005 112.665 -170.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.935 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 82.3 Cg_exo -51.68 -22.74 13.8 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.674 3.583 . . . . 0.68000000000000005 114.374 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.485 HG22 ' CE2' ' A' ' 176' ' ' TYR . 2.2 p -71.09 -53.77 13.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.672 0.748 . . . . 0.76000000000000001 109.816 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.65 -43.39 93.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.42 -1.264 . . . . 1.5900000000000001 111.544 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 43' ' ' PRO . 2.5 m -91.97 13.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 0.66000000000000003 111.903 -173.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -82.68 -28.71 30.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.162 -0.472 . . . . 0.79000000000000004 110.391 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 18.1 m120 -109.23 -169.86 1.56 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.62 -0.718 . . . . 1.9099999999999999 110.668 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -86.14 158.05 55.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.274 -0.639 . . . . 1.4299999999999999 109.274 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 122' ' ' TRP . 72.0 Cg_endo -81.64 160.43 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.112 1.875 . . . . 0.37 111.004 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -81.61 -21.23 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.141 0.496 . . . . 0.44 109.878 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.537 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 69.2 m -158.11 143.49 16.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.362 0.601 . . . . 0.38 112.551 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.905 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.92 161.0 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.717 -1.129 . . . . 0.29999999999999999 107.955 170.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.984 ' HA ' HD13 ' A' ' 58' ' ' LEU . 37.9 t 176.02 119.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.98 0.419 . . . . 0.34999999999999998 110.421 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 165' ' ' ALA . 50.0 p-90 -81.15 147.93 29.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.848 -1.538 . . . . 2.7200000000000002 106.848 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -66.38 91.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.859 0.837 . . . . 1.51 110.904 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.32 -1.31 3.68 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 114.864 -1.062 . . . . 0.80000000000000004 111.799 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.984 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.1 tt -54.68 128.58 33.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.83 0.452 . . . . 0.57999999999999996 110.511 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.804 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -77.8 -26.95 50.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.092 -0.504 . . . . 0.73999999999999999 111.67 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.715 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.5 p 70.59 13.33 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.396 1.078 . . . . 1.03 110.5 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -133.05 -25.66 0.65 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.83999999999999997 113.263 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.804 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 18.8 mtpt -84.22 156.74 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.968 0.384 . . . . 1.6699999999999999 110.084 -175.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.978 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.9 mt -92.29 128.16 38.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.72 -0.474 . . . . 0.57999999999999996 109.72 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.51 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 17.3 m-85 -121.37 150.78 40.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.601 0.239 . . . . 0.80000000000000004 110.523 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.933 HG23 HG12 ' A' ' 90' ' ' VAL . 2.7 m -97.16 105.91 18.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.638 -0.875 . . . . 0.35999999999999999 108.638 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.705 HD13 HG12 ' A' ' 124' ' ' VAL . 49.7 tp -109.23 113.01 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.823 -0.626 . . . . 0.58999999999999997 110.46 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.8 t -112.51 123.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.916 -0.584 . . . . 0.39000000000000001 110.754 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.4 mt -88.64 131.65 34.89 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.744 -0.836 . . . . 0.59999999999999998 108.744 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.869 HG21 HG11 ' A' ' 17' ' ' VAL . 8.8 t -139.05 148.91 43.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.867 0.365 . . . . 0.35999999999999999 111.302 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 27.7 t70 -127.45 94.56 37.89 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.758 -0.655 . . . . 1.9199999999999999 109.487 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.8 Cg_endo -50.79 -40.06 57.28 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 124.153 3.236 . . . . 1.25 113.799 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.8 m-20 -86.54 43.03 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.605 0.594 . . . . 1.29 112.605 -167.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.11 138.1 19.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.801 -0.181 . . . . 0.5 110.615 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.548 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 87.8 Cg_endo -83.28 -24.49 11.13 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.575 -1.427 . . . . 0.62 112.993 1.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.9 p -130.81 150.85 51.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.177 -0.465 . . . . 0.75 109.933 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.778 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 42.5 mtm105 -67.83 -23.55 65.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.934 -0.575 . . . . 2.8799999999999999 111.878 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.724 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.6 -10.68 39.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 1.3799999999999999 111.145 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 13.4 t70 -154.18 77.01 5.63 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.176 0.512 . . . . 1.3700000000000001 110.116 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 81.5 Cg_endo -79.42 86.37 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.532 2.154 . . . . 0.80000000000000004 112.363 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.6 mttm -70.67 -50.3 38.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.747 -1.115 . . . . 1.02 110.589 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.69 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.9 m-85 -82.05 20.93 0.94 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.453 -0.794 . . . . 1.1699999999999999 111.437 -172.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 8.0 tmm_? -71.97 123.58 23.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.888 -0.412 . . . . 2.9300000000000002 109.888 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 4.8 mp0 -100.08 135.95 40.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.895 0.379 . . . . 2.23 110.886 -0.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.402 ' HD1' ' O ' ' A' ' 146' ' ' ARG . 15.1 t90 -79.38 146.52 32.8 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.977 -1.12 . . . . 1.4299999999999999 107.977 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 47.0 p-80 -124.51 127.54 47.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 1.26 110.751 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.997 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 21.0 t-80 -70.66 -37.15 73.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.906 -1.043 . . . . 2.1400000000000001 110.219 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.622 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.4 p90 -168.36 173.61 7.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.01 -0.367 . . . . 1.51 110.01 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.654 ' HG ' HD12 ' A' ' 103' ' ' LEU . 18.4 tp -134.95 113.98 12.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.087 -0.506 . . . . 0.33000000000000002 109.776 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -122.71 132.64 70.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.671 -0.695 . . . . 0.31 110.627 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.933 HG12 HG23 ' A' ' 65' ' ' THR . 5.6 m -128.15 164.93 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.312 -0.996 . . . . 0.27000000000000002 108.312 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.978 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.0 m-20 59.16 18.64 6.66 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 123.526 0.516 . . . . 1.76 111.096 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.3 ttm -70.12 110.01 4.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.31 108.588 176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 19.4 ttmm -76.48 92.67 3.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.733 -1.121 . . . . 1.21 111.179 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.715 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.2 -123.13 6.75 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.853 -1.067 . . . . 0.29999999999999999 112.898 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' HA ' HD11 ' A' ' 53' ' ' ILE . 26.1 p-10 -113.41 22.27 14.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.332 -0.434 . . . . 1.04 111.024 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.63 106.84 18.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.489 0.661 . . . . 0.77000000000000002 109.919 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 97' ' ' ILE . 4.6 mm -57.01 -30.66 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.307 -1.315 . . . . 0.40999999999999998 111.274 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -82.87 -26.68 31.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 0.68000000000000005 111.655 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -84.82 14.9 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 1.26 111.616 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 109.35 3.62 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.787 -0.72 . . . . 0.34999999999999998 111.902 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.4 m -61.55 106.26 0.63 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.363 0.601 . . . . 0.45000000000000001 109.549 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 p -85.8 121.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.257 -0.883 . . . . 0.56999999999999995 111.414 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.654 HD12 ' HG ' ' A' ' 88' ' ' LEU . 18.4 mt -100.48 -43.13 6.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.012 0.911 . . . . 0.45000000000000001 109.231 173.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 t -123.98 110.39 14.74 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.159 -1.423 . . . . 0.37 107.159 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.895 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -59.31 164.44 3.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.851 -0.613 . . . . 1.1499999999999999 112.469 -171.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 11.0 p90 -80.76 98.27 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.414 -0.812 . . . . 4.6900000000000004 110.231 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.775 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.6 t -67.33 -53.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.85999999999999999 111.332 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.41 -162.53 12.87 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.551 -0.833 . . . . 0.67000000000000004 112.312 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.595 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 29.0 t -77.72 117.56 19.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.919 -0.4 . . . . 0.51000000000000001 109.919 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.646 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -143.47 57.04 0.55 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.699 -0.763 . . . . 0.81999999999999995 112.461 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.767 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 1.4 Cg_endo -87.01 131.25 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.245 2.63 . . . . 0.84999999999999998 112.346 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.65 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.7 Cg_exo -56.74 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.207 1.938 . . . . 0.87 110.53 171.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.17 112.87 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 1.8500000000000001 110.528 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.89 -6.38 19.97 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.842 -0.694 . . . . 1.1799999999999999 112.121 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.709 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 78.4 p -83.92 -20.95 32.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.772 0.32 . . . . 0.96999999999999997 111.318 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.414 ' HA3' ' HE ' ' A' ' 76' ' ' ARG . . . 107.77 -174.24 19.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.155 -0.545 . . . . 1.97 112.381 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 4.4 mm? -68.59 122.82 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.667 0.27 . . . . 0.93999999999999995 110.726 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.767 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.8 m-70 -98.45 121.55 40.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.129 0.49 . . . . 2.23 110.207 176.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.728 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 1.6 ptt180 -107.13 94.11 4.92 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.083 -0.962 . . . . 2.3100000000000001 111.461 -168.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.635 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 33.6 m-85 -75.15 111.06 10.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.195 -0.669 . . . . 0.78000000000000003 109.195 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.7 t -94.76 132.46 38.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.785 -0.643 . . . . 0.27000000000000002 110.09 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.767 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 31.0 m95 -89.4 121.89 32.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.303 -0.629 . . . . 1.99 109.303 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 76.1 mt -116.47 117.5 30.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.159 0.436 . . . . 0.38 110.221 175.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.705 HG12 HD13 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -115.07 137.89 47.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.263 -0.273 . . . . 0.31 110.263 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.83 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 47.9 t80 -130.6 137.63 49.74 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.301 -0.259 . . . . 5.1200000000000001 110.301 175.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.71 105.07 17.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.227 -0.657 . . . . 2.4100000000000001 109.227 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.479 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -76.98 175.1 9.87 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.428 0.632 . . . . 1.3100000000000001 111.29 -173.535 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.17 -29.27 66.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.103 -0.953 . . . . 2.3999999999999999 109.231 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 10.9 ptt-85 -159.66 164.59 19.95 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.511 -1.222 . . . . 3.5099999999999998 111.254 -172.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.546 ' HG3' HD12 ' A' ' 63' ' ' LEU . 31.4 Cg_exo -55.86 142.98 83.33 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.453 2.769 . . . . 1.21 112.916 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.506 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.0 mm? -68.97 154.43 42.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.567 0.951 . . . . 0.90000000000000002 113.567 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HE2' ' OD2' ' A' ' 134' ' ' ASP . 21.5 tptm -141.35 86.78 2.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.44 -1.255 . . . . 2.8999999999999999 108.0 167.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.74 -46.42 8.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.774 -0.648 . . . . 1.8999999999999999 112.678 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.451 ' OD2' ' HE2' ' A' ' 132' ' ' LYS . 61.7 m-20 57.32 47.55 16.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 2.96 110.7 -174.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -99.43 146.92 32.61 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.539 -0.755 . . . . 1.3899999999999999 109.973 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.73 106.19 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.133 2.555 . . . . 1.27 112.474 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.43 115.36 2.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.241 -0.436 . . . . 0.85999999999999999 110.659 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.0 mt -109.38 147.52 32.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 1.6100000000000001 110.203 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 58.0 m -109.32 36.64 2.85 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.572 -0.74 . . . . 1.8799999999999999 110.38 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.895 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 4.5 p30 57.05 4.56 0.18 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.62 1.168 . . . . 0.75 113.041 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.58 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 83.9 mtt180 -97.39 136.27 38.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 3.3599999999999999 110.819 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.67 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 53.7 m 77.46 118.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.582 -1.19 . . . . 0.94999999999999996 111.147 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -89.42 34.08 4.12 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.169 -0.923 . . . . 1.1200000000000001 112.426 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.68 -28.83 63.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.23 0.538 . . . . 2.6600000000000001 110.597 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -119.87 68.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 1.8700000000000001 110.852 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 78.5 mtt180 -75.52 -76.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.182 0.515 . . . . 4.7300000000000004 111.063 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.4 -148.05 5.97 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.664 -0.779 . . . . 0.65000000000000002 112.532 -174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.69 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 68.25 17.76 9.28 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.51 0.671 . . . . 1.0800000000000001 110.208 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -110.01 104.68 13.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.235 -0.893 . . . . 1.8899999999999999 109.303 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -54.82 120.65 7.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.635 -0.711 . . . . 1.29 112.2 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 17' ' ' VAL . 4.6 m -60.38 -30.1 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.611 -0.722 . . . . 0.78000000000000003 110.705 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.12 -35.47 80.38 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.67000000000000004 110.445 173.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 69.1 m -68.59 -33.96 74.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.77000000000000002 110.306 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.704 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 58.1 m-85 -67.39 -43.66 80.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.92000000000000004 110.44 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 21.4 ptt180 -69.53 -41.46 75.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.327 -0.397 . . . . 2.8900000000000001 110.354 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 53.6 mtmt -62.61 -27.31 69.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.564 0.221 . . . . 0.96999999999999997 111.416 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -53.61 -53.33 53.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.5800000000000001 110.909 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 5.2 t80 -107.89 20.96 18.09 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.439 -0.904 . . . . 5.4500000000000002 111.011 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.57 42.59 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.384 -0.825 . . . . 2.4199999999999999 111.69 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.83 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.2 mp -90.77 155.27 18.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.265 -0.88 . . . . 1.27 109.751 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.926 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -122.87 -153.85 0.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.454 -0.573 . . . . 3.5899999999999999 109.454 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.926 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -53.98 140.31 51.72 Favored Pre-proline 0 N--CA 1.456 -0.165 0 CA-C-O 121.168 0.509 . . . . 0.76000000000000001 111.114 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 7.0 Cg_exo -70.65 170.7 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.981 3.121 . . . . 0.53000000000000003 113.404 -167.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.887 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -92.8 -36.07 7.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 115.155 -0.929 . . . . 0.44 110.058 177.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -144.84 144.21 31.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.153 -0.619 . . . . 0.27000000000000002 111.962 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.767 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 150.8 23.1 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.813 -1.085 . . . . 0.23999999999999999 112.093 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.966 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -167.82 152.57 6.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.403 -0.962 . . . . 0.34000000000000002 108.403 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.805 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -122.03 142.72 50.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.985 0.421 . . . . 1.1100000000000001 111.091 -176.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.697 ' HD2' HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -130.0 109.97 11.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 0.80000000000000004 108.671 172.195 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 4.3 pt20 -100.09 133.89 43.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.381 0.511 . . . . 2.5299999999999998 112.381 -170.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.36 151.4 44.42 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.146 -0.934 . . . . 0.59999999999999998 109.625 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -113.27 -64.29 1.33 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.516 0.932 . . . . 2.3799999999999999 113.516 -173.039 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.596 ' HA ' HG21 ' A' ' 177' ' ' VAL . 12.8 t90 178.45 74.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.017 -0.364 . . . . 3.96 110.017 -176.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.935 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -72.48 -62.21 1.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.795 0.294 . . . . 1.53 111.795 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.563 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 32.0 t70 177.18 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.095 -0.502 . . . . 1.26 110.915 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.485 ' CE2' HG22 ' A' ' 44' ' ' THR . 11.2 m-30 -78.79 1.58 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.384 -0.371 . . . . 2.2200000000000002 111.667 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.77 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 72.7 t -67.57 -54.21 19.11 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.5 110.204 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.77 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.4 Cg_exo -51.4 -35.25 53.92 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.331 2.021 . . . . 0.57999999999999996 112.35 170.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.693 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 26.3 mmmt -72.79 -24.75 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.848 0.314 . . . . 2.1400000000000001 111.848 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.2 tp -70.49 -46.29 64.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.033 -0.729 . . . . 0.66000000000000003 109.033 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.32 -37.98 79.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.559 -0.746 . . . . 1.8899999999999999 109.331 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.693 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.0 mm-40 -56.18 -55.57 31.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.808 -1.087 . . . . 1.53 110.687 170.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.73 -33.35 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 1.49 112.333 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 76.4 mt -63.76 -1.14 1.23 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.4 0.519 . . . . 0.76000000000000001 112.4 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.482 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.8 m -78.13 -2.81 39.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.444 0.64 . . . . 1.05 109.534 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 77.51 44.13 13.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.197 -0.911 . . . . 1.1699999999999999 111.206 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.482 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.3 mmmt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.341 -0.837 . . . . 2.0 110.597 -174.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.531 ' SD ' ' HD2' ' A' ' 2' ' ' PRO . 39.2 tpp . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.989 -0.375 . . . . 5.04 109.989 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.531 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 55.3 Cg_exo -54.52 113.68 1.48 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.353 2.702 . . . . 2.1299999999999999 112.757 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.694 HG12 ' HB2' ' A' ' 24' ' ' PRO . 3.5 t 67.29 113.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.101 -0.954 . . . . 1.47 111.725 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.5 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 27.9 t70 -152.84 157.7 41.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.57 -0.9 . . . . 1.8100000000000001 108.57 176.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.497 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.8 mm? -79.18 28.85 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.667 0.27 . . . . 0.69999999999999996 110.804 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 4' ' ' ASP . 7.9 m -62.96 -29.12 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 1.96 111.18 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.486 ' HB2' HD12 ' A' ' 12' ' ' LEU . 90.5 mttt -124.51 50.84 1.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.158 -0.474 . . . . 2.6600000000000001 110.231 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.624 ' HD1' ' HG3' ' A' ' 15' ' ' GLN . 4.8 p90 -71.61 -38.65 70.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 3.98 111.453 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.714 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 73.9 p -142.9 24.14 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.63 111.451 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.516 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.25 -125.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.15 -0.78 . . . . 0.47999999999999998 111.15 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.7 Cg_endo -51.11 -40.62 59.62 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 123.326 2.684 . . . . 0.53000000000000003 110.049 168.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.731 HD11 ' HA3' ' A' ' 38' ' ' GLY . 36.4 mt -88.71 78.25 7.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.688 -1.142 . . . . 1.1699999999999999 109.319 169.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 1.2 m -73.72 64.1 0.91 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.547 0.689 . . . . 0.70999999999999996 109.907 176.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.648 ' HB3' HG21 ' A' ' 121' ' ' VAL . 12.0 mt -79.73 -30.18 40.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.551 -0.749 . . . . 0.45000000000000001 110.39 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 74.7 mm-40 -73.74 16.13 0.23 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.915 0.709 . . . . 2.1200000000000001 112.915 -175.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.7 mt-10 -82.63 -13.53 56.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.851 -0.796 . . . . 1.9299999999999999 108.851 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.934 HG12 HG21 ' A' ' 151' ' ' VAL . 49.0 t -85.36 -74.92 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 114.878 -1.055 . . . . 0.63 111.525 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -122.09 -157.91 0.75 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.178 -0.465 . . . . 2.9900000000000002 111.14 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -87.15 151.26 23.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 1.6000000000000001 110.445 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 40.7 mt-30 -67.12 126.15 92.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.934 -0.395 . . . . 3.5499999999999998 109.934 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.694 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -73.23 159.41 47.21 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.214 1.943 . . . . 0.57999999999999996 111.824 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.867 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 21.0 pt20 -74.62 -13.45 60.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.74 -0.664 . . . . 1.3899999999999999 111.491 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.795 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 3.1 m80 -160.93 164.57 18.8 Favored Pre-proline 0 CA--C 1.519 -0.249 0 CA-C-O 121.016 0.436 . . . . 1.45 110.83 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.694 ' HB2' HG12 ' A' ' 3' ' ' VAL . 3.6 Cg_endo -85.82 131.14 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.487 2.792 . . . . 0.40000000000000002 111.438 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.864 HD23 ' HB3' ' A' ' 122' ' ' TRP . 25.6 tp -80.52 143.58 33.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.691 0.282 . . . . 0.28999999999999998 111.457 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.494 ' H ' HD12 ' A' ' 25' ' ' LEU . 63.2 m-70 -110.07 123.98 50.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.753 -0.462 . . . . 1.24 109.753 172.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.005 HG13 HG22 ' A' ' 53' ' ' ILE . 14.8 t -130.37 134.93 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.072 -0.714 . . . . 0.46999999999999997 109.072 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -127.37 140.64 52.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.093 0.473 . . . . 0.31 110.435 -177.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -103.12 172.67 6.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.541 -0.54 . . . . 0.67000000000000004 109.541 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.8 67.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.492 0.663 . . . . 0.55000000000000004 110.678 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.43 4.33 33.02 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.316 -0.856 . . . . 0.81000000000000005 112.753 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.44 -168.54 3.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.46999999999999997 110.472 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -162.36 149.95 14.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.977 -0.556 . . . . 0.33000000000000002 109.905 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.757 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -105.29 60.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.167 -1.42 . . . . 0.39000000000000001 107.167 166.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.27 25.63 5.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.0 0.905 . . . . 0.98999999999999999 109.921 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 16.9 tt0 -148.31 128.0 13.34 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.833 -1.076 . . . . 2.5600000000000001 108.582 167.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -69.62 111.41 5.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 0.40999999999999998 109.546 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.731 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.88 16.47 59.63 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.83 -0.623 . . . . 0.58999999999999997 113.029 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.91 149.28 41.55 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.507 -0.553 . . . . 0.34000000000000002 109.507 174.037 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 14.4 p -75.54 132.77 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.55000000000000004 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.9 tp -131.92 170.59 14.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.93 -0.767 . . . . 0.45000000000000001 108.93 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.94 152.18 62.42 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.209 0.448 . . . . 0.56000000000000005 112.209 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 87.8 Cg_exo -50.93 -46.47 30.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.319 2.679 . . . . 0.68000000000000005 113.981 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.49 -31.65 64.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 0.76000000000000001 111.75 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -83.71 -10.73 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.815 -0.629 . . . . 1.5900000000000001 112.113 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 41' ' ' LEU . 30.4 m -131.72 30.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.547 0.689 . . . . 0.66000000000000003 111.007 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.73 -29.21 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.79000000000000004 110.854 -174.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -114.83 -173.21 2.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 1.9099999999999999 110.225 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.16 155.41 87.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.15 -0.315 . . . . 1.4299999999999999 110.15 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.44 155.66 28.43 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.799 1.666 . . . . 0.37 110.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -78.47 -23.31 46.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.238 -0.282 . . . . 0.44 110.238 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.438 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.1 m -159.79 147.23 16.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.38 112.083 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.005 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.57 170.21 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.283 -0.871 . . . . 0.29999999999999999 108.973 172.477 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.008 ' HA ' HD13 ' A' ' 58' ' ' LEU . 29.2 t 179.52 116.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.406 0.622 . . . . 0.34999999999999998 109.631 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.549 ' CG ' HG21 ' A' ' 124' ' ' VAL . 1.2 p90 -100.85 -171.2 1.96 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.226 -0.897 . . . . 2.7200000000000002 110.116 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' HG12 ' A' ' 164' ' ' VAL . 22.1 t0 -69.61 119.58 14.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.005 0.431 . . . . 1.51 111.004 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.24 34.48 54.87 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.742 -0.742 . . . . 0.80000000000000004 112.656 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.008 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.3 tt -67.53 125.41 26.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.919 -0.771 . . . . 0.57999999999999996 108.919 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.673 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 23.9 t70 -89.85 -12.79 38.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.73999999999999999 110.884 -173.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.683 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 54.3 m 62.13 20.81 11.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.948 -1.024 . . . . 1.03 109.558 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.571 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -153.86 -24.4 0.04 OUTLIER Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.866 -0.683 . . . . 0.83999999999999997 113.852 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.673 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 45.4 mtpt -77.0 156.82 31.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.661 0.731 . . . . 1.6699999999999999 109.904 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.706 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 37.2 mt -94.0 125.17 38.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.947 -0.76 . . . . 0.57999999999999996 108.947 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.9 m-85 -125.03 156.94 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.745 -0.382 . . . . 0.80000000000000004 110.002 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.633 HG23 HG12 ' A' ' 90' ' ' VAL . 46.7 m -98.07 110.98 23.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.547 . . . . 0.35999999999999999 109.522 175.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.543 HD13 ' CZ3' ' A' ' 55' ' ' TRP . 21.0 tp -107.48 109.75 21.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.177 -0.465 . . . . 0.58999999999999997 109.753 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.3 t -117.93 120.81 65.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.39000000000000001 111.112 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.875 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.5 mt -83.22 145.96 28.85 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.947 -0.76 . . . . 0.59999999999999998 108.947 168.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.752 HG21 HG11 ' A' ' 17' ' ' VAL . 10.5 t -146.46 145.69 30.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.683 0.278 . . . . 0.35999999999999999 110.936 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 28.2 t70 -125.59 98.37 34.68 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 1.9199999999999999 109.421 174.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.4 Cg_endo -50.32 -38.04 51.48 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 124.135 3.224 . . . . 1.25 114.216 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 71.3 m-20 -103.59 54.18 0.75 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.293 0.568 . . . . 1.29 111.928 -165.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . . . -104.64 137.12 19.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.5 109.864 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 63.6 Cg_endo -74.44 -30.27 6.08 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.682 -1.383 . . . . 0.62 113.268 1.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.619 ' HB3' HG22 ' A' ' 115' ' ' THR . 33.6 p -137.88 165.95 25.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.589 -0.278 . . . . 0.75 110.877 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.589 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 29.2 mtp180 -68.04 -36.61 80.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 2.8799999999999999 110.851 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.761 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -76.13 -12.68 60.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.53 . . . . 1.3799999999999999 111.711 -176.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.537 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.3 t70 -154.93 77.56 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 1.3700000000000001 110.258 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.92 97.54 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.608 2.205 . . . . 0.80000000000000004 112.885 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.577 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 26.4 mttm -85.52 -48.41 8.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.848 -1.069 . . . . 1.02 110.197 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 87.4 m-85 -79.99 14.16 1.94 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 111.55 -171.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.0 ttt85 -66.83 125.14 24.95 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.991 0.367 . . . . 2.9300000000000002 111.991 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.839 ' HG2' HG13 ' A' ' 17' ' ' VAL . 6.2 mp0 -95.45 140.15 30.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.671 0.388 . . . . 2.23 110.154 -5.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 14.4 t90 -86.4 91.15 8.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.529 . . . . 1.4299999999999999 110.106 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 38.4 p-80 -63.16 130.43 44.56 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.419 -0.586 . . . . 1.26 109.419 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.9 t60 -79.22 -31.88 43.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.898 -0.592 . . . . 2.1400000000000001 110.958 -173.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.626 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 28.7 p90 -168.42 178.56 4.79 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.198 -0.668 . . . . 1.51 109.198 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.47 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.1 tp -140.39 113.56 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.388 . . . . 0.33000000000000002 110.064 175.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.742 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.7 t -122.77 130.32 74.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.592 -0.731 . . . . 0.31 110.707 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.633 HG12 HG23 ' A' ' 65' ' ' THR . 13.4 m -133.62 165.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.986 -1.006 . . . . 0.27000000000000002 108.496 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.706 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.2 t30 63.54 13.37 7.17 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.024 -0.361 . . . . 1.76 110.024 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.742 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.9 ttm -67.67 101.98 1.12 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.603 -0.888 . . . . 0.31 108.603 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.8 ttmm -80.74 92.87 6.1 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.096 -1.411 . . . . 1.21 110.982 -170.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 78.13 -130.38 10.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.913 -1.039 . . . . 0.29999999999999999 112.668 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.548 ' HA ' HD11 ' A' ' 53' ' ' ILE . 25.8 p-10 -109.92 24.43 13.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.21 0.528 . . . . 1.04 110.735 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.98 107.11 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.835 -0.621 . . . . 0.77000000000000002 109.951 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 97' ' ' ILE . 4.5 mm -56.37 -32.71 36.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.573 -1.194 . . . . 0.40999999999999998 110.856 -177.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.3 m -73.01 -26.41 61.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.748 -0.66 . . . . 0.68000000000000005 112.002 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.7 m -78.44 -6.56 55.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 1.26 111.42 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.42 102.42 1.61 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.645 -0.788 . . . . 0.34999999999999998 112.11 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.1 m -68.46 107.99 3.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.464 0.65 . . . . 0.45000000000000001 109.655 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -79.57 119.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.892 -1.049 . . . . 0.56999999999999995 112.102 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.435 HD12 ' HG ' ' A' ' 88' ' ' LEU . 61.9 mt -95.14 -39.12 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.03 0.919 . . . . 0.45000000000000001 109.159 171.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.7 t -128.08 114.79 17.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.257 -1.386 . . . . 0.37 107.257 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.468 ' HA ' HG21 ' A' ' 102' ' ' VAL . 6.9 t0 -63.01 161.72 12.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.569 0.699 . . . . 1.1499999999999999 112.784 -168.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -91.09 93.91 9.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.984 -1.007 . . . . 4.6900000000000004 109.318 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.849 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 54.5 t -71.02 -46.18 68.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.167 0.508 . . . . 0.85999999999999999 111.89 -176.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.429 ' HA3' ' NZ ' ' A' ' 47' ' ' LYS . . . 115.86 -177.94 17.31 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.358 -0.925 . . . . 0.67000000000000004 112.294 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.8 t -64.13 122.37 16.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.551 0.176 . . . . 0.51000000000000001 111.336 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -142.72 63.87 0.5 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.051 -0.595 . . . . 0.81999999999999995 111.908 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.642 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 43.9 Cg_endo -97.7 121.9 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.504 2.803 . . . . 0.84999999999999998 112.673 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.491 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 50.7 Cg_exo -54.5 154.37 20.02 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.63 2.22 . . . . 0.87 111.736 173.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -72.02 131.04 42.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.433 . . . . 1.8500000000000001 111.146 -175.356 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.03 14.88 73.88 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.772 -0.649 . . . . 1.1799999999999999 113.163 175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 75' ' ' SER . 35.5 p -77.73 -15.37 59.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.672 0.619 . . . . 0.96999999999999997 112.672 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 103.92 13.02 28.46 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.141 -1.028 . . . . 1.97 112.823 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.0 mm? 76.94 105.08 0.07 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 124.604 0.826 . . . . 0.93999999999999995 111.142 177.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.65 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 5.0 m170 -66.66 121.23 14.93 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.383 -0.826 . . . . 2.23 110.044 175.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.663 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 13.1 ptp180 -116.3 80.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.832 0.825 . . . . 2.3100000000000001 110.364 -175.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 7.3 m-85 -63.69 120.26 11.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.289 -1.323 . . . . 0.78000000000000003 109.688 -177.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.699 HG22 ' HB3' ' A' ' 168' ' ' CYS . 24.6 t -97.94 131.68 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.107 -0.497 . . . . 0.27000000000000002 110.511 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.864 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.51 119.68 30.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.586 -0.733 . . . . 1.99 110.057 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -116.77 123.77 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.481 -0.192 . . . . 0.38 110.481 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.549 HG21 ' CG ' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -122.47 137.64 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.577 0.227 . . . . 0.31 111.098 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.999 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 17.7 t80 -136.66 140.65 42.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.085 -0.339 . . . . 5.1200000000000001 110.085 171.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.568 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 7.3 pt-20 -89.06 112.32 23.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.197 0.522 . . . . 2.4100000000000001 109.75 171.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.16 172.39 11.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.3100000000000001 110.013 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.98 -18.43 53.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.218 -0.901 . . . . 2.3999999999999999 109.408 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 11.4 ptt-85 -158.28 162.22 27.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.9 -1.046 . . . . 3.5099999999999998 111.67 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.557 ' HG3' HD12 ' A' ' 63' ' ' LEU . 26.0 Cg_exo -57.74 140.83 94.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.274 2.649 . . . . 1.21 111.575 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.626 ' HG ' HG11 ' A' ' 90' ' ' VAL . 3.2 mm? -64.57 143.72 57.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.156 0.503 . . . . 0.90000000000000002 111.817 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -129.32 61.46 1.54 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.232 -1.025 . . . . 2.8999999999999999 108.232 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.983 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 86.2 m -77.22 -55.42 5.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.253 -1.34 . . . . 1.8999999999999999 111.52 -172.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 60.85 35.02 19.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.292 0.568 . . . . 2.96 110.195 -172.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.983 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 59.0 mm-40 -77.62 137.23 63.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 108.616 -0.883 . . . . 1.3899999999999999 108.616 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.78 106.95 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.273 2.649 . . . . 1.27 112.728 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.1 mm -61.94 115.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.85999999999999999 110.546 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -104.43 149.28 25.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.267 0.556 . . . . 1.6100000000000001 110.352 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 162.39 13.53 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.416 -0.957 . . . . 1.8799999999999999 108.416 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.849 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 5.0 p30 -77.49 16.84 0.58 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.98 0.419 . . . . 0.75 111.45 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.696 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 54.0 mtt180 -104.8 136.75 43.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.663 -0.495 . . . . 3.3599999999999999 109.663 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.615 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 49.3 m 77.27 117.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.18 0.992 . . . . 0.94999999999999996 111.232 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -106.29 41.56 2.14 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.301 -0.863 . . . . 1.1200000000000001 112.794 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.25 -47.82 47.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 2.6600000000000001 109.78 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -97.63 54.35 1.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.633 -1.167 . . . . 1.8700000000000001 110.672 -173.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 76.9 mtt180 -69.71 -77.29 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 4.7300000000000004 111.017 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -120.74 -143.05 6.66 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.792 -0.718 . . . . 0.65000000000000002 112.478 -174.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 67.36 18.51 10.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.963 0.887 . . . . 1.0800000000000001 109.769 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.18 105.58 13.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.397 -1.274 . . . . 1.8899999999999999 108.223 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -59.99 129.88 43.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.189 -0.459 . . . . 1.29 111.81 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.934 HG21 HG12 ' A' ' 17' ' ' VAL . 17.1 m -64.39 -24.92 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.78000000000000003 110.306 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.526 ' HB1' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -44.41 90.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.431 -0.804 . . . . 0.67000000000000004 109.599 172.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -61.39 -40.53 94.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.77000000000000002 111.033 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 37.2 m-85 -58.3 -53.94 52.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.435 . . . . 0.92000000000000004 111.396 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -70.76 -45.42 64.79 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.98 -0.288 . . . . 2.8900000000000001 111.217 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.526 ' HE2' ' HB1' ' A' ' 152' ' ' ALA . 58.8 mtmt -62.17 -25.95 68.06 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.724 0.297 . . . . 0.96999999999999997 111.356 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.48 -52.76 58.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 1.5800000000000001 111.053 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 12.4 t80 -102.14 18.64 20.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.88 -0.728 . . . . 5.4500000000000002 110.541 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.66 38.38 5.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.354 -0.839 . . . . 2.4199999999999999 111.948 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.999 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.0 mp -88.76 148.78 23.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.875 -0.602 . . . . 1.27 109.703 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.503 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 13.2 tpt180 -117.91 -152.15 0.5 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.468 -0.333 . . . . 3.5899999999999999 110.126 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.503 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -56.0 143.97 60.27 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-O 120.989 0.424 . . . . 0.76000000000000001 111.278 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.694 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 4.8 Cg_exo -73.2 159.88 46.4 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.876 3.05 . . . . 0.53000000000000003 113.723 -170.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.867 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 11.8 t -81.34 -31.02 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.086 -0.961 . . . . 0.44 109.751 173.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.795 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -156.95 148.76 22.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.053 -0.659 . . . . 0.27000000000000002 111.855 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.69 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 147.04 17.64 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.23999999999999999 111.349 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.638 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.0 t -160.58 149.6 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.969 -0.752 . . . . 0.34000000000000002 108.969 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.699 ' HB3' HG22 ' A' ' 121' ' ' VAL . 15.4 p -126.9 149.02 49.99 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.894 -0.722 . . . . 1.1100000000000001 111.589 -175.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 46.2 p90 -129.08 127.61 41.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.887 -1.153 . . . . 0.80000000000000004 107.887 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 1.2 pt20 -104.65 133.01 50.21 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.045 -0.662 . . . . 2.5299999999999998 110.07 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -120.82 141.75 50.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.59999999999999998 112.199 -170.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.641 ' HG2' HD11 ' A' ' 117' ' ' LEU . 46.2 mt-10 -89.21 -173.1 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.809 -1.087 . . . . 2.3799999999999999 111.617 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.537 ' HA ' HG21 ' A' ' 177' ' ' VAL . 55.7 t90 -98.3 75.65 2.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.361 -0.977 . . . . 3.96 108.361 175.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -73.13 -57.19 4.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.386 -0.37 . . . . 1.53 111.906 -172.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.524 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.8 t70 179.44 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.118 0.567 . . . . 1.26 110.335 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -81.34 0.78 35.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 2.2200000000000002 112.113 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.825 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 93.2 t -67.88 -54.66 15.93 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.342 -0.244 . . . . 0.5 110.342 174.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.3 Cg_exo -53.83 -43.06 61.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.504 2.136 . . . . 0.57999999999999996 111.949 171.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.3 mmmm -70.83 -24.3 62.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 2.1400000000000001 111.561 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.641 HD11 HG12 ' A' ' 107' ' ' VAL . 61.9 tp -66.99 -47.85 70.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 0.66000000000000003 109.529 172.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.61 -37.76 87.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.66 -0.7 . . . . 1.8899999999999999 109.445 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.729 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.3 mm-40 -56.56 -44.87 81.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.932 -1.031 . . . . 1.53 110.842 172.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.96 -29.85 65.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.745 . . . . 1.49 111.497 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.615 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.2 mt -64.85 -8.66 16.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.934 0.346 . . . . 0.76000000000000001 111.934 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.513 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 66.6 m -73.91 -3.11 26.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 1.05 110.364 172.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.696 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.54 58.04 6.2 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.826 -0.91 . . . . 1.1699999999999999 110.826 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.9 mmmt . . . . . 0 C--O 1.241 0.654 0 CA-C-O 118.651 -0.69 . . . . 2.0 111.304 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 3.7 p . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.336 0.589 . . . . 1.47 109.673 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.3 155.92 34.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.784 -0.644 . . . . 1.8100000000000001 109.953 -168.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.491 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -72.67 2.21 6.95 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 112.331 0.493 . . . . 0.69999999999999996 112.331 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 m -55.91 -21.85 22.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.77 0.319 . . . . 1.96 111.755 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -101.13 27.6 5.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.563 -0.289 . . . . 2.6600000000000001 110.701 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.576 ' HE3' ' HB2' ' A' ' 20' ' ' GLN . 5.1 p-90 -70.64 -28.44 64.81 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.639 0.607 . . . . 3.98 112.639 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -144.96 14.59 1.51 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.713 -0.395 . . . . 0.63 111.139 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.63 -115.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.483 -0.647 . . . . 0.47999999999999998 111.483 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.1 Cg_endo -51.28 -46.2 32.69 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.356 2.704 . . . . 0.53000000000000003 110.925 167.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.707 HD11 ' HA3' ' A' ' 38' ' ' GLY . 11.5 mt -88.97 103.44 16.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.15 -0.932 . . . . 1.1699999999999999 110.125 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.18 65.35 4.33 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.257 0.551 . . . . 0.70999999999999996 110.546 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.816 HD22 HG21 ' A' ' 121' ' ' VAL . 15.5 mt -76.16 -15.05 60.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.543 . . . . 0.45000000000000001 110.45 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -66.73 -8.46 28.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 2.1200000000000001 111.308 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.468 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 9.4 mt-10 -81.85 -7.62 59.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.235 -0.439 . . . . 1.9299999999999999 110.107 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.733 HG11 HG21 ' A' ' 69' ' ' THR . 53.3 t -124.88 -61.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 0.63 111.389 -175.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -125.2 169.34 12.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.678 -0.409 . . . . 2.9900000000000002 110.404 -172.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -90.5 25.37 2.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 1.6000000000000001 111.799 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.576 ' HB2' ' HE3' ' A' ' 8' ' ' TRP . 1.6 tt0 67.05 120.48 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 O-C-N 124.151 0.907 . . . . 3.5499999999999998 110.986 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 19.2 Cg_exo -65.17 158.37 52.46 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.403 2.069 . . . . 0.57999999999999996 112.124 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.857 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.4 pt20 -73.42 -16.19 61.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 1.3899999999999999 111.034 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.774 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 21.2 m80 -149.36 156.43 39.59 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.691 -0.686 . . . . 1.45 109.565 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 6.3 Cg_endo -87.28 126.66 2.35 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.891 2.394 . . . . 0.40000000000000002 110.97 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.2 tp -75.92 140.44 42.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.791 0.329 . . . . 0.28999999999999998 110.916 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -106.04 119.74 39.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 1.24 109.625 173.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.882 HG13 HG22 ' A' ' 53' ' ' ILE . 21.8 t -126.17 138.19 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.995 -0.742 . . . . 0.46999999999999997 108.995 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -136.74 136.95 39.4 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.026 0.441 . . . . 0.31 110.655 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 60.9 t80 -99.65 169.3 9.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.315 -0.624 . . . . 0.67000000000000004 109.315 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.86 65.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.471 0.653 . . . . 0.55000000000000004 110.488 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.651 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -116.03 20.06 13.19 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.028 -0.987 . . . . 0.81000000000000005 112.673 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 45' ' ' GLN . . . -154.36 -170.5 3.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.845 0.355 . . . . 0.46999999999999997 110.416 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.92 159.76 24.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.33000000000000002 109.82 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.722 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.1 t -122.4 63.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.253 -1.388 . . . . 0.39000000000000001 107.253 166.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.4 t70 -100.27 19.89 15.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.154 -0.93 . . . . 0.98999999999999999 109.808 -173.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 44.5 mt-10 -144.05 131.1 20.54 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.09 -0.959 . . . . 2.5600000000000001 108.593 172.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -74.66 111.33 9.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.416 0.627 . . . . 0.40999999999999998 110.272 -172.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.707 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 80.53 21.27 64.6 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.295 -0.866 . . . . 0.58999999999999997 111.89 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.722 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.26 149.76 44.23 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.474 -0.565 . . . . 0.34000000000000002 109.474 175.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.96 127.81 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.267 0.555 . . . . 0.55000000000000004 110.54 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.597 HD22 HG22 ' A' ' 34' ' ' VAL . 8.9 tp -131.18 169.12 16.36 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.634 -0.876 . . . . 0.45000000000000001 108.634 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.82 151.81 58.22 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 120.582 -0.447 . . . . 0.56000000000000005 111.535 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.639 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 63.3 Cg_exo -53.64 -39.6 82.48 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.017 2.478 . . . . 0.68000000000000005 112.075 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -35.24 61.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.109 -0.496 . . . . 0.76000000000000001 111.404 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 44.9 mt-30 -82.79 -23.14 33.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 1.5900000000000001 112.125 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.569 ' HB ' ' OH ' ' A' ' 106' ' ' TYR . 30.0 m -119.88 30.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.195 0.521 . . . . 0.66000000000000003 112.169 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 6.31 21.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.955 0.407 . . . . 0.79000000000000004 111.089 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 36.4 m-20 -148.59 172.88 13.81 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.509 -0.552 . . . . 1.9099999999999999 109.509 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -62.77 149.4 89.59 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 110.017 -0.364 . . . . 1.4299999999999999 110.017 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.64 145.7 23.4 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.963 1.775 . . . . 0.37 110.266 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -18.7 62.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.491 -0.322 . . . . 0.44 110.728 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.2 m -159.66 144.7 15.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.872 0.694 . . . . 0.38 112.872 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.882 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.39 164.79 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.705 -1.134 . . . . 0.29999999999999999 108.041 170.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.076 ' HA ' HD13 ' A' ' 58' ' ' LEU . 28.9 t 176.17 122.26 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.764 -0.458 . . . . 0.34999999999999998 109.764 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.7 p-90 -81.0 166.67 20.59 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.757 -0.831 . . . . 2.7200000000000002 108.757 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.425 ' HB3' ' CG ' ' A' ' 23' ' ' HIS . 17.1 t70 -65.64 83.06 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 1.51 111.081 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.92 31.48 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.655 -0.702 . . . . 0.80000000000000004 112.319 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.076 HD13 ' HA ' ' A' ' 54' ' ' SER . 8.4 tt -66.33 129.05 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.008 0.432 . . . . 0.57999999999999996 111.062 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.797 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.5 t70 -77.75 -29.92 51.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.854 -0.612 . . . . 0.73999999999999999 112.078 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.693 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 74.8 m 76.76 -6.12 2.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.096 -0.956 . . . . 1.03 110.926 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.22 6.64 14.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.155 -0.545 . . . . 0.83999999999999997 112.39 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.797 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.8 mtpt -100.69 152.53 20.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.015 0.436 . . . . 1.6699999999999999 111.093 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.774 HD21 ' HE2' ' A' ' 93' ' ' LYS . 44.2 mt -97.25 130.98 44.39 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.557 -0.905 . . . . 0.57999999999999996 108.557 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.722 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.2 OUTLIER -130.2 163.94 25.6 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.636 -0.505 . . . . 0.80000000000000004 109.636 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.609 HG23 HG12 ' A' ' 90' ' ' VAL . 75.2 m -102.32 104.82 15.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.459 -0.571 . . . . 0.35999999999999999 109.459 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.745 HD13 HG12 ' A' ' 124' ' ' VAL . 43.7 tp -102.49 115.33 30.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.124 0.488 . . . . 0.58999999999999997 110.527 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 88' ' ' LEU . 23.3 t -120.88 129.04 76.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.713 -0.676 . . . . 0.39000000000000001 111.06 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.889 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.3 mt -83.37 136.76 34.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 0.59999999999999998 108.478 167.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.733 HG21 HG11 ' A' ' 17' ' ' VAL . 15.1 t -140.27 163.69 32.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.205 -0.294 . . . . 0.35999999999999999 110.205 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 17.7 t70 -155.95 103.27 2.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.304 0.573 . . . . 1.9199999999999999 110.858 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.724 ' HD3' HG21 ' A' ' 17' ' ' VAL . 12.4 Cg_endo -56.98 -34.89 98.45 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.65 2.9 . . . . 1.25 114.169 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.56 38.87 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.986 0.365 . . . . 1.29 111.986 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' CB ' ' HB2' ' A' ' 84' ' ' TRP . . . -104.68 127.62 28.53 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 111.488 0.181 . . . . 0.5 111.488 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 92.9 Cg_endo -85.12 -24.03 10.8 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.435 -1.485 . . . . 0.62 112.859 -0.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.571 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.9 p -135.4 154.85 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.032 -0.531 . . . . 0.75 110.09 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -72.15 -24.6 61.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.388 -0.369 . . . . 2.8799999999999999 111.134 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 3.2 ptpt -72.03 -21.86 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 1.3799999999999999 110.535 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.22 86.88 1.01 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.306 -0.861 . . . . 1.3700000000000001 109.24 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -86.38 86.65 0.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.509 2.139 . . . . 0.80000000000000004 112.507 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 22.2 mttm -70.98 -53.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.936 -1.483 . . . . 1.02 111.689 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.81 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 85.2 m-85 -78.28 12.07 2.08 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.894 -0.594 . . . . 1.1699999999999999 111.027 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 24.2 ttt180 -73.15 125.42 27.67 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.8 0.44 . . . . 2.9300000000000002 110.267 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.512 ' OE1' ' HA ' ' A' ' 150' ' ' LYS . 23.1 mt-10 -94.84 134.33 37.59 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.846 0.458 . . . . 2.23 110.457 2.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.761 ' HE1' ' HB2' ' A' ' 146' ' ' ARG . 4.8 t90 -89.34 91.12 8.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.939 -0.393 . . . . 1.4299999999999999 109.939 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 12.5 p80 -74.57 109.52 8.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.778 -0.823 . . . . 1.26 108.778 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.41 -8.47 54.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.803 -0.635 . . . . 2.1400000000000001 112.233 -168.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.889 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 30.3 t80 -166.29 142.93 5.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.06 -0.348 . . . . 1.51 110.06 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.675 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.6 tp -142.77 114.65 8.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.981 0.419 . . . . 0.33000000000000002 110.623 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.555 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -132.57 134.93 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.31 110.74 176.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.709 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 15.0 m -129.03 158.01 41.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.138 -1.06 . . . . 0.27000000000000002 108.138 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.689 ' OD1' ' HB3' ' A' ' 130' ' ' PRO . 6.1 t30 63.78 19.69 11.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.023 0.44 . . . . 1.76 109.925 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.555 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.0 ttm -67.4 106.9 2.24 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.781 -0.822 . . . . 0.31 108.781 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.774 ' HE2' HD21 ' A' ' 63' ' ' LEU . 13.2 ttmt -83.55 89.68 7.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.994 -1.003 . . . . 1.21 111.077 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 83.98 -126.26 7.49 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.636 -1.166 . . . . 0.29999999999999999 113.208 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.478 ' HA ' HD11 ' A' ' 53' ' ' ILE . 29.6 p30 -117.32 27.62 8.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.315 -0.442 . . . . 1.04 110.88 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -97.12 112.46 24.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.321 0.582 . . . . 0.77000000000000002 109.658 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 53' ' ' ILE . 5.1 mm -58.53 -26.44 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.408 -1.269 . . . . 0.40999999999999998 111.349 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 m -87.6 -31.34 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.117 -0.492 . . . . 0.68000000000000005 111.718 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.1 m -80.29 19.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.266 0.469 . . . . 1.26 112.266 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 92' ' ' MET . . . -102.61 114.11 4.79 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 111.189 -0.764 . . . . 0.34999999999999998 111.189 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 84.9 m -58.54 107.0 0.45 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.67 . . . . 0.45000000000000001 109.776 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.94 116.42 29.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.084 . . . . 0.56999999999999995 112.333 -172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.675 HD12 ' HG ' ' A' ' 88' ' ' LEU . 9.3 mt -98.61 -51.48 3.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.974 0.893 . . . . 0.45000000000000001 108.859 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.1 t -118.61 102.23 8.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.394 -1.275 . . . . 0.37 107.747 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HB3' ' N ' ' A' ' 140' ' ' ASN . 38.2 t0 -65.24 157.63 28.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.547 -0.751 . . . . 1.1499999999999999 112.323 -169.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.569 ' OH ' ' HB ' ' A' ' 46' ' ' VAL . 85.7 t80 -74.19 107.52 6.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.595 -0.729 . . . . 4.6900000000000004 109.172 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.4 t -84.69 -26.91 6.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.566 -0.743 . . . . 0.85999999999999999 112.242 -172.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.23 -174.41 19.7 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 111.13 -0.788 . . . . 0.67000000000000004 111.13 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.639 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.7 t -78.21 134.47 37.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.429 0.614 . . . . 0.51000000000000001 109.811 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.655 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -160.0 66.06 0.27 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.367 -0.444 . . . . 0.81999999999999995 112.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.898 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 46.4 Cg_endo -99.15 149.52 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.89 3.06 . . . . 0.84999999999999998 113.78 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.594 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 26.6 Cg_exo -64.07 143.32 84.24 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.074 2.516 . . . . 0.87 112.443 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 121.19 17.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 1.8500000000000001 110.823 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.46 15.11 30.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.86 -0.686 . . . . 1.1799999999999999 112.367 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.594 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 72.1 p -96.68 -1.19 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.947 0.403 . . . . 0.96999999999999997 111.028 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.36 -161.89 27.85 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.042 -0.823 . . . . 1.97 111.042 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.6 mm? -79.95 99.06 7.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.36 0.6 . . . . 0.93999999999999995 109.567 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -72.1 120.54 17.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.883 -1.053 . . . . 2.23 109.09 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.849 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp85 -121.96 99.76 6.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.914 0.709 . . . . 2.3100000000000001 112.914 -165.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.608 ' HB3' HD22 ' A' ' 68' ' ' LEU . 65.9 m-85 -82.09 129.39 34.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.444 -0.576 . . . . 0.78000000000000003 109.444 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.961 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.5 t -102.33 133.56 45.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.925 -0.579 . . . . 0.27000000000000002 109.719 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.694 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 67.2 m95 -88.32 119.59 28.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.754 -0.832 . . . . 1.99 108.754 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.26 118.77 32.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 117.797 0.271 . . . . 0.38 110.815 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.745 HG12 HD13 ' A' ' 66' ' ' LEU . 1.9 m -102.36 133.22 46.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.069 -0.652 . . . . 0.31 109.262 172.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 92.2 m-85 -106.84 155.68 19.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.875 0.369 . . . . 5.1200000000000001 111.084 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.596 ' HB2' HG22 ' A' ' 164' ' ' VAL . 12.3 tp10 -101.32 119.95 39.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.304 -0.862 . . . . 2.4100000000000001 110.833 -176.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.722 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -133.46 150.06 51.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.461 -0.791 . . . . 1.3100000000000001 109.991 174.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 129' ' ' ARG . 1.6 p30 -83.4 -12.47 56.42 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.183 -0.917 . . . . 2.3999999999999999 111.452 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.505 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . 65.9 mtp180 -135.9 163.06 53.08 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 3.5099999999999998 111.837 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.689 ' HB3' ' OD1' ' A' ' 91' ' ' ASN . 19.3 Cg_exo -71.85 24.71 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.806 1 C-N-CA 125.61 4.207 . . . . 1.21 115.833 -170.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.709 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? 71.99 -178.76 0.21 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.685 0.755 . . . . 0.90000000000000002 112.909 172.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -165.72 79.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.221 -1.354 . . . . 2.8999999999999999 108.896 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.415 ' HB2' HD11 ' A' ' 103' ' ' LEU . 63.0 m -101.94 115.89 31.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.705 . . . . 1.8999999999999999 110.33 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.44 19.52 8.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.534 -0.757 . . . . 2.96 110.485 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -66.08 125.24 89.76 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.562 -0.744 . . . . 1.3899999999999999 110.466 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.46 129.02 21.97 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.239 2.626 . . . . 1.27 112.713 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.31 116.66 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.43 . . . . 0.85999999999999999 110.34 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.9 mt -106.19 2.48 26.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.339 0.496 . . . . 1.6100000000000001 112.339 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.0 p 52.04 -157.66 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.536 0.522 . . . . 1.8799999999999999 110.009 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.674 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.3 p-10 -98.01 -6.03 32.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.256 -0.646 . . . . 0.75 109.256 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.617 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 12.4 mtt180 -84.99 141.47 30.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.241 -0.436 . . . . 3.3599999999999999 110.352 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.572 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 30.5 m 72.66 125.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.219 0.949 . . . . 0.94999999999999996 111.103 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.501 ' HA2' ' CD ' ' A' ' 146' ' ' ARG . . . -107.53 -5.97 33.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.437 -0.801 . . . . 1.1200000000000001 113.006 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.94 -54.15 49.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.324 0.583 . . . . 2.6600000000000001 112.542 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.89 7.3 31.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.506 -0.77 . . . . 1.8700000000000001 111.672 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.761 ' HB2' ' HE1' ' A' ' 84' ' ' TRP . 28.1 mtp85 -88.84 -16.15 32.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.084 0.469 . . . . 4.7300000000000004 110.742 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -112.07 173.08 15.22 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.489 -0.863 . . . . 0.65000000000000002 112.485 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.4 mttt 69.61 36.55 2.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.841 0.829 . . . . 1.0800000000000001 110.836 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -123.09 172.4 8.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.809 -1.087 . . . . 1.8899999999999999 109.261 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.512 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 13.0 mmmm -117.26 133.0 56.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 1.29 111.932 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.755 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.6 m -67.35 -26.27 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.664 -0.698 . . . . 0.78000000000000003 110.005 173.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.36 -38.33 90.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.67000000000000004 109.627 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 m -63.78 -34.53 78.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.656 -0.702 . . . . 0.77000000000000002 110.462 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.755 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 59.7 m-85 -71.56 -47.5 54.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.92000000000000004 111.523 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 152' ' ' ALA . 6.9 ptm180 -66.9 -39.92 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.647 0.26 . . . . 2.8900000000000001 110.571 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -71.95 -25.78 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.607 -0.269 . . . . 0.96999999999999997 111.185 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 43.6 tptt -53.91 -52.92 59.02 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.355 -0.384 . . . . 1.5800000000000001 111.309 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.581 ' HD2' HD11 ' A' ' 160' ' ' LEU . 16.6 t80 -111.25 10.61 21.74 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.788 -0.765 . . . . 5.4500000000000002 111.322 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.8 39.34 4.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.035 -0.53 . . . . 2.4199999999999999 112.395 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 127' ' ' GLN . 0.2 OUTLIER -80.95 125.11 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.236 -0.653 . . . . 1.27 109.236 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.401 ' HB3' ' H ' ' A' ' 162' ' ' ALA . 8.0 tpt180 -60.32 -85.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 3.5899999999999999 111.874 -168.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 161' ' ' ARG . . . -135.66 160.9 65.9 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.721 -0.474 . . . . 0.76000000000000001 109.721 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.455 ' HB2' ' CA ' ' A' ' 21' ' ' PRO . 37.0 Cg_exo -58.44 142.24 97.74 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.68 2.254 . . . . 0.53000000000000003 112.748 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.857 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.6 t -88.42 -36.06 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 109.385 -0.598 . . . . 0.44 109.385 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.774 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.68 143.45 25.49 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.667 -0.697 . . . . 0.27000000000000002 111.232 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.9 145.59 14.81 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.055 -0.975 . . . . 0.23999999999999999 111.587 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.484 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 14.3 t -158.03 133.61 8.98 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.584 -0.525 . . . . 0.34000000000000002 109.584 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.961 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -107.24 141.9 37.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.213 0.53 . . . . 1.1100000000000001 111.418 -175.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 30.5 p90 -124.23 117.92 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.748 -1.204 . . . . 0.80000000000000004 107.748 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -101.73 132.96 47.16 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.725 -0.79 . . . . 2.5299999999999998 111.103 179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.427 ' HB1' ' HD3' ' A' ' 43' ' ' PRO . . . -149.91 145.89 26.76 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.561 -1.199 . . . . 0.59999999999999998 108.687 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.898 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 13.8 pt-20 -131.58 -160.3 1.03 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.697 -0.401 . . . . 2.3799999999999999 111.021 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.731 ' HA ' HG21 ' A' ' 177' ' ' VAL . 24.3 t90 -64.89 85.05 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.866 0.467 . . . . 3.96 111.38 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.611 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 8.5 p-10 -74.47 -59.12 2.87 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.361 -0.212 . . . . 1.53 110.757 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.5 t70 173.43 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.808 0.843 . . . . 1.26 109.897 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -81.97 -9.08 59.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 2.2200000000000002 111.64 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.743 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 69.2 t -54.67 -53.24 62.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 0.5 111.561 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.743 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.3 Cg_exo -49.7 -35.26 37.98 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.888 2.392 . . . . 0.57999999999999996 112.891 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 38.1 mmtm -74.47 -23.79 58.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.962 0.356 . . . . 2.1400000000000001 111.962 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.655 HD23 ' HA3' ' A' ' 110' ' ' GLY . 28.4 tp -70.76 -44.3 67.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.916 -0.772 . . . . 0.66000000000000003 108.916 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.03 -34.52 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.762 -0.654 . . . . 1.8899999999999999 109.242 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.686 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.5 mm-40 -56.48 -42.37 78.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.931 -1.031 . . . . 1.53 110.89 172.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.465 ' NE2' HD21 ' A' ' 140' ' ' ASN . 39.9 tt0 -77.82 -38.0 47.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.572 -0.74 . . . . 1.49 112.41 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 21.5 mt -63.29 0.24 0.7 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 0.76000000000000001 113.479 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.407 ' HB2' ' CE ' ' A' ' 187' ' ' LYS . 12.8 m -67.58 -19.55 65.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.086 -0.709 . . . . 1.05 109.086 170.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 104.14 44.17 1.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.586 -1.006 . . . . 1.1699999999999999 110.586 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.407 ' CE ' ' HB2' ' A' ' 185' ' ' SER . 22.9 mmtp . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.563 -0.732 . . . . 2.0 109.832 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 36' ' ' GLU . 16.5 t . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.482 0.658 . . . . 1.47 110.522 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 6' ' ' SER . 20.1 t70 -148.98 157.71 43.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.35 -0.841 . . . . 1.8100000000000001 109.445 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.415 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.7 mm? -74.96 19.28 0.15 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 111.53 0.196 . . . . 0.69999999999999996 111.53 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 4' ' ' ASP . 27.5 t -68.67 -19.92 64.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 1.96 110.364 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.877 ' HB3' HD12 ' A' ' 12' ' ' LEU . 90.9 mttt -113.82 30.67 7.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.727 -0.67 . . . . 2.6600000000000001 110.597 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.625 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -72.88 -33.94 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.312 -0.404 . . . . 3.98 112.041 -173.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.798 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 36.5 p -150.21 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.673 -0.411 . . . . 0.63 111.894 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -79.73 -126.58 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.456 -0.878 . . . . 0.47999999999999998 110.946 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.9 Cg_endo -51.87 -36.43 63.38 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.219 2.613 . . . . 0.53000000000000003 110.214 166.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.877 HD12 ' HB3' ' A' ' 7' ' ' LYS . 40.7 mt -87.74 81.83 7.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.772 -1.103 . . . . 1.1699999999999999 109.282 170.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -74.73 63.13 1.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.474 0.654 . . . . 0.70999999999999996 110.703 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 ' CG2' ' A' ' 121' ' ' VAL . 33.8 mt -78.91 -21.62 47.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.548 -0.751 . . . . 0.45000000000000001 110.617 -176.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.798 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -73.18 6.88 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.587 -0.733 . . . . 2.1200000000000001 110.647 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -79.45 -22.51 44.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.428 0.633 . . . . 1.9299999999999999 110.091 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.907 HG11 HG21 ' A' ' 69' ' ' THR . 3.0 t -86.03 -65.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.63 110.669 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.88 -178.11 5.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.491 -0.484 . . . . 2.9900000000000002 111.095 -176.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -62.1 179.1 0.31 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.766 0.826 . . . . 1.6000000000000001 112.125 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG2' ' HD1' ' A' ' 8' ' ' TRP . 27.0 mt-30 -90.74 128.6 47.68 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.126 -0.488 . . . . 3.5499999999999998 110.128 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.603 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 10.1 Cg_exo -70.41 159.34 53.26 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.264 1.976 . . . . 0.57999999999999996 112.292 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.898 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 5.4 pt20 -77.48 -15.62 59.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.754 -0.657 . . . . 1.3899999999999999 111.153 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.776 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.8 m80 -153.02 159.73 31.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 1.45 110.089 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.8 Cg_endo -86.16 130.85 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.329 2.686 . . . . 0.40000000000000002 110.919 174.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 124' ' ' VAL . 29.9 tp -79.84 143.45 34.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.646 0.26 . . . . 0.28999999999999998 110.897 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -114.94 110.11 19.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 1.24 110.236 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 53' ' ' ILE . 17.0 t -114.71 146.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.546 -0.538 . . . . 0.46999999999999997 109.546 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.54 144.57 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.335 0.254 . . . . 0.31 110.819 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.478 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 36.3 t80 -110.41 173.99 6.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.268 -0.642 . . . . 0.67000000000000004 109.268 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.06 -52.88 63.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.451 0.643 . . . . 0.55000000000000004 110.398 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.24 -6.56 44.85 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.237 -0.892 . . . . 0.81000000000000005 112.724 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.02 -171.37 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.46999999999999997 110.831 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.68 154.7 16.23 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 109.999 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 88.2 t -101.56 63.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.548 -1.649 . . . . 0.39000000000000001 106.548 163.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.24 18.69 2.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.036 -1.438 . . . . 0.98999999999999999 110.163 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.555 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.3 mm-40 -159.7 142.12 13.57 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.457 -0.792 . . . . 2.5600000000000001 109.881 173.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -76.48 111.59 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.644 -0.873 . . . . 0.40999999999999998 108.644 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.715 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 86.7 20.93 52.79 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.666 -0.778 . . . . 0.58999999999999997 112.424 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.67 152.18 30.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.286 -0.635 . . . . 0.34000000000000002 109.286 172.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.6 p -81.78 136.77 22.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.182 0.515 . . . . 0.55000000000000004 110.975 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 41' ' ' LEU . 7.0 tp -131.11 169.03 16.44 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.057 -1.09 . . . . 0.45000000000000001 108.057 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.3 p -123.21 152.43 63.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 119.472 -0.891 . . . . 0.56000000000000005 113.129 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 75.9 Cg_exo -51.74 -33.92 51.98 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.608 3.539 . . . . 0.68000000000000005 114.05 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -65.4 -32.34 73.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.614 0.721 . . . . 0.76000000000000001 110.756 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -82.33 -43.91 16.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.012 -0.995 . . . . 1.5900000000000001 111.451 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.552 HG21 ' HE2' ' A' ' 169' ' ' TYR . 12.3 m -102.64 30.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.265 0.469 . . . . 0.66000000000000003 112.265 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.74 -12.05 59.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.465 -0.568 . . . . 0.79000000000000004 109.465 175.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -167.98 2.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.492 -0.776 . . . . 1.9099999999999999 109.836 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.423 ' HD3' HG22 ' A' ' 97' ' ' ILE . 98.6 mtt180 -77.94 158.78 77.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.088 -0.338 . . . . 1.4299999999999999 110.088 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 59.9 Cg_endo -79.23 161.44 26.05 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.996 1.797 . . . . 0.37 111.127 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.413 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.1 t -80.41 -22.4 41.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.55 -0.295 . . . . 0.44 110.363 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.4 m -162.68 143.51 9.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.391 0.615 . . . . 0.38 112.478 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.913 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -137.02 167.17 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.819 -1.082 . . . . 0.29999999999999999 108.274 170.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.066 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.6 t 175.91 128.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.34999999999999998 109.909 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 53.4 p-90 -91.07 160.91 15.35 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.519 -1.289 . . . . 2.7200000000000002 107.519 172.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.29 84.18 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.074 0.464 . . . . 1.51 111.092 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.92 17.44 2.79 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.401 -0.818 . . . . 0.80000000000000004 112.022 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.066 HD13 ' HA ' ' A' ' 54' ' ' SER . 5.4 tt -57.02 127.13 30.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.919 0.39 . . . . 0.57999999999999996 110.429 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.822 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 31.5 t70 -75.91 -24.21 55.57 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.608 . . . . 0.73999999999999999 112.01 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.665 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 67.2 m 68.89 15.35 8.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.278 -0.874 . . . . 1.03 110.422 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.55 -33.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.601 -0.727 . . . . 0.83999999999999997 112.666 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.822 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 24.7 mtpt -71.34 149.89 45.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 1.6699999999999999 110.72 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.904 HD23 ' HG2' ' A' ' 93' ' ' LYS . 3.8 mt -85.77 125.45 33.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.337 -0.847 . . . . 0.57999999999999996 109.494 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.475 ' HE2' ' HA2' ' A' ' 94' ' ' GLY . 5.5 m-85 -120.84 148.09 44.5 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.714 -0.394 . . . . 0.80000000000000004 110.436 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.63 HG23 HG12 ' A' ' 90' ' ' VAL . 62.7 m -96.89 104.97 17.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.35999999999999999 108.148 170.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.537 HD13 HG12 ' A' ' 124' ' ' VAL . 43.4 tp -104.39 109.09 20.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.668 -0.696 . . . . 0.58999999999999997 109.658 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' CD1' ' A' ' 88' ' ' LEU . 25.6 t -111.97 127.44 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.696 -0.684 . . . . 0.39000000000000001 110.429 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.021 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.3 mt -88.27 134.12 33.88 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.542 -0.91 . . . . 0.59999999999999998 108.542 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.907 HG21 HG11 ' A' ' 17' ' ' VAL . 9.7 t -137.58 156.45 48.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.459 -0.2 . . . . 0.35999999999999999 110.459 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.493 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 10.2 t70 -140.15 94.89 8.59 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.306 -0.628 . . . . 1.9199999999999999 109.306 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.5 Cg_endo -52.2 -36.68 68.03 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.722 2.948 . . . . 1.25 113.734 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.8 m-20 -89.32 43.83 1.17 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 1.29 111.542 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.68 139.28 19.94 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.446 -0.343 . . . . 0.5 110.143 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -80.18 -28.51 7.15 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 123.084 -1.632 . . . . 0.62 112.813 2.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.646 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 84.7 p -125.67 149.75 48.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.079 -0.51 . . . . 0.75 110.371 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.552 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 3.0 tmm_? -65.03 -28.91 69.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.419 0.628 . . . . 2.8799999999999999 109.651 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.0 ptpt -74.48 -21.06 59.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.848 -0.615 . . . . 1.3799999999999999 110.992 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.0 t70 -159.63 88.9 1.97 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.485 . . . . 1.3700000000000001 110.26 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 83.6 Cg_endo -84.37 93.63 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.67 2.247 . . . . 0.80000000000000004 113.234 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.5 mttm -83.9 -41.29 17.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.216 -0.902 . . . . 1.02 111.065 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.731 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 30.6 m-85 -78.98 8.47 5.57 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 116.032 -0.531 . . . . 1.1699999999999999 111.798 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -65.74 125.22 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.729 -0.471 . . . . 2.9300000000000002 109.729 177.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE1' HG13 ' A' ' 151' ' ' VAL . 5.1 tm-20 -93.12 134.13 35.59 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.49 0.716 . . . . 2.23 109.878 -0.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE3' ' HB3' ' A' ' 70' ' ' ASP . 80.7 t90 -108.67 131.08 55.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.63 -0.507 . . . . 1.4299999999999999 109.63 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 20.1 p80 -112.17 141.12 46.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.379 0.609 . . . . 1.26 111.328 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 1.021 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 7.2 t60 -82.6 -39.39 22.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.202 -0.908 . . . . 2.1400000000000001 110.884 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.584 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 20.3 p90 -167.16 173.18 9.3 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.601 -0.518 . . . . 1.51 109.601 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.529 ' HG ' HD12 ' A' ' 103' ' ' LEU . 16.6 tp -134.62 113.04 11.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.33000000000000002 110.178 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.637 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.8 t -121.25 132.11 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.641 -0.708 . . . . 0.31 110.146 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 6.2 m -129.71 162.94 36.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.084 -0.962 . . . . 0.27000000000000002 108.64 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.741 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 72.2 m-20 58.43 23.24 10.41 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.721 0.638 . . . . 1.76 111.418 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.637 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.4 ttm -73.84 102.69 4.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.1 -1.074 . . . . 0.31 108.1 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.904 ' HG2' HD23 ' A' ' 63' ' ' LEU . 2.8 mtpm? -77.1 93.77 3.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.265 -0.879 . . . . 1.21 110.951 -171.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 85.37 -127.63 8.32 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.542 -0.754 . . . . 0.29999999999999999 112.633 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 53' ' ' ILE . 10.3 p30 -111.96 18.01 19.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.225 0.536 . . . . 1.04 110.551 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -81.5 99.88 9.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.621 . . . . 0.77000000000000002 110.07 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.423 HG22 ' HD3' ' A' ' 49' ' ' ARG . 5.0 mm -56.3 -30.17 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.774 -1.103 . . . . 0.40999999999999998 111.389 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 m -75.92 -42.56 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.084 -0.507 . . . . 0.68000000000000005 111.856 -172.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -79.93 8.16 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 1.26 111.712 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.95 102.06 1.1 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.881 -0.887 . . . . 0.34999999999999998 110.881 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.0 m -59.07 106.88 0.47 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.412 0.625 . . . . 0.45000000000000001 110.018 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.7 116.75 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.806 -1.088 . . . . 0.56999999999999995 111.327 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.529 HD12 ' HG ' ' A' ' 88' ' ' LEU . 41.8 mt -96.74 -37.49 10.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.036 0.922 . . . . 0.45000000000000001 109.213 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.8 t -127.9 115.5 18.68 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.386 -1.339 . . . . 0.37 107.386 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 16.5 t0 -65.32 161.3 19.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.764 -0.653 . . . . 1.1499999999999999 112.656 -168.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 24.0 p90 -85.46 61.91 7.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.383 -0.826 . . . . 4.6900000000000004 112.367 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.898 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 60.3 t -42.29 -49.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 114.294 1.22 . . . . 0.85999999999999999 114.294 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.39 -168.97 13.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.154 -1.022 . . . . 0.67000000000000004 113.048 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 35.8 t -78.77 147.93 33.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.363 -0.236 . . . . 0.51000000000000001 110.363 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.855 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 172.48 61.83 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 O-C-N 123.418 0.449 . . . . 0.81999999999999995 112.36 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.783 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 9.4 Cg_endo -91.9 132.44 1.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.111 2.541 . . . . 0.84999999999999998 112.382 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.563 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 84.4 Cg_exo -50.03 143.8 23.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.263 2.642 . . . . 0.87 112.435 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 113.16 3.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.494 . . . . 1.8500000000000001 110.926 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.49 -2.35 27.84 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.961 -0.638 . . . . 1.1799999999999999 112.299 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.646 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 74.4 p -77.83 -21.69 51.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.273 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.34 -153.19 17.16 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.862 -0.608 . . . . 1.97 111.846 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -98.5 110.83 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.927 -0.397 . . . . 0.93999999999999995 109.927 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -77.07 109.56 11.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.177 -0.465 . . . . 2.23 110.019 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 7.0 ptt180 -101.9 92.56 4.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.636 . . . . 2.3100000000000001 111.468 -171.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 41.0 m-85 -78.79 120.8 23.95 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.674 -0.694 . . . . 0.78000000000000003 109.791 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.651 ' CG2' HD22 ' A' ' 14' ' ' LEU . 15.1 t -98.57 128.89 49.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.27000000000000002 110.479 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.764 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -89.5 119.64 30.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.041 -0.527 . . . . 1.99 109.77 178.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 48.9 mt -116.43 119.15 34.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.378 -0.231 . . . . 0.38 110.378 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.537 HG12 HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -117.71 137.44 51.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 0.31 110.961 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 1.037 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 49.1 t80 -140.78 133.26 28.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.589 -0.278 . . . . 5.1200000000000001 110.322 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.447 ' HG2' HG21 ' A' ' 164' ' ' VAL . 7.1 pt-20 -83.06 116.32 22.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.807 -0.812 . . . . 2.4100000000000001 108.807 170.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.64 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -78.74 174.39 11.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.498 0.666 . . . . 1.3100000000000001 112.03 -168.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.28 -22.46 63.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.682 -1.145 . . . . 2.3999999999999999 109.823 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.64 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 8.2 ptt180 -146.49 163.06 31.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.444 -1.253 . . . . 3.5099999999999998 111.31 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -64.95 41.87 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.757 0 C-N-CA 124.684 3.589 . . . . 1.21 113.403 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 2.7 mm? 74.42 167.42 0.29 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.934 -1.03 . . . . 0.90000000000000002 113.152 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -157.15 71.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.991 -1.459 . . . . 2.8999999999999999 107.844 171.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.438 ' SG ' HD21 ' A' ' 103' ' ' LEU . 3.8 p -93.39 -75.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.077 -0.965 . . . . 1.8999999999999999 110.958 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 56.34 31.29 18.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.461 0.648 . . . . 2.96 109.886 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 133' ' ' CYS . 32.3 mm-40 -82.32 139.85 45.18 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.046 -0.979 . . . . 1.3899999999999999 109.841 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.72 112.44 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.898 2.399 . . . . 1.27 112.446 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.47 131.04 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 0.85999999999999999 111.065 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.9 mt -110.83 149.39 30.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.05 -0.523 . . . . 1.6100000000000001 110.639 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.6 m -102.86 157.74 16.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.283 -1.006 . . . . 1.8799999999999999 108.283 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.898 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 11.7 p-10 -81.59 30.36 0.36 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.396 0.617 . . . . 0.75 111.579 -173.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.654 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 14.2 mtt180 -115.54 147.48 40.65 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.884 -0.784 . . . . 3.3599999999999999 108.884 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.602 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 16.5 m 66.18 178.15 0.21 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.94 0.775 . . . . 0.94999999999999996 110.599 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -143.39 33.17 1.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.041 -1.076 . . . . 1.1200000000000001 112.701 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.66 -27.41 63.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.049 0.388 . . . . 2.6600000000000001 112.049 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -113.78 67.49 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.076 0.465 . . . . 1.8700000000000001 110.9 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 99.3 mtt180 -79.71 -79.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.711 -0.677 . . . . 4.7300000000000004 112.114 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.12 -142.73 3.52 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.65000000000000002 113.009 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.731 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 39.7 mttm 66.33 34.15 6.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.719 0.771 . . . . 1.0800000000000001 109.944 -173.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 69.8 m-85 -113.63 177.06 4.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.82 -1.082 . . . . 1.8899999999999999 109.647 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -119.75 112.24 19.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.366 -0.379 . . . . 1.29 111.945 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.741 HG21 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.49 -36.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.78000000000000003 111.791 172.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.81 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.67000000000000004 110.617 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.5 m -65.17 -44.86 87.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.77000000000000002 110.263 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.642 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 66.9 m-85 -59.11 -47.01 86.85 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.601 0.715 . . . . 0.92000000000000004 110.199 174.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 161' ' ' ARG . 28.9 ttm180 -59.21 -48.64 80.87 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.809 -1.087 . . . . 2.8900000000000001 111.634 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -66.76 -36.53 82.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.96999999999999997 110.637 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -55.83 -51.04 68.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.078 -0.965 . . . . 1.5800000000000001 111.41 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.454 ' CB ' HD13 ' A' ' 160' ' ' LEU . 22.7 m-85 -83.29 -5.6 59.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.729 -0.669 . . . . 5.4500000000000002 111.416 -174.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 68.53 46.74 0.97 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.814 0.816 . . . . 2.4199999999999999 111.134 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.037 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.6 mp -105.69 175.39 5.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.666 -1.152 . . . . 1.27 110.378 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.897 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 6.1 tpt180 -147.64 -158.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.52 -0.918 . . . . 3.5899999999999999 108.52 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.897 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -47.74 142.25 6.91 Favored Pre-proline 0 C--O 1.231 0.125 0 CA-C-O 121.122 0.487 . . . . 0.76000000000000001 111.732 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 7.9 Cg_exo -70.2 161.31 46.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.651 2.901 . . . . 0.53000000000000003 113.191 -168.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.898 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -87.69 -24.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.014 -0.994 . . . . 0.44 109.236 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.776 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -159.83 150.29 18.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.701 -0.681 . . . . 0.27000000000000002 111.63 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.556 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.61 149.87 21.88 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.086 -0.961 . . . . 0.23999999999999999 111.607 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.545 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.1 t -167.88 152.74 6.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.677 -0.86 . . . . 0.34000000000000002 108.677 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 14.3 p -129.21 148.07 51.11 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.164 -0.614 . . . . 1.1100000000000001 111.355 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.553 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 32.1 p90 -130.05 127.85 40.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.003 -1.11 . . . . 0.80000000000000004 108.003 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -105.14 132.91 50.76 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.897 -0.721 . . . . 2.5299999999999998 111.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -131.2 144.31 51.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.411 -0.813 . . . . 0.59999999999999998 109.24 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.783 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 pt-20 -126.74 -161.73 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 2.3799999999999999 111.103 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.895 ' HA ' HG21 ' A' ' 177' ' ' VAL . 4.1 t90 -71.93 81.48 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 3.96 111.036 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.532 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 5.6 t70 -73.08 -61.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.341 -0.39 . . . . 1.53 110.859 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.592 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 29.0 t70 172.79 -35.04 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.402 -0.817 . . . . 1.26 110.087 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -80.54 13.1 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 2.2200000000000002 111.516 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.895 HG21 ' HA ' ' A' ' 173' ' ' TRP . 84.0 t -72.59 -53.37 5.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.931 -0.577 . . . . 0.5 110.105 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.752 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.2 Cg_exo -50.84 -30.8 31.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.693 2.262 . . . . 0.57999999999999996 111.902 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.2 mmmt -72.4 -23.56 61.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 2.1400000000000001 111.473 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.855 HD22 ' HA3' ' A' ' 110' ' ' GLY . 14.8 tp -70.9 -44.13 66.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.414 -0.587 . . . . 0.66000000000000003 109.414 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.66 -40.28 91.48 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.556 0.693 . . . . 1.8899999999999999 109.273 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 8.2 mm-40 -56.41 -48.3 77.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.671 -1.15 . . . . 1.53 110.647 171.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.334 -0.848 . . . . 1.49 111.97 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.602 ' HA ' ' H ' ' A' ' 142' ' ' SER . 40.4 mt -68.42 2.78 2.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.577 -0.283 . . . . 0.76000000000000001 111.629 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.656 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.7 m -78.8 -2.73 40.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.336 0.589 . . . . 1.05 109.869 173.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.654 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 76.44 60.57 2.99 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.313 -0.858 . . . . 1.1699999999999999 111.29 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.656 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.4 mmmt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.577 -0.725 . . . . 2.0 110.549 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 24' ' ' PRO . 23.4 t . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 121.359 0.599 . . . . 1.47 110.134 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -143.46 31.02 1.35 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.977 -1.011 . . . . 1.8100000000000001 110.628 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.4 mm? 68.85 10.7 8.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.071 -1.422 . . . . 0.69999999999999996 113.041 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -67.12 -8.97 34.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.539 0.57 . . . . 1.96 112.539 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.867 ' HB3' HD12 ' A' ' 12' ' ' LEU . 99.4 mttt -133.68 36.12 3.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.29 -0.256 . . . . 2.6600000000000001 111.333 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.45 -17.96 40.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.274 0.472 . . . . 3.98 112.274 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 p -153.42 20.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.872 0.368 . . . . 0.63 111.595 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.48 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -80.88 -124.67 0.62 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.006 -0.838 . . . . 0.47999999999999998 111.006 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 14.3 Cg_endo -53.61 -35.45 77.38 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.261 2.641 . . . . 0.53000000000000003 110.679 166.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 7' ' ' LYS . 25.3 mt -87.57 86.04 7.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 1.1699999999999999 109.322 172.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 60.9 0.72 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.70999999999999996 110.898 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.798 HD22 HG21 ' A' ' 121' ' ' VAL . 20.9 mt -73.2 -19.56 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.45000000000000001 110.275 -176.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -64.55 -22.53 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 2.1200000000000001 110.846 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -64.86 -25.29 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.38 0.609 . . . . 1.9299999999999999 109.66 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 151' ' ' VAL . 92.1 t -92.39 -70.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.024 -0.989 . . . . 0.63 110.154 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.48 174.67 5.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 2.9900000000000002 110.621 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.96 29.64 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 1.6000000000000001 112.282 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 27.9 mt-30 64.26 112.45 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.02 0.825 . . . . 3.5499999999999998 111.005 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 19.9 Cg_exo -63.98 152.05 82.56 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.439 2.092 . . . . 0.57999999999999996 112.759 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.872 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.3 pt20 -76.66 -18.77 58.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.281 -0.872 . . . . 1.3899999999999999 111.021 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.791 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 40.0 m-70 -145.53 159.43 48.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 123.658 0.783 . . . . 1.45 109.068 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB3' HG12 ' A' ' 3' ' ' VAL . 5.4 Cg_endo -85.93 131.05 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.706 2.271 . . . . 0.40000000000000002 111.967 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.913 HD23 ' HB3' ' A' ' 122' ' ' TRP . 15.6 tp -82.01 145.04 30.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.731 0.301 . . . . 0.28999999999999998 110.478 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.466 ' H ' HD12 ' A' ' 25' ' ' LEU . 32.8 m80 -116.49 127.82 54.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.88 -0.415 . . . . 1.24 109.88 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 53' ' ' ILE . 23.0 t -132.25 140.92 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.355 -0.609 . . . . 0.46999999999999997 109.355 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -137.59 142.82 41.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.983 0.421 . . . . 0.31 110.789 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 38.3 t80 -105.16 176.72 5.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.157 -0.683 . . . . 0.67000000000000004 109.157 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -52.66 62.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.448 0.642 . . . . 0.55000000000000004 110.284 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.45 7.59 32.25 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.167 -0.924 . . . . 0.81000000000000005 112.597 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB2' ' NE2' ' A' ' 45' ' ' GLN . . . -146.15 -170.97 3.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.46999999999999997 110.53 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.25 163.49 25.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.589 -0.732 . . . . 0.33000000000000002 109.34 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.758 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 88.6 t -116.52 66.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.304 -1.369 . . . . 0.39000000000000001 107.304 165.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.0 14.01 33.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.053 -0.976 . . . . 0.98999999999999999 109.608 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.803 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.1 tm-20 -138.07 122.38 18.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.126 -1.435 . . . . 2.5600000000000001 107.126 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -68.1 111.54 4.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.426 0.631 . . . . 0.40999999999999998 110.685 -170.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.757 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 84.06 10.19 81.06 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.54 -0.754 . . . . 0.58999999999999997 112.409 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -64.2 154.25 35.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 110.28 -0.267 . . . . 0.34000000000000002 110.28 176.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.31 127.77 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.469 0.652 . . . . 0.55000000000000004 111.296 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.5 HD22 HG22 ' A' ' 34' ' ' VAL . 7.0 tp -124.69 169.12 12.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.823 -1.177 . . . . 0.45000000000000001 107.823 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p -118.17 151.95 49.89 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 119.48 -0.888 . . . . 0.56000000000000005 112.718 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.603 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 51.0 Cg_exo -56.38 -34.47 94.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.875 3.05 . . . . 0.68000000000000005 113.284 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -33.67 72.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.76000000000000001 110.696 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 32' ' ' ALA . 93.1 mt-30 -82.12 -46.68 13.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.036 . . . . 1.5900000000000001 111.395 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG11 ' CE2' ' A' ' 169' ' ' TYR . 6.1 m -95.62 28.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 112.731 0.641 . . . . 0.66000000000000003 112.731 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -85.8 -11.7 52.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.823 0.344 . . . . 0.79000000000000004 110.617 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -135.5 -151.88 0.44 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 1.9099999999999999 109.285 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HD3' HG22 ' A' ' 97' ' ' ILE . 81.5 mtt180 -87.92 158.64 50.05 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.149 -0.315 . . . . 1.4299999999999999 110.149 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 76.3 Cg_endo -83.5 165.37 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.237 1.958 . . . . 0.37 110.573 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 t -88.09 -20.31 25.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.599 -0.441 . . . . 0.44 110.596 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -158.69 142.58 15.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.085 0.469 . . . . 0.38 111.918 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.09 170.05 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.29999999999999999 108.471 171.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.016 ' HA ' HD13 ' A' ' 58' ' ' LEU . 40.4 t 174.23 116.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.517 0.511 . . . . 0.34999999999999998 109.866 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 54.4 p-90 -76.97 159.56 29.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.669 -0.863 . . . . 2.7200000000000002 108.669 173.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 29.3 t70 -68.63 85.36 0.3 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.054 0.454 . . . . 1.51 110.5 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.47 6.33 3.83 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.492 -0.776 . . . . 0.80000000000000004 112.259 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.016 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -51.71 129.41 26.08 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.163 0.506 . . . . 0.57999999999999996 111.554 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -79.25 -28.11 42.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.73999999999999999 111.404 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.661 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 24.3 t 67.14 22.07 9.92 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.125 -0.943 . . . . 1.03 110.08 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -42.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.784 -0.722 . . . . 0.83999999999999997 113.079 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -90.73 169.08 11.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 120.823 0.344 . . . . 1.6699999999999999 110.772 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.1 mt -93.8 147.52 22.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.711 -0.677 . . . . 0.57999999999999996 109.344 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.503 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.0 m-85 -135.09 168.56 18.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.265 -0.643 . . . . 0.80000000000000004 109.265 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.877 HG23 HG12 ' A' ' 90' ' ' VAL . 2.4 m -103.83 104.43 14.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.325 -0.62 . . . . 0.35999999999999999 109.325 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.701 HD13 HG12 ' A' ' 124' ' ' VAL . 57.7 tp -108.16 117.01 33.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.034 0.445 . . . . 0.58999999999999997 110.616 -174.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.9 t -114.89 147.09 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.083 -0.508 . . . . 0.39000000000000001 110.38 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.97 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.2 mt -110.5 122.11 46.95 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.78 -1.192 . . . . 0.59999999999999998 107.78 166.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 9.0 t -133.16 151.28 51.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.726 0.298 . . . . 0.35999999999999999 110.711 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.654 ' OD2' ' HB3' ' A' ' 84' ' ' TRP . 4.6 p-10 -132.31 101.8 14.57 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-O 121.613 0.721 . . . . 1.9199999999999999 111.213 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 4.1 Cg_endo -48.06 -38.4 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.828 3.018 . . . . 1.25 114.386 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.85 48.82 1.4 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -171.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . . . -106.46 127.76 27.56 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.176 -0.305 . . . . 0.5 110.176 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.619 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -82.64 -30.46 4.78 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.315 -1.536 . . . . 0.62 113.142 -1.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.687 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -121.16 157.81 29.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.107 -0.497 . . . . 0.75 110.944 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -67.81 -45.53 74.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 2.8799999999999999 111.342 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.725 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -72.35 -19.31 61.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 1.3799999999999999 111.442 -175.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.97 84.24 5.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.2 0.524 . . . . 1.3700000000000001 110.141 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.87 102.24 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.643 2.228 . . . . 0.80000000000000004 112.691 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.619 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 16.9 mttm -83.09 -55.23 4.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.981 -1.008 . . . . 1.02 110.669 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.695 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.7 m-85 -82.86 19.77 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 111.481 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 50.3 ttp180 -65.72 124.05 21.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.36 -0.382 . . . . 2.9300000000000002 110.21 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.0 mp0 -102.4 138.99 38.59 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.819 0.342 . . . . 2.23 110.957 0.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.654 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 17.1 t90 -88.19 161.91 16.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.412 -1.329 . . . . 1.4299999999999999 107.412 171.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 11.0 p80 -138.04 114.67 10.51 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.184 0.516 . . . . 1.26 110.435 -174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.97 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 3.7 t-160 -52.99 -42.57 65.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.029 -0.987 . . . . 2.1400000000000001 110.585 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 18.5 p90 -167.55 163.33 14.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.706 0.288 . . . . 1.51 110.747 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.8 tp -126.83 114.18 17.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.33000000000000002 109.23 175.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.721 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -119.78 134.06 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.534 0.683 . . . . 0.31 111.182 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.877 HG12 HG23 ' A' ' 65' ' ' THR . 6.2 m -128.04 168.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.477 -0.934 . . . . 0.27000000000000002 108.477 175.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.767 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.8 m-20 59.11 21.77 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.075 0.464 . . . . 1.76 111.3 173.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.721 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.9 ttm -76.72 115.07 16.15 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.673 -0.862 . . . . 0.31 108.673 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -82.72 98.32 9.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.125 -0.943 . . . . 1.21 111.039 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 69.59 -119.42 9.17 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.203 -0.908 . . . . 0.29999999999999999 112.273 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.508 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.6 p-10 -114.57 25.54 10.93 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.09 0.471 . . . . 1.04 110.598 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.4 106.03 18.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.343 0.592 . . . . 0.77000000000000002 109.977 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.454 HG22 ' HD3' ' A' ' 49' ' ' ARG . 5.1 mm -56.81 -29.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 111.913 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.1 m -81.85 -37.27 27.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.883 0.698 . . . . 0.68000000000000005 112.883 -170.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.6 p -67.27 -19.59 65.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.85 0.315 . . . . 1.26 111.85 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.06 105.65 0.58 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.859 -0.61 . . . . 0.34999999999999998 112.982 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 97.7 m -65.16 107.31 1.52 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.282 0.563 . . . . 0.45000000000000001 110.004 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.6 p -76.78 119.15 24.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.184 -0.916 . . . . 0.56999999999999995 111.287 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 88' ' ' LEU . 57.1 mt -97.39 -47.03 5.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.091 0.948 . . . . 0.45000000000000001 109.159 172.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 t -114.35 106.02 13.82 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.977 -1.49 . . . . 0.37 106.977 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.3 OUTLIER -56.89 156.97 6.04 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.763 0.664 . . . . 1.1499999999999999 112.178 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.3 p90 -77.25 87.8 3.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 4.6900000000000004 111.095 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' ' 140' ' ' ASN . 24.0 t -61.77 -53.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.76 -0.655 . . . . 0.85999999999999999 110.68 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.692 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 115.98 -164.89 12.19 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.086 -1.054 . . . . 0.67000000000000004 112.548 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.476 ' OG ' ' HG3' ' A' ' 43' ' ' PRO . 23.9 t -77.89 131.98 37.73 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.568 0.216 . . . . 0.51000000000000001 110.545 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.42 68.11 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.81999999999999995 112.713 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.856 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 20.4 Cg_endo -96.33 113.19 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.434 2.756 . . . . 0.84999999999999998 112.708 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.604 ' HB2' HG23 ' A' ' 115' ' ' THR . 89.1 Cg_exo -51.15 143.23 33.13 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.798 2.332 . . . . 0.87 111.709 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 110.97 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.25 0.548 . . . . 1.8500000000000001 110.952 -175.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.48 21.63 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 1.1799999999999999 112.312 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.687 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 70.1 p -77.41 -30.3 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.628 0.252 . . . . 0.96999999999999997 111.415 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.95 -168.78 12.88 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.41 -0.676 . . . . 1.97 111.41 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -80.28 108.97 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.243 0.544 . . . . 0.93999999999999995 109.916 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 2.2 t60 -79.74 106.21 11.6 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 2.23 109.535 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.824 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp180 -97.57 114.67 26.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.402 1.096 . . . . 2.3100000000000001 111.358 -172.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 28.7 m-85 -92.31 120.65 33.05 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.231 -1.349 . . . . 0.78000000000000003 108.683 172.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 168' ' ' CYS . 19.4 t -97.99 128.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.619 . . . . 0.27000000000000002 109.81 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.913 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.02 119.2 29.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.127 -0.694 . . . . 1.99 109.127 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.88 119.92 27.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.374 0.131 . . . . 0.38 111.169 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.701 HG12 HD13 ' A' ' 66' ' ' LEU . 1.5 m -104.85 136.17 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.566 -0.454 . . . . 0.31 109.869 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 88.4 m-85 -114.5 148.7 37.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.441 . . . . 5.1200000000000001 110.483 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.1 tt0 -101.42 119.06 38.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.836 -0.62 . . . . 2.4100000000000001 110.837 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.56 ' HG2' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -104.2 160.83 14.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 1.3100000000000001 110.479 176.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.04 -26.57 64.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.879 -1.055 . . . . 2.3999999999999999 110.172 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.594 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 11.8 ptp180 -159.24 171.83 6.87 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 3.5099999999999998 111.132 -174.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 81.3 Cg_exo -48.08 148.37 7.0 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.098 2.532 . . . . 1.21 112.677 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.661 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -78.12 152.63 32.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.884 -0.598 . . . . 0.90000000000000002 111.263 -172.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -130.98 68.05 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.643 -0.873 . . . . 2.8999999999999999 108.643 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.475 ' HB2' HD11 ' A' ' 103' ' ' LEU . 66.3 m -95.72 106.44 18.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.233 -0.894 . . . . 1.8999999999999999 110.897 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.22 31.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.636 -0.711 . . . . 2.96 110.357 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 11.8 mm-40 -71.32 150.17 94.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.357 -0.838 . . . . 1.3899999999999999 110.426 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.36 106.64 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.325 2.684 . . . . 1.27 113.138 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.2 mm -63.54 121.33 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.85999999999999999 110.863 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 69.1 mt -105.49 155.07 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 1.6100000000000001 110.266 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 141' ' ' ARG . 65.5 m -113.45 17.17 18.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.73 -0.668 . . . . 1.8799999999999999 110.737 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.933 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.1 OUTLIER 65.49 -29.21 0.12 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.21 1.404 . . . . 0.75 111.705 -178.231 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.9 ttt180 -56.45 140.15 46.79 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.68 0.792 . . . . 3.3599999999999999 111.088 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 28.6 m 73.78 114.05 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 124.194 0.934 . . . . 0.94999999999999996 111.639 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.01 12.8 34.82 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.436 -0.802 . . . . 1.1200000000000001 112.303 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.76 -38.65 87.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.597 0.713 . . . . 2.6600000000000001 110.676 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -98.34 59.53 1.34 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.039 -0.982 . . . . 1.8700000000000001 109.597 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -86.71 -92.95 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.832 -0.622 . . . . 4.7300000000000004 112.371 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -119.99 -156.22 9.89 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.232 -0.985 . . . . 0.65000000000000002 113.633 -166.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.695 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 94.5 mttt 65.66 24.61 11.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.147 0.975 . . . . 1.0800000000000001 109.755 -171.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.54 95.27 5.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.372 -1.286 . . . . 1.8899999999999999 108.236 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.48 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 22.0 mmmt -54.05 129.98 36.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.215 -0.902 . . . . 1.29 112.622 -173.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.66 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 29.0 m -65.48 -23.72 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.443 -0.577 . . . . 0.78000000000000003 109.443 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.49 -42.14 98.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.36 -0.837 . . . . 0.67000000000000004 109.577 172.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 37.2 m -64.82 -32.54 74.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.018 -0.537 . . . . 0.77000000000000002 110.22 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.66 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 27.6 m-85 -69.91 -48.86 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.92000000000000004 111.068 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.621 ' HD2' ' HG3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -67.23 -29.36 68.99 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.954 -0.298 . . . . 2.8900000000000001 110.832 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.621 ' HG3' ' HD2' ' A' ' 155' ' ' ARG . 54.7 mtmt -77.49 -26.91 51.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.783 -0.19 . . . . 0.96999999999999997 111.401 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -54.45 -53.9 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.537 -0.302 . . . . 1.5800000000000001 111.136 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.435 ' OH ' ' HG3' ' A' ' 129' ' ' ARG . 12.9 t80 -111.1 5.99 20.53 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.485 -0.886 . . . . 5.4500000000000002 110.597 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 58.81 53.68 5.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.326 -0.852 . . . . 2.4199999999999999 112.467 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 125' ' ' TYR . 0.4 OUTLIER -81.08 -12.31 59.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.272 -0.877 . . . . 1.27 110.303 176.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.431 ' HD2' ' NH2' ' A' ' 155' ' ' ARG . 7.5 tpt180 69.9 -87.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.978 -1.01 . . . . 3.5899999999999999 112.297 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -128.07 156.51 76.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.821 0.343 . . . . 0.76000000000000001 111.211 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.3 Cg_exo -71.24 139.78 35.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.285 2.657 . . . . 0.53000000000000003 112.464 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.872 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -87.74 -30.78 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.376 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.85 143.7 21.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.987 -0.552 . . . . 0.27000000000000002 111.544 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.55 143.27 11.28 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 114.926 -1.034 . . . . 0.23999999999999999 111.881 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.5 t -156.83 133.61 10.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.34000000000000002 108.927 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.863 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -110.31 151.29 27.59 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.568 0.699 . . . . 1.1100000000000001 111.756 -173.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 120' ' ' TYR . 49.2 p90 -137.73 127.51 25.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.657 -1.609 . . . . 0.80000000000000004 106.657 173.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -105.55 133.25 50.6 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.363 -0.935 . . . . 2.5299999999999998 111.435 177.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.08 -0.964 . . . . 0.59999999999999998 110.072 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.72 -168.94 1.73 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 2.3799999999999999 110.947 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.745 ' HA ' HG21 ' A' ' 177' ' ' VAL . 29.4 t90 -83.99 77.3 9.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.786 -0.643 . . . . 3.96 109.729 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -57.04 4.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.654 -0.248 . . . . 1.53 111.257 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.537 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.0 t70 175.68 -33.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.358 0.663 . . . . 1.26 110.73 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.65 6.7 14.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.908 0.385 . . . . 2.2200000000000002 111.925 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.808 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 66.3 t -69.42 -53.52 12.81 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.281 -0.418 . . . . 0.5 110.083 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.808 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 61.7 Cg_exo -51.32 -37.03 59.52 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.609 2.206 . . . . 0.57999999999999996 112.021 169.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.5 mmmt -67.7 -24.37 65.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.165 -0.47 . . . . 2.1400000000000001 111.705 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.644 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 58.3 tp -69.11 -47.44 65.15 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.66000000000000003 109.57 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.8 -38.68 79.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 1.8899999999999999 109.42 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.9 mm-40 -57.26 -43.08 82.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.892 -1.049 . . . . 1.53 111.267 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -76.55 -30.34 57.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.707 0.632 . . . . 1.49 112.707 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 84.9 mt -63.39 1.47 0.52 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.996 0.739 . . . . 0.76000000000000001 112.996 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.722 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 49.3 m -88.81 3.05 52.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.463 0.649 . . . . 1.05 109.789 170.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.539 ' N ' ' HG3' ' A' ' 141' ' ' ARG . . . 69.45 51.65 25.44 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.066 -0.97 . . . . 1.1699999999999999 111.335 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.4 mmmt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.456 -0.783 . . . . 2.0 110.072 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' A' ' 26' ' ' HIS . 21.4 t . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 121.363 0.601 . . . . 1.47 112.131 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 6' ' ' SER . 24.0 t70 -144.78 157.96 43.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.175 -1.375 . . . . 1.8100000000000001 107.524 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.438 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.0 mm? -75.19 23.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.09 0.405 . . . . 0.69999999999999996 111.882 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.0 t -72.27 -16.72 61.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 1.96 110.123 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HB3' HD12 ' A' ' 12' ' ' LEU . 37.8 mttm -122.13 31.41 6.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 2.6600000000000001 111.173 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -26.36 31.63 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.245 0.832 . . . . 3.98 113.245 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -152.43 25.51 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.014 -0.429 . . . . 0.63 111.377 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.16 -122.39 0.96 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.753 -0.939 . . . . 0.47999999999999998 110.753 174.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -51.9 -38.49 68.5 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.255 2.636 . . . . 0.53000000000000003 110.921 167.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.635 HD11 ' HA3' ' A' ' 38' ' ' GLY . 45.9 mt -87.37 89.09 7.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.258 -0.883 . . . . 1.1699999999999999 109.661 173.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.53 71.75 1.86 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.412 0.625 . . . . 0.70999999999999996 110.485 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.857 HD22 HG21 ' A' ' 121' ' ' VAL . 23.8 mt -80.12 -11.98 59.71 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.795 . . . . 0.45000000000000001 110.04 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.535 ' HG2' ' HG3' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -67.69 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.446 -0.797 . . . . 2.1200000000000001 110.859 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -77.5 -20.11 54.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.707 0.765 . . . . 1.9299999999999999 109.423 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG1' HG21 ' A' ' 151' ' ' VAL . 62.8 t -98.13 -57.03 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.53 -1.214 . . . . 0.63 111.341 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -134.92 172.79 12.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.459 -0.337 . . . . 2.9900000000000002 110.685 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -85.93 31.61 0.62 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.538 0.94 . . . . 1.6000000000000001 113.538 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HG3' ' HG2' ' A' ' 15' ' ' GLN . 97.7 mt-30 64.4 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.541 0 O-C-N 123.507 0.505 . . . . 3.5499999999999998 110.721 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 15.2 Cg_exo -66.35 150.4 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.207 1.938 . . . . 0.57999999999999996 112.671 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.879 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.8 pt20 -72.39 -15.92 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.125 -0.943 . . . . 1.3899999999999999 111.264 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.789 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 24.1 m80 -148.91 157.43 40.39 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 1.45 109.274 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.5 Cg_endo -86.82 127.33 2.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.40000000000000002 111.266 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.874 HD23 ' HB3' ' A' ' 122' ' ' TRP . 22.8 tp -76.61 144.3 39.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.997 -0.372 . . . . 0.28999999999999998 109.997 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.59 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 36.0 m80 -122.91 109.23 13.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.045 0.45 . . . . 1.24 110.038 176.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 53' ' ' ILE . 39.6 t -112.93 139.3 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.61 . . . . 0.46999999999999997 109.476 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -133.26 142.2 48.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.431 0.634 . . . . 0.31 110.938 -176.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -102.54 171.12 7.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.67000000000000004 109.006 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.65 -51.86 61.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.37 0.605 . . . . 0.55000000000000004 110.773 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.97 9.52 15.81 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.066 -0.97 . . . . 0.81000000000000005 112.478 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.68 -171.01 3.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 122.631 -0.335 . . . . 0.46999999999999997 110.469 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.13 155.32 18.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.158 -0.474 . . . . 0.33000000000000002 110.351 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.803 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.6 t -102.32 63.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.804 -1.554 . . . . 0.39000000000000001 106.804 163.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.31 20.78 8.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.887 -1.051 . . . . 0.98999999999999999 109.384 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.5 tm-20 -145.67 119.93 9.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.047 -1.094 . . . . 2.5600000000000001 108.047 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -66.45 110.63 3.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.997 0.427 . . . . 0.40999999999999998 109.959 -175.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.873 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 93.27 2.44 65.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.068 -0.587 . . . . 0.58999999999999997 112.703 177.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -67.05 149.39 50.66 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.764 0.316 . . . . 0.34000000000000002 110.677 -178.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.11 132.01 33.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.357 0.598 . . . . 0.55000000000000004 111.043 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.499 HD22 HG22 ' A' ' 34' ' ' VAL . 6.8 tp -124.11 169.2 11.93 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.391 -1.337 . . . . 0.45000000000000001 107.391 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.1 p -114.67 150.46 44.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 118.804 -1.159 . . . . 0.56000000000000005 113.141 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 52.9 Cg_exo -55.74 -32.43 84.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.435 3.423 . . . . 0.68000000000000005 113.91 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -65.12 -36.65 84.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.644 0.735 . . . . 0.76000000000000001 110.189 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -75.28 -56.38 4.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.799 -1.091 . . . . 1.5900000000000001 110.603 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG11 ' CE1' ' A' ' 169' ' ' TYR . 28.7 m -89.31 28.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.884 0.698 . . . . 0.66000000000000003 112.884 -173.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -85.64 -15.49 42.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.766 -0.828 . . . . 0.79000000000000004 108.766 172.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 17.9 t-20 -121.12 -170.29 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.714 -1.13 . . . . 1.9099999999999999 108.988 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 86.2 mtt180 -85.42 161.51 51.25 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.445 -0.576 . . . . 1.4299999999999999 109.445 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 66.8 Cg_endo -78.96 160.38 27.14 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.819 1.68 . . . . 0.37 110.539 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 t -85.23 -18.17 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.915 -0.402 . . . . 0.44 109.915 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 70.1 m -159.36 147.99 17.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.27 0.557 . . . . 0.38 111.778 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.935 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.69 167.87 18.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.145 -1.057 . . . . 0.29999999999999999 108.145 170.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.061 ' HA ' HD13 ' A' ' 58' ' ' LEU . 38.5 t 179.01 114.27 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.102 0.477 . . . . 0.34999999999999998 110.168 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 56.3 p-90 -78.4 157.34 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.088 -1.078 . . . . 2.7200000000000002 108.088 172.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.419 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 28.4 t70 -62.67 88.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.191 0.52 . . . . 1.51 110.918 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.5 20.59 4.62 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.444 -0.798 . . . . 0.80000000000000004 112.275 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.061 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -51.1 130.3 25.76 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.107 0.563 . . . . 0.57999999999999996 111.485 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.697 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 24.1 t70 -75.72 -28.68 58.66 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.808 -0.633 . . . . 0.73999999999999999 111.451 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.688 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 43.0 m 69.18 9.44 7.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.389 -0.823 . . . . 1.03 110.733 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -135.53 -43.77 0.11 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.849 -0.691 . . . . 0.83999999999999997 113.253 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.897 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 20.2 mtpt -66.59 149.63 50.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.6699999999999999 110.645 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.998 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.1 mt -88.09 126.77 35.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.555 -0.748 . . . . 0.57999999999999996 109.239 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.897 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -118.84 161.4 20.23 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.224 0.465 . . . . 0.80000000000000004 110.889 177.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.453 HG23 HG12 ' A' ' 90' ' ' VAL . 89.6 m -97.4 105.3 17.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.35999999999999999 109.259 172.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.85 110.13 22.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.471 -0.786 . . . . 0.58999999999999997 109.835 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.6 t -115.32 126.7 72.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.018 0.437 . . . . 0.39000000000000001 111.055 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.957 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -91.19 131.39 36.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.215 -1.031 . . . . 0.59999999999999998 108.215 166.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 12.0 t -133.63 140.64 47.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.877 -0.329 . . . . 0.35999999999999999 110.339 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.644 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 38.2 t70 -121.85 97.58 46.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 121.132 0.491 . . . . 1.9199999999999999 110.064 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 10.7 Cg_endo -56.14 178.31 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.2 2.6 . . . . 1.25 112.538 171.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.841 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 71.3 m-20 52.56 35.7 18.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.926 -1.034 . . . . 1.29 112.861 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.99 138.48 19.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.148 -0.315 . . . . 0.5 110.148 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.694 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 56.7 Cg_endo -77.27 -34.52 3.28 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.089 -1.629 . . . . 0.62 112.968 0.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.712 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.1 p -119.87 156.81 30.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 0.75 110.214 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.841 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 46.8 mtm180 -72.48 -23.53 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 2.8799999999999999 111.482 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.83 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -92.72 -11.62 33.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 1.3799999999999999 110.947 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.45 78.58 6.28 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-O 121.583 0.706 . . . . 1.3700000000000001 109.584 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.79 95.15 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.848 2.365 . . . . 0.80000000000000004 113.348 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.694 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 12.1 mttm -81.74 -52.29 7.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.095 -0.957 . . . . 1.02 111.17 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.634 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 50.7 m-85 -76.53 -5.44 47.63 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.886 -0.597 . . . . 1.1699999999999999 111.897 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.55 ' HG3' ' HA ' ' A' ' 71' ' ' PRO . 70.1 ttt180 -67.43 130.36 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.275 -0.17 . . . . 2.9300000000000002 110.867 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.516 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 29.9 mm-40 -86.96 130.8 34.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.981 0.42 . . . . 2.23 110.771 -0.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.673 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.5 t90 -86.75 91.18 8.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 1.4299999999999999 109.513 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 35.2 p-80 -67.19 121.72 16.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.529 0.681 . . . . 1.26 109.979 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.957 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 30.3 t-80 -65.39 -34.86 79.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.034 -0.985 . . . . 2.1400000000000001 110.369 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.589 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 39.6 p90 -168.8 172.39 7.86 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.578 -0.527 . . . . 1.51 109.578 175.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.2 tp -132.22 113.7 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.641 -0.503 . . . . 0.33000000000000002 109.641 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.68 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.8 t -121.28 132.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.533 0.682 . . . . 0.31 110.678 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 65' ' ' THR . 9.1 m -128.45 167.4 23.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.879 -1.156 . . . . 0.27000000000000002 107.879 175.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.998 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.5 m-20 60.71 19.66 9.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.203 0.525 . . . . 1.76 110.895 172.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.68 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.1 ttm -73.97 114.57 12.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.971 -0.752 . . . . 0.31 108.971 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 ttmm -80.82 98.56 7.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.512 -1.222 . . . . 1.21 110.988 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.688 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 62.68 -115.3 7.83 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.512 -0.851 . . . . 0.29999999999999999 112.312 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.58 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.2 p-10 -115.06 24.34 11.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.933 0.396 . . . . 1.04 111.611 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.06 103.0 15.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.451 0.643 . . . . 0.77000000000000002 110.247 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.437 ' H ' HG12 ' A' ' 97' ' ' ILE . 7.7 mm -56.18 -32.34 34.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.851 -1.068 . . . . 0.40999999999999998 111.831 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 m -78.98 -37.39 39.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.091 -0.504 . . . . 0.68000000000000005 111.779 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.3 p -61.05 -29.69 69.88 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.728 0.299 . . . . 1.26 111.331 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -50.38 107.77 0.4 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.536 -0.756 . . . . 0.34999999999999998 112.669 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.4 m -72.29 107.8 5.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.256 0.551 . . . . 0.45000000000000001 109.923 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 p -76.46 122.18 30.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.56999999999999995 111.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.644 HD12 ' HG ' ' A' ' 88' ' ' LEU . 66.0 mt -100.47 -45.69 5.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.085 0.945 . . . . 0.45000000000000001 109.32 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.1 t -122.92 112.34 17.73 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.171 -1.418 . . . . 0.37 107.171 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.637 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 4.1 t0 -59.05 159.94 6.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.944 -1.026 . . . . 1.1499999999999999 113.024 -167.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.511 ' H ' ' HD1' ' A' ' 106' ' ' TYR . 3.3 p90 -80.16 86.66 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.3 -0.864 . . . . 4.6900000000000004 110.764 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.864 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 38.3 t -63.97 -46.05 95.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.85999999999999999 111.087 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.541 ' HA2' ' HE2' ' A' ' 86' ' ' HIS . . . 109.51 -168.13 13.13 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.467 -0.873 . . . . 0.67000000000000004 112.577 174.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.9 t -70.29 133.24 46.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.51000000000000001 109.935 174.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -169.73 61.22 0.19 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.695 -0.764 . . . . 0.81999999999999995 112.891 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 97.7 Cg_endo -93.35 140.39 1.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.072 2.515 . . . . 0.84999999999999998 112.434 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 37.1 Cg_exo -61.55 141.84 92.86 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.702 2.268 . . . . 0.87 111.598 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.487 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -69.02 123.93 22.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.8500000000000001 110.987 -176.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.77 59.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 1.1799999999999999 112.642 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.712 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 75.1 p -78.82 -12.68 60.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 110.706 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.29 165.92 41.78 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.18 -0.768 . . . . 1.97 111.18 -174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.837 HD12 ' HG3' ' A' ' 170' ' ' GLN . 3.8 mm? -79.49 130.13 35.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.317 -0.623 . . . . 0.93999999999999995 109.317 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.449 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 4.2 m170 -92.63 -121.32 0.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.975 -1.12 . . . . 2.23 107.975 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.783 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 14.3 ptt-85 177.3 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.344 0.498 . . . . 2.3100000000000001 112.344 169.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.644 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 31.4 m-85 -69.86 101.2 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.768 -0.826 . . . . 0.78000000000000003 108.768 173.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.857 HG21 HD22 ' A' ' 14' ' ' LEU . 17.3 t -89.99 126.07 42.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.957 0.408 . . . . 0.27000000000000002 109.949 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.874 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.06 117.9 28.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.812 -0.81 . . . . 1.99 108.812 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -122.07 129.01 52.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.511 0.195 . . . . 0.38 110.94 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 165' ' ' ALA . 1.3 m -112.21 131.78 62.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.31 110.139 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.64 ' CB ' HD23 ' A' ' 160' ' ' LEU . 97.8 m-85 -117.69 122.5 43.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.252 -0.885 . . . . 5.1200000000000001 109.258 174.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.98 113.08 25.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.012 0.434 . . . . 2.4100000000000001 109.873 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.6 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -80.57 175.6 10.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.665 -0.698 . . . . 1.3100000000000001 109.439 177.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.02 -6.34 57.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.729 -0.669 . . . . 2.3999999999999999 109.851 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.503 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.2 ptp180 -165.65 167.38 9.16 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 115.307 -0.86 . . . . 3.5099999999999998 111.267 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.545 ' HG3' HD12 ' A' ' 63' ' ' LEU . 35.6 Cg_exo -55.58 147.71 57.59 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.979 2.453 . . . . 1.21 111.631 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.453 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 3.8 mm? -71.83 148.89 45.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.621 . . . . 0.90000000000000002 112.532 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 15.4 tptm -103.26 77.81 1.56 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.707 -1.22 . . . . 2.8999999999999999 107.707 165.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.2 p -90.62 99.79 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.399 -0.818 . . . . 1.8999999999999999 111.797 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.2 14.03 21.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.506 -0.77 . . . . 2.96 109.102 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.26 135.28 96.05 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.3899999999999999 110.278 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.64 116.56 2.81 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.017 2.478 . . . . 1.27 112.946 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.6 mm -69.03 115.95 8.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.005 -0.368 . . . . 0.85999999999999999 110.005 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 145' ' ' HIS . 31.6 mt -114.93 152.61 32.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.427 0.632 . . . . 1.6100000000000001 111.26 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -96.51 154.13 17.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.055 -0.975 . . . . 1.8799999999999999 108.609 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.864 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 -77.88 -1.41 31.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.75 111.024 -173.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.742 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 88.4 mtt180 -78.94 157.2 28.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.581 -0.525 . . . . 3.3599999999999999 109.581 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.518 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 79.8 p 58.06 117.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.82 1.248 . . . . 0.94999999999999996 112.651 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -79.35 18.21 7.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.309 -0.859 . . . . 1.1200000000000001 113.514 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -69.82 -41.34 75.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.559 0.695 . . . . 2.6600000000000001 110.4 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.555 ' HB3' HD13 ' A' ' 138' ' ' LEU . 4.4 m80 -95.11 46.48 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.174 -0.921 . . . . 1.8700000000000001 110.862 -170.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 51.3 mtt180 -76.77 -78.78 0.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.026 0.441 . . . . 4.7300000000000004 111.925 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -137.57 -121.58 2.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.107 -1.044 . . . . 0.65000000000000002 113.042 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.634 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 47.2 mttm 64.88 29.17 12.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.616 0.722 . . . . 1.0800000000000001 110.51 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -127.52 146.87 50.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.903 -1.044 . . . . 1.8899999999999999 109.77 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 13.8 mmmm -87.59 140.57 29.38 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.038 -0.528 . . . . 1.29 111.098 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.558 HG21 ' CG1' ' A' ' 17' ' ' VAL . 3.0 t -62.11 -35.18 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.43 -0.952 . . . . 0.78000000000000003 108.43 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.75 81.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.396 -1.275 . . . . 0.67000000000000004 110.448 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 74.1 m -59.31 -47.07 86.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.77000000000000002 111.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.539 ' O ' ' HB3' ' A' ' 157' ' ' LYS . 59.1 m-85 -62.49 -48.97 77.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.827 0.822 . . . . 0.92000000000000004 110.611 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -60.1 -49.3 78.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.414 -1.266 . . . . 2.8900000000000001 111.135 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -67.73 -26.48 66.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.96999999999999997 111.502 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 45.0 tptt -52.6 -53.25 49.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 1.5800000000000001 111.626 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.507 ' HB3' HD13 ' A' ' 160' ' ' LEU . 17.2 t80 -104.41 14.94 29.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.845 -0.742 . . . . 5.4500000000000002 110.422 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 60.37 47.67 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.158 -0.928 . . . . 2.4199999999999999 111.857 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.64 HD23 ' CB ' ' A' ' 125' ' ' TYR . 5.5 mp -80.1 138.9 37.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.388 -0.824 . . . . 1.27 108.875 173.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -72.18 -82.32 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.079 0.4 . . . . 3.5899999999999999 112.079 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.17 164.54 36.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.882 -0.414 . . . . 0.76000000000000001 109.882 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.533 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 20.0 Cg_exo -62.3 134.62 49.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.621 2.214 . . . . 0.53000000000000003 112.566 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.879 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.1 t -89.73 -31.74 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 109.593 -0.521 . . . . 0.44 109.593 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.789 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -155.08 145.01 21.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.16 -0.616 . . . . 0.27000000000000002 111.876 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.1 140.45 9.12 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.023 -0.99 . . . . 0.23999999999999999 111.74 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -152.99 127.41 9.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.532 -0.544 . . . . 0.34000000000000002 109.532 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.873 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.55 144.29 29.71 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.263 0.554 . . . . 1.1100000000000001 112.082 -174.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.594 ' CE1' HG11 ' A' ' 46' ' ' VAL . 5.9 p90 -133.27 122.52 24.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.279 -1.378 . . . . 0.80000000000000004 107.279 168.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.837 ' HG3' HD12 ' A' ' 117' ' ' LEU . 3.9 tp-100 -101.44 156.31 17.54 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.042 -1.036 . . . . 2.5299999999999998 111.626 171.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.489 ' H ' ' CD ' ' A' ' 170' ' ' GLN . . . -149.0 139.07 22.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.422 -0.353 . . . . 0.59999999999999998 110.206 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.766 ' HB3' HD11 ' A' ' 117' ' ' LEU . 12.2 pt-20 -106.65 -168.44 1.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.05 0.452 . . . . 2.3799999999999999 111.87 -173.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.621 ' HA ' HG21 ' A' ' 177' ' ' VAL . 6.9 t90 -77.81 71.38 4.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.661 -0.699 . . . . 3.96 110.168 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.683 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 1.5 t70 -72.59 -62.49 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 1.53 112.615 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.0 t70 -175.06 -45.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.067 0.46 . . . . 1.26 111.143 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.677 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 5.1 m-85 -80.45 7.94 8.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 2.2200000000000002 111.979 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.775 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 94.4 t -72.91 -54.32 4.68 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.083 171.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.775 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -51.92 -41.92 60.82 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.358 2.039 . . . . 0.57999999999999996 111.868 169.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 0.5 OUTLIER -65.85 -25.16 67.07 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.397 -0.365 . . . . 2.1400000000000001 111.068 178.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.688 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 66.5 tp -68.4 -47.62 66.84 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.229 -0.656 . . . . 0.66000000000000003 109.229 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.43 -39.43 83.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.82 -0.627 . . . . 1.8899999999999999 109.478 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 16.4 mm-40 -56.0 -44.45 78.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.772 -1.104 . . . . 1.53 110.795 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.31 -32.45 58.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.366 -0.834 . . . . 1.49 111.958 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 83.0 mt -63.6 -7.07 6.27 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.181 0.437 . . . . 0.76000000000000001 112.181 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.625 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 16.4 m -68.19 -11.42 59.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.489 0.661 . . . . 1.05 109.714 172.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.742 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 87.23 54.83 2.48 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.137 -0.938 . . . . 1.1699999999999999 110.88 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.1 mmmt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.503 -0.76 . . . . 2.0 110.328 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 24' ' ' PRO . 7.2 t . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.719 0.295 . . . . 1.47 111.546 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -146.29 37.83 1.04 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.768 0.794 . . . . 1.8100000000000001 110.12 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 24' ' ' PRO . 2.1 mm? 58.88 37.01 24.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.509 -1.223 . . . . 0.69999999999999996 108.416 -165.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -58.2 -42.93 87.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.456 -1.247 . . . . 1.96 112.021 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.926 ' HB2' HD12 ' A' ' 12' ' ' LEU . 49.9 mttm -136.48 60.94 1.65 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 2.6600000000000001 109.482 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.457 ' CE3' ' HB2' ' A' ' 20' ' ' GLN . 22.5 p-90 -69.06 -35.75 76.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.13 -0.941 . . . . 3.98 112.009 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 84.5 p -147.24 17.56 1.2 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.542 -0.463 . . . . 0.63 111.904 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -75.52 -124.67 0.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.758 . . . . 0.47999999999999998 111.782 177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.4 Cg_endo -49.94 -40.41 49.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.248 2.632 . . . . 0.53000000000000003 110.268 168.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.926 HD12 ' HB2' ' A' ' 7' ' ' LYS . 22.2 mt -88.1 83.62 6.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.85 -1.068 . . . . 1.1699999999999999 109.218 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 m -74.57 62.66 1.04 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.618 0.723 . . . . 0.70999999999999996 110.397 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.586 HD22 ' CG2' ' A' ' 121' ' ' VAL . 46.0 mt -76.52 -17.46 59.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 0.45000000000000001 110.825 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.7 OUTLIER -64.99 -21.53 66.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.877 -0.601 . . . . 2.1200000000000001 109.919 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.66 -28.51 65.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.35 0.595 . . . . 1.9299999999999999 110.65 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.747 HG11 HG21 ' A' ' 69' ' ' THR . 52.0 t -83.99 -73.47 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.265 -0.88 . . . . 0.63 109.684 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.779 ' HB2' HG21 ' A' ' 151' ' ' VAL . 48.3 t0 -139.32 161.19 38.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.846 -0.615 . . . . 2.9900000000000002 109.659 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 163' ' ' PRO . 32.6 mt-10 -64.09 153.42 37.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.652 -0.703 . . . . 1.6000000000000001 111.846 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.457 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 20.1 tt0 -56.05 124.26 58.24 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 3.5499999999999998 110.34 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 19.6 Cg_exo -64.47 154.84 69.57 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.318 2.012 . . . . 0.57999999999999996 112.069 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.934 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.8 pt20 -73.74 -15.55 61.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.606 -0.725 . . . . 1.3899999999999999 111.121 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.735 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 19.5 m80 -146.45 158.81 46.45 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 1.45 108.995 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 3' ' ' VAL . 8.1 Cg_endo -88.53 132.55 2.56 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.952 2.435 . . . . 0.40000000000000002 111.519 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.864 HD23 ' HB3' ' A' ' 122' ' ' TRP . 15.3 tp -84.5 139.83 31.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 111.018 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -106.8 131.33 54.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.468 . . . . 1.24 109.93 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 53' ' ' ILE . 16.1 t -134.39 142.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.12 -0.696 . . . . 0.46999999999999997 109.12 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -140.76 140.96 34.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.917 0.389 . . . . 0.31 110.83 -176.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -105.61 178.28 4.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.751 -0.833 . . . . 0.67000000000000004 108.751 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -52.18 57.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.507 0.67 . . . . 0.55000000000000004 110.463 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.57 -0.14 49.67 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.26 -0.882 . . . . 0.81000000000000005 112.836 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.76 -169.8 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.46999999999999997 110.966 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.56 152.84 16.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.651 -0.704 . . . . 0.33000000000000002 109.645 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.715 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 99.7 t -106.73 64.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.26 -1.385 . . . . 0.39000000000000001 107.26 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -93.39 6.31 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.014 -0.993 . . . . 0.98999999999999999 109.704 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 43.8 mt-10 -133.91 132.7 40.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.191 -0.913 . . . . 2.5600000000000001 109.071 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.6 OUTLIER -75.74 109.56 9.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.139 -0.689 . . . . 0.40999999999999998 109.139 -176.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.731 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 93.07 6.18 63.43 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.536 -0.756 . . . . 0.58999999999999997 112.777 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.715 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.55 147.68 52.95 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.493 -0.558 . . . . 0.34000000000000002 109.493 176.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.47 134.7 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.094 0.473 . . . . 0.55000000000000004 110.957 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 46' ' ' VAL . 7.4 tp -127.41 169.32 13.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.662 -0.866 . . . . 0.45000000000000001 108.662 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 25.1 p -121.08 156.64 56.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.287 -0.565 . . . . 0.56000000000000005 112.227 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.718 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 12.0 Cg_endo -55.5 -30.23 72.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.288 3.325 . . . . 0.68000000000000005 114.402 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -69.87 -32.48 70.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.76000000000000001 110.774 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -79.98 -29.19 39.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.846 -1.07 . . . . 1.5900000000000001 111.241 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.531 ' CG1' HD23 ' A' ' 41' ' ' LEU . 16.7 m -118.21 30.19 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.451 . . . . 0.66000000000000003 111.762 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.01 -21.08 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.601 -0.518 . . . . 0.79000000000000004 109.601 176.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.0 -170.85 2.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.316 -0.857 . . . . 1.9099999999999999 109.617 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.1 156.85 89.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.362 -0.607 . . . . 1.4299999999999999 109.362 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.93 153.72 25.6 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.588 1.526 . . . . 0.37 109.962 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -80.15 -14.93 58.09 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.353 -0.539 . . . . 0.44 110.555 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -161.51 143.38 11.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.457 0.54 . . . . 0.38 112.457 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.905 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -140.17 175.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.104 -1.072 . . . . 0.29999999999999999 108.104 170.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.976 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.8 t 169.56 125.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.497 0.498 . . . . 0.34999999999999998 110.039 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 60.2 p-90 -88.13 153.7 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.672 -0.862 . . . . 2.7200000000000002 108.672 173.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.76 91.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 1.51 110.954 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.66 8.71 8.09 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.836 -0.62 . . . . 0.80000000000000004 112.42 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.976 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.7 tt -56.76 129.0 39.4 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.848 0.459 . . . . 0.57999999999999996 110.857 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.39 -29.04 56.96 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.771 -0.65 . . . . 0.73999999999999999 111.744 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.669 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.2 m 74.23 0.33 3.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.475 -0.784 . . . . 1.03 110.821 -175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.31 -34.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.058 -0.591 . . . . 0.83999999999999997 113.879 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -97.34 166.72 11.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.37 0.605 . . . . 1.6699999999999999 112.076 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.746 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.0 mt -91.9 134.02 35.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.57999999999999996 110.109 -175.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.563 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 7.0 m-85 -124.35 162.83 22.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.892 0.314 . . . . 0.80000000000000004 110.194 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.478 HG23 HG12 ' A' ' 90' ' ' VAL . 86.3 m -102.15 109.74 21.51 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.557 -0.534 . . . . 0.35999999999999999 109.557 174.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 124' ' ' VAL . 53.0 tp -109.09 118.89 37.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.773 0.321 . . . . 0.58999999999999997 110.523 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.1 130.58 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.39000000000000001 110.742 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -90.88 141.91 28.33 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.756 -0.831 . . . . 0.59999999999999998 108.756 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.747 HG21 HG11 ' A' ' 17' ' ' VAL . 12.9 t -140.62 148.13 40.42 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.889 -0.324 . . . . 0.35999999999999999 110.66 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 22.5 t70 -133.82 97.44 15.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 121.265 0.555 . . . . 1.9199999999999999 109.959 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.555 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 3.4 Cg_endo -45.78 -47.63 13.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.489 3.459 . . . . 1.25 114.827 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 76' ' ' ARG . 30.1 m-20 -86.98 52.77 2.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.473 0.545 . . . . 1.29 112.473 -167.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.67 20.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.15 -0.477 . . . . 0.5 110.115 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 85.9 Cg_endo -82.14 -23.53 13.43 Favored 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.527 -1.447 . . . . 0.62 112.858 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.771 ' HB3' HG22 ' A' ' 115' ' ' THR . 6.4 p -137.74 153.66 49.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.75 110.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.501 ' HG3' ' OD1' ' A' ' 72' ' ' ASP . 78.9 ttt180 -68.82 -23.15 64.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.328 0.585 . . . . 2.8799999999999999 110.499 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.4 ptpt -76.21 -17.05 59.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.81 -0.632 . . . . 1.3799999999999999 110.496 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 7.9 t0 -162.97 72.63 2.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 1.3700000000000001 109.876 -172.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.28 87.99 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.266 1.978 . . . . 0.80000000000000004 112.179 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.3 mttm -76.27 -51.42 12.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.449 -1.25 . . . . 1.02 110.548 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 86.5 m-85 -80.37 19.29 0.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.155 -0.93 . . . . 1.1699999999999999 111.555 -171.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.695 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 17.2 ttp180 -69.54 126.64 30.34 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.16 -0.311 . . . . 2.9300000000000002 110.16 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.695 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 2.2 mp0 -98.66 135.35 40.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.945 0.402 . . . . 2.23 110.471 -4.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.61 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.7 t90 -80.94 135.45 35.88 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.15 -0.685 . . . . 1.4299999999999999 109.15 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 6.4 p80 -108.29 132.47 53.66 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.251 -0.58 . . . . 1.26 109.453 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.2 t-160 -83.75 -26.37 29.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.135 -0.484 . . . . 2.1400000000000001 111.514 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.696 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 23.4 p90 -168.74 178.55 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.302 -0.629 . . . . 1.51 109.302 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HG ' HD12 ' A' ' 103' ' ' LEU . 36.3 tp -141.41 114.26 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.155 0.285 . . . . 0.33000000000000002 110.416 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.697 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -120.39 132.4 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.422 0.63 . . . . 0.31 110.931 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.478 HG12 HG23 ' A' ' 65' ' ' THR . 13.5 m -133.46 166.02 30.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.149 -1.056 . . . . 0.27000000000000002 108.149 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t-20 62.16 17.38 9.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.742 0.306 . . . . 1.76 110.292 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.697 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.2 ttm -70.27 108.53 4.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.761 -0.829 . . . . 0.31 108.761 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.2 ttmm -83.48 90.42 7.21 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.817 -1.083 . . . . 1.21 110.633 -171.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.52 -126.62 7.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.943 -1.026 . . . . 0.29999999999999999 112.271 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 3.7 p-10 -111.78 24.2 12.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.411 0.624 . . . . 1.04 110.354 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.07 110.75 22.12 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.459 -0.791 . . . . 0.77000000000000002 110.157 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 97' ' ' ILE . 4.6 mm -62.28 -23.7 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.489 -1.232 . . . . 0.40999999999999998 111.188 -175.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.8 m -81.52 -40.74 22.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.68000000000000005 112.272 -172.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.1 p -70.64 -21.41 62.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.642 0.238 . . . . 1.26 111.642 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.22 102.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.266 -0.492 . . . . 0.34999999999999998 112.324 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.5 m -68.83 106.93 2.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.445 -0.576 . . . . 0.45000000000000001 109.445 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.589 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 14.8 p -90.72 116.21 31.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.316 -0.856 . . . . 0.56999999999999995 110.898 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.428 HD12 ' HG ' ' A' ' 88' ' ' LEU . 7.3 mt -89.59 -45.92 9.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.015 0.912 . . . . 0.45000000000000001 109.364 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.2 t -112.1 106.67 15.36 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.387 -1.708 . . . . 0.37 106.387 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.964 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.7 t0 -62.39 161.29 11.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.1499999999999999 112.529 -165.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -78.07 100.44 6.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.377 -0.829 . . . . 4.6900000000000004 108.902 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 33.1 t -71.12 -39.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.645 . . . . 0.85999999999999999 112.263 -173.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.51 171.45 28.08 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.768 -0.729 . . . . 0.67000000000000004 112.665 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.718 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 27.7 t -61.54 139.6 58.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.149 0.474 . . . . 0.51000000000000001 110.723 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.866 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -176.63 61.82 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.81999999999999995 111.613 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 177' ' ' VAL . 87.0 Cg_endo -85.46 136.18 5.42 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.553 2.169 . . . . 0.84999999999999998 112.929 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.757 ' HB2' HG21 ' A' ' 115' ' ' THR . 42.2 Cg_exo -57.51 148.18 74.23 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.77 2.313 . . . . 0.87 111.533 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.422 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -76.94 125.19 28.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.248 -0.433 . . . . 1.8500000000000001 111.092 -176.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.58 18.6 37.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.814 -0.708 . . . . 1.1799999999999999 112.049 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 75' ' ' SER . 70.3 p -103.55 -12.89 16.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.764 0.316 . . . . 0.96999999999999997 111.423 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.46 21.36 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.56 -0.616 . . . . 1.97 111.56 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -86.41 129.1 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.831 0.348 . . . . 0.93999999999999995 110.181 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.705 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.8 m-70 -94.1 115.63 27.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.89 -0.411 . . . . 2.23 109.89 177.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.572 ' HD2' HD21 ' A' ' 14' ' ' LEU . 6.0 ptt180 -104.29 84.94 2.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 2.3100000000000001 110.689 -172.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.621 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 22.2 m-85 -69.28 117.24 10.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.539 -0.755 . . . . 0.78000000000000003 109.539 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.586 ' CG2' HD22 ' A' ' 14' ' ' LEU . 11.6 t -95.9 129.24 46.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.841 -0.618 . . . . 0.27000000000000002 110.152 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.864 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.56 118.92 28.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.908 -0.587 . . . . 1.99 109.594 178.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.08 119.29 33.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.389 -0.226 . . . . 0.38 110.389 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -108.26 136.3 44.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.356 -0.538 . . . . 0.31 109.958 174.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.65 ' HB2' HD23 ' A' ' 160' ' ' LEU . 55.9 m-85 -113.88 144.25 43.35 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.904 -0.589 . . . . 5.1200000000000001 109.773 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.55 ' HB2' HG21 ' A' ' 164' ' ' VAL . 42.4 tt0 -105.87 112.0 24.89 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.485 -0.561 . . . . 2.4100000000000001 109.485 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.563 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.13 179.25 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.3100000000000001 109.788 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.51 -27.33 37.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.659 0.742 . . . . 2.3999999999999999 109.258 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.674 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 3.5 ptp180 -153.86 174.39 3.83 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 114.535 -1.212 . . . . 3.5099999999999998 111.619 -171.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.674 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 55.7 Cg_exo -52.23 152.8 14.22 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.096 2.53 . . . . 1.21 112.119 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.459 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.4 mm? -76.53 152.78 35.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 0.90000000000000002 111.977 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.76 68.96 0.68 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.225 -0.898 . . . . 2.8999999999999999 108.749 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 p -82.75 118.71 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.471 -0.786 . . . . 1.8999999999999999 111.159 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.36 8.88 33.87 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.703 -0.851 . . . . 2.96 108.703 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.54 116.92 47.91 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.667 -1.151 . . . . 1.3899999999999999 109.943 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.63 131.28 32.7 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.933 2.422 . . . . 1.27 112.155 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.4 mm -59.32 115.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.743 -0.466 . . . . 0.85999999999999999 109.743 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 145' ' ' HIS . 77.9 mt -96.46 -13.93 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.6100000000000001 112.422 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 2.4 m 59.91 -172.51 0.12 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.933 0.397 . . . . 1.8799999999999999 110.313 -172.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.964 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 25.1 p-10 -115.69 37.95 3.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.204 0.526 . . . . 0.75 110.207 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.636 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 6.9 mtm180 -116.29 136.08 53.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.276 0.56 . . . . 3.3599999999999999 111.809 -169.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.73 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.2 m 66.96 2.23 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.876 -1.056 . . . . 0.94999999999999996 113.585 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.63 92.49 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.508 -0.769 . . . . 1.1200000000000001 111.784 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.83 -49.97 73.82 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.047 0.758 . . . . 2.6600000000000001 113.047 -172.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.595 ' HB2' HD13 ' A' ' 138' ' ' LEU . 43.1 m80 -117.0 69.24 0.75 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.868 -0.79 . . . . 1.8700000000000001 108.868 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.464 ' O ' ' HD1' ' A' ' 84' ' ' TRP . 5.1 ttm180 -73.81 -81.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.31 -1.314 . . . . 4.7300000000000004 112.189 -170.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.623 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -124.38 -168.41 12.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.174 -1.012 . . . . 0.65000000000000002 112.926 -169.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.2 mttt 67.73 29.18 6.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.603 0.716 . . . . 1.0800000000000001 110.099 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.67 113.16 25.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.882 -1.054 . . . . 1.8899999999999999 109.415 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 12.3 mmmm -69.94 127.98 34.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.313 0.578 . . . . 1.29 111.767 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.43 -33.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.992 -1.004 . . . . 0.78000000000000003 111.44 175.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.58 -35.53 80.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.67000000000000004 110.415 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.412 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 67.1 m -68.4 -35.5 77.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 -0.227 . . . . 0.77000000000000002 110.874 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.753 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 64.9 m-85 -58.96 -52.58 65.13 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.032 0.444 . . . . 0.92000000000000004 110.522 176.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 2.7 ptt-85 -69.12 -38.53 78.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.013 -0.54 . . . . 2.8900000000000001 111.422 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.5 mtmt -61.29 -28.42 69.18 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.75 0.278 . . . . 0.96999999999999997 111.75 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -54.88 -54.01 48.01 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.122 0.264 . . . . 1.5800000000000001 111.547 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.562 ' HB3' HD13 ' A' ' 160' ' ' LEU . 12.9 t80 -105.1 15.04 28.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.575 -0.85 . . . . 5.4500000000000002 110.479 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 61.91 45.91 7.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 2.4199999999999999 111.739 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.65 HD23 ' HB2' ' A' ' 125' ' ' TYR . 7.0 mp -81.52 176.35 9.75 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.472 -0.785 . . . . 1.27 110.604 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.559 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.0 tpt180 -101.74 -164.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.267 -0.424 . . . . 3.5899999999999999 110.5 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.559 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -71.44 166.17 41.76 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 109.704 -0.48 . . . . 0.76000000000000001 109.704 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 31.9 Cg_exo -55.2 138.04 78.28 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.53000000000000003 113.08 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.934 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -88.76 -29.85 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 CA-C-N 115.555 -0.748 . . . . 0.44 109.027 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.735 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.91 148.19 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.442 -0.503 . . . . 0.27000000000000002 111.358 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.761 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -151.22 147.01 16.48 Favored Glycine 0 N--CA 1.436 -1.317 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 112.273 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -165.54 139.67 4.69 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.431 -0.951 . . . . 0.34000000000000002 108.431 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.646 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 16.6 p -118.63 144.95 45.81 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 1.1100000000000001 111.265 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.2 p90 -127.85 127.1 42.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.655 -1.239 . . . . 0.80000000000000004 107.655 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.705 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -106.03 133.17 51.16 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.659 -0.651 . . . . 2.5299999999999998 111.734 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -128.92 145.96 51.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.195 -0.911 . . . . 0.59999999999999998 109.616 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.409 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -121.36 -172.3 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.661 0.267 . . . . 2.3799999999999999 110.863 -177.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.981 ' HA ' HG21 ' A' ' 177' ' ' VAL . 29.9 t90 -74.76 82.8 2.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.74 -0.467 . . . . 3.96 109.74 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.47 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.3 OUTLIER -72.09 -61.62 1.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.867 -0.606 . . . . 1.53 111.293 176.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.573 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.4 t70 169.55 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.826 0.704 . . . . 1.26 109.644 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 60.7 m-85 -81.22 10.82 4.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.219 0.533 . . . . 2.2200000000000002 111.346 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.981 HG21 ' HA ' ' A' ' 173' ' ' TRP . 74.8 t -72.31 -49.39 9.32 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.5 110.712 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.8 Cg_exo -49.05 -26.34 10.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.947 2.431 . . . . 0.57999999999999996 113.06 170.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 18.1 mmmt -67.4 -24.65 65.69 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.34 0.256 . . . . 2.1400000000000001 111.629 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.866 HD23 ' HA3' ' A' ' 110' ' ' GLY . 21.5 tp -78.25 -40.75 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.112 -0.635 . . . . 0.66000000000000003 109.358 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.65 -35.26 74.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.944 -0.762 . . . . 1.8899999999999999 108.944 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 0.9 OUTLIER -55.51 -56.49 19.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.495 -1.23 . . . . 1.53 109.73 172.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -69.6 -39.02 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.705 -1.134 . . . . 1.49 112.549 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.73 ' HA ' ' H ' ' A' ' 142' ' ' SER . 74.1 mt -71.5 6.99 1.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 111.686 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.511 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 19.9 m -77.76 -3.45 41.34 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.31 -0.626 . . . . 1.05 109.31 168.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.636 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 75.1 49.67 9.36 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.839 -0.904 . . . . 1.1699999999999999 110.839 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.1 mmtp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.678 -0.677 . . . . 2.0 110.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 121.051 0.453 . . . . 1.47 111.953 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -146.13 160.53 41.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.889 -1.152 . . . . 1.8100000000000001 107.889 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 30.78 0.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.69999999999999996 111.005 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -76.92 -18.44 58.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.139 0.495 . . . . 1.96 110.517 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -114.36 33.44 5.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.052 0.453 . . . . 2.6600000000000001 110.25 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.732 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.1 p90 -73.89 -28.2 61.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 3.98 111.921 -174.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -147.65 11.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.63 110.641 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -76.75 -118.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.84 -0.618 . . . . 0.47999999999999998 111.671 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.2 Cg_endo -49.21 -45.89 28.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.232 2.621 . . . . 0.53000000000000003 110.703 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.755 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 9.4 mp -89.72 102.21 14.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.298 -0.864 . . . . 1.1699999999999999 111.249 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 65.98 2.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.70999999999999996 110.408 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 121' ' ' VAL . 22.0 mt -74.32 -17.45 60.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.45000000000000001 111.423 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -69.65 -5.99 28.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.294 -0.412 . . . . 2.1200000000000001 111.44 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.14 -14.12 60.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.938 0.399 . . . . 1.9299999999999999 111.41 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.924 HG11 HG21 ' A' ' 69' ' ' THR . 60.9 t -91.49 -71.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.509 -0.769 . . . . 0.63 110.744 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.541 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 23.4 t0 -155.26 176.38 12.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.483 -0.932 . . . . 2.9900000000000002 108.483 -170.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.89 100.1 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.864 -0.421 . . . . 1.6000000000000001 109.864 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.732 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -43.14 128.58 3.41 Favored Pre-proline 0 C--O 1.234 0.283 0 O-C-N 124.142 0.901 . . . . 3.5499999999999998 110.38 -176.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 53.0 Cg_exo -52.87 166.86 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.499 2.799 . . . . 0.57999999999999996 114.516 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.88 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 9.7 pt20 -84.16 -11.88 55.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.474 -1.239 . . . . 1.3899999999999999 111.812 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.73 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 14.8 m-70 -147.02 157.78 45.94 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 123.11 0.564 . . . . 1.45 110.072 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.42 123.5 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.326 2.684 . . . . 0.40000000000000002 111.652 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 16.9 tp -79.06 136.36 37.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.716 0.294 . . . . 0.28999999999999998 110.732 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.31 117.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.924 -0.399 . . . . 1.24 109.924 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.871 HG13 HG22 ' A' ' 53' ' ' ILE . 26.4 t -123.27 144.62 32.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.171 -0.678 . . . . 0.46999999999999997 109.171 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 144.22 32.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.797 0.332 . . . . 0.31 110.701 -173.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.469 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 17.8 t80 -108.92 178.52 4.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 0.67000000000000004 109.348 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -52.8 64.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 0.55000000000000004 110.843 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.69 11.23 15.84 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.596 -0.729 . . . . 0.81000000000000005 112.494 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.44 -171.3 3.38 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.877 0.37 . . . . 0.46999999999999997 110.164 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.69 154.23 17.94 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.88 -0.6 . . . . 0.33000000000000002 109.543 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.8 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 89.9 t -100.16 61.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 106.968 -1.493 . . . . 0.39000000000000001 106.968 166.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -96.14 27.68 3.56 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.402 -1.272 . . . . 0.98999999999999999 109.301 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -153.98 125.76 7.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.917 -1.142 . . . . 2.5600000000000001 107.917 173.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.8 OUTLIER -74.67 110.38 8.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.081 0.467 . . . . 0.40999999999999998 109.963 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.78 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 98.81 -3.27 58.81 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.635 -0.793 . . . . 0.58999999999999997 112.483 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -62.85 150.44 41.72 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.304 0.242 . . . . 0.34000000000000002 110.393 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.61 127.57 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.55000000000000004 110.672 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 34' ' ' VAL . 5.7 tp -115.87 169.72 9.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.153 -1.425 . . . . 0.45000000000000001 107.153 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 2.6 p -113.47 150.17 42.77 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.88 -1.128 . . . . 0.56000000000000005 113.369 -174.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 35.8 Cg_exo -61.23 -27.78 84.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.208 3.272 . . . . 0.68000000000000005 113.196 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.426 HG22 ' CD2' ' A' ' 176' ' ' TYR . 10.4 p -65.3 -40.28 93.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.84 . . . . 0.76000000000000001 109.972 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -81.46 -50.87 8.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.466 -1.243 . . . . 1.5900000000000001 111.399 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.79 ' HB ' ' HE2' ' A' ' 169' ' ' TYR . 3.8 m -85.56 25.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.209 0.528 . . . . 0.66000000000000003 112.366 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -81.25 -20.03 41.84 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.083 -0.71 . . . . 0.79000000000000004 109.083 175.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -119.5 -161.88 0.89 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.84 -1.073 . . . . 1.9099999999999999 110.052 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.645 HH22 HG21 ' A' ' 89' ' ' VAL . 29.5 mtp180 -91.38 165.84 20.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.168 -0.308 . . . . 1.4299999999999999 110.168 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 57.3 Cg_endo -75.81 169.13 22.85 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.912 1.742 . . . . 0.37 110.725 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -91.3 -18.39 24.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.787 -0.365 . . . . 0.44 110.121 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.0 m -160.77 142.52 12.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.38 112.101 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.871 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -137.99 168.21 20.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.322 -0.992 . . . . 0.29999999999999999 108.322 171.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.953 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.3 t 169.18 122.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.368 0.417 . . . . 0.34999999999999998 110.333 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.562 ' CB ' ' HB2' ' A' ' 165' ' ' ALA . 46.8 p-90 -82.65 150.99 26.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.165 -1.42 . . . . 2.7200000000000002 107.165 169.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -68.28 87.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.826 0.822 . . . . 1.51 111.15 -174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.71 -1.38 3.2 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.919 -1.037 . . . . 0.80000000000000004 111.626 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.953 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.8 tt -52.17 128.61 25.42 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.087 0.555 . . . . 0.57999999999999996 110.336 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.808 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 33.9 t70 -75.09 -27.18 59.8 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.73999999999999999 111.757 -173.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.634 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 15.9 m 73.03 2.56 4.42 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.979 -1.01 . . . . 1.03 110.192 -172.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.81 -9.06 2.6 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.127 -0.559 . . . . 0.83999999999999997 113.5 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.808 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 35.4 mtpt -94.75 161.05 14.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.251 0.525 . . . . 1.6699999999999999 109.918 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 60.8 mt -95.11 134.49 37.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.399 -0.593 . . . . 0.57999999999999996 109.399 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -133.59 145.92 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.42 -0.585 . . . . 0.80000000000000004 109.42 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.653 HG23 HG12 ' A' ' 90' ' ' VAL . 60.2 m -95.96 105.27 17.27 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.704 -0.85 . . . . 0.35999999999999999 108.704 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.737 HD13 HG12 ' A' ' 124' ' ' VAL . 49.3 tp -100.54 109.93 22.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.58999999999999997 110.193 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 88' ' ' LEU . 27.4 t -110.15 121.1 62.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.39000000000000001 110.533 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.974 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.0 mt -81.91 138.98 34.91 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.465 -0.939 . . . . 0.59999999999999998 108.465 167.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.924 HG21 HG11 ' A' ' 17' ' ' VAL . 8.9 t -144.79 147.39 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.858 -0.337 . . . . 0.35999999999999999 110.858 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 9.1 t0 -131.84 95.56 22.37 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.546 0.688 . . . . 1.9199999999999999 109.745 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 18.8 Cg_endo -60.01 -11.63 16.11 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 124.126 3.217 . . . . 1.25 114.065 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 118' ' ' HIS . 2.3 t70 -106.61 26.46 9.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.405 0.621 . . . . 1.29 110.431 -167.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' A' ' 84' ' ' TRP . . . -103.33 144.79 29.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.052 -0.522 . . . . 0.5 111.591 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -84.86 -24.47 10.2 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.207 -1.58 . . . . 0.62 112.819 -0.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.594 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 62.1 p -134.72 149.67 50.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.75 109.371 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.69 -26.86 64.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 2.8799999999999999 111.473 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.667 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -69.82 -23.5 63.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.44 -0.345 . . . . 1.3799999999999999 111.025 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -157.62 84.03 2.84 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.912 0.386 . . . . 1.3700000000000001 110.379 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.5 81.54 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.593 2.195 . . . . 0.80000000000000004 112.025 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.2 mttm -66.68 -48.18 70.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.295 -1.321 . . . . 1.02 111.46 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 48.7 m-85 -83.59 8.82 13.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.343 -0.844 . . . . 1.1699999999999999 112.16 -166.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 53.9 ttp180 -58.28 122.79 14.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 2.9300000000000002 110.794 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mp0 -101.14 131.93 46.85 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.839 0.352 . . . . 2.23 110.796 -2.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 12.5 t90 -79.52 93.66 5.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 1.4299999999999999 110.113 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.9 p-80 -67.44 123.8 21.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.352 0.596 . . . . 1.26 109.421 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.974 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 11.5 t60 -76.64 -30.76 56.99 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.622 -0.717 . . . . 2.1400000000000001 110.324 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.0 p90 -168.48 174.2 7.03 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.6 -0.519 . . . . 1.51 109.6 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' A' ' 103' ' ' LEU . 19.7 tp -134.55 114.2 12.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.907 -0.405 . . . . 0.33000000000000002 109.907 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.645 HG21 HH22 ' A' ' 49' ' ' ARG . 1.7 t -123.54 131.76 72.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.757 -0.656 . . . . 0.31 110.903 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.653 HG12 HG23 ' A' ' 65' ' ' THR . 15.0 m -133.28 163.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.957 -1.02 . . . . 0.27000000000000002 108.529 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.613 ' ND2' ' HB3' ' A' ' 130' ' ' PRO . 2.5 t-20 62.85 18.34 10.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.333 0.396 . . . . 1.76 110.008 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.473 ' HE3' HG11 ' A' ' 89' ' ' VAL . 5.4 ttm -69.94 106.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.074 -0.713 . . . . 0.31 109.074 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 12.9 ttmm -84.21 89.72 7.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.616 -1.175 . . . . 1.21 110.697 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 82.48 -127.18 7.82 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.875 -1.057 . . . . 0.29999999999999999 112.632 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 26.5 p-10 -115.6 24.02 11.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 1.04 111.432 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -89.42 105.71 17.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.378 0.608 . . . . 0.77000000000000002 109.729 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.546 HD13 HD12 ' A' ' 53' ' ' ILE . 10.7 mm -49.98 -35.91 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.291 -1.322 . . . . 0.40999999999999998 111.387 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 m -80.88 -31.49 35.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.685 -0.689 . . . . 0.68000000000000005 111.834 -172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -72.76 -11.21 60.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 1.26 111.565 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.0 102.33 1.05 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.554 -0.831 . . . . 0.34999999999999998 111.602 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.9 m -61.98 109.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.478 0.656 . . . . 0.45000000000000001 110.066 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.6 p -83.2 117.49 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.825 -1.079 . . . . 0.56999999999999995 111.588 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.3 mt -92.85 -39.02 11.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.018 0.913 . . . . 0.45000000000000001 109.372 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 22.0 t -127.44 110.27 12.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.446 -1.316 . . . . 0.37 107.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.998 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -56.76 161.78 2.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.122 0.889 . . . . 1.1499999999999999 112.921 -170.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -83.86 101.33 11.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.37 -0.832 . . . . 4.6900000000000004 110.283 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.748 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 25.9 t -69.3 -41.46 81.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.893 -0.594 . . . . 0.85999999999999999 111.748 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.39 -176.55 24.39 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.67000000000000004 112.333 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.463 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 27.0 t -63.7 123.17 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.67 0.235 . . . . 0.51000000000000001 110.803 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -154.3 61.74 0.37 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.9 -0.667 . . . . 0.81999999999999995 112.708 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 73.9 Cg_endo -94.51 123.35 0.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.922 2.415 . . . . 0.84999999999999998 112.669 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.655 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.7 Cg_exo -52.56 140.77 54.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.884 2.39 . . . . 0.87 111.814 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.542 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -64.53 125.31 24.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.141 0.495 . . . . 1.8500000000000001 110.839 -177.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.08 -4.02 60.55 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.615 -0.802 . . . . 1.1799999999999999 112.856 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.655 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 74.0 p -78.1 -15.82 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.699 -0.295 . . . . 0.96999999999999997 111.261 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 171.33 39.37 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.876 -0.602 . . . . 1.97 111.862 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 172' ' ' GLU . 3.7 mm? -82.37 115.58 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.956 -0.757 . . . . 0.93999999999999995 108.956 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.774 ' N ' ' HG2' ' A' ' 170' ' ' GLN . 75.2 m-70 -88.61 -134.3 0.09 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.2 -0.667 . . . . 2.23 109.2 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.755 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 2.8 ptt180 -176.53 100.9 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.743 0.646 . . . . 2.3100000000000001 112.743 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' HD1' ' HB2' ' A' ' 70' ' ' ASP . 19.3 m-85 -77.78 106.79 9.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.359 -0.978 . . . . 0.78000000000000003 108.359 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.886 HG21 HD22 ' A' ' 14' ' ' LEU . 5.2 t -96.26 133.48 37.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.412 -0.358 . . . . 0.27000000000000002 110.122 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.8 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -87.74 119.41 28.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.652 -0.499 . . . . 1.99 109.652 178.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.5 mt -115.31 117.77 31.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.71 -0.478 . . . . 0.38 109.71 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.737 HG12 HD13 ' A' ' 66' ' ' LEU . 1.7 m -104.18 128.93 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.179 -0.608 . . . . 0.31 109.663 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.522 ' HD2' ' O ' ' A' ' 161' ' ' ARG . 21.0 m-85 -109.72 124.76 51.8 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.069 -0.715 . . . . 5.1200000000000001 109.069 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.92 131.15 43.99 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.346 -0.541 . . . . 2.4100000000000001 109.689 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 20.7 mt-30 -93.7 130.35 39.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.943 -0.572 . . . . 1.3100000000000001 111.044 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.69 -11.17 59.85 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.509 -0.922 . . . . 2.3999999999999999 108.509 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 1.1 ptt180 -164.71 150.57 8.95 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 114.44 -1.255 . . . . 3.5099999999999998 109.919 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.613 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 15.1 Cg_exo -66.56 132.68 29.72 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.198 2.599 . . . . 1.21 112.49 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 133' ' ' CYS . 3.6 mm? -64.17 151.69 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.753 -0.658 . . . . 0.90000000000000002 111.335 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 39.08 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.25 1.024 . . . . 2.8999999999999999 109.866 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.762 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.7 m -53.44 138.49 33.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.51 -1.677 . . . . 1.8999999999999999 113.058 -172.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.55 18.18 10.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.07 -0.968 . . . . 2.96 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.762 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.8 mm-40 -69.14 126.71 92.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.758 -0.655 . . . . 1.3899999999999999 110.413 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.06 116.43 2.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.162 2.575 . . . . 1.27 112.288 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mm -63.0 115.08 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.85999999999999999 110.553 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 67.5 mt -100.61 146.4 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.533 -0.543 . . . . 1.6100000000000001 109.533 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 141' ' ' ARG . 55.5 m -111.35 35.39 3.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.721 -0.672 . . . . 1.8799999999999999 111.234 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.998 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.4 OUTLIER 63.22 -18.61 0.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.027 1.331 . . . . 0.75 113.537 175.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.4 mtt180 -84.55 135.9 34.02 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.188 -0.301 . . . . 3.3599999999999999 110.188 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.647 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.9 m 81.97 131.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.97 1.419 . . . . 0.94999999999999996 110.641 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.12 33.98 5.91 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 112.399 -175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.01 -30.48 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.625 0.25 . . . . 2.6600000000000001 111.424 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.99 70.61 1.35 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.211 0.529 . . . . 1.8700000000000001 111.013 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 49.3 mtt180 -79.94 -66.06 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 4.7300000000000004 110.419 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.467 ' H ' ' HD1' ' A' ' 81' ' ' TYR . . . -130.36 -143.42 5.36 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.693 -0.765 . . . . 0.65000000000000002 112.079 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.685 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 64.83 23.55 12.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.516 0.674 . . . . 1.0800000000000001 110.473 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -119.79 125.97 49.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.997 -1.002 . . . . 1.8899999999999999 108.394 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -76.9 127.76 33.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.333 0.587 . . . . 1.29 111.703 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.899 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 4.5 m -61.01 -31.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.04 -0.982 . . . . 0.78000000000000003 110.967 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.74 -39.77 92.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.773 -0.649 . . . . 0.67000000000000004 109.999 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.7 m -67.56 -34.77 77.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.396 -0.366 . . . . 0.77000000000000002 111.127 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.899 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 33.2 m-85 -59.28 -50.32 74.46 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.92000000000000004 110.058 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -63.02 -50.15 71.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.875 -1.057 . . . . 2.8900000000000001 111.139 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.0 mtmt -62.32 -27.92 69.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.281 -0.418 . . . . 0.96999999999999997 111.766 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -53.98 -53.48 52.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.193 -0.458 . . . . 1.5800000000000001 111.352 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.512 ' CG ' HD13 ' A' ' 131' ' ' LEU . 54.0 t80 -103.97 9.92 36.41 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.274 -0.571 . . . . 5.4500000000000002 111.222 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 65.37 44.0 3.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.558 0.694 . . . . 2.4199999999999999 110.18 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 160' ' ' LEU . 2.3 tp -78.45 164.68 24.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.062 -0.972 . . . . 1.27 111.037 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.633 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 22.4 tpt180 -86.9 -179.47 6.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 3.5899999999999999 109.763 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.633 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -75.93 160.4 78.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.119 -0.326 . . . . 0.76000000000000001 110.119 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.69 141.97 96.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.802 2.335 . . . . 0.53000000000000003 113.201 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.88 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.1 t -95.06 -39.44 10.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.608 -0.723 . . . . 0.44 110.15 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -136.94 145.02 43.74 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.035 -0.666 . . . . 0.27000000000000002 111.794 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.8 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.39 149.11 21.22 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.258 -0.883 . . . . 0.23999999999999999 112.626 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 25' ' ' LEU . 12.5 t -170.59 142.0 1.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.369 -0.604 . . . . 0.34000000000000002 109.369 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.78 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -108.9 144.72 36.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.032 0.444 . . . . 1.1100000000000001 111.93 -174.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.79 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 1.9 p90 -137.63 105.5 5.64 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.007 -0.738 . . . . 0.80000000000000004 109.007 171.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.774 ' HG2' ' N ' ' A' ' 118' ' ' HIS . 7.8 tp-100 -100.39 169.61 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.679 -1.263 . . . . 2.5299999999999998 112.132 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' A' ' 170' ' ' GLN . . . -146.23 160.19 42.31 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.134 -0.691 . . . . 0.59999999999999998 109.134 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HB3' HD11 ' A' ' 117' ' ' LEU . 12.4 pt-20 -109.44 -171.99 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.314 -0.403 . . . . 2.3799999999999999 110.448 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.589 ' CZ2' ' HG3' ' A' ' 178' ' ' PRO . 8.3 t90 -80.48 68.85 6.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.435 . . . . 3.96 109.897 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.8 -61.33 1.82 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.453 -0.34 . . . . 1.53 111.839 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 16.6 t70 -168.94 -55.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.088 0.403 . . . . 1.26 112.088 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.426 ' CD2' HG22 ' A' ' 44' ' ' THR . 50.7 m-85 -81.57 11.21 4.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.48 0.548 . . . . 2.2200000000000002 112.48 -176.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.737 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 91.3 t -71.61 -53.68 7.23 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.579 -0.526 . . . . 0.5 109.579 171.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.0 Cg_exo -49.74 -43.22 41.16 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.706 2.271 . . . . 0.57999999999999996 112.603 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.669 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 4.7 mmmp? -70.35 -24.69 63.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.896 0.332 . . . . 2.1400000000000001 111.896 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.671 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 51.7 tp -70.39 -47.63 59.95 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.333 -0.617 . . . . 0.66000000000000003 109.333 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.22 -37.44 77.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 1.8899999999999999 109.449 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 4.8 mm-40 -60.14 -45.68 92.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.91 -1.041 . . . . 1.53 111.271 172.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.07 -32.49 72.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 1.49 111.864 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 63.4 mt -63.13 0.11 0.66 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.149 0.796 . . . . 0.76000000000000001 113.149 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.445 ' HB2' ' HE2' ' A' ' 187' ' ' LYS . 14.5 m -74.07 -9.86 59.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.305 0.574 . . . . 1.05 109.967 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.61 58.26 3.9 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.591 -1.003 . . . . 1.1699999999999999 110.591 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 182' ' ' GLU . 71.1 mmtt . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.341 -0.838 . . . . 2.0 110.655 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 121.307 0.575 . . . . 1.47 111.647 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -155.22 154.81 32.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.562 -0.533 . . . . 1.8100000000000001 109.562 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.461 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.3 mm? -81.19 27.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.48 0.178 . . . . 0.69999999999999996 111.48 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 2.0 m -62.5 -29.89 70.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.991 0.424 . . . . 1.96 111.391 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 12' ' ' LEU . 6.8 mptt -120.66 51.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.397 -0.365 . . . . 2.6600000000000001 110.109 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.42 ' HE3' ' O ' ' A' ' 5' ' ' LEU . 12.9 p90 -72.39 -23.32 61.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.45 . . . . 3.98 111.244 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 70.7 p -148.34 7.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.427 -0.509 . . . . 0.63 112.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.14 -122.28 0.08 OUTLIER Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.806 -0.711 . . . . 0.47999999999999998 112.102 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.0 Cg_endo -49.37 -42.35 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.259 2.639 . . . . 0.53000000000000003 110.253 168.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.597 HD11 ' HA3' ' A' ' 38' ' ' GLY . 17.7 mt -88.0 81.98 7.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.646 -1.161 . . . . 1.1699999999999999 109.323 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -74.7 62.14 1.04 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.542 0.687 . . . . 0.70999999999999996 110.438 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 121' ' ' VAL . 36.4 mt -79.04 -19.93 50.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.183 -0.917 . . . . 0.45000000000000001 110.922 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -61.13 -15.5 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 2.1200000000000001 111.262 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.7 -32.8 74.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 110.984 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.501 HG12 HG21 ' A' ' 151' ' ' VAL . 98.1 t -90.33 -64.15 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.532 -0.758 . . . . 0.63 110.883 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HA ' HH22 ' A' ' 155' ' ' ARG . 5.8 p-10 -115.06 175.95 5.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.077 0.465 . . . . 2.9900000000000002 111.101 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 20.6 mt-10 -95.09 33.92 1.46 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.879 -0.6 . . . . 1.6000000000000001 111.412 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER 52.38 133.67 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.217 1.407 . . . . 3.5499999999999998 113.459 -176.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' CA ' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -80.74 154.17 20.23 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.843 2.362 . . . . 0.57999999999999996 113.711 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.848 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 6.3 pt20 -74.51 -18.75 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.793 -1.094 . . . . 1.3899999999999999 111.011 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.77 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.1 m80 -145.93 156.87 51.34 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.525 -0.761 . . . . 1.45 109.7 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 5.0 Cg_endo -85.83 127.43 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 123.056 2.504 . . . . 0.40000000000000002 111.16 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.452 HD23 ' CB ' ' A' ' 122' ' ' TRP . 17.9 tp -76.97 142.04 40.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.492 -0.322 . . . . 0.28999999999999998 110.572 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 27.0 m-70 -109.26 115.58 30.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.565 -0.531 . . . . 1.24 109.565 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.862 HG13 HG22 ' A' ' 53' ' ' ILE . 15.2 t -126.48 119.81 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 0.46999999999999997 109.691 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -117.68 138.8 51.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.158 0.504 . . . . 0.31 110.411 -177.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -98.16 172.41 7.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.94 -0.573 . . . . 0.67000000000000004 109.474 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.8 -52.28 64.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.215 0.531 . . . . 0.55000000000000004 110.739 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.98 -14.68 14.46 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.351 -0.84 . . . . 0.81000000000000005 112.549 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.37 -170.0 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.021 0.438 . . . . 0.46999999999999997 110.614 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -162.74 141.76 8.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.762 -0.653 . . . . 0.33000000000000002 110.464 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 92.6 t -91.73 61.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.929 -1.508 . . . . 0.39000000000000001 106.929 165.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -85.59 10.61 12.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.672 -1.149 . . . . 0.98999999999999999 110.702 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.1 tt0 -146.16 134.38 21.71 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.732 -0.667 . . . . 2.5600000000000001 109.431 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.786 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -73.48 111.27 8.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.46 -0.571 . . . . 0.40999999999999998 109.46 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.597 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 90.5 17.59 51.96 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.156 -0.545 . . . . 0.58999999999999997 112.548 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.85 150.68 32.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 0.34000000000000002 109.703 174.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 12.9 p -78.73 134.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.55000000000000004 110.66 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.5 tp -131.37 169.7 15.66 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.276 -1.009 . . . . 0.45000000000000001 108.276 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 3.3 p -122.01 158.1 55.97 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.623 0.601 . . . . 0.56000000000000005 112.623 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 9.5 Cg_endo -51.35 -48.76 19.69 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.528 2.819 . . . . 0.68000000000000005 113.818 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 p -61.73 -32.84 73.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 0.76000000000000001 111.687 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.73 -11.44 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.995 -0.548 . . . . 1.5900000000000001 111.604 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.528 ' CG1' HD23 ' A' ' 41' ' ' LEU . 29.4 m -129.65 28.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.354 0.597 . . . . 0.66000000000000003 111.112 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.32 -21.77 25.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.555 -0.748 . . . . 0.79000000000000004 110.135 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.03 -173.0 2.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.839 -0.618 . . . . 1.9099999999999999 109.569 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.86 155.38 77.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.108 -0.33 . . . . 1.4299999999999999 110.108 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.6 152.87 29.9 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.117 1.878 . . . . 0.37 110.732 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 t -76.8 -18.25 58.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.419 -0.355 . . . . 0.44 110.057 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 58.8 m -160.33 143.29 13.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.556 0.693 . . . . 0.38 112.363 -176.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.862 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -138.66 168.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.864 -1.162 . . . . 0.29999999999999999 107.864 170.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.024 ' HA ' HD13 ' A' ' 58' ' ' LEU . 37.3 t 171.96 123.9 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.484 -0.561 . . . . 0.34999999999999998 109.484 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.724 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.3 p-90 -82.23 154.75 25.26 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.862 -1.162 . . . . 2.7200000000000002 107.862 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.59 89.13 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.009 0.433 . . . . 1.51 110.861 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.91 13.09 4.64 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.487 -0.778 . . . . 0.80000000000000004 112.011 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.024 HD13 ' HA ' ' A' ' 54' ' ' SER . 5.3 tt -54.23 129.52 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.19 0.519 . . . . 0.57999999999999996 111.267 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.778 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 36.1 t70 -76.42 -27.93 56.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.73999999999999999 111.531 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 50.2 m 72.91 1.0 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.054 -0.975 . . . . 1.03 110.52 -172.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.65 -26.87 1.52 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.69 -0.686 . . . . 0.83999999999999997 112.733 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.778 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 34.3 mtpt -77.53 149.27 34.93 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.086 0.469 . . . . 1.6699999999999999 110.549 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.636 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 43.0 mt -87.69 126.72 35.14 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.163 -0.926 . . . . 0.57999999999999996 108.736 173.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.7 m-85 -121.44 163.69 18.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.52 -0.472 . . . . 0.80000000000000004 110.168 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.981 HG23 HG12 ' A' ' 90' ' ' VAL . 4.0 m -106.56 105.35 15.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.129 -0.693 . . . . 0.35999999999999999 109.129 173.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.618 HD13 HG12 ' A' ' 124' ' ' VAL . 52.8 tp -102.8 116.34 32.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.001 0.429 . . . . 0.58999999999999997 110.517 -176.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.6 t -119.78 129.91 74.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.049 -0.523 . . . . 0.39000000000000001 110.67 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.1 mt -93.38 137.06 33.05 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.791 -0.818 . . . . 0.59999999999999998 108.791 171.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 7.0 t -139.47 149.2 43.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.656 0.265 . . . . 0.35999999999999999 111.65 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.56 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 16.0 t0 -133.8 90.71 26.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.538 0.685 . . . . 1.9199999999999999 109.697 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.9 Cg_endo -54.81 -26.54 48.31 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 124.034 3.156 . . . . 1.25 114.431 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 58.5 m-20 -85.16 36.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.065 0.395 . . . . 1.29 112.065 -168.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.93 140.34 20.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.19 -0.319 . . . . 0.5 111.566 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.0 Cg_endo -78.88 -28.04 7.86 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 122.848 -1.73 . . . . 0.62 112.037 -0.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -133.37 143.47 48.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.182 -0.917 . . . . 0.75 108.761 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 37.3 ttp180 -72.33 -23.08 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 2.8799999999999999 112.23 -174.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.763 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -75.57 -11.51 60.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.49 . . . . 1.3799999999999999 110.419 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -162.14 75.5 2.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 1.3700000000000001 109.572 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.06 103.33 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.656 2.237 . . . . 0.80000000000000004 112.994 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.6 mttm -88.05 -48.64 7.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.704 -1.134 . . . . 1.02 110.918 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.739 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 56.0 m-85 -80.45 2.4 25.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.14 -0.937 . . . . 1.1699999999999999 112.336 -165.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.3 ttp180 -60.62 128.69 37.84 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.241 -0.651 . . . . 2.9300000000000002 109.241 172.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 6.1 tm-20 -88.45 128.71 35.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.933 0.893 . . . . 2.23 110.903 2.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.44 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 22.1 t90 -114.75 91.92 3.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.819 -0.628 . . . . 1.4299999999999999 109.86 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 4.5 p-80 -83.92 158.88 21.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.061 0.934 . . . . 1.26 112.535 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 1.079 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t-80 -100.99 -38.45 8.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.047 -1.433 . . . . 2.1400000000000001 111.378 -172.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 55.3 t80 -167.11 137.58 3.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.076 -0.249 . . . . 1.51 110.469 -165.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.56 ' CD1' HG22 ' A' ' 67' ' ' VAL . 22.4 tp -126.74 114.42 17.95 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.249 0.343 . . . . 0.33000000000000002 110.41 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -123.79 135.93 61.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.421 0.629 . . . . 0.31 110.823 175.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.981 HG12 HG23 ' A' ' 65' ' ' THR . 8.1 m -130.19 162.65 37.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.27000000000000002 108.851 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.662 ' H ' HD23 ' A' ' 131' ' ' LEU . 1.0 OUTLIER 61.54 20.21 11.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.321 0.388 . . . . 1.76 110.863 177.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 89' ' ' VAL . 11.2 ttm -70.49 111.31 5.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.83 -0.804 . . . . 0.31 108.83 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.449 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 18.1 ttmm -87.78 87.4 7.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.893 -1.048 . . . . 1.21 110.341 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 88.57 -129.52 9.65 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 114.878 -1.055 . . . . 0.29999999999999999 112.495 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 32.3 p30 -116.17 27.13 9.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 1.04 110.888 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -93.93 112.51 24.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.77000000000000002 109.924 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 53' ' ' ILE . 5.6 mm -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.578 -1.192 . . . . 0.40999999999999998 111.231 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.9 m -85.59 -34.33 21.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.887 -0.597 . . . . 0.68000000000000005 112.023 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -63.49 -29.4 70.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.26 111.766 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.21 110.91 2.74 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.791 -0.64 . . . . 0.34999999999999998 113.471 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.0 m -70.58 107.43 3.88 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.195 -0.668 . . . . 0.45000000000000001 109.195 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 105' ' ' ASP . 8.3 p -87.29 145.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.67 0.748 . . . . 0.56999999999999995 111.989 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.531 HD12 ' HG ' ' A' ' 88' ' ' LEU . 13.8 mt -119.4 -32.3 4.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.689 -1.141 . . . . 0.45000000000000001 109.12 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 14.7 t -131.55 102.02 5.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.769 -1.196 . . . . 0.37 107.769 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.923 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.9 OUTLIER -64.59 169.07 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 1.1499999999999999 113.2 -167.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' H ' ' HD1' ' A' ' 106' ' ' TYR . 4.1 p90 -74.34 88.73 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.947 -1.024 . . . . 4.6900000000000004 110.936 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.68 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 23.8 t -66.49 -49.15 77.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.85999999999999999 111.082 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.53 -170.18 13.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.798 -0.715 . . . . 0.67000000000000004 112.338 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.9 t -67.3 125.56 26.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 0.51000000000000001 109.824 173.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.721 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -159.01 63.55 0.3 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.615 -0.802 . . . . 0.81999999999999995 112.922 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.554 ' HB2' ' HD1' ' A' ' 173' ' ' TRP . 10.1 Cg_endo -89.68 133.73 2.21 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.884 2.39 . . . . 0.84999999999999998 111.844 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.712 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 53.0 Cg_exo -53.32 129.35 33.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.149 . . . . 0.87 111.196 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.553 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.8 OUTLIER -60.56 121.36 11.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.191 0.52 . . . . 1.8500000000000001 111.712 -174.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.68 -6.39 52.21 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.479 -0.782 . . . . 1.1799999999999999 113.252 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.712 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -80.65 -5.98 57.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.2 0.444 . . . . 0.96999999999999997 112.2 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.62 178.38 45.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.915 -0.659 . . . . 1.97 111.571 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.56 144.93 56.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.93999999999999995 110.657 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 1.0 OUTLIER -121.93 130.88 53.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.138 -0.69 . . . . 2.23 109.138 174.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.634 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 8.4 ptp85 -110.72 95.71 5.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.4 0.619 . . . . 2.3100000000000001 111.361 -170.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 69' ' ' THR . 36.8 m-85 -73.87 113.55 11.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.78000000000000003 109.357 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.682 HG21 HD22 ' A' ' 14' ' ' LEU . 7.1 t -90.52 129.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.604 -0.726 . . . . 0.27000000000000002 110.062 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.665 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 77.4 m95 -87.54 117.98 26.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.943 -1.132 . . . . 1.99 107.943 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.52 118.37 30.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.24 -0.184 . . . . 0.38 110.557 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.618 HG12 HD13 ' A' ' 66' ' ' LEU . 1.2 m -105.33 128.24 59.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.342 -0.614 . . . . 0.31 109.342 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.47 ' HB2' HD23 ' A' ' 160' ' ' LEU . 88.2 m-85 -110.62 146.53 35.98 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.794 -0.639 . . . . 5.1200000000000001 109.618 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.648 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.9 tt0 -105.58 109.88 22.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.028 -0.533 . . . . 2.4100000000000001 109.954 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.642 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -72.38 172.52 10.25 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.447 -0.797 . . . . 1.3100000000000001 109.644 177.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -85.59 -15.21 43.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.794 -0.639 . . . . 2.3999999999999999 109.397 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.51 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 5.2 ppt_? -158.1 168.5 12.32 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.138 -0.937 . . . . 3.5099999999999998 110.861 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 87.2 Cg_exo -47.93 147.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.045 2.497 . . . . 1.21 113.025 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.803 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -71.5 157.05 38.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.795 -0.638 . . . . 0.90000000000000002 112.006 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -146.93 79.36 1.52 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.092 -0.958 . . . . 2.8999999999999999 108.493 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.576 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 3.5 m -102.25 139.9 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.086 0.469 . . . . 1.8999999999999999 111.183 -173.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -112.89 17.73 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 2.96 109.533 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 15.8 mm-40 -68.81 132.17 90.82 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.259 -0.882 . . . . 1.3899999999999999 110.941 -174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.13 111.36 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.465 2.776 . . . . 1.27 113.065 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.24 125.64 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.711 -0.677 . . . . 0.85999999999999999 111.583 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -112.12 141.22 46.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.566 -0.531 . . . . 1.6100000000000001 109.566 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 141' ' ' ARG . 19.6 m -102.13 40.59 1.32 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.569 -0.741 . . . . 1.8799999999999999 110.728 -173.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 59.11 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.992 1.317 . . . . 0.75 113.506 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.601 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 47.0 mtt85 -84.59 155.78 21.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.121 -0.696 . . . . 3.3599999999999999 109.121 173.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.591 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 10.3 p 52.72 120.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.769 1.227 . . . . 0.94999999999999996 113.05 -171.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -97.3 30.99 8.21 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.119 -0.946 . . . . 1.1200000000000001 112.308 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.54 -34.67 72.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.937 0.717 . . . . 2.6600000000000001 112.937 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -125.65 42.05 3.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.305 0.574 . . . . 1.8700000000000001 111.417 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.514 ' HD2' HG21 ' A' ' 107' ' ' VAL . 42.7 mtp180 -87.47 -18.3 30.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.031 -0.532 . . . . 4.7300000000000004 112.157 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -145.25 -171.59 15.04 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 119.056 -1.545 . . . . 0.65000000000000002 114.884 -173.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.739 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.0 mttt 61.87 37.5 15.27 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 114.319 -0.94 . . . . 1.0800000000000001 110.887 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 80.4 m-85 -120.71 173.99 6.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.275 -1.33 . . . . 1.8899999999999999 108.281 170.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 12.1 mmmm -117.27 123.53 46.8 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.679 -0.408 . . . . 1.29 111.679 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 17' ' ' VAL . 6.6 m -57.98 -26.09 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.852 -0.613 . . . . 0.78000000000000003 110.791 174.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -68.15 -43.59 77.93 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.905 -0.589 . . . . 0.67000000000000004 109.93 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.587 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 23.7 m -61.88 -39.16 90.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.77000000000000002 110.273 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -62.53 -48.85 77.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.248 -0.433 . . . . 0.92000000000000004 110.96 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.8 ptp180 -67.38 -33.8 75.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.86 -0.336 . . . . 2.8900000000000001 110.723 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 48.8 mtmt -67.94 -28.63 67.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 0.96999999999999997 110.825 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -72.8 -51.88 17.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 110.965 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.741 ' HB2' HD13 ' A' ' 160' ' ' LEU . 12.3 m-85 -84.48 -2.11 56.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.363 -0.38 . . . . 5.4500000000000002 111.978 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 19.4 mm-40 69.19 45.63 0.86 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.689 0.757 . . . . 2.4199999999999999 110.932 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.741 HD13 ' HB2' ' A' ' 158' ' ' TYR . 5.7 mp -99.53 140.17 34.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.768 -1.106 . . . . 1.27 109.541 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -88.97 -84.43 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 3.5899999999999999 111.451 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.53 163.16 48.93 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.76000000000000001 109.579 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.498 ' HB2' ' CA ' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.8 133.27 41.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.48 2.12 . . . . 0.53000000000000003 112.128 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.848 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -89.12 -31.49 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 108.927 -0.768 . . . . 0.44 108.927 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.77 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.57 144.64 24.58 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.5 -0.773 . . . . 0.27000000000000002 111.261 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.665 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.94 146.82 16.66 Favored Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 115.006 -0.997 . . . . 0.23999999999999999 111.682 176.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.786 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.4 t -160.11 131.21 5.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.945 -0.761 . . . . 0.34000000000000002 108.945 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 16.5 p -110.91 138.25 47.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.177 0.513 . . . . 1.1100000000000001 110.862 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 120' ' ' TYR . 28.1 p90 -119.57 125.37 48.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.078 -1.082 . . . . 0.80000000000000004 108.078 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -103.92 132.2 50.4 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.754 -0.779 . . . . 2.5299999999999998 109.928 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -124.33 140.04 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 0.59999999999999998 111.613 -172.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.62 151.67 26.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 2.3799999999999999 111.341 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.973 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -76.26 68.35 2.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.21 -0.904 . . . . 3.96 108.949 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.54 -61.53 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.143 -0.935 . . . . 1.53 112.32 -170.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.591 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.2 t70 -171.44 -38.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.868 0.366 . . . . 1.26 111.802 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -80.03 2.04 25.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 2.2200000000000002 110.605 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.973 HG21 ' HA ' ' A' ' 173' ' ' TRP . 48.7 t -69.46 -51.22 17.17 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.761 -0.654 . . . . 0.5 111.371 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.9 Cg_exo -50.29 -31.72 30.6 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.253 1.968 . . . . 0.57999999999999996 112.567 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.68 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.08 -22.68 63.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.401 . . . . 2.1400000000000001 111.42 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.721 HD23 ' HA3' ' A' ' 110' ' ' GLY . 42.6 tp -68.36 -44.45 75.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.313 -0.555 . . . . 0.66000000000000003 109.591 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -61.4 -37.8 84.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.292 -0.633 . . . . 1.8899999999999999 109.292 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.68 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.3 mm-40 -55.19 -42.03 72.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.909 -1.041 . . . . 1.53 110.319 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.629 ' HA ' ' HB2' ' A' ' 187' ' ' LYS . 5.4 tt0 -77.35 -35.31 54.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 1.49 112.453 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.591 ' HA ' ' H ' ' A' ' 142' ' ' SER . 80.7 mt -63.34 -2.85 1.63 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.003 0.372 . . . . 0.76000000000000001 112.003 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.765 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.4 m -81.53 13.94 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 1.05 109.566 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.601 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 69.84 46.31 53.59 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.065 -0.97 . . . . 1.1699999999999999 111.201 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.765 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.451 -0.785 . . . . 2.0 109.993 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.835 0.35 . . . . 1.47 110.277 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.558 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 15.6 t70 -162.2 156.57 21.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.816 -0.809 . . . . 1.8100000000000001 108.816 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.457 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.8 mm? -80.46 20.8 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.657 0.265 . . . . 0.69999999999999996 111.101 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -11.73 61.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.126 0.488 . . . . 1.96 110.906 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.566 ' HB3' HD12 ' A' ' 12' ' ' LEU . 95.3 mttt -116.86 30.88 7.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 2.6600000000000001 110.352 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.821 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -75.62 -23.4 56.37 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.452 0.538 . . . . 3.98 112.452 -173.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 13.7 p -152.9 26.47 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 0.63 111.199 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.97 -119.66 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.014 -0.834 . . . . 0.47999999999999998 111.014 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 19.4 Cg_endo -55.47 -36.47 94.27 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.832 2.355 . . . . 0.53000000000000003 110.329 164.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.761 HD11 ' HA3' ' A' ' 38' ' ' GLY . 13.4 mt -89.05 85.74 6.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.638 -1.164 . . . . 1.1699999999999999 110.669 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -74.78 62.41 1.08 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.70999999999999996 110.728 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.577 HD22 ' CG2' ' A' ' 121' ' ' VAL . 46.7 mt -78.03 -16.67 57.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.45000000000000001 111.577 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.49 -12.29 56.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.272 0.558 . . . . 2.1200000000000001 110.43 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -67.92 -20.27 65.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 1.9299999999999999 111.056 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.814 HG11 HG21 ' A' ' 69' ' ' THR . 70.6 t -92.09 -66.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.794 -0.639 . . . . 0.63 110.791 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.75 170.86 14.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 2.9900000000000002 110.682 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -70.22 105.79 3.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 1.6000000000000001 109.285 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.821 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 27.5 mm-40 -47.53 134.73 10.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 O-C-N 123.91 0.756 . . . . 3.5499999999999998 112.346 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 39.0 Cg_exo -62.43 169.04 8.72 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.389 3.392 . . . . 0.57999999999999996 114.898 -167.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.901 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 11.4 pt20 -82.25 -13.25 57.33 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.74 -1.118 . . . . 1.3899999999999999 111.907 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.77 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.6 m170 -149.09 159.52 37.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.871 -0.604 . . . . 1.45 109.544 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 3.9 Cg_endo -85.44 127.96 3.4 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.079 2.519 . . . . 0.40000000000000002 111.101 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 122' ' ' TRP . 26.9 tp -78.0 147.84 34.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.735 0.303 . . . . 0.28999999999999998 110.854 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -116.72 107.72 15.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.867 -0.42 . . . . 1.24 109.867 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.903 HG13 HG22 ' A' ' 53' ' ' ILE . 6.9 t -114.56 127.91 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.085 -0.709 . . . . 0.46999999999999997 109.085 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -126.27 138.82 53.65 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.923 0.392 . . . . 0.31 110.678 -176.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.42 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 36.6 t80 -101.51 170.96 7.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.019 -0.537 . . . . 0.67000000000000004 109.66 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.82 68.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.463 0.649 . . . . 0.55000000000000004 110.654 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -112.47 13.67 25.42 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.253 -0.885 . . . . 0.81000000000000005 112.511 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.4 -171.1 3.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.935 0.398 . . . . 0.46999999999999997 110.634 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.48 147.1 10.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.757 -0.656 . . . . 0.33000000000000002 110.203 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.842 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -104.36 58.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.084 -1.45 . . . . 0.39000000000000001 107.084 165.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.74 30.26 1.85 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.98999999999999999 109.793 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.4 tt0 -157.86 127.91 6.14 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.126 -0.943 . . . . 2.5600000000000001 108.827 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.591 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -68.58 111.17 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.40999999999999998 110.026 -176.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.761 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.11 14.86 63.64 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.447 -0.797 . . . . 0.58999999999999997 112.756 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.842 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.89 147.03 47.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 0.34000000000000002 109.653 175.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.2 p -74.38 132.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.912 0.387 . . . . 0.55000000000000004 110.956 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.56 HD22 HG22 ' A' ' 34' ' ' VAL . 6.3 tp -132.46 167.21 20.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.952 -0.759 . . . . 0.45000000000000001 108.952 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.86 157.07 47.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.699 0.629 . . . . 0.56000000000000005 112.699 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 89.3 Cg_exo -50.56 -45.84 32.77 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.158 2.572 . . . . 0.68000000000000005 113.044 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.63 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 8.2 p -54.65 -39.63 68.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.58 0.705 . . . . 0.76000000000000001 111.214 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -83.32 -7.91 59.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.01 -0.995 . . . . 1.5900000000000001 112.425 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' CE1' ' A' ' 169' ' ' TYR . 17.8 m -131.84 27.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.372 0.606 . . . . 0.66000000000000003 111.543 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -95.55 5.36 51.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.79000000000000004 110.574 -175.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -152.5 179.02 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 109.442 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -68.53 148.47 98.12 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.118 -0.327 . . . . 1.4299999999999999 110.118 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.43 166.29 26.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.059 1.839 . . . . 0.37 110.823 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -87.92 -19.09 27.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.894 -0.41 . . . . 0.44 109.894 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.531 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 47.6 m -158.1 143.11 16.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.785 0.661 . . . . 0.38 112.785 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.903 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.27 157.67 25.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.502 -1.226 . . . . 0.29999999999999999 107.915 170.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.897 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 t 173.77 135.42 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.11 -0.7 . . . . 0.34999999999999998 109.11 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.789 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -88.96 177.1 6.75 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 2.7200000000000002 108.229 173.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.67 76.86 0.11 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.873 0.368 . . . . 1.51 110.693 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.88 40.4 0.99 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.293 -0.48 . . . . 0.80000000000000004 112.84 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.897 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.5 tt -65.17 127.87 33.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.57999999999999996 110.145 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.2 -30.5 68.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.844 -0.616 . . . . 0.73999999999999999 111.947 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.534 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 44.8 m 72.14 -3.69 2.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.12 -0.946 . . . . 1.03 110.752 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.64 5.7 26.18 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.834 -0.621 . . . . 0.83999999999999997 112.501 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 9.0 mmpt? -111.86 160.33 17.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.614 0.245 . . . . 1.6699999999999999 110.366 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.771 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 mt -97.46 141.85 30.03 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.518 -1.29 . . . . 0.57999999999999996 107.518 168.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CE2' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -136.72 147.2 46.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.842 -0.343 . . . . 0.80000000000000004 110.205 -178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.917 HG23 HG12 ' A' ' 90' ' ' VAL . 4.4 m -95.7 104.76 16.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.622 -0.881 . . . . 0.35999999999999999 108.622 174.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.1 tp -101.7 109.12 20.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.587 -0.733 . . . . 0.58999999999999997 109.387 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 88' ' ' LEU . 20.9 t -115.3 122.45 69.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.405 -0.361 . . . . 0.39000000000000001 110.95 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.911 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -86.62 134.03 33.66 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.744 -0.836 . . . . 0.59999999999999998 108.744 169.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.814 HG21 HG11 ' A' ' 17' ' ' VAL . 13.3 t -138.9 148.56 43.78 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.928 -0.309 . . . . 0.35999999999999999 111.073 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 30.4 t70 -131.22 99.37 17.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.264 0.554 . . . . 1.9199999999999999 110.217 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.531 ' HD3' HG21 ' A' ' 17' ' ' VAL . 10.3 Cg_endo -53.4 -34.29 70.57 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 124.179 3.252 . . . . 1.25 114.437 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.815 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -89.96 40.2 0.99 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.174 0.435 . . . . 1.29 112.174 -168.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.06 144.92 29.65 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.708 -0.224 . . . . 0.5 111.506 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.0 Cg_endo -83.83 -20.58 18.78 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 123.259 -1.559 . . . . 0.62 112.102 -0.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.714 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 77.7 p -134.87 146.82 49.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.75 109.846 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.815 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 58.7 mtp180 -70.3 -22.74 62.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.916 0.339 . . . . 2.8799999999999999 111.916 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.849 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.45 -14.8 45.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.277 0.561 . . . . 1.3799999999999999 110.517 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.44 79.51 4.9 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.004 -0.739 . . . . 1.3700000000000001 109.004 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.97 81.28 1.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.863 2.376 . . . . 0.80000000000000004 113.049 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 13.6 mttm -71.99 -51.57 21.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.514 -1.221 . . . . 1.02 111.251 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.715 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 38.9 m-85 -86.39 19.11 2.89 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.401 -0.818 . . . . 1.1699999999999999 111.896 -167.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 6.7 ttp180 -67.05 127.19 31.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.856 -0.611 . . . . 2.9300000000000002 110.06 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.8 mp0 -98.2 138.61 35.22 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.328 0.251 . . . . 2.23 110.36 -1.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.467 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 5.9 t90 -89.88 105.81 18.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 1.4299999999999999 110.03 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.9 p80 -80.82 122.43 27.18 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.452 0.644 . . . . 1.26 110.203 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.911 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.6 t-160 -61.8 -40.56 95.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.981 -1.009 . . . . 2.1400000000000001 110.649 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 104' ' ' SER . 26.0 p90 -167.17 178.45 5.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.622 -0.511 . . . . 1.51 109.622 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.8 tp -141.84 113.65 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.708 0.289 . . . . 0.33000000000000002 110.247 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.53 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.8 t -120.42 132.47 69.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.817 -0.628 . . . . 0.31 110.573 176.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.917 HG12 HG23 ' A' ' 65' ' ' THR . 3.8 m -129.92 166.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.095 -1.076 . . . . 0.27000000000000002 108.095 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.771 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 91.1 m-20 60.85 20.44 10.65 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 123.486 0.491 . . . . 1.76 111.141 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.52 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -72.28 115.17 11.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.693 -0.854 . . . . 0.31 108.693 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 15.1 ttmm -87.06 93.17 9.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.314 -0.857 . . . . 1.21 111.307 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 60' ' ' SER . . . 80.33 -129.75 9.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 114.829 -1.078 . . . . 0.29999999999999999 112.48 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.473 ' HA ' HD11 ' A' ' 53' ' ' ILE . 26.1 p30 -112.91 22.12 14.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.604 0.716 . . . . 1.04 110.512 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.31 112.79 24.48 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.992 -1.004 . . . . 0.77000000000000002 109.609 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.453 HD13 HD12 ' A' ' 53' ' ' ILE . 5.3 mm -59.95 -27.6 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.358 -1.292 . . . . 0.40999999999999998 111.103 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -69.73 -51.36 34.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.68000000000000005 112.112 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 p -61.85 -20.55 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.822 0.675 . . . . 1.26 112.822 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 92' ' ' MET . . . -52.91 103.08 0.11 Allowed Glycine 0 N--CA 1.449 -0.455 0 O-C-N 123.352 0.408 . . . . 0.34999999999999998 112.92 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.4 m -68.05 107.39 2.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.436 0.636 . . . . 0.45000000000000001 109.773 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.68 120.77 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.896 -1.047 . . . . 0.56999999999999995 111.617 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 133' ' ' CYS . 55.8 mt -99.32 -44.71 6.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.227 1.013 . . . . 0.45000000000000001 109.289 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.9 t -120.51 111.9 18.27 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.885 -1.524 . . . . 0.37 106.885 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.842 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 2.3 t0 -64.84 162.04 17.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.551 -0.75 . . . . 1.1499999999999999 112.018 -170.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 31.0 p90 -81.23 61.22 4.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.339 0.866 . . . . 4.6900000000000004 113.339 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.926 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 27.0 t -37.54 -47.32 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.017 0.927 . . . . 0.85999999999999999 113.365 -171.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 107.12 -172.45 17.97 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.655 -0.783 . . . . 0.67000000000000004 112.505 173.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.4 t -68.9 117.29 10.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.564 -0.532 . . . . 0.51000000000000001 109.564 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.767 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -148.2 61.43 0.44 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.389 -0.91 . . . . 0.81999999999999995 112.662 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.677 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 9.8 Cg_endo -91.87 127.15 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.495 2.796 . . . . 0.84999999999999998 112.734 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.579 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.9 Cg_exo -53.8 146.02 47.53 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.796 2.331 . . . . 0.87 111.775 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.457 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -62.51 119.61 9.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.288 -0.414 . . . . 1.8500000000000001 111.221 -177.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.9 -1.51 55.29 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.861 -0.685 . . . . 1.1799999999999999 113.146 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 77.7 p -77.39 -26.33 51.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.998 0.399 . . . . 0.96999999999999997 112.002 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 -178.61 17.83 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.953 -0.641 . . . . 1.97 112.232 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.4 mm? -81.8 116.85 21.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.615 0.245 . . . . 0.93999999999999995 110.39 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.695 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 40.6 m-70 -92.81 126.8 38.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.416 -0.356 . . . . 2.23 110.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.505 ' HD2' HD21 ' A' ' 14' ' ' LEU . 8.9 ptt180 -108.56 85.92 2.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.757 -0.656 . . . . 2.3100000000000001 110.664 -172.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.51 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 5.8 m-85 -69.73 116.69 10.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.592 -0.731 . . . . 0.78000000000000003 109.549 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.577 ' CG2' HD22 ' A' ' 14' ' ' LEU . 15.1 t -97.43 128.96 48.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.037 -0.528 . . . . 0.27000000000000002 110.714 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.679 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 48.7 m95 -88.57 121.54 31.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.177 -0.675 . . . . 1.99 109.177 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.2 mt -118.31 119.91 36.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.624 0.193 . . . . 0.38 110.791 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.497 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -117.52 140.0 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.722 0.296 . . . . 0.31 111.121 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.716 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 89.3 t80 -129.53 129.09 44.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.177 -0.465 . . . . 5.1200000000000001 109.812 174.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.63 103.2 2.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.549 0.69 . . . . 2.4100000000000001 109.22 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 23.0 mt-30 -58.41 135.85 57.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.033 -0.985 . . . . 1.3100000000000001 112.028 -171.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.8 -13.25 61.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.486 -0.779 . . . . 2.3999999999999999 109.603 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.544 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 7.7 ptp180 -173.51 161.75 3.31 Favored Pre-proline 0 CA--C 1.515 -0.381 0 CA-C-N 114.838 -1.073 . . . . 3.5099999999999998 109.637 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.58 136.22 65.74 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.9 2.4 . . . . 1.21 110.691 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 158' ' ' TYR . 4.1 mm? -68.11 146.89 53.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.721 1.008 . . . . 0.90000000000000002 113.721 -167.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -99.1 96.52 7.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.176 -1.375 . . . . 2.8999999999999999 108.073 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.455 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.4 p -124.88 109.64 13.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.91 -0.586 . . . . 1.8999999999999999 111.728 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -102.72 18.18 22.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.908 -0.775 . . . . 2.96 108.908 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.79 135.41 96.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.183 -0.917 . . . . 1.3899999999999999 111.195 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.5 113.89 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.39 2.727 . . . . 1.27 112.531 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.49 120.28 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.85999999999999999 110.056 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 71.3 mt -99.66 154.59 18.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.13 0.49 . . . . 1.6100000000000001 110.54 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.704 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 72.1 m -108.03 31.56 5.43 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.263 -0.881 . . . . 1.8799999999999999 109.689 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.926 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 54.9 12.53 0.61 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.485 1.116 . . . . 0.75 111.553 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 139' ' ' SER . 17.1 mtm180 -96.71 146.85 24.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.3599999999999999 110.097 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.654 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.4 m 77.89 131.14 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.519 1.137 . . . . 0.94999999999999996 111.958 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.624 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -87.46 -6.5 77.46 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.086 -0.961 . . . . 1.1200000000000001 112.655 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.46 -42.75 70.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.605 0.717 . . . . 2.6600000000000001 111.374 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -97.3 20.01 12.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.354 -0.839 . . . . 1.8700000000000001 111.012 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.624 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 63.9 mtt180 -76.7 -69.92 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 4.7300000000000004 111.835 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.509 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -117.3 -173.01 16.32 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.217 -0.992 . . . . 0.65000000000000002 113.369 -171.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.715 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.5 mttt 68.33 21.89 8.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.728 0.775 . . . . 1.0800000000000001 110.602 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.661 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 87.7 m-85 -111.3 97.71 6.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.807 -1.088 . . . . 1.8899999999999999 108.476 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 13.2 mmmm -59.49 123.27 16.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 1.29 112.168 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.568 HG21 ' CG1' ' A' ' 17' ' ' VAL . 16.8 m -63.84 -25.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.242 -0.89 . . . . 0.78000000000000003 110.6 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.73 72.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.67000000000000004 109.608 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 m -59.81 -43.7 94.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.77000000000000002 110.633 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 149' ' ' PHE . 7.0 m-85 -58.56 -53.27 60.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.037 -0.528 . . . . 0.92000000000000004 111.584 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -69.76 -39.74 76.52 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.479 -0.488 . . . . 2.8900000000000001 111.379 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.61 -32.3 72.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.97 0.414 . . . . 0.96999999999999997 110.405 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -66.8 -51.38 56.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.527 -0.76 . . . . 1.5800000000000001 110.918 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.851 ' HB3' HD11 ' A' ' 131' ' ' LEU . 21.6 m-85 -80.23 3.91 19.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.075 -0.511 . . . . 5.4500000000000002 111.744 -172.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 8.4 mm-40 70.55 30.67 3.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.589 0.555 . . . . 2.4199999999999999 111.016 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.716 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.3 mp -102.34 134.24 45.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.563 -0.744 . . . . 1.27 109.79 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 7.8 tpt180 -102.74 -78.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 3.5899999999999999 111.181 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -125.85 145.77 52.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 0.76000000000000001 110.805 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 2.9 Cg_exo -74.61 161.63 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.908 3.072 . . . . 0.53000000000000003 113.537 -172.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.901 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 14.4 t -91.43 -26.88 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.632 -1.167 . . . . 0.44 109.895 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.789 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -152.58 145.2 24.2 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.003 -0.679 . . . . 0.27000000000000002 112.231 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.44 151.05 23.36 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.035 -0.984 . . . . 0.23999999999999999 112.018 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.591 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.1 t -165.57 141.15 5.11 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.449 -0.945 . . . . 0.34000000000000002 108.449 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.609 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 17.3 p -119.0 149.32 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.034 -0.667 . . . . 1.1100000000000001 111.045 -175.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.606 ' CE1' HG11 ' A' ' 46' ' ' VAL . 35.7 p90 -130.32 129.71 43.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.94 -1.133 . . . . 0.80000000000000004 107.94 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.695 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -101.52 133.78 45.63 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.867 -0.733 . . . . 2.5299999999999998 111.417 177.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.94 152.17 49.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.59999999999999998 109.501 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.603 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -126.37 -162.41 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.006 0.432 . . . . 2.3799999999999999 111.322 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.457 ' CG ' ' HG2' ' A' ' 113' ' ' LYS . 89.6 t90 -70.46 103.2 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.96 -0.564 . . . . 3.96 110.343 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 2.0 t70 -73.69 -62.06 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.583 -0.28 . . . . 1.53 110.371 171.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.586 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 11.5 t70 169.45 -50.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 1.26 110.434 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.63 ' OH ' ' HA ' ' A' ' 44' ' ' THR . 2.4 p90 -82.72 9.8 8.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.189 0.519 . . . . 2.2200000000000002 111.094 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.767 HG13 ' HA2' ' A' ' 110' ' ' GLY . 48.1 t -58.47 -49.15 95.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.972 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 175' ' ' ASP . 72.9 Cg_exo -47.89 -33.75 20.59 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.039 2.493 . . . . 0.57999999999999996 112.899 168.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 3.0 mmmp? -72.69 -25.56 61.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.636 0.255 . . . . 2.1400000000000001 111.108 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.528 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 62.5 tp -70.58 -44.29 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.049 -0.723 . . . . 0.66000000000000003 109.049 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.27 -32.95 74.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.316 -0.856 . . . . 1.8899999999999999 109.446 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.5 mm-40 -60.84 -38.29 85.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.955 -1.02 . . . . 1.53 111.02 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.33 -27.08 56.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.74 -0.663 . . . . 1.49 111.439 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.654 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.2 mt -65.93 6.6 0.35 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.852 0.686 . . . . 0.76000000000000001 112.852 -177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.746 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.2 m -77.15 8.31 4.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 1.05 109.955 173.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 68.89 50.54 34.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.104 -0.798 . . . . 1.1699999999999999 111.104 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.746 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.8 mmmt . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.667 -0.682 . . . . 2.0 110.582 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 110.275 -0.268 . . . . 1.47 110.275 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.776 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 2.2 p30 -163.39 179.93 6.98 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.142 -1.058 . . . . 1.8100000000000001 108.142 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 8' ' ' TRP . 2.7 mm? -80.93 36.01 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.69999999999999996 110.866 -170.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -51.91 -40.1 60.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 1.96 111.834 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.572 ' HB2' HD12 ' A' ' 12' ' ' LEU . 92.0 mttt -116.17 46.16 1.62 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.868 -0.419 . . . . 2.6600000000000001 109.868 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.639 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -66.43 -24.21 66.42 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.286 -0.416 . . . . 3.98 111.328 -173.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.1 p -151.6 26.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.951 -0.3 . . . . 0.63 111.347 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.505 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.85 -125.5 0.81 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.888 -0.885 . . . . 0.47999999999999998 110.888 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -52.02 -36.29 64.45 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.109 2.54 . . . . 0.53000000000000003 110.342 167.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.773 HD11 ' HA3' ' A' ' 38' ' ' GLY . 35.3 mt -87.87 79.26 8.14 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.825 -1.08 . . . . 1.1699999999999999 109.606 171.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -71.44 66.73 0.48 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.615 0.722 . . . . 0.70999999999999996 109.82 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.927 HD23 HH11 ' A' ' 119' ' ' ARG . 44.1 mt -80.45 -16.39 54.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.741 -0.663 . . . . 0.45000000000000001 110.65 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -64.13 -16.17 61.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.589 -0.732 . . . . 2.1200000000000001 111.225 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.551 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 39.3 mt-10 -62.34 -30.33 71.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.189 0.519 . . . . 1.9299999999999999 110.546 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 69' ' ' THR . 85.7 t -93.41 -64.03 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.63 111.16 -174.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 163' ' ' PRO . 7.1 p-10 -130.04 169.05 15.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.152 -0.476 . . . . 2.9900000000000002 110.219 -171.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -74.57 88.16 2.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.443 -0.947 . . . . 1.6000000000000001 108.443 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 2.7 tp-100 -38.34 122.61 1.1 Allowed Pre-proline 0 C--O 1.237 0.433 0 O-C-N 124.925 1.391 . . . . 3.5499999999999998 111.901 -166.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.724 ' HG3' ' HB2' ' A' ' 163' ' ' PRO . 81.5 Cg_exo -50.29 161.64 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 125.235 3.957 . . . . 0.57999999999999996 116.193 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 12.6 pt20 -79.1 -6.96 57.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 113.837 -1.529 . . . . 1.3899999999999999 111.46 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.722 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.6 m170 -154.28 158.85 32.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.468 -0.787 . . . . 1.45 109.236 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.776 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 6.0 Cg_endo -86.74 129.12 2.98 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.193 2.595 . . . . 0.40000000000000002 111.844 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 ' HB3' ' A' ' 122' ' ' TRP . 21.5 tp -78.88 144.54 34.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.654 -0.248 . . . . 0.28999999999999998 110.728 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.403 ' H ' HD12 ' A' ' 25' ' ' LEU . 86.2 m-70 -112.64 112.94 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 1.24 109.89 174.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 53' ' ' ILE . 12.0 t -121.12 137.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.423 -0.584 . . . . 0.46999999999999997 109.423 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.557 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -132.4 141.24 48.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.271 0.558 . . . . 0.31 111.063 -177.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -103.14 173.32 6.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.857 -0.794 . . . . 0.67000000000000004 108.857 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.41 -52.29 65.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.291 0.567 . . . . 0.55000000000000004 110.347 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.96 14.77 23.83 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.178 -0.919 . . . . 0.81000000000000005 112.999 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.54 -172.25 4.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.46999999999999997 111.148 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.95 151.61 12.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.71 -0.677 . . . . 0.33000000000000002 110.05 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.795 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 86.2 t -109.23 65.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.157 -1.423 . . . . 0.39000000000000001 107.157 164.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.83 21.07 16.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.002 -0.999 . . . . 0.98999999999999999 109.15 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -145.83 128.1 15.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.687 -1.227 . . . . 2.5600000000000001 107.687 176.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -77.96 111.74 14.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.611 0.72 . . . . 0.40999999999999998 110.803 -170.122 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 83.17 22.35 57.28 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.742 -1.117 . . . . 0.58999999999999997 111.385 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -77.68 148.73 34.84 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.388 -0.597 . . . . 0.34000000000000002 109.388 173.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.96 133.44 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.001 0.429 . . . . 0.55000000000000004 110.874 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.566 HD22 HG22 ' A' ' 34' ' ' VAL . 7.4 tp -131.58 170.29 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.45000000000000001 108.618 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.6 p -120.03 158.46 50.25 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.317 0.858 . . . . 0.56000000000000005 113.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 74.9 Cg_exo -50.29 -49.19 17.12 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.438 2.759 . . . . 0.68000000000000005 113.569 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.7 p -55.72 -42.83 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.462 0.649 . . . . 0.76000000000000001 111.52 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -73.21 -12.32 60.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.874 -1.057 . . . . 1.5900000000000001 112.225 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.562 ' CG1' HD23 ' A' ' 41' ' ' LEU . 31.5 m -131.7 28.25 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.087 0.47 . . . . 0.66000000000000003 111.455 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -85.12 -33.85 22.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.818 -0.628 . . . . 0.79000000000000004 110.467 -176.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.46 -155.89 0.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.786 -0.643 . . . . 1.9099999999999999 109.556 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -84.01 157.19 63.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.394 -0.595 . . . . 1.4299999999999999 109.394 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.4 160.44 28.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.755 1.637 . . . . 0.37 110.594 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -82.15 -20.72 37.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.105 -0.332 . . . . 0.44 110.105 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 57.9 m -160.32 144.86 14.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.239 0.542 . . . . 0.38 112.056 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.971 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.1 168.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.154 -0.93 . . . . 0.29999999999999999 108.575 171.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.02 ' HA ' HD13 ' A' ' 58' ' ' LEU . 29.3 t 174.04 122.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.462 -0.57 . . . . 0.34999999999999998 109.462 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.737 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -79.45 179.52 7.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.337 -0.986 . . . . 2.7200000000000002 108.337 174.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.8 80.8 0.29 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.15 0.5 . . . . 1.51 110.473 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.17 41.58 1.51 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.633 -0.712 . . . . 0.80000000000000004 112.386 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.02 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -55.54 133.74 50.41 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.83 0.452 . . . . 0.57999999999999996 111.51 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.55 -27.38 60.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.848 -0.615 . . . . 0.73999999999999999 111.867 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.626 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 49.3 m 68.23 8.32 6.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.561 -0.745 . . . . 1.03 110.834 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.689 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -137.17 -47.87 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.905 -0.589 . . . . 0.83999999999999997 112.662 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.798 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 8.3 mmpt? -58.66 144.54 42.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.231 0.538 . . . . 1.6699999999999999 111.411 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.735 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 31.0 mt -86.82 127.73 35.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.111 -0.95 . . . . 0.57999999999999996 109.486 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.798 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -122.3 158.66 29.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.55 -0.46 . . . . 0.80000000000000004 110.278 176.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.724 HG23 HG12 ' A' ' 90' ' ' VAL . 96.0 m -98.51 109.39 22.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.392 -0.596 . . . . 0.35999999999999999 109.392 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 tp -106.15 116.83 32.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 110.052 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.9 t -120.98 132.43 70.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.76 0.314 . . . . 0.39000000000000001 110.74 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.922 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -97.49 131.57 44.0 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.508 -0.923 . . . . 0.59999999999999998 108.508 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.716 HG21 HG11 ' A' ' 17' ' ' VAL . 11.0 t -138.82 147.53 42.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.142 0.428 . . . . 0.35999999999999999 111.657 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 25.6 t70 -131.28 97.43 19.82 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.161 0.505 . . . . 1.9199999999999999 109.805 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.9 Cg_endo -51.63 -34.56 53.58 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.99 3.127 . . . . 1.25 114.298 176.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.737 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -86.97 44.82 1.2 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.654 0.612 . . . . 1.29 112.654 -170.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.08 142.12 23.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.687 -0.233 . . . . 0.5 110.706 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 92.1 Cg_endo -85.07 -24.76 9.58 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 123.465 -1.473 . . . . 0.62 113.096 -0.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.714 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 13.2 p -128.76 146.45 50.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.75 109.793 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.737 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 50.8 mtp180 -65.99 -21.89 66.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 2.8799999999999999 111.141 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 6.0 ptpt -79.66 -14.26 58.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 1.3799999999999999 110.829 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 16.4 t70 -162.09 80.51 1.88 Allowed Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.007 -0.542 . . . . 1.3700000000000001 110.188 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 85.6 Cg_endo -80.95 87.21 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.543 2.162 . . . . 0.80000000000000004 112.93 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -74.74 -50.97 15.49 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.738 -1.119 . . . . 1.02 110.661 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.708 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.1 m-85 -85.45 21.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 1.1699999999999999 111.742 -166.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.551 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 29.4 ttt180 -71.66 129.56 38.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.382 -0.372 . . . . 2.9300000000000002 110.685 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 3.0 mp0 -96.44 132.04 42.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.859 0.361 . . . . 2.23 110.632 -3.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.56 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 11.9 t90 -82.65 140.3 33.23 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.012 -0.736 . . . . 1.4299999999999999 109.012 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 28.6 p80 -117.72 127.15 53.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.633 0.73 . . . . 1.26 111.258 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.922 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 15.5 t-80 -65.45 -35.89 82.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.806 -1.088 . . . . 2.1400000000000001 110.36 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.548 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 12.0 p90 -168.06 176.79 5.9 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.651 -0.249 . . . . 1.51 110.363 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.55 ' HG ' HD12 ' A' ' 103' ' ' LEU . 21.5 tp -135.77 113.53 11.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.33000000000000002 109.657 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.714 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.9 t -119.66 133.23 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.648 -0.706 . . . . 0.31 110.19 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.897 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 22.2 m -133.94 161.75 40.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.285 -0.871 . . . . 0.27000000000000002 108.956 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t30 60.71 22.01 11.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.661 0.601 . . . . 1.76 110.353 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.714 ' HE3' HG11 ' A' ' 89' ' ' VAL . 6.7 ttm -71.88 110.3 6.31 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.175 -0.676 . . . . 0.31 109.175 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 20.9 ttmm -80.34 98.28 7.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.21 . . . . 1.21 111.133 -173.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.81 -121.76 20.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.603 -0.726 . . . . 0.29999999999999999 112.509 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.8 p-10 -113.26 21.42 15.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.567 -0.316 . . . . 1.04 111.735 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -89.51 104.22 16.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.415 0.626 . . . . 0.77000000000000002 109.848 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 97' ' ' ILE . 5.2 mm -55.55 -31.28 28.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.584 -1.189 . . . . 0.40999999999999998 111.561 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -81.04 -26.38 36.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.68000000000000005 111.602 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.05 -13.04 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.492 -0.322 . . . . 1.26 111.225 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.62 100.53 0.83 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.78 -0.724 . . . . 0.34999999999999998 111.579 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.2 m -60.24 106.55 0.54 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.476 0.655 . . . . 0.45000000000000001 109.668 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -80.19 113.1 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.847 -1.07 . . . . 0.56999999999999995 111.214 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.55 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.7 mt -93.2 -41.97 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.99 0.9 . . . . 0.45000000000000001 109.243 174.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 11.9 t -122.68 112.22 17.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.192 -1.41 . . . . 0.37 107.192 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 3.4 t70 -59.96 164.41 3.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.652 -0.704 . . . . 1.1499999999999999 112.217 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 10.3 p90 -79.24 72.27 5.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.269 -0.878 . . . . 4.6900000000000004 111.002 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.725 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 28.1 t -51.45 -44.68 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 0.85999999999999999 111.447 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.69 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 97.72 -171.75 26.57 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.26 -0.971 . . . . 0.67000000000000004 113.416 171.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 41.0 t -73.42 128.68 36.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.778 -0.452 . . . . 0.51000000000000001 109.778 174.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.602 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . 171.99 58.64 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.211 -0.995 . . . . 0.81999999999999995 113.706 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.405 ' HD3' ' H ' ' A' ' 110' ' ' GLY . 62.9 Cg_endo -86.69 -176.66 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.628 2.219 . . . . 0.84999999999999998 111.005 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.628 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 48.1 Cg_exo -57.14 142.25 94.38 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.464 1.443 . . . . 0.87 111.81 172.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.414 ' CD ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -66.1 114.69 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.514 -0.766 . . . . 1.8500000000000001 111.46 -177.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.15 12.7 38.59 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 1.1799999999999999 113.698 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 34.0 p -81.65 2.09 31.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.82 1.044 . . . . 0.96999999999999997 113.82 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.25 -179.73 27.16 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.612 -0.804 . . . . 1.97 112.375 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -83.41 118.03 23.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.938 0.399 . . . . 0.93999999999999995 110.141 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.692 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 47.1 m-70 -91.39 117.76 29.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.103 -0.499 . . . . 2.23 110.952 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.927 HH11 HD23 ' A' ' 14' ' ' LEU . 9.9 ptt180 -91.51 82.01 5.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.67 -0.695 . . . . 2.3100000000000001 111.313 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.548 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 42.4 m-85 -67.76 109.39 3.33 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.753 -0.832 . . . . 0.78000000000000003 108.753 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 14' ' ' LEU . 21.9 t -88.09 127.32 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.901 -0.59 . . . . 0.27000000000000002 109.971 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.846 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.92 117.53 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.486 -0.931 . . . . 1.99 108.486 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 mt -121.26 127.57 51.52 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.959 0.162 . . . . 0.38 110.899 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.602 HG21 ' HE3' ' A' ' 55' ' ' TRP . 1.1 m -114.4 131.54 66.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.459 -0.496 . . . . 0.31 109.917 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.729 ' HB2' HD23 ' A' ' 160' ' ' LEU . 48.4 m-85 -111.95 149.13 32.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.325 -0.62 . . . . 5.1200000000000001 109.325 176.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.93 126.66 48.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.671 0.748 . . . . 2.4100000000000001 110.449 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.506 ' HG2' HD21 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -96.82 175.51 6.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.183 -0.917 . . . . 1.3100000000000001 108.714 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.53 2.71 42.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.547 0.689 . . . . 2.3999999999999999 109.498 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.407 ' H ' ' HB2' ' A' ' 127' ' ' GLN . 1.3 ptp180 -160.66 164.98 18.24 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.947 -1.024 . . . . 3.5099999999999998 111.206 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.01 155.42 33.81 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.027 2.485 . . . . 1.21 110.946 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.897 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.4 mm? -84.14 145.91 28.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.311 0.577 . . . . 0.90000000000000002 112.143 -172.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -124.31 66.06 1.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.142 -0.935 . . . . 2.8999999999999999 108.741 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 5.2 m -93.6 120.99 34.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.537 -0.756 . . . . 1.8999999999999999 110.395 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.88 14.97 30.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 2.96 109.936 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -64.73 132.14 95.35 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.429 -0.805 . . . . 1.3899999999999999 110.563 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -47.09 117.08 2.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.539 2.826 . . . . 1.27 113.067 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.19 118.67 6.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.85999999999999999 110.496 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.4 mt -92.7 156.08 17.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 1.6100000000000001 110.608 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 50.2 m -116.03 32.57 6.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.8799999999999999 110.172 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.725 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER 66.75 -21.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.238 1.415 . . . . 0.75 113.45 175.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 54.9 mtt180 -78.31 135.44 37.51 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.776 -0.37 . . . . 3.3599999999999999 110.868 -175.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.713 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 62.1 m 81.84 146.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.559 -1.201 . . . . 0.94999999999999996 110.674 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.453 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -108.22 12.71 37.04 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.867 -0.682 . . . . 1.1200000000000001 113.038 -170.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.17 -15.22 62.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.324 0.49 . . . . 2.6600000000000001 112.324 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -121.58 34.85 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.087 0.47 . . . . 1.8700000000000001 110.324 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.453 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 26.6 mtt180 -81.05 -69.68 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.662 -0.699 . . . . 4.7300000000000004 111.902 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -128.31 -164.38 11.55 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.447 -0.882 . . . . 0.65000000000000002 112.763 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.708 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 65.43 25.27 11.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.441 0.639 . . . . 1.0800000000000001 110.229 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.26 112.31 21.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.083 -0.962 . . . . 1.8899999999999999 109.095 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 13.7 mmmm -67.18 122.17 17.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.805 -0.634 . . . . 1.29 111.525 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.801 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.2 m -62.85 -27.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.78000000000000003 110.351 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.31 -43.34 99.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.759 172.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 34.9 m -63.87 -39.33 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.944 -0.571 . . . . 0.77000000000000002 110.618 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.801 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 50.4 m-85 -58.81 -52.05 67.37 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.649 -0.251 . . . . 0.92000000000000004 110.999 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.943 -0.303 . . . . 2.8900000000000001 111.358 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.4 mtmt -64.17 -42.25 96.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.38 0.609 . . . . 0.96999999999999997 109.935 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -58.77 -53.27 60.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 1.5800000000000001 111.449 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.41 -3.33 58.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 5.4500000000000002 111.493 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 68.22 40.89 2.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.792 -0.64 . . . . 2.4199999999999999 111.27 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.729 HD23 ' HB2' ' A' ' 125' ' ' TYR . 5.4 mp -95.97 146.34 24.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.451 -0.795 . . . . 1.27 112.008 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.755 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 14.5 tpt180 -82.73 -171.24 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.291 -0.868 . . . . 3.5899999999999999 109.853 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.755 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -60.98 155.74 52.35 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.76000000000000001 110.639 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.724 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 13.2 Cg_exo -66.7 141.93 61.89 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.968 2.445 . . . . 0.53000000000000003 112.279 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.861 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 12.2 t -89.47 -34.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.794 -0.639 . . . . 0.44 110.092 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.737 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -146.26 141.37 27.28 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.903 -0.719 . . . . 0.27000000000000002 112.128 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.56 148.94 20.93 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.024 -0.989 . . . . 0.23999999999999999 111.976 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.6 t -159.85 133.05 6.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.798 -0.816 . . . . 0.34000000000000002 108.798 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.576 ' SG ' HD13 ' A' ' 12' ' ' LEU . 22.2 p -111.07 142.42 43.25 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 1.1100000000000001 111.33 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.548 ' CE2' ' HB2' ' A' ' 120' ' ' TYR . 32.3 p90 -126.61 134.14 50.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.567 -0.901 . . . . 0.80000000000000004 108.567 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.807 HE22 ' HA2' ' A' ' 38' ' ' GLY . 24.1 mp0 -98.6 131.88 44.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.212 -0.595 . . . . 2.5299999999999998 110.104 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -121.21 142.37 49.98 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.36 0.412 . . . . 0.59999999999999998 110.345 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -97.18 -171.8 2.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 2.3799999999999999 111.263 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.853 ' HA ' HG21 ' A' ' 177' ' ' VAL . 28.5 p90 -97.41 53.62 1.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.226 -0.897 . . . . 3.96 110.508 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.506 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 32.6 t70 -60.28 -61.74 2.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.6 0.963 . . . . 1.53 113.6 -168.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.668 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.9 t70 -167.4 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.017 0.377 . . . . 1.26 112.017 -175.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -71.95 -3.89 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.148 0.499 . . . . 2.2200000000000002 110.876 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.853 HG21 ' HA ' ' A' ' 173' ' ' TRP . 25.6 t -71.02 -55.1 6.78 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.749 . . . . 0.5 111.316 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.729 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.4 Cg_exo -58.2 -32.09 94.98 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.999 1.799 . . . . 0.57999999999999996 111.764 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.3 mmmt -74.06 -24.77 59.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 2.1400000000000001 111.913 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.686 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 43.9 tp -70.53 -47.25 61.33 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.13 -0.628 . . . . 0.66000000000000003 109.375 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -59.27 -35.46 73.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.603 -0.726 . . . . 1.8899999999999999 109.405 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.3 -51.48 68.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.807 -1.088 . . . . 1.53 111.002 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -69.17 -32.04 71.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 1.49 112.277 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.713 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.1 mt -62.77 3.65 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.503 0.927 . . . . 0.76000000000000001 113.503 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.611 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 47.7 m -82.84 13.34 3.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.413 0.625 . . . . 1.05 109.336 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.82 44.1 57.14 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.368 -0.833 . . . . 1.1699999999999999 111.162 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 28.8 mmmt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.344 -0.836 . . . . 2.0 109.841 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 37' ' ' LEU . 21.2 t . . . . . 0 C--O 1.235 0.295 0 N-CA-C 110.217 -0.29 . . . . 1.47 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.27 33.93 0.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.057 0.932 . . . . 1.8100000000000001 110.49 -173.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.552 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.5 mm? 60.11 20.86 10.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.414 -1.266 . . . . 0.69999999999999996 110.757 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.72 -33.72 64.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.613 0.765 . . . . 1.96 112.334 -171.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.645 ' CB ' HD12 ' A' ' 12' ' ' LEU . 76.1 mttt -135.75 50.18 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.207 -0.451 . . . . 2.6600000000000001 110.375 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.432 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -72.87 -28.71 62.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.341 0.497 . . . . 3.98 112.341 -176.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 19.5 p -152.65 29.11 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.63 111.208 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.26 -122.69 0.83 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.957 -0.857 . . . . 0.47999999999999998 110.957 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.6 Cg_endo -52.8 -37.56 76.7 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.222 2.615 . . . . 0.53000000000000003 110.343 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.833 HD11 ' HA3' ' A' ' 38' ' ' GLY . 16.5 mt -87.73 83.06 7.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.951 -1.022 . . . . 1.1699999999999999 109.657 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -73.5 63.42 0.8 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.519 0.676 . . . . 0.70999999999999996 110.497 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 121' ' ' VAL . 58.9 mt -71.19 -16.6 62.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.729 -0.669 . . . . 0.45000000000000001 109.79 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -70.42 -4.47 22.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.49 -0.777 . . . . 2.1200000000000001 110.694 177.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.89 -27.06 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.624 -0.88 . . . . 1.9299999999999999 108.624 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 151' ' ' VAL . 60.0 t -99.1 -71.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.609 -1.178 . . . . 0.63 110.408 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HB2' HH22 ' A' ' 155' ' ' ARG . 7.5 p-10 -110.7 153.35 25.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 111.564 -172.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 26.1 mt-10 -65.51 142.15 58.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.001 -1.0 . . . . 1.6000000000000001 109.326 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 98.7 mt-30 -55.61 120.59 33.17 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 123.335 0.397 . . . . 3.5499999999999998 111.132 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 20' ' ' GLN . 23.2 Cg_exo -64.27 162.08 31.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.051 2.501 . . . . 0.57999999999999996 112.685 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.899 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.9 pt20 -84.82 -12.85 52.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.779 -0.646 . . . . 1.3899999999999999 111.217 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.778 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 66.3 m-70 -153.2 161.43 29.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.415 -0.957 . . . . 1.45 108.415 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.7 Cg_endo -88.22 132.27 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.852 2.368 . . . . 0.40000000000000002 112.233 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 122' ' ' TRP . 28.3 tp -78.31 144.75 35.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.807 -0.442 . . . . 0.28999999999999998 109.807 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.463 ' H ' HD12 ' A' ' 25' ' ' LEU . 31.4 m80 -122.81 113.35 19.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.609 -0.515 . . . . 1.24 109.609 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 53' ' ' ILE . 10.6 t -117.65 136.43 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.731 -0.47 . . . . 0.46999999999999997 109.731 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -134.45 136.79 43.48 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.061 0.458 . . . . 0.31 111.076 -176.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -97.16 176.26 5.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.975 -0.75 . . . . 0.67000000000000004 108.975 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.68 62.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.508 0.671 . . . . 0.55000000000000004 110.191 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.91 1.56 31.74 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 115.089 -0.959 . . . . 0.81000000000000005 112.666 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB2' HE21 ' A' ' 45' ' ' GLN . . . -138.16 -174.75 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.633 0.254 . . . . 0.46999999999999997 110.605 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.58 149.64 11.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.154 -0.476 . . . . 0.33000000000000002 110.392 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.815 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 96.2 t -101.78 62.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 106.71 -1.589 . . . . 0.39000000000000001 106.71 163.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.77 -9.3 59.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.032 -1.44 . . . . 0.98999999999999999 110.882 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -131.44 134.56 46.34 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.567 -0.901 . . . . 2.5600000000000001 108.567 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.621 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -75.84 109.62 9.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.376 -0.601 . . . . 0.40999999999999998 109.376 -175.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.833 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 85.07 23.38 49.16 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.391 -0.822 . . . . 0.58999999999999997 112.471 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.815 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -80.19 149.52 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.627 -0.508 . . . . 0.34000000000000002 109.627 171.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -73.86 133.02 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.155 0.502 . . . . 0.55000000000000004 110.983 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.461 HD22 HG22 ' A' ' 34' ' ' VAL . 7.9 tp -131.06 168.55 17.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.115 -1.069 . . . . 0.45000000000000001 108.115 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 23.2 p -121.87 157.13 58.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 119.569 -0.853 . . . . 0.56000000000000005 112.349 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 10.1 Cg_endo -51.53 -41.99 57.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.093 2.529 . . . . 0.68000000000000005 113.028 -176.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -62.71 -26.82 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.111 -0.495 . . . . 0.76000000000000001 112.159 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 32' ' ' ALA . 56.7 mt-30 -82.27 -25.34 34.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.945 -0.571 . . . . 1.5900000000000001 111.289 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 169' ' ' TYR . 18.5 m -122.01 29.11 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.66000000000000003 111.552 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.12 -7.33 58.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.014 -0.539 . . . . 0.79000000000000004 110.202 -177.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.461 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 59.2 m-80 -127.26 -174.91 3.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.603 -0.726 . . . . 1.9099999999999999 109.315 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.597 ' NH2' ' HB ' ' A' ' 102' ' ' VAL . 72.5 mtt180 -77.0 155.11 82.84 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.75 -0.463 . . . . 1.4299999999999999 109.75 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.23 153.42 18.62 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.06 1.84 . . . . 0.37 110.874 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -79.25 -18.57 52.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.909 0.385 . . . . 0.44 110.223 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.482 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -157.0 141.35 16.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.524 0.678 . . . . 0.38 112.446 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.913 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.23 158.28 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.773 -1.103 . . . . 0.29999999999999999 108.503 172.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.115 ' HA ' HD13 ' A' ' 58' ' ' LEU . 26.3 t -179.23 122.04 0.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.976 -0.379 . . . . 0.34999999999999998 109.976 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.829 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -76.12 156.0 34.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.347 -1.353 . . . . 2.7200000000000002 107.347 170.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.529 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 17.8 t70 -59.84 85.9 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.25 0.548 . . . . 1.51 110.715 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.93 15.17 5.33 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.61 -0.723 . . . . 0.80000000000000004 112.765 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.115 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.2 tt -50.79 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.505 . . . . 0.57999999999999996 111.182 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.4 t70 -71.14 -29.97 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.644 -0.707 . . . . 0.73999999999999999 111.453 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 m 72.82 15.44 4.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.679 -1.146 . . . . 1.03 110.245 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.78 -6.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.474 -0.87 . . . . 0.83999999999999997 114.03 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.5 mtpt -96.17 161.27 14.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.028 0.914 . . . . 1.6699999999999999 110.46 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 51.5 mt -90.97 132.32 36.04 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.878 -0.786 . . . . 0.57999999999999996 108.878 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.564 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -132.83 147.72 52.31 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.646 -0.421 . . . . 0.80000000000000004 110.317 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.649 HG23 HG12 ' A' ' 90' ' ' VAL . 65.5 m -95.54 105.57 17.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.772 -0.825 . . . . 0.35999999999999999 108.772 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 57.1 tp -106.49 113.48 27.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.552 -0.749 . . . . 0.58999999999999997 109.697 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 88' ' ' LEU . 44.3 t -114.42 129.45 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.39000000000000001 110.452 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.0 mt -85.17 124.04 31.37 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.64 -0.874 . . . . 0.59999999999999998 108.64 168.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -135.83 138.18 42.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.926 0.393 . . . . 0.35999999999999999 110.011 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 17.6 p-10 -125.93 102.23 28.45 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 121.523 0.678 . . . . 1.9199999999999999 110.729 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -54.77 -177.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.378 2.718 . . . . 1.25 112.808 170.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.636 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.6 m-20 55.1 41.42 31.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 1.29 111.274 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.57 140.58 21.22 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 115.726 -0.67 . . . . 0.5 110.176 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.502 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 90.6 Cg_endo -81.65 -26.44 9.03 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.003 -1.665 . . . . 0.62 112.475 2.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.783 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 89.3 p -123.11 146.13 47.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.592 . . . . 0.75 110.314 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.636 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 74.4 ttt180 -67.55 -23.21 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 2.8799999999999999 111.257 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.722 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -82.87 -18.35 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 1.3799999999999999 111.064 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.15 90.12 2.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.048 -0.524 . . . . 1.3700000000000001 109.875 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 91.8 Cg_endo -85.33 93.46 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.863 2.375 . . . . 0.80000000000000004 113.814 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.502 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.4 mttm -82.69 -50.3 8.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.749 0.785 . . . . 1.02 110.477 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.79 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 63.7 m-85 -88.1 25.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.966 -1.015 . . . . 1.1699999999999999 111.225 -170.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.703 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.52 128.7 33.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.306 -0.406 . . . . 2.9300000000000002 110.445 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.703 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.0 mp0 -94.83 149.59 21.09 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.067 0.46 . . . . 2.23 110.773 -3.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.524 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 4.4 t90 -92.06 137.37 32.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.08 -1.081 . . . . 1.4299999999999999 108.08 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.473 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 9.1 p-80 -110.5 141.06 44.17 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.339 -0.615 . . . . 1.26 109.339 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 -15.14 12.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.248 0.833 . . . . 2.1400000000000001 113.248 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.496 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 3.2 p90 -169.38 166.59 10.34 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.447 -0.205 . . . . 1.51 110.447 162.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 67' ' ' VAL . 33.6 tp -133.84 113.96 12.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.151 -0.477 . . . . 0.33000000000000002 109.922 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.527 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -123.83 132.47 71.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.658 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 65' ' ' THR . 22.1 m -134.02 161.17 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.101 -0.954 . . . . 0.27000000000000002 108.793 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.3 t30 63.37 16.79 9.79 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.506 0.504 . . . . 1.76 110.273 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.527 ' HE3' HG11 ' A' ' 89' ' ' VAL . 6.8 ttm -67.42 111.8 4.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.718 -0.845 . . . . 0.31 108.718 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -87.64 96.89 10.59 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.005 -0.998 . . . . 1.21 111.016 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.63 -126.49 9.11 Favored Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 114.857 -1.065 . . . . 0.29999999999999999 112.284 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.534 ' HA ' HD11 ' A' ' 53' ' ' ILE . 4.4 p-10 -112.56 23.26 13.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 1.04 110.7 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.9 109.02 19.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.77000000000000002 109.908 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -59.45 -33.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.40999999999999998 110.625 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.3 m -73.6 -34.75 65.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.795 -0.638 . . . . 0.68000000000000005 111.951 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.5 -6.16 48.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.882 0.327 . . . . 1.26 111.882 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 92' ' ' MET . . . -70.82 96.6 0.6 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.451 -0.881 . . . . 0.34999999999999998 111.836 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.8 m -60.96 107.73 0.76 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.45000000000000001 110.325 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.597 ' HB ' ' NH2' ' A' ' 49' ' ' ARG . 7.5 p -87.51 130.25 37.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.86 -1.064 . . . . 0.56999999999999995 111.76 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 10.3 mt -112.2 -49.94 2.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.101 0.953 . . . . 0.45000000000000001 108.874 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.3 t -109.58 99.67 8.83 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.005 -1.48 . . . . 0.37 107.005 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.475 ' HB2' ' N ' ' A' ' 140' ' ' ASN . 3.7 m-20 -56.86 157.58 5.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.139 -0.937 . . . . 1.1499999999999999 113.114 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 14.7 p90 -74.31 107.58 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.782 -1.099 . . . . 4.6900000000000004 110.143 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.3 t -80.72 -15.69 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.543 0.687 . . . . 0.85999999999999999 110.276 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.53 -146.61 22.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.998 -0.62 . . . . 0.67000000000000004 111.801 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.593 ' O ' HD22 ' A' ' 180' ' ' LEU . 14.2 t -83.2 140.92 32.28 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.677 -0.49 . . . . 0.51000000000000001 109.677 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.61 68.5 0.19 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.354 -0.927 . . . . 0.81999999999999995 113.747 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.431 ' O ' HG11 ' A' ' 177' ' ' VAL . 57.6 Cg_endo -98.35 122.7 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.527 2.818 . . . . 0.84999999999999998 112.304 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 74.3 Cg_exo -50.93 146.68 20.92 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.045 2.497 . . . . 0.87 112.474 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 116.92 5.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 1.8500000000000001 111.482 -174.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.27 64.19 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.952 -0.567 . . . . 1.1799999999999999 113.777 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.783 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 51.3 p -79.82 -62.76 1.59 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.087 0.444 . . . . 0.96999999999999997 112.113 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.35 178.06 30.12 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.07 -0.812 . . . . 1.97 111.07 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -71.74 106.89 4.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.972 0.415 . . . . 0.93999999999999995 110.557 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 3.4 m-70 -77.31 116.55 18.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 2.23 110.115 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.819 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 9.7 ptt180 -94.87 90.09 5.89 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.464 -0.789 . . . . 2.3100000000000001 110.642 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.57 ' HE1' ' HB3' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.99 107.63 6.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.86 -0.793 . . . . 0.78000000000000003 108.86 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 168' ' ' CYS . 19.9 t -90.36 129.52 41.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.569 -0.742 . . . . 0.27000000000000002 109.479 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.643 ' HB2' HD23 ' A' ' 25' ' ' LEU . 23.3 m95 -89.93 119.74 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.397 -0.964 . . . . 1.99 108.397 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 79.5 mt -113.72 119.68 38.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.734 0.243 . . . . 0.38 111.205 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.565 HG12 HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -119.18 135.22 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.249 0.547 . . . . 0.31 111.328 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.79 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 72.3 t80 -128.35 128.88 45.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 5.1200000000000001 109.121 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.537 ' HG2' HG21 ' A' ' 164' ' ' VAL . 6.5 pt-20 -67.53 107.63 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.096 -0.705 . . . . 2.4100000000000001 109.096 175.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 18.6 mt-30 -56.42 137.56 52.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.387 -0.824 . . . . 1.3100000000000001 112.392 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.42 -26.17 68.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.887 -1.051 . . . . 2.3999999999999999 108.691 168.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 8.6 ptp180 -167.29 158.73 10.31 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 114.111 -1.404 . . . . 3.5099999999999998 109.762 -177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HA ' ' NE2' ' A' ' 127' ' ' GLN . 15.4 Cg_exo -61.69 131.95 37.94 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.759 2.306 . . . . 1.21 110.383 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.448 ' HG ' HG11 ' A' ' 90' ' ' VAL . 4.2 mm? -64.41 152.35 41.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.955 1.094 . . . . 0.90000000000000002 113.955 -166.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -109.65 85.69 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.224 -1.353 . . . . 2.8999999999999999 108.651 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.782 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 58.3 m -132.06 116.35 16.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 1.8999999999999999 111.412 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -106.26 39.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.714 -0.847 . . . . 2.96 108.714 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.9 mm-40 -73.89 131.44 81.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.801 -1.091 . . . . 1.3899999999999999 110.585 -173.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.8 119.96 4.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.408 2.739 . . . . 1.27 112.7 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 15.2 mm -70.11 115.2 8.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.578 -0.527 . . . . 0.85999999999999999 109.578 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.88 -14.44 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.651 0.611 . . . . 1.6100000000000001 112.651 -170.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' A' ' 105' ' ' ASP . 37.1 m 55.43 23.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.489 0.922 . . . . 1.8799999999999999 113.489 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.625 ' HA ' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER 60.29 -2.78 0.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.21 1.004 . . . . 0.75 113.515 172.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.584 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 66.5 mtt180 -100.12 135.91 40.83 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.16 -0.338 . . . . 3.3599999999999999 110.137 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.604 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.0 m 82.26 131.9 0.05 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 124.524 1.14 . . . . 0.94999999999999996 111.396 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.7 41.6 2.16 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.196 -0.911 . . . . 1.1200000000000001 113.109 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -71.68 -34.34 69.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 2.6600000000000001 110.921 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -125.34 73.51 1.32 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 1.8700000000000001 110.721 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.429 ' HB3' ' CE2' ' A' ' 84' ' ' TRP . 63.8 mtt180 -78.73 -77.15 0.17 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.155 -0.93 . . . . 4.7300000000000004 111.549 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -132.72 -137.16 3.88 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.708 -0.758 . . . . 0.65000000000000002 112.908 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.79 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 90.3 mttt 65.04 28.37 12.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.717 0.77 . . . . 1.0800000000000001 110.246 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -103.92 167.94 9.45 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.909 -1.041 . . . . 1.8899999999999999 108.763 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 11.8 mmmm -117.35 117.53 29.75 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.002 -0.37 . . . . 1.29 110.002 173.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.685 HG21 HG12 ' A' ' 17' ' ' VAL . 27.8 m -61.14 -24.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 0.78000000000000003 110.8 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.15 82.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.852 -0.613 . . . . 0.67000000000000004 109.505 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.9 m -65.53 -35.43 80.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.77000000000000002 110.692 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.684 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 26.9 m-85 -58.65 -56.36 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.92000000000000004 110.685 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.492 HH22 ' HB2' ' A' ' 18' ' ' ASP . 18.4 ptp180 -66.02 -43.22 88.28 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.8900000000000001 110.682 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -62.79 -36.16 82.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.682 0.277 . . . . 0.96999999999999997 111.607 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -63.04 -45.17 93.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.165 0.507 . . . . 1.5800000000000001 110.846 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 131' ' ' LEU . 20.8 m-85 -83.0 1.86 37.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 5.4500000000000002 110.478 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 64.19 33.07 12.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.163 -0.926 . . . . 2.4199999999999999 111.125 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.79 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -92.79 179.19 5.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.652 -1.158 . . . . 1.27 109.14 173.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.687 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.9 tpt180 -149.05 -146.91 0.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.422 -0.585 . . . . 3.5899999999999999 109.422 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.687 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -55.22 143.47 54.77 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 121.109 0.481 . . . . 0.76000000000000001 111.038 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 4.1 Cg_exo -73.01 157.39 51.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.798 2.998 . . . . 0.53000000000000003 112.813 -170.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.899 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -86.1 -24.48 6.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.562 -0.903 . . . . 0.44 108.562 174.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.829 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -158.97 148.35 18.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.667 -0.697 . . . . 0.27000000000000002 111.915 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.9 153.72 25.53 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.638 -1.165 . . . . 0.23999999999999999 110.918 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.427 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.7 t -166.44 144.08 5.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.83 -0.804 . . . . 0.34000000000000002 108.83 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.591 ' HB3' HG22 ' A' ' 121' ' ' VAL . 25.4 p -124.93 141.83 51.87 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.074 -0.65 . . . . 1.1100000000000001 111.483 -173.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.593 ' CE2' HG21 ' A' ' 46' ' ' VAL . 26.0 p90 -123.92 130.75 53.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.254 -1.017 . . . . 0.80000000000000004 108.254 171.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.833 HE22 ' HA2' ' A' ' 38' ' ' GLY . 24.4 mp0 -97.78 132.47 43.37 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 2.5299999999999998 110.17 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.57 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . . . -134.68 145.59 48.68 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.089 -0.708 . . . . 0.59999999999999998 109.089 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -170.54 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 2.3799999999999999 111.562 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.838 ' HA ' HG21 ' A' ' 177' ' ' VAL . 36.1 p90 -80.18 54.67 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 3.96 112.1 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -50.55 -60.44 3.02 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.487 0.551 . . . . 1.53 112.487 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.57 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.6 t70 -173.68 -44.53 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.007 0.432 . . . . 1.26 111.283 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -80.42 6.99 10.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.21 -0.45 . . . . 2.2200000000000002 111.667 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 173' ' ' TRP . 71.2 t -72.54 -52.79 6.28 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.077 -0.51 . . . . 0.5 110.546 174.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.688 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -50.35 -34.26 40.2 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.464 2.109 . . . . 0.57999999999999996 112.158 169.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.683 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.7 mmmt -74.09 -25.19 59.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 2.1400000000000001 111.196 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 24.9 tp -70.53 -44.91 66.57 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.275 -0.639 . . . . 0.66000000000000003 109.275 172.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -58.32 -40.12 81.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.07 -0.715 . . . . 1.8899999999999999 109.07 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.683 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.58 -50.67 71.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.81 -1.086 . . . . 1.53 110.897 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -65.18 -33.09 75.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.635 -0.711 . . . . 1.49 112.16 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 55.8 mt -66.47 4.29 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.76000000000000001 111.641 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.855 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.3 m -79.71 3.13 20.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 1.05 109.581 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 79.04 48.0 7.24 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.162 -0.926 . . . . 1.1699999999999999 111.306 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.855 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.0 mmmt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.508 -0.758 . . . . 2.0 110.241 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.756 HG13 ' HB2' ' A' ' 37' ' ' LEU . 22.5 t . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.806 0.336 . . . . 1.47 110.835 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.09 155.21 41.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.85 -0.796 . . . . 1.8100000000000001 108.85 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.6 mm? -83.49 8.12 14.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.863 0.69 . . . . 0.69999999999999996 112.863 -169.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 t -66.15 -27.07 67.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.977 0.417 . . . . 1.96 111.042 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 66.2 mttm -92.57 9.43 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.47 -0.332 . . . . 2.6600000000000001 111.655 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.764 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 57.4 t-105 -66.58 -24.96 66.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.398 0.518 . . . . 3.98 112.398 -172.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.499 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 14.1 p -136.33 21.53 3.19 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.36 -0.536 . . . . 0.63 111.8 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.6 -126.37 1.45 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.822 -0.704 . . . . 0.47999999999999998 111.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.12 -35.46 62.36 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.334 2.689 . . . . 0.53000000000000003 110.056 166.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.599 HD11 ' HA3' ' A' ' 38' ' ' GLY . 12.5 mt -87.6 86.8 7.24 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.564 -1.198 . . . . 1.1699999999999999 108.986 171.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.8 m -78.44 66.97 4.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.485 0.66 . . . . 0.70999999999999996 110.467 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 HG21 ' A' ' 121' ' ' VAL . 29.0 mt -78.75 -4.97 51.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.468 -0.787 . . . . 0.45000000000000001 111.216 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 12.9 mm100 -68.27 -13.4 62.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.047 0.451 . . . . 2.1200000000000001 110.39 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.52 -28.14 69.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 1.9299999999999999 110.262 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.58 ' CG1' HG21 ' A' ' 151' ' ' VAL . 71.5 t -86.36 -73.57 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.63 110.653 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -162.5 169.06 20.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.818 -0.353 . . . . 2.9900000000000002 110.811 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -49.04 147.41 2.87 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.089 0.956 . . . . 1.6000000000000001 113.279 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.764 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 68.1 mt-30 -59.37 128.39 85.68 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 115.536 -0.756 . . . . 3.5499999999999998 109.913 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 11.1 Cg_exo -70.02 157.28 60.4 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.913 2.409 . . . . 0.57999999999999996 111.893 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.852 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 7.2 pt20 -73.4 -18.79 61.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 1.3899999999999999 111.314 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.818 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 47.2 m-70 -148.07 160.23 37.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.606 -0.725 . . . . 1.45 109.139 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.0 Cg_endo -86.0 131.92 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.05 2.5 . . . . 0.40000000000000002 111.832 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 122' ' ' TRP . 20.6 tp -80.68 141.08 35.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.328 . . . . 0.28999999999999998 110.724 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.42 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.41 123.91 51.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.445 -0.343 . . . . 1.24 110.15 170.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 53' ' ' ILE . 17.6 t -121.5 143.26 34.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.525 -0.917 . . . . 0.46999999999999997 108.525 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -136.86 142.83 42.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.135 0.493 . . . . 0.31 110.791 -176.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -108.64 176.91 4.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.16 -0.681 . . . . 0.67000000000000004 109.16 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.89 -51.81 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.55000000000000004 111.803 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.75 -13.34 9.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.677 -0.692 . . . . 0.81000000000000005 112.835 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.26 -165.12 1.36 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.46999999999999997 110.914 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.0 165.99 26.61 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.367 -0.833 . . . . 0.33000000000000002 109.748 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.77 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 93.4 t -107.44 64.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.303 -1.739 . . . . 0.39000000000000001 106.303 160.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.12 1.72 49.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.198 -1.364 . . . . 0.98999999999999999 109.949 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 43.7 mt-10 -135.62 126.06 26.75 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.408 -0.815 . . . . 2.5600000000000001 109.865 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.756 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -71.95 110.13 6.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.149 -0.686 . . . . 0.40999999999999998 109.149 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.93 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 90.01 28.31 18.49 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.258 -0.883 . . . . 0.58999999999999997 111.973 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.77 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -93.29 151.05 20.04 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.842 -0.429 . . . . 0.34000000000000002 109.842 174.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.4 p -78.19 135.98 25.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.55000000000000004 111.098 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 169' ' ' TYR . 8.4 tp -131.46 170.58 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.152 -1.425 . . . . 0.45000000000000001 107.152 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 p -116.17 148.61 41.89 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 118.669 -1.212 . . . . 0.56000000000000005 113.362 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 1.079 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 53.4 Cg_exo -55.38 -40.76 83.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.491 3.461 . . . . 0.68000000000000005 113.914 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -33.32 63.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.517 0.675 . . . . 0.76000000000000001 110.715 174.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -81.75 -58.46 2.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.909 . . . . 1.5900000000000001 110.704 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 43' ' ' PRO . 6.3 m -81.42 28.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.386 0.612 . . . . 0.66000000000000003 112.079 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -82.21 -31.44 30.32 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.69 -0.856 . . . . 0.79000000000000004 108.69 174.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.437 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 19.0 m120 -112.13 -149.78 0.45 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.849 -1.069 . . . . 1.9099999999999999 110.319 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.579 ' HD3' HG22 ' A' ' 97' ' ' ILE . 99.5 mtt180 -99.11 157.25 34.39 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.246 -0.433 . . . . 1.4299999999999999 109.964 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.98 166.28 25.18 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.402 2.068 . . . . 0.37 110.574 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -81.48 -25.47 36.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.03 0.443 . . . . 0.44 110.018 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.2 m -159.27 149.56 19.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.165 0.507 . . . . 0.38 111.97 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.12 158.71 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.288 -1.004 . . . . 0.29999999999999999 108.288 171.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.103 ' HA ' HD13 ' A' ' 58' ' ' LEU . 32.7 t -176.4 113.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.917 0.389 . . . . 0.34999999999999998 110.104 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -72.42 157.67 37.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.664 -1.235 . . . . 2.7200000000000002 107.664 172.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.97 87.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.523 0.514 . . . . 1.51 110.611 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.3 21.51 4.05 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.753 -0.658 . . . . 0.80000000000000004 112.749 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.103 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -57.69 129.14 40.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.984 0.421 . . . . 0.57999999999999996 110.565 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.623 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 26.2 t70 -79.69 -27.74 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.505 . . . . 0.73999999999999999 111.502 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.535 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 52.7 m 77.84 -5.67 2.08 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.3 1.0 . . . . 1.03 110.278 -171.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.31 21.49 5.15 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.874 -0.603 . . . . 0.83999999999999997 112.794 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.623 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 9.7 mtpt -113.0 145.02 41.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 122.535 -0.391 . . . . 1.6699999999999999 110.752 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.617 HD21 ' HE2' ' A' ' 93' ' ' LYS . 44.5 mt -91.0 124.87 35.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.191 -0.67 . . . . 0.57999999999999996 109.191 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -127.18 161.38 28.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.754 -0.379 . . . . 0.80000000000000004 109.98 177.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.668 HG23 HG12 ' A' ' 90' ' ' VAL . 63.3 m -97.45 106.57 18.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.715 -0.846 . . . . 0.35999999999999999 108.715 169.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.2 tp -103.58 109.37 21.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.448 -0.796 . . . . 0.58999999999999997 109.69 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.5 t -113.87 136.74 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.39000000000000001 110.69 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.861 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.8 mt -104.61 126.4 51.66 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.73 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 10.1 t -135.22 150.75 50.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.878 0.37 . . . . 0.35999999999999999 111.315 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.468 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 6.8 t70 -130.47 94.25 30.19 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-O 121.51 0.671 . . . . 1.9199999999999999 110.39 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 13.0 Cg_endo -56.49 -30.91 84.2 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.83 3.02 . . . . 1.25 114.108 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -90.74 39.58 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.641 . . . . 1.29 112.732 -167.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.48 140.44 21.07 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.77 -0.456 . . . . 0.5 109.77 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.571 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 98.3 Cg_endo -80.19 -21.62 17.38 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.864 -1.307 . . . . 0.62 113.351 2.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 88.5 p -139.75 162.85 34.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.746 -0.206 . . . . 0.75 111.072 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.476 ' NE ' HH12 ' A' ' 119' ' ' ARG . 1.0 OUTLIER -64.4 -36.8 85.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.234 0.54 . . . . 2.8799999999999999 110.61 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.2 ptpt -71.63 -18.17 62.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 1.3799999999999999 111.224 -175.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.5 t70 -161.43 86.62 1.65 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.402 . . . . 1.3700000000000001 110.648 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.1 Cg_endo -84.0 91.64 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.902 2.401 . . . . 0.80000000000000004 112.946 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.571 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 39.3 mttm -82.63 -45.37 14.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 1.02 110.793 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.765 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.9 m-85 -81.0 16.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 1.1699999999999999 111.776 -171.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.93 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 9.1 ttp180 -62.3 125.04 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.068 -0.345 . . . . 2.9300000000000002 110.068 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.93 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.1 mp0 -107.72 133.98 51.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.503 0.321 . . . . 2.23 110.356 -4.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -76.9 164.85 25.41 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.813 -1.18 . . . . 1.4299999999999999 107.813 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.73 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 p80 -145.94 123.18 11.55 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.826 -0.546 . . . . 1.26 110.329 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.861 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.3 t-160 -62.13 -40.86 97.35 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.418 -0.81 . . . . 2.1400000000000001 109.552 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.9 p90 -167.77 171.56 9.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.963 -0.295 . . . . 1.51 110.465 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HG ' HD12 ' A' ' 103' ' ' LEU . 30.1 tp -129.96 113.09 14.16 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.144 -0.687 . . . . 0.33000000000000002 109.144 173.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.643 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.1 t -118.36 134.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.847 -0.615 . . . . 0.31 110.649 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.948 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 19.7 m -134.53 157.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.63 -0.714 . . . . 0.27000000000000002 109.61 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t30 61.18 22.28 12.62 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.601 0.563 . . . . 1.76 110.455 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.643 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -70.71 111.68 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.725 -0.843 . . . . 0.31 108.725 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 63' ' ' LEU . 18.2 ttmm -87.59 100.38 12.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.162 -0.926 . . . . 1.21 111.045 -172.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 77.17 -122.84 6.29 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.255 -0.884 . . . . 0.29999999999999999 112.883 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.575 ' HA ' HD11 ' A' ' 53' ' ' ILE . 9.2 p30 -118.14 21.09 12.94 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 1.04 110.736 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.68 105.68 15.66 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.787 -0.642 . . . . 0.77000000000000002 109.77 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.579 HG22 ' HD3' ' A' ' 49' ' ' ARG . 4.8 mm -62.89 -25.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.867 -1.06 . . . . 0.40999999999999998 111.384 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 m -84.41 -29.62 26.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.68000000000000005 111.994 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 m -80.26 -3.84 50.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.943 0.402 . . . . 1.26 111.706 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.14 106.42 1.88 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.761 -0.733 . . . . 0.34999999999999998 111.303 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.2 m -64.31 106.84 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.228 -0.656 . . . . 0.45000000000000001 109.228 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.19 111.8 24.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.43 -0.805 . . . . 0.56999999999999995 110.86 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.598 HD12 ' HG ' ' A' ' 88' ' ' LEU . 5.1 mt -87.85 -39.96 14.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.039 0.923 . . . . 0.45000000000000001 109.935 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.4 t -114.36 105.88 13.66 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.72 -1.585 . . . . 0.37 106.72 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.2 t70 -57.73 158.1 6.59 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.873 0.733 . . . . 1.1499999999999999 111.992 -169.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 23.0 p90 -85.74 77.54 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 4.6900000000000004 111.305 -171.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 140' ' ' ASN . 36.7 t -60.48 -45.05 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.85999999999999999 111.485 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.682 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 106.24 -168.33 14.8 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.385 -0.912 . . . . 0.67000000000000004 112.576 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.9 t -65.91 126.63 29.15 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.759 -0.46 . . . . 0.51000000000000001 109.759 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.606 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -152.56 54.49 0.46 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.994 -0.622 . . . . 0.81999999999999995 112.727 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 1.025 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 11.3 Cg_endo -98.52 153.61 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.022 3.148 . . . . 0.84999999999999998 113.232 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 111' ' ' PRO . 31.6 Cg_exo -61.34 150.16 86.14 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.008 2.472 . . . . 0.87 112.499 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -67.17 122.05 16.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.347 -0.842 . . . . 1.8500000000000001 111.571 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.6 50.33 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.927 -0.654 . . . . 1.1799999999999999 112.996 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.612 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 21.7 p -78.5 -13.59 59.76 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.943 0.72 . . . . 0.96999999999999997 112.943 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.31 24.31 6.56 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.09 -1.052 . . . . 1.97 113.38 172.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.58 HD13 ' HG2' ' A' ' 172' ' ' GLU . 4.0 mm? 68.56 103.79 0.05 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.807 -0.697 . . . . 0.93999999999999995 111.549 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 11.6 m170 -76.64 134.18 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.789 -0.641 . . . . 2.23 109.695 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 1.035 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 8.0 ptp85 -112.9 96.7 6.1 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.347 0.594 . . . . 2.3100000000000001 111.094 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 45.4 m-85 -72.15 114.59 10.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.511 -0.768 . . . . 0.78000000000000003 109.247 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.618 HG21 HD22 ' A' ' 14' ' ' LEU . 31.3 t -90.4 129.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.61 -0.723 . . . . 0.27000000000000002 110.439 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.879 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.56 119.49 30.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.546 -0.752 . . . . 1.99 109.396 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 84.0 mt -118.37 127.61 53.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.333 0.111 . . . . 0.38 111.089 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.42 HG12 HD22 ' A' ' 25' ' ' LEU . 1.4 m -115.53 139.41 42.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.31 109.352 171.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CB ' HD23 ' A' ' 160' ' ' LEU . 84.9 m-85 -118.83 164.32 15.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.862 0.363 . . . . 5.1200000000000001 111.427 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.62 118.2 33.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.438 -0.801 . . . . 2.4100000000000001 109.071 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -97.81 166.96 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.184 0.516 . . . . 1.3100000000000001 110.477 -175.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.52 -22.31 54.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.513 -0.767 . . . . 2.3999999999999999 109.563 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.79 164.18 19.67 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.821 -1.081 . . . . 3.5099999999999998 110.277 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.463 ' HG3' HD12 ' A' ' 63' ' ' LEU . 53.7 Cg_exo -51.74 135.67 49.67 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.605 2.203 . . . . 1.21 112.02 175.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.948 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.3 mm? -55.63 147.48 18.16 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.2 0.815 . . . . 0.90000000000000002 113.2 -171.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -130.73 80.36 1.94 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.574 -1.194 . . . . 2.8999999999999999 108.09 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.477 ' SG ' HG11 ' A' ' 90' ' ' VAL . 60.1 m -104.1 112.86 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.765 -0.652 . . . . 1.8999999999999999 110.23 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.53 18.58 12.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.09 -0.959 . . . . 2.96 110.216 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.87 130.2 94.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.444 -0.798 . . . . 1.3899999999999999 109.999 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -47.44 118.55 2.99 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.309 2.673 . . . . 1.27 113.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.3 mm -60.43 115.76 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.971 -0.558 . . . . 0.85999999999999999 110.618 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.8 152.19 19.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 1.6100000000000001 109.841 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 m -99.59 156.43 17.07 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.089 -1.078 . . . . 1.8799999999999999 108.089 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.772 ' HA ' HG22 ' A' ' 107' ' ' VAL . 1.7 p-10 -81.89 6.85 14.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.333 0.587 . . . . 0.75 110.432 -174.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 46.6 mtt-85 -102.76 135.49 44.31 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.548 -0.751 . . . . 3.3599999999999999 109.427 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.61 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.9 m 83.27 140.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.828 1.33 . . . . 0.94999999999999996 110.551 -175.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -102.22 46.71 1.22 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.511 -0.768 . . . . 1.1200000000000001 111.433 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.98 -29.96 66.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.928 0.394 . . . . 2.6600000000000001 111.489 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -124.51 70.05 1.11 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.037 0.446 . . . . 1.8700000000000001 111.232 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 63.7 mtp180 -87.93 30.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 4.7300000000000004 111.989 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.77 -143.83 17.81 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.176 -1.012 . . . . 0.65000000000000002 113.388 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.765 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.8 mttt 60.94 42.21 13.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.855 0.836 . . . . 1.0800000000000001 110.687 -174.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -133.66 158.38 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.444 -1.253 . . . . 1.8899999999999999 108.872 174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 12.3 mmmm -96.8 120.84 37.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.15 0.282 . . . . 1.29 110.775 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.7 m -61.27 -33.05 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.78000000000000003 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -58.84 -44.6 90.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.736 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.4 m -62.13 -37.75 86.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.479 . . . . 0.77000000000000002 111.064 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.62 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 48.1 m-85 -59.27 -56.74 18.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.898 0.38 . . . . 0.92000000000000004 110.742 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 160' ' ' LEU . 4.3 ppt_? -71.13 -28.77 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.111 0.412 . . . . 2.8900000000000001 112.111 -176.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 52.5 mtmt -65.8 -25.99 67.48 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.404 -0.185 . . . . 0.96999999999999997 111.331 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 17.8 tptm -53.17 -46.37 68.9 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.58 0.229 . . . . 1.5800000000000001 110.716 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.43 ' HB3' HD13 ' A' ' 160' ' ' LEU . 20.7 t80 -99.8 11.81 38.3 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.77 -0.772 . . . . 5.4500000000000002 109.957 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.18 41.31 6.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.171 -0.922 . . . . 2.4199999999999999 112.83 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB2' ' HB2' ' A' ' 155' ' ' ARG . 6.4 mp -73.74 137.2 43.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.466 -0.788 . . . . 1.27 109.171 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -86.0 -53.28 5.18 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.7 0.63 . . . . 3.5899999999999999 112.7 -169.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -164.8 161.95 14.95 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.947 -0.57 . . . . 0.76000000000000001 110.233 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 15.9 Cg_exo -66.96 140.6 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.845 2.363 . . . . 0.53000000000000003 112.776 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.852 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -86.61 -29.55 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.739 -0.837 . . . . 0.44 108.739 173.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -152.57 146.77 25.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.616 -0.72 . . . . 0.27000000000000002 111.221 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.87 156.85 27.13 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.2 -0.909 . . . . 0.23999999999999999 111.716 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.615 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 5.8 t -168.87 151.12 4.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.571 -0.9 . . . . 0.34000000000000002 108.571 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 12' ' ' LEU . 26.5 p -129.37 140.34 51.4 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.878 -0.729 . . . . 1.1100000000000001 111.371 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 120' ' ' TYR . 51.1 p90 -122.1 137.47 54.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.16 -1.052 . . . . 0.80000000000000004 108.16 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 1.035 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 26.2 mp0 -100.04 133.58 44.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.468 0.576 . . . . 2.5299999999999998 110.985 177.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -157.4 114.32 3.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.59999999999999998 110.069 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 1.025 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 6.4 pt-20 -109.94 -91.08 0.46 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 119.649 -0.82 . . . . 2.3799999999999999 111.77 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.893 ' H ' ' HG3' ' A' ' 172' ' ' GLU . 18.7 t90 -117.34 78.79 1.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.887 0.767 . . . . 3.96 111.672 -170.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 1.079 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -76.0 -59.64 2.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.658 -0.417 . . . . 1.53 110.937 173.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.1 t70 -178.84 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.339 0.137 0 N-CA-C 111.924 0.342 . . . . 1.26 111.924 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.723 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.45 5.49 14.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 2.2200000000000002 111.851 -178.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.771 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 84.0 t -72.57 -53.5 5.74 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.068 -0.514 . . . . 0.5 110.978 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.771 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.4 Cg_exo -49.78 -45.36 32.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.383 2.056 . . . . 0.57999999999999996 111.882 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.634 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.17 -24.25 64.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.506 -0.315 . . . . 2.1400000000000001 111.654 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 48.4 tp -68.98 -47.85 64.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.187 -0.605 . . . . 0.66000000000000003 109.393 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.73 -37.9 80.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.47 0.652 . . . . 1.8899999999999999 109.479 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 7.5 mm-40 -56.22 -47.87 77.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.706 -1.134 . . . . 1.53 111.148 172.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.09 -29.38 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.416 -0.811 . . . . 1.49 112.927 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 64.5 mt -63.29 5.95 0.14 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.227 0.825 . . . . 0.76000000000000001 113.227 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.755 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 16.5 m -82.78 -1.97 53.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.307 0.575 . . . . 1.05 109.532 168.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 84.85 45.59 5.96 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.783 -0.927 . . . . 1.1699999999999999 110.783 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.755 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.2 mmtp . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.739 -0.648 . . . . 2.0 110.385 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.232 0.171 0 CA-C-O 121.701 0.762 . . . . 1.47 111.751 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 19.2 t70 -162.78 159.93 24.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.083 -1.417 . . . . 1.8100000000000001 107.816 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.528 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.2 mm? -80.55 24.08 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.74 0.245 . . . . 0.69999999999999996 111.088 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -51.56 -53.71 35.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.965 -0.561 . . . . 1.96 111.805 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.603 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.5 tptm -125.16 49.2 1.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.275 0.56 . . . . 2.6600000000000001 109.941 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.617 ' HD1' HD11 ' A' ' 37' ' ' LEU . 2.8 t90 -74.58 -8.54 56.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.517 -0.765 . . . . 3.98 111.046 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 9.0 p -136.36 22.92 3.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.223 0.535 . . . . 0.63 110.56 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA3' ' HG3' ' A' ' 7' ' ' LYS . . . -86.9 -120.44 1.3 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.516 -0.633 . . . . 0.47999999999999998 111.516 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 11.6 Cg_endo -51.35 -40.49 61.78 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.551 2.834 . . . . 0.53000000000000003 110.402 167.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.68 HD11 ' HA3' ' A' ' 38' ' ' GLY . 19.2 mt -87.34 88.22 7.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.012 -0.995 . . . . 1.1699999999999999 109.045 171.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 4.6 m -75.66 63.87 1.64 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.509 0.671 . . . . 0.70999999999999996 110.674 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 121' ' ' VAL . 27.8 mt -75.94 -7.94 55.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.693 -0.685 . . . . 0.45000000000000001 110.091 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 6.5 tp-100 -73.38 -7.82 53.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 2.1200000000000001 110.992 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.561 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 22.1 mt-10 -63.45 -37.06 85.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.176 -0.676 . . . . 1.9299999999999999 109.176 171.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.889 HG12 HG21 ' A' ' 151' ' ' VAL . 31.9 t -76.65 -73.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.494 -1.23 . . . . 0.63 111.635 -175.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.498 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 30.3 t0 -152.09 170.19 20.55 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.633 -0.506 . . . . 2.9900000000000002 109.633 -172.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.701 ' HG3' HH12 ' A' ' 155' ' ' ARG . 30.8 mt-10 -60.3 149.96 31.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.472 0.545 . . . . 1.6000000000000001 112.472 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.542 HE21 ' HB3' ' A' ' 8' ' ' TRP . 52.0 mt-30 -60.54 120.43 52.36 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 115.444 -0.798 . . . . 3.5499999999999998 109.118 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 36.8 Cg_exo -58.7 155.42 37.5 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.656 2.237 . . . . 0.57999999999999996 112.396 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.89 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 10.1 pt20 -71.64 -17.56 62.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.455 -0.793 . . . . 1.3899999999999999 111.265 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.81 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 53.1 m-70 -149.75 157.47 38.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.534 0.734 . . . . 1.45 109.172 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 2.1 Cg_endo -84.89 129.82 4.08 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.97 2.447 . . . . 0.40000000000000002 112.019 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.699 HD23 ' HB3' ' A' ' 122' ' ' TRP . 22.1 tp -78.95 139.79 38.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.522 0.201 . . . . 0.28999999999999998 110.594 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -110.99 125.73 54.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.47 -0.567 . . . . 1.24 109.47 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.92 HG13 HG22 ' A' ' 53' ' ' ILE . 13.0 t -131.65 135.66 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.426 -0.583 . . . . 0.46999999999999997 109.426 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.3 OUTLIER -137.15 137.9 39.7 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.001 0.429 . . . . 0.31 110.736 -177.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -98.38 175.41 6.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.38 -0.97 . . . . 0.67000000000000004 108.38 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.25 59.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.247 0.546 . . . . 0.55000000000000004 110.855 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.2 -7.99 34.32 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.415 -0.812 . . . . 0.81000000000000005 112.606 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.07 -173.17 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.719 -0.283 . . . . 0.46999999999999997 110.412 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.1 166.05 23.95 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.224 -0.444 . . . . 0.33000000000000002 110.246 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 89.4 t -113.23 64.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 106.521 -1.659 . . . . 0.39000000000000001 106.521 162.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.14 16.1 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.438 -1.255 . . . . 0.98999999999999999 109.78 -174.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 4.6 tm-20 -148.5 125.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.071 -1.085 . . . . 2.5600000000000001 108.071 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.9 OUTLIER -71.86 110.19 6.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.847 -0.427 . . . . 0.40999999999999998 109.847 -174.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.68 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 88.71 14.83 60.67 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.708 -0.678 . . . . 0.58999999999999997 112.573 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -72.29 154.64 40.86 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 110.145 -0.316 . . . . 0.34000000000000002 110.145 175.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 8.8 p -80.34 129.6 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.301 0.572 . . . . 0.55000000000000004 110.972 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.459 HD23 ' CG1' ' A' ' 46' ' ' VAL . 6.2 tp -124.2 165.13 18.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.559 -1.274 . . . . 0.45000000000000001 107.559 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.97 152.69 49.0 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 119.148 -1.021 . . . . 0.56000000000000005 113.375 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.651 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 70.9 Cg_exo -51.38 -46.43 31.52 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.401 2.734 . . . . 0.68000000000000005 113.338 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -27.58 65.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.998 0.428 . . . . 0.76000000000000001 111.452 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.2 -48.68 10.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.978 -0.556 . . . . 1.5900000000000001 110.914 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.493 HG11 ' CE2' ' A' ' 169' ' ' TYR . 10.7 m -95.17 29.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.53 0.681 . . . . 0.66000000000000003 112.323 -175.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 6.52 42.77 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.31 -0.626 . . . . 0.79000000000000004 109.31 178.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -148.17 177.85 9.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.118 -0.946 . . . . 1.9099999999999999 109.572 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -78.88 152.36 77.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.405 -0.361 . . . . 1.4299999999999999 110.096 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.09 156.59 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.403 2.068 . . . . 0.37 111.479 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -77.45 -23.76 50.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.44 110.355 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 67.3 m -153.02 141.07 20.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.66 0.615 . . . . 0.38 112.66 -175.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.92 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.82 166.26 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.997 -1.001 . . . . 0.29999999999999999 108.313 169.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.074 ' HA ' HD13 ' A' ' 58' ' ' LEU . 31.3 t 176.12 117.7 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.985 0.421 . . . . 0.34999999999999998 110.096 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 29.9 p-90 -79.27 154.82 28.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.707 -1.22 . . . . 2.7200000000000002 107.707 172.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.422 ' HB3' ' HD1' ' A' ' 23' ' ' HIS . 35.7 t70 -64.64 85.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.811 0.339 . . . . 1.51 111.364 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.02 20.3 2.28 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.991 -0.549 . . . . 0.80000000000000004 112.021 -175.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.074 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.5 tt -63.01 129.07 38.78 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.937 0.495 . . . . 0.57999999999999996 111.072 -177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.534 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 26.1 t70 -74.82 -28.0 60.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.054 -0.521 . . . . 0.73999999999999999 111.635 -175.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.637 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.7 m 74.32 2.12 4.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.302 -0.863 . . . . 1.03 110.422 -172.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -130.21 -35.81 0.41 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.671 -0.695 . . . . 0.83999999999999997 112.372 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 12.2 mtpt -63.29 146.26 53.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.908 0.385 . . . . 1.6699999999999999 110.302 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.838 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 25.6 mt -87.37 138.7 31.25 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.794 -1.187 . . . . 0.57999999999999996 107.794 172.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.639 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 11.5 m-85 -128.71 157.51 41.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.80000000000000004 109.822 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.446 HG23 HG12 ' A' ' 90' ' ' VAL . 91.8 m -96.86 105.28 17.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.397 -0.594 . . . . 0.35999999999999999 109.397 172.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 17.6 tp -100.84 109.6 21.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.444 -0.798 . . . . 0.58999999999999997 109.563 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.1 125.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.45 . . . . 0.39000000000000001 110.987 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 ' HE1' ' A' ' 169' ' ' TYR . 3.4 mt -85.5 129.86 34.72 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.416 -0.957 . . . . 0.59999999999999998 108.416 167.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.837 HG21 HG11 ' A' ' 17' ' ' VAL . 9.0 t -138.11 138.79 39.04 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.7 -0.481 . . . . 0.35999999999999999 109.7 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.557 ' HB3' ' HA ' ' A' ' 120' ' ' TYR . 11.2 p-10 -132.67 99.78 15.3 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-O 121.617 0.722 . . . . 1.9199999999999999 111.026 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.7 Cg_endo -55.48 -173.9 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.582 2.854 . . . . 1.25 112.386 171.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.858 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 2.1 m-20 56.93 33.81 23.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.17 0.509 . . . . 1.29 111.127 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' H ' ' HB2' ' A' ' 82' ' ' ARG . . . -104.34 137.19 19.16 Favored Pre-proline 0 C--O 1.22 -0.469 0 CA-C-N 116.054 -0.521 . . . . 0.5 110.647 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -79.5 -31.12 5.1 Favored 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.016 -1.66 . . . . 0.62 112.556 0.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.615 ' HB3' HG22 ' A' ' 115' ' ' THR . 92.7 p -125.24 153.44 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.75 109.977 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.858 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 45.5 mtp180 -71.99 -23.18 61.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.301 -0.409 . . . . 2.8799999999999999 111.599 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.832 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.73 -10.89 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.932 0.396 . . . . 1.3799999999999999 110.79 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -155.2 82.3 3.95 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.34 -0.615 . . . . 1.3700000000000001 109.34 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -89.1 97.67 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.034 2.489 . . . . 0.80000000000000004 113.279 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 6.5 mtmm -88.13 -58.7 2.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.119 -0.946 . . . . 1.02 111.16 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.506 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 70.0 m-85 -66.89 -23.37 65.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.969 -0.56 . . . . 1.1699999999999999 110.994 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.561 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -48.0 117.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.412 0.445 . . . . 2.9300000000000002 109.891 177.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 38.8 mt-10 -89.71 130.99 35.91 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.561 0.744 . . . . 2.23 112.217 7.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.524 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 4.6 t90 -90.56 134.37 34.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.832 -0.803 . . . . 1.4299999999999999 108.832 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.511 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 13.8 p-80 -106.07 129.74 54.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.876 -0.787 . . . . 1.26 108.876 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -91.11 -23.76 20.2 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.29 0.478 . . . . 2.1400000000000001 112.29 -171.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.501 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 6.5 p90 -169.2 170.7 8.5 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.062 -0.347 . . . . 1.51 110.062 167.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.9 tp -131.89 114.0 14.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.546 -0.297 . . . . 0.33000000000000002 110.411 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -119.92 133.4 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.05 -0.523 . . . . 0.31 110.827 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.458 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 5.3 m -131.61 168.1 24.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.123 -1.065 . . . . 0.27000000000000002 108.123 174.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.838 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 8.8 m-20 59.96 19.28 8.33 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.37 0.419 . . . . 1.76 111.588 173.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.467 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.6 ttm -74.16 111.26 9.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.464 -0.939 . . . . 0.31 108.464 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.3 ttmm -79.71 91.5 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.191 -0.913 . . . . 1.21 111.196 -170.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.639 ' HA2' ' HE1' ' A' ' 64' ' ' TYR . . . 72.41 -117.45 6.24 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.857 -1.065 . . . . 0.29999999999999999 112.166 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 53' ' ' ILE . 27.6 p-10 -111.55 26.38 10.71 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.428 0.632 . . . . 1.04 110.122 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.39 104.19 16.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.247 -0.888 . . . . 0.77000000000000002 109.946 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 53' ' ' ILE . 4.6 mm -59.85 -28.55 41.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.111 -0.949 . . . . 0.40999999999999998 111.233 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.1 m -78.65 -42.76 27.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.68000000000000005 112.469 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 p -65.21 -24.16 67.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.412 0.523 . . . . 1.26 112.412 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 99.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.761 0.663 . . . . 0.34999999999999998 113.316 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 99.4 m -65.78 105.45 1.28 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.121 -0.696 . . . . 0.45000000000000001 109.121 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 9.5 p -93.4 109.57 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.4 -0.818 . . . . 0.56999999999999995 110.839 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.67 -41.78 23.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.12 0.962 . . . . 0.45000000000000001 109.824 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.0 t -115.04 100.19 7.99 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.247 -1.39 . . . . 0.37 107.247 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -52.69 156.85 1.77 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.298 0.999 . . . . 1.1499999999999999 113.161 -167.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 4.1 p90 -76.61 96.19 4.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.942 -1.026 . . . . 4.6900000000000004 110.739 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.808 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 21.8 t -67.72 -31.63 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.844 -0.616 . . . . 0.85999999999999999 111.76 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.45 173.09 49.49 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.756 -0.735 . . . . 0.67000000000000004 111.912 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 38.7 t -54.53 135.7 45.69 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.22 0.51 . . . . 0.51000000000000001 110.834 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.885 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . 169.77 70.68 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.81999999999999995 113.289 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.14 150.23 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.739 2.293 . . . . 0.84999999999999998 110.898 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.667 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 85.0 Cg_exo -43.48 126.48 5.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.728 2.286 . . . . 0.87 112.321 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.538 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -61.68 115.5 4.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 1.8500000000000001 110.749 -175.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.72 23.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.716 -0.754 . . . . 1.1799999999999999 112.407 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.667 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.7 p -76.86 -60.99 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.758 0.279 . . . . 0.96999999999999997 111.405 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.41 28.33 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.857 -0.687 . . . . 1.97 112.081 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.1 mm? -73.21 123.27 23.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.93999999999999995 110.477 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -102.01 112.81 25.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.051 0.453 . . . . 2.23 110.35 176.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.537 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 2.0 ptt180 -85.74 90.5 8.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.504 -0.771 . . . . 2.3100000000000001 110.703 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.737 ' HE2' ' HB3' ' A' ' 171' ' ' ALA . 3.3 m-85 -74.29 112.57 10.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.022 -0.733 . . . . 0.78000000000000003 109.022 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 168' ' ' CYS . 13.8 t -94.01 126.01 46.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.948 -0.569 . . . . 0.27000000000000002 109.638 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.699 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.34 119.56 30.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.721 -0.672 . . . . 1.99 109.738 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 83.6 mt -115.99 138.62 51.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.647 -0.131 . . . . 0.38 110.647 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.507 HG12 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -122.69 140.71 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.695 -0.483 . . . . 0.31 109.695 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.61 ' HB2' HD23 ' A' ' 160' ' ' LEU . 97.2 m-85 -117.37 165.54 13.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.996 0.427 . . . . 5.1200000000000001 111.191 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -110.38 137.61 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.25 -0.886 . . . . 2.4100000000000001 109.983 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.63 ' HG3' ' HG ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.26 153.84 47.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.357 0.599 . . . . 1.3100000000000001 110.014 177.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.01 -2.17 46.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.045 -0.98 . . . . 2.3999999999999999 111.051 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.532 HH22 ' HB2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -166.17 168.61 7.41 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.16 -0.927 . . . . 3.5099999999999998 109.753 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.15 150.54 24.4 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.559 2.173 . . . . 1.21 111.791 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.458 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? -72.21 158.45 35.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.633 0.73 . . . . 0.90000000000000002 112.42 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.71 127.2 32.33 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.584 -1.265 . . . . 2.8999999999999999 107.584 167.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.9 m -146.44 -63.23 0.3 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.866 -0.606 . . . . 1.8999999999999999 109.728 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 58.83 37.99 24.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.395 0.617 . . . . 2.96 110.809 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.58 137.0 63.32 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.264 -0.88 . . . . 1.3899999999999999 109.54 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.85 106.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.132 2.554 . . . . 1.27 112.175 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.7 mm -55.77 119.12 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.534 -0.757 . . . . 0.85999999999999999 111.36 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 81.4 mt -88.49 158.71 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.086 -0.709 . . . . 1.6100000000000001 109.086 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.702 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 64.5 m -112.63 31.28 6.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.713 -0.221 . . . . 1.8799999999999999 111.008 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.838 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 1.1 p-10 54.92 12.64 0.63 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.202 0.939 . . . . 0.75 111.693 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.702 ' HG3' ' O ' ' A' ' 139' ' ' SER . 5.5 mtm180 -98.2 153.61 18.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.933 -0.395 . . . . 3.3599999999999999 109.933 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.663 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 44.4 m 67.5 165.68 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.275 -0.875 . . . . 0.94999999999999996 111.824 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.0 23.07 5.93 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.474 -0.87 . . . . 1.1200000000000001 112.401 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -71.01 -26.25 63.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.205 0.446 . . . . 2.6600000000000001 112.205 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -131.27 61.01 1.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.304 0.573 . . . . 1.8700000000000001 110.751 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.88 -71.05 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.264 -0.88 . . . . 4.7300000000000004 110.663 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -124.44 -153.41 8.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.53 -0.843 . . . . 0.65000000000000002 112.226 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.2 mttt 66.51 32.5 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.151 0.977 . . . . 1.0800000000000001 109.831 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -124.9 103.97 8.34 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.11 -1.405 . . . . 1.8899999999999999 108.81 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -62.85 120.19 10.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 1.29 111.875 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.889 HG21 HG12 ' A' ' 17' ' ' VAL . 8.2 m -62.66 -31.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.78000000000000003 110.581 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -59.12 -38.8 80.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.866 -0.606 . . . . 0.67000000000000004 110.154 174.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.6 m -66.86 -38.6 86.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.546 . . . . 0.77000000000000002 110.624 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.763 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 62.0 m-85 -61.56 -53.07 61.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.92000000000000004 111.126 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.701 HH12 ' HG3' ' A' ' 19' ' ' GLU . 8.7 ptm180 -66.21 -39.69 89.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 2.8900000000000001 111.641 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.8 mtmt -68.08 -46.77 70.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.605 0.24 . . . . 0.96999999999999997 111.169 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -60.87 -51.64 68.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.5800000000000001 111.587 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.67 0.08 31.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.271 -0.422 . . . . 5.4500000000000002 111.624 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.532 ' HB2' HH22 ' A' ' 129' ' ' ARG . 70.8 mm-40 66.1 46.36 2.15 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.763 0.664 . . . . 2.4199999999999999 110.996 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.63 ' HG ' ' HG3' ' A' ' 127' ' ' GLN . 5.6 mp -102.35 15.09 30.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.643 0.608 . . . . 1.27 112.643 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 61.89 -94.45 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.649 0.38 . . . . 3.5899999999999999 111.809 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -154.3 168.82 11.11 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 109.455 -0.572 . . . . 0.76000000000000001 109.455 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 38.9 Cg_exo -57.16 129.03 32.14 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.406 2.071 . . . . 0.53000000000000003 112.91 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.89 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -84.38 -33.06 8.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.279 -0.638 . . . . 0.44 109.279 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.81 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.23 149.79 29.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.831 -0.622 . . . . 0.27000000000000002 111.258 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -153.25 144.75 11.73 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.357 -0.838 . . . . 0.23999999999999999 112.009 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -157.97 137.78 12.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.45 -0.574 . . . . 0.34000000000000002 109.45 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.829 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -108.54 144.93 35.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.325 0.583 . . . . 1.1100000000000001 111.791 -174.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.52 ' HE1' HD21 ' A' ' 68' ' ' LEU . 34.0 p90 -135.07 119.62 18.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.378 -1.341 . . . . 0.80000000000000004 107.378 172.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -100.14 133.23 44.83 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.866 -0.734 . . . . 2.5299999999999998 111.451 -178.325 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.737 ' HB3' ' HE2' ' A' ' 120' ' ' TYR . . . -129.87 147.99 51.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.491 -0.777 . . . . 0.59999999999999998 109.739 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 117' ' ' LEU . 12.6 pt-20 -110.71 -172.52 2.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.045 -0.525 . . . . 2.3799999999999999 111.09 -176.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.84 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.7 OUTLIER -85.11 64.47 8.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 3.96 111.173 -177.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.7 t70 -53.16 -61.78 2.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.573 -0.739 . . . . 1.53 112.332 -176.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.556 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.3 t70 -177.27 -40.74 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.943 0.402 . . . . 1.26 110.92 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -78.17 2.73 17.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.079 0.466 . . . . 2.2200000000000002 111.058 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 173' ' ' TRP . 39.8 t -72.52 -53.83 5.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.5 110.507 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 73.4 Cg_exo -52.79 -33.5 60.85 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.128 1.886 . . . . 0.57999999999999996 111.966 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 43.4 mmtm -74.35 -24.92 59.24 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.737 0.273 . . . . 2.1400000000000001 111.737 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.885 HD23 ' HA3' ' A' ' 110' ' ' GLY . 62.3 tp -66.57 -46.16 76.92 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.66000000000000003 108.764 170.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -60.44 -37.97 82.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.355 -0.839 . . . . 1.8899999999999999 109.533 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.712 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 24.9 mm-40 -56.65 -41.57 77.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.299 -0.864 . . . . 1.53 111.088 172.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.48 -31.63 57.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.615 -0.721 . . . . 1.49 111.881 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.663 ' HA ' ' H ' ' A' ' 142' ' ' SER . 21.2 mt -65.1 5.64 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.629 0.603 . . . . 0.76000000000000001 112.629 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 16.9 m -66.07 -19.89 65.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.613 0.72 . . . . 1.05 109.791 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 88.76 62.93 1.35 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 110.791 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt . . . . . 0 C--O 1.244 0.78 0 CA-C-O 118.449 -0.786 . . . . 2.0 109.984 -176.833 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 24' ' ' PRO . 4.5 t . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.783 -0.451 . . . . 1.47 109.783 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -154.36 158.74 40.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.928 -0.397 . . . . 1.8100000000000001 109.928 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.57 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -95.19 22.69 6.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.688 -0.233 . . . . 0.69999999999999996 110.962 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 m -80.05 -1.3 39.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 1.96 111.481 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 11.3 mptt -118.87 22.28 12.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.321 -0.622 . . . . 2.6600000000000001 109.321 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.639 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 1.9 p90 -61.93 -32.79 73.23 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 3.98 113.565 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -139.99 18.59 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.988 -0.445 . . . . 0.63 111.508 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.15 -122.14 0.78 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.263 -0.735 . . . . 0.47999999999999998 111.263 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.5 Cg_endo -50.1 -40.64 50.64 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.539 2.826 . . . . 0.53000000000000003 110.696 167.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 23.1 mt -87.23 78.49 8.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.21 -0.904 . . . . 1.1699999999999999 108.752 170.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -73.26 64.98 0.82 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.702 0.763 . . . . 0.70999999999999996 110.507 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.653 HD22 ' CG2' ' A' ' 121' ' ' VAL . 28.7 mt -81.44 -7.05 59.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.181 -0.918 . . . . 0.45000000000000001 111.326 -173.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -2.06 20.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.428 0.632 . . . . 2.1200000000000001 110.332 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.87 -7.67 55.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 1.9299999999999999 110.743 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.806 HG11 HG21 ' A' ' 69' ' ' THR . 71.3 t -98.5 -70.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.684 . . . . 0.63 111.112 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.696 ' OD2' ' HD2' ' A' ' 155' ' ' ARG . 22.2 t0 -164.32 -178.45 5.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.807 -1.183 . . . . 2.9900000000000002 107.807 -167.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.35 149.84 41.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.322 0.582 . . . . 1.6000000000000001 111.104 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 5.6 tp60 -81.87 138.6 46.57 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.735 . . . . 3.5499999999999998 110.736 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.641 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 13.4 Cg_exo -68.51 164.86 31.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.021 2.481 . . . . 0.57999999999999996 112.95 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.919 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.9 pt20 -90.52 -1.62 57.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.765 . . . . 1.3899999999999999 111.929 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.75 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.4 m170 -158.88 159.78 29.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 123.059 0.544 . . . . 1.45 109.919 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.3 Cg_endo -84.83 127.46 3.6 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.059 2.506 . . . . 0.40000000000000002 111.251 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 122' ' ' TRP . 36.0 tp -79.85 145.66 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.694 -0.23 . . . . 0.28999999999999998 110.768 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.416 ' H ' HD12 ' A' ' 25' ' ' LEU . 51.0 m-70 -114.72 121.24 42.73 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.982 -0.748 . . . . 1.24 108.982 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.906 HG13 HG22 ' A' ' 53' ' ' ILE . 19.4 t -122.83 144.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.108 -0.701 . . . . 0.46999999999999997 109.108 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -140.02 136.32 33.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.237 0.542 . . . . 0.31 111.107 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.602 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 46.0 t80 -101.97 170.2 8.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.174 -0.676 . . . . 0.67000000000000004 109.174 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.47 63.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.342 0.591 . . . . 0.55000000000000004 110.391 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.602 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -117.45 19.16 11.68 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.123 -0.944 . . . . 0.81000000000000005 112.703 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -151.7 -172.37 4.2 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.46999999999999997 110.783 177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.37 154.9 17.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.991 -0.55 . . . . 0.33000000000000002 110.13 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.754 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 87.8 t -119.21 68.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.192 -1.41 . . . . 0.39000000000000001 107.192 164.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -105.7 21.56 17.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.979 -1.01 . . . . 0.98999999999999999 108.851 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 22.4 tt0 -144.42 117.58 8.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.718 -1.128 . . . . 2.5600000000000001 108.486 174.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -66.88 110.56 3.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.40999999999999998 109.475 -177.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 95.24 12.94 53.9 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.531 -0.759 . . . . 0.58999999999999997 112.557 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.93 149.05 32.44 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.09 -0.337 . . . . 0.34000000000000002 110.09 177.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.9 134.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.55000000000000004 111.324 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 34' ' ' VAL . 8.2 tp -132.27 171.11 14.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.703 -0.851 . . . . 0.45000000000000001 108.703 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -120.5 150.81 52.89 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.67 0.748 . . . . 0.56000000000000005 112.485 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 72.4 Cg_exo -54.92 -29.99 66.64 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.604 3.536 . . . . 0.68000000000000005 113.963 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -42.53 88.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.659 0.742 . . . . 0.76000000000000001 110.275 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -74.93 -14.4 60.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.613 -1.176 . . . . 1.5900000000000001 111.822 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 169' ' ' TYR . 24.9 m -125.48 24.32 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.173 0.511 . . . . 0.66000000000000003 111.647 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.75 -18.55 40.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.505 0.669 . . . . 0.79000000000000004 109.206 177.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 52.0 t30 -125.03 -179.58 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.701 -1.136 . . . . 1.9099999999999999 108.751 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.88 150.68 78.66 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.616 -0.513 . . . . 1.4299999999999999 109.616 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' HG13 ' A' ' 97' ' ' ILE . 55.2 Cg_endo -73.88 158.75 46.04 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.978 1.785 . . . . 0.37 110.436 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.442 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.6 t -79.75 -18.8 50.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 0.44 109.858 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 m -161.21 147.41 14.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.632 0.73 . . . . 0.38 112.164 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.906 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.13 165.6 23.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.756 -1.111 . . . . 0.29999999999999999 108.249 170.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.034 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 t 178.96 111.98 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.938 0.399 . . . . 0.34999999999999998 109.929 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 51.1 p-90 -68.87 167.97 14.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.552 -1.277 . . . . 2.7200000000000002 107.552 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -70.2 70.31 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.191 0.519 . . . . 1.51 111.187 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.83 22.99 0.64 Allowed Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.446 -0.797 . . . . 0.80000000000000004 112.423 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.034 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.7 tt -54.88 132.31 46.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.89 0.476 . . . . 0.57999999999999996 111.674 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.432 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 18.8 t70 -78.9 -28.81 44.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.844 -0.616 . . . . 0.73999999999999999 111.996 -175.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.7 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 64.6 m 71.82 1.97 4.11 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.462 -0.79 . . . . 1.03 110.769 -172.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.65 14.54 4.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.992 -0.549 . . . . 0.83999999999999997 112.719 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 1.5 mmpt? -119.26 164.82 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 1.6699999999999999 109.956 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 63.7 mt -103.2 125.6 49.96 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.367 -0.605 . . . . 0.57999999999999996 109.367 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -120.72 148.33 44.1 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.806 -0.357 . . . . 0.80000000000000004 110.812 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.984 HG23 HG12 ' A' ' 90' ' ' VAL . 3.1 m -96.56 105.74 17.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.691 -0.855 . . . . 0.35999999999999999 108.691 173.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 124' ' ' VAL . 50.2 tp -109.69 117.76 34.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.274 -0.421 . . . . 0.58999999999999997 110.907 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.603 HG22 HD13 ' A' ' 88' ' ' LEU . 21.0 t -119.0 123.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.865 -0.607 . . . . 0.39000000000000001 110.553 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 1.2 mt -90.03 133.68 34.68 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.038 -1.097 . . . . 0.59999999999999998 108.038 168.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.806 HG21 HG11 ' A' ' 17' ' ' VAL . 8.8 t -142.75 149.16 38.36 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.692 -0.403 . . . . 0.35999999999999999 111.84 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 10.8 t70 -135.71 97.5 12.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 121.522 0.677 . . . . 1.9199999999999999 109.488 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.475 ' HG2' ' HE1' ' A' ' 118' ' ' HIS . 18.6 Cg_endo -57.82 -7.42 3.35 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 124.62 3.547 . . . . 1.25 115.848 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 1.8 m-20 -124.77 51.42 1.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.533 0.683 . . . . 1.29 111.534 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.58 143.77 27.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.19 -0.913 . . . . 0.5 109.391 172.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 34.6 Cg_endo -70.92 -35.89 2.62 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.53 -1.446 . . . . 0.62 113.431 1.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 115' ' ' THR . 72.2 p -131.59 166.82 20.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.75 111.312 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 51.5 ttt180 -71.33 -23.09 61.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.0 -0.546 . . . . 2.8799999999999999 110.839 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.736 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.15 -11.52 38.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.509 . . . . 1.3799999999999999 110.656 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 6.9 t70 -149.64 79.73 7.83 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.699 -0.682 . . . . 1.3700000000000001 109.958 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.2 Cg_endo -89.77 94.24 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.741 2.294 . . . . 0.80000000000000004 113.287 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.557 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.9 mttm -88.17 -44.09 11.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.284 -0.871 . . . . 1.02 110.541 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.687 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 27.9 m-85 -88.54 18.12 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.175 -0.921 . . . . 1.1699999999999999 112.032 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.7 ttm180 -64.2 125.83 25.78 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.916 0.135 . . . . 2.9300000000000002 111.236 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.0 mp0 -97.67 134.25 41.11 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.065 -0.346 . . . . 2.23 110.065 -5.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 11.2 t90 -80.57 100.32 8.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.427 0.632 . . . . 1.4299999999999999 109.927 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 33.2 p-80 -84.2 126.08 32.8 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.553 0.692 . . . . 1.26 110.18 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 1.006 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 19.5 t-80 -67.9 -34.7 77.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.05 -0.977 . . . . 2.1400000000000001 110.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 68' ' ' LEU . 44.2 p90 -169.29 170.67 8.4 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.117 0.261 . . . . 1.51 110.311 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HG ' HD12 ' A' ' 103' ' ' LEU . 17.0 tp -133.33 114.08 13.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.065 -0.516 . . . . 0.33000000000000002 109.701 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.807 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.7 t -122.32 132.54 70.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.6 0.714 . . . . 0.31 111.153 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.984 HG12 HG23 ' A' ' 65' ' ' THR . 9.9 m -130.86 160.53 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.85 -1.068 . . . . 0.27000000000000002 108.419 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t-20 62.62 20.52 12.08 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.203 0.314 . . . . 1.76 110.625 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.807 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.3 ttm -71.51 110.35 6.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.277 -0.638 . . . . 0.31 109.277 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.01 94.71 5.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.578 -1.192 . . . . 1.21 110.937 -171.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 72.72 -120.27 7.37 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.801 -1.09 . . . . 0.29999999999999999 112.426 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.533 ' HA ' HD11 ' A' ' 53' ' ' ILE . 8.7 p30 -112.76 17.59 18.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.188 0.518 . . . . 1.04 110.473 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.58 102.53 12.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.707 -0.679 . . . . 0.77000000000000002 109.911 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 97' ' ' ILE . 3.8 mm -58.71 -27.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.702 -1.135 . . . . 0.40999999999999998 111.624 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -77.94 -38.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.68000000000000005 111.975 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 m -74.87 -3.55 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 1.26 112.005 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.74 106.79 2.04 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.363 -0.695 . . . . 0.34999999999999998 111.363 177.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -61.46 107.39 0.78 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.281 0.562 . . . . 0.45000000000000001 109.734 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.8 p -83.47 113.28 22.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.081 -0.963 . . . . 0.56999999999999995 111.4 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.632 HD12 ' HG ' ' A' ' 88' ' ' LEU . 40.6 mt -90.4 -45.8 8.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.79 0.805 . . . . 0.45000000000000001 109.537 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.6 t -122.84 112.25 17.65 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.132 -1.433 . . . . 0.37 107.132 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 10.7 t0 -61.99 164.97 5.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.42 -0.809 . . . . 1.1499999999999999 112.699 -168.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 13.8 p90 -82.69 92.08 7.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 4.6900000000000004 110.76 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.712 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 40.3 t -75.09 -46.29 39.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.177 0.513 . . . . 0.85999999999999999 111.02 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.691 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 109.84 -174.82 18.14 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.439 -0.886 . . . . 0.67000000000000004 112.996 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 43' ' ' PRO . 42.2 t -66.58 140.25 57.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.287 -0.634 . . . . 0.51000000000000001 109.287 172.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.725 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -174.13 55.52 0.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.71 -0.757 . . . . 0.81999999999999995 112.854 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 57.5 Cg_endo -96.05 157.02 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.327 2.684 . . . . 0.84999999999999998 112.516 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.6 ' O ' HG23 ' A' ' 115' ' ' THR . 53.0 Cg_exo -54.89 154.54 21.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.058 2.505 . . . . 0.87 112.282 174.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.3 116.5 15.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.77 0.319 . . . . 1.8500000000000001 111.034 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.77 34.35 4.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.652 -0.785 . . . . 1.1799999999999999 112.924 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 112' ' ' PRO . 82.7 p -77.98 -18.27 56.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.729 0.3 . . . . 0.96999999999999997 110.637 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 104.41 3.14 44.21 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 120.916 -0.659 . . . . 1.97 112.132 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 172' ' ' GLU . 4.1 mm? 71.69 102.52 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.299 -0.951 . . . . 0.93999999999999995 111.079 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.518 ' CG ' ' H ' ' A' ' 119' ' ' ARG . 21.4 t-80 -110.69 -172.33 2.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.416 -0.957 . . . . 2.23 108.416 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 1.3 ptp180 -147.55 120.22 8.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.282 0.563 . . . . 2.3100000000000001 111.676 -163.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 6.5 m-85 -80.34 127.33 32.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.577 -1.192 . . . . 0.78000000000000003 108.825 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.653 ' CG2' HD22 ' A' ' 14' ' ' LEU . 16.9 t -104.19 130.83 54.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.154 -0.475 . . . . 0.27000000000000002 110.856 -177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.696 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 27.0 m95 -89.56 120.3 30.74 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 1.99 108.935 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 86.5 mt -115.49 118.59 33.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.934 0.334 . . . . 0.38 110.77 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.636 HG12 HD13 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -116.46 139.82 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.399 -0.223 . . . . 0.31 110.399 177.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.856 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 71.3 t80 -127.03 137.28 53.03 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.866 -0.334 . . . . 5.1200000000000001 111.0 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.536 ' H ' ' CG2' ' A' ' 164' ' ' VAL . 9.1 tp10 -88.05 96.65 10.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.49 -0.93 . . . . 2.4100000000000001 108.49 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.626 ' HG2' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -72.63 167.72 20.16 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.251 0.548 . . . . 1.3100000000000001 109.696 -176.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -80.84 -4.62 55.35 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.464 -0.789 . . . . 2.3999999999999999 109.747 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 3.2 ptp180 -165.06 161.9 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.337 -0.847 . . . . 3.5099999999999998 110.913 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.416 ' HG3' HD12 ' A' ' 63' ' ' LEU . 51.4 Cg_exo -55.91 143.72 80.95 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.509 2.806 . . . . 1.21 112.442 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.626 HD11 ' HG2' ' A' ' 127' ' ' GLN . 2.3 mm? -79.91 141.83 35.72 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.90000000000000002 110.767 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 20.2 tptm -132.64 67.26 1.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.435 -0.95 . . . . 2.8999999999999999 108.435 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.779 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 61.4 m -82.23 122.65 28.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.178 -0.919 . . . . 1.8999999999999999 110.443 -177.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.39 25.55 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.926 -0.579 . . . . 2.96 110.26 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.779 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 12.8 mm-40 -62.38 142.18 96.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.52 -0.764 . . . . 1.3899999999999999 109.894 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.69 110.14 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.313 2.675 . . . . 1.27 112.696 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.41 115.49 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.85999999999999999 110.323 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.8 mt -108.15 155.54 20.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.284 0.564 . . . . 1.6100000000000001 110.639 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.9 m -105.11 159.26 15.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.176 -1.046 . . . . 1.8799999999999999 108.176 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.712 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.0 p-10 -78.75 7.11 7.5 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.739 -0.384 . . . . 0.75 110.666 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.58 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 11.0 mtt180 -98.17 135.17 40.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.548 -0.538 . . . . 3.3599999999999999 109.548 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.719 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 20.5 m 73.38 117.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 O-C-N 124.316 1.01 . . . . 0.94999999999999996 109.686 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.21 27.66 15.12 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.583 -0.818 . . . . 1.1200000000000001 113.669 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -71.29 -25.13 62.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.929 0.395 . . . . 2.6600000000000001 111.026 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.92 30.48 6.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.949 0.404 . . . . 1.8700000000000001 111.177 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 42.7 mtp180 -60.9 -46.39 90.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 4.7300000000000004 110.782 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.52 -154.82 7.71 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.743 -0.741 . . . . 0.65000000000000002 111.889 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.687 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.0 mttt 67.2 17.32 10.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.254 0.55 . . . . 1.0800000000000001 111.137 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -122.13 112.24 17.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.441 -0.799 . . . . 1.8899999999999999 109.106 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -62.45 129.7 41.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 1.29 112.496 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.649 HG21 ' CG1' ' A' ' 17' ' ' VAL . 4.6 m -62.94 -32.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.78000000000000003 110.761 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.21 95.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.586 -0.734 . . . . 0.67000000000000004 110.02 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.77000000000000002 110.693 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.616 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 32.7 m-85 -61.73 -50.62 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 0.92000000000000004 110.965 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.696 ' HD2' ' OD2' ' A' ' 18' ' ' ASP . 6.5 ptm85 -70.12 -40.01 75.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.396 -0.365 . . . . 2.8900000000000001 111.135 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -66.05 -26.03 67.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 111.637 0.236 . . . . 0.96999999999999997 111.637 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -53.76 -49.36 68.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.679 0.275 . . . . 1.5800000000000001 110.608 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.516 ' HB3' HD13 ' A' ' 160' ' ' LEU . 6.6 t80 -99.64 15.31 27.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.759 -0.776 . . . . 5.4500000000000002 109.917 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 58.4 43.6 19.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.295 -0.866 . . . . 2.4199999999999999 111.682 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.856 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 3.4 mp -86.13 120.54 27.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.767 -0.651 . . . . 1.27 111.027 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.91 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -79.62 -173.7 3.92 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.914 -0.402 . . . . 3.5899999999999999 109.914 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.91 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -43.5 146.41 0.93 Allowed Pre-proline 0 N--CA 1.466 0.328 0 C-N-CA 123.82 0.848 . . . . 0.76000000000000001 113.009 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 6.5 Cg_exo -71.54 169.65 20.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.965 3.11 . . . . 0.53000000000000003 113.969 -170.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 21.4 t -95.3 -30.8 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.44 110.364 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.75 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.3 146.9 27.78 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.828 -0.749 . . . . 0.27000000000000002 112.302 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.97 148.07 19.12 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 114.458 -1.246 . . . . 0.23999999999999999 111.603 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 10.5 t -159.72 149.43 18.33 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.469 -0.937 . . . . 0.34000000000000002 108.469 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 21.2 p -123.8 146.68 48.17 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.12 -0.632 . . . . 1.1100000000000001 111.166 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 33.4 p90 -130.23 142.03 50.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.413 -1.329 . . . . 0.80000000000000004 107.413 175.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 1.1 pt20 -115.66 134.64 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.192 -0.603 . . . . 2.5299999999999998 111.558 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.14 153.87 33.64 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.751 0.657 . . . . 0.59999999999999998 110.072 -172.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.695 ' HG2' HD11 ' A' ' 117' ' ' LEU . 2.5 pt-20 -133.91 -106.73 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.677 0.621 . . . . 2.3799999999999999 112.677 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.695 ' HA ' HG21 ' A' ' 177' ' ' VAL . 31.9 t90 -118.12 84.1 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.15 0.5 . . . . 3.96 110.232 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.871 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 7.2 t70 -73.26 -62.4 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.898 -0.592 . . . . 1.53 111.725 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 14.4 t70 173.41 -44.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.776 -0.647 . . . . 1.26 109.675 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -80.34 9.55 5.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.548 -0.751 . . . . 2.2200000000000002 111.117 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.73 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 83.9 t -72.8 -53.99 5.04 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.5 109.926 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.73 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.6 Cg_exo -51.53 -37.8 63.31 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.299 1.999 . . . . 0.57999999999999996 111.424 169.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.677 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.7 mmtp -71.54 -23.38 61.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 2.1400000000000001 111.38 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.4 tp -67.81 -48.24 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.052 -0.722 . . . . 0.66000000000000003 109.052 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.7 -32.39 73.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.01 -0.541 . . . . 1.8899999999999999 109.737 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 11.7 mm-40 -55.7 -48.45 75.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.39 -0.823 . . . . 1.53 110.329 171.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.98 -33.16 63.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.288 -0.869 . . . . 1.49 112.002 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.719 ' HA ' ' H ' ' A' ' 142' ' ' SER . 37.6 mt -63.16 -1.83 1.14 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.496 0.554 . . . . 0.76000000000000001 112.496 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.708 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 13.1 m -73.7 -2.62 24.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.434 0.635 . . . . 1.05 109.92 172.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.14 39.8 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.835 -0.906 . . . . 1.1699999999999999 110.835 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.708 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.519 -0.753 . . . . 2.0 110.061 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.761 HG22 ' HA ' ' A' ' 36' ' ' GLU . 19.8 t . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.153 0.501 . . . . 1.47 111.462 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.432 ' O ' HD12 ' A' ' 37' ' ' LEU . 2.5 p30 -155.61 163.49 39.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.153 -1.054 . . . . 1.8100000000000001 108.153 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.522 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -88.28 29.11 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.633 -0.427 . . . . 0.69999999999999996 111.081 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 -7.82 59.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.303 0.573 . . . . 1.96 109.867 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 8.7 mptt -113.33 29.09 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 2.6600000000000001 109.608 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.648 ' HZ3' ' HG3' ' A' ' 15' ' ' GLN . 11.4 p-90 -67.87 -36.11 79.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.356 -0.838 . . . . 3.98 111.693 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 75.3 p -144.03 19.92 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.646 -0.421 . . . . 0.63 111.601 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.44 -118.37 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.86 -0.686 . . . . 0.47999999999999998 111.633 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.4 Cg_endo -47.14 -51.77 8.87 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.434 2.756 . . . . 0.53000000000000003 110.787 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.898 HD23 HD21 ' A' ' 14' ' ' LEU . 6.5 mp -88.95 98.39 11.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 1.1699999999999999 110.831 171.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 69.6 m -76.49 66.17 2.46 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.334 0.588 . . . . 0.70999999999999996 110.26 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.898 HD21 HD23 ' A' ' 12' ' ' LEU . 57.9 mt -73.85 -16.88 61.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.509 -0.769 . . . . 0.45000000000000001 111.225 -176.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.648 ' HG3' ' HZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -64.09 -15.08 58.84 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.05 0.452 . . . . 2.1200000000000001 110.857 -178.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -60.4 -23.27 64.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.255 0.55 . . . . 1.9299999999999999 110.666 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.885 HG11 HG21 ' A' ' 69' ' ' THR . 87.3 t -103.53 -64.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.328 -0.851 . . . . 0.63 110.877 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HA ' HH22 ' A' ' 155' ' ' ARG . 4.8 p-10 -116.43 172.44 7.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.134 0.492 . . . . 2.9900000000000002 111.283 -175.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.58 28.65 1.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.632 -0.713 . . . . 1.6000000000000001 112.365 -171.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 4.5 tt0 65.41 116.95 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 123.191 0.596 . . . . 3.5499999999999998 110.691 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 20.4 Cg_exo -65.77 158.74 52.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.683 2.255 . . . . 0.57999999999999996 112.959 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.885 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.4 pt20 -77.41 -13.89 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.247 -0.888 . . . . 1.3899999999999999 110.789 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.748 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 70.7 m-70 -149.73 156.51 38.67 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-N 115.461 -0.79 . . . . 1.45 109.458 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -85.84 125.98 2.85 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.955 2.437 . . . . 0.40000000000000002 110.771 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.568 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 27.0 tp -80.02 148.12 31.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.874 0.369 . . . . 0.28999999999999998 111.012 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.47 ' H ' HD12 ' A' ' 25' ' ' LEU . 33.1 m170 -118.12 128.73 55.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.775 -0.454 . . . . 1.24 109.775 170.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.962 HG13 HG22 ' A' ' 53' ' ' ILE . 32.6 t -128.8 119.64 50.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.825 -0.806 . . . . 0.46999999999999997 108.825 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.6 OUTLIER -115.68 138.49 51.04 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.343 0.592 . . . . 0.31 111.431 -171.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 33.6 t80 -100.31 176.78 5.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.784 -0.644 . . . . 0.67000000000000004 109.275 174.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.58 65.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.277 0.561 . . . . 0.55000000000000004 110.63 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.57 -0.57 29.24 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.438 -0.801 . . . . 0.81000000000000005 112.845 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.54 -174.22 3.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.46999999999999997 110.914 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.75 144.25 8.64 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.56 -0.746 . . . . 0.33000000000000002 110.022 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.843 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.7 t -95.06 69.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 106.996 -1.483 . . . . 0.39000000000000001 106.996 163.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -103.22 28.4 6.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.106 -0.952 . . . . 0.98999999999999999 109.236 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' A' ' 3' ' ' VAL . 49.9 mt-10 -150.32 134.05 16.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.765 -1.107 . . . . 2.5600000000000001 109.086 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.722 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.36 114.02 11.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.40999999999999998 110.136 -175.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.476 ' CA ' HE22 ' A' ' 170' ' ' GLN . . . 78.88 29.59 51.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.9 -0.667 . . . . 0.58999999999999997 111.518 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.843 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -90.29 152.92 20.83 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.22 0.208 . . . . 0.34000000000000002 110.625 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.459 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.7 p -78.77 134.68 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.335 0.588 . . . . 0.55000000000000004 111.487 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 34' ' ' VAL . 7.6 tp -132.87 169.87 16.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.462 -0.94 . . . . 0.45000000000000001 108.462 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.6 p -115.02 151.39 45.54 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.024 -0.67 . . . . 0.56000000000000005 112.309 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 50.5 Cg_exo -56.91 -28.96 80.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.164 3.243 . . . . 0.68000000000000005 113.298 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 p -65.09 -41.21 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.615 0.721 . . . . 0.76000000000000001 110.528 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -80.47 -17.69 50.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.684 -1.144 . . . . 1.5900000000000001 111.414 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 42' ' ' THR . 28.2 m -125.66 30.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.66000000000000003 111.439 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -78.08 -21.93 49.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.457 0.646 . . . . 0.79000000000000004 109.266 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 49' ' ' ARG . 3.3 t-20 -131.89 177.91 7.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.404 -1.271 . . . . 1.9099999999999999 108.725 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.539 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 98.7 mtt180 -67.13 151.97 96.57 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.188 -0.301 . . . . 1.4299999999999999 110.188 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 60.6 Cg_endo -74.75 161.68 38.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.192 1.928 . . . . 0.37 110.744 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -82.12 -21.24 36.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.107 0.48 . . . . 0.44 109.919 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -158.56 149.82 20.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.38 111.96 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.962 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -138.5 165.29 25.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.05 -1.093 . . . . 0.29999999999999999 108.05 169.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.037 ' HA ' HD13 ' A' ' 58' ' ' LEU . 39.7 t -179.86 116.85 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.192 0.52 . . . . 0.34999999999999998 110.204 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.7 p-90 -78.78 163.27 25.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.189 -1.041 . . . . 2.7200000000000002 108.189 172.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.18 86.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.086 0.47 . . . . 1.51 110.939 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.0 29.44 2.81 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.677 -0.692 . . . . 0.80000000000000004 112.472 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.037 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.3 tt -60.66 129.83 43.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.04 0.447 . . . . 0.57999999999999996 110.853 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.801 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -80.69 -21.38 41.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.73999999999999999 111.927 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.659 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 75.7 m 69.56 2.01 3.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.456 -0.793 . . . . 1.03 110.957 -171.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.15 -2.63 3.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.731 -0.747 . . . . 0.83999999999999997 113.336 -176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.801 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 38.6 mtpt -93.93 145.69 24.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.451 0.625 . . . . 1.6699999999999999 109.637 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.907 HD23 ' HG2' ' A' ' 93' ' ' LYS . 2.9 mt -84.77 144.01 28.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.665 -1.235 . . . . 0.57999999999999996 107.665 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -140.72 166.05 25.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.841 -0.8 . . . . 0.80000000000000004 108.841 173.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 90' ' ' VAL . 88.5 m -105.03 105.16 15.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.222 -0.659 . . . . 0.35999999999999999 109.222 171.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.628 HD13 HG12 ' A' ' 124' ' ' VAL . 52.1 tp -104.59 115.57 30.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.232 0.539 . . . . 0.58999999999999997 110.429 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.0 t -121.11 123.72 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.645 -0.707 . . . . 0.39000000000000001 110.489 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 5.5 mt -81.51 139.38 35.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.167 -1.049 . . . . 0.59999999999999998 108.167 167.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.885 HG21 HG11 ' A' ' 17' ' ' VAL . 14.8 t -140.73 153.59 45.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.695 -0.402 . . . . 0.35999999999999999 110.94 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.523 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 15.7 t70 -140.69 102.16 6.49 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.251 0.548 . . . . 1.9199999999999999 110.219 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -55.37 -28.93 65.7 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.746 2.964 . . . . 1.25 114.788 174.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -100.43 43.81 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 1.29 111.974 -167.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 84' ' ' TRP . . . -108.51 136.43 19.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 122.241 -0.287 . . . . 0.5 110.872 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.714 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 66.2 Cg_endo -74.85 -25.75 9.89 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.277 -1.551 . . . . 0.62 112.657 0.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.562 ' HB3' HG22 ' A' ' 115' ' ' THR . 86.6 p -139.07 160.3 40.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.604 . . . . 0.75 109.945 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -72.32 -26.16 61.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 2.8799999999999999 111.858 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.824 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.85 -13.41 48.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.146 0.498 . . . . 1.3799999999999999 110.508 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.516 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 21.8 t0 -150.9 73.01 8.73 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.357 -0.838 . . . . 1.3700000000000001 109.149 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 43.6 Cg_endo -89.99 88.87 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.765 2.31 . . . . 0.80000000000000004 113.034 -175.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.714 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 38.0 mttm -78.2 -45.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.773 -1.103 . . . . 1.02 111.035 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 77.8 m-85 -82.74 10.62 7.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.194 -0.912 . . . . 1.1699999999999999 111.986 -169.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 37.8 ttp180 -70.16 127.76 33.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.185 -0.302 . . . . 2.9300000000000002 110.185 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 48.9 mt-10 -94.6 129.6 41.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.025 0.44 . . . . 2.23 110.56 0.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.706 ' HD1' ' HB3' ' A' ' 81' ' ' TYR . 9.9 t90 -88.48 90.3 8.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 1.4299999999999999 109.756 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.5 p80 -75.61 120.15 20.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.596 0.712 . . . . 1.26 109.872 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 6.1 t-160 -70.75 -24.44 62.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.365 -0.834 . . . . 2.1400000000000001 111.011 -172.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.735 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 19.0 p90 -168.26 179.03 4.67 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.696 -0.483 . . . . 1.51 109.696 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.408 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.2 tp -142.75 114.48 8.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.33000000000000002 110.434 174.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.735 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -126.49 132.37 70.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.31 110.475 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.648 ' HB ' HD23 ' A' ' 131' ' ' LEU . 6.4 m -124.54 166.2 20.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.722 -1.214 . . . . 0.27000000000000002 107.722 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.787 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 92.8 m-20 59.56 19.55 8.07 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.374 0.421 . . . . 1.76 111.363 172.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.709 ' HE3' HG11 ' A' ' 89' ' ' VAL . 10.8 ttm -71.64 108.48 5.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.582 -0.895 . . . . 0.31 108.582 175.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.907 ' HG2' HD23 ' A' ' 63' ' ' LEU . 1.9 mtpm? -82.03 94.79 7.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.083 -0.962 . . . . 1.21 111.091 -170.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.5 -119.65 5.58 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.06 -0.973 . . . . 0.29999999999999999 112.58 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.562 ' HA ' HD11 ' A' ' 53' ' ' ILE . 25.3 p-10 -117.62 29.94 7.56 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 1.04 111.002 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -96.71 105.59 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.534 0.683 . . . . 0.77000000000000002 110.034 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 97' ' ' ILE . 8.4 mm -58.6 -33.38 48.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.565 -1.198 . . . . 0.40999999999999998 111.459 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.2 m -82.61 -35.51 26.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.844 -0.616 . . . . 0.68000000000000005 111.906 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 m -73.28 -6.04 43.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.493 -0.321 . . . . 1.26 111.711 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.3 107.87 2.16 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.628 -0.589 . . . . 0.34999999999999998 111.628 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -57.99 107.01 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.534 0.683 . . . . 0.45000000000000001 109.602 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.8 p -85.91 121.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.826 -1.079 . . . . 0.56999999999999995 111.631 -173.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.508 HD22 ' HB2' ' A' ' 135' ' ' GLU . 68.7 mt -102.0 -46.73 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.161 -0.927 . . . . 0.45000000000000001 109.255 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.0 t -126.16 108.21 11.1 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.162 -1.422 . . . . 0.37 107.162 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.412 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.7 t0 -57.2 155.72 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 1.1499999999999999 112.673 -169.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 43.2 t80 -74.02 95.32 2.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.29 -0.868 . . . . 4.6900000000000004 109.783 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.4 t -78.96 142.34 14.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.268 -1.012 . . . . 0.85999999999999999 108.268 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.21 179.33 45.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.67000000000000004 112.975 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 28.7 t -54.92 141.3 34.06 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.16 0.184 . . . . 0.51000000000000001 111.084 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -164.83 70.55 0.19 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.168 -0.539 . . . . 0.81999999999999995 112.367 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.773 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 89.4 Cg_endo -92.53 133.76 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.022 2.481 . . . . 0.84999999999999998 113.257 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 38.5 Cg_exo -59.11 137.31 78.57 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.649 2.233 . . . . 0.87 111.395 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.554 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.08 118.21 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 1.8500000000000001 111.005 -178.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.63 -3.07 32.34 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.555 -0.831 . . . . 1.1799999999999999 112.087 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.609 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 62.1 p -81.77 -10.47 59.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 0.96999999999999997 110.57 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.16 -155.94 19.97 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.267 -0.733 . . . . 1.97 111.267 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -90.37 108.23 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.56 -0.533 . . . . 0.93999999999999995 109.56 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -72.22 113.75 9.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.474 -175.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 1.021 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 1.1 ptt180 -102.77 95.12 5.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.315 0.579 . . . . 2.3100000000000001 112.201 -169.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.603 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 16.9 m-85 -83.81 120.52 26.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.536 -0.756 . . . . 0.78000000000000003 109.123 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.847 HG21 HD22 ' A' ' 14' ' ' LEU . 6.7 t -100.14 131.98 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 110.008 -0.367 . . . . 0.27000000000000002 110.008 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.694 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 69.2 m95 -88.07 119.52 28.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.205 -0.665 . . . . 1.99 109.205 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.6 mt -118.85 118.79 32.5 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 121.104 -0.238 . . . . 0.38 110.654 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.628 HG12 HD13 ' A' ' 66' ' ' LEU . 1.4 m -105.12 128.36 59.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.165 -0.68 . . . . 0.31 109.165 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.655 ' CB ' HD23 ' A' ' 160' ' ' LEU . 86.2 m-85 -107.64 162.26 14.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.372 -0.376 . . . . 5.1200000000000001 111.006 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.94 113.13 26.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.717 0.77 . . . . 2.4100000000000001 112.806 -171.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.859 ' HB3' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -107.71 148.65 29.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.419 -0.809 . . . . 1.3100000000000001 110.064 171.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.17 -9.5 59.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.302 -0.863 . . . . 2.3999999999999999 110.716 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.475 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.5 ptp180 -147.59 168.09 12.02 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.601 -0.727 . . . . 3.5099999999999998 111.641 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 22.6 Cg_exo -61.61 141.26 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.707 2.272 . . . . 1.21 110.539 172.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.648 HD23 ' HB ' ' A' ' 90' ' ' VAL . 3.2 mm? -73.9 145.21 44.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.681 0.623 . . . . 0.90000000000000002 112.681 -169.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -102.2 104.34 14.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.965 -1.016 . . . . 2.8999999999999999 108.811 171.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.459 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.3 p -124.44 112.23 16.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.113 -0.494 . . . . 1.8999999999999999 111.803 -175.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -99.19 13.53 32.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.033 -0.729 . . . . 2.96 109.033 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HB2' HD22 ' A' ' 103' ' ' LEU . 9.2 mm-40 -63.04 130.01 93.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.212 -0.904 . . . . 1.3899999999999999 110.56 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.56 112.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.032 2.488 . . . . 1.27 112.435 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.5 mm -61.87 115.57 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 0.85999999999999999 110.855 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.14 152.27 23.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 1.6100000000000001 109.808 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.5 m -91.33 -173.44 3.61 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.676 -0.861 . . . . 1.8799999999999999 108.676 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.707 ' HA ' HG22 ' A' ' 107' ' ' VAL . 2.1 p-10 -92.86 7.62 43.07 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.015 -0.674 . . . . 0.75 110.175 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.879 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 85.7 mtt180 -95.97 145.45 25.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 3.3599999999999999 109.972 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.617 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 21.9 m 73.85 126.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.145 -0.934 . . . . 0.94999999999999996 111.516 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.81 33.9 5.41 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.298 -0.865 . . . . 1.1200000000000001 111.709 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -52.75 19.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 2.6600000000000001 113.312 -172.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -122.19 47.44 1.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.427 0.632 . . . . 1.8700000000000001 111.304 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.418 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 22.6 mmt180 -88.17 -27.44 21.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.728 -0.669 . . . . 4.7300000000000004 111.138 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -129.33 -169.0 12.47 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.982 -1.104 . . . . 0.65000000000000002 113.121 -174.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.732 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 79.3 mttt 65.99 34.33 7.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.603 0.715 . . . . 1.0800000000000001 110.805 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.78 167.53 12.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.078 -0.964 . . . . 1.8899999999999999 109.608 174.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -116.81 120.95 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.199 -0.455 . . . . 1.29 111.083 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.801 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 35.6 m -64.83 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.78000000000000003 110.301 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.58 -44.68 93.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.024 -0.534 . . . . 0.67000000000000004 109.708 172.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.3 m -64.16 -38.39 90.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.77000000000000002 110.099 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.801 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.5 m-85 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.58 -0.282 . . . . 0.92000000000000004 111.315 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.6 ptp180 -63.84 -43.87 94.89 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.979 -0.288 . . . . 2.8900000000000001 110.345 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -68.64 -29.9 68.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.32 . . . . 0.96999999999999997 111.119 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -59.09 -51.9 68.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 111.376 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.519 ' HB3' HD12 ' A' ' 131' ' ' LEU . 49.9 m-85 -89.95 4.27 50.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.965 -0.561 . . . . 5.4500000000000002 111.711 -173.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 72.16 33.12 1.62 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.762 0.664 . . . . 2.4199999999999999 111.213 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 127' ' ' GLN . 4.5 mp -100.54 172.44 7.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.21 -0.904 . . . . 1.27 109.372 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 31.0 tpt180 -131.99 -95.92 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.317 -0.553 . . . . 3.5899999999999999 111.953 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -105.28 146.28 32.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.919 0.39 . . . . 0.76000000000000001 110.989 -173.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 17.0 Cg_exo -65.71 141.74 67.32 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.274 2.649 . . . . 0.53000000000000003 112.872 -170.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.885 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.0 t -78.16 -32.66 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.44 109.757 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.748 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -154.08 147.52 25.01 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.276 -0.569 . . . . 0.27000000000000002 111.695 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.58 144.14 11.87 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.937 -1.029 . . . . 0.23999999999999999 111.592 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -159.25 135.2 8.81 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.152 -0.684 . . . . 0.34000000000000002 109.152 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.858 ' SG ' ' HB2' ' A' ' 119' ' ' ARG . 27.3 t -113.54 145.88 40.54 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.398 -0.521 . . . . 1.1100000000000001 111.696 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 27.0 p90 -129.08 131.18 47.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.067 -0.716 . . . . 0.80000000000000004 109.067 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 1.021 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 17.3 mp0 -98.46 132.22 44.09 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.441 -0.504 . . . . 2.5299999999999998 110.272 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.57 139.06 54.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.848 -0.427 . . . . 0.59999999999999998 109.848 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.18 -168.76 1.51 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.073 -0.512 . . . . 2.3799999999999999 110.939 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.69 ' HA ' HG21 ' A' ' 177' ' ' VAL . 22.7 t90 -87.23 78.57 8.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 3.96 109.847 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.609 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -72.81 -59.17 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.35 -0.386 . . . . 1.53 111.086 -177.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.572 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 15.4 t70 175.81 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.987 0.515 . . . . 1.26 110.479 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.495 ' HB3' ' CD ' ' A' ' 47' ' ' LYS . 36.9 m-85 -81.28 -0.64 41.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 2.2200000000000002 111.758 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.842 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 99.1 t -63.25 -54.83 41.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.17 -0.468 . . . . 0.5 110.794 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.842 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.0 Cg_exo -50.77 -43.71 44.99 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.658 2.239 . . . . 0.57999999999999996 111.923 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.675 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 30.3 mmmt -66.24 -23.55 66.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.08 -0.509 . . . . 2.1400000000000001 111.917 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.695 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 36.0 tp -66.04 -48.67 70.31 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.058 -0.657 . . . . 0.66000000000000003 109.574 172.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.26 -35.19 79.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.356 0.598 . . . . 1.8899999999999999 109.656 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.675 ' HG3' ' HD2' ' A' ' 179' ' ' LYS . 4.8 mm-40 -55.97 -48.26 76.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.927 -1.033 . . . . 1.53 110.122 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -74.39 -33.47 63.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 1.49 112.187 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 71.1 mt -62.25 -10.69 11.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.646 0.26 . . . . 0.76000000000000001 111.66 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.619 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 50.9 m -77.08 6.99 5.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.224 0.535 . . . . 1.05 110.441 173.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.879 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 68.89 60.82 5.02 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.268 -0.878 . . . . 1.1699999999999999 111.327 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.6 mmmt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.518 -0.753 . . . . 2.0 111.125 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.0 t . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.319 0.58 . . . . 1.47 111.007 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 6' ' ' SER . 32.0 t70 -152.04 158.15 42.64 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.752 -1.113 . . . . 1.8100000000000001 108.268 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.718 HD12 HE21 ' A' ' 20' ' ' GLN . 2.7 mm? -78.9 30.91 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.837 0.351 . . . . 0.69999999999999996 110.765 -175.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.647 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 3.9 m -59.1 -54.69 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.97 -0.559 . . . . 1.96 111.581 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HD2' ' HB2' ' A' ' 6' ' ' SER . 8.8 mptt -99.73 40.48 1.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.819 0.342 . . . . 2.6600000000000001 110.288 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.584 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 3.4 p-90 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.779 -0.646 . . . . 3.98 112.094 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 p -141.54 20.62 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.907 0.384 . . . . 0.63 111.394 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.77 -122.54 0.31 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.35 -0.7 . . . . 0.47999999999999998 111.35 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.4 Cg_endo -51.48 -40.12 63.49 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.13 2.553 . . . . 0.53000000000000003 109.815 166.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.854 HD11 ' HA3' ' A' ' 38' ' ' GLY . 25.9 mt -87.73 81.26 7.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.433 -1.258 . . . . 1.1699999999999999 109.863 172.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -71.75 66.97 0.56 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.05 -0.722 . . . . 0.70999999999999996 109.05 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 121' ' ' VAL . 46.0 mt -75.16 -12.74 60.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.698 -0.683 . . . . 0.45000000000000001 110.797 -175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -65.65 -15.19 62.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 2.1200000000000001 111.237 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.16 -21.72 66.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.165 0.507 . . . . 1.9299999999999999 110.078 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.789 HG11 HG21 ' A' ' 69' ' ' THR . 76.1 t -89.56 -71.59 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.464 -0.789 . . . . 0.63 110.775 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.582 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 9.8 t70 -156.58 174.72 15.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.543 -0.54 . . . . 2.9900000000000002 109.543 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -63.95 120.84 12.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.298 . . . . 1.6000000000000001 110.285 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.718 HE21 HD12 ' A' ' 5' ' ' LEU . 48.2 tp60 -53.82 127.93 53.49 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.752 -0.658 . . . . 3.5499999999999998 110.567 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.662 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.0 Cg_exo -58.28 161.89 13.03 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.331 2.688 . . . . 0.57999999999999996 113.498 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.904 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 8.8 pt20 -69.86 -19.48 63.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.894 -1.048 . . . . 1.3899999999999999 112.0 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.695 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m80 -146.56 159.04 45.64 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.165 -0.47 . . . . 1.45 110.424 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.2 Cg_endo -85.19 128.65 3.67 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.208 2.605 . . . . 0.40000000000000002 111.436 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.48 HD22 ' CG1' ' A' ' 124' ' ' VAL . 26.7 tp -80.84 146.89 30.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.526 0.203 . . . . 0.28999999999999998 110.769 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -115.38 109.54 18.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.103 -0.332 . . . . 1.24 110.103 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.878 HG13 HG22 ' A' ' 53' ' ' ILE . 13.8 t -116.35 140.4 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.46999999999999997 110.049 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -137.59 137.66 38.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.3 -0.409 . . . . 0.31 110.889 -177.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.658 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 22.2 t80 -97.36 177.26 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.833 -0.802 . . . . 0.67000000000000004 108.833 174.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.41 -52.53 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.514 0.673 . . . . 0.55000000000000004 110.059 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.17 8.79 38.78 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.006 -0.997 . . . . 0.81000000000000005 112.651 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.57 -169.7 3.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.46999999999999997 110.704 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.51 158.2 23.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.737 -0.665 . . . . 0.33000000000000002 109.8 176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.885 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 79.8 t -111.43 65.87 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.624 -1.621 . . . . 0.39000000000000001 106.624 163.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -97.69 25.31 5.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.17 0.986 . . . . 0.98999999999999999 109.062 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.6 122.57 10.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.524 -1.217 . . . . 2.5600000000000001 108.02 174.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.2 tt -70.94 111.37 6.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.194 0.521 . . . . 0.40999999999999998 109.709 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.854 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 82.15 26.26 49.01 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.343 -0.844 . . . . 0.58999999999999997 111.862 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -83.74 153.17 24.3 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.93 -0.396 . . . . 0.34000000000000002 109.93 174.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.55 133.46 30.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.425 0.631 . . . . 0.55000000000000004 111.285 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.8 tp -131.22 170.08 15.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.558 -0.904 . . . . 0.45000000000000001 108.558 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.36 152.41 54.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 O-C-N 121.665 -0.647 . . . . 0.56000000000000005 112.491 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 77.1 Cg_exo -51.78 -35.35 58.33 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.749 3.633 . . . . 0.68000000000000005 114.722 -171.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.9 p -65.64 -35.03 79.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.76000000000000001 110.36 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.43 -14.14 55.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.4 -1.273 . . . . 1.5900000000000001 111.686 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 41' ' ' LEU . 23.9 m -128.49 20.04 2.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.287 0.565 . . . . 0.66000000000000003 111.656 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.79 -26.55 31.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.751 -0.659 . . . . 0.79000000000000004 109.545 179.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -116.77 -178.02 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.699 -1.137 . . . . 1.9099999999999999 109.182 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' HB3' HG21 ' A' ' 97' ' ' ILE . 77.9 mtt180 -72.9 152.9 91.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.932 -0.766 . . . . 1.4299999999999999 108.932 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.658 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 49.2 Cg_endo -74.94 175.02 11.77 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.413 1.409 . . . . 0.37 110.39 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -96.93 -16.26 20.75 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.274 -0.571 . . . . 0.44 110.059 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.477 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 75.3 m -159.75 144.32 14.99 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.38 112.436 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.878 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.24 169.21 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.996 -1.112 . . . . 0.29999999999999999 107.996 171.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.083 ' HA ' HD13 ' A' ' 58' ' ' LEU . 36.8 t 176.87 127.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.918 0.39 . . . . 0.34999999999999998 110.088 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 32.8 p-90 -92.91 167.73 11.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.933 -1.136 . . . . 2.7200000000000002 107.933 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.4 78.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 1.51 111.045 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.02 26.01 0.86 Allowed Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.565 -0.743 . . . . 0.80000000000000004 112.06 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.083 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.7 tt -65.35 128.48 36.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.071 0.462 . . . . 0.57999999999999996 110.939 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.76 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 33.5 t70 -75.39 -25.68 57.84 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 0.73999999999999999 111.756 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 25.3 p 70.0 8.87 6.88 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.475 1.11 . . . . 1.03 110.331 -171.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -3.4 1.42 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.83999999999999997 113.405 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.76 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 39.5 mtpt -96.51 151.97 19.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.38 0.59 . . . . 1.6699999999999999 110.217 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.695 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 45.2 mt -88.15 124.96 34.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.629 -0.714 . . . . 0.57999999999999996 109.977 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.613 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.6 m-85 -120.99 152.0 39.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.919 -0.312 . . . . 0.80000000000000004 110.683 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.456 HG23 HG12 ' A' ' 90' ' ' VAL . 57.1 m -97.32 110.63 23.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 0.35999999999999999 109.149 170.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.672 HD13 HG12 ' A' ' 124' ' ' VAL . 48.8 tp -113.16 118.69 35.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.58999999999999997 110.497 -175.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.3 t -116.64 126.29 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.39000000000000001 110.619 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.963 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 2.9 mt -92.76 133.76 35.72 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.472 -0.936 . . . . 0.59999999999999998 108.472 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.789 HG21 HG11 ' A' ' 17' ' ' VAL . 9.3 t -137.55 147.42 45.12 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.616 -0.434 . . . . 0.35999999999999999 111.899 -176.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 18.5 t70 -123.82 97.15 41.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.69 -0.686 . . . . 1.9199999999999999 109.8 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.2 Cg_endo -51.39 -35.11 53.3 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 124.076 3.184 . . . . 1.25 114.797 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 60.8 m-20 -99.45 49.69 0.94 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 1.29 112.397 -168.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.45 142.75 25.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.5 110.295 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 98.5 Cg_endo -83.66 -23.11 13.38 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.814 -1.328 . . . . 0.62 112.753 1.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.689 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 24.7 p -129.67 144.13 51.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.75 109.816 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 40.0 ttt180 -62.46 -26.68 68.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 2.8799999999999999 111.212 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.8 ptpt -76.25 -21.64 56.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.042 0.449 . . . . 1.3799999999999999 111.111 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 18.1 t70 -154.14 85.6 3.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.022 -0.536 . . . . 1.3700000000000001 109.674 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -82.2 87.91 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.451 2.101 . . . . 0.80000000000000004 112.717 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 32.0 mttm -75.15 -49.88 18.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.039 -0.982 . . . . 1.02 110.085 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.759 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.2 m-85 -84.53 22.1 1.36 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 111.903 -169.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.5 ttm180 -74.9 127.74 33.91 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.136 0.272 . . . . 2.9300000000000002 110.522 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.508 ' OE1' HG22 ' A' ' 151' ' ' VAL . 4.2 mp0 -97.04 137.44 36.12 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.043 0.449 . . . . 2.23 110.497 -3.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.545 ' CD1' ' HG2' ' A' ' 146' ' ' ARG . 16.8 t90 -85.37 146.04 27.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.996 -1.113 . . . . 1.4299999999999999 107.996 173.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 48.6 p-80 -122.04 129.48 52.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.282 0.563 . . . . 1.26 110.357 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 38.5 t-80 -68.1 -34.74 76.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.032 -0.986 . . . . 2.1400000000000001 110.09 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.522 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 40.3 p90 -168.69 172.62 7.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.045 -0.354 . . . . 1.51 110.045 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HG ' HD12 ' A' ' 103' ' ' LEU . 44.0 tp -133.96 113.9 12.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.507 -0.553 . . . . 0.33000000000000002 109.507 173.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.617 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -120.92 134.73 63.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.819 -0.628 . . . . 0.31 110.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' A' ' 131' ' ' LEU . 15.9 m -132.79 161.47 41.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 107.691 -1.226 . . . . 0.27000000000000002 107.691 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.695 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 t30 63.34 18.16 10.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.221 0.534 . . . . 1.76 110.221 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.617 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.0 ttm -68.11 111.36 4.44 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.94 -0.763 . . . . 0.31 108.94 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.592 ' HE2' HD21 ' A' ' 63' ' ' LEU . 14.5 ttmt -85.71 101.83 13.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.722 -1.126 . . . . 1.21 111.318 -170.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.15 -124.2 27.47 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 114.959 -1.019 . . . . 0.29999999999999999 112.43 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.575 ' HA ' HD11 ' A' ' 53' ' ' ILE . 3.7 p-10 -110.56 21.79 16.18 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.982 0.42 . . . . 1.04 110.756 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.79 109.4 20.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.723 0.773 . . . . 0.77000000000000002 109.971 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 50' ' ' PRO . 5.3 mm -62.38 -31.18 50.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.097 -1.41 . . . . 0.40999999999999998 111.246 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.1 m -78.29 -37.09 45.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.874 -0.603 . . . . 0.68000000000000005 111.997 -172.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.3 m -70.05 -8.6 50.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.765 0.283 . . . . 1.26 111.765 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 92' ' ' MET . . . -67.41 100.11 0.57 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.977 -0.63 . . . . 0.34999999999999998 111.779 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.5 m -60.33 107.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.671 0.748 . . . . 0.45000000000000001 110.11 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 105' ' ' ASP . 4.6 p -86.69 127.63 40.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.667 -1.151 . . . . 0.56999999999999995 111.527 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 11.3 mt -102.01 -54.72 2.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.116 0.96 . . . . 0.45000000000000001 109.141 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.1 t -106.43 100.15 9.69 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.885 -1.524 . . . . 0.37 106.885 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 1.007 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -55.37 160.7 2.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.002 -0.999 . . . . 1.1499999999999999 112.782 -169.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.1 p90 -74.09 90.76 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.514 -0.766 . . . . 4.6900000000000004 110.879 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.707 HG12 HD21 ' A' ' 180' ' ' LEU . 35.6 t -63.96 -40.07 87.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.902 -0.59 . . . . 0.85999999999999999 110.353 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.559 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 103.3 -173.03 21.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.667 -0.778 . . . . 0.67000000000000004 112.7 174.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 t -64.6 115.03 4.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.411 -0.589 . . . . 0.51000000000000001 109.411 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.674 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -144.68 58.18 0.52 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.81999999999999995 112.943 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.671 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -89.21 125.71 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.303 2.669 . . . . 0.84999999999999998 111.94 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.719 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 82.5 Cg_exo -46.21 132.98 15.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.415 2.076 . . . . 0.87 111.273 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.0 110.83 2.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.005 -0.543 . . . . 1.8500000000000001 111.012 -171.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.0 -5.27 25.59 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.594 -0.73 . . . . 1.1799999999999999 113.062 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.719 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -77.58 -9.92 59.21 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.698 0.629 . . . . 0.96999999999999997 112.698 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.01 -170.48 25.01 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.707 . . . . 1.97 111.994 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -73.42 144.82 46.19 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.866 0.365 . . . . 0.93999999999999995 110.757 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.671 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.6 m-70 -120.76 123.0 41.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.073 -0.512 . . . . 2.23 110.303 176.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.842 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 11.1 ptt180 -100.0 92.17 5.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.536 -0.756 . . . . 2.3100000000000001 111.406 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 69' ' ' THR . 40.6 m-85 -75.74 112.2 11.87 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.157 -0.683 . . . . 0.78000000000000003 109.157 175.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.843 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.0 t -96.49 133.74 36.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.774 . . . . 0.27000000000000002 109.66 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.62 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 35.5 m95 -89.29 132.61 34.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.193 -0.669 . . . . 1.99 109.193 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 82.7 mt -127.62 118.33 23.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.742 0.246 . . . . 0.38 110.344 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.672 HG12 HD13 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -114.2 145.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.716 0.293 . . . . 0.31 110.434 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.702 ' CD1' ' HG ' ' A' ' 160' ' ' LEU . 35.8 t80 -123.87 153.46 41.06 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.613 -0.514 . . . . 5.1200000000000001 109.613 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -108.35 88.87 2.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.033 -0.729 . . . . 2.4100000000000001 109.033 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -74.7 175.04 8.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.971 0.891 . . . . 1.3100000000000001 111.795 -172.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.86 -16.48 28.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.774 -1.557 . . . . 2.3999999999999999 109.964 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.549 ' HD2' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -144.63 160.53 47.28 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.413 -0.812 . . . . 3.5099999999999998 111.204 -176.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 131' ' ' LEU . 25.5 Cg_exo -70.43 14.12 0.31 Allowed 'Trans proline' 0 N--CA 1.484 0.919 0 C-N-CA 124.81 3.674 . . . . 1.21 114.501 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.567 HD12 ' SG ' ' A' ' 133' ' ' CYS . 4.1 mm? 81.13 168.34 0.14 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.679 0.792 . . . . 0.90000000000000002 112.864 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -160.53 78.48 0.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.315 -1.312 . . . . 2.8999999999999999 107.75 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.753 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.1 m -99.91 130.04 46.05 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.451 -0.795 . . . . 1.8999999999999999 111.214 -173.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -93.74 18.73 9.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.34 -0.845 . . . . 2.96 109.975 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.753 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 6.9 mm-40 -76.23 116.37 55.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.476 -0.783 . . . . 1.3899999999999999 109.923 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.72 137.37 42.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.362 2.708 . . . . 1.27 113.63 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.0 mm -73.47 115.77 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.764 -0.458 . . . . 0.85999999999999999 109.764 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -92.02 -10.86 37.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.966 0.728 . . . . 1.6100000000000001 112.966 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.9 m 51.98 25.12 2.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.292 0.849 . . . . 1.8799999999999999 113.292 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 1.007 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.1 p-10 50.54 21.99 0.97 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.202 1.001 . . . . 0.75 113.414 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.516 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 46.4 mtt180 -110.32 142.22 42.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.189 -0.3 . . . . 3.3599999999999999 110.189 172.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.638 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 55.0 m 77.07 151.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.215 0.947 . . . . 0.94999999999999996 111.703 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 146' ' ' ARG . . . -120.41 14.03 10.13 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.486 -0.779 . . . . 1.1200000000000001 112.849 -174.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.48 -22.27 62.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.472 . . . . 2.6600000000000001 111.035 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -119.82 46.3 1.97 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.228 -0.656 . . . . 1.8700000000000001 109.228 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.545 ' HG2' ' CD1' ' A' ' 84' ' ' TRP . 10.0 ttm180 -75.14 -71.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.145 -0.934 . . . . 4.7300000000000004 111.531 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -120.42 -154.66 9.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 0.65000000000000002 112.31 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.759 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.0 mttt 65.45 35.77 7.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.402 0.62 . . . . 1.0800000000000001 110.256 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -120.11 104.45 10.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.169 -0.923 . . . . 1.8899999999999999 109.745 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -53.84 120.56 6.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.916 -0.584 . . . . 1.29 111.785 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 2.4 m -62.04 -29.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.78000000000000003 111.183 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.743 ' HB1' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -37.55 87.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.67000000000000004 110.169 174.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.6 m -65.99 -33.29 75.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.546 -0.297 . . . . 0.77000000000000002 110.785 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.892 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 49.9 m-85 -62.24 -54.1 45.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.054 0.454 . . . . 0.92000000000000004 110.56 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 9.6 ptt180 -70.01 -51.57 31.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 2.8900000000000001 111.853 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.743 ' HE2' ' HB1' ' A' ' 152' ' ' ALA . 58.7 mtmt -62.01 -24.5 67.08 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.427 -0.17 . . . . 0.96999999999999997 111.367 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -52.05 -53.12 46.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 1.5800000000000001 111.425 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.549 ' OH ' ' HD2' ' A' ' 129' ' ' ARG . 12.7 t80 -104.43 29.55 6.0 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.796 -0.762 . . . . 5.4500000000000002 110.511 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 71.53 26.59 3.17 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.252 -0.886 . . . . 2.4199999999999999 111.842 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.702 ' HG ' ' CD1' ' A' ' 125' ' ' TYR . 7.8 mp -83.68 124.51 30.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.901 -0.407 . . . . 1.27 109.901 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -73.26 -75.87 0.14 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.721 -0.672 . . . . 3.5899999999999999 112.6 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.56 ' H ' ' HE2' ' A' ' 125' ' ' TYR . . . -150.51 150.99 30.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.547 0.213 . . . . 0.76000000000000001 110.668 -176.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.42 152.17 78.6 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.55 2.833 . . . . 0.53000000000000003 114.016 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.904 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.6 t -93.81 -37.39 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 115.025 -0.989 . . . . 0.44 110.568 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -143.27 144.16 32.02 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.011 -0.676 . . . . 0.27000000000000002 111.703 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' A' ' 21' ' ' PRO . . . -146.7 150.88 23.19 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.114 -0.948 . . . . 0.23999999999999999 112.343 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.584 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.2 t -164.62 156.08 15.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.293 -1.003 . . . . 0.34000000000000002 108.293 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.843 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -131.42 150.23 52.23 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.872 -0.517 . . . . 1.1100000000000001 112.04 -172.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.496 ' HD2' ' HE1' ' A' ' 122' ' ' TRP . 51.1 p90 -136.0 135.01 39.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.608 -0.886 . . . . 0.80000000000000004 108.608 171.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.842 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 12.9 mp0 -99.65 133.8 43.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.575 0.625 . . . . 2.5299999999999998 110.386 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.48 137.33 54.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.935 0.397 . . . . 0.59999999999999998 111.416 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.98 -170.2 3.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.447 -0.797 . . . . 2.3799999999999999 110.914 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.873 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -105.48 77.39 1.28 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.979 -0.748 . . . . 3.96 108.979 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.591 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 13.7 t70 -72.19 -61.24 1.86 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.167 0.803 . . . . 1.53 113.167 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.633 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 12.4 t70 -167.5 -46.78 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.216 0.532 . . . . 1.26 110.951 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 37.9 m-85 -71.8 -2.8 18.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 2.2200000000000002 111.691 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.873 HG21 ' HA ' ' A' ' 173' ' ' TRP . 66.8 t -73.17 -55.37 3.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.57 -0.286 . . . . 0.5 111.414 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 47.6 Cg_exo -58.22 -29.72 88.49 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.271 1.98 . . . . 0.57999999999999996 111.274 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.0 mmmm -74.7 -24.77 58.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 111.17 177.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.707 HD21 HG12 ' A' ' 107' ' ' VAL . 51.2 tp -76.08 -42.07 48.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.502 -0.555 . . . . 0.66000000000000003 109.502 172.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -58.87 -38.27 78.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.69 -0.686 . . . . 1.8899999999999999 109.185 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.676 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.8 mm-40 -58.21 -42.73 86.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.791 -1.095 . . . . 1.53 110.985 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -76.41 -32.23 58.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 1.49 112.759 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.638 ' HA ' ' H ' ' A' ' 142' ' ' SER . 60.9 mt -62.99 -4.97 2.52 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.786 0.662 . . . . 0.76000000000000001 112.786 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.533 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 20.1 m -78.65 1.49 22.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.531 0.682 . . . . 1.05 109.766 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 76.37 50.94 6.99 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.1 -0.954 . . . . 1.1699999999999999 111.184 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.533 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.7 mmmt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.359 -0.829 . . . . 2.0 110.37 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 7.2 p . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 121.283 0.563 . . . . 1.47 111.013 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 6' ' ' SER . 25.2 t70 -167.03 163.43 15.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.696 -0.853 . . . . 1.8100000000000001 108.696 -172.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -76.56 25.81 0.14 Allowed 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 120.537 0.208 . . . . 0.69999999999999996 111.113 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 4' ' ' ASP . 31.1 m -62.91 -27.34 69.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 1.96 111.692 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -116.38 48.26 1.29 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.87 0.367 . . . . 2.6600000000000001 110.258 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -75.09 -29.74 60.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 3.98 111.724 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 36.6 p -148.14 11.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.535 -0.466 . . . . 0.63 112.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.46 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.729 . . . . 0.47999999999999998 111.733 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.3 Cg_endo -48.88 -48.83 16.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.201 2.601 . . . . 0.53000000000000003 110.381 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.72 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 8.1 mp -87.99 88.94 7.8 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.354 -0.839 . . . . 1.1699999999999999 110.258 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 7.4 m -76.12 67.02 2.37 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.354 0.597 . . . . 0.70999999999999996 110.095 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 121' ' ' VAL . 23.5 mt -71.12 -13.91 62.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.496 -0.775 . . . . 0.45000000000000001 111.164 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -65.61 -14.84 61.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.131 -0.486 . . . . 2.1200000000000001 111.477 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.34 -19.76 65.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.29 0.567 . . . . 1.9299999999999999 110.507 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.903 HG12 HG21 ' A' ' 151' ' ' VAL . 40.6 t -93.76 -72.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.477 -0.783 . . . . 0.63 111.27 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 19' ' ' GLU . 25.5 t70 -149.97 -170.99 3.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.557 -0.905 . . . . 2.9900000000000002 108.557 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.821 ' HG3' HH12 ' A' ' 155' ' ' ARG . 15.6 mt-10 -81.64 163.72 22.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.789 0.804 . . . . 1.6000000000000001 113.114 -167.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.49 126.95 89.29 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.415 -1.266 . . . . 3.5499999999999998 110.387 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 6.3 Cg_exo -75.28 154.25 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.839 1.693 . . . . 0.57999999999999996 111.166 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.946 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 20.4 pt20 -81.44 -1.19 44.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.293 -0.412 . . . . 1.3899999999999999 111.726 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.769 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 13.7 m80 -160.54 159.95 25.83 Favored Pre-proline 0 CA--C 1.516 -0.362 0 C-N-CA 123.35 0.66 . . . . 1.45 109.583 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -86.87 128.54 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 123.132 2.555 . . . . 0.40000000000000002 110.994 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.607 HD22 HG12 ' A' ' 124' ' ' VAL . 43.9 tp -80.1 145.9 32.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.696 0.284 . . . . 0.28999999999999998 111.183 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -109.36 130.33 55.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.311 -0.626 . . . . 1.24 109.311 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 53' ' ' ILE . 16.0 t -134.16 118.8 29.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.487 -0.931 . . . . 0.46999999999999997 108.487 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.3 OUTLIER -117.98 136.78 53.29 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 0.31 111.283 -172.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -97.0 173.82 7.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.279 -0.637 . . . . 0.67000000000000004 109.279 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.52 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.5 0.667 . . . . 0.55000000000000004 110.548 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 -6.14 37.55 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.163 -0.926 . . . . 0.81000000000000005 112.763 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.91 -171.96 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.858 0.329 . . . . 0.46999999999999997 110.52 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.73 153.73 17.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.113 -0.494 . . . . 0.33000000000000002 110.301 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.795 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 84.9 t -109.85 69.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 107.406 -1.331 . . . . 0.39000000000000001 107.406 165.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 34.2 t70 -102.49 20.46 17.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.967 -1.015 . . . . 0.98999999999999999 109.072 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.631 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 52.3 mt-10 -143.84 134.54 25.05 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.48 -1.236 . . . . 2.5600000000000001 108.955 172.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.696 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -81.36 112.49 18.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.794 -0.639 . . . . 0.40999999999999998 109.985 -174.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.59 52.53 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.256 -0.738 . . . . 0.58999999999999997 111.256 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.705 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.09 149.44 26.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.321 -0.251 . . . . 0.34000000000000002 110.321 177.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 10.2 p -74.52 131.81 34.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 0.55000000000000004 110.967 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.611 HD22 HG22 ' A' ' 34' ' ' VAL . 9.2 tp -133.0 170.7 15.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.485 -0.931 . . . . 0.45000000000000001 108.485 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -121.24 149.86 52.71 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 119.4 -0.92 . . . . 0.56000000000000005 111.802 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.741 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 39.8 Cg_exo -61.31 -28.62 84.73 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.201 3.267 . . . . 0.68000000000000005 113.651 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -28.61 67.37 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.546 0.689 . . . . 0.76000000000000001 110.542 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 42' ' ' THR . 97.5 mt-30 -77.88 -52.94 8.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.848 -1.069 . . . . 1.5900000000000001 111.228 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 169' ' ' TYR . 3.9 m -99.16 32.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.695 0.628 . . . . 0.66000000000000003 112.695 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.82 -30.72 61.49 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.346 -0.542 . . . . 0.79000000000000004 110.039 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.06 179.88 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 1.9099999999999999 109.971 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 96.8 mtt180 -66.89 159.38 76.06 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.868 0.366 . . . . 1.4299999999999999 110.797 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 71.3 Cg_endo -79.57 157.54 25.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.072 1.848 . . . . 0.37 110.944 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -82.23 -18.06 43.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.684 -0.488 . . . . 0.44 109.684 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 71.5 m -160.68 147.24 15.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.504 0.669 . . . . 0.38 112.003 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.921 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -137.46 166.29 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.29999999999999999 108.207 169.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.084 ' HA ' HD13 ' A' ' 58' ' ' LEU . 43.5 t 176.82 111.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.122 0.487 . . . . 0.34999999999999998 110.323 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.638 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 51.4 p-90 -73.3 152.89 40.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.616 -1.253 . . . . 2.7200000000000002 107.616 171.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.66 89.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.51 111.12 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.48 17.45 4.35 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.757 -0.656 . . . . 0.80000000000000004 112.236 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.084 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.3 tt -51.9 129.07 25.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.113 0.565 . . . . 0.57999999999999996 111.734 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.748 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 17.9 t70 -72.28 -30.67 65.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.538 -0.756 . . . . 0.73999999999999999 111.503 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.446 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.4 m 76.46 -5.6 2.15 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.818 -1.083 . . . . 1.03 110.604 -172.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.06 -8.34 5.61 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.948 -0.644 . . . . 0.83999999999999997 113.556 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 29.4 mtpt -94.7 142.85 26.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.423 0.611 . . . . 1.6699999999999999 110.962 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.72 HD21 ' HE2' ' A' ' 93' ' ' LYS . 46.7 mt -78.56 125.65 29.65 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.539 -0.912 . . . . 0.57999999999999996 108.539 171.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.514 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -121.13 163.04 19.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.465 -0.494 . . . . 0.80000000000000004 109.978 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.695 HG23 HG12 ' A' ' 90' ' ' VAL . 69.1 m -104.24 105.49 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.355 -0.609 . . . . 0.35999999999999999 109.355 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.544 HD23 ' HE2' ' A' ' 87' ' ' PHE . 25.3 tp -100.25 114.58 28.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.766 -0.457 . . . . 0.58999999999999997 109.766 -177.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.7 t -116.71 121.77 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.907 0.384 . . . . 0.39000000000000001 111.344 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -81.52 134.38 35.51 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.555 -1.276 . . . . 0.59999999999999998 107.555 168.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.838 HG21 HG11 ' A' ' 17' ' ' VAL . 10.3 t -140.35 142.74 35.56 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.014 0.435 . . . . 0.35999999999999999 110.479 176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 7.1 p-10 -130.66 95.59 25.93 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-O 121.653 0.74 . . . . 1.9199999999999999 110.188 174.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.5 Cg_endo -52.92 -31.95 54.98 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.937 3.091 . . . . 1.25 112.837 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.734 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 5.1 m-20 -82.79 45.98 1.04 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 1.29 111.094 -172.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.41 130.23 23.65 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.696 -0.483 . . . . 0.5 109.696 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.583 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.3 Cg_endo -79.17 -30.38 5.78 Favored 'Cis proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.147 -1.605 . . . . 0.62 112.982 1.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.718 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 98.6 p -125.59 156.64 38.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.33 -0.395 . . . . 0.75 111.224 -177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.734 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 52.0 ttp180 -72.19 -23.85 61.33 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.049 -0.523 . . . . 2.8799999999999999 111.129 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.779 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.08 -11.26 39.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.434 . . . . 1.3799999999999999 110.64 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -156.32 84.32 3.25 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 1.3700000000000001 109.814 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.95 91.74 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.065 2.51 . . . . 0.80000000000000004 113.353 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.583 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.8 mttm -76.11 -49.59 16.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.162 -0.926 . . . . 1.02 110.849 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.822 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 91.8 m-85 -82.78 14.05 3.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.798 -1.092 . . . . 1.1699999999999999 111.538 -169.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.5 ttt180 -67.02 128.49 36.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.956 -0.566 . . . . 2.9300000000000002 111.024 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 2.5 mp0 -99.7 137.15 38.57 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.876 0.369 . . . . 2.23 110.545 -3.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.548 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.2 t90 -93.79 130.48 39.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.923 -0.769 . . . . 1.4299999999999999 108.923 175.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 44.1 p-80 -98.66 123.18 42.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.999 -0.741 . . . . 1.26 108.999 173.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -91.57 -11.13 38.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.553 -0.749 . . . . 2.1400000000000001 111.714 -170.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 1.034 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 40.8 t80 -167.95 136.23 2.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.873 -0.417 . . . . 1.51 109.873 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HG ' HD12 ' A' ' 103' ' ' LEU . 22.7 tp -134.28 114.42 12.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.33000000000000002 110.263 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.823 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -130.09 135.49 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.681 -0.69 . . . . 0.31 110.638 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.695 HG12 HG23 ' A' ' 65' ' ' THR . 13.9 m -130.09 163.57 35.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.115 -0.948 . . . . 0.27000000000000002 108.612 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.677 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.9 t-20 64.94 14.22 9.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.841 0.353 . . . . 1.76 110.416 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.823 ' HE3' HG11 ' A' ' 89' ' ' VAL . 14.3 ttm -68.93 103.97 1.96 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.702 -0.851 . . . . 0.31 108.702 174.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.72 ' HE2' HD21 ' A' ' 63' ' ' LEU . 21.2 ttmm -85.73 98.53 10.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.401 -0.818 . . . . 1.21 110.918 -171.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.29 -123.09 6.0 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.971 -1.013 . . . . 0.29999999999999999 112.186 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.526 ' HA ' HD11 ' A' ' 53' ' ' ILE . 5.3 p-10 -118.1 31.08 6.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.539 0.685 . . . . 1.04 110.391 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.62 114.96 27.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.062 -0.972 . . . . 0.77000000000000002 110.289 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 97' ' ' ILE . 3.1 mm -66.81 -19.95 26.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.698 -1.137 . . . . 0.40999999999999998 110.951 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.1 m -80.34 -52.99 7.04 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.669 0.618 . . . . 0.68000000000000005 112.669 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 p -61.67 -20.79 63.82 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.714 0.293 . . . . 1.26 111.712 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.02 102.18 0.19 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.765 -0.652 . . . . 0.34999999999999998 111.987 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 107.17 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.453 0.644 . . . . 0.45000000000000001 109.723 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.486 ' O ' HD12 ' A' ' 137' ' ' ILE . 2.6 p -74.51 118.27 19.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.825 -1.08 . . . . 0.56999999999999995 111.846 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.72 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.3 mt -97.83 -45.26 6.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.971 0.891 . . . . 0.45000000000000001 108.888 172.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.8 t -126.57 106.46 9.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.615 -1.175 . . . . 0.37 107.858 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 6.3 t0 -61.86 158.15 16.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 1.1499999999999999 112.387 -169.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -78.91 98.67 6.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.026 -0.988 . . . . 4.6900000000000004 109.664 -178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.679 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 30.1 t -74.56 -23.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.85999999999999999 111.471 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.11 -179.65 45.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.413 -0.898 . . . . 0.67000000000000004 111.858 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.3 t -60.54 133.62 56.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.862 -0.422 . . . . 0.51000000000000001 109.862 172.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.657 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -172.53 66.01 0.13 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.814 -0.708 . . . . 0.81999999999999995 112.337 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -93.29 140.24 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.816 2.344 . . . . 0.84999999999999998 112.977 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HB2' HG23 ' A' ' 115' ' ' THR . 72.6 Cg_exo -51.15 135.01 44.82 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.531 2.154 . . . . 0.87 111.331 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 117.0 5.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.213 -0.292 . . . . 1.8500000000000001 110.213 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.46 -4.28 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.798 -0.715 . . . . 1.1799999999999999 111.963 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 72.9 p -79.13 -16.59 56.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.763 0.316 . . . . 0.96999999999999997 111.302 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.75 -169.4 23.22 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.844 -0.616 . . . . 1.97 111.846 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.39 98.3 1.4 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.93999999999999995 109.935 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -75.77 103.93 6.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.421 -0.809 . . . . 2.23 109.204 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.851 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -99.72 92.96 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.405 0.621 . . . . 2.3100000000000001 111.668 -173.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.551 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 1.1 m-85 -76.88 133.44 39.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.78000000000000003 109.449 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.4 t -108.63 133.16 54.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.948 -0.39 . . . . 0.27000000000000002 109.948 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.795 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 1.5 m-90 -89.53 127.84 35.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.372 -0.603 . . . . 1.99 109.372 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 mt -118.75 119.39 34.29 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.867 -0.419 . . . . 0.38 109.867 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.607 HG12 HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -106.96 132.68 53.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.41 -0.516 . . . . 0.31 109.682 175.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.619 ' HB2' HD23 ' A' ' 160' ' ' LEU . 24.3 m-85 -115.35 149.55 37.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.147 -0.478 . . . . 5.1200000000000001 110.055 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.537 ' HB2' HG21 ' A' ' 164' ' ' VAL . 42.6 tt0 -101.31 117.93 35.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.154 0.502 . . . . 2.4100000000000001 109.894 174.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -89.88 158.86 17.25 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.626 -0.879 . . . . 1.3100000000000001 108.626 173.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.401 ' OD2' ' HG3' ' A' ' 129' ' ' ARG . 2.3 p-10 -76.4 -10.83 59.69 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.601 -0.727 . . . . 2.3999999999999999 110.805 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.661 ' NH2' ' HB2' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -162.56 177.31 1.98 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 3.5099999999999998 109.246 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 51.3 Cg_exo -54.0 174.54 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.275 1.984 . . . . 1.21 112.589 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.66 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.6 mm? -93.38 163.73 13.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.52 0.563 . . . . 0.90000000000000002 112.52 -171.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.95 45.57 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.62 1.2 . . . . 2.8999999999999999 109.868 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.492 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.2 p -62.65 -69.17 0.28 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.264 -1.789 . . . . 1.8999999999999999 111.664 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 57.87 32.34 21.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.837 0.827 . . . . 2.96 110.173 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.637 ' HB2' HD22 ' A' ' 103' ' ' LEU . 57.9 mm-40 -81.85 139.99 46.83 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.547 -0.751 . . . . 1.3899999999999999 110.809 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.38 125.2 8.75 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.37 2.714 . . . . 1.27 112.397 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 102' ' ' VAL . 33.4 mm -76.94 123.1 32.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.85999999999999999 111.454 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.9 mt -94.82 155.37 16.83 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.346 -0.613 . . . . 1.6100000000000001 109.346 174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.0 m -119.41 38.37 3.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.558 0.218 . . . . 1.8799999999999999 111.508 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.9 OUTLIER 56.76 0.81 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.714 1.206 . . . . 0.75 113.418 177.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.554 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.0 mtt180 -97.64 148.51 23.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.919 -0.488 . . . . 3.3599999999999999 109.797 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.618 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.4 m 74.46 115.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.113 0.883 . . . . 0.94999999999999996 112.364 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -87.9 38.17 3.19 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 1.1200000000000001 111.54 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.05 -39.91 71.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.77 0.795 . . . . 2.6600000000000001 110.757 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -99.25 64.68 1.37 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.088 -0.96 . . . . 1.8700000000000001 110.053 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.584 ' O ' ' HB3' ' A' ' 81' ' ' TYR . 26.9 mtm180 -87.09 39.74 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 4.7300000000000004 112.048 -175.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . 76.91 -117.4 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.935 -0.65 . . . . 0.65000000000000002 114.001 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.822 ' CG ' ' HA ' ' A' ' 81' ' ' TYR . 79.9 mttt 60.35 39.85 18.25 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.121 0.486 . . . . 1.0800000000000001 110.8 -171.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.442 ' HD2' ' CE2' ' A' ' 154' ' ' PHE . 43.5 t80 -150.37 135.83 18.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.846 -0.616 . . . . 1.8899999999999999 109.622 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -54.17 119.56 5.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.507 -0.77 . . . . 1.29 112.792 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.903 HG21 HG12 ' A' ' 17' ' ' VAL . 4.3 m -59.03 -35.15 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.335 -0.848 . . . . 0.78000000000000003 110.832 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.78 -33.02 72.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.863 -0.608 . . . . 0.67000000000000004 110.456 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -70.47 -37.71 74.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.242 -0.435 . . . . 0.77000000000000002 110.667 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.442 ' CE2' ' HD2' ' A' ' 149' ' ' PHE . 53.7 m-85 -64.28 -48.22 76.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.702 0.763 . . . . 0.92000000000000004 109.518 173.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.821 HH12 ' HG3' ' A' ' 19' ' ' GLU . 21.3 ttt180 -55.59 -50.31 70.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.4 -1.273 . . . . 2.8900000000000001 111.723 177.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -70.63 -28.91 65.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.96999999999999997 111.126 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 44.3 tptt -59.84 -40.51 88.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 1.5800000000000001 110.818 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.49 ' HB3' ' CD1' ' A' ' 131' ' ' LEU . 22.5 m-85 -88.53 5.97 40.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.077 -0.511 . . . . 5.4500000000000002 110.516 -177.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.661 ' HB2' ' NH2' ' A' ' 129' ' ' ARG . 34.0 mm-40 67.21 33.85 5.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.261 -0.881 . . . . 2.4199999999999999 111.336 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 125' ' ' TYR . 4.0 mp -90.62 140.64 29.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.666 0.269 . . . . 1.27 111.28 -177.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -71.56 -78.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 3.5899999999999999 111.385 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -155.44 166.92 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.61 -0.515 . . . . 0.76000000000000001 109.61 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.544 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 23.2 Cg_exo -60.95 137.95 75.61 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.592 2.195 . . . . 0.53000000000000003 113.276 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.946 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 6.3 t -93.18 -26.94 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 115.465 -0.789 . . . . 0.44 109.279 174.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.769 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.56 147.35 25.3 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.917 -0.583 . . . . 0.27000000000000002 111.806 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -144.32 142.21 10.84 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.725 -1.125 . . . . 0.23999999999999999 111.429 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.696 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 7.6 t -155.72 137.04 13.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.149 -0.686 . . . . 0.34000000000000002 109.149 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.867 ' HB2' HG22 ' A' ' 121' ' ' VAL . 6.7 t -116.51 145.26 43.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.24 0.543 . . . . 1.1100000000000001 111.106 -174.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 25.2 p90 -128.52 129.62 46.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.346 -1.353 . . . . 0.80000000000000004 107.346 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.848 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -110.47 132.52 54.11 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.714 -0.794 . . . . 2.5299999999999998 111.044 -178.25 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -149.33 135.64 19.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.59999999999999998 109.558 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -118.26 -136.75 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.51 -0.314 . . . . 2.3799999999999999 110.907 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -80.27 96.91 6.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 3.96 111.746 -172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.741 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 3.1 t70 -73.62 -62.16 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 1.53 110.396 170.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.553 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.7 t70 159.29 -39.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.024 1.329 . . . . 1.26 108.373 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.03 0.24 36.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 2.2200000000000002 110.864 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.798 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 76.8 t -62.49 -53.92 53.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.02 -0.536 . . . . 0.5 110.478 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.798 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.2 Cg_exo -51.97 -35.46 60.79 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.468 2.112 . . . . 0.57999999999999996 112.022 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 13.5 mmmm -73.9 -26.97 60.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 2.1400000000000001 111.499 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.66 HD21 HG12 ' A' ' 107' ' ' VAL . 44.0 tp -69.09 -46.91 66.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.66000000000000003 109.063 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.35 -34.94 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 1.8899999999999999 109.393 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.714 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.2 mm-40 -63.28 -43.87 96.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.985 -1.007 . . . . 1.53 110.922 173.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.444 ' HA ' ' CG ' ' A' ' 187' ' ' LYS . 2.4 tt0 -65.29 -27.84 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.49 111.406 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.618 ' HA ' ' H ' ' A' ' 142' ' ' SER . 59.4 mt -66.31 6.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.511 0.559 . . . . 0.76000000000000001 112.511 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.739 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 15.3 m -80.99 0.15 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.674 0.75 . . . . 1.05 109.086 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.52 33.07 17.52 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 111.228 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.739 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 31.6 mmtp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.372 -0.823 . . . . 2.0 110.991 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 2.7 p . . . . . 0 N--CA 1.444 -0.73 0 CA-C-O 121.714 0.768 . . . . 1.47 110.224 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.459 ' HA ' ' CG ' ' A' ' 24' ' ' PRO . 3.4 p30 -169.56 -175.48 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.921 -1.036 . . . . 1.8100000000000001 108.557 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.474 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.5 mm? -78.61 24.81 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.918 0.34 . . . . 0.69999999999999996 111.918 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 t -72.9 -19.88 61.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.731 0.777 . . . . 1.96 109.388 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HB3' HD12 ' A' ' 12' ' ' LEU . 79.8 mttt -117.33 36.72 4.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 2.6600000000000001 110.174 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.859 ' HB2' HE21 ' A' ' 20' ' ' GLN . 0.2 OUTLIER -78.4 -37.22 44.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 3.98 112.294 -176.43 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 11.6 p -145.3 27.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.63 110.995 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.87 -122.31 0.31 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.912 -0.875 . . . . 0.47999999999999998 110.912 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.72 -38.56 77.3 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.183 2.588 . . . . 0.53000000000000003 110.568 166.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.788 HD11 ' HA3' ' A' ' 38' ' ' GLY . 17.5 mt -87.85 83.73 7.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 110.027 173.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.34 68.96 0.79 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.375 0.607 . . . . 0.70999999999999996 110.112 175.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 121' ' ' VAL . 57.0 mt -79.21 -16.83 55.94 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.702 -0.681 . . . . 0.45000000000000001 110.775 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.84 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 9.3 tm0? -69.1 -12.87 62.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.362 0.601 . . . . 2.1200000000000001 110.534 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.16 -23.74 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 109.78 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.726 HG11 HG21 ' A' ' 69' ' ' THR . 48.6 t -90.44 -68.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.722 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -119.9 -177.24 3.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.713 -0.676 . . . . 2.9900000000000002 109.917 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 16.8 mt-10 -90.56 20.26 4.74 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.854 0.316 . . . . 1.6000000000000001 111.854 -173.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.859 HE21 ' HB2' ' A' ' 8' ' ' TRP . 5.7 mm100 67.82 136.85 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.361 1.038 . . . . 3.5499999999999998 112.427 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 4.3 Cg_exo -79.83 157.79 24.36 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.229 2.62 . . . . 0.57999999999999996 112.804 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.901 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.5 pt20 -77.94 -27.09 49.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.893 -1.049 . . . . 1.3899999999999999 111.857 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.762 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 79.6 m-70 -132.48 158.55 75.38 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.843 -0.799 . . . . 1.45 108.843 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CG ' ' HA ' ' A' ' 4' ' ' ASP . 4.3 Cg_endo -85.81 128.27 3.28 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.664 2.243 . . . . 0.40000000000000002 111.113 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 122' ' ' TRP . 38.0 tp -78.66 148.4 33.18 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.093 -0.336 . . . . 0.28999999999999998 110.093 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.429 ' H ' HD12 ' A' ' 25' ' ' LEU . 44.5 m80 -118.89 130.14 55.57 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.502 -0.555 . . . . 1.24 109.502 172.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.847 HG13 HG22 ' A' ' 53' ' ' ILE . 19.2 t -127.75 146.26 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.682 -0.858 . . . . 0.46999999999999997 108.682 177.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 143.18 32.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.974 0.416 . . . . 0.31 111.05 -177.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 34.5 t80 -110.77 173.22 6.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.5 -0.556 . . . . 0.67000000000000004 109.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.51 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.18 0.514 . . . . 0.55000000000000004 110.886 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.38 15.44 10.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.399 -0.818 . . . . 0.81000000000000005 112.361 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -146.32 -172.79 4.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.885 0.374 . . . . 0.46999999999999997 110.734 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.665 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -164.01 159.89 21.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.797 -0.638 . . . . 0.33000000000000002 110.041 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.67 HG13 ' HZ1' ' A' ' 39' ' ' LYS . 87.3 t -114.3 67.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.585 -1.635 . . . . 0.39000000000000001 106.585 162.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -102.63 23.19 12.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.582 -1.19 . . . . 0.98999999999999999 109.092 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -150.93 132.95 15.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.852 -1.067 . . . . 2.5600000000000001 108.304 174.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -76.65 110.76 11.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.182 0.515 . . . . 0.40999999999999998 109.703 -173.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 86.7 16.73 61.17 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.343 -0.844 . . . . 0.58999999999999997 112.227 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.67 ' HZ1' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.13 149.92 44.29 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.399 -0.593 . . . . 0.34000000000000002 109.399 173.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.05 129.32 37.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.441 0.639 . . . . 0.55000000000000004 111.029 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.6 tp -120.91 169.39 10.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.181 -1.044 . . . . 0.45000000000000001 108.181 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.1 p -128.04 151.73 76.41 Favored Pre-proline 0 C--N 1.322 -0.587 0 C-N-CA 119.724 -0.79 . . . . 0.56000000000000005 112.512 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.587 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.2 Cg_exo -55.58 -24.65 45.93 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.303 3.335 . . . . 0.68000000000000005 114.01 -176.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -62.88 -38.3 90.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 122.11 0.957 . . . . 0.76000000000000001 110.093 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.09 -46.19 14.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.785 -1.552 . . . . 1.5900000000000001 111.266 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 169' ' ' TYR . 6.7 m -100.51 31.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.459 0.54 . . . . 0.66000000000000003 112.459 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -82.66 -7.87 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.419 0.628 . . . . 0.79000000000000004 109.367 172.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -142.0 -177.82 5.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.952 -1.022 . . . . 1.9099999999999999 109.072 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -71.79 156.26 91.3 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.765 -0.457 . . . . 1.4299999999999999 109.765 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 57.8 Cg_endo -76.62 162.65 32.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.612 1.541 . . . . 0.37 110.216 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.4 t -85.67 -19.2 31.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.631 -0.427 . . . . 0.44 110.152 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -159.5 147.43 17.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.38 112.413 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.847 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.36 172.44 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.825 -1.08 . . . . 0.29999999999999999 108.382 170.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.042 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.5 t 170.97 127.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.462 0.476 . . . . 0.34999999999999998 110.013 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.838 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -81.87 162.06 22.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.459 -0.941 . . . . 2.7200000000000002 108.459 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 22.2 t70 -59.43 79.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.237 0.542 . . . . 1.51 110.712 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.71 24.44 3.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.751 -0.659 . . . . 0.80000000000000004 112.958 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.042 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -54.3 128.25 30.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.067 0.434 . . . . 0.57999999999999996 110.547 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.735 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 29.5 t70 -78.38 -12.76 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.73999999999999999 111.439 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.44 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 70.7 p 51.23 30.04 5.45 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.94 -1.027 . . . . 1.03 110.906 -173.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.38 8.17 0.21 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.594 -0.73 . . . . 0.83999999999999997 112.873 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.735 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 19.4 mtpt -109.99 157.49 19.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 1.6699999999999999 109.481 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 65.3 mt -94.54 125.09 38.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.798 -0.816 . . . . 0.57999999999999996 108.798 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.526 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -120.11 149.62 41.92 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.634 -0.426 . . . . 0.80000000000000004 110.76 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.682 HG23 HG12 ' A' ' 90' ' ' VAL . 61.3 m -96.87 105.95 18.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.511 -0.922 . . . . 0.35999999999999999 108.511 170.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.634 HD13 HG12 ' A' ' 124' ' ' VAL . 47.5 tp -106.8 109.87 21.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.716 -0.674 . . . . 0.58999999999999997 110.189 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.1 t -114.79 123.02 70.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.745 -0.661 . . . . 0.39000000000000001 110.679 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.79 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.4 mt -84.37 137.93 33.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.723 -0.843 . . . . 0.59999999999999998 108.723 169.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.726 HG21 HG11 ' A' ' 17' ' ' VAL . 11.3 t -139.68 145.1 37.99 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.847 -0.341 . . . . 0.35999999999999999 110.635 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 24.8 t70 -128.85 96.39 29.54 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.324 0.583 . . . . 1.9199999999999999 110.273 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.0 Cg_endo -51.36 -37.85 61.61 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.046 3.164 . . . . 1.25 114.747 178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 44.1 m-20 -96.33 46.69 1.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.341 0.497 . . . . 1.29 112.341 -166.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.82 137.91 19.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.5 110.794 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.5 Cg_endo -82.39 -20.19 20.36 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.44 -1.483 . . . . 0.62 112.465 0.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.775 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 96.6 p -134.01 146.8 50.74 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.832 -0.622 . . . . 0.75 110.472 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.591 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 63.1 ttt180 -66.45 -26.39 67.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.208 -0.451 . . . . 2.8799999999999999 111.796 -174.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.762 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -89.0 -11.22 44.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.029 0.443 . . . . 1.3799999999999999 110.862 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -153.2 82.37 4.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.856 -0.611 . . . . 1.3700000000000001 109.528 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 96.1 Cg_endo -87.95 88.23 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.81 2.34 . . . . 0.80000000000000004 113.16 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.576 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.7 mttm -71.52 -53.44 13.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.15 -0.932 . . . . 1.02 110.726 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.772 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 36.2 m-85 -78.75 17.83 0.67 Allowed 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.211 -0.904 . . . . 1.1699999999999999 111.642 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' A' ' 79' ' ' PRO . 32.4 ttt180 -74.2 129.59 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.216 0.323 . . . . 2.9300000000000002 111.71 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.485 ' HG2' HG13 ' A' ' 17' ' ' VAL . 22.1 mp0 -89.05 140.51 29.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 122.807 0.443 . . . . 2.23 110.605 -6.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.1 t90 -86.21 91.5 8.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.532 -0.544 . . . . 1.4299999999999999 109.532 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.1 p80 -71.86 121.84 19.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.768 0.794 . . . . 1.26 109.698 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.79 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t60 -72.72 -35.22 67.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.917 -1.038 . . . . 2.1400000000000001 111.166 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.731 ' HD1' ' HB2' ' A' ' 68' ' ' LEU . 2.4 p90 -168.08 178.16 5.2 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.666 -0.494 . . . . 1.51 109.666 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.4 tp -140.71 114.01 8.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.776 0.322 . . . . 0.33000000000000002 110.64 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.651 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -121.85 133.01 69.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.78 -0.645 . . . . 0.31 110.667 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 65' ' ' THR . 16.2 m -133.37 161.55 41.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.409 -0.96 . . . . 0.27000000000000002 108.409 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t-20 62.55 18.98 10.92 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.383 0.427 . . . . 1.76 110.608 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.651 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -68.18 110.67 4.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.789 -0.819 . . . . 0.31 108.789 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.563 ' HE2' HD21 ' A' ' 63' ' ' LEU . 13.8 ttmm -91.57 97.33 10.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.177 -0.92 . . . . 1.21 111.012 -171.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 64' ' ' TYR . . . 81.91 -130.62 9.82 Favored Glycine 0 CA--C 1.505 -0.568 0 CA-C-N 115.242 -0.89 . . . . 0.29999999999999999 112.45 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 30.8 p-10 -117.29 26.48 9.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.098 0.475 . . . . 1.04 111.044 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.77 110.43 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.77000000000000002 110.034 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 50' ' ' PRO . 7.3 mm -58.86 -28.92 39.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.511 -1.222 . . . . 0.40999999999999998 111.396 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -82.24 -29.99 31.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.982 -0.554 . . . . 0.68000000000000005 111.765 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -77.73 -6.68 54.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.845 0.313 . . . . 1.26 111.845 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.43 107.11 2.28 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.913 -0.661 . . . . 0.34999999999999998 111.828 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 106.97 0.46 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.403 0.62 . . . . 0.45000000000000001 110.332 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.3 p -89.55 109.52 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.827 -1.079 . . . . 0.56999999999999995 111.203 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' A' ' 88' ' ' LEU . 29.4 mt -89.18 -45.25 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.023 -0.99 . . . . 0.45000000000000001 109.813 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 t -116.65 105.76 12.79 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.952 -1.499 . . . . 0.37 106.952 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.2 t0 -54.88 150.97 9.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.1499999999999999 112.831 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -77.37 103.29 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.114 -0.948 . . . . 4.6900000000000004 109.223 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 48.4 t -78.33 -57.62 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.148 -0.478 . . . . 0.85999999999999999 112.244 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 132.85 175.59 14.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.647 -0.787 . . . . 0.67000000000000004 112.435 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.482 ' HB2' HG23 ' A' ' 46' ' ' VAL . 30.3 t -61.14 131.82 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.486 0.143 . . . . 0.51000000000000001 110.66 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.451 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -152.46 63.89 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 O-C-N 123.573 0.546 . . . . 0.81999999999999995 112.297 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.609 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 4.0 Cg_endo -90.34 113.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.611 2.874 . . . . 0.84999999999999998 112.593 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.3 Cg_exo -56.43 147.74 66.6 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.897 2.398 . . . . 0.87 111.986 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 117.08 9.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.097 -0.502 . . . . 1.8500000000000001 111.063 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.46 6.15 56.63 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.953 -0.642 . . . . 1.1799999999999999 112.7 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.775 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 80.0 p -89.42 -22.68 22.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.96999999999999997 111.728 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.61 173.29 20.1 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.828 -0.624 . . . . 1.97 111.743 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.3 mm? -74.72 113.15 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.062 -0.347 . . . . 0.93999999999999995 110.062 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.718 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.0 m-70 -79.76 116.21 19.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 2.23 110.52 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.542 HH11 HD23 ' A' ' 14' ' ' LEU . 13.5 ptt180 -98.34 85.36 3.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.601 -0.727 . . . . 2.3100000000000001 110.781 -172.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.518 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 20.7 m-85 -71.73 114.11 9.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.257 -0.645 . . . . 0.78000000000000003 109.257 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.708 HG21 HD22 ' A' ' 14' ' ' LEU . 19.4 t -94.68 130.58 43.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.169 -0.469 . . . . 0.27000000000000002 110.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.668 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 59.7 m95 -88.68 119.27 29.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.895 -0.78 . . . . 1.99 108.895 177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.4 mt -113.84 118.61 34.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.709 0.232 . . . . 0.38 110.683 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.634 HG12 HD13 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -117.53 136.68 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.31 110.788 179.136 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.859 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 59.0 t80 -132.03 129.01 39.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.423 -0.353 . . . . 5.1200000000000001 110.256 173.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.877 ' HG2' HG21 ' A' ' 164' ' ' VAL . 8.9 pt-20 -82.22 104.62 12.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.76 -0.829 . . . . 2.4100000000000001 108.76 171.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.24 168.21 19.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.169 0.509 . . . . 1.3100000000000001 109.752 -176.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.65 -7.2 53.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.582 -0.735 . . . . 2.3999999999999999 110.347 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HG3' ' HE2' ' A' ' 158' ' ' TYR . 20.0 ptt180 -167.01 160.23 11.02 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.561 -0.745 . . . . 3.5099999999999998 111.02 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HG3' HD12 ' A' ' 63' ' ' LEU . 31.2 Cg_exo -56.75 140.45 91.02 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.544 2.829 . . . . 1.21 112.596 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.8 mm? -65.16 149.52 49.77 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.401 0.519 . . . . 0.90000000000000002 112.401 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 11.6 tptm -120.96 90.68 3.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 2.8999999999999999 107.781 164.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' A' ' 103' ' ' LEU . 4.8 p -70.52 -69.77 0.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.334 -0.848 . . . . 1.8999999999999999 111.961 -171.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 59.26 28.96 18.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.267 0.556 . . . . 2.96 109.753 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -99.62 138.23 20.39 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.427 -0.806 . . . . 1.3899999999999999 109.426 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.28 115.17 1.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.113 2.542 . . . . 1.27 112.871 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.27 118.15 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.909 -0.404 . . . . 0.85999999999999999 109.909 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.4 mt -114.78 147.88 39.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.459 . . . . 1.6100000000000001 110.55 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -86.21 169.82 12.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.285 -0.871 . . . . 1.8799999999999999 109.237 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.815 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 14.3 p-10 -86.13 30.49 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.112 0.482 . . . . 0.75 111.571 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.583 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 96.8 mtt180 -117.96 148.26 42.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.426 -0.352 . . . . 3.3599999999999999 110.557 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.689 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 25.4 m 71.06 141.16 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.938 -1.028 . . . . 0.94999999999999996 111.232 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.03 28.71 14.4 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.585 -0.734 . . . . 1.1200000000000001 111.519 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.64 -51.61 26.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.316 0.647 . . . . 2.6600000000000001 112.672 -172.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -117.73 31.03 6.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.41 0.624 . . . . 1.8700000000000001 111.327 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.458 ' HB3' ' HE1' ' A' ' 84' ' ' TRP . 18.0 mmt180 -87.65 -36.03 17.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 4.7300000000000004 110.56 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -117.19 176.02 15.99 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.551 -0.833 . . . . 0.65000000000000002 112.707 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.772 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.3 mttt 64.33 41.94 5.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.535 0.683 . . . . 1.0800000000000001 111.449 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.98 149.02 49.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.044 -0.98 . . . . 1.8899999999999999 109.252 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -97.96 122.93 41.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.991 0.424 . . . . 1.29 111.697 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.645 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.8 m -61.29 -26.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.672 -0.695 . . . . 0.78000000000000003 110.224 174.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -61.7 -46.79 88.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.364 -0.834 . . . . 0.67000000000000004 110.186 173.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.0 m -63.97 -35.92 82.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.094 -0.503 . . . . 0.77000000000000002 110.823 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.645 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.6 m-85 -65.27 -49.98 67.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.399 -0.364 . . . . 0.92000000000000004 111.093 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 1.8 ptm180 -69.0 -39.31 79.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 2.8900000000000001 111.02 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.72 -27.58 68.43 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 111.503 0.186 . . . . 0.96999999999999997 111.503 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -53.93 -54.06 44.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 1.5800000000000001 111.495 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.517 ' HE2' ' HG3' ' A' ' 129' ' ' ARG . 9.2 t80 -107.58 18.87 20.94 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.766 -0.773 . . . . 5.4500000000000002 110.75 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 63.78 46.87 3.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.408 -0.814 . . . . 2.4199999999999999 111.149 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.859 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -91.47 123.14 34.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.185 -0.916 . . . . 1.27 109.831 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -86.52 -150.39 0.15 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.4 -0.364 . . . . 3.5899999999999999 110.441 -178.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -62.73 142.85 96.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 0.76000000000000001 110.541 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 16.5 Cg_exo -66.33 160.73 43.93 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 123.795 2.997 . . . . 0.53000000000000003 113.513 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.901 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.7 t -89.74 -35.58 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-N 115.48 -0.782 . . . . 0.44 110.089 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -149.72 145.91 26.93 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.912 -0.715 . . . . 0.27000000000000002 111.75 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.36 143.02 10.34 Favored Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.545 -1.207 . . . . 0.23999999999999999 111.344 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 t -155.5 142.4 19.04 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.055 -1.091 . . . . 0.34000000000000002 108.055 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.616 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 13.1 p -120.31 141.27 50.17 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.951 -0.699 . . . . 1.1100000000000001 110.551 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.0 p90 -125.56 123.29 38.77 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.693 -1.225 . . . . 0.80000000000000004 107.693 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.718 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -101.03 132.39 46.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.621 -0.832 . . . . 2.5299999999999998 110.623 177.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.07 155.75 29.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.567 -0.742 . . . . 0.59999999999999998 110.696 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.39 -177.38 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.173 0.511 . . . . 2.3799999999999999 111.38 -175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.664 ' HA ' HG21 ' A' ' 177' ' ' VAL . 30.0 t90 -84.99 78.44 9.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 3.96 109.018 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 9.2 t70 -71.99 -62.74 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 1.53 111.687 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 33.5 t70 174.69 -35.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.277 0.56 . . . . 1.26 110.917 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -80.21 5.26 15.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 2.2200000000000002 110.999 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.825 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 64.8 t -72.42 -54.45 5.34 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.5 110.479 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 77.2 Cg_exo -51.47 -37.73 62.5 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.545 2.163 . . . . 0.57999999999999996 112.33 172.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.685 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.6 mmmt -73.09 -23.3 60.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 2.1400000000000001 111.42 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.783 HD11 HG12 ' A' ' 107' ' ' VAL . 40.3 tp -69.62 -46.59 65.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.104 -0.702 . . . . 0.66000000000000003 109.104 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -59.61 -36.86 77.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 1.8899999999999999 109.811 173.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.1 mm-40 -54.73 -46.65 74.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.83 -1.077 . . . . 1.53 110.339 172.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -73.73 -36.01 65.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.474 -0.785 . . . . 1.49 111.744 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.689 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.7 mt -67.16 5.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.263 0.468 . . . . 0.76000000000000001 112.263 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.694 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 33.8 m -84.12 0.02 50.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.377 0.608 . . . . 1.05 109.462 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.583 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.35 55.34 8.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.223 -0.899 . . . . 1.1699999999999999 111.346 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.694 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 1.4 mmmp? . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.169 -0.919 . . . . 2.0 110.75 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.619 HG13 ' HB2' ' A' ' 24' ' ' PRO . 7.4 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 120.947 0.403 . . . . 1.47 111.434 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -154.11 153.47 31.91 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.175 -0.676 . . . . 1.8100000000000001 109.175 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.516 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -78.16 16.19 0.8 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.851 0.315 . . . . 0.69999999999999996 111.851 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.3 t -64.14 -16.18 61.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 1.96 110.805 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.665 ' HB3' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -113.47 31.48 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 2.6600000000000001 110.536 -177.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.695 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.4 OUTLIER -73.55 -41.27 63.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.852 0.358 . . . . 3.98 111.93 -174.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.9 p -145.03 32.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.463 0.649 . . . . 0.63 110.003 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.12 -118.1 0.21 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.966 -0.854 . . . . 0.47999999999999998 110.966 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 18.6 Cg_endo -56.89 -38.37 96.07 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 123.175 2.583 . . . . 0.53000000000000003 110.854 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 7' ' ' LYS . 9.3 mt -88.58 101.75 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.1699999999999999 110.034 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -83.29 71.34 10.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.837 0.827 . . . . 0.70999999999999996 110.106 175.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.624 HD22 ' CG2' ' A' ' 121' ' ' VAL . 22.7 mt -79.09 -15.49 58.1 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.465 -0.789 . . . . 0.45000000000000001 109.915 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.655 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -74.46 -6.67 49.65 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.375 -0.83 . . . . 2.1200000000000001 111.204 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 13' ' ' SER . 14.2 mt-10 -68.91 -22.83 64.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.323 0.582 . . . . 1.9299999999999999 109.577 177.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.873 HG12 HG21 ' A' ' 151' ' ' VAL . 46.1 t -89.03 -71.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.163 -0.926 . . . . 0.63 111.41 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.487 ' HB2' HG21 ' A' ' 151' ' ' VAL . 26.5 t70 -149.74 174.65 12.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.935 -0.575 . . . . 2.9900000000000002 109.525 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -54.95 151.04 9.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.288 0.566 . . . . 1.6000000000000001 111.279 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.655 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 27.6 mm-40 -86.96 138.27 32.94 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.872 -0.603 . . . . 3.5499999999999998 109.942 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.67 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 8.1 Cg_exo -71.24 161.52 45.51 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.377 2.718 . . . . 0.57999999999999996 113.299 -170.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.7 pt20 -82.38 -18.07 43.32 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.326 -0.852 . . . . 1.3899999999999999 111.74 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.755 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.2 m80 -141.9 159.68 58.5 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.538 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.619 ' HB2' HG13 ' A' ' 3' ' ' VAL . 5.0 Cg_endo -85.72 125.73 2.87 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.763 2.309 . . . . 0.40000000000000002 111.175 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 122' ' ' TRP . 16.2 tp -71.55 137.74 48.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.28999999999999998 110.131 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.59 107.82 19.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.8 -0.444 . . . . 1.24 109.8 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.928 HG13 HG22 ' A' ' 53' ' ' ILE . 6.6 t -114.46 143.34 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.149 -0.686 . . . . 0.46999999999999997 109.149 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.39 139.58 31.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.99 0.424 . . . . 0.31 111.413 -174.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -104.72 173.34 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.238 -0.653 . . . . 0.67000000000000004 109.238 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.17 66.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.485 0.659 . . . . 0.55000000000000004 110.726 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.1 -0.87 33.68 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.28 -0.873 . . . . 0.81000000000000005 112.957 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.36 -170.39 2.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.46999999999999997 111.266 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.39 154.4 16.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.63 -0.713 . . . . 0.33000000000000002 109.734 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.726 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 86.6 t -113.14 69.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.145 -1.428 . . . . 0.39000000000000001 107.145 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 20.5 t70 -105.41 18.55 22.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.234 -0.894 . . . . 0.98999999999999999 109.358 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.35 135.85 24.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.521 -0.918 . . . . 2.5600000000000001 108.521 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -80.79 111.38 17.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.405 0.622 . . . . 0.40999999999999998 110.547 -171.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 91.32 11.74 60.7 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.989 -1.005 . . . . 0.58999999999999997 111.848 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.726 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.4 144.53 46.35 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.394 -0.595 . . . . 0.34000000000000002 109.394 176.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 9.7 p -77.24 136.2 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.55000000000000004 110.99 -178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.629 HD22 HG22 ' A' ' 34' ' ' VAL . 7.2 tp -131.99 168.85 17.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.556 -0.905 . . . . 0.45000000000000001 108.556 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.92 152.04 48.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.565 -0.454 . . . . 0.56000000000000005 112.045 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 50.3 Cg_exo -57.41 -34.11 97.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.805 3.003 . . . . 0.68000000000000005 112.855 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.507 HG23 ' CD1' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -60.37 -39.91 88.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.463 0.649 . . . . 0.76000000000000001 110.772 176.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -81.64 -13.24 58.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.943 -1.026 . . . . 1.5900000000000001 111.752 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.601 HG11 ' CE2' ' A' ' 169' ' ' TYR . 33.0 m -128.24 28.65 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.66000000000000003 111.583 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.551 ' HZ2' HD13 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -86.76 -10.75 52.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.414 0.626 . . . . 0.79000000000000004 109.337 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -132.91 174.21 10.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.745 -1.116 . . . . 1.9099999999999999 108.38 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -71.29 153.56 94.08 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 110.229 -0.286 . . . . 1.4299999999999999 110.229 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.35 156.18 46.02 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.136 1.89 . . . . 0.37 110.844 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -77.71 -20.78 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.809 0.338 . . . . 0.44 110.216 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -159.07 143.56 15.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.482 0.658 . . . . 0.38 112.619 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.928 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -137.83 164.34 28.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.778 -1.101 . . . . 0.29999999999999999 108.155 170.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.016 ' HA ' HD13 ' A' ' 58' ' ' LEU . 35.1 t 174.69 118.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.15 -0.315 . . . . 0.34999999999999998 110.15 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.877 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -73.12 155.76 39.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.273 -1.01 . . . . 2.7200000000000002 108.273 172.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.89 88.05 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.042 0.448 . . . . 1.51 110.302 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.95 10.62 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.64 -0.709 . . . . 0.80000000000000004 112.182 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.016 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.8 tt -51.03 128.74 22.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.09 0.556 . . . . 0.57999999999999996 111.37 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.818 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 24.4 t70 -72.73 -32.59 65.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.723 -0.671 . . . . 0.73999999999999999 111.332 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.553 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.7 t 71.52 15.02 6.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 114.998 -1.001 . . . . 1.03 109.831 -174.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.53 10.52 2.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.526 -0.761 . . . . 0.83999999999999997 112.901 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.818 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 22.9 mtpt -117.76 154.45 31.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.803 -0.443 . . . . 1.6699999999999999 109.803 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.832 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 24.2 mt -92.5 130.87 38.04 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.796 -0.816 . . . . 0.57999999999999996 108.796 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.648 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -125.54 158.36 34.76 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.56 -0.456 . . . . 0.80000000000000004 110.871 176.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.459 HG23 HG12 ' A' ' 90' ' ' VAL . 60.0 m -97.72 106.14 18.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.149 -0.685 . . . . 0.35999999999999999 109.149 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 124' ' ' VAL . 53.0 tp -104.24 111.23 23.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.58999999999999997 110.394 -176.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.417 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.0 t -116.74 125.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 0.39000000000000001 110.727 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.5 -0.926 . . . . 0.59999999999999998 108.5 167.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.74 HG21 HG11 ' A' ' 17' ' ' VAL . 10.6 t -136.66 146.81 46.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.04 -0.355 . . . . 0.35999999999999999 110.04 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 14.9 t0 -126.28 97.27 34.75 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.457 -0.571 . . . . 1.9199999999999999 109.457 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.5 ' HD3' HG21 ' A' ' 17' ' ' VAL . 6.5 Cg_endo -49.08 -46.89 23.73 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.904 3.069 . . . . 1.25 113.485 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.655 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 7.4 m-20 -90.81 53.09 2.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.422 0.629 . . . . 1.29 111.14 -171.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.98 138.88 19.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.932 -0.576 . . . . 0.5 110.828 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.585 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 88.1 Cg_endo -83.43 -22.7 14.35 Favored 'Cis proline' 0 C--N 1.343 0.282 0 C-N-CA 123.327 -1.531 . . . . 0.62 112.621 1.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.657 ' HB3' HG22 ' A' ' 115' ' ' THR . 58.9 p -128.46 147.3 50.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.565 -0.743 . . . . 0.75 110.277 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.655 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 21.2 ttt180 -64.6 -26.65 68.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.257 0.551 . . . . 2.8799999999999999 110.429 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.9 ptpt -78.72 -14.83 59.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 1.3799999999999999 110.89 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t70 -162.94 87.49 1.33 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.942 -0.572 . . . . 1.3700000000000001 110.111 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.2 Cg_endo -85.2 83.92 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.697 2.265 . . . . 0.80000000000000004 112.806 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -72.08 -47.85 48.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.884 -1.053 . . . . 1.02 110.48 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.689 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 54.6 m-85 -88.53 21.28 2.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.002 -0.999 . . . . 1.1699999999999999 111.729 -168.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.858 ' HD3' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -74.01 125.85 29.18 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.173 -0.306 . . . . 2.9300000000000002 110.173 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.858 ' HG3' ' HD3' ' A' ' 82' ' ' ARG . 1.5 mp0 -94.87 138.78 32.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.043 0.449 . . . . 2.23 110.986 -2.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.455 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 16.0 t90 -91.72 138.64 31.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.188 -0.671 . . . . 1.4299999999999999 109.188 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -113.44 133.61 55.1 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.221 -0.659 . . . . 1.26 109.221 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.88 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 5.2 t60 -82.75 -35.81 26.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.72 -0.673 . . . . 2.1400000000000001 110.527 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.689 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 22.0 p90 -167.62 177.19 6.01 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.552 -0.536 . . . . 1.51 109.552 177.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.57 ' HG ' HD12 ' A' ' 103' ' ' LEU . 23.3 tp -141.27 113.8 8.22 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.245 0.341 . . . . 0.33000000000000002 110.25 176.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.689 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.668 -0.697 . . . . 0.31 110.57 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.527 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 4.5 m -129.05 166.88 25.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.591 -0.892 . . . . 0.27000000000000002 108.591 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.832 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 m-20 60.45 18.89 8.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.955 0.407 . . . . 1.76 111.172 172.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.582 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.4 ttm -72.49 116.71 13.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.97 -0.752 . . . . 0.31 108.97 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.3 ttmm -90.4 100.63 13.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.126 -0.943 . . . . 1.21 110.972 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 75.59 -121.42 6.37 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.353 -0.839 . . . . 0.29999999999999999 112.537 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 28.2 p30 -120.55 29.09 7.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.208 0.528 . . . . 1.04 111.052 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -97.15 109.61 22.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.834 -0.621 . . . . 0.77000000000000002 110.183 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 53' ' ' ILE . 7.6 mm -54.74 -30.86 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.716 -1.129 . . . . 0.40999999999999998 111.483 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.0 m -83.21 -35.53 25.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.016 -0.538 . . . . 0.68000000000000005 112.32 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.8 p -61.28 -24.97 66.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 1.26 111.759 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.8 110.11 1.53 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.65 -0.704 . . . . 0.34999999999999998 113.012 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.4 m -66.44 107.59 2.09 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.344 -0.613 . . . . 0.45000000000000001 109.344 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.3 126.63 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.223 -0.898 . . . . 0.56999999999999995 111.579 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.57 HD12 ' HG ' ' A' ' 88' ' ' LEU . 22.8 mt -106.87 -49.6 3.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.181 0.991 . . . . 0.45000000000000001 108.713 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.8 t -120.57 112.72 19.28 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.678 -1.601 . . . . 0.37 106.678 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.3 t0 -70.52 167.95 17.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.407 0.623 . . . . 1.1499999999999999 112.429 -166.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -83.52 88.24 7.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.973 -1.012 . . . . 4.6900000000000004 109.731 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.839 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.0 t -61.72 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.713 -0.676 . . . . 0.85999999999999999 112.094 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.88 -176.96 17.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.67000000000000004 111.695 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.0 t -71.69 127.06 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.975 0.387 . . . . 0.51000000000000001 110.536 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.544 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -150.51 63.67 0.4 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.805 -0.712 . . . . 0.81999999999999995 112.448 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.636 ' HB3' ' CE1' ' A' ' 118' ' ' HIS . 96.5 Cg_endo -93.05 145.36 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.062 2.508 . . . . 0.84999999999999998 113.3 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HD2' HG21 ' A' ' 115' ' ' THR . 32.1 Cg_exo -60.56 154.04 57.0 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.641 2.227 . . . . 0.87 111.351 169.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -68.43 126.46 29.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 1.8500000000000001 110.896 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.76 37.1 20.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 1.1799999999999999 113.221 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 75' ' ' SER . 28.6 p -84.32 -13.12 53.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.393 0.516 . . . . 0.96999999999999997 112.393 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 89.83 11.77 63.17 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.27 -0.967 . . . . 1.97 112.101 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 172' ' ' GLU . 3.8 mm? 72.37 100.79 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.593 0.819 . . . . 0.93999999999999995 111.446 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -96.26 164.75 12.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.043 -0.725 . . . . 2.23 109.043 175.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.609 ' HD2' HD21 ' A' ' 14' ' ' LEU . 2.7 ptt180 -127.29 106.22 9.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.015 0.436 . . . . 2.3100000000000001 112.061 -160.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.581 ' OH ' ' HE1' ' A' ' 118' ' ' HIS . 6.8 m-85 -73.66 110.79 8.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.848 -0.797 . . . . 0.78000000000000003 108.848 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.624 ' CG2' HD22 ' A' ' 14' ' ' LEU . 16.6 t -94.82 125.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.291 -0.413 . . . . 0.27000000000000002 110.373 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.78 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -87.99 118.6 27.66 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.091 -0.707 . . . . 1.99 109.091 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.98 119.03 33.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.578 -0.156 . . . . 0.38 110.578 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.631 HG12 HD13 ' A' ' 66' ' ' LEU . 1.7 m -105.61 126.24 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.157 -0.617 . . . . 0.31 109.824 173.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -108.09 124.21 49.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 5.1200000000000001 109.02 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' HG21 ' A' ' 164' ' ' VAL . 27.6 tt0 -94.38 96.98 9.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.991 0.424 . . . . 2.4100000000000001 110.137 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.648 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -73.24 163.97 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.77 -0.65 . . . . 1.3100000000000001 109.67 175.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.76 3.14 38.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.56 -0.746 . . . . 2.3999999999999999 110.04 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.427 ' H ' ' HB2' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -165.64 153.23 9.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 3.5099999999999998 111.355 -169.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HG3' HD12 ' A' ' 63' ' ' LEU . 32.0 Cg_exo -59.59 141.08 96.61 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.701 2.934 . . . . 1.21 112.094 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.527 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.6 mm? -68.43 151.56 46.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.90000000000000002 112.434 -170.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -115.9 64.23 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.403 -0.962 . . . . 2.8999999999999999 108.403 171.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 46.2 m -96.98 92.4 6.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.218 -0.901 . . . . 1.8999999999999999 110.194 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.85 40.66 0.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.963 . . . . 2.96 109.976 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -89.16 127.98 53.33 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.16 -0.927 . . . . 1.3899999999999999 110.091 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.1 127.85 18.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.225 2.617 . . . . 1.27 112.588 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.25 121.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.85999999999999999 110.11 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.4 mt -98.82 -13.95 19.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.393 -0.367 . . . . 1.6100000000000001 111.815 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m 55.65 -162.23 0.16 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.428 -0.351 . . . . 1.8799999999999999 110.669 -173.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.933 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.2 p-10 -117.72 16.43 14.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.162 0.506 . . . . 0.75 111.072 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.564 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 23.2 mtt180 -107.71 137.27 46.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.205 -0.452 . . . . 3.3599999999999999 109.988 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.601 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 67.9 m 74.42 113.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.185 0.928 . . . . 0.94999999999999996 111.089 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.4 36.06 2.96 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.293 -0.867 . . . . 1.1200000000000001 112.296 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.01 -51.25 33.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.677 0.751 . . . . 2.6600000000000001 110.387 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -92.79 53.86 2.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.968 -1.015 . . . . 1.8700000000000001 110.437 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 146' ' ' ARG . 44.0 mtt85 -76.49 -83.91 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.644 -0.707 . . . . 4.7300000000000004 111.343 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -126.29 -154.74 8.73 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.655 -0.783 . . . . 0.65000000000000002 112.777 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 81.0 mttt 65.93 23.18 11.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.787 0.803 . . . . 1.0800000000000001 109.789 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -107.66 173.57 6.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.632 -1.167 . . . . 1.8899999999999999 108.876 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.35 119.94 37.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.549 -0.296 . . . . 1.29 111.187 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.922 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 18.4 m -66.06 -25.36 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.423 -0.584 . . . . 0.78000000000000003 109.423 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.02 83.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.194 -0.912 . . . . 0.67000000000000004 109.986 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 57.4 m -66.91 -36.74 82.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.426 -0.352 . . . . 0.77000000000000002 110.996 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.922 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 52.0 m-85 -61.7 -49.95 74.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.732 0.301 . . . . 0.92000000000000004 110.799 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 156' ' ' LYS . 5.9 ptp180 -69.15 -44.47 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.509 -0.314 . . . . 2.8900000000000001 111.199 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.478 ' N ' ' HG3' ' A' ' 155' ' ' ARG . 58.5 mtmt -63.04 -26.99 69.1 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.436 0.161 . . . . 0.96999999999999997 111.436 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -53.15 -50.57 64.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.52 0.512 . . . . 1.5800000000000001 110.721 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -104.09 9.92 36.18 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.18 -0.608 . . . . 5.4500000000000002 110.511 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 57.51 39.79 27.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.2 1.0 . . . . 2.4199999999999999 110.229 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.539 HD12 ' H ' ' A' ' 161' ' ' ARG . 1.7 tp -76.22 156.06 33.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.057 -1.429 . . . . 1.27 111.552 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.539 ' H ' HD12 ' A' ' 160' ' ' LEU . 9.0 mpt_? -96.87 -166.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 3.5899999999999999 111.856 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.04 158.08 77.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.76000000000000001 111.892 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -70.38 150.52 64.59 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.269 2.646 . . . . 0.53000000000000003 113.205 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 10.5 t -93.72 -31.47 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.448 -0.796 . . . . 0.44 109.861 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -147.44 146.45 29.56 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.997 -0.681 . . . . 0.27000000000000002 112.109 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.744 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -150.74 155.76 26.34 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.72 -1.127 . . . . 0.23999999999999999 111.655 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.463 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.2 t -169.73 133.2 1.23 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.897 -0.779 . . . . 0.34000000000000002 108.897 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.617 ' SG ' HD13 ' A' ' 12' ' ' LEU . 17.5 p -110.93 141.15 44.75 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.257 -0.577 . . . . 1.1100000000000001 110.609 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.601 ' CE2' HG11 ' A' ' 46' ' ' VAL . 25.9 p90 -127.32 123.16 35.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.419 -0.956 . . . . 0.80000000000000004 108.419 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -100.08 138.14 37.56 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.439 -0.504 . . . . 2.5299999999999998 110.672 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.414 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . . . -138.01 146.92 43.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.94 -0.573 . . . . 0.59999999999999998 109.976 -174.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.444 ' HB3' ' CD1' ' A' ' 117' ' ' LEU . 14.1 pt-20 -121.67 -168.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.34 . . . . 2.3799999999999999 111.34 -176.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.697 ' HA ' HG21 ' A' ' 177' ' ' VAL . 14.1 t90 -76.91 83.85 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 3.96 110.887 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.569 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.5 p-10 -74.41 -59.83 2.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 111.545 0.202 . . . . 1.53 111.545 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.578 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.9 t70 178.05 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.086 0.555 . . . . 1.26 110.185 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 44' ' ' THR . 72.4 m-85 -82.53 -2.27 53.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 2.2200000000000002 111.874 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.799 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 94.4 t -58.7 -54.04 60.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.473 -0.33 . . . . 0.5 110.49 172.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.799 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.5 Cg_exo -51.31 -36.1 56.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.635 2.223 . . . . 0.57999999999999996 112.445 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 29.2 mmmt -74.12 -24.71 59.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 2.1400000000000001 110.78 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 59.0 tp -69.44 -46.09 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.429 -0.582 . . . . 0.66000000000000003 109.429 172.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.445 -0.798 . . . . 1.8899999999999999 108.898 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 42.5 mm-40 -58.19 -50.21 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.803 -1.09 . . . . 1.53 110.941 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.489 ' NE2' HD21 ' A' ' 140' ' ' ASN . 34.8 tt0 -64.17 -33.81 76.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.581 -0.736 . . . . 1.49 111.934 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 77.1 mt -62.47 0.03 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.691 0.626 . . . . 0.76000000000000001 112.691 -177.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.637 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.6 m -82.2 8.9 9.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.063 0.459 . . . . 1.05 110.133 171.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.6 54.95 9.12 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.974 -0.85 . . . . 1.1699999999999999 110.974 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.637 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.6 mmmt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.576 -0.726 . . . . 2.0 110.981 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 24' ' ' PRO . 3.7 t . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 121.799 0.809 . . . . 1.47 111.873 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -159.18 157.09 30.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.119 -1.067 . . . . 1.8100000000000001 108.119 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD12 ' OE1' ' A' ' 20' ' ' GLN . 2.6 mm? -76.95 22.6 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.048 -0.261 . . . . 0.69999999999999996 111.631 -174.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 m -67.64 -21.21 65.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 1.96 111.505 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.95 37.07 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 2.6600000000000001 110.192 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.445 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 9.0 p-90 -75.76 -29.03 58.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.42 0.526 . . . . 3.98 112.42 -174.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.441 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 70.8 p -156.18 20.27 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.63 111.017 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -82.6 -117.64 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.664 -0.575 . . . . 0.47999999999999998 111.664 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.6 Cg_endo -51.65 -42.08 58.24 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.225 2.616 . . . . 0.53000000000000003 110.279 167.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.728 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 10.2 mp -90.01 94.91 9.98 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.747 -1.115 . . . . 1.1699999999999999 110.965 172.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -74.2 61.45 0.86 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.351 0.596 . . . . 0.70999999999999996 110.211 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.79 HD22 HG21 ' A' ' 121' ' ' VAL . 40.5 mt -68.46 -13.41 62.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.45000000000000001 110.902 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.441 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 22.3 mm-40 -73.57 -1.29 18.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.086 -0.506 . . . . 2.1200000000000001 111.675 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.57 -10.58 59.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.169 0.509 . . . . 1.9299999999999999 109.792 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.869 HG11 HG21 ' A' ' 69' ' ' THR . 58.7 t -92.83 -76.82 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.63 110.196 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.596 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 10.1 t70 -155.59 -178.25 7.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.396 -0.964 . . . . 2.9900000000000002 108.396 -175.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.74 152.99 41.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.047 0.451 . . . . 1.6000000000000001 110.766 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.484 ' OE1' HD12 ' A' ' 5' ' ' LEU . 8.2 tp-100 -78.12 129.88 74.14 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.072 -0.513 . . . . 3.5499999999999998 110.413 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.2 Cg_exo -58.22 159.39 19.08 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.965 2.443 . . . . 0.57999999999999996 113.001 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.9 ' HG3' ' HD2' ' A' ' 23' ' ' HIS . 20.3 pt20 -78.96 -8.18 58.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 1.3899999999999999 111.653 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.9 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 64.8 m-70 -148.17 157.63 42.49 Favored Pre-proline 0 CA--C 1.515 -0.385 0 C-N-CA 123.246 0.619 . . . . 1.45 109.78 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.722 ' HB2' HG12 ' A' ' 3' ' ' VAL . 5.6 Cg_endo -87.67 123.94 1.85 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.318 2.679 . . . . 0.40000000000000002 111.239 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.55 ' O ' HG11 ' A' ' 3' ' ' VAL . 20.6 tp -79.04 131.58 36.32 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.32 -0.237 . . . . 0.28999999999999998 111.353 -175.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -100.04 112.9 25.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.007 -0.368 . . . . 1.24 110.007 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 53' ' ' ILE . 22.1 t -116.59 142.03 32.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.264 -0.643 . . . . 0.46999999999999997 109.264 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -136.3 138.93 42.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.903 0.382 . . . . 0.31 110.117 -177.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.405 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 42.7 t80 -99.87 171.58 7.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.447 -0.575 . . . . 0.67000000000000004 109.447 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.65 62.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.55000000000000004 110.596 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.53 9.37 19.67 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.432 -0.804 . . . . 0.81000000000000005 112.504 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -142.34 -168.23 2.68 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 110.165 -0.309 . . . . 0.46999999999999997 110.165 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -161.36 155.23 22.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 110.768 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.763 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.8 t -107.77 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.919 -1.512 . . . . 0.39000000000000001 106.919 166.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.69 22.2 4.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.98999999999999999 109.833 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -150.64 130.24 13.08 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.051 -0.977 . . . . 2.5600000000000001 109.847 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.966 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.1 tt -71.96 112.92 8.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.342 -0.614 . . . . 0.40999999999999998 109.342 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.598 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 89.97 19.22 47.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.89 -0.671 . . . . 0.58999999999999997 112.256 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.763 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.6 147.26 27.08 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.275 -0.639 . . . . 0.34000000000000002 109.275 175.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.3 p -78.42 130.45 36.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.283 0.563 . . . . 0.55000000000000004 110.821 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.697 HD23 ' HD2' ' A' ' 169' ' ' TYR . 8.7 tp -129.99 149.74 51.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.545 -1.279 . . . . 0.45000000000000001 107.545 177.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 46' ' ' VAL . 3.9 p -95.86 150.74 37.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 C-N-CA 119.47 -0.892 . . . . 0.56000000000000005 112.665 -170.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.935 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 82.3 Cg_exo -51.68 -22.74 13.8 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.674 3.583 . . . . 0.68000000000000005 114.374 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.485 HG22 ' CE2' ' A' ' 176' ' ' TYR . 2.2 p -71.09 -53.77 13.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.672 0.748 . . . . 0.76000000000000001 109.816 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.65 -43.39 93.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.42 -1.264 . . . . 1.5900000000000001 111.544 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 43' ' ' PRO . 2.5 m -91.97 13.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 0.66000000000000003 111.903 -173.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -82.68 -28.71 30.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.162 -0.472 . . . . 0.79000000000000004 110.391 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 18.1 m120 -109.23 -169.86 1.56 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.62 -0.718 . . . . 1.9099999999999999 110.668 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -86.14 158.05 55.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.274 -0.639 . . . . 1.4299999999999999 109.274 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 122' ' ' TRP . 72.0 Cg_endo -81.64 160.43 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.112 1.875 . . . . 0.37 111.004 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -81.61 -21.23 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.141 0.496 . . . . 0.44 109.878 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.537 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 69.2 m -158.11 143.49 16.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.362 0.601 . . . . 0.38 112.551 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.905 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.92 161.0 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.717 -1.129 . . . . 0.29999999999999999 107.955 170.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.984 ' HA ' HD13 ' A' ' 58' ' ' LEU . 37.9 t 176.02 119.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.98 0.419 . . . . 0.34999999999999998 110.421 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 165' ' ' ALA . 50.0 p-90 -81.15 147.93 29.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.848 -1.538 . . . . 2.7200000000000002 106.848 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -66.38 91.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.859 0.837 . . . . 1.51 110.904 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.32 -1.31 3.68 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 114.864 -1.062 . . . . 0.80000000000000004 111.799 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.984 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.1 tt -54.68 128.58 33.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.83 0.452 . . . . 0.57999999999999996 110.511 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.804 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -77.8 -26.95 50.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.092 -0.504 . . . . 0.73999999999999999 111.67 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.715 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.5 p 70.59 13.33 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.396 1.078 . . . . 1.03 110.5 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -133.05 -25.66 0.65 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.83999999999999997 113.263 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.804 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 18.8 mtpt -84.22 156.74 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.968 0.384 . . . . 1.6699999999999999 110.084 -175.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.978 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.9 mt -92.29 128.16 38.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.72 -0.474 . . . . 0.57999999999999996 109.72 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.51 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 17.3 m-85 -121.37 150.78 40.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.601 0.239 . . . . 0.80000000000000004 110.523 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.933 HG23 HG12 ' A' ' 90' ' ' VAL . 2.7 m -97.16 105.91 18.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.638 -0.875 . . . . 0.35999999999999999 108.638 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.705 HD13 HG12 ' A' ' 124' ' ' VAL . 49.7 tp -109.23 113.01 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.823 -0.626 . . . . 0.58999999999999997 110.46 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.8 t -112.51 123.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.916 -0.584 . . . . 0.39000000000000001 110.754 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.4 mt -88.64 131.65 34.89 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.744 -0.836 . . . . 0.59999999999999998 108.744 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.869 HG21 HG11 ' A' ' 17' ' ' VAL . 8.8 t -139.05 148.91 43.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.867 0.365 . . . . 0.35999999999999999 111.302 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 27.7 t70 -127.45 94.56 37.89 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.758 -0.655 . . . . 1.9199999999999999 109.487 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.8 Cg_endo -50.79 -40.06 57.28 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 124.153 3.236 . . . . 1.25 113.799 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.8 m-20 -86.54 43.03 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.605 0.594 . . . . 1.29 112.605 -167.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.11 138.1 19.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.801 -0.181 . . . . 0.5 110.615 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.548 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 87.8 Cg_endo -83.28 -24.49 11.13 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.575 -1.427 . . . . 0.62 112.993 1.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.9 p -130.81 150.85 51.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.177 -0.465 . . . . 0.75 109.933 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.778 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 42.5 mtm105 -67.83 -23.55 65.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.934 -0.575 . . . . 2.8799999999999999 111.878 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.724 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.6 -10.68 39.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 1.3799999999999999 111.145 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.418 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 13.4 t70 -154.18 77.01 5.63 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.176 0.512 . . . . 1.3700000000000001 110.116 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 81.5 Cg_endo -79.42 86.37 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.532 2.154 . . . . 0.80000000000000004 112.363 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.6 mttm -70.67 -50.3 38.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.747 -1.115 . . . . 1.02 110.589 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.69 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.9 m-85 -82.05 20.93 0.94 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.453 -0.794 . . . . 1.1699999999999999 111.437 -172.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 8.0 tmm_? -71.97 123.58 23.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.888 -0.412 . . . . 2.9300000000000002 109.888 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 4.8 mp0 -100.08 135.95 40.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.895 0.379 . . . . 2.23 110.886 -0.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.402 ' HD1' ' O ' ' A' ' 146' ' ' ARG . 15.1 t90 -79.38 146.52 32.8 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.977 -1.12 . . . . 1.4299999999999999 107.977 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 47.0 p-80 -124.51 127.54 47.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 1.26 110.751 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.997 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.7 t60 -70.66 -37.15 73.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.906 -1.043 . . . . 2.1400000000000001 110.219 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.622 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.4 p90 -168.36 173.61 7.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.01 -0.367 . . . . 1.51 110.01 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.654 ' HG ' HD12 ' A' ' 103' ' ' LEU . 18.4 tp -134.95 113.98 12.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.087 -0.506 . . . . 0.33000000000000002 109.776 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -122.71 132.64 70.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.671 -0.695 . . . . 0.31 110.627 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.933 HG12 HG23 ' A' ' 65' ' ' THR . 5.6 m -128.15 164.93 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.312 -0.996 . . . . 0.27000000000000002 108.312 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.978 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.0 m-20 59.16 18.64 6.66 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 123.526 0.516 . . . . 1.76 111.096 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.3 ttm -70.12 110.01 4.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.31 108.588 176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 19.4 ttmm -76.48 92.67 3.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.733 -1.121 . . . . 1.21 111.179 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.715 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.2 -123.13 6.75 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.853 -1.067 . . . . 0.29999999999999999 112.898 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.51 ' HA ' HD11 ' A' ' 53' ' ' ILE . 26.1 p-10 -113.41 22.27 14.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.332 -0.434 . . . . 1.04 111.024 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.63 106.84 18.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.489 0.661 . . . . 0.77000000000000002 109.919 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 97' ' ' ILE . 4.6 mm -57.01 -30.66 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.307 -1.315 . . . . 0.40999999999999998 111.274 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -82.87 -26.68 31.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 0.68000000000000005 111.655 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -84.82 14.9 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 1.26 111.616 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 109.35 3.62 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.787 -0.72 . . . . 0.34999999999999998 111.902 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.4 m -61.55 106.26 0.63 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.363 0.601 . . . . 0.45000000000000001 109.549 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 p -85.8 121.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.257 -0.883 . . . . 0.56999999999999995 111.414 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.654 HD12 ' HG ' ' A' ' 88' ' ' LEU . 18.4 mt -100.48 -43.13 6.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.012 0.911 . . . . 0.45000000000000001 109.231 173.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 t -123.98 110.39 14.74 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.159 -1.423 . . . . 0.37 107.159 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.895 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -59.31 164.44 3.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.851 -0.613 . . . . 1.1499999999999999 112.469 -171.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 11.0 p90 -80.76 98.27 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.414 -0.812 . . . . 4.6900000000000004 110.231 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.775 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.6 t -67.33 -53.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.85999999999999999 111.332 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 117.41 -162.53 12.87 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.551 -0.833 . . . . 0.67000000000000004 112.312 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.595 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 29.0 t -77.72 117.56 19.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.919 -0.4 . . . . 0.51000000000000001 109.919 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.646 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -143.47 57.04 0.55 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.699 -0.763 . . . . 0.81999999999999995 112.461 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.767 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 1.4 Cg_endo -87.01 131.25 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.245 2.63 . . . . 0.84999999999999998 112.346 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.65 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.7 Cg_exo -56.74 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.207 1.938 . . . . 0.87 110.53 171.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.17 112.87 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 1.8500000000000001 110.528 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.89 -6.38 19.97 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.842 -0.694 . . . . 1.1799999999999999 112.121 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.709 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 78.4 p -83.92 -20.95 32.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.772 0.32 . . . . 0.96999999999999997 111.318 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.414 ' HA3' ' HE ' ' A' ' 76' ' ' ARG . . . 107.77 -174.24 19.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.155 -0.545 . . . . 1.97 112.381 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 4.4 mm? -68.59 122.82 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.667 0.27 . . . . 0.93999999999999995 110.726 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.767 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.8 m-70 -98.45 121.55 40.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.129 0.49 . . . . 2.23 110.207 176.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.728 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 1.6 ptt180 -107.13 94.11 4.92 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.083 -0.962 . . . . 2.3100000000000001 111.461 -168.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.635 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 33.6 m-85 -75.15 111.06 10.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.195 -0.669 . . . . 0.78000000000000003 109.195 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.7 t -94.76 132.46 38.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.785 -0.643 . . . . 0.27000000000000002 110.09 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.767 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 31.0 m95 -89.4 121.89 32.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.303 -0.629 . . . . 1.99 109.303 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 76.1 mt -116.47 117.5 30.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.159 0.436 . . . . 0.38 110.221 175.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.705 HG12 HD13 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -115.07 137.89 47.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.263 -0.273 . . . . 0.31 110.263 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.83 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 47.9 t80 -130.6 137.63 49.74 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.301 -0.259 . . . . 5.1200000000000001 110.301 175.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.71 105.07 17.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.227 -0.657 . . . . 2.4100000000000001 109.227 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.479 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -76.98 175.1 9.87 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.428 0.632 . . . . 1.3100000000000001 111.29 -173.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.17 -29.27 66.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.103 -0.953 . . . . 2.3999999999999999 109.231 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 10.9 ptt-85 -159.66 164.59 19.95 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.511 -1.222 . . . . 3.5099999999999998 111.254 -172.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.546 ' HG3' HD12 ' A' ' 63' ' ' LEU . 31.4 Cg_exo -55.86 142.98 83.33 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.453 2.769 . . . . 1.21 112.916 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.506 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.0 mm? -68.97 154.43 42.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.567 0.951 . . . . 0.90000000000000002 113.567 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HE2' ' OD2' ' A' ' 134' ' ' ASP . 21.5 tptm -141.35 86.78 2.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.44 -1.255 . . . . 2.8999999999999999 108.0 167.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.74 -46.42 8.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.774 -0.648 . . . . 1.8999999999999999 112.678 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.451 ' OD2' ' HE2' ' A' ' 132' ' ' LYS . 61.7 m-20 57.32 47.55 16.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 2.96 110.7 -174.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -99.43 146.92 32.61 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.539 -0.755 . . . . 1.3899999999999999 109.973 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.73 106.19 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.133 2.555 . . . . 1.27 112.474 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.43 115.36 2.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.241 -0.436 . . . . 0.85999999999999999 110.659 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.0 mt -109.38 147.52 32.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 1.6100000000000001 110.203 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 58.0 m -109.32 36.64 2.85 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.572 -0.74 . . . . 1.8799999999999999 110.38 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.895 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.8 OUTLIER 57.05 4.56 0.18 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.62 1.168 . . . . 0.75 113.041 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.58 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 83.9 mtt180 -97.39 136.27 38.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 3.3599999999999999 110.819 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.67 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 53.7 m 77.46 118.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.582 -1.19 . . . . 0.94999999999999996 111.147 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -89.42 34.08 4.12 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.169 -0.923 . . . . 1.1200000000000001 112.426 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.68 -28.83 63.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.23 0.538 . . . . 2.6600000000000001 110.597 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -119.87 68.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 1.8700000000000001 110.852 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 78.5 mtt180 -75.52 -76.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.182 0.515 . . . . 4.7300000000000004 111.063 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.4 -148.05 5.97 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.664 -0.779 . . . . 0.65000000000000002 112.532 -174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.69 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 68.25 17.76 9.28 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.51 0.671 . . . . 1.0800000000000001 110.208 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -110.01 104.68 13.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.235 -0.893 . . . . 1.8899999999999999 109.303 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -54.82 120.65 7.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.635 -0.711 . . . . 1.29 112.2 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 17' ' ' VAL . 4.6 m -60.38 -30.1 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.611 -0.722 . . . . 0.78000000000000003 110.705 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.12 -35.47 80.38 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.67000000000000004 110.445 173.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 69.1 m -68.59 -33.96 74.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.77000000000000002 110.306 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.704 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 58.1 m-85 -67.39 -43.66 80.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.92000000000000004 110.44 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 21.4 ptt180 -69.53 -41.46 75.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.327 -0.397 . . . . 2.8900000000000001 110.354 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 53.6 mtmt -62.61 -27.31 69.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.564 0.221 . . . . 0.96999999999999997 111.416 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -53.61 -53.33 53.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.5800000000000001 110.909 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 5.2 t80 -107.89 20.96 18.09 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.439 -0.904 . . . . 5.4500000000000002 111.011 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.57 42.59 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.384 -0.825 . . . . 2.4199999999999999 111.69 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.83 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.2 mp -90.77 155.27 18.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.265 -0.88 . . . . 1.27 109.751 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.926 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -122.87 -153.85 0.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.454 -0.573 . . . . 3.5899999999999999 109.454 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.926 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -53.98 140.31 51.72 Favored Pre-proline 0 N--CA 1.456 -0.165 0 CA-C-O 121.168 0.509 . . . . 0.76000000000000001 111.114 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 7.0 Cg_exo -70.65 170.7 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.981 3.121 . . . . 0.53000000000000003 113.404 -167.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.887 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -92.8 -36.07 7.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 115.155 -0.929 . . . . 0.44 110.058 177.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -144.84 144.21 31.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.153 -0.619 . . . . 0.27000000000000002 111.962 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.767 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 150.8 23.1 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.813 -1.085 . . . . 0.23999999999999999 112.093 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.966 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -167.82 152.57 6.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.403 -0.962 . . . . 0.34000000000000002 108.403 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.805 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -122.03 142.72 50.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.985 0.421 . . . . 1.1100000000000001 111.091 -176.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.697 ' HD2' HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -130.0 109.97 11.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 0.80000000000000004 108.671 172.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -100.09 133.89 43.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.381 0.511 . . . . 2.5299999999999998 112.381 -170.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.36 151.4 44.42 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.146 -0.934 . . . . 0.59999999999999998 109.625 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -113.27 -64.29 1.33 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.516 0.932 . . . . 2.3799999999999999 113.516 -173.039 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.596 ' HA ' HG21 ' A' ' 177' ' ' VAL . 12.8 t90 178.45 74.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.017 -0.364 . . . . 3.96 110.017 -176.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.935 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -72.48 -62.21 1.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.795 0.294 . . . . 1.53 111.795 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.563 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 32.0 t70 177.18 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.095 -0.502 . . . . 1.26 110.915 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.485 ' CE2' HG22 ' A' ' 44' ' ' THR . 11.2 m-30 -78.79 1.58 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.384 -0.371 . . . . 2.2200000000000002 111.667 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.77 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 72.7 t -67.57 -54.21 19.11 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.5 110.204 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.77 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.4 Cg_exo -51.4 -35.25 53.92 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.331 2.021 . . . . 0.57999999999999996 112.35 170.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.693 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 26.3 mmmt -72.79 -24.75 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.848 0.314 . . . . 2.1400000000000001 111.848 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.2 tp -70.49 -46.29 64.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.033 -0.729 . . . . 0.66000000000000003 109.033 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.32 -37.98 79.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.559 -0.746 . . . . 1.8899999999999999 109.331 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.693 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.0 mm-40 -56.18 -55.57 31.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.808 -1.087 . . . . 1.53 110.687 170.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -63.73 -33.35 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 1.49 112.333 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 76.4 mt -63.76 -1.14 1.23 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.4 0.519 . . . . 0.76000000000000001 112.4 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.482 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.8 m -78.13 -2.81 39.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.444 0.64 . . . . 1.05 109.534 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 77.51 44.13 13.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.197 -0.911 . . . . 1.1699999999999999 111.206 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.482 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.3 mmmt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.341 -0.837 . . . . 2.0 110.597 -174.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.694 HG12 ' HB2' ' A' ' 24' ' ' PRO . 3.5 t . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.549 0.69 . . . . 1.47 111.725 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.5 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 27.9 t70 -152.84 157.7 41.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.57 -0.9 . . . . 1.8100000000000001 108.57 176.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.497 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.8 mm? -79.18 28.85 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.667 0.27 . . . . 0.69999999999999996 110.804 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 4' ' ' ASP . 7.9 m -62.96 -29.12 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 1.96 111.18 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.486 ' HB2' HD12 ' A' ' 12' ' ' LEU . 90.5 mttt -124.51 50.84 1.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.158 -0.474 . . . . 2.6600000000000001 110.231 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.624 ' HD1' ' HG3' ' A' ' 15' ' ' GLN . 4.8 p90 -71.61 -38.65 70.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 3.98 111.453 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.714 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 73.9 p -142.9 24.14 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.63 111.451 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.516 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.25 -125.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.15 -0.78 . . . . 0.47999999999999998 111.15 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.7 Cg_endo -51.11 -40.62 59.62 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 123.326 2.684 . . . . 0.53000000000000003 110.049 168.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.731 HD11 ' HA3' ' A' ' 38' ' ' GLY . 36.4 mt -88.71 78.25 7.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.688 -1.142 . . . . 1.1699999999999999 109.319 169.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 1.2 m -73.72 64.1 0.91 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.547 0.689 . . . . 0.70999999999999996 109.907 176.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.648 ' HB3' HG21 ' A' ' 121' ' ' VAL . 12.0 mt -79.73 -30.18 40.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.551 -0.749 . . . . 0.45000000000000001 110.39 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 74.7 mm-40 -73.74 16.13 0.23 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.915 0.709 . . . . 2.1200000000000001 112.915 -175.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.7 mt-10 -82.63 -13.53 56.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.851 -0.796 . . . . 1.9299999999999999 108.851 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.934 HG12 HG21 ' A' ' 151' ' ' VAL . 49.0 t -85.36 -74.92 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 114.878 -1.055 . . . . 0.63 111.525 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -122.09 -157.91 0.75 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.178 -0.465 . . . . 2.9900000000000002 111.14 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -87.15 151.26 23.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 1.6000000000000001 110.445 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 40.7 mt-30 -67.12 126.15 92.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.934 -0.395 . . . . 3.5499999999999998 109.934 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.694 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -73.23 159.41 47.21 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.214 1.943 . . . . 0.57999999999999996 111.824 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.867 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 21.0 pt20 -74.62 -13.45 60.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.74 -0.664 . . . . 1.3899999999999999 111.491 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.795 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 3.1 m80 -160.93 164.57 18.8 Favored Pre-proline 0 CA--C 1.519 -0.249 0 CA-C-O 121.016 0.436 . . . . 1.45 110.83 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.694 ' HB2' HG12 ' A' ' 3' ' ' VAL . 3.6 Cg_endo -85.82 131.14 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.487 2.792 . . . . 0.40000000000000002 111.438 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.864 HD23 ' HB3' ' A' ' 122' ' ' TRP . 25.6 tp -80.52 143.58 33.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.691 0.282 . . . . 0.28999999999999998 111.457 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.494 ' H ' HD12 ' A' ' 25' ' ' LEU . 63.2 m-70 -110.07 123.98 50.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.753 -0.462 . . . . 1.24 109.753 172.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.005 HG13 HG22 ' A' ' 53' ' ' ILE . 14.8 t -130.37 134.93 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.072 -0.714 . . . . 0.46999999999999997 109.072 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -127.37 140.64 52.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.093 0.473 . . . . 0.31 110.435 -177.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -103.12 172.67 6.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.541 -0.54 . . . . 0.67000000000000004 109.541 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.8 67.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.492 0.663 . . . . 0.55000000000000004 110.678 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.43 4.33 33.02 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.316 -0.856 . . . . 0.81000000000000005 112.753 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.44 -168.54 3.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.46999999999999997 110.472 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -162.36 149.95 14.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.977 -0.556 . . . . 0.33000000000000002 109.905 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.757 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -105.29 60.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.167 -1.42 . . . . 0.39000000000000001 107.167 166.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.27 25.63 5.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.0 0.905 . . . . 0.98999999999999999 109.921 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 16.9 tt0 -148.31 128.0 13.34 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.833 -1.076 . . . . 2.5600000000000001 108.582 167.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -69.62 111.41 5.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 0.40999999999999998 109.546 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.731 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.88 16.47 59.63 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.83 -0.623 . . . . 0.58999999999999997 113.029 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.91 149.28 41.55 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.507 -0.553 . . . . 0.34000000000000002 109.507 174.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 14.4 p -75.54 132.77 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.55000000000000004 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.9 tp -131.92 170.59 14.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.93 -0.767 . . . . 0.45000000000000001 108.93 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.94 152.18 62.42 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.209 0.448 . . . . 0.56000000000000005 112.209 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 87.8 Cg_exo -50.93 -46.47 30.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.319 2.679 . . . . 0.68000000000000005 113.981 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.49 -31.65 64.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 0.76000000000000001 111.75 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -83.71 -10.73 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.815 -0.629 . . . . 1.5900000000000001 112.113 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 41' ' ' LEU . 30.4 m -131.72 30.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.547 0.689 . . . . 0.66000000000000003 111.007 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.73 -29.21 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.79000000000000004 110.854 -174.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -114.83 -173.21 2.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 1.9099999999999999 110.225 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.16 155.41 87.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.15 -0.315 . . . . 1.4299999999999999 110.15 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.44 155.66 28.43 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.799 1.666 . . . . 0.37 110.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -78.47 -23.31 46.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.238 -0.282 . . . . 0.44 110.238 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.438 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.1 m -159.79 147.23 16.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.38 112.083 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.005 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.57 170.21 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.283 -0.871 . . . . 0.29999999999999999 108.973 172.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.008 ' HA ' HD13 ' A' ' 58' ' ' LEU . 29.2 t 179.52 116.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.406 0.622 . . . . 0.34999999999999998 109.631 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.549 ' CG ' HG21 ' A' ' 124' ' ' VAL . 1.2 p90 -100.85 -171.2 1.96 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.226 -0.897 . . . . 2.7200000000000002 110.116 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' HG12 ' A' ' 164' ' ' VAL . 22.1 t0 -69.61 119.58 14.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.005 0.431 . . . . 1.51 111.004 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.24 34.48 54.87 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.742 -0.742 . . . . 0.80000000000000004 112.656 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.008 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.3 tt -67.53 125.41 26.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.919 -0.771 . . . . 0.57999999999999996 108.919 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.673 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 23.9 t70 -89.85 -12.79 38.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.73999999999999999 110.884 -173.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.683 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 54.3 m 62.13 20.81 11.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.948 -1.024 . . . . 1.03 109.558 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.571 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -153.86 -24.4 0.04 OUTLIER Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.866 -0.683 . . . . 0.83999999999999997 113.852 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.673 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 45.4 mtpt -77.0 156.82 31.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.661 0.731 . . . . 1.6699999999999999 109.904 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.706 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 37.2 mt -94.0 125.17 38.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.947 -0.76 . . . . 0.57999999999999996 108.947 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.9 m-85 -125.03 156.94 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.745 -0.382 . . . . 0.80000000000000004 110.002 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.633 HG23 HG12 ' A' ' 90' ' ' VAL . 46.7 m -98.07 110.98 23.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.547 . . . . 0.35999999999999999 109.522 175.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.543 HD13 ' CZ3' ' A' ' 55' ' ' TRP . 21.0 tp -107.48 109.75 21.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.177 -0.465 . . . . 0.58999999999999997 109.753 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.3 t -117.93 120.81 65.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.39000000000000001 111.112 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.875 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.5 mt -83.22 145.96 28.85 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.947 -0.76 . . . . 0.59999999999999998 108.947 168.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.752 HG21 HG11 ' A' ' 17' ' ' VAL . 10.5 t -146.46 145.69 30.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.683 0.278 . . . . 0.35999999999999999 110.936 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 28.2 t70 -125.59 98.37 34.68 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 1.9199999999999999 109.421 174.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.4 Cg_endo -50.32 -38.04 51.48 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 124.135 3.224 . . . . 1.25 114.216 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 71.3 m-20 -103.59 54.18 0.75 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.293 0.568 . . . . 1.29 111.928 -165.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . . . -104.64 137.12 19.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.5 109.864 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 63.6 Cg_endo -74.44 -30.27 6.08 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.682 -1.383 . . . . 0.62 113.268 1.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.619 ' HB3' HG22 ' A' ' 115' ' ' THR . 33.6 p -137.88 165.95 25.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.589 -0.278 . . . . 0.75 110.877 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.589 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 29.2 mtp180 -68.04 -36.61 80.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 2.8799999999999999 110.851 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.761 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -76.13 -12.68 60.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.53 . . . . 1.3799999999999999 111.711 -176.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.537 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.3 t70 -154.93 77.56 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 1.3700000000000001 110.258 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.92 97.54 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.608 2.205 . . . . 0.80000000000000004 112.885 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.577 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 26.4 mttm -85.52 -48.41 8.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.848 -1.069 . . . . 1.02 110.197 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 87.4 m-85 -79.99 14.16 1.94 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 111.55 -171.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.0 ttt85 -66.83 125.14 24.95 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.991 0.367 . . . . 2.9300000000000002 111.991 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.839 ' HG2' HG13 ' A' ' 17' ' ' VAL . 6.2 mp0 -95.45 140.15 30.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.671 0.388 . . . . 2.23 110.154 -5.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 14.4 t90 -86.4 91.15 8.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.529 . . . . 1.4299999999999999 110.106 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.7 p80 -63.16 130.43 44.56 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.419 -0.586 . . . . 1.26 109.419 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.9 t60 -79.22 -31.88 43.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.898 -0.592 . . . . 2.1400000000000001 110.958 -173.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.626 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 28.7 p90 -168.42 178.56 4.79 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.198 -0.668 . . . . 1.51 109.198 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.47 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.1 tp -140.39 113.56 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.388 . . . . 0.33000000000000002 110.064 175.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.742 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.7 t -122.77 130.32 74.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.592 -0.731 . . . . 0.31 110.707 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.633 HG12 HG23 ' A' ' 65' ' ' THR . 13.4 m -133.62 165.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.986 -1.006 . . . . 0.27000000000000002 108.496 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.706 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.2 t30 63.54 13.37 7.17 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.024 -0.361 . . . . 1.76 110.024 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.742 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.9 ttm -67.67 101.98 1.12 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.603 -0.888 . . . . 0.31 108.603 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.8 ttmm -80.74 92.87 6.1 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.096 -1.411 . . . . 1.21 110.982 -170.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 78.13 -130.38 10.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.913 -1.039 . . . . 0.29999999999999999 112.668 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.548 ' HA ' HD11 ' A' ' 53' ' ' ILE . 25.8 p-10 -109.92 24.43 13.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.21 0.528 . . . . 1.04 110.735 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.98 107.11 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.835 -0.621 . . . . 0.77000000000000002 109.951 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 97' ' ' ILE . 4.5 mm -56.37 -32.71 36.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.573 -1.194 . . . . 0.40999999999999998 110.856 -177.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.3 m -73.01 -26.41 61.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.748 -0.66 . . . . 0.68000000000000005 112.002 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.7 m -78.44 -6.56 55.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 1.26 111.42 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.42 102.42 1.61 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.645 -0.788 . . . . 0.34999999999999998 112.11 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.1 m -68.46 107.99 3.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.464 0.65 . . . . 0.45000000000000001 109.655 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -79.57 119.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.892 -1.049 . . . . 0.56999999999999995 112.102 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.435 HD12 ' HG ' ' A' ' 88' ' ' LEU . 61.9 mt -95.14 -39.12 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.03 0.919 . . . . 0.45000000000000001 109.159 171.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.7 t -128.08 114.79 17.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.257 -1.386 . . . . 0.37 107.257 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.468 ' HA ' HG21 ' A' ' 102' ' ' VAL . 6.9 t0 -63.01 161.72 12.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.569 0.699 . . . . 1.1499999999999999 112.784 -168.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -91.09 93.91 9.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.984 -1.007 . . . . 4.6900000000000004 109.318 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.849 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 54.5 t -71.02 -46.18 68.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.167 0.508 . . . . 0.85999999999999999 111.89 -176.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.429 ' HA3' ' NZ ' ' A' ' 47' ' ' LYS . . . 115.86 -177.94 17.31 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.358 -0.925 . . . . 0.67000000000000004 112.294 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.8 t -64.13 122.37 16.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.551 0.176 . . . . 0.51000000000000001 111.336 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -142.72 63.87 0.5 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.051 -0.595 . . . . 0.81999999999999995 111.908 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.642 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 43.9 Cg_endo -97.7 121.9 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.504 2.803 . . . . 0.84999999999999998 112.673 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.491 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 50.7 Cg_exo -54.5 154.37 20.02 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.63 2.22 . . . . 0.87 111.736 173.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -72.02 131.04 42.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.433 . . . . 1.8500000000000001 111.146 -175.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.03 14.88 73.88 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.772 -0.649 . . . . 1.1799999999999999 113.163 175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 75' ' ' SER . 35.5 p -77.73 -15.37 59.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.672 0.619 . . . . 0.96999999999999997 112.672 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 103.92 13.02 28.46 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.141 -1.028 . . . . 1.97 112.823 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.0 mm? 76.94 105.08 0.07 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 124.604 0.826 . . . . 0.93999999999999995 111.142 177.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.65 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 5.0 m170 -66.66 121.23 14.93 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.383 -0.826 . . . . 2.23 110.044 175.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.663 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 13.1 ptp180 -116.3 80.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.832 0.825 . . . . 2.3100000000000001 110.364 -175.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 7.3 m-85 -63.69 120.26 11.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.289 -1.323 . . . . 0.78000000000000003 109.688 -177.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.699 HG22 ' HB3' ' A' ' 168' ' ' CYS . 24.6 t -97.94 131.68 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.107 -0.497 . . . . 0.27000000000000002 110.511 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.864 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.51 119.68 30.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.586 -0.733 . . . . 1.99 110.057 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -116.77 123.77 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.481 -0.192 . . . . 0.38 110.481 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.549 HG21 ' CG ' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -122.47 137.64 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.577 0.227 . . . . 0.31 111.098 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.999 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 17.7 t80 -136.66 140.65 42.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.085 -0.339 . . . . 5.1200000000000001 110.085 171.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.568 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 7.3 pt-20 -89.06 112.32 23.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.197 0.522 . . . . 2.4100000000000001 109.75 171.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.16 172.39 11.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.3100000000000001 110.013 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.98 -18.43 53.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.218 -0.901 . . . . 2.3999999999999999 109.408 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 11.4 ptt-85 -158.28 162.22 27.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.9 -1.046 . . . . 3.5099999999999998 111.67 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.557 ' HG3' HD12 ' A' ' 63' ' ' LEU . 26.0 Cg_exo -57.74 140.83 94.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.274 2.649 . . . . 1.21 111.575 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.626 ' HG ' HG11 ' A' ' 90' ' ' VAL . 3.2 mm? -64.57 143.72 57.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.156 0.503 . . . . 0.90000000000000002 111.817 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -129.32 61.46 1.54 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.232 -1.025 . . . . 2.8999999999999999 108.232 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.983 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 86.2 m -77.22 -55.42 5.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.253 -1.34 . . . . 1.8999999999999999 111.52 -172.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 60.85 35.02 19.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.292 0.568 . . . . 2.96 110.195 -172.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.983 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 59.0 mm-40 -77.62 137.23 63.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 108.616 -0.883 . . . . 1.3899999999999999 108.616 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.78 106.95 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.273 2.649 . . . . 1.27 112.728 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.1 mm -61.94 115.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.85999999999999999 110.546 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -104.43 149.28 25.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.267 0.556 . . . . 1.6100000000000001 110.352 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 162.39 13.53 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.416 -0.957 . . . . 1.8799999999999999 108.416 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.849 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.2 p-10 -77.49 16.84 0.58 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.98 0.419 . . . . 0.75 111.45 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.696 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 54.0 mtt180 -104.8 136.75 43.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.663 -0.495 . . . . 3.3599999999999999 109.663 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.615 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 49.3 m 77.27 117.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.18 0.992 . . . . 0.94999999999999996 111.232 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -106.29 41.56 2.14 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.301 -0.863 . . . . 1.1200000000000001 112.794 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.25 -47.82 47.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 2.6600000000000001 109.78 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -97.63 54.35 1.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.633 -1.167 . . . . 1.8700000000000001 110.672 -173.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 76.9 mtt180 -69.71 -77.29 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 4.7300000000000004 111.017 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -120.74 -143.05 6.66 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.792 -0.718 . . . . 0.65000000000000002 112.478 -174.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 67.36 18.51 10.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.963 0.887 . . . . 1.0800000000000001 109.769 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.18 105.58 13.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.397 -1.274 . . . . 1.8899999999999999 108.223 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -59.99 129.88 43.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.189 -0.459 . . . . 1.29 111.81 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.934 HG21 HG12 ' A' ' 17' ' ' VAL . 17.1 m -64.39 -24.92 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.78000000000000003 110.306 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.526 ' HB1' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -44.41 90.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.431 -0.804 . . . . 0.67000000000000004 109.599 172.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -61.39 -40.53 94.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.77000000000000002 111.033 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 37.2 m-85 -58.3 -53.94 52.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.435 . . . . 0.92000000000000004 111.396 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -70.76 -45.42 64.79 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.98 -0.288 . . . . 2.8900000000000001 111.217 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.526 ' HE2' ' HB1' ' A' ' 152' ' ' ALA . 58.8 mtmt -62.17 -25.95 68.06 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.724 0.297 . . . . 0.96999999999999997 111.356 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.48 -52.76 58.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 1.5800000000000001 111.053 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 12.4 t80 -102.14 18.64 20.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.88 -0.728 . . . . 5.4500000000000002 110.541 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.66 38.38 5.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.354 -0.839 . . . . 2.4199999999999999 111.948 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.999 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.0 mp -88.76 148.78 23.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.875 -0.602 . . . . 1.27 109.703 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.503 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 13.2 tpt180 -117.91 -152.15 0.5 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.468 -0.333 . . . . 3.5899999999999999 110.126 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.503 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -56.0 143.97 60.27 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-O 120.989 0.424 . . . . 0.76000000000000001 111.278 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.694 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 4.8 Cg_exo -73.2 159.88 46.4 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.876 3.05 . . . . 0.53000000000000003 113.723 -170.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.867 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 11.8 t -81.34 -31.02 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.086 -0.961 . . . . 0.44 109.751 173.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.795 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -156.95 148.76 22.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.053 -0.659 . . . . 0.27000000000000002 111.855 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.69 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 147.04 17.64 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.23999999999999999 111.349 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.638 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.0 t -160.58 149.6 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.969 -0.752 . . . . 0.34000000000000002 108.969 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.699 ' HB3' HG22 ' A' ' 121' ' ' VAL . 15.4 p -126.9 149.02 49.99 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.894 -0.722 . . . . 1.1100000000000001 111.589 -175.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 46.2 p90 -129.08 127.61 41.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.887 -1.153 . . . . 0.80000000000000004 107.887 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.65 133.01 50.21 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.045 -0.662 . . . . 2.5299999999999998 110.07 178.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -120.82 141.75 50.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.59999999999999998 112.199 -170.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.641 ' HG2' HD11 ' A' ' 117' ' ' LEU . 46.2 mt-10 -89.21 -173.1 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.809 -1.087 . . . . 2.3799999999999999 111.617 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.537 ' HA ' HG21 ' A' ' 177' ' ' VAL . 55.7 t90 -98.3 75.65 2.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.361 -0.977 . . . . 3.96 108.361 175.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -73.13 -57.19 4.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.386 -0.37 . . . . 1.53 111.906 -172.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.524 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.8 t70 179.44 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.118 0.567 . . . . 1.26 110.335 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -81.34 0.78 35.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 2.2200000000000002 112.113 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.825 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 93.2 t -67.88 -54.66 15.93 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.342 -0.244 . . . . 0.5 110.342 174.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.3 Cg_exo -53.83 -43.06 61.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.504 2.136 . . . . 0.57999999999999996 111.949 171.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.3 mmmm -70.83 -24.3 62.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 2.1400000000000001 111.561 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.641 HD11 HG12 ' A' ' 107' ' ' VAL . 61.9 tp -66.99 -47.85 70.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 0.66000000000000003 109.529 172.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.61 -37.76 87.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.66 -0.7 . . . . 1.8899999999999999 109.445 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.729 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.3 mm-40 -56.56 -44.87 81.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.932 -1.031 . . . . 1.53 110.842 172.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.96 -29.85 65.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.745 . . . . 1.49 111.497 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.615 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.2 mt -64.85 -8.66 16.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.934 0.346 . . . . 0.76000000000000001 111.934 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.513 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 66.6 m -73.91 -3.11 26.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 1.05 110.364 172.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.696 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.54 58.04 6.2 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.826 -0.91 . . . . 1.1699999999999999 110.826 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.9 mmmt . . . . . 0 C--O 1.241 0.654 0 CA-C-O 118.651 -0.69 . . . . 2.0 111.304 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.275 0.084 . . . . 5.04 111.043 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.27 160.36 39.07 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.562 2.175 . . . . 2.1299999999999999 112.386 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 3.7 p -106.12 125.9 61.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.153 -0.931 . . . . 1.47 109.673 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.3 155.92 34.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.784 -0.644 . . . . 1.8100000000000001 109.953 -168.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.491 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -72.67 2.21 6.95 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 112.331 0.493 . . . . 0.69999999999999996 112.331 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 m -55.91 -21.85 22.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.77 0.319 . . . . 1.96 111.755 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -101.13 27.6 5.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.563 -0.289 . . . . 2.6600000000000001 110.701 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.576 ' HE3' ' HB2' ' A' ' 20' ' ' GLN . 5.1 p-90 -70.64 -28.44 64.81 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.639 0.607 . . . . 3.98 112.639 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -144.96 14.59 1.51 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.713 -0.395 . . . . 0.63 111.139 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.63 -115.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.483 -0.647 . . . . 0.47999999999999998 111.483 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.1 Cg_endo -51.28 -46.2 32.69 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.356 2.704 . . . . 0.53000000000000003 110.925 167.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.707 HD11 ' HA3' ' A' ' 38' ' ' GLY . 11.5 mt -88.97 103.44 16.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.15 -0.932 . . . . 1.1699999999999999 110.125 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.18 65.35 4.33 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.257 0.551 . . . . 0.70999999999999996 110.546 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.816 HD22 HG21 ' A' ' 121' ' ' VAL . 15.5 mt -76.16 -15.05 60.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.543 . . . . 0.45000000000000001 110.45 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -66.73 -8.46 28.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 2.1200000000000001 111.308 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.468 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 9.4 mt-10 -81.85 -7.62 59.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.235 -0.439 . . . . 1.9299999999999999 110.107 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.733 HG11 HG21 ' A' ' 69' ' ' THR . 53.3 t -124.88 -61.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 0.63 111.389 -175.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -125.2 169.34 12.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.678 -0.409 . . . . 2.9900000000000002 110.404 -172.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -90.5 25.37 2.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 1.6000000000000001 111.799 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.576 ' HB2' ' HE3' ' A' ' 8' ' ' TRP . 1.6 tt0 67.05 120.48 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 O-C-N 124.151 0.907 . . . . 3.5499999999999998 110.986 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 19.2 Cg_exo -65.17 158.37 52.46 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.403 2.069 . . . . 0.57999999999999996 112.124 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.857 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.4 pt20 -73.42 -16.19 61.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 1.3899999999999999 111.034 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.774 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 21.2 m80 -149.36 156.43 39.59 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.691 -0.686 . . . . 1.45 109.565 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 6.3 Cg_endo -87.28 126.66 2.35 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.891 2.394 . . . . 0.40000000000000002 110.97 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.2 tp -75.92 140.44 42.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.791 0.329 . . . . 0.28999999999999998 110.916 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -106.04 119.74 39.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 1.24 109.625 173.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.882 HG13 HG22 ' A' ' 53' ' ' ILE . 21.8 t -126.17 138.19 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.995 -0.742 . . . . 0.46999999999999997 108.995 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -136.74 136.95 39.4 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.026 0.441 . . . . 0.31 110.655 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 60.9 t80 -99.65 169.3 9.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.315 -0.624 . . . . 0.67000000000000004 109.315 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.86 65.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.471 0.653 . . . . 0.55000000000000004 110.488 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.651 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -116.03 20.06 13.19 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.028 -0.987 . . . . 0.81000000000000005 112.673 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 45' ' ' GLN . . . -154.36 -170.5 3.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.845 0.355 . . . . 0.46999999999999997 110.416 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.92 159.76 24.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.895 -0.593 . . . . 0.33000000000000002 109.82 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.722 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.1 t -122.4 63.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.253 -1.388 . . . . 0.39000000000000001 107.253 166.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.4 t70 -100.27 19.89 15.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.154 -0.93 . . . . 0.98999999999999999 109.808 -173.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 44.5 mt-10 -144.05 131.1 20.54 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.09 -0.959 . . . . 2.5600000000000001 108.593 172.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -74.66 111.33 9.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.416 0.627 . . . . 0.40999999999999998 110.272 -172.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.707 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 80.53 21.27 64.6 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.295 -0.866 . . . . 0.58999999999999997 111.89 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.722 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.26 149.76 44.23 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.474 -0.565 . . . . 0.34000000000000002 109.474 175.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.96 127.81 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.267 0.555 . . . . 0.55000000000000004 110.54 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.597 HD22 HG22 ' A' ' 34' ' ' VAL . 8.9 tp -131.18 169.12 16.36 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.634 -0.876 . . . . 0.45000000000000001 108.634 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.82 151.81 58.22 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 120.582 -0.447 . . . . 0.56000000000000005 111.535 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.639 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 63.3 Cg_exo -53.64 -39.6 82.48 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.017 2.478 . . . . 0.68000000000000005 112.075 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -35.24 61.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.109 -0.496 . . . . 0.76000000000000001 111.404 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 44.9 mt-30 -82.79 -23.14 33.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 1.5900000000000001 112.125 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.569 ' HB ' ' OH ' ' A' ' 106' ' ' TYR . 30.0 m -119.88 30.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.195 0.521 . . . . 0.66000000000000003 112.169 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 6.31 21.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.955 0.407 . . . . 0.79000000000000004 111.089 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 36.4 m-20 -148.59 172.88 13.81 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.509 -0.552 . . . . 1.9099999999999999 109.509 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -62.77 149.4 89.59 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 110.017 -0.364 . . . . 1.4299999999999999 110.017 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.64 145.7 23.4 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.963 1.775 . . . . 0.37 110.266 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -18.7 62.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.491 -0.322 . . . . 0.44 110.728 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.2 m -159.66 144.7 15.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.872 0.694 . . . . 0.38 112.872 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.882 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.39 164.79 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.705 -1.134 . . . . 0.29999999999999999 108.041 170.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.076 ' HA ' HD13 ' A' ' 58' ' ' LEU . 28.9 t 176.17 122.26 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.764 -0.458 . . . . 0.34999999999999998 109.764 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.7 p-90 -81.0 166.67 20.59 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.757 -0.831 . . . . 2.7200000000000002 108.757 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.425 ' HB3' ' CG ' ' A' ' 23' ' ' HIS . 17.1 t70 -65.64 83.06 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 1.51 111.081 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.92 31.48 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.655 -0.702 . . . . 0.80000000000000004 112.319 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.076 HD13 ' HA ' ' A' ' 54' ' ' SER . 8.4 tt -66.33 129.05 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.008 0.432 . . . . 0.57999999999999996 111.062 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.797 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.5 t70 -77.75 -29.92 51.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.854 -0.612 . . . . 0.73999999999999999 112.078 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.693 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 74.8 m 76.76 -6.12 2.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.096 -0.956 . . . . 1.03 110.926 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.22 6.64 14.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.155 -0.545 . . . . 0.83999999999999997 112.39 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.797 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.8 mtpt -100.69 152.53 20.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.015 0.436 . . . . 1.6699999999999999 111.093 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.774 HD21 ' HE2' ' A' ' 93' ' ' LYS . 44.2 mt -97.25 130.98 44.39 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.557 -0.905 . . . . 0.57999999999999996 108.557 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.722 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.2 OUTLIER -130.2 163.94 25.6 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.636 -0.505 . . . . 0.80000000000000004 109.636 175.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.609 HG23 HG12 ' A' ' 90' ' ' VAL . 75.2 m -102.32 104.82 15.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.459 -0.571 . . . . 0.35999999999999999 109.459 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.745 HD13 HG12 ' A' ' 124' ' ' VAL . 43.7 tp -102.49 115.33 30.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.124 0.488 . . . . 0.58999999999999997 110.527 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 88' ' ' LEU . 23.3 t -120.88 129.04 76.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.713 -0.676 . . . . 0.39000000000000001 111.06 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.889 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.3 mt -83.37 136.76 34.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 0.59999999999999998 108.478 167.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.733 HG21 HG11 ' A' ' 17' ' ' VAL . 15.1 t -140.27 163.69 32.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.205 -0.294 . . . . 0.35999999999999999 110.205 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 17.7 t70 -155.95 103.27 2.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.304 0.573 . . . . 1.9199999999999999 110.858 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.724 ' HD3' HG21 ' A' ' 17' ' ' VAL . 12.4 Cg_endo -56.98 -34.89 98.45 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.65 2.9 . . . . 1.25 114.169 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.56 38.87 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.986 0.365 . . . . 1.29 111.986 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' CB ' ' HB2' ' A' ' 84' ' ' TRP . . . -104.68 127.62 28.53 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 111.488 0.181 . . . . 0.5 111.488 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 92.9 Cg_endo -85.12 -24.03 10.8 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.435 -1.485 . . . . 0.62 112.859 -0.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.571 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.9 p -135.4 154.85 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.032 -0.531 . . . . 0.75 110.09 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -72.15 -24.6 61.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.388 -0.369 . . . . 2.8799999999999999 111.134 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 3.2 ptpt -72.03 -21.86 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 1.3799999999999999 110.535 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.22 86.88 1.01 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.306 -0.861 . . . . 1.3700000000000001 109.24 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -86.38 86.65 0.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.509 2.139 . . . . 0.80000000000000004 112.507 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 22.2 mttm -70.98 -53.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.936 -1.483 . . . . 1.02 111.689 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.81 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 85.2 m-85 -78.28 12.07 2.08 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.894 -0.594 . . . . 1.1699999999999999 111.027 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 24.2 ttt180 -73.15 125.42 27.67 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.8 0.44 . . . . 2.9300000000000002 110.267 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.512 ' OE1' ' HA ' ' A' ' 150' ' ' LYS . 23.1 mt-10 -94.84 134.33 37.59 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.846 0.458 . . . . 2.23 110.457 2.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.761 ' HE1' ' HB2' ' A' ' 146' ' ' ARG . 4.8 t90 -89.34 91.12 8.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.939 -0.393 . . . . 1.4299999999999999 109.939 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 12.5 p80 -74.57 109.52 8.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.778 -0.823 . . . . 1.26 108.778 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.41 -8.47 54.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.803 -0.635 . . . . 2.1400000000000001 112.233 -168.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.889 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 30.3 t80 -166.29 142.93 5.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.06 -0.348 . . . . 1.51 110.06 -174.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.675 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.6 tp -142.77 114.65 8.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.981 0.419 . . . . 0.33000000000000002 110.623 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.555 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -132.57 134.93 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.31 110.74 176.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.709 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 15.0 m -129.03 158.01 41.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.138 -1.06 . . . . 0.27000000000000002 108.138 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.689 ' OD1' ' HB3' ' A' ' 130' ' ' PRO . 6.1 t30 63.78 19.69 11.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.023 0.44 . . . . 1.76 109.925 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.555 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.0 ttm -67.4 106.9 2.24 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.781 -0.822 . . . . 0.31 108.781 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.774 ' HE2' HD21 ' A' ' 63' ' ' LEU . 13.2 ttmt -83.55 89.68 7.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.994 -1.003 . . . . 1.21 111.077 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 83.98 -126.26 7.49 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.636 -1.166 . . . . 0.29999999999999999 113.208 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.478 ' HA ' HD11 ' A' ' 53' ' ' ILE . 29.6 p30 -117.32 27.62 8.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.315 -0.442 . . . . 1.04 110.88 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -97.12 112.46 24.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.321 0.582 . . . . 0.77000000000000002 109.658 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 53' ' ' ILE . 5.1 mm -58.53 -26.44 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.408 -1.269 . . . . 0.40999999999999998 111.349 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 m -87.6 -31.34 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.117 -0.492 . . . . 0.68000000000000005 111.718 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.1 m -80.29 19.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.266 0.469 . . . . 1.26 112.266 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 92' ' ' MET . . . -102.61 114.11 4.79 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 111.189 -0.764 . . . . 0.34999999999999998 111.189 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 84.9 m -58.54 107.0 0.45 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.508 0.67 . . . . 0.45000000000000001 109.776 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.94 116.42 29.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.084 . . . . 0.56999999999999995 112.333 -172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.675 HD12 ' HG ' ' A' ' 88' ' ' LEU . 9.3 mt -98.61 -51.48 3.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.974 0.893 . . . . 0.45000000000000001 108.859 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.1 t -118.61 102.23 8.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.394 -1.275 . . . . 0.37 107.747 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HB3' ' N ' ' A' ' 140' ' ' ASN . 38.2 t0 -65.24 157.63 28.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.547 -0.751 . . . . 1.1499999999999999 112.323 -169.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.569 ' OH ' ' HB ' ' A' ' 46' ' ' VAL . 85.7 t80 -74.19 107.52 6.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.595 -0.729 . . . . 4.6900000000000004 109.172 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.4 t -84.69 -26.91 6.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.566 -0.743 . . . . 0.85999999999999999 112.242 -172.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.23 -174.41 19.7 Favored Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 111.13 -0.788 . . . . 0.67000000000000004 111.13 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.639 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.7 t -78.21 134.47 37.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.429 0.614 . . . . 0.51000000000000001 109.811 172.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.655 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -160.0 66.06 0.27 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.367 -0.444 . . . . 0.81999999999999995 112.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.898 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 46.4 Cg_endo -99.15 149.52 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.89 3.06 . . . . 0.84999999999999998 113.78 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.594 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 26.6 Cg_exo -64.07 143.32 84.24 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.074 2.516 . . . . 0.87 112.443 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 121.19 17.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 1.8500000000000001 110.823 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.46 15.11 30.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.86 -0.686 . . . . 1.1799999999999999 112.367 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.594 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 72.1 p -96.68 -1.19 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.947 0.403 . . . . 0.96999999999999997 111.028 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.36 -161.89 27.85 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.042 -0.823 . . . . 1.97 111.042 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.6 mm? -79.95 99.06 7.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.36 0.6 . . . . 0.93999999999999995 109.567 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -72.1 120.54 17.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.883 -1.053 . . . . 2.23 109.09 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.849 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp85 -121.96 99.76 6.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.914 0.709 . . . . 2.3100000000000001 112.914 -165.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.608 ' HB3' HD22 ' A' ' 68' ' ' LEU . 65.9 m-85 -82.09 129.39 34.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.444 -0.576 . . . . 0.78000000000000003 109.444 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.961 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.5 t -102.33 133.56 45.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.925 -0.579 . . . . 0.27000000000000002 109.719 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.694 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 67.2 m95 -88.32 119.59 28.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.754 -0.832 . . . . 1.99 108.754 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.26 118.77 32.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 117.797 0.271 . . . . 0.38 110.815 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.745 HG12 HD13 ' A' ' 66' ' ' LEU . 1.9 m -102.36 133.22 46.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.069 -0.652 . . . . 0.31 109.262 172.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 92.2 m-85 -106.84 155.68 19.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.875 0.369 . . . . 5.1200000000000001 111.084 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.596 ' HB2' HG22 ' A' ' 164' ' ' VAL . 12.3 tp10 -101.32 119.95 39.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.304 -0.862 . . . . 2.4100000000000001 110.833 -176.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.722 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -133.46 150.06 51.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.461 -0.791 . . . . 1.3100000000000001 109.991 174.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 129' ' ' ARG . 1.6 p30 -83.4 -12.47 56.42 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.183 -0.917 . . . . 2.3999999999999999 111.452 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.505 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . 65.9 mtp180 -135.9 163.06 53.08 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 3.5099999999999998 111.837 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.689 ' HB3' ' OD1' ' A' ' 91' ' ' ASN . 19.3 Cg_exo -71.85 24.71 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.806 1 C-N-CA 125.61 4.207 . . . . 1.21 115.833 -170.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.709 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? 71.99 -178.76 0.21 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.685 0.755 . . . . 0.90000000000000002 112.909 172.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -165.72 79.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.221 -1.354 . . . . 2.8999999999999999 108.896 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.415 ' HB2' HD11 ' A' ' 103' ' ' LEU . 63.0 m -101.94 115.89 31.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.648 -0.705 . . . . 1.8999999999999999 110.33 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.44 19.52 8.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.534 -0.757 . . . . 2.96 110.485 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -66.08 125.24 89.76 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.562 -0.744 . . . . 1.3899999999999999 110.466 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.46 129.02 21.97 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.239 2.626 . . . . 1.27 112.713 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.31 116.66 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.43 . . . . 0.85999999999999999 110.34 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.9 mt -106.19 2.48 26.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.339 0.496 . . . . 1.6100000000000001 112.339 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.0 p 52.04 -157.66 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.536 0.522 . . . . 1.8799999999999999 110.009 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.674 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.3 p-10 -98.01 -6.03 32.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.256 -0.646 . . . . 0.75 109.256 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.617 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 12.4 mtt180 -84.99 141.47 30.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.241 -0.436 . . . . 3.3599999999999999 110.352 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.572 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 30.5 m 72.66 125.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.219 0.949 . . . . 0.94999999999999996 111.103 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.501 ' HA2' ' CD ' ' A' ' 146' ' ' ARG . . . -107.53 -5.97 33.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.437 -0.801 . . . . 1.1200000000000001 113.006 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.94 -54.15 49.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.324 0.583 . . . . 2.6600000000000001 112.542 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.89 7.3 31.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.506 -0.77 . . . . 1.8700000000000001 111.672 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.761 ' HB2' ' HE1' ' A' ' 84' ' ' TRP . 28.1 mtp85 -88.84 -16.15 32.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.084 0.469 . . . . 4.7300000000000004 110.742 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -112.07 173.08 15.22 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.489 -0.863 . . . . 0.65000000000000002 112.485 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.4 mttt 69.61 36.55 2.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.841 0.829 . . . . 1.0800000000000001 110.836 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -123.09 172.4 8.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.809 -1.087 . . . . 1.8899999999999999 109.261 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.512 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 13.0 mmmm -117.26 133.0 56.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 1.29 111.932 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.755 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.6 m -67.35 -26.27 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.664 -0.698 . . . . 0.78000000000000003 110.005 173.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.36 -38.33 90.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.67000000000000004 109.627 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.2 m -63.78 -34.53 78.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.656 -0.702 . . . . 0.77000000000000002 110.462 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.755 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 59.7 m-85 -71.56 -47.5 54.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.92000000000000004 111.523 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 152' ' ' ALA . 6.9 ptm180 -66.9 -39.92 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.647 0.26 . . . . 2.8900000000000001 110.571 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -71.95 -25.78 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.607 -0.269 . . . . 0.96999999999999997 111.185 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 43.6 tptt -53.91 -52.92 59.02 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.355 -0.384 . . . . 1.5800000000000001 111.309 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.581 ' HD2' HD11 ' A' ' 160' ' ' LEU . 16.6 t80 -111.25 10.61 21.74 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.788 -0.765 . . . . 5.4500000000000002 111.322 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.8 39.34 4.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.035 -0.53 . . . . 2.4199999999999999 112.395 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 127' ' ' GLN . 0.2 OUTLIER -80.95 125.11 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.236 -0.653 . . . . 1.27 109.236 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.401 ' HB3' ' H ' ' A' ' 162' ' ' ALA . 8.0 tpt180 -60.32 -85.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 3.5899999999999999 111.874 -168.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 161' ' ' ARG . . . -135.66 160.9 65.9 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.721 -0.474 . . . . 0.76000000000000001 109.721 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.455 ' HB2' ' CA ' ' A' ' 21' ' ' PRO . 37.0 Cg_exo -58.44 142.24 97.74 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.68 2.254 . . . . 0.53000000000000003 112.748 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.857 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.6 t -88.42 -36.06 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 109.385 -0.598 . . . . 0.44 109.385 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.774 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.68 143.45 25.49 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.667 -0.697 . . . . 0.27000000000000002 111.232 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.9 145.59 14.81 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.055 -0.975 . . . . 0.23999999999999999 111.587 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.484 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 14.3 t -158.03 133.61 8.98 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.584 -0.525 . . . . 0.34000000000000002 109.584 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.961 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -107.24 141.9 37.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.213 0.53 . . . . 1.1100000000000001 111.418 -175.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 30.5 p90 -124.23 117.92 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.748 -1.204 . . . . 0.80000000000000004 107.748 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -101.73 132.96 47.16 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.725 -0.79 . . . . 2.5299999999999998 111.103 179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.427 ' HB1' ' HD3' ' A' ' 43' ' ' PRO . . . -149.91 145.89 26.76 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.561 -1.199 . . . . 0.59999999999999998 108.687 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.898 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 13.8 pt-20 -131.58 -160.3 1.03 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.697 -0.401 . . . . 2.3799999999999999 111.021 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.731 ' HA ' HG21 ' A' ' 177' ' ' VAL . 24.3 t90 -64.89 85.05 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.866 0.467 . . . . 3.96 111.38 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.611 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 8.5 p-10 -74.47 -59.12 2.87 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.361 -0.212 . . . . 1.53 110.757 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.5 t70 173.43 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.808 0.843 . . . . 1.26 109.897 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -81.97 -9.08 59.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 2.2200000000000002 111.64 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.743 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 69.2 t -54.67 -53.24 62.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 0.5 111.561 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.743 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.3 Cg_exo -49.7 -35.26 37.98 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.888 2.392 . . . . 0.57999999999999996 112.891 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 38.1 mmtm -74.47 -23.79 58.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.962 0.356 . . . . 2.1400000000000001 111.962 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.655 HD23 ' HA3' ' A' ' 110' ' ' GLY . 28.4 tp -70.76 -44.3 67.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.916 -0.772 . . . . 0.66000000000000003 108.916 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.03 -34.52 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.762 -0.654 . . . . 1.8899999999999999 109.242 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.686 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.5 mm-40 -56.48 -42.37 78.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.931 -1.031 . . . . 1.53 110.89 172.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.465 ' NE2' HD21 ' A' ' 140' ' ' ASN . 39.9 tt0 -77.82 -38.0 47.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.572 -0.74 . . . . 1.49 112.41 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 21.5 mt -63.29 0.24 0.7 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 0.76000000000000001 113.479 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.407 ' HB2' ' CE ' ' A' ' 187' ' ' LYS . 12.8 m -67.58 -19.55 65.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.086 -0.709 . . . . 1.05 109.086 170.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 104.14 44.17 1.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.586 -1.006 . . . . 1.1699999999999999 110.586 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.407 ' CE ' ' HB2' ' A' ' 185' ' ' SER . 22.9 mmtp . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.563 -0.732 . . . . 2.0 109.832 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.214 0.054 . . . . 5.04 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.67 98.39 0.24 Allowed 'Trans proline' 0 CA--C 1.515 -0.447 0 C-N-CA 122.874 2.383 . . . . 2.1299999999999999 112.131 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 36' ' ' GLU . 16.5 t 65.4 113.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.572 -1.195 . . . . 1.47 110.522 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 6' ' ' SER . 20.1 t70 -148.98 157.71 43.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.35 -0.841 . . . . 1.8100000000000001 109.445 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.415 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.7 mm? -74.96 19.28 0.15 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 111.53 0.196 . . . . 0.69999999999999996 111.53 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 4' ' ' ASP . 27.5 t -68.67 -19.92 64.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 1.96 110.364 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.877 ' HB3' HD12 ' A' ' 12' ' ' LEU . 90.9 mttt -113.82 30.67 7.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.727 -0.67 . . . . 2.6600000000000001 110.597 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.625 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -72.88 -33.94 66.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.312 -0.404 . . . . 3.98 112.041 -173.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.798 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 36.5 p -150.21 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.673 -0.411 . . . . 0.63 111.894 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -79.73 -126.58 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.456 -0.878 . . . . 0.47999999999999998 110.946 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.9 Cg_endo -51.87 -36.43 63.38 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.219 2.613 . . . . 0.53000000000000003 110.214 166.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.877 HD12 ' HB3' ' A' ' 7' ' ' LYS . 40.7 mt -87.74 81.83 7.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.772 -1.103 . . . . 1.1699999999999999 109.282 170.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -74.73 63.13 1.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.474 0.654 . . . . 0.70999999999999996 110.703 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 ' CG2' ' A' ' 121' ' ' VAL . 33.8 mt -78.91 -21.62 47.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.548 -0.751 . . . . 0.45000000000000001 110.617 -176.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.798 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -73.18 6.88 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.587 -0.733 . . . . 2.1200000000000001 110.647 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -79.45 -22.51 44.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.428 0.633 . . . . 1.9299999999999999 110.091 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.907 HG11 HG21 ' A' ' 69' ' ' THR . 3.0 t -86.03 -65.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.63 110.669 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -137.88 -178.11 5.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.491 -0.484 . . . . 2.9900000000000002 111.095 -176.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -62.1 179.1 0.31 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.766 0.826 . . . . 1.6000000000000001 112.125 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG2' ' HD1' ' A' ' 8' ' ' TRP . 27.0 mt-30 -90.74 128.6 47.68 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.126 -0.488 . . . . 3.5499999999999998 110.128 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.603 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 10.1 Cg_exo -70.41 159.34 53.26 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.264 1.976 . . . . 0.57999999999999996 112.292 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.898 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 5.4 pt20 -77.48 -15.62 59.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.754 -0.657 . . . . 1.3899999999999999 111.153 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.776 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.8 m80 -153.02 159.73 31.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 1.45 110.089 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.8 Cg_endo -86.16 130.85 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.329 2.686 . . . . 0.40000000000000002 110.919 174.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 124' ' ' VAL . 29.9 tp -79.84 143.45 34.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.646 0.26 . . . . 0.28999999999999998 110.897 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -114.94 110.11 19.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 1.24 110.236 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 53' ' ' ILE . 17.0 t -114.71 146.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.546 -0.538 . . . . 0.46999999999999997 109.546 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.54 144.57 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.335 0.254 . . . . 0.31 110.819 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.478 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 36.3 t80 -110.41 173.99 6.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.268 -0.642 . . . . 0.67000000000000004 109.268 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.06 -52.88 63.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.451 0.643 . . . . 0.55000000000000004 110.398 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.24 -6.56 44.85 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.237 -0.892 . . . . 0.81000000000000005 112.724 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.02 -171.37 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.46999999999999997 110.831 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.68 154.7 16.23 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 109.999 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 88.2 t -101.56 63.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.548 -1.649 . . . . 0.39000000000000001 106.548 163.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.24 18.69 2.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.036 -1.438 . . . . 0.98999999999999999 110.163 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.555 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.3 mm-40 -159.7 142.12 13.57 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.457 -0.792 . . . . 2.5600000000000001 109.881 173.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -76.48 111.59 12.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.644 -0.873 . . . . 0.40999999999999998 108.644 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.715 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 86.7 20.93 52.79 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.666 -0.778 . . . . 0.58999999999999997 112.424 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.67 152.18 30.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.286 -0.635 . . . . 0.34000000000000002 109.286 172.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.6 p -81.78 136.77 22.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.182 0.515 . . . . 0.55000000000000004 110.975 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 41' ' ' LEU . 7.0 tp -131.11 169.03 16.44 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.057 -1.09 . . . . 0.45000000000000001 108.057 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.3 p -123.21 152.43 63.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 119.472 -0.891 . . . . 0.56000000000000005 113.129 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 75.9 Cg_exo -51.74 -33.92 51.98 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.608 3.539 . . . . 0.68000000000000005 114.05 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -65.4 -32.34 73.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.614 0.721 . . . . 0.76000000000000001 110.756 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -82.33 -43.91 16.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.012 -0.995 . . . . 1.5900000000000001 111.451 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.552 HG21 ' HE2' ' A' ' 169' ' ' TYR . 12.3 m -102.64 30.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.265 0.469 . . . . 0.66000000000000003 112.265 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.74 -12.05 59.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.465 -0.568 . . . . 0.79000000000000004 109.465 175.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -167.98 2.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.492 -0.776 . . . . 1.9099999999999999 109.836 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.423 ' HD3' HG22 ' A' ' 97' ' ' ILE . 98.6 mtt180 -77.94 158.78 77.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 110.088 -0.338 . . . . 1.4299999999999999 110.088 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 59.9 Cg_endo -79.23 161.44 26.05 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.996 1.797 . . . . 0.37 111.127 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.413 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.1 t -80.41 -22.4 41.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.55 -0.295 . . . . 0.44 110.363 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.4 m -162.68 143.51 9.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.391 0.615 . . . . 0.38 112.478 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.913 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -137.02 167.17 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.819 -1.082 . . . . 0.29999999999999999 108.274 170.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.066 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.6 t 175.91 128.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.954 0.407 . . . . 0.34999999999999998 109.909 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 53.4 p-90 -91.07 160.91 15.35 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.519 -1.289 . . . . 2.7200000000000002 107.519 172.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.29 84.18 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.074 0.464 . . . . 1.51 111.092 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.92 17.44 2.79 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.401 -0.818 . . . . 0.80000000000000004 112.022 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.066 HD13 ' HA ' ' A' ' 54' ' ' SER . 5.4 tt -57.02 127.13 30.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.919 0.39 . . . . 0.57999999999999996 110.429 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.822 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 31.5 t70 -75.91 -24.21 55.57 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.608 . . . . 0.73999999999999999 112.01 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.665 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 67.2 m 68.89 15.35 8.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.278 -0.874 . . . . 1.03 110.422 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.55 -33.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.601 -0.727 . . . . 0.83999999999999997 112.666 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.822 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 24.7 mtpt -71.34 149.89 45.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 1.6699999999999999 110.72 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.904 HD23 ' HG2' ' A' ' 93' ' ' LYS . 3.8 mt -85.77 125.45 33.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.337 -0.847 . . . . 0.57999999999999996 109.494 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.475 ' HE2' ' HA2' ' A' ' 94' ' ' GLY . 5.5 m-85 -120.84 148.09 44.5 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.714 -0.394 . . . . 0.80000000000000004 110.436 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.63 HG23 HG12 ' A' ' 90' ' ' VAL . 62.7 m -96.89 104.97 17.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.35999999999999999 108.148 170.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.537 HD13 HG12 ' A' ' 124' ' ' VAL . 43.4 tp -104.39 109.09 20.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.668 -0.696 . . . . 0.58999999999999997 109.658 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' CD1' ' A' ' 88' ' ' LEU . 25.6 t -111.97 127.44 69.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.696 -0.684 . . . . 0.39000000000000001 110.429 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.021 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.3 mt -88.27 134.12 33.88 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.542 -0.91 . . . . 0.59999999999999998 108.542 168.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.907 HG21 HG11 ' A' ' 17' ' ' VAL . 9.7 t -137.58 156.45 48.08 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.459 -0.2 . . . . 0.35999999999999999 110.459 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.493 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 10.2 t70 -140.15 94.89 8.59 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.306 -0.628 . . . . 1.9199999999999999 109.306 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.5 Cg_endo -52.2 -36.68 68.03 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.722 2.948 . . . . 1.25 113.734 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.8 m-20 -89.32 43.83 1.17 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.129 0.49 . . . . 1.29 111.542 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.68 139.28 19.94 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.446 -0.343 . . . . 0.5 110.143 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -80.18 -28.51 7.15 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 123.084 -1.632 . . . . 0.62 112.813 2.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.646 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 84.7 p -125.67 149.75 48.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.079 -0.51 . . . . 0.75 110.371 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.552 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 3.0 tmm_? -65.03 -28.91 69.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.419 0.628 . . . . 2.8799999999999999 109.651 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.0 ptpt -74.48 -21.06 59.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.848 -0.615 . . . . 1.3799999999999999 110.992 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.0 t70 -159.63 88.9 1.97 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.485 . . . . 1.3700000000000001 110.26 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 83.6 Cg_endo -84.37 93.63 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.67 2.247 . . . . 0.80000000000000004 113.234 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.5 mttm -83.9 -41.29 17.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.216 -0.902 . . . . 1.02 111.065 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.731 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 30.6 m-85 -78.98 8.47 5.57 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 116.032 -0.531 . . . . 1.1699999999999999 111.798 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -65.74 125.22 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.729 -0.471 . . . . 2.9300000000000002 109.729 177.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE1' HG13 ' A' ' 151' ' ' VAL . 5.1 tm-20 -93.12 134.13 35.59 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.49 0.716 . . . . 2.23 109.878 -0.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.419 ' CE3' ' HB3' ' A' ' 70' ' ' ASP . 80.7 t90 -108.67 131.08 55.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.63 -0.507 . . . . 1.4299999999999999 109.63 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 20.1 p80 -112.17 141.12 46.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.379 0.609 . . . . 1.26 111.328 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 1.021 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 7.2 t60 -82.6 -39.39 22.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.202 -0.908 . . . . 2.1400000000000001 110.884 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.584 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 20.3 p90 -167.16 173.18 9.3 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.601 -0.518 . . . . 1.51 109.601 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.529 ' HG ' HD12 ' A' ' 103' ' ' LEU . 16.6 tp -134.62 113.04 11.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.33000000000000002 110.178 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.637 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.8 t -121.25 132.11 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.641 -0.708 . . . . 0.31 110.146 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.776 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 6.2 m -129.71 162.94 36.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.084 -0.962 . . . . 0.27000000000000002 108.64 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.741 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 72.2 m-20 58.43 23.24 10.41 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.721 0.638 . . . . 1.76 111.418 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.637 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.4 ttm -73.84 102.69 4.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.1 -1.074 . . . . 0.31 108.1 174.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.904 ' HG2' HD23 ' A' ' 63' ' ' LEU . 2.8 mtpm? -77.1 93.77 3.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.265 -0.879 . . . . 1.21 110.951 -171.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 85.37 -127.63 8.32 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.542 -0.754 . . . . 0.29999999999999999 112.633 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 53' ' ' ILE . 10.3 p30 -111.96 18.01 19.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.225 0.536 . . . . 1.04 110.551 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -81.5 99.88 9.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.621 . . . . 0.77000000000000002 110.07 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.423 HG22 ' HD3' ' A' ' 49' ' ' ARG . 5.0 mm -56.3 -30.17 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.774 -1.103 . . . . 0.40999999999999998 111.389 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 m -75.92 -42.56 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.084 -0.507 . . . . 0.68000000000000005 111.856 -172.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -79.93 8.16 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 1.26 111.712 -175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.95 102.06 1.1 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.881 -0.887 . . . . 0.34999999999999998 110.881 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.0 m -59.07 106.88 0.47 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.412 0.625 . . . . 0.45000000000000001 110.018 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.7 116.75 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.806 -1.088 . . . . 0.56999999999999995 111.327 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.529 HD12 ' HG ' ' A' ' 88' ' ' LEU . 41.8 mt -96.74 -37.49 10.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.036 0.922 . . . . 0.45000000000000001 109.213 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.8 t -127.9 115.5 18.68 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.386 -1.339 . . . . 0.37 107.386 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 16.5 t0 -65.32 161.3 19.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.764 -0.653 . . . . 1.1499999999999999 112.656 -168.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 24.0 p90 -85.46 61.91 7.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.383 -0.826 . . . . 4.6900000000000004 112.367 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.898 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 60.3 t -42.29 -49.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 114.294 1.22 . . . . 0.85999999999999999 114.294 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.39 -168.97 13.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.154 -1.022 . . . . 0.67000000000000004 113.048 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 35.8 t -78.77 147.93 33.16 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.363 -0.236 . . . . 0.51000000000000001 110.363 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.855 ' HA3' HD22 ' A' ' 180' ' ' LEU . . . 172.48 61.83 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 O-C-N 123.418 0.449 . . . . 0.81999999999999995 112.36 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.783 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 9.4 Cg_endo -91.9 132.44 1.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.111 2.541 . . . . 0.84999999999999998 112.382 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.563 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 84.4 Cg_exo -50.03 143.8 23.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.263 2.642 . . . . 0.87 112.435 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 113.16 3.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.494 . . . . 1.8500000000000001 110.926 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.49 -2.35 27.84 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.961 -0.638 . . . . 1.1799999999999999 112.299 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.646 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 74.4 p -77.83 -21.69 51.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.817 0.341 . . . . 0.96999999999999997 111.273 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.34 -153.19 17.16 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.862 -0.608 . . . . 1.97 111.846 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -98.5 110.83 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.927 -0.397 . . . . 0.93999999999999995 109.927 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -77.07 109.56 11.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.177 -0.465 . . . . 2.23 110.019 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 7.0 ptt180 -101.9 92.56 4.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.636 . . . . 2.3100000000000001 111.468 -171.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 41.0 m-85 -78.79 120.8 23.95 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.674 -0.694 . . . . 0.78000000000000003 109.791 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.651 ' CG2' HD22 ' A' ' 14' ' ' LEU . 15.1 t -98.57 128.89 49.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.27000000000000002 110.479 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.764 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -89.5 119.64 30.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.041 -0.527 . . . . 1.99 109.77 178.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 48.9 mt -116.43 119.15 34.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.378 -0.231 . . . . 0.38 110.378 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.537 HG12 HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -117.71 137.44 51.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 0.31 110.961 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 1.037 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 49.1 t80 -140.78 133.26 28.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.589 -0.278 . . . . 5.1200000000000001 110.322 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.447 ' HG2' HG21 ' A' ' 164' ' ' VAL . 7.1 pt-20 -83.06 116.32 22.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.807 -0.812 . . . . 2.4100000000000001 108.807 170.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.64 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -78.74 174.39 11.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.498 0.666 . . . . 1.3100000000000001 112.03 -168.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.28 -22.46 63.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.682 -1.145 . . . . 2.3999999999999999 109.823 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.64 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 8.2 ptt180 -146.49 163.06 31.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.444 -1.253 . . . . 3.5099999999999998 111.31 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -64.95 41.87 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.757 0 C-N-CA 124.684 3.589 . . . . 1.21 113.403 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 2.7 mm? 74.42 167.42 0.29 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.934 -1.03 . . . . 0.90000000000000002 113.152 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -157.15 71.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.991 -1.459 . . . . 2.8999999999999999 107.844 171.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.438 ' SG ' HD21 ' A' ' 103' ' ' LEU . 3.8 p -93.39 -75.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.077 -0.965 . . . . 1.8999999999999999 110.958 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 56.34 31.29 18.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.461 0.648 . . . . 2.96 109.886 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 133' ' ' CYS . 32.3 mm-40 -82.32 139.85 45.18 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.046 -0.979 . . . . 1.3899999999999999 109.841 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.72 112.44 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.898 2.399 . . . . 1.27 112.446 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.47 131.04 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 0.85999999999999999 111.065 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.9 mt -110.83 149.39 30.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.05 -0.523 . . . . 1.6100000000000001 110.639 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.6 m -102.86 157.74 16.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.283 -1.006 . . . . 1.8799999999999999 108.283 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.898 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 11.7 p-10 -81.59 30.36 0.36 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.396 0.617 . . . . 0.75 111.579 -173.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.654 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 14.2 mtt180 -115.54 147.48 40.65 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.884 -0.784 . . . . 3.3599999999999999 108.884 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.602 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 16.5 m 66.18 178.15 0.21 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.94 0.775 . . . . 0.94999999999999996 110.599 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -143.39 33.17 1.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.041 -1.076 . . . . 1.1200000000000001 112.701 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.66 -27.41 63.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.049 0.388 . . . . 2.6600000000000001 112.049 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -113.78 67.49 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.076 0.465 . . . . 1.8700000000000001 110.9 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 99.3 mtt180 -79.71 -79.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.711 -0.677 . . . . 4.7300000000000004 112.114 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.12 -142.73 3.52 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.65000000000000002 113.009 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.731 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 39.7 mttm 66.33 34.15 6.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.719 0.771 . . . . 1.0800000000000001 109.944 -173.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 69.8 m-85 -113.63 177.06 4.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.82 -1.082 . . . . 1.8899999999999999 109.647 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -119.75 112.24 19.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.366 -0.379 . . . . 1.29 111.945 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.741 HG21 HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.49 -36.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.78000000000000003 111.791 172.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.81 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.67000000000000004 110.617 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.5 m -65.17 -44.86 87.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.77000000000000002 110.263 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.642 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 66.9 m-85 -59.11 -47.01 86.85 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.601 0.715 . . . . 0.92000000000000004 110.199 174.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 161' ' ' ARG . 28.9 ttm180 -59.21 -48.64 80.87 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.809 -1.087 . . . . 2.8900000000000001 111.634 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -66.76 -36.53 82.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.96999999999999997 110.637 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -55.83 -51.04 68.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.078 -0.965 . . . . 1.5800000000000001 111.41 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.454 ' CB ' HD13 ' A' ' 160' ' ' LEU . 22.7 m-85 -83.29 -5.6 59.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.729 -0.669 . . . . 5.4500000000000002 111.416 -174.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 68.53 46.74 0.97 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.814 0.816 . . . . 2.4199999999999999 111.134 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.037 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.6 mp -105.69 175.39 5.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.666 -1.152 . . . . 1.27 110.378 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.897 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 6.1 tpt180 -147.64 -158.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.52 -0.918 . . . . 3.5899999999999999 108.52 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.897 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -47.74 142.25 6.91 Favored Pre-proline 0 C--O 1.231 0.125 0 CA-C-O 121.122 0.487 . . . . 0.76000000000000001 111.732 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 7.9 Cg_exo -70.2 161.31 46.45 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.651 2.901 . . . . 0.53000000000000003 113.191 -168.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.898 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -87.69 -24.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.014 -0.994 . . . . 0.44 109.236 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.776 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -159.83 150.29 18.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.701 -0.681 . . . . 0.27000000000000002 111.63 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.556 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.61 149.87 21.88 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.086 -0.961 . . . . 0.23999999999999999 111.607 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.545 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.1 t -167.88 152.74 6.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.677 -0.86 . . . . 0.34000000000000002 108.677 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 14.3 p -129.21 148.07 51.11 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.164 -0.614 . . . . 1.1100000000000001 111.355 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.553 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 32.1 p90 -130.05 127.85 40.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.003 -1.11 . . . . 0.80000000000000004 108.003 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -105.14 132.91 50.76 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.897 -0.721 . . . . 2.5299999999999998 111.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -131.2 144.31 51.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.411 -0.813 . . . . 0.59999999999999998 109.24 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.783 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 pt-20 -126.74 -161.73 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.88 -0.328 . . . . 2.3799999999999999 111.103 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.895 ' HA ' HG21 ' A' ' 177' ' ' VAL . 4.1 t90 -71.93 81.48 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.318 -0.401 . . . . 3.96 111.036 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.532 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 5.6 t70 -73.08 -61.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.341 -0.39 . . . . 1.53 110.859 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.592 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 29.0 t70 172.79 -35.04 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.402 -0.817 . . . . 1.26 110.087 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -80.54 13.1 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 2.2200000000000002 111.516 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.895 HG21 ' HA ' ' A' ' 173' ' ' TRP . 84.0 t -72.59 -53.37 5.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.931 -0.577 . . . . 0.5 110.105 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.752 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.2 Cg_exo -50.84 -30.8 31.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.693 2.262 . . . . 0.57999999999999996 111.902 169.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.2 mmmt -72.4 -23.56 61.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 2.1400000000000001 111.473 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.855 HD22 ' HA3' ' A' ' 110' ' ' GLY . 14.8 tp -70.9 -44.13 66.89 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.414 -0.587 . . . . 0.66000000000000003 109.414 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.66 -40.28 91.48 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.556 0.693 . . . . 1.8899999999999999 109.273 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 8.2 mm-40 -56.41 -48.3 77.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.671 -1.15 . . . . 1.53 110.647 171.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.334 -0.848 . . . . 1.49 111.97 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.602 ' HA ' ' H ' ' A' ' 142' ' ' SER . 40.4 mt -68.42 2.78 2.1 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.577 -0.283 . . . . 0.76000000000000001 111.629 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.656 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.7 m -78.8 -2.73 40.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.336 0.589 . . . . 1.05 109.869 173.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.654 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 76.44 60.57 2.99 Favored Glycine 0 CA--C 1.505 -0.551 0 CA-C-N 115.313 -0.858 . . . . 1.1699999999999999 111.29 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.656 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.4 mmmt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.577 -0.725 . . . . 2.0 110.549 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.52 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 13.7 tpt . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 110.216 -0.29 . . . . 5.04 110.216 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 19.3 Cg_exo -66.92 149.03 83.05 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.488 2.125 . . . . 2.1299999999999999 111.067 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 24' ' ' PRO . 23.4 t -78.04 105.35 7.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.359 0.599 . . . . 1.47 110.134 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -143.46 31.02 1.35 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.977 -1.011 . . . . 1.8100000000000001 110.628 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.4 mm? 68.85 10.7 8.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.071 -1.422 . . . . 0.69999999999999996 113.041 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -67.12 -8.97 34.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.539 0.57 . . . . 1.96 112.539 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.867 ' HB3' HD12 ' A' ' 12' ' ' LEU . 99.4 mttt -133.68 36.12 3.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.29 -0.256 . . . . 2.6600000000000001 111.333 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.45 -17.96 40.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.274 0.472 . . . . 3.98 112.274 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 p -153.42 20.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.872 0.368 . . . . 0.63 111.595 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.48 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -80.88 -124.67 0.62 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.006 -0.838 . . . . 0.47999999999999998 111.006 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 14.3 Cg_endo -53.61 -35.45 77.38 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.261 2.641 . . . . 0.53000000000000003 110.679 166.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 7' ' ' LYS . 25.3 mt -87.57 86.04 7.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.121 -0.945 . . . . 1.1699999999999999 109.322 172.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 60.9 0.72 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.70999999999999996 110.898 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.798 HD22 HG21 ' A' ' 121' ' ' VAL . 20.9 mt -73.2 -19.56 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.788 -0.642 . . . . 0.45000000000000001 110.275 -176.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -64.55 -22.53 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 2.1200000000000001 110.846 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -64.86 -25.29 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.38 0.609 . . . . 1.9299999999999999 109.66 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 151' ' ' VAL . 92.1 t -92.39 -70.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.024 -0.989 . . . . 0.63 110.154 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.48 174.67 5.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 2.9900000000000002 110.621 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.96 29.64 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 1.6000000000000001 112.282 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 27.9 mt-30 64.26 112.45 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.02 0.825 . . . . 3.5499999999999998 111.005 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 19.9 Cg_exo -63.98 152.05 82.56 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.439 2.092 . . . . 0.57999999999999996 112.759 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.872 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.3 pt20 -76.66 -18.77 58.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.281 -0.872 . . . . 1.3899999999999999 111.021 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.791 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 40.0 m-70 -145.53 159.43 48.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 123.658 0.783 . . . . 1.45 109.068 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB3' HG12 ' A' ' 3' ' ' VAL . 5.4 Cg_endo -85.93 131.05 3.71 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.706 2.271 . . . . 0.40000000000000002 111.967 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.913 HD23 ' HB3' ' A' ' 122' ' ' TRP . 15.6 tp -82.01 145.04 30.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.731 0.301 . . . . 0.28999999999999998 110.478 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.466 ' H ' HD12 ' A' ' 25' ' ' LEU . 32.8 m80 -116.49 127.82 54.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.88 -0.415 . . . . 1.24 109.88 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 53' ' ' ILE . 23.0 t -132.25 140.92 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.355 -0.609 . . . . 0.46999999999999997 109.355 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -137.59 142.82 41.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.983 0.421 . . . . 0.31 110.789 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 38.3 t80 -105.16 176.72 5.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.157 -0.683 . . . . 0.67000000000000004 109.157 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -52.66 62.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.448 0.642 . . . . 0.55000000000000004 110.284 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.45 7.59 32.25 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.167 -0.924 . . . . 0.81000000000000005 112.597 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB2' ' NE2' ' A' ' 45' ' ' GLN . . . -146.15 -170.97 3.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.46999999999999997 110.53 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.25 163.49 25.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.589 -0.732 . . . . 0.33000000000000002 109.34 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.758 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 88.6 t -116.52 66.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.304 -1.369 . . . . 0.39000000000000001 107.304 165.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.0 14.01 33.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.053 -0.976 . . . . 0.98999999999999999 109.608 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.803 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.1 tm-20 -138.07 122.38 18.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.126 -1.435 . . . . 2.5600000000000001 107.126 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -68.1 111.54 4.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.426 0.631 . . . . 0.40999999999999998 110.685 -170.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.757 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 84.06 10.19 81.06 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.54 -0.754 . . . . 0.58999999999999997 112.409 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -64.2 154.25 35.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 110.28 -0.267 . . . . 0.34000000000000002 110.28 176.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.31 127.77 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.469 0.652 . . . . 0.55000000000000004 111.296 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.5 HD22 HG22 ' A' ' 34' ' ' VAL . 7.0 tp -124.69 169.12 12.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.823 -1.177 . . . . 0.45000000000000001 107.823 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p -118.17 151.95 49.89 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 119.48 -0.888 . . . . 0.56000000000000005 112.718 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.603 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 51.0 Cg_exo -56.38 -34.47 94.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.875 3.05 . . . . 0.68000000000000005 113.284 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -33.67 72.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.76000000000000001 110.696 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 32' ' ' ALA . 93.1 mt-30 -82.12 -46.68 13.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.036 . . . . 1.5900000000000001 111.395 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG11 ' CE2' ' A' ' 169' ' ' TYR . 6.1 m -95.62 28.49 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 112.731 0.641 . . . . 0.66000000000000003 112.731 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -85.8 -11.7 52.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.823 0.344 . . . . 0.79000000000000004 110.617 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -135.5 -151.88 0.44 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 1.9099999999999999 109.285 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HD3' HG22 ' A' ' 97' ' ' ILE . 81.5 mtt180 -87.92 158.64 50.05 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.149 -0.315 . . . . 1.4299999999999999 110.149 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 76.3 Cg_endo -83.5 165.37 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.237 1.958 . . . . 0.37 110.573 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 t -88.09 -20.31 25.87 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.599 -0.441 . . . . 0.44 110.596 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -158.69 142.58 15.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.085 0.469 . . . . 0.38 111.918 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.09 170.05 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.29999999999999999 108.471 171.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.016 ' HA ' HD13 ' A' ' 58' ' ' LEU . 40.4 t 174.23 116.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.517 0.511 . . . . 0.34999999999999998 109.866 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 54.4 p-90 -76.97 159.56 29.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.669 -0.863 . . . . 2.7200000000000002 108.669 173.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 29.3 t70 -68.63 85.36 0.3 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.054 0.454 . . . . 1.51 110.5 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.47 6.33 3.83 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.492 -0.776 . . . . 0.80000000000000004 112.259 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.016 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -51.71 129.41 26.08 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.163 0.506 . . . . 0.57999999999999996 111.554 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -79.25 -28.11 42.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.73999999999999999 111.404 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.661 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 24.3 t 67.14 22.07 9.92 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.125 -0.943 . . . . 1.03 110.08 -176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -42.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.784 -0.722 . . . . 0.83999999999999997 113.079 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -90.73 169.08 11.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 120.823 0.344 . . . . 1.6699999999999999 110.772 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.1 mt -93.8 147.52 22.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.711 -0.677 . . . . 0.57999999999999996 109.344 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.503 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.0 m-85 -135.09 168.56 18.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.265 -0.643 . . . . 0.80000000000000004 109.265 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.877 HG23 HG12 ' A' ' 90' ' ' VAL . 2.4 m -103.83 104.43 14.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.325 -0.62 . . . . 0.35999999999999999 109.325 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.701 HD13 HG12 ' A' ' 124' ' ' VAL . 57.7 tp -108.16 117.01 33.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.034 0.445 . . . . 0.58999999999999997 110.616 -174.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.9 t -114.89 147.09 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.083 -0.508 . . . . 0.39000000000000001 110.38 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.97 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.2 mt -110.5 122.11 46.95 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.78 -1.192 . . . . 0.59999999999999998 107.78 166.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 9.0 t -133.16 151.28 51.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.726 0.298 . . . . 0.35999999999999999 110.711 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.654 ' OD2' ' HB3' ' A' ' 84' ' ' TRP . 4.6 p-10 -132.31 101.8 14.57 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-O 121.613 0.721 . . . . 1.9199999999999999 111.213 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 4.1 Cg_endo -48.06 -38.4 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.828 3.018 . . . . 1.25 114.386 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.85 48.82 1.4 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -171.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . . . -106.46 127.76 27.56 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.176 -0.305 . . . . 0.5 110.176 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.619 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -82.64 -30.46 4.78 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.315 -1.536 . . . . 0.62 113.142 -1.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.687 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -121.16 157.81 29.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.107 -0.497 . . . . 0.75 110.944 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -67.81 -45.53 74.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 2.8799999999999999 111.342 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.725 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -72.35 -19.31 61.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 1.3799999999999999 111.442 -175.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.97 84.24 5.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.2 0.524 . . . . 1.3700000000000001 110.141 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -86.87 102.24 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.643 2.228 . . . . 0.80000000000000004 112.691 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.619 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 16.9 mttm -83.09 -55.23 4.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.981 -1.008 . . . . 1.02 110.669 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.695 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.7 m-85 -82.86 19.77 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 111.481 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 50.3 ttp180 -65.72 124.05 21.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.36 -0.382 . . . . 2.9300000000000002 110.21 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.0 mp0 -102.4 138.99 38.59 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.819 0.342 . . . . 2.23 110.957 0.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.654 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 17.1 t90 -88.19 161.91 16.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.412 -1.329 . . . . 1.4299999999999999 107.412 171.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 11.0 p80 -138.04 114.67 10.51 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.184 0.516 . . . . 1.26 110.435 -174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.97 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 3.7 t-160 -52.99 -42.57 65.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.029 -0.987 . . . . 2.1400000000000001 110.585 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 18.5 p90 -167.55 163.33 14.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.706 0.288 . . . . 1.51 110.747 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 103' ' ' LEU . 20.8 tp -126.83 114.18 17.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.33000000000000002 109.23 175.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.721 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -119.78 134.06 64.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.534 0.683 . . . . 0.31 111.182 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.877 HG12 HG23 ' A' ' 65' ' ' THR . 6.2 m -128.04 168.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.477 -0.934 . . . . 0.27000000000000002 108.477 175.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.767 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.8 m-20 59.11 21.77 9.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.075 0.464 . . . . 1.76 111.3 173.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.721 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.9 ttm -76.72 115.07 16.15 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.673 -0.862 . . . . 0.31 108.673 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -82.72 98.32 9.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.125 -0.943 . . . . 1.21 111.039 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 69.59 -119.42 9.17 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.203 -0.908 . . . . 0.29999999999999999 112.273 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.508 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.6 p-10 -114.57 25.54 10.93 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.09 0.471 . . . . 1.04 110.598 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.4 106.03 18.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.343 0.592 . . . . 0.77000000000000002 109.977 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG22 ' HD3' ' A' ' 49' ' ' ARG . 5.1 mm -56.81 -29.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 111.913 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.1 m -81.85 -37.27 27.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.883 0.698 . . . . 0.68000000000000005 112.883 -170.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.6 p -67.27 -19.59 65.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.85 0.315 . . . . 1.26 111.85 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.06 105.65 0.58 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.859 -0.61 . . . . 0.34999999999999998 112.982 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 97.7 m -65.16 107.31 1.52 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.282 0.563 . . . . 0.45000000000000001 110.004 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.6 p -76.78 119.15 24.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.184 -0.916 . . . . 0.56999999999999995 111.287 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 88' ' ' LEU . 57.1 mt -97.39 -47.03 5.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.091 0.948 . . . . 0.45000000000000001 109.159 172.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 t -114.35 106.02 13.82 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.977 -1.49 . . . . 0.37 106.977 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.3 OUTLIER -56.89 156.97 6.04 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.763 0.664 . . . . 1.1499999999999999 112.178 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.3 p90 -77.25 87.8 3.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 4.6900000000000004 111.095 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' ' 140' ' ' ASN . 24.0 t -61.77 -53.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.76 -0.655 . . . . 0.85999999999999999 110.68 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.692 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 115.98 -164.89 12.19 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.086 -1.054 . . . . 0.67000000000000004 112.548 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.476 ' OG ' ' HG3' ' A' ' 43' ' ' PRO . 23.9 t -77.89 131.98 37.73 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.568 0.216 . . . . 0.51000000000000001 110.545 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.42 68.11 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.81999999999999995 112.713 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.856 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 20.4 Cg_endo -96.33 113.19 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.434 2.756 . . . . 0.84999999999999998 112.708 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.604 ' HB2' HG23 ' A' ' 115' ' ' THR . 89.1 Cg_exo -51.15 143.23 33.13 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.798 2.332 . . . . 0.87 111.709 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 110.97 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.25 0.548 . . . . 1.8500000000000001 110.952 -175.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.48 21.63 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 1.1799999999999999 112.312 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.687 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 70.1 p -77.41 -30.3 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.628 0.252 . . . . 0.96999999999999997 111.415 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.95 -168.78 12.88 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.41 -0.676 . . . . 1.97 111.41 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -80.28 108.97 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.243 0.544 . . . . 0.93999999999999995 109.916 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 2.2 t60 -79.74 106.21 11.6 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 2.23 109.535 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.824 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 3.8 ptp180 -97.57 114.67 26.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.402 1.096 . . . . 2.3100000000000001 111.358 -172.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 28.7 m-85 -92.31 120.65 33.05 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.231 -1.349 . . . . 0.78000000000000003 108.683 172.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 168' ' ' CYS . 19.4 t -97.99 128.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.619 . . . . 0.27000000000000002 109.81 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.913 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.02 119.2 29.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.127 -0.694 . . . . 1.99 109.127 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.7 mt -126.88 119.92 27.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.374 0.131 . . . . 0.38 111.169 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.701 HG12 HD13 ' A' ' 66' ' ' LEU . 1.5 m -104.85 136.17 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.566 -0.454 . . . . 0.31 109.869 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 88.4 m-85 -114.5 148.7 37.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.441 . . . . 5.1200000000000001 110.483 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.1 tt0 -101.42 119.06 38.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.836 -0.62 . . . . 2.4100000000000001 110.837 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.56 ' HG2' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -104.2 160.83 14.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 1.3100000000000001 110.479 176.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.04 -26.57 64.1 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.879 -1.055 . . . . 2.3999999999999999 110.172 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.594 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 11.8 ptp180 -159.24 171.83 6.87 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 3.5099999999999998 111.132 -174.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 81.3 Cg_exo -48.08 148.37 7.0 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.098 2.532 . . . . 1.21 112.677 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.661 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -78.12 152.63 32.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.884 -0.598 . . . . 0.90000000000000002 111.263 -172.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -130.98 68.05 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.643 -0.873 . . . . 2.8999999999999999 108.643 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.475 ' HB2' HD11 ' A' ' 103' ' ' LEU . 66.3 m -95.72 106.44 18.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.233 -0.894 . . . . 1.8999999999999999 110.897 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.22 31.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.636 -0.711 . . . . 2.96 110.357 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 11.8 mm-40 -71.32 150.17 94.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.357 -0.838 . . . . 1.3899999999999999 110.426 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.36 106.64 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.325 2.684 . . . . 1.27 113.138 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.2 mm -63.54 121.33 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.85999999999999999 110.863 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 69.1 mt -105.49 155.07 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 1.6100000000000001 110.266 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 141' ' ' ARG . 65.5 m -113.45 17.17 18.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.73 -0.668 . . . . 1.8799999999999999 110.737 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.933 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.1 OUTLIER 65.49 -29.21 0.12 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.21 1.404 . . . . 0.75 111.705 -178.231 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.9 ttt180 -56.45 140.15 46.79 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.68 0.792 . . . . 3.3599999999999999 111.088 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 28.6 m 73.78 114.05 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 124.194 0.934 . . . . 0.94999999999999996 111.639 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.01 12.8 34.82 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.436 -0.802 . . . . 1.1200000000000001 112.303 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.76 -38.65 87.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.597 0.713 . . . . 2.6600000000000001 110.676 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -98.34 59.53 1.34 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.039 -0.982 . . . . 1.8700000000000001 109.597 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -86.71 -92.95 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.832 -0.622 . . . . 4.7300000000000004 112.371 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -119.99 -156.22 9.89 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.232 -0.985 . . . . 0.65000000000000002 113.633 -166.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.695 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 94.5 mttt 65.66 24.61 11.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.147 0.975 . . . . 1.0800000000000001 109.755 -171.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.54 95.27 5.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.372 -1.286 . . . . 1.8899999999999999 108.236 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.48 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 22.0 mmmt -54.05 129.98 36.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.215 -0.902 . . . . 1.29 112.622 -173.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.66 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 29.0 m -65.48 -23.72 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.443 -0.577 . . . . 0.78000000000000003 109.443 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.49 -42.14 98.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.36 -0.837 . . . . 0.67000000000000004 109.577 172.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 37.2 m -64.82 -32.54 74.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.018 -0.537 . . . . 0.77000000000000002 110.22 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.66 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 27.6 m-85 -69.91 -48.86 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.92000000000000004 111.068 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.621 ' HD2' ' HG3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -67.23 -29.36 68.99 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.954 -0.298 . . . . 2.8900000000000001 110.832 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.621 ' HG3' ' HD2' ' A' ' 155' ' ' ARG . 54.7 mtmt -77.49 -26.91 51.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.783 -0.19 . . . . 0.96999999999999997 111.401 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -54.45 -53.9 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.537 -0.302 . . . . 1.5800000000000001 111.136 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.435 ' OH ' ' HG3' ' A' ' 129' ' ' ARG . 12.9 t80 -111.1 5.99 20.53 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 119.485 -0.886 . . . . 5.4500000000000002 110.597 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 58.81 53.68 5.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.326 -0.852 . . . . 2.4199999999999999 112.467 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 125' ' ' TYR . 0.4 OUTLIER -81.08 -12.31 59.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.272 -0.877 . . . . 1.27 110.303 176.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.431 ' HD2' ' NH2' ' A' ' 155' ' ' ARG . 7.5 tpt180 69.9 -87.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.978 -1.01 . . . . 3.5899999999999999 112.297 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -128.07 156.51 76.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.821 0.343 . . . . 0.76000000000000001 111.211 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.3 Cg_exo -71.24 139.78 35.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.285 2.657 . . . . 0.53000000000000003 112.464 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.872 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -87.74 -30.78 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.376 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.85 143.7 21.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.987 -0.552 . . . . 0.27000000000000002 111.544 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.55 143.27 11.28 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 114.926 -1.034 . . . . 0.23999999999999999 111.881 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.5 t -156.83 133.61 10.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.927 -0.768 . . . . 0.34000000000000002 108.927 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.863 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -110.31 151.29 27.59 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.568 0.699 . . . . 1.1100000000000001 111.756 -173.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 120' ' ' TYR . 49.2 p90 -137.73 127.51 25.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.657 -1.609 . . . . 0.80000000000000004 106.657 173.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -105.55 133.25 50.6 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.363 -0.935 . . . . 2.5299999999999998 111.435 177.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.08 -0.964 . . . . 0.59999999999999998 110.072 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.72 -168.94 1.73 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 2.3799999999999999 110.947 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.745 ' HA ' HG21 ' A' ' 177' ' ' VAL . 29.4 t90 -83.99 77.3 9.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.786 -0.643 . . . . 3.96 109.729 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -57.04 4.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.654 -0.248 . . . . 1.53 111.257 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.537 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.0 t70 175.68 -33.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.358 0.663 . . . . 1.26 110.73 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.65 6.7 14.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.908 0.385 . . . . 2.2200000000000002 111.925 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.808 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 66.3 t -69.42 -53.52 12.81 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.281 -0.418 . . . . 0.5 110.083 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.808 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 61.7 Cg_exo -51.32 -37.03 59.52 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.609 2.206 . . . . 0.57999999999999996 112.021 169.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.5 mmmt -67.7 -24.37 65.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.165 -0.47 . . . . 2.1400000000000001 111.705 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.644 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 58.3 tp -69.11 -47.44 65.15 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.66000000000000003 109.57 172.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.8 -38.68 79.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 1.8899999999999999 109.42 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.9 mm-40 -57.26 -43.08 82.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.892 -1.049 . . . . 1.53 111.267 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -76.55 -30.34 57.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.707 0.632 . . . . 1.49 112.707 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 84.9 mt -63.39 1.47 0.52 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.996 0.739 . . . . 0.76000000000000001 112.996 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.722 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 49.3 m -88.81 3.05 52.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.463 0.649 . . . . 1.05 109.789 170.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.539 ' N ' ' HG3' ' A' ' 141' ' ' ARG . . . 69.45 51.65 25.44 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.066 -0.97 . . . . 1.1699999999999999 111.335 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.4 mmmt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.456 -0.783 . . . . 2.0 110.072 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.398 0.142 . . . . 5.04 110.999 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.04 139.75 25.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.95 2.433 . . . . 2.1299999999999999 111.537 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' A' ' 26' ' ' HIS . 21.4 t -57.96 121.79 6.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.446 -0.797 . . . . 1.47 112.131 -171.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 6' ' ' SER . 24.0 t70 -144.78 157.96 43.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.175 -1.375 . . . . 1.8100000000000001 107.524 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.438 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.0 mm? -75.19 23.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.09 0.405 . . . . 0.69999999999999996 111.882 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.0 t -72.27 -16.72 61.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 1.96 110.123 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HB3' HD12 ' A' ' 12' ' ' LEU . 37.8 mttm -122.13 31.41 6.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 2.6600000000000001 111.173 -175.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -26.36 31.63 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.245 0.832 . . . . 3.98 113.245 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -152.43 25.51 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.014 -0.429 . . . . 0.63 111.377 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.16 -122.39 0.96 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.753 -0.939 . . . . 0.47999999999999998 110.753 174.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -51.9 -38.49 68.5 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.255 2.636 . . . . 0.53000000000000003 110.921 167.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.635 HD11 ' HA3' ' A' ' 38' ' ' GLY . 45.9 mt -87.37 89.09 7.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.258 -0.883 . . . . 1.1699999999999999 109.661 173.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.53 71.75 1.86 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.412 0.625 . . . . 0.70999999999999996 110.485 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.857 HD22 HG21 ' A' ' 121' ' ' VAL . 23.8 mt -80.12 -11.98 59.71 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.795 . . . . 0.45000000000000001 110.04 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.535 ' HG2' ' HG3' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -67.69 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.446 -0.797 . . . . 2.1200000000000001 110.859 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -77.5 -20.11 54.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.707 0.765 . . . . 1.9299999999999999 109.423 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG1' HG21 ' A' ' 151' ' ' VAL . 62.8 t -98.13 -57.03 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.53 -1.214 . . . . 0.63 111.341 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -134.92 172.79 12.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.459 -0.337 . . . . 2.9900000000000002 110.685 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -85.93 31.61 0.62 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.538 0.94 . . . . 1.6000000000000001 113.538 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HG3' ' HG2' ' A' ' 15' ' ' GLN . 97.7 mt-30 64.4 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.541 0 O-C-N 123.507 0.505 . . . . 3.5499999999999998 110.721 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 15.2 Cg_exo -66.35 150.4 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.207 1.938 . . . . 0.57999999999999996 112.671 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.879 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 2.8 pt20 -72.39 -15.92 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.125 -0.943 . . . . 1.3899999999999999 111.264 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.789 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 24.1 m80 -148.91 157.43 40.39 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 1.45 109.274 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.5 Cg_endo -86.82 127.33 2.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.40000000000000002 111.266 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.874 HD23 ' HB3' ' A' ' 122' ' ' TRP . 22.8 tp -76.61 144.3 39.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.997 -0.372 . . . . 0.28999999999999998 109.997 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.59 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 36.0 m80 -122.91 109.23 13.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.045 0.45 . . . . 1.24 110.038 176.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 53' ' ' ILE . 39.6 t -112.93 139.3 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.61 . . . . 0.46999999999999997 109.476 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -133.26 142.2 48.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.431 0.634 . . . . 0.31 110.938 -176.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -102.54 171.12 7.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.67000000000000004 109.006 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.65 -51.86 61.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.37 0.605 . . . . 0.55000000000000004 110.773 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.97 9.52 15.81 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.066 -0.97 . . . . 0.81000000000000005 112.478 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.68 -171.01 3.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 122.631 -0.335 . . . . 0.46999999999999997 110.469 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.13 155.32 18.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.158 -0.474 . . . . 0.33000000000000002 110.351 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.803 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.6 t -102.32 63.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.804 -1.554 . . . . 0.39000000000000001 106.804 163.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.31 20.78 8.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.887 -1.051 . . . . 0.98999999999999999 109.384 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.5 tm-20 -145.67 119.93 9.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.047 -1.094 . . . . 2.5600000000000001 108.047 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -66.45 110.63 3.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.997 0.427 . . . . 0.40999999999999998 109.959 -175.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.873 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 93.27 2.44 65.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.068 -0.587 . . . . 0.58999999999999997 112.703 177.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -67.05 149.39 50.66 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.764 0.316 . . . . 0.34000000000000002 110.677 -178.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.11 132.01 33.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.357 0.598 . . . . 0.55000000000000004 111.043 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.499 HD22 HG22 ' A' ' 34' ' ' VAL . 6.8 tp -124.11 169.2 11.93 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.391 -1.337 . . . . 0.45000000000000001 107.391 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.1 p -114.67 150.46 44.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 118.804 -1.159 . . . . 0.56000000000000005 113.141 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 52.9 Cg_exo -55.74 -32.43 84.14 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.435 3.423 . . . . 0.68000000000000005 113.91 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -65.12 -36.65 84.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.644 0.735 . . . . 0.76000000000000001 110.189 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -75.28 -56.38 4.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.799 -1.091 . . . . 1.5900000000000001 110.603 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG11 ' CE1' ' A' ' 169' ' ' TYR . 28.7 m -89.31 28.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.884 0.698 . . . . 0.66000000000000003 112.884 -173.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -85.64 -15.49 42.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.766 -0.828 . . . . 0.79000000000000004 108.766 172.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 17.9 t-20 -121.12 -170.29 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.714 -1.13 . . . . 1.9099999999999999 108.988 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 86.2 mtt180 -85.42 161.51 51.25 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.445 -0.576 . . . . 1.4299999999999999 109.445 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 122' ' ' TRP . 66.8 Cg_endo -78.96 160.38 27.14 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.819 1.68 . . . . 0.37 110.539 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 t -85.23 -18.17 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.915 -0.402 . . . . 0.44 109.915 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 70.1 m -159.36 147.99 17.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.27 0.557 . . . . 0.38 111.778 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.935 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.69 167.87 18.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.145 -1.057 . . . . 0.29999999999999999 108.145 170.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.061 ' HA ' HD13 ' A' ' 58' ' ' LEU . 38.5 t 179.01 114.27 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.102 0.477 . . . . 0.34999999999999998 110.168 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 56.3 p-90 -78.4 157.34 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.088 -1.078 . . . . 2.7200000000000002 108.088 172.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.419 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 28.4 t70 -62.67 88.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.191 0.52 . . . . 1.51 110.918 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.5 20.59 4.62 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.444 -0.798 . . . . 0.80000000000000004 112.275 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.061 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -51.1 130.3 25.76 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.107 0.563 . . . . 0.57999999999999996 111.485 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.697 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 24.1 t70 -75.72 -28.68 58.66 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.808 -0.633 . . . . 0.73999999999999999 111.451 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.688 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 43.0 m 69.18 9.44 7.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.389 -0.823 . . . . 1.03 110.733 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -135.53 -43.77 0.11 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.849 -0.691 . . . . 0.83999999999999997 113.253 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.897 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 20.2 mtpt -66.59 149.63 50.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.6699999999999999 110.645 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.998 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.1 mt -88.09 126.77 35.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.555 -0.748 . . . . 0.57999999999999996 109.239 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.897 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -118.84 161.4 20.23 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.224 0.465 . . . . 0.80000000000000004 110.889 177.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.453 HG23 HG12 ' A' ' 90' ' ' VAL . 89.6 m -97.4 105.3 17.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.35999999999999999 109.259 172.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.85 110.13 22.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.471 -0.786 . . . . 0.58999999999999997 109.835 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.6 t -115.32 126.7 72.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.018 0.437 . . . . 0.39000000000000001 111.055 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.957 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -91.19 131.39 36.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.215 -1.031 . . . . 0.59999999999999998 108.215 166.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 12.0 t -133.63 140.64 47.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.877 -0.329 . . . . 0.35999999999999999 110.339 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.644 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 38.2 t70 -121.85 97.58 46.08 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-O 121.132 0.491 . . . . 1.9199999999999999 110.064 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 10.7 Cg_endo -56.14 178.31 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.2 2.6 . . . . 1.25 112.538 171.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.841 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 71.3 m-20 52.56 35.7 18.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.926 -1.034 . . . . 1.29 112.861 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.99 138.48 19.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.148 -0.315 . . . . 0.5 110.148 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.694 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 56.7 Cg_endo -77.27 -34.52 3.28 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.089 -1.629 . . . . 0.62 112.968 0.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.712 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 93.1 p -119.87 156.81 30.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 0.75 110.214 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.841 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 46.8 mtm180 -72.48 -23.53 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 2.8799999999999999 111.482 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.83 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -92.72 -11.62 33.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 1.3799999999999999 110.947 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.45 78.58 6.28 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-O 121.583 0.706 . . . . 1.3700000000000001 109.584 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.79 95.15 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.848 2.365 . . . . 0.80000000000000004 113.348 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.694 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 12.1 mttm -81.74 -52.29 7.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.095 -0.957 . . . . 1.02 111.17 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.634 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 50.7 m-85 -76.53 -5.44 47.63 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.886 -0.597 . . . . 1.1699999999999999 111.897 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.55 ' HG3' ' HA ' ' A' ' 71' ' ' PRO . 70.1 ttt180 -67.43 130.36 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.275 -0.17 . . . . 2.9300000000000002 110.867 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.516 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 29.9 mm-40 -86.96 130.8 34.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.981 0.42 . . . . 2.23 110.771 -0.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.673 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.5 t90 -86.75 91.18 8.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 1.4299999999999999 109.513 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 35.2 p-80 -67.19 121.72 16.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.529 0.681 . . . . 1.26 109.979 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.957 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 30.3 t-80 -65.39 -34.86 79.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.034 -0.985 . . . . 2.1400000000000001 110.369 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.589 ' HE1' ' HB ' ' A' ' 89' ' ' VAL . 39.6 p90 -168.8 172.39 7.86 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.578 -0.527 . . . . 1.51 109.578 175.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.2 tp -132.22 113.7 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.641 -0.503 . . . . 0.33000000000000002 109.641 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.68 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.8 t -121.28 132.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.533 0.682 . . . . 0.31 110.678 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 65' ' ' THR . 9.1 m -128.45 167.4 23.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.879 -1.156 . . . . 0.27000000000000002 107.879 175.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.998 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 6.5 m-20 60.71 19.66 9.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.203 0.525 . . . . 1.76 110.895 172.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.68 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.1 ttm -73.97 114.57 12.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.971 -0.752 . . . . 0.31 108.971 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 22.1 ttmm -80.82 98.56 7.86 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.512 -1.222 . . . . 1.21 110.988 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.688 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 62.68 -115.3 7.83 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.512 -0.851 . . . . 0.29999999999999999 112.312 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.58 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.2 p-10 -115.06 24.34 11.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.933 0.396 . . . . 1.04 111.611 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.06 103.0 15.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.451 0.643 . . . . 0.77000000000000002 110.247 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.437 ' H ' HG12 ' A' ' 97' ' ' ILE . 7.7 mm -56.18 -32.34 34.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.851 -1.068 . . . . 0.40999999999999998 111.831 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 m -78.98 -37.39 39.54 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.091 -0.504 . . . . 0.68000000000000005 111.779 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.3 p -61.05 -29.69 69.88 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.728 0.299 . . . . 1.26 111.331 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -50.38 107.77 0.4 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.536 -0.756 . . . . 0.34999999999999998 112.669 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.4 m -72.29 107.8 5.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.256 0.551 . . . . 0.45000000000000001 109.923 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 p -76.46 122.18 30.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.56999999999999995 111.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.644 HD12 ' HG ' ' A' ' 88' ' ' LEU . 66.0 mt -100.47 -45.69 5.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.085 0.945 . . . . 0.45000000000000001 109.32 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.1 t -122.92 112.34 17.73 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.171 -1.418 . . . . 0.37 107.171 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.637 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 4.1 t0 -59.05 159.94 6.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.944 -1.026 . . . . 1.1499999999999999 113.024 -167.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.511 ' H ' ' HD1' ' A' ' 106' ' ' TYR . 3.3 p90 -80.16 86.66 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.3 -0.864 . . . . 4.6900000000000004 110.764 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.864 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 38.3 t -63.97 -46.05 95.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.85999999999999999 111.087 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.541 ' HA2' ' HE2' ' A' ' 86' ' ' HIS . . . 109.51 -168.13 13.13 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.467 -0.873 . . . . 0.67000000000000004 112.577 174.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.9 t -70.29 133.24 46.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.51000000000000001 109.935 174.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.597 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -169.73 61.22 0.19 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.695 -0.764 . . . . 0.81999999999999995 112.891 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 97.7 Cg_endo -93.35 140.39 1.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.072 2.515 . . . . 0.84999999999999998 112.434 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 37.1 Cg_exo -61.55 141.84 92.86 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.702 2.268 . . . . 0.87 111.598 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.487 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -69.02 123.93 22.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.8500000000000001 110.987 -176.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.77 59.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.719 -0.753 . . . . 1.1799999999999999 112.642 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.712 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 75.1 p -78.82 -12.68 60.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 110.706 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.29 165.92 41.78 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.18 -0.768 . . . . 1.97 111.18 -174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.837 HD12 ' HG3' ' A' ' 170' ' ' GLN . 3.8 mm? -79.49 130.13 35.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.317 -0.623 . . . . 0.93999999999999995 109.317 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.449 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 4.2 m170 -92.63 -121.32 0.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.975 -1.12 . . . . 2.23 107.975 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.783 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 14.3 ptt-85 177.3 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.344 0.498 . . . . 2.3100000000000001 112.344 169.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.644 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 31.4 m-85 -69.86 101.2 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.768 -0.826 . . . . 0.78000000000000003 108.768 173.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.857 HG21 HD22 ' A' ' 14' ' ' LEU . 17.3 t -89.99 126.07 42.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.957 0.408 . . . . 0.27000000000000002 109.949 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.874 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.06 117.9 28.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.812 -0.81 . . . . 1.99 108.812 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -122.07 129.01 52.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.511 0.195 . . . . 0.38 110.94 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 165' ' ' ALA . 1.3 m -112.21 131.78 62.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.31 110.139 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.64 ' CB ' HD23 ' A' ' 160' ' ' LEU . 97.8 m-85 -117.69 122.5 43.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.252 -0.885 . . . . 5.1200000000000001 109.258 174.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.98 113.08 25.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.012 0.434 . . . . 2.4100000000000001 109.873 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.6 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -80.57 175.6 10.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.665 -0.698 . . . . 1.3100000000000001 109.439 177.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.02 -6.34 57.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.729 -0.669 . . . . 2.3999999999999999 109.851 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.503 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.2 ptp180 -165.65 167.38 9.16 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 115.307 -0.86 . . . . 3.5099999999999998 111.267 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.545 ' HG3' HD12 ' A' ' 63' ' ' LEU . 35.6 Cg_exo -55.58 147.71 57.59 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.979 2.453 . . . . 1.21 111.631 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.453 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 3.8 mm? -71.83 148.89 45.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.621 . . . . 0.90000000000000002 112.532 -171.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 15.4 tptm -103.26 77.81 1.56 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.707 -1.22 . . . . 2.8999999999999999 107.707 165.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.2 p -90.62 99.79 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.399 -0.818 . . . . 1.8999999999999999 111.797 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.2 14.03 21.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.506 -0.77 . . . . 2.96 109.102 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.26 135.28 96.05 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.3899999999999999 110.278 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.64 116.56 2.81 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.017 2.478 . . . . 1.27 112.946 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.6 mm -69.03 115.95 8.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.005 -0.368 . . . . 0.85999999999999999 110.005 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 145' ' ' HIS . 31.6 mt -114.93 152.61 32.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.427 0.632 . . . . 1.6100000000000001 111.26 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -96.51 154.13 17.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.055 -0.975 . . . . 1.8799999999999999 108.609 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.864 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 -77.88 -1.41 31.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.75 111.024 -173.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.742 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 88.4 mtt180 -78.94 157.2 28.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.581 -0.525 . . . . 3.3599999999999999 109.581 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.518 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 79.8 p 58.06 117.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.82 1.248 . . . . 0.94999999999999996 112.651 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -79.35 18.21 7.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.309 -0.859 . . . . 1.1200000000000001 113.514 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -69.82 -41.34 75.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.559 0.695 . . . . 2.6600000000000001 110.4 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.555 ' HB3' HD13 ' A' ' 138' ' ' LEU . 4.4 m80 -95.11 46.48 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.174 -0.921 . . . . 1.8700000000000001 110.862 -170.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 51.3 mtt180 -76.77 -78.78 0.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.026 0.441 . . . . 4.7300000000000004 111.925 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -137.57 -121.58 2.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.107 -1.044 . . . . 0.65000000000000002 113.042 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.634 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 47.2 mttm 64.88 29.17 12.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.616 0.722 . . . . 1.0800000000000001 110.51 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -127.52 146.87 50.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.903 -1.044 . . . . 1.8899999999999999 109.77 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 13.8 mmmm -87.59 140.57 29.38 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.038 -0.528 . . . . 1.29 111.098 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.558 HG21 ' CG1' ' A' ' 17' ' ' VAL . 3.0 t -62.11 -35.18 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.43 -0.952 . . . . 0.78000000000000003 108.43 172.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.75 81.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.396 -1.275 . . . . 0.67000000000000004 110.448 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 74.1 m -59.31 -47.07 86.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.77000000000000002 111.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.539 ' O ' ' HB3' ' A' ' 157' ' ' LYS . 59.1 m-85 -62.49 -48.97 77.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.827 0.822 . . . . 0.92000000000000004 110.611 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -60.1 -49.3 78.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.414 -1.266 . . . . 2.8900000000000001 111.135 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -67.73 -26.48 66.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.96999999999999997 111.502 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 45.0 tptt -52.6 -53.25 49.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 1.5800000000000001 111.626 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.507 ' HB3' HD13 ' A' ' 160' ' ' LEU . 17.2 t80 -104.41 14.94 29.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.845 -0.742 . . . . 5.4500000000000002 110.422 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 60.37 47.67 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.158 -0.928 . . . . 2.4199999999999999 111.857 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.64 HD23 ' CB ' ' A' ' 125' ' ' TYR . 5.5 mp -80.1 138.9 37.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.388 -0.824 . . . . 1.27 108.875 173.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -72.18 -82.32 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.079 0.4 . . . . 3.5899999999999999 112.079 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.17 164.54 36.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.882 -0.414 . . . . 0.76000000000000001 109.882 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.533 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 20.0 Cg_exo -62.3 134.62 49.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.621 2.214 . . . . 0.53000000000000003 112.566 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.879 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.1 t -89.73 -31.74 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 109.593 -0.521 . . . . 0.44 109.593 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.789 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -155.08 145.01 21.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.16 -0.616 . . . . 0.27000000000000002 111.876 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.1 140.45 9.12 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.023 -0.99 . . . . 0.23999999999999999 111.74 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -152.99 127.41 9.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.532 -0.544 . . . . 0.34000000000000002 109.532 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.873 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.55 144.29 29.71 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.263 0.554 . . . . 1.1100000000000001 112.082 -174.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.594 ' CE1' HG11 ' A' ' 46' ' ' VAL . 5.9 p90 -133.27 122.52 24.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.279 -1.378 . . . . 0.80000000000000004 107.279 168.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.837 ' HG3' HD12 ' A' ' 117' ' ' LEU . 3.9 tp-100 -101.44 156.31 17.54 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.042 -1.036 . . . . 2.5299999999999998 111.626 171.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.489 ' H ' ' CD ' ' A' ' 170' ' ' GLN . . . -149.0 139.07 22.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.422 -0.353 . . . . 0.59999999999999998 110.206 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.766 ' HB3' HD11 ' A' ' 117' ' ' LEU . 12.2 pt-20 -106.65 -168.44 1.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.05 0.452 . . . . 2.3799999999999999 111.87 -173.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.621 ' HA ' HG21 ' A' ' 177' ' ' VAL . 6.9 t90 -77.81 71.38 4.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.661 -0.699 . . . . 3.96 110.168 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.683 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 1.5 t70 -72.59 -62.49 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 1.53 112.615 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.0 t70 -175.06 -45.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.067 0.46 . . . . 1.26 111.143 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.677 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 5.1 m-85 -80.45 7.94 8.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 2.2200000000000002 111.979 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.775 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 94.4 t -72.91 -54.32 4.68 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.083 171.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.775 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -51.92 -41.92 60.82 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.358 2.039 . . . . 0.57999999999999996 111.868 169.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 0.5 OUTLIER -65.85 -25.16 67.07 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.397 -0.365 . . . . 2.1400000000000001 111.068 178.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.688 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 66.5 tp -68.4 -47.62 66.84 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.229 -0.656 . . . . 0.66000000000000003 109.229 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.43 -39.43 83.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.82 -0.627 . . . . 1.8899999999999999 109.478 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 16.4 mm-40 -56.0 -44.45 78.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.772 -1.104 . . . . 1.53 110.795 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.31 -32.45 58.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.366 -0.834 . . . . 1.49 111.958 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 83.0 mt -63.6 -7.07 6.27 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.181 0.437 . . . . 0.76000000000000001 112.181 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.625 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 16.4 m -68.19 -11.42 59.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.489 0.661 . . . . 1.05 109.714 172.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.742 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 87.23 54.83 2.48 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.137 -0.938 . . . . 1.1699999999999999 110.88 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.1 mmmt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.503 -0.76 . . . . 2.0 110.328 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 10.4 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.438 0.161 . . . . 5.04 110.574 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 16.7 Cg_exo -67.57 139.14 47.86 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.111 2.541 . . . . 2.1299999999999999 112.151 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 24' ' ' PRO . 7.2 t -55.83 123.88 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.48 -0.782 . . . . 1.47 111.546 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -146.29 37.83 1.04 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.768 0.794 . . . . 1.8100000000000001 110.12 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 24' ' ' PRO . 2.1 mm? 58.88 37.01 24.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.509 -1.223 . . . . 0.69999999999999996 108.416 -165.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -58.2 -42.93 87.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.456 -1.247 . . . . 1.96 112.021 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.926 ' HB2' HD12 ' A' ' 12' ' ' LEU . 49.9 mttm -136.48 60.94 1.65 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 2.6600000000000001 109.482 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.457 ' CE3' ' HB2' ' A' ' 20' ' ' GLN . 22.5 p-90 -69.06 -35.75 76.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.13 -0.941 . . . . 3.98 112.009 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 84.5 p -147.24 17.56 1.2 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.542 -0.463 . . . . 0.63 111.904 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -75.52 -124.67 0.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.758 . . . . 0.47999999999999998 111.782 177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.4 Cg_endo -49.94 -40.41 49.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.248 2.632 . . . . 0.53000000000000003 110.268 168.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.926 HD12 ' HB2' ' A' ' 7' ' ' LYS . 22.2 mt -88.1 83.62 6.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.85 -1.068 . . . . 1.1699999999999999 109.218 172.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 m -74.57 62.66 1.04 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.618 0.723 . . . . 0.70999999999999996 110.397 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD22 ' CG2' ' A' ' 121' ' ' VAL . 46.0 mt -76.52 -17.46 59.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 0.45000000000000001 110.825 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.7 OUTLIER -64.99 -21.53 66.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.877 -0.601 . . . . 2.1200000000000001 109.919 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.66 -28.51 65.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.35 0.595 . . . . 1.9299999999999999 110.65 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.747 HG11 HG21 ' A' ' 69' ' ' THR . 52.0 t -83.99 -73.47 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.265 -0.88 . . . . 0.63 109.684 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.779 ' HB2' HG21 ' A' ' 151' ' ' VAL . 48.3 t0 -139.32 161.19 38.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.846 -0.615 . . . . 2.9900000000000002 109.659 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 163' ' ' PRO . 32.6 mt-10 -64.09 153.42 37.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.652 -0.703 . . . . 1.6000000000000001 111.846 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.457 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 20.1 tt0 -56.05 124.26 58.24 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.643 -0.708 . . . . 3.5499999999999998 110.34 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 19.6 Cg_exo -64.47 154.84 69.57 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.318 2.012 . . . . 0.57999999999999996 112.069 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.934 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.8 pt20 -73.74 -15.55 61.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.606 -0.725 . . . . 1.3899999999999999 111.121 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.735 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 19.5 m80 -146.45 158.81 46.45 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 1.45 108.995 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 3' ' ' VAL . 8.1 Cg_endo -88.53 132.55 2.56 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.952 2.435 . . . . 0.40000000000000002 111.519 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.864 HD23 ' HB3' ' A' ' 122' ' ' TRP . 15.3 tp -84.5 139.83 31.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 111.018 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -106.8 131.33 54.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.169 -0.468 . . . . 1.24 109.93 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 53' ' ' ILE . 16.1 t -134.39 142.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.12 -0.696 . . . . 0.46999999999999997 109.12 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -140.76 140.96 34.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.917 0.389 . . . . 0.31 110.83 -176.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -105.61 178.28 4.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.751 -0.833 . . . . 0.67000000000000004 108.751 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -52.18 57.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.507 0.67 . . . . 0.55000000000000004 110.463 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.57 -0.14 49.67 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.26 -0.882 . . . . 0.81000000000000005 112.836 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.76 -169.8 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.46999999999999997 110.966 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.56 152.84 16.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.651 -0.704 . . . . 0.33000000000000002 109.645 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.715 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 99.7 t -106.73 64.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.26 -1.385 . . . . 0.39000000000000001 107.26 165.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -93.39 6.31 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.014 -0.993 . . . . 0.98999999999999999 109.704 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 43.8 mt-10 -133.91 132.7 40.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.191 -0.913 . . . . 2.5600000000000001 109.071 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.6 OUTLIER -75.74 109.56 9.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.139 -0.689 . . . . 0.40999999999999998 109.139 -176.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.731 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 93.07 6.18 63.43 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.536 -0.756 . . . . 0.58999999999999997 112.777 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.715 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.55 147.68 52.95 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.493 -0.558 . . . . 0.34000000000000002 109.493 176.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.47 134.7 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.094 0.473 . . . . 0.55000000000000004 110.957 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 46' ' ' VAL . 7.4 tp -127.41 169.32 13.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.662 -0.866 . . . . 0.45000000000000001 108.662 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 25.1 p -121.08 156.64 56.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.287 -0.565 . . . . 0.56000000000000005 112.227 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.718 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 12.0 Cg_endo -55.5 -30.23 72.91 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.288 3.325 . . . . 0.68000000000000005 114.402 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -69.87 -32.48 70.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.76000000000000001 110.774 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -79.98 -29.19 39.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.846 -1.07 . . . . 1.5900000000000001 111.241 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.531 ' CG1' HD23 ' A' ' 41' ' ' LEU . 16.7 m -118.21 30.19 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.451 . . . . 0.66000000000000003 111.762 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.01 -21.08 33.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.601 -0.518 . . . . 0.79000000000000004 109.601 176.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.0 -170.85 2.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.316 -0.857 . . . . 1.9099999999999999 109.617 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -73.1 156.85 89.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.362 -0.607 . . . . 1.4299999999999999 109.362 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.93 153.72 25.6 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.588 1.526 . . . . 0.37 109.962 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -80.15 -14.93 58.09 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.353 -0.539 . . . . 0.44 110.555 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -161.51 143.38 11.67 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.457 0.54 . . . . 0.38 112.457 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.905 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -140.17 175.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.104 -1.072 . . . . 0.29999999999999999 108.104 170.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.976 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.8 t 169.56 125.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.497 0.498 . . . . 0.34999999999999998 110.039 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 60.2 p-90 -88.13 153.7 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.672 -0.862 . . . . 2.7200000000000002 108.672 173.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.76 91.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 1.51 110.954 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.66 8.71 8.09 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.836 -0.62 . . . . 0.80000000000000004 112.42 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.976 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.7 tt -56.76 129.0 39.4 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.848 0.459 . . . . 0.57999999999999996 110.857 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -76.39 -29.04 56.96 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.771 -0.65 . . . . 0.73999999999999999 111.744 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.669 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.2 m 74.23 0.33 3.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.475 -0.784 . . . . 1.03 110.821 -175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.31 -34.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.058 -0.591 . . . . 0.83999999999999997 113.879 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -97.34 166.72 11.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.37 0.605 . . . . 1.6699999999999999 112.076 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.746 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 22.0 mt -91.9 134.02 35.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.57999999999999996 110.109 -175.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.563 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 7.0 m-85 -124.35 162.83 22.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.892 0.314 . . . . 0.80000000000000004 110.194 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.478 HG23 HG12 ' A' ' 90' ' ' VAL . 86.3 m -102.15 109.74 21.51 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.557 -0.534 . . . . 0.35999999999999999 109.557 174.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 124' ' ' VAL . 53.0 tp -109.09 118.89 37.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.773 0.321 . . . . 0.58999999999999997 110.523 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.1 130.58 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.39000000000000001 110.742 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -90.88 141.91 28.33 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.756 -0.831 . . . . 0.59999999999999998 108.756 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.747 HG21 HG11 ' A' ' 17' ' ' VAL . 12.9 t -140.62 148.13 40.42 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.889 -0.324 . . . . 0.35999999999999999 110.66 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 22.5 t70 -133.82 97.44 15.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 121.265 0.555 . . . . 1.9199999999999999 109.959 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.555 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 3.4 Cg_endo -45.78 -47.63 13.56 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.489 3.459 . . . . 1.25 114.827 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 76' ' ' ARG . 30.1 m-20 -86.98 52.77 2.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.473 0.545 . . . . 1.29 112.473 -167.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.67 20.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.15 -0.477 . . . . 0.5 110.115 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 85.9 Cg_endo -82.14 -23.53 13.43 Favored 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.527 -1.447 . . . . 0.62 112.858 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.771 ' HB3' HG22 ' A' ' 115' ' ' THR . 6.4 p -137.74 153.66 49.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.75 110.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.501 ' HG3' ' OD1' ' A' ' 72' ' ' ASP . 78.9 ttt180 -68.82 -23.15 64.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.328 0.585 . . . . 2.8799999999999999 110.499 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 8.4 ptpt -76.21 -17.05 59.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.81 -0.632 . . . . 1.3799999999999999 110.496 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 7.9 t0 -162.97 72.63 2.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 1.3700000000000001 109.876 -172.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.28 87.99 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.266 1.978 . . . . 0.80000000000000004 112.179 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.3 mttm -76.27 -51.42 12.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.449 -1.25 . . . . 1.02 110.548 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 86.5 m-85 -80.37 19.29 0.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.155 -0.93 . . . . 1.1699999999999999 111.555 -171.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.695 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 17.2 ttp180 -69.54 126.64 30.34 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.16 -0.311 . . . . 2.9300000000000002 110.16 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.695 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 2.2 mp0 -98.66 135.35 40.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.945 0.402 . . . . 2.23 110.471 -4.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.61 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.7 t90 -80.94 135.45 35.88 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.15 -0.685 . . . . 1.4299999999999999 109.15 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 6.4 p80 -108.29 132.47 53.66 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.251 -0.58 . . . . 1.26 109.453 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.2 t-160 -83.75 -26.37 29.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.135 -0.484 . . . . 2.1400000000000001 111.514 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.696 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 23.4 p90 -168.74 178.55 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.302 -0.629 . . . . 1.51 109.302 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HG ' HD12 ' A' ' 103' ' ' LEU . 36.3 tp -141.41 114.26 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.155 0.285 . . . . 0.33000000000000002 110.416 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.697 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -120.39 132.4 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.422 0.63 . . . . 0.31 110.931 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.478 HG12 HG23 ' A' ' 65' ' ' THR . 13.5 m -133.46 166.02 30.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.149 -1.056 . . . . 0.27000000000000002 108.149 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t-20 62.16 17.38 9.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.742 0.306 . . . . 1.76 110.292 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.697 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.2 ttm -70.27 108.53 4.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.761 -0.829 . . . . 0.31 108.761 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.2 ttmm -83.48 90.42 7.21 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.817 -1.083 . . . . 1.21 110.633 -171.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.52 -126.62 7.55 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.943 -1.026 . . . . 0.29999999999999999 112.271 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 3.7 p-10 -111.78 24.2 12.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.411 0.624 . . . . 1.04 110.354 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.07 110.75 22.12 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.459 -0.791 . . . . 0.77000000000000002 110.157 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 97' ' ' ILE . 4.6 mm -62.28 -23.7 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.489 -1.232 . . . . 0.40999999999999998 111.188 -175.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.8 m -81.52 -40.74 22.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.68000000000000005 112.272 -172.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.1 p -70.64 -21.41 62.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.642 0.238 . . . . 1.26 111.642 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.22 102.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.266 -0.492 . . . . 0.34999999999999998 112.324 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.5 m -68.83 106.93 2.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.445 -0.576 . . . . 0.45000000000000001 109.445 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.589 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 14.8 p -90.72 116.21 31.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.316 -0.856 . . . . 0.56999999999999995 110.898 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.428 HD12 ' HG ' ' A' ' 88' ' ' LEU . 7.3 mt -89.59 -45.92 9.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.015 0.912 . . . . 0.45000000000000001 109.364 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.2 t -112.1 106.67 15.36 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.387 -1.708 . . . . 0.37 106.387 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.964 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.7 t0 -62.39 161.29 11.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.1499999999999999 112.529 -165.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -78.07 100.44 6.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.377 -0.829 . . . . 4.6900000000000004 108.902 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 33.1 t -71.12 -39.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.645 . . . . 0.85999999999999999 112.263 -173.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.51 171.45 28.08 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.768 -0.729 . . . . 0.67000000000000004 112.665 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.718 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 27.7 t -61.54 139.6 58.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.149 0.474 . . . . 0.51000000000000001 110.723 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.866 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -176.63 61.82 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.81999999999999995 111.613 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 177' ' ' VAL . 87.0 Cg_endo -85.46 136.18 5.42 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.553 2.169 . . . . 0.84999999999999998 112.929 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.757 ' HB2' HG21 ' A' ' 115' ' ' THR . 42.2 Cg_exo -57.51 148.18 74.23 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.77 2.313 . . . . 0.87 111.533 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.422 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -76.94 125.19 28.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.248 -0.433 . . . . 1.8500000000000001 111.092 -176.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.58 18.6 37.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.814 -0.708 . . . . 1.1799999999999999 112.049 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 75' ' ' SER . 70.3 p -103.55 -12.89 16.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.764 0.316 . . . . 0.96999999999999997 111.423 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.46 21.36 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.56 -0.616 . . . . 1.97 111.56 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.5 mm? -86.41 129.1 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.831 0.348 . . . . 0.93999999999999995 110.181 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.705 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.8 m-70 -94.1 115.63 27.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.89 -0.411 . . . . 2.23 109.89 177.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.572 ' HD2' HD21 ' A' ' 14' ' ' LEU . 6.0 ptt180 -104.29 84.94 2.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 2.3100000000000001 110.689 -172.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.621 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 22.2 m-85 -69.28 117.24 10.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.539 -0.755 . . . . 0.78000000000000003 109.539 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.586 ' CG2' HD22 ' A' ' 14' ' ' LEU . 11.6 t -95.9 129.24 46.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.841 -0.618 . . . . 0.27000000000000002 110.152 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.864 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.56 118.92 28.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.908 -0.587 . . . . 1.99 109.594 178.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.08 119.29 33.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.389 -0.226 . . . . 0.38 110.389 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -108.26 136.3 44.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.356 -0.538 . . . . 0.31 109.958 174.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.65 ' HB2' HD23 ' A' ' 160' ' ' LEU . 55.9 m-85 -113.88 144.25 43.35 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.904 -0.589 . . . . 5.1200000000000001 109.773 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.55 ' HB2' HG21 ' A' ' 164' ' ' VAL . 42.4 tt0 -105.87 112.0 24.89 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.485 -0.561 . . . . 2.4100000000000001 109.485 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.563 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -84.13 179.25 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.3100000000000001 109.788 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.51 -27.33 37.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.659 0.742 . . . . 2.3999999999999999 109.258 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.674 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 3.5 ptp180 -153.86 174.39 3.83 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 114.535 -1.212 . . . . 3.5099999999999998 111.619 -171.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.674 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 55.7 Cg_exo -52.23 152.8 14.22 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.096 2.53 . . . . 1.21 112.119 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.459 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.4 mm? -76.53 152.78 35.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 0.90000000000000002 111.977 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.76 68.96 0.68 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.225 -0.898 . . . . 2.8999999999999999 108.749 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 p -82.75 118.71 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.471 -0.786 . . . . 1.8999999999999999 111.159 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.36 8.88 33.87 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.703 -0.851 . . . . 2.96 108.703 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.54 116.92 47.91 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.667 -1.151 . . . . 1.3899999999999999 109.943 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.63 131.28 32.7 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.933 2.422 . . . . 1.27 112.155 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.4 mm -59.32 115.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.743 -0.466 . . . . 0.85999999999999999 109.743 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 145' ' ' HIS . 77.9 mt -96.46 -13.93 22.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.6100000000000001 112.422 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 2.4 m 59.91 -172.51 0.12 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.933 0.397 . . . . 1.8799999999999999 110.313 -172.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.964 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 25.1 p-10 -115.69 37.95 3.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.204 0.526 . . . . 0.75 110.207 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.636 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 6.9 mtm180 -116.29 136.08 53.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.276 0.56 . . . . 3.3599999999999999 111.809 -169.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.73 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.2 m 66.96 2.23 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.876 -1.056 . . . . 0.94999999999999996 113.585 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.63 92.49 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.508 -0.769 . . . . 1.1200000000000001 111.784 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.83 -49.97 73.82 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.047 0.758 . . . . 2.6600000000000001 113.047 -172.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.595 ' HB2' HD13 ' A' ' 138' ' ' LEU . 43.1 m80 -117.0 69.24 0.75 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.868 -0.79 . . . . 1.8700000000000001 108.868 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.464 ' O ' ' HD1' ' A' ' 84' ' ' TRP . 5.1 ttm180 -73.81 -81.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.31 -1.314 . . . . 4.7300000000000004 112.189 -170.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.623 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -124.38 -168.41 12.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.174 -1.012 . . . . 0.65000000000000002 112.926 -169.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.2 mttt 67.73 29.18 6.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.603 0.716 . . . . 1.0800000000000001 110.099 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.67 113.16 25.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.882 -1.054 . . . . 1.8899999999999999 109.415 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 12.3 mmmm -69.94 127.98 34.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.313 0.578 . . . . 1.29 111.767 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.43 -33.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.992 -1.004 . . . . 0.78000000000000003 111.44 175.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 155' ' ' ARG . . . -63.58 -35.53 80.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.67000000000000004 110.415 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.412 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 67.1 m -68.4 -35.5 77.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 -0.227 . . . . 0.77000000000000002 110.874 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.753 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 64.9 m-85 -58.96 -52.58 65.13 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.032 0.444 . . . . 0.92000000000000004 110.522 176.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 2.7 ptt-85 -69.12 -38.53 78.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.013 -0.54 . . . . 2.8900000000000001 111.422 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.5 mtmt -61.29 -28.42 69.18 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.75 0.278 . . . . 0.96999999999999997 111.75 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -54.88 -54.01 48.01 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.122 0.264 . . . . 1.5800000000000001 111.547 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.562 ' HB3' HD13 ' A' ' 160' ' ' LEU . 12.9 t80 -105.1 15.04 28.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.575 -0.85 . . . . 5.4500000000000002 110.479 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 61.91 45.91 7.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 2.4199999999999999 111.739 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.65 HD23 ' HB2' ' A' ' 125' ' ' TYR . 7.0 mp -81.52 176.35 9.75 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.472 -0.785 . . . . 1.27 110.604 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.559 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.0 tpt180 -101.74 -164.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.267 -0.424 . . . . 3.5899999999999999 110.5 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.559 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -71.44 166.17 41.76 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 109.704 -0.48 . . . . 0.76000000000000001 109.704 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 31.9 Cg_exo -55.2 138.04 78.28 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.53000000000000003 113.08 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.934 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -88.76 -29.85 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 CA-C-N 115.555 -0.748 . . . . 0.44 109.027 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.735 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.91 148.19 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.442 -0.503 . . . . 0.27000000000000002 111.358 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.761 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -151.22 147.01 16.48 Favored Glycine 0 N--CA 1.436 -1.317 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 112.273 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -165.54 139.67 4.69 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.431 -0.951 . . . . 0.34000000000000002 108.431 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.646 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 16.6 p -118.63 144.95 45.81 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 1.1100000000000001 111.265 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.2 p90 -127.85 127.1 42.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.655 -1.239 . . . . 0.80000000000000004 107.655 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.705 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -106.03 133.17 51.16 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.659 -0.651 . . . . 2.5299999999999998 111.734 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -128.92 145.96 51.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.195 -0.911 . . . . 0.59999999999999998 109.616 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.409 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -121.36 -172.3 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.661 0.267 . . . . 2.3799999999999999 110.863 -177.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.981 ' HA ' HG21 ' A' ' 177' ' ' VAL . 29.9 t90 -74.76 82.8 2.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.74 -0.467 . . . . 3.96 109.74 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.3 OUTLIER -72.09 -61.62 1.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.867 -0.606 . . . . 1.53 111.293 176.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.573 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.4 t70 169.55 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.826 0.704 . . . . 1.26 109.644 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 60.7 m-85 -81.22 10.82 4.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.219 0.533 . . . . 2.2200000000000002 111.346 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.981 HG21 ' HA ' ' A' ' 173' ' ' TRP . 74.8 t -72.31 -49.39 9.32 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.5 110.712 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.8 Cg_exo -49.05 -26.34 10.29 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.947 2.431 . . . . 0.57999999999999996 113.06 170.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 18.1 mmmt -67.4 -24.65 65.69 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.34 0.256 . . . . 2.1400000000000001 111.629 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.866 HD23 ' HA3' ' A' ' 110' ' ' GLY . 21.5 tp -78.25 -40.75 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.112 -0.635 . . . . 0.66000000000000003 109.358 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.65 -35.26 74.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.944 -0.762 . . . . 1.8899999999999999 108.944 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 0.9 OUTLIER -55.51 -56.49 19.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.495 -1.23 . . . . 1.53 109.73 172.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -69.6 -39.02 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.705 -1.134 . . . . 1.49 112.549 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.73 ' HA ' ' H ' ' A' ' 142' ' ' SER . 74.1 mt -71.5 6.99 1.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.005 0.431 . . . . 0.76000000000000001 111.686 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.511 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 19.9 m -77.76 -3.45 41.34 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.31 -0.626 . . . . 1.05 109.31 168.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.636 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 75.1 49.67 9.36 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.839 -0.904 . . . . 1.1699999999999999 110.839 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.1 mmtp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.678 -0.677 . . . . 2.0 110.138 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.613 -0.143 . . . . 5.04 110.613 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 75.3 Cg_exo -50.33 132.15 33.66 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.581 2.854 . . . . 2.1299999999999999 113.184 -173.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t -55.71 127.8 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.707 -1.133 . . . . 1.47 111.953 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -146.13 160.53 41.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.889 -1.152 . . . . 1.8100000000000001 107.889 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 30.78 0.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.69999999999999996 111.005 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -76.92 -18.44 58.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.139 0.495 . . . . 1.96 110.517 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -114.36 33.44 5.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.052 0.453 . . . . 2.6600000000000001 110.25 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.732 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.1 p90 -73.89 -28.2 61.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 3.98 111.921 -174.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -147.65 11.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.63 110.641 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -76.75 -118.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.84 -0.618 . . . . 0.47999999999999998 111.671 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.2 Cg_endo -49.21 -45.89 28.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.232 2.621 . . . . 0.53000000000000003 110.703 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.755 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 9.4 mp -89.72 102.21 14.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.298 -0.864 . . . . 1.1699999999999999 111.249 173.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 65.98 2.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.70999999999999996 110.408 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 121' ' ' VAL . 22.0 mt -74.32 -17.45 60.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.45000000000000001 111.423 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -69.65 -5.99 28.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.294 -0.412 . . . . 2.1200000000000001 111.44 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.14 -14.12 60.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.938 0.399 . . . . 1.9299999999999999 111.41 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.924 HG11 HG21 ' A' ' 69' ' ' THR . 60.9 t -91.49 -71.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.509 -0.769 . . . . 0.63 110.744 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.541 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 23.4 t0 -155.26 176.38 12.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.483 -0.932 . . . . 2.9900000000000002 108.483 -170.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.89 100.1 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.864 -0.421 . . . . 1.6000000000000001 109.864 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.732 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -43.14 128.58 3.41 Favored Pre-proline 0 C--O 1.234 0.283 0 O-C-N 124.142 0.901 . . . . 3.5499999999999998 110.38 -176.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 53.0 Cg_exo -52.87 166.86 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.499 2.799 . . . . 0.57999999999999996 114.516 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.88 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 9.7 pt20 -84.16 -11.88 55.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.474 -1.239 . . . . 1.3899999999999999 111.812 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.73 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 14.8 m-70 -147.02 157.78 45.94 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 123.11 0.564 . . . . 1.45 110.072 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -86.42 123.5 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.326 2.684 . . . . 0.40000000000000002 111.652 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 16.9 tp -79.06 136.36 37.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.716 0.294 . . . . 0.28999999999999998 110.732 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.31 117.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.924 -0.399 . . . . 1.24 109.924 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.871 HG13 HG22 ' A' ' 53' ' ' ILE . 26.4 t -123.27 144.62 32.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.171 -0.678 . . . . 0.46999999999999997 109.171 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 144.22 32.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.797 0.332 . . . . 0.31 110.701 -173.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.469 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 17.8 t80 -108.92 178.52 4.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 0.67000000000000004 109.348 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -52.8 64.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 0.55000000000000004 110.843 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.69 11.23 15.84 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.596 -0.729 . . . . 0.81000000000000005 112.494 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.44 -171.3 3.38 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.877 0.37 . . . . 0.46999999999999997 110.164 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.69 154.23 17.94 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.88 -0.6 . . . . 0.33000000000000002 109.543 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.8 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 89.9 t -100.16 61.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 106.968 -1.493 . . . . 0.39000000000000001 106.968 166.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -96.14 27.68 3.56 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.402 -1.272 . . . . 0.98999999999999999 109.301 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -153.98 125.76 7.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.917 -1.142 . . . . 2.5600000000000001 107.917 173.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.8 OUTLIER -74.67 110.38 8.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.081 0.467 . . . . 0.40999999999999998 109.963 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.78 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 98.81 -3.27 58.81 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.635 -0.793 . . . . 0.58999999999999997 112.483 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -62.85 150.44 41.72 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.304 0.242 . . . . 0.34000000000000002 110.393 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.61 127.57 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.55000000000000004 110.672 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 34' ' ' VAL . 5.7 tp -115.87 169.72 9.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.153 -1.425 . . . . 0.45000000000000001 107.153 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 2.6 p -113.47 150.17 42.77 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.88 -1.128 . . . . 0.56000000000000005 113.369 -174.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 35.8 Cg_exo -61.23 -27.78 84.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.208 3.272 . . . . 0.68000000000000005 113.196 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.426 HG22 ' CD2' ' A' ' 176' ' ' TYR . 10.4 p -65.3 -40.28 93.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.865 0.84 . . . . 0.76000000000000001 109.972 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -81.46 -50.87 8.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.466 -1.243 . . . . 1.5900000000000001 111.399 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.79 ' HB ' ' HE2' ' A' ' 169' ' ' TYR . 3.8 m -85.56 25.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.209 0.528 . . . . 0.66000000000000003 112.366 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -81.25 -20.03 41.84 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.083 -0.71 . . . . 0.79000000000000004 109.083 175.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -119.5 -161.88 0.89 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.84 -1.073 . . . . 1.9099999999999999 110.052 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.645 HH22 HG21 ' A' ' 89' ' ' VAL . 29.5 mtp180 -91.38 165.84 20.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.168 -0.308 . . . . 1.4299999999999999 110.168 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 57.3 Cg_endo -75.81 169.13 22.85 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.912 1.742 . . . . 0.37 110.725 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -91.3 -18.39 24.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.787 -0.365 . . . . 0.44 110.121 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.0 m -160.77 142.52 12.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.38 112.101 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.871 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -137.99 168.21 20.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.322 -0.992 . . . . 0.29999999999999999 108.322 171.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.953 ' HA ' HD13 ' A' ' 58' ' ' LEU . 47.3 t 169.18 122.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.368 0.417 . . . . 0.34999999999999998 110.333 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.562 ' CB ' ' HB2' ' A' ' 165' ' ' ALA . 46.8 p-90 -82.65 150.99 26.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.165 -1.42 . . . . 2.7200000000000002 107.165 169.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -68.28 87.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.826 0.822 . . . . 1.51 111.15 -174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.71 -1.38 3.2 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.919 -1.037 . . . . 0.80000000000000004 111.626 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.953 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.8 tt -52.17 128.61 25.42 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.087 0.555 . . . . 0.57999999999999996 110.336 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.808 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 33.9 t70 -75.09 -27.18 59.8 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.73999999999999999 111.757 -173.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.634 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 15.9 m 73.03 2.56 4.42 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.979 -1.01 . . . . 1.03 110.192 -172.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.81 -9.06 2.6 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.127 -0.559 . . . . 0.83999999999999997 113.5 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.808 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 35.4 mtpt -94.75 161.05 14.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.251 0.525 . . . . 1.6699999999999999 109.918 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 60.8 mt -95.11 134.49 37.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.399 -0.593 . . . . 0.57999999999999996 109.399 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -133.59 145.92 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.42 -0.585 . . . . 0.80000000000000004 109.42 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.653 HG23 HG12 ' A' ' 90' ' ' VAL . 60.2 m -95.96 105.27 17.27 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.704 -0.85 . . . . 0.35999999999999999 108.704 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.737 HD13 HG12 ' A' ' 124' ' ' VAL . 49.3 tp -100.54 109.93 22.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.58999999999999997 110.193 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 88' ' ' LEU . 27.4 t -110.15 121.1 62.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.39000000000000001 110.533 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.974 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.0 mt -81.91 138.98 34.91 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.465 -0.939 . . . . 0.59999999999999998 108.465 167.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.924 HG21 HG11 ' A' ' 17' ' ' VAL . 8.9 t -144.79 147.39 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.858 -0.337 . . . . 0.35999999999999999 110.858 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 9.1 t0 -131.84 95.56 22.37 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.546 0.688 . . . . 1.9199999999999999 109.745 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 18.8 Cg_endo -60.01 -11.63 16.11 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 124.126 3.217 . . . . 1.25 114.065 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 118' ' ' HIS . 2.3 t70 -106.61 26.46 9.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.405 0.621 . . . . 1.29 110.431 -167.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' A' ' 84' ' ' TRP . . . -103.33 144.79 29.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.052 -0.522 . . . . 0.5 111.591 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 96.0 Cg_endo -84.86 -24.47 10.2 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.207 -1.58 . . . . 0.62 112.819 -0.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.594 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 62.1 p -134.72 149.67 50.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 0.75 109.371 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.69 -26.86 64.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 2.8799999999999999 111.473 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.667 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -69.82 -23.5 63.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.44 -0.345 . . . . 1.3799999999999999 111.025 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -157.62 84.03 2.84 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.912 0.386 . . . . 1.3700000000000001 110.379 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.5 81.54 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.593 2.195 . . . . 0.80000000000000004 112.025 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.2 mttm -66.68 -48.18 70.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.295 -1.321 . . . . 1.02 111.46 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 48.7 m-85 -83.59 8.82 13.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.343 -0.844 . . . . 1.1699999999999999 112.16 -166.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 53.9 ttp180 -58.28 122.79 14.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 2.9300000000000002 110.794 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mp0 -101.14 131.93 46.85 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.839 0.352 . . . . 2.23 110.796 -2.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 12.5 t90 -79.52 93.66 5.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 1.4299999999999999 110.113 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.9 p-80 -67.44 123.8 21.42 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.352 0.596 . . . . 1.26 109.421 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.974 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 11.5 t60 -76.64 -30.76 56.99 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.622 -0.717 . . . . 2.1400000000000001 110.324 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.0 p90 -168.48 174.2 7.03 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.6 -0.519 . . . . 1.51 109.6 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' A' ' 103' ' ' LEU . 19.7 tp -134.55 114.2 12.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.907 -0.405 . . . . 0.33000000000000002 109.907 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.645 HG21 HH22 ' A' ' 49' ' ' ARG . 1.7 t -123.54 131.76 72.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.757 -0.656 . . . . 0.31 110.903 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.653 HG12 HG23 ' A' ' 65' ' ' THR . 15.0 m -133.28 163.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.957 -1.02 . . . . 0.27000000000000002 108.529 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.613 ' ND2' ' HB3' ' A' ' 130' ' ' PRO . 2.5 t-20 62.85 18.34 10.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.333 0.396 . . . . 1.76 110.008 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.473 ' HE3' HG11 ' A' ' 89' ' ' VAL . 5.4 ttm -69.94 106.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.074 -0.713 . . . . 0.31 109.074 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 12.9 ttmm -84.21 89.72 7.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.616 -1.175 . . . . 1.21 110.697 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 82.48 -127.18 7.82 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.875 -1.057 . . . . 0.29999999999999999 112.632 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 26.5 p-10 -115.6 24.02 11.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 1.04 111.432 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -89.42 105.71 17.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.378 0.608 . . . . 0.77000000000000002 109.729 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.546 HD13 HD12 ' A' ' 53' ' ' ILE . 10.7 mm -49.98 -35.91 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.291 -1.322 . . . . 0.40999999999999998 111.387 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 m -80.88 -31.49 35.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.685 -0.689 . . . . 0.68000000000000005 111.834 -172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -72.76 -11.21 60.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 1.26 111.565 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.0 102.33 1.05 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.554 -0.831 . . . . 0.34999999999999998 111.602 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.9 m -61.98 109.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.478 0.656 . . . . 0.45000000000000001 110.066 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.6 p -83.2 117.49 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.825 -1.079 . . . . 0.56999999999999995 111.588 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.3 mt -92.85 -39.02 11.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.018 0.913 . . . . 0.45000000000000001 109.372 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 22.0 t -127.44 110.27 12.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.446 -1.316 . . . . 0.37 107.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.998 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -56.76 161.78 2.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.122 0.889 . . . . 1.1499999999999999 112.921 -170.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -83.86 101.33 11.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.37 -0.832 . . . . 4.6900000000000004 110.283 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.748 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 25.9 t -69.3 -41.46 81.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.893 -0.594 . . . . 0.85999999999999999 111.748 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.39 -176.55 24.39 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.67000000000000004 112.333 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.463 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 27.0 t -63.7 123.17 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.67 0.235 . . . . 0.51000000000000001 110.803 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -154.3 61.74 0.37 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.9 -0.667 . . . . 0.81999999999999995 112.708 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 73.9 Cg_endo -94.51 123.35 0.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.922 2.415 . . . . 0.84999999999999998 112.669 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.655 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.7 Cg_exo -52.56 140.77 54.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.884 2.39 . . . . 0.87 111.814 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.542 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -64.53 125.31 24.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.141 0.495 . . . . 1.8500000000000001 110.839 -177.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.08 -4.02 60.55 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.615 -0.802 . . . . 1.1799999999999999 112.856 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.655 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 74.0 p -78.1 -15.82 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.699 -0.295 . . . . 0.96999999999999997 111.261 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 171.33 39.37 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.876 -0.602 . . . . 1.97 111.862 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 172' ' ' GLU . 3.7 mm? -82.37 115.58 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.956 -0.757 . . . . 0.93999999999999995 108.956 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.774 ' N ' ' HG2' ' A' ' 170' ' ' GLN . 75.2 m-70 -88.61 -134.3 0.09 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.2 -0.667 . . . . 2.23 109.2 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.755 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 2.8 ptt180 -176.53 100.9 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.743 0.646 . . . . 2.3100000000000001 112.743 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' HD1' ' HB2' ' A' ' 70' ' ' ASP . 19.3 m-85 -77.78 106.79 9.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.359 -0.978 . . . . 0.78000000000000003 108.359 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.886 HG21 HD22 ' A' ' 14' ' ' LEU . 5.2 t -96.26 133.48 37.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.412 -0.358 . . . . 0.27000000000000002 110.122 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.8 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -87.74 119.41 28.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.652 -0.499 . . . . 1.99 109.652 178.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.5 mt -115.31 117.77 31.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.71 -0.478 . . . . 0.38 109.71 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.737 HG12 HD13 ' A' ' 66' ' ' LEU . 1.7 m -104.18 128.93 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.179 -0.608 . . . . 0.31 109.663 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.522 ' HD2' ' O ' ' A' ' 161' ' ' ARG . 21.0 m-85 -109.72 124.76 51.8 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.069 -0.715 . . . . 5.1200000000000001 109.069 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.92 131.15 43.99 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.346 -0.541 . . . . 2.4100000000000001 109.689 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 20.7 mt-30 -93.7 130.35 39.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.943 -0.572 . . . . 1.3100000000000001 111.044 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.69 -11.17 59.85 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.509 -0.922 . . . . 2.3999999999999999 108.509 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 1.1 ptt180 -164.71 150.57 8.95 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 114.44 -1.255 . . . . 3.5099999999999998 109.919 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.613 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 15.1 Cg_exo -66.56 132.68 29.72 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.198 2.599 . . . . 1.21 112.49 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 133' ' ' CYS . 3.6 mm? -64.17 151.69 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.753 -0.658 . . . . 0.90000000000000002 111.335 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 39.08 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.25 1.024 . . . . 2.8999999999999999 109.866 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.762 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.7 m -53.44 138.49 33.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.51 -1.677 . . . . 1.8999999999999999 113.058 -172.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.55 18.18 10.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.07 -0.968 . . . . 2.96 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.762 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.8 mm-40 -69.14 126.71 92.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.758 -0.655 . . . . 1.3899999999999999 110.413 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.06 116.43 2.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.162 2.575 . . . . 1.27 112.288 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mm -63.0 115.08 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.85999999999999999 110.553 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 67.5 mt -100.61 146.4 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.533 -0.543 . . . . 1.6100000000000001 109.533 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 141' ' ' ARG . 55.5 m -111.35 35.39 3.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.721 -0.672 . . . . 1.8799999999999999 111.234 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.998 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.4 OUTLIER 63.22 -18.61 0.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.027 1.331 . . . . 0.75 113.537 175.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 139' ' ' SER . 1.4 mtt180 -84.55 135.9 34.02 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.188 -0.301 . . . . 3.3599999999999999 110.188 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.647 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.9 m 81.97 131.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.97 1.419 . . . . 0.94999999999999996 110.641 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.12 33.98 5.91 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 112.399 -175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.01 -30.48 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.625 0.25 . . . . 2.6600000000000001 111.424 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.99 70.61 1.35 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.211 0.529 . . . . 1.8700000000000001 111.013 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 49.3 mtt180 -79.94 -66.06 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 4.7300000000000004 110.419 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.467 ' H ' ' HD1' ' A' ' 81' ' ' TYR . . . -130.36 -143.42 5.36 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.693 -0.765 . . . . 0.65000000000000002 112.079 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.685 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 64.83 23.55 12.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.516 0.674 . . . . 1.0800000000000001 110.473 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -119.79 125.97 49.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.997 -1.002 . . . . 1.8899999999999999 108.394 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -76.9 127.76 33.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.333 0.587 . . . . 1.29 111.703 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.899 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 4.5 m -61.01 -31.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.04 -0.982 . . . . 0.78000000000000003 110.967 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.74 -39.77 92.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.773 -0.649 . . . . 0.67000000000000004 109.999 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.7 m -67.56 -34.77 77.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.396 -0.366 . . . . 0.77000000000000002 111.127 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.899 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 33.2 m-85 -59.28 -50.32 74.46 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.92000000000000004 110.058 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -63.02 -50.15 71.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.875 -1.057 . . . . 2.8900000000000001 111.139 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.0 mtmt -62.32 -27.92 69.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.281 -0.418 . . . . 0.96999999999999997 111.766 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -53.98 -53.48 52.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.193 -0.458 . . . . 1.5800000000000001 111.352 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.512 ' CG ' HD13 ' A' ' 131' ' ' LEU . 54.0 t80 -103.97 9.92 36.41 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.274 -0.571 . . . . 5.4500000000000002 111.222 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 65.37 44.0 3.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.558 0.694 . . . . 2.4199999999999999 110.18 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 160' ' ' LEU . 2.3 tp -78.45 164.68 24.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.062 -0.972 . . . . 1.27 111.037 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.633 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 22.4 tpt180 -86.9 -179.47 6.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 3.5899999999999999 109.763 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.633 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -75.93 160.4 78.68 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.119 -0.326 . . . . 0.76000000000000001 110.119 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.69 141.97 96.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.802 2.335 . . . . 0.53000000000000003 113.201 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.88 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.1 t -95.06 -39.44 10.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.608 -0.723 . . . . 0.44 110.15 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -136.94 145.02 43.74 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.035 -0.666 . . . . 0.27000000000000002 111.794 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.8 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -145.39 149.11 21.22 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.258 -0.883 . . . . 0.23999999999999999 112.626 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 25' ' ' LEU . 12.5 t -170.59 142.0 1.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.369 -0.604 . . . . 0.34000000000000002 109.369 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.78 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -108.9 144.72 36.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.032 0.444 . . . . 1.1100000000000001 111.93 -174.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.79 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 1.9 p90 -137.63 105.5 5.64 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.007 -0.738 . . . . 0.80000000000000004 109.007 171.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.774 ' HG2' ' N ' ' A' ' 118' ' ' HIS . 7.8 tp-100 -100.39 169.61 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 120.679 -1.263 . . . . 2.5299999999999998 112.132 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' A' ' 170' ' ' GLN . . . -146.23 160.19 42.31 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.134 -0.691 . . . . 0.59999999999999998 109.134 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HB3' HD11 ' A' ' 117' ' ' LEU . 12.4 pt-20 -109.44 -171.99 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.314 -0.403 . . . . 2.3799999999999999 110.448 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.589 ' CZ2' ' HG3' ' A' ' 178' ' ' PRO . 8.3 t90 -80.48 68.85 6.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.435 . . . . 3.96 109.897 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.8 -61.33 1.82 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.453 -0.34 . . . . 1.53 111.839 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 16.6 t70 -168.94 -55.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.088 0.403 . . . . 1.26 112.088 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.426 ' CD2' HG22 ' A' ' 44' ' ' THR . 50.7 m-85 -81.57 11.21 4.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.48 0.548 . . . . 2.2200000000000002 112.48 -176.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.737 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 91.3 t -71.61 -53.68 7.23 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.579 -0.526 . . . . 0.5 109.579 171.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.0 Cg_exo -49.74 -43.22 41.16 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.706 2.271 . . . . 0.57999999999999996 112.603 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.669 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 4.7 mmmp? -70.35 -24.69 63.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.896 0.332 . . . . 2.1400000000000001 111.896 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.671 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 51.7 tp -70.39 -47.63 59.95 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.333 -0.617 . . . . 0.66000000000000003 109.333 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.22 -37.44 77.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 1.8899999999999999 109.449 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 4.8 mm-40 -60.14 -45.68 92.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.91 -1.041 . . . . 1.53 111.271 172.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.07 -32.49 72.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 1.49 111.864 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 63.4 mt -63.13 0.11 0.66 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.149 0.796 . . . . 0.76000000000000001 113.149 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.445 ' HB2' ' HE2' ' A' ' 187' ' ' LYS . 14.5 m -74.07 -9.86 59.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.305 0.574 . . . . 1.05 109.967 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 75.61 58.26 3.9 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.591 -1.003 . . . . 1.1699999999999999 110.591 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 182' ' ' GLU . 71.1 mmtt . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.341 -0.838 . . . . 2.0 110.655 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.677 0.275 . . . . 5.04 110.967 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 14.9 Cg_exo -70.4 108.97 2.32 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.933 2.422 . . . . 2.1299999999999999 112.24 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t 65.88 129.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.335 -0.848 . . . . 1.47 111.647 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -155.22 154.81 32.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.562 -0.533 . . . . 1.8100000000000001 109.562 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.461 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.3 mm? -81.19 27.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.48 0.178 . . . . 0.69999999999999996 111.48 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 2.0 m -62.5 -29.89 70.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.991 0.424 . . . . 1.96 111.391 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 12' ' ' LEU . 6.8 mptt -120.66 51.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.397 -0.365 . . . . 2.6600000000000001 110.109 -175.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.42 ' HE3' ' O ' ' A' ' 5' ' ' LEU . 12.9 p90 -72.39 -23.32 61.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.45 . . . . 3.98 111.244 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 70.7 p -148.34 7.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.427 -0.509 . . . . 0.63 112.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.14 -122.28 0.08 OUTLIER Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.806 -0.711 . . . . 0.47999999999999998 112.102 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.0 Cg_endo -49.37 -42.35 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.259 2.639 . . . . 0.53000000000000003 110.253 168.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.597 HD11 ' HA3' ' A' ' 38' ' ' GLY . 17.7 mt -88.0 81.98 7.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.646 -1.161 . . . . 1.1699999999999999 109.323 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -74.7 62.14 1.04 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.542 0.687 . . . . 0.70999999999999996 110.438 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 121' ' ' VAL . 36.4 mt -79.04 -19.93 50.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.183 -0.917 . . . . 0.45000000000000001 110.922 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -61.13 -15.5 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 2.1200000000000001 111.262 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.7 -32.8 74.34 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 110.984 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.501 HG12 HG21 ' A' ' 151' ' ' VAL . 98.1 t -90.33 -64.15 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.532 -0.758 . . . . 0.63 110.883 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HA ' HH22 ' A' ' 155' ' ' ARG . 5.8 p-10 -115.06 175.95 5.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.077 0.465 . . . . 2.9900000000000002 111.101 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 20.6 mt-10 -95.09 33.92 1.46 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.879 -0.6 . . . . 1.6000000000000001 111.412 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER 52.38 133.67 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.217 1.407 . . . . 3.5499999999999998 113.459 -176.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' CA ' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -80.74 154.17 20.23 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.843 2.362 . . . . 0.57999999999999996 113.711 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.848 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 6.3 pt20 -74.51 -18.75 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.793 -1.094 . . . . 1.3899999999999999 111.011 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.77 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.1 m80 -145.93 156.87 51.34 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.525 -0.761 . . . . 1.45 109.7 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 23' ' ' HIS . 5.0 Cg_endo -85.83 127.43 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 123.056 2.504 . . . . 0.40000000000000002 111.16 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.452 HD23 ' CB ' ' A' ' 122' ' ' TRP . 17.9 tp -76.97 142.04 40.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.492 -0.322 . . . . 0.28999999999999998 110.572 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 27.0 m-70 -109.26 115.58 30.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.565 -0.531 . . . . 1.24 109.565 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.862 HG13 HG22 ' A' ' 53' ' ' ILE . 15.2 t -126.48 119.81 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 0.46999999999999997 109.691 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -117.68 138.8 51.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.158 0.504 . . . . 0.31 110.411 -177.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -98.16 172.41 7.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.94 -0.573 . . . . 0.67000000000000004 109.474 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.8 -52.28 64.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.215 0.531 . . . . 0.55000000000000004 110.739 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.98 -14.68 14.46 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.351 -0.84 . . . . 0.81000000000000005 112.549 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.37 -170.0 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.021 0.438 . . . . 0.46999999999999997 110.614 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -162.74 141.76 8.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.762 -0.653 . . . . 0.33000000000000002 110.464 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 92.6 t -91.73 61.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.929 -1.508 . . . . 0.39000000000000001 106.929 165.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 2' ' ' PRO . 36.5 t70 -85.59 10.61 12.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.672 -1.149 . . . . 0.98999999999999999 110.702 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.1 tt0 -146.16 134.38 21.71 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.732 -0.667 . . . . 2.5600000000000001 109.431 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.786 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -73.48 111.27 8.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.46 -0.571 . . . . 0.40999999999999998 109.46 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.597 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 90.5 17.59 51.96 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.156 -0.545 . . . . 0.58999999999999997 112.548 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.85 150.68 32.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 0.34000000000000002 109.703 174.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 12.9 p -78.73 134.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.55000000000000004 110.66 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.5 tp -131.37 169.7 15.66 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.276 -1.009 . . . . 0.45000000000000001 108.276 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 3.3 p -122.01 158.1 55.97 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.623 0.601 . . . . 0.56000000000000005 112.623 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 9.5 Cg_endo -51.35 -48.76 19.69 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.528 2.819 . . . . 0.68000000000000005 113.818 -173.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 p -61.73 -32.84 73.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 0.76000000000000001 111.687 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.73 -11.44 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.995 -0.548 . . . . 1.5900000000000001 111.604 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.528 ' CG1' HD23 ' A' ' 41' ' ' LEU . 29.4 m -129.65 28.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.354 0.597 . . . . 0.66000000000000003 111.112 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.32 -21.77 25.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.555 -0.748 . . . . 0.79000000000000004 110.135 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.03 -173.0 2.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.839 -0.618 . . . . 1.9099999999999999 109.569 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.86 155.38 77.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.108 -0.33 . . . . 1.4299999999999999 110.108 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.6 152.87 29.9 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.117 1.878 . . . . 0.37 110.732 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 t -76.8 -18.25 58.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.419 -0.355 . . . . 0.44 110.057 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 58.8 m -160.33 143.29 13.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.556 0.693 . . . . 0.38 112.363 -176.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.862 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -138.66 168.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.864 -1.162 . . . . 0.29999999999999999 107.864 170.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.024 ' HA ' HD13 ' A' ' 58' ' ' LEU . 37.3 t 171.96 123.9 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.484 -0.561 . . . . 0.34999999999999998 109.484 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.724 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.3 p-90 -82.23 154.75 25.26 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.862 -1.162 . . . . 2.7200000000000002 107.862 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.59 89.13 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.009 0.433 . . . . 1.51 110.861 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.91 13.09 4.64 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.487 -0.778 . . . . 0.80000000000000004 112.011 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.024 HD13 ' HA ' ' A' ' 54' ' ' SER . 5.3 tt -54.23 129.52 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.19 0.519 . . . . 0.57999999999999996 111.267 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.778 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 36.1 t70 -76.42 -27.93 56.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.73999999999999999 111.531 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 50.2 m 72.91 1.0 3.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.054 -0.975 . . . . 1.03 110.52 -172.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.65 -26.87 1.52 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.69 -0.686 . . . . 0.83999999999999997 112.733 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.778 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 34.3 mtpt -77.53 149.27 34.93 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.086 0.469 . . . . 1.6699999999999999 110.549 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.636 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 43.0 mt -87.69 126.72 35.14 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.163 -0.926 . . . . 0.57999999999999996 108.736 173.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.7 m-85 -121.44 163.69 18.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.52 -0.472 . . . . 0.80000000000000004 110.168 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.981 HG23 HG12 ' A' ' 90' ' ' VAL . 4.0 m -106.56 105.35 15.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.129 -0.693 . . . . 0.35999999999999999 109.129 173.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.618 HD13 HG12 ' A' ' 124' ' ' VAL . 52.8 tp -102.8 116.34 32.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.001 0.429 . . . . 0.58999999999999997 110.517 -176.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 88' ' ' LEU . 3.6 t -119.78 129.91 74.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.049 -0.523 . . . . 0.39000000000000001 110.67 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.079 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.1 mt -93.38 137.06 33.05 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.791 -0.818 . . . . 0.59999999999999998 108.791 171.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 7.0 t -139.47 149.2 43.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.656 0.265 . . . . 0.35999999999999999 111.65 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.56 ' HB2' ' CD2' ' A' ' 120' ' ' TYR . 16.0 t0 -133.8 90.71 26.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.538 0.685 . . . . 1.9199999999999999 109.697 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.9 Cg_endo -54.81 -26.54 48.31 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 124.034 3.156 . . . . 1.25 114.431 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 58.5 m-20 -85.16 36.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.065 0.395 . . . . 1.29 112.065 -168.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.93 140.34 20.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.19 -0.319 . . . . 0.5 111.566 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.0 Cg_endo -78.88 -28.04 7.86 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 122.848 -1.73 . . . . 0.62 112.037 -0.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.2 p -133.37 143.47 48.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.182 -0.917 . . . . 0.75 108.761 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 37.3 ttp180 -72.33 -23.08 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 2.8799999999999999 112.23 -174.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.763 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -75.57 -11.51 60.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.49 . . . . 1.3799999999999999 110.419 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -162.14 75.5 2.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 1.3700000000000001 109.572 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.06 103.33 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.656 2.237 . . . . 0.80000000000000004 112.994 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.6 mttm -88.05 -48.64 7.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.704 -1.134 . . . . 1.02 110.918 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.739 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 56.0 m-85 -80.45 2.4 25.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.14 -0.937 . . . . 1.1699999999999999 112.336 -165.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.3 ttp180 -60.62 128.69 37.84 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.241 -0.651 . . . . 2.9300000000000002 109.241 172.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 6.1 tm-20 -88.45 128.71 35.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.933 0.893 . . . . 2.23 110.903 2.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.44 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 22.1 t90 -114.75 91.92 3.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.819 -0.628 . . . . 1.4299999999999999 109.86 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 4.5 p-80 -83.92 158.88 21.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.061 0.934 . . . . 1.26 112.535 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 1.079 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t-80 -100.99 -38.45 8.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.047 -1.433 . . . . 2.1400000000000001 111.378 -172.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 55.3 t80 -167.11 137.58 3.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.076 -0.249 . . . . 1.51 110.469 -165.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.56 ' CD1' HG22 ' A' ' 67' ' ' VAL . 22.4 tp -126.74 114.42 17.95 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.249 0.343 . . . . 0.33000000000000002 110.41 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -123.79 135.93 61.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.421 0.629 . . . . 0.31 110.823 175.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.981 HG12 HG23 ' A' ' 65' ' ' THR . 8.1 m -130.19 162.65 37.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.27000000000000002 108.851 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.662 ' H ' HD23 ' A' ' 131' ' ' LEU . 1.0 OUTLIER 61.54 20.21 11.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.321 0.388 . . . . 1.76 110.863 177.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 89' ' ' VAL . 11.2 ttm -70.49 111.31 5.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.83 -0.804 . . . . 0.31 108.83 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.449 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 18.1 ttmm -87.78 87.4 7.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.893 -1.048 . . . . 1.21 110.341 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 88.57 -129.52 9.65 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 114.878 -1.055 . . . . 0.29999999999999999 112.495 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 32.3 p30 -116.17 27.13 9.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.173 0.511 . . . . 1.04 110.888 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -93.93 112.51 24.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.77000000000000002 109.924 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 53' ' ' ILE . 5.6 mm -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.578 -1.192 . . . . 0.40999999999999998 111.231 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.9 m -85.59 -34.33 21.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.887 -0.597 . . . . 0.68000000000000005 112.023 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -63.49 -29.4 70.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.26 111.766 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.21 110.91 2.74 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.791 -0.64 . . . . 0.34999999999999998 113.471 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.0 m -70.58 107.43 3.88 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.195 -0.668 . . . . 0.45000000000000001 109.195 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 105' ' ' ASP . 8.3 p -87.29 145.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.67 0.748 . . . . 0.56999999999999995 111.989 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.531 HD12 ' HG ' ' A' ' 88' ' ' LEU . 13.8 mt -119.4 -32.3 4.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.689 -1.141 . . . . 0.45000000000000001 109.12 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 14.7 t -131.55 102.02 5.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.769 -1.196 . . . . 0.37 107.769 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.923 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.9 OUTLIER -64.59 169.07 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 1.1499999999999999 113.2 -167.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' H ' ' HD1' ' A' ' 106' ' ' TYR . 4.1 p90 -74.34 88.73 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.947 -1.024 . . . . 4.6900000000000004 110.936 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.68 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 23.8 t -66.49 -49.15 77.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.85999999999999999 111.082 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.53 -170.18 13.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.798 -0.715 . . . . 0.67000000000000004 112.338 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.9 t -67.3 125.56 26.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 0.51000000000000001 109.824 173.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.721 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -159.01 63.55 0.3 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.615 -0.802 . . . . 0.81999999999999995 112.922 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.554 ' HB2' ' HD1' ' A' ' 173' ' ' TRP . 10.1 Cg_endo -89.68 133.73 2.21 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.884 2.39 . . . . 0.84999999999999998 111.844 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.712 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 53.0 Cg_exo -53.32 129.35 33.16 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.149 . . . . 0.87 111.196 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.553 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.8 OUTLIER -60.56 121.36 11.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.191 0.52 . . . . 1.8500000000000001 111.712 -174.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.68 -6.39 52.21 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.479 -0.782 . . . . 1.1799999999999999 113.252 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.712 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -80.65 -5.98 57.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.2 0.444 . . . . 0.96999999999999997 112.2 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.62 178.38 45.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.915 -0.659 . . . . 1.97 111.571 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.56 144.93 56.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.93999999999999995 110.657 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 1.0 OUTLIER -121.93 130.88 53.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.138 -0.69 . . . . 2.23 109.138 174.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.634 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 8.4 ptp85 -110.72 95.71 5.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.4 0.619 . . . . 2.3100000000000001 111.361 -170.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 69' ' ' THR . 36.8 m-85 -73.87 113.55 11.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.78000000000000003 109.357 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.682 HG21 HD22 ' A' ' 14' ' ' LEU . 7.1 t -90.52 129.51 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.604 -0.726 . . . . 0.27000000000000002 110.062 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.665 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 77.4 m95 -87.54 117.98 26.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.943 -1.132 . . . . 1.99 107.943 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.52 118.37 30.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.24 -0.184 . . . . 0.38 110.557 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.618 HG12 HD13 ' A' ' 66' ' ' LEU . 1.2 m -105.33 128.24 59.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.342 -0.614 . . . . 0.31 109.342 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.47 ' HB2' HD23 ' A' ' 160' ' ' LEU . 88.2 m-85 -110.62 146.53 35.98 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.794 -0.639 . . . . 5.1200000000000001 109.618 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.648 ' HB2' HG21 ' A' ' 164' ' ' VAL . 36.9 tt0 -105.58 109.88 22.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.028 -0.533 . . . . 2.4100000000000001 109.954 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.642 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -72.38 172.52 10.25 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.447 -0.797 . . . . 1.3100000000000001 109.644 177.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -85.59 -15.21 43.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.794 -0.639 . . . . 2.3999999999999999 109.397 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.51 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 5.2 ppt_? -158.1 168.5 12.32 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.138 -0.937 . . . . 3.5099999999999998 110.861 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 87.2 Cg_exo -47.93 147.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.045 2.497 . . . . 1.21 113.025 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.803 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.1 mm? -71.5 157.05 38.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.795 -0.638 . . . . 0.90000000000000002 112.006 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -146.93 79.36 1.52 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.092 -0.958 . . . . 2.8999999999999999 108.493 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.576 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 3.5 m -102.25 139.9 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.086 0.469 . . . . 1.8999999999999999 111.183 -173.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -112.89 17.73 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 2.96 109.533 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 15.8 mm-40 -68.81 132.17 90.82 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.259 -0.882 . . . . 1.3899999999999999 110.941 -174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.13 111.36 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.465 2.776 . . . . 1.27 113.065 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.24 125.64 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.711 -0.677 . . . . 0.85999999999999999 111.583 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -112.12 141.22 46.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.566 -0.531 . . . . 1.6100000000000001 109.566 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 141' ' ' ARG . 19.6 m -102.13 40.59 1.32 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.569 -0.741 . . . . 1.8799999999999999 110.728 -173.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 59.11 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.992 1.317 . . . . 0.75 113.506 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.601 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 47.0 mtt85 -84.59 155.78 21.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.121 -0.696 . . . . 3.3599999999999999 109.121 173.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.591 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 10.3 p 52.72 120.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.769 1.227 . . . . 0.94999999999999996 113.05 -171.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -97.3 30.99 8.21 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.119 -0.946 . . . . 1.1200000000000001 112.308 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.54 -34.67 72.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.937 0.717 . . . . 2.6600000000000001 112.937 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -125.65 42.05 3.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.305 0.574 . . . . 1.8700000000000001 111.417 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.514 ' HD2' HG21 ' A' ' 107' ' ' VAL . 42.7 mtp180 -87.47 -18.3 30.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.031 -0.532 . . . . 4.7300000000000004 112.157 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -145.25 -171.59 15.04 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 119.056 -1.545 . . . . 0.65000000000000002 114.884 -173.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.739 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.0 mttt 61.87 37.5 15.27 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 114.319 -0.94 . . . . 1.0800000000000001 110.887 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 80.4 m-85 -120.71 173.99 6.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.275 -1.33 . . . . 1.8899999999999999 108.281 170.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.417 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 12.1 mmmm -117.27 123.53 46.8 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.679 -0.408 . . . . 1.29 111.679 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 17' ' ' VAL . 6.6 m -57.98 -26.09 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.852 -0.613 . . . . 0.78000000000000003 110.791 174.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -68.15 -43.59 77.93 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.905 -0.589 . . . . 0.67000000000000004 109.93 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.587 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 23.7 m -61.88 -39.16 90.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.982 -0.554 . . . . 0.77000000000000002 110.273 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -62.53 -48.85 77.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.248 -0.433 . . . . 0.92000000000000004 110.96 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.8 ptp180 -67.38 -33.8 75.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.86 -0.336 . . . . 2.8900000000000001 110.723 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 48.8 mtmt -67.94 -28.63 67.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 0.96999999999999997 110.825 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -72.8 -51.88 17.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 110.965 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.741 ' HB2' HD13 ' A' ' 160' ' ' LEU . 12.3 m-85 -84.48 -2.11 56.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.363 -0.38 . . . . 5.4500000000000002 111.978 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 19.4 mm-40 69.19 45.63 0.86 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.689 0.757 . . . . 2.4199999999999999 110.932 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.741 HD13 ' HB2' ' A' ' 158' ' ' TYR . 5.7 mp -99.53 140.17 34.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.768 -1.106 . . . . 1.27 109.541 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -88.97 -84.43 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.291 -0.413 . . . . 3.5899999999999999 111.451 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.53 163.16 48.93 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.76000000000000001 109.579 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.498 ' HB2' ' CA ' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.8 133.27 41.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.48 2.12 . . . . 0.53000000000000003 112.128 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.848 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 t -89.12 -31.49 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 108.927 -0.768 . . . . 0.44 108.927 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.77 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.57 144.64 24.58 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.5 -0.773 . . . . 0.27000000000000002 111.261 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.665 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.94 146.82 16.66 Favored Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 115.006 -0.997 . . . . 0.23999999999999999 111.682 176.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.786 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.4 t -160.11 131.21 5.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.945 -0.761 . . . . 0.34000000000000002 108.945 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 16.5 p -110.91 138.25 47.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.177 0.513 . . . . 1.1100000000000001 110.862 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 120' ' ' TYR . 28.1 p90 -119.57 125.37 48.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.078 -1.082 . . . . 0.80000000000000004 108.078 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -103.92 132.2 50.4 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.754 -0.779 . . . . 2.5299999999999998 109.928 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -124.33 140.04 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 0.59999999999999998 111.613 -172.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.62 151.67 26.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 2.3799999999999999 111.341 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.973 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -76.26 68.35 2.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.21 -0.904 . . . . 3.96 108.949 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.54 -61.53 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.143 -0.935 . . . . 1.53 112.32 -170.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.591 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 37.2 t70 -171.44 -38.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.868 0.366 . . . . 1.26 111.802 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -80.03 2.04 25.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.32 0.581 . . . . 2.2200000000000002 110.605 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.973 HG21 ' HA ' ' A' ' 173' ' ' TRP . 48.7 t -69.46 -51.22 17.17 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.761 -0.654 . . . . 0.5 111.371 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 84.9 Cg_exo -50.29 -31.72 30.6 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.253 1.968 . . . . 0.57999999999999996 112.567 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.68 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.08 -22.68 63.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.317 -0.401 . . . . 2.1400000000000001 111.42 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.721 HD23 ' HA3' ' A' ' 110' ' ' GLY . 42.6 tp -68.36 -44.45 75.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.313 -0.555 . . . . 0.66000000000000003 109.591 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -61.4 -37.8 84.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.292 -0.633 . . . . 1.8899999999999999 109.292 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.68 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.3 mm-40 -55.19 -42.03 72.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.909 -1.041 . . . . 1.53 110.319 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.629 ' HA ' ' HB2' ' A' ' 187' ' ' LYS . 5.4 tt0 -77.35 -35.31 54.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 1.49 112.453 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.591 ' HA ' ' H ' ' A' ' 142' ' ' SER . 80.7 mt -63.34 -2.85 1.63 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.003 0.372 . . . . 0.76000000000000001 112.003 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.765 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.4 m -81.53 13.94 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 1.05 109.566 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.601 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 69.84 46.31 53.59 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.065 -0.97 . . . . 1.1699999999999999 111.201 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.765 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.451 -0.785 . . . . 2.0 109.993 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 3.6 mpp? . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.531 -0.174 . . . . 5.04 110.531 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 51.8 Cg_exo -55.12 146.23 60.34 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.277 2.652 . . . . 2.1299999999999999 112.779 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.66 134.57 26.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.844 -0.616 . . . . 1.47 110.277 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.558 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 15.6 t70 -162.2 156.57 21.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.816 -0.809 . . . . 1.8100000000000001 108.816 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.457 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.8 mm? -80.46 20.8 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.657 0.265 . . . . 0.69999999999999996 111.101 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -11.73 61.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.126 0.488 . . . . 1.96 110.906 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.566 ' HB3' HD12 ' A' ' 12' ' ' LEU . 95.3 mttt -116.86 30.88 7.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 2.6600000000000001 110.352 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.821 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -75.62 -23.4 56.37 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.452 0.538 . . . . 3.98 112.452 -173.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 13.7 p -152.9 26.47 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 0.63 111.199 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.97 -119.66 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.014 -0.834 . . . . 0.47999999999999998 111.014 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 19.4 Cg_endo -55.47 -36.47 94.27 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.832 2.355 . . . . 0.53000000000000003 110.329 164.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.761 HD11 ' HA3' ' A' ' 38' ' ' GLY . 13.4 mt -89.05 85.74 6.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.638 -1.164 . . . . 1.1699999999999999 110.669 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -74.78 62.41 1.08 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.70999999999999996 110.728 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.577 HD22 ' CG2' ' A' ' 121' ' ' VAL . 46.7 mt -78.03 -16.67 57.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.45000000000000001 111.577 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.49 -12.29 56.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.272 0.558 . . . . 2.1200000000000001 110.43 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -67.92 -20.27 65.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 1.9299999999999999 111.056 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.814 HG11 HG21 ' A' ' 69' ' ' THR . 70.6 t -92.09 -66.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.794 -0.639 . . . . 0.63 110.791 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.75 170.86 14.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 2.9900000000000002 110.682 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -70.22 105.79 3.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 1.6000000000000001 109.285 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.821 ' HG3' ' HB2' ' A' ' 8' ' ' TRP . 27.5 mm-40 -47.53 134.73 10.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 O-C-N 123.91 0.756 . . . . 3.5499999999999998 112.346 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 39.0 Cg_exo -62.43 169.04 8.72 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.389 3.392 . . . . 0.57999999999999996 114.898 -167.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.901 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 11.4 pt20 -82.25 -13.25 57.33 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.74 -1.118 . . . . 1.3899999999999999 111.907 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.77 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.6 m170 -149.09 159.52 37.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.871 -0.604 . . . . 1.45 109.544 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 3.9 Cg_endo -85.44 127.96 3.4 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.079 2.519 . . . . 0.40000000000000002 111.101 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 122' ' ' TRP . 26.9 tp -78.0 147.84 34.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.735 0.303 . . . . 0.28999999999999998 110.854 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -116.72 107.72 15.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.867 -0.42 . . . . 1.24 109.867 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.903 HG13 HG22 ' A' ' 53' ' ' ILE . 6.9 t -114.56 127.91 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.085 -0.709 . . . . 0.46999999999999997 109.085 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -126.27 138.82 53.65 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.923 0.392 . . . . 0.31 110.678 -176.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.42 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 36.6 t80 -101.51 170.96 7.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.019 -0.537 . . . . 0.67000000000000004 109.66 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.82 68.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.463 0.649 . . . . 0.55000000000000004 110.654 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -112.47 13.67 25.42 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.253 -0.885 . . . . 0.81000000000000005 112.511 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.4 -171.1 3.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.935 0.398 . . . . 0.46999999999999997 110.634 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.48 147.1 10.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.757 -0.656 . . . . 0.33000000000000002 110.203 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.842 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -104.36 58.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.084 -1.45 . . . . 0.39000000000000001 107.084 165.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.74 30.26 1.85 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.98999999999999999 109.793 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 8.4 tt0 -157.86 127.91 6.14 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.126 -0.943 . . . . 2.5600000000000001 108.827 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.591 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -68.58 111.17 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.40999999999999998 110.026 -176.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.761 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.11 14.86 63.64 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.447 -0.797 . . . . 0.58999999999999997 112.756 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.842 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.89 147.03 47.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 0.34000000000000002 109.653 175.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.2 p -74.38 132.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.912 0.387 . . . . 0.55000000000000004 110.956 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.56 HD22 HG22 ' A' ' 34' ' ' VAL . 6.3 tp -132.46 167.21 20.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.952 -0.759 . . . . 0.45000000000000001 108.952 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.86 157.07 47.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.699 0.629 . . . . 0.56000000000000005 112.699 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 89.3 Cg_exo -50.56 -45.84 32.77 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.158 2.572 . . . . 0.68000000000000005 113.044 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.63 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 8.2 p -54.65 -39.63 68.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.58 0.705 . . . . 0.76000000000000001 111.214 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -83.32 -7.91 59.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.01 -0.995 . . . . 1.5900000000000001 112.425 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' CE1' ' A' ' 169' ' ' TYR . 17.8 m -131.84 27.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.372 0.606 . . . . 0.66000000000000003 111.543 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -95.55 5.36 51.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.79000000000000004 110.574 -175.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -152.5 179.02 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 109.442 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -68.53 148.47 98.12 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.118 -0.327 . . . . 1.4299999999999999 110.118 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.43 166.29 26.19 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.059 1.839 . . . . 0.37 110.823 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -87.92 -19.09 27.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.894 -0.41 . . . . 0.44 109.894 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.531 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 47.6 m -158.1 143.11 16.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 112.785 0.661 . . . . 0.38 112.785 -176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.903 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.27 157.67 25.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.502 -1.226 . . . . 0.29999999999999999 107.915 170.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.897 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 t 173.77 135.42 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.11 -0.7 . . . . 0.34999999999999998 109.11 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.789 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -88.96 177.1 6.75 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.229 -1.026 . . . . 2.7200000000000002 108.229 173.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.67 76.86 0.11 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.873 0.368 . . . . 1.51 110.693 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.88 40.4 0.99 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.293 -0.48 . . . . 0.80000000000000004 112.84 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.897 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.5 tt -65.17 127.87 33.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.57999999999999996 110.145 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.2 -30.5 68.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.844 -0.616 . . . . 0.73999999999999999 111.947 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.534 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 44.8 m 72.14 -3.69 2.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.12 -0.946 . . . . 1.03 110.752 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.64 5.7 26.18 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.834 -0.621 . . . . 0.83999999999999997 112.501 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 9.0 mmpt? -111.86 160.33 17.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.614 0.245 . . . . 1.6699999999999999 110.366 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.771 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 mt -97.46 141.85 30.03 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.518 -1.29 . . . . 0.57999999999999996 107.518 168.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CE2' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -136.72 147.2 46.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.842 -0.343 . . . . 0.80000000000000004 110.205 -178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.917 HG23 HG12 ' A' ' 90' ' ' VAL . 4.4 m -95.7 104.76 16.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.622 -0.881 . . . . 0.35999999999999999 108.622 174.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.1 tp -101.7 109.12 20.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.587 -0.733 . . . . 0.58999999999999997 109.387 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 88' ' ' LEU . 20.9 t -115.3 122.45 69.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.405 -0.361 . . . . 0.39000000000000001 110.95 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.911 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -86.62 134.03 33.66 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.744 -0.836 . . . . 0.59999999999999998 108.744 169.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.814 HG21 HG11 ' A' ' 17' ' ' VAL . 13.3 t -138.9 148.56 43.78 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.928 -0.309 . . . . 0.35999999999999999 111.073 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 30.4 t70 -131.22 99.37 17.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.264 0.554 . . . . 1.9199999999999999 110.217 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.531 ' HD3' HG21 ' A' ' 17' ' ' VAL . 10.3 Cg_endo -53.4 -34.29 70.57 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 124.179 3.252 . . . . 1.25 114.437 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.815 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -89.96 40.2 0.99 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.174 0.435 . . . . 1.29 112.174 -168.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.06 144.92 29.65 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.708 -0.224 . . . . 0.5 111.506 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.0 Cg_endo -83.83 -20.58 18.78 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 123.259 -1.559 . . . . 0.62 112.102 -0.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.714 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 77.7 p -134.87 146.82 49.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.75 109.846 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.815 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 58.7 mtp180 -70.3 -22.74 62.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.916 0.339 . . . . 2.8799999999999999 111.916 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.849 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.45 -14.8 45.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.277 0.561 . . . . 1.3799999999999999 110.517 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.44 79.51 4.9 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.004 -0.739 . . . . 1.3700000000000001 109.004 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.97 81.28 1.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.863 2.376 . . . . 0.80000000000000004 113.049 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 13.6 mttm -71.99 -51.57 21.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.514 -1.221 . . . . 1.02 111.251 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.715 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 38.9 m-85 -86.39 19.11 2.89 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.401 -0.818 . . . . 1.1699999999999999 111.896 -167.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 6.7 ttp180 -67.05 127.19 31.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.856 -0.611 . . . . 2.9300000000000002 110.06 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.8 mp0 -98.2 138.61 35.22 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.328 0.251 . . . . 2.23 110.36 -1.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.467 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 5.9 t90 -89.88 105.81 18.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 1.4299999999999999 110.03 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.9 p80 -80.82 122.43 27.18 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.452 0.644 . . . . 1.26 110.203 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.911 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.6 t-160 -61.8 -40.56 95.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.981 -1.009 . . . . 2.1400000000000001 110.649 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 104' ' ' SER . 26.0 p90 -167.17 178.45 5.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.622 -0.511 . . . . 1.51 109.622 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.8 tp -141.84 113.65 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.708 0.289 . . . . 0.33000000000000002 110.247 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.53 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.8 t -120.42 132.47 69.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.817 -0.628 . . . . 0.31 110.573 176.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.917 HG12 HG23 ' A' ' 65' ' ' THR . 3.8 m -129.92 166.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.095 -1.076 . . . . 0.27000000000000002 108.095 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.771 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 91.1 m-20 60.85 20.44 10.65 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 123.486 0.491 . . . . 1.76 111.141 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.52 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -72.28 115.17 11.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.693 -0.854 . . . . 0.31 108.693 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 15.1 ttmm -87.06 93.17 9.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.314 -0.857 . . . . 1.21 111.307 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 60' ' ' SER . . . 80.33 -129.75 9.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 114.829 -1.078 . . . . 0.29999999999999999 112.48 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.473 ' HA ' HD11 ' A' ' 53' ' ' ILE . 26.1 p30 -112.91 22.12 14.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.604 0.716 . . . . 1.04 110.512 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.31 112.79 24.48 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.992 -1.004 . . . . 0.77000000000000002 109.609 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.453 HD13 HD12 ' A' ' 53' ' ' ILE . 5.3 mm -59.95 -27.6 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.358 -1.292 . . . . 0.40999999999999998 111.103 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -69.73 -51.36 34.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.68000000000000005 112.112 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 p -61.85 -20.55 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.822 0.675 . . . . 1.26 112.822 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 92' ' ' MET . . . -52.91 103.08 0.11 Allowed Glycine 0 N--CA 1.449 -0.455 0 O-C-N 123.352 0.408 . . . . 0.34999999999999998 112.92 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.4 m -68.05 107.39 2.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.436 0.636 . . . . 0.45000000000000001 109.773 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.68 120.77 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.896 -1.047 . . . . 0.56999999999999995 111.617 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 133' ' ' CYS . 55.8 mt -99.32 -44.71 6.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.227 1.013 . . . . 0.45000000000000001 109.289 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 12.9 t -120.51 111.9 18.27 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.885 -1.524 . . . . 0.37 106.885 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.842 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 2.3 t0 -64.84 162.04 17.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.551 -0.75 . . . . 1.1499999999999999 112.018 -170.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 31.0 p90 -81.23 61.22 4.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.339 0.866 . . . . 4.6900000000000004 113.339 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.926 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 27.0 t -37.54 -47.32 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.017 0.927 . . . . 0.85999999999999999 113.365 -171.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 107.12 -172.45 17.97 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.655 -0.783 . . . . 0.67000000000000004 112.505 173.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.4 t -68.9 117.29 10.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.564 -0.532 . . . . 0.51000000000000001 109.564 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.767 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -148.2 61.43 0.44 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.389 -0.91 . . . . 0.81999999999999995 112.662 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.677 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 9.8 Cg_endo -91.87 127.15 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 123.495 2.796 . . . . 0.84999999999999998 112.734 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.579 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 76.9 Cg_exo -53.8 146.02 47.53 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.796 2.331 . . . . 0.87 111.775 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.457 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -62.51 119.61 9.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.288 -0.414 . . . . 1.8500000000000001 111.221 -177.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.9 -1.51 55.29 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.861 -0.685 . . . . 1.1799999999999999 113.146 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 77.7 p -77.39 -26.33 51.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.998 0.399 . . . . 0.96999999999999997 112.002 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 -178.61 17.83 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.953 -0.641 . . . . 1.97 112.232 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.4 mm? -81.8 116.85 21.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.615 0.245 . . . . 0.93999999999999995 110.39 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.695 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 40.6 m-70 -92.81 126.8 38.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.416 -0.356 . . . . 2.23 110.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.505 ' HD2' HD21 ' A' ' 14' ' ' LEU . 8.9 ptt180 -108.56 85.92 2.19 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.757 -0.656 . . . . 2.3100000000000001 110.664 -172.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.51 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 5.8 m-85 -69.73 116.69 10.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.592 -0.731 . . . . 0.78000000000000003 109.549 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.577 ' CG2' HD22 ' A' ' 14' ' ' LEU . 15.1 t -97.43 128.96 48.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.037 -0.528 . . . . 0.27000000000000002 110.714 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.679 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 48.7 m95 -88.57 121.54 31.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.177 -0.675 . . . . 1.99 109.177 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.2 mt -118.31 119.91 36.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.624 0.193 . . . . 0.38 110.791 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.497 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -117.52 140.0 42.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.722 0.296 . . . . 0.31 111.121 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.716 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 89.3 t80 -129.53 129.09 44.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.177 -0.465 . . . . 5.1200000000000001 109.812 174.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.63 103.2 2.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.549 0.69 . . . . 2.4100000000000001 109.22 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 23.0 mt-30 -58.41 135.85 57.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.033 -0.985 . . . . 1.3100000000000001 112.028 -171.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.8 -13.25 61.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.486 -0.779 . . . . 2.3999999999999999 109.603 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.544 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 7.7 ptp180 -173.51 161.75 3.31 Favored Pre-proline 0 CA--C 1.515 -0.381 0 CA-C-N 114.838 -1.073 . . . . 3.5099999999999998 109.637 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.58 136.22 65.74 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.9 2.4 . . . . 1.21 110.691 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 158' ' ' TYR . 4.1 mm? -68.11 146.89 53.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.721 1.008 . . . . 0.90000000000000002 113.721 -167.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -99.1 96.52 7.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.176 -1.375 . . . . 2.8999999999999999 108.073 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.455 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.4 p -124.88 109.64 13.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.91 -0.586 . . . . 1.8999999999999999 111.728 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -102.72 18.18 22.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.908 -0.775 . . . . 2.96 108.908 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.79 135.41 96.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.183 -0.917 . . . . 1.3899999999999999 111.195 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.5 113.89 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.39 2.727 . . . . 1.27 112.531 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.49 120.28 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.85999999999999999 110.056 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 71.3 mt -99.66 154.59 18.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.13 0.49 . . . . 1.6100000000000001 110.54 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.704 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 72.1 m -108.03 31.56 5.43 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.263 -0.881 . . . . 1.8799999999999999 109.689 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.926 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 1.4 p-10 54.9 12.53 0.61 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.485 1.116 . . . . 0.75 111.553 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 139' ' ' SER . 17.1 mtm180 -96.71 146.85 24.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.3599999999999999 110.097 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.654 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.4 m 77.89 131.14 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.519 1.137 . . . . 0.94999999999999996 111.958 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.624 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -87.46 -6.5 77.46 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.086 -0.961 . . . . 1.1200000000000001 112.655 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.46 -42.75 70.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.605 0.717 . . . . 2.6600000000000001 111.374 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -97.3 20.01 12.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.354 -0.839 . . . . 1.8700000000000001 111.012 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.624 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 63.9 mtt180 -76.7 -69.92 0.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 4.7300000000000004 111.835 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.509 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -117.3 -173.01 16.32 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.217 -0.992 . . . . 0.65000000000000002 113.369 -171.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.715 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.5 mttt 68.33 21.89 8.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.728 0.775 . . . . 1.0800000000000001 110.602 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.661 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 87.7 m-85 -111.3 97.71 6.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.807 -1.088 . . . . 1.8899999999999999 108.476 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 13.2 mmmm -59.49 123.27 16.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 1.29 112.168 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.568 HG21 ' CG1' ' A' ' 17' ' ' VAL . 16.8 m -63.84 -25.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.242 -0.89 . . . . 0.78000000000000003 110.6 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.73 72.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.67000000000000004 109.608 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 m -59.81 -43.7 94.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.77000000000000002 110.633 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 149' ' ' PHE . 7.0 m-85 -58.56 -53.27 60.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.037 -0.528 . . . . 0.92000000000000004 111.584 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -69.76 -39.74 76.52 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.479 -0.488 . . . . 2.8900000000000001 111.379 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.61 -32.3 72.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.97 0.414 . . . . 0.96999999999999997 110.405 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -66.8 -51.38 56.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.527 -0.76 . . . . 1.5800000000000001 110.918 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.851 ' HB3' HD11 ' A' ' 131' ' ' LEU . 21.6 m-85 -80.23 3.91 19.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.075 -0.511 . . . . 5.4500000000000002 111.744 -172.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 8.4 mm-40 70.55 30.67 3.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.589 0.555 . . . . 2.4199999999999999 111.016 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.716 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.3 mp -102.34 134.24 45.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.563 -0.744 . . . . 1.27 109.79 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 7.8 tpt180 -102.74 -78.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 3.5899999999999999 111.181 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -125.85 145.77 52.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.009 0.433 . . . . 0.76000000000000001 110.805 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 2.9 Cg_exo -74.61 161.63 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.908 3.072 . . . . 0.53000000000000003 113.537 -172.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.901 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 14.4 t -91.43 -26.88 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.632 -1.167 . . . . 0.44 109.895 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.789 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -152.58 145.2 24.2 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.003 -0.679 . . . . 0.27000000000000002 112.231 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.44 151.05 23.36 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.035 -0.984 . . . . 0.23999999999999999 112.018 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.591 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.1 t -165.57 141.15 5.11 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.449 -0.945 . . . . 0.34000000000000002 108.449 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.609 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 17.3 p -119.0 149.32 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.034 -0.667 . . . . 1.1100000000000001 111.045 -175.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.606 ' CE1' HG11 ' A' ' 46' ' ' VAL . 35.7 p90 -130.32 129.71 43.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.94 -1.133 . . . . 0.80000000000000004 107.94 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.695 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -101.52 133.78 45.63 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.867 -0.733 . . . . 2.5299999999999998 111.417 177.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.94 152.17 49.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.218 -0.901 . . . . 0.59999999999999998 109.501 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.603 ' HB3' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -126.37 -162.41 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.006 0.432 . . . . 2.3799999999999999 111.322 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.457 ' CG ' ' HG2' ' A' ' 113' ' ' LYS . 89.6 t90 -70.46 103.2 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.96 -0.564 . . . . 3.96 110.343 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 2.0 t70 -73.69 -62.06 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.583 -0.28 . . . . 1.53 110.371 171.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.586 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 11.5 t70 169.45 -50.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 1.26 110.434 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.63 ' OH ' ' HA ' ' A' ' 44' ' ' THR . 2.4 p90 -82.72 9.8 8.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.189 0.519 . . . . 2.2200000000000002 111.094 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.767 HG13 ' HA2' ' A' ' 110' ' ' GLY . 48.1 t -58.47 -49.15 95.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.972 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 175' ' ' ASP . 72.9 Cg_exo -47.89 -33.75 20.59 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.039 2.493 . . . . 0.57999999999999996 112.899 168.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 3.0 mmmp? -72.69 -25.56 61.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.636 0.255 . . . . 2.1400000000000001 111.108 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.528 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 62.5 tp -70.58 -44.29 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.049 -0.723 . . . . 0.66000000000000003 109.049 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.27 -32.95 74.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.316 -0.856 . . . . 1.8899999999999999 109.446 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 18.5 mm-40 -60.84 -38.29 85.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.955 -1.02 . . . . 1.53 111.02 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.33 -27.08 56.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.74 -0.663 . . . . 1.49 111.439 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.654 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.2 mt -65.93 6.6 0.35 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.852 0.686 . . . . 0.76000000000000001 112.852 -177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.746 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 19.2 m -77.15 8.31 4.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 1.05 109.955 173.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 68.89 50.54 34.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.104 -0.798 . . . . 1.1699999999999999 111.104 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.746 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.8 mmmt . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.667 -0.682 . . . . 2.0 110.582 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.141 -0.318 . . . . 5.04 110.141 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.46 104.41 1.57 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.341 2.027 . . . . 2.1299999999999999 110.88 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.4 p -112.12 146.7 16.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.45 -1.25 . . . . 1.47 110.275 -173.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.776 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 2.2 p30 -163.39 179.93 6.98 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.142 -1.058 . . . . 1.8100000000000001 108.142 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 8' ' ' TRP . 2.7 mm? -80.93 36.01 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.69999999999999996 110.866 -170.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -51.91 -40.1 60.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.886 -0.597 . . . . 1.96 111.834 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.572 ' HB2' HD12 ' A' ' 12' ' ' LEU . 92.0 mttt -116.17 46.16 1.62 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.868 -0.419 . . . . 2.6600000000000001 109.868 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.639 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -66.43 -24.21 66.42 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.286 -0.416 . . . . 3.98 111.328 -173.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.1 p -151.6 26.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.951 -0.3 . . . . 0.63 111.347 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.505 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.85 -125.5 0.81 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.888 -0.885 . . . . 0.47999999999999998 110.888 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.8 Cg_endo -52.02 -36.29 64.45 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.109 2.54 . . . . 0.53000000000000003 110.342 167.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.773 HD11 ' HA3' ' A' ' 38' ' ' GLY . 35.3 mt -87.87 79.26 8.14 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.825 -1.08 . . . . 1.1699999999999999 109.606 171.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -71.44 66.73 0.48 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.615 0.722 . . . . 0.70999999999999996 109.82 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.927 HD23 HH11 ' A' ' 119' ' ' ARG . 44.1 mt -80.45 -16.39 54.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.741 -0.663 . . . . 0.45000000000000001 110.65 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -64.13 -16.17 61.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.589 -0.732 . . . . 2.1200000000000001 111.225 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.551 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 39.3 mt-10 -62.34 -30.33 71.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.189 0.519 . . . . 1.9299999999999999 110.546 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 69' ' ' THR . 85.7 t -93.41 -64.03 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.63 111.16 -174.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 163' ' ' PRO . 7.1 p-10 -130.04 169.05 15.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.152 -0.476 . . . . 2.9900000000000002 110.219 -171.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -74.57 88.16 2.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.443 -0.947 . . . . 1.6000000000000001 108.443 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HG2' ' HB2' ' A' ' 8' ' ' TRP . 2.7 tp-100 -38.34 122.61 1.1 Allowed Pre-proline 0 C--O 1.237 0.433 0 O-C-N 124.925 1.391 . . . . 3.5499999999999998 111.901 -166.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.724 ' HG3' ' HB2' ' A' ' 163' ' ' PRO . 81.5 Cg_exo -50.29 161.64 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 125.235 3.957 . . . . 0.57999999999999996 116.193 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 12.6 pt20 -79.1 -6.96 57.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 113.837 -1.529 . . . . 1.3899999999999999 111.46 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.722 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 7.6 m170 -154.28 158.85 32.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.468 -0.787 . . . . 1.45 109.236 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.776 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 6.0 Cg_endo -86.74 129.12 2.98 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.193 2.595 . . . . 0.40000000000000002 111.844 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 ' HB3' ' A' ' 122' ' ' TRP . 21.5 tp -78.88 144.54 34.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.654 -0.248 . . . . 0.28999999999999998 110.728 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.403 ' H ' HD12 ' A' ' 25' ' ' LEU . 86.2 m-70 -112.64 112.94 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 1.24 109.89 174.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 53' ' ' ILE . 12.0 t -121.12 137.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.423 -0.584 . . . . 0.46999999999999997 109.423 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.557 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -132.4 141.24 48.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.271 0.558 . . . . 0.31 111.063 -177.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -103.14 173.32 6.35 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.857 -0.794 . . . . 0.67000000000000004 108.857 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.41 -52.29 65.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.291 0.567 . . . . 0.55000000000000004 110.347 176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.96 14.77 23.83 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.178 -0.919 . . . . 0.81000000000000005 112.999 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.54 -172.25 4.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.46999999999999997 111.148 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.95 151.61 12.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.71 -0.677 . . . . 0.33000000000000002 110.05 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.795 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 86.2 t -109.23 65.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.157 -1.423 . . . . 0.39000000000000001 107.157 164.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.83 21.07 16.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.002 -0.999 . . . . 0.98999999999999999 109.15 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -145.83 128.1 15.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.687 -1.227 . . . . 2.5600000000000001 107.687 176.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -77.96 111.74 14.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.611 0.72 . . . . 0.40999999999999998 110.803 -170.122 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 83.17 22.35 57.28 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.742 -1.117 . . . . 0.58999999999999997 111.385 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -77.68 148.73 34.84 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.388 -0.597 . . . . 0.34000000000000002 109.388 173.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.96 133.44 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.001 0.429 . . . . 0.55000000000000004 110.874 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.566 HD22 HG22 ' A' ' 34' ' ' VAL . 7.4 tp -131.58 170.29 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.45000000000000001 108.618 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.6 p -120.03 158.46 50.25 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.317 0.858 . . . . 0.56000000000000005 113.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 74.9 Cg_exo -50.29 -49.19 17.12 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.438 2.759 . . . . 0.68000000000000005 113.569 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.7 p -55.72 -42.83 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.462 0.649 . . . . 0.76000000000000001 111.52 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -73.21 -12.32 60.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.874 -1.057 . . . . 1.5900000000000001 112.225 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.562 ' CG1' HD23 ' A' ' 41' ' ' LEU . 31.5 m -131.7 28.25 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.087 0.47 . . . . 0.66000000000000003 111.455 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -85.12 -33.85 22.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.818 -0.628 . . . . 0.79000000000000004 110.467 -176.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.46 -155.89 0.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.786 -0.643 . . . . 1.9099999999999999 109.556 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -84.01 157.19 63.39 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.394 -0.595 . . . . 1.4299999999999999 109.394 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.4 160.44 28.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.755 1.637 . . . . 0.37 110.594 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -82.15 -20.72 37.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.105 -0.332 . . . . 0.44 110.105 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 57.9 m -160.32 144.86 14.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.239 0.542 . . . . 0.38 112.056 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.971 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.1 168.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.154 -0.93 . . . . 0.29999999999999999 108.575 171.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.02 ' HA ' HD13 ' A' ' 58' ' ' LEU . 29.3 t 174.04 122.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.462 -0.57 . . . . 0.34999999999999998 109.462 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.737 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -79.45 179.52 7.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.337 -0.986 . . . . 2.7200000000000002 108.337 174.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -68.8 80.8 0.29 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.15 0.5 . . . . 1.51 110.473 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.17 41.58 1.51 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.633 -0.712 . . . . 0.80000000000000004 112.386 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.02 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -55.54 133.74 50.41 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.83 0.452 . . . . 0.57999999999999996 111.51 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.55 -27.38 60.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.848 -0.615 . . . . 0.73999999999999999 111.867 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.626 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 49.3 m 68.23 8.32 6.5 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.561 -0.745 . . . . 1.03 110.834 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.689 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -137.17 -47.87 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.905 -0.589 . . . . 0.83999999999999997 112.662 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.798 ' HB2' ' HE1' ' A' ' 64' ' ' TYR . 8.3 mmpt? -58.66 144.54 42.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.231 0.538 . . . . 1.6699999999999999 111.411 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.735 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 31.0 mt -86.82 127.73 35.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.111 -0.95 . . . . 0.57999999999999996 109.486 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.798 ' HE1' ' HB2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -122.3 158.66 29.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.55 -0.46 . . . . 0.80000000000000004 110.278 176.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.724 HG23 HG12 ' A' ' 90' ' ' VAL . 96.0 m -98.51 109.39 22.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.392 -0.596 . . . . 0.35999999999999999 109.392 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 tp -106.15 116.83 32.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 110.052 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.9 t -120.98 132.43 70.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.76 0.314 . . . . 0.39000000000000001 110.74 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.922 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.7 mt -97.49 131.57 44.0 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.508 -0.923 . . . . 0.59999999999999998 108.508 168.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.716 HG21 HG11 ' A' ' 17' ' ' VAL . 11.0 t -138.82 147.53 42.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.142 0.428 . . . . 0.35999999999999999 111.657 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 25.6 t70 -131.28 97.43 19.82 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.161 0.505 . . . . 1.9199999999999999 109.805 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.9 Cg_endo -51.63 -34.56 53.58 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.99 3.127 . . . . 1.25 114.298 176.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.737 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.7 m-20 -86.97 44.82 1.2 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.654 0.612 . . . . 1.29 112.654 -170.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.08 142.12 23.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.687 -0.233 . . . . 0.5 110.706 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 92.1 Cg_endo -85.07 -24.76 9.58 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 123.465 -1.473 . . . . 0.62 113.096 -0.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.714 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 13.2 p -128.76 146.45 50.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.75 109.793 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.737 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 50.8 mtp180 -65.99 -21.89 66.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 2.8799999999999999 111.141 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 6.0 ptpt -79.66 -14.26 58.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 1.3799999999999999 110.829 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 16.4 t70 -162.09 80.51 1.88 Allowed Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.007 -0.542 . . . . 1.3700000000000001 110.188 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 85.6 Cg_endo -80.95 87.21 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.543 2.162 . . . . 0.80000000000000004 112.93 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -74.74 -50.97 15.49 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.738 -1.119 . . . . 1.02 110.661 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.708 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.1 m-85 -85.45 21.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 1.1699999999999999 111.742 -166.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.551 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 29.4 ttt180 -71.66 129.56 38.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.382 -0.372 . . . . 2.9300000000000002 110.685 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 3.0 mp0 -96.44 132.04 42.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.859 0.361 . . . . 2.23 110.632 -3.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.56 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 11.9 t90 -82.65 140.3 33.23 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.012 -0.736 . . . . 1.4299999999999999 109.012 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 28.6 p80 -117.72 127.15 53.64 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.633 0.73 . . . . 1.26 111.258 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.922 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 15.5 t-80 -65.45 -35.89 82.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.806 -1.088 . . . . 2.1400000000000001 110.36 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.548 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 12.0 p90 -168.06 176.79 5.9 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.651 -0.249 . . . . 1.51 110.363 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.55 ' HG ' HD12 ' A' ' 103' ' ' LEU . 21.5 tp -135.77 113.53 11.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.05 -0.523 . . . . 0.33000000000000002 109.657 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.714 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.9 t -119.66 133.23 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.648 -0.706 . . . . 0.31 110.19 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.897 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 22.2 m -133.94 161.75 40.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.285 -0.871 . . . . 0.27000000000000002 108.956 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t30 60.71 22.01 11.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.661 0.601 . . . . 1.76 110.353 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.714 ' HE3' HG11 ' A' ' 89' ' ' VAL . 6.7 ttm -71.88 110.3 6.31 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.175 -0.676 . . . . 0.31 109.175 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 20.9 ttmm -80.34 98.28 7.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.539 -1.21 . . . . 1.21 111.133 -173.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.81 -121.76 20.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.603 -0.726 . . . . 0.29999999999999999 112.509 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HA ' HD11 ' A' ' 53' ' ' ILE . 28.8 p-10 -113.26 21.42 15.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.567 -0.316 . . . . 1.04 111.735 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -89.51 104.22 16.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.415 0.626 . . . . 0.77000000000000002 109.848 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 97' ' ' ILE . 5.2 mm -55.55 -31.28 28.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.584 -1.189 . . . . 0.40999999999999998 111.561 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -81.04 -26.38 36.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.68000000000000005 111.602 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.05 -13.04 60.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.492 -0.322 . . . . 1.26 111.225 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.62 100.53 0.83 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.78 -0.724 . . . . 0.34999999999999998 111.579 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.2 m -60.24 106.55 0.54 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.476 0.655 . . . . 0.45000000000000001 109.668 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -80.19 113.1 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.847 -1.07 . . . . 0.56999999999999995 111.214 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.55 HD12 ' HG ' ' A' ' 88' ' ' LEU . 47.7 mt -93.2 -41.97 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.99 0.9 . . . . 0.45000000000000001 109.243 174.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 11.9 t -122.68 112.22 17.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.192 -1.41 . . . . 0.37 107.192 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 3.4 t70 -59.96 164.41 3.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.652 -0.704 . . . . 1.1499999999999999 112.217 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 10.3 p90 -79.24 72.27 5.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.269 -0.878 . . . . 4.6900000000000004 111.002 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.725 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 28.1 t -51.45 -44.68 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.628 -0.715 . . . . 0.85999999999999999 111.447 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.69 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 97.72 -171.75 26.57 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.26 -0.971 . . . . 0.67000000000000004 113.416 171.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 41.0 t -73.42 128.68 36.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.778 -0.452 . . . . 0.51000000000000001 109.778 174.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.602 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . 171.99 58.64 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.211 -0.995 . . . . 0.81999999999999995 113.706 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.405 ' HD3' ' H ' ' A' ' 110' ' ' GLY . 62.9 Cg_endo -86.69 -176.66 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.628 2.219 . . . . 0.84999999999999998 111.005 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.628 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 48.1 Cg_exo -57.14 142.25 94.38 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.464 1.443 . . . . 0.87 111.81 172.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.414 ' CD ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -66.1 114.69 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.514 -0.766 . . . . 1.8500000000000001 111.46 -177.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.15 12.7 38.59 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 1.1799999999999999 113.698 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.714 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 34.0 p -81.65 2.09 31.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.82 1.044 . . . . 0.96999999999999997 113.82 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.25 -179.73 27.16 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.612 -0.804 . . . . 1.97 112.375 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -83.41 118.03 23.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.938 0.399 . . . . 0.93999999999999995 110.141 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.692 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 47.1 m-70 -91.39 117.76 29.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.103 -0.499 . . . . 2.23 110.952 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.927 HH11 HD23 ' A' ' 14' ' ' LEU . 9.9 ptt180 -91.51 82.01 5.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.67 -0.695 . . . . 2.3100000000000001 111.313 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.548 ' HB2' ' CE2' ' A' ' 169' ' ' TYR . 42.4 m-85 -67.76 109.39 3.33 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.753 -0.832 . . . . 0.78000000000000003 108.753 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 14' ' ' LEU . 21.9 t -88.09 127.32 41.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.901 -0.59 . . . . 0.27000000000000002 109.971 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.846 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.92 117.53 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.486 -0.931 . . . . 1.99 108.486 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 mt -121.26 127.57 51.52 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.959 0.162 . . . . 0.38 110.899 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.602 HG21 ' HE3' ' A' ' 55' ' ' TRP . 1.1 m -114.4 131.54 66.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.459 -0.496 . . . . 0.31 109.917 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.729 ' HB2' HD23 ' A' ' 160' ' ' LEU . 48.4 m-85 -111.95 149.13 32.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.325 -0.62 . . . . 5.1200000000000001 109.325 176.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.93 126.66 48.89 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.671 0.748 . . . . 2.4100000000000001 110.449 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.506 ' HG2' HD21 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -96.82 175.51 6.33 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.183 -0.917 . . . . 1.3100000000000001 108.714 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.53 2.71 42.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.547 0.689 . . . . 2.3999999999999999 109.498 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.407 ' H ' ' HB2' ' A' ' 127' ' ' GLN . 1.3 ptp180 -160.66 164.98 18.24 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.947 -1.024 . . . . 3.5099999999999998 111.206 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.01 155.42 33.81 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.027 2.485 . . . . 1.21 110.946 169.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.897 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.4 mm? -84.14 145.91 28.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.311 0.577 . . . . 0.90000000000000002 112.143 -172.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -124.31 66.06 1.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.142 -0.935 . . . . 2.8999999999999999 108.741 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 5.2 m -93.6 120.99 34.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.537 -0.756 . . . . 1.8999999999999999 110.395 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.88 14.97 30.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.667 -0.697 . . . . 2.96 109.936 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -64.73 132.14 95.35 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.429 -0.805 . . . . 1.3899999999999999 110.563 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -47.09 117.08 2.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.539 2.826 . . . . 1.27 113.067 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.19 118.67 6.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.85999999999999999 110.496 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.4 mt -92.7 156.08 17.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 1.6100000000000001 110.608 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 50.2 m -116.03 32.57 6.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.8799999999999999 110.172 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.725 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER 66.75 -21.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.238 1.415 . . . . 0.75 113.45 175.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 54.9 mtt180 -78.31 135.44 37.51 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.776 -0.37 . . . . 3.3599999999999999 110.868 -175.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.713 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 62.1 m 81.84 146.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.559 -1.201 . . . . 0.94999999999999996 110.674 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.453 ' HA2' ' HG3' ' A' ' 146' ' ' ARG . . . -108.22 12.71 37.04 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.867 -0.682 . . . . 1.1200000000000001 113.038 -170.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.17 -15.22 62.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.324 0.49 . . . . 2.6600000000000001 112.324 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -121.58 34.85 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.087 0.47 . . . . 1.8700000000000001 110.324 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.453 ' HG3' ' HA2' ' A' ' 143' ' ' GLY . 26.6 mtt180 -81.05 -69.68 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.662 -0.699 . . . . 4.7300000000000004 111.902 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -128.31 -164.38 11.55 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.447 -0.882 . . . . 0.65000000000000002 112.763 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.708 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 65.43 25.27 11.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.441 0.639 . . . . 1.0800000000000001 110.229 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.26 112.31 21.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.083 -0.962 . . . . 1.8899999999999999 109.095 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 13.7 mmmm -67.18 122.17 17.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.805 -0.634 . . . . 1.29 111.525 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.801 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 17.2 m -62.85 -27.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.78000000000000003 110.351 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -61.31 -43.34 99.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.759 172.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 34.9 m -63.87 -39.33 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.944 -0.571 . . . . 0.77000000000000002 110.618 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.801 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 50.4 m-85 -58.81 -52.05 67.37 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.649 -0.251 . . . . 0.92000000000000004 110.999 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.943 -0.303 . . . . 2.8900000000000001 111.358 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 58.4 mtmt -64.17 -42.25 96.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.38 0.609 . . . . 0.96999999999999997 109.935 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -58.77 -53.27 60.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 1.5800000000000001 111.449 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.41 -3.33 58.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.403 -0.362 . . . . 5.4500000000000002 111.493 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 68.22 40.89 2.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.792 -0.64 . . . . 2.4199999999999999 111.27 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.729 HD23 ' HB2' ' A' ' 125' ' ' TYR . 5.4 mp -95.97 146.34 24.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.451 -0.795 . . . . 1.27 112.008 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.755 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 14.5 tpt180 -82.73 -171.24 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.291 -0.868 . . . . 3.5899999999999999 109.853 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.755 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -60.98 155.74 52.35 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.76000000000000001 110.639 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.724 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 13.2 Cg_exo -66.7 141.93 61.89 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.968 2.445 . . . . 0.53000000000000003 112.279 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.861 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 12.2 t -89.47 -34.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.794 -0.639 . . . . 0.44 110.092 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.737 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -146.26 141.37 27.28 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.903 -0.719 . . . . 0.27000000000000002 112.128 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.56 148.94 20.93 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.024 -0.989 . . . . 0.23999999999999999 111.976 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.6 t -159.85 133.05 6.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.798 -0.816 . . . . 0.34000000000000002 108.798 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.576 ' SG ' HD13 ' A' ' 12' ' ' LEU . 22.2 p -111.07 142.42 43.25 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 1.1100000000000001 111.33 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.548 ' CE2' ' HB2' ' A' ' 120' ' ' TYR . 32.3 p90 -126.61 134.14 50.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.567 -0.901 . . . . 0.80000000000000004 108.567 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.807 HE22 ' HA2' ' A' ' 38' ' ' GLY . 24.1 mp0 -98.6 131.88 44.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.212 -0.595 . . . . 2.5299999999999998 110.104 173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -121.21 142.37 49.98 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.36 0.412 . . . . 0.59999999999999998 110.345 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -97.18 -171.8 2.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 2.3799999999999999 111.263 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.853 ' HA ' HG21 ' A' ' 177' ' ' VAL . 28.5 p90 -97.41 53.62 1.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.226 -0.897 . . . . 3.96 110.508 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.506 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 32.6 t70 -60.28 -61.74 2.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.6 0.963 . . . . 1.53 113.6 -168.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.668 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.9 t70 -167.4 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.017 0.377 . . . . 1.26 112.017 -175.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -71.95 -3.89 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.148 0.499 . . . . 2.2200000000000002 110.876 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.853 HG21 ' HA ' ' A' ' 173' ' ' TRP . 25.6 t -71.02 -55.1 6.78 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.749 . . . . 0.5 111.316 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.729 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.4 Cg_exo -58.2 -32.09 94.98 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.999 1.799 . . . . 0.57999999999999996 111.764 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.3 mmmt -74.06 -24.77 59.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 2.1400000000000001 111.913 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.686 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 43.9 tp -70.53 -47.25 61.33 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.13 -0.628 . . . . 0.66000000000000003 109.375 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -59.27 -35.46 73.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.603 -0.726 . . . . 1.8899999999999999 109.405 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.3 -51.48 68.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.807 -1.088 . . . . 1.53 111.002 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -69.17 -32.04 71.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 1.49 112.277 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.713 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.1 mt -62.77 3.65 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.503 0.927 . . . . 0.76000000000000001 113.503 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.611 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 47.7 m -82.84 13.34 3.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.413 0.625 . . . . 1.05 109.336 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.82 44.1 57.14 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.368 -0.833 . . . . 1.1699999999999999 111.162 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 28.8 mmmt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.344 -0.836 . . . . 2.0 109.841 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 121.293 0.568 . . . . 5.04 109.598 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.86 138.23 47.77 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 124.17 3.246 . . . . 2.1299999999999999 114.22 -162.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 37' ' ' LEU . 21.2 t -55.18 132.7 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.167 -1.378 . . . . 1.47 110.217 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.27 33.93 0.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.057 0.932 . . . . 1.8100000000000001 110.49 -173.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD22 ' HG3' ' A' ' 24' ' ' PRO . 1.5 mm? 60.11 20.86 10.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.414 -1.266 . . . . 0.69999999999999996 110.757 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.72 -33.72 64.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.613 0.765 . . . . 1.96 112.334 -171.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.645 ' CB ' HD12 ' A' ' 12' ' ' LEU . 76.1 mttt -135.75 50.18 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.207 -0.451 . . . . 2.6600000000000001 110.375 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.432 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -72.87 -28.71 62.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.341 0.497 . . . . 3.98 112.341 -176.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 19.5 p -152.65 29.11 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.63 111.208 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.26 -122.69 0.83 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.957 -0.857 . . . . 0.47999999999999998 110.957 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.6 Cg_endo -52.8 -37.56 76.7 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.222 2.615 . . . . 0.53000000000000003 110.343 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.833 HD11 ' HA3' ' A' ' 38' ' ' GLY . 16.5 mt -87.73 83.06 7.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.951 -1.022 . . . . 1.1699999999999999 109.657 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -73.5 63.42 0.8 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.519 0.676 . . . . 0.70999999999999996 110.497 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 121' ' ' VAL . 58.9 mt -71.19 -16.6 62.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.729 -0.669 . . . . 0.45000000000000001 109.79 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -70.42 -4.47 22.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.49 -0.777 . . . . 2.1200000000000001 110.694 177.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.89 -27.06 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.624 -0.88 . . . . 1.9299999999999999 108.624 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 151' ' ' VAL . 60.0 t -99.1 -71.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.609 -1.178 . . . . 0.63 110.408 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HB2' HH22 ' A' ' 155' ' ' ARG . 7.5 p-10 -110.7 153.35 25.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 111.564 -172.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 26.1 mt-10 -65.51 142.15 58.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.001 -1.0 . . . . 1.6000000000000001 109.326 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 98.7 mt-30 -55.61 120.59 33.17 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 123.335 0.397 . . . . 3.5499999999999998 111.132 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 20' ' ' GLN . 23.2 Cg_exo -64.27 162.08 31.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.051 2.501 . . . . 0.57999999999999996 112.685 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.899 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 16.9 pt20 -84.82 -12.85 52.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.779 -0.646 . . . . 1.3899999999999999 111.217 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.778 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 66.3 m-70 -153.2 161.43 29.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.415 -0.957 . . . . 1.45 108.415 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HG3' HD22 ' A' ' 5' ' ' LEU . 5.7 Cg_endo -88.22 132.27 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.852 2.368 . . . . 0.40000000000000002 112.233 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 122' ' ' TRP . 28.3 tp -78.31 144.75 35.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.807 -0.442 . . . . 0.28999999999999998 109.807 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.463 ' H ' HD12 ' A' ' 25' ' ' LEU . 31.4 m80 -122.81 113.35 19.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.609 -0.515 . . . . 1.24 109.609 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 53' ' ' ILE . 10.6 t -117.65 136.43 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.731 -0.47 . . . . 0.46999999999999997 109.731 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -134.45 136.79 43.48 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.061 0.458 . . . . 0.31 111.076 -176.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -97.16 176.26 5.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.975 -0.75 . . . . 0.67000000000000004 108.975 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.68 62.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.508 0.671 . . . . 0.55000000000000004 110.191 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.91 1.56 31.74 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 115.089 -0.959 . . . . 0.81000000000000005 112.666 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB2' HE21 ' A' ' 45' ' ' GLN . . . -138.16 -174.75 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.633 0.254 . . . . 0.46999999999999997 110.605 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.58 149.64 11.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.154 -0.476 . . . . 0.33000000000000002 110.392 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.815 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 96.2 t -101.78 62.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 106.71 -1.589 . . . . 0.39000000000000001 106.71 163.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.77 -9.3 59.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.032 -1.44 . . . . 0.98999999999999999 110.882 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -131.44 134.56 46.34 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.567 -0.901 . . . . 2.5600000000000001 108.567 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.621 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -75.84 109.62 9.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.376 -0.601 . . . . 0.40999999999999998 109.376 -175.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.833 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 85.07 23.38 49.16 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.391 -0.822 . . . . 0.58999999999999997 112.471 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.815 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -80.19 149.52 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.627 -0.508 . . . . 0.34000000000000002 109.627 171.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -73.86 133.02 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.155 0.502 . . . . 0.55000000000000004 110.983 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.461 HD22 HG22 ' A' ' 34' ' ' VAL . 7.9 tp -131.06 168.55 17.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.115 -1.069 . . . . 0.45000000000000001 108.115 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 23.2 p -121.87 157.13 58.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 119.569 -0.853 . . . . 0.56000000000000005 112.349 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 10.1 Cg_endo -51.53 -41.99 57.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.093 2.529 . . . . 0.68000000000000005 113.028 -176.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -62.71 -26.82 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.111 -0.495 . . . . 0.76000000000000001 112.159 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 32' ' ' ALA . 56.7 mt-30 -82.27 -25.34 34.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.945 -0.571 . . . . 1.5900000000000001 111.289 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 169' ' ' TYR . 18.5 m -122.01 29.11 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.66000000000000003 111.552 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -87.12 -7.33 58.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.014 -0.539 . . . . 0.79000000000000004 110.202 -177.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.461 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 59.2 m-80 -127.26 -174.91 3.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.603 -0.726 . . . . 1.9099999999999999 109.315 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.597 ' NH2' ' HB ' ' A' ' 102' ' ' VAL . 72.5 mtt180 -77.0 155.11 82.84 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.75 -0.463 . . . . 1.4299999999999999 109.75 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.23 153.42 18.62 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.06 1.84 . . . . 0.37 110.874 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -79.25 -18.57 52.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.909 0.385 . . . . 0.44 110.223 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.482 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -157.0 141.35 16.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.524 0.678 . . . . 0.38 112.446 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.913 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.23 158.28 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.773 -1.103 . . . . 0.29999999999999999 108.503 172.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.115 ' HA ' HD13 ' A' ' 58' ' ' LEU . 26.3 t -179.23 122.04 0.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.976 -0.379 . . . . 0.34999999999999998 109.976 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.829 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -76.12 156.0 34.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.347 -1.353 . . . . 2.7200000000000002 107.347 170.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.529 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 17.8 t70 -59.84 85.9 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.25 0.548 . . . . 1.51 110.715 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.93 15.17 5.33 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.61 -0.723 . . . . 0.80000000000000004 112.765 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.115 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.2 tt -50.79 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.505 . . . . 0.57999999999999996 111.182 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 23.4 t70 -71.14 -29.97 65.89 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.644 -0.707 . . . . 0.73999999999999999 111.453 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 m 72.82 15.44 4.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.679 -1.146 . . . . 1.03 110.245 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.78 -6.98 0.3 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.474 -0.87 . . . . 0.83999999999999997 114.03 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 30.5 mtpt -96.17 161.27 14.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.028 0.914 . . . . 1.6699999999999999 110.46 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 51.5 mt -90.97 132.32 36.04 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.878 -0.786 . . . . 0.57999999999999996 108.878 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.564 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.3 OUTLIER -132.83 147.72 52.31 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.646 -0.421 . . . . 0.80000000000000004 110.317 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.649 HG23 HG12 ' A' ' 90' ' ' VAL . 65.5 m -95.54 105.57 17.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.772 -0.825 . . . . 0.35999999999999999 108.772 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 57.1 tp -106.49 113.48 27.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.552 -0.749 . . . . 0.58999999999999997 109.697 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 88' ' ' LEU . 44.3 t -114.42 129.45 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.39000000000000001 110.452 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.0 mt -85.17 124.04 31.37 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.64 -0.874 . . . . 0.59999999999999998 108.64 168.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -135.83 138.18 42.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.926 0.393 . . . . 0.35999999999999999 110.011 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 17.6 p-10 -125.93 102.23 28.45 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 121.523 0.678 . . . . 1.9199999999999999 110.729 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -54.77 -177.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.378 2.718 . . . . 1.25 112.808 170.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.636 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 4.6 m-20 55.1 41.42 31.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 1.29 111.274 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.57 140.58 21.22 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 115.726 -0.67 . . . . 0.5 110.176 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.502 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 90.6 Cg_endo -81.65 -26.44 9.03 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.003 -1.665 . . . . 0.62 112.475 2.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.783 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 89.3 p -123.11 146.13 47.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.592 . . . . 0.75 110.314 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.636 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 74.4 ttt180 -67.55 -23.21 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 2.8799999999999999 111.257 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.722 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -82.87 -18.35 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 1.3799999999999999 111.064 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.15 90.12 2.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.048 -0.524 . . . . 1.3700000000000001 109.875 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 91.8 Cg_endo -85.33 93.46 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.863 2.375 . . . . 0.80000000000000004 113.814 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.502 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 23.4 mttm -82.69 -50.3 8.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.749 0.785 . . . . 1.02 110.477 174.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.79 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 63.7 m-85 -88.1 25.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.966 -1.015 . . . . 1.1699999999999999 111.225 -170.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.703 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.52 128.7 33.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.306 -0.406 . . . . 2.9300000000000002 110.445 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.703 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.0 mp0 -94.83 149.59 21.09 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.067 0.46 . . . . 2.23 110.773 -3.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.524 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 4.4 t90 -92.06 137.37 32.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.08 -1.081 . . . . 1.4299999999999999 108.08 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.473 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 9.1 p-80 -110.5 141.06 44.17 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.339 -0.615 . . . . 1.26 109.339 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 -15.14 12.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.248 0.833 . . . . 2.1400000000000001 113.248 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.496 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 3.2 p90 -169.38 166.59 10.34 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.447 -0.205 . . . . 1.51 110.447 162.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 67' ' ' VAL . 33.6 tp -133.84 113.96 12.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.151 -0.477 . . . . 0.33000000000000002 109.922 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.527 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -123.83 132.47 71.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.658 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 65' ' ' THR . 22.1 m -134.02 161.17 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.101 -0.954 . . . . 0.27000000000000002 108.793 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.3 t30 63.37 16.79 9.79 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.506 0.504 . . . . 1.76 110.273 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.527 ' HE3' HG11 ' A' ' 89' ' ' VAL . 6.8 ttm -67.42 111.8 4.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.718 -0.845 . . . . 0.31 108.718 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -87.64 96.89 10.59 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.005 -0.998 . . . . 1.21 111.016 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.63 -126.49 9.11 Favored Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 114.857 -1.065 . . . . 0.29999999999999999 112.284 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.534 ' HA ' HD11 ' A' ' 53' ' ' ILE . 4.4 p-10 -112.56 23.26 13.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 1.04 110.7 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.9 109.02 19.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.77000000000000002 109.908 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -59.45 -33.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.40999999999999998 110.625 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.3 m -73.6 -34.75 65.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.795 -0.638 . . . . 0.68000000000000005 111.951 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -75.5 -6.16 48.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.882 0.327 . . . . 1.26 111.882 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 92' ' ' MET . . . -70.82 96.6 0.6 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.451 -0.881 . . . . 0.34999999999999998 111.836 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.8 m -60.96 107.73 0.76 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.45000000000000001 110.325 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.597 ' HB ' ' NH2' ' A' ' 49' ' ' ARG . 7.5 p -87.51 130.25 37.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.86 -1.064 . . . . 0.56999999999999995 111.76 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 10.3 mt -112.2 -49.94 2.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.101 0.953 . . . . 0.45000000000000001 108.874 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.3 t -109.58 99.67 8.83 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.005 -1.48 . . . . 0.37 107.005 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.475 ' HB2' ' N ' ' A' ' 140' ' ' ASN . 3.7 m-20 -56.86 157.58 5.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.139 -0.937 . . . . 1.1499999999999999 113.114 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 14.7 p90 -74.31 107.58 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.782 -1.099 . . . . 4.6900000000000004 110.143 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.3 t -80.72 -15.69 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.543 0.687 . . . . 0.85999999999999999 110.276 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.53 -146.61 22.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.998 -0.62 . . . . 0.67000000000000004 111.801 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.593 ' O ' HD22 ' A' ' 180' ' ' LEU . 14.2 t -83.2 140.92 32.28 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.677 -0.49 . . . . 0.51000000000000001 109.677 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.61 68.5 0.19 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.354 -0.927 . . . . 0.81999999999999995 113.747 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.431 ' O ' HG11 ' A' ' 177' ' ' VAL . 57.6 Cg_endo -98.35 122.7 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.527 2.818 . . . . 0.84999999999999998 112.304 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 74.3 Cg_exo -50.93 146.68 20.92 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.045 2.497 . . . . 0.87 112.474 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 116.92 5.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 1.8500000000000001 111.482 -174.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.27 64.19 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.952 -0.567 . . . . 1.1799999999999999 113.777 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.783 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 51.3 p -79.82 -62.76 1.59 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.087 0.444 . . . . 0.96999999999999997 112.113 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.35 178.06 30.12 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.07 -0.812 . . . . 1.97 111.07 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -71.74 106.89 4.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.972 0.415 . . . . 0.93999999999999995 110.557 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 3.4 m-70 -77.31 116.55 18.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 2.23 110.115 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.819 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 9.7 ptt180 -94.87 90.09 5.89 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.464 -0.789 . . . . 2.3100000000000001 110.642 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.57 ' HE1' ' HB3' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -73.99 107.63 6.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.86 -0.793 . . . . 0.78000000000000003 108.86 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 168' ' ' CYS . 19.9 t -90.36 129.52 41.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.569 -0.742 . . . . 0.27000000000000002 109.479 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.643 ' HB2' HD23 ' A' ' 25' ' ' LEU . 23.3 m95 -89.93 119.74 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.397 -0.964 . . . . 1.99 108.397 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 79.5 mt -113.72 119.68 38.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.734 0.243 . . . . 0.38 111.205 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.565 HG12 HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -119.18 135.22 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.249 0.547 . . . . 0.31 111.328 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.79 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 72.3 t80 -128.35 128.88 45.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 5.1200000000000001 109.121 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.537 ' HG2' HG21 ' A' ' 164' ' ' VAL . 6.5 pt-20 -67.53 107.63 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.096 -0.705 . . . . 2.4100000000000001 109.096 175.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 18.6 mt-30 -56.42 137.56 52.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.387 -0.824 . . . . 1.3100000000000001 112.392 -171.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.42 -26.17 68.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.887 -1.051 . . . . 2.3999999999999999 108.691 168.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 8.6 ptp180 -167.29 158.73 10.31 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 114.111 -1.404 . . . . 3.5099999999999998 109.762 -177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HA ' ' NE2' ' A' ' 127' ' ' GLN . 15.4 Cg_exo -61.69 131.95 37.94 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.759 2.306 . . . . 1.21 110.383 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.448 ' HG ' HG11 ' A' ' 90' ' ' VAL . 4.2 mm? -64.41 152.35 41.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.955 1.094 . . . . 0.90000000000000002 113.955 -166.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -109.65 85.69 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.224 -1.353 . . . . 2.8999999999999999 108.651 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.782 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 58.3 m -132.06 116.35 16.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 1.8999999999999999 111.412 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -106.26 39.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.714 -0.847 . . . . 2.96 108.714 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 18.9 mm-40 -73.89 131.44 81.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.801 -1.091 . . . . 1.3899999999999999 110.585 -173.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.8 119.96 4.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.408 2.739 . . . . 1.27 112.7 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 15.2 mm -70.11 115.2 8.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.578 -0.527 . . . . 0.85999999999999999 109.578 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.88 -14.44 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.651 0.611 . . . . 1.6100000000000001 112.651 -170.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' A' ' 105' ' ' ASP . 37.1 m 55.43 23.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.489 0.922 . . . . 1.8799999999999999 113.489 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.625 ' HA ' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER 60.29 -2.78 0.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.21 1.004 . . . . 0.75 113.515 172.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.584 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 66.5 mtt180 -100.12 135.91 40.83 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.16 -0.338 . . . . 3.3599999999999999 110.137 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.604 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 70.0 m 82.26 131.9 0.05 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 124.524 1.14 . . . . 0.94999999999999996 111.396 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.7 41.6 2.16 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.196 -0.911 . . . . 1.1200000000000001 113.109 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -71.68 -34.34 69.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 2.6600000000000001 110.921 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -125.34 73.51 1.32 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 1.8700000000000001 110.721 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.429 ' HB3' ' CE2' ' A' ' 84' ' ' TRP . 63.8 mtt180 -78.73 -77.15 0.17 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.155 -0.93 . . . . 4.7300000000000004 111.549 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -132.72 -137.16 3.88 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.708 -0.758 . . . . 0.65000000000000002 112.908 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.79 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 90.3 mttt 65.04 28.37 12.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.717 0.77 . . . . 1.0800000000000001 110.246 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -103.92 167.94 9.45 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.909 -1.041 . . . . 1.8899999999999999 108.763 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 150' ' ' LYS . 11.8 mmmm -117.35 117.53 29.75 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.002 -0.37 . . . . 1.29 110.002 173.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.685 HG21 HG12 ' A' ' 17' ' ' VAL . 27.8 m -61.14 -24.6 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 0.78000000000000003 110.8 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.15 82.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.852 -0.613 . . . . 0.67000000000000004 109.505 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.9 m -65.53 -35.43 80.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.77000000000000002 110.692 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.684 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 26.9 m-85 -58.65 -56.36 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.92000000000000004 110.685 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.492 HH22 ' HB2' ' A' ' 18' ' ' ASP . 18.4 ptp180 -66.02 -43.22 88.28 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.8900000000000001 110.682 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -62.79 -36.16 82.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.682 0.277 . . . . 0.96999999999999997 111.607 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -63.04 -45.17 93.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.165 0.507 . . . . 1.5800000000000001 110.846 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 131' ' ' LEU . 20.8 m-85 -83.0 1.86 37.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.178 -0.465 . . . . 5.4500000000000002 110.478 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 64.19 33.07 12.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.163 -0.926 . . . . 2.4199999999999999 111.125 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.79 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -92.79 179.19 5.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.652 -1.158 . . . . 1.27 109.14 173.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.687 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 12.9 tpt180 -149.05 -146.91 0.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.422 -0.585 . . . . 3.5899999999999999 109.422 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.687 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -55.22 143.47 54.77 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 121.109 0.481 . . . . 0.76000000000000001 111.038 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 4.1 Cg_exo -73.01 157.39 51.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.798 2.998 . . . . 0.53000000000000003 112.813 -170.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.899 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 5.4 t -86.1 -24.48 6.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.562 -0.903 . . . . 0.44 108.562 174.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.829 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -158.97 148.35 18.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.667 -0.697 . . . . 0.27000000000000002 111.915 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.9 153.72 25.53 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.638 -1.165 . . . . 0.23999999999999999 110.918 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.427 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.7 t -166.44 144.08 5.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.83 -0.804 . . . . 0.34000000000000002 108.83 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.591 ' HB3' HG22 ' A' ' 121' ' ' VAL . 25.4 p -124.93 141.83 51.87 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.074 -0.65 . . . . 1.1100000000000001 111.483 -173.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.593 ' CE2' HG21 ' A' ' 46' ' ' VAL . 26.0 p90 -123.92 130.75 53.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.254 -1.017 . . . . 0.80000000000000004 108.254 171.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.833 HE22 ' HA2' ' A' ' 38' ' ' GLY . 24.4 mp0 -97.78 132.47 43.37 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 2.5299999999999998 110.17 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.57 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . . . -134.68 145.59 48.68 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.089 -0.708 . . . . 0.59999999999999998 109.089 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -170.54 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 2.3799999999999999 111.562 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.838 ' HA ' HG21 ' A' ' 177' ' ' VAL . 36.1 p90 -80.18 54.67 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 3.96 112.1 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -50.55 -60.44 3.02 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.487 0.551 . . . . 1.53 112.487 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.57 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.6 t70 -173.68 -44.53 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.007 0.432 . . . . 1.26 111.283 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -80.42 6.99 10.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.21 -0.45 . . . . 2.2200000000000002 111.667 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 173' ' ' TRP . 71.2 t -72.54 -52.79 6.28 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.077 -0.51 . . . . 0.5 110.546 174.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.688 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 76.4 Cg_exo -50.35 -34.26 40.2 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.464 2.109 . . . . 0.57999999999999996 112.158 169.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.683 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 30.7 mmmt -74.09 -25.19 59.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 2.1400000000000001 111.196 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 24.9 tp -70.53 -44.91 66.57 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.275 -0.639 . . . . 0.66000000000000003 109.275 172.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -58.32 -40.12 81.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.07 -0.715 . . . . 1.8899999999999999 109.07 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.683 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 3.7 mm-40 -56.58 -50.67 71.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.81 -1.086 . . . . 1.53 110.897 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -65.18 -33.09 75.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.635 -0.711 . . . . 1.49 112.16 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 55.8 mt -66.47 4.29 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.76000000000000001 111.641 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.855 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.3 m -79.71 3.13 20.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 1.05 109.581 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 79.04 48.0 7.24 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.162 -0.926 . . . . 1.1699999999999999 111.306 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.855 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 25.0 mmmt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.508 -0.758 . . . . 2.0 110.241 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' HD2' ' A' ' 2' ' ' PRO . 6.0 tpt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.418 -0.586 . . . . 5.04 109.418 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.446 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 19.5 Cg_exo -37.15 135.78 0.36 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.249 3.299 . . . . 2.1299999999999999 114.159 -175.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.756 HG13 ' HB2' ' A' ' 37' ' ' LEU . 22.5 t -73.83 148.71 8.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.881 -1.054 . . . . 1.47 110.835 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.09 155.21 41.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.85 -0.796 . . . . 1.8100000000000001 108.85 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.6 mm? -83.49 8.12 14.94 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.863 0.69 . . . . 0.69999999999999996 112.863 -169.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 t -66.15 -27.07 67.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.977 0.417 . . . . 1.96 111.042 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 66.2 mttm -92.57 9.43 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.47 -0.332 . . . . 2.6600000000000001 111.655 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.764 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 57.4 t-105 -66.58 -24.96 66.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.398 0.518 . . . . 3.98 112.398 -172.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.499 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 14.1 p -136.33 21.53 3.19 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.36 -0.536 . . . . 0.63 111.8 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -84.6 -126.37 1.45 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.822 -0.704 . . . . 0.47999999999999998 111.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.12 -35.46 62.36 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 123.334 2.689 . . . . 0.53000000000000003 110.056 166.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.599 HD11 ' HA3' ' A' ' 38' ' ' GLY . 12.5 mt -87.6 86.8 7.24 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.564 -1.198 . . . . 1.1699999999999999 108.986 171.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.8 m -78.44 66.97 4.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.485 0.66 . . . . 0.70999999999999996 110.467 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 HG21 ' A' ' 121' ' ' VAL . 29.0 mt -78.75 -4.97 51.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.468 -0.787 . . . . 0.45000000000000001 111.216 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 12.9 mm100 -68.27 -13.4 62.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.047 0.451 . . . . 2.1200000000000001 110.39 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.52 -28.14 69.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 1.9299999999999999 110.262 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.58 ' CG1' HG21 ' A' ' 151' ' ' VAL . 71.5 t -86.36 -73.57 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.63 110.653 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -162.5 169.06 20.96 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.818 -0.353 . . . . 2.9900000000000002 110.811 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -49.04 147.41 2.87 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.089 0.956 . . . . 1.6000000000000001 113.279 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.764 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 68.1 mt-30 -59.37 128.39 85.68 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 115.536 -0.756 . . . . 3.5499999999999998 109.913 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 11.1 Cg_exo -70.02 157.28 60.4 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.913 2.409 . . . . 0.57999999999999996 111.893 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.852 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 7.2 pt20 -73.4 -18.79 61.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 1.3899999999999999 111.314 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.818 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 47.2 m-70 -148.07 160.23 37.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.606 -0.725 . . . . 1.45 109.139 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.0 Cg_endo -86.0 131.92 3.84 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.05 2.5 . . . . 0.40000000000000002 111.832 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 122' ' ' TRP . 20.6 tp -80.68 141.08 35.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.328 . . . . 0.28999999999999998 110.724 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.42 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.41 123.91 51.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.445 -0.343 . . . . 1.24 110.15 170.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 53' ' ' ILE . 17.6 t -121.5 143.26 34.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.525 -0.917 . . . . 0.46999999999999997 108.525 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -136.86 142.83 42.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.135 0.493 . . . . 0.31 110.791 -176.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -108.64 176.91 4.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.16 -0.681 . . . . 0.67000000000000004 109.16 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.89 -51.81 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.55000000000000004 111.803 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.75 -13.34 9.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.677 -0.692 . . . . 0.81000000000000005 112.835 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.26 -165.12 1.36 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.134 0.492 . . . . 0.46999999999999997 110.914 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.0 165.99 26.61 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.367 -0.833 . . . . 0.33000000000000002 109.748 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.77 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 93.4 t -107.44 64.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.303 -1.739 . . . . 0.39000000000000001 106.303 160.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.12 1.72 49.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.198 -1.364 . . . . 0.98999999999999999 109.949 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 43.7 mt-10 -135.62 126.06 26.75 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.408 -0.815 . . . . 2.5600000000000001 109.865 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.756 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -71.95 110.13 6.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.149 -0.686 . . . . 0.40999999999999998 109.149 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.93 ' HA2' HE22 ' A' ' 170' ' ' GLN . . . 90.01 28.31 18.49 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.258 -0.883 . . . . 0.58999999999999997 111.973 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.77 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -93.29 151.05 20.04 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.842 -0.429 . . . . 0.34000000000000002 109.842 174.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.4 p -78.19 135.98 25.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.55000000000000004 111.098 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 169' ' ' TYR . 8.4 tp -131.46 170.58 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.152 -1.425 . . . . 0.45000000000000001 107.152 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 p -116.17 148.61 41.89 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 118.669 -1.212 . . . . 0.56000000000000005 113.362 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 1.079 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 53.4 Cg_exo -55.38 -40.76 83.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.491 3.461 . . . . 0.68000000000000005 113.914 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -33.32 63.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.517 0.675 . . . . 0.76000000000000001 110.715 174.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -81.75 -58.46 2.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.909 . . . . 1.5900000000000001 110.704 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 43' ' ' PRO . 6.3 m -81.42 28.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.386 0.612 . . . . 0.66000000000000003 112.079 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HD2' ' HB3' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -82.21 -31.44 30.32 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.69 -0.856 . . . . 0.79000000000000004 108.69 174.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.437 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 19.0 m120 -112.13 -149.78 0.45 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.849 -1.069 . . . . 1.9099999999999999 110.319 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.579 ' HD3' HG22 ' A' ' 97' ' ' ILE . 99.5 mtt180 -99.11 157.25 34.39 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.246 -0.433 . . . . 1.4299999999999999 109.964 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.98 166.28 25.18 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.402 2.068 . . . . 0.37 110.574 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -81.48 -25.47 36.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.03 0.443 . . . . 0.44 110.018 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.2 m -159.27 149.56 19.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.165 0.507 . . . . 0.38 111.97 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.12 158.71 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.288 -1.004 . . . . 0.29999999999999999 108.288 171.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.103 ' HA ' HD13 ' A' ' 58' ' ' LEU . 32.7 t -176.4 113.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.917 0.389 . . . . 0.34999999999999998 110.104 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -72.42 157.67 37.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.664 -1.235 . . . . 2.7200000000000002 107.664 172.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.97 87.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.523 0.514 . . . . 1.51 110.611 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.3 21.51 4.05 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.753 -0.658 . . . . 0.80000000000000004 112.749 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.103 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.8 tt -57.69 129.14 40.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.984 0.421 . . . . 0.57999999999999996 110.565 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.623 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 26.2 t70 -79.69 -27.74 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.505 . . . . 0.73999999999999999 111.502 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.535 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 52.7 m 77.84 -5.67 2.08 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.3 1.0 . . . . 1.03 110.278 -171.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.31 21.49 5.15 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.874 -0.603 . . . . 0.83999999999999997 112.794 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.623 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 9.7 mtpt -113.0 145.02 41.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 122.535 -0.391 . . . . 1.6699999999999999 110.752 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.617 HD21 ' HE2' ' A' ' 93' ' ' LYS . 44.5 mt -91.0 124.87 35.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.191 -0.67 . . . . 0.57999999999999996 109.191 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -127.18 161.38 28.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.754 -0.379 . . . . 0.80000000000000004 109.98 177.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.668 HG23 HG12 ' A' ' 90' ' ' VAL . 63.3 m -97.45 106.57 18.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.715 -0.846 . . . . 0.35999999999999999 108.715 169.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.2 tp -103.58 109.37 21.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.448 -0.796 . . . . 0.58999999999999997 109.69 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.5 t -113.87 136.74 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.39000000000000001 110.69 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.861 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 3.8 mt -104.61 126.4 51.66 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.73 ' HA ' ' HA ' ' A' ' 85' ' ' HIS . 10.1 t -135.22 150.75 50.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.878 0.37 . . . . 0.35999999999999999 111.315 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 6.8 t70 -130.47 94.25 30.19 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-O 121.51 0.671 . . . . 1.9199999999999999 110.39 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 13.0 Cg_endo -56.49 -30.91 84.2 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.83 3.02 . . . . 1.25 114.108 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -90.74 39.58 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.641 . . . . 1.29 112.732 -167.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.48 140.44 21.07 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.77 -0.456 . . . . 0.5 109.77 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.571 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 98.3 Cg_endo -80.19 -21.62 17.38 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.864 -1.307 . . . . 0.62 113.351 2.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 88.5 p -139.75 162.85 34.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.746 -0.206 . . . . 0.75 111.072 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.476 ' NE ' HH12 ' A' ' 119' ' ' ARG . 1.0 OUTLIER -64.4 -36.8 85.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.234 0.54 . . . . 2.8799999999999999 110.61 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.2 ptpt -71.63 -18.17 62.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 1.3799999999999999 111.224 -175.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.5 t70 -161.43 86.62 1.65 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.317 -0.402 . . . . 1.3700000000000001 110.648 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.1 Cg_endo -84.0 91.64 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.902 2.401 . . . . 0.80000000000000004 112.946 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.571 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 39.3 mttm -82.63 -45.37 14.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 1.02 110.793 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.765 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.9 m-85 -81.0 16.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 1.1699999999999999 111.776 -171.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.93 ' HG2' ' HG3' ' A' ' 83' ' ' GLU . 9.1 ttp180 -62.3 125.04 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.068 -0.345 . . . . 2.9300000000000002 110.068 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.93 ' HG3' ' HG2' ' A' ' 82' ' ' ARG . 3.1 mp0 -107.72 133.98 51.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.503 0.321 . . . . 2.23 110.356 -4.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -76.9 164.85 25.41 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.813 -1.18 . . . . 1.4299999999999999 107.813 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.73 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 p80 -145.94 123.18 11.55 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.826 -0.546 . . . . 1.26 110.329 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.861 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 2.3 t-160 -62.13 -40.86 97.35 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.418 -0.81 . . . . 2.1400000000000001 109.552 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.9 p90 -167.77 171.56 9.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.963 -0.295 . . . . 1.51 110.465 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HG ' HD12 ' A' ' 103' ' ' LEU . 30.1 tp -129.96 113.09 14.16 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.144 -0.687 . . . . 0.33000000000000002 109.144 173.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.643 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.1 t -118.36 134.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.847 -0.615 . . . . 0.31 110.649 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.948 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 19.7 m -134.53 157.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.63 -0.714 . . . . 0.27000000000000002 109.61 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.1 t30 61.18 22.28 12.62 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.601 0.563 . . . . 1.76 110.455 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.643 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -70.71 111.68 6.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.725 -0.843 . . . . 0.31 108.725 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 63' ' ' LEU . 18.2 ttmm -87.59 100.38 12.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.162 -0.926 . . . . 1.21 111.045 -172.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 77.17 -122.84 6.29 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.255 -0.884 . . . . 0.29999999999999999 112.883 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.575 ' HA ' HD11 ' A' ' 53' ' ' ILE . 9.2 p30 -118.14 21.09 12.94 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 1.04 110.736 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.68 105.68 15.66 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.787 -0.642 . . . . 0.77000000000000002 109.77 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.579 HG22 ' HD3' ' A' ' 49' ' ' ARG . 4.8 mm -62.89 -25.95 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.867 -1.06 . . . . 0.40999999999999998 111.384 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 m -84.41 -29.62 26.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.68000000000000005 111.994 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 m -80.26 -3.84 50.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.943 0.402 . . . . 1.26 111.706 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.14 106.42 1.88 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.761 -0.733 . . . . 0.34999999999999998 111.303 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.2 m -64.31 106.84 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.228 -0.656 . . . . 0.45000000000000001 109.228 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.19 111.8 24.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.43 -0.805 . . . . 0.56999999999999995 110.86 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.598 HD12 ' HG ' ' A' ' 88' ' ' LEU . 5.1 mt -87.85 -39.96 14.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.039 0.923 . . . . 0.45000000000000001 109.935 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.4 t -114.36 105.88 13.66 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.72 -1.585 . . . . 0.37 106.72 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.2 t70 -57.73 158.1 6.59 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.873 0.733 . . . . 1.1499999999999999 111.992 -169.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 23.0 p90 -85.74 77.54 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 4.6900000000000004 111.305 -171.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 140' ' ' ASN . 36.7 t -60.48 -45.05 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.588 -0.733 . . . . 0.85999999999999999 111.485 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.682 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 106.24 -168.33 14.8 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.385 -0.912 . . . . 0.67000000000000004 112.576 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.9 t -65.91 126.63 29.15 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.759 -0.46 . . . . 0.51000000000000001 109.759 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.606 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -152.56 54.49 0.46 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.994 -0.622 . . . . 0.81999999999999995 112.727 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 1.025 ' HG2' ' HA ' ' A' ' 172' ' ' GLU . 11.3 Cg_endo -98.52 153.61 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.022 3.148 . . . . 0.84999999999999998 113.232 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 111' ' ' PRO . 31.6 Cg_exo -61.34 150.16 86.14 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.008 2.472 . . . . 0.87 112.499 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -67.17 122.05 16.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.347 -0.842 . . . . 1.8500000000000001 111.571 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.6 50.33 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.927 -0.654 . . . . 1.1799999999999999 112.996 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.612 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 21.7 p -78.5 -13.59 59.76 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.943 0.72 . . . . 0.96999999999999997 112.943 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.31 24.31 6.56 Favored Glycine 0 CA--C 1.506 -0.49 0 C-N-CA 120.09 -1.052 . . . . 1.97 113.38 172.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.58 HD13 ' HG2' ' A' ' 172' ' ' GLU . 4.0 mm? 68.56 103.79 0.05 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.807 -0.697 . . . . 0.93999999999999995 111.549 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 11.6 m170 -76.64 134.18 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.789 -0.641 . . . . 2.23 109.695 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 1.035 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 8.0 ptp85 -112.9 96.7 6.1 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.347 0.594 . . . . 2.3100000000000001 111.094 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 169' ' ' TYR . 45.4 m-85 -72.15 114.59 10.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.511 -0.768 . . . . 0.78000000000000003 109.247 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.618 HG21 HD22 ' A' ' 14' ' ' LEU . 31.3 t -90.4 129.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.61 -0.723 . . . . 0.27000000000000002 110.439 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.879 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.56 119.49 30.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.546 -0.752 . . . . 1.99 109.396 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 84.0 mt -118.37 127.61 53.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.333 0.111 . . . . 0.38 111.089 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.42 HG12 HD22 ' A' ' 25' ' ' LEU . 1.4 m -115.53 139.41 42.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.31 109.352 171.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CB ' HD23 ' A' ' 160' ' ' LEU . 84.9 m-85 -118.83 164.32 15.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.862 0.363 . . . . 5.1200000000000001 111.427 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.62 118.2 33.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.438 -0.801 . . . . 2.4100000000000001 109.071 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -97.81 166.96 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.184 0.516 . . . . 1.3100000000000001 110.477 -175.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.52 -22.31 54.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.513 -0.767 . . . . 2.3999999999999999 109.563 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.79 164.18 19.67 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.821 -1.081 . . . . 3.5099999999999998 110.277 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.463 ' HG3' HD12 ' A' ' 63' ' ' LEU . 53.7 Cg_exo -51.74 135.67 49.67 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.605 2.203 . . . . 1.21 112.02 175.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.948 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.3 mm? -55.63 147.48 18.16 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.2 0.815 . . . . 0.90000000000000002 113.2 -171.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -130.73 80.36 1.94 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.574 -1.194 . . . . 2.8999999999999999 108.09 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.477 ' SG ' HG11 ' A' ' 90' ' ' VAL . 60.1 m -104.1 112.86 26.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.765 -0.652 . . . . 1.8999999999999999 110.23 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.53 18.58 12.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.09 -0.959 . . . . 2.96 110.216 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.87 130.2 94.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.444 -0.798 . . . . 1.3899999999999999 109.999 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -47.44 118.55 2.99 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.309 2.673 . . . . 1.27 113.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.3 mm -60.43 115.76 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.971 -0.558 . . . . 0.85999999999999999 110.618 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.8 152.19 19.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 1.6100000000000001 109.841 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 m -99.59 156.43 17.07 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.089 -1.078 . . . . 1.8799999999999999 108.089 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.772 ' HA ' HG22 ' A' ' 107' ' ' VAL . 1.7 p-10 -81.89 6.85 14.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.333 0.587 . . . . 0.75 110.432 -174.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 46.6 mtt-85 -102.76 135.49 44.31 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.548 -0.751 . . . . 3.3599999999999999 109.427 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.61 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 19.9 m 83.27 140.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.828 1.33 . . . . 0.94999999999999996 110.551 -175.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -102.22 46.71 1.22 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.511 -0.768 . . . . 1.1200000000000001 111.433 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.98 -29.96 66.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.928 0.394 . . . . 2.6600000000000001 111.489 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -124.51 70.05 1.11 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.037 0.446 . . . . 1.8700000000000001 111.232 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 63.7 mtp180 -87.93 30.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 4.7300000000000004 111.989 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 112.77 -143.83 17.81 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.176 -1.012 . . . . 0.65000000000000002 113.388 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.765 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 78.8 mttt 60.94 42.21 13.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.855 0.836 . . . . 1.0800000000000001 110.687 -174.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -133.66 158.38 43.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.444 -1.253 . . . . 1.8899999999999999 108.872 174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 150' ' ' LYS . 12.3 mmmm -96.8 120.84 37.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.15 0.282 . . . . 1.29 110.775 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.7 m -61.27 -33.05 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.78000000000000003 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -58.84 -44.6 90.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.886 -0.597 . . . . 0.67000000000000004 109.736 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.4 m -62.13 -37.75 86.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.479 . . . . 0.77000000000000002 111.064 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.62 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 48.1 m-85 -59.27 -56.74 18.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.898 0.38 . . . . 0.92000000000000004 110.742 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 160' ' ' LEU . 4.3 ppt_? -71.13 -28.77 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.111 0.412 . . . . 2.8900000000000001 112.111 -176.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 52.5 mtmt -65.8 -25.99 67.48 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.404 -0.185 . . . . 0.96999999999999997 111.331 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 17.8 tptm -53.17 -46.37 68.9 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.58 0.229 . . . . 1.5800000000000001 110.716 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.43 ' HB3' HD13 ' A' ' 160' ' ' LEU . 20.7 t80 -99.8 11.81 38.3 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.77 -0.772 . . . . 5.4500000000000002 109.957 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.18 41.31 6.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.171 -0.922 . . . . 2.4199999999999999 112.83 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB2' ' HB2' ' A' ' 155' ' ' ARG . 6.4 mp -73.74 137.2 43.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.466 -0.788 . . . . 1.27 109.171 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -86.0 -53.28 5.18 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.7 0.63 . . . . 3.5899999999999999 112.7 -169.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -164.8 161.95 14.95 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.947 -0.57 . . . . 0.76000000000000001 110.233 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 15.9 Cg_exo -66.96 140.6 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.845 2.363 . . . . 0.53000000000000003 112.776 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.852 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -86.61 -29.55 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.739 -0.837 . . . . 0.44 108.739 173.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -152.57 146.77 25.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.616 -0.72 . . . . 0.27000000000000002 111.221 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -147.87 156.85 27.13 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.2 -0.909 . . . . 0.23999999999999999 111.716 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.615 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 5.8 t -168.87 151.12 4.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.571 -0.9 . . . . 0.34000000000000002 108.571 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 12' ' ' LEU . 26.5 p -129.37 140.34 51.4 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.878 -0.729 . . . . 1.1100000000000001 111.371 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 120' ' ' TYR . 51.1 p90 -122.1 137.47 54.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.16 -1.052 . . . . 0.80000000000000004 108.16 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 1.035 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 26.2 mp0 -100.04 133.58 44.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.468 0.576 . . . . 2.5299999999999998 110.985 177.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -157.4 114.32 3.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.991 -0.55 . . . . 0.59999999999999998 110.069 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 1.025 ' HA ' ' HG2' ' A' ' 111' ' ' PRO . 6.4 pt-20 -109.94 -91.08 0.46 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 119.649 -0.82 . . . . 2.3799999999999999 111.77 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.893 ' H ' ' HG3' ' A' ' 172' ' ' GLU . 18.7 t90 -117.34 78.79 1.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.887 0.767 . . . . 3.96 111.672 -170.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 1.079 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -76.0 -59.64 2.67 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.658 -0.417 . . . . 1.53 110.937 173.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 28.1 t70 -178.84 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.339 0.137 0 N-CA-C 111.924 0.342 . . . . 1.26 111.924 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.723 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.45 5.49 14.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 2.2200000000000002 111.851 -178.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.771 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 84.0 t -72.57 -53.5 5.74 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.068 -0.514 . . . . 0.5 110.978 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.771 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.4 Cg_exo -49.78 -45.36 32.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.383 2.056 . . . . 0.57999999999999996 111.882 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.634 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 31.6 mmmt -69.17 -24.25 64.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.506 -0.315 . . . . 2.1400000000000001 111.654 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 48.4 tp -68.98 -47.85 64.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.187 -0.605 . . . . 0.66000000000000003 109.393 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.73 -37.9 80.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.47 0.652 . . . . 1.8899999999999999 109.479 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 7.5 mm-40 -56.22 -47.87 77.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.706 -1.134 . . . . 1.53 111.148 172.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.09 -29.38 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.416 -0.811 . . . . 1.49 112.927 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 64.5 mt -63.29 5.95 0.14 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.227 0.825 . . . . 0.76000000000000001 113.227 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.755 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 16.5 m -82.78 -1.97 53.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.307 0.575 . . . . 1.05 109.532 168.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 84.85 45.59 5.96 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.783 -0.927 . . . . 1.1699999999999999 110.783 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.755 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 28.2 mmtp . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.739 -0.648 . . . . 2.0 110.385 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.838 -0.43 . . . . 5.04 109.838 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.14 137.18 69.85 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.379 2.052 . . . . 2.1299999999999999 110.711 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.0 t -57.68 105.06 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.701 0.762 . . . . 1.47 111.751 -172.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 19.2 t70 -162.78 159.93 24.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.083 -1.417 . . . . 1.8100000000000001 107.816 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.528 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.2 mm? -80.55 24.08 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.74 0.245 . . . . 0.69999999999999996 111.088 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -51.56 -53.71 35.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.965 -0.561 . . . . 1.96 111.805 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.603 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.5 tptm -125.16 49.2 1.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.275 0.56 . . . . 2.6600000000000001 109.941 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.617 ' HD1' HD11 ' A' ' 37' ' ' LEU . 2.8 t90 -74.58 -8.54 56.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.517 -0.765 . . . . 3.98 111.046 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 9.0 p -136.36 22.92 3.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.223 0.535 . . . . 0.63 110.56 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA3' ' HG3' ' A' ' 7' ' ' LYS . . . -86.9 -120.44 1.3 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.516 -0.633 . . . . 0.47999999999999998 111.516 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 11.6 Cg_endo -51.35 -40.49 61.78 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.551 2.834 . . . . 0.53000000000000003 110.402 167.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.68 HD11 ' HA3' ' A' ' 38' ' ' GLY . 19.2 mt -87.34 88.22 7.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.012 -0.995 . . . . 1.1699999999999999 109.045 171.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 4.6 m -75.66 63.87 1.64 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.509 0.671 . . . . 0.70999999999999996 110.674 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 121' ' ' VAL . 27.8 mt -75.94 -7.94 55.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.693 -0.685 . . . . 0.45000000000000001 110.091 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 6.5 tp-100 -73.38 -7.82 53.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 2.1200000000000001 110.992 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.561 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 22.1 mt-10 -63.45 -37.06 85.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.176 -0.676 . . . . 1.9299999999999999 109.176 171.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.889 HG12 HG21 ' A' ' 151' ' ' VAL . 31.9 t -76.65 -73.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.494 -1.23 . . . . 0.63 111.635 -175.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 30.3 t0 -152.09 170.19 20.55 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.633 -0.506 . . . . 2.9900000000000002 109.633 -172.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.701 ' HG3' HH12 ' A' ' 155' ' ' ARG . 30.8 mt-10 -60.3 149.96 31.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.472 0.545 . . . . 1.6000000000000001 112.472 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.542 HE21 ' HB3' ' A' ' 8' ' ' TRP . 52.0 mt-30 -60.54 120.43 52.36 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 115.444 -0.798 . . . . 3.5499999999999998 109.118 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 36.8 Cg_exo -58.7 155.42 37.5 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.656 2.237 . . . . 0.57999999999999996 112.396 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.89 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 10.1 pt20 -71.64 -17.56 62.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.455 -0.793 . . . . 1.3899999999999999 111.265 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.81 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 53.1 m-70 -149.75 157.47 38.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.534 0.734 . . . . 1.45 109.172 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HG3' ' HA ' ' A' ' 4' ' ' ASP . 2.1 Cg_endo -84.89 129.82 4.08 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.97 2.447 . . . . 0.40000000000000002 112.019 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.699 HD23 ' HB3' ' A' ' 122' ' ' TRP . 22.1 tp -78.95 139.79 38.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.522 0.201 . . . . 0.28999999999999998 110.594 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -110.99 125.73 54.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.47 -0.567 . . . . 1.24 109.47 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.92 HG13 HG22 ' A' ' 53' ' ' ILE . 13.0 t -131.65 135.66 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.426 -0.583 . . . . 0.46999999999999997 109.426 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.3 OUTLIER -137.15 137.9 39.7 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.001 0.429 . . . . 0.31 110.736 -177.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -98.38 175.41 6.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.38 -0.97 . . . . 0.67000000000000004 108.38 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.25 59.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.247 0.546 . . . . 0.55000000000000004 110.855 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.2 -7.99 34.32 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.415 -0.812 . . . . 0.81000000000000005 112.606 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.07 -173.17 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.719 -0.283 . . . . 0.46999999999999997 110.412 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.1 166.05 23.95 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.224 -0.444 . . . . 0.33000000000000002 110.246 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 89.4 t -113.23 64.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 106.521 -1.659 . . . . 0.39000000000000001 106.521 162.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.14 16.1 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.438 -1.255 . . . . 0.98999999999999999 109.78 -174.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 4.6 tm-20 -148.5 125.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.071 -1.085 . . . . 2.5600000000000001 108.071 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.9 OUTLIER -71.86 110.19 6.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.847 -0.427 . . . . 0.40999999999999998 109.847 -174.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.68 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 88.71 14.83 60.67 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.708 -0.678 . . . . 0.58999999999999997 112.573 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -72.29 154.64 40.86 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 110.145 -0.316 . . . . 0.34000000000000002 110.145 175.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 8.8 p -80.34 129.6 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.301 0.572 . . . . 0.55000000000000004 110.972 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.459 HD23 ' CG1' ' A' ' 46' ' ' VAL . 6.2 tp -124.2 165.13 18.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.559 -1.274 . . . . 0.45000000000000001 107.559 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.97 152.69 49.0 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 119.148 -1.021 . . . . 0.56000000000000005 113.375 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.651 ' HG2' ' HB3' ' A' ' 174' ' ' ASP . 70.9 Cg_exo -51.38 -46.43 31.52 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.401 2.734 . . . . 0.68000000000000005 113.338 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -27.58 65.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.998 0.428 . . . . 0.76000000000000001 111.452 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.2 -48.68 10.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.978 -0.556 . . . . 1.5900000000000001 110.914 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.493 HG11 ' CE2' ' A' ' 169' ' ' TYR . 10.7 m -95.17 29.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.53 0.681 . . . . 0.66000000000000003 112.323 -175.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 6.52 42.77 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.31 -0.626 . . . . 0.79000000000000004 109.31 178.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -148.17 177.85 9.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.118 -0.946 . . . . 1.9099999999999999 109.572 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -78.88 152.36 77.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.405 -0.361 . . . . 1.4299999999999999 110.096 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.09 156.59 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.403 2.068 . . . . 0.37 111.479 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.1 t -77.45 -23.76 50.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.44 110.355 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 67.3 m -153.02 141.07 20.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.66 0.615 . . . . 0.38 112.66 -175.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.92 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -140.82 166.26 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.997 -1.001 . . . . 0.29999999999999999 108.313 169.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.074 ' HA ' HD13 ' A' ' 58' ' ' LEU . 31.3 t 176.12 117.7 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.985 0.421 . . . . 0.34999999999999998 110.096 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 29.9 p-90 -79.27 154.82 28.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.707 -1.22 . . . . 2.7200000000000002 107.707 172.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.422 ' HB3' ' HD1' ' A' ' 23' ' ' HIS . 35.7 t70 -64.64 85.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.811 0.339 . . . . 1.51 111.364 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 125.02 20.3 2.28 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.991 -0.549 . . . . 0.80000000000000004 112.021 -175.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.074 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.5 tt -63.01 129.07 38.78 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.937 0.495 . . . . 0.57999999999999996 111.072 -177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.534 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 26.1 t70 -74.82 -28.0 60.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.054 -0.521 . . . . 0.73999999999999999 111.635 -175.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.637 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.7 m 74.32 2.12 4.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.302 -0.863 . . . . 1.03 110.422 -172.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -130.21 -35.81 0.41 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.671 -0.695 . . . . 0.83999999999999997 112.372 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 12.2 mtpt -63.29 146.26 53.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.908 0.385 . . . . 1.6699999999999999 110.302 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.838 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 25.6 mt -87.37 138.7 31.25 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.794 -1.187 . . . . 0.57999999999999996 107.794 172.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.639 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 11.5 m-85 -128.71 157.51 41.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.80000000000000004 109.822 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.446 HG23 HG12 ' A' ' 90' ' ' VAL . 91.8 m -96.86 105.28 17.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.397 -0.594 . . . . 0.35999999999999999 109.397 172.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 17.6 tp -100.84 109.6 21.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.444 -0.798 . . . . 0.58999999999999997 109.563 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.1 125.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.45 . . . . 0.39000000000000001 110.987 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 ' HE1' ' A' ' 169' ' ' TYR . 3.4 mt -85.5 129.86 34.72 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.416 -0.957 . . . . 0.59999999999999998 108.416 167.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.837 HG21 HG11 ' A' ' 17' ' ' VAL . 9.0 t -138.11 138.79 39.04 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.7 -0.481 . . . . 0.35999999999999999 109.7 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.557 ' HB3' ' HA ' ' A' ' 120' ' ' TYR . 11.2 p-10 -132.67 99.78 15.3 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-O 121.617 0.722 . . . . 1.9199999999999999 111.026 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.7 Cg_endo -55.48 -173.9 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.582 2.854 . . . . 1.25 112.386 171.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.858 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 2.1 m-20 56.93 33.81 23.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.17 0.509 . . . . 1.29 111.127 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' H ' ' HB2' ' A' ' 82' ' ' ARG . . . -104.34 137.19 19.16 Favored Pre-proline 0 C--O 1.22 -0.469 0 CA-C-N 116.054 -0.521 . . . . 0.5 110.647 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 71.7 Cg_endo -79.5 -31.12 5.1 Favored 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.016 -1.66 . . . . 0.62 112.556 0.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.615 ' HB3' HG22 ' A' ' 115' ' ' THR . 92.7 p -125.24 153.44 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.75 109.977 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.858 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 45.5 mtp180 -71.99 -23.18 61.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.301 -0.409 . . . . 2.8799999999999999 111.599 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.832 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.73 -10.89 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.932 0.396 . . . . 1.3799999999999999 110.79 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -155.2 82.3 3.95 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.34 -0.615 . . . . 1.3700000000000001 109.34 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -89.1 97.67 0.35 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.034 2.489 . . . . 0.80000000000000004 113.279 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 6.5 mtmm -88.13 -58.7 2.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.119 -0.946 . . . . 1.02 111.16 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.506 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 70.0 m-85 -66.89 -23.37 65.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.969 -0.56 . . . . 1.1699999999999999 110.994 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.561 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -48.0 117.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.412 0.445 . . . . 2.9300000000000002 109.891 177.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 38.8 mt-10 -89.71 130.99 35.91 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.561 0.744 . . . . 2.23 112.217 7.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.524 ' HA ' ' CA ' ' A' ' 147' ' ' GLY . 4.6 t90 -90.56 134.37 34.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.832 -0.803 . . . . 1.4299999999999999 108.832 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.511 ' N ' ' HD1' ' A' ' 84' ' ' TRP . 13.8 p-80 -106.07 129.74 54.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.876 -0.787 . . . . 1.26 108.876 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -91.11 -23.76 20.2 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.29 0.478 . . . . 2.1400000000000001 112.29 -171.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.501 ' HZ ' ' HE1' ' A' ' 122' ' ' TRP . 6.5 p90 -169.2 170.7 8.5 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.062 -0.347 . . . . 1.51 110.062 167.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.9 tp -131.89 114.0 14.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.546 -0.297 . . . . 0.33000000000000002 110.411 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -119.92 133.4 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.05 -0.523 . . . . 0.31 110.827 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.458 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 5.3 m -131.61 168.1 24.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.123 -1.065 . . . . 0.27000000000000002 108.123 174.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.838 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 8.8 m-20 59.96 19.28 8.33 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.37 0.419 . . . . 1.76 111.588 173.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.467 ' HE3' HG11 ' A' ' 89' ' ' VAL . 9.6 ttm -74.16 111.26 9.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.464 -0.939 . . . . 0.31 108.464 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.3 ttmm -79.71 91.5 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.191 -0.913 . . . . 1.21 111.196 -170.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.639 ' HA2' ' HE1' ' A' ' 64' ' ' TYR . . . 72.41 -117.45 6.24 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.857 -1.065 . . . . 0.29999999999999999 112.166 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 53' ' ' ILE . 27.6 p-10 -111.55 26.38 10.71 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.428 0.632 . . . . 1.04 110.122 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.39 104.19 16.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.247 -0.888 . . . . 0.77000000000000002 109.946 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 53' ' ' ILE . 4.6 mm -59.85 -28.55 41.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.111 -0.949 . . . . 0.40999999999999998 111.233 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.1 m -78.65 -42.76 27.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.68000000000000005 112.469 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 p -65.21 -24.16 67.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.412 0.523 . . . . 1.26 112.412 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 99.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.761 0.663 . . . . 0.34999999999999998 113.316 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 99.4 m -65.78 105.45 1.28 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.121 -0.696 . . . . 0.45000000000000001 109.121 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 9.5 p -93.4 109.57 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.4 -0.818 . . . . 0.56999999999999995 110.839 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.67 -41.78 23.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.12 0.962 . . . . 0.45000000000000001 109.824 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.0 t -115.04 100.19 7.99 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.247 -1.39 . . . . 0.37 107.247 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -52.69 156.85 1.77 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.298 0.999 . . . . 1.1499999999999999 113.161 -167.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 4.1 p90 -76.61 96.19 4.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.942 -1.026 . . . . 4.6900000000000004 110.739 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.808 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 21.8 t -67.72 -31.63 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.844 -0.616 . . . . 0.85999999999999999 111.76 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.45 173.09 49.49 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.756 -0.735 . . . . 0.67000000000000004 111.912 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 38.7 t -54.53 135.7 45.69 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.22 0.51 . . . . 0.51000000000000001 110.834 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.885 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . 169.77 70.68 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.81999999999999995 113.289 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.14 150.23 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.739 2.293 . . . . 0.84999999999999998 110.898 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.667 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 85.0 Cg_exo -43.48 126.48 5.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.728 2.286 . . . . 0.87 112.321 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.538 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -61.68 115.5 4.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 1.8500000000000001 110.749 -175.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.72 23.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.716 -0.754 . . . . 1.1799999999999999 112.407 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.667 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.7 p -76.86 -60.99 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.758 0.279 . . . . 0.96999999999999997 111.405 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.41 28.33 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.857 -0.687 . . . . 1.97 112.081 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 172' ' ' GLU . 4.1 mm? -73.21 123.27 23.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.93999999999999995 110.477 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -102.01 112.81 25.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.051 0.453 . . . . 2.23 110.35 176.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.537 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 2.0 ptt180 -85.74 90.5 8.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.504 -0.771 . . . . 2.3100000000000001 110.703 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.737 ' HE2' ' HB3' ' A' ' 171' ' ' ALA . 3.3 m-85 -74.29 112.57 10.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.022 -0.733 . . . . 0.78000000000000003 109.022 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 168' ' ' CYS . 13.8 t -94.01 126.01 46.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.948 -0.569 . . . . 0.27000000000000002 109.638 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.699 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -90.34 119.56 30.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.721 -0.672 . . . . 1.99 109.738 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 83.6 mt -115.99 138.62 51.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.647 -0.131 . . . . 0.38 110.647 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.507 HG12 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -122.69 140.71 45.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.695 -0.483 . . . . 0.31 109.695 171.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.61 ' HB2' HD23 ' A' ' 160' ' ' LEU . 97.2 m-85 -117.37 165.54 13.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.996 0.427 . . . . 5.1200000000000001 111.191 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -110.38 137.61 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.25 -0.886 . . . . 2.4100000000000001 109.983 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.63 ' HG3' ' HG ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.26 153.84 47.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.357 0.599 . . . . 1.3100000000000001 110.014 177.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.01 -2.17 46.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.045 -0.98 . . . . 2.3999999999999999 111.051 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.532 HH22 ' HB2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -166.17 168.61 7.41 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.16 -0.927 . . . . 3.5099999999999998 109.753 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.15 150.54 24.4 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.559 2.173 . . . . 1.21 111.791 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.458 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.5 mm? -72.21 158.45 35.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.633 0.73 . . . . 0.90000000000000002 112.42 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.71 127.2 32.33 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.584 -1.265 . . . . 2.8999999999999999 107.584 167.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.9 m -146.44 -63.23 0.3 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.866 -0.606 . . . . 1.8999999999999999 109.728 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 58.83 37.99 24.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.395 0.617 . . . . 2.96 110.809 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.58 137.0 63.32 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.264 -0.88 . . . . 1.3899999999999999 109.54 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.85 106.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.132 2.554 . . . . 1.27 112.175 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.7 mm -55.77 119.12 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.534 -0.757 . . . . 0.85999999999999999 111.36 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 81.4 mt -88.49 158.71 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.086 -0.709 . . . . 1.6100000000000001 109.086 175.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.702 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 64.5 m -112.63 31.28 6.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.713 -0.221 . . . . 1.8799999999999999 111.008 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.838 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 1.1 p-10 54.92 12.64 0.63 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.202 0.939 . . . . 0.75 111.693 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.702 ' HG3' ' O ' ' A' ' 139' ' ' SER . 5.5 mtm180 -98.2 153.61 18.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.933 -0.395 . . . . 3.3599999999999999 109.933 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.663 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 44.4 m 67.5 165.68 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.275 -0.875 . . . . 0.94999999999999996 111.824 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.0 23.07 5.93 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.474 -0.87 . . . . 1.1200000000000001 112.401 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -71.01 -26.25 63.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.205 0.446 . . . . 2.6600000000000001 112.205 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -131.27 61.01 1.65 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.304 0.573 . . . . 1.8700000000000001 110.751 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.88 -71.05 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.264 -0.88 . . . . 4.7300000000000004 110.663 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 84' ' ' TRP . . . -124.44 -153.41 8.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.53 -0.843 . . . . 0.65000000000000002 112.226 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 96.2 mttt 66.51 32.5 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.151 0.977 . . . . 1.0800000000000001 109.831 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -124.9 103.97 8.34 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.11 -1.405 . . . . 1.8899999999999999 108.81 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -62.85 120.19 10.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 1.29 111.875 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.889 HG21 HG12 ' A' ' 17' ' ' VAL . 8.2 m -62.66 -31.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.78000000000000003 110.581 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . -59.12 -38.8 80.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.866 -0.606 . . . . 0.67000000000000004 110.154 174.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.6 m -66.86 -38.6 86.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.546 . . . . 0.77000000000000002 110.624 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.763 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 62.0 m-85 -61.56 -53.07 61.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.92000000000000004 111.126 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.701 HH12 ' HG3' ' A' ' 19' ' ' GLU . 8.7 ptm180 -66.21 -39.69 89.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 2.8900000000000001 111.641 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 152' ' ' ALA . 51.8 mtmt -68.08 -46.77 70.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.605 0.24 . . . . 0.96999999999999997 111.169 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -60.87 -51.64 68.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.069 -0.514 . . . . 1.5800000000000001 111.587 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.67 0.08 31.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.271 -0.422 . . . . 5.4500000000000002 111.624 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.532 ' HB2' HH22 ' A' ' 129' ' ' ARG . 70.8 mm-40 66.1 46.36 2.15 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.763 0.664 . . . . 2.4199999999999999 110.996 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.63 ' HG ' ' HG3' ' A' ' 127' ' ' GLN . 5.6 mp -102.35 15.09 30.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.643 0.608 . . . . 1.27 112.643 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 61.89 -94.45 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.649 0.38 . . . . 3.5899999999999999 111.809 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -154.3 168.82 11.11 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 109.455 -0.572 . . . . 0.76000000000000001 109.455 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 38.9 Cg_exo -57.16 129.03 32.14 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.406 2.071 . . . . 0.53000000000000003 112.91 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.89 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 2.8 t -84.38 -33.06 8.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.279 -0.638 . . . . 0.44 109.279 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.81 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -151.23 149.79 29.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.831 -0.622 . . . . 0.27000000000000002 111.258 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -153.25 144.75 11.73 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.357 -0.838 . . . . 0.23999999999999999 112.009 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -157.97 137.78 12.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.45 -0.574 . . . . 0.34000000000000002 109.45 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.829 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -108.54 144.93 35.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.325 0.583 . . . . 1.1100000000000001 111.791 -174.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.52 ' HE1' HD21 ' A' ' 68' ' ' LEU . 34.0 p90 -135.07 119.62 18.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.378 -1.341 . . . . 0.80000000000000004 107.378 172.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -100.14 133.23 44.83 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.866 -0.734 . . . . 2.5299999999999998 111.451 -178.325 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.737 ' HB3' ' HE2' ' A' ' 120' ' ' TYR . . . -129.87 147.99 51.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.491 -0.777 . . . . 0.59999999999999998 109.739 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 117' ' ' LEU . 12.6 pt-20 -110.71 -172.52 2.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.045 -0.525 . . . . 2.3799999999999999 111.09 -176.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.84 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.7 OUTLIER -85.11 64.47 8.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.519 -0.764 . . . . 3.96 111.173 -177.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.7 t70 -53.16 -61.78 2.08 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.573 -0.739 . . . . 1.53 112.332 -176.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.556 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 24.3 t70 -177.27 -40.74 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.943 0.402 . . . . 1.26 110.92 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -78.17 2.73 17.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.079 0.466 . . . . 2.2200000000000002 111.058 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 173' ' ' TRP . 39.8 t -72.52 -53.83 5.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.5 110.507 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 73.4 Cg_exo -52.79 -33.5 60.85 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.128 1.886 . . . . 0.57999999999999996 111.966 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 43.4 mmtm -74.35 -24.92 59.24 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.737 0.273 . . . . 2.1400000000000001 111.737 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.885 HD23 ' HA3' ' A' ' 110' ' ' GLY . 62.3 tp -66.57 -46.16 76.92 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.66000000000000003 108.764 170.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -60.44 -37.97 82.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.355 -0.839 . . . . 1.8899999999999999 109.533 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.712 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 24.9 mm-40 -56.65 -41.57 77.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.299 -0.864 . . . . 1.53 111.088 172.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.48 -31.63 57.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.615 -0.721 . . . . 1.49 111.881 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.663 ' HA ' ' H ' ' A' ' 142' ' ' SER . 21.2 mt -65.1 5.64 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.629 0.603 . . . . 0.76000000000000001 112.629 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 16.9 m -66.07 -19.89 65.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.613 0.72 . . . . 1.05 109.791 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 88.76 62.93 1.35 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 110.791 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt . . . . . 0 C--O 1.244 0.78 0 CA-C-O 118.449 -0.786 . . . . 2.0 109.984 -176.833 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 8.1 tpt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.768 -0.456 . . . . 5.04 109.768 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 20.2 Cg_exo -67.08 122.64 9.97 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.556 2.171 . . . . 2.1299999999999999 111.835 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 24' ' ' PRO . 4.5 t -103.17 152.16 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.02 -0.536 . . . . 1.47 109.783 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -154.36 158.74 40.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.928 -0.397 . . . . 1.8100000000000001 109.928 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.57 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -95.19 22.69 6.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.688 -0.233 . . . . 0.69999999999999996 110.962 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 m -80.05 -1.3 39.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 1.96 111.481 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' A' ' 12' ' ' LEU . 11.3 mptt -118.87 22.28 12.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.321 -0.622 . . . . 2.6600000000000001 109.321 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.639 ' CD1' ' HG2' ' A' ' 20' ' ' GLN . 1.9 p90 -61.93 -32.79 73.23 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 3.98 113.565 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -139.99 18.59 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.988 -0.445 . . . . 0.63 111.508 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -83.15 -122.14 0.78 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.263 -0.735 . . . . 0.47999999999999998 111.263 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 10.5 Cg_endo -50.1 -40.64 50.64 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.539 2.826 . . . . 0.53000000000000003 110.696 167.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 23.1 mt -87.23 78.49 8.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.21 -0.904 . . . . 1.1699999999999999 108.752 170.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -73.26 64.98 0.82 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.702 0.763 . . . . 0.70999999999999996 110.507 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.653 HD22 ' CG2' ' A' ' 121' ' ' VAL . 28.7 mt -81.44 -7.05 59.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.181 -0.918 . . . . 0.45000000000000001 111.326 -173.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -2.06 20.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.428 0.632 . . . . 2.1200000000000001 110.332 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.87 -7.67 55.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 1.9299999999999999 110.743 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.806 HG11 HG21 ' A' ' 69' ' ' THR . 71.3 t -98.5 -70.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.684 . . . . 0.63 111.112 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.696 ' OD2' ' HD2' ' A' ' 155' ' ' ARG . 22.2 t0 -164.32 -178.45 5.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.807 -1.183 . . . . 2.9900000000000002 107.807 -167.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.35 149.84 41.16 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.322 0.582 . . . . 1.6000000000000001 111.104 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HG2' ' CD1' ' A' ' 8' ' ' TRP . 5.6 tp60 -81.87 138.6 46.57 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.735 . . . . 3.5499999999999998 110.736 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.641 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 13.4 Cg_exo -68.51 164.86 31.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.021 2.481 . . . . 0.57999999999999996 112.95 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.919 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.9 pt20 -90.52 -1.62 57.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.765 . . . . 1.3899999999999999 111.929 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.75 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.4 m170 -158.88 159.78 29.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 123.059 0.544 . . . . 1.45 109.919 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 3.3 Cg_endo -84.83 127.46 3.6 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.059 2.506 . . . . 0.40000000000000002 111.251 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 122' ' ' TRP . 36.0 tp -79.85 145.66 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.694 -0.23 . . . . 0.28999999999999998 110.768 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.416 ' H ' HD12 ' A' ' 25' ' ' LEU . 51.0 m-70 -114.72 121.24 42.73 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.982 -0.748 . . . . 1.24 108.982 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.906 HG13 HG22 ' A' ' 53' ' ' ILE . 19.4 t -122.83 144.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.108 -0.701 . . . . 0.46999999999999997 109.108 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -140.02 136.32 33.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.237 0.542 . . . . 0.31 111.107 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.602 ' HD2' ' H ' ' A' ' 31' ' ' GLY . 46.0 t80 -101.97 170.2 8.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.174 -0.676 . . . . 0.67000000000000004 109.174 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.47 63.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.342 0.591 . . . . 0.55000000000000004 110.391 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.602 ' H ' ' HD2' ' A' ' 29' ' ' TYR . . . -117.45 19.16 11.68 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.123 -0.944 . . . . 0.81000000000000005 112.703 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -151.7 -172.37 4.2 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.46999999999999997 110.783 177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.37 154.9 17.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.991 -0.55 . . . . 0.33000000000000002 110.13 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.754 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 87.8 t -119.21 68.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.192 -1.41 . . . . 0.39000000000000001 107.192 164.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 1' ' ' MET . 28.2 t70 -105.7 21.56 17.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.979 -1.01 . . . . 0.98999999999999999 108.851 -175.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 22.4 tt0 -144.42 117.58 8.94 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.718 -1.128 . . . . 2.5600000000000001 108.486 174.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.6 OUTLIER -66.88 110.56 3.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.40999999999999998 109.475 -177.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 95.24 12.94 53.9 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.531 -0.759 . . . . 0.58999999999999997 112.557 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -78.93 149.05 32.44 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.09 -0.337 . . . . 0.34000000000000002 110.09 177.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.9 134.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.55000000000000004 111.324 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 34' ' ' VAL . 8.2 tp -132.27 171.11 14.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.703 -0.851 . . . . 0.45000000000000001 108.703 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -120.5 150.81 52.89 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 121.67 0.748 . . . . 0.56000000000000005 112.485 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 72.4 Cg_exo -54.92 -29.99 66.64 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.604 3.536 . . . . 0.68000000000000005 113.963 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -42.53 88.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.659 0.742 . . . . 0.76000000000000001 110.275 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -74.93 -14.4 60.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.613 -1.176 . . . . 1.5900000000000001 111.822 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 169' ' ' TYR . 24.9 m -125.48 24.32 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.173 0.511 . . . . 0.66000000000000003 111.647 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.75 -18.55 40.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.505 0.669 . . . . 0.79000000000000004 109.206 177.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 52.0 t30 -125.03 -179.58 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.701 -1.136 . . . . 1.9099999999999999 108.751 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.88 150.68 78.66 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.616 -0.513 . . . . 1.4299999999999999 109.616 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' HG13 ' A' ' 97' ' ' ILE . 55.2 Cg_endo -73.88 158.75 46.04 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.978 1.785 . . . . 0.37 110.436 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.442 ' H ' ' HA ' ' A' ' 29' ' ' TYR . 6.6 t -79.75 -18.8 50.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 0.44 109.858 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 m -161.21 147.41 14.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.632 0.73 . . . . 0.38 112.164 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.906 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.13 165.6 23.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.756 -1.111 . . . . 0.29999999999999999 108.249 170.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.034 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.4 t 178.96 111.98 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.938 0.399 . . . . 0.34999999999999998 109.929 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 51.1 p-90 -68.87 167.97 14.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.552 -1.277 . . . . 2.7200000000000002 107.552 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -70.2 70.31 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.191 0.519 . . . . 1.51 111.187 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.83 22.99 0.64 Allowed Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.446 -0.797 . . . . 0.80000000000000004 112.423 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.034 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.7 tt -54.88 132.31 46.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.89 0.476 . . . . 0.57999999999999996 111.674 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.432 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 18.8 t70 -78.9 -28.81 44.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.844 -0.616 . . . . 0.73999999999999999 111.996 -175.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.7 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 64.6 m 71.82 1.97 4.11 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.462 -0.79 . . . . 1.03 110.769 -172.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.65 14.54 4.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.992 -0.549 . . . . 0.83999999999999997 112.719 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 1.5 mmpt? -119.26 164.82 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 1.6699999999999999 109.956 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 63.7 mt -103.2 125.6 49.96 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.367 -0.605 . . . . 0.57999999999999996 109.367 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -120.72 148.33 44.1 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.806 -0.357 . . . . 0.80000000000000004 110.812 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.984 HG23 HG12 ' A' ' 90' ' ' VAL . 3.1 m -96.56 105.74 17.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.691 -0.855 . . . . 0.35999999999999999 108.691 173.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 124' ' ' VAL . 50.2 tp -109.69 117.76 34.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.274 -0.421 . . . . 0.58999999999999997 110.907 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG22 HD13 ' A' ' 88' ' ' LEU . 21.0 t -119.0 123.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.865 -0.607 . . . . 0.39000000000000001 110.553 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 1.2 mt -90.03 133.68 34.68 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.038 -1.097 . . . . 0.59999999999999998 108.038 168.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.806 HG21 HG11 ' A' ' 17' ' ' VAL . 8.8 t -142.75 149.16 38.36 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.692 -0.403 . . . . 0.35999999999999999 111.84 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 10.8 t70 -135.71 97.5 12.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 121.522 0.677 . . . . 1.9199999999999999 109.488 173.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.475 ' HG2' ' HE1' ' A' ' 118' ' ' HIS . 18.6 Cg_endo -57.82 -7.42 3.35 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 124.62 3.547 . . . . 1.25 115.848 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 1.8 m-20 -124.77 51.42 1.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.533 0.683 . . . . 1.29 111.534 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.58 143.77 27.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.19 -0.913 . . . . 0.5 109.391 172.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 34.6 Cg_endo -70.92 -35.89 2.62 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.53 -1.446 . . . . 0.62 113.431 1.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 115' ' ' THR . 72.2 p -131.59 166.82 20.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.75 111.312 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 51.5 ttt180 -71.33 -23.09 61.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.0 -0.546 . . . . 2.8799999999999999 110.839 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.736 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.15 -11.52 38.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.509 . . . . 1.3799999999999999 110.656 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.647 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 6.9 t70 -149.64 79.73 7.83 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.699 -0.682 . . . . 1.3700000000000001 109.958 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.2 Cg_endo -89.77 94.24 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.741 2.294 . . . . 0.80000000000000004 113.287 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.557 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.9 mttm -88.17 -44.09 11.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.284 -0.871 . . . . 1.02 110.541 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.687 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 27.9 m-85 -88.54 18.12 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.175 -0.921 . . . . 1.1699999999999999 112.032 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.7 ttm180 -64.2 125.83 25.78 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.916 0.135 . . . . 2.9300000000000002 111.236 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 6.0 mp0 -97.67 134.25 41.11 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.065 -0.346 . . . . 2.23 110.065 -5.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 11.2 t90 -80.57 100.32 8.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.427 0.632 . . . . 1.4299999999999999 109.927 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 33.2 p-80 -84.2 126.08 32.8 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.553 0.692 . . . . 1.26 110.18 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 1.006 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 19.5 t-80 -67.9 -34.7 77.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.05 -0.977 . . . . 2.1400000000000001 110.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 68' ' ' LEU . 44.2 p90 -169.29 170.67 8.4 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.117 0.261 . . . . 1.51 110.311 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HG ' HD12 ' A' ' 103' ' ' LEU . 17.0 tp -133.33 114.08 13.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.065 -0.516 . . . . 0.33000000000000002 109.701 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.807 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.7 t -122.32 132.54 70.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.6 0.714 . . . . 0.31 111.153 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.984 HG12 HG23 ' A' ' 65' ' ' THR . 9.9 m -130.86 160.53 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.85 -1.068 . . . . 0.27000000000000002 108.419 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t-20 62.62 20.52 12.08 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.203 0.314 . . . . 1.76 110.625 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.807 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.3 ttm -71.51 110.35 6.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.277 -0.638 . . . . 0.31 109.277 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.01 94.71 5.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.578 -1.192 . . . . 1.21 110.937 -171.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 72.72 -120.27 7.37 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.801 -1.09 . . . . 0.29999999999999999 112.426 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.533 ' HA ' HD11 ' A' ' 53' ' ' ILE . 8.7 p30 -112.76 17.59 18.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.188 0.518 . . . . 1.04 110.473 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.58 102.53 12.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.707 -0.679 . . . . 0.77000000000000002 109.911 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 97' ' ' ILE . 3.8 mm -58.71 -27.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.702 -1.135 . . . . 0.40999999999999998 111.624 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -77.94 -38.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.68000000000000005 111.975 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 m -74.87 -3.55 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 1.26 112.005 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.74 106.79 2.04 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.363 -0.695 . . . . 0.34999999999999998 111.363 177.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.1 m -61.46 107.39 0.78 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.281 0.562 . . . . 0.45000000000000001 109.734 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.8 p -83.47 113.28 22.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.081 -0.963 . . . . 0.56999999999999995 111.4 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.632 HD12 ' HG ' ' A' ' 88' ' ' LEU . 40.6 mt -90.4 -45.8 8.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.79 0.805 . . . . 0.45000000000000001 109.537 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.6 t -122.84 112.25 17.65 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.132 -1.433 . . . . 0.37 107.132 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 10.7 t0 -61.99 164.97 5.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.42 -0.809 . . . . 1.1499999999999999 112.699 -168.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 13.8 p90 -82.69 92.08 7.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 4.6900000000000004 110.76 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.712 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 40.3 t -75.09 -46.29 39.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.177 0.513 . . . . 0.85999999999999999 111.02 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.691 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 109.84 -174.82 18.14 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.439 -0.886 . . . . 0.67000000000000004 112.996 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 43' ' ' PRO . 42.2 t -66.58 140.25 57.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.287 -0.634 . . . . 0.51000000000000001 109.287 172.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.725 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -174.13 55.52 0.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.71 -0.757 . . . . 0.81999999999999995 112.854 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 110' ' ' GLY . 57.5 Cg_endo -96.05 157.02 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.327 2.684 . . . . 0.84999999999999998 112.516 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.6 ' O ' HG23 ' A' ' 115' ' ' THR . 53.0 Cg_exo -54.89 154.54 21.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.058 2.505 . . . . 0.87 112.282 174.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -74.3 116.5 15.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.77 0.319 . . . . 1.8500000000000001 111.034 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.77 34.35 4.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.652 -0.785 . . . . 1.1799999999999999 112.924 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 112' ' ' PRO . 82.7 p -77.98 -18.27 56.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.729 0.3 . . . . 0.96999999999999997 110.637 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 104.41 3.14 44.21 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 120.916 -0.659 . . . . 1.97 112.132 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 172' ' ' GLU . 4.1 mm? 71.69 102.52 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.299 -0.951 . . . . 0.93999999999999995 111.079 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.518 ' CG ' ' H ' ' A' ' 119' ' ' ARG . 21.4 t-80 -110.69 -172.33 2.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.416 -0.957 . . . . 2.23 108.416 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 1.3 ptp180 -147.55 120.22 8.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.282 0.563 . . . . 2.3100000000000001 111.676 -163.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 6.5 m-85 -80.34 127.33 32.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.577 -1.192 . . . . 0.78000000000000003 108.825 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.653 ' CG2' HD22 ' A' ' 14' ' ' LEU . 16.9 t -104.19 130.83 54.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.154 -0.475 . . . . 0.27000000000000002 110.856 -177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.696 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 27.0 m95 -89.56 120.3 30.74 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 1.99 108.935 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 86.5 mt -115.49 118.59 33.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.934 0.334 . . . . 0.38 110.77 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.636 HG12 HD13 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -116.46 139.82 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.399 -0.223 . . . . 0.31 110.399 177.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.856 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 71.3 t80 -127.03 137.28 53.03 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.866 -0.334 . . . . 5.1200000000000001 111.0 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.536 ' H ' ' CG2' ' A' ' 164' ' ' VAL . 9.1 tp10 -88.05 96.65 10.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.49 -0.93 . . . . 2.4100000000000001 108.49 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.626 ' HG2' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -72.63 167.72 20.16 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.251 0.548 . . . . 1.3100000000000001 109.696 -176.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -80.84 -4.62 55.35 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.464 -0.789 . . . . 2.3999999999999999 109.747 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 127' ' ' GLN . 3.2 ptp180 -165.06 161.9 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.337 -0.847 . . . . 3.5099999999999998 110.913 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.416 ' HG3' HD12 ' A' ' 63' ' ' LEU . 51.4 Cg_exo -55.91 143.72 80.95 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.509 2.806 . . . . 1.21 112.442 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.626 HD11 ' HG2' ' A' ' 127' ' ' GLN . 2.3 mm? -79.91 141.83 35.72 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.90000000000000002 110.767 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 20.2 tptm -132.64 67.26 1.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.435 -0.95 . . . . 2.8999999999999999 108.435 168.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.779 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 61.4 m -82.23 122.65 28.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.178 -0.919 . . . . 1.8999999999999999 110.443 -177.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.39 25.55 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.926 -0.579 . . . . 2.96 110.26 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.779 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 12.8 mm-40 -62.38 142.18 96.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.52 -0.764 . . . . 1.3899999999999999 109.894 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.69 110.14 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.313 2.675 . . . . 1.27 112.696 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.41 115.49 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.85999999999999999 110.323 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.8 mt -108.15 155.54 20.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.284 0.564 . . . . 1.6100000000000001 110.639 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.9 m -105.11 159.26 15.99 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.176 -1.046 . . . . 1.8799999999999999 108.176 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.712 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.0 p-10 -78.75 7.11 7.5 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.739 -0.384 . . . . 0.75 110.666 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.58 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 11.0 mtt180 -98.17 135.17 40.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.548 -0.538 . . . . 3.3599999999999999 109.548 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.719 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 20.5 m 73.38 117.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 O-C-N 124.316 1.01 . . . . 0.94999999999999996 109.686 -174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.21 27.66 15.12 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.583 -0.818 . . . . 1.1200000000000001 113.669 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -71.29 -25.13 62.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.929 0.395 . . . . 2.6600000000000001 111.026 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.92 30.48 6.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.949 0.404 . . . . 1.8700000000000001 111.177 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 42.7 mtp180 -60.9 -46.39 90.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 4.7300000000000004 110.782 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.52 -154.82 7.71 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.743 -0.741 . . . . 0.65000000000000002 111.889 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.687 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.0 mttt 67.2 17.32 10.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.254 0.55 . . . . 1.0800000000000001 111.137 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -122.13 112.24 17.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.441 -0.799 . . . . 1.8899999999999999 109.106 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -62.45 129.7 41.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 1.29 112.496 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.649 HG21 ' CG1' ' A' ' 17' ' ' VAL . 4.6 m -62.94 -32.13 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.78000000000000003 110.761 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.21 95.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.586 -0.734 . . . . 0.67000000000000004 110.02 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.77000000000000002 110.693 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.616 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 32.7 m-85 -61.73 -50.62 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 0.92000000000000004 110.965 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.696 ' HD2' ' OD2' ' A' ' 18' ' ' ASP . 6.5 ptm85 -70.12 -40.01 75.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.396 -0.365 . . . . 2.8900000000000001 111.135 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -66.05 -26.03 67.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 111.637 0.236 . . . . 0.96999999999999997 111.637 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -53.76 -49.36 68.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.679 0.275 . . . . 1.5800000000000001 110.608 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.516 ' HB3' HD13 ' A' ' 160' ' ' LEU . 6.6 t80 -99.64 15.31 27.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.759 -0.776 . . . . 5.4500000000000002 109.917 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 58.4 43.6 19.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.295 -0.866 . . . . 2.4199999999999999 111.682 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.856 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 3.4 mp -86.13 120.54 27.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.767 -0.651 . . . . 1.27 111.027 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.91 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -79.62 -173.7 3.92 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.914 -0.402 . . . . 3.5899999999999999 109.914 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.91 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -43.5 146.41 0.93 Allowed Pre-proline 0 N--CA 1.466 0.328 0 C-N-CA 123.82 0.848 . . . . 0.76000000000000001 113.009 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 6.5 Cg_exo -71.54 169.65 20.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.965 3.11 . . . . 0.53000000000000003 113.969 -170.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 21.4 t -95.3 -30.8 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.44 110.364 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.75 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -149.3 146.9 27.78 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.828 -0.749 . . . . 0.27000000000000002 112.302 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.97 148.07 19.12 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 114.458 -1.246 . . . . 0.23999999999999999 111.603 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 10.5 t -159.72 149.43 18.33 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.469 -0.937 . . . . 0.34000000000000002 108.469 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 21.2 p -123.8 146.68 48.17 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.12 -0.632 . . . . 1.1100000000000001 111.166 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 33.4 p90 -130.23 142.03 50.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.413 -1.329 . . . . 0.80000000000000004 107.413 175.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 1.1 pt20 -115.66 134.64 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.192 -0.603 . . . . 2.5299999999999998 111.558 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.14 153.87 33.64 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.751 0.657 . . . . 0.59999999999999998 110.072 -172.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.695 ' HG2' HD11 ' A' ' 117' ' ' LEU . 2.5 pt-20 -133.91 -106.73 0.23 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.677 0.621 . . . . 2.3799999999999999 112.677 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.695 ' HA ' HG21 ' A' ' 177' ' ' VAL . 31.9 t90 -118.12 84.1 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.15 0.5 . . . . 3.96 110.232 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.871 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 7.2 t70 -73.26 -62.4 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.898 -0.592 . . . . 1.53 111.725 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 14.4 t70 173.41 -44.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.776 -0.647 . . . . 1.26 109.675 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -80.34 9.55 5.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.548 -0.751 . . . . 2.2200000000000002 111.117 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.73 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 83.9 t -72.8 -53.99 5.04 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.5 109.926 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.73 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 56.6 Cg_exo -51.53 -37.8 63.31 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.299 1.999 . . . . 0.57999999999999996 111.424 169.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.677 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.7 mmtp -71.54 -23.38 61.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 2.1400000000000001 111.38 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.4 tp -67.81 -48.24 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.052 -0.722 . . . . 0.66000000000000003 109.052 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.7 -32.39 73.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.01 -0.541 . . . . 1.8899999999999999 109.737 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 11.7 mm-40 -55.7 -48.45 75.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.39 -0.823 . . . . 1.53 110.329 171.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -73.98 -33.16 63.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.288 -0.869 . . . . 1.49 112.002 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.719 ' HA ' ' H ' ' A' ' 142' ' ' SER . 37.6 mt -63.16 -1.83 1.14 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.496 0.554 . . . . 0.76000000000000001 112.496 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.708 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 13.1 m -73.7 -2.62 24.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.434 0.635 . . . . 1.05 109.92 172.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.14 39.8 8.31 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.835 -0.906 . . . . 1.1699999999999999 110.835 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.708 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.519 -0.753 . . . . 2.0 110.061 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.789 -0.449 . . . . 5.04 109.789 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -46.59 137.3 15.47 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.617 2.878 . . . . 2.1299999999999999 113.221 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.761 HG22 ' HA ' ' A' ' 36' ' ' GLU . 19.8 t -88.22 144.12 9.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.501 -0.772 . . . . 1.47 111.462 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.432 ' O ' HD12 ' A' ' 37' ' ' LEU . 2.5 p30 -155.61 163.49 39.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.153 -1.054 . . . . 1.8100000000000001 108.153 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.522 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.9 mm? -88.28 29.11 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.633 -0.427 . . . . 0.69999999999999996 111.081 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 -7.82 59.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.303 0.573 . . . . 1.96 109.867 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 8.7 mptt -113.33 29.09 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 2.6600000000000001 109.608 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.648 ' HZ3' ' HG3' ' A' ' 15' ' ' GLN . 11.4 p-90 -67.87 -36.11 79.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.356 -0.838 . . . . 3.98 111.693 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 75.3 p -144.03 19.92 1.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.646 -0.421 . . . . 0.63 111.601 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -74.44 -118.37 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.86 -0.686 . . . . 0.47999999999999998 111.633 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.4 Cg_endo -47.14 -51.77 8.87 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.434 2.756 . . . . 0.53000000000000003 110.787 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.898 HD23 HD21 ' A' ' 14' ' ' LEU . 6.5 mp -88.95 98.39 11.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 1.1699999999999999 110.831 171.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 69.6 m -76.49 66.17 2.46 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.334 0.588 . . . . 0.70999999999999996 110.26 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.898 HD21 HD23 ' A' ' 12' ' ' LEU . 57.9 mt -73.85 -16.88 61.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.509 -0.769 . . . . 0.45000000000000001 111.225 -176.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.648 ' HG3' ' HZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -64.09 -15.08 58.84 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.05 0.452 . . . . 2.1200000000000001 110.857 -178.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -60.4 -23.27 64.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.255 0.55 . . . . 1.9299999999999999 110.666 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.885 HG11 HG21 ' A' ' 69' ' ' THR . 87.3 t -103.53 -64.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.328 -0.851 . . . . 0.63 110.877 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HA ' HH22 ' A' ' 155' ' ' ARG . 4.8 p-10 -116.43 172.44 7.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.134 0.492 . . . . 2.9900000000000002 111.283 -175.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.58 28.65 1.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.632 -0.713 . . . . 1.6000000000000001 112.365 -171.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 4.5 tt0 65.41 116.95 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 123.191 0.596 . . . . 3.5499999999999998 110.691 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 20.4 Cg_exo -65.77 158.74 52.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.683 2.255 . . . . 0.57999999999999996 112.959 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.885 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 18.4 pt20 -77.41 -13.89 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.247 -0.888 . . . . 1.3899999999999999 110.789 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.748 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 70.7 m-70 -149.73 156.51 38.67 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-N 115.461 -0.79 . . . . 1.45 109.458 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -85.84 125.98 2.85 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.955 2.437 . . . . 0.40000000000000002 110.771 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.568 ' HB2' ' HB1' ' A' ' 165' ' ' ALA . 27.0 tp -80.02 148.12 31.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.874 0.369 . . . . 0.28999999999999998 111.012 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.47 ' H ' HD12 ' A' ' 25' ' ' LEU . 33.1 m170 -118.12 128.73 55.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.775 -0.454 . . . . 1.24 109.775 170.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.962 HG13 HG22 ' A' ' 53' ' ' ILE . 32.6 t -128.8 119.64 50.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.825 -0.806 . . . . 0.46999999999999997 108.825 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.6 OUTLIER -115.68 138.49 51.04 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.343 0.592 . . . . 0.31 111.431 -171.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 33.6 t80 -100.31 176.78 5.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.784 -0.644 . . . . 0.67000000000000004 109.275 174.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.58 65.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.277 0.561 . . . . 0.55000000000000004 110.63 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.57 -0.57 29.24 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.438 -0.801 . . . . 0.81000000000000005 112.845 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.54 -174.22 3.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.46999999999999997 110.914 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.75 144.25 8.64 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.56 -0.746 . . . . 0.33000000000000002 110.022 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.843 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 97.7 t -95.06 69.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 106.996 -1.483 . . . . 0.39000000000000001 106.996 163.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -103.22 28.4 6.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.106 -0.952 . . . . 0.98999999999999999 109.236 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' A' ' 3' ' ' VAL . 49.9 mt-10 -150.32 134.05 16.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.765 -1.107 . . . . 2.5600000000000001 109.086 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.722 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.36 114.02 11.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.40999999999999998 110.136 -175.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' CA ' HE22 ' A' ' 170' ' ' GLN . . . 78.88 29.59 51.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.9 -0.667 . . . . 0.58999999999999997 111.518 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.843 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -90.29 152.92 20.83 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.22 0.208 . . . . 0.34000000000000002 110.625 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.459 ' N ' ' HG2' ' A' ' 39' ' ' LYS . 10.7 p -78.77 134.68 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.335 0.588 . . . . 0.55000000000000004 111.487 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 34' ' ' VAL . 7.6 tp -132.87 169.87 16.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.462 -0.94 . . . . 0.45000000000000001 108.462 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.6 p -115.02 151.39 45.54 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.024 -0.67 . . . . 0.56000000000000005 112.309 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 50.5 Cg_exo -56.91 -28.96 80.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.164 3.243 . . . . 0.68000000000000005 113.298 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 p -65.09 -41.21 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.615 0.721 . . . . 0.76000000000000001 110.528 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -80.47 -17.69 50.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.684 -1.144 . . . . 1.5900000000000001 111.414 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 42' ' ' THR . 28.2 m -125.66 30.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.095 0.474 . . . . 0.66000000000000003 111.439 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -78.08 -21.93 49.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.457 0.646 . . . . 0.79000000000000004 109.266 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 49' ' ' ARG . 3.3 t-20 -131.89 177.91 7.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.404 -1.271 . . . . 1.9099999999999999 108.725 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.539 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 98.7 mtt180 -67.13 151.97 96.57 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.188 -0.301 . . . . 1.4299999999999999 110.188 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 60.6 Cg_endo -74.75 161.68 38.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.192 1.928 . . . . 0.37 110.744 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -82.12 -21.24 36.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.107 0.48 . . . . 0.44 109.919 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 68.7 m -158.56 149.82 20.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.38 111.96 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.962 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -138.5 165.29 25.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.05 -1.093 . . . . 0.29999999999999999 108.05 169.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.037 ' HA ' HD13 ' A' ' 58' ' ' LEU . 39.7 t -179.86 116.85 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.192 0.52 . . . . 0.34999999999999998 110.204 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 45.7 p-90 -78.78 163.27 25.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.189 -1.041 . . . . 2.7200000000000002 108.189 172.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.18 86.4 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.086 0.47 . . . . 1.51 110.939 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.0 29.44 2.81 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.677 -0.692 . . . . 0.80000000000000004 112.472 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.037 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.3 tt -60.66 129.83 43.47 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.04 0.447 . . . . 0.57999999999999996 110.853 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.801 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -80.69 -21.38 41.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.73999999999999999 111.927 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.659 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 75.7 m 69.56 2.01 3.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.456 -0.793 . . . . 1.03 110.957 -171.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.15 -2.63 3.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.731 -0.747 . . . . 0.83999999999999997 113.336 -176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.801 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 38.6 mtpt -93.93 145.69 24.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.451 0.625 . . . . 1.6699999999999999 109.637 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.907 HD23 ' HG2' ' A' ' 93' ' ' LYS . 2.9 mt -84.77 144.01 28.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.665 -1.235 . . . . 0.57999999999999996 107.665 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -140.72 166.05 25.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.841 -0.8 . . . . 0.80000000000000004 108.841 173.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 90' ' ' VAL . 88.5 m -105.03 105.16 15.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.222 -0.659 . . . . 0.35999999999999999 109.222 171.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.628 HD13 HG12 ' A' ' 124' ' ' VAL . 52.1 tp -104.59 115.57 30.58 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.232 0.539 . . . . 0.58999999999999997 110.429 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.0 t -121.11 123.72 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.645 -0.707 . . . . 0.39000000000000001 110.489 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 5.5 mt -81.51 139.38 35.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.167 -1.049 . . . . 0.59999999999999998 108.167 167.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.885 HG21 HG11 ' A' ' 17' ' ' VAL . 14.8 t -140.73 153.59 45.98 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.695 -0.402 . . . . 0.35999999999999999 110.94 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 15.7 t70 -140.69 102.16 6.49 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.251 0.548 . . . . 1.9199999999999999 110.219 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 11.0 Cg_endo -55.37 -28.93 65.7 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.746 2.964 . . . . 1.25 114.788 174.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -100.43 43.81 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 1.29 111.974 -167.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 84' ' ' TRP . . . -108.51 136.43 19.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 122.241 -0.287 . . . . 0.5 110.872 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.714 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 66.2 Cg_endo -74.85 -25.75 9.89 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.277 -1.551 . . . . 0.62 112.657 0.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.562 ' HB3' HG22 ' A' ' 115' ' ' THR . 86.6 p -139.07 160.3 40.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.604 . . . . 0.75 109.945 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -72.32 -26.16 61.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 2.8799999999999999 111.858 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.824 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.85 -13.41 48.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.146 0.498 . . . . 1.3799999999999999 110.508 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 21.8 t0 -150.9 73.01 8.73 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.357 -0.838 . . . . 1.3700000000000001 109.149 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 43.6 Cg_endo -89.99 88.87 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.765 2.31 . . . . 0.80000000000000004 113.034 -175.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.714 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 38.0 mttm -78.2 -45.8 22.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.773 -1.103 . . . . 1.02 111.035 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.732 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 77.8 m-85 -82.74 10.62 7.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.194 -0.912 . . . . 1.1699999999999999 111.986 -169.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 37.8 ttp180 -70.16 127.76 33.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.185 -0.302 . . . . 2.9300000000000002 110.185 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 48.9 mt-10 -94.6 129.6 41.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.025 0.44 . . . . 2.23 110.56 0.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.706 ' HD1' ' HB3' ' A' ' 81' ' ' TYR . 9.9 t90 -88.48 90.3 8.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 1.4299999999999999 109.756 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.5 p80 -75.61 120.15 20.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.596 0.712 . . . . 1.26 109.872 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 6.1 t-160 -70.75 -24.44 62.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.365 -0.834 . . . . 2.1400000000000001 111.011 -172.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.735 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 19.0 p90 -168.26 179.03 4.67 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.696 -0.483 . . . . 1.51 109.696 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.408 ' CD1' HG22 ' A' ' 67' ' ' VAL . 24.2 tp -142.75 114.48 8.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.33000000000000002 110.434 174.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.735 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -126.49 132.37 70.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.31 110.475 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.648 ' HB ' HD23 ' A' ' 131' ' ' LEU . 6.4 m -124.54 166.2 20.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.722 -1.214 . . . . 0.27000000000000002 107.722 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.787 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 92.8 m-20 59.56 19.55 8.07 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.374 0.421 . . . . 1.76 111.363 172.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.709 ' HE3' HG11 ' A' ' 89' ' ' VAL . 10.8 ttm -71.64 108.48 5.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.582 -0.895 . . . . 0.31 108.582 175.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.907 ' HG2' HD23 ' A' ' 63' ' ' LEU . 1.9 mtpm? -82.03 94.79 7.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.083 -0.962 . . . . 1.21 111.091 -170.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.5 -119.65 5.58 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.06 -0.973 . . . . 0.29999999999999999 112.58 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.562 ' HA ' HD11 ' A' ' 53' ' ' ILE . 25.3 p-10 -117.62 29.94 7.56 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 1.04 111.002 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -96.71 105.59 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.534 0.683 . . . . 0.77000000000000002 110.034 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 97' ' ' ILE . 8.4 mm -58.6 -33.38 48.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.565 -1.198 . . . . 0.40999999999999998 111.459 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.2 m -82.61 -35.51 26.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.844 -0.616 . . . . 0.68000000000000005 111.906 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 m -73.28 -6.04 43.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.493 -0.321 . . . . 1.26 111.711 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.3 107.87 2.16 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.628 -0.589 . . . . 0.34999999999999998 111.628 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -57.99 107.01 0.42 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.534 0.683 . . . . 0.45000000000000001 109.602 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 5.8 p -85.91 121.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.826 -1.079 . . . . 0.56999999999999995 111.631 -173.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.508 HD22 ' HB2' ' A' ' 135' ' ' GLU . 68.7 mt -102.0 -46.73 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.161 -0.927 . . . . 0.45000000000000001 109.255 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.0 t -126.16 108.21 11.1 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.162 -1.422 . . . . 0.37 107.162 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.412 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.7 t0 -57.2 155.72 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 1.1499999999999999 112.673 -169.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 43.2 t80 -74.02 95.32 2.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.29 -0.868 . . . . 4.6900000000000004 109.783 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 140' ' ' ASN . 23.4 t -78.96 142.34 14.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.268 -1.012 . . . . 0.85999999999999999 108.268 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.21 179.33 45.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.67000000000000004 112.975 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 28.7 t -54.92 141.3 34.06 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.16 0.184 . . . . 0.51000000000000001 111.084 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -164.83 70.55 0.19 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.168 -0.539 . . . . 0.81999999999999995 112.367 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.773 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 89.4 Cg_endo -92.53 133.76 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.022 2.481 . . . . 0.84999999999999998 113.257 176.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 38.5 Cg_exo -59.11 137.31 78.57 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.649 2.233 . . . . 0.87 111.395 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.554 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.08 118.21 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 1.8500000000000001 111.005 -178.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.63 -3.07 32.34 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.555 -0.831 . . . . 1.1799999999999999 112.087 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.609 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 62.1 p -81.77 -10.47 59.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 0.96999999999999997 110.57 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.16 -155.94 19.97 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.267 -0.733 . . . . 1.97 111.267 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.4 mm? -90.37 108.23 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.56 -0.533 . . . . 0.93999999999999995 109.56 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -72.22 113.75 9.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.474 -175.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 1.021 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 1.1 ptt180 -102.77 95.12 5.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.315 0.579 . . . . 2.3100000000000001 112.201 -169.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.603 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 16.9 m-85 -83.81 120.52 26.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.536 -0.756 . . . . 0.78000000000000003 109.123 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.847 HG21 HD22 ' A' ' 14' ' ' LEU . 6.7 t -100.14 131.98 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 110.008 -0.367 . . . . 0.27000000000000002 110.008 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.694 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 69.2 m95 -88.07 119.52 28.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.205 -0.665 . . . . 1.99 109.205 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.6 mt -118.85 118.79 32.5 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 121.104 -0.238 . . . . 0.38 110.654 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.628 HG12 HD13 ' A' ' 66' ' ' LEU . 1.4 m -105.12 128.36 59.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.165 -0.68 . . . . 0.31 109.165 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.655 ' CB ' HD23 ' A' ' 160' ' ' LEU . 86.2 m-85 -107.64 162.26 14.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.372 -0.376 . . . . 5.1200000000000001 111.006 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.94 113.13 26.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.717 0.77 . . . . 2.4100000000000001 112.806 -171.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.859 ' HB3' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -107.71 148.65 29.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.419 -0.809 . . . . 1.3100000000000001 110.064 171.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.17 -9.5 59.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.302 -0.863 . . . . 2.3999999999999999 110.716 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.475 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 9.5 ptp180 -147.59 168.09 12.02 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.601 -0.727 . . . . 3.5099999999999998 111.641 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 22.6 Cg_exo -61.61 141.26 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.707 2.272 . . . . 1.21 110.539 172.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.648 HD23 ' HB ' ' A' ' 90' ' ' VAL . 3.2 mm? -73.9 145.21 44.97 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.681 0.623 . . . . 0.90000000000000002 112.681 -169.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -102.2 104.34 14.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.965 -1.016 . . . . 2.8999999999999999 108.811 171.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.459 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.3 p -124.44 112.23 16.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.113 -0.494 . . . . 1.8999999999999999 111.803 -175.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -99.19 13.53 32.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.033 -0.729 . . . . 2.96 109.033 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HB2' HD22 ' A' ' 103' ' ' LEU . 9.2 mm-40 -63.04 130.01 93.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.212 -0.904 . . . . 1.3899999999999999 110.56 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.56 112.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.032 2.488 . . . . 1.27 112.435 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.5 mm -61.87 115.57 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 0.85999999999999999 110.855 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 63.2 mt -106.14 152.27 23.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 1.6100000000000001 109.808 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.5 m -91.33 -173.44 3.61 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.676 -0.861 . . . . 1.8799999999999999 108.676 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.707 ' HA ' HG22 ' A' ' 107' ' ' VAL . 2.1 p-10 -92.86 7.62 43.07 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.015 -0.674 . . . . 0.75 110.175 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.879 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 85.7 mtt180 -95.97 145.45 25.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 3.3599999999999999 109.972 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.617 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 21.9 m 73.85 126.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.145 -0.934 . . . . 0.94999999999999996 111.516 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.81 33.9 5.41 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.298 -0.865 . . . . 1.1200000000000001 111.709 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -52.75 19.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 2.6600000000000001 113.312 -172.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -122.19 47.44 1.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.427 0.632 . . . . 1.8700000000000001 111.304 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.418 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 22.6 mmt180 -88.17 -27.44 21.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.728 -0.669 . . . . 4.7300000000000004 111.138 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -129.33 -169.0 12.47 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 119.982 -1.104 . . . . 0.65000000000000002 113.121 -174.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.732 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 79.3 mttt 65.99 34.33 7.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.603 0.715 . . . . 1.0800000000000001 110.805 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.78 167.53 12.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.078 -0.964 . . . . 1.8899999999999999 109.608 174.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -116.81 120.95 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.199 -0.455 . . . . 1.29 111.083 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.801 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 35.6 m -64.83 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.78000000000000003 110.301 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.58 -44.68 93.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.024 -0.534 . . . . 0.67000000000000004 109.708 172.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.3 m -64.16 -38.39 90.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.77000000000000002 110.099 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.801 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.5 m-85 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.58 -0.282 . . . . 0.92000000000000004 111.315 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 6.6 ptp180 -63.84 -43.87 94.89 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.979 -0.288 . . . . 2.8900000000000001 110.345 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -68.64 -29.9 68.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.32 . . . . 0.96999999999999997 111.119 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -59.09 -51.9 68.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 111.376 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.519 ' HB3' HD12 ' A' ' 131' ' ' LEU . 49.9 m-85 -89.95 4.27 50.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.965 -0.561 . . . . 5.4500000000000002 111.711 -173.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 72.16 33.12 1.62 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.762 0.664 . . . . 2.4199999999999999 111.213 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 127' ' ' GLN . 4.5 mp -100.54 172.44 7.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.21 -0.904 . . . . 1.27 109.372 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 31.0 tpt180 -131.99 -95.92 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.317 -0.553 . . . . 3.5899999999999999 111.953 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -105.28 146.28 32.42 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.919 0.39 . . . . 0.76000000000000001 110.989 -173.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 17.0 Cg_exo -65.71 141.74 67.32 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.274 2.649 . . . . 0.53000000000000003 112.872 -170.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.885 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 3.0 t -78.16 -32.66 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.44 109.757 174.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.748 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -154.08 147.52 25.01 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 120.276 -0.569 . . . . 0.27000000000000002 111.695 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -148.58 144.14 11.87 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.937 -1.029 . . . . 0.23999999999999999 111.592 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -159.25 135.2 8.81 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.152 -0.684 . . . . 0.34000000000000002 109.152 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.858 ' SG ' ' HB2' ' A' ' 119' ' ' ARG . 27.3 t -113.54 145.88 40.54 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.398 -0.521 . . . . 1.1100000000000001 111.696 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 27.0 p90 -129.08 131.18 47.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.067 -0.716 . . . . 0.80000000000000004 109.067 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 1.021 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 17.3 mp0 -98.46 132.22 44.09 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.441 -0.504 . . . . 2.5299999999999998 110.272 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.57 139.06 54.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.848 -0.427 . . . . 0.59999999999999998 109.848 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.18 -168.76 1.51 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.073 -0.512 . . . . 2.3799999999999999 110.939 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.69 ' HA ' HG21 ' A' ' 177' ' ' VAL . 22.7 t90 -87.23 78.57 8.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 3.96 109.847 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.609 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -72.81 -59.17 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.35 -0.386 . . . . 1.53 111.086 -177.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.572 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 15.4 t70 175.81 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.987 0.515 . . . . 1.26 110.479 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.495 ' HB3' ' CD ' ' A' ' 47' ' ' LYS . 36.9 m-85 -81.28 -0.64 41.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 2.2200000000000002 111.758 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.842 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 99.1 t -63.25 -54.83 41.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.17 -0.468 . . . . 0.5 110.794 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.842 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.0 Cg_exo -50.77 -43.71 44.99 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.658 2.239 . . . . 0.57999999999999996 111.923 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.675 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 30.3 mmmt -66.24 -23.55 66.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.08 -0.509 . . . . 2.1400000000000001 111.917 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.695 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 36.0 tp -66.04 -48.67 70.31 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.058 -0.657 . . . . 0.66000000000000003 109.574 172.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.26 -35.19 79.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.356 0.598 . . . . 1.8899999999999999 109.656 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.675 ' HG3' ' HD2' ' A' ' 179' ' ' LYS . 4.8 mm-40 -55.97 -48.26 76.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.927 -1.033 . . . . 1.53 110.122 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -74.39 -33.47 63.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 1.49 112.187 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 71.1 mt -62.25 -10.69 11.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.646 0.26 . . . . 0.76000000000000001 111.66 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.619 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 50.9 m -77.08 6.99 5.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.224 0.535 . . . . 1.05 110.441 173.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.879 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 68.89 60.82 5.02 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.268 -0.878 . . . . 1.1699999999999999 111.327 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.6 mmmt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.518 -0.753 . . . . 2.0 111.125 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.524 0.202 . . . . 5.04 111.081 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.55 153.92 63.23 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.602 2.201 . . . . 2.1299999999999999 111.242 173.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.0 t -66.39 116.01 5.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.319 0.58 . . . . 1.47 111.007 -175.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 6' ' ' SER . 32.0 t70 -152.04 158.15 42.64 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.752 -1.113 . . . . 1.8100000000000001 108.268 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.718 HD12 HE21 ' A' ' 20' ' ' GLN . 2.7 mm? -78.9 30.91 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.837 0.351 . . . . 0.69999999999999996 110.765 -175.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.647 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 3.9 m -59.1 -54.69 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.97 -0.559 . . . . 1.96 111.581 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HD2' ' HB2' ' A' ' 6' ' ' SER . 8.8 mptt -99.73 40.48 1.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.819 0.342 . . . . 2.6600000000000001 110.288 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.584 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 3.4 p-90 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.779 -0.646 . . . . 3.98 112.094 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 p -141.54 20.62 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.907 0.384 . . . . 0.63 111.394 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.77 -122.54 0.31 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.35 -0.7 . . . . 0.47999999999999998 111.35 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.4 Cg_endo -51.48 -40.12 63.49 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.13 2.553 . . . . 0.53000000000000003 109.815 166.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.854 HD11 ' HA3' ' A' ' 38' ' ' GLY . 25.9 mt -87.73 81.26 7.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.433 -1.258 . . . . 1.1699999999999999 109.863 172.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -71.75 66.97 0.56 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.05 -0.722 . . . . 0.70999999999999996 109.05 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.837 HD22 HG21 ' A' ' 121' ' ' VAL . 46.0 mt -75.16 -12.74 60.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.698 -0.683 . . . . 0.45000000000000001 110.797 -175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -65.65 -15.19 62.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 2.1200000000000001 111.237 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.16 -21.72 66.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.165 0.507 . . . . 1.9299999999999999 110.078 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.789 HG11 HG21 ' A' ' 69' ' ' THR . 76.1 t -89.56 -71.59 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.464 -0.789 . . . . 0.63 110.775 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.582 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 9.8 t70 -156.58 174.72 15.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.543 -0.54 . . . . 2.9900000000000002 109.543 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -63.95 120.84 12.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.298 . . . . 1.6000000000000001 110.285 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.718 HE21 HD12 ' A' ' 5' ' ' LEU . 48.2 tp60 -53.82 127.93 53.49 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.752 -0.658 . . . . 3.5499999999999998 110.567 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.662 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.0 Cg_exo -58.28 161.89 13.03 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.331 2.688 . . . . 0.57999999999999996 113.498 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.904 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 8.8 pt20 -69.86 -19.48 63.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.894 -1.048 . . . . 1.3899999999999999 112.0 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.695 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m80 -146.56 159.04 45.64 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.165 -0.47 . . . . 1.45 110.424 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HG3' HD22 ' A' ' 5' ' ' LEU . 3.2 Cg_endo -85.19 128.65 3.67 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.208 2.605 . . . . 0.40000000000000002 111.436 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.48 HD22 ' CG1' ' A' ' 124' ' ' VAL . 26.7 tp -80.84 146.89 30.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.526 0.203 . . . . 0.28999999999999998 110.769 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -115.38 109.54 18.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.103 -0.332 . . . . 1.24 110.103 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.878 HG13 HG22 ' A' ' 53' ' ' ILE . 13.8 t -116.35 140.4 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.46999999999999997 110.049 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -137.59 137.66 38.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.3 -0.409 . . . . 0.31 110.889 -177.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.658 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 22.2 t80 -97.36 177.26 5.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.833 -0.802 . . . . 0.67000000000000004 108.833 174.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.41 -52.53 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.514 0.673 . . . . 0.55000000000000004 110.059 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.17 8.79 38.78 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.006 -0.997 . . . . 0.81000000000000005 112.651 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.57 -169.7 3.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.46999999999999997 110.704 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -162.51 158.2 23.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.737 -0.665 . . . . 0.33000000000000002 109.8 176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.885 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 79.8 t -111.43 65.87 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.624 -1.621 . . . . 0.39000000000000001 106.624 163.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -97.69 25.31 5.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.17 0.986 . . . . 0.98999999999999999 109.062 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.6 122.57 10.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.524 -1.217 . . . . 2.5600000000000001 108.02 174.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.2 tt -70.94 111.37 6.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.194 0.521 . . . . 0.40999999999999998 109.709 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.854 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 82.15 26.26 49.01 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.343 -0.844 . . . . 0.58999999999999997 111.862 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -83.74 153.17 24.3 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.93 -0.396 . . . . 0.34000000000000002 109.93 174.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.55 133.46 30.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.425 0.631 . . . . 0.55000000000000004 111.285 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.8 tp -131.22 170.08 15.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.558 -0.904 . . . . 0.45000000000000001 108.558 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.36 152.41 54.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 O-C-N 121.665 -0.647 . . . . 0.56000000000000005 112.491 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 77.1 Cg_exo -51.78 -35.35 58.33 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.749 3.633 . . . . 0.68000000000000005 114.722 -171.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.9 p -65.64 -35.03 79.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.76000000000000001 110.36 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -82.43 -14.14 55.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.4 -1.273 . . . . 1.5900000000000001 111.686 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 41' ' ' LEU . 23.9 m -128.49 20.04 2.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.287 0.565 . . . . 0.66000000000000003 111.656 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.79 -26.55 31.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.751 -0.659 . . . . 0.79000000000000004 109.545 179.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -116.77 -178.02 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.699 -1.137 . . . . 1.9099999999999999 109.182 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' HB3' HG21 ' A' ' 97' ' ' ILE . 77.9 mtt180 -72.9 152.9 91.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.932 -0.766 . . . . 1.4299999999999999 108.932 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.658 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 49.2 Cg_endo -74.94 175.02 11.77 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.413 1.409 . . . . 0.37 110.39 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -96.93 -16.26 20.75 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.274 -0.571 . . . . 0.44 110.059 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.477 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 75.3 m -159.75 144.32 14.99 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.38 112.436 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.878 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.24 169.21 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.996 -1.112 . . . . 0.29999999999999999 107.996 171.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.083 ' HA ' HD13 ' A' ' 58' ' ' LEU . 36.8 t 176.87 127.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.918 0.39 . . . . 0.34999999999999998 110.088 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 32.8 p-90 -92.91 167.73 11.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.933 -1.136 . . . . 2.7200000000000002 107.933 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.4 78.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 1.51 111.045 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.02 26.01 0.86 Allowed Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.565 -0.743 . . . . 0.80000000000000004 112.06 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.083 HD13 ' HA ' ' A' ' 54' ' ' SER . 2.7 tt -65.35 128.48 36.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.071 0.462 . . . . 0.57999999999999996 110.939 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.76 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 33.5 t70 -75.39 -25.68 57.84 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 0.73999999999999999 111.756 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 25.3 p 70.0 8.87 6.88 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.475 1.11 . . . . 1.03 110.331 -171.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.29 -3.4 1.42 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.83999999999999997 113.405 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.76 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 39.5 mtpt -96.51 151.97 19.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.38 0.59 . . . . 1.6699999999999999 110.217 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.695 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 45.2 mt -88.15 124.96 34.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.629 -0.714 . . . . 0.57999999999999996 109.977 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.613 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 2.6 m-85 -120.99 152.0 39.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.919 -0.312 . . . . 0.80000000000000004 110.683 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.456 HG23 HG12 ' A' ' 90' ' ' VAL . 57.1 m -97.32 110.63 23.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 0.35999999999999999 109.149 170.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.672 HD13 HG12 ' A' ' 124' ' ' VAL . 48.8 tp -113.16 118.69 35.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.58999999999999997 110.497 -175.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.3 t -116.64 126.29 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.39000000000000001 110.619 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.963 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 2.9 mt -92.76 133.76 35.72 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.472 -0.936 . . . . 0.59999999999999998 108.472 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.789 HG21 HG11 ' A' ' 17' ' ' VAL . 9.3 t -137.55 147.42 45.12 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.616 -0.434 . . . . 0.35999999999999999 111.899 -176.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 18.5 t70 -123.82 97.15 41.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.69 -0.686 . . . . 1.9199999999999999 109.8 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.2 Cg_endo -51.39 -35.11 53.3 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 124.076 3.184 . . . . 1.25 114.797 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 60.8 m-20 -99.45 49.69 0.94 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.397 0.517 . . . . 1.29 112.397 -168.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.45 142.75 25.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.5 110.295 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 98.5 Cg_endo -83.66 -23.11 13.38 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.814 -1.328 . . . . 0.62 112.753 1.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.689 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 24.7 p -129.67 144.13 51.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.75 109.816 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 40.0 ttt180 -62.46 -26.68 68.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 2.8799999999999999 111.212 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.8 ptpt -76.25 -21.64 56.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.042 0.449 . . . . 1.3799999999999999 111.111 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 18.1 t70 -154.14 85.6 3.85 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.022 -0.536 . . . . 1.3700000000000001 109.674 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -82.2 87.91 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.451 2.101 . . . . 0.80000000000000004 112.717 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 32.0 mttm -75.15 -49.88 18.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.039 -0.982 . . . . 1.02 110.085 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.759 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 72.2 m-85 -84.53 22.1 1.36 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 111.903 -169.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.5 ttm180 -74.9 127.74 33.91 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.136 0.272 . . . . 2.9300000000000002 110.522 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' OE1' HG22 ' A' ' 151' ' ' VAL . 4.2 mp0 -97.04 137.44 36.12 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.043 0.449 . . . . 2.23 110.497 -3.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.545 ' CD1' ' HG2' ' A' ' 146' ' ' ARG . 16.8 t90 -85.37 146.04 27.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.996 -1.113 . . . . 1.4299999999999999 107.996 173.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 48.6 p-80 -122.04 129.48 52.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.282 0.563 . . . . 1.26 110.357 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 38.5 t-80 -68.1 -34.74 76.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.032 -0.986 . . . . 2.1400000000000001 110.09 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.522 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 40.3 p90 -168.69 172.62 7.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.045 -0.354 . . . . 1.51 110.045 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' HG ' HD12 ' A' ' 103' ' ' LEU . 44.0 tp -133.96 113.9 12.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.507 -0.553 . . . . 0.33000000000000002 109.507 173.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.617 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -120.92 134.73 63.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.819 -0.628 . . . . 0.31 110.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' A' ' 131' ' ' LEU . 15.9 m -132.79 161.47 41.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 107.691 -1.226 . . . . 0.27000000000000002 107.691 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.695 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 t30 63.34 18.16 10.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.221 0.534 . . . . 1.76 110.221 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.617 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.0 ttm -68.11 111.36 4.44 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.94 -0.763 . . . . 0.31 108.94 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.592 ' HE2' HD21 ' A' ' 63' ' ' LEU . 14.5 ttmt -85.71 101.83 13.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.722 -1.126 . . . . 1.21 111.318 -170.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 65.15 -124.2 27.47 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 114.959 -1.019 . . . . 0.29999999999999999 112.43 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.575 ' HA ' HD11 ' A' ' 53' ' ' ILE . 3.7 p-10 -110.56 21.79 16.18 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.982 0.42 . . . . 1.04 110.756 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.79 109.4 20.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.723 0.773 . . . . 0.77000000000000002 109.971 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 50' ' ' PRO . 5.3 mm -62.38 -31.18 50.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.097 -1.41 . . . . 0.40999999999999998 111.246 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.1 m -78.29 -37.09 45.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.874 -0.603 . . . . 0.68000000000000005 111.997 -172.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.3 m -70.05 -8.6 50.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.765 0.283 . . . . 1.26 111.765 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 92' ' ' MET . . . -67.41 100.11 0.57 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.977 -0.63 . . . . 0.34999999999999998 111.779 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.5 m -60.33 107.52 0.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.671 0.748 . . . . 0.45000000000000001 110.11 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 105' ' ' ASP . 4.6 p -86.69 127.63 40.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.667 -1.151 . . . . 0.56999999999999995 111.527 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 11.3 mt -102.01 -54.72 2.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.116 0.96 . . . . 0.45000000000000001 109.141 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.1 t -106.43 100.15 9.69 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.885 -1.524 . . . . 0.37 106.885 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 1.007 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -55.37 160.7 2.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.002 -0.999 . . . . 1.1499999999999999 112.782 -169.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 18.1 p90 -74.09 90.76 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.514 -0.766 . . . . 4.6900000000000004 110.879 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.707 HG12 HD21 ' A' ' 180' ' ' LEU . 35.6 t -63.96 -40.07 87.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.902 -0.59 . . . . 0.85999999999999999 110.353 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.559 ' HA2' ' NE2' ' A' ' 86' ' ' HIS . . . 103.3 -173.03 21.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.667 -0.778 . . . . 0.67000000000000004 112.7 174.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 t -64.6 115.03 4.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.411 -0.589 . . . . 0.51000000000000001 109.411 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.674 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -144.68 58.18 0.52 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.81999999999999995 112.943 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.671 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -89.21 125.71 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.303 2.669 . . . . 0.84999999999999998 111.94 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.719 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 82.5 Cg_exo -46.21 132.98 15.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.415 2.076 . . . . 0.87 111.273 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' HB2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -65.0 110.83 2.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.005 -0.543 . . . . 1.8500000000000001 111.012 -171.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.0 -5.27 25.59 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.594 -0.73 . . . . 1.1799999999999999 113.062 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.719 ' CG2' ' HB2' ' A' ' 112' ' ' PRO . 66.4 p -77.58 -9.92 59.21 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.698 0.629 . . . . 0.96999999999999997 112.698 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.01 -170.48 25.01 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.707 . . . . 1.97 111.994 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 4.5 mm? -73.42 144.82 46.19 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.866 0.365 . . . . 0.93999999999999995 110.757 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.671 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.6 m-70 -120.76 123.0 41.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.073 -0.512 . . . . 2.23 110.303 176.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.842 ' HB3' ' HG3' ' A' ' 170' ' ' GLN . 11.1 ptt180 -100.0 92.17 5.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.536 -0.756 . . . . 2.3100000000000001 111.406 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 69' ' ' THR . 40.6 m-85 -75.74 112.2 11.87 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.157 -0.683 . . . . 0.78000000000000003 109.157 175.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.843 HG22 ' HB2' ' A' ' 168' ' ' CYS . 17.0 t -96.49 133.74 36.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.774 . . . . 0.27000000000000002 109.66 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.62 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 35.5 m95 -89.29 132.61 34.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.193 -0.669 . . . . 1.99 109.193 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 82.7 mt -127.62 118.33 23.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.742 0.246 . . . . 0.38 110.344 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.672 HG12 HD13 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -114.2 145.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.716 0.293 . . . . 0.31 110.434 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.702 ' CD1' ' HG ' ' A' ' 160' ' ' LEU . 35.8 t80 -123.87 153.46 41.06 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.613 -0.514 . . . . 5.1200000000000001 109.613 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -108.35 88.87 2.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.033 -0.729 . . . . 2.4100000000000001 109.033 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -74.7 175.04 8.29 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.971 0.891 . . . . 1.3100000000000001 111.795 -172.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.86 -16.48 28.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.774 -1.557 . . . . 2.3999999999999999 109.964 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.549 ' HD2' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -144.63 160.53 47.28 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.413 -0.812 . . . . 3.5099999999999998 111.204 -176.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 131' ' ' LEU . 25.5 Cg_exo -70.43 14.12 0.31 Allowed 'Trans proline' 0 N--CA 1.484 0.919 0 C-N-CA 124.81 3.674 . . . . 1.21 114.501 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.567 HD12 ' SG ' ' A' ' 133' ' ' CYS . 4.1 mm? 81.13 168.34 0.14 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.679 0.792 . . . . 0.90000000000000002 112.864 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -160.53 78.48 0.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.315 -1.312 . . . . 2.8999999999999999 107.75 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.753 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 78.1 m -99.91 130.04 46.05 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.451 -0.795 . . . . 1.8999999999999999 111.214 -173.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -93.74 18.73 9.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.34 -0.845 . . . . 2.96 109.975 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.753 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 6.9 mm-40 -76.23 116.37 55.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.476 -0.783 . . . . 1.3899999999999999 109.923 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.72 137.37 42.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.362 2.708 . . . . 1.27 113.63 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.0 mm -73.47 115.77 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.764 -0.458 . . . . 0.85999999999999999 109.764 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -92.02 -10.86 37.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.966 0.728 . . . . 1.6100000000000001 112.966 -171.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.9 m 51.98 25.12 2.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.292 0.849 . . . . 1.8799999999999999 113.292 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 1.007 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.1 p-10 50.54 21.99 0.97 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.202 1.001 . . . . 0.75 113.414 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.516 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 46.4 mtt180 -110.32 142.22 42.25 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.189 -0.3 . . . . 3.3599999999999999 110.189 172.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.638 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 55.0 m 77.07 151.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.215 0.947 . . . . 0.94999999999999996 111.703 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 146' ' ' ARG . . . -120.41 14.03 10.13 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.486 -0.779 . . . . 1.1200000000000001 112.849 -174.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.48 -22.27 62.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.472 . . . . 2.6600000000000001 111.035 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -119.82 46.3 1.97 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.228 -0.656 . . . . 1.8700000000000001 109.228 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.545 ' HG2' ' CD1' ' A' ' 84' ' ' TRP . 10.0 ttm180 -75.14 -71.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.145 -0.934 . . . . 4.7300000000000004 111.531 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 81' ' ' TYR . . . -120.42 -154.66 9.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 0.65000000000000002 112.31 -175.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.759 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 84.0 mttt 65.45 35.77 7.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.402 0.62 . . . . 1.0800000000000001 110.256 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -120.11 104.45 10.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.169 -0.923 . . . . 1.8899999999999999 109.745 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -53.84 120.56 6.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.916 -0.584 . . . . 1.29 111.785 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 2.4 m -62.04 -29.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.78000000000000003 111.183 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.743 ' HB1' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -37.55 87.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.67000000000000004 110.169 174.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.6 m -65.99 -33.29 75.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.546 -0.297 . . . . 0.77000000000000002 110.785 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.892 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 49.9 m-85 -62.24 -54.1 45.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.054 0.454 . . . . 0.92000000000000004 110.56 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 9.6 ptt180 -70.01 -51.57 31.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 2.8900000000000001 111.853 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.743 ' HE2' ' HB1' ' A' ' 152' ' ' ALA . 58.7 mtmt -62.01 -24.5 67.08 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.427 -0.17 . . . . 0.96999999999999997 111.367 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -52.05 -53.12 46.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 1.5800000000000001 111.425 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.549 ' OH ' ' HD2' ' A' ' 129' ' ' ARG . 12.7 t80 -104.43 29.55 6.0 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.796 -0.762 . . . . 5.4500000000000002 110.511 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 71.53 26.59 3.17 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.252 -0.886 . . . . 2.4199999999999999 111.842 173.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.702 ' HG ' ' CD1' ' A' ' 125' ' ' TYR . 7.8 mp -83.68 124.51 30.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.901 -0.407 . . . . 1.27 109.901 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -73.26 -75.87 0.14 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.721 -0.672 . . . . 3.5899999999999999 112.6 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.56 ' H ' ' HE2' ' A' ' 125' ' ' TYR . . . -150.51 150.99 30.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.547 0.213 . . . . 0.76000000000000001 110.668 -176.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HB2' ' HG3' ' A' ' 21' ' ' PRO . 17.9 Cg_exo -62.42 152.17 78.6 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.55 2.833 . . . . 0.53000000000000003 114.016 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.904 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.6 t -93.81 -37.39 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 115.025 -0.989 . . . . 0.44 110.568 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -143.27 144.16 32.02 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.011 -0.676 . . . . 0.27000000000000002 111.703 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' A' ' 21' ' ' PRO . . . -146.7 150.88 23.19 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.114 -0.948 . . . . 0.23999999999999999 112.343 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.584 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 13.2 t -164.62 156.08 15.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.293 -1.003 . . . . 0.34000000000000002 108.293 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.843 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -131.42 150.23 52.23 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.872 -0.517 . . . . 1.1100000000000001 112.04 -172.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.496 ' HD2' ' HE1' ' A' ' 122' ' ' TRP . 51.1 p90 -136.0 135.01 39.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.608 -0.886 . . . . 0.80000000000000004 108.608 171.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.842 ' HG3' ' HB3' ' A' ' 119' ' ' ARG . 12.9 mp0 -99.65 133.8 43.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.575 0.625 . . . . 2.5299999999999998 110.386 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -122.48 137.33 54.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.935 0.397 . . . . 0.59999999999999998 111.416 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.98 -170.2 3.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.447 -0.797 . . . . 2.3799999999999999 110.914 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.873 ' HA ' HG21 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -105.48 77.39 1.28 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.979 -0.748 . . . . 3.96 108.979 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.591 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 13.7 t70 -72.19 -61.24 1.86 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.167 0.803 . . . . 1.53 113.167 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.633 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 12.4 t70 -167.5 -46.78 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.216 0.532 . . . . 1.26 110.951 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 37.9 m-85 -71.8 -2.8 18.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 2.2200000000000002 111.691 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.873 HG21 ' HA ' ' A' ' 173' ' ' TRP . 66.8 t -73.17 -55.37 3.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.57 -0.286 . . . . 0.5 111.414 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 47.6 Cg_exo -58.22 -29.72 88.49 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.271 1.98 . . . . 0.57999999999999996 111.274 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.0 mmmm -74.7 -24.77 58.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 111.17 177.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.707 HD21 HG12 ' A' ' 107' ' ' VAL . 51.2 tp -76.08 -42.07 48.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.502 -0.555 . . . . 0.66000000000000003 109.502 172.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -58.87 -38.27 78.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.69 -0.686 . . . . 1.8899999999999999 109.185 171.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.676 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.8 mm-40 -58.21 -42.73 86.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.791 -1.095 . . . . 1.53 110.985 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -76.41 -32.23 58.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 1.49 112.759 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.638 ' HA ' ' H ' ' A' ' 142' ' ' SER . 60.9 mt -62.99 -4.97 2.52 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.786 0.662 . . . . 0.76000000000000001 112.786 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.533 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 20.1 m -78.65 1.49 22.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.531 0.682 . . . . 1.05 109.766 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 76.37 50.94 6.99 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.1 -0.954 . . . . 1.1699999999999999 111.184 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.533 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 26.7 mmmt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.359 -0.829 . . . . 2.0 110.37 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.51 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 10.1 tpt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.46 -0.2 . . . . 5.04 110.46 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 31.2 Cg_exo -59.64 120.11 7.73 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.755 2.304 . . . . 2.1299999999999999 111.78 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 7.2 p -58.57 133.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.746 -1.115 . . . . 1.47 111.013 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 6' ' ' SER . 25.2 t70 -167.03 163.43 15.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.696 -0.853 . . . . 1.8100000000000001 108.696 -172.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -76.56 25.81 0.14 Allowed 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 120.537 0.208 . . . . 0.69999999999999996 111.113 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 4' ' ' ASP . 31.1 m -62.91 -27.34 69.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 1.96 111.692 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -116.38 48.26 1.29 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.87 0.367 . . . . 2.6600000000000001 110.258 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -75.09 -29.74 60.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 3.98 111.724 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 36.6 p -148.14 11.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.535 -0.466 . . . . 0.63 112.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -73.46 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.729 . . . . 0.47999999999999998 111.733 177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 9.3 Cg_endo -48.88 -48.83 16.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.201 2.601 . . . . 0.53000000000000003 110.381 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.72 ' HG ' ' HD3' ' A' ' 119' ' ' ARG . 8.1 mp -87.99 88.94 7.8 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.354 -0.839 . . . . 1.1699999999999999 110.258 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 7.4 m -76.12 67.02 2.37 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.354 0.597 . . . . 0.70999999999999996 110.095 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 121' ' ' VAL . 23.5 mt -71.12 -13.91 62.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.496 -0.775 . . . . 0.45000000000000001 111.164 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -65.61 -14.84 61.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.131 -0.486 . . . . 2.1200000000000001 111.477 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.34 -19.76 65.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.29 0.567 . . . . 1.9299999999999999 110.507 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.903 HG12 HG21 ' A' ' 151' ' ' VAL . 40.6 t -93.76 -72.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.477 -0.783 . . . . 0.63 111.27 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 19' ' ' GLU . 25.5 t70 -149.97 -170.99 3.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.557 -0.905 . . . . 2.9900000000000002 108.557 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.821 ' HG3' HH12 ' A' ' 155' ' ' ARG . 15.6 mt-10 -81.64 163.72 22.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.789 0.804 . . . . 1.6000000000000001 113.114 -167.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.49 126.95 89.29 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.415 -1.266 . . . . 3.5499999999999998 110.387 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 163' ' ' PRO . 6.3 Cg_exo -75.28 154.25 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 121.839 1.693 . . . . 0.57999999999999996 111.166 178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.946 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 20.4 pt20 -81.44 -1.19 44.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.293 -0.412 . . . . 1.3899999999999999 111.726 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.769 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 13.7 m80 -160.54 159.95 25.83 Favored Pre-proline 0 CA--C 1.516 -0.362 0 C-N-CA 123.35 0.66 . . . . 1.45 109.583 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -86.87 128.54 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 123.132 2.555 . . . . 0.40000000000000002 110.994 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.607 HD22 HG12 ' A' ' 124' ' ' VAL . 43.9 tp -80.1 145.9 32.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.696 0.284 . . . . 0.28999999999999998 111.183 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -109.36 130.33 55.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.311 -0.626 . . . . 1.24 109.311 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 53' ' ' ILE . 16.0 t -134.16 118.8 29.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.487 -0.931 . . . . 0.46999999999999997 108.487 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.3 OUTLIER -117.98 136.78 53.29 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 0.31 111.283 -172.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -97.0 173.82 7.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.279 -0.637 . . . . 0.67000000000000004 109.279 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.52 68.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.5 0.667 . . . . 0.55000000000000004 110.548 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 -6.14 37.55 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.163 -0.926 . . . . 0.81000000000000005 112.763 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.91 -171.96 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.858 0.329 . . . . 0.46999999999999997 110.52 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' CB ' HG22 ' A' ' 28' ' ' THR . . . -162.73 153.73 17.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.113 -0.494 . . . . 0.33000000000000002 110.301 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.795 HG21 ' HZ3' ' A' ' 122' ' ' TRP . 84.9 t -109.85 69.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 107.406 -1.331 . . . . 0.39000000000000001 107.406 165.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 34.2 t70 -102.49 20.46 17.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.967 -1.015 . . . . 0.98999999999999999 109.072 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.631 ' HB2' ' CB ' ' A' ' 39' ' ' LYS . 52.3 mt-10 -143.84 134.54 25.05 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.48 -1.236 . . . . 2.5600000000000001 108.955 172.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.696 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -81.36 112.49 18.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.794 -0.639 . . . . 0.40999999999999998 109.985 -174.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.59 52.53 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.256 -0.738 . . . . 0.58999999999999997 111.256 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.705 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.09 149.44 26.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.321 -0.251 . . . . 0.34000000000000002 110.321 177.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 10.2 p -74.52 131.81 34.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 0.55000000000000004 110.967 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.611 HD22 HG22 ' A' ' 34' ' ' VAL . 9.2 tp -133.0 170.7 15.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.485 -0.931 . . . . 0.45000000000000001 108.485 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -121.24 149.86 52.71 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 119.4 -0.92 . . . . 0.56000000000000005 111.802 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.741 ' HD2' ' HB2' ' A' ' 174' ' ' ASP . 39.8 Cg_exo -61.31 -28.62 84.73 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.201 3.267 . . . . 0.68000000000000005 113.651 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -28.61 67.37 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.546 0.689 . . . . 0.76000000000000001 110.542 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 42' ' ' THR . 97.5 mt-30 -77.88 -52.94 8.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.848 -1.069 . . . . 1.5900000000000001 111.228 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 169' ' ' TYR . 3.9 m -99.16 32.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.695 0.628 . . . . 0.66000000000000003 112.695 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.82 -30.72 61.49 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.346 -0.542 . . . . 0.79000000000000004 110.039 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.06 179.88 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 1.9099999999999999 109.971 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 96.8 mtt180 -66.89 159.38 76.06 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.868 0.366 . . . . 1.4299999999999999 110.797 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 49' ' ' ARG . 71.3 Cg_endo -79.57 157.54 25.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.072 1.848 . . . . 0.37 110.944 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.9 t -82.23 -18.06 43.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.684 -0.488 . . . . 0.44 109.684 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 71.5 m -160.68 147.24 15.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.504 0.669 . . . . 0.38 112.003 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.921 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -137.46 166.29 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.29999999999999999 108.207 169.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.084 ' HA ' HD13 ' A' ' 58' ' ' LEU . 43.5 t 176.82 111.47 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.122 0.487 . . . . 0.34999999999999998 110.323 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.638 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 51.4 p-90 -73.3 152.89 40.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.616 -1.253 . . . . 2.7200000000000002 107.616 171.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.66 89.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.51 111.12 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.48 17.45 4.35 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.757 -0.656 . . . . 0.80000000000000004 112.236 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.084 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.3 tt -51.9 129.07 25.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.113 0.565 . . . . 0.57999999999999996 111.734 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.748 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 17.9 t70 -72.28 -30.67 65.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.538 -0.756 . . . . 0.73999999999999999 111.503 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.446 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 20.4 m 76.46 -5.6 2.15 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.818 -1.083 . . . . 1.03 110.604 -172.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.06 -8.34 5.61 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.948 -0.644 . . . . 0.83999999999999997 113.556 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 29.4 mtpt -94.7 142.85 26.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 117.423 0.611 . . . . 1.6699999999999999 110.962 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.72 HD21 ' HE2' ' A' ' 93' ' ' LYS . 46.7 mt -78.56 125.65 29.65 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.539 -0.912 . . . . 0.57999999999999996 108.539 171.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.514 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.9 OUTLIER -121.13 163.04 19.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.465 -0.494 . . . . 0.80000000000000004 109.978 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.695 HG23 HG12 ' A' ' 90' ' ' VAL . 69.1 m -104.24 105.49 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.355 -0.609 . . . . 0.35999999999999999 109.355 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.544 HD23 ' HE2' ' A' ' 87' ' ' PHE . 25.3 tp -100.25 114.58 28.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.766 -0.457 . . . . 0.58999999999999997 109.766 -177.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.7 t -116.71 121.77 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.907 0.384 . . . . 0.39000000000000001 111.344 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -81.52 134.38 35.51 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.555 -1.276 . . . . 0.59999999999999998 107.555 168.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.838 HG21 HG11 ' A' ' 17' ' ' VAL . 10.3 t -140.35 142.74 35.56 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.014 0.435 . . . . 0.35999999999999999 110.479 176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 7.1 p-10 -130.66 95.59 25.93 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-O 121.653 0.74 . . . . 1.9199999999999999 110.188 174.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.5 Cg_endo -52.92 -31.95 54.98 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.937 3.091 . . . . 1.25 112.837 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.734 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 5.1 m-20 -82.79 45.98 1.04 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 1.29 111.094 -172.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.41 130.23 23.65 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.696 -0.483 . . . . 0.5 109.696 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.583 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 73.3 Cg_endo -79.17 -30.38 5.78 Favored 'Cis proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.147 -1.605 . . . . 0.62 112.982 1.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.718 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 98.6 p -125.59 156.64 38.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.33 -0.395 . . . . 0.75 111.224 -177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.734 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 52.0 ttp180 -72.19 -23.85 61.33 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.049 -0.523 . . . . 2.8799999999999999 111.129 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.779 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.08 -11.26 39.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.434 . . . . 1.3799999999999999 110.64 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -156.32 84.32 3.25 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 1.3700000000000001 109.814 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.95 91.74 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.065 2.51 . . . . 0.80000000000000004 113.353 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.583 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 42.8 mttm -76.11 -49.59 16.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.162 -0.926 . . . . 1.02 110.849 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.822 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 91.8 m-85 -82.78 14.05 3.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.798 -1.092 . . . . 1.1699999999999999 111.538 -169.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.5 ttt180 -67.02 128.49 36.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.956 -0.566 . . . . 2.9300000000000002 111.024 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 82' ' ' ARG . 2.5 mp0 -99.7 137.15 38.57 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.876 0.369 . . . . 2.23 110.545 -3.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.548 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 11.2 t90 -93.79 130.48 39.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.923 -0.769 . . . . 1.4299999999999999 108.923 175.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 44.1 p-80 -98.66 123.18 42.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.999 -0.741 . . . . 1.26 108.999 173.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -91.57 -11.13 38.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.553 -0.749 . . . . 2.1400000000000001 111.714 -170.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 1.034 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 40.8 t80 -167.95 136.23 2.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.873 -0.417 . . . . 1.51 109.873 -175.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HG ' HD12 ' A' ' 103' ' ' LEU . 22.7 tp -134.28 114.42 12.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.33000000000000002 110.263 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.823 HG11 ' HE3' ' A' ' 92' ' ' MET . 0.9 OUTLIER -130.09 135.49 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.681 -0.69 . . . . 0.31 110.638 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.695 HG12 HG23 ' A' ' 65' ' ' THR . 13.9 m -130.09 163.57 35.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.115 -0.948 . . . . 0.27000000000000002 108.612 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.677 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.9 t-20 64.94 14.22 9.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.841 0.353 . . . . 1.76 110.416 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.823 ' HE3' HG11 ' A' ' 89' ' ' VAL . 14.3 ttm -68.93 103.97 1.96 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.702 -0.851 . . . . 0.31 108.702 174.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.72 ' HE2' HD21 ' A' ' 63' ' ' LEU . 21.2 ttmm -85.73 98.53 10.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.401 -0.818 . . . . 1.21 110.918 -171.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 79.29 -123.09 6.0 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.971 -1.013 . . . . 0.29999999999999999 112.186 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.526 ' HA ' HD11 ' A' ' 53' ' ' ILE . 5.3 p-10 -118.1 31.08 6.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.539 0.685 . . . . 1.04 110.391 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.62 114.96 27.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.062 -0.972 . . . . 0.77000000000000002 110.289 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 97' ' ' ILE . 3.1 mm -66.81 -19.95 26.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.698 -1.137 . . . . 0.40999999999999998 110.951 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.1 m -80.34 -52.99 7.04 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.669 0.618 . . . . 0.68000000000000005 112.669 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 p -61.67 -20.79 63.82 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.714 0.293 . . . . 1.26 111.712 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.02 102.18 0.19 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.765 -0.652 . . . . 0.34999999999999998 111.987 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 107.17 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.453 0.644 . . . . 0.45000000000000001 109.723 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.486 ' O ' HD12 ' A' ' 137' ' ' ILE . 2.6 p -74.51 118.27 19.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.825 -1.08 . . . . 0.56999999999999995 111.846 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.72 HD12 ' HG ' ' A' ' 88' ' ' LEU . 38.3 mt -97.83 -45.26 6.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.971 0.891 . . . . 0.45000000000000001 108.888 172.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.8 t -126.57 106.46 9.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.615 -1.175 . . . . 0.37 107.858 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 6.3 t0 -61.86 158.15 16.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 1.1499999999999999 112.387 -169.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -78.91 98.67 6.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.026 -0.988 . . . . 4.6900000000000004 109.664 -178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.679 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 30.1 t -74.56 -23.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.85999999999999999 111.471 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.11 -179.65 45.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.413 -0.898 . . . . 0.67000000000000004 111.858 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.3 t -60.54 133.62 56.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.862 -0.422 . . . . 0.51000000000000001 109.862 172.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.657 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -172.53 66.01 0.13 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.814 -0.708 . . . . 0.81999999999999995 112.337 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -93.29 140.24 1.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.816 2.344 . . . . 0.84999999999999998 112.977 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HB2' HG23 ' A' ' 115' ' ' THR . 72.6 Cg_exo -51.15 135.01 44.82 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.531 2.154 . . . . 0.87 111.331 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 117.0 5.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.213 -0.292 . . . . 1.8500000000000001 110.213 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.46 -4.28 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.798 -0.715 . . . . 1.1799999999999999 111.963 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 72.9 p -79.13 -16.59 56.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.763 0.316 . . . . 0.96999999999999997 111.302 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.75 -169.4 23.22 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.844 -0.616 . . . . 1.97 111.846 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.39 98.3 1.4 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.93999999999999995 109.935 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -75.77 103.93 6.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.421 -0.809 . . . . 2.23 109.204 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.851 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -99.72 92.96 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.405 0.621 . . . . 2.3100000000000001 111.668 -173.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.551 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 1.1 m-85 -76.88 133.44 39.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.443 -0.799 . . . . 0.78000000000000003 109.449 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.4 t -108.63 133.16 54.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.948 -0.39 . . . . 0.27000000000000002 109.948 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.795 ' HZ3' HG21 ' A' ' 34' ' ' VAL . 1.5 m-90 -89.53 127.84 35.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.372 -0.603 . . . . 1.99 109.372 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 mt -118.75 119.39 34.29 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.867 -0.419 . . . . 0.38 109.867 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.607 HG12 HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -106.96 132.68 53.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.41 -0.516 . . . . 0.31 109.682 175.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.619 ' HB2' HD23 ' A' ' 160' ' ' LEU . 24.3 m-85 -115.35 149.55 37.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.147 -0.478 . . . . 5.1200000000000001 110.055 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.537 ' HB2' HG21 ' A' ' 164' ' ' VAL . 42.6 tt0 -101.31 117.93 35.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.154 0.502 . . . . 2.4100000000000001 109.894 174.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -89.88 158.86 17.25 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.626 -0.879 . . . . 1.3100000000000001 108.626 173.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.401 ' OD2' ' HG3' ' A' ' 129' ' ' ARG . 2.3 p-10 -76.4 -10.83 59.69 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.601 -0.727 . . . . 2.3999999999999999 110.805 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.661 ' NH2' ' HB2' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -162.56 177.31 1.98 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.364 -0.835 . . . . 3.5099999999999998 109.246 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 129' ' ' ARG . 51.3 Cg_exo -54.0 174.54 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.275 1.984 . . . . 1.21 112.589 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.66 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 4.6 mm? -93.38 163.73 13.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.52 0.563 . . . . 0.90000000000000002 112.52 -171.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.95 45.57 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.62 1.2 . . . . 2.8999999999999999 109.868 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.492 ' SG ' HD21 ' A' ' 103' ' ' LEU . 1.2 p -62.65 -69.17 0.28 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.264 -1.789 . . . . 1.8999999999999999 111.664 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 57.87 32.34 21.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.837 0.827 . . . . 2.96 110.173 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.637 ' HB2' HD22 ' A' ' 103' ' ' LEU . 57.9 mm-40 -81.85 139.99 46.83 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.547 -0.751 . . . . 1.3899999999999999 110.809 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.38 125.2 8.75 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.37 2.714 . . . . 1.27 112.397 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 102' ' ' VAL . 33.4 mm -76.94 123.1 32.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.85999999999999999 111.454 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.9 mt -94.82 155.37 16.83 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.346 -0.613 . . . . 1.6100000000000001 109.346 174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 70.0 m -119.41 38.37 3.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.558 0.218 . . . . 1.8799999999999999 111.508 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.9 OUTLIER 56.76 0.81 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.714 1.206 . . . . 0.75 113.418 177.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.554 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.0 mtt180 -97.64 148.51 23.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.919 -0.488 . . . . 3.3599999999999999 109.797 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.618 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 50.4 m 74.46 115.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.113 0.883 . . . . 0.94999999999999996 112.364 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -87.9 38.17 3.19 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 1.1200000000000001 111.54 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.05 -39.91 71.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.77 0.795 . . . . 2.6600000000000001 110.757 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -99.25 64.68 1.37 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.088 -0.96 . . . . 1.8700000000000001 110.053 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.584 ' O ' ' HB3' ' A' ' 81' ' ' TYR . 26.9 mtm180 -87.09 39.74 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 4.7300000000000004 112.048 -175.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . 76.91 -117.4 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.935 -0.65 . . . . 0.65000000000000002 114.001 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.822 ' CG ' ' HA ' ' A' ' 81' ' ' TYR . 79.9 mttt 60.35 39.85 18.25 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.121 0.486 . . . . 1.0800000000000001 110.8 -171.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.442 ' HD2' ' CE2' ' A' ' 154' ' ' PHE . 43.5 t80 -150.37 135.83 18.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.846 -0.616 . . . . 1.8899999999999999 109.622 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -54.17 119.56 5.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.507 -0.77 . . . . 1.29 112.792 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.903 HG21 HG12 ' A' ' 17' ' ' VAL . 4.3 m -59.03 -35.15 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.335 -0.848 . . . . 0.78000000000000003 110.832 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.78 -33.02 72.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.863 -0.608 . . . . 0.67000000000000004 110.456 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.1 m -70.47 -37.71 74.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.242 -0.435 . . . . 0.77000000000000002 110.667 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.442 ' CE2' ' HD2' ' A' ' 149' ' ' PHE . 53.7 m-85 -64.28 -48.22 76.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.702 0.763 . . . . 0.92000000000000004 109.518 173.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.821 HH12 ' HG3' ' A' ' 19' ' ' GLU . 21.3 ttt180 -55.59 -50.31 70.45 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.4 -1.273 . . . . 2.8900000000000001 111.723 177.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -70.63 -28.91 65.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.96999999999999997 111.126 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 154' ' ' PHE . 44.3 tptt -59.84 -40.51 88.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.338 0.59 . . . . 1.5800000000000001 110.818 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.49 ' HB3' ' CD1' ' A' ' 131' ' ' LEU . 22.5 m-85 -88.53 5.97 40.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.077 -0.511 . . . . 5.4500000000000002 110.516 -177.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.661 ' HB2' ' NH2' ' A' ' 129' ' ' ARG . 34.0 mm-40 67.21 33.85 5.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.261 -0.881 . . . . 2.4199999999999999 111.336 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 125' ' ' TYR . 4.0 mp -90.62 140.64 29.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.666 0.269 . . . . 1.27 111.28 -177.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -71.56 -78.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 3.5899999999999999 111.385 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -155.44 166.92 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.61 -0.515 . . . . 0.76000000000000001 109.61 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.544 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 23.2 Cg_exo -60.95 137.95 75.61 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.592 2.195 . . . . 0.53000000000000003 113.276 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.946 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 6.3 t -93.18 -26.94 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 115.465 -0.789 . . . . 0.44 109.279 174.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.769 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -153.56 147.35 25.3 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.917 -0.583 . . . . 0.27000000000000002 111.806 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -144.32 142.21 10.84 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.725 -1.125 . . . . 0.23999999999999999 111.429 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.696 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 7.6 t -155.72 137.04 13.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.149 -0.686 . . . . 0.34000000000000002 109.149 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.867 ' HB2' HG22 ' A' ' 121' ' ' VAL . 6.7 t -116.51 145.26 43.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.24 0.543 . . . . 1.1100000000000001 111.106 -174.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 25.2 p90 -128.52 129.62 46.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.346 -1.353 . . . . 0.80000000000000004 107.346 177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.848 ' HB3' ' HB3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -110.47 132.52 54.11 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.714 -0.794 . . . . 2.5299999999999998 111.044 -178.25 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -149.33 135.64 19.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.59999999999999998 109.558 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -118.26 -136.75 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.51 -0.314 . . . . 2.3799999999999999 110.907 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -80.27 96.91 6.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 3.96 111.746 -172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.741 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 3.1 t70 -73.62 -62.16 1.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 1.53 110.396 170.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.553 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 26.7 t70 159.29 -39.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.024 1.329 . . . . 1.26 108.373 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.03 0.24 36.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 2.2200000000000002 110.864 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.798 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 76.8 t -62.49 -53.92 53.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.02 -0.536 . . . . 0.5 110.478 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.798 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 72.2 Cg_exo -51.97 -35.46 60.79 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.468 2.112 . . . . 0.57999999999999996 112.022 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 13.5 mmmm -73.9 -26.97 60.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 2.1400000000000001 111.499 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.66 HD21 HG12 ' A' ' 107' ' ' VAL . 44.0 tp -69.09 -46.91 66.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.66000000000000003 109.063 172.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.35 -34.94 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 1.8899999999999999 109.393 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.714 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 5.2 mm-40 -63.28 -43.87 96.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.985 -1.007 . . . . 1.53 110.922 173.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.444 ' HA ' ' CG ' ' A' ' 187' ' ' LYS . 2.4 tt0 -65.29 -27.84 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.49 111.406 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.618 ' HA ' ' H ' ' A' ' 142' ' ' SER . 59.4 mt -66.31 6.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.511 0.559 . . . . 0.76000000000000001 112.511 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.739 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 15.3 m -80.99 0.15 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.674 0.75 . . . . 1.05 109.086 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 85.52 33.07 17.52 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 111.228 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.739 ' HE3' ' HB2' ' A' ' 185' ' ' SER . 31.6 mmtp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.372 -0.823 . . . . 2.0 110.991 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 1.1 mpt? . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.53 0.205 . . . . 5.04 110.499 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 16.8 Cg_exo -68.38 129.52 19.28 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.105 2.537 . . . . 2.1299999999999999 112.728 -176.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 2.7 p -98.26 111.52 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 114.801 -1.09 . . . . 1.47 110.224 176.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.459 ' HA ' ' CG ' ' A' ' 24' ' ' PRO . 3.4 p30 -169.56 -175.48 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.921 -1.036 . . . . 1.8100000000000001 108.557 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.474 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.5 mm? -78.61 24.81 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.918 0.34 . . . . 0.69999999999999996 111.918 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 t -72.9 -19.88 61.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.731 0.777 . . . . 1.96 109.388 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HB3' HD12 ' A' ' 12' ' ' LEU . 79.8 mttt -117.33 36.72 4.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 2.6600000000000001 110.174 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.859 ' HB2' HE21 ' A' ' 20' ' ' GLN . 0.2 OUTLIER -78.4 -37.22 44.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 3.98 112.294 -176.43 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 11.6 p -145.3 27.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.63 110.995 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.87 -122.31 0.31 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.912 -0.875 . . . . 0.47999999999999998 110.912 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 12.4 Cg_endo -52.72 -38.56 77.3 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.183 2.588 . . . . 0.53000000000000003 110.568 166.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.788 HD11 ' HA3' ' A' ' 38' ' ' GLY . 17.5 mt -87.85 83.73 7.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.916 -1.038 . . . . 1.1699999999999999 110.027 173.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.34 68.96 0.79 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.375 0.607 . . . . 0.70999999999999996 110.112 175.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 121' ' ' VAL . 57.0 mt -79.21 -16.83 55.94 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.702 -0.681 . . . . 0.45000000000000001 110.775 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.84 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 9.3 tm0? -69.1 -12.87 62.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.362 0.601 . . . . 2.1200000000000001 110.534 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.16 -23.74 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 109.78 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.726 HG11 HG21 ' A' ' 69' ' ' THR . 48.6 t -90.44 -68.15 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.722 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -119.9 -177.24 3.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.713 -0.676 . . . . 2.9900000000000002 109.917 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 16.8 mt-10 -90.56 20.26 4.74 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.854 0.316 . . . . 1.6000000000000001 111.854 -173.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.859 HE21 ' HB2' ' A' ' 8' ' ' TRP . 5.7 mm100 67.82 136.85 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.361 1.038 . . . . 3.5499999999999998 112.427 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 4.3 Cg_exo -79.83 157.79 24.36 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.229 2.62 . . . . 0.57999999999999996 112.804 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.901 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.5 pt20 -77.94 -27.09 49.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.893 -1.049 . . . . 1.3899999999999999 111.857 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.762 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 79.6 m-70 -132.48 158.55 75.38 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.843 -0.799 . . . . 1.45 108.843 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CG ' ' HA ' ' A' ' 4' ' ' ASP . 4.3 Cg_endo -85.81 128.27 3.28 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.664 2.243 . . . . 0.40000000000000002 111.113 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 122' ' ' TRP . 38.0 tp -78.66 148.4 33.18 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.093 -0.336 . . . . 0.28999999999999998 110.093 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.429 ' H ' HD12 ' A' ' 25' ' ' LEU . 44.5 m80 -118.89 130.14 55.57 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.502 -0.555 . . . . 1.24 109.502 172.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.847 HG13 HG22 ' A' ' 53' ' ' ILE . 19.2 t -127.75 146.26 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.682 -0.858 . . . . 0.46999999999999997 108.682 177.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.49 143.18 32.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.974 0.416 . . . . 0.31 111.05 -177.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' A' ' 50' ' ' PRO . 34.5 t80 -110.77 173.22 6.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.5 -0.556 . . . . 0.67000000000000004 109.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.51 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.18 0.514 . . . . 0.55000000000000004 110.886 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.38 15.44 10.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.399 -0.818 . . . . 0.81000000000000005 112.361 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -146.32 -172.79 4.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.885 0.374 . . . . 0.46999999999999997 110.734 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.665 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -164.01 159.89 21.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.797 -0.638 . . . . 0.33000000000000002 110.041 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.67 HG13 ' HZ1' ' A' ' 39' ' ' LYS . 87.3 t -114.3 67.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.585 -1.635 . . . . 0.39000000000000001 106.585 162.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -102.63 23.19 12.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.582 -1.19 . . . . 0.98999999999999999 109.092 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -150.93 132.95 15.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.852 -1.067 . . . . 2.5600000000000001 108.304 174.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -76.65 110.76 11.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.182 0.515 . . . . 0.40999999999999998 109.703 -173.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 86.7 16.73 61.17 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.343 -0.844 . . . . 0.58999999999999997 112.227 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.67 ' HZ1' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -72.13 149.92 44.29 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.399 -0.593 . . . . 0.34000000000000002 109.399 173.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -81.05 129.32 37.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.441 0.639 . . . . 0.55000000000000004 111.029 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 7.6 tp -120.91 169.39 10.51 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.181 -1.044 . . . . 0.45000000000000001 108.181 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.1 p -128.04 151.73 76.41 Favored Pre-proline 0 C--N 1.322 -0.587 0 C-N-CA 119.724 -0.79 . . . . 0.56000000000000005 112.512 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.587 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 52.2 Cg_exo -55.58 -24.65 45.93 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.303 3.335 . . . . 0.68000000000000005 114.01 -176.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 p -62.88 -38.3 90.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 122.11 0.957 . . . . 0.76000000000000001 110.093 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.09 -46.19 14.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.785 -1.552 . . . . 1.5900000000000001 111.266 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 169' ' ' TYR . 6.7 m -100.51 31.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.459 0.54 . . . . 0.66000000000000003 112.459 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -82.66 -7.87 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.419 0.628 . . . . 0.79000000000000004 109.367 172.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -142.0 -177.82 5.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.952 -1.022 . . . . 1.9099999999999999 109.072 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -71.79 156.26 91.3 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.765 -0.457 . . . . 1.4299999999999999 109.765 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 57.8 Cg_endo -76.62 162.65 32.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.612 1.541 . . . . 0.37 110.216 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.4 t -85.67 -19.2 31.26 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.631 -0.427 . . . . 0.44 110.152 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -159.5 147.43 17.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.38 112.413 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.847 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.36 172.44 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.825 -1.08 . . . . 0.29999999999999999 108.382 170.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.042 ' HA ' HD13 ' A' ' 58' ' ' LEU . 30.5 t 170.97 127.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.462 0.476 . . . . 0.34999999999999998 110.013 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.838 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -81.87 162.06 22.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.459 -0.941 . . . . 2.7200000000000002 108.459 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 23' ' ' HIS . 22.2 t70 -59.43 79.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.237 0.542 . . . . 1.51 110.712 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.71 24.44 3.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.751 -0.659 . . . . 0.80000000000000004 112.958 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.042 HD13 ' HA ' ' A' ' 54' ' ' SER . 1.1 tt -54.3 128.25 30.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.067 0.434 . . . . 0.57999999999999996 110.547 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.735 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 29.5 t70 -78.38 -12.76 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.73999999999999999 111.439 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.44 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 70.7 p 51.23 30.04 5.45 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.94 -1.027 . . . . 1.03 110.906 -173.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.38 8.17 0.21 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.594 -0.73 . . . . 0.83999999999999997 112.873 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.735 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 19.4 mtpt -109.99 157.49 19.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 1.6699999999999999 109.481 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 65.3 mt -94.54 125.09 38.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.798 -0.816 . . . . 0.57999999999999996 108.798 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.526 ' CE1' ' HZ3' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -120.11 149.62 41.92 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.634 -0.426 . . . . 0.80000000000000004 110.76 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.682 HG23 HG12 ' A' ' 90' ' ' VAL . 61.3 m -96.87 105.95 18.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.511 -0.922 . . . . 0.35999999999999999 108.511 170.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.634 HD13 HG12 ' A' ' 124' ' ' VAL . 47.5 tp -106.8 109.87 21.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.716 -0.674 . . . . 0.58999999999999997 110.189 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.1 t -114.79 123.02 70.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.745 -0.661 . . . . 0.39000000000000001 110.679 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.79 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 6.4 mt -84.37 137.93 33.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.723 -0.843 . . . . 0.59999999999999998 108.723 169.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.726 HG21 HG11 ' A' ' 17' ' ' VAL . 11.3 t -139.68 145.1 37.99 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.847 -0.341 . . . . 0.35999999999999999 110.635 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.486 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 24.8 t70 -128.85 96.39 29.54 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.324 0.583 . . . . 1.9199999999999999 110.273 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 10.0 Cg_endo -51.36 -37.85 61.61 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.046 3.164 . . . . 1.25 114.747 178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 44.1 m-20 -96.33 46.69 1.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.341 0.497 . . . . 1.29 112.341 -166.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.82 137.91 19.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.5 110.794 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 95.5 Cg_endo -82.39 -20.19 20.36 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.44 -1.483 . . . . 0.62 112.465 0.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.775 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 96.6 p -134.01 146.8 50.74 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.832 -0.622 . . . . 0.75 110.472 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.591 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 63.1 ttt180 -66.45 -26.39 67.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.208 -0.451 . . . . 2.8799999999999999 111.796 -174.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.762 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -89.0 -11.22 44.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.029 0.443 . . . . 1.3799999999999999 110.862 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -153.2 82.37 4.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.856 -0.611 . . . . 1.3700000000000001 109.528 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 96.1 Cg_endo -87.95 88.23 0.56 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.81 2.34 . . . . 0.80000000000000004 113.16 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.576 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 34.7 mttm -71.52 -53.44 13.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.15 -0.932 . . . . 1.02 110.726 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.772 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 36.2 m-85 -78.75 17.83 0.67 Allowed 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.211 -0.904 . . . . 1.1699999999999999 111.642 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' A' ' 79' ' ' PRO . 32.4 ttt180 -74.2 129.59 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.216 0.323 . . . . 2.9300000000000002 111.71 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.485 ' HG2' HG13 ' A' ' 17' ' ' VAL . 22.1 mp0 -89.05 140.51 29.37 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 122.807 0.443 . . . . 2.23 110.605 -6.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 13.1 t90 -86.21 91.5 8.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.532 -0.544 . . . . 1.4299999999999999 109.532 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 17.1 p80 -71.86 121.84 19.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.768 0.794 . . . . 1.26 109.698 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.79 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t60 -72.72 -35.22 67.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.917 -1.038 . . . . 2.1400000000000001 111.166 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.731 ' HD1' ' HB2' ' A' ' 68' ' ' LEU . 2.4 p90 -168.08 178.16 5.2 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.666 -0.494 . . . . 1.51 109.666 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 103' ' ' LEU . 26.4 tp -140.71 114.01 8.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.776 0.322 . . . . 0.33000000000000002 110.64 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.651 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.5 t -121.85 133.01 69.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.78 -0.645 . . . . 0.31 110.667 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 65' ' ' THR . 16.2 m -133.37 161.55 41.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.409 -0.96 . . . . 0.27000000000000002 108.409 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 1.7 t-20 62.55 18.98 10.92 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.383 0.427 . . . . 1.76 110.608 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.651 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.6 ttm -68.18 110.67 4.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.789 -0.819 . . . . 0.31 108.789 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.563 ' HE2' HD21 ' A' ' 63' ' ' LEU . 13.8 ttmm -91.57 97.33 10.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.177 -0.92 . . . . 1.21 111.012 -171.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 64' ' ' TYR . . . 81.91 -130.62 9.82 Favored Glycine 0 CA--C 1.505 -0.568 0 CA-C-N 115.242 -0.89 . . . . 0.29999999999999999 112.45 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 30.8 p-10 -117.29 26.48 9.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.098 0.475 . . . . 1.04 111.044 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.77 110.43 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.77000000000000002 110.034 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 50' ' ' PRO . 7.3 mm -58.86 -28.92 39.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.511 -1.222 . . . . 0.40999999999999998 111.396 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -82.24 -29.99 31.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.982 -0.554 . . . . 0.68000000000000005 111.765 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -77.73 -6.68 54.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.845 0.313 . . . . 1.26 111.845 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.43 107.11 2.28 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.913 -0.661 . . . . 0.34999999999999998 111.828 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 106.97 0.46 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.403 0.62 . . . . 0.45000000000000001 110.332 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 105' ' ' ASP . 2.3 p -89.55 109.52 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.827 -1.079 . . . . 0.56999999999999995 111.203 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' A' ' 88' ' ' LEU . 29.4 mt -89.18 -45.25 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.023 -0.99 . . . . 0.45000000000000001 109.813 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 t -116.65 105.76 12.79 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.952 -1.499 . . . . 0.37 106.952 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 22.2 t0 -54.88 150.97 9.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.245 -0.889 . . . . 1.1499999999999999 112.831 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -77.37 103.29 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.114 -0.948 . . . . 4.6900000000000004 109.223 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.815 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 48.4 t -78.33 -57.62 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.148 -0.478 . . . . 0.85999999999999999 112.244 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 132.85 175.59 14.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.647 -0.787 . . . . 0.67000000000000004 112.435 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.482 ' HB2' HG23 ' A' ' 46' ' ' VAL . 30.3 t -61.14 131.82 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.486 0.143 . . . . 0.51000000000000001 110.66 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.451 ' HA2' HG13 ' A' ' 177' ' ' VAL . . . -152.46 63.89 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 O-C-N 123.573 0.546 . . . . 0.81999999999999995 112.297 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.609 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 4.0 Cg_endo -90.34 113.58 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.611 2.874 . . . . 0.84999999999999998 112.593 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.3 Cg_exo -56.43 147.74 66.6 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.897 2.398 . . . . 0.87 111.986 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 117.08 9.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.097 -0.502 . . . . 1.8500000000000001 111.063 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.46 6.15 56.63 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.953 -0.642 . . . . 1.1799999999999999 112.7 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.775 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 80.0 p -89.42 -22.68 22.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.96999999999999997 111.728 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.61 173.29 20.1 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.828 -0.624 . . . . 1.97 111.743 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.3 mm? -74.72 113.15 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.062 -0.347 . . . . 0.93999999999999995 110.062 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.718 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 28.0 m-70 -79.76 116.21 19.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 2.23 110.52 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.542 HH11 HD23 ' A' ' 14' ' ' LEU . 13.5 ptt180 -98.34 85.36 3.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.601 -0.727 . . . . 2.3100000000000001 110.781 -172.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.518 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 20.7 m-85 -71.73 114.11 9.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.257 -0.645 . . . . 0.78000000000000003 109.257 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.708 HG21 HD22 ' A' ' 14' ' ' LEU . 19.4 t -94.68 130.58 43.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.169 -0.469 . . . . 0.27000000000000002 110.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.668 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 59.7 m95 -88.68 119.27 29.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.895 -0.78 . . . . 1.99 108.895 177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 80.4 mt -113.84 118.61 34.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.709 0.232 . . . . 0.38 110.683 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.634 HG12 HD13 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -117.53 136.68 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.742 0.306 . . . . 0.31 110.788 179.136 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.859 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 59.0 t80 -132.03 129.01 39.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.423 -0.353 . . . . 5.1200000000000001 110.256 173.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.877 ' HG2' HG21 ' A' ' 164' ' ' VAL . 8.9 pt-20 -82.22 104.62 12.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.76 -0.829 . . . . 2.4100000000000001 108.76 171.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.24 168.21 19.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.169 0.509 . . . . 1.3100000000000001 109.752 -176.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.65 -7.2 53.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.582 -0.735 . . . . 2.3999999999999999 110.347 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HG3' ' HE2' ' A' ' 158' ' ' TYR . 20.0 ptt180 -167.01 160.23 11.02 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.561 -0.745 . . . . 3.5099999999999998 111.02 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HG3' HD12 ' A' ' 63' ' ' LEU . 31.2 Cg_exo -56.75 140.45 91.02 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.544 2.829 . . . . 1.21 112.596 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.8 mm? -65.16 149.52 49.77 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.401 0.519 . . . . 0.90000000000000002 112.401 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 11.6 tptm -120.96 90.68 3.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 2.8999999999999999 107.781 164.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' A' ' 103' ' ' LEU . 4.8 p -70.52 -69.77 0.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.334 -0.848 . . . . 1.8999999999999999 111.961 -171.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 59.26 28.96 18.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.267 0.556 . . . . 2.96 109.753 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -99.62 138.23 20.39 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.427 -0.806 . . . . 1.3899999999999999 109.426 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.28 115.17 1.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.113 2.542 . . . . 1.27 112.871 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.27 118.15 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.909 -0.404 . . . . 0.85999999999999999 109.909 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.4 mt -114.78 147.88 39.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.459 . . . . 1.6100000000000001 110.55 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -86.21 169.82 12.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.285 -0.871 . . . . 1.8799999999999999 109.237 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.815 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 14.3 p-10 -86.13 30.49 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.112 0.482 . . . . 0.75 111.571 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.583 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 96.8 mtt180 -117.96 148.26 42.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.426 -0.352 . . . . 3.3599999999999999 110.557 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.689 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 25.4 m 71.06 141.16 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.938 -1.028 . . . . 0.94999999999999996 111.232 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.03 28.71 14.4 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.585 -0.734 . . . . 1.1200000000000001 111.519 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.64 -51.61 26.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.316 0.647 . . . . 2.6600000000000001 112.672 -172.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -117.73 31.03 6.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.41 0.624 . . . . 1.8700000000000001 111.327 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.458 ' HB3' ' HE1' ' A' ' 84' ' ' TRP . 18.0 mmt180 -87.65 -36.03 17.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 4.7300000000000004 110.56 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -117.19 176.02 15.99 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.551 -0.833 . . . . 0.65000000000000002 112.707 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.772 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 86.3 mttt 64.33 41.94 5.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.535 0.683 . . . . 1.0800000000000001 111.449 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.98 149.02 49.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.044 -0.98 . . . . 1.8899999999999999 109.252 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -97.96 122.93 41.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.991 0.424 . . . . 1.29 111.697 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.645 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 11.8 m -61.29 -26.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.672 -0.695 . . . . 0.78000000000000003 110.224 174.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -61.7 -46.79 88.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.364 -0.834 . . . . 0.67000000000000004 110.186 173.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.0 m -63.97 -35.92 82.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.094 -0.503 . . . . 0.77000000000000002 110.823 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.645 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 43.6 m-85 -65.27 -49.98 67.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.399 -0.364 . . . . 0.92000000000000004 111.093 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 1.8 ptm180 -69.0 -39.31 79.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 2.8900000000000001 111.02 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.72 -27.58 68.43 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 111.503 0.186 . . . . 0.96999999999999997 111.503 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -53.93 -54.06 44.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 1.5800000000000001 111.495 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.517 ' HE2' ' HG3' ' A' ' 129' ' ' ARG . 9.2 t80 -107.58 18.87 20.94 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.766 -0.773 . . . . 5.4500000000000002 110.75 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 63.78 46.87 3.81 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.408 -0.814 . . . . 2.4199999999999999 111.149 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.859 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -91.47 123.14 34.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.185 -0.916 . . . . 1.27 109.831 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -86.52 -150.39 0.15 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.4 -0.364 . . . . 3.5899999999999999 110.441 -178.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . . . -62.73 142.85 96.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 0.76000000000000001 110.541 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 16.5 Cg_exo -66.33 160.73 43.93 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 123.795 2.997 . . . . 0.53000000000000003 113.513 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.901 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 9.7 t -89.74 -35.58 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-N 115.48 -0.782 . . . . 0.44 110.089 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -149.72 145.91 26.93 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.912 -0.715 . . . . 0.27000000000000002 111.75 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -149.36 143.02 10.34 Favored Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.545 -1.207 . . . . 0.23999999999999999 111.344 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.4 t -155.5 142.4 19.04 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.055 -1.091 . . . . 0.34000000000000002 108.055 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.616 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 13.1 p -120.31 141.27 50.17 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.951 -0.699 . . . . 1.1100000000000001 110.551 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 41.0 p90 -125.56 123.29 38.77 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.693 -1.225 . . . . 0.80000000000000004 107.693 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.718 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -101.03 132.39 46.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.621 -0.832 . . . . 2.5299999999999998 110.623 177.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -118.07 155.75 29.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.567 -0.742 . . . . 0.59999999999999998 110.696 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.39 -177.38 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.173 0.511 . . . . 2.3799999999999999 111.38 -175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.664 ' HA ' HG21 ' A' ' 177' ' ' VAL . 30.0 t90 -84.99 78.44 9.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 3.96 109.018 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 9.2 t70 -71.99 -62.74 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 1.53 111.687 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 33.5 t70 174.69 -35.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.277 0.56 . . . . 1.26 110.917 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -80.21 5.26 15.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 2.2200000000000002 110.999 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.825 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 64.8 t -72.42 -54.45 5.34 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.5 110.479 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 77.2 Cg_exo -51.47 -37.73 62.5 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.545 2.163 . . . . 0.57999999999999996 112.33 172.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.685 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 32.6 mmmt -73.09 -23.3 60.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 2.1400000000000001 111.42 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.783 HD11 HG12 ' A' ' 107' ' ' VAL . 40.3 tp -69.62 -46.59 65.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.104 -0.702 . . . . 0.66000000000000003 109.104 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -59.61 -36.86 77.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 1.8899999999999999 109.811 173.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 2.1 mm-40 -54.73 -46.65 74.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.83 -1.077 . . . . 1.53 110.339 172.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -73.73 -36.01 65.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.474 -0.785 . . . . 1.49 111.744 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.689 ' HA ' ' H ' ' A' ' 142' ' ' SER . 72.7 mt -67.16 5.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.263 0.468 . . . . 0.76000000000000001 112.263 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.694 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 33.8 m -84.12 0.02 50.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.377 0.608 . . . . 1.05 109.462 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.583 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.35 55.34 8.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.223 -0.899 . . . . 1.1699999999999999 111.346 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.694 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 1.4 mmmp? . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.169 -0.919 . . . . 2.0 110.75 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 tpt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.719 -0.474 . . . . 5.04 109.719 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.88 111.63 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.236 2.624 . . . . 2.1299999999999999 113.536 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.619 HG13 ' HB2' ' A' ' 24' ' ' PRO . 7.4 p -54.16 146.06 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.633 -1.167 . . . . 1.47 111.434 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -154.11 153.47 31.91 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.175 -0.676 . . . . 1.8100000000000001 109.175 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD21 ' C ' ' A' ' 23' ' ' HIS . 2.7 mm? -78.16 16.19 0.8 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.851 0.315 . . . . 0.69999999999999996 111.851 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.3 t -64.14 -16.18 61.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 1.96 110.805 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.665 ' HB3' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -113.47 31.48 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 2.6600000000000001 110.536 -177.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.695 ' H ' ' HE3' ' A' ' 8' ' ' TRP . 0.4 OUTLIER -73.55 -41.27 63.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.852 0.358 . . . . 3.98 111.93 -174.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.9 p -145.03 32.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.463 0.649 . . . . 0.63 110.003 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -78.12 -118.1 0.21 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.966 -0.854 . . . . 0.47999999999999998 110.966 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 18.6 Cg_endo -56.89 -38.37 96.07 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 123.175 2.583 . . . . 0.53000000000000003 110.854 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 7' ' ' LYS . 9.3 mt -88.58 101.75 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.1699999999999999 110.034 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -83.29 71.34 10.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.837 0.827 . . . . 0.70999999999999996 110.106 175.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.624 HD22 ' CG2' ' A' ' 121' ' ' VAL . 22.7 mt -79.09 -15.49 58.1 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.465 -0.789 . . . . 0.45000000000000001 109.915 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.655 ' HG2' ' HG2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -74.46 -6.67 49.65 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.375 -0.83 . . . . 2.1200000000000001 111.204 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 13' ' ' SER . 14.2 mt-10 -68.91 -22.83 64.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.323 0.582 . . . . 1.9299999999999999 109.577 177.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.873 HG12 HG21 ' A' ' 151' ' ' VAL . 46.1 t -89.03 -71.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.163 -0.926 . . . . 0.63 111.41 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.487 ' HB2' HG21 ' A' ' 151' ' ' VAL . 26.5 t70 -149.74 174.65 12.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.935 -0.575 . . . . 2.9900000000000002 109.525 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -54.95 151.04 9.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.288 0.566 . . . . 1.6000000000000001 111.279 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.655 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 27.6 mm-40 -86.96 138.27 32.94 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.872 -0.603 . . . . 3.5499999999999998 109.942 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.67 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 8.1 Cg_exo -71.24 161.52 45.51 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.377 2.718 . . . . 0.57999999999999996 113.299 -170.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.859 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 3.7 pt20 -82.38 -18.07 43.32 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.326 -0.852 . . . . 1.3899999999999999 111.74 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.755 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 2.2 m80 -141.9 159.68 58.5 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.538 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.619 ' HB2' HG13 ' A' ' 3' ' ' VAL . 5.0 Cg_endo -85.72 125.73 2.87 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.763 2.309 . . . . 0.40000000000000002 111.175 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 122' ' ' TRP . 16.2 tp -71.55 137.74 48.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.28999999999999998 110.131 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -105.59 107.82 19.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.8 -0.444 . . . . 1.24 109.8 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.928 HG13 HG22 ' A' ' 53' ' ' ILE . 6.6 t -114.46 143.34 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.149 -0.686 . . . . 0.46999999999999997 109.149 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -142.39 139.58 31.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.99 0.424 . . . . 0.31 111.413 -174.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -104.72 173.34 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.238 -0.653 . . . . 0.67000000000000004 109.238 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.17 66.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.485 0.659 . . . . 0.55000000000000004 110.726 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.1 -0.87 33.68 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.28 -0.873 . . . . 0.81000000000000005 112.957 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.36 -170.39 2.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.46999999999999997 111.266 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -163.39 154.4 16.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.63 -0.713 . . . . 0.33000000000000002 109.734 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.726 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 86.6 t -113.14 69.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.145 -1.428 . . . . 0.39000000000000001 107.145 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 20.5 t70 -105.41 18.55 22.07 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.234 -0.894 . . . . 0.98999999999999999 109.358 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.35 135.85 24.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.521 -0.918 . . . . 2.5600000000000001 108.521 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 168' ' ' CYS . 0.5 OUTLIER -80.79 111.38 17.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.405 0.622 . . . . 0.40999999999999998 110.547 -171.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 91.32 11.74 60.7 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.989 -1.005 . . . . 0.58999999999999997 111.848 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.726 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.4 144.53 46.35 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.394 -0.595 . . . . 0.34000000000000002 109.394 176.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 9.7 p -77.24 136.2 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.075 0.464 . . . . 0.55000000000000004 110.99 -178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.629 HD22 HG22 ' A' ' 34' ' ' VAL . 7.2 tp -131.99 168.85 17.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.556 -0.905 . . . . 0.45000000000000001 108.556 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.92 152.04 48.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.565 -0.454 . . . . 0.56000000000000005 112.045 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 174' ' ' ASP . 50.3 Cg_exo -57.41 -34.11 97.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.805 3.003 . . . . 0.68000000000000005 112.855 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.507 HG23 ' CD1' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -60.37 -39.91 88.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.463 0.649 . . . . 0.76000000000000001 110.772 176.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -81.64 -13.24 58.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.943 -1.026 . . . . 1.5900000000000001 111.752 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.601 HG11 ' CE2' ' A' ' 169' ' ' TYR . 33.0 m -128.24 28.65 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.66000000000000003 111.583 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.551 ' HZ2' HD13 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -86.76 -10.75 52.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.414 0.626 . . . . 0.79000000000000004 109.337 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -132.91 174.21 10.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.745 -1.116 . . . . 1.9099999999999999 108.38 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -71.29 153.56 94.08 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 110.229 -0.286 . . . . 1.4299999999999999 110.229 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.35 156.18 46.02 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.136 1.89 . . . . 0.37 110.844 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 t -77.71 -20.78 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.809 0.338 . . . . 0.44 110.216 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.5 m -159.07 143.56 15.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.482 0.658 . . . . 0.38 112.619 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.928 HG22 HG13 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -137.83 164.34 28.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.778 -1.101 . . . . 0.29999999999999999 108.155 170.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.016 ' HA ' HD13 ' A' ' 58' ' ' LEU . 35.1 t 174.69 118.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.15 -0.315 . . . . 0.34999999999999998 110.15 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.877 ' HB2' ' HB2' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -73.12 155.76 39.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.273 -1.01 . . . . 2.7200000000000002 108.273 172.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.89 88.05 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.042 0.448 . . . . 1.51 110.302 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.95 10.62 5.68 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.64 -0.709 . . . . 0.80000000000000004 112.182 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.016 HD13 ' HA ' ' A' ' 54' ' ' SER . 3.8 tt -51.03 128.74 22.32 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.09 0.556 . . . . 0.57999999999999996 111.37 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.818 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 24.4 t70 -72.73 -32.59 65.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.723 -0.671 . . . . 0.73999999999999999 111.332 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.553 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.7 t 71.52 15.02 6.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 114.998 -1.001 . . . . 1.03 109.831 -174.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.53 10.52 2.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.526 -0.761 . . . . 0.83999999999999997 112.901 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.818 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 22.9 mtpt -117.76 154.45 31.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.803 -0.443 . . . . 1.6699999999999999 109.803 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.832 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 24.2 mt -92.5 130.87 38.04 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.796 -0.816 . . . . 0.57999999999999996 108.796 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.648 ' HA ' ' OE1' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -125.54 158.36 34.76 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.56 -0.456 . . . . 0.80000000000000004 110.871 176.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.459 HG23 HG12 ' A' ' 90' ' ' VAL . 60.0 m -97.72 106.14 18.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.149 -0.685 . . . . 0.35999999999999999 109.149 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 124' ' ' VAL . 53.0 tp -104.24 111.23 23.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.58999999999999997 110.394 -176.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.417 HG22 ' CD1' ' A' ' 88' ' ' LEU . 22.0 t -116.74 125.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 0.39000000000000001 110.727 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.3 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.5 -0.926 . . . . 0.59999999999999998 108.5 167.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.74 HG21 HG11 ' A' ' 17' ' ' VAL . 10.6 t -136.66 146.81 46.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.04 -0.355 . . . . 0.35999999999999999 110.04 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 14.9 t0 -126.28 97.27 34.75 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.457 -0.571 . . . . 1.9199999999999999 109.457 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.5 ' HD3' HG21 ' A' ' 17' ' ' VAL . 6.5 Cg_endo -49.08 -46.89 23.73 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.904 3.069 . . . . 1.25 113.485 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.655 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 7.4 m-20 -90.81 53.09 2.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.422 0.629 . . . . 1.29 111.14 -171.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -103.98 138.88 19.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.932 -0.576 . . . . 0.5 110.828 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.585 ' HD3' ' HD1' ' A' ' 81' ' ' TYR . 88.1 Cg_endo -83.43 -22.7 14.35 Favored 'Cis proline' 0 C--N 1.343 0.282 0 C-N-CA 123.327 -1.531 . . . . 0.62 112.621 1.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.657 ' HB3' HG22 ' A' ' 115' ' ' THR . 58.9 p -128.46 147.3 50.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.565 -0.743 . . . . 0.75 110.277 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.655 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 21.2 ttt180 -64.6 -26.65 68.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.257 0.551 . . . . 2.8799999999999999 110.429 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 4.9 ptpt -78.72 -14.83 59.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 1.3799999999999999 110.89 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t70 -162.94 87.49 1.33 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.942 -0.572 . . . . 1.3700000000000001 110.111 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 94.2 Cg_endo -85.2 83.92 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.697 2.265 . . . . 0.80000000000000004 112.806 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -72.08 -47.85 48.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.884 -1.053 . . . . 1.02 110.48 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.689 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 54.6 m-85 -88.53 21.28 2.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.002 -0.999 . . . . 1.1699999999999999 111.729 -168.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.858 ' HD3' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -74.01 125.85 29.18 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.173 -0.306 . . . . 2.9300000000000002 110.173 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.858 ' HG3' ' HD3' ' A' ' 82' ' ' ARG . 1.5 mp0 -94.87 138.78 32.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.043 0.449 . . . . 2.23 110.986 -2.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.455 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 16.0 t90 -91.72 138.64 31.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.188 -0.671 . . . . 1.4299999999999999 109.188 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -113.44 133.61 55.1 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.221 -0.659 . . . . 1.26 109.221 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.88 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 5.2 t60 -82.75 -35.81 26.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.72 -0.673 . . . . 2.1400000000000001 110.527 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.689 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 22.0 p90 -167.62 177.19 6.01 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.552 -0.536 . . . . 1.51 109.552 177.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.57 ' HG ' HD12 ' A' ' 103' ' ' LEU . 23.3 tp -141.27 113.8 8.22 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.245 0.341 . . . . 0.33000000000000002 110.25 176.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.689 ' HB ' ' HE2' ' A' ' 87' ' ' PHE . 1.5 t -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.668 -0.697 . . . . 0.31 110.57 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.527 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 4.5 m -129.05 166.88 25.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.591 -0.892 . . . . 0.27000000000000002 108.591 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.832 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.5 m-20 60.45 18.89 8.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.955 0.407 . . . . 1.76 111.172 172.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.582 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.4 ttm -72.49 116.71 13.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.97 -0.752 . . . . 0.31 108.97 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HB2' ' HE2' ' A' ' 93' ' ' LYS . 19.3 ttmm -90.4 100.63 13.43 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.126 -0.943 . . . . 1.21 110.972 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 75.59 -121.42 6.37 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.353 -0.839 . . . . 0.29999999999999999 112.537 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 28.2 p30 -120.55 29.09 7.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.208 0.528 . . . . 1.04 111.052 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -97.15 109.61 22.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.834 -0.621 . . . . 0.77000000000000002 110.183 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 53' ' ' ILE . 7.6 mm -54.74 -30.86 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.716 -1.129 . . . . 0.40999999999999998 111.483 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.0 m -83.21 -35.53 25.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.016 -0.538 . . . . 0.68000000000000005 112.32 -172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.8 p -61.28 -24.97 66.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 1.26 111.759 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.8 110.11 1.53 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.65 -0.704 . . . . 0.34999999999999998 113.012 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.4 m -66.44 107.59 2.09 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.344 -0.613 . . . . 0.45000000000000001 109.344 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.3 126.63 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.223 -0.898 . . . . 0.56999999999999995 111.579 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.57 HD12 ' HG ' ' A' ' 88' ' ' LEU . 22.8 mt -106.87 -49.6 3.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.181 0.991 . . . . 0.45000000000000001 108.713 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.8 t -120.57 112.72 19.28 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.678 -1.601 . . . . 0.37 106.678 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 1.3 t0 -70.52 167.95 17.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.407 0.623 . . . . 1.1499999999999999 112.429 -166.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -83.52 88.24 7.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.973 -1.012 . . . . 4.6900000000000004 109.731 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.839 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.0 t -61.72 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.713 -0.676 . . . . 0.85999999999999999 112.094 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.88 -176.96 17.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.67000000000000004 111.695 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 29.0 t -71.69 127.06 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.975 0.387 . . . . 0.51000000000000001 110.536 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.544 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -150.51 63.67 0.4 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.805 -0.712 . . . . 0.81999999999999995 112.448 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.636 ' HB3' ' CE1' ' A' ' 118' ' ' HIS . 96.5 Cg_endo -93.05 145.36 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.062 2.508 . . . . 0.84999999999999998 113.3 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HD2' HG21 ' A' ' 115' ' ' THR . 32.1 Cg_exo -60.56 154.04 57.0 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.641 2.227 . . . . 0.87 111.351 169.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -68.43 126.46 29.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 1.8500000000000001 110.896 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.76 37.1 20.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 1.1799999999999999 113.221 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 75' ' ' SER . 28.6 p -84.32 -13.12 53.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.393 0.516 . . . . 0.96999999999999997 112.393 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 89.83 11.77 63.17 Favored Glycine 0 CA--C 1.505 -0.556 0 C-N-CA 120.27 -0.967 . . . . 1.97 112.101 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 172' ' ' GLU . 3.8 mm? 72.37 100.79 0.07 Allowed 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.593 0.819 . . . . 0.93999999999999995 111.446 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -96.26 164.75 12.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.043 -0.725 . . . . 2.23 109.043 175.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.609 ' HD2' HD21 ' A' ' 14' ' ' LEU . 2.7 ptt180 -127.29 106.22 9.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.015 0.436 . . . . 2.3100000000000001 112.061 -160.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.581 ' OH ' ' HE1' ' A' ' 118' ' ' HIS . 6.8 m-85 -73.66 110.79 8.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.848 -0.797 . . . . 0.78000000000000003 108.848 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.624 ' CG2' HD22 ' A' ' 14' ' ' LEU . 16.6 t -94.82 125.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.291 -0.413 . . . . 0.27000000000000002 110.373 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.78 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -87.99 118.6 27.66 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.091 -0.707 . . . . 1.99 109.091 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.98 119.03 33.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.578 -0.156 . . . . 0.38 110.578 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.631 HG12 HD13 ' A' ' 66' ' ' LEU . 1.7 m -105.61 126.24 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.157 -0.617 . . . . 0.31 109.824 173.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -108.09 124.21 49.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 5.1200000000000001 109.02 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' HG21 ' A' ' 164' ' ' VAL . 27.6 tt0 -94.38 96.98 9.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.991 0.424 . . . . 2.4100000000000001 110.137 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.648 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -73.24 163.97 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.77 -0.65 . . . . 1.3100000000000001 109.67 175.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.76 3.14 38.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.56 -0.746 . . . . 2.3999999999999999 110.04 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.427 ' H ' ' HB2' ' A' ' 127' ' ' GLN . 0.8 OUTLIER -165.64 153.23 9.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.774 -0.648 . . . . 3.5099999999999998 111.355 -169.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HG3' HD12 ' A' ' 63' ' ' LEU . 32.0 Cg_exo -59.59 141.08 96.61 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.701 2.934 . . . . 1.21 112.094 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.527 ' HG ' ' HB ' ' A' ' 90' ' ' VAL . 3.6 mm? -68.43 151.56 46.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.90000000000000002 112.434 -170.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -115.9 64.23 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.403 -0.962 . . . . 2.8999999999999999 108.403 171.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 131' ' ' LEU . 46.2 m -96.98 92.4 6.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.218 -0.901 . . . . 1.8999999999999999 110.194 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.85 40.66 0.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.963 . . . . 2.96 109.976 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -89.16 127.98 53.33 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.16 -0.927 . . . . 1.3899999999999999 110.091 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.1 127.85 18.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.225 2.617 . . . . 1.27 112.588 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.25 121.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.85999999999999999 110.11 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.4 mt -98.82 -13.95 19.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.393 -0.367 . . . . 1.6100000000000001 111.815 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m 55.65 -162.23 0.16 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.428 -0.351 . . . . 1.8799999999999999 110.669 -173.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.933 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 2.2 p-10 -117.72 16.43 14.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.162 0.506 . . . . 0.75 111.072 -176.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.564 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 23.2 mtt180 -107.71 137.27 46.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.205 -0.452 . . . . 3.3599999999999999 109.988 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.601 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 67.9 m 74.42 113.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.185 0.928 . . . . 0.94999999999999996 111.089 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.4 36.06 2.96 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.293 -0.867 . . . . 1.1200000000000001 112.296 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.01 -51.25 33.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.677 0.751 . . . . 2.6600000000000001 110.387 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -92.79 53.86 2.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.968 -1.015 . . . . 1.8700000000000001 110.437 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 146' ' ' ARG . 44.0 mtt85 -76.49 -83.91 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.644 -0.707 . . . . 4.7300000000000004 111.343 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -126.29 -154.74 8.73 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.655 -0.783 . . . . 0.65000000000000002 112.777 -171.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 81.0 mttt 65.93 23.18 11.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.787 0.803 . . . . 1.0800000000000001 109.789 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -107.66 173.57 6.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.632 -1.167 . . . . 1.8899999999999999 108.876 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.35 119.94 37.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.549 -0.296 . . . . 1.29 111.187 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.922 ' HA ' ' HD2' ' A' ' 154' ' ' PHE . 18.4 m -66.06 -25.36 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.423 -0.584 . . . . 0.78000000000000003 109.423 173.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.02 83.31 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.194 -0.912 . . . . 0.67000000000000004 109.986 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 57.4 m -66.91 -36.74 82.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.426 -0.352 . . . . 0.77000000000000002 110.996 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.922 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 52.0 m-85 -61.7 -49.95 74.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.732 0.301 . . . . 0.92000000000000004 110.799 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 156' ' ' LYS . 5.9 ptp180 -69.15 -44.47 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.509 -0.314 . . . . 2.8900000000000001 111.199 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.478 ' N ' ' HG3' ' A' ' 155' ' ' ARG . 58.5 mtmt -63.04 -26.99 69.1 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.436 0.161 . . . . 0.96999999999999997 111.436 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -53.15 -50.57 64.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.52 0.512 . . . . 1.5800000000000001 110.721 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -104.09 9.92 36.18 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.18 -0.608 . . . . 5.4500000000000002 110.511 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 57.51 39.79 27.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.2 1.0 . . . . 2.4199999999999999 110.229 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.539 HD12 ' H ' ' A' ' 161' ' ' ARG . 1.7 tp -76.22 156.06 33.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.057 -1.429 . . . . 1.27 111.552 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.539 ' H ' HD12 ' A' ' 160' ' ' LEU . 9.0 mpt_? -96.87 -166.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 3.5899999999999999 111.856 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.04 158.08 77.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.76000000000000001 111.892 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -70.38 150.52 64.59 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.269 2.646 . . . . 0.53000000000000003 113.205 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 10.5 t -93.72 -31.47 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.448 -0.796 . . . . 0.44 109.861 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 55' ' ' TRP . . . -147.44 146.45 29.56 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.997 -0.681 . . . . 0.27000000000000002 112.109 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.744 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -150.74 155.76 26.34 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.72 -1.127 . . . . 0.23999999999999999 111.655 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.463 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 11.2 t -169.73 133.2 1.23 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.897 -0.779 . . . . 0.34000000000000002 108.897 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.617 ' SG ' HD13 ' A' ' 12' ' ' LEU . 17.5 p -110.93 141.15 44.75 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.257 -0.577 . . . . 1.1100000000000001 110.609 -175.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.601 ' CE2' HG11 ' A' ' 46' ' ' VAL . 25.9 p90 -127.32 123.16 35.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.419 -0.956 . . . . 0.80000000000000004 108.419 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -100.08 138.14 37.56 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.439 -0.504 . . . . 2.5299999999999998 110.672 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . . . -138.01 146.92 43.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.94 -0.573 . . . . 0.59999999999999998 109.976 -174.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.444 ' HB3' ' CD1' ' A' ' 117' ' ' LEU . 14.1 pt-20 -121.67 -168.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.34 . . . . 2.3799999999999999 111.34 -176.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.697 ' HA ' HG21 ' A' ' 177' ' ' VAL . 14.1 t90 -76.91 83.85 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 3.96 110.887 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.569 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.5 p-10 -74.41 -59.83 2.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 111.545 0.202 . . . . 1.53 111.545 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.578 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 13.9 t70 178.05 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.086 0.555 . . . . 1.26 110.185 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 44' ' ' THR . 72.4 m-85 -82.53 -2.27 53.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 2.2200000000000002 111.874 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.799 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 94.4 t -58.7 -54.04 60.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.473 -0.33 . . . . 0.5 110.49 172.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.799 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.5 Cg_exo -51.31 -36.1 56.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.635 2.223 . . . . 0.57999999999999996 112.445 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 29.2 mmmt -74.12 -24.71 59.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 2.1400000000000001 110.78 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 59.0 tp -69.44 -46.09 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.429 -0.582 . . . . 0.66000000000000003 109.429 172.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.445 -0.798 . . . . 1.8899999999999999 108.898 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 42.5 mm-40 -58.19 -50.21 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.803 -1.09 . . . . 1.53 110.941 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.489 ' NE2' HD21 ' A' ' 140' ' ' ASN . 34.8 tt0 -64.17 -33.81 76.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.581 -0.736 . . . . 1.49 111.934 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 77.1 mt -62.47 0.03 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.691 0.626 . . . . 0.76000000000000001 112.691 -177.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.637 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.6 m -82.2 8.9 9.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.063 0.459 . . . . 1.05 110.133 171.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 70.6 54.95 9.12 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.974 -0.85 . . . . 1.1699999999999999 110.974 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.637 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.6 mmmt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.576 -0.726 . . . . 2.0 110.981 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 12.3 tpt . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.501 -0.185 . . . . 5.04 110.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 17.3 Cg_exo -68.36 93.41 0.41 Allowed 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 122.904 2.403 . . . . 2.1299999999999999 111.826 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 24' ' ' PRO . 3.7 t 61.47 113.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.214 -1.357 . . . . 1.47 111.873 -176.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -159.18 157.09 30.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.119 -1.067 . . . . 1.8100000000000001 108.119 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD12 ' OE1' ' A' ' 20' ' ' GLN . 2.6 mm? -76.95 22.6 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.048 -0.261 . . . . 0.69999999999999996 111.631 -174.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 m -67.64 -21.21 65.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 1.96 111.505 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.95 37.07 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 2.6600000000000001 110.192 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.445 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . 9.0 p-90 -75.76 -29.03 58.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.42 0.526 . . . . 3.98 112.42 -174.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.441 ' HB3' ' HG2' ' A' ' 15' ' ' GLN . 70.8 p -156.18 20.27 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.63 111.017 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -82.6 -117.64 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.664 -0.575 . . . . 0.47999999999999998 111.664 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.6 Cg_endo -51.65 -42.08 58.24 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.225 2.616 . . . . 0.53000000000000003 110.279 167.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.728 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 10.2 mp -90.01 94.91 9.98 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.747 -1.115 . . . . 1.1699999999999999 110.965 172.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -74.2 61.45 0.86 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.351 0.596 . . . . 0.70999999999999996 110.211 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.79 HD22 HG21 ' A' ' 121' ' ' VAL . 40.5 mt -68.46 -13.41 62.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.45000000000000001 110.902 -175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.441 ' HG2' ' HB3' ' A' ' 9' ' ' SER . 22.3 mm-40 -73.57 -1.29 18.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.086 -0.506 . . . . 2.1200000000000001 111.675 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.57 -10.58 59.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.169 0.509 . . . . 1.9299999999999999 109.792 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.869 HG11 HG21 ' A' ' 69' ' ' THR . 58.7 t -92.83 -76.82 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.463 -0.789 . . . . 0.63 110.196 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.596 ' HB2' ' CG2' ' A' ' 151' ' ' VAL . 10.1 t70 -155.59 -178.25 7.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.396 -0.964 . . . . 2.9900000000000002 108.396 -175.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.74 152.99 41.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.047 0.451 . . . . 1.6000000000000001 110.766 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.484 ' OE1' HD12 ' A' ' 5' ' ' LEU . 8.2 tp-100 -78.12 129.88 74.14 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.072 -0.513 . . . . 3.5499999999999998 110.413 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HG2' ' HA3' ' A' ' 166' ' ' GLY . 32.2 Cg_exo -58.22 159.39 19.08 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.965 2.443 . . . . 0.57999999999999996 113.001 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.9 ' HG3' ' HD2' ' A' ' 23' ' ' HIS . 20.3 pt20 -78.96 -8.18 58.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 1.3899999999999999 111.653 -175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.9 ' HD2' ' HG3' ' A' ' 22' ' ' GLN . 64.8 m-70 -148.17 157.63 42.49 Favored Pre-proline 0 CA--C 1.515 -0.385 0 C-N-CA 123.246 0.619 . . . . 1.45 109.78 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.722 ' HB2' HG12 ' A' ' 3' ' ' VAL . 5.6 Cg_endo -87.67 123.94 1.85 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.318 2.679 . . . . 0.40000000000000002 111.239 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.55 ' O ' HG11 ' A' ' 3' ' ' VAL . 20.6 tp -79.04 131.58 36.32 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.32 -0.237 . . . . 0.28999999999999998 111.353 -175.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -100.04 112.9 25.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.007 -0.368 . . . . 1.24 110.007 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 53' ' ' ILE . 22.1 t -116.59 142.03 32.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.264 -0.643 . . . . 0.46999999999999997 109.264 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -136.3 138.93 42.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.903 0.382 . . . . 0.31 110.117 -177.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.405 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 42.7 t80 -99.87 171.58 7.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.447 -0.575 . . . . 0.67000000000000004 109.447 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.65 62.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.984 0.421 . . . . 0.55000000000000004 110.596 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.53 9.37 19.67 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.432 -0.804 . . . . 0.81000000000000005 112.504 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . . . -142.34 -168.23 2.68 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 110.165 -0.309 . . . . 0.46999999999999997 110.165 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 28' ' ' THR . . . -161.36 155.23 22.13 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 110.768 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.763 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 67.8 t -107.77 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.919 -1.512 . . . . 0.39000000000000001 106.919 166.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.69 22.2 4.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.98999999999999999 109.833 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -150.64 130.24 13.08 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.051 -0.977 . . . . 2.5600000000000001 109.847 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.966 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 1.1 tt -71.96 112.92 8.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.342 -0.614 . . . . 0.40999999999999998 109.342 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.598 ' HA2' ' SG ' ' A' ' 168' ' ' CYS . . . 89.97 19.22 47.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.89 -0.671 . . . . 0.58999999999999997 112.256 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.763 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -84.6 147.26 27.08 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.275 -0.639 . . . . 0.34000000000000002 109.275 175.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 7.3 p -78.42 130.45 36.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.283 0.563 . . . . 0.55000000000000004 110.821 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.697 HD23 ' HD2' ' A' ' 169' ' ' TYR . 8.7 tp -129.99 149.74 51.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.545 -1.279 . . . . 0.45000000000000001 107.545 177.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 46' ' ' VAL . 3.9 p -95.86 150.74 37.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 C-N-CA 119.47 -0.892 . . . . 0.56000000000000005 112.665 -170.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.935 ' HG2' ' H ' ' A' ' 174' ' ' ASP . 82.3 Cg_exo -51.68 -22.74 13.8 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.674 3.583 . . . . 0.68000000000000005 114.374 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.485 HG22 ' CE2' ' A' ' 176' ' ' TYR . 2.2 p -71.09 -53.77 13.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.672 0.748 . . . . 0.76000000000000001 109.816 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.65 -43.39 93.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.42 -1.264 . . . . 1.5900000000000001 111.544 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 43' ' ' PRO . 2.5 m -91.97 13.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 0.66000000000000003 111.903 -173.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -82.68 -28.71 30.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.162 -0.472 . . . . 0.79000000000000004 110.391 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 106' ' ' TYR . 18.1 m120 -109.23 -169.86 1.56 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.62 -0.718 . . . . 1.9099999999999999 110.668 -177.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -86.14 158.05 55.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.274 -0.639 . . . . 1.4299999999999999 109.274 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 122' ' ' TRP . 72.0 Cg_endo -81.64 160.43 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.112 1.875 . . . . 0.37 111.004 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 t -81.61 -21.23 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.141 0.496 . . . . 0.44 109.878 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.537 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 69.2 m -158.11 143.49 16.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.362 0.601 . . . . 0.38 112.551 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.905 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -139.92 161.0 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.717 -1.129 . . . . 0.29999999999999999 107.955 170.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.984 ' HA ' HD13 ' A' ' 58' ' ' LEU . 37.9 t 176.02 119.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.98 0.419 . . . . 0.34999999999999998 110.421 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 165' ' ' ALA . 50.0 p-90 -81.15 147.93 29.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.848 -1.538 . . . . 2.7200000000000002 106.848 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -66.38 91.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.859 0.837 . . . . 1.51 110.904 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.32 -1.31 3.68 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 114.864 -1.062 . . . . 0.80000000000000004 111.799 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.984 HD13 ' HA ' ' A' ' 54' ' ' SER . 7.1 tt -54.68 128.58 33.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.83 0.452 . . . . 0.57999999999999996 110.511 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.804 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . 25.3 t70 -77.8 -26.95 50.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.092 -0.504 . . . . 0.73999999999999999 111.67 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.715 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 22.5 p 70.59 13.33 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.396 1.078 . . . . 1.03 110.5 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -133.05 -25.66 0.65 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.83999999999999997 113.263 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.804 ' HG3' ' HB3' ' A' ' 59' ' ' ASP . 18.8 mtpt -84.22 156.74 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.968 0.384 . . . . 1.6699999999999999 110.084 -175.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.978 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 16.9 mt -92.29 128.16 38.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.72 -0.474 . . . . 0.57999999999999996 109.72 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.51 ' HE1' ' HA2' ' A' ' 94' ' ' GLY . 17.3 m-85 -121.37 150.78 40.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.601 0.239 . . . . 0.80000000000000004 110.523 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.933 HG23 HG12 ' A' ' 90' ' ' VAL . 2.7 m -97.16 105.91 18.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.638 -0.875 . . . . 0.35999999999999999 108.638 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.705 HD13 HG12 ' A' ' 124' ' ' VAL . 49.7 tp -109.23 113.01 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.823 -0.626 . . . . 0.58999999999999997 110.46 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 88' ' ' LEU . 23.8 t -112.51 123.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.916 -0.584 . . . . 0.39000000000000001 110.754 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.997 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 4.4 mt -88.64 131.65 34.89 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.744 -0.836 . . . . 0.59999999999999998 108.744 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.869 HG21 HG11 ' A' ' 17' ' ' VAL . 8.8 t -139.05 148.91 43.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.867 0.365 . . . . 0.35999999999999999 111.302 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 27.7 t70 -127.45 94.56 37.89 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.758 -0.655 . . . . 1.9199999999999999 109.487 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.8 Cg_endo -50.79 -40.06 57.28 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 124.153 3.236 . . . . 1.25 113.799 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 3.8 m-20 -86.54 43.03 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.605 0.594 . . . . 1.29 112.605 -167.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 79' ' ' PRO . . . -104.11 138.1 19.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.801 -0.181 . . . . 0.5 110.615 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.548 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 87.8 Cg_endo -83.28 -24.49 11.13 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.575 -1.427 . . . . 0.62 112.993 1.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 78.9 p -130.81 150.85 51.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.177 -0.465 . . . . 0.75 109.933 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.778 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 42.5 mtm105 -67.83 -23.55 65.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.934 -0.575 . . . . 2.8799999999999999 111.878 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.724 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -91.6 -10.68 39.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.326 -0.397 . . . . 1.3799999999999999 111.145 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 13.4 t70 -154.18 77.01 5.63 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.176 0.512 . . . . 1.3700000000000001 110.116 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 81.5 Cg_endo -79.42 86.37 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.532 2.154 . . . . 0.80000000000000004 112.363 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.6 mttm -70.67 -50.3 38.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.747 -1.115 . . . . 1.02 110.589 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.69 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 41.9 m-85 -82.05 20.93 0.94 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.453 -0.794 . . . . 1.1699999999999999 111.437 -172.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 8.0 tmm_? -71.97 123.58 23.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.888 -0.412 . . . . 2.9300000000000002 109.888 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 4.8 mp0 -100.08 135.95 40.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.895 0.379 . . . . 2.23 110.886 -0.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.402 ' HD1' ' O ' ' A' ' 146' ' ' ARG . 15.1 t90 -79.38 146.52 32.8 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.977 -1.12 . . . . 1.4299999999999999 107.977 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 47.0 p-80 -124.51 127.54 47.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 1.26 110.751 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.997 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 4.7 t60 -70.66 -37.15 73.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.906 -1.043 . . . . 2.1400000000000001 110.219 -177.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.622 ' CE2' HD12 ' A' ' 68' ' ' LEU . 8.4 p90 -168.36 173.61 7.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.01 -0.367 . . . . 1.51 110.01 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.654 ' HG ' HD12 ' A' ' 103' ' ' LEU . 18.4 tp -134.95 113.98 12.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.087 -0.506 . . . . 0.33000000000000002 109.776 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.652 HG11 ' HE3' ' A' ' 92' ' ' MET . 2.0 t -122.71 132.64 70.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.671 -0.695 . . . . 0.31 110.627 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.933 HG12 HG23 ' A' ' 65' ' ' THR . 5.6 m -128.15 164.93 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.312 -0.996 . . . . 0.27000000000000002 108.312 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.978 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 7.0 m-20 59.16 18.64 6.66 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 123.526 0.516 . . . . 1.76 111.096 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.652 ' HE3' HG11 ' A' ' 89' ' ' VAL . 8.3 ttm -70.12 110.01 4.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.31 108.588 176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 19.4 ttmm -76.48 92.67 3.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.733 -1.121 . . . . 1.21 111.179 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.715 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 76.2 -123.13 6.75 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.853 -1.067 . . . . 0.29999999999999999 112.898 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' HA ' HD11 ' A' ' 53' ' ' ILE . 26.1 p-10 -113.41 22.27 14.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.332 -0.434 . . . . 1.04 111.024 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.63 106.84 18.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.489 0.661 . . . . 0.77000000000000002 109.919 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 97' ' ' ILE . 4.6 mm -57.01 -30.66 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.307 -1.315 . . . . 0.40999999999999998 111.274 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 m -82.87 -26.68 31.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.053 -0.521 . . . . 0.68000000000000005 111.655 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -84.82 14.9 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 1.26 111.616 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.93 109.35 3.62 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.787 -0.72 . . . . 0.34999999999999998 111.902 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.4 m -61.55 106.26 0.63 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.363 0.601 . . . . 0.45000000000000001 109.549 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 p -85.8 121.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.257 -0.883 . . . . 0.56999999999999995 111.414 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.654 HD12 ' HG ' ' A' ' 88' ' ' LEU . 18.4 mt -100.48 -43.13 6.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.012 0.911 . . . . 0.45000000000000001 109.231 173.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 t -123.98 110.39 14.74 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.159 -1.423 . . . . 0.37 107.159 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.895 ' HB3' ' HB3' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -59.31 164.44 3.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.851 -0.613 . . . . 1.1499999999999999 112.469 -171.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 87' ' ' PHE . 11.0 p90 -80.76 98.27 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.414 -0.812 . . . . 4.6900000000000004 110.231 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.775 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 35.6 t -67.33 -53.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.85999999999999999 111.332 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 86' ' ' HIS . . . 117.41 -162.53 12.87 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.551 -0.833 . . . . 0.67000000000000004 112.312 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.595 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 29.0 t -77.72 117.56 19.23 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.919 -0.4 . . . . 0.51000000000000001 109.919 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.646 ' HA3' HD23 ' A' ' 180' ' ' LEU . . . -143.47 57.04 0.55 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.699 -0.763 . . . . 0.81999999999999995 112.461 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.767 ' HB3' ' CD2' ' A' ' 118' ' ' HIS . 1.4 Cg_endo -87.01 131.25 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.245 2.63 . . . . 0.84999999999999998 112.346 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.65 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 52.7 Cg_exo -56.74 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.207 1.938 . . . . 0.87 110.53 171.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.17 112.87 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 1.8500000000000001 110.528 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.89 -6.38 19.97 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.842 -0.694 . . . . 1.1799999999999999 112.121 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.709 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 78.4 p -83.92 -20.95 32.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.772 0.32 . . . . 0.96999999999999997 111.318 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.414 ' HA3' ' HE ' ' A' ' 76' ' ' ARG . . . 107.77 -174.24 19.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.155 -0.545 . . . . 1.97 112.381 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 4.4 mm? -68.59 122.82 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.667 0.27 . . . . 0.93999999999999995 110.726 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.767 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 17.8 m-70 -98.45 121.55 40.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.129 0.49 . . . . 2.23 110.207 176.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.728 ' NH1' ' HA ' ' A' ' 12' ' ' LEU . 1.6 ptt180 -107.13 94.11 4.92 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.083 -0.962 . . . . 2.3100000000000001 111.461 -168.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.635 ' HB2' ' CE1' ' A' ' 169' ' ' TYR . 33.6 m-85 -75.15 111.06 10.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.195 -0.669 . . . . 0.78000000000000003 109.195 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 168' ' ' CYS . 11.7 t -94.76 132.46 38.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.785 -0.643 . . . . 0.27000000000000002 110.09 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.767 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 31.0 m95 -89.4 121.89 32.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.303 -0.629 . . . . 1.99 109.303 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 76.1 mt -116.47 117.5 30.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.159 0.436 . . . . 0.38 110.221 175.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.705 HG12 HD13 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -115.07 137.89 47.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.263 -0.273 . . . . 0.31 110.263 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.83 ' CD2' ' HG ' ' A' ' 160' ' ' LEU . 47.9 t80 -130.6 137.63 49.74 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.301 -0.259 . . . . 5.1200000000000001 110.301 175.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.71 105.07 17.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.227 -0.657 . . . . 2.4100000000000001 109.227 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.479 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -76.98 175.1 9.87 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.428 0.632 . . . . 1.3100000000000001 111.29 -173.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.17 -29.27 66.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.103 -0.953 . . . . 2.3999999999999999 109.231 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 10.9 ptt-85 -159.66 164.59 19.95 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.511 -1.222 . . . . 3.5099999999999998 111.254 -172.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.546 ' HG3' HD12 ' A' ' 63' ' ' LEU . 31.4 Cg_exo -55.86 142.98 83.33 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.453 2.769 . . . . 1.21 112.916 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.506 HD21 ' OG1' ' A' ' 65' ' ' THR . 4.0 mm? -68.97 154.43 42.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.567 0.951 . . . . 0.90000000000000002 113.567 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HE2' ' OD2' ' A' ' 134' ' ' ASP . 21.5 tptm -141.35 86.78 2.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.44 -1.255 . . . . 2.8999999999999999 108.0 167.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.74 -46.42 8.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.774 -0.648 . . . . 1.8999999999999999 112.678 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.451 ' OD2' ' HE2' ' A' ' 132' ' ' LYS . 61.7 m-20 57.32 47.55 16.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 2.96 110.7 -174.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -99.43 146.92 32.61 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.539 -0.755 . . . . 1.3899999999999999 109.973 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.73 106.19 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.133 2.555 . . . . 1.27 112.474 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.43 115.36 2.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.241 -0.436 . . . . 0.85999999999999999 110.659 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.0 mt -109.38 147.52 32.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 1.6100000000000001 110.203 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 58.0 m -109.32 36.64 2.85 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.572 -0.74 . . . . 1.8799999999999999 110.38 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.895 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.8 OUTLIER 57.05 4.56 0.18 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.62 1.168 . . . . 0.75 113.041 177.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.58 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 83.9 mtt180 -97.39 136.27 38.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 3.3599999999999999 110.819 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.67 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 53.7 m 77.46 118.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.582 -1.19 . . . . 0.94999999999999996 111.147 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -89.42 34.08 4.12 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.169 -0.923 . . . . 1.1200000000000001 112.426 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.68 -28.83 63.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.23 0.538 . . . . 2.6600000000000001 110.597 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -119.87 68.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 1.8700000000000001 110.852 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 78.5 mtt180 -75.52 -76.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.182 0.515 . . . . 4.7300000000000004 111.063 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 81' ' ' TYR . . . -132.4 -148.05 5.97 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.664 -0.779 . . . . 0.65000000000000002 112.532 -174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.69 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.7 mttt 68.25 17.76 9.28 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.51 0.671 . . . . 1.0800000000000001 110.208 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -110.01 104.68 13.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.235 -0.893 . . . . 1.8899999999999999 109.303 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -54.82 120.65 7.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.635 -0.711 . . . . 1.29 112.2 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 17' ' ' VAL . 4.6 m -60.38 -30.1 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.611 -0.722 . . . . 0.78000000000000003 110.705 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 155' ' ' ARG . . . -63.12 -35.47 80.38 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.67000000000000004 110.445 173.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 69.1 m -68.59 -33.96 74.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.77000000000000002 110.306 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.704 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 58.1 m-85 -67.39 -43.66 80.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.92000000000000004 110.44 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 152' ' ' ALA . 21.4 ptt180 -69.53 -41.46 75.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.327 -0.397 . . . . 2.8900000000000001 110.354 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 153' ' ' SER . 53.6 mtmt -62.61 -27.31 69.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.564 0.221 . . . . 0.96999999999999997 111.416 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -53.61 -53.33 53.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.078 -0.51 . . . . 1.5800000000000001 110.909 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 5.2 t80 -107.89 20.96 18.09 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.439 -0.904 . . . . 5.4500000000000002 111.011 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.57 42.59 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.384 -0.825 . . . . 2.4199999999999999 111.69 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.83 ' HG ' ' CD2' ' A' ' 125' ' ' TYR . 8.2 mp -90.77 155.27 18.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.265 -0.88 . . . . 1.27 109.751 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.926 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 7.7 tpt180 -122.87 -153.85 0.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.454 -0.573 . . . . 3.5899999999999999 109.454 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.926 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -53.98 140.31 51.72 Favored Pre-proline 0 N--CA 1.456 -0.165 0 CA-C-O 121.168 0.509 . . . . 0.76000000000000001 111.114 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 162' ' ' ALA . 7.0 Cg_exo -70.65 170.7 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.981 3.121 . . . . 0.53000000000000003 113.404 -167.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.887 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 4.7 t -92.8 -36.07 7.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 115.155 -0.929 . . . . 0.44 110.058 177.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -144.84 144.21 31.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.153 -0.619 . . . . 0.27000000000000002 111.962 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.767 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 150.8 23.1 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.813 -1.085 . . . . 0.23999999999999999 112.093 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.966 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -167.82 152.57 6.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.403 -0.962 . . . . 0.34000000000000002 108.403 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.805 ' HB2' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -122.03 142.72 50.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.985 0.421 . . . . 1.1100000000000001 111.091 -176.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.697 ' HD2' HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -130.0 109.97 11.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 0.80000000000000004 108.671 172.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -100.09 133.89 43.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.381 0.511 . . . . 2.5299999999999998 112.381 -170.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.36 151.4 44.42 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.146 -0.934 . . . . 0.59999999999999998 109.625 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -113.27 -64.29 1.33 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.516 0.932 . . . . 2.3799999999999999 113.516 -173.039 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.596 ' HA ' HG21 ' A' ' 177' ' ' VAL . 12.8 t90 178.45 74.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.017 -0.364 . . . . 3.96 110.017 -176.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.935 ' H ' ' HG2' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -72.48 -62.21 1.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.795 0.294 . . . . 1.53 111.795 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.563 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 32.0 t70 177.18 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.095 -0.502 . . . . 1.26 110.915 -173.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.485 ' CE2' HG22 ' A' ' 44' ' ' THR . 11.2 m-30 -78.79 1.58 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.384 -0.371 . . . . 2.2200000000000002 111.667 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.77 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 72.7 t -67.57 -54.21 19.11 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.5 110.204 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.77 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 74.4 Cg_exo -51.4 -35.25 53.92 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.331 2.021 . . . . 0.57999999999999996 112.35 170.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.693 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 26.3 mmmt -72.79 -24.75 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.848 0.314 . . . . 2.1400000000000001 111.848 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 55.2 tp -70.49 -46.29 64.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.033 -0.729 . . . . 0.66000000000000003 109.033 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.32 -37.98 79.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.559 -0.746 . . . . 1.8899999999999999 109.331 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.693 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.0 mm-40 -56.18 -55.57 31.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.808 -1.087 . . . . 1.53 110.687 170.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -63.73 -33.35 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 1.49 112.333 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 180' ' ' LEU . 76.4 mt -63.76 -1.14 1.23 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.4 0.519 . . . . 0.76000000000000001 112.4 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.482 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 15.8 m -78.13 -2.81 39.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.444 0.64 . . . . 1.05 109.534 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 141' ' ' ARG . . . 77.51 44.13 13.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.197 -0.911 . . . . 1.1699999999999999 111.206 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.482 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 27.3 mmmt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.341 -0.837 . . . . 2.0 110.597 -174.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.531 ' SD ' ' HD2' ' A' ' 2' ' ' PRO . 39.2 tpp . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.989 -0.375 . . . . 5.04 109.989 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.531 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 55.3 Cg_exo -54.52 113.68 1.48 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.353 2.702 . . . . 2.1299999999999999 112.757 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.694 HG12 ' HB2' ' A' ' 24' ' ' PRO . 3.5 t 67.29 113.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.101 -0.954 . . . . 1.47 111.725 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.5 ' HA ' ' HG3' ' A' ' 24' ' ' PRO . 27.9 t70 -152.84 157.7 41.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.57 -0.9 . . . . 1.8100000000000001 108.57 176.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.497 HD22 ' HG3' ' A' ' 24' ' ' PRO . 2.8 mm? -79.18 28.85 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.667 0.27 . . . . 0.69999999999999996 110.804 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 4' ' ' ASP . 7.9 m -62.96 -29.12 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 1.96 111.18 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.486 ' HB2' HD12 ' A' ' 12' ' ' LEU . 90.5 mttt -124.51 50.84 1.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.158 -0.474 . . . . 2.6600000000000001 110.231 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.624 ' HD1' ' HG3' ' A' ' 15' ' ' GLN . 4.8 p90 -71.61 -38.65 70.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 3.98 111.453 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.714 ' HB3' ' HB2' ' A' ' 15' ' ' GLN . 73.9 p -142.9 24.14 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.63 111.451 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.516 ' HA3' ' HD2' ' A' ' 11' ' ' PRO . . . -81.25 -125.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.15 -0.78 . . . . 0.47999999999999998 111.15 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' HA3' ' A' ' 10' ' ' GLY . 11.7 Cg_endo -51.11 -40.62 59.62 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 123.326 2.684 . . . . 0.53000000000000003 110.049 168.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.731 HD11 ' HA3' ' A' ' 38' ' ' GLY . 36.4 mt -88.71 78.25 7.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.688 -1.142 . . . . 1.1699999999999999 109.319 169.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 1.2 m -73.72 64.1 0.91 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.547 0.689 . . . . 0.70999999999999996 109.907 176.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.648 ' HB3' HG21 ' A' ' 121' ' ' VAL . 12.0 mt -79.73 -30.18 40.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.551 -0.749 . . . . 0.45000000000000001 110.39 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 9' ' ' SER . 74.7 mm-40 -73.74 16.13 0.23 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.915 0.709 . . . . 2.1200000000000001 112.915 -175.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 13' ' ' SER . 23.7 mt-10 -82.63 -13.53 56.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.851 -0.796 . . . . 1.9299999999999999 108.851 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.934 HG12 HG21 ' A' ' 151' ' ' VAL . 49.0 t -85.36 -74.92 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 114.878 -1.055 . . . . 0.63 111.525 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -122.09 -157.91 0.75 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.178 -0.465 . . . . 2.9900000000000002 111.14 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -87.15 151.26 23.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 1.6000000000000001 110.445 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 40.7 mt-30 -67.12 126.15 92.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.934 -0.395 . . . . 3.5499999999999998 109.934 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.694 ' HB3' ' HB2' ' A' ' 163' ' ' PRO . 3.5 Cg_exo -73.23 159.41 47.21 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.214 1.943 . . . . 0.57999999999999996 111.824 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.867 ' HG2' ' HA ' ' A' ' 164' ' ' VAL . 21.0 pt20 -74.62 -13.45 60.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.74 -0.664 . . . . 1.3899999999999999 111.491 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.795 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 3.1 m80 -160.93 164.57 18.8 Favored Pre-proline 0 CA--C 1.519 -0.249 0 CA-C-O 121.016 0.436 . . . . 1.45 110.83 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.694 ' HB2' HG12 ' A' ' 3' ' ' VAL . 3.6 Cg_endo -85.82 131.14 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.487 2.792 . . . . 0.40000000000000002 111.438 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.864 HD23 ' HB3' ' A' ' 122' ' ' TRP . 25.6 tp -80.52 143.58 33.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.691 0.282 . . . . 0.28999999999999998 111.457 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.494 ' H ' HD12 ' A' ' 25' ' ' LEU . 63.2 m-70 -110.07 123.98 50.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.753 -0.462 . . . . 1.24 109.753 172.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.005 HG13 HG22 ' A' ' 53' ' ' ILE . 14.8 t -130.37 134.93 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.072 -0.714 . . . . 0.46999999999999997 109.072 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -127.37 140.64 52.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.093 0.473 . . . . 0.31 110.435 -177.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -103.12 172.67 6.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.541 -0.54 . . . . 0.67000000000000004 109.541 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.8 67.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.492 0.663 . . . . 0.55000000000000004 110.678 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.43 4.33 33.02 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.316 -0.856 . . . . 0.81000000000000005 112.753 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.44 -168.54 3.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.46999999999999997 110.472 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -162.36 149.95 14.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.977 -0.556 . . . . 0.33000000000000002 109.905 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.757 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 85.9 t -105.29 60.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.167 -1.42 . . . . 0.39000000000000001 107.167 166.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.27 25.63 5.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.0 0.905 . . . . 0.98999999999999999 109.921 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 16.9 tt0 -148.31 128.0 13.34 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.833 -1.076 . . . . 2.5600000000000001 108.582 167.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 167' ' ' THR . 0.9 OUTLIER -69.62 111.41 5.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 0.40999999999999998 109.546 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.731 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 87.88 16.47 59.63 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.83 -0.623 . . . . 0.58999999999999997 113.029 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.91 149.28 41.55 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.507 -0.553 . . . . 0.34000000000000002 109.507 174.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' HG2' ' A' ' 170' ' ' GLN . 14.4 p -75.54 132.77 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.55000000000000004 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 6.9 tp -131.92 170.59 14.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.93 -0.767 . . . . 0.45000000000000001 108.93 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.94 152.18 62.42 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.209 0.448 . . . . 0.56000000000000005 112.209 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 109' ' ' SER . 87.8 Cg_exo -50.93 -46.47 30.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.319 2.679 . . . . 0.68000000000000005 113.981 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.49 -31.65 64.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.046 0.45 . . . . 0.76000000000000001 111.75 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -83.71 -10.73 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.815 -0.629 . . . . 1.5900000000000001 112.113 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 41' ' ' LEU . 30.4 m -131.72 30.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.547 0.689 . . . . 0.66000000000000003 111.007 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.73 -29.21 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.79000000000000004 110.854 -174.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -114.83 -173.21 2.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 1.9099999999999999 110.225 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.16 155.41 87.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 110.15 -0.315 . . . . 1.4299999999999999 110.15 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.44 155.66 28.43 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.799 1.666 . . . . 0.37 110.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -78.47 -23.31 46.54 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.238 -0.282 . . . . 0.44 110.238 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.438 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 72.1 m -159.79 147.23 16.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.38 112.083 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.005 HG22 HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.57 170.21 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.283 -0.871 . . . . 0.29999999999999999 108.973 172.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.008 ' HA ' HD13 ' A' ' 58' ' ' LEU . 29.2 t 179.52 116.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.406 0.622 . . . . 0.34999999999999998 109.631 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.549 ' CG ' HG21 ' A' ' 124' ' ' VAL . 1.2 p90 -100.85 -171.2 1.96 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.226 -0.897 . . . . 2.7200000000000002 110.116 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' HG12 ' A' ' 164' ' ' VAL . 22.1 t0 -69.61 119.58 14.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.005 0.431 . . . . 1.51 111.004 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.24 34.48 54.87 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.742 -0.742 . . . . 0.80000000000000004 112.656 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.008 HD13 ' HA ' ' A' ' 54' ' ' SER . 4.3 tt -67.53 125.41 26.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.919 -0.771 . . . . 0.57999999999999996 108.919 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.673 ' CB ' ' HG3' ' A' ' 62' ' ' LYS . 23.9 t70 -89.85 -12.79 38.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.73999999999999999 110.884 -173.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.683 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 54.3 m 62.13 20.81 11.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.948 -1.024 . . . . 1.03 109.558 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.571 ' O ' ' HG3' ' A' ' 93' ' ' LYS . . . -153.86 -24.4 0.04 OUTLIER Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.866 -0.683 . . . . 0.83999999999999997 113.852 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.673 ' HG3' ' CB ' ' A' ' 59' ' ' ASP . 45.4 mtpt -77.0 156.82 31.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.661 0.731 . . . . 1.6699999999999999 109.904 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.706 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 37.2 mt -94.0 125.17 38.47 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.947 -0.76 . . . . 0.57999999999999996 108.947 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 1.9 m-85 -125.03 156.94 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.745 -0.382 . . . . 0.80000000000000004 110.002 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.633 HG23 HG12 ' A' ' 90' ' ' VAL . 46.7 m -98.07 110.98 23.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.547 . . . . 0.35999999999999999 109.522 175.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.543 HD13 ' CZ3' ' A' ' 55' ' ' TRP . 21.0 tp -107.48 109.75 21.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.177 -0.465 . . . . 0.58999999999999997 109.753 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 88' ' ' LEU . 21.3 t -117.93 120.81 65.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.39000000000000001 111.112 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.875 ' HB3' ' HB3' ' A' ' 86' ' ' HIS . 5.5 mt -83.22 145.96 28.85 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.947 -0.76 . . . . 0.59999999999999998 108.947 168.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.752 HG21 HG11 ' A' ' 17' ' ' VAL . 10.5 t -146.46 145.69 30.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.683 0.278 . . . . 0.35999999999999999 110.936 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HA ' ' HD2' ' A' ' 71' ' ' PRO . 28.2 t70 -125.59 98.37 34.68 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 1.9199999999999999 109.421 174.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 9.4 Cg_endo -50.32 -38.04 51.48 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 124.135 3.224 . . . . 1.25 114.216 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 71.3 m-20 -103.59 54.18 0.75 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.293 0.568 . . . . 1.29 111.928 -165.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . . . -104.64 137.12 19.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.5 109.864 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 63.6 Cg_endo -74.44 -30.27 6.08 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.682 -1.383 . . . . 0.62 113.268 1.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.619 ' HB3' HG22 ' A' ' 115' ' ' THR . 33.6 p -137.88 165.95 25.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.589 -0.278 . . . . 0.75 110.877 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.589 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 29.2 mtp180 -68.04 -36.61 80.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 2.8799999999999999 110.851 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.761 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -76.13 -12.68 60.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.035 -0.53 . . . . 1.3799999999999999 111.711 -176.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.537 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 8.3 t70 -154.93 77.56 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 1.3700000000000001 110.258 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.92 97.54 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.608 2.205 . . . . 0.80000000000000004 112.885 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.577 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 26.4 mttm -85.52 -48.41 8.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.848 -1.069 . . . . 1.02 110.197 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HA ' ' HG3' ' A' ' 148' ' ' LYS . 87.4 m-85 -79.99 14.16 1.94 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.145 -0.934 . . . . 1.1699999999999999 111.55 -171.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 30.0 ttt85 -66.83 125.14 24.95 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.991 0.367 . . . . 2.9300000000000002 111.991 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.839 ' HG2' HG13 ' A' ' 17' ' ' VAL . 6.2 mp0 -95.45 140.15 30.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.671 0.388 . . . . 2.23 110.154 -5.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 146' ' ' ARG . 14.4 t90 -86.4 91.15 8.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.529 . . . . 1.4299999999999999 110.106 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.7 p80 -63.16 130.43 44.56 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.419 -0.586 . . . . 1.26 109.419 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 68' ' ' LEU . 13.9 t60 -79.22 -31.88 43.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.898 -0.592 . . . . 2.1400000000000001 110.958 -173.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.626 ' HE2' ' HB ' ' A' ' 89' ' ' VAL . 28.7 p90 -168.42 178.56 4.79 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.198 -0.668 . . . . 1.51 109.198 177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.47 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.1 tp -140.39 113.56 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.388 . . . . 0.33000000000000002 110.064 175.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.742 HG11 ' HE3' ' A' ' 92' ' ' MET . 1.7 t -122.77 130.32 74.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.592 -0.731 . . . . 0.31 110.707 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.633 HG12 HG23 ' A' ' 65' ' ' THR . 13.4 m -133.62 165.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.986 -1.006 . . . . 0.27000000000000002 108.496 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.706 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 3.2 t30 63.54 13.37 7.17 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.024 -0.361 . . . . 1.76 110.024 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.742 ' HE3' HG11 ' A' ' 89' ' ' VAL . 7.9 ttm -67.67 101.98 1.12 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.603 -0.888 . . . . 0.31 108.603 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 61' ' ' GLY . 18.8 ttmm -80.74 92.87 6.1 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.096 -1.411 . . . . 1.21 110.982 -170.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 78.13 -130.38 10.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.913 -1.039 . . . . 0.29999999999999999 112.668 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.548 ' HA ' HD11 ' A' ' 53' ' ' ILE . 25.8 p-10 -109.92 24.43 13.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.21 0.528 . . . . 1.04 110.735 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.98 107.11 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.835 -0.621 . . . . 0.77000000000000002 109.951 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 97' ' ' ILE . 4.5 mm -56.37 -32.71 36.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.573 -1.194 . . . . 0.40999999999999998 110.856 -177.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.3 m -73.01 -26.41 61.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.748 -0.66 . . . . 0.68000000000000005 112.002 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.7 m -78.44 -6.56 55.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 1.26 111.42 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.42 102.42 1.61 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.645 -0.788 . . . . 0.34999999999999998 112.11 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.1 m -68.46 107.99 3.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.464 0.65 . . . . 0.45000000000000001 109.655 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 105' ' ' ASP . 3.3 p -79.57 119.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.892 -1.049 . . . . 0.56999999999999995 112.102 -175.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.435 HD12 ' HG ' ' A' ' 88' ' ' LEU . 61.9 mt -95.14 -39.12 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.03 0.919 . . . . 0.45000000000000001 109.159 171.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.7 t -128.08 114.79 17.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.257 -1.386 . . . . 0.37 107.257 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.468 ' HA ' HG21 ' A' ' 102' ' ' VAL . 6.9 t0 -63.01 161.72 12.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.569 0.699 . . . . 1.1499999999999999 112.784 -168.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -91.09 93.91 9.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.984 -1.007 . . . . 4.6900000000000004 109.318 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.849 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 54.5 t -71.02 -46.18 68.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.167 0.508 . . . . 0.85999999999999999 111.89 -176.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.429 ' HA3' ' NZ ' ' A' ' 47' ' ' LYS . . . 115.86 -177.94 17.31 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.358 -0.925 . . . . 0.67000000000000004 112.294 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB3' ' HA ' ' A' ' 43' ' ' PRO . 30.8 t -64.13 122.37 16.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.551 0.176 . . . . 0.51000000000000001 111.336 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -142.72 63.87 0.5 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.051 -0.595 . . . . 0.81999999999999995 111.908 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.642 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . 43.9 Cg_endo -97.7 121.9 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.504 2.803 . . . . 0.84999999999999998 112.673 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.491 ' HB2' ' CG2' ' A' ' 115' ' ' THR . 50.7 Cg_exo -54.5 154.37 20.02 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.63 2.22 . . . . 0.87 111.736 173.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -72.02 131.04 42.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.433 . . . . 1.8500000000000001 111.146 -175.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.03 14.88 73.88 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.772 -0.649 . . . . 1.1799999999999999 113.163 175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 75' ' ' SER . 35.5 p -77.73 -15.37 59.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.672 0.619 . . . . 0.96999999999999997 112.672 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' LEU . . . 103.92 13.02 28.46 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.141 -1.028 . . . . 1.97 112.823 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . 4.0 mm? 76.94 105.08 0.07 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 124.604 0.826 . . . . 0.93999999999999995 111.142 177.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.65 ' O ' ' HA ' ' A' ' 170' ' ' GLN . 5.0 m170 -66.66 121.23 14.93 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.383 -0.826 . . . . 2.23 110.044 175.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.663 ' HB3' ' HB3' ' A' ' 170' ' ' GLN . 13.1 ptp180 -116.3 80.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.832 0.825 . . . . 2.3100000000000001 110.364 -175.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 7.3 m-85 -63.69 120.26 11.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.289 -1.323 . . . . 0.78000000000000003 109.688 -177.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.699 HG22 ' HB3' ' A' ' 168' ' ' CYS . 24.6 t -97.94 131.68 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.107 -0.497 . . . . 0.27000000000000002 110.511 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.864 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.51 119.68 30.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.586 -0.733 . . . . 1.99 110.057 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -116.77 123.77 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.481 -0.192 . . . . 0.38 110.481 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.549 HG21 ' CG ' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -122.47 137.64 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.577 0.227 . . . . 0.31 111.098 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.999 ' HD2' ' HG ' ' A' ' 160' ' ' LEU . 17.7 t80 -136.66 140.65 42.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.085 -0.339 . . . . 5.1200000000000001 110.085 171.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.568 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 7.3 pt-20 -89.06 112.32 23.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.197 0.522 . . . . 2.4100000000000001 109.75 171.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -73.16 172.39 11.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.3100000000000001 110.013 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.98 -18.43 53.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.218 -0.901 . . . . 2.3999999999999999 109.408 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 11.4 ptt-85 -158.28 162.22 27.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.9 -1.046 . . . . 3.5099999999999998 111.67 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.557 ' HG3' HD12 ' A' ' 63' ' ' LEU . 26.0 Cg_exo -57.74 140.83 94.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.274 2.649 . . . . 1.21 111.575 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.626 ' HG ' HG11 ' A' ' 90' ' ' VAL . 3.2 mm? -64.57 143.72 57.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.156 0.503 . . . . 0.90000000000000002 111.817 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -129.32 61.46 1.54 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.232 -1.025 . . . . 2.8999999999999999 108.232 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.983 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . 86.2 m -77.22 -55.42 5.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.253 -1.34 . . . . 1.8999999999999999 111.52 -172.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 60.85 35.02 19.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.292 0.568 . . . . 2.96 110.195 -172.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.983 ' HG2' ' HB3' ' A' ' 133' ' ' CYS . 59.0 mm-40 -77.62 137.23 63.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 108.616 -0.883 . . . . 1.3899999999999999 108.616 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.78 106.95 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.273 2.649 . . . . 1.27 112.728 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.1 mm -61.94 115.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.85999999999999999 110.546 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -104.43 149.28 25.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.267 0.556 . . . . 1.6100000000000001 110.352 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 162.39 13.53 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.416 -0.957 . . . . 1.8799999999999999 108.416 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.849 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.2 p-10 -77.49 16.84 0.58 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.98 0.419 . . . . 0.75 111.45 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.696 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 54.0 mtt180 -104.8 136.75 43.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.663 -0.495 . . . . 3.3599999999999999 109.663 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.615 ' H ' ' HA ' ' A' ' 184' ' ' LEU . 49.3 m 77.27 117.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.18 0.992 . . . . 0.94999999999999996 111.232 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -106.29 41.56 2.14 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.301 -0.863 . . . . 1.1200000000000001 112.794 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.25 -47.82 47.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 2.6600000000000001 109.78 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -97.63 54.35 1.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.633 -1.167 . . . . 1.8700000000000001 110.672 -173.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 84' ' ' TRP . 76.9 mtt180 -69.71 -77.29 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 4.7300000000000004 111.017 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 84' ' ' TRP . . . -120.74 -143.05 6.66 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.792 -0.718 . . . . 0.65000000000000002 112.478 -174.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' A' ' 81' ' ' TYR . 89.8 mttt 67.36 18.51 10.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.963 0.887 . . . . 1.0800000000000001 109.769 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.18 105.58 13.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.397 -1.274 . . . . 1.8899999999999999 108.223 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -59.99 129.88 43.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.189 -0.459 . . . . 1.29 111.81 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.934 HG21 HG12 ' A' ' 17' ' ' VAL . 17.1 m -64.39 -24.92 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.78000000000000003 110.306 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.526 ' HB1' ' HE2' ' A' ' 156' ' ' LYS . . . -64.7 -44.41 90.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.431 -0.804 . . . . 0.67000000000000004 109.599 172.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -61.39 -40.53 94.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.77000000000000002 111.033 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HD2' ' HA ' ' A' ' 151' ' ' VAL . 37.2 m-85 -58.3 -53.94 52.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.435 . . . . 0.92000000000000004 111.396 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -70.76 -45.42 64.79 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.98 -0.288 . . . . 2.8900000000000001 111.217 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.526 ' HE2' ' HB1' ' A' ' 152' ' ' ALA . 58.8 mtmt -62.17 -25.95 68.06 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.724 0.297 . . . . 0.96999999999999997 111.356 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.48 -52.76 58.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 1.5800000000000001 111.053 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 129' ' ' ARG . 12.4 t80 -102.14 18.64 20.31 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.88 -0.728 . . . . 5.4500000000000002 110.541 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.66 38.38 5.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.354 -0.839 . . . . 2.4199999999999999 111.948 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.999 ' HG ' ' HD2' ' A' ' 125' ' ' TYR . 9.0 mp -88.76 148.78 23.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.875 -0.602 . . . . 1.27 109.703 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.503 ' HG3' ' H ' ' A' ' 162' ' ' ALA . 13.2 tpt180 -117.91 -152.15 0.5 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.468 -0.333 . . . . 3.5899999999999999 110.126 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.503 ' H ' ' HG3' ' A' ' 161' ' ' ARG . . . -56.0 143.97 60.27 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-O 120.989 0.424 . . . . 0.76000000000000001 111.278 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.694 ' HB2' ' HB3' ' A' ' 21' ' ' PRO . 4.8 Cg_exo -73.2 159.88 46.4 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.876 3.05 . . . . 0.53000000000000003 113.723 -170.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.867 ' HA ' ' HG2' ' A' ' 22' ' ' GLN . 11.8 t -81.34 -31.02 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.086 -0.961 . . . . 0.44 109.751 173.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.795 ' HA ' ' O ' ' A' ' 23' ' ' HIS . . . -156.95 148.76 22.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.053 -0.659 . . . . 0.27000000000000002 111.855 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.69 ' HA2' ' O ' ' A' ' 122' ' ' TRP . . . -146.63 147.04 17.64 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.23999999999999999 111.349 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.638 ' HA ' ' HG ' ' A' ' 37' ' ' LEU . 6.0 t -160.58 149.6 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.969 -0.752 . . . . 0.34000000000000002 108.969 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.699 ' HB3' HG22 ' A' ' 121' ' ' VAL . 15.4 p -126.9 149.02 49.99 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.894 -0.722 . . . . 1.1100000000000001 111.589 -175.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 120' ' ' TYR . 46.2 p90 -129.08 127.61 41.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.887 -1.153 . . . . 0.80000000000000004 107.887 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -104.65 133.01 50.21 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.045 -0.662 . . . . 2.5299999999999998 110.07 178.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 41' ' ' LEU . . . -120.82 141.75 50.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.59999999999999998 112.199 -170.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.641 ' HG2' HD11 ' A' ' 117' ' ' LEU . 46.2 mt-10 -89.21 -173.1 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.809 -1.087 . . . . 2.3799999999999999 111.617 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.537 ' HA ' HG21 ' A' ' 177' ' ' VAL . 55.7 t90 -98.3 75.65 2.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.361 -0.977 . . . . 3.96 108.361 175.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -73.13 -57.19 4.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.386 -0.37 . . . . 1.53 111.906 -172.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.524 ' O ' ' HD2' ' A' ' 178' ' ' PRO . 20.8 t70 179.44 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.118 0.567 . . . . 1.26 110.335 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -81.34 0.78 35.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 2.2200000000000002 112.113 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.825 ' HB ' ' HD3' ' A' ' 178' ' ' PRO . 93.2 t -67.88 -54.66 15.93 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.342 -0.244 . . . . 0.5 110.342 174.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 177' ' ' VAL . 52.3 Cg_exo -53.83 -43.06 61.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.504 2.136 . . . . 0.57999999999999996 111.949 171.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 182' ' ' GLU . 12.3 mmmm -70.83 -24.3 62.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 2.1400000000000001 111.561 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.641 HD11 HG12 ' A' ' 107' ' ' VAL . 61.9 tp -66.99 -47.85 70.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.529 -0.545 . . . . 0.66000000000000003 109.529 172.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.61 -37.76 87.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.66 -0.7 . . . . 1.8899999999999999 109.445 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.729 ' HB2' ' HA ' ' A' ' 179' ' ' LYS . 13.3 mm-40 -56.56 -44.87 81.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.932 -1.031 . . . . 1.53 110.842 172.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.96 -29.85 65.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.745 . . . . 1.49 111.497 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.615 ' HA ' ' H ' ' A' ' 142' ' ' SER . 68.2 mt -64.85 -8.66 16.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.934 0.346 . . . . 0.76000000000000001 111.934 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.513 ' HB2' ' HD3' ' A' ' 187' ' ' LYS . 66.6 m -73.91 -3.11 26.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 1.05 110.364 172.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.696 ' HA2' ' HD3' ' A' ' 141' ' ' ARG . . . 70.54 58.04 6.2 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.826 -0.91 . . . . 1.1699999999999999 110.826 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 29.9 mmmt . . . . . 0 C--O 1.241 0.654 0 CA-C-O 118.651 -0.69 . . . . 2.0 111.304 -172.455 . . . . . . . . 1 1 . 1 stop_ save_